ID	Gene Name	Species	BBID	BIOCARTA	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KW_BIOLOGICAL_PROCESS	UP_KW_CELLULAR_COMPONENT	UP_KW_DEVELOPMENTAL_STAGE	UP_KW_DISEASE	UP_KW_DOMAIN	UP_KW_LIGAND	UP_KW_MOLECULAR_FUNCTION	UP_KW_PTM	UP_SEQ_FEATURE
P15428	15-hydroxyprostaglandin dehydrogenase(HPGD)	Homo sapiens			GO:0001822~kidney development,GO:0006693~prostaglandin metabolic process,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007565~female pregnancy,GO:0007567~parturition,GO:0019372~lipoxygenase pathway,GO:0030728~ovulation,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0043065~positive regulation of apoptotic process,GO:0045471~response to ethanol,GO:0045786~negative regulation of cell cycle,GO:0070493~thrombin-activated receptor signaling pathway,GO:0097070~ductus arteriosus closure,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:1905828~regulation of prostaglandin catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016323~basolateral plasma membrane,GO:0070062~extracellular exosome,	GO:0004957~prostaglandin E receptor activity,GO:0016404~15-hydroxyprostaglandin dehydrogenase (NAD+) activity,GO:0016491~oxidoreductase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0042802~identical protein binding,GO:0051287~NAD binding,GO:0070403~NAD+ binding,	IPR002347:SDR_fam,IPR020904:Sc_DH/Rdtase_CS,IPR036291:NAD(P)-bd_dom_sf,	hsa00590:Arachidonic acid metabolism,hsa05202:Transcriptional misregulation in cancer,	119900~Digital clubbing, isolated congenital,259100~Cranioosteoarthropathy,259100~Hypertrophic osteoarthropathy, primary, autosomal recessive 1,			KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0644~Prostaglandin metabolism,	KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,KW-0225~Disease variant,		KW-0520~NAD,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,MUTAGEN:K->Q: Loss 15-hydroxyprostaglandin dehydrogenase activity.,MUTAGEN:Q->A: Loss of activity.,MUTAGEN:Q->E,H,N: Reduced affinity for NAD and prostaglandin E2.,MUTAGEN:Y->A: Loss of activity.,MUTAGEN:Y->F: Loss 15-hydroxyprostaglandin dehydrogenase activity.,
P06623	2',3'-cyclic nucleotide 3' phosphodiesterase(CNP)	Bos taurus			GO:0009214~cyclic nucleotide catabolic process,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0042470~melanosome,	GO:0003723~RNA binding,GO:0004113~2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,	IPR008431:CNPase,IPR009097:Cyclic_Pdiesterase,IPR027417:P-loop_NTPase,IPR047325:CNPase_cat,			PIRSF000970:CNPase,			KW-0472~Membrane,					KW-0378~Hydrolase,KW-0694~RNA-binding,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,	ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,LIPID:S-farnesyl cysteine,PROPEP:Removed in mature form,
Q6NV34	2,4-dienoyl CoA reductase 2, peroxisomal(decr2)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0009062~fatty acid catabolic process,	GO:0005777~peroxisome,	GO:0008670~2,4-dienoyl-CoA reductase (NADPH) activity,GO:0016491~oxidoreductase activity,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,IPR045017:DECR2-like,	dre04146:Peroxisome,				KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0576~Peroxisome,				KW-0521~NADP,	KW-0560~Oxidoreductase,		MOTIF:Microbody targeting signal,
Q96SZ5	2-aminoethanethiol dioxygenase(ADO)	Homo sapiens			GO:0071456~cellular response to hypoxia,	GO:0005829~cytosol,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0046872~metal ion binding,GO:0047800~cysteamine dioxygenase activity,	IPR011051:RmlC_Cupin_sf,IPR012864:PCO/ADO,IPR014710:RmlC-like_jellyroll,	hsa00430:Taurine and hypotaurine metabolism,hsa01100:Metabolic pathways,									KW-0408~Iron,KW-0479~Metal-binding,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0883~Thioether bond,	CROSSLNK:3'-(S-cysteinyl)-tyrosine (Cys-Tyr),MUTAGEN:Y->A,F: Significant reduction in enzyme activity.,MUTAGEN:Y->A: Moderate reduction in enzyme activity.,MUTAGEN:Y->A: No significant reduction in enzyme activity.,REGION:Disordered,
A3KGZ2	2-oxoglutarate and iron-dependent oxygenase domain containing 2(ogfod2)	Danio rerio					GO:0005506~iron ion binding,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0031418~L-ascorbic acid binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR005123:Oxoglu/Fe-dep_dioxygenase,IPR006620:Pro_4_hyd_alph,				SM00702:P4Hc,						KW-0408~Iron,KW-0479~Metal-binding,KW-0847~Vitamin C,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,		DOMAIN:Fe2OG dioxygenase,
Q15392	24-dehydrocholesterol reductase(DHCR24)	Homo sapiens			GO:0006695~cholesterol biosynthetic process,GO:0007265~Ras protein signal transduction,GO:0008104~protein localization,GO:0008202~steroid metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0009725~response to hormone,GO:0009888~tissue development,GO:0030539~male genitalia development,GO:0031639~plasminogen activation,GO:0033489~cholesterol biosynthetic process via desmosterol,GO:0033490~cholesterol biosynthetic process via lathosterol,GO:0042987~amyloid precursor protein catabolic process,GO:0043588~skin development,GO:0061024~membrane organization,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0000246~delta24(24-1) sterol reductase activity,GO:0005515~protein binding,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0019899~enzyme binding,GO:0042605~peptide antigen binding,GO:0050614~delta24-sterol reductase activity,GO:0071949~FAD binding,	IPR006094:Oxid_FAD_bind_N,IPR016166:FAD-bd_PCMH,IPR016169:FAD-bd_PCMH_sub2,IPR036318:FAD-bd_PCMH-like_sf,IPR040165:Diminuto-like,	hsa00100:Steroid biosynthesis,hsa01100:Metabolic pathways,	602398~Desmosterolosis,			KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,		KW-0225~Disease variant,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0274~FAD,KW-0285~Flavoprotein,KW-0521~NADP,	KW-0560~Oxidoreductase,		DOMAIN:FAD-binding PCMH-type,SITE:Cleavage; by caspase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
P00347	3-hydroxy-3-methylglutaryl-CoA reductase(Hmgcr)	Cricetulus griseus			GO:0006695~cholesterol biosynthetic process,GO:0008299~isoprenoid biosynthetic process,GO:0008542~visual learning,GO:0015936~coenzyme A metabolic process,GO:0016126~sterol biosynthetic process,GO:0042177~negative regulation of protein catabolic process,GO:0050709~negative regulation of protein secretion,GO:0060291~long-term synaptic potentiation,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:1900222~negative regulation of beta-amyloid clearance,	GO:0005778~peroxisomal membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0004420~hydroxymethylglutaryl-CoA reductase (NADPH) activity,GO:0005515~protein binding,GO:0030695~GTPase regulator activity,GO:0050661~NADP binding,GO:0070402~NADPH binding,	IPR000731:SSD,IPR002202:HMG_CoA_Rdtase,IPR004554:HMG_CoA_Rdtase_eu_arc,IPR004816:HMG_CoA_Rdtase_metazoan,IPR009023:HMG_CoA_Rdtase_NAD(P)-bd_sf,IPR009029:HMG_CoA_Rdtase_sub-bd_dom_sf,IPR023074:HMG_CoA_Rdtase_cat_sf,IPR023076:HMG_CoA_Rdtase_CS,IPR023282:HMG_CoA_Rdtase_N,	cge00900:Terpenoid backbone biosynthesis,cge01100:Metabolic pathways,cge04152:AMPK signaling pathway,cge04976:Bile secretion,				KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0576~Peroxisome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Charge relay system,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:SSD,MOTIF:INSIG-binding motif,MUTAGEN:A->P: Abolishes sterol-mediated interaction with INSIG1, and no ubiquitination nor degradation.,MUTAGEN:F->A: Very little effect on the sterol-mediated ubiquitination and degradation of HMGCR. Completely abolishes the sterol effect on ubiquitination and degradation of HMGCR; when associated with A-75; A-76 and A-77.,MUTAGEN:G->R: Abolishes sterol-mediated interaction with INSIG1, and no ubiquitination nor degradation.,MUTAGEN:I->A: Greatly reduced sterol-mediated ubiquitination and degradation of HMGCR. Completely abolishes the sterol effect on ubiquitination and degradation of HMGCR; when associated with A-75; A-77 and A-78.,MUTAGEN:K->R: Little effect on sterol plus mevalonate-stimulated ubiquitination and degradation of HMGCR in the presence of INSIG1. No sterol plus mevalonate-stimulated ubiquitination and degradation of HMGCR in the presence of INSIG1; when associated with R-248.,MUTAGEN:K->R: Some reduction in sterol plus mevalonate-stimulated ubiquitination and degradation of HMGCR in the presence of INSIG1. No sterol plus mevalonate-stimulated ubiquitination and degradation of HMGCR in the presence of INSIG1; when associated with R-89.,MUTAGEN:S->A: Abolishes phosphorylation by AMPK. Blocks inhibition of sterol synthesis induced by ATP depletion.,MUTAGEN:S->N: Abolishes sterol-mediated interaction with INSIG1, and no ubiquitination nor degradation.,MUTAGEN:Y->A: Greatly reduced sterol-mediated ubiquitination and degradation of HMGCR. Marked reduction in the sterol-mediated ubiquitination and degradation of HMGCR; when associated with A-75. Completely abolishes the sterol effect on ubiquitination and degradation of HMGCR; when associated with A-75; A-76 and A-78.,MUTAGEN:Y->A: Very little effect on the sterol-mediated ubiquitination and degradation of HMGCR. Marked reduction in the sterol-mediated ubiquitination and degradation of HMGCR; when associated with A-77. Completely abolishes the sterol effect on ubiquitination and degradation of HMGCR; when associated with A-76; A-77 and A-78.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
P23228	3-hydroxy-3-methylglutaryl-CoA synthase 1(HMGCS1)	Gallus gallus			GO:0006084~acetyl-CoA metabolic process,GO:0006695~cholesterol biosynthetic process,GO:0010142~farnesyl diphosphate biosynthetic process, mevalonate pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004421~hydroxymethylglutaryl-CoA synthase activity,	IPR000590:HMG_CoA_synt_AS,IPR010122:HMG_CoA_synthase_euk,IPR013528:HMG_CoA_synth_N,IPR013746:HMG_CoA_synt_C_dom,IPR016039:Thiolase-like,	gga00280:Valine, leucine and isoleucine degradation,gga00650:Butanoate metabolism,gga00900:Terpenoid backbone biosynthesis,gga01100:Metabolic pathways,gga03320:PPAR signaling pathway,				KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0963~Cytoplasm,					KW-0808~Transferase,		ACT_SITE:Acyl-thioester intermediate,ACT_SITE:Proton donor/acceptor,DOMAIN:Hydroxymethylglutaryl-coenzyme A synthase C-terminal,DOMAIN:Hydroxymethylglutaryl-coenzyme A synthase N-terminal,MUTAGEN:C->A: Does not significantly affect biophysicochemical properties.,
Q9QY80	3-hydroxyacyl-CoA dehydratase 1(Hacd1)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0007275~multicellular organism development,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0010811~positive regulation of cell-substrate adhesion,GO:0014902~myotube differentiation,GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0042761~very long-chain fatty acid biosynthetic process,GO:0065003~macromolecular complex assembly,GO:0071529~cementum mineralization,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0016829~lyase activity,GO:0018812~3-hydroxyacyl-CoA dehydratase activity,GO:0019899~enzyme binding,GO:0046848~hydroxyapatite binding,	IPR007482:Tyr_Pase-like_PTPLA,	mmu00062:Fatty acid elongation,mmu01040:Biosynthesis of unsaturated fatty acids,mmu01100:Metabolic pathways,mmu01212:Fatty acid metabolism,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0456~Lyase,KW-9996~Developmental protein,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q6Y1H2	3-hydroxyacyl-CoA dehydratase 2(HACD2)	Homo sapiens			GO:0006633~fatty acid biosynthetic process,GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0018812~3-hydroxyacyl-CoA dehydratase activity,GO:0019899~enzyme binding,	IPR007482:Tyr_Pase-like_PTPLA,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0456~Lyase,	KW-0007~Acetylation,KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:P->R: Does not restore any protein tyrosine phosphatase activity.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q7SY06	3-hydroxyacyl-CoA dehydratase 3(hacd3)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0016829~lyase activity,GO:0018812~3-hydroxyacyl-CoA dehydratase activity,	IPR007052:CS_dom,IPR007482:Tyr_Pase-like_PTPLA,IPR008978:HSP20-like_chaperone,	dre00062:Fatty acid elongation,dre01040:Biosynthesis of unsaturated fatty acids,dre01100:Metabolic pathways,dre01212:Fatty acid metabolism,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0456~Lyase,		DOMAIN:CS,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
A2AKM2	3-hydroxyacyl-CoA dehydratase 4(Hacd4)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0016829~lyase activity,GO:0018812~3-hydroxyacyl-CoA dehydratase activity,GO:0019899~enzyme binding,	IPR007482:Tyr_Pase-like_PTPLA,	mmu00062:Fatty acid elongation,mmu01040:Biosynthesis of unsaturated fatty acids,mmu01100:Metabolic pathways,mmu01212:Fatty acid metabolism,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0456~Lyase,		TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q9X248	3-oxoacyl-[acyl-carrier-protein] reductase FabG(fabG)	Thermotoga maritima MSB8			GO:0030497~fatty acid elongation,		GO:0004316~3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,GO:0050661~NADP binding,GO:0051287~NAD binding,	IPR002347:SDR_fam,IPR011284:3oxo_ACP_reduc,IPR020904:Sc_DH/Rdtase_CS,IPR036291:NAD(P)-bd_dom_sf,				SM00822:PKS_KR,	KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,					KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,
Q91YE9	5'-nucleotidase, cytosolic IB(Nt5c1b)	Mus musculus			GO:0000255~allantoin metabolic process,GO:0006196~AMP catabolic process,GO:0009116~nucleoside metabolic process,GO:0009117~nucleotide metabolic process,GO:0043605~cellular amide catabolic process,GO:0046085~adenosine metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0008253~5'-nucleotidase activity,GO:0016787~hydrolase activity,	IPR010394:5-nucleotidase,	mmu00230:Purine metabolism,mmu00240:Pyrimidine metabolism,mmu00760:Nicotinate and nicotinamide metabolism,mmu01100:Metabolic pathways,mmu01232:Nucleotide metabolism,				KW-0546~Nucleotide metabolism,	KW-0963~Cytoplasm,				KW-0460~Magnesium,	KW-0378~Hydrolase,		ACT_SITE:Nucleophile,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q969T7	5'-nucleotidase, cytosolic IIIB(NT5C3B)	Homo sapiens			GO:0009117~nucleotide metabolic process,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0005515~protein binding,GO:0008253~5'-nucleotidase activity,	IPR006434:Pyrimidine_nucleotidase_eu,IPR023214:HAD_sf,IPR036412:HAD-like_sf,	hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,				KW-0546~Nucleotide metabolism,	KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,REGION:Disordered,
O14841	5-oxoprolinase, ATP-hydrolysing(OPLAH)	Homo sapiens			GO:0006749~glutathione metabolic process,	GO:0005829~cytosol,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0017168~5-oxoprolinase (ATP-hydrolyzing) activity,GO:0042802~identical protein binding,	IPR002821:Hydantoinase_A,IPR003692:Hydantoinase_B,IPR008040:Hydant_A_N,IPR029385:Speriolin_N,IPR045079:Oxoprolinase_fam,	hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,	260005~5-oxoprolinase deficiency,				KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,DOMAIN:Hydantoinase A/oxoprolinase,DOMAIN:Hydantoinase B/oxoprolinase,DOMAIN:Hydantoinase/oxoprolinase N-terminal,DOMAIN:Speriolin N-terminal,REGION:Disordered,
P61928	60S ribosomal protein L37-like(LOC120097744)	Rattus norvegicus			GO:0006412~translation,GO:1901798~positive regulation of signal transduction by p53 class mediator,	GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0045202~synapse,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019838~growth factor binding,GO:0019843~rRNA binding,GO:0046872~metal ion binding,GO:0097371~MDM2/MDM4 family protein binding,GO:1990948~ubiquitin ligase inhibitor activity,	IPR001569:Ribosomal_eL37,IPR011331:Ribosomal_eL37/eL43,IPR011332:Ribosomal_zn-bd,IPR018267:Ribosomal_eL37_CS,						KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0694~RNA-binding,KW-0699~rRNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Disordered,TRANSMEM:Helical,ZN_FING:C4-type,
Q9UKA4	A-kinase anchoring protein 11(AKAP11)	Homo sapiens			GO:0003091~renal water homeostasis,GO:0008104~protein localization,GO:0030866~cortical actin cytoskeleton organization,GO:0035556~intracellular signal transduction,GO:0036010~protein localization to endosome,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0008157~protein phosphatase 1 binding,GO:0034237~protein kinase A regulatory subunit binding,GO:0051018~protein kinase A binding,	IPR008382:SPHK1-interactor_AKAP_110,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,REGION:PKA-RII subunit binding domain,
Q7Z7G0	ABI family member 3 binding protein(ABI3BP)	Homo sapiens			GO:0008285~negative regulation of cell proliferation,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,GO:1904597~negative regulation of connective tissue replacement involved in inflammatory response wound healing,GO:1905209~positive regulation of cardiocyte differentiation,	GO:0005576~extracellular region,GO:0005614~interstitial matrix,GO:0005615~extracellular space,	GO:0005201~extracellular matrix structural constituent,GO:0005518~collagen binding,GO:0008201~heparin binding,	IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR049109:TARSH/FNDC1_C,				SM00060:FN3,		KW-0964~Secreted,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,REGION:Disordered,
O14672	ADAM metallopeptidase domain 10(ADAM10)	Homo sapiens		h_appPathway:Generation of amyloid b-peptide by PS1,	GO:0001701~in utero embryonic development,GO:0006468~protein phosphorylation,GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0007162~negative regulation of cell adhesion,GO:0007219~Notch signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0008593~regulation of Notch signaling pathway,GO:0010629~negative regulation of gene expression,GO:0010820~positive regulation of T cell chemotaxis,GO:0016485~protein processing,GO:0022617~extracellular matrix disassembly,GO:0030307~positive regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0034332~adherens junction organization,GO:0034612~response to tumor necrosis factor,GO:0038004~epidermal growth factor receptor ligand maturation,GO:0042117~monocyte activation,GO:0042987~amyloid precursor protein catabolic process,GO:0046931~pore complex assembly,GO:0051089~constitutive protein ectodomain proteolysis,GO:0051128~regulation of cellular component organization,GO:0090102~cochlea development,GO:1901342~regulation of vasculature development,GO:1901998~toxin transport,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0005798~Golgi-associated vesicle,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030136~clathrin-coated vesicle,GO:0030424~axon,GO:0030425~dendrite,GO:0035579~specific granule membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0046930~pore complex,GO:0070062~extracellular exosome,GO:0070821~tertiary granule membrane,GO:0097038~perinuclear endoplasmic reticulum,GO:0097060~synaptic membrane,GO:0097197~tetraspanin-enriched microdomain,GO:0098978~glutamatergic synapse,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005102~receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0060090~binding, bridging,GO:0070573~metallodipeptidase activity,GO:1902945~metalloendopeptidase activity involved in amyloid precursor protein catabolic process,	IPR001590:Peptidase_M12B,IPR001762:Disintegrin_dom,IPR002870:Peptidase_M12B_N,IPR024079:MetalloPept_cat_dom_sf,IPR034025:ADAM10_ADAM17,IPR036436:Disintegrin_dom_sf,IPR049038:ADAM10_Cys-rich,	hsa04148:Efferocytosis,hsa05010:Alzheimer disease,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,	615537~Reticulate acropigmentation of Kitamura,615590~Alzheimer disease 18, susceptibility to,		SM00050:DISIN,	KW-0914~Notch signaling pathway,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,		KW-0026~Alzheimer disease,KW-0225~Disease variant,KW-0523~Neurodegeneration,KW-1008~Amyloidosis,	KW-0729~SH3-binding,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:Disintegrin,DOMAIN:Peptidase M12B,DOMAIN:Peptidase M12B propeptide,MOTIF:Cysteine switch,MOTIF:SH3-binding,MUTAGEN:E->A: Loss of proteolytic activity. Abrogates APP cleavage. Reduces Notch signaling.,MUTAGEN:PLAR->AAAA: Strongly reduces interaction and prevents ADAM10 maturation.,MUTAGEN:YCDVFMRCR->ACDVFMRCA: Strongly reduces interaction and ADAM10 maturation.,MUTAGEN:YCDVFMRCR->ECDVFMRCE: Strongly reduces interaction and prevents ADAM10 maturation.,REGION:Disordered,REGION:Interaction with AP2A1, AP2A2 and AP2M1,SITE:Cleavage; by furin and PCSK7,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q61824	ADAM metallopeptidase domain 12(Adam12)	Mus musculus		m_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,	GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0045766~positive regulation of angiogenesis,	GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0016787~hydrolase activity,GO:0017124~SH3 domain binding,GO:0046872~metal ion binding,	IPR000742:EGF-like_dom,IPR001590:Peptidase_M12B,IPR001762:Disintegrin_dom,IPR002870:Peptidase_M12B_N,IPR006586:ADAM_Cys-rich,IPR018358:Disintegrin_CS,IPR024079:MetalloPept_cat_dom_sf,IPR034027:Reprolysin_adamalysin,IPR036436:Disintegrin_dom_sf,				SM00050:DISIN,SM00608:ACR,	KW-0130~Cell adhesion,	KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0729~SH3-binding,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Disintegrin,DOMAIN:EGF-like,DOMAIN:Peptidase M12B,DOMAIN:Peptidase M12B propeptide,MOTIF:Cysteine switch,MOTIF:SH3-binding; class I,MOTIF:SH3-binding; class II,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P78536	ADAM metallopeptidase domain 17(ADAM17)	Homo sapiens		h_erbb4Pathway:g-Secretase mediated ErbB4 Signaling Pathway ,h_notchPathway:Proteolysis and Signaling Pathway of Notch ,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,	GO:0001666~response to hypoxia,GO:0002446~neutrophil mediated immunity,GO:0002467~germinal center formation,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0007155~cell adhesion,GO:0007219~Notch signaling pathway,GO:0007220~Notch receptor processing,GO:0008284~positive regulation of cell proliferation,GO:0009410~response to xenobiotic stimulus,GO:0010820~positive regulation of T cell chemotaxis,GO:0016485~protein processing,GO:0030183~B cell differentiation,GO:0030307~positive regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0032502~developmental process,GO:0032722~positive regulation of chemokine production,GO:0033025~regulation of mast cell apoptotic process,GO:0033077~T cell differentiation in thymus,GO:0033627~cell adhesion mediated by integrin,GO:0035313~wound healing, spreading of epidermal cells,GO:0042987~amyloid precursor protein catabolic process,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0048536~spleen development,GO:0048870~cell motility,GO:0050830~defense response to Gram-positive bacterium,GO:0050896~response to stimulus,GO:0051128~regulation of cellular component organization,GO:0071403~cellular response to high density lipoprotein particle stimulus,GO:0071679~commissural neuron axon guidance,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1903265~positive regulation of tumor necrosis factor-mediated signaling pathway,GO:1905564~positive regulation of vascular endothelial cell proliferation,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005788~endoplasmic reticulum lumen,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0032587~ruffle membrane,GO:0045121~membrane raft,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005112~Notch binding,GO:0005138~interleukin-6 receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0017124~SH3 domain binding,GO:0030165~PDZ domain binding,GO:0043120~tumor necrosis factor binding,GO:0046872~metal ion binding,GO:1902945~metalloendopeptidase activity involved in amyloid precursor protein catabolic process,	IPR001590:Peptidase_M12B,IPR001762:Disintegrin_dom,IPR024079:MetalloPept_cat_dom_sf,IPR032029:ADAM17_MPD,IPR034025:ADAM10_ADAM17,IPR036436:Disintegrin_dom_sf,	hsa04148:Efferocytosis,hsa04330:Notch signaling pathway,hsa05010:Alzheimer disease,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05171:Coronavirus disease - COVID-19,	614328~Inflammatory skin and bowel disease, neonatal, 1,		SM00050:DISIN,	KW-0914~Notch signaling pathway,	KW-0472~Membrane,			KW-0729~SH3-binding,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:Disintegrin,DOMAIN:Peptidase M12B,MOTIF:Cysteine switch,MOTIF:SH3-binding,REGION:Crambin-like,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9H013	ADAM metallopeptidase domain 19(ADAM19)	Homo sapiens			GO:0001890~placenta development,GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0010628~positive regulation of gene expression,GO:0016485~protein processing,GO:0042987~amyloid precursor protein catabolic process,GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0046872~metal ion binding,GO:1902945~metalloendopeptidase activity involved in amyloid precursor protein catabolic process,	IPR000742:EGF-like_dom,IPR001590:Peptidase_M12B,IPR001762:Disintegrin_dom,IPR002870:Peptidase_M12B_N,IPR006586:ADAM_Cys-rich,IPR018358:Disintegrin_CS,IPR024079:MetalloPept_cat_dom_sf,IPR034027:Reprolysin_adamalysin,IPR036436:Disintegrin_dom_sf,				SM00050:DISIN,SM00608:ACR,		KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0729~SH3-binding,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Disintegrin,DOMAIN:EGF-like,DOMAIN:Peptidase M12B,DOMAIN:Peptidase M12B propeptide,MOTIF:Cysteine switch,MOTIF:SH3-binding,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8WXS8	ADAM metallopeptidase with thrombospondin type 1 motif 14(ADAMTS14)	Homo sapiens			GO:0006508~proteolysis,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030574~collagen catabolic process,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0046872~metal ion binding,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR002870:Peptidase_M12B_N,IPR006586:ADAM_Cys-rich,IPR010294:ADAMTS_spacer1,IPR010909:PLAC,IPR013273:ADAMTS/ADAMTS-like,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,SM00608:ACR,	KW-0177~Collagen degradation,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Disintegrin,DOMAIN:PLAC,DOMAIN:Peptidase M12B,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,REGION:Disordered,REGION:Spacer,
P59384	ADAM metallopeptidase with thrombospondin type 1 motif 15(Adamts15)	Mus musculus			GO:0006508~proteolysis,GO:0007520~myoblast fusion,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009986~cell surface,GO:0031012~extracellular matrix,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0050840~extracellular matrix binding,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR002870:Peptidase_M12B_N,IPR006586:ADAM_Cys-rich,IPR010294:ADAMTS_spacer1,IPR013273:ADAMTS/ADAMTS-like,IPR013277:Pept_M12B_ADAM-TS8,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,SM00608:ACR,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Disintegrin,DOMAIN:Peptidase M12B,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,MOTIF:Cysteine switch,MUTAGEN:N->Q: Reduced glycosylation.,MUTAGEN:R->A: Reduced propeptide cleavage.,REGION:Disordered,REGION:Spacer,SITE:Cleavage; by furin,
Q8TE57	ADAM metallopeptidase with thrombospondin type 1 motif 16(ADAMTS16)	Homo sapiens			GO:0001658~branching involved in ureteric bud morphogenesis,GO:0003073~regulation of systemic arterial blood pressure,GO:0006508~proteolysis,GO:0030198~extracellular matrix organization,GO:0048232~male gamete generation,GO:1902017~regulation of cilium assembly,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0046872~metal ion binding,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR002870:Peptidase_M12B_N,IPR010294:ADAMTS_spacer1,IPR010909:PLAC,IPR013273:ADAMTS/ADAMTS-like,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:Disintegrin,DOMAIN:PLAC,DOMAIN:Peptidase M12B,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,DOMAIN:TSP type-1 5,DOMAIN:TSP type-1 6,MOTIF:Cysteine switch,REGION:Disordered,REGION:Spacer,
P79331	ADAM metallopeptidase with thrombospondin type 1 motif 2(ADAMTS2)	Bos taurus			GO:0006508~proteolysis,GO:0007283~spermatogenesis,GO:0016485~protein processing,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030324~lung development,GO:0030574~collagen catabolic process,GO:0032964~collagen biosynthetic process,GO:0043588~skin development,GO:0097435~supramolecular fiber organization,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR002870:Peptidase_M12B_N,IPR010294:ADAMTS_spacer1,IPR010909:PLAC,IPR013273:ADAMTS/ADAMTS-like,IPR013275:Pept_M12B_ADAM-TS2,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,	KW-0177~Collagen degradation,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Disintegrin,DOMAIN:PLAC,DOMAIN:Peptidase M12B,DOMAIN:Peptidase M12B propeptide,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,MOTIF:Cell attachment site,REGION:Disordered,REGION:Spacer,
O15072	ADAM metallopeptidase with thrombospondin type 1 motif 3(ADAMTS3)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0006508~proteolysis,GO:0007229~integrin-mediated signaling pathway,GO:0010573~vascular endothelial growth factor production,GO:0016485~protein processing,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030574~collagen catabolic process,GO:0032964~collagen biosynthetic process,GO:0097435~supramolecular fiber organization,GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0008270~zinc ion binding,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR002870:Peptidase_M12B_N,IPR010294:ADAMTS_spacer1,IPR010909:PLAC,IPR013273:ADAMTS/ADAMTS-like,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,		618154~Hennekam lymphangiectasia-lymphedema syndrome 3,		SM00209:TSP1,		KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0358~Heparin-binding,KW-0378~Hydrolase,KW-0401~Integrin,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Disintegrin,DOMAIN:PLAC,DOMAIN:Peptidase M12B,DOMAIN:Peptidase M12B propeptide,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,REGION:Disordered,REGION:Spacer,
Q9UKP5	ADAM metallopeptidase with thrombospondin type 1 motif 6(ADAMTS6)	Homo sapiens			GO:0001822~kidney development,GO:0003279~cardiac septum development,GO:0006508~proteolysis,GO:0030198~extracellular matrix organization,GO:0035904~aorta development,GO:0060976~coronary vasculature development,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0046872~metal ion binding,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR002870:Peptidase_M12B_N,IPR010294:ADAMTS_spacer1,IPR010909:PLAC,IPR013273:ADAMTS/ADAMTS-like,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Disintegrin,DOMAIN:PLAC,DOMAIN:Peptidase M12B,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,DOMAIN:TSP type-1 5,REGION:Spacer,
Q9UP79	ADAM metallopeptidase with thrombospondin type 1 motif 8(ADAMTS8)	Homo sapiens			GO:0006508~proteolysis,GO:0008285~negative regulation of cell proliferation,GO:0030198~extracellular matrix organization,GO:0035435~phosphate ion transmembrane transport,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0008201~heparin binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0009673~low-affinity phosphate transmembrane transporter activity,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR002870:Peptidase_M12B_N,IPR006586:ADAM_Cys-rich,IPR010294:ADAMTS_spacer1,IPR013273:ADAMTS/ADAMTS-like,IPR013277:Pept_M12B_ADAM-TS8,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,SM00608:ACR,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0358~Heparin-binding,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Disintegrin,DOMAIN:Peptidase M12B,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,REGION:Disordered,REGION:Spacer,
Q9P2N4	ADAM metallopeptidase with thrombospondin type 1 motif 9(ADAMTS9)	Homo sapiens			GO:0003179~heart valve morphogenesis,GO:0003229~ventricular cardiac muscle tissue development,GO:0006508~proteolysis,GO:0009617~response to bacterium,GO:0010596~negative regulation of endothelial cell migration,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0030198~extracellular matrix organization,GO:0030318~melanocyte differentiation,GO:0035909~aorta morphogenesis,GO:0045636~positive regulation of melanocyte differentiation,GO:0090673~endothelial cell-matrix adhesion,GO:1903671~negative regulation of sprouting angiogenesis,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0009986~cell surface,GO:0031012~extracellular matrix,GO:0043231~intracellular membrane-bounded organelle,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR002870:Peptidase_M12B_N,IPR010294:ADAMTS_spacer1,IPR012314:Pept_M12B_GON-ADAMTSs,IPR013273:ADAMTS/ADAMTS-like,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,	KW-0653~Protein transport,KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0256~Endoplasmic reticulum,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Disintegrin,DOMAIN:GON,DOMAIN:Peptidase M12B,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 10,DOMAIN:TSP type-1 11,DOMAIN:TSP type-1 12,DOMAIN:TSP type-1 13,DOMAIN:TSP type-1 14,DOMAIN:TSP type-1 15,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,DOMAIN:TSP type-1 5,DOMAIN:TSP type-1 6,DOMAIN:TSP type-1 7,DOMAIN:TSP type-1 8,DOMAIN:TSP type-1 9,MOTIF:Cysteine switch,MUTAGEN:R->A: No effect on mature form production.,MUTAGEN:R->A: No mature form produced.,REGION:Disordered,REGION:Spacer,SITE:Cleavage,
Q9WUQ1	ADAM metallopeptidase with thrombospondin type 1 motif, 1(Adamts1)	Rattus norvegicus			GO:0001542~ovulation from ovarian follicle,GO:0001822~kidney development,GO:0006508~proteolysis,GO:0010976~positive regulation of neuron projection development,GO:0016525~negative regulation of angiogenesis,GO:0030198~extracellular matrix organization,GO:0060347~heart trabecula formation,GO:0071305~cellular response to vitamin D,GO:0071374~cellular response to parathyroid hormone stimulus,GO:0071380~cellular response to prostaglandin E stimulus,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0031410~cytoplasmic vesicle,	GO:0004222~metalloendopeptidase activity,GO:0008201~heparin binding,GO:0008270~zinc ion binding,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR002870:Peptidase_M12B_N,IPR006586:ADAM_Cys-rich,IPR010294:ADAMTS_spacer1,IPR013273:ADAMTS/ADAMTS-like,IPR013274:Pept_M12B_ADAM-TS1,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,SM00608:ACR,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0358~Heparin-binding,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Disintegrin,DOMAIN:Peptidase M12B,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,MOTIF:Cysteine switch,REGION:Disordered,REGION:Spacer,
Q8BLI0	ADAMTS-like 1(Adamtsl1)	Mus musculus			GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,		IPR000884:TSP1_rpt,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR010294:ADAMTS_spacer1,IPR010909:PLAC,IPR013098:Ig_I-set,IPR013273:ADAMTS/ADAMTS-like,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR036383:TSP1_rpt_sf,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,SM00408:IGc2,SM00409:IG,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Fuc...) serine,CARBOHYD:O-linked (Fuc...) threonine,DOMAIN:ADAMTS/ADAMTS-like Spacer 1,DOMAIN:ADAMTS/ADAMTS-like cysteine-rich,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:PLAC,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,DOMAIN:TSP type-1 5,DOMAIN:TSP type-1 6,DOMAIN:TSP type-1 7,DOMAIN:TSP type-1 8,DOMAIN:TSP type-1 9,REGION:Disordered,
Q6IQ32	ADNP homeobox 2(ADNP2)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0010468~regulation of gene expression,	GO:0000785~chromatin,GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001356:Homeobox_dom,IPR009057:Homeobox-like_sf,IPR013087:Znf_C2H2_type,IPR038861:ADNP/ADNP2,IPR045762:ADNP_Znf,				SM00355:ZnF_C2H2,SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0371~Homeobox,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DNA_BIND:Homeobox,DOMAIN:ADNP zinc finger,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3; degenerate,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5; degenerate,ZN_FING:C2H2-type 6; degenerate,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9; degenerate,
A4QP16	ADNP homeobox 2a(adnp2a)	Danio rerio			GO:0010468~regulation of gene expression,GO:0043249~erythrocyte maturation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR038861:ADNP/ADNP2,IPR045762:ADNP_Znf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0371~Homeobox,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		DNA_BIND:Homeobox,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3; degenerate,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5; degenerate,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8; degenerate,
P26990	ADP ribosylation factor 6(ARF6)	Gallus gallus			GO:0001889~liver development,GO:0006207~'de novo' pyrimidine nucleobase biosynthetic process,GO:0006541~glutamine metabolic process,GO:0006886~intracellular protein transport,GO:0007399~nervous system development,GO:0010976~positive regulation of neuron projection development,GO:0016192~vesicle-mediated transport,GO:0030154~cell differentiation,GO:0030838~positive regulation of actin filament polymerization,GO:0030866~cortical actin cytoskeleton organization,GO:0032456~endocytic recycling,GO:0034394~protein localization to cell surface,GO:0035020~regulation of Rac protein signal transduction,GO:0036010~protein localization to endosome,GO:0050714~positive regulation of protein secretion,GO:0051489~regulation of filopodium assembly,GO:0051549~positive regulation of keratinocyte migration,GO:0060998~regulation of dendritic spine development,GO:0072659~protein localization to plasma membrane,GO:0090162~establishment of epithelial cell polarity,GO:0097178~ruffle assembly,GO:0097284~hepatocyte apoptotic process,GO:1902217~erythrocyte apoptotic process,GO:1903078~positive regulation of protein localization to plasma membrane,GO:2000009~negative regulation of protein localization to cell surface,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0030139~endocytic vesicle,GO:0031527~filopodium membrane,GO:0032154~cleavage furrow,GO:0032587~ruffle membrane,GO:0055038~recycling endosome membrane,GO:0090543~Flemming body,	GO:0003924~GTPase activity,GO:0004088~carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0031996~thioesterase binding,GO:0035591~signaling adaptor activity,GO:0046872~metal ion binding,	IPR002474:CarbamoylP_synth_ssu_N,IPR005225:Small_GTP-bd_dom,IPR005479:CbamoylP_synth_lsu-like_ATP-bd,IPR005480:CarbamoylP_synth_lsu_oligo,IPR005483:CbamoylP_synth_lsu_CPSase_dom,IPR006274:CarbamoylP_synth_ssu,IPR006275:CarbamoylP_synth_lsu,IPR006689:Small_GTPase_ARF/SAR,IPR011607:MGS-like_dom,IPR011761:ATP-grasp,IPR013815:ATP_grasp_subdomain_1,IPR016185:PreATP-grasp_dom_sf,IPR017926:GATASE,IPR024156:Small_GTPase_ARF,IPR027417:P-loop_NTPase,IPR029062:Class_I_gatase-like,IPR035686:CPSase_GATase1,IPR036480:CarbP_synth_ssu_N_sf,IPR036897:CarbamoylP_synth_lsu_oligo_sf,IPR036914:MGS-like_dom_sf,IPR041838:Arf6,	gga04144:Endocytosis,gga05132:Salmonella infection,			SM00175:RAB,SM00177:ARF,SM00178:SAR,SM00851:MGS,SM01096:CPSase_L_D3,SM01097:CPSase_sm_chain,	KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0436~Ligase,	KW-0449~Lipoprotein,KW-0519~Myristate,	DOMAIN:ATP-grasp,DOMAIN:Carbamoyl-phosphate synthetase large subunit-like ATP-binding,DOMAIN:MGS-like,LIPID:N-myristoyl glycine,LIPID:N6-myristoyl lysine,
P36404	ADP ribosylation factor like GTPase 2(ARL2)	Homo sapiens			GO:0006110~regulation of glycolytic process,GO:0006457~protein folding,GO:0007098~centrosome cycle,GO:0010811~positive regulation of cell-substrate adhesion,GO:0031113~regulation of microtubule polymerization,GO:0031116~positive regulation of microtubule polymerization,GO:0034260~negative regulation of GTPase activity,GO:0051457~maintenance of protein location in nucleus,GO:0070830~bicellular tight junction assembly,GO:1903715~regulation of aerobic respiration,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0015630~microtubule cytoskeleton,GO:0016328~lateral plasma membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR005225:Small_GTP-bd_dom,IPR006689:Small_GTPase_ARF/SAR,IPR027417:P-loop_NTPase,IPR044612:ARL2/3,IPR045873:Arl2,		619082~Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1,		SM00175:RAB,SM00177:ARF,SM00178:SAR,	KW-0131~Cell cycle,	KW-0206~Cytoskeleton,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0898~Cataract,		KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0519~Myristate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),LIPID:N-myristoyl glycine,MUTAGEN:F->A: Reduces interaction with ARL2BP. Inhibits the interaction with TBCD and rescues the TBCD-induced microtubule destruction.,MUTAGEN:I->R: Reduces interaction with ARL2BP.,MUTAGEN:L->A: Does not reduce interaction with ARL2BP.,MUTAGEN:L->A: Reduces interaction with ARL2BP.,MUTAGEN:L->D: Reduces interaction with ARL2BP.,MUTAGEN:Q->L: Induces cell cycle arrest, reduces ability to form microtubules and centrosome fragmentation. Inhibits the interaction with TBCD and does not rescue the TBCD-induced microtubule destruction. Interacts with ARL2BP and PDE6D.,MUTAGEN:T->A: Does not inhibit the interaction with TBCD and rescues the TBCD-induced microtubule destruction.,MUTAGEN:T->N: Does not inhibit the interaction with TBCD and rescues the TBCD-induced microtubule destruction. Reduces interaction with ARL2BP. Inhibits accumulation of STAT3 in the nucleus.,MUTAGEN:Y->A: Does not reduce interaction with ARL2BP.,MUTAGEN:Y->A: Reduces interaction with ARL2BP.,
Q1MTE5	ADP ribosylation factor like GTPase 3b(arl3b)	Danio rerio			GO:0000281~mitotic cytokinesis,GO:0007049~cell cycle,GO:0015031~protein transport,GO:0051301~cell division,GO:0060271~cilium assembly,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005876~spindle microtubule,GO:0005881~cytoplasmic microtubule,GO:0005929~cilium,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0030496~midbody,GO:0032391~photoreceptor connecting cilium,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0008017~microtubule binding,GO:0019003~GDP binding,	IPR005225:Small_GTP-bd_dom,IPR006689:Small_GTPase_ARF/SAR,IPR027417:P-loop_NTPase,IPR044612:ARL2/3,				SM00175:RAB,SM00177:ARF,SM00178:SAR,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0653~Protein transport,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0519~Myristate,	LIPID:N-myristoyl glycine,
Q9D4P0	ADP-ribosylation factor-like 5B(Arl5b)	Mus musculus			GO:0006886~intracellular protein transport,GO:0016192~vesicle-mediated transport,GO:1903292~protein localization to Golgi membrane,	GO:0005737~cytoplasm,GO:0005802~trans-Golgi network,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR005225:Small_GTP-bd_dom,IPR006689:Small_GTPase_ARF/SAR,IPR024156:Small_GTPase_ARF,IPR027417:P-loop_NTPase,				SM00177:ARF,SM00178:SAR,						KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0519~Myristate,	LIPID:N-myristoyl glycine,
Q502P0	ADP-ribosylation factor-like 6 interacting protein 4(arl6ip4)	Danio rerio			GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016607~nuclear speck,		IPR019532:Nucl_RNA-splicing_assoc_SR-25,					KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,							COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,REGION:Disordered,
Q9ESC8	AF4/FMR2 family, member 4(Aff4)	Mus musculus			GO:0007286~spermatid development,GO:0010468~regulation of gene expression,GO:0034976~response to endoplasmic reticulum stress,	GO:0000791~euchromatin,GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0008023~transcription elongation factor complex,GO:0032783~ELL-EAF complex,	GO:0005515~protein binding,	IPR007797:AF4/FMR2,IPR043639:AF4_int,IPR043640:AF4/FMR2_CHD,	mmu03250:Viral life cycle - HIV-1,				KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0656~Proto-oncogene,				KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:AF4/FMR2 C-terminal homology,REGION:Disordered,
Q5TYS0	AFG1 like ATPase b(afg1lb)	Danio rerio			GO:0003341~cilium movement,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR005654:ATPase_AFG1-like,IPR027417:P-loop_NTPase,										KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q8JHH5	AFG2 interacting ribosome maturation factor(airim)	Danio rerio			GO:0042254~ribosome biogenesis,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR029159:CA109-like,					KW-0690~Ribosome biogenesis,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0217~Developmental protein,KW-9996~Developmental protein,
Q68EI3	AGBL carboxypeptidase 5(agbl5)	Danio rerio			GO:0006508~proteolysis,GO:0035608~protein deglutamylation,GO:0035609~C-terminal protein deglutamylation,GO:0035610~protein side chain deglutamylation,GO:0035611~protein branching point deglutamylation,GO:0043009~chordate embryonic development,GO:0051607~defense response to virus,GO:0060271~cilium assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0030496~midbody,GO:0072686~mitotic spindle,	GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000834:Peptidase_M14,IPR034286:M14_AGBL5-like,IPR040626:Pepdidase_M14_N,						KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,		ACT_SITE:Proton donor/acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Cytosolic carboxypeptidase N-terminal,DOMAIN:Peptidase M14,DOMAIN:Peptidase M14 carboxypeptidase A,REGION:Disordered,
P31751	AKT serine/threonine kinase 2(AKT2)	Homo sapiens			GO:0005978~glycogen biosynthetic process,GO:0006006~glucose metabolic process,GO:0006417~regulation of translation,GO:0007165~signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0008643~carbohydrate transport,GO:0010748~negative regulation of plasma membrane long-chain fatty acid transport,GO:0010907~positive regulation of glucose metabolic process,GO:0010918~positive regulation of mitochondrial membrane potential,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0032000~positive regulation of fatty acid beta-oxidation,GO:0032287~peripheral nervous system myelin maintenance,GO:0032869~cellular response to insulin stimulus,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0043066~negative regulation of apoptotic process,GO:0045444~fat cell differentiation,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0046326~positive regulation of glucose import,GO:0051726~regulation of cell cycle,GO:0060644~mammary gland epithelial cell differentiation,GO:0071486~cellular response to high light intensity,GO:0072659~protein localization to plasma membrane,GO:0090314~positive regulation of protein targeting to membrane,GO:0097473~retinal rod cell apoptotic process,GO:2000147~positive regulation of cell motility,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0032587~ruffle membrane,GO:0032991~macromolecular complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR001849:PH_domain,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011993:PH-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,IPR034677:Akt2,IPR039026:PH_PKB,	hsa01521:EGFR tyrosine kinase inhibitor resistance,hsa01522:Endocrine resistance,hsa01524:Platinum drug resistance,hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04072:Phospholipase D signaling pathway,hsa04140:Autophagy - animal,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04218:Cellular senescence,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04370:VEGF signaling pathway,hsa04371:Apelin signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04613:Neutrophil extracellular trap formation,hsa04620:Toll-like receptor signaling pathway,hsa04625:C-type lectin receptor signaling pathway,hsa04630:JAK-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04926:Relaxin signaling pathway,hsa04929:GnRH secretion,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04935:Growth hormone synthesis, secretion and action,hsa04936:Alcoholic liver disease,hsa04973:Carbohydrate digestion and absorption,hsa05010:Alzheimer disease,hsa05017:Spinocerebellar ataxia,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05135:Yersinia infection,hsa05142:Chagas disease,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05163:Human cytomegalovirus infection,hsa05164:Influenza A,hsa05165:Human papillomavirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05168:Herpes simplex virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05170:Human immunodeficiency virus 1 infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05207:Chemical carcinogenesis - receptor activation,hsa05208:Chemical carcinogenesis - reactive oxygen species,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05224:Breast cancer,hsa05225:Hepatocellular carcinoma,hsa05226:Gastric cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,hsa05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,hsa05415:Diabetic cardiomyopathy,hsa05417:Lipid and atherosclerosis,hsa05418:Fluid shear stress and atherosclerosis,	125853~Diabetes mellitus, type II,240900~Hypoinsulinemic hypoglycemia with hemihypertrophy,		SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,	KW-0053~Apoptosis,KW-0119~Carbohydrate metabolism,KW-0313~Glucose metabolism,KW-0320~Glycogen biosynthesis,KW-0321~Glycogen metabolism,KW-0762~Sugar transport,KW-0810~Translation regulation,KW-0813~Transport,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0967~Endosome,KW-1003~Cell membrane,		KW-0219~Diabetes mellitus,KW-0225~Disease variant,KW-0656~Proto-oncogene,		KW-0067~ATP-binding,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:O-linked (GlcNAc) serine,CARBOHYD:O-linked (GlcNAc) threonine,COMPBIAS:Basic and acidic residues,DOMAIN:AGC-kinase C-terminal,DOMAIN:PH,DOMAIN:Protein kinase,MUTAGEN:S->A: Impairs interaction with TTC3; when associated with A-309.,MUTAGEN:S->D: Constitutively active; when associated with E-309.,MUTAGEN:T->A: Impairs interaction with TTC3; when associated with A-474.,MUTAGEN:T->E: Constitutively active; when associated with D-474.,REGION:Disordered,
Q9Y243	AKT serine/threonine kinase 3(AKT3)	Homo sapiens			GO:0000002~mitochondrial genome maintenance,GO:0001938~positive regulation of endothelial cell proliferation,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032008~positive regulation of TOR signaling,GO:0035556~intracellular signal transduction,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045766~positive regulation of angiogenesis,GO:0045793~positive regulation of cell size,GO:0048854~brain morphogenesis,GO:0048873~homeostasis of number of cells within a tissue,GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis,GO:1905564~positive regulation of vascular endothelial cell proliferation,GO:1905653~positive regulation of artery morphogenesis,GO:2000773~negative regulation of cellular senescence,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR001849:PH_domain,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011993:PH-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,IPR034675:Akt3,IPR039026:PH_PKB,	hsa01521:EGFR tyrosine kinase inhibitor resistance,hsa01522:Endocrine resistance,hsa01524:Platinum drug resistance,hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04072:Phospholipase D signaling pathway,hsa04140:Autophagy - animal,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04218:Cellular senescence,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04370:VEGF signaling pathway,hsa04371:Apelin signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04613:Neutrophil extracellular trap formation,hsa04620:Toll-like receptor signaling pathway,hsa04625:C-type lectin receptor signaling pathway,hsa04630:JAK-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04926:Relaxin signaling pathway,hsa04929:GnRH secretion,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04935:Growth hormone synthesis, secretion and action,hsa04936:Alcoholic liver disease,hsa04973:Carbohydrate digestion and absorption,hsa05010:Alzheimer disease,hsa05017:Spinocerebellar ataxia,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05135:Yersinia infection,hsa05142:Chagas disease,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05163:Human cytomegalovirus infection,hsa05164:Influenza A,hsa05165:Human papillomavirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05168:Herpes simplex virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05170:Human immunodeficiency virus 1 infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05207:Chemical carcinogenesis - receptor activation,hsa05208:Chemical carcinogenesis - reactive oxygen species,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05224:Breast cancer,hsa05225:Hepatocellular carcinoma,hsa05226:Gastric cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,hsa05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,hsa05415:Diabetic cardiomyopathy,hsa05417:Lipid and atherosclerosis,hsa05418:Fluid shear stress and atherosclerosis,	615937~Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,		SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,		KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:O-linked (GlcNAc) threonine,COMPBIAS:Polar residues,DOMAIN:AGC-kinase C-terminal,DOMAIN:PH,DOMAIN:Protein kinase,MUTAGEN:S->A: 67% decrease of activity after pervanadate treatment.,MUTAGEN:S->D: 1.4-fold increase of phosphorylation steady state level, 50% decrease of activity after pervanadate treatment.,MUTAGEN:T->A: No activation after pervanadate treatment.,MUTAGEN:T->A: No effect.,MUTAGEN:T->D: 2-fold increase of phosphorylation steady state level, no activation after pervanadate treatment.,MUTAGEN:T->D: No effect.,REGION:Disordered,
P51826	ALF transcription elongation factor 3(AFF3)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0010468~regulation of gene expression,GO:0034612~response to tumor necrosis factor,GO:0035116~embryonic hindlimb morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016604~nuclear body,GO:0032783~ELL-EAF complex,	GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR007797:AF4/FMR2,IPR043639:AF4_int,IPR043640:AF4/FMR2_CHD,		619297~KINSSHIP syndrome,			KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0225~Disease variant,KW-0242~Dwarfism,KW-0991~Intellectual disability,			KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:AF4/FMR2 C-terminal homology,REGION:Disordered,
Q9H553	ALG2 alpha-1,3/1,6-mannosyltransferase(ALG2)	Homo sapiens			GO:0006486~protein glycosylation,GO:0006488~dolichol-linked oligosaccharide biosynthetic process,GO:0006490~oligosaccharide-lipid intermediate biosynthetic process,GO:0051592~response to calcium ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0000033~alpha-1,3-mannosyltransferase activity,GO:0004378~GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,GO:0048306~calcium-dependent protein binding,GO:0102704~GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,	IPR001296:Glyco_trans_1,IPR027054:ALG2,IPR028098:Glyco_trans_4-like_N,	hsa00510:N-Glycan biosynthesis,hsa00513:Various types of N-glycan biosynthesis,hsa01100:Metabolic pathways,	607906~Congenital disorder of glycosylation, type Ii,616228~Myasthenic syndrome, congenital, 14, with tubular aggregates,				KW-0472~Membrane,		KW-0225~Disease variant,KW-0900~Congenital disorder of glycosylation,KW-1004~Congenital myasthenic syndrome,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,		TRANSMEM:Helical,
Q9H6U8	ALG9 alpha-1,2-mannosyltransferase(ALG9)	Homo sapiens			GO:0006486~protein glycosylation,GO:0006487~protein N-linked glycosylation,GO:0006488~dolichol-linked oligosaccharide biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0000026~alpha-1,2-mannosyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0052918~dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,GO:0052926~dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,	IPR005599:GPI_mannosylTrfase,	hsa00510:N-Glycan biosynthesis,hsa00513:Various types of N-glycan biosynthesis,hsa01100:Metabolic pathways,	263210~Gillessen-Kaesbach-Nishimura syndrome,608776~Congenital disorder of glycosylation, type Il,				KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,KW-0900~Congenital disorder of glycosylation,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,SITE:Breakpoint for translocation,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
O00192	ARVCF delta catenin family member(ARVCF)	Homo sapiens			GO:0006397~mRNA processing,GO:0007043~cell-cell junction assembly,GO:0007155~cell adhesion,GO:0008380~RNA splicing,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:1990124~messenger ribonucleoprotein complex,	GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR000225:Armadillo,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR028435:Plakophilin/d_Catenin,				SM00185:ARM,	KW-0130~Cell adhesion,KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Required for interaction with RNA-binding proteins DDX5, HNRNPH2 and SRSF1 and with mRNAs,REPEAT:ARM,REPEAT:ARM 1,REPEAT:ARM 10,REPEAT:ARM 2,REPEAT:ARM 3,REPEAT:ARM 4,REPEAT:ARM 5,REPEAT:ARM 6,REPEAT:ARM 7,REPEAT:ARM 8,REPEAT:ARM 9,
Q99MY8	ASH1 like histone lysine methyltransferase(Ash1l)	Mus musculus			GO:0000165~MAPK cascade,GO:0001501~skeletal system development,GO:0002674~negative regulation of acute inflammatory response,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007338~single fertilization,GO:0009791~post-embryonic development,GO:0010468~regulation of gene expression,GO:0010934~macrophage cytokine production,GO:0030317~flagellated sperm motility,GO:0032259~methylation,GO:0032635~interleukin-6 production,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043409~negative regulation of MAPK cascade,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046697~decidualization,GO:0048733~sebaceous gland development,GO:0050728~negative regulation of inflammatory response,GO:0061038~uterus morphogenesis,GO:1903699~tarsal gland development,GO:1903709~uterine gland development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005794~Golgi apparatus,GO:0005923~bicellular tight junction,GO:0070161~anchoring junction,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0042054~histone methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0046872~metal ion binding,GO:0046974~histone methyltransferase activity (H3-K9 specific),GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001025:BAH_dom,IPR001214:SET_dom,IPR001487:Bromodomain,IPR001965:Znf_PHD,IPR003616:Post-SET_dom,IPR006560:AWS_dom,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR017956:AT_hook_DNA-bd_motif,IPR019786:Zinc_finger_PHD-type_CS,IPR036427:Bromodomain-like_sf,IPR043151:BAH_sf,IPR043319:PHD_ASH1L,IPR043320:Bromo_ASH1L,IPR046341:SET_dom_sf,	mmu00310:Lysine degradation,mmu01100:Metabolic pathways,			SM00249:PHD,SM00297:BROMO,SM00317:SET,SM00384:AT_hook,SM00439:BAH,SM00570:AWS,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0796~Tight junction,KW-0965~Cell junction,			KW-0103~Bromodomain,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0010~Activator,KW-0156~Chromatin regulator,KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:A.T hook 1,DNA_BIND:A.T hook 2,DNA_BIND:A.T hook 3,DOMAIN:AWS,DOMAIN:BAH,DOMAIN:Bromo,DOMAIN:Post-SET,DOMAIN:SET,REGION:Catalytic domain,REGION:Disordered,ZN_FING:PHD-type,
Q03989	AT-rich interaction domain 5A(ARID5A)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002062~chondrocyte differentiation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032729~positive regulation of interferon-gamma production,GO:0032740~positive regulation of interleukin-17 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0045087~innate immune response,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071222~cellular response to lipopolysaccharide,GO:0071391~cellular response to estrogen stimulus,GO:1901985~positive regulation of protein acetylation,GO:2000318~positive regulation of T-helper 17 type immune response,GO:2000556~positive regulation of T-helper 1 cell cytokine production,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0030331~estrogen receptor binding,GO:0035613~RNA stem-loop binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0046965~retinoid X receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0050681~androgen receptor binding,	IPR001606:ARID_dom,IPR036431:ARID_dom_sf,				SM00501:BRIGHT,SM01014:ARID,	KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,KW-0694~RNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:ARID,REGION:Disordered,REGION:Interaction with SOX9,
Q13315	ATM serine/threonine kinase(ATM)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,H_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,	GO:0000077~DNA damage checkpoint,GO:0000425~macropexophagy,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0001541~ovarian follicle development,GO:0001666~response to hypoxia,GO:0001756~somitogenesis,GO:0002331~pre-B cell allelic exclusion,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006338~chromatin remodeling,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007094~mitotic spindle assembly checkpoint,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0007131~reciprocal meiotic recombination,GO:0007140~male meiosis,GO:0007143~female meiotic division,GO:0007165~signal transduction,GO:0007420~brain development,GO:0007507~heart development,GO:0008340~determination of adult lifespan,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009791~post-embryonic development,GO:0010212~response to ionizing radiation,GO:0010506~regulation of autophagy,GO:0010628~positive regulation of gene expression,GO:0018105~peptidyl-serine phosphorylation,GO:0030335~positive regulation of cell migration,GO:0030889~negative regulation of B cell proliferation,GO:0032210~regulation of telomere maintenance via telomerase,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0033151~V(D)J recombination,GO:0034614~cellular response to reactive oxygen species,GO:0035264~multicellular organism growth,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0036289~peptidyl-serine autophosphorylation,GO:0042159~lipoprotein catabolic process,GO:0042770~signal transduction in response to DNA damage,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043525~positive regulation of neuron apoptotic process,GO:0045141~meiotic telomere clustering,GO:0045785~positive regulation of cell adhesion,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046777~protein autophosphorylation,GO:0048538~thymus development,GO:0048599~oocyte development,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0071044~histone mRNA catabolic process,GO:0071300~cellular response to retinoic acid,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:0071500~cellular response to nitrosative stress,GO:0090398~cellular senescence,GO:0090399~replicative senescence,GO:0097694~establishment of RNA localization to telomere,GO:0097695~establishment of macromolecular complex localization to telomere,GO:1900034~regulation of cellular response to heat,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1903626~positive regulation of DNA catabolic process,GO:1903978~regulation of microglial cell activation,GO:1904262~negative regulation of TORC1 signaling,GO:1904354~negative regulation of telomere capping,GO:1904358~positive regulation of telomere maintenance via telomere lengthening,GO:1904884~positive regulation of telomerase catalytic core complex assembly,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005782~peroxisomal matrix,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,GO:1990391~DNA repair complex,	GO:0003677~DNA binding,GO:0004674~protein serine/threonine kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0035979~histone kinase activity (H2A-S139 specific),GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,	IPR000403:PI3/4_kinase_cat_dom,IPR003151:PIK-rel_kinase_FAT,IPR003152:FATC_dom,IPR011009:Kinase-like_dom_sf,IPR014009:PIK_FAT,IPR016024:ARM-type_fold,IPR018936:PI3/4_kinase_CS,IPR021668:TAN,IPR036940:PI3/4_kinase_cat_sf,IPR038980:ATM_plant,IPR044107:PIKKc_ATM,	hsa01524:Platinum drug resistance,hsa03440:Homologous recombination,hsa04064:NF-kappa B signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04218:Cellular senescence,hsa05131:Shigellosis,hsa05165:Human papillomavirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05170:Human immunodeficiency virus 1 infection,hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,	114480~Breast cancer, susceptibility to,208900~Ataxia-telangiectasia,Lymphoma, B-cell non-Hodgkin, somatic~Lymphoma, B-cell non-Hodgkin, somatic,Lymphoma, mantle cell, somatic~Lymphoma, mantle cell, somatic,T-cell prolymphocytic leukemia, somatic~T-cell prolymphocytic leukemia, somatic,		SM00146:PI3Kc,SM01342:TAN,SM01343:FATC,	KW-0131~Cell cycle,KW-0227~DNA damage,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0576~Peroxisome,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,		KW-0043~Tumor suppressor,KW-0225~Disease variant,KW-0523~Neurodegeneration,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:FAT,DOMAIN:FATC,DOMAIN:PI3K/PI4K catalytic,DOMAIN:Telomere-length maintenance and DNA damage repair,MOTIF:Microbody targeting signal; atypical,MUTAGEN:D->A: Loss of kinase activity.,MUTAGEN:D->N: Decreased phosphorylation of target proteins.,MUTAGEN:E->K: Decreased phosphorylation of target proteins.,MUTAGEN:K->E: Decreased phosphorylation of target proteins.,MUTAGEN:K->Q: Mimics acetylation, preventing dephosphorylation and subsequent ATM deactivation during the late stage of DNA damage response.,MUTAGEN:K->R: Loss of DNA damage-inducible acetylation. Retains constitutive kinase activity, but blocks DNA damage-induced kinase activation. Disrupts dimer and abolishes S-1981 autophosphorylation.,MUTAGEN:K->R: Retains DNA damage-inducible acetylation and S-1981 autophosphorylation.,MUTAGEN:L->P: Loss of phosphorylation of target proteins.,MUTAGEN:N->K: Loss of kinase activity.,MUTAGEN:P->L: Loss of phosphorylation of target proteins.,MUTAGEN:Q->P: Loss of phosphorylation of target proteins.,MUTAGEN:R->Q: Abolished interaction with PEX5 and translocation to peroxisomes in response to reactive oxygen species (ROS).,MUTAGEN:S->A: Loss of IR-induced S-1893 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1981 autophosphorylation.,MUTAGEN:S->A: Loss of IR-induced S-1981 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1893 autophosphorylation. No dimer disruption.,MUTAGEN:S->A: Loss of IR-induced S-367 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-1893 nor S-1981 autophosphorylation.,MUTAGEN:S->D,E: Disrupts the dimer.,MUTAGEN:S->L: Loss of phosphorylation of target proteins.,MUTAGEN:S->T: No effect on phosphorylation of target proteins.,MUTAGEN:V->L: Decreased phosphorylation of target proteins.,MUTAGEN:Y->C: Loss of phosphorylation of target proteins.,REGION:Activation loop,REGION:Catalytic loop,REGION:G-loop,REGION:Interaction with ABL1,
Q9NRK6	ATP binding cassette subfamily B member 10(ABCB10)	Homo sapiens			GO:0006783~heme biosynthetic process,GO:0006839~mitochondrial transport,GO:0034514~mitochondrial unfolded protein response,GO:0045648~positive regulation of erythrocyte differentiation,GO:0046985~positive regulation of hemoglobin biosynthetic process,GO:0048821~erythrocyte development,GO:0055085~transmembrane transport,GO:0070455~positive regulation of heme biosynthetic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0031966~mitochondrial membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042803~protein homodimerization activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR011527:ABC1_TM_dom,IPR017871:ABC_transporter-like_CS,IPR027417:P-loop_NTPase,IPR036640:ABC1_TM_sf,IPR039421:Type_1_exporter,	hsa02010:ABC transporters,			SM00382:AAA,	KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0318~Glutathionylation,	DOMAIN:ABC transmembrane type-1,DOMAIN:ABC transporter,MUTAGEN:C->G: Does not affect ATPase activity; when associated with S-215 and L-224. Activated by Zn (II) mesoporphyrin; when associated with S-215 and L-224.,MUTAGEN:C->L: Does not affect ATPase activity; when associated withS-215 and G-582. Activated by Zn (II) mesoporphyrin; when associated with S-215 and G-582.,MUTAGEN:C->S: Does not affect ATPase activity; when associated with L-224 and G-582. Activated by Zn (II) mesoporphyrin; when associated with L-224 and G-582.,MUTAGEN:D->A: Does not rescue hemoglobin and heme biosynthetic process.,MUTAGEN:E->A: Does not rescue hemoglobin and heme biosynthetic process.,MUTAGEN:K->E: Increases hemoglobin biosynthetic process.,MUTAGEN:Q->H: Does not rescue hemoglobin and heme biosynthetic process.,MUTAGEN:S->R: Does not rescue hemoglobin and heme biosynthetic process.,TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSIT:Mitochondrion,TRANSMEM:Helical,
B8K1W2	ATP binding cassette subfamily B member 11(ABCB11)	Canis lupus familiaris			GO:0006631~fatty acid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0006855~drug transmembrane transport,GO:0008206~bile acid metabolic process,GO:0015721~bile acid and bile salt transport,GO:0015722~canalicular bile acid transport,GO:0016567~protein ubiquitination,GO:0031998~regulation of fatty acid beta-oxidation,GO:0042632~cholesterol homeostasis,GO:0046618~drug export,GO:0055085~transmembrane transport,GO:0055091~phospholipid homeostasis,GO:1904251~regulation of bile acid metabolic process,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0046581~intercellular canaliculus,GO:0046691~intracellular canaliculus,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,	GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0015125~bile acid transmembrane transporter activity,GO:0015126~canalicular bile acid transmembrane transporter activity,GO:0015432~bile acid-exporting ATPase activity,GO:0016887~ATPase activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR011527:ABC1_TM_dom,IPR017871:ABC_transporter-like_CS,IPR027417:P-loop_NTPase,IPR036640:ABC1_TM_sf,IPR039421:Type_1_exporter,	cfa01522:Endocrine resistance,cfa02010:ABC transporters,cfa04976:Bile secretion,cfa04979:Cholesterol metabolism,			SM00382:AAA,	KW-0813~Transport,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:ABC transmembrane type-1,DOMAIN:ABC transmembrane type-1 1,DOMAIN:ABC transmembrane type-1 2,DOMAIN:ABC transporter,DOMAIN:ABC transporter 1,DOMAIN:ABC transporter 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O95342	ATP binding cassette subfamily B member 11(ABCB11)	Homo sapiens		h_mrpPathway:Multi-Drug Resistance Factors,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	GO:0006631~fatty acid metabolic process,GO:0006699~bile acid biosynthetic process,GO:0006805~xenobiotic metabolic process,GO:0006855~drug transmembrane transport,GO:0006979~response to oxidative stress,GO:0008206~bile acid metabolic process,GO:0014070~response to organic cyclic compound,GO:0015721~bile acid and bile salt transport,GO:0015722~canalicular bile acid transport,GO:0016567~protein ubiquitination,GO:0031998~regulation of fatty acid beta-oxidation,GO:0034219~carbohydrate transmembrane transport,GO:0038183~bile acid signaling pathway,GO:0042632~cholesterol homeostasis,GO:0043627~response to estrogen,GO:0045471~response to ethanol,GO:0046618~drug export,GO:0055085~transmembrane transport,GO:0055088~lipid homeostasis,GO:0055091~phospholipid homeostasis,GO:1904251~regulation of bile acid metabolic process,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0046581~intercellular canaliculus,GO:0046691~intracellular canaliculus,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0015125~bile acid transmembrane transporter activity,GO:0015126~canalicular bile acid transmembrane transporter activity,GO:0015144~carbohydrate transmembrane transporter activity,GO:0015432~bile acid-exporting ATPase activity,GO:0016887~ATPase activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR011527:ABC1_TM_dom,IPR017871:ABC_transporter-like_CS,IPR027417:P-loop_NTPase,IPR036640:ABC1_TM_sf,IPR039421:Type_1_exporter,	hsa01522:Endocrine resistance,hsa02010:ABC transporters,hsa04976:Bile secretion,hsa04979:Cholesterol metabolism,	601847~Cholestasis, progressive familial intrahepatic 2,605479~Cholestasis, benign recurrent intrahepatic, 2,		SM00382:AAA,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0988~Intrahepatic cholestasis,	KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:ABC transmembrane type-1,DOMAIN:ABC transmembrane type-1 1,DOMAIN:ABC transmembrane type-1 2,DOMAIN:ABC transporter,DOMAIN:ABC transporter 1,DOMAIN:ABC transporter 2,MUTAGEN:Missing: Does not affect ATPase-coupled bile acid transport activity. Decreases protein stability.,MUTAGEN:Y->A: Loss of interaction with AP2A1 and AP2A2. Promotes ABCB11 plasma membrane trafficking. Does not affect plasma membrane localization. Inhibits ABCB11 internalization.,REGION:Disordered,REGION:Interaction with HAX1,REGION:Mediates internalization from the plasma membrane,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9H222	ATP binding cassette subfamily G member 5(ABCG5)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	GO:0006869~lipid transport,GO:0007584~response to nutrient,GO:0009410~response to xenobiotic stimulus,GO:0010212~response to ionizing radiation,GO:0010949~negative regulation of intestinal phytosterol absorption,GO:0014850~response to muscle activity,GO:0015918~sterol transport,GO:0030299~intestinal cholesterol absorption,GO:0033344~cholesterol efflux,GO:0038183~bile acid signaling pathway,GO:0042632~cholesterol homeostasis,GO:0045796~negative regulation of intestinal cholesterol absorption,GO:0055085~transmembrane transport,GO:0070328~triglyceride homeostasis,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,GO:0043235~receptor complex,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR013525:ABC2_TM,IPR027417:P-loop_NTPase,IPR043926:ABCG_dom,	hsa02010:ABC transporters,hsa04975:Fat digestion and absorption,hsa04976:Bile secretion,hsa04979:Cholesterol metabolism,	618666~Sitosterolemia 2,		SM00382:AAA,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:ABC transmembrane type-2,DOMAIN:ABC transporter,MUTAGEN:A->F: Strongly decreases cholesterol secretion into bile.,MUTAGEN:KT->RA: Abolishes increase of the very low basal ATPase activity by cholate.,MUTAGEN:Y->A: Strongly decreases cholesterol secretion into bile.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q91V92	ATP citrate lyase(Acly)	Mus musculus		m_malatexPathway:Shuttle for transfer of acetyl groups from mitochondria to the cytosol,	GO:0006084~acetyl-CoA metabolic process,GO:0006085~acetyl-CoA biosynthetic process,GO:0006099~tricarboxylic acid cycle,GO:0006101~citrate metabolic process,GO:0006107~oxaloacetate metabolic process,GO:0006629~lipid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0008610~lipid biosynthetic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0003878~ATP citrate synthase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0046912~transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,	IPR002020:Citrate_synthase,IPR003781:CoA-bd,IPR005809:Succ_CoA_synthase_bsu,IPR005811:CoA_ligase,IPR014608:ATP-citrate_synthase,IPR016102:Succinyl-CoA_synth-like,IPR016142:Citrate_synth-like_lrg_a-sub,IPR016143:Citrate_synth-like_sm_a-sub,IPR017440:Cit_synth/succinyl-CoA_lig_AS,IPR017866:Succ-CoA_synthase_bsu_CS,IPR032263:Citrate-bd,IPR033847:Citrt_syn/SCS-alpha_CS,IPR036291:NAD(P)-bd_dom_sf,IPR036969:Citrate_synthase_sf,	mmu00020:Citrate cycle (TCA cycle),mmu01100:Metabolic pathways,		PIRSF036511:ATP_citrt_syn,	SM00881:CoA_binding,	KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Tele-phosphohistidine intermediate,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,DOMAIN:ATP-citrate lyase/succinyl-CoA ligase,DOMAIN:ATP-citrate synthase citrate-binding,DOMAIN:ATP-grasp,DOMAIN:CoA-binding,MUTAGEN:K->R: Abolished ubiquitination by the BCR(KLHL25)complex, leading to imapired differentiation of inducible regulatory T (iTreg) cells; when associated with R-530 and R-536.,MUTAGEN:K->R: Abolished ubiquitination by the BCR(KLHL25)complex, leading to imapired differentiation of inducible regulatory T (iTreg) cells; when associated with R-530 and R-544.,MUTAGEN:K->R: Abolished ubiquitination by the BCR(KLHL25)complex, leading to imapired differentiation of inducible regulatory T (iTreg) cells; when associated with R-536 and R-544.,REGION:Disordered,
Q5RFH0	ATP synthase membrane subunit g(ATP5MG)	Pongo abelii			GO:0015986~ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005753~mitochondrial proton-transporting ATP synthase complex,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR006808:ATP_synth_F0_gsu_mt,IPR016702:ATP_synth_su_G_mt_met,	pon00190:Oxidative phosphorylation,pon01100:Metabolic pathways,pon04714:Thermogenesis,		PIRSF017835:ATP-synth_g_mitoch_animal,		KW-0066~ATP synthesis,KW-0375~Hydrogen ion transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0138~CF(0),KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,						KW-0007~Acetylation,
Q1L987	ATP synthase mitochondrial F1 complex assembly factor 1(atpaf1)	Danio rerio			GO:0033615~mitochondrial proton-transporting ATP synthase complex assembly,GO:0065003~macromolecular complex assembly,	GO:0005739~mitochondrion,		IPR010591:ATP11,						KW-0496~Mitochondrion,			KW-0809~Transit peptide,				TRANSIT:Mitochondrion,
B2RX12	ATP-binding cassette, sub-family C member 3(Abcc3)	Mus musculus		m_mrpPathway:Multi-Drug Resistance Factors,m_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	GO:0006855~drug transmembrane transport,GO:0006869~lipid transport,GO:0015721~bile acid and bile salt transport,GO:0015722~canalicular bile acid transport,GO:0042908~xenobiotic transport,GO:0055085~transmembrane transport,GO:0071716~leukotriene transport,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0098590~plasma membrane region,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0015164~glucuronoside transmembrane transporter activity,GO:0015431~glutathione S-conjugate-exporting ATPase activity,GO:0015432~bile acid-exporting ATPase activity,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042910~xenobiotic transporter activity,GO:0071714~icosanoid transmembrane transporter activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR005292:MRP,IPR011527:ABC1_TM_dom,IPR017871:ABC_transporter-like_CS,IPR027417:P-loop_NTPase,IPR036640:ABC1_TM_sf,	mmu01523:Antifolate resistance,mmu02010:ABC transporters,mmu04976:Bile secretion,			SM00382:AAA,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:ABC transmembrane type-1,DOMAIN:ABC transmembrane type-1 1,DOMAIN:ABC transmembrane type-1 2,DOMAIN:ABC transporter,DOMAIN:ABC transporter 1,DOMAIN:ABC transporter 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=13,TRANSMEM:Helical; Name=14,TRANSMEM:Helical; Name=15,TRANSMEM:Helical; Name=16,TRANSMEM:Helical; Name=17,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q99LE6	ATP-binding cassette, sub-family F member 2(Abcf2)	Mus musculus				GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR017871:ABC_transporter-like_CS,IPR027417:P-loop_NTPase,IPR032781:ABC_tran_Xtn,				SM00382:AAA,					KW-0175~Coiled coil,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:ABC transporter,DOMAIN:ABC transporter 1,DOMAIN:ABC transporter 2,REGION:Disordered,
Q2HZ96	ATPase Na+/K+ transporting family member beta 4(ATP1B4)	Gallus gallus			GO:0006355~regulation of transcription, DNA-templated,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:1902600~hydrogen ion transmembrane transport,	GO:0005637~nuclear inner membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,		IPR000402:Na/K_ATPase_sub_beta,IPR038702:Na/K_ATPase_sub_beta_sf,	gga04260:Cardiac muscle contraction,gga04261:Adrenergic signaling in cardiomyocytes,				KW-0375~Hydrogen ion transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9ULI0	ATPase family AAA domain containing 2B(ATAD2B)	Homo sapiens			GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003682~chromatin binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042393~histone binding,GO:0070577~lysine-acetylated histone binding,	IPR001487:Bromodomain,IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR003960:ATPase_AAA_CS,IPR018359:Bromodomain_CS,IPR027417:P-loop_NTPase,IPR036427:Bromodomain-like_sf,IPR041569:AAA_lid_3,IPR045199:ATAD2-like,				SM00297:BROMO,SM00382:AAA,		KW-0539~Nucleus,			KW-0103~Bromodomain,KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:AAA ATPase AAA+ lid,DOMAIN:Bromo,REGION:Disordered,
Q4QY64	ATPase family, AAA domain containing 5(Atad5)	Mus musculus			GO:0002377~immunoglobulin production,GO:0006974~cellular response to DNA damage stimulus,GO:0008283~cell proliferation,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0030890~positive regulation of B cell proliferation,GO:0033260~nuclear DNA replication,GO:0042770~signal transduction in response to DNA damage,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0045190~isotype switching,GO:0045740~positive regulation of DNA replication,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0090304~nucleic acid metabolic process,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902751~positive regulation of cell cycle G2/M phase transition,	GO:0005634~nucleus,GO:0031391~Elg1 RFC-like complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR027417:P-loop_NTPase,				SM00382:AAA,	KW-0227~DNA damage,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:AAA+ ATPase,MOTIF:LXCXE motif,REGION:Disordered,REGION:Interaction with RAD51 and RFC5,REGION:Interaction with WDR48,
Q9Y2Q0	ATPase phospholipid transporting 8A1(ATP8A1)	Homo sapiens			GO:0007612~learning,GO:0015914~phospholipid transport,GO:0030335~positive regulation of cell migration,GO:0034220~ion transmembrane transport,GO:0045332~phospholipid translocation,GO:0061092~positive regulation of phospholipid translocation,GO:0098655~cation transmembrane transport,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0030672~synaptic vesicle membrane,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0035577~azurophil granule membrane,GO:0035579~specific granule membrane,GO:0042584~chromaffin granule membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,GO:1990531~Lem3p-Dnf1p complex,	GO:0000287~magnesium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019829~cation-transporting ATPase activity,GO:0090556~phosphatidylserine-translocating ATPase activity,	IPR001757:P_typ_ATPase,IPR006539:P-type_ATPase_IV,IPR008250:ATPase_P-typ_transduc_dom_A_sf,IPR018303:ATPase_P-typ_P_site,IPR023214:HAD_sf,IPR023298:ATPase_P-typ_TM_dom_sf,IPR023299:ATPase_P-typ_cyto_dom_N,IPR032630:P_typ_ATPase_c,IPR032631:P-type_ATPase_N,IPR036412:HAD-like_sf,IPR044492:P_typ_ATPase_HD_dom,	hsa04148:Efferocytosis,				KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0597~Phosphoprotein,	ACT_SITE:4-aspartylphosphate intermediate,COMPBIAS:Basic and acidic residues,DOMAIN:P-type ATPase C-terminal,DOMAIN:P-type ATPase N-terminal,REGION:Disordered,SITE:Involved in the recognition of the lipid substrate on the exoplasmic side,SITE:Involved in the release of the transported lipid into the cytosolic leaflet,TOPO_DOM:Cytoplasmic,TOPO_DOM:Exoplasmic loop,TRANSMEM:Helical,
P98198	ATPase phospholipid transporting 8B2(ATP8B2)	Homo sapiens			GO:0007030~Golgi organization,GO:0015914~phospholipid transport,GO:0034220~ion transmembrane transport,GO:0045332~phospholipid translocation,	GO:0005730~nucleolus,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016020~membrane,GO:1990531~Lem3p-Dnf1p complex,	GO:0000287~magnesium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0090554~phosphatidylcholine-translocating ATPase activity,	IPR001757:P_typ_ATPase,IPR006539:P-type_ATPase_IV,IPR008250:ATPase_P-typ_transduc_dom_A_sf,IPR018303:ATPase_P-typ_P_site,IPR023214:HAD_sf,IPR023298:ATPase_P-typ_TM_dom_sf,IPR023299:ATPase_P-typ_cyto_dom_N,IPR032630:P_typ_ATPase_c,IPR032631:P-type_ATPase_N,IPR036412:HAD-like_sf,IPR044492:P_typ_ATPase_HD_dom,					KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0597~Phosphoprotein,	ACT_SITE:4-aspartylphosphate intermediate,DOMAIN:P-type ATPase C-terminal,DOMAIN:P-type ATPase N-terminal,MUTAGEN:D->N: Impairs ATPase activity.,MUTAGEN:E->Q: Impairs ATPase flippase activity.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Exoplasmic loop,TRANSMEM:Helical,
O75110	ATPase phospholipid transporting 9A (putative)(ATP9A)	Homo sapiens			GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006897~endocytosis,GO:0015914~phospholipid transport,GO:0045332~phospholipid translocation,GO:0048812~neuron projection morphogenesis,GO:1903542~negative regulation of exosomal secretion,GO:1905279~regulation of retrograde transport, endosome to Golgi,GO:2001135~regulation of endocytic recycling,	GO:0005768~endosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0031901~early endosome membrane,GO:0031902~late endosome membrane,GO:0032588~trans-Golgi network membrane,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,	GO:0000287~magnesium ion binding,GO:0002020~protease binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR001757:P_typ_ATPase,IPR006539:P-type_ATPase_IV,IPR008250:ATPase_P-typ_transduc_dom_A_sf,IPR018303:ATPase_P-typ_P_site,IPR023214:HAD_sf,IPR023298:ATPase_P-typ_TM_dom_sf,IPR023299:ATPase_P-typ_cyto_dom_N,IPR032630:P_typ_ATPase_c,IPR032631:P-type_ATPase_N,IPR036412:HAD-like_sf,IPR044492:P_typ_ATPase_HD_dom,		620242~Neurodevelopmental disorder with poor growth and behavioral abnormalities,			KW-0445~Lipid transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0007~Acetylation,	ACT_SITE:4-aspartylphosphate intermediate,DOMAIN:P-type ATPase C-terminal,DOMAIN:P-type ATPase N-terminal,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O54827	ATPase, class V, type 10A(Atp10a)	Mus musculus			GO:0006869~lipid transport,GO:0015914~phospholipid transport,GO:0045332~phospholipid translocation,GO:1903527~positive regulation of membrane tubulation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:1990531~Lem3p-Dnf1p complex,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0046872~metal ion binding,GO:0090554~phosphatidylcholine-translocating ATPase activity,	IPR001757:P_typ_ATPase,IPR006539:P-type_ATPase_IV,IPR008250:ATPase_P-typ_transduc_dom_A_sf,IPR018303:ATPase_P-typ_P_site,IPR023214:HAD_sf,IPR023298:ATPase_P-typ_TM_dom_sf,IPR023299:ATPase_P-typ_cyto_dom_N,IPR032630:P_typ_ATPase_c,IPR032631:P-type_ATPase_N,IPR036412:HAD-like_sf,IPR044492:P_typ_ATPase_HD_dom,					KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0597~Phosphoprotein,	ACT_SITE:4-aspartylphosphate intermediate,COMPBIAS:Basic and acidic residues,DOMAIN:P-type ATPase C-terminal,DOMAIN:P-type ATPase N-terminal,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Exoplasmic loop,TRANSMEM:Helical,
Q58EA2	Aly/REF export factor L homeolog(alyref.L)	Xenopus laevis			GO:0006397~mRNA processing,GO:0006405~RNA export from nucleus,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR025715:FoP_C,IPR035979:RBD_domain_sf,	xla03013:Nucleocytoplasmic transport,xla03015:mRNA surveillance pathway,xla03040:Spliceosome,xla05168:Herpes simplex virus 1 infection,			SM00360:RRM,SM01218:FoP_duplication,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0509~mRNA transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0143~Chaperone,KW-0694~RNA-binding,		COMPBIAS:Polar residues,DOMAIN:RRM,REGION:Disordered,
Q99490	ArfGAP with GTPase domain, ankyrin repeat and PH domain 2(AGAP2)	Homo sapiens			GO:0007259~JAK-STAT cascade,GO:0015031~protein transport,GO:0016197~endosomal transport,GO:0030036~actin cytoskeleton organization,GO:0033598~mammary gland epithelial cell proliferation,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0042177~negative regulation of protein catabolic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045860~positive regulation of protein kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046488~phosphatidylinositol metabolic process,GO:0051897~positive regulation of protein kinase B signaling,GO:0060749~mammary gland alveolus development,GO:0090630~activation of GTPase activity,GO:1904019~epithelial cell apoptotic process,GO:1904036~negative regulation of epithelial cell apoptotic process,GO:1905430~cellular response to glycine,GO:2000010~positive regulation of protein localization to cell surface,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0070062~extracellular exosome,GO:0090543~Flemming body,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,	GO:0003924~GTPase activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0019901~protein kinase binding,GO:0030295~protein kinase activator activity,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0035255~ionotropic glutamate receptor binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,	IPR001164:ArfGAP_dom,IPR001806:Small_GTPase,IPR001849:PH_domain,IPR002110:Ankyrin_rpt,IPR011993:PH-like_dom_sf,IPR027417:P-loop_NTPase,IPR036770:Ankyrin_rpt-contain_sf,IPR037278:ARFGAP/RecO,IPR038508:ArfGAP_dom_sf,	hsa04068:FoxO signaling pathway,hsa04144:Endocytosis,			SM00105:ArfGap,SM00173:RAS,SM00175:RAB,SM00233:PH,	KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,	KW-0040~ANK repeat,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0342~GTP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0343~GTPase activation,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Arf-GAP,DOMAIN:PH,REGION:Disordered,REGION:G domain,REGION:Interaction with EPB41L1,REGION:Interaction with PLCG1,REGION:Interactions with HOMER1 and NF2,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,ZN_FING:C4-type,
Q6IVG4	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2(ACAP2)	Oryctolagus cuniculus			GO:0030029~actin filament-based process,GO:0032456~endocytic recycling,GO:1990090~cellular response to nerve growth factor stimulus,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0010008~endosome membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001164:ArfGAP_dom,IPR001849:PH_domain,IPR002110:Ankyrin_rpt,IPR004148:BAR_dom,IPR011993:PH-like_dom_sf,IPR027267:AH/BAR_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,IPR037278:ARFGAP/RecO,IPR038508:ArfGAP_dom_sf,IPR045258:ACAP1/2/3-like,	ocu04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,		KW-0472~Membrane,KW-0967~Endosome,			KW-0040~ANK repeat,KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0343~GTPase activation,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Arf-GAP,DOMAIN:BAR,DOMAIN:PH,REGION:Disordered,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,ZN_FING:C4-type,
Q8WV28	B cell linker(BLNK)	Homo sapiens		h_bcrPathway:BCR Signaling Pathway,	GO:0006954~inflammatory response,GO:0006959~humoral immune response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0010628~positive regulation of gene expression,GO:0030183~B cell differentiation,GO:0035556~intracellular signal transduction,GO:0050853~B cell receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0035591~signaling adaptor activity,GO:0042169~SH2 domain binding,GO:0043274~phospholipase binding,GO:1990782~protein tyrosine kinase binding,	IPR000980:SH2,IPR036860:SH2_dom_sf,	hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04662:B cell receptor signaling pathway,hsa05169:Epstein-Barr virus infection,hsa05340:Primary immunodeficiency,	613502~Agammaglobulinemia 4,		SM00252:SH2,	KW-0075~B-cell activation,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0727~SH2 domain,			KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DOMAIN:SH2,MUTAGEN:Y->F: Significant phosphorylation reduction; when associated with F-72; F-84 and F-178.,MUTAGEN:Y->F: Significant phosphorylation reduction; when associated with F-72; F-84 and F-96.,MUTAGEN:Y->F: Significant phosphorylation reduction; when associated with F-72; F-96 and F-178.,MUTAGEN:Y->F: Significant phosphorylation reduction; when associated with F-84; F-96 and F-178.,REGION:Disordered,
Q5ZM39	B-cell CLL/lymphoma 6(BCL6)	Gallus gallus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0001817~regulation of cytokine production,GO:0001953~negative regulation of cell-matrix adhesion,GO:0002467~germinal center formation,GO:0002682~regulation of immune system process,GO:0002829~negative regulation of type 2 immune response,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0007266~Rho protein signal transduction,GO:0007283~spermatogenesis,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0030036~actin cytoskeleton organization,GO:0030183~B cell differentiation,GO:0030308~negative regulation of cell growth,GO:0030890~positive regulation of B cell proliferation,GO:0032764~negative regulation of mast cell cytokine production,GO:0035024~negative regulation of Rho protein signal transduction,GO:0042092~type 2 immune response,GO:0042127~regulation of cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043087~regulation of GTPase activity,GO:0043380~regulation of memory T cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048294~negative regulation of isotype switching to IgE isotypes,GO:0048821~erythrocyte development,GO:0050727~regulation of inflammatory response,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ_dom,IPR011333:SKP1/BTB/POZ_sf,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,	gga04068:FoxO signaling pathway,			SM00225:BTB,SM00355:ZnF_C2H2,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,		COMPBIAS:Polar residues,DOMAIN:BTB,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,
Q4KM52	B-cell linker(Blnk)	Rattus norvegicus			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0010628~positive regulation of gene expression,GO:0035556~intracellular signal transduction,GO:0042113~B cell activation,GO:0050853~B cell receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0008289~lipid binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0035591~signaling adaptor activity,GO:0042169~SH2 domain binding,GO:0043274~phospholipase binding,GO:1990782~protein tyrosine kinase binding,	IPR000980:SH2,IPR036860:SH2_dom_sf,	rno04064:NF-kappa B signaling pathway,rno04380:Osteoclast differentiation,rno04662:B cell receptor signaling pathway,rno05169:Epstein-Barr virus infection,rno05340:Primary immunodeficiency,			SM00252:SH2,	KW-0075~B-cell activation,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0727~SH2 domain,			KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DOMAIN:SH2,REGION:Disordered,
Q99933	BAG cochaperone 1(BAG1)	Homo sapiens			GO:0006915~apoptotic process,GO:0007166~cell surface receptor signaling pathway,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0050821~protein stabilization,GO:0051085~chaperone mediated protein folding requiring cofactor,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0051087~chaperone binding,	IPR000626:Ubiquitin-like_dom,IPR003103:BAG_domain,IPR017093:BAG-1,IPR029071:Ubiquitin-like_domsf,IPR036533:BAG_dom_sf,IPR039773:BAG_chaperone_regulator,	hsa04141:Protein processing in endoplasmic reticulum,		PIRSF037029:BAG_1,	SM00213:UBQ,SM00264:BAG,	KW-0053~Apoptosis,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0143~Chaperone,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BAG,DOMAIN:Ubiquitin-like,MUTAGEN:RK->AA: Significant loss of interaction with HSPA8.,REGION:7 X 6 AA tandem repeat of E-E-X(4),REGION:Disordered,REGION:Interaction with HSPA8,REGION:Interaction with PPP1R15A,REPEAT:1,REPEAT:2,REPEAT:3,REPEAT:4,REPEAT:5,REPEAT:6,REPEAT:7,
Q9DBJ3	BAI1-associated protein 2-like 1(Baiap2l1)	Mus musculus			GO:0007009~plasma membrane organization,GO:0030833~regulation of actin filament polymerization,GO:0030838~positive regulation of actin filament polymerization,GO:0032956~regulation of actin cytoskeleton organization,GO:0051017~actin filament bundle assembly,GO:0051764~actin crosslink formation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,	GO:0003779~actin binding,GO:0070064~proline-rich region binding,	IPR001452:SH3_domain,IPR013606:I-BAR_dom,IPR027267:AH/BAR_dom_sf,IPR027681:IRSp53/IRTKS/Pinkbar,IPR030060:Baiap2l1_I-BAR_dom,IPR035592:IRTKS_SH3,IPR036028:SH3-like_dom_sf,				SM00326:SH3,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0728~SH3 domain,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:IMD,DOMAIN:SH3,REGION:Binds F-actin,REGION:Disordered,
Q58DL5	BCAR3 adaptor protein, NSP family member(BCAR3)	Bos taurus			GO:0002089~lens morphogenesis in camera-type eye,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0043410~positive regulation of MAPK cascade,GO:0043547~positive regulation of GTPase activity,GO:0086100~endothelin receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0016020~membrane,	GO:0001784~phosphotyrosine binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0019900~kinase binding,	IPR000980:SH2,IPR001895:RASGEF_cat_dom,IPR023578:Ras_GEF_dom_sf,IPR036860:SH2_dom_sf,IPR036964:RASGEF_cat_dom_sf,IPR044102:SH2_SHEP1/BCAR3/NSP1,				SM00147:RasGEF,SM00252:SH2,		KW-0963~Cytoplasm,KW-0965~Cell junction,			KW-0727~SH2 domain,		KW-0344~Guanine-nucleotide releasing factor,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Ras-GEF,DOMAIN:SH2,REGION:Disordered,REGION:Mediates the interaction with BCAR1/p130CAS,SITE:Required for interaction with NEDD9,
Q6DC66	BCL2 family apoptosis regulator BOK a(boka)	Danio rerio			GO:0006915~apoptotic process,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0042981~regulation of apoptotic process,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005741~mitochondrial outer membrane,GO:0016020~membrane,	GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002475:Bcl2-like,IPR026298:Bcl-2_fam,IPR036834:Bcl-2-like_sf,IPR046371:Bcl-2_BH1-3,				SM00337:BCL,	KW-0053~Apoptosis,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:Bcl-2 Bcl-2 homology region 1-3,MOTIF:BH1,MOTIF:BH2,MOTIF:BH3,MOTIF:BH4,TRANSMEM:Helical,
Q7T381	BCL2 family apoptosis regulator BOK b(bokb)	Danio rerio			GO:0006915~apoptotic process,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0042981~regulation of apoptotic process,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005741~mitochondrial outer membrane,GO:0016020~membrane,	GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002475:Bcl2-like,IPR003093:Bcl2_BH4,IPR026298:Bcl-2_fam,IPR036834:Bcl-2-like_sf,IPR046371:Bcl-2_BH1-3,				SM00337:BCL,	KW-0053~Apoptosis,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:Apoptosis regulator Bcl-2 family BH4,MOTIF:BH1,MOTIF:BH2,MOTIF:BH3,MOTIF:BH4,TRANSMEM:Helical,
Q9BXK5	BCL2 like 13(BCL2L13)	Homo sapiens			GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0042981~regulation of apoptotic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0031966~mitochondrial membrane,	GO:0005515~protein binding,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,	IPR002475:Bcl2-like,IPR036834:Bcl-2-like_sf,IPR042398:BCL2L13,IPR046371:Bcl-2_BH1-3,	hsa04137:Mitophagy - animal,hsa05134:Legionellosis,				KW-0053~Apoptosis,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Bcl-2 Bcl-2 homology region 1-3,MOTIF:BH1,MOTIF:BH2,MOTIF:BH3,MOTIF:BH4,REGION:Disordered,REPEAT:A,REPEAT:A; approximate,REPEAT:B,REPEAT:B; approximate,TRANSMEM:Helical,
Q91YN9	BCL2-associated athanogene 2(Bag2)	Mus musculus			GO:0010954~positive regulation of protein processing,GO:0019538~protein metabolic process,GO:0031397~negative regulation of protein ubiquitination,GO:0032091~negative regulation of protein binding,GO:0050821~protein stabilization,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1904667~negative regulation of ubiquitin protein ligase activity,	GO:0005874~microtubule,GO:0030424~axon,GO:0030425~dendrite,GO:0101031~chaperone complex,GO:1901588~dendritic microtubule,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0044325~ion channel binding,GO:0048156~tau protein binding,GO:0051087~chaperone binding,	IPR003103:BAG_domain,IPR037689:BAG2,	mmu04141:Protein processing in endoplasmic reticulum,			SM00264:BAG,					KW-0175~Coiled coil,		KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:BAG,REGION:Disordered,
Q5H9F3	BCL6 corepressor like 1(BCORL1)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,	GO:0003714~transcription corepressor activity,	IPR002110:Ankyrin_rpt,IPR032365:PUFD,IPR036770:Ankyrin_rpt-contain_sf,IPR038227:PUFD_som_sf,IPR047144:BCOR-like,	hsa03083:Polycomb repressive complex,	301029~Shukla-Vernon syndrome,		SM00248:ANK,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0225~Disease variant,KW-0991~Intellectual disability,KW-1268~Autism spectrum disorder,	KW-0040~ANK repeat,KW-0677~Repeat,		KW-0156~Chromatin regulator,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BCL-6 corepressor PCGF1 binding,MOTIF:Nuclear localization signal,MUTAGEN:DL->AS: Strongly reduced repressor activity. Interferes with CTBP1 binding.,MUTAGEN:L->D,R: Slightly inhibits interaction with PCGF1.,REGION:Disordered,REGION:PCGF Ub-like fold domain (PUFD); required for the interaction with the KDM2B-SKP1 heterodimeric complex,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,
Q8TD16	BICD cargo adaptor 2(BICD2)	Homo sapiens			GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007018~microtubule-based movement,GO:0015031~protein transport,GO:0034067~protein localization to Golgi apparatus,GO:0051028~mRNA transport,GO:0051642~centrosome localization,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0072385~minus-end-directed organelle transport along microtubule,GO:0072393~microtubule anchoring at microtubule organizing center,	GO:0005635~nuclear envelope,GO:0005642~annulate lamellae,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0031267~small GTPase binding,GO:0034452~dynactin binding,GO:0051959~dynein light intermediate chain binding,GO:0070840~dynein complex binding,	IPR018477:BICD,	hsa03250:Viral life cycle - HIV-1,	615290~Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant,618291~Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant,			KW-0509~mRNA transport,KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0539~Nucleus,KW-0906~Nuclear pore complex,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0523~Neurodegeneration,	KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,REGION:Interaction with KIF5A,REGION:Interaction with RANBP2,REGION:Interacts with DYNLL1, DYNC1H1, DYNC1I2, DCTN1 and DCTN2,REGION:Interacts with RAB6A,
Q9BWV1	BOC cell adhesion associated, oncogene regulated(BOC)	Homo sapiens			GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0045663~positive regulation of myoblast differentiation,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0030424~axon,GO:0044295~axonal growth cone,	GO:0005515~protein binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,	hsa04340:Hedgehog signaling pathway,hsa04360:Axon guidance,			SM00060:FN3,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8CFK2	BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit(Brf1)	Mus musculus		m_RNApol3Pathway:RNA polymerase III transcription,	GO:0006352~DNA-templated transcription, initiation,GO:0006383~transcription from RNA polymerase III promoter,GO:0043488~regulation of mRNA stability,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0070897~DNA-templated transcriptional preinitiation complex assembly,	GO:0000126~transcription factor TFIIIB complex,GO:0005634~nucleus,GO:0097550~transcriptional preinitiation complex,	GO:0000995~transcription factor activity, core RNA polymerase III binding,GO:0001006~RNA polymerase III type 3 promoter sequence-specific DNA binding,GO:0017025~TBP-class protein binding,GO:0046872~metal ion binding,	IPR000812:TFIIB,IPR011665:BRF1_TBP-bd_dom,IPR013137:Znf_TFIIB,IPR013150:TFIIB_cyclin,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,				SM00385:CYCLIN,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DOMAIN:Brf1 TBP-binding,DOMAIN:TFIIB-type,REGION:Disordered,REPEAT:1,REPEAT:2,ZN_FING:TFIIB-type,
Q6AXK4	BRISC and BRCA1 A complex member 1(babam1)	Danio rerio			GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006325~chromatin organization,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0010212~response to ionizing radiation,GO:0045739~positive regulation of DNA repair,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016604~nuclear body,GO:0070531~BRCA1-A complex,GO:0070552~BRISC complex,		IPR026126:BABAM1,IPR036465:vWFA_dom_sf,	dre03440:Homologous recombination,				KW-0131~Cell cycle,KW-0132~Cell division,KW-0227~DNA damage,KW-0234~DNA repair,KW-0498~Mitosis,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0156~Chromatin regulator,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:VWFA-like,
P97303	BTB and CNC homology, basic leucine zipper transcription factor 2(Bach2)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0051170~nuclear import,GO:0090721~primary adaptive immune response involving T cells and B cells,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043167~ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000210:BTB/POZ_dom,IPR004826:bZIP_Maf,IPR004827:bZIP,IPR008917:TF_DNA-bd_sf,IPR011333:SKP1/BTB/POZ_sf,IPR043321:bZIP_BACH,IPR046347:bZIP_sf,IPR047167:NFE2-like,				SM00225:BTB,SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DISULFID:Interchain; redox-active,DOMAIN:BTB,DOMAIN:BZIP,DOMAIN:bZIP,MOTIF:Nuclear export signal,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
O43683	BUB1 mitotic checkpoint serine/threonine kinase(BUB1)	Homo sapiens			GO:0006338~chromatin remodeling,GO:0006915~apoptotic process,GO:0007059~chromosome segregation,GO:0007063~regulation of sister chromatid cohesion,GO:0007094~mitotic spindle assembly checkpoint,GO:0016310~phosphorylation,GO:0051301~cell division,GO:0051754~meiotic sister chromatid cohesion, centromeric,GO:0051983~regulation of chromosome segregation,GO:2000720~positive regulation of maintenance of mitotic sister chromatid cohesion, centromeric,	GO:0000776~kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0043229~intracellular organelle,GO:0043231~intracellular membrane-bounded organelle,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013212:Mad3/Bub1_I,IPR015661:Bub1/Mad3,IPR017441:Protein_kinase_ATP_BS,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,	114500~Colorectal cancer with chromosomal instability, somatic,620183~Microcephaly 30, primary, autosomal recessive,		SM00220:S_TKc,SM00777:Mad3_BUB1_I,	KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,KW-0945~Host-virus interaction,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,		KW-0905~Primary microcephaly,KW-0991~Intellectual disability,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,DOMAIN:BUB1 N-terminal,DOMAIN:Protein kinase,MOTIF:KEN box 1,MOTIF:KEN box 2,MOTIF:Nuclear localization signal,MUTAGEN:A->D,W: Loss of interaction with KNL1.,MUTAGEN:A->S: Partial rescue of the spindle-assembly checkpoint activity. Increased rate of chromosome congression errors. Impaired localization to kinetochores and loss of kinetochore binding of CENPF, SGO1 and BUBR1 but not of MCAK, MAD1L1 or MAD2L1.,MUTAGEN:E->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-535 and A-537.,MUTAGEN:E->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-625 and A-627.,MUTAGEN:K->A: Loss of activity.,MUTAGEN:K->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-536 and A-537.,MUTAGEN:K->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-626 and A-627.,MUTAGEN:L->G: Loss of interaction with KNL1.,MUTAGEN:N->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-535 and A-536.,MUTAGEN:N->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-625 and A-626.,MUTAGEN:T->A: Diminished interaction with PLK1.,REGION:Disordered,REGION:Essential for loading of BUBR1, MAD1L1 and MAD2L1 to kinetochores,REGION:Necessary for interaction with BUB3,REGION:Necessary for interaction with KNL1,REGION:Necessary for kinetochore localization,
Q9Z1S0	BUB1B, mitotic checkpoint serine/threonine kinase(Bub1b)	Mus musculus			GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007091~metaphase/anaphase transition of mitotic cell cycle,GO:0007094~mitotic spindle assembly checkpoint,GO:0016310~phosphorylation,GO:0051301~cell division,GO:0051754~meiotic sister chromatid cohesion, centromeric,GO:0071459~protein localization to chromosome, centromeric region,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005829~cytosol,GO:0033597~mitotic checkpoint complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR011009:Kinase-like_dom_sf,IPR013212:Mad3/Bub1_I,IPR015661:Bub1/Mad3,	mmu04110:Cell cycle,mmu05166:Human T-cell leukemia virus 1 infection,			SM00777:Mad3_BUB1_I,	KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,		KW-0043~Tumor suppressor,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:BUB1 N-terminal,DOMAIN:Protein kinase,MOTIF:D-box,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Necessary for interaction with KNL1,SITE:Cleavage; by caspase-3,
O70454	BUD31 homolog(Bud31)	Rattus norvegicus			GO:0000398~mRNA splicing, via spliceosome,GO:0045893~positive regulation of transcription, DNA-templated,GO:2000825~positive regulation of androgen receptor activity,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0071007~U2-type catalytic step 2 spliceosome,	GO:0016922~ligand-dependent nuclear receptor binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,	IPR001748:BUD31,IPR018230:BUD31/G10-rel_CS,	rno03040:Spliceosome,				KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,						KW-0007~Acetylation,	MOTIF:Nuclear localization signal,REGION:Interaction with AR,
Q68EL3	Bet1 golgi vesicular membrane trafficking protein-like(bet1l)	Danio rerio			GO:0015031~protein transport,GO:0042147~retrograde transport, endosome to Golgi,GO:2000156~regulation of retrograde vesicle-mediated transport, Golgi to ER,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0031201~SNARE complex,	GO:0005484~SNAP receptor activity,	IPR000727:T_SNARE_dom,IPR039899:BET1_SNARE,	dre04130:SNARE interactions in vesicular transport,				KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:t-SNARE coiled-coil homology,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Anchor for type IV membrane protein,
P08520	Beta-galactoside-binding lectin (LEG_ELEEL)	Electrophorus electricus					GO:0030246~carbohydrate binding,	IPR001079:Galectin_CRD,IPR013320:ConA-like_dom_sf,IPR044156:Galectin-like,				SM00276:GLECT,SM00908:Gal-bind_lectin,						KW-0430~Lectin,		KW-0007~Acetylation,	DOMAIN:Galectin,
Q5U4T7	BicC family RNA binding protein 1 L homeolog(bicc1.L)	Xenopus laevis					GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR001660:SAM,IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR013761:SAM/pointed_sf,IPR036612:KH_dom_type_1_sf,IPR037974:BICC1_SAM_dom,IPR047549:BICC1_KH-I_rpt1,IPR047553:BICC1_KH-I_rpt3,IPR047554:BICC1_KH-I_rpt2,				SM00322:KH,SM00454:SAM,					KW-0677~Repeat,		KW-0217~Developmental protein,KW-0694~RNA-binding,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:KH 1,DOMAIN:KH 2,DOMAIN:SAM,REGION:Disordered,
P35991	Bruton agammaglobulinemia tyrosine kinase(Btk)	Mus musculus		m_bcrPathway:BCR Signaling Pathway,m_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,m_ptdinsPathway:Phosphoinositides and their downstream targets.,	GO:0001780~neutrophil homeostasis,GO:0001805~positive regulation of type III hypersensitivity,GO:0001812~positive regulation of type I hypersensitivity,GO:0001818~negative regulation of cytokine production,GO:0002250~adaptive immune response,GO:0002344~B cell affinity maturation,GO:0002376~immune system process,GO:0002553~histamine secretion by mast cell,GO:0002639~positive regulation of immunoglobulin production,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0010033~response to organic substance,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030167~proteoglycan catabolic process,GO:0030889~negative regulation of B cell proliferation,GO:0030890~positive regulation of B cell proliferation,GO:0032496~response to lipopolysaccharide,GO:0032693~negative regulation of interleukin-10 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034614~cellular response to reactive oxygen species,GO:0035556~intracellular signal transduction,GO:0045087~innate immune response,GO:0048469~cell maturation,GO:0050766~positive regulation of phagocytosis,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0050869~negative regulation of B cell activation,GO:0061516~monocyte proliferation,GO:0070664~negative regulation of leukocyte proliferation,GO:0071226~cellular response to molecule of fungal origin,GO:0098761~cellular response to interleukin-7,GO:1900227~positive regulation of NLRP3 inflammasome complex assembly,GO:1901647~positive regulation of synoviocyte proliferation,GO:1990959~eosinophil homeostasis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008289~lipid binding,GO:0016004~phospholipase activator activity,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0042802~identical protein binding,GO:0043274~phospholipase binding,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR000980:SH2,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001452:SH3_domain,IPR001562:Znf_Btk_motif,IPR001849:PH_domain,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011993:PH-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR035574:BTK_SH3,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,	mmu04064:NF-kappa B signaling pathway,mmu04380:Osteoclast differentiation,mmu04611:Platelet activation,mmu04662:B cell receptor signaling pathway,mmu04664:Fc epsilon RI signaling pathway,mmu05169:Epstein-Barr virus infection,mmu05340:Primary immunodeficiency,			SM00107:BTK,SM00219:TyrKc,SM00233:PH,SM00252:SH2,SM00326:SH3,	KW-0053~Apoptosis,KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0727~SH2 domain,KW-0728~SH3 domain,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0446~Lipid-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:PH,DOMAIN:Protein kinase,DOMAIN:SH2,DOMAIN:SH3,MOTIF:CAV1-binding,MUTAGEN:E->K: Constitutive activation.,MUTAGEN:K->R: Loss of activity and no phosphorylation.,MUTAGEN:Y->F: No autophosphorylation.,REGION:Disordered,REGION:Inositol-(1,3,4,5)-tetrakisphosphate 1-binding,ZN_FING:Btk-type,
O18793	C-C motif chemokine receptor 2(CCR2)	Macaca mulatta			GO:0001974~blood vessel remodeling,GO:0002548~monocyte chemotaxis,GO:0002724~regulation of T cell cytokine production,GO:0002827~positive regulation of T-helper 1 type immune response,GO:0002829~negative regulation of type 2 immune response,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0006968~cellular defense response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010574~regulation of vascular endothelial growth factor production,GO:0010820~positive regulation of T cell chemotaxis,GO:0016525~negative regulation of angiogenesis,GO:0019233~sensory perception of pain,GO:0019722~calcium-mediated signaling,GO:0019725~cellular homeostasis,GO:0030097~hemopoiesis,GO:0032729~positive regulation of interferon-gamma production,GO:0032743~positive regulation of interleukin-2 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0035696~monocyte extravasation,GO:0035705~T-helper 17 cell chemotaxis,GO:0043310~negative regulation of eosinophil degranulation,GO:0045580~regulation of T cell differentiation,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0048873~homeostasis of number of cells within a tissue,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0060326~cell chemotaxis,GO:0061756~leukocyte adhesion to vascular endothelial cell,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090265~positive regulation of immune complex clearance by monocytes and macrophages,GO:0090594~inflammatory response to wounding,GO:0097350~neutrophil clearance,GO:1903238~positive regulation of leukocyte tethering or rolling,GO:1905517~macrophage migration,GO:1905521~regulation of macrophage migration,GO:2000412~positive regulation of thymocyte migration,GO:2000439~positive regulation of monocyte extravasation,GO:2000451~positive regulation of CD8-positive, alpha-beta T cell extravasation,GO:2000464~positive regulation of astrocyte chemotaxis,GO:2000473~positive regulation of hematopoietic stem cell migration,	GO:0001650~fibrillar center,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,	GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,GO:0031727~CCR2 chemokine receptor binding,GO:0035715~chemokine (C-C motif) ligand 2 binding,GO:0035716~chemokine (C-C motif) ligand 12 binding,GO:0035717~chemokine (C-C motif) ligand 7 binding,	IPR000276:GPCR_Rhodpsn,IPR000355:Chemokine_rcpt,IPR002237:Chemokine_CCR2,IPR017452:GPCR_Rhodpsn_7TM,	mcc04060:Cytokine-cytokine receptor interaction,mcc04061:Viral protein interaction with cytokine and cytokine receptor,mcc04062:Chemokine signaling pathway,			SM01381:7TM_GPCR_Srsx,	KW-0395~Inflammatory response,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0765~Sulfation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P51683	C-C motif chemokine receptor 2(Ccr2)	Mus musculus		m_nktPathway:Selective expression of chemokine receptors during T-cell polarization,	GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0001974~blood vessel remodeling,GO:0002246~wound healing involved in inflammatory response,GO:0002437~inflammatory response to antigenic stimulus,GO:0002548~monocyte chemotaxis,GO:0002724~regulation of T cell cytokine production,GO:0002827~positive regulation of T-helper 1 type immune response,GO:0002829~negative regulation of type 2 immune response,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010574~regulation of vascular endothelial growth factor production,GO:0010820~positive regulation of T cell chemotaxis,GO:0016525~negative regulation of angiogenesis,GO:0019221~cytokine-mediated signaling pathway,GO:0019233~sensory perception of pain,GO:0019722~calcium-mediated signaling,GO:0019725~cellular homeostasis,GO:0030097~hemopoiesis,GO:0032729~positive regulation of interferon-gamma production,GO:0032743~positive regulation of interleukin-2 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0035696~monocyte extravasation,GO:0035705~T-helper 17 cell chemotaxis,GO:0043277~apoptotic cell clearance,GO:0043310~negative regulation of eosinophil degranulation,GO:0045580~regulation of T cell differentiation,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0048873~homeostasis of number of cells within a tissue,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0050870~positive regulation of T cell activation,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0055093~response to hyperoxia,GO:0060326~cell chemotaxis,GO:0061756~leukocyte adhesion to vascular endothelial cell,GO:0070098~chemokine-mediated signaling pathway,GO:0071675~regulation of mononuclear cell migration,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090265~positive regulation of immune complex clearance by monocytes and macrophages,GO:0090594~inflammatory response to wounding,GO:0097350~neutrophil clearance,GO:1900745~positive regulation of p38MAPK cascade,GO:1903238~positive regulation of leukocyte tethering or rolling,GO:1905517~macrophage migration,GO:1905521~regulation of macrophage migration,GO:2000404~regulation of T cell migration,GO:2000412~positive regulation of thymocyte migration,GO:2000439~positive regulation of monocyte extravasation,GO:2000451~positive regulation of CD8-positive, alpha-beta T cell extravasation,GO:2000464~positive regulation of astrocyte chemotaxis,GO:2000473~positive regulation of hematopoietic stem cell migration,	GO:0001650~fibrillar center,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0048471~perinuclear region of cytoplasm,	GO:0004930~G-protein coupled receptor activity,GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016493~C-C chemokine receptor activity,GO:0019955~cytokine binding,GO:0031727~CCR2 chemokine receptor binding,GO:0035715~chemokine (C-C motif) ligand 2 binding,GO:0035716~chemokine (C-C motif) ligand 12 binding,GO:0035717~chemokine (C-C motif) ligand 7 binding,GO:0042802~identical protein binding,GO:0071791~chemokine (C-C motif) ligand 5 binding,	IPR000276:GPCR_Rhodpsn,IPR000355:Chemokine_rcpt,IPR002237:Chemokine_CCR2,IPR017452:GPCR_Rhodpsn_7TM,	mmu04060:Cytokine-cytokine receptor interaction,mmu04061:Viral protein interaction with cytokine and cytokine receptor,mmu04062:Chemokine signaling pathway,				KW-0395~Inflammatory response,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P51680	C-C motif chemokine receptor 4(Ccr4)	Mus musculus			GO:0001764~neuron migration,GO:0002507~tolerance induction,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0009617~response to bacterium,GO:0019722~calcium-mediated signaling,GO:0048872~homeostasis of number of cells,GO:0050927~positive regulation of positive chemotaxis,GO:0060326~cell chemotaxis,GO:1904936~interneuron migration,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0043025~neuronal cell body,	GO:0004930~G-protein coupled receptor activity,GO:0004950~chemokine receptor activity,GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,	IPR000276:GPCR_Rhodpsn,IPR000355:Chemokine_rcpt,IPR002239:Chemokine_CCR4,IPR017452:GPCR_Rhodpsn_7TM,	mmu04060:Cytokine-cytokine receptor interaction,mmu04061:Viral protein interaction with cytokine and cytokine receptor,mmu04062:Chemokine signaling pathway,mmu05167:Kaposi sarcoma-associated herpesvirus infection,mmu05203:Viral carcinogenesis,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P49300	C-type lectin domain family 10, member A(Clec10a)	Mus musculus			GO:0002248~connective tissue replacement involved in inflammatory response wound healing,GO:0044419~interspecies interaction between organisms,	GO:0009897~external side of plasma membrane,GO:0016020~membrane,	GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0042806~fucose binding,	IPR001304:C-type_lectin-like,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR018378:C-type_lectin_CS,IPR033989:CD209-like_CTLD,				SM00034:CLECT,		KW-0472~Membrane,			KW-0175~Coiled coil,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0430~Lectin,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:C-type lectin,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q7TSQ1	C-type lectin domain family 18, member A(Clec18a)	Mus musculus				GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,	IPR000742:EGF-like_dom,IPR001283:CRISP-related,IPR001304:C-type_lectin-like,IPR014044:CAP_domain,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR018378:C-type_lectin_CS,IPR035940:CAP_sf,				SM00034:CLECT,SM00181:EGF,SM00198:SCP,		KW-0964~Secreted,			KW-0245~EGF-like domain,	KW-0430~Lectin,	KW-0675~Receptor,	KW-1015~Disulfide bond,	COMPBIAS:Polar residues,DOMAIN:C-type lectin,DOMAIN:EGF-like,DOMAIN:SCP,REGION:Disordered,
A1A5X5	C1q and TNF related 12(c1qtnf12)	Danio rerio			GO:0046324~regulation of glucose import,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005179~hormone activity,	IPR001073:C1q_dom,IPR008983:Tumour_necrosis_fac-like_dom,						KW-0964~Secreted,			KW-0732~Signal,		KW-0372~Hormone,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:C1q,REGION:Disordered,
Q9QXP7	C1q and tumor necrosis factor related protein 1(C1qtnf1)	Mus musculus			GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010544~negative regulation of platelet activation,GO:0010628~positive regulation of gene expression,GO:0010906~regulation of glucose metabolic process,GO:0043410~positive regulation of MAPK cascade,GO:0051897~positive regulation of protein kinase B signaling,GO:0090331~negative regulation of platelet aggregation,GO:2000860~positive regulation of aldosterone secretion,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0005518~collagen binding,GO:0042802~identical protein binding,	IPR001073:C1q_dom,IPR008160:Collagen,IPR008983:Tumour_necrosis_fac-like_dom,				SM00110:C1Q,		KW-0964~Secreted,			KW-0176~Collagen,KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:C1q,DOMAIN:Collagen-like,REGION:Disordered,
P0C7U4	C3a anaphylatoxin chemotactic receptor(c3ar1)	Danio rerio			GO:0002430~complement receptor mediated signaling pathway,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004878~complement component C5a receptor activity,GO:0004930~G-protein coupled receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000826:Formyl_rcpt-rel,IPR017452:GPCR_Rhodpsn_7TM,	dre04080:Neuroactive ligand-receptor interaction,				KW-0145~Chemotaxis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q8N3C7	CAP-Gly domain containing linker protein family member 4(CLIP4)	Homo sapiens			GO:0031122~cytoplasmic microtubule organization,	GO:0005634~nucleus,GO:0005938~cell cortex,GO:0016020~membrane,GO:0035371~microtubule plus-end,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0051010~microtubule plus-end binding,	IPR000938:CAP-Gly_domain,IPR002110:Ankyrin_rpt,IPR036770:Ankyrin_rpt-contain_sf,IPR036859:CAP-Gly_dom_sf,				SM00248:ANK,SM01052:CAP_GLY,		KW-0472~Membrane,			KW-0040~ANK repeat,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:CAP-Gly,DOMAIN:CAP-Gly 1,DOMAIN:CAP-Gly 2,DOMAIN:CAP-Gly 3,REGION:Disordered,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,TRANSMEM:Helical,
O15519	CASP8 and FADD like apoptosis regulator(CFLAR)	Homo sapiens	36.Death_of_Key_Intracellular_Targets,86.Apoptosis_Nematode&_Vert,	h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,	GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0007519~skeletal muscle tissue development,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010976~positive regulation of neuron projection development,GO:0014732~skeletal muscle atrophy,GO:0014842~regulation of skeletal muscle satellite cell proliferation,GO:0014866~skeletal myofibril assembly,GO:0030182~neuron differentiation,GO:0030216~keratinocyte differentiation,GO:0030218~erythrocyte differentiation,GO:0032869~cellular response to insulin stimulus,GO:0033574~response to testosterone,GO:0042060~wound healing,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043403~skeletal muscle tissue regeneration,GO:0043525~positive regulation of neuron apoptotic process,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060544~regulation of necroptotic process,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071456~cellular response to hypoxia,GO:0071549~cellular response to dexamethasone stimulus,GO:0071732~cellular response to nitric oxide,GO:0072126~positive regulation of glomerular mesangial cell proliferation,GO:0097194~execution phase of apoptosis,GO:1901740~negative regulation of myoblast fusion,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1903055~positive regulation of extracellular matrix organization,GO:1903427~negative regulation of reactive oxygen species biosynthetic process,GO:1903845~negative regulation of cellular response to transforming growth factor beta stimulus,GO:1903944~negative regulation of hepatocyte apoptotic process,GO:2000347~positive regulation of hepatocyte proliferation,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0097342~ripoptosome,	GO:0002020~protease binding,GO:0004197~cysteine-type endopeptidase activity,GO:0005123~death receptor binding,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0044877~macromolecular complex binding,GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process,GO:0097199~cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:0097200~cysteine-type endopeptidase activity involved in execution phase of apoptosis,	IPR001309:Pept_C14_p20,IPR001875:DED_dom,IPR011029:DEATH-like_dom_sf,IPR011600:Pept_C14_caspase,IPR015917:Pept_C14A,IPR029030:Caspase-like_dom_sf,	hsa04064:NF-kappa B signaling pathway,hsa04140:Autophagy - animal,hsa04210:Apoptosis,hsa04217:Necroptosis,hsa04668:TNF signaling pathway,hsa05142:Chagas disease,hsa05160:Hepatitis C,			SM00031:DED,SM00115:CASc,	KW-0053~Apoptosis,KW-0945~Host-virus interaction,				KW-0677~Repeat,				DOMAIN:Caspase family p20,DOMAIN:DED,DOMAIN:DED 1,DOMAIN:DED 2,MUTAGEN:D->N,A: Abolishes proteolytic processing.,MUTAGEN:Y->F: Decreases apoptosis-inducing activity. Reduces interaction with caspase-3 and proteolytic processing.,REGION:Caspase,REGION:Interaction with CASP3,REGION:Interaction with CASP8,REGION:Interaction with CASP8 propeptide,REGION:Interaction with CASP8 subunits p18 and p10,REGION:Interaction with FADD,REGION:Interaction with TRAF1 and TRAF2,REGION:Not proteolytically processed and involved in apoptosis inhibition,SITE:Cleavage; by CASP8,
P62634	CCHC-type zinc finger, nucleic acid binding protein(Cnbp)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071919~G-quadruplex DNA formation,GO:2000767~positive regulation of cytoplasmic translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,	GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0008270~zinc ion binding,GO:0045182~translation regulator activity,GO:0051880~G-quadruplex DNA binding,	IPR001878:Znf_CCHC,IPR036875:Znf_CCHC_sf,				SM00343:ZnF_C2HC,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	DOMAIN:CCHC-type,REGION:RNA-binding Arg/Gly-rich region (RGG-box),ZN_FING:CCHC-type 1,ZN_FING:CCHC-type 2,ZN_FING:CCHC-type 3,ZN_FING:CCHC-type 4,ZN_FING:CCHC-type 5,ZN_FING:CCHC-type 6,ZN_FING:CCHC-type 7,
Q8K0V4	CCR4-NOT transcription complex, subunit 3(Cnot3)	Mus musculus			GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0001829~trophectodermal cell differentiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006417~regulation of translation,GO:0007275~multicellular organism development,GO:0031047~gene silencing by RNA,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:2000036~regulation of stem cell population maintenance,	GO:0000932~P-body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030014~CCR4-NOT complex,GO:0030015~CCR4-NOT core complex,	GO:0005515~protein binding,	IPR007207:Not_N,IPR007282:NOT2/3/5_C,IPR012270:CCR4-NOT_su3/5,IPR038635:CCR4-NOT_su2/3/5_C_sf,IPR040168:Not2/3/5,	mmu03018:RNA degradation,		PIRSF005290:NOT_su_3_5,		KW-0804~Transcription,KW-0805~Transcription regulation,KW-0810~Translation regulation,KW-0943~RNA-mediated gene silencing,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0217~Developmental protein,KW-0678~Repressor,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CCR4-Not complex component Not N-terminal,DOMAIN:NOT2/NOT3/NOT5 C-terminal,REGION:Disordered,REGION:Repressor domain,
P51680	CCR4-NOT transcription complex, subunit 6(Cnot6)	Mus musculus			GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0001764~neuron migration,GO:0002507~tolerance induction,GO:0006417~regulation of translation,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008284~positive regulation of cell proliferation,GO:0009617~response to bacterium,GO:0010606~positive regulation of cytoplasmic mRNA processing body assembly,GO:0019722~calcium-mediated signaling,GO:0031047~gene silencing by RNA,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0048872~homeostasis of number of cells,GO:0050927~positive regulation of positive chemotaxis,GO:0060326~cell chemotaxis,GO:0070966~nuclear-transcribed mRNA catabolic process, no-go decay,GO:1904936~interneuron migration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0030014~CCR4-NOT complex,GO:0043025~neuronal cell body,	GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0004532~exoribonuclease activity,GO:0004535~poly(A)-specific ribonuclease activity,GO:0016493~C-C chemokine receptor activity,GO:0016787~hydrolase activity,GO:0019957~C-C chemokine binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0046872~metal ion binding,	IPR000276:GPCR_Rhodpsn,IPR000355:Chemokine_rcpt,IPR001611:Leu-rich_rpt,IPR002239:Chemokine_CCR4,IPR003591:Leu-rich_rpt_typical-subtyp,IPR005135:Endo/exonuclease/phosphatase,IPR017452:GPCR_Rhodpsn_7TM,IPR032675:LRR_dom_sf,IPR034966:Cnot6,IPR036691:Endo/exonu/phosph_ase_sf,	mmu03018:RNA degradation,			SM00369:LRR_TYP,SM01381:7TM_GPCR_Srsx,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0810~Translation regulation,KW-0943~RNA-mediated gene silencing,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0010~Activator,KW-0269~Exonuclease,KW-0297~G-protein coupled receptor,KW-0378~Hydrolase,KW-0540~Nuclease,KW-0675~Receptor,KW-0694~RNA-binding,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Nuclease domain,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
A2BHJ4	CCR4-NOT transcription complex, subunit 6-like(cnot6l)	Danio rerio			GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0031047~gene silencing by RNA,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030014~CCR4-NOT complex,	GO:0003824~catalytic activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0004535~poly(A)-specific ribonuclease activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR005135:Endo/exonuclease/phosphatase,IPR032675:LRR_dom_sf,IPR034967:Deadenylase_CCR4b,IPR036691:Endo/exonu/phosph_ase_sf,	dre03018:RNA degradation,			SM00369:LRR_TYP,	KW-0507~mRNA processing,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0810~Translation regulation,KW-0943~RNA-mediated gene silencing,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0269~Exonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,		ACT_SITE:Proton donor/acceptor,DOMAIN:Endonuclease/exonuclease/phosphatase,REGION:Nuclease domain,REGION:Required for interaction with cnot1, cnot3 and cnot7,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,
Q3ZBH3	CD151 molecule(CD151)	Bos taurus			GO:0016477~cell migration,GO:0030335~positive regulation of cell migration,GO:0042098~T cell proliferation,GO:0044319~wound healing, spreading of cells,GO:0045807~positive regulation of endocytosis,	GO:0005604~basement membrane,GO:0009986~cell surface,GO:0016020~membrane,	GO:0005178~integrin binding,	IPR000301:Tetraspanin_animals,IPR008952:Tetraspanin_EC2_sf,IPR018499:Tetraspanin/Peripherin,			PIRSF002419:Tetraspanin,			KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,LIPID:S-palmitoyl cysteine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q91ZX1	CD209a antigen(Cd209a)	Mus musculus			GO:0006897~endocytosis,GO:0006955~immune response,GO:0042102~positive regulation of T cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0044419~interspecies interaction between organisms,GO:0046718~viral entry into host cell,GO:0097323~B cell adhesion,GO:1903902~positive regulation of viral life cycle,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,	GO:0001618~virus receptor activity,GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,GO:0097367~carbohydrate derivative binding,	IPR001304:C-type_lectin-like,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR018378:C-type_lectin_CS,IPR033989:CD209-like_CTLD,	mmu03260:Virion - Human immunodeficiency virus,mmu03264:Virion - Flavivirus,mmu04145:Phagosome,mmu04625:C-type lectin receptor signaling pathway,mmu05152:Tuberculosis,mmu05162:Measles,			SM00034:CLECT,	KW-0254~Endocytosis,	KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0430~Lectin,KW-0465~Mannose-binding,KW-0479~Metal-binding,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:C-type lectin,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P25942	CD40 molecule(CD40)	Homo sapiens	125.T_Cells_CNS-APCs,15.T-cell_polarization-chemokine_receptors,19.Cytokine_microglia,5.B7_CD40_B-cell_activa,50.Hypothesis_of_bronchial_asthma,55.Allergen_recognition_by_Th2_or_Th0_cell,58.(CD40L)_immnosurveillance,99.NF-kB_activation,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,h_cd40Pathway:CD40L Signaling Pathway,h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,h_th1th2Pathway:Th1/Th2 Differentiation,	GO:0001934~positive regulation of protein phosphorylation,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006874~cellular calcium ion homeostasis,GO:0006954~inflammatory response,GO:0019724~B cell mediated immunity,GO:0023035~CD40 signaling pathway,GO:0030168~platelet activation,GO:0030890~positive regulation of B cell proliferation,GO:0032735~positive regulation of interleukin-12 production,GO:0033590~response to cobalamin,GO:0034341~response to interferon-gamma,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0036018~cellular response to erythropoietin,GO:0042100~B cell proliferation,GO:0042113~B cell activation,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0042832~defense response to protozoan,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043406~positive regulation of MAP kinase activity,GO:0043491~protein kinase B signaling,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0043547~positive regulation of GTPase activity,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0050776~regulation of immune response,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051607~defense response to virus,GO:0065003~macromolecular complex assembly,GO:0071222~cellular response to lipopolysaccharide,GO:0071260~cellular response to mechanical stimulus,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0090037~positive regulation of protein kinase C signaling,GO:1901652~response to peptide,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0035631~CD40 receptor complex,GO:0043025~neuronal cell body,GO:0043196~varicosity,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0003823~antigen binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0031625~ubiquitin protein ligase binding,GO:0038023~signaling receptor activity,	IPR001368:TNFR/NGFR_Cys_rich_reg,IPR020435:TNFR_5,IPR034021:TNFRSF5_N,	hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04514:Cell adhesion molecules,hsa04620:Toll-like receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa05144:Malaria,hsa05145:Toxoplasmosis,hsa05166:Human T-cell leukemia virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05202:Transcriptional misregulation in cancer,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05330:Allograft rejection,hsa05340:Primary immunodeficiency,hsa05416:Viral myocarditis,hsa05417:Lipid and atherosclerosis,	606843~Immunodeficiency with hyper-IgM, type 3,		SM00208:TNFR,	KW-0391~Immunity,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:TNFR-Cys,REGION:Disordered,REPEAT:TNFR-Cys,REPEAT:TNFR-Cys 1,REPEAT:TNFR-Cys 2,REPEAT:TNFR-Cys 3,REPEAT:TNFR-Cys 4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q61003	CD6 antigen(Cd6)	Mus musculus			GO:0001771~immunological synapse formation,GO:0001934~positive regulation of protein phosphorylation,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0042102~positive regulation of T cell proliferation,GO:1900017~positive regulation of cytokine production involved in inflammatory response,	GO:0001772~immunological synapse,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0042101~T cell receptor complex,	GO:0001530~lipopolysaccharide binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0070891~lipoteichoic acid binding,	IPR001190:SRCR,IPR017448:SRCR-like_dom,IPR036772:SRCR-like_dom_sf,	mmu04514:Cell adhesion molecules,			SM00202:SR,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:SRCR,DOMAIN:SRCR 1,DOMAIN:SRCR 2,DOMAIN:SRCR 3,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q08BW6	CDAN1 interacting nuclease 1(cdin1)	Danio rerio			GO:0030218~erythrocyte differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR029404:CDIN1,						KW-0539~Nucleus,KW-0963~Cytoplasm,
P61025	CDC28 protein kinase 1b(Cks1b)	Mus musculus		m_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,	GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0009790~embryo development,GO:0044772~mitotic cell cycle phase transition,GO:0048144~fibroblast proliferation,GO:0051301~cell division,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0019005~SCF ubiquitin ligase complex,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0042393~histone binding,GO:0043130~ubiquitin binding,GO:0061575~cyclin-dependent protein serine/threonine kinase activator activity,	IPR000789:Cyclin-dep_kinase_reg-sub,IPR036858:Cyclin-dep_kinase_reg-sub_sf,	mmu05200:Pathways in cancer,mmu05222:Small cell lung cancer,			SM01084:CKS,	KW-0131~Cell cycle,KW-0132~Cell division,							KW-0007~Acetylation,	COMPBIAS:Polar residues,REGION:Disordered,
Q96HQ2	CDKN2A interacting protein N-terminal like(CDKN2AIPNL)	Homo sapiens					GO:0005515~protein binding,	IPR021859:XTBD,												KW-0007~Acetylation,	DOMAIN:XRN2-binding (XTBD),MUTAGEN:Y->A: Abolishes binding to XRN2.,
A0JN61	CGRP receptor component(CRCP)	Bos taurus			GO:0006383~transcription from RNA polymerase III promoter,GO:0006384~transcription initiation from RNA polymerase III promoter,GO:0045087~innate immune response,GO:0051607~defense response to virus,	GO:0005666~DNA-directed RNA polymerase III complex,GO:0005886~plasma membrane,GO:0009360~DNA polymerase III complex,	GO:0000166~nucleotide binding,GO:0003899~DNA-directed 5'-3' RNA polymerase activity,	IPR005574:Rpb4/RPC9,IPR006590:RNA_pol_Rpb4/RPC9_core,IPR010997:HRDC-like_sf,IPR038324:Rpb4/RPC9_sf,IPR038846:RPC9,	bta03020:RNA polymerase,			SM00657:RPOL4c,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,	KW-0240~DNA-directed RNA polymerase,KW-0472~Membrane,KW-0539~Nucleus,KW-1003~Cell membrane,KW-9994~DNA-directed RNA polymerase,							DOMAIN:RNA polymerase Rpb4/RPC9 core,REGION:Disordered,
Q80TV8	CLIP associating protein 1(Clasp1)	Mus musculus			GO:0000226~microtubule cytoskeleton organization,GO:0001578~microtubule bundle formation,GO:0006903~vesicle targeting,GO:0007020~microtubule nucleation,GO:0007026~negative regulation of microtubule depolymerization,GO:0007030~Golgi organization,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0010458~exit from mitosis,GO:0010470~regulation of gastrulation,GO:0010634~positive regulation of epithelial cell migration,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0016477~cell migration,GO:0030010~establishment of cell polarity,GO:0030953~astral microtubule organization,GO:0031023~microtubule organizing center organization,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0034453~microtubule anchoring,GO:0040001~establishment of mitotic spindle localization,GO:0045921~positive regulation of exocytosis,GO:0051128~regulation of cellular component organization,GO:0051294~establishment of spindle orientation,GO:0051301~cell division,GO:0051497~negative regulation of stress fiber assembly,GO:0051893~regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0090091~positive regulation of extracellular matrix disassembly,GO:0090307~mitotic spindle assembly,GO:1903690~negative regulation of wound healing, spreading of epidermal cells,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0005881~cytoplasmic microtubule,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0015630~microtubule cytoskeleton,GO:0030981~cortical microtubule cytoskeleton,GO:0031592~centrosomal corona,GO:0045180~basal cortex,GO:0072686~mitotic spindle,	GO:0002162~dystroglycan binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0043515~kinetochore binding,GO:0051010~microtubule plus-end binding,	IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR021133:HEAT_type_2,IPR024395:CLASP_N_dom,IPR034085:TOG,IPR048491:XMAP215_CLASP_TOG,				SM01349:TOG,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0995~Kinetochore,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:TOG,REGION:Disordered,REGION:Interaction with CLIP2 and RSN,REGION:Interaction with PHLDB2,REGION:Interaction with microtubules, MAPRE1 and MAPRE3,REGION:Localization to kinetochores,REPEAT:HEAT,REPEAT:HEAT 1,REPEAT:HEAT 2,REPEAT:HEAT 3,REPEAT:HEAT 4,REPEAT:HEAT 5,REPEAT:HEAT 6,REPEAT:HEAT 7,
Q6DEL2	CLPTM1 regulator of GABA type A receptor forward trafficking(clptm1)	Danio rerio			GO:0030154~cell differentiation,	GO:0012505~endomembrane system,GO:0016020~membrane,		IPR008429:CLPTM1,					KW-0221~Differentiation,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9GZQ3	COMM domain containing 5(COMMD5)	Homo sapiens				GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR017920:COMM,IPR037357:COMMD5,					KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0007~Acetylation,	DOMAIN:COMM,
Q9CZG3	COMM domain containing 8(Commd8)	Mus musculus				GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,		IPR017920:COMM,IPR047155:COMMD4/6/7/8,IPR047235:COMMD8,					KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,							DOMAIN:COMM,
B5X4H8	CT054 protein(ct054)	Salmo salar			GO:0032218~riboflavin transport,	GO:0005886~plasma membrane,	GO:0032217~riboflavin transporter activity,	IPR009357:Riboflavin_transptr,					KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,TRANSMEM:Helical,
Q9PTJ6	CTD small phosphatase like(CTDSPL)	Gallus gallus				GO:0005634~nucleus,	GO:0004721~phosphoprotein phosphatase activity,GO:0008420~CTD phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0046872~metal ion binding,	IPR004274:FCP1_dom,IPR011948:Dullard_phosphatase,IPR023214:HAD_sf,IPR036412:HAD-like_sf,IPR040078:RNA_Pol_CTD_Phosphatase,				SM00577:CPDc,		KW-0539~Nucleus,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0904~Protein phosphatase,		ACT_SITE:4-aspartylphosphate intermediate,ACT_SITE:Proton donor,DOMAIN:FCP1 homology,REGION:Disordered,SITE:Transition state stabilizer,
A0JMF1	CTS telomere maintenance complex component 1(ctc1)	Danio rerio			GO:0010833~telomere maintenance via telomere lengthening,GO:0045740~positive regulation of DNA replication,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:1990879~CST complex,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0042162~telomeric DNA binding,	IPR029156:CTC1,IPR042617:CTC1-like,						KW-0158~Chromosome,KW-0539~Nucleus,KW-0779~Telomere,					KW-0238~DNA-binding,		REGION:Disordered,
Q9P2B4	CTTNBP2 N-terminal like(CTTNBP2NL)	Homo sapiens			GO:0006470~protein dephosphorylation,GO:0032410~negative regulation of transporter activity,GO:0034763~negative regulation of transmembrane transport,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,	GO:0005515~protein binding,GO:0051721~protein phosphatase 2A binding,	IPR019131:Cortactin-binding_p2_N,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Cortactin-binding protein-2 N-terminal,REGION:Disordered,
Q80T79	CUB and Sushi multiple domains 3(Csmd3)	Mus musculus			GO:0050773~regulation of dendrite development,	GO:0005886~plasma membrane,GO:0016020~membrane,		IPR000436:Sushi_SCR_CCP_dom,IPR000859:CUB_dom,IPR035914:Sperma_CUB_dom_sf,IPR035976:Sushi/SCR/CCP_sf,				SM00032:CCP,SM00042:CUB,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0768~Sushi,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:CUB,DOMAIN:CUB 1,DOMAIN:CUB 10,DOMAIN:CUB 11,DOMAIN:CUB 12,DOMAIN:CUB 13,DOMAIN:CUB 14,DOMAIN:CUB 2,DOMAIN:CUB 3,DOMAIN:CUB 4,DOMAIN:CUB 5,DOMAIN:CUB 6,DOMAIN:CUB 7,DOMAIN:CUB 8,DOMAIN:CUB 9,DOMAIN:Sushi,DOMAIN:Sushi 1,DOMAIN:Sushi 10,DOMAIN:Sushi 11,DOMAIN:Sushi 12,DOMAIN:Sushi 13,DOMAIN:Sushi 14,DOMAIN:Sushi 15,DOMAIN:Sushi 16,DOMAIN:Sushi 17,DOMAIN:Sushi 18,DOMAIN:Sushi 19,DOMAIN:Sushi 2,DOMAIN:Sushi 20,DOMAIN:Sushi 21,DOMAIN:Sushi 22,DOMAIN:Sushi 23,DOMAIN:Sushi 24,DOMAIN:Sushi 25,DOMAIN:Sushi 26,DOMAIN:Sushi 27,DOMAIN:Sushi 28,DOMAIN:Sushi 3,DOMAIN:Sushi 4,DOMAIN:Sushi 5,DOMAIN:Sushi 6,DOMAIN:Sushi 7,DOMAIN:Sushi 8,DOMAIN:Sushi 9,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5U462	CUB domain containing protein 1(Cdcp1)	Mus musculus				GO:0005886~plasma membrane,GO:0016020~membrane,		IPR035914:Sperma_CUB_dom_sf,IPR038811:CDCP1,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:CUB,REGION:Disordered,SITE:Cleavage; by ST14/MT-SP1,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q921M7	CYFIP related Rac1 interactor B(Cyrib)	Mus musculus			GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0030334~regulation of cell migration,GO:0030833~regulation of actin filament polymerization,GO:0030837~negative regulation of actin filament polymerization,GO:0032729~positive regulation of interferon-gamma production,GO:0050870~positive regulation of T cell activation,GO:0050920~regulation of chemotaxis,GO:0051058~negative regulation of small GTPase mediated signal transduction,GO:0071219~cellular response to molecule of bacterial origin,GO:0090140~regulation of mitochondrial fission,GO:2000114~regulation of establishment of cell polarity,GO:2000568~positive regulation of memory T cell activation,	GO:0005739~mitochondrion,GO:0005929~cilium,GO:0016020~membrane,	GO:0005515~protein binding,GO:0023030~MHC class Ib protein binding, via antigen binding groove,GO:0031267~small GTPase binding,	IPR009828:CYRIA/CYRIB_Rac1-bd,IPR039789:CYRI,						KW-0472~Membrane,KW-0496~Mitochondrion,						KW-0449~Lipoprotein,KW-0519~Myristate,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:CYRIA/CYRIB Rac1 binding,LIPID:N-myristoyl glycine,
P28648	Cd63 molecule(Cd63)	Rattus norvegicus			GO:0002092~positive regulation of receptor internalization,GO:0007160~cell-matrix adhesion,GO:0010633~negative regulation of epithelial cell migration,GO:0015031~protein transport,GO:0016477~cell migration,GO:0030855~epithelial cell differentiation,GO:0035646~endosome to melanosome transport,GO:0043473~pigmentation,GO:0045785~positive regulation of cell adhesion,GO:0045807~positive regulation of endocytosis,GO:0048757~pigment granule maturation,GO:0050931~pigment cell differentiation,GO:1900746~regulation of vascular endothelial growth factor signaling pathway,GO:1901379~regulation of potassium ion transmembrane transport,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005771~multivesicular body,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0031902~late endosome membrane,GO:0031904~endosome lumen,GO:0032585~multivesicular body membrane,GO:0032991~macromolecular complex,GO:0042470~melanosome,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,GO:0097487~multivesicular body, internal vesicle,	GO:0005515~protein binding,GO:0044877~macromolecular complex binding,	IPR000301:Tetraspanin_animals,IPR008952:Tetraspanin_EC2_sf,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin_CS,IPR042028:CD63_LEL,	rno04142:Lysosome,rno05205:Proteoglycans in cancer,		PIRSF002419:Tetraspanin,		KW-0653~Protein transport,KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,KW-0964~Secreted,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,	CARBOHYD:N-linked (GlcNAc...) asparagine,MOTIF:Lysosomal targeting motif,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5SPB6	ChaC, cation transport regulator homolog 1 (E. coli)(chac1)	Danio rerio			GO:0006751~glutathione catabolic process,GO:0006915~apoptotic process,GO:0006986~response to unfolded protein,GO:0007219~Notch signaling pathway,GO:0007399~nervous system development,GO:0010955~negative regulation of protein processing,GO:0022008~neurogenesis,GO:0045746~negative regulation of Notch signaling pathway,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,	GO:0003839~gamma-glutamylcyclotransferase activity,GO:0005112~Notch binding,GO:0016829~lyase activity,	IPR006840:ChaC,IPR013024:GGCT-like,IPR036568:GGCT-like_sf,	dre00480:Glutathione metabolism,dre01100:Metabolic pathways,				KW-0053~Apoptosis,KW-0524~Neurogenesis,KW-0834~Unfolded protein response,KW-0914~Notch signaling pathway,	KW-0333~Golgi apparatus,KW-0963~Cytoplasm,					KW-0456~Lyase,		ACT_SITE:Proton acceptor,
B5X3W7	Choline transporter-like protein 2(ctl2)	Salmo salar			GO:0015871~choline transport,GO:0034229~ethanolamine transport,GO:0055085~transmembrane transport,	GO:0005741~mitochondrial outer membrane,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0015220~choline transmembrane transporter activity,GO:0015297~antiporter activity,GO:0034228~ethanolamine transmembrane transporter activity,	IPR007603:Choline_transptr-like,					KW-0050~Antiport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P80646	Chymotrypsin B (CTRB_GADMO)	Gadus morhua			GO:0006508~proteolysis,GO:0007586~digestion,	GO:0005576~extracellular region,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR043504:Peptidase_S1_PA_chymotrypsin,				SM00020:Tryp_SPc,	KW-0222~Digestion,	KW-0964~Secreted,					KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,DOMAIN:Peptidase S1,
Q9DBL7	Coenzyme A synthase(Coasy)	Mus musculus			GO:0008152~metabolic process,GO:0009058~biosynthetic process,GO:0015937~coenzyme A biosynthetic process,GO:0016310~phosphorylation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005759~mitochondrial matrix,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0004140~dephospho-CoA kinase activity,GO:0004595~pantetheine-phosphate adenylyltransferase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,	IPR001977:Depp_CoAkinase,IPR004821:Cyt_trans-like,IPR014729:Rossmann-like_a/b/a_fold,IPR027417:P-loop_NTPase,	mmu00770:Pantothenate and CoA biosynthesis,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,				KW-0173~Coenzyme A biosynthesis,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0511~Multifunctional enzyme,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	DOMAIN:DPCK,MUTAGEN:H->A: Phosphopantetheine adenylyltransferase activity abolished.,REGION:Phosphopantetheine adenylyltransferase,
A2V9Y8	D-amino acid oxidase(DAO)	Macaca fascicularis			GO:0006562~proline catabolic process,GO:0019478~D-amino acid catabolic process,GO:0036088~D-serine catabolic process,GO:0042416~dopamine biosynthetic process,GO:0046416~D-amino acid metabolic process,GO:0055130~D-alanine catabolic process,	GO:0005741~mitochondrial outer membrane,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005829~cytosol,	GO:0003884~D-amino-acid oxidase activity,GO:0042802~identical protein binding,GO:0071949~FAD binding,	IPR006076:FAD-dep_OxRdtase,IPR006181:D-amino_acid_oxidase_CS,IPR023209:DAO,	mcf00260:Glycine, serine and threonine metabolism,mcf00330:Arginine and proline metabolism,mcf00470:D-Amino acid metabolism,mcf01100:Metabolic pathways,mcf04146:Peroxisome,		PIRSF000189:D-aa_oxidase,			KW-0576~Peroxisome,				KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,		DOMAIN:FAD dependent oxidoreductase,MOTIF:Microbody targeting signal,
Q8BH86	D-glutamate cyclase(Dglucy)	Mus musculus			GO:0006536~glutamate metabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0016829~lyase activity,GO:0047820~D-glutamate cyclase activity,	IPR009906:D-Glu_cyclase,IPR017135:D-Glu_cyclase_mito,IPR025504:GLUCM_C,IPR038021:Putative_hydro-lyase,	mmu00470:D-Amino acid metabolism,mmu01100:Metabolic pathways,		PIRSF037204:UCP037204,			KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0456~Lyase,	KW-0007~Acetylation,	DOMAIN:D-glutamate cyclase-like C-terminal,REGION:Disordered,TRANSIT:Mitochondrion,
Q8CJH2	DAB adaptor protein 1(Dab1)	Rattus norvegicus			GO:0001764~neuron migration,GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007259~JAK-STAT cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007409~axonogenesis,GO:0007494~midgut development,GO:0007628~adult walking behavior,GO:0009410~response to xenobiotic stimulus,GO:0016358~dendrite development,GO:0021517~ventral spinal cord development,GO:0021589~cerebellum structural organization,GO:0021766~hippocampus development,GO:0021795~cerebral cortex cell migration,GO:0021799~cerebral cortex radially oriented cell migration,GO:0021813~cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,GO:0021942~radial glia guided migration of Purkinje cell,GO:0021987~cerebral cortex development,GO:0030154~cell differentiation,GO:0030182~neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0046426~negative regulation of JAK-STAT cascade,GO:0048708~astrocyte differentiation,GO:0048712~negative regulation of astrocyte differentiation,GO:0050771~negative regulation of axonogenesis,GO:0051645~Golgi localization,GO:0097475~motor neuron migration,GO:0097477~lateral motor column neuron migration,	GO:0005737~cytoplasm,GO:0005903~brush border,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0043548~phosphatidylinositol 3-kinase binding,	IPR006020:PTB/PI_dom,IPR011993:PH-like_dom_sf,IPR048559:DAB1/2_SBM,IPR048561:Dab_PTB,	rno05017:Spinocerebellar ataxia,			SM00462:PTB,	KW-0221~Differentiation,KW-0524~Neurogenesis,						KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PID,REGION:Disordered,
Q9UBU7	DBF4-CDC7 kinase regulatory subunit(DBF4)	Homo sapiens			GO:0000082~G1/S transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:1901987~regulation of cell cycle phase transition,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0031431~Dbf4-dependent protein kinase complex,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0008270~zinc ion binding,GO:0043539~protein serine/threonine kinase activator activity,	IPR006572:Znf_DBF,IPR036420:BRCT_dom_sf,IPR038545:Znf_DBF_sf,IPR047340:RUNDC3A_B,	hsa04110:Cell cycle,			SM00586:ZnF_DBF,	KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BRCT 1,DOMAIN:BRCT 2,DOMAIN:DBF4-type,MOTIF:Integrase domain-binding motif 1 (IBM1),MOTIF:Integrase domain-binding motif 2 (IBM2),MUTAGEN:F->A: Loss of interaction with PSIP1; when associated with A-631.,MUTAGEN:F->A: Loss of interaction with PSIP1; when associated with A-634.,MUTAGEN:S->D: Phosphomimetic mutant. Increased interaction with PSIP1.,MUTAGEN:S->D: Phosphomimetic mutant. Increased interaction with PSIP1; when associated with D-667.,MUTAGEN:S->D: Phosphomimetic mutant. Increased interaction with PSIP1; when associated with D-669.,REGION:Disordered,ZN_FING:DBF4-type,
Q5RHX6	DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae)(dcun1d4)	Danio rerio			GO:0045116~protein neddylation,GO:2000436~positive regulation of protein neddylation,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,	GO:0031624~ubiquitin conjugating enzyme binding,GO:0032182~ubiquitin-like protein binding,GO:0097602~cullin family protein binding,	IPR005176:PONY_dom,IPR014764:DCN-prot,IPR042460:DCN1-like_PONY,						KW-0539~Nucleus,							COMPBIAS:Basic and acidic residues,DOMAIN:DCUN1,REGION:Disordered,
Q5R9B8	DDB1 and CUL4 associated factor 6(DCAF6)	Pongo abelii			GO:0016567~protein ubiquitination,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0005515~protein binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,	IPR000048:IQ_motif_EF-hand-BS,IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR036322:WD40_repeat_dom_sf,IPR045151:DCAF8,				SM00320:WD40,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0853~WD repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:IQ,REGION:Disordered,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q5ZJF6	DEAD-box helicase 10(DDX10)	Gallus gallus			GO:0006364~rRNA processing,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,	IPR000629:RNA-helicase_DEAD-box_CS,IPR001650:Helicase_C,IPR011545:DEAD/DEAH_box_helicase_dom,IPR014001:Helicase_ATP-bd,IPR014014:RNA_helicase_DEAD_Q_motif,IPR025313:DUF4217,IPR027417:P-loop_NTPase,				SM00487:DEXDc,SM00490:HELICc,SM01178:DUF4217,					KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,KW-0694~RNA-binding,		COMPBIAS:Basic and acidic residues,DOMAIN:DEAD-box RNA helicase Q,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAD box,MOTIF:Q motif,REGION:Disordered,
O88450	DEAF1 transcription factor(Deaf1)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001662~behavioral fear response,GO:0001843~neural tube closure,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008542~visual learning,GO:0033599~regulation of mammary gland epithelial cell proliferation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048706~embryonic skeletal system development,	GO:0001650~fibrillar center,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000770:SAND_dom,IPR002893:Znf_MYND,IPR010919:SAND-like_dom_sf,IPR024119:TF_DEAF-1,				SM00258:SAND,	KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0964~Secreted,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,DOMAIN:MYND-type,DOMAIN:SAND,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with LMO4,ZN_FING:MYND-type,
Q7L7V1	DEAH-box helicase 32 (putative)(DHX32)	Homo sapiens				GO:0005622~intracellular,GO:0005681~spliceosomal complex,GO:0005739~mitochondrion,	GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR007502:Helicase-assoc_dom,IPR011709:DEAD-box_helicase_OB_fold,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR048333:HA2_WH,				SM00847:HA2,		KW-0496~Mitochondrion,KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,	KW-0007~Acetylation,	DOMAIN:Helicase ATP-binding,DOMAIN:Helicase-associated,MOTIF:DEAH box,REGION:Disordered,
Q8IY37	DEAH-box helicase 37(DHX37)	Homo sapiens			GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0007420~brain development,GO:0042254~ribosome biogenesis,GO:0042255~ribosome assembly,GO:0042274~ribosomal small subunit biogenesis,GO:2000020~positive regulation of male gonad development,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,GO:0032040~small-subunit processome,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0034511~U3 snoRNA binding,	IPR001650:Helicase_C,IPR007502:Helicase-assoc_dom,IPR011545:DEAD/DEAH_box_helicase_dom,IPR011709:DEAD-box_helicase_OB_fold,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR048333:HA2_WH,		273250~46XY sex reversal 11,618731~Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies,		SM00487:DEXDc,SM00490:HELICc,SM00847:HA2,		KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0991~Intellectual disability,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,MUTAGEN:T->A: Impairs the catalytic activity of the helicase.,REGION:Disordered,
Q7SYB5	DEF6 guanine nucleotide exchange factor a(def6a)	Danio rerio			GO:0042074~cell migration involved in gastrulation,GO:0060026~convergent extension,GO:0060027~convergent extension involved in gastrulation,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR001849:PH_domain,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,				SM00233:PH,					KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,DOMAIN:PH,REGION:Disordered,
Q7TNV0	DEK proto-oncogene(Dek)	Mus musculus			GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0035066~positive regulation of histone acetylation,GO:0044838~cell quiescence,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:2000779~regulation of double-strand break repair,GO:2001032~regulation of double-strand break repair via nonhomologous end joining,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0043292~contractile fiber,	GO:0003677~DNA binding,GO:0042393~histone binding,	IPR003034:SAP_dom,IPR014876:DEK_C,IPR036361:SAP_dom_sf,IPR044198:DEK,				SM00513:SAP,		KW-0539~Nucleus,					KW-0156~Chromatin regulator,KW-0238~DNA-binding,	KW-0013~ADP-ribosylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DOMAIN:DEK-C,DOMAIN:SAP,MOTIF:Nuclear localization signal,REGION:Disordered,
Q7Z401	DENN domain containing 4A(DENND4A)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0032483~regulation of Rab protein signal transduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031410~cytoplasmic vesicle,	GO:0003677~DNA binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR001194:cDENN_dom,IPR002885:Pentatricopeptide_rpt,IPR005112:dDENN_dom,IPR005113:uDENN_dom,IPR011990:TPR-like_helical_dom_sf,IPR018798:MVB12A/B,IPR023341:MABP,IPR037516:Tripartite_DENN,IPR043153:DENN_C,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0238~DNA-binding,KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:MABP,DOMAIN:UDENN,DOMAIN:cDENN,DOMAIN:dDENN,DOMAIN:uDENN,MOTIF:Bipartite nuclear localization signal,REGION:Disordered,REPEAT:PPR,REPEAT:PPR 1,REPEAT:PPR 2,
Q6ZUT9	DENN domain containing 5B(DENND5B)	Homo sapiens			GO:1905885~positive regulation of triglyceride transport,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0031267~small GTPase binding,	IPR001024:PLAT/LH2_dom,IPR001194:cDENN_dom,IPR004012:Run_dom,IPR005112:dDENN_dom,IPR005113:uDENN_dom,IPR036392:PLAT/LH2_dom_sf,IPR037213:Run_dom_sf,IPR037516:Tripartite_DENN,IPR043153:DENN_C,IPR047277:PLAT_RAB6IP1,IPR047278:DEN5A/B,IPR047292:RUN2_DENND5B,IPR047293:RUN1_DENND5B,				SM00593:RUN,SM00799:DENN,SM00800:uDENN,SM00801:dDENN,		KW-0472~Membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0344~Guanine-nucleotide releasing factor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:PLAT,DOMAIN:RUN,DOMAIN:RUN 1,DOMAIN:RUN 2,DOMAIN:UDENN,DOMAIN:cDENN,DOMAIN:dDENN,DOMAIN:uDENN,TRANSMEM:Helical,
Q803Q4	DEP domain containing 1a(depdc1a)	Danio rerio			GO:0007165~signal transduction,GO:0035556~intracellular signal transduction,GO:0048468~cell development,GO:0048731~system development,		GO:0005096~GTPase activator activity,	IPR000198:RhoGAP_dom,IPR000591:DEP_dom,IPR008936:Rho_GTPase_activation_prot,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,				SM00049:DEP,							KW-0343~GTPase activation,		COMPBIAS:Polar residues,DOMAIN:DEP,DOMAIN:Rho-GAP,REGION:Disordered,
Q3B8Q1	DExD-box helicase 21(Ddx21)	Rattus norvegicus			GO:0002735~positive regulation of myeloid dendritic cell cytokine production,GO:0006364~rRNA processing,GO:0006366~transcription from RNA polymerase II promoter,GO:0009615~response to virus,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043330~response to exogenous dsRNA,GO:0045087~innate immune response,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0051607~defense response to virus,	GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0003729~mRNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0019843~rRNA binding,GO:0030515~snoRNA binding,GO:0035198~miRNA binding,GO:0042802~identical protein binding,GO:0097322~7SK snRNA binding,	IPR001650:Helicase_C,IPR011545:DEAD/DEAH_box_helicase_dom,IPR012562:GUCT,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR035979:RBD_domain_sf,				SM00487:DEXDc,SM00490:HELICc,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0698~rRNA processing,KW-0804~Transcription,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAD box,MOTIF:Q motif,REGION:3 X 5 AA repeats,REGION:Disordered,REPEAT:1,REPEAT:2,REPEAT:3,
Q5U216	DExD-box helicase 39A(Ddx39a)	Rattus norvegicus			GO:0000398~mRNA splicing, via spliceosome,GO:0006406~mRNA export from nucleus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003729~mRNA binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0042802~identical protein binding,	IPR001650:Helicase_C,IPR011545:DEAD/DEAH_box_helicase_dom,IPR014001:Helicase_ATP-bd,IPR014014:RNA_helicase_DEAD_Q_motif,IPR027417:P-loop_NTPase,				SM00487:DEXDc,SM00490:HELICc,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:DEAD-box RNA helicase Q,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DECD box,MOTIF:Q motif,REGION:Disordered,
Q96C10	DExH-box helicase 58(DHX58)	Homo sapiens			GO:0002753~cytoplasmic pattern recognition receptor signaling pathway,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0032480~negative regulation of type I interferon production,GO:0032481~positive regulation of type I interferon production,GO:0039534~negative regulation of MDA-5 signaling pathway,GO:0039536~negative regulation of RIG-I signaling pathway,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045824~negative regulation of innate immune response,GO:0051607~defense response to virus,GO:1900245~positive regulation of MDA-5 signaling pathway,GO:1900246~positive regulation of RIG-I signaling pathway,	GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0046872~metal ion binding,	IPR001650:Helicase_C,IPR006935:Helicase/UvrB_N,IPR014001:Helicase_ATP-bd,IPR021673:RLR_CTR,IPR027417:P-loop_NTPase,IPR038557:RLR_C_sf,IPR041204:RIG-I-like_C,	hsa04622:RIG-I-like receptor signaling pathway,			SM00487:DEXDc,SM00490:HELICc,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0945~Host-virus interaction,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0347~Helicase,KW-0378~Hydrolase,KW-0694~RNA-binding,		DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,DOMAIN:RLR CTR,MOTIF:DECH box,MUTAGEN:DECH->AACA: Loss of dsRNA-induced ATPase activity.,MUTAGEN:FTRT->ATRA: Loss of dsRNA-induced ATPase activity. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,MUTAGEN:K->A: Loss of dsRNA-induced ATPase activity. No effect on ds-RNA binding. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,MUTAGEN:K->E: Abolishes RNA binding.,MUTAGEN:QARGR->AARGA: Loss of dsRNA-induced ATPase activity. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,MUTAGEN:TAS->AAA: Loss of dsRNA-induced ATPase activity. Loss of ds-RNA binding. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,MUTAGEN:TSVAE->ASVAA: Loss of dsRNA-induced ATPase activity. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,REGION:RNA-binding,
Q28141	DExH-box helicase 9(DHX9)	Bos taurus			GO:0000380~alternative mRNA splicing, via spliceosome,GO:0006260~DNA replication,GO:0006353~DNA-templated transcription, termination,GO:0006954~inflammatory response,GO:0010501~RNA secondary structure unwinding,GO:0032508~DNA duplex unwinding,GO:0032727~positive regulation of interferon-alpha production,GO:0032728~positive regulation of interferon-beta production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0035195~gene silencing by miRNA,GO:0039695~DNA-templated viral transcription,GO:0044806~G-quadruplex DNA unwinding,GO:0045087~innate immune response,GO:0045739~positive regulation of DNA repair,GO:0045740~positive regulation of DNA replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046833~positive regulation of RNA export from nucleus,GO:0048146~positive regulation of fibroblast proliferation,GO:0048511~rhythmic process,GO:0050434~positive regulation of viral transcription,GO:0050684~regulation of mRNA processing,GO:0051028~mRNA transport,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060760~positive regulation of response to cytokine stimulus,GO:0070922~small RNA loading onto RISC,GO:0070934~CRD-mediated mRNA stabilization,GO:0071356~cellular response to tumor necrosis factor,GO:0071360~cellular response to exogenous dsRNA,GO:1900152~negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:1903608~protein localization to cytoplasmic stress granule,GO:1904973~positive regulation of viral translation,GO:1905698~positive regulation of polysome binding,GO:2000373~positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,GO:2000765~regulation of cytoplasmic translation,GO:2000767~positive regulation of cytoplasmic translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005726~perichromatin fibrils,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005844~polysome,GO:0015629~actin cytoskeleton,GO:0016442~RISC complex,GO:0016604~nuclear body,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0042788~polysomal ribosome,GO:0070578~RISC-loading complex,GO:0070937~CRD-mediated mRNA stability complex,GO:0097165~nuclear stress granule,GO:1990904~ribonucleoprotein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000993~RNA polymerase II core binding,GO:0001069~regulatory region RNA binding,GO:0003677~DNA binding,GO:0003688~DNA replication origin binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017111~nucleoside-triphosphatase activity,GO:0031490~chromatin DNA binding,GO:0033679~3'-5' DNA/RNA helicase activity,GO:0034458~3'-5' RNA helicase activity,GO:0035197~siRNA binding,GO:0035613~RNA stem-loop binding,GO:0043138~3'-5' DNA helicase activity,GO:0045142~triplex DNA binding,GO:0046872~metal ion binding,GO:0047429~nucleoside-triphosphate diphosphatase activity,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0061676~importin-alpha family protein binding,GO:0070063~RNA polymerase binding,GO:1905172~RISC complex binding,GO:1905538~polysome binding,GO:1990518~single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,GO:1990825~sequence-specific mRNA binding,GO:1990841~promoter-specific chromatin binding,	IPR001650:Helicase_C,IPR002464:DNA/RNA_helicase_DEAH_CS,IPR007502:Helicase-assoc_dom,IPR011545:DEAD/DEAH_box_helicase_dom,IPR011709:DEAD-box_helicase_OB_fold,IPR014001:Helicase_ATP-bd,IPR014720:dsRBD_dom,IPR027417:P-loop_NTPase,IPR044445:DHX9_DSRM_1,IPR044446:DHX9_DSRM_2,IPR044447:DHX9_DEXHc,IPR048333:HA2_WH,				SM00358:DSRM,SM00487:DEXDc,SM00490:HELICc,SM00847:HA2,	KW-0090~Biological rhythms,KW-0235~DNA replication,KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0509~mRNA transport,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0806~Transcription termination,KW-0810~Translation regulation,KW-0813~Transport,KW-0943~RNA-mediated gene silencing,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0010~Activator,KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:DRBM 1,DOMAIN:DRBM 2,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEIH box,MOTIF:Nuclear localization signal (NLS1),MOTIF:Nuclear localization signal (NLS2),REGION:Core helicase,REGION:Disordered,REGION:HA2,REGION:Interaction with BRCA1,REGION:Interaction with CREBBP,REGION:MTAD,REGION:NTD region,REGION:Necessary for interaction with H2AX,REGION:Necessary for interaction with RNA polymerase II holoenzyme,REGION:OB-fold,REGION:RGG,REGION:siRNA-binding,
Q6PFD5	DLG associated protein 3(Dlgap3)	Mus musculus			GO:0023052~signaling,GO:0050804~modulation of synaptic transmission,GO:0065003~macromolecular complex assembly,GO:0098962~regulation of postsynaptic neurotransmitter receptor activity,GO:0099563~modification of synaptic structure,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0031594~neuromuscular junction,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0045202~synapse,GO:0098978~glutamatergic synapse,GO:0098981~cholinergic synapse,GO:0099572~postsynaptic specialization,	GO:0001540~beta-amyloid binding,GO:0019904~protein domain specific binding,GO:0030165~PDZ domain binding,GO:0060090~binding, bridging,GO:0097110~scaffold protein binding,	IPR005026:SAPAP,						KW-0472~Membrane,KW-0770~Synapse,KW-1003~Cell membrane,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,
Q8K4R9	DLG associated protein 5(Dlgap5)	Mus musculus			GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007346~regulation of mitotic cell cycle,GO:0023052~signaling,GO:0051382~kinetochore assembly,GO:0051642~centrosome localization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0031616~spindle pole centrosome,GO:0072686~mitotic spindle,	GO:0008017~microtubule binding,	IPR005026:SAPAP,					KW-0131~Cell cycle,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q92072	DNA methyltransferase 1(DNMT1)	Gallus gallus			GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0090116~C-5 methylation of cytosine,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0008270~zinc ion binding,GO:1990841~promoter-specific chromatin binding,	IPR001025:BAH_dom,IPR001525:C5_MeTfrase,IPR002857:Znf_CXXC,IPR010506:DMAP1-bd,IPR017198:DNMT1-like,IPR018117:C5_DNA_meth_AS,IPR022702:Cytosine_MeTrfase1_RFD,IPR029063:SAM-dependent_MTases_sf,IPR031303:C5_meth_CS,IPR043151:BAH_sf,	gga00270:Cysteine and methionine metabolism,gga01100:Metabolic pathways,		PIRSF037404:DNMT1,	SM00439:BAH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0238~DNA-binding,KW-0489~Methyltransferase,KW-0678~Repressor,KW-0808~Transferase,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:BAH,DOMAIN:BAH 1,DOMAIN:BAH 2,DOMAIN:CXXC-type,DOMAIN:DMAP1-binding,DOMAIN:SAM-dependent MTase C5-type,MUTAGEN:V->H: No loss of interaction with PCNA.,REGION:8 X 2 AA tandem repeats of K-G,REGION:Disordered,REGION:Interaction with PCNA,REPEAT:1,REPEAT:2,REPEAT:3,REPEAT:4,REPEAT:5,REPEAT:6,REPEAT:7,REPEAT:8; approximate,SITE:Important for activity,ZN_FING:CXXC-type,
Q1LZ53	DNA methyltransferase 3 alpha(Dnmt3a)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006305~DNA alkylation,GO:0006306~DNA methylation,GO:0006346~methylation-dependent chromatin silencing,GO:0007283~spermatogenesis,GO:0009410~response to xenobiotic stimulus,GO:0009636~response to toxic substance,GO:0010212~response to ionizing radiation,GO:0010288~response to lead ion,GO:0010468~regulation of gene expression,GO:0030182~neuron differentiation,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol,GO:0032776~DNA methylation on cytosine,GO:0033189~response to vitamin A,GO:0042220~response to cocaine,GO:0043045~DNA methylation involved in embryo development,GO:0044027~hypermethylation of CpG island,GO:0045471~response to ethanol,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046500~S-adenosylmethionine metabolic process,GO:0071230~cellular response to amino acid stimulus,GO:0071361~cellular response to ethanol,GO:0071456~cellular response to hypoxia,GO:0071514~genetic imprinting,GO:0090116~C-5 methylation of cytosine,GO:0097284~hepatocyte apoptotic process,GO:1900039~positive regulation of cellular response to hypoxia,GO:1903926~cellular response to bisphenol A,	GO:0000775~chromosome, centromeric region,GO:0000791~euchromatin,GO:0000792~heterochromatin,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:1902494~catalytic complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0042802~identical protein binding,GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,	IPR000313:PWWP_dom,IPR001525:C5_MeTfrase,IPR018117:C5_DNA_meth_AS,IPR025766:ADD,IPR029063:SAM-dependent_MTases_sf,IPR040552:DNMT3_ADD,IPR044108:ADD_DNMT3A,	rno00270:Cysteine and methionine metabolism,rno01100:Metabolic pathways,rno04148:Efferocytosis,rno05206:MicroRNAs in cancer,			SM00293:PWWP,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0156~Chromatin regulator,KW-0238~DNA-binding,KW-0489~Methyltransferase,KW-0678~Repressor,KW-0808~Transferase,	KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:ADD,DOMAIN:PHD-type,DOMAIN:PWWP,DOMAIN:SAM-dependent MTase C5-type,REGION:Disordered,REGION:Interaction with DNMT1 and DNMT3B,REGION:Interaction with the PRC2/EED-EZH2 complex,ZN_FING:GATA-type; atypical,ZN_FING:PHD-type; atypical,
O88509	DNA methyltransferase 3B(Dnmt3b)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0006306~DNA methylation,GO:0006346~methylation-dependent chromatin silencing,GO:0009410~response to xenobiotic stimulus,GO:0009636~response to toxic substance,GO:0010212~response to ionizing radiation,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0014823~response to activity,GO:0031000~response to caffeine,GO:0031503~protein complex localization,GO:0032259~methylation,GO:0032355~response to estradiol,GO:0033189~response to vitamin A,GO:0042220~response to cocaine,GO:0043045~DNA methylation involved in embryo development,GO:0045666~positive regulation of neuron differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0071230~cellular response to amino acid stimulus,GO:0071455~cellular response to hyperoxia,GO:0071549~cellular response to dexamethasone stimulus,GO:0090116~C-5 methylation of cytosine,	GO:0000775~chromosome, centromeric region,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:1902494~catalytic complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0009008~DNA-methyltransferase activity,GO:0016740~transferase activity,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,GO:0051718~DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates,GO:0051719~DNA (cytosine-5-)-methyltransferase activity, acting on CpN substrates,	IPR000313:PWWP_dom,IPR001525:C5_MeTfrase,IPR011011:Znf_FYVE_PHD,IPR018117:C5_DNA_meth_AS,IPR025766:ADD,IPR029063:SAM-dependent_MTases_sf,IPR030488:DNMT3B_ADD,IPR040552:DNMT3_ADD,	mmu00270:Cysteine and methionine metabolism,mmu01100:Metabolic pathways,mmu05206:MicroRNAs in cancer,			SM00293:PWWP,		KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0010~Activator,KW-0238~DNA-binding,KW-0489~Methyltransferase,KW-0678~Repressor,KW-0808~Transferase,	KW-0164~Citrullination,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:ADD,DOMAIN:PHD-type,DOMAIN:PWWP,DOMAIN:SAM-dependent MTase C5-type,MUTAGEN:A->T: Significantly reduces activity.,MUTAGEN:D->G: Significantly reduces activity.,MUTAGEN:G->S: Significantly reduces activity.,MUTAGEN:L->T: Significantly reduces activity.,MUTAGEN:PC->GT: No effect on localization.,MUTAGEN:S->P: Prevents accumulation in pericentric heterochromatin.,MUTAGEN:V->G: Loss of activity.,MUTAGEN:V->M: Significantly reduces activity.,MUTAGEN:VW->RR: Prevents accumulation in pericentric heterochromatin.,REGION:Disordered,REGION:Interaction with DNMT1 and DNMT3A,REGION:Interaction with the PRC2/EED-EZH2 complex,ZN_FING:GATA-type; atypical,ZN_FING:PHD-type; atypical,
Q7TQ07	DNA polymerase N(Poln)	Mus musculus			GO:0000724~double-strand break repair via homologous recombination,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006974~cellular response to DNA damage stimulus,GO:0019985~translesion synthesis,GO:0036297~interstrand cross-link repair,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0030332~cyclin binding,	IPR001098:DNA-dir_DNA_pol_A_palm_dom,IPR002298:DNA_polymerase_A,IPR036397:RNaseH_sf,IPR040940:DNA_pol_P_Exo,IPR043502:DNA/RNA_pol_sf,	mmu03460:Fanconi anemia pathway,			SM00482:POLAc,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0238~DNA-binding,KW-0239~DNA-directed DNA polymerase,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,DOMAIN:DNA-directed DNA polymerase family A palm,REGION:Disordered,TRANSMEM:Helical,
P49642	DNA primase subunit 1(PRIM1)	Homo sapiens			GO:0006269~DNA replication, synthesis of RNA primer,GO:0006270~DNA replication initiation,	GO:0000428~DNA-directed RNA polymerase complex,GO:0005654~nucleoplasm,GO:0005658~alpha DNA polymerase:primase complex,GO:0016020~membrane,	GO:0000287~magnesium ion binding,GO:0003896~DNA primase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016779~nucleotidyltransferase activity,GO:0032553~ribonucleotide binding,GO:0046872~metal ion binding,	IPR002755:DNA_primase_S,IPR014052:DNA_primase_ssu_euk/arc,	hsa03030:DNA replication,	620005~Primordial dwarfism-immunodeficiency-lipodystrophy syndrome,			KW-0235~DNA replication,KW-0804~Transcription,	KW-0240~DNA-directed RNA polymerase,KW-0639~Primosome,KW-9994~DNA-directed RNA polymerase,		KW-0225~Disease variant,KW-0242~Dwarfism,		KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,	MOTIF:Zinc knuckle motif,MUTAGEN:D->A: Loss of primase activity.,MUTAGEN:D->A: Slightly decreases primase activity.,MUTAGEN:D->N: Decreases the binding affinity for NTPs.,MUTAGEN:E->A: Strongly decreases primase activity, which can be partially rescued by increasing primase concentration.,MUTAGEN:H->A: Abolishes NTP binding. Loss of primase activity.,MUTAGEN:H->A: Decreases the binding affinity for NTPs. Loss of primase activity.,MUTAGEN:H->A: Strongly decreases primase activity, which can be partially rescued by increasing primase concentration.,MUTAGEN:K->A: Decreases primase activity.,MUTAGEN:K->A: Decreases the binding affinity for NTPs. Loss of primase activity.,MUTAGEN:R->A: Abolishes NTP binding.,MUTAGEN:R->A: Loss of primase activity.,MUTAGEN:S->A: Abolishes NTP binding.,MUTAGEN:Y->A: Decreases primase activity.,REGION:Disordered,
Q6AXJ3	Dexi homolog (mouse)(dexi)	Danio rerio						IPR023259:Dexamethasone-induced,
Q9Y485	Dmx like 1(DMXL1)	Homo sapiens			GO:0007035~vacuolar acidification,	GO:0043291~RAVE complex,		IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR022033:Rav1p_C,IPR036322:WD40_repeat_dom_sf,	hsa04142:Lysosome,			SM00320:WD40,					KW-0677~Repeat,KW-0853~WD repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:RAVE complex protein Rav1 C-terminal,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 10,REPEAT:WD 11,REPEAT:WD 12,REPEAT:WD 14,REPEAT:WD 15,REPEAT:WD 16,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,REPEAT:WD 8,REPEAT:WD 9,
G3H0N9	DnaJ heat shock protein family (Hsp40) member B9(Dnajb9)	Cricetulus griseus			GO:0002639~positive regulation of immunoglobulin production,GO:0006986~response to unfolded protein,GO:0030183~B cell differentiation,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0034976~response to endoplasmic reticulum stress,GO:1903895~negative regulation of IRE1-mediated unfolded protein response,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0030544~Hsp70 protein binding,GO:0051087~chaperone binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ_domain,IPR018253:DnaJ_domain_CS,IPR036869:J_dom_sf,				SM00271:DnaJ,	KW-0834~Unfolded protein response,	KW-0256~Endoplasmic reticulum,			KW-0732~Signal,		KW-0143~Chaperone,	KW-0597~Phosphoprotein,	DOMAIN:J,MUTAGEN:H->Q: Abolishes ability to stimulate ATPase activity of HSPA5/BiP.,REGION:Divergent targeting domain,
Q9R0T3	DnaJ heat shock protein family (Hsp40) member C3(Dnajc3)	Rattus norvegicus			GO:0006986~response to unfolded protein,GO:0034975~protein folding in endoplasmic reticulum,GO:0034976~response to endoplasmic reticulum stress,GO:0036494~positive regulation of translation initiation in response to endoplasmic reticulum stress,GO:0043066~negative regulation of apoptotic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070417~cellular response to cold,GO:1903912~negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005790~smooth endoplasmic reticulum,GO:0005829~cytosol,	GO:0004860~protein kinase inhibitor activity,GO:0019901~protein kinase binding,GO:0051087~chaperone binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ_domain,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR036869:J_dom_sf,	rno04141:Protein processing in endoplasmic reticulum,rno05164:Influenza A,			SM00028:TPR,SM00271:DnaJ,	KW-0834~Unfolded protein response,	KW-0256~Endoplasmic reticulum,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,KW-0802~TPR repeat,			KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DOMAIN:J,REGION:Disordered,REGION:Flexible linker,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
O00716	E2F transcription factor 3(E2F3)	Homo sapiens			GO:0000082~G1/S transition of mitotic cell cycle,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0008284~positive regulation of cell proliferation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070345~negative regulation of fat cell proliferation,GO:1905461~positive regulation of vascular associated smooth muscle cell apoptotic process,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001216~bacterial-type RNA polymerase transcriptional activator activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,GO:1990837~sequence-specific double-stranded DNA binding,	IPR003316:E2F_WHTH_DNA-bd_dom,IPR015633:E2F,IPR032198:E2F_CC-MB,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR037241:E2F-DP_heterodim,	hsa01522:Endocrine resistance,hsa04110:Cell cycle,hsa04218:Cellular senescence,hsa04934:Cushing syndrome,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05163:Human cytomegalovirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05224:Breast cancer,hsa05225:Hepatocellular carcinoma,hsa05226:Gastric cancer,			SM01372:E2F_TDP,	KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,		DOMAIN:E2F transcription factor CC-MB,DOMAIN:E2F/DP family winged-helix DNA-binding,MOTIF:DEF box,REGION:Cyclin A/CDK2 binding,REGION:Dimerization,REGION:Disordered,REGION:Leucine-zipper,REGION:Retinoblastoma protein binding,REGION:Transactivation,
F1QZ88	E2F transcription factor 8(e2f8)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001946~lymphangiogenesis,GO:0002040~sprouting angiogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0008045~motor neuron axon guidance,GO:0032466~negative regulation of cytokinesis,GO:0032877~positive regulation of DNA endoreduplication,GO:0033301~cell cycle comprising mitosis without cytokinesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060718~chorionic trophoblast cell differentiation,GO:0070365~hepatocyte differentiation,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001217~bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR003316:E2F_WHTH_DNA-bd_dom,IPR015633:E2F,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,				SM01372:E2F_TDP,	KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
P56273	E3 ubiquitin-protein ligase Mdm2(LOC108713153)	Xenopus laevis			GO:0006915~apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0051726~regulation of cell cycle,GO:0065008~regulation of biological quality,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR001876:Znf_RanBP2,IPR003121:SWIB_MDM2_domain,IPR013083:Znf_RING/FYVE/PHD,IPR016495:p53_neg-reg_MDM_2/4,IPR028340:Mdm2,IPR036443:Znf_RanBP2_sf,IPR036885:SWIB_MDM2_dom_sf,IPR044080:MDM2_mRING-HC-C2H2C4,	xla04068:FoxO signaling pathway,xla04110:Cell cycle,xla04115:p53 signaling pathway,xla04120:Ubiquitin mediated proteolysis,xla04144:Endocytosis,xla04218:Cellular senescence,xla04625:C-type lectin receptor signaling pathway,		PIRSF006748:p53_MDM_2/4,PIRSF500700:MDM2,		KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:DM2,DOMAIN:RING-type,DOMAIN:RanBP2-type,DOMAIN:SWIB/MDM2,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Region II,ZN_FING:RING-type,ZN_FING:RanBP2-type,
A0A0R4IWI1	EBF transcription factor 1a(ebf1a)	Danio rerio			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR002909:IPT_dom,IPR003523:Transcription_factor_COE,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR018350:Transcription_factor_COE_CS,IPR032200:COE_DBD,IPR032201:COE_HLH,IPR038006:COE_IPT,IPR038173:COE_DBD_sf,				SM00429:IPT,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		DOMAIN:IPT/TIG,REGION:Disordered,REGION:Interaction with DNA,SITE:Interaction with DNA,ZN_FING:C5-type,
Q08CK1	ECSIT signaling integrator(ecsit)	Danio rerio			GO:0002376~immune system process,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0045087~innate immune response,GO:0051341~regulation of oxidoreductase activity,GO:0061635~regulation of protein complex stability,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,		IPR010418:ECSIT,IPR029342:ECIST_C,IPR046448:ECSIT_N,	dre04010:MAPK signaling pathway,			SM01284:ECSIT_Cterm,	KW-0391~Immunity,KW-0399~Innate immunity,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0809~Transit peptide,				COMPBIAS:Basic and acidic residues,DOMAIN:ECSIT C-terminal,REGION:Disordered,TRANSIT:Mitochondrion,
Q5D013	EEF1A lysine methyltransferase 2(eef1akmt2)	Danio rerio			GO:0018022~peptidyl-lysine methylation,GO:0032259~methylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0008168~methyltransferase activity,GO:0008169~C-methyltransferase activity,GO:0008170~N-methyltransferase activity,GO:0008171~O-methyltransferase activity,GO:0008172~S-methyltransferase activity,GO:0008425~2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016740~transferase activity,GO:0030792~methylarsonite methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0051994~P-methyltransferase activity,	IPR025714:Methyltranfer_dom,IPR026635:Efm4/METTL10,IPR029063:SAM-dependent_MTases_sf,						KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:Methyltransferase,
Q5T8I3	EEIG family member 2(EEIG2)	Homo sapiens						IPR019448:NT-C2,IPR039931:EEIG1/2-like,												KW-0597~Phosphoprotein,	DOMAIN:C2 NT-type,
Q17QM6	EF-hand domain family member D1(EFHD1)	Bos taurus			GO:1900069~regulation of cellular hyperosmotic salinity response,	GO:0005743~mitochondrial inner membrane,		IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR040365:EFHD1/2,				SM00054:EFh,		KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,			COMPBIAS:Pro residues,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,REGION:Disordered,
Q9UHF1	EGF like domain multiple 7(EGFL7)	Homo sapiens			GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001938~positive regulation of endothelial cell proliferation,GO:0007155~cell adhesion,GO:0045746~negative regulation of Notch signaling pathway,GO:0048856~anatomical structure development,	GO:0005576~extracellular region,GO:0009986~cell surface,	GO:0005102~receptor binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR011489:EMI_domain,IPR013111:EGF_extracell,IPR018097:EGF_Ca-bd_CS,				SM00179:EGF_CA,SM00181:EGF,	KW-0037~Angiogenesis,KW-0130~Cell adhesion,KW-0221~Differentiation,	KW-0964~Secreted,			KW-0175~Coiled coil,KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-1015~Disulfide bond,	DOMAIN:EGF-like 1,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EMI,MOTIF:Cell attachment site,MUTAGEN:G->A: Disrupts RGD motif and results in a 79% loss of cell adhesion.,
O43854	EGF like repeats and discoidin domains 3(EDIL3)	Homo sapiens			GO:0007155~cell adhesion,GO:0010811~positive regulation of cell-substrate adhesion,	GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005178~integrin binding,GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000421:FA58C,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR008979:Galactose-bd-like_sf,IPR013032:EGF-like_CS,IPR018097:EGF_Ca-bd_CS,				SM00179:EGF_CA,SM00181:EGF,SM00231:FA58C,	KW-0130~Cell adhesion,	KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Fuc...) threonine,CARBOHYD:O-linked (GalNAc...) threonine,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:F5/8 type C 1,DOMAIN:F5/8 type C 2,MOTIF:Cell attachment site,
Q63HQ2	EGF like, fibronectin type III and laminin G domains(EGFLAM)	Homo sapiens			GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,	GO:0005604~basement membrane,GO:0005614~interstitial matrix,GO:0009986~cell surface,GO:0042995~cell projection,GO:0043083~synaptic cleft,GO:0048786~presynaptic active zone,GO:0098684~photoreceptor ribbon synapse,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005539~glycosaminoglycan binding,	IPR000742:EGF-like_dom,IPR001791:Laminin_G,IPR001881:EGF-like_Ca-bd_dom,IPR003961:FN3_dom,IPR013320:ConA-like_dom_sf,IPR013783:Ig-like_fold,IPR036116:FN3_sf,				SM00060:FN3,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,		KW-0272~Extracellular matrix,KW-0770~Synapse,KW-0964~Secreted,KW-0966~Cell projection,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0357~Heparan sulfate,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Laminin G,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G-like 2,DOMAIN:Laminin G-like 3,
Q8AVH7	EGF-like-domain, multiple 6 S homeolog(egfl6.S)	Xenopus laevis			GO:0007155~cell adhesion,GO:0030154~cell differentiation,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0016020~membrane,	GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR000998:MAM_dom,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR013320:ConA-like_dom_sf,IPR018097:EGF_Ca-bd_CS,				SM00137:MAM,SM00179:EGF_CA,SM00181:EGF,	KW-0130~Cell adhesion,KW-0221~Differentiation,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0175~Coiled coil,KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-1015~Disulfide bond,	DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:MAM,REGION:Disordered,
Q8N3D4	EH domain binding protein 1 like 1(EHBP1L1)	Homo sapiens				GO:0005768~endosome,GO:0016020~membrane,		IPR001715:CH_dom,IPR019448:NT-C2,IPR022735:bMERB_dom,IPR036872:CH_dom_sf,				SM00033:CH,SM01203:DUF3585,		KW-0967~Endosome,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2 NT-type,DOMAIN:Calponin-homology (CH),DOMAIN:bMERB,MOTIF:CAAX motif,REGION:Disordered,
Q9NZN3	EH domain containing 3(EHD3)	Homo sapiens			GO:0001881~receptor recycling,GO:0006897~endocytosis,GO:0015031~protein transport,GO:0032456~endocytic recycling,GO:0034498~early endosome to Golgi transport,GO:0051260~protein homooligomerization,GO:0055117~regulation of cardiac muscle contraction,GO:0060271~cilium assembly,GO:0072659~protein localization to plasma membrane,GO:0086036~regulation of cardiac muscle cell membrane potential,GO:0090160~Golgi to lysosome transport,GO:1903358~regulation of Golgi organization,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0010008~endosome membrane,GO:0020018~ciliary pocket membrane,GO:0030139~endocytic vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0055038~recycling endosome membrane,	GO:0003676~nucleic acid binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,	IPR000261:EH_dom,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR027417:P-loop_NTPase,IPR030381:G_DYNAMIN_dom,IPR031692:EHD_N,IPR040990:DUF5600,IPR045063:Dynamin_N,	hsa04144:Endocytosis,			SM00027:EH,	KW-0653~Protein transport,KW-0813~Transport,KW-0970~Cilium biogenesis/degradation,	KW-0472~Membrane,KW-0966~Cell projection,KW-0967~Endosome,KW-0969~Cilium,KW-1003~Cell membrane,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DOMAIN:Dynamin-type G,DOMAIN:EF-hand,DOMAIN:EH,MUTAGEN:G->R: Abolishes ATP-binding and localizes to cytoplasm.,MUTAGEN:K->R: Abolishes sumoylation and localization to tubular structures of the ERC, impairs fast recycling activity from the ERC, no effect on homooligomerization; when associated with R-511.,MUTAGEN:K->R: Abolishes sumoylation localization to tubular structures of the ERC, impairs fast recycling activity from the ERC, no effect on homooligomerization;; when associated with R-315.,MUTAGEN:V->P: Greatly reduces oligomerization and interaction with RAB11FIP2.,MUTAGEN:W->A: Abolishes interaction with RAB11FIP2.,REGION:G1 motif,REGION:G2 motif,REGION:G3 motif,REGION:G4 motif,REGION:G5 motif,
Q4V8H8	EH-domain containing 2(Ehd2)	Rattus norvegicus			GO:0006897~endocytosis,GO:0030866~cortical actin cytoskeleton organization,GO:0032456~endocytic recycling,GO:0060271~cilium assembly,GO:0072659~protein localization to plasma membrane,GO:0097320~plasma membrane tubulation,GO:1901741~positive regulation of myoblast fusion,GO:2001137~positive regulation of endocytic recycling,	GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0010008~endosome membrane,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0030139~endocytic vesicle,GO:0045171~intercellular bridge,GO:0048471~perinuclear region of cytoplasm,GO:0055038~recycling endosome membrane,	GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0019904~protein domain specific binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000261:EH_dom,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR027417:P-loop_NTPase,IPR030381:G_DYNAMIN_dom,IPR031692:EHD_N,IPR040990:DUF5600,IPR045063:Dynamin_N,	rno04144:Endocytosis,			SM00027:EH,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0106~Calcium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	DOMAIN:Dynamin-type G,DOMAIN:EF-hand,DOMAIN:EH,REGION:Disordered,REGION:G1 motif,REGION:G2 motif,REGION:G3 motif,REGION:G4 motif,REGION:G5 motif,REGION:Mediates membrane-binding,
Q14576	ELAV like RNA binding protein 3(ELAVL3)	Homo sapiens			GO:0007399~nervous system development,GO:0030154~cell differentiation,	GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,	IPR000504:RRM_dom,IPR002343:Hud_Sxl_RNA,IPR003954:RRM_dom_euk,IPR006548:ELAD_HU_SF,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034915:HuC_RRM3,IPR035979:RBD_domain_sf,				SM00360:RRM,SM00361:RRM_1,	KW-0221~Differentiation,KW-0524~Neurogenesis,				KW-0677~Repeat,		KW-0217~Developmental protein,KW-0694~RNA-binding,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,REGION:Disordered,
Q9BW60	ELOVL fatty acid elongase 1(ELOVL1)	Homo sapiens			GO:0006636~unsaturated fatty acid biosynthetic process,GO:0019367~fatty acid elongation, saturated fatty acid,GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0034625~fatty acid elongation, monounsaturated fatty acid,GO:0034626~fatty acid elongation, polyunsaturated fatty acid,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0036109~alpha-linolenic acid metabolic process,GO:0042761~very long-chain fatty acid biosynthetic process,GO:0043651~linoleic acid metabolic process,GO:0046513~ceramide biosynthetic process,GO:0061436~establishment of skin barrier,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0009922~fatty acid elongase activity,	IPR002076:ELO_fam,IPR030457:ELO_CS,IPR033681:ELOVL1,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,	618527~Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies,			KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,KW-0977~Ichthyosis,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0007~Acetylation,	MOTIF:Di-lysine motif,TRANSMEM:Helical,
A0A0C5PHQ7	ELOVL fatty acid elongase 5(elovl5)	Tachysurus fulvidraco			GO:0006636~unsaturated fatty acid biosynthetic process,GO:0019367~fatty acid elongation, saturated fatty acid,GO:0030148~sphingolipid biosynthetic process,GO:0034625~fatty acid elongation, monounsaturated fatty acid,GO:0034626~fatty acid elongation, polyunsaturated fatty acid,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0030425~dendrite,	GO:0009922~fatty acid elongase activity,	IPR002076:ELO_fam,IPR033677:ELOVL5,	tfd00062:Fatty acid elongation,tfd01040:Biosynthesis of unsaturated fatty acids,tfd01100:Metabolic pathways,tfd01212:Fatty acid metabolism,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0966~Cell projection,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,		COMPBIAS:Polar residues,REGION:Disordered,TRANSMEM:Helical,
Q9H5J4	ELOVL fatty acid elongase 6(ELOVL6)	Homo sapiens			GO:0006636~unsaturated fatty acid biosynthetic process,GO:0019367~fatty acid elongation, saturated fatty acid,GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0034625~fatty acid elongation, monounsaturated fatty acid,GO:0034626~fatty acid elongation, polyunsaturated fatty acid,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042759~long-chain fatty acid biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0009923~fatty acid elongase complex,	GO:0005515~protein binding,GO:0009922~fatty acid elongase activity,	IPR002076:ELO_fam,IPR030457:ELO_CS,IPR033675:ELOVL6,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
Q4V8C3	EMAP like 1(Eml1)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0002244~hematopoietic progenitor cell differentiation,GO:0007052~mitotic spindle organization,GO:0007405~neuroblast proliferation,GO:0007420~brain development,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0048471~perinuclear region of cytoplasm,GO:0072686~mitotic spindle,GO:0097431~mitotic spindle pole,GO:1990023~mitotic spindle midzone,	GO:0008017~microtubule binding,GO:0015631~tubulin binding,	IPR001680:WD40_rpt,IPR005108:HELP,IPR011047:Quinoprotein_ADH-like_supfam,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR036322:WD40_repeat_dom_sf,				SM00320:WD40,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:HELP,REGION:Disordered,REGION:Tandem atypical propeller in EMLs,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 10,REPEAT:WD 11,REPEAT:WD 12,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,REPEAT:WD 8,REPEAT:WD 9,
Q7ZUV7	EMSY transcriptional repressor, BRCA2 interacting(emsy)	Danio rerio			GO:0006281~DNA repair,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,		IPR005491:ENT_dom,IPR033482:EMSY,IPR036142:ENT_dom-like_sf,				SM01191:ENT,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0156~Chromatin regulator,KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:ENT,REGION:Disordered,
P29318	EPH receptor A3(EPHA3)	Gallus gallus			GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007411~axon guidance,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0010976~positive regulation of neuron projection development,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0032956~regulation of actin cytoskeleton organization,GO:0043087~regulation of GTPase activity,GO:0045806~negative regulation of endocytosis,GO:0048013~ephrin receptor signaling pathway,GO:0051893~regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0071300~cellular response to retinoic acid,GO:0097155~fasciculation of sensory neuron axon,GO:0097156~fasciculation of motor neuron axon,GO:1903078~positive regulation of protein localization to plasma membrane,	GO:0005654~nucleoplasm,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0043005~neuron projection,	GO:0005003~ephrin receptor activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR001090:Ephrin_rcpt_lig-bd_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001426:Tyr_kinase_rcpt_V_CS,IPR001660:SAM,IPR003961:FN3_dom,IPR008266:Tyr_kinase_AS,IPR008979:Galactose-bd-like_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR011009:Kinase-like_dom_sf,IPR011641:Tyr-kin_ephrin_A/B_rcpt-like,IPR013761:SAM/pointed_sf,IPR013783:Ig-like_fold,IPR016257:Tyr_kinase_ephrin_rcpt,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR027936:Eph_TM,IPR034266:EphA3_rcpt_lig-bd,IPR036116:FN3_sf,			PIRSF000666:TyrPK_ephrin_receptor,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:Ephrin_rec_like,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Eph LBD,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Protein kinase,DOMAIN:SAM,MOTIF:PDZ-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q15375	EPH receptor A7(EPHA7)	Homo sapiens			GO:0001934~positive regulation of protein phosphorylation,GO:0006468~protein phosphorylation,GO:0007411~axon guidance,GO:0007420~brain development,GO:0016310~phosphorylation,GO:0022407~regulation of cell-cell adhesion,GO:0031290~retinal ganglion cell axon guidance,GO:0031952~regulation of protein autophosphorylation,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0048013~ephrin receptor signaling pathway,GO:0048671~negative regulation of collateral sprouting,GO:0048755~branching morphogenesis of a nerve,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050804~modulation of synaptic transmission,GO:0050919~negative chemotaxis,GO:0051402~neuron apoptotic process,GO:0051964~negative regulation of synapse assembly,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0072178~nephric duct morphogenesis,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0098978~glutamatergic synapse,	GO:0004713~protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008046~axon guidance receptor activity,GO:0019838~growth factor binding,GO:0045499~chemorepellent activity,	IPR000719:Prot_kinase_dom,IPR001090:Ephrin_rcpt_lig-bd_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001426:Tyr_kinase_rcpt_V_CS,IPR001660:SAM,IPR003961:FN3_dom,IPR008266:Tyr_kinase_AS,IPR008979:Galactose-bd-like_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR011009:Kinase-like_dom_sf,IPR011641:Tyr-kin_ephrin_A/B_rcpt-like,IPR013761:SAM/pointed_sf,IPR013783:Ig-like_fold,IPR016257:Tyr_kinase_ephrin_rcpt,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR027936:Eph_TM,IPR034283:EphA7_rcpt_lig-bd,IPR036116:FN3_sf,	hsa04360:Axon guidance,		PIRSF000666:TyrPK_ephrin_receptor,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:Ephrin_rec_like,	KW-0053~Apoptosis,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Eph LBD,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Protein kinase,DOMAIN:SAM,MOTIF:PDZ-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O43402	ER membrane protein complex subunit 8(EMC8)	Homo sapiens			GO:0045050~protein insertion into ER membrane by stop-transfer membrane-anchor sequence,GO:0071816~tail-anchored membrane protein insertion into ER membrane,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0072546~ER membrane protein complex,	GO:0005515~protein binding,GO:0032977~membrane insertase activity,	IPR005366:EMC8/9,IPR037518:MPN,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,							DOMAIN:MPN,
Q5T890	ERCC excision repair 6 like 2(ERCC6L2)	Homo sapiens			GO:0006338~chromatin remodeling,GO:0034614~cellular response to reactive oxygen species,GO:0036297~interstrand cross-link repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005829~cytosol,GO:0032991~macromolecular complex,	GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019901~protein kinase binding,	IPR000330:SNF2_N,IPR001650:Helicase_C,IPR002464:DNA/RNA_helicase_DEAH_CS,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR029256:Heliccase-ass-bd,IPR038718:SNF2-like_sf,		615715~Bone marrow failure syndrome 2,		SM00487:DEXDc,SM00490:HELICc,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0206~Cytoskeleton,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,DOMAIN:Helicase-associated putative binding,DOMAIN:SNF2 N-terminal,MOTIF:DEAH box,REGION:Disordered,
Q03468	ERCC excision repair 6, chromatin remodeling factor(ERCC6)	Homo sapiens			GO:0000012~single strand break repair,GO:0000077~DNA damage checkpoint,GO:0000303~response to superoxide,GO:0002230~positive regulation of defense response to virus by host,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006284~base-excision repair,GO:0006290~pyrimidine dimer repair,GO:0006338~chromatin remodeling,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006979~response to oxidative stress,GO:0007254~JNK cascade,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009636~response to toxic substance,GO:0010165~response to X-ray,GO:0010224~response to UV-B,GO:0010332~response to gamma radiation,GO:0010628~positive regulation of gene expression,GO:0022008~neurogenesis,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0033141~positive regulation of peptidyl-serine phosphorylation of STAT protein,GO:0034243~regulation of transcription elongation from RNA polymerase II promoter,GO:0035066~positive regulation of histone acetylation,GO:0035264~multicellular organism growth,GO:0042262~DNA protection,GO:0045494~photoreceptor cell maintenance,GO:0045739~positive regulation of DNA repair,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter,GO:0097680~double-strand break repair via classical nonhomologous end joining,GO:1905168~positive regulation of double-strand break repair via homologous recombination,GO:2001033~negative regulation of double-strand break repair via nonhomologous end joining,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0008023~transcription elongation factor complex,GO:0016604~nuclear body,GO:0090734~site of DNA damage,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0016887~ATPase activity,GO:0030296~protein tyrosine kinase activator activity,GO:0043565~sequence-specific DNA binding,GO:0070063~RNA polymerase binding,	IPR000330:SNF2_N,IPR001650:Helicase_C,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR029526:PGBD,IPR038718:SNF2-like_sf,	hsa03420:Nucleotide excision repair,	133540~Cockayne syndrome, type B,211980~Lung cancer, susceptibility to,214150~Cerebrooculofacioskeletal syndrome 1,278800~De Sanctis-Cacchione syndrome,600630~UV-sensitive syndrome 1,613761~Macular degeneration, age-related, susceptibility to, 5,616946~Premature ovarian failure 11,		SM00487:DEXDc,SM00490:HELICc,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0172~Cockayne syndrome,KW-0209~Deafness,KW-0225~Disease variant,KW-0242~Dwarfism,KW-0857~Xeroderma pigmentosum,KW-0898~Cataract,KW-0913~Age-related macular degeneration,KW-0991~Intellectual disability,KW-1066~Premature ovarian failure,KW-9997~Cockayne syndrome,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3),DISULFID:Interchain,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,DOMAIN:PiggyBac transposable element-derived protein,MOTIF:DEAH box,MUTAGEN:K->R: Loss of sumoylation and defects in transcription-coupled nucleotide excision repair.,MUTAGEN:K->R: No loss of sumoylation; when associated with R-1457 and R-1487. No loss of sumoylation; when associated with R-1487.,MUTAGEN:K->R: No loss of sumoylation; when associated with R-1457 and R-1489. No loss of sumoylation; when associated with R-1489.,MUTAGEN:K->R: No loss of sumoylation; when associated with R-1487 and R-1489.,MUTAGEN:L->G: Loss of interaction with RIF1; when associated with G-1470 and G-1486.,MUTAGEN:L->G: Loss of interaction with RIF1; when associated with G-1486 and G-1488.,MUTAGEN:LL->GG: Fails to bind polyubiquitin chains.,MUTAGEN:S->A: Non-phosphorylatable by ATM. Loss of chromatin remodeling activity and its ability to promote the intramolecular interaction of the N-terminal domain with the helicase ATP-binding domain.,MUTAGEN:S->A: Non-phosphorylatable by CDK2. Loss of chromatin remodeling activity and its ability to promote the intramolecular interaction of the N-terminal domain with the helicase ATP-binding domain.,MUTAGEN:S->D: Phosphomimetic mutant. No loss of chromatin remodeling activity and its ability to promote the intramolecular interaction of the N-terminal domain with the helicase ATP-binding domain.,MUTAGEN:W->G: Loss of interaction with RIF1; when associated with G-1470 and G-1488.,REGION:Disordered,REGION:Essential for its interaction with RNA polymerase II, transcription-coupled nucleotide excision repair activity, association with chromatin after UV irradiation and for mediating the UV-induced translocation of ERRC8 to the nuclear matrix,REGION:N-terminal domain; essential for its chromatin remodeling activity,REGION:Ubiquitin-binding domain (UBD),REGION:Winged-helix domain (WHD),
P84089	ERH mRNA splicing and mitosis factor(Erh)	Mus musculus			GO:0001649~osteoblast differentiation,GO:0007049~cell cycle,	GO:0005634~nucleus,GO:0016020~membrane,GO:0030496~midbody,GO:0034709~methylosome,	GO:0008327~methyl-CpG binding,	IPR000781:ERH,IPR035912:EHR_sf,			PIRSF016393:Enh_rudimentary,		KW-0131~Cell cycle,	KW-0539~Nucleus,						KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),
Q5HZL1	ERI1 exoribonuclease family member 2 L homeolog(eri2.L)	Xenopus laevis					GO:0000175~3'-5'-exoribonuclease activity,GO:0003676~nucleic acid binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR010666:Znf_GRF,IPR012337:RNaseH-like_sf,IPR013520:Exonuclease_RNaseT/DNA_pol3,IPR036397:RNaseH_sf,IPR047201:ERI-1_3'hExo-like,				SM00479:EXOIII,					KW-0863~Zinc-finger,	KW-0460~Magnesium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0269~Exonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,		ACT_SITE:Proton acceptor,DOMAIN:Exonuclease,DOMAIN:GRF-type,ZN_FING:GRF-type,
P41161	ETS variant transcription factor 5(ETV5)	Homo sapiens		h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0034599~cellular response to oxidative stress,GO:0045666~positive regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048133~male germ-line stem cell asymmetric division,GO:0060252~positive regulation of glial cell proliferation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000418:Ets_dom,IPR006715:ETS_PEA3_N,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR046328:ETS_fam,	hsa05202:Transcriptional misregulation in cancer,hsa05215:Prostate cancer,			SM00413:ETS,		KW-0539~Nucleus,					KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:ETS,DOMAIN:PEA3-type ETS-domain transcription factor N-terminal,REGION:Disordered,
P50548	ETS2 repressor factor(ERF)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets_dom,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR046328:ETS_fam,		600775~Craniosynostosis 4,617180~Chitayat syndrome,		SM00413:ETS,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0225~Disease variant,KW-0989~Craniosynostosis,			KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:ETS,DOMAIN:ETS,MUTAGEN:T->A: Loss of a phosphorylation site.,REGION:Disordered,
Q9Z191	EYA transcriptional coactivator and phosphatase 4(Eya4)	Mus musculus			GO:0006281~DNA repair,GO:0006325~chromatin organization,GO:0006974~cellular response to DNA damage stimulus,GO:0007275~multicellular organism development,GO:0007605~sensory perception of sound,GO:0030154~cell differentiation,GO:0042474~middle ear morphogenesis,GO:0045739~positive regulation of DNA repair,GO:0048839~inner ear development,GO:0048856~anatomical structure development,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR006545:EYA_dom,IPR028472:EYA_fam,IPR038102:EYA_dom_sf,IPR042577:EYA_dom_metazoan,					KW-0227~DNA damage,KW-0234~DNA repair,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0010~Activator,KW-0156~Chromatin regulator,KW-0217~Developmental protein,KW-0378~Hydrolase,KW-0904~Protein phosphatase,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,
Q7SIG3	Elastase-1 (ELA1_SALSA)	Salmo salar			GO:0006508~proteolysis,	GO:0005576~extracellular region,	GO:0004252~serine-type endopeptidase activity,GO:0046872~metal ion binding,	IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR043504:Peptidase_S1_PA_chymotrypsin,				SM00020:Tryp_SPc,		KW-0964~Secreted,				KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,DOMAIN:Peptidase S1,
P70459	Ets2 repressor factor(Erf)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010668~ectodermal cell differentiation,GO:0030154~cell differentiation,GO:0060707~trophoblast giant cell differentiation,GO:0060710~chorio-allantoic fusion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets_dom,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR046328:ETS_fam,				SM00413:ETS,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:ETS,DOMAIN:ETS,REGION:Disordered,
Q6X9E4	F-box and WD repeat domain containing 12(FBXW12)	Homo sapiens			GO:0016567~protein ubiquitination,	GO:0005829~cytosol,GO:0016020~membrane,		IPR001810:F-box_dom,IPR011044:Quino_amine_DH_bsu,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR036047:F-box-like_dom_sf,IPR036322:WD40_repeat_dom_sf,				SM00256:FBOX,	KW-0833~Ubl conjugation pathway,	KW-0472~Membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-0853~WD repeat,KW-1133~Transmembrane helix,				DOMAIN:F-box,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,REPEAT:WD 8,TRANSMEM:Helical,
B5X441	F-box only protein 37(fbx37)	Salmo salar			GO:0000086~G2/M transition of mitotic cell cycle,GO:0009953~dorsal/ventral pattern formation,GO:0016567~protein ubiquitination,GO:0030282~bone mineralization,GO:0030513~positive regulation of BMP signaling pathway,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0019005~SCF ubiquitin ligase complex,	GO:0005515~protein binding,	IPR001810:F-box_dom,IPR006553:Leu-rich_rpt_Cys-con_subtyp,IPR032675:LRR_dom_sf,IPR036047:F-box-like_dom_sf,				SM00367:LRR_CC,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,				DOMAIN:F-box,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,
Q4G163	F-box protein 43(FBXO43)	Homo sapiens			GO:0007088~regulation of mitotic nuclear division,GO:0010948~negative regulation of cell cycle process,GO:0016567~protein ubiquitination,GO:0045835~negative regulation of meiotic nuclear division,GO:0051321~meiotic cell cycle,	GO:0005634~nucleus,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001810:F-box_dom,IPR002867:IBR_dom,IPR044064:ZF_ZBR,IPR047147:FBX5_43,	hsa04114:Oocyte meiosis,	619696~Spermatogenic failure 64,619697~Oocyte/zygote/embryo maturation arrest 12,		SM00647:IBR,	KW-0469~Meiosis,KW-0833~Ubl conjugation pathway,			KW-0225~Disease variant,	KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:F-box,MUTAGEN:DS->AA: Impairs ubiquitination and degradation in response to calcium.,REGION:Disordered,ZN_FING:ZBR-type,
Q8CAT8	F-box protein 48(Fbxo48)	Mus musculus			GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,	GO:0019005~SCF ubiquitin ligase complex,		IPR001810:F-box_dom,IPR036047:F-box-like_dom_sf,IPR045118:FBXO9/FBXO48,				SM00256:FBOX,									DOMAIN:F-box,REGION:Disordered,
B5X441	F-box/LRR-repeat protein 15(LOC106577353)	Salmo salar			GO:0000086~G2/M transition of mitotic cell cycle,GO:0009953~dorsal/ventral pattern formation,GO:0016567~protein ubiquitination,GO:0030282~bone mineralization,GO:0030513~positive regulation of BMP signaling pathway,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0019005~SCF ubiquitin ligase complex,	GO:0005515~protein binding,	IPR001810:F-box_dom,IPR006553:Leu-rich_rpt_Cys-con_subtyp,IPR032675:LRR_dom_sf,IPR036047:F-box-like_dom_sf,				SM00367:LRR_CC,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,				DOMAIN:F-box,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,
O88792	F11 receptor(F11r)	Mus musculus			GO:0001817~regulation of cytokine production,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0008360~regulation of cell shape,GO:0030855~epithelial cell differentiation,GO:0031032~actomyosin structure organization,GO:0032956~regulation of actin cytoskeleton organization,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035683~memory T cell extravasation,GO:0045777~positive regulation of blood pressure,GO:0050892~intestinal absorption,GO:0051493~regulation of cytoskeleton organization,GO:0051497~negative regulation of stress fiber assembly,GO:0071260~cellular response to mechanical stimulus,GO:0072659~protein localization to plasma membrane,GO:0090557~establishment of endothelial intestinal barrier,GO:0090559~regulation of membrane permeability,GO:0098609~cell-cell adhesion,GO:1901731~positive regulation of platelet aggregation,GO:1902396~protein localization to bicellular tight junction,GO:1903142~positive regulation of establishment of endothelial barrier,GO:2000810~regulation of bicellular tight junction assembly,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0032991~macromolecular complex,GO:0036057~slit diaphragm,GO:0070160~occluding junction,GO:0070161~anchoring junction,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0030165~PDZ domain binding,GO:0042803~protein homodimerization activity,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR042456:F11R,	mmu04514:Cell adhesion molecules,mmu04530:Tight junction,mmu04670:Leukocyte transendothelial migration,			SM00406:IGv,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like V-type 1,DOMAIN:Ig-like V-type 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9BXW9	FA complementation group D2(FANCD2)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,	GO:0006281~DNA repair,GO:0007129~synapsis,GO:0007276~gamete generation,GO:0010332~response to gamma radiation,GO:0031573~intra-S DNA damage checkpoint,GO:0034599~cellular response to oxidative stress,GO:0036297~interstrand cross-link repair,GO:0045589~regulation of regulatory T cell differentiation,GO:0048854~brain morphogenesis,GO:0050727~regulation of inflammatory response,GO:0097150~neuronal stem cell population maintenance,GO:1990918~double-strand break repair involved in meiotic recombination,GO:2000348~regulation of CD40 signaling pathway,	GO:0000785~chromatin,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0016604~nuclear body,GO:1990391~DNA repair complex,	GO:0005515~protein binding,GO:0070182~DNA polymerase binding,	IPR029448:FANCD2,	hsa03460:Fanconi anemia pathway,	227646~Fanconi anemia, complementation group D2,			KW-0131~Cell cycle,KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,		KW-0225~Disease variant,KW-0923~Fanconi anemia,				KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),MUTAGEN:K->R: Abolishes ubiquitination; impairs chromatin binding, foci formation and DNA repair. Abolishes interaction with MTMR15/FAN1. No effect on S-222 phosphorylation by ATM.,MUTAGEN:S->A: No effect on phosphorylation by ATM.,MUTAGEN:S->A: Reduces phosphorylation by ATM. No effect on ubiquitination, foci formation or DNA repair ability, but impairs S-phase checkpoint activation.,MUTAGEN:S->A: Reduces phosphorylation by ATM; when associated with A-1401 and A-1404.,MUTAGEN:S->A: Reduces phosphorylation by ATM; when associated with A-1401 and A-1418.,MUTAGEN:S->A: Reduces phosphorylation by ATM; when associated with A-1404 and A-1418.,REGION:Disordered,REGION:Interaction with BRCA2,REGION:Interaction with FANCE,
Q8IXL6	FAM20C golgi associated secretory pathway kinase(FAM20C)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0019538~protein metabolic process,GO:0030501~positive regulation of bone mineralization,GO:0031214~biomineral tissue development,GO:0036179~osteoclast maturation,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0043687~post-translational protein modification,GO:0045669~positive regulation of osteoblast differentiation,GO:0046777~protein autophosphorylation,GO:0051174~regulation of phosphorus metabolic process,GO:0070166~enamel mineralization,GO:0071895~odontoblast differentiation,GO:0097187~dentinogenesis,	GO:0000139~Golgi membrane,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030145~manganese ion binding,GO:0043621~protein self-association,	IPR009581:FAM20_C,IPR024869:FAM20,		259775~Raine syndrome,			KW-0091~Biomineralization,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0964~Secreted,		KW-0225~Disease variant,	KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DISULFID:Interchain,MUTAGEN:C->S: No effect on homodimer formation. Complete disruption of homodimer formation but no effect on secretion; when associated with S-46.,MUTAGEN:C->S: No effect on homodimer formation. Complete disruption of homodimer formation but no effect on secretion; when associated with S-48.,MUTAGEN:D->A: Abrogates kinase activity.,MUTAGEN:D->A: Unable to bind manganese. Abrogates kinase activity. Loss of ERO1A phosphorylation. Loss of autophosphorylation. Loss of ability to promote osteoblast differentiation.,MUTAGEN:DLLP->AAAA: Loss of membrane localization with more efficient secretion and loss of propeptide cleavage. Reduced oligomerization.,MUTAGEN:E->A,Q: Strongly reduced kinase activity.,MUTAGEN:E->A: Reduced kinase activity.,MUTAGEN:I->A: No effect on secretion.,MUTAGEN:K->A: Reduced kinase activity.,MUTAGEN:L->S: Impaired secretion.,MUTAGEN:LQD->AAA: No effect on secretion or activity.,MUTAGEN:N->A: Impaired secretion; when associated with A-101 and A-335.,MUTAGEN:N->A: Impaired secretion; when associated with A-101 and A-470.,MUTAGEN:N->A: Impaired secretion; when associated with A-335 and A-470.,MUTAGEN:Q->A: Impaired secretion. Loss of ability to promote osteoblast differentiation; when associated with A-89.,MUTAGEN:R->A: Impaired secretion. Loss of ability to promote osteoblast differentiation; when associated with A-92.,MUTAGEN:R->A: Reduced kinase activity.,MUTAGEN:S->A: Abolishes phosphorylation.,REGION:Disordered,REGION:Kinase domain,SITE:Cleavage; by MBTPS1,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q28DE0	FAST kinase domains 1(fastkd1)	Xenopus tropicalis			GO:0000963~mitochondrial RNA processing,GO:0044528~regulation of mitochondrial mRNA stability,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0035770~ribonucleoprotein granule,	GO:0003723~RNA binding,	IPR010622:FAST_Leu-rich,IPR013579:FAST_2,IPR013584:RAP,				SM00952:RAP,		KW-0496~Mitochondrion,			KW-0809~Transit peptide,				DOMAIN:RAP,TRANSIT:Mitochondrion,
Q8R508	FAT atypical cadherin 3(Fat3)	Rattus norvegicus			GO:0000902~cell morphogenesis,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0010842~retina layer formation,GO:0016358~dendrite development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048699~generation of neurons,GO:0098609~cell-cell adhesion,GO:1904936~interneuron migration,GO:2000171~negative regulation of dendrite development,	GO:0005886~plasma membrane,GO:0030425~dendrite,	GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001791:Laminin_G,IPR001881:EGF-like_Ca-bd_dom,IPR002126:Cadherin-like_dom,IPR013032:EGF-like_CS,IPR013320:ConA-like_dom_sf,IPR015919:Cadherin-like_sf,IPR018097:EGF_Ca-bd_CS,IPR020894:Cadherin_CS,				SM00112:CA,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	KW-0130~Cell adhesion,	KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0488~Methylation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 10,DOMAIN:Cadherin 11,DOMAIN:Cadherin 12,DOMAIN:Cadherin 13,DOMAIN:Cadherin 14,DOMAIN:Cadherin 15,DOMAIN:Cadherin 16,DOMAIN:Cadherin 17,DOMAIN:Cadherin 18,DOMAIN:Cadherin 19,DOMAIN:Cadherin 2,DOMAIN:Cadherin 20,DOMAIN:Cadherin 21,DOMAIN:Cadherin 22,DOMAIN:Cadherin 23,DOMAIN:Cadherin 24,DOMAIN:Cadherin 25,DOMAIN:Cadherin 26,DOMAIN:Cadherin 27,DOMAIN:Cadherin 28,DOMAIN:Cadherin 29,DOMAIN:Cadherin 3,DOMAIN:Cadherin 30,DOMAIN:Cadherin 31,DOMAIN:Cadherin 32,DOMAIN:Cadherin 33,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,DOMAIN:Cadherin 7,DOMAIN:Cadherin 8,DOMAIN:Cadherin 9,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:Laminin G,DOMAIN:Laminin G-like,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6V0I7	FAT atypical cadherin 4(FAT4)	Homo sapiens			GO:0001658~branching involved in ureteric bud morphogenesis,GO:0003007~heart morphogenesis,GO:0007009~plasma membrane organization,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007219~Notch signaling pathway,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0021987~cerebral cortex development,GO:0022008~neurogenesis,GO:0035329~hippo signaling,GO:0043931~ossification involved in bone maturation,GO:0048565~digestive tract development,GO:0060122~inner ear receptor stereocilium organization,GO:0072137~condensed mesenchymal cell proliferation,GO:0072307~regulation of metanephric nephron tubule epithelial cell differentiation,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001791:Laminin_G,IPR001881:EGF-like_Ca-bd_dom,IPR002126:Cadherin-like_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR013032:EGF-like_CS,IPR013320:ConA-like_dom_sf,IPR015919:Cadherin-like_sf,IPR018097:EGF_Ca-bd_CS,IPR020894:Cadherin_CS,IPR039808:Cadherin,	hsa04392:Hippo signaling pathway - multiple species,	615546~Van Maldergem syndrome 2,616006~Hennekam lymphangiectasia-lymphedema syndrome 2,		SM00112:CA,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0209~Deafness,KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 10,DOMAIN:Cadherin 11,DOMAIN:Cadherin 12,DOMAIN:Cadherin 13,DOMAIN:Cadherin 14,DOMAIN:Cadherin 15,DOMAIN:Cadherin 16,DOMAIN:Cadherin 17,DOMAIN:Cadherin 18,DOMAIN:Cadherin 19,DOMAIN:Cadherin 2,DOMAIN:Cadherin 20,DOMAIN:Cadherin 21,DOMAIN:Cadherin 22,DOMAIN:Cadherin 23,DOMAIN:Cadherin 24,DOMAIN:Cadherin 25,DOMAIN:Cadherin 26,DOMAIN:Cadherin 27,DOMAIN:Cadherin 28,DOMAIN:Cadherin 29,DOMAIN:Cadherin 3,DOMAIN:Cadherin 30,DOMAIN:Cadherin 31,DOMAIN:Cadherin 32,DOMAIN:Cadherin 33,DOMAIN:Cadherin 34,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,DOMAIN:Cadherin 7,DOMAIN:Cadherin 8,DOMAIN:Cadherin 9,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:Laminin G,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G-like 2,REGION:Disordered,REGION:Necessary and sufficient for interaction with MPDZ,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5RFQ0	FCF1 rRNA-processing protein(FCF1)	Pongo abelii			GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0042274~ribosomal small subunit biogenesis,	GO:0005730~nucleolus,GO:0032040~small-subunit processome,		IPR002716:PIN_dom,IPR006984:Fcf1/Utp23,IPR029060:PIN-like_dom_sf,IPR037503:Fcf1_PIN,	pon03008:Ribosome biogenesis in eukaryotes,			SM00670:PINc,	KW-0690~Ribosome biogenesis,KW-0698~rRNA processing,	KW-0539~Nucleus,							COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,DOMAIN:PIN,DOMAIN:PINc,REGION:Disordered,
O94868	FCH and double SH3 domains 2(FCHSD2)	Homo sapiens			GO:0007274~neuromuscular synaptic transmission,GO:0015031~protein transport,GO:0030833~regulation of actin filament polymerization,GO:0030838~positive regulation of actin filament polymerization,GO:0061024~membrane organization,GO:0072583~clathrin-dependent endocytosis,GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation,	GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0031594~neuromuscular junction,GO:0055037~recycling endosome,GO:0070161~anchoring junction,	GO:0005515~protein binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,	IPR001060:FCH_dom,IPR001452:SH3_domain,IPR027267:AH/BAR_dom_sf,IPR031160:F_BAR,IPR034934:FCHSD2_F-BAR_dom,IPR035460:FCHSD_SH3_1,IPR035556:FCHSD2_SH3_2,IPR036028:SH3-like_dom_sf,				SM00055:FCH,SM00326:SH3,	KW-0254~Endocytosis,KW-0653~Protein transport,KW-0813~Transport,	KW-0168~Coated pit,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0728~SH3 domain,	KW-0446~Lipid-binding,		KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:F-BAR,DOMAIN:SH3,DOMAIN:SH3 1,DOMAIN:SH3 2,MUTAGEN:F->S: Abolishes interaction with ITSN1 and location at clathrin-coated pits; when associated with S-576.,MUTAGEN:P->A: Loss of ability to promote actin polymerization; when associated with A-524.,MUTAGEN:S->A: Impaired recruitment to the cell membrane.,MUTAGEN:S->E: Increased recruitment to the cell membrane.,MUTAGEN:VL->KK: Abolishes interaction with ITSN1.,MUTAGEN:Y->A: Loss of ability to promote actin polymerization; when associated with A-478.,MUTAGEN:Y->A: Loss of ability to promote actin polymerization; when associated with A-480.,MUTAGEN:Y->A: Loss of ability to promote actin polymerization; when associated with A-521.,MUTAGEN:Y->S: Abolishes interaction with ITSN1 and location at clathrin-coated pits; when associated with S-607.,REGION:Disordered,REGION:Required and sufficient for location at clathrin-coated pits,
Q5JV73	FERM and PDZ domain containing 3(FRMPD3)	Homo sapiens				GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030667~secretory granule membrane,GO:0070821~tertiary granule membrane,		IPR000299:FERM_domain,IPR001478:PDZ,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR035963:FERM_2,IPR036034:PDZ_sf,IPR041779:FRMPD1/3/4_FERM_C,IPR049385:FAK1-like_FERM_C,				SM00228:PDZ,SM00295:B41,									COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:FERM,DOMAIN:PDZ,REGION:Disordered,
Q7Z6J6	FERM domain containing 5(FRMD5)	Homo sapiens			GO:0030334~regulation of cell migration,GO:0031032~actomyosin structure organization,GO:0045785~positive regulation of cell adhesion,GO:2000146~negative regulation of cell motility,	GO:0005856~cytoskeleton,GO:0005912~adherens junction,GO:0016020~membrane,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0019901~protein kinase binding,	IPR000299:FERM_domain,IPR000798:Ez/rad/moesin-like,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR014847:FA,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019747:FERM_CS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR035963:FERM_2,		620094~Neurodevelopmental disorder with eye movement abnormalities and ataxia,		SM00295:B41,SM01195:FA,SM01196:FERM_C,		KW-0472~Membrane,KW-0965~Cell junction,		KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:FERM,DOMAIN:FERM C-terminal PH-like,DOMAIN:FERM adjacent,REGION:Disordered,REGION:Interaction with ROCK1,TRANSMEM:Helical,
Q96NE9	FERM domain containing 6(FRMD6)	Homo sapiens			GO:0003383~apical constriction,GO:0008104~protein localization,GO:0032970~regulation of actin filament-based process,GO:0035332~positive regulation of hippo signaling,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0043296~apical junction complex,GO:0098592~cytoplasmic side of apical plasma membrane,	GO:0005515~protein binding,	IPR000299:FERM_domain,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR035963:FERM_2,IPR041781:FRMD6-FERM_C,IPR047145:FRMD6-like,	hsa04390:Hippo signaling pathway,hsa04392:Hippo signaling pathway - multiple species,			SM00295:B41,SM01196:FERM_C,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,						KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:FERM,REGION:Disordered,
Q9BQL6	FERM domain containing kindlin 1(FERMT1)	Homo sapiens			GO:0001954~positive regulation of cell-matrix adhesion,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0010629~negative regulation of gene expression,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0033625~positive regulation of integrin activation,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0042308~negative regulation of protein import into nucleus,GO:0043616~keratinocyte proliferation,GO:0051546~keratinocyte migration,GO:0051886~negative regulation of timing of anagen,GO:0071636~positive regulation of transforming growth factor beta production,GO:0071711~basement membrane organization,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090162~establishment of epithelial cell polarity,GO:1903691~positive regulation of wound healing, spreading of epidermal cells,GO:2000647~negative regulation of stem cell proliferation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0030054~cell junction,GO:0032587~ruffle membrane,GO:0070161~anchoring junction,GO:0071944~cell periphery,	GO:0005178~integrin binding,GO:0051015~actin filament binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR035963:FERM_2,IPR037837:PH_Kindlin/fermitin,IPR037843:Kindlin/fermitin,IPR040790:Kindlin_2_N,		173650~Kindler syndrome,		SM00233:PH,SM00295:B41,	KW-0130~Cell adhesion,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0225~Disease variant,				KW-0597~Phosphoprotein,	DOMAIN:FERM,DOMAIN:Kindlin-2 N-terminal,DOMAIN:PH,
F1LYQ8	FERM, ARH/RhoGEF and pleckstrin domain protein 1(Farp1)	Rattus norvegicus			GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007416~synapse assembly,GO:0016601~Rac protein signal transduction,GO:0048813~dendrite morphogenesis,GO:0098942~retrograde trans-synaptic signaling by trans-synaptic protein complex,GO:0098974~postsynaptic actin cytoskeleton organization,GO:1904395~positive regulation of skeletal muscle acetylcholine-gated channel clustering,GO:1905606~regulation of presynapse assembly,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0009898~cytoplasmic side of plasma membrane,GO:0030175~filopodium,GO:0030425~dendrite,GO:0043197~dendritic spine,GO:0098890~extrinsic component of postsynaptic membrane,GO:0098978~glutamatergic synapse,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0008092~cytoskeletal protein binding,GO:0031267~small GTPase binding,	IPR000219:DH-domain,IPR000299:FERM_domain,IPR000798:Ez/rad/moesin-like,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR014847:FA,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019747:FERM_CS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR035899:DBL_dom_sf,IPR035963:FERM_2,IPR041788:FARP1/FARP2/FRMD7_FERM_C,				SM00233:PH,SM00295:B41,SM00325:RhoGEF,SM01195:FA,SM01196:FERM_C,		KW-0472~Membrane,KW-0770~Synapse,KW-0771~Synaptosome,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0677~Repeat,		KW-0217~Developmental protein,KW-0344~Guanine-nucleotide releasing factor,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:FERM,DOMAIN:PH,DOMAIN:PH 1,DOMAIN:PH 2,REGION:Disordered,
Q91VS8	FERM, RhoGEF and pleckstrin domain protein 2(Farp2)	Mus musculus			GO:0007155~cell adhesion,GO:0016322~neuron remodeling,GO:0016601~Rac protein signal transduction,GO:0022405~hair cycle process,GO:0030036~actin cytoskeleton organization,GO:0030316~osteoclast differentiation,GO:0033623~regulation of integrin activation,GO:0071526~semaphorin-plexin signaling pathway,GO:0071800~podosome assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0008092~cytoskeletal protein binding,	IPR000219:DH-domain,IPR000299:FERM_domain,IPR000798:Ez/rad/moesin-like,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR014847:FA,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019747:FERM_CS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR035899:DBL_dom_sf,IPR035963:FERM_2,IPR041788:FARP1/FARP2/FRMD7_FERM_C,	mmu04015:Rap1 signaling pathway,mmu04520:Adherens junction,			SM00233:PH,SM00295:B41,SM00325:RhoGEF,SM01195:FA,SM01196:FERM_C,					KW-0677~Repeat,		KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:FERM,DOMAIN:PH 1,DOMAIN:PH 2,MUTAGEN:L->Q: Increases guanyl-nucleotide exchange factor activity with RAC1; when associated with R-730.,MUTAGEN:L->R: Increases guanyl-nucleotide exchange factor activity with RAC1; when associated with Q-733.,REGION:Disordered,
A3FEM2	FEV transcription factor, ETS family member(fev)	Danio rerio			GO:0003158~endothelium development,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0030154~cell differentiation,GO:0048856~anatomical structure development,GO:0060218~hematopoietic stem cell differentiation,	GO:0005634~nucleus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets_dom,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR046328:ETS_fam,				SM00413:ETS,	KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		DNA_BIND:ETS,DOMAIN:ETS,
Q5ZJ24	FGFR1OP N-terminal like(FOPNL)	Gallus gallus			GO:0030030~cell projection organization,GO:0034453~microtubule anchoring,GO:0060271~cilium assembly,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0031514~motile cilium,GO:0034451~centriolar satellite,GO:0036064~ciliary basal body,	GO:0005515~protein binding,	IPR006594:LisH,IPR018993:FOP_dimerisation-dom_N,				SM00667:LisH,	KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0732~Signal,				DOMAIN:FGFR1 oncogene partner (FOP) N-terminal dimerisation,DOMAIN:LisH,REGION:Disordered,REGION:Necessary and sufficient for homooligomerization and localization to centrosomes and pericentriolar satellites,
Q6NUW9	FGGY carbohydrate kinase domain containing(fggy)	Danio rerio			GO:0005975~carbohydrate metabolic process,GO:0016310~phosphorylation,GO:0019321~pentose metabolic process,GO:0046835~carbohydrate phosphorylation,	GO:0005737~cytoplasm,	GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0019150~D-ribulokinase activity,	IPR000577:Carb_kinase_FGGY,IPR006003:FGGY_RbtK-like,IPR018484:FGGY_N,IPR018485:FGGY_C,IPR043129:ATPase_NBD,	dre00040:Pentose and glucuronate interconversions,dre01100:Metabolic pathways,		PIRSF000538:GlpK,								KW-0418~Kinase,KW-0808~Transferase,
Q9C0D6	FH2 domain containing 1(FHDC1)	Homo sapiens			GO:0030041~actin filament polymerization,GO:0043149~stress fiber assembly,GO:0060271~cilium assembly,GO:0090161~Golgi ribbon formation,	GO:0005794~Golgi apparatus,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005884~actin filament,GO:0005929~cilium,	GO:0003779~actin binding,GO:0008017~microtubule binding,	IPR015425:FH2_Formin,IPR042201:FH2_Formin_sf,				SM00498:FH2,	KW-0970~Cilium biogenesis/degradation,	KW-0333~Golgi apparatus,KW-0493~Microtubule,KW-0966~Cell projection,					KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:FH2,MUTAGEN:I->A: Loss of actin-binding and ability to induce Golgi ribbon formation. Induces a significant increase in average cilia length.,REGION:Disordered,REGION:MTBD; microtubule-binding domain,
Q61576	FK506 binding protein 10(Fkbp10)	Mus musculus			GO:0001701~in utero embryonic development,GO:0006457~protein folding,GO:0017185~peptidyl-lysine hydroxylation,GO:0018208~peptidyl-proline modification,GO:0030199~collagen fibril organization,GO:0035909~aorta morphogenesis,GO:0042060~wound healing,GO:0085029~extracellular matrix assembly,	GO:0005758~mitochondrial intermembrane space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005509~calcium ion binding,GO:0005528~FK506 binding,GO:0016853~isomerase activity,GO:0046872~metal ion binding,	IPR001179:PPIase_FKBP_dom,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR046357:PPIase_dom_sf,				SM00054:EFh,		KW-0256~Endoplasmic reticulum,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0413~Isomerase,KW-0697~Rotamase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:PPIase FKBP-type,DOMAIN:PPIase FKBP-type 1,DOMAIN:PPIase FKBP-type 2,DOMAIN:PPIase FKBP-type 3,DOMAIN:PPIase FKBP-type 4,MOTIF:Prevents secretion from ER,REGION:Disordered,
P45878	FK506 binding protein 2(Fkbp2)	Mus musculus			GO:0000413~protein peptidyl-prolyl isomerization,GO:0061077~chaperone-mediated protein folding,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0016853~isomerase activity,	IPR001179:PPIase_FKBP_dom,IPR044609:FKBP2/11,IPR046357:PPIase_dom_sf,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,		KW-0413~Isomerase,KW-0697~Rotamase,		DOMAIN:PPIase FKBP-type,MOTIF:Prevents secretion from ER,REGION:Disordered,
Q62446	FK506 binding protein 3(Fkbp3)	Mus musculus				GO:0005634~nucleus,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0016853~isomerase activity,	IPR001179:PPIase_FKBP_dom,IPR041200:FKBP3_BTHB,IPR043368:FKBP3,IPR046357:PPIase_dom_sf,						KW-0539~Nucleus,					KW-0413~Isomerase,KW-0697~Rotamase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:FKBP3 basic tilted helix bundle,DOMAIN:PPIase FKBP-type,REGION:Disordered,
Q2HJ89	FKBP prolyl isomerase 10(FKBP10)	Bos taurus			GO:0001701~in utero embryonic development,GO:0006457~protein folding,GO:0030199~collagen fibril organization,GO:0035909~aorta morphogenesis,GO:0042060~wound healing,GO:0085029~extracellular matrix assembly,	GO:0005758~mitochondrial intermembrane space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005509~calcium ion binding,GO:0005528~FK506 binding,	IPR001179:PPIase_FKBP_dom,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR046357:PPIase_dom_sf,				SM00054:EFh,		KW-0256~Endoplasmic reticulum,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0413~Isomerase,KW-0697~Rotamase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:PPIase FKBP-type 1,DOMAIN:PPIase FKBP-type 2,DOMAIN:PPIase FKBP-type 3,DOMAIN:PPIase FKBP-type 4,MOTIF:Prevents secretion from ER,REGION:Disordered,
Q9TRY0	FKBP prolyl isomerase 4(FKBP4)	Bos taurus			GO:0010977~negative regulation of neuron projection development,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0061077~chaperone-mediated protein folding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005874~microtubule,GO:0044295~axonal growth cone,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0031072~heat shock protein binding,	IPR001179:PPIase_FKBP_dom,IPR001440:TPR_1,IPR011990:TPR-like_helical_dom_sf,IPR013105:TPR_2,IPR019734:TPR_repeat,IPR046357:PPIase_dom_sf,	bta04915:Estrogen signaling pathway,			SM00028:TPR,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0802~TPR repeat,		KW-0143~Chaperone,KW-0413~Isomerase,KW-0697~Rotamase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	DOMAIN:PPIase FKBP-type,DOMAIN:PPIase FKBP-type 1,DOMAIN:PPIase FKBP-type 2,REGION:Disordered,REGION:Interaction with tubulin,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
Q9Y680	FKBP prolyl isomerase 7(FKBP7)	Homo sapiens			GO:0018208~peptidyl-proline modification,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005528~FK506 binding,	IPR001179:PPIase_FKBP_dom,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR046357:PPIase_dom_sf,						KW-0256~Endoplasmic reticulum,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0413~Isomerase,KW-0697~Rotamase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:PPIase FKBP-type,MOTIF:Retention in the endoplasmic reticulum,REGION:Disordered,
O95302	FKBP prolyl isomerase 9(FKBP9)	Homo sapiens			GO:0006457~protein folding,	GO:0005783~endoplasmic reticulum,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005509~calcium ion binding,	IPR001179:PPIase_FKBP_dom,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR046357:PPIase_dom_sf,				SM00054:EFh,		KW-0256~Endoplasmic reticulum,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0413~Isomerase,KW-0697~Rotamase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:PPIase FKBP-type,DOMAIN:PPIase FKBP-type 1,DOMAIN:PPIase FKBP-type 2,DOMAIN:PPIase FKBP-type 3,DOMAIN:PPIase FKBP-type 4,MOTIF:Prevents secretion from ER,
P18625	FOS like 2, AP-1 transcription factor subunit(FOSL2)	Gallus gallus			GO:0000902~cell morphogenesis,GO:0001649~osteoblast differentiation,GO:0001666~response to hypoxia,GO:0001865~NK T cell differentiation,GO:0002062~chondrocyte differentiation,GO:0002437~inflammatory response to antigenic stimulus,GO:0003334~keratinocyte development,GO:0003417~growth plate cartilage development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009410~response to xenobiotic stimulus,GO:0010467~gene expression,GO:0030183~B cell differentiation,GO:0030223~neutrophil differentiation,GO:0030225~macrophage differentiation,GO:0030282~bone mineralization,GO:0030316~osteoclast differentiation,GO:0032496~response to lipopolysaccharide,GO:0032964~collagen biosynthetic process,GO:0035264~multicellular organism growth,GO:0035962~response to interleukin-13,GO:0035988~chondrocyte proliferation,GO:0036446~myofibroblast differentiation,GO:0040014~regulation of multicellular organism growth,GO:0042100~B cell proliferation,GO:0042593~glucose homeostasis,GO:0045087~innate immune response,GO:0045444~fat cell differentiation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048745~smooth muscle tissue development,GO:0048771~tissue remodeling,GO:0048873~homeostasis of number of cells within a tissue,GO:0050852~T cell receptor signaling pathway,GO:0051384~response to glucocorticoid,GO:0060427~lung connective tissue development,GO:0060613~fat pad development,GO:0061144~alveolar secondary septum development,GO:0070254~mucus secretion,GO:0098760~response to interleukin-7,GO:1901142~insulin metabolic process,GO:1904606~fat cell apoptotic process,GO:1904760~regulation of myofibroblast differentiation,GO:1904975~response to bleomycin,GO:1990823~response to leukemia inhibitory factor,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000837:AP-1,IPR004827:bZIP,IPR046347:bZIP_sf,				SM00338:BRLZ,		KW-0539~Nucleus,		KW-0656~Proto-oncogene,	KW-0175~Coiled coil,		KW-0238~DNA-binding,		COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
Q5SZK8	FRAS1 related extracellular matrix 2(FREM2)	Homo sapiens			GO:0001654~eye development,GO:0001822~kidney development,GO:0002009~morphogenesis of an epithelium,GO:0007154~cell communication,GO:0007155~cell adhesion,GO:0007507~heart development,GO:0009653~anatomical structure morphogenesis,GO:0042733~embryonic digit morphogenesis,GO:0048839~inner ear development,	GO:0005604~basement membrane,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR003644:Calx_beta,IPR038081:CalX-like_sf,IPR039005:CSPG_rpt,IPR045658:FRAS1-rel_N,	hsa04512:ECM-receptor interaction,	123570~Cryptophthalmos, unilateral or bilateral, isolated,617666~Fraser syndrome 2,		SM00237:Calx_beta,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Calx-beta 1,DOMAIN:Calx-beta 2,DOMAIN:Calx-beta 3,DOMAIN:Calx-beta 4,DOMAIN:Calx-beta 5,REGION:Disordered,REPEAT:CSPG 1,REPEAT:CSPG 10,REPEAT:CSPG 11,REPEAT:CSPG 12,REPEAT:CSPG 2,REPEAT:CSPG 3,REPEAT:CSPG 4,REPEAT:CSPG 5,REPEAT:CSPG 6,REPEAT:CSPG 7,REPEAT:CSPG 8,REPEAT:CSPG 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5R5T1	FYVE, RhoGEF and PH domain containing 3(FGD3)	Pongo abelii			GO:0007010~cytoskeleton organization,GO:0046847~filopodium assembly,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0046872~metal ion binding,	IPR000219:DH-domain,IPR000306:Znf_FYVE,IPR001849:PH_domain,IPR011011:Znf_FYVE_PHD,IPR011993:PH-like_dom_sf,IPR013083:Znf_RING/FYVE/PHD,IPR017455:Znf_FYVE-rel,IPR035899:DBL_dom_sf,IPR035941:FGD1-4_PH2,	pon04810:Regulation of actin cytoskeleton,			SM00064:FYVE,SM00233:PH,SM00325:RhoGEF,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:FYVE-type,DOMAIN:PH,DOMAIN:PH 1,DOMAIN:PH 2,REGION:Disordered,ZN_FING:FYVE-type,
Q6ZV73	FYVE, RhoGEF and PH domain containing 6(FGD6)	Homo sapiens			GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0030036~actin cytoskeleton organization,GO:0043087~regulation of GTPase activity,GO:0046847~filopodium assembly,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005856~cytoskeleton,GO:0030027~lamellipodium,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0031267~small GTPase binding,GO:0046872~metal ion binding,	IPR000219:DH-domain,IPR000306:Znf_FYVE,IPR001849:PH_domain,IPR011011:Znf_FYVE_PHD,IPR011993:PH-like_dom_sf,IPR013083:Znf_RING/FYVE/PHD,IPR017455:Znf_FYVE-rel,IPR035899:DBL_dom_sf,IPR037743:FGD6_N_PH,				SM00064:FYVE,SM00233:PH,SM00325:RhoGEF,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DH,DOMAIN:FYVE-type,DOMAIN:PH,DOMAIN:PH 1,DOMAIN:PH 2,REGION:Disordered,ZN_FING:FYVE-type,
Q9UNN5	Fas associated factor 1(FAF1)	Homo sapiens		h_fasPathway:FAS signaling pathway ( CD95 ),	GO:0006915~apoptotic process,GO:0007253~cytoplasmic sequestering of NF-kappaB,GO:0030155~regulation of cell adhesion,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0031334~positive regulation of protein complex assembly,GO:0036503~ERAD pathway,GO:0042176~regulation of protein catabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045732~positive regulation of protein catabolic process,GO:0045740~positive regulation of DNA replication,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0031265~CD95 death-inducing signaling complex,GO:0034098~VCP-NPL4-UFD1 AAA ATPase complex,GO:0048471~perinuclear region of cytoplasm,GO:1990917~ooplasm,	GO:0005515~protein binding,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0043130~ubiquitin binding,GO:0051059~NF-kappaB binding,	IPR001012:UBX_dom,IPR006577:UAS,IPR029071:Ubiquitin-like_domsf,IPR033043:FAF1-like_UBX,IPR036249:Thioredoxin-like_sf,IPR044541:FAF1_UBA,				SM00166:UBX,SM00594:UAS,	KW-0053~Apoptosis,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:UBA,DOMAIN:UBX,REGION:Disordered,TRANSMEM:Helical,
Q7LL04	Fe/ascorbate oxidoreductase family protein(SPCC1494.01)	Schizosaccharomyces pombe			GO:0044283~small molecule biosynthetic process,GO:1901362~organic cyclic compound biosynthetic process,	GO:0005634~nucleus,GO:0005829~cytosol,		IPR005123:Oxoglu/Fe-dep_dioxygenase,IPR026992:DIOX_N,IPR027443:IPNS-like_sf,IPR044861:IPNS-like_FE2OG_OXY,						KW-0539~Nucleus,KW-0963~Cytoplasm,							DOMAIN:Fe2OG dioxygenase,
Q08BB1	G elongation factor, mitochondrial 1(gfm1)	Danio rerio			GO:0006412~translation,GO:0006414~translational elongation,GO:0070125~mitochondrial translational elongation,	GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR000640:EFG_V-like,IPR000795:T_Tr_GTP-bd_dom,IPR004161:EFTu-like_2,IPR004540:Transl_elong_EFG/EF2,IPR005225:Small_GTP-bd_dom,IPR005517:Transl_elong_EFG/EF2_IV,IPR009000:Transl_B-barrel_sf,IPR009022:EFG_III,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR027417:P-loop_NTPase,IPR031157:G_TR_CS,IPR035647:EFG_III/V,IPR035649:EFG_V,IPR041095:EFG_II,IPR047872:EFG_IV,				SM00838:EFG_C,SM00889:EFG_IV,	KW-0648~Protein biosynthesis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0251~Elongation factor,		DOMAIN:tr-type G,TRANSIT:Mitochondrion,
P04897	G protein subunit alpha i2(Gnai2)	Rattus norvegicus			GO:0001973~adenosine receptor signaling pathway,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0030335~positive regulation of cell migration,GO:0032930~positive regulation of superoxide anion generation,GO:0035810~positive regulation of urine volume,GO:0045955~negative regulation of calcium ion-dependent exocytosis,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0050805~negative regulation of synaptic transmission,GO:0051301~cell division,GO:0051924~regulation of calcium ion transport,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:2000179~positive regulation of neural precursor cell proliferation,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0030496~midbody,GO:0044297~cell body,GO:0045202~synapse,GO:0070382~exocytic vesicle,GO:0098992~neuronal dense core vesicle,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR001019:Gprotein_alpha_su,IPR001408:Gprotein_alpha_I,IPR011025:GproteinA_insert,IPR027417:P-loop_NTPase,	rno04015:Rap1 signaling pathway,rno04022:cGMP-PKG signaling pathway,rno04024:cAMP signaling pathway,rno04062:Chemokine signaling pathway,rno04071:Sphingolipid signaling pathway,rno04261:Adrenergic signaling in cardiomyocytes,rno04360:Axon guidance,rno04371:Apelin signaling pathway,rno04540:Gap junction,rno04611:Platelet activation,rno04670:Leukocyte transendothelial migration,rno04713:Circadian entrainment,rno04723:Retrograde endocannabinoid signaling,rno04724:Glutamatergic synapse,rno04725:Cholinergic synapse,rno04726:Serotonergic synapse,rno04727:GABAergic synapse,rno04728:Dopaminergic synapse,rno04730:Long-term depression,rno04914:Progesterone-mediated oocyte maturation,rno04915:Estrogen signaling pathway,rno04916:Melanogenesis,rno04921:Oxytocin signaling pathway,rno04923:Regulation of lipolysis in adipocytes,rno04924:Renin secretion,rno04926:Relaxin signaling pathway,rno04928:Parathyroid hormone synthesis, secretion and action,rno04934:Cushing syndrome,rno04935:Growth hormone synthesis, secretion and action,rno04971:Gastric acid secretion,rno05012:Parkinson disease,rno05030:Cocaine addiction,rno05032:Morphine addiction,rno05034:Alcoholism,rno05133:Pertussis,rno05142:Chagas disease,rno05145:Toxoplasmosis,rno05163:Human cytomegalovirus infection,rno05170:Human immunodeficiency virus 1 infection,rno05200:Pathways in cancer,rno05207:Chemical carcinogenesis - receptor activation,			SM00275:G_alpha,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0807~Transducer,	KW-0449~Lipoprotein,KW-0519~Myristate,KW-0564~Palmitate,	DOMAIN:G-alpha,LIPID:N-myristoyl glycine,LIPID:S-palmitoyl cysteine,MUTAGEN:A->G: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; R-90; K-92; A-98; A-99; A-111; G-112; T-121 and A-122.,MUTAGEN:C->G: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; R-90; K-92; G-96; A-98; A-99; A-111; T-121 and A-122. Does not increase sensitivity to RGS14 GTPase activity; when associated with G-111; T-121 and A-122.,MUTAGEN:E->A: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; R-90; K-92; G-96; A-98; A-99; A-111; G-112 and T-121. Does not increase sensitivity to RGS14 GTPase activity; when associated with G-111; G-112 and T-121.,MUTAGEN:K->R: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-90; K-92; G-96; A-98; A-99; A-111; G-112; T-121 and A-122.,MUTAGEN:M->I: Increases sensitivity to RGS14 GTPase activity; when associated with I-85; R-86; R-90; K-92; G-96; A-98; A-99; A-111; G-112; T-121 and A-122. Does not increase sensitivity to RGS14 GTPase activity; when associated with I-85 and A-111.,MUTAGEN:Missing: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; R-90; K-92; G-96; A-98; A-99; A-111; G-112; T-121 and A-122. Does not increase sensitivity to RGS14 GTPase activity; when associated with G-111; G-112; T-121 and A-122.,MUTAGEN:N->R: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; K-92; G-96; A-98; A-99; A-111; G-112; T-121 and A-122.,MUTAGEN:P->A: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; R-90; K-92; G-96; A-99; A-111; G-112; T-121 and A-122.,MUTAGEN:P->T: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; R-90; K-92; G-96; A-98; A-99; A-111; G-112 and A-122. Does not increase sensitivity to RGS14 GTPase activity; when associated with G-111; G-112 and A-122.,MUTAGEN:Q->A: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; R-90; K-92; G-96; A-98; A-111; G-112; T-121 and A-122.,MUTAGEN:Q->K: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; R-90; G-96; A-98; A-99; A-111; G-112; T-121 and A-122.,MUTAGEN:S->A: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; I-85; R-86; R-90; K-92; G-96; A-98; A-99; G-112; T-121 and A-122. Does not increase sensitivity to RGS14 GTPase activity; when associated with G-112; T-121 and A-122. Does not increase sensitivity to RGS14 GTPase activity; when associated with I-82 and A-85.,MUTAGEN:V->I: Increases sensitivity to RGS14 GTPase activity; when associated with I-82; R-86; R-90; K-92; G-96; A-98; A-99; A-111; G-112; T-121 and A-122. Does not increase sensitivity to RGS14 GTPase activity; when associated with I-82 and A-111.,REGION:G1 motif,REGION:G2 motif,REGION:G3 motif,REGION:G4 motif,REGION:G5 motif,
P09471	G protein subunit alpha o1(GNAO1)	Homo sapiens			GO:0006936~muscle contraction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007212~dopamine receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031821~G-protein coupled serotonin receptor binding,GO:0031852~mu-type opioid receptor binding,GO:0046872~metal ion binding,GO:0051430~corticotropin-releasing hormone receptor 1 binding,	IPR001019:Gprotein_alpha_su,IPR001408:Gprotein_alpha_I,IPR011025:GproteinA_insert,IPR027417:P-loop_NTPase,	hsa04015:Rap1 signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa04926:Relaxin signaling pathway,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05142:Chagas disease,hsa05145:Toxoplasmosis,hsa05163:Human cytomegalovirus infection,hsa05170:Human immunodeficiency virus 1 infection,	615473~Developmental and epileptic encephalopathy 17,617493~Neurodevelopmental disorder with involuntary movements,		SM00275:G_alpha,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0887~Epilepsy,		KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0807~Transducer,	KW-0013~ADP-ribosylation,KW-0449~Lipoprotein,KW-0519~Myristate,KW-0564~Palmitate,	DOMAIN:G-alpha,LIPID:N-myristoyl glycine,LIPID:S-palmitoyl cysteine,REGION:Disordered,REGION:G1 motif,REGION:G2 motif,REGION:G3 motif,REGION:G4 motif,REGION:G5 motif,
Q2PKF4	G protein subunit alpha q(GNAQ)	Sus scrofa			GO:0001508~action potential,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007215~glutamate receptor signaling pathway,GO:0007603~phototransduction, visible light,GO:0009649~entrainment of circadian clock,GO:0010543~regulation of platelet activation,GO:0050821~protein stabilization,GO:0060158~phospholipase C-activating dopamine receptor signaling pathway,GO:0060828~regulation of canonical Wnt signaling pathway,	GO:0001750~photoreceptor outer segment,GO:0005794~Golgi apparatus,GO:0005834~heterotrimeric G-protein complex,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0045202~synapse,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0005096~GTPase activator activity,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR000654:Gprotein_alpha_Q,IPR001019:Gprotein_alpha_su,IPR011025:GproteinA_insert,IPR027417:P-loop_NTPase,	ssc04015:Rap1 signaling pathway,ssc04020:Calcium signaling pathway,ssc04022:cGMP-PKG signaling pathway,ssc04062:Chemokine signaling pathway,ssc04071:Sphingolipid signaling pathway,ssc04261:Adrenergic signaling in cardiomyocytes,ssc04270:Vascular smooth muscle contraction,ssc04371:Apelin signaling pathway,ssc04540:Gap junction,ssc04611:Platelet activation,ssc04713:Circadian entrainment,ssc04720:Long-term potentiation,ssc04723:Retrograde endocannabinoid signaling,ssc04724:Glutamatergic synapse,ssc04725:Cholinergic synapse,ssc04726:Serotonergic synapse,ssc04728:Dopaminergic synapse,ssc04730:Long-term depression,ssc04750:Inflammatory mediator regulation of TRP channels,ssc04911:Insulin secretion,ssc04912:GnRH signaling pathway,ssc04915:Estrogen signaling pathway,ssc04916:Melanogenesis,ssc04918:Thyroid hormone synthesis,ssc04921:Oxytocin signaling pathway,ssc04922:Glucagon signaling pathway,ssc04924:Renin secretion,ssc04925:Aldosterone synthesis and secretion,ssc04927:Cortisol synthesis and secretion,ssc04928:Parathyroid hormone synthesis, secretion and action,ssc04929:GnRH secretion,ssc04934:Cushing syndrome,ssc04935:Growth hormone synthesis, secretion and action,ssc04961:Endocrine and other factor-regulated calcium reabsorption,ssc04970:Salivary secretion,ssc04971:Gastric acid secretion,ssc04972:Pancreatic secretion,ssc05010:Alzheimer disease,ssc05016:Huntington disease,ssc05017:Spinocerebellar ataxia,ssc05022:Pathways of neurodegeneration - multiple diseases,ssc05135:Yersinia infection,ssc05142:Chagas disease,ssc05143:African trypanosomiasis,ssc05146:Amoebiasis,ssc05163:Human cytomegalovirus infection,ssc05170:Human immunodeficiency virus 1 infection,ssc05200:Pathways in cancer,			SM00275:G_alpha,		KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0807~Transducer,	KW-0449~Lipoprotein,KW-0564~Palmitate,	DOMAIN:G-alpha,LIPID:S-palmitoyl cysteine,REGION:G1 motif,REGION:G2 motif,REGION:G3 motif,REGION:G4 motif,REGION:G5 motif,
P54313	G protein subunit beta 2(Gnb2)	Rattus norvegicus			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:1901379~regulation of potassium ion transmembrane transport,	GO:0005737~cytoplasm,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0032991~macromolecular complex,GO:0044297~cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0005246~calcium channel regulator activity,GO:0030159~receptor signaling complex scaffold activity,GO:0044877~macromolecular complex binding,GO:0051020~GTPase binding,	IPR001632:Gprotein_B,IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016346:Guanine_nucleotide-bd_bsu,IPR019775:WD40_repeat_CS,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,	rno04014:Ras signaling pathway,rno04062:Chemokine signaling pathway,rno04151:PI3K-Akt signaling pathway,rno04371:Apelin signaling pathway,rno04713:Circadian entrainment,rno04723:Retrograde endocannabinoid signaling,rno04724:Glutamatergic synapse,rno04725:Cholinergic synapse,rno04726:Serotonergic synapse,rno04727:GABAergic synapse,rno04728:Dopaminergic synapse,rno04926:Relaxin signaling pathway,rno05032:Morphine addiction,rno05034:Alcoholism,rno05163:Human cytomegalovirus infection,rno05167:Kaposi sarcoma-associated herpesvirus infection,rno05170:Human immunodeficiency virus 1 infection,rno05200:Pathways in cancer,		PIRSF002394:GN-bd_beta,	SM00320:WD40,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0853~WD repeat,		KW-0807~Transducer,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q9UNW8	G protein-coupled receptor 132(GPR132)	Homo sapiens			GO:0000082~G1/S transition of mitotic cell cycle,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010972~negative regulation of G2/M transition of mitotic cell cycle,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:GPCR_Rhodpsn,IPR005388:G2A_lysphc_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	hsa04148:Efferocytosis,				KW-0346~Stress response,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,MUTAGEN:K->A: Decreased IP1 accumulation at any pH.,MUTAGEN:K->A: No change in basal activity.,MUTAGEN:R->A: Decreased basal activity at alkaline pH and loss of proton-sensing activity at low pH.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q9Z282	G protein-coupled receptor 132(Gpr132)	Mus musculus			GO:0000082~G1/S transition of mitotic cell cycle,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010972~negative regulation of G2/M transition of mitotic cell cycle,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:GPCR_Rhodpsn,IPR005388:G2A_lysphc_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	mmu04148:Efferocytosis,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:R->A: Enhanced surface expression and a lower localization to endosomal vesicles.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q17QQ5	G protein-coupled receptor 137(GPR137)	Bos taurus			GO:0006914~autophagy,GO:0010506~regulation of autophagy,GO:0030278~regulation of ossification,GO:0045124~regulation of bone resorption,GO:0045671~negative regulation of osteoclast differentiation,GO:0045779~negative regulation of bone resorption,GO:0046850~regulation of bone remodeling,GO:1904263~positive regulation of TORC1 signaling,	GO:0005765~lysosomal membrane,		IPR029723:GPR137,					KW-0072~Autophagy,	KW-0458~Lysosome,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
E7F594	G protein-coupled receptor 137Ba(gpr137ba)	Danio rerio			GO:0006914~autophagy,GO:0010506~regulation of autophagy,GO:0043087~regulation of GTPase activity,GO:0045671~negative regulation of osteoclast differentiation,GO:0045779~negative regulation of bone resorption,GO:0046849~bone remodeling,GO:1904263~positive regulation of TORC1 signaling,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0016020~membrane,		IPR029723:GPR137,					KW-0072~Autophagy,	KW-0458~Lysosome,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,		COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
E7F594	G protein-coupled receptor 137c(gpr137c)	Danio rerio			GO:0006914~autophagy,GO:0010506~regulation of autophagy,GO:0043087~regulation of GTPase activity,GO:0045671~negative regulation of osteoclast differentiation,GO:0045779~negative regulation of bone resorption,GO:0046849~bone remodeling,GO:1904263~positive regulation of TORC1 signaling,	GO:0005765~lysosomal membrane,GO:0016020~membrane,		IPR029723:GPR137,					KW-0072~Autophagy,	KW-0458~Lysosome,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,		COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q7Z601	G protein-coupled receptor 142(GPR142)	Homo sapiens			GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030054~cell junction,	GO:0004930~G-protein coupled receptor activity,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,		COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q8K451	G protein-coupled receptor 156(Gpr156)	Rattus norvegicus			GO:0007186~G-protein coupled receptor signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,	GO:0005886~plasma membrane,GO:0038039~G-protein coupled receptor heterodimeric complex,	GO:0004965~G-protein coupled GABA receptor activity,	IPR002455:GPCR3_GABA-B,IPR017978:GPCR_3_C,IPR041946:GPR156_7TM,	rno04080:Neuroactive ligand-receptor interaction,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 3 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
D4A6L0	G protein-coupled receptor 158(Gpr158)	Rattus norvegicus			GO:0001956~positive regulation of neurotransmitter secretion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007420~brain development,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0050807~regulation of synapse organization,GO:0050890~cognition,GO:0072659~protein localization to plasma membrane,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0045211~postsynaptic membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0008047~enzyme activator activity,	IPR017978:GPCR_3_C,IPR043458:GPR158/179,						KW-0472~Membrane,KW-0539~Nucleus,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:G-protein coupled receptors family 3 profile,MOTIF:VCPWE motif 1,MOTIF:VCPWE motif 2,MOTIF:VCPWE motif 3,REGION:Cache-like region,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q9I918	G protein-coupled receptor 173(gpr173)	Danio rerio			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q99680	G protein-coupled receptor 22(GPR22)	Homo sapiens			GO:0007186~G-protein coupled receptor signaling pathway,GO:0030030~cell projection organization,GO:0032870~cellular response to hormone stimulus,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,GO:0042277~peptide binding,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,					KW-0970~Cilium biogenesis/degradation,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
A0A2R9YJI3	G protein-coupled receptor 22a(gpr22a)	Danio rerio			GO:0001947~heart looping,GO:0003140~determination of left/right asymmetry in lateral mesoderm,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007368~determination of left/right symmetry,GO:0030030~cell projection organization,GO:0032870~cellular response to hormone stimulus,GO:0061371~determination of heart left/right asymmetry,GO:0070121~Kupffer's vesicle development,GO:0071907~determination of digestive tract left/right asymmetry,GO:0071910~determination of liver left/right asymmetry,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,GO:0042277~peptide binding,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,					KW-0970~Cilium biogenesis/degradation,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,		COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q8K3J9	G protein-coupled receptor, family C, group 5, member C(Gprc5c)	Mus musculus			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007601~visual perception,	GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0004930~G-protein coupled receptor activity,GO:0005118~sevenless binding,GO:0030295~protein kinase activator activity,	IPR002956:Bride_of_7less,IPR017978:GPCR_3_C,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 3 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
O00451	GDNF family receptor alpha 2(GFRA2)	Homo sapiens			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007399~nervous system development,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0019898~extrinsic component of membrane,GO:0043235~receptor complex,	GO:0016167~glial cell-derived neurotrophic factor receptor activity,GO:0038023~signaling receptor activity,	IPR003438:GDNF_rcpt,IPR003504:GDNF_rcpt_a2,IPR016017:GDNF/GAS1,IPR017372:Glial_neurotroph_fac_rcpt_a1/2,IPR037193:GDNF_alpha,			PIRSF038071:GDNF_family_receptor_alpha,	SM00907:GDNF,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:GDNF/GAS1,LIPID:GPI-anchor amidated serine,PROPEP:Removed in mature form,REGION:Disordered,
O93512	GDNF family receptor alpha 4(GFRA4)	Gallus gallus			GO:0007399~nervous system development,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0043235~receptor complex,GO:0098552~side of membrane,	GO:0016167~glial cell-derived neurotrophic factor receptor activity,GO:0038023~signaling receptor activity,	IPR003438:GDNF_rcpt,IPR016017:GDNF/GAS1,IPR017372:Glial_neurotroph_fac_rcpt_a1/2,IPR037193:GDNF_alpha,			PIRSF038071:GDNF_family_receptor_alpha,	SM00907:GDNF,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:GDNF/GAS1,LIPID:GPI-anchor amidated serine,PROPEP:Removed in mature form,
E7FGY2	GID complex subunit 8 homolog b (S. cerevisiae)(gid8b)	Danio rerio			GO:0016055~Wnt signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048263~determination of dorsal identity,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR006594:LisH,IPR006595:CTLH_C,IPR013144:CRA_dom,IPR024964:CTLH/CRA,				SM00667:LisH,SM00668:CTLH,SM00757:CRA,	KW-0879~Wnt signaling pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0217~Developmental protein,KW-9996~Developmental protein,		DOMAIN:CTLH,DOMAIN:LisH,
Q7ZT47	GINS complex subunit 1 (Psf1 homolog) S homeolog(gins1.S)	Xenopus laevis			GO:0006260~DNA replication,	GO:0000811~GINS complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0071162~CMG complex,	GO:0003682~chromatin binding,	IPR005339:GINS_Psf1,IPR021151:GINS_A,IPR036224:GINS_bundle-like_dom_sf,					KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,
Q7ZT01	GINS complex subunit 3 (Psf3 homolog) L homeolog(gins3.L)	Xenopus laevis			GO:0006260~DNA replication,	GO:0000811~GINS complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0071162~CMG complex,	GO:0003682~chromatin binding,	IPR010492:GINS_Psf3,IPR021151:GINS_A,IPR036224:GINS_bundle-like_dom_sf,IPR038437:GINS_Psf3_sf,					KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,
Q7ZT48	GINS complex subunit 4 (Sld5 homolog) L homeolog(gins4.L)	Xenopus laevis			GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,	GO:0000811~GINS complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0071162~CMG complex,	GO:0003682~chromatin binding,	IPR008591:GINS_Sld5,IPR021151:GINS_A,IPR031633:SLD5_C,IPR036224:GINS_bundle-like_dom_sf,IPR038749:Sld5_GINS_A,			PIRSF007764:Sld5,		KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,							DOMAIN:DNA replication complex GINS protein SLD5 C-terminal,DOMAIN:GINS subunit,
Q9IA31	GLI family zinc finger 3(GLI3)	Gallus gallus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007224~smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0060173~limb development,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,IPR043359:GLI-like,	gga04340:Hedgehog signaling pathway,			SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0732~Signal,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,
Q9BZE0	GLIS family zinc finger 2(GLIS2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007417~central nervous system development,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061005~cell differentiation involved in kidney development,GO:0061484~hematopoietic stem cell homeostasis,GO:1900182~positive regulation of protein localization to nucleus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0097730~non-motile cilium,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,IPR043359:GLI-like,		611498~Nephronophthisis 7,		SM00355:ZnF_C2H2,	KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0983~Nephronophthisis,KW-1186~Ciliopathy,	KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0678~Repressor,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:C2H2-type,REGION:Disordered,REGION:Interaction with CTNND1,REGION:Transcription activation,REGION:Transcription repression,SITE:Cleavage,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2; atypical,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,
P24799	GNAS complex locus S homeolog(gnas.S)	Xenopus laevis			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0051716~cellular response to stimulus,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR000367:Gprotein_alpha_S,IPR001019:Gprotein_alpha_su,IPR011025:GproteinA_insert,IPR027417:P-loop_NTPase,	xla04020:Calcium signaling pathway,xla04261:Adrenergic signaling in cardiomyocytes,xla04270:Vascular smooth muscle contraction,xla04540:Gap junction,xla04912:GnRH signaling pathway,xla04916:Melanogenesis,			SM00275:G_alpha,		KW-0472~Membrane,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0807~Transducer,	KW-0449~Lipoprotein,KW-0564~Palmitate,	COMPBIAS:Basic and acidic residues,DOMAIN:G-alpha,LIPID:N-palmitoyl glycine,LIPID:S-palmitoyl cysteine,REGION:Disordered,REGION:G1 motif,REGION:G2 motif,REGION:G3 motif,REGION:G4 motif,REGION:G5 motif,
B5X1G3	GPR89A(si:ch73-390b10.2)	Salmo salar			GO:0015031~protein transport,GO:0034220~ion transmembrane transport,GO:0051452~intracellular pH reduction,	GO:0000139~Golgi membrane,GO:0032580~Golgi cisterna membrane,GO:0034702~ion channel complex,	GO:0008308~voltage-gated anion channel activity,	IPR015672:GPHR/GTG,IPR022535:Golgi_pH-regulator_cons_dom,IPR025969:ABA_GPCR_dom,					KW-0406~Ion transport,KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0407~Ion channel,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Abscisic acid G-protein coupled receptor-like,DOMAIN:Golgi pH regulator conserved,TRANSMEM:Helical,
Q80TI0	GRAM domain containing 1B(Gramd1b)	Mus musculus			GO:0006869~lipid transport,GO:0032366~intracellular sterol transport,GO:0042632~cholesterol homeostasis,GO:0071397~cellular response to cholesterol,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0044232~organelle membrane contact site,	GO:0001786~phosphatidylserine binding,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0070300~phosphatidic acid binding,	IPR004182:GRAM,IPR011993:PH-like_dom_sf,IPR031968:VASt,				SM00568:GRAM,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0446~Lipid-binding,		KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:GRAM,DOMAIN:VASt,REGION:Disordered,TRANSMEM:Helical,
Q5FVG8	GRAM domain containing 2B(Gramd2b)	Rattus norvegicus				GO:0005881~cytoplasmic microtubule,GO:0016020~membrane,	GO:0042802~identical protein binding,	IPR004182:GRAM,IPR011993:PH-like_dom_sf,				SM00568:GRAM,		KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:GRAM,REGION:Disordered,TRANSMEM:Helical,
A6QLK6	GRB2 related adaptor protein(GRAP)	Bos taurus			GO:0007165~signal transduction,GO:0007605~sensory perception of sound,GO:0043408~regulation of MAPK cascade,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0008180~COP9 signalosome,GO:0098793~presynapse,	GO:0001784~phosphotyrosine binding,GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,	IPR000980:SH2,IPR001452:SH3_domain,IPR035645:GRAP_N_SH3,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,IPR043539:Grb2-like,				SM00252:SH2,SM00326:SH3,		KW-0472~Membrane,KW-0770~Synapse,			KW-0677~Repeat,KW-0727~SH2 domain,KW-0728~SH3 domain,				COMPBIAS:Polar residues,DOMAIN:SH2,DOMAIN:SH3,DOMAIN:SH3 1,DOMAIN:SH3 2,REGION:Disordered,
Q9JHZ4	GRIP1 associated protein 1(Gripap1)	Rattus norvegicus			GO:0098887~neurotransmitter receptor transport, endosome to postsynaptic membrane,GO:1903828~negative regulation of cellular protein localization,GO:1903910~negative regulation of receptor clustering,GO:1905244~regulation of modification of synaptic structure,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0042734~presynaptic membrane,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0055038~recycling endosome membrane,GO:0098837~postsynaptic recycling endosome,GO:0098978~glutamatergic synapse,GO:0098998~extrinsic component of postsynaptic early endosome membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0035255~ionotropic glutamate receptor binding,GO:0042802~identical protein binding,	IPR026204:GRIPAP1,					KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-0967~Endosome,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,MUTAGEN:D->E: No in vitro cleavage by caspase-3; when associated with E-591. Results in loss of JNK activation; when associated with E-591.,MUTAGEN:D->E: No in vitro cleavage by caspase-3; when associated with E-594. Results in loss of JNK activation; when associated with E-594.,REGION:Disordered,SITE:Cleavage; by caspase-3,TRANSMEM:Helical,
Q9BZE4	GTP binding protein 4(GTPBP4)	Homo sapiens			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001649~osteoblast differentiation,GO:0008156~negative regulation of DNA replication,GO:0008285~negative regulation of cell proliferation,GO:0022408~negative regulation of cell-cell adhesion,GO:0030336~negative regulation of cell migration,GO:0031397~negative regulation of protein ubiquitination,GO:0033342~negative regulation of collagen binding,GO:0042273~ribosomal large subunit biogenesis,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:1990275~preribosome binding,	IPR005225:Small_GTP-bd_dom,IPR006073:GTP-bd,IPR010674:NOG1_Rossman_fold_dom,IPR012973:NOG_C,IPR024926:NOG1,IPR027417:P-loop_NTPase,IPR031167:G_OBG,IPR041623:NOG1_N,	hsa03008:Ribosome biogenesis in eukaryotes,		PIRSF038919:NOG1,		KW-0690~Ribosome biogenesis,	KW-0539~Nucleus,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:NOG1 N-terminal helical,DOMAIN:OBG-type G,REGION:Disordered,
Q6PBT6	GTP cyclohydrolase I feedback regulator(gchfr)	Danio rerio			GO:0009890~negative regulation of biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0044549~GTP cyclohydrolase binding,	IPR009112:GTP_CycHdrlase_I_reg,IPR036717:GFRP_sf,						KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,
A0JMI9	GTP dependent ribosome recycling factor mitochondrial 2(gfm2)	Danio rerio			GO:0006412~translation,GO:0032543~mitochondrial translation,GO:0032790~ribosome disassembly,	GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR000640:EFG_V-like,IPR000795:T_Tr_GTP-bd_dom,IPR004161:EFTu-like_2,IPR005225:Small_GTP-bd_dom,IPR005517:Transl_elong_EFG/EF2_IV,IPR009000:Transl_B-barrel_sf,IPR009022:EFG_III,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR027417:P-loop_NTPase,IPR030851:EFG2,IPR031157:G_TR_CS,IPR035647:EFG_III/V,IPR035649:EFG_V,IPR041095:EFG_II,				SM00838:EFG_C,SM00889:EFG_IV,	KW-0648~Protein biosynthesis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,		DOMAIN:Elongation factor EFG,DOMAIN:Translation elongation factor EFG/EF2,DOMAIN:tr-type G,TRANSIT:Mitochondrion,
Q9NUV9	GTPase, IMAP family member 4(GIMAP4)	Homo sapiens				GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,	GO:0005525~GTP binding,	IPR006703:G_AIG1,IPR027417:P-loop_NTPase,IPR045058:GIMA/IAN/Toc,						KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:AIG1-type G,DOMAIN:IQ,REGION:Disordered,REGION:G1,REGION:G2,REGION:G3,REGION:G4,REGION:G5,
G3X987	GTPase, IMAP family member 9(Gimap9)	Mus musculus					GO:0000166~nucleotide binding,GO:0005525~GTP binding,	IPR006703:G_AIG1,IPR027417:P-loop_NTPase,IPR045058:GIMA/IAN/Toc,										KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			DOMAIN:AIG1-type G,REGION:G1,REGION:G2,REGION:G3,REGION:G4,REGION:G5,
Q7Z2Y8	GTPase, very large interferon inducible pseudogene 1(GVINP1)	Homo sapiens				GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005525~GTP binding,	IPR027417:P-loop_NTPase,IPR029028:Alpha/beta_knot_MTases,IPR030383:G_VLIG_dom,						KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			COMPBIAS:Polar residues,DOMAIN:VLIG-type G,REGION:Disordered,
Q8INF0	Guanylyl cyclase at 88E(Gyc88E)	Drosophila melanogaster			GO:0000302~response to reactive oxygen species,GO:0001666~response to hypoxia,GO:0006182~cGMP biosynthetic process,GO:0009190~cyclic nucleotide biosynthetic process,GO:0019934~cGMP-mediated signaling,GO:0035556~intracellular signal transduction,GO:0038060~nitric oxide-cGMP-mediated signaling pathway,GO:0070482~response to oxygen levels,	GO:0008074~guanylate cyclase complex, soluble,	GO:0003924~GTPase activity,GO:0004383~guanylate cyclase activity,GO:0005525~GTP binding,GO:0016829~lyase activity,GO:0016849~phosphorus-oxygen lyase activity,GO:0019825~oxygen binding,GO:0019826~oxygen sensor activity,GO:0019899~enzyme binding,GO:0020037~heme binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0070025~carbon monoxide binding,GO:0070026~nitric oxide binding,	IPR001054:A/G_cyclase,IPR011644:Heme_NO-bd,IPR011645:HNOB_dom_associated,IPR018297:A/G_cyclase_CS,IPR024096:NO_sig/Golgi_transp_ligand-bd,IPR029787:Nucleotide_cyclase,IPR038158:H-NOX_domain_sf,IPR042463:HNOB_dom_associated_sf,	dme00230:Purine metabolism,dme01100:Metabolic pathways,			SM00044:CYCc,	KW-0141~cGMP biosynthesis,	KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0342~GTP-binding,KW-0349~Heme,KW-0408~Iron,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0456~Lyase,	KW-0325~Glycoprotein,	BINDING:proximal binding residue,COMPBIAS:Polar residues,DOMAIN:Guanylate cyclase,DOMAIN:Heme NO-binding,REGION:Disordered,
Q6GM86	H2A.X variant histone S homeolog(h2ax.S)	Xenopus laevis			GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0051321~meiotic cell cycle,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005813~centrosome,	GO:0003677~DNA binding,GO:0030527~structural constituent of chromatin,GO:0046982~protein heterodimerization activity,	IPR002119:Histone_H2A,IPR007125:Histone_H2A/H2B/H3,IPR009072:Histone-fold,IPR032454:Histone_H2A_C,IPR032458:Histone_H2A_CS,	xla03082:ATP-dependent chromatin remodeling,xla04217:Necroptosis,			SM00414:H2A,	KW-0131~Cell cycle,KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0469~Meiosis,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0544~Nucleosome core,					KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Histone H2A C-terminal,DOMAIN:Histone H2A/H2B/H3,MOTIF:[ST]-Q motif,REGION:Disordered,
Q5BJ65	H2A.Z variant histone 2(h2az2)	Xenopus tropicalis			GO:0070828~heterochromatin organization,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005882~intermediate filament,	GO:0003677~DNA binding,GO:0005198~structural molecule activity,GO:0030527~structural constituent of chromatin,GO:0031492~nucleosomal DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone_H2A,IPR002957:Keratin_I,IPR007125:Histone_H2A/H2B/H3,IPR009072:Histone-fold,IPR018039:IF_conserved,IPR032454:Histone_H2A_C,IPR032458:Histone_H2A_CS,IPR039008:IF_rod_dom,	xtr03082:ATP-dependent chromatin remodeling,xtr04217:Necroptosis,			SM00414:H2A,SM01391:Filament,		KW-0158~Chromosome,KW-0416~Keratin,KW-0539~Nucleus,KW-0544~Nucleosome core,			KW-0175~Coiled coil,		KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Histone H2A C-terminal,DOMAIN:Histone H2A/H2B/H3,DOMAIN:IF rod,REGION:Disordered,
Q6P823	H3 histone, family 3B (H3.3B)(h3f3b)	Xenopus tropicalis				GO:0000786~nucleosome,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0030527~structural constituent of chromatin,GO:0046982~protein heterodimerization activity,	IPR000164:Histone_H3/CENP-A,IPR007125:Histone_H2A/H2B/H3,IPR009072:Histone-fold,				SM00428:H3,		KW-0158~Chromosome,KW-0539~Nucleus,KW-0544~Nucleosome core,					KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0013~ADP-ribosylation,KW-0379~Hydroxylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:Histone H2A/H2B/H3,REGION:Disordered,SITE:Interaction with zmynd11,
Q68CZ6	HAUS augmin like complex subunit 3(HAUS3)	Homo sapiens			GO:0007098~centrosome cycle,GO:0010968~regulation of microtubule nucleation,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0005813~centrosome,GO:0005829~cytosol,GO:0070652~HAUS complex,GO:0072686~mitotic spindle,GO:1990498~mitotic spindle microtubule,	GO:0005515~protein binding,	IPR026206:HAUS3,IPR032733:HAUS3_N,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,
Q9H6D7	HAUS augmin like complex subunit 4(HAUS4)	Homo sapiens			GO:0007098~centrosome cycle,GO:0010968~regulation of microtubule nucleation,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0005813~centrosome,GO:0005829~cytosol,GO:0070652~HAUS complex,GO:1990498~mitotic spindle microtubule,	GO:0005515~protein binding,GO:0051011~microtubule minus-end binding,	IPR026214:HAUS4_met,IPR029327:HAUS4,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,							REGION:Disordered,
O94927	HAUS augmin like complex subunit 5(HAUS5)	Homo sapiens			GO:0007098~centrosome cycle,GO:0010968~regulation of microtubule nucleation,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0005813~centrosome,GO:0005829~cytosol,GO:0070652~HAUS complex,GO:1990498~mitotic spindle microtubule,	GO:0005515~protein binding,	IPR026215:HAUS5_metazoa,IPR029131:HAUS5,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Disordered,
Q8BHX1	HAUS augmin-like complex, subunit 1(Haus1)	Mus musculus			GO:0007049~cell cycle,GO:0007098~centrosome cycle,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0070652~HAUS complex,GO:1990498~mitotic spindle microtubule,		IPR026243:HAUS1,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,
A0JMF7	HAUS augmin-like complex, subunit 6(haus6)	Danio rerio			GO:0000226~microtubule cytoskeleton organization,GO:0007049~cell cycle,GO:0007098~centrosome cycle,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0070652~HAUS complex,GO:1990498~mitotic spindle microtubule,	GO:0008017~microtubule binding,	IPR026797:HAUS_6,IPR028163:HAUS_6_N,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,
Q9P2D3	HEAT repeat containing 5B(HEATR5B)	Homo sapiens			GO:0006897~endocytosis,GO:0008104~protein localization,GO:0015031~protein transport,GO:0042147~retrograde transport, endosome to Golgi,	GO:0005829~cytosol,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0030136~clathrin-coated vesicle,GO:0030139~endocytic vesicle,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR040108:Laa1/Sip1/HEATR5,IPR046837:Laa1/Sip1/HEATR5-like_HEAT,					KW-0653~Protein transport,KW-0813~Transport,	KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,REGION:Disordered,REPEAT:HEAT 1,REPEAT:HEAT 2,REPEAT:HEAT 3,
Q5PQN1	HECT and RLD domain containing E3 ubiquitin protein ligase 4(Herc4)	Rattus norvegicus			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007283~spermatogenesis,GO:0016567~protein ubiquitination,GO:0030154~cell differentiation,GO:0045879~negative regulation of smoothened signaling pathway,	GO:0001650~fibrillar center,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0061630~ubiquitin protein ligase activity,	IPR000408:Reg_chr_condens,IPR000569:HECT_dom,IPR009091:RCC1/BLIP-II,IPR035983:Hect_E3_ubiquitin_ligase,	rno04120:Ubiquitin mediated proteolysis,			SM00119:HECTc,	KW-0221~Differentiation,KW-0744~Spermatogenesis,KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0808~Transferase,		ACT_SITE:Glycyl thioester intermediate,DOMAIN:HECT,REPEAT:RCC1,REPEAT:RCC1 1,REPEAT:RCC1 2,REPEAT:RCC1 3,REPEAT:RCC1 4,REPEAT:RCC1 5,REPEAT:RCC1 6,REPEAT:RCC1 7,
Q8IVU3	HECT and RLD domain containing E3 ubiquitin protein ligase family member 6(HERC6)	Homo sapiens			GO:0000209~protein polyubiquitination,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009617~response to bacterium,GO:0016567~protein ubiquitination,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0061630~ubiquitin protein ligase activity,	IPR000408:Reg_chr_condens,IPR000569:HECT_dom,IPR009091:RCC1/BLIP-II,IPR035983:Hect_E3_ubiquitin_ligase,IPR044611:E3A/B/C-like,				SM00119:HECTc,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0808~Transferase,		ACT_SITE:Glycyl thioester intermediate,DOMAIN:HECT,REGION:Disordered,REPEAT:RCC1,REPEAT:RCC1 1,REPEAT:RCC1 2,REPEAT:RCC1 3,REPEAT:RCC1 4,REPEAT:RCC1 5,
Q3U487	HECT domain E3 ubiquitin protein ligase 3(Hectd3)	Mus musculus			GO:0016567~protein ubiquitination,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0016740~transferase activity,GO:0019905~syntaxin binding,	IPR000569:HECT_dom,IPR004939:APC_su10/DOC_dom,IPR008979:Galactose-bd-like_sf,IPR035983:Hect_E3_ubiquitin_ligase,IPR042469:HECTD3,				SM00119:HECTc,SM01337:APC10,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,					KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Glycyl thioester intermediate,DOMAIN:DOC,DOMAIN:HECT,
Q9P2P5	HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2(HECW2)	Homo sapiens			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0048814~regulation of dendrite morphogenesis,GO:2000650~negative regulation of sodium ion transmembrane transporter activity,	GO:0005737~cytoplasm,GO:0072686~mitotic spindle,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR000008:C2_dom,IPR000569:HECT_dom,IPR001202:WW_dom,IPR024928:E3_ub_ligase_SMURF1,IPR032348:HECW_N,IPR035892:C2_domain_sf,IPR035983:Hect_E3_ubiquitin_ligase,IPR036020:WW_dom_sf,IPR037795:C2_HECW,IPR040524:HECW1_helix,		617268~Neurodevelopmental disorder with hypotonia, seizures, and absent language,	PIRSF001569:E3_ub_ligase_SMURF1,	SM00119:HECTc,SM00239:C2,SM00456:WW,	KW-0833~Ubl conjugation pathway,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0175~Coiled coil,KW-0677~Repeat,		KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Glycyl thioester intermediate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:E3 ubiquitin-protein ligase HECW1/2 N-terminal,DOMAIN:HECT,DOMAIN:WW,DOMAIN:WW 1,DOMAIN:WW 2,REGION:Disordered,REGION:Interaction with TP73,
Q7Z6Z7	HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1(HUWE1)	Homo sapiens			GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006338~chromatin remodeling,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0007030~Golgi organization,GO:0010637~negative regulation of mitochondrial fusion,GO:0030154~cell differentiation,GO:0031398~positive regulation of protein ubiquitination,GO:0032922~circadian regulation of gene expression,GO:0061025~membrane fusion,GO:0098779~positive regulation of macromitophagy in response to mitochondrial depolarization,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016020~membrane,GO:0034774~secretory granule lumen,GO:0070062~extracellular exosome,GO:1904813~ficolin-1-rich granule lumen,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR000569:HECT_dom,IPR004170:WWE-dom,IPR009060:UBA-like_sf,IPR010309:E3_Ub_ligase_DUF908,IPR010314:E3_Ub_ligase_DUF913,IPR011989:ARM-like,IPR015940:UBA,IPR016024:ARM-type_fold,IPR025527:HUWE1/Rev1_UBM,IPR035983:Hect_E3_ubiquitin_ligase,IPR037197:WWE_dom_sf,IPR041918:UBA_HUWE1,	hsa04120:Ubiquitin mediated proteolysis,hsa04137:Mitophagy - animal,	309590~Intellectual developmental disorder, X-linked syndromic, Turner type,		SM00119:HECTc,SM00165:UBA,	KW-0090~Biological rhythms,KW-0221~Differentiation,KW-0227~DNA damage,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0238~DNA-binding,KW-0808~Transferase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	ACT_SITE:Glycyl thioester intermediate,COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DISULFID:Interchain,DOMAIN:DUF908,DOMAIN:DUF913,DOMAIN:HECT,DOMAIN:UBA,DOMAIN:UIM,DOMAIN:WWE,MUTAGEN:C->A,D: Loss of activity.,MUTAGEN:Y->S: Loss of activity.,REGION:Disordered,TRANSMEM:Helical,
A8MVW5	HEPACAM family member 2(HEPACAM2)	Homo sapiens			GO:0007098~centrosome cycle,GO:0051301~cell division,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005819~spindle,GO:0016020~membrane,GO:0030496~midbody,GO:0043231~intracellular membrane-bounded organelle,GO:0072686~mitotic spindle,	GO:0005515~protein binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00408:IGc2,SM00409:IG,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0013~ADP-ribosylation,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
Q8AYB8	HOP homeobox(hopx)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,	IPR001356:Homeobox_dom,IPR009057:Homeobox-like_sf,IPR039162:HOPX,				SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0371~Homeobox,		KW-0217~Developmental protein,KW-0678~Repressor,KW-9996~Developmental protein,		DNA_BIND:Homeobox; degenerate,
P20171	HRas proto-oncogene, GTPase(Hras)	Rattus norvegicus			GO:0001889~liver development,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014044~Schwann cell development,GO:0030335~positive regulation of cell migration,GO:0032729~positive regulation of interferon-gamma production,GO:0032956~regulation of actin cytoskeleton organization,GO:0035900~response to isolation stress,GO:0042088~T-helper 1 type immune response,GO:0042127~regulation of cell proliferation,GO:0042552~myelination,GO:0042832~defense response to protozoan,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0045445~myoblast differentiation,GO:0045740~positive regulation of DNA replication,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048144~fibroblast proliferation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048642~negative regulation of skeletal muscle tissue development,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050852~T cell receptor signaling pathway,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0060612~adipose tissue development,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071480~cellular response to gamma radiation,GO:0090303~positive regulation of wound healing,GO:0090314~positive regulation of protein targeting to membrane,GO:0090398~cellular senescence,GO:0090402~oncogene-induced cell senescence,GO:0097193~intrinsic apoptotic signaling pathway,GO:1900029~positive regulation of ruffle assembly,GO:2000630~positive regulation of miRNA metabolic process,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0098978~glutamatergic synapse,GO:1905360~GTPase complex,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0043495~protein anchor,GO:0044877~macromolecular complex binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR020849:Small_GTPase_Ras-type,IPR027417:P-loop_NTPase,	rno01521:EGFR tyrosine kinase inhibitor resistance,rno01522:Endocrine resistance,rno04010:MAPK signaling pathway,rno04012:ErbB signaling pathway,rno04014:Ras signaling pathway,rno04015:Rap1 signaling pathway,rno04062:Chemokine signaling pathway,rno04068:FoxO signaling pathway,rno04071:Sphingolipid signaling pathway,rno04072:Phospholipase D signaling pathway,rno04137:Mitophagy - animal,rno04140:Autophagy - animal,rno04144:Endocytosis,rno04150:mTOR signaling pathway,rno04151:PI3K-Akt signaling pathway,rno04210:Apoptosis,rno04211:Longevity regulating pathway,rno04213:Longevity regulating pathway - multiple species,rno04218:Cellular senescence,rno04360:Axon guidance,rno04370:VEGF signaling pathway,rno04371:Apelin signaling pathway,rno04510:Focal adhesion,rno04540:Gap junction,rno04550:Signaling pathways regulating pluripotency of stem cells,rno04625:C-type lectin receptor signaling pathway,rno04630:JAK-STAT signaling pathway,rno04650:Natural killer cell mediated cytotoxicity,rno04660:T cell receptor signaling pathway,rno04662:B cell receptor signaling pathway,rno04664:Fc epsilon RI signaling pathway,rno04714:Thermogenesis,rno04720:Long-term potentiation,rno04722:Neurotrophin signaling pathway,rno04725:Cholinergic synapse,rno04726:Serotonergic synapse,rno04730:Long-term depression,rno04810:Regulation of actin cytoskeleton,rno04910:Insulin signaling pathway,rno04912:GnRH signaling pathway,rno04915:Estrogen signaling pathway,rno04916:Melanogenesis,rno04917:Prolactin signaling pathway,rno04919:Thyroid hormone signaling pathway,rno04921:Oxytocin signaling pathway,rno04926:Relaxin signaling pathway,rno04929:GnRH secretion,rno04933:AGE-RAGE signaling pathway in diabetic complications,rno04935:Growth hormone synthesis, secretion and action,rno05010:Alzheimer disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05034:Alcoholism,rno05132:Salmonella infection,rno05160:Hepatitis C,rno05161:Hepatitis B,rno05163:Human cytomegalovirus infection,rno05165:Human papillomavirus infection,rno05166:Human T-cell leukemia virus 1 infection,rno05167:Kaposi sarcoma-associated herpesvirus infection,rno05170:Human immunodeficiency virus 1 infection,rno05200:Pathways in cancer,rno05203:Viral carcinogenesis,rno05205:Proteoglycans in cancer,rno05206:MicroRNAs in cancer,rno05207:Chemical carcinogenesis - receptor activation,rno05208:Chemical carcinogenesis - reactive oxygen species,rno05210:Colorectal cancer,rno05211:Renal cell carcinoma,rno05213:Endometrial cancer,rno05214:Glioma,rno05215:Prostate cancer,rno05216:Thyroid cancer,rno05218:Melanoma,rno05219:Bladder cancer,rno05220:Chronic myeloid leukemia,rno05221:Acute myeloid leukemia,rno05223:Non-small cell lung cancer,rno05224:Breast cancer,rno05225:Hepatocellular carcinoma,rno05226:Gastric cancer,rno05230:Central carbon metabolism in cancer,rno05231:Choline metabolism in cancer,rno05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,rno05417:Lipid and atherosclerosis,			SM00173:RAS,SM00174:RHO,SM00175:RAB,		KW-0333~Golgi apparatus,KW-0472~Membrane,KW-1003~Cell membrane,		KW-0656~Proto-oncogene,		KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0488~Methylation,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0636~Prenylation,KW-0702~S-nitrosylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),LIPID:S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine; alternate,LIPID:S-farnesyl cysteine,LIPID:S-palmitoyl cysteine,LIPID:S-palmitoyl cysteine; alternate,MOTIF:Effector region,MUTAGEN:C->S: Interacts but does not stimulate PLCE1; when associated with L-61.,MUTAGEN:D->N: Reduced interaction and stimulation of PLCE1; when associated with L-61.,MUTAGEN:E->G: Reduced interaction and stimulation of PLCE1; when associated with L-61.,MUTAGEN:N->G: Interacts and partially stimulates PLCE1; when associated with L-61.,MUTAGEN:Q->L: Constitutively active. Constitutively interacts and stimulates PLCE1 phospholipase activity. Reduced interaction and stimulation of PLCE1; when associated with G-37 and N-38. No interaction and stimulation of PLCE1; when associated with S-35 and C-40. Interacts and partially stimulates PLCE1; when associated with G-26. Interacts but does not stimulate PLCE1; when associated with S-186.,MUTAGEN:T->S: No interaction and stimulation of PLCE1; when associated with L-61.,MUTAGEN:Y->C: No interaction and stimulation of PLCE1; when associated with L-61.,PROPEP:Removed in mature form,REGION:Disordered,REGION:Hypervariable region,
P24724	HSP90(TpMuguga_02g00244)	Theileria parva strain Muguga			GO:0006457~protein folding,GO:0034605~cellular response to heat,GO:0050821~protein stabilization,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0032991~macromolecular complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0051082~unfolded protein binding,	IPR001404:Hsp90_fam,IPR003594:HATPase_C,IPR019805:Heat_shock_protein_90_CS,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR020575:Hsp90_N,IPR036890:HATPase_C_sf,IPR037196:HSP90_C,	tpv04141:Protein processing in endoplasmic reticulum,		PIRSF002583:Hsp90,	SM00387:HATPase_c,	KW-0346~Stress response,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,		COMPBIAS:Basic and acidic residues,MOTIF:TPR repeat-binding,REGION:Disordered,
Q2KI52	HYLS1 centriolar and ciliogenesis associated(HYLS1)	Bos taurus			GO:0060271~cilium assembly,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0097730~non-motile cilium,		IPR026227:HYLS1,IPR027918:HYLS1_C_dom,					KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,							COMPBIAS:Polar residues,REGION:Disordered,
Q9Y5R4	HemK methyltransferase family member 1(HEMK1)	Homo sapiens			GO:0006306~DNA methylation,GO:0008152~metabolic process,GO:0019538~protein metabolic process,	GO:0005739~mitochondrion,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,	IPR002052:DNA_methylase_N6_adenine_CS,IPR002295:N4/N6-MTase_EcoPI_Mod-like,IPR004556:HemK-like,IPR007848:Small_mtfrase_dom,IPR019874:Release_fac_Glu-N5_MeTfrase,IPR029063:SAM-dependent_MTases_sf,IPR040758:PrmC_N,IPR041698:Methyltransf_25,						KW-0496~Mitochondrion,				KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:Methyltransferase,DOMAIN:Methyltransferase small,DOMAIN:Release factor glutamine methyltransferase N-terminal,REGION:Disordered,
F4JTS8	Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase family protein(NOV)	Arabidopsis thaliana			GO:0001708~cell fate specification,GO:0009793~embryo development ending in seed dormancy,GO:0009926~auxin polar transport,GO:0010305~leaf vascular tissue pattern formation,GO:0019827~stem cell population maintenance,GO:0048364~root development,	GO:0005634~nucleus,		IPR024975:NOV_C,IPR036890:HATPase_C_sf,						KW-0539~Nucleus,							COMPBIAS:Basic and acidic residues,DOMAIN:Protein NO VEIN C-terminal,MOTIF:Nuclear localization signal 1,MOTIF:Nuclear localization signal 2,MUTAGEN:P->S: In nov-1; many auxin-dependent development defects including narrow rosette leaves with few veins. Abnormal presence of starch granules in roots columella stem cells associated with an altered maintenance of cortex/endodermis stem cells. Enhanced effect of 1-naphthylphthalamic acid (NPA), an inhibitor of polar auxin transport. Disturbed subcellular localizations of PIN1, PIN2, PIN3, PIN4 and PIN7 in leaf primordia and root tips.,REGION:Disordered,
A9JRB3	HtrA serine peptidase 1b(htra1b)	Danio rerio			GO:0006508~proteolysis,GO:0012501~programmed cell death,GO:0043065~positive regulation of apoptotic process,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0016787~hydrolase activity,GO:0019838~growth factor binding,	IPR000867:IGFBP-like,IPR001478:PDZ,IPR001940:Peptidase_S1C,IPR002350:Kazal_dom,IPR009003:Peptidase_S1_PA,IPR009030:Growth_fac_rcpt_cys_sf,IPR036034:PDZ_sf,IPR036058:Kazal_dom_sf,IPR041489:PDZ_6,				SM00121:IB,SM00228:PDZ,SM00280:KAZAL,		KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0732~Signal,		KW-0340~Growth factor binding,KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,DOMAIN:IGFBP N-terminal,DOMAIN:Kazal-like,DOMAIN:PDZ,REGION:Serine protease,SITE:Involved in trimer stabilization,
A0JNK3	HtrA serine peptidase 2(HTRA2)	Bos taurus			GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0012501~programmed cell death,GO:0043065~positive regulation of apoptotic process,	GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0031966~mitochondrial membrane,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,	IPR001478:PDZ,IPR001940:Peptidase_S1C,IPR009003:Peptidase_S1_PA,IPR036034:PDZ_sf,IPR041489:PDZ_6,	bta04210:Apoptosis,bta04215:Apoptosis - multiple species,bta05012:Parkinson disease,bta05022:Pathways of neurodegeneration - multiple diseases,			SM00228:PDZ,	KW-0053~Apoptosis,	KW-0472~Membrane,KW-0496~Mitochondrion,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0865~Zymogen,	ACT_SITE:Charge relay system,DOMAIN:PDZ,MOTIF:IAP-binding motif,REGION:Serine protease,TRANSIT:Mitochondrion,TRANSMEM:Helical,
D3ZA76	HtrA serine peptidase 3(Htra3)	Rattus norvegicus			GO:0006508~proteolysis,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,	GO:0005576~extracellular region,	GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008236~serine-type peptidase activity,GO:0042802~identical protein binding,	IPR000867:IGFBP-like,IPR001478:PDZ,IPR001940:Peptidase_S1C,IPR002350:Kazal_dom,IPR009003:Peptidase_S1_PA,IPR009030:Growth_fac_rcpt_cys_sf,IPR036034:PDZ_sf,IPR036058:Kazal_dom_sf,IPR041489:PDZ_6,				SM00121:IB,SM00228:PDZ,SM00280:KAZAL,		KW-0964~Secreted,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,DOMAIN:IGFBP N-terminal,DOMAIN:Kazal-like,DOMAIN:PDZ,REGION:Serine protease,
Q5XJN2	IFI30 lysosomal thiol reductase a(ifi30a)	Danio rerio			GO:0002376~immune system process,	GO:0005576~extracellular region,GO:0005764~lysosome,	GO:0016491~oxidoreductase activity,GO:0016667~oxidoreductase activity, acting on a sulfur group of donors,GO:0016671~oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,GO:0047134~protein-disulfide reductase activity,	IPR003119:SAP_A,IPR004911:Interferon-induced_GILT,					KW-0391~Immunity,	KW-0458~Lysosome,KW-0964~Secreted,			KW-0676~Redox-active center,KW-0732~Signal,		KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Redox-active,
Q8C208	IKAROS family zinc finger 4(Ikzf4)	Mus musculus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051260~protein homooligomerization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0032991~macromolecular complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019904~protein domain specific binding,GO:0043425~bHLH transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:C2H2-type,MOTIF:CTBP-binding motif PEDLG,REGION:Disordered,REGION:Interaction with FOXP3,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,
Q9C086	INO80 complex subunit B(INO80B)	Homo sapiens			GO:0000723~telomere maintenance,GO:0006275~regulation of DNA replication,GO:0006281~DNA repair,GO:0006282~regulation of DNA repair,GO:0006310~DNA recombination,GO:0006338~chromatin remodeling,GO:0033044~regulation of chromosome organization,GO:0045739~positive regulation of DNA repair,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045995~regulation of embryonic development,GO:0051726~regulation of cell cycle,GO:0060382~regulation of DNA strand elongation,GO:1904507~positive regulation of telomere maintenance in response to DNA damage,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016604~nuclear body,GO:0031011~Ino80 complex,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006880:INO80B_C,IPR007529:Znf_HIT,IPR029523:INO80B/Ies2,	hsa03082:ATP-dependent chromatin remodeling,			SM01406:PAPA-1,	KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:INO80 complex subunit B-like conserved region,REGION:Disordered,ZN_FING:HIT-type,
Q6ZPV2	INO80 complex subunit(Ino80)	Mus musculus			GO:0000070~mitotic sister chromatid segregation,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0006275~regulation of DNA replication,GO:0006281~DNA repair,GO:0006282~regulation of DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:0030307~positive regulation of cell growth,GO:0033044~regulation of chromosome organization,GO:0034644~cellular response to UV,GO:0045739~positive regulation of DNA repair,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045995~regulation of embryonic development,GO:0051225~spindle assembly,GO:0051301~cell division,GO:0051726~regulation of cell cycle,GO:0060382~regulation of DNA strand elongation,GO:0070914~UV-damage excision repair,GO:0071479~cellular response to ionizing radiation,GO:1904507~positive regulation of telomere maintenance in response to DNA damage,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016604~nuclear body,GO:0031011~Ino80 complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003779~actin binding,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0042393~histone binding,GO:0043014~alpha-tubulin binding,	IPR000330:SNF2_N,IPR001650:Helicase_C,IPR014001:Helicase_ATP-bd,IPR020838:DBINO,IPR027417:P-loop_NTPase,IPR031047:DEXQc_INO80,IPR038718:SNF2-like_sf,	mmu03082:ATP-dependent chromatin remodeling,			SM00487:DEXDc,SM00490:HELICc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0498~Mitosis,	KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0009~Actin-binding,KW-0238~DNA-binding,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:DBINO,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,REGION:Assembles INO80 complex module consisting of conserved components ACTR8, ACTL6A and YY1,REGION:Assembles INO80 complex module consisting of conserved components INO80B, INO80C, ACTR5, RVBL1, RVBL2,REGION:Assembles INO80 complex module with putative regulatory components INO80E, INO80F, UCHL5, NFRKB, MCRS1 and IN80D,REGION:Disordered,
Q8BP00	IQ calmodulin-binding motif containing 1(Iqcb1)	Mus musculus			GO:0030030~cell projection organization,GO:0045494~photoreceptor cell maintenance,GO:0048496~maintenance of animal organ identity,GO:0060271~cilium assembly,GO:0061824~cytosolic ciliogenesis,	GO:0001750~photoreceptor outer segment,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005929~cilium,GO:0015630~microtubule cytoskeleton,GO:0032391~photoreceptor connecting cilium,GO:0045171~intercellular bridge,GO:0072686~mitotic spindle,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0019899~enzyme binding,GO:0030674~protein binding, bridging,	IPR000048:IQ_motif_EF-hand-BS,IPR016024:ARM-type_fold,IPR027417:P-loop_NTPase,IPR028765:IQCB1,				SM00015:IQ,	KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0112~Calmodulin-binding,		DOMAIN:IQ 1,DOMAIN:IQ 2,DOMAIN:IQ 3,DOMAIN:IQ 4,REGION:Interaction with BBS1, BBS2, BBS4, BBS7, BBS8 and BBS9,REGION:Interaction with BBS1, BBS8 and BBS9,REGION:Interaction with CEP290, BBS1, BBS2, BBS4, BBS5, BBS7, BBS8 and BBS9,
Q8R0S2	IQ motif and Sec7 domain 1(Iqsec1)	Mus musculus			GO:0030036~actin cytoskeleton organization,GO:0032012~regulation of ARF protein signal transduction,GO:0051549~positive regulation of keratinocyte migration,GO:0060996~dendritic spine development,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0008021~synaptic vesicle,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,GO:0045202~synapse,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,GO:0099092~postsynaptic density, intracellular component,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0008289~lipid binding,GO:0019901~protein kinase binding,	IPR000048:IQ_motif_EF-hand-BS,IPR000904:Sec7_dom,IPR011993:PH-like_dom_sf,IPR023394:Sec7_C_sf,IPR033742:IQSEC_PH,IPR035999:Sec7_dom_sf,	mmu04144:Endocytosis,			SM00222:Sec7,		KW-0539~Nucleus,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,	KW-0446~Lipid-binding,	KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:IQ,DOMAIN:PH,DOMAIN:SEC7,REGION:Disordered,
Q76M68	IQ motif and Sec7 domain ArfGEF 3(Iqsec3)	Rattus norvegicus			GO:0030036~actin cytoskeleton organization,GO:0032012~regulation of ARF protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0090630~activation of GTPase activity,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,GO:0098982~GABA-ergic synapse,GO:0099629~postsynaptic specialization of symmetric synapse,	GO:0005085~guanyl-nucleotide exchange factor activity,	IPR000048:IQ_motif_EF-hand-BS,IPR000904:Sec7_dom,IPR011993:PH-like_dom_sf,IPR023394:Sec7_C_sf,IPR033742:IQSEC_PH,IPR035999:Sec7_dom_sf,	rno04144:Endocytosis,			SM00222:Sec7,		KW-0770~Synapse,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:IQ,DOMAIN:PH,DOMAIN:SEC7,REGION:Disordered,
P46940	IQ motif containing GTPase activating protein 1(IQGAP1)	Homo sapiens			GO:0001817~regulation of cytokine production,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007346~regulation of mitotic cell cycle,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010761~fibroblast migration,GO:0016477~cell migration,GO:0035305~negative regulation of dephosphorylation,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0043410~positive regulation of MAPK cascade,GO:0045860~positive regulation of protein kinase activity,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0071277~cellular response to calcium ion,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0072015~glomerular visceral epithelial cell development,GO:1903479~mitotic actomyosin contractile ring assembly actin filament organization,GO:1990138~neuron projection extension,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0009898~cytoplasmic side of plasma membrane,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0030424~axon,GO:0030426~growth cone,GO:0030496~midbody,GO:0030667~secretory granule membrane,GO:0030864~cortical actin cytoskeleton,GO:0036057~slit diaphragm,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0043005~neuron projection,GO:0070062~extracellular exosome,GO:1990904~ribonucleoprotein complex,	GO:0005078~MAP-kinase scaffold activity,GO:0005095~GTPase inhibitor activity,GO:0005096~GTPase activator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0031267~small GTPase binding,GO:0043539~protein serine/threonine kinase activator activity,GO:0044548~S100 protein binding,GO:0045296~cadherin binding,GO:0051015~actin filament binding,GO:0060090~binding, bridging,	IPR000048:IQ_motif_EF-hand-BS,IPR000593:RasGAP_C,IPR001202:WW_dom,IPR001715:CH_dom,IPR001936:RasGAP_dom,IPR008936:Rho_GTPase_activation_prot,IPR023152:RasGAP_CS,IPR027417:P-loop_NTPase,IPR036872:CH_dom_sf,	hsa04520:Adherens junction,hsa04810:Regulation of actin cytoskeleton,hsa05205:Proteoglycans in cancer,			SM00015:IQ,SM00033:CH,SM00323:RasGAP,SM00456:WW,	KW-0945~Host-virus interaction,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,		KW-0112~Calmodulin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Calponin-homology (CH),DOMAIN:IQ 1,DOMAIN:IQ 2,DOMAIN:IQ 3,DOMAIN:IQ 4,DOMAIN:Ras-GAP,DOMAIN:WW,MUTAGEN:S->A: Abolishes neurite outgrowth promoting activity; when associated with A-1441.,MUTAGEN:S->A: Abolishes neurite outgrowth promoting activity; when associated with A-1443.,MUTAGEN:S->D: Strongly enhances neurite outgrowth promoting activity; when associated with A-1441.,MUTAGEN:S->E: Strongly enhances neurite outgrowth promoting activity; when associated with A-1443.,REGION:C1,REGION:C2,REGION:Disordered,
Q922B9	ITPR interacting domain containing 2(Itprid2)	Mus musculus				GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005102~receptor binding,GO:0051015~actin filament binding,	IPR029325:ITPR-bd,IPR029326:SSFA2_C,IPR043444:TESPA1-like,				SM01257:KRAP_IP3R_bind,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:ITPR-interacting,REGION:Disordered,
P03988	Ig mu chain C region secreted form (IGHM_RABIT)	Oryctolagus cuniculus				GO:0005576~extracellular region,		IPR003006:Ig/MHC_CS,IPR003597:Ig_C1-set,IPR007110:Ig-like_dom,IPR013151:Immunoglobulin,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00407:IGc1,		KW-0964~Secreted,			KW-0393~Immunoglobulin domain,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (with heavy chain),DISULFID:Interchain (with light chain),REGION:CH1,REGION:CH2,REGION:CH3,REGION:CH4,
P0DOX7	Immunoglobulin kappa light chain (IGK_HUMAN)	Homo sapiens			GO:0002250~adaptive immune response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0019814~immunoglobulin complex,		IPR003006:Ig/MHC_CS,IPR003597:Ig_C1-set,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00406:IGv,SM00407:IGc1,SM00409:IG,	KW-0391~Immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,KW-1280~Immunoglobulin,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,			KW-1015~Disulfide bond,	DISULFID:Interchain (with a heavy chain),DOMAIN:Ig-like 1,DOMAIN:Ig-like 2,REGION:Constant (C) domain,REGION:Variable (V) domain, involved in antigen recognition,
P0DOX8	Immunoglobulin lambda-1 light chain (IGL1_HUMAN)	Homo sapiens			GO:0002250~adaptive immune response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0019814~immunoglobulin complex,		IPR003006:Ig/MHC_CS,IPR003597:Ig_C1-set,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00406:IGv,SM00407:IGc1,SM00409:IG,	KW-0391~Immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,KW-1280~Immunoglobulin,			KW-0393~Immunoglobulin domain,			KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	DISULFID:Interchain (with heavy chain),DOMAIN:Ig-like 1,DOMAIN:Ig-like 2,REGION:Constant (C) domain,REGION:Variable (V) domain, involved in antigen recognition,
P97812	Indian hedgehog(Ihh)	Mus musculus			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001569~branching involved in blood vessel morphogenesis,GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0001708~cell fate specification,GO:0001763~morphogenesis of a branching structure,GO:0001944~vasculature development,GO:0001947~heart looping,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002062~chondrocyte differentiation,GO:0003382~epithelial cell morphogenesis,GO:0003406~retinal pigment epithelium development,GO:0003413~chondrocyte differentiation involved in endochondral bone morphogenesis,GO:0006029~proteoglycan metabolic process,GO:0006508~proteolysis,GO:0007224~smoothened signaling pathway,GO:0007267~cell-cell signaling,GO:0007275~multicellular organism development,GO:0007389~pattern specification process,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009612~response to mechanical stimulus,GO:0009790~embryo development,GO:0009880~embryonic pattern specification,GO:0010468~regulation of gene expression,GO:0016539~intein-mediated protein splicing,GO:0016540~protein autoprocessing,GO:0030704~vitelline membrane formation,GO:0031016~pancreas development,GO:0032331~negative regulation of chondrocyte differentiation,GO:0032355~response to estradiol,GO:0032967~positive regulation of collagen biosynthetic process,GO:0033085~negative regulation of T cell differentiation in thymus,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0035264~multicellular organism growth,GO:0035988~chondrocyte proliferation,GO:0040008~regulation of growth,GO:0042733~embryonic digit morphogenesis,GO:0043010~camera-type eye development,GO:0043066~negative regulation of apoptotic process,GO:0045453~bone resorption,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046639~negative regulation of alpha-beta T cell differentiation,GO:0048074~negative regulation of eye pigmentation,GO:0048469~cell maturation,GO:0048513~animal organ development,GO:0048557~embryonic digestive tract morphogenesis,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048666~neuron development,GO:0048731~system development,GO:0048745~smooth muscle tissue development,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051216~cartilage development,GO:0060135~maternal process involved in female pregnancy,GO:0060220~camera-type eye photoreceptor cell fate commitment,GO:0060323~head morphogenesis,GO:0060350~endochondral bone morphogenesis,GO:0061053~somite development,GO:0072498~embryonic skeletal joint development,GO:0090136~epithelial cell-cell adhesion,GO:0097264~self proteolysis,GO:0097421~liver regeneration,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0005113~patched binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0016740~transferase activity,GO:0016787~hydrolase activity,GO:0034189~very-low-density lipoprotein particle binding,GO:0046872~metal ion binding,	IPR000320:Hedgehog_signalling_dom,IPR001657:Hedgehog,IPR001767:Hedgehog_Hint,IPR003586:Hint_dom_C,IPR003587:Hint_dom_N,IPR006141:Intein_N,IPR009045:Hedgehog_sig/DD-Pept_Zn-bd_sf,IPR036844:Hint_dom_sf,	mmu04340:Hedgehog signaling pathway,mmu05205:Proteoglycans in cancer,		PIRSF009400:Peptidase_C46,	SM00305:HintC,SM00306:HintN,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0378~Hydrolase,KW-0645~Protease,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0068~Autocatalytic cleavage,KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Hint,LIPID:Cholesterol glycine ester,LIPID:N-palmitoyl cysteine,REGION:Disordered,SITE:Cleavage; by autolysis,SITE:Essential for auto-cleavage,SITE:Involved in auto-cleavage,SITE:Involved in cholesterol transfer,
Q75R65	Janus kinase 2(JAK2)	Gallus gallus			GO:0006325~chromatin organization,GO:0007165~signal transduction,GO:0007259~JAK-STAT cascade,GO:0008284~positive regulation of cell proliferation,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0030097~hemopoiesis,GO:0030154~cell differentiation,GO:0030218~erythrocyte differentiation,GO:0035556~intracellular signal transduction,GO:0042976~activation of Janus kinase activity,GO:0042981~regulation of apoptotic process,GO:0043687~post-translational protein modification,GO:0046777~protein autophosphorylation,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0012505~endomembrane system,GO:0016020~membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005126~cytokine receptor binding,GO:0005131~growth hormone receptor binding,GO:0005524~ATP binding,GO:0020037~heme binding,GO:0035401~histone kinase activity (H3-Y41 specific),GO:0042393~histone binding,	IPR000299:FERM_domain,IPR000719:Prot_kinase_dom,IPR000980:SH2,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011993:PH-like_dom_sf,IPR016251:Tyr_kinase_non-rcpt_Jak/Tyk2,IPR017441:Protein_kinase_ATP_BS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR020635:Tyr_kinase_cat_dom,IPR020693:Tyr_kinase_non-rcpt_Jak2,IPR035588:PTK_Jak2_rpt1,IPR035589:PTKc_Jak2_rpt2,IPR035860:JAK2_SH2,IPR035963:FERM_2,IPR036860:SH2_dom_sf,IPR037838:JAK2_FERM_C-lobe,IPR041046:FERM_F2,IPR041155:FERM_F1,IPR041381:JAK1-3/TYK2_PHL_dom,	gga04148:Efferocytosis,gga04217:Necroptosis,gga04920:Adipocytokine signaling pathway,gga05164:Influenza A,gga05168:Herpes simplex virus 1 infection,		PIRSF000636:TyrPK_Jak,	SM00219:TyrKc,SM00252:SH2,SM00295:B41,		KW-0472~Membrane,KW-0539~Nucleus,			KW-0677~Repeat,KW-0727~SH2 domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0156~Chromatin regulator,KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:FERM,DOMAIN:Protein kinase,DOMAIN:Protein kinase 1,DOMAIN:Protein kinase 2,DOMAIN:SH2,DOMAIN:SH2; atypical,TRANSMEM:Helical,
O57607	K18, simple type I keratin(LOC100136778)	Oncorhynchus mykiss			GO:0045104~intermediate filament cytoskeleton organization,	GO:0005882~intermediate filament,GO:0045095~keratin filament,	GO:0005198~structural molecule activity,	IPR002957:Keratin_I,IPR018039:IF_conserved,IPR039008:IF_rod_dom,				SM01391:Filament,		KW-0403~Intermediate filament,KW-0416~Keratin,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	DOMAIN:IF rod,REGION:Coil 1A,REGION:Coil 1B,REGION:Coil 2,REGION:Disordered,REGION:Head,REGION:Linker 1,REGION:Linker 12,REGION:Tail,SITE:Stutter,
Q499B3	KAT8 regulatory NSL complex subunit 3(kansl3)	Danio rerio			GO:0006325~chromatin organization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0044545~NSL complex,		IPR026555:NSL3/Tex30,IPR029058:AB_hydrolase,IPR046879:KANL3/Tex30_Abhydrolase,						KW-0539~Nucleus,					KW-0156~Chromatin regulator,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:KANL3/Tex30 alpha/beta hydrolase-like,REGION:Disordered,
Q07666	KH RNA binding domain containing, signal transduction associated 1(KHDRBS1)	Homo sapiens		h_sam68Pathway:Regulation of Splicing through Sam68,	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0007283~spermatogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045948~positive regulation of translational initiation,GO:0046831~regulation of RNA export from nucleus,GO:0046833~positive regulation of RNA export from nucleus,GO:0050852~T cell receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0032991~macromolecular complex,GO:0070618~Grb2-Sos complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0035591~signaling adaptor activity,GO:0042169~SH2 domain binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:1990782~protein tyrosine kinase binding,	IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR032335:Sam68-YY,IPR032571:Qua1_dom,IPR036612:KH_dom_type_1_sf,IPR045071:BBP-like,				SM00322:KH,	KW-0131~Cell cycle,KW-0507~mRNA processing,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0729~SH3-binding,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:K Homology,DOMAIN:KH,MUTAGEN:E->A: Impairs homodimerization.,MUTAGEN:E->K: Disrupts interaction with APC.,MUTAGEN:F->S: Disrupts homodimerization, impairs influence on alternative splicing.,MUTAGEN:V->F: Disrupts binding to poly(A). Decreased binding to the BCL2L1 mRNA. Loss of function in BCL2L1 splicing. Changed nuclear localization.,MUTAGEN:Y->E: Fails to influence alternative splicing of CD44, NRXN2 and NRXN3.,MUTAGEN:Y->F: Completely blocks nuclear localization.,MUTAGEN:Y->F: No effect on the nuclear localization.,MUTAGEN:Y->K: Impairs interaction with APC.,MUTAGEN:Y->S: Impairs homodimerization.,REGION:Disordered,REGION:Interaction with HNRNPA1,REGION:Interaction with ZBTB7A,REGION:Involved in homodimerization,
Q6NZ18	KH domain containing 4, pre-mRNA splicing factor(khdc4)	Danio rerio			GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,	GO:0003723~RNA binding,	IPR031121:RIK/BLOM7,IPR036612:KH_dom_type_1_sf,IPR047889:KHDC4_KH-I_second,IPR047890:KHDC4_KH-I_first,					KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:KH 1,DOMAIN:KH 2,REGION:Disordered,REGION:Required for nuclear retention,
Q8JFR5	KIT proto-oncogene, receptor tyrosine kinase a(kita)	Danio rerio			GO:0002244~hematopoietic progenitor cell differentiation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007275~multicellular organism development,GO:0014831~gastro-intestinal system smooth muscle contraction,GO:0016310~phosphorylation,GO:0030154~cell differentiation,GO:0030183~B cell differentiation,GO:0030318~melanocyte differentiation,GO:0030335~positive regulation of cell migration,GO:0038093~Fc receptor signaling pathway,GO:0038109~Kit signaling pathway,GO:0043406~positive regulation of MAP kinase activity,GO:0043473~pigmentation,GO:0046427~positive regulation of JAK-STAT cascade,GO:0048066~developmental pigmentation,GO:0048865~stem cell fate commitment,GO:0097324~melanocyte migration,GO:1902362~melanocyte apoptotic process,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019838~growth factor binding,GO:0019955~cytokine binding,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001824:Tyr_kinase_rcpt_3_CS,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013783:Ig-like_fold,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR027263:SCGF_receptor,IPR036179:Ig-like_dom_sf,	dre04010:MAPK signaling pathway,dre04916:Melanogenesis,		PIRSF000615:TyrPK_CSF1-R,PIRSF500951:SCGF_recepter,	SM00219:TyrKc,SM00220:S_TKc,SM00408:IGc2,SM00409:IG,	KW-0221~Differentiation,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Protein kinase,REGION:Disordered,SITE:Important for interaction with phosphotyrosine-binding proteins,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8AXC6	KIT proto-oncogene, receptor tyrosine kinase a(kita)	Takifugu rubripes			GO:0006468~protein phosphorylation,GO:0007275~multicellular organism development,GO:0016310~phosphorylation,GO:0030183~B cell differentiation,GO:0030335~positive regulation of cell migration,GO:0038093~Fc receptor signaling pathway,GO:0038109~Kit signaling pathway,GO:0043406~positive regulation of MAP kinase activity,GO:0046427~positive regulation of JAK-STAT cascade,	GO:0005886~plasma membrane,GO:0043235~receptor complex,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0019955~cytokine binding,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001824:Tyr_kinase_rcpt_3_CS,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR027263:SCGF_receptor,IPR036179:Ig-like_dom_sf,	tru04010:MAPK signaling pathway,tru04916:Melanogenesis,		PIRSF000615:TyrPK_CSF1-R,PIRSF500951:SCGF_recepter,	SM00219:TyrKc,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Protein kinase,REGION:Disordered,SITE:Important for interaction with phosphotyrosine-binding proteins,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q13887	KLF transcription factor 5(KLF5)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001525~angiogenesis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0014816~skeletal muscle satellite cell differentiation,GO:0014901~satellite cell activation involved in skeletal muscle regeneration,GO:0014908~myotube differentiation involved in skeletal muscle regeneration,GO:0030033~microvillus assembly,GO:0032534~regulation of microvillus assembly,GO:0045600~positive regulation of fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060576~intestinal epithelial cell development,GO:0061586~positive regulation of transcription by transcription factor localization,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0043426~MRF binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,	hsa05207:Chemical carcinogenesis - receptor activation,			SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:C2H2-type,MOTIF:9aaTAD,MUTAGEN:Missing: Impairs ubiquitination and degradation.,REGION:Disordered,REGION:Interaction with WWP1,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,
Q8BJ66	Kazal-type serine peptidase inhibitor domain 1(Kazald1)	Mus musculus			GO:0001503~ossification,GO:0001558~regulation of cell growth,GO:0007275~multicellular organism development,GO:0009966~regulation of signal transduction,GO:0030154~cell differentiation,GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0005614~interstitial matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0005520~insulin-like growth factor binding,	IPR000867:IGFBP-like,IPR002350:Kazal_dom,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR011390:IGFBP_rP_mac25,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR036058:Kazal_dom_sf,IPR036179:Ig-like_dom_sf,			PIRSF018239:IGFBP_rP_mac25,	SM00280:KAZAL,SM00408:IGc2,SM00409:IG,	KW-0221~Differentiation,KW-0892~Osteogenesis,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0393~Immunoglobulin domain,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:IGFBP N-terminal,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:Kazal-like,REGION:Disordered,
P23276	Kell metallo-endopeptidase (Kell blood group)(KEL)	Homo sapiens			GO:0006508~proteolysis,GO:0006874~cellular calcium ion homeostasis,GO:0008361~regulation of cell size,GO:0010961~cellular magnesium ion homeostasis,GO:0016485~protein processing,GO:0031133~regulation of axon diameter,GO:0042310~vasoconstriction,GO:0042552~myelination,GO:0048741~skeletal muscle fiber development,GO:0051649~establishment of localization in cell,GO:0071805~potassium ion transmembrane transport,GO:1901380~negative regulation of potassium ion transmembrane transport,	GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000718:Peptidase_M13,IPR008753:Peptidase_M13_N,IPR018497:Peptidase_M13_C,IPR024079:MetalloPept_cat_dom_sf,IPR042089:Peptidase_M13_dom_2,		110900~Blood group, Kell,				KW-0472~Membrane,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0095~Blood group antigen,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:N-linked (GlcNAc...) asparagine; in KEL2 antigen,COMPBIAS:Basic and acidic residues,DISULFID:Interchain (with C-347 in XK),DOMAIN:Peptidase M13,DOMAIN:Peptidase M13 C-terminal,DOMAIN:Peptidase M13 N-terminal,MUTAGEN:C->S: Loss of Kell-XK complex.,MUTAGEN:C->S: No loss of Kell-XK complex.,MUTAGEN:E->G: Loss of catalytic activity.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q8K1S5	Kruppel-like transcription factor 11(Klf11)	Mus musculus			GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0008285~negative regulation of cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:1901653~cellular response to peptide,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016604~nuclear body,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0053~Apoptosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,		REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,
Q9EPW2	Kruppel-like transcription factor 15(Klf15)	Mus musculus			GO:0001678~cellular glucose homeostasis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010001~glial cell differentiation,GO:0010468~regulation of gene expression,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0030111~regulation of Wnt signaling pathway,GO:0032868~response to insulin,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046326~positive regulation of glucose import,GO:0072112~glomerular visceral epithelial cell differentiation,GO:1901653~cellular response to peptide,GO:2000757~negative regulation of peptidyl-lysine acetylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,		DOMAIN:C2H2-type,MOTIF:9aaTAD,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,
Q2KIR8	L-threonine dehydrogenase(TDH)	Bos taurus			GO:0006567~threonine catabolic process,GO:0019518~L-threonine catabolic process to glycine,	GO:0005739~mitochondrion,	GO:0008743~L-threonine 3-dehydrogenase activity,GO:0042802~identical protein binding,	IPR001509:Epimerase_deHydtase,IPR036291:NAD(P)-bd_dom_sf,	bta00260:Glycine, serine and threonine metabolism,bta01100:Metabolic pathways,					KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0520~NAD,	KW-0560~Oxidoreductase,		ACT_SITE:Proton donor/acceptor,DOMAIN:NAD-dependent epimerase/dehydratase,TRANSIT:Mitochondrion,
Q90478	L1 cell adhesion molecule, paralog b(l1camb)	Danio rerio			GO:0007155~cell adhesion,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007420~brain development,GO:0010628~positive regulation of gene expression,GO:0030154~cell differentiation,GO:0031103~axon regeneration,GO:0045773~positive regulation of axon extension,GO:0060536~cartilage morphogenesis,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0042995~cell projection,GO:0044295~axonal growth cone,	GO:0098632~protein binding involved in cell-cell adhesion,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013151:Immunoglobulin,IPR013783:Ig-like_fold,IPR026966:Neurofascin/L1/NrCAM_C,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q1JQD9	L3MBTL histone methyl-lysine binding protein 2(L3MBTL2)	Bos taurus			GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0035064~methylated histone binding,	IPR004092:Mbt,IPR012313:Znf_FCS,IPR038603:Znf_FCS_sf,IPR047356:MBT_L3MBTL2_rpt1,IPR047357:MBT_L3MBTL2_rpt2,	bta03083:Polycomb repressive complex,			SM00561:MBT,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0156~Chromatin regulator,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:FCS-type,REGION:Disordered,REPEAT:MBT,REPEAT:MBT 1,REPEAT:MBT 2,REPEAT:MBT 3,REPEAT:MBT 4,ZN_FING:FCS-type,
Q9NZR2	LDL receptor related protein 1B(LRP1B)	Homo sapiens			GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0015031~protein transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0005041~low-density lipoprotein receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000033:LDLR_classB_rpt,IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR002172:LDrepeatLR_classA_rpt,IPR009030:Growth_fac_rcpt_cys_sf,IPR011042:6-blade_b-propeller_TolB-like,IPR018097:EGF_Ca-bd_CS,IPR023415:LDLR_class-A_CS,IPR026823:cEGF,IPR032485:LRP1-like_beta_prop,IPR036055:LDL_receptor-like_sf,				SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	KW-0254~Endocytosis,	KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10,DOMAIN:EGF-like 11,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13,DOMAIN:EGF-like 14,DOMAIN:EGF-like 15,DOMAIN:EGF-like 16,DOMAIN:EGF-like 17,DOMAIN:EGF-like 18,DOMAIN:EGF-like 19,DOMAIN:EGF-like 20,DOMAIN:EGF-like 21,DOMAIN:EGF-like 22,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,DOMAIN:EGF-like 9,DOMAIN:LDL-receptor class A 1,DOMAIN:LDL-receptor class A 10,DOMAIN:LDL-receptor class A 11,DOMAIN:LDL-receptor class A 12,DOMAIN:LDL-receptor class A 13,DOMAIN:LDL-receptor class A 14,DOMAIN:LDL-receptor class A 15,DOMAIN:LDL-receptor class A 16,DOMAIN:LDL-receptor class A 17,DOMAIN:LDL-receptor class A 18,DOMAIN:LDL-receptor class A 19,DOMAIN:LDL-receptor class A 2,DOMAIN:LDL-receptor class A 20,DOMAIN:LDL-receptor class A 21,DOMAIN:LDL-receptor class A 22,DOMAIN:LDL-receptor class A 23,DOMAIN:LDL-receptor class A 24,DOMAIN:LDL-receptor class A 25,DOMAIN:LDL-receptor class A 26,DOMAIN:LDL-receptor class A 27,DOMAIN:LDL-receptor class A 28,DOMAIN:LDL-receptor class A 29,DOMAIN:LDL-receptor class A 3,DOMAIN:LDL-receptor class A 30,DOMAIN:LDL-receptor class A 31,DOMAIN:LDL-receptor class A 32,DOMAIN:LDL-receptor class A 4,DOMAIN:LDL-receptor class A 5,DOMAIN:LDL-receptor class A 6,DOMAIN:LDL-receptor class A 7,DOMAIN:LDL-receptor class A 8,DOMAIN:LDL-receptor class A 9,MOTIF:Endocytosis signal,REPEAT:LDL-receptor class B,REPEAT:LDL-receptor class B 1,REPEAT:LDL-receptor class B 10,REPEAT:LDL-receptor class B 11,REPEAT:LDL-receptor class B 12,REPEAT:LDL-receptor class B 13,REPEAT:LDL-receptor class B 14,REPEAT:LDL-receptor class B 15,REPEAT:LDL-receptor class B 16,REPEAT:LDL-receptor class B 17,REPEAT:LDL-receptor class B 19,REPEAT:LDL-receptor class B 2,REPEAT:LDL-receptor class B 20,REPEAT:LDL-receptor class B 21,REPEAT:LDL-receptor class B 22,REPEAT:LDL-receptor class B 23,REPEAT:LDL-receptor class B 24,REPEAT:LDL-receptor class B 25,REPEAT:LDL-receptor class B 26,REPEAT:LDL-receptor class B 27,REPEAT:LDL-receptor class B 28,REPEAT:LDL-receptor class B 29,REPEAT:LDL-receptor class B 3,REPEAT:LDL-receptor class B 30,REPEAT:LDL-receptor class B 31,REPEAT:LDL-receptor class B 32,REPEAT:LDL-receptor class B 33,REPEAT:LDL-receptor class B 34,REPEAT:LDL-receptor class B 4,REPEAT:LDL-receptor class B 5,REPEAT:LDL-receptor class B 6,REPEAT:LDL-receptor class B 7,REPEAT:LDL-receptor class B 8,REPEAT:LDL-receptor class B 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O75096	LDL receptor related protein 4(LRP4)	Homo sapiens			GO:0001822~kidney development,GO:0001942~hair follicle development,GO:0006897~endocytosis,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0009953~dorsal/ventral pattern formation,GO:0009954~proximal/distal pattern formation,GO:0016055~Wnt signaling pathway,GO:0030279~negative regulation of ossification,GO:0035022~positive regulation of Rac protein signal transduction,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042733~embryonic digit morphogenesis,GO:0048699~generation of neurons,GO:0048813~dendrite morphogenesis,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050771~negative regulation of axonogenesis,GO:0050808~synapse organization,GO:0051124~synaptic growth at neuromuscular junction,GO:0060173~limb development,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097104~postsynaptic membrane assembly,GO:0097105~presynaptic membrane assembly,GO:1901631~positive regulation of presynaptic membrane organization,GO:1904395~positive regulation of skeletal muscle acetylcholine-gated channel clustering,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0030425~dendrite,GO:0031594~neuromuscular junction,GO:0043025~neuronal cell body,GO:0044853~plasma membrane raft,GO:0097060~synaptic membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0030971~receptor tyrosine kinase binding,GO:0034185~apolipoprotein binding,GO:0042803~protein homodimerization activity,GO:0097110~scaffold protein binding,	IPR000033:LDLR_classB_rpt,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR002172:LDrepeatLR_classA_rpt,IPR009030:Growth_fac_rcpt_cys_sf,IPR011042:6-blade_b-propeller_TolB-like,IPR018097:EGF_Ca-bd_CS,IPR023415:LDLR_class-A_CS,IPR026823:cEGF,IPR036055:LDL_receptor-like_sf,		212780~Cenani-Lenz syndactyly syndrome,614305~Sclerosteosis 2,616304~Myasthenic syndrome, congenital, 17,		SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	KW-0221~Differentiation,KW-0254~Endocytosis,KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-1004~Congenital myasthenic syndrome,	KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EGF-like 1; calcium-binding,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3,DOMAIN:LDL-receptor class A 1,DOMAIN:LDL-receptor class A 2,DOMAIN:LDL-receptor class A 3,DOMAIN:LDL-receptor class A 4,DOMAIN:LDL-receptor class A 5,DOMAIN:LDL-receptor class A 6,DOMAIN:LDL-receptor class A 7,DOMAIN:LDL-receptor class A 8,MOTIF:Endocytosis signal,MUTAGEN:I->A: Compromises AGRN-mediated up-regulation of MUSK signaling.,MUTAGEN:N->A: Compromises Wnt-suppressive activity.,MUTAGEN:V->A: Compromises AGRN-mediated up-regulation of MUSK signaling.,MUTAGEN:Y->A: Compromises Wnt-suppressive activity.,REGION:Disordered,REPEAT:LDL-receptor class B 1,REPEAT:LDL-receptor class B 10,REPEAT:LDL-receptor class B 11,REPEAT:LDL-receptor class B 12,REPEAT:LDL-receptor class B 13,REPEAT:LDL-receptor class B 14,REPEAT:LDL-receptor class B 15,REPEAT:LDL-receptor class B 16,REPEAT:LDL-receptor class B 17,REPEAT:LDL-receptor class B 18,REPEAT:LDL-receptor class B 19,REPEAT:LDL-receptor class B 2,REPEAT:LDL-receptor class B 20,REPEAT:LDL-receptor class B 3,REPEAT:LDL-receptor class B 4,REPEAT:LDL-receptor class B 5,REPEAT:LDL-receptor class B 6,REPEAT:LDL-receptor class B 7,REPEAT:LDL-receptor class B 8,REPEAT:LDL-receptor class B 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O75197	LDL receptor related protein 5(LRP5)	Homo sapiens			GO:0001702~gastrulation with mouth forming second,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002076~osteoblast development,GO:0006007~glucose catabolic process,GO:0006865~amino acid transport,GO:0006897~endocytosis,GO:0008078~mesodermal cell migration,GO:0008203~cholesterol metabolic process,GO:0008217~regulation of blood pressure,GO:0008284~positive regulation of cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0010467~gene expression,GO:0033687~osteoblast proliferation,GO:0033690~positive regulation of osteoblast proliferation,GO:0035019~somatic stem cell population maintenance,GO:0035426~extracellular matrix-cell signaling,GO:0042074~cell migration involved in gastrulation,GO:0042632~cholesterol homeostasis,GO:0042733~embryonic digit morphogenesis,GO:0042981~regulation of apoptotic process,GO:0043434~response to peptide hormone,GO:0045600~positive regulation of fat cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045840~positive regulation of mitotic nuclear division,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046849~bone remodeling,GO:0048539~bone marrow development,GO:0060033~anatomical structure regression,GO:0060042~retina morphogenesis in camera-type eye,GO:0060070~canonical Wnt signaling pathway,GO:0060349~bone morphogenesis,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060612~adipose tissue development,GO:0060764~cell-cell signaling involved in mammary gland development,GO:0060856~establishment of blood-brain barrier,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0061304~retinal blood vessel morphogenesis,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:0098609~cell-cell adhesion,GO:1902262~apoptotic process involved in blood vessel morphogenesis,GO:1990963~establishment of blood-retinal barrier,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0043235~receptor complex,GO:1990851~Wnt-Frizzled-LRP5/6 complex,GO:1990909~Wnt signalosome,	GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0017147~Wnt-protein binding,GO:0042813~Wnt-activated receptor activity,	IPR000033:LDLR_classB_rpt,IPR000742:EGF-like_dom,IPR002172:LDrepeatLR_classA_rpt,IPR011042:6-blade_b-propeller_TolB-like,IPR017049:LRP5/6,IPR023415:LDLR_class-A_CS,IPR036055:LDL_receptor-like_sf,	hsa04150:mTOR signaling pathway,hsa04310:Wnt signaling pathway,hsa04928:Parathyroid hormone synthesis, secretion and action,hsa05010:Alzheimer disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05200:Pathways in cancer,hsa05224:Breast cancer,hsa05225:Hepatocellular carcinoma,hsa05226:Gastric cancer,	144750~Endosteal hyperostosis,259770~Osteoporosis-pseudoglioma syndrome,601813~Exudative vitreoretinopathy 4,601884~Bone mineral density variability 1,607634~Osteopetrosis, autosomal dominant 1,617875~Polycystic liver disease 4 with or without kidney cysts,	PIRSF036314:LDL_recpt-rel_p5/6,	SM00135:LY,SM00181:EGF,SM00192:LDLa,	KW-0254~Endocytosis,KW-0879~Wnt signaling pathway,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,KW-0987~Osteopetrosis,KW-1065~Osteogenesis imperfecta,	KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:LDL-receptor class A 1,DOMAIN:LDL-receptor class A 2,DOMAIN:LDL-receptor class A 3,MOTIF:PPPSP motif A,MOTIF:PPPSP motif B,MOTIF:PPPSP motif C,MOTIF:PPPSP motif D,MOTIF:PPPSP motif E,REGION:Beta-propeller 1,REGION:Beta-propeller 2,REGION:Beta-propeller 3,REGION:Beta-propeller 4,REGION:Disordered,REPEAT:LDL-receptor class B,REPEAT:LDL-receptor class B 1,REPEAT:LDL-receptor class B 10,REPEAT:LDL-receptor class B 11,REPEAT:LDL-receptor class B 12,REPEAT:LDL-receptor class B 13,REPEAT:LDL-receptor class B 14,REPEAT:LDL-receptor class B 15,REPEAT:LDL-receptor class B 16,REPEAT:LDL-receptor class B 17,REPEAT:LDL-receptor class B 18,REPEAT:LDL-receptor class B 19,REPEAT:LDL-receptor class B 2,REPEAT:LDL-receptor class B 20,REPEAT:LDL-receptor class B 3,REPEAT:LDL-receptor class B 4,REPEAT:LDL-receptor class B 5,REPEAT:LDL-receptor class B 6,REPEAT:LDL-receptor class B 7,REPEAT:LDL-receptor class B 8,REPEAT:LDL-receptor class B 9,REPEAT:YWTD 1,REPEAT:YWTD 10,REPEAT:YWTD 11,REPEAT:YWTD 2,REPEAT:YWTD 3,REPEAT:YWTD 4,REPEAT:YWTD 5,REPEAT:YWTD 6,REPEAT:YWTD 7,REPEAT:YWTD 8,REPEAT:YWTD 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8JHF2	LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase(lfng)	Danio rerio			GO:0007219~Notch signaling pathway,GO:0007389~pattern specification process,GO:0007399~nervous system development,GO:0008593~regulation of Notch signaling pathway,GO:0030154~cell differentiation,GO:0031101~fin regeneration,GO:0045665~negative regulation of neuron differentiation,GO:0055016~hypochord development,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0033829~O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,GO:0046872~metal ion binding,	IPR003378:Fringe-like,IPR017374:Fringe,	dre00514:Other types of O-glycan biosynthesis,dre04330:Notch signaling pathway,		PIRSF038073:B-acetylgalactosaminyltfrase,		KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0914~Notch signaling pathway,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0464~Manganese,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-0328~Glycosyltransferase,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,SITE:Cleavage; by furin-like protease,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q5XNR9	LIF receptor subunit alpha(LIFR)	Canis lupus dingo			GO:0008284~positive regulation of cell proliferation,GO:0019221~cytokine-mediated signaling pathway,GO:0038165~oncostatin-M-mediated signaling pathway,	GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0004896~cytokine receptor activity,GO:0004923~leukemia inhibitory factor receptor activity,GO:0004924~oncostatin-M receptor activity,GO:0005127~ciliary neurotrophic factor receptor binding,GO:0019838~growth factor binding,GO:0019955~cytokine binding,	IPR003529:Hematopoietin_rcpt_Gp130_CS,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR040817:LIFR_D2,IPR040901:LIFR_N,IPR048497:LIF-R-like_Ig-like,	clud04060:Cytokine-cytokine receptor interaction,clud04550:Signaling pathways regulating pluripotency of stem cells,clud04630:JAK-STAT signaling pathway,			SM00060:FN3,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,MOTIF:Box 1 motif,MOTIF:WSXWS motif,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5XNR9	LIF receptor subunit alpha(LIFR)	Canis lupus familiaris			GO:0008284~positive regulation of cell proliferation,GO:0019221~cytokine-mediated signaling pathway,GO:0038165~oncostatin-M-mediated signaling pathway,	GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0004896~cytokine receptor activity,GO:0004923~leukemia inhibitory factor receptor activity,GO:0004924~oncostatin-M receptor activity,GO:0005127~ciliary neurotrophic factor receptor binding,GO:0019838~growth factor binding,GO:0019955~cytokine binding,	IPR003529:Hematopoietin_rcpt_Gp130_CS,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR040817:LIFR_D2,IPR040901:LIFR_N,IPR048497:LIF-R-like_Ig-like,	cfa04060:Cytokine-cytokine receptor interaction,cfa04550:Signaling pathways regulating pluripotency of stem cells,cfa04630:JAK-STAT signaling pathway,			SM00060:FN3,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,MOTIF:Box 1 motif,MOTIF:WSXWS motif,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O77506	LIM and SH3 protein 1(LASP1)	Oryctolagus cuniculus			GO:0006811~ion transport,	GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0005938~cell cortex,	GO:0003779~actin binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,	IPR000900:Nebulin_repeat,IPR001452:SH3_domain,IPR001781:Znf_LIM,IPR035630:Lasp1_SH3,IPR036028:SH3-like_dom_sf,				SM00132:LIM,SM00227:NEBU,SM00326:SH3,	KW-0406~Ion transport,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0440~LIM domain,KW-0677~Repeat,KW-0728~SH3 domain,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:LIM zinc-binding,DOMAIN:SH3,REGION:Disordered,REPEAT:Nebulin 1,REPEAT:Nebulin 2,
Q8WWI1	LIM domain 7(LMO7)	Homo sapiens			GO:0016567~protein ubiquitination,GO:0023051~regulation of signaling,GO:0030155~regulation of cell adhesion,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016020~membrane,GO:0016324~apical plasma membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0042805~actinin binding,GO:0046872~metal ion binding,	IPR001478:PDZ,IPR001715:CH_dom,IPR001781:Znf_LIM,IPR003096:SM22_calponin,IPR029978:LMO-7,IPR031865:DUF4757,IPR036034:PDZ_sf,IPR036872:CH_dom_sf,	hsa04520:Adherens junction,			SM00033:CH,SM00132:LIM,SM00228:PDZ,		KW-0472~Membrane,			KW-0175~Coiled coil,KW-0440~LIM domain,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Calponin-homology (CH),DOMAIN:DUF4757,DOMAIN:LIM zinc-binding,DOMAIN:PDZ,REGION:Disordered,TRANSMEM:Helical,
Q8JFQ2	LIM domain only 1(lmo1)	Danio rerio			GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048513~animal organ development,	GO:0005634~nucleus,	GO:0003713~transcription coactivator activity,GO:0046872~metal ion binding,	IPR001781:Znf_LIM,				SM00132:LIM,		KW-0539~Nucleus,			KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,			DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,
Q6DJ06	LIM domain only 4, gene 1(lmo4.1)	Xenopus tropicalis			GO:0007369~gastrulation,GO:0007399~nervous system development,GO:0007498~mesoderm development,GO:0030154~cell differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,		GO:0003712~transcription cofactor activity,GO:0046872~metal ion binding,	IPR001781:Znf_LIM,IPR019381:Phosphofurin_acidic_CS-1,				SM00132:LIM,	KW-0221~Differentiation,KW-0306~Gastrulation,KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,				KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,REGION:Disordered,
Q1LWV4	LIM homeobox 9(lhx9)	Danio rerio			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0021794~thalamus development,GO:0030182~neuron differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048513~animal organ development,GO:0048665~neuron fate specification,GO:0097380~dorsal spinal cord interneuron anterior axon guidance,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001356:Homeobox_dom,IPR001781:Znf_LIM,IPR009057:Homeobox-like_sf,IPR017970:Homeobox_CS,				SM00132:LIM,SM00389:HOX,		KW-0539~Nucleus,			KW-0371~Homeobox,KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		COMPBIAS:Polar residues,DNA_BIND:Homeobox,DOMAIN:Homeobox,DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,REGION:Disordered,
Q15334	LLGL scribble cell polarity complex component 1(LLGL1)	Homo sapiens			GO:0006887~exocytosis,GO:0006893~Golgi to plasma membrane transport,GO:0007409~axonogenesis,GO:0008593~regulation of Notch signaling pathway,GO:0030866~cortical actin cytoskeleton organization,GO:0032878~regulation of establishment or maintenance of cell polarity,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0050708~regulation of protein secretion,GO:0051294~establishment of spindle orientation,GO:0065003~macromolecular complex assembly,	GO:0000137~Golgi cis cisterna,GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0030424~axon,GO:0030864~cortical actin cytoskeleton,GO:0031901~early endosome membrane,GO:0032588~trans-Golgi network membrane,	GO:0005096~GTPase activator activity,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0045159~myosin II binding,	IPR000664:Lethal2_giant,IPR001680:WD40_rpt,IPR013577:LLGL2,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR036322:WD40_repeat_dom_sf,	hsa04390:Hippo signaling pathway,hsa04530:Tight junction,hsa05165:Human papillomavirus infection,			SM00320:WD40,	KW-0268~Exocytosis,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0967~Endosome,			KW-0677~Repeat,KW-0853~WD repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Lethal giant larvae homologue 2,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 10,REPEAT:WD 11,REPEAT:WD 12,REPEAT:WD 13,REPEAT:WD 14,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,REPEAT:WD 8,REPEAT:WD 9,
D3YY23	LON peptidase N-terminal domain and ring finger 1(Lonrf1)	Mus musculus				GO:0005737~cytoplasm,	GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR003111:Lon_prtase_N,IPR011990:TPR-like_helical_dom_sf,IPR013083:Znf_RING/FYVE/PHD,IPR015947:PUA-like_sf,IPR017907:Znf_RING_CS,IPR019734:TPR_repeat,IPR046336:Lon_prtase_N_sf,				SM00028:TPR,SM00184:RING,SM00464:LON,					KW-0677~Repeat,KW-0802~TPR repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Lon N-terminal,DOMAIN:RING-type,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,ZN_FING:RING-type 1,ZN_FING:RING-type 2,
Q9Y608	LRR binding FLII interacting protein 2(LRRFIP2)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0016055~Wnt signaling pathway,		GO:0005515~protein binding,GO:0030275~LRR domain binding,	IPR019139:LRRFIP1/2,					KW-0879~Wnt signaling pathway,				KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MUTAGEN:S->A: No change in LPS-induced NFKB activity.,MUTAGEN:S->A: Reduction in LPS-induced NFKB activity.,MUTAGEN:S->E: No change in LPS-induced NFKB activity. Interacts with MYD88 in an LPS-inducible manner.,REGION:DVL3-binding,REGION:Disordered,
O15116	LSM1 homolog, mRNA degradation associated(LSM1)	Homo sapiens			GO:0000290~deadenylation-dependent decapping of nuclear-transcribed mRNA,GO:0000375~RNA splicing, via transesterification reactions,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0019827~stem cell population maintenance,GO:0030182~neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0071044~histone mRNA catabolic process,	GO:0000932~P-body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:1990124~messenger ribonucleoprotein complex,GO:1990726~Lsm1-7-Pat1 complex,	GO:0000339~RNA cap binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR034104:Lsm1,IPR044642:PTHR15588,IPR047575:Sm,	hsa03018:RNA degradation,			SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	DOMAIN:Sm,
P62311	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated(Lsm3)	Mus musculus			GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0033962~cytoplasmic mRNA processing body assembly,	GO:0000932~P-body,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071005~U2-type precatalytic spliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990726~Lsm1-7-Pat1 complex,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0030629~U6 snRNA 3'-end binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR034105:Lsm3,IPR040002:Sm-like_LSM3,IPR047575:Sm,	mmu03018:RNA degradation,mmu03040:Spliceosome,			SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,					KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,	DOMAIN:Sm,
Q5R628	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated(LSM5)	Pongo abelii			GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006402~mRNA catabolic process,GO:0008380~RNA splicing,GO:0009617~response to bacterium,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0005737~cytoplasm,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071005~U2-type precatalytic spliceosome,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0046982~protein heterodimerization activity,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR033871:LSm5,IPR047575:Sm,	pon03018:RNA degradation,pon03040:Spliceosome,			SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,					KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,	DOMAIN:Sm,REGION:Disordered,
Q9UK45	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated(LSM7)	Homo sapiens			GO:0000398~mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005688~U6 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005829~cytosol,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071004~U2-type prespliceosome,GO:0071005~U2-type precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017070~U6 snRNA binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR017132:Lsm7,IPR044641:Lsm7/SmG-like,IPR047575:Sm,	hsa03018:RNA degradation,hsa03040:Spliceosome,		PIRSF037188:U6_snRNA_Lsm7,	SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,					KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,	DOMAIN:Sm,
Q8WV07	LTO1 maturation factor of ABCE1(LTO1)	Homo sapiens			GO:0000723~telomere maintenance,GO:0006413~translational initiation,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,	GO:0005515~protein binding,	IPR019191:Essential_protein_Yae1_N,						KW-0539~Nucleus,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Essential protein Yae1 N-terminal,REGION:deca-GX3 motif; required for interaction with YAE1 and the CIA complex,
Q07014	LYN proto-oncogene, Src family tyrosine kinase(Lyn)	Rattus norvegicus			GO:0001782~B cell homeostasis,GO:0001817~regulation of cytokine production,GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002244~hematopoietic progenitor cell differentiation,GO:0002250~adaptive immune response,GO:0002431~Fc receptor mediated stimulatory signaling pathway,GO:0002513~tolerance induction to self antigen,GO:0002553~histamine secretion by mast cell,GO:0002576~platelet degranulation,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002774~Fc receptor mediated inhibitory signaling pathway,GO:0002902~regulation of B cell apoptotic process,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006991~response to sterol depletion,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009410~response to xenobiotic stimulus,GO:0009636~response to toxic substance,GO:0009725~response to hormone,GO:0009743~response to carbohydrate,GO:0010976~positive regulation of neuron projection development,GO:0014003~oligodendrocyte development,GO:0014070~response to organic cyclic compound,GO:0016310~phosphorylation,GO:0030097~hemopoiesis,GO:0030218~erythrocyte differentiation,GO:0030222~eosinophil differentiation,GO:0030335~positive regulation of cell migration,GO:0030889~negative regulation of B cell proliferation,GO:0031175~neuron projection development,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0031668~cellular response to extracellular stimulus,GO:0032868~response to insulin,GO:0033003~regulation of mast cell activation,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0034136~negative regulation of toll-like receptor 2 signaling pathway,GO:0034142~toll-like receptor 4 signaling pathway,GO:0034144~negative regulation of toll-like receptor 4 signaling pathway,GO:0034605~cellular response to heat,GO:0035556~intracellular signal transduction,GO:0038043~interleukin-5-mediated signaling pathway,GO:0038159~C-X-C chemokine receptor CXCR4 signaling pathway,GO:0042327~positive regulation of phosphorylation,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0043200~response to amino acid,GO:0043304~regulation of mast cell degranulation,GO:0043407~negative regulation of MAP kinase activity,GO:0043434~response to peptide hormone,GO:0045087~innate immune response,GO:0045646~regulation of erythrocyte differentiation,GO:0048678~response to axon injury,GO:0050727~regulation of inflammatory response,GO:0050853~B cell receptor signaling pathway,GO:0050855~regulation of B cell receptor signaling pathway,GO:0051279~regulation of release of sequestered calcium ion into cytosol,GO:0060252~positive regulation of glial cell proliferation,GO:0060369~positive regulation of Fc receptor mediated stimulatory signaling pathway,GO:0070304~positive regulation of stress-activated protein kinase signaling cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0070447~positive regulation of oligodendrocyte progenitor proliferation,GO:0070667~negative regulation of mast cell proliferation,GO:0070668~positive regulation of mast cell proliferation,GO:0071300~cellular response to retinoic acid,GO:0090025~regulation of monocyte chemotaxis,GO:0090330~regulation of platelet aggregation,GO:0097028~dendritic cell differentiation,GO:1902532~negative regulation of intracellular signal transduction,GO:2000670~positive regulation of dendritic cell apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0009898~cytoplasmic side of plasma membrane,GO:0009986~cell surface,GO:0030061~mitochondrial crista,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031966~mitochondrial membrane,GO:0032991~macromolecular complex,GO:0034666~integrin alpha2-beta1 complex,GO:0043231~intracellular membrane-bounded organelle,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0098978~glutamatergic synapse,GO:0099091~postsynaptic specialization, intracellular component,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005161~platelet-derived growth factor receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0017124~SH3 domain binding,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0043015~gamma-tubulin binding,GO:0043208~glycosphingolipid binding,GO:0044325~ion channel binding,GO:0044877~macromolecular complex binding,GO:0046875~ephrin receptor binding,GO:0051219~phosphoprotein binding,GO:0097110~scaffold protein binding,	IPR000719:Prot_kinase_dom,IPR000980:SH2,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001452:SH3_domain,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR035748:Lyn_SH3,IPR035852:Lyn_SH2,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,IPR043539:Grb2-like,	rno04062:Chemokine signaling pathway,rno04064:NF-kappa B signaling pathway,rno04611:Platelet activation,rno04662:B cell receptor signaling pathway,rno04664:Fc epsilon RI signaling pathway,rno04666:Fc gamma R-mediated phagocytosis,rno04730:Long-term depression,rno05167:Kaposi sarcoma-associated herpesvirus infection,rno05169:Epstein-Barr virus infection,rno05203:Viral carcinogenesis,rno05417:Lipid and atherosclerosis,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,KW-1064~Adaptive immunity,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0656~Proto-oncogene,	KW-0727~SH2 domain,KW-0728~SH3 domain,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0449~Lipoprotein,KW-0519~Myristate,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Protein kinase,DOMAIN:SH2,DOMAIN:SH3,LIPID:N-myristoyl glycine,LIPID:S-palmitoyl cysteine,REGION:Disordered,
B5X5U9	LYR motif containing 4(lyrm4)	Salmo salar			GO:0016226~iron-sulfur cluster assembly,	GO:0005739~mitochondrion,GO:0016020~membrane,GO:1990221~L-cysteine desulfurase complex,		IPR008011:Complex1_LYR_dom,IPR045297:Complex1_LYR_LYRM4,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:Complex 1 LYR protein,TRANSMEM:Helical,
Q71RC2	La ribonucleoprotein 4(LARP4)	Homo sapiens			GO:0006412~translation,GO:0007010~cytoskeleton organization,GO:0010608~posttranscriptional regulation of gene expression,GO:0022604~regulation of cell morphogenesis,GO:0045727~positive regulation of translation,	GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,	IPR006630:La_HTH,IPR034903:LARP4_RRM,IPR035979:RBD_domain_sf,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR045180:La_dom_prot,				SM00715:LA,	KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,					KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:HTH La-type RNA-binding,DOMAIN:RRM,MUTAGEN:L->A: Nearly abolishes interaction with PABPC1; when associated with A-22.,MUTAGEN:W->A: Nearly abolishes interaction with PABPC1; when associated with A-15.,REGION:Disordered,REGION:Interaction with PABPC1,REGION:Interaction with the poly-A tract of mRNA,
Q9NX58	Ly1 antibody reactive(LYAR)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006364~rRNA processing,GO:0045087~innate immune response,GO:0045824~negative regulation of innate immune response,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:0048821~erythrocyte development,GO:0050766~positive regulation of phagocytosis,	GO:0001750~photoreceptor outer segment,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR014898:Znf_C2H2_LYAR,IPR036236:Znf_C2H2_sf,IPR039999:LYAR,IPR041010:Znf-ACC,					KW-0391~Immunity,KW-0399~Innate immunity,KW-0698~rRNA processing,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Acetyl-coA carboxylase zinc finger,DOMAIN:Zinc finger C2H2 LYAR-type,MUTAGEN:Missing: Decreases the production of 28S rRNA and the formation of pre-60S particle.,REGION:Disordered,ZN_FING:C2HC LYAR-type 1,ZN_FING:C2HC LYAR-type 2,
Q9D1Q1	M phase phosphoprotein 6(Mphosph6)	Mus musculus			GO:0000460~maturation of 5.8S rRNA,GO:0006364~rRNA processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003723~RNA binding,	IPR019324:MPP6,	mmu03018:RNA degradation,				KW-0698~rRNA processing,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MOTIF:Nuclear localization signal,
Q15013	MAD2L1 binding protein(MAD2L1BP)	Homo sapiens			GO:0007096~regulation of exit from mitosis,GO:1902426~deactivation of mitotic spindle assembly checkpoint,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0031965~nuclear membrane,	GO:0005515~protein binding,	IPR009511:MAD1/Cdc20-bound-Mad2-bd,	hsa04110:Cell cycle,					KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,	MUTAGEN:F->A: Loss of interaction with MAD2L1 and disruption of ability to overcome spindle checkpoint-dependent mitotic arrest; when associated with A-83.,MUTAGEN:Q->A: Loss of interaction with MAD2L1 and disruption of ability to overcome spindle checkpoint-dependent mitotic arrest; when associated with A-191.,REGION:Interaction with MAD2L1,
Q98UK5	MAF bZIP transcription factor Ba(mafba)	Danio rerio			GO:0001946~lymphangiogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009880~embryonic pattern specification,GO:0009952~anterior/posterior pattern specification,GO:0021571~rhombomere 5 development,GO:0021572~rhombomere 6 development,GO:0021654~rhombomere boundary formation,GO:0021742~abducens nucleus development,GO:0039021~pronephric glomerulus development,GO:0046548~retinal rod cell development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR004826:bZIP_Maf,IPR004827:bZIP,IPR008917:TF_DNA-bd_sf,IPR013592:Maf_TF_N,IPR024874:Transcription_factor_Maf_fam,IPR046347:bZIP_sf,				SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
Q9UDY8	MALT1 paracaspase(MALT1)	Homo sapiens			GO:0001923~B-1 B cell differentiation,GO:0002726~positive regulation of T cell cytokine production,GO:0006508~proteolysis,GO:0006952~defense response,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0009620~response to fungus,GO:0031398~positive regulation of protein ubiquitination,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032743~positive regulation of interleukin-2 production,GO:0042098~T cell proliferation,GO:0042113~B cell activation,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045087~innate immune response,GO:0050852~T cell receptor signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051168~nuclear export,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:2000321~positive regulation of T-helper 17 cell differentiation,	GO:0001650~fibrillar center,GO:0002096~polkadots,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032449~CBM complex,GO:0032991~macromolecular complex,GO:0048471~perinuclear region of cytoplasm,	GO:0002020~protease binding,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0019209~kinase activator activity,GO:0036094~small molecule binding,GO:0042802~identical protein binding,GO:0043621~protein self-association,	IPR001309:Pept_C14_p20,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR011029:DEATH-like_dom_sf,IPR011600:Pept_C14_caspase,IPR013783:Ig-like_fold,IPR029030:Caspase-like_dom_sf,IPR033540:MALT1_IG-like_dom_sf,IPR036179:Ig-like_dom_sf,IPR037940:MALT1_Death,IPR041077:MALT1_Ig,	hsa04064:NF-kappa B signaling pathway,hsa04625:C-type lectin receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa05131:Shigellosis,hsa05152:Tuberculosis,	615468~Immunodeficiency 12,		SM00408:IGc2,SM00409:IG,	KW-0391~Immunity,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0393~Immunoglobulin domain,KW-0677~Repeat,		KW-0378~Hydrolase,KW-0645~Protease,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DOMAIN:Caspase family p20,DOMAIN:Death,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,MOTIF:Nuclear export signal,MUTAGEN:C->A: Slight decrease in NF-kappa-B activation.,MUTAGEN:E->A: Abolishes binding to TRAF6.,REGION:Caspase-like,REGION:Disordered,SITE:Breakpoint for translocation to form BIRC2-MALT1,
Q16644	MAPK activated protein kinase 3(MAPKAPK3)	Homo sapiens		h_hsp27Pathway:Stress Induction of HSP Regulation,h_mapkPathway:MAPKinase Signaling Pathway,	GO:0000165~MAPK cascade,GO:0002224~toll-like receptor signaling pathway,GO:0007165~signal transduction,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032496~response to lipopolysaccharide,GO:0034097~response to cytokine,GO:0035556~intracellular signal transduction,GO:0044351~macropinocytosis,GO:0046777~protein autophosphorylation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0050896~response to stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0004708~MAP kinase kinase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0009931~calcium-dependent protein serine/threonine kinase activity,GO:0051019~mitogen-activated protein kinase binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR027442:MAPKAPK_C,	hsa04010:MAPK signaling pathway,hsa04370:VEGF signaling pathway,	617111~Macular dystrophy, patterned, 3,		SM00220:S_TKc,		KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,MOTIF:Bipartite nuclear localization signal 1,MOTIF:Bipartite nuclear localization signal 2,MOTIF:Nuclear export signal (NES),MUTAGEN:K->M: Higher affinity toward PCH2.,REGION:Autoinhibitory helix,REGION:Disordered,REGION:p38 MAPK-binding site,
Q66H84	MAPK activated protein kinase 3(Mapkapk3)	Rattus norvegicus			GO:0002224~toll-like receptor signaling pathway,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032496~response to lipopolysaccharide,GO:0034097~response to cytokine,GO:0035556~intracellular signal transduction,GO:0044351~macropinocytosis,GO:0046777~protein autophosphorylation,GO:0050896~response to stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0009931~calcium-dependent protein serine/threonine kinase activity,GO:0051019~mitogen-activated protein kinase binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR027442:MAPKAPK_C,	rno04010:MAPK signaling pathway,rno04370:VEGF signaling pathway,			SM00220:S_TKc,		KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,MOTIF:Bipartite nuclear localization signal 1,MOTIF:Bipartite nuclear localization signal 2,MOTIF:Nuclear export signal (NES),REGION:Autoinhibitory helix,REGION:Disordered,REGION:p38 MAPK-binding site,
Q0II70	MAPK regulated corepressor interacting protein 2(MCRIP2)	Bos taurus				GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,		IPR029428:MCRIP,						KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,REGION:Disordered,
B4ZIX8	MAU2, sister chromatid cohesion factor S homeolog(mau2.S)	Xenopus laevis			GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007064~mitotic sister chromatid cohesion,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0051301~cell division,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032116~SMC loading complex,GO:0090694~Scc2-Scc4 cohesin loading complex,	GO:0005515~protein binding,	IPR011990:TPR-like_helical_dom_sf,IPR019440:MAU2,	xla04110:Cell cycle,				KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0802~TPR repeat,				REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,
Q7SX95	MAX dimerization protein 3(mxd3)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046983~protein dimerization activity,	IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,				SM00353:HLH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0238~DNA-binding,KW-0678~Repressor,		DOMAIN:BHLH,DOMAIN:bHLH,REGION:Disordered,
Q8CHN8	MBL associated serine protease 1(Masp1)	Rattus norvegicus			GO:0001867~complement activation, lectin pathway,GO:0006508~proteolysis,GO:0006956~complement activation,GO:0031638~zymogen activation,GO:0045087~innate immune response,GO:0045916~negative regulation of complement activation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0048306~calcium-dependent protein binding,	IPR000436:Sushi_SCR_CCP_dom,IPR000742:EGF-like_dom,IPR000859:CUB_dom,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR001881:EGF-like_Ca-bd_dom,IPR009003:Peptidase_S1_PA,IPR018097:EGF_Ca-bd_CS,IPR018114:TRYPSIN_HIS,IPR024175:Pept_S1A_C1r/C1S/mannan-bd,IPR033116:TRYPSIN_SER,IPR035914:Sperma_CUB_dom_sf,IPR035976:Sushi/SCR/CCP_sf,IPR043504:Peptidase_S1_PA_chymotrypsin,	rno04610:Complement and coagulation cascades,rno05150:Staphylococcus aureus infection,rno05171:Coronavirus disease - COVID-19,		PIRSF001155:C1r_C1s_MASP,	SM00020:Tryp_SPc,SM00032:CCP,SM00042:CUB,SM00179:EGF_CA,	KW-0391~Immunity,KW-0399~Innate immunity,KW-1018~Complement activation lectin pathway,	KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0068~Autocatalytic cleavage,KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between heavy and light chains),DOMAIN:CUB,DOMAIN:CUB 1,DOMAIN:CUB 2,DOMAIN:EGF-like; calcium-binding,DOMAIN:Peptidase S1,DOMAIN:Sushi,DOMAIN:Sushi 1,DOMAIN:Sushi 2,MUTAGEN:S->A: Prevents protease self-activation through proteolytic cleavage into heavy and light chain.,REGION:Homodimerization,REGION:Interaction with FCN2,REGION:Interaction with MBL1,REGION:Interaction with MBL2,SITE:Cleavage; by autolysis,
O15068	MCF.2 cell line derived transforming sequence like(MCF2L)	Homo sapiens			GO:0035025~positive regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0019898~extrinsic component of membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0035091~phosphatidylinositol binding,	IPR000219:DH-domain,IPR001251:CRAL-TRIO_dom,IPR001331:GDS_CDC24_CS,IPR001452:SH3_domain,IPR001849:PH_domain,IPR002017:Spectrin_repeat,IPR011993:PH-like_dom_sf,IPR018159:Spectrin/alpha-actinin,IPR035532:DBS_SH3,IPR035534:DBS_PH,IPR035899:DBL_dom_sf,IPR036028:SH3-like_dom_sf,IPR036865:CRAL-TRIO_dom_sf,				SM00150:SPEC,SM00233:PH,SM00325:RhoGEF,SM00326:SH3,SM00516:SEC14,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0656~Proto-oncogene,	KW-0175~Coiled coil,KW-0728~SH3 domain,KW-0732~Signal,	KW-0446~Lipid-binding,	KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CRAL-TRIO,DOMAIN:DH,DOMAIN:PH,DOMAIN:SH3,REGION:Disordered,REPEAT:Spectrin,
Q0P4G8	MDM2 binding protein(mtbp)	Xenopus tropicalis			GO:0007049~cell cycle,GO:0007089~traversing start control point of mitotic cell cycle,GO:0031396~regulation of protein ubiquitination,GO:0034501~protein localization to kinetochore,GO:0051726~regulation of cell cycle,	GO:0000776~kinetochore,		IPR029418:MTBP_C,IPR029420:MTBP_central,IPR029421:MTBP_N,IPR039061:MTBP,	xtr04110:Cell cycle,				KW-0131~Cell cycle,KW-0338~Growth arrest,KW-0833~Ubl conjugation pathway,								COMPBIAS:Polar residues,DOMAIN:DM2,DOMAIN:MDN2-binding protein C-terminal,REGION:Disordered,
Q6ZN28	MET transcriptional regulator MACC1(MACC1)	Homo sapiens			GO:0007165~signal transduction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051781~positive regulation of cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0008083~growth factor activity,	IPR000906:ZU5_dom,IPR001452:SH3_domain,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0728~SH3 domain,		KW-0010~Activator,KW-0339~Growth factor,KW-0497~Mitogen,	KW-0597~Phosphoprotein,	DOMAIN:SH3,DOMAIN:ZU5,
Q5YB40	MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase(mfng)	Danio rerio			GO:0007389~pattern specification process,GO:0008593~regulation of Notch signaling pathway,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0033829~O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,GO:0046872~metal ion binding,	IPR003378:Fringe-like,IPR017374:Fringe,	dre00514:Other types of O-glycan biosynthesis,dre04330:Notch signaling pathway,		PIRSF038073:B-acetylgalactosaminyltfrase,			KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0464~Manganese,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-0328~Glycosyltransferase,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q6DEJ6	MFSD2 lysolipid transporter A, lysophospholipid b(mfsd2ab)	Danio rerio			GO:0006869~lipid transport,GO:0008643~carbohydrate transport,GO:0015908~fatty acid transport,GO:0045056~transcytosis,GO:0051977~lysophospholipid transport,GO:0060856~establishment of blood-brain barrier,GO:0071702~organic substance transport,GO:1990379~lipid transport across blood brain barrier,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0015245~fatty acid transporter activity,GO:0015293~symporter activity,GO:0051978~lysophospholipid transporter activity,	IPR036259:MFS_trans_sf,IPR039672:MFS_2,					KW-0445~Lipid transport,KW-0769~Symport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
D3ZEN0	MICAL-like 2(Micall2)	Rattus norvegicus			GO:0016043~cellular component organization,GO:0030036~actin cytoskeleton organization,GO:0030041~actin filament polymerization,GO:0031175~neuron projection development,GO:0032456~endocytic recycling,GO:0034446~substrate adhesion-dependent cell spreading,GO:0070830~bicellular tight junction assembly,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0032432~actin filament bundle,GO:0043005~neuron projection,GO:0055037~recycling endosome,	GO:0031005~filamin binding,GO:0031267~small GTPase binding,GO:0042805~actinin binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,	IPR001715:CH_dom,IPR001781:Znf_LIM,IPR022735:bMERB_dom,IPR036872:CH_dom_sf,	rno04530:Tight junction,			SM00033:CH,SM00132:LIM,SM01203:DUF3585,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0796~Tight junction,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0440~LIM domain,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BMERB,DOMAIN:Calponin-homology (CH),DOMAIN:LIM zinc-binding,DOMAIN:bMERB,REGION:Disordered,REGION:Forms an intramolecular interaction with the C-terminal coiled coil domain keeping the protein in a closed conformation,REGION:Forms an intramolecular interaction with the N-terminal Calponin-homology and LIM zinc-binding domains-containing region keeping the protein in a closed conformation,REGION:Mediates interaction with RAB13 and is required for transition from the closed to the open conformation,REGION:Mediates targeting to the cell plasma membrane,REGION:Necessary and sufficient for interaction with actinins,
Q8AWD1	MID1 interacting protein 1, like(mid1ip1l)	Danio rerio			GO:0046890~regulation of lipid biosynthetic process,GO:0051493~regulation of cytoskeleton organization,GO:2000197~regulation of ribonucleoprotein complex localization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,		IPR009786:Spot_14,						KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,							COMPBIAS:Polar residues,REGION:Disordered,
Q1LUV9	MID1 interacting protein 1b(mid1ip1b)	Danio rerio			GO:0046890~regulation of lipid biosynthetic process,GO:0061842~microtubule organizing center localization,GO:0072175~epithelial tube formation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,		IPR009786:Spot_14,						KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,
Q3UQI9	MINDY lysine 48 deubiquitinase 4(Mindy4)	Mus musculus			GO:0006508~proteolysis,GO:0071108~protein K48-linked deubiquitination,		GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,GO:1990380~Lys48-specific deubiquitinase activity,	IPR025257:MINDY-3/4_CD,IPR039785:MINY3/4,				SM01174:DUF4205,	KW-0833~Ubl conjugation pathway,						KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Deubiquitinating enzyme MINDY-3/4 conserved,REGION:Disordered,
Q1T769	MIS12, kinetochore complex component(MIS12)	Gallus gallus			GO:0000070~mitotic sister chromatid segregation,GO:0000278~mitotic cell cycle,GO:0007059~chromosome segregation,GO:0034501~protein localization to kinetochore,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0051382~kinetochore assembly,	GO:0000444~MIS12/MIND type complex,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,		IPR008685:Centromere_Mis12,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0995~Kinetochore,			KW-0175~Coiled coil,
Q6P0N0	MIS18 binding protein 1(MIS18BP1)	Homo sapiens			GO:0007049~cell cycle,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001005:SANT/Myb,IPR009057:Homeobox-like_sf,IPR015216:SANTA,IPR017884:SANT_dom,IPR039110:KNL2-like,				SM00717:SANT,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,					KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:SANT,DOMAIN:SANTA,REGION:Disordered,
Q3T1J9	MOB kinase activator 1A(Mob1a)	Rattus norvegicus			GO:0001934~positive regulation of protein phosphorylation,GO:0035329~hippo signaling,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0030295~protein kinase activator activity,GO:0046872~metal ion binding,	IPR005301:MOB_kinase_act_fam,IPR036703:MOB_kinase_act_sf,	rno04390:Hippo signaling pathway,rno04392:Hippo signaling pathway - multiple species,			SM01388:Mob1_phocein,						KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,KW-0597~Phosphoprotein,
Q9Y6X9	MORC family CW-type zinc finger 2(MORC2)	Homo sapiens			GO:0006338~chromatin remodeling,GO:0006631~fatty acid metabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0090309~positive regulation of methylation-dependent chromatin silencing,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016363~nuclear matrix,	GO:0000287~magnesium ion binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016887~ATPase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR011124:Znf_CW,IPR036890:HATPase_C_sf,IPR041006:Morc_S5,		616688~Charcot-Marie-Tooth disease, axonal, type 2Z,619090~Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy,			KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0144~Charcot-Marie-Tooth disease,KW-0225~Disease variant,KW-0242~Dwarfism,KW-0523~Neurodegeneration,KW-0622~Neuropathy,KW-0991~Intellectual disability,	KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MUTAGEN:D->A: Loss of ATP-binding and ATPase activity. Loss of binding to ATP and ATPase activity; when associated with A-69. Prevents chromatin remodeling.,MUTAGEN:D->A: No effect on binding to ATP and ATPase activity; when associated with A-68.,MUTAGEN:N->A: Loss of ATP-binding and ATPase activity. Does not homodimerizes. Seems to abolish chromatin compaction.,MUTAGEN:R->A: Increases HUSH-dependent gene silencing.,MUTAGEN:R->E: Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity; when associated with E-326 and E-329.,MUTAGEN:R->E: Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity; when associated with E-326 and E-333.,MUTAGEN:R->E: Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity; when associated with E-329 and E-333.,MUTAGEN:R->E: No effect on HUSH-dependent gene silencing.,MUTAGEN:S->A: Abolishes phosphorylation by PAK1. Not recruited on damaged chromatin. Loss of ATPase activity. Prevents chromatin remodeling. Upon irradiation, increases levels of damaged DNA.,MUTAGEN:S->A: No effect on phosphorylation by PAK1.,MUTAGEN:Y->A: Abolishes homodimerization. No effect on ATPase activity. Loss of HUSH-dependent gene silencing.,REGION:Disordered,ZN_FING:CW-type,
Q803V5	MTOR associated protein, LST8 homolog (S. cerevisiae)(mlst8)	Danio rerio			GO:0031929~TOR signaling,GO:0032956~regulation of actin cytoskeleton organization,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0031931~TORC1 complex,GO:0031932~TORC2 complex,		IPR001680:WD40_rpt,IPR011047:Quinoprotein_ADH-like_supfam,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR037588:MLST8,	dre04136:Autophagy - other,dre04140:Autophagy - animal,dre04150:mTOR signaling pathway,			SM00320:WD40,		KW-0458~Lysosome,KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0853~WD repeat,				REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q6P9S0	MTSS I-BAR domain containing 2(Mtss2)	Mus musculus			GO:0007009~plasma membrane organization,GO:0030031~cell projection assembly,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0061024~membrane organization,GO:0090630~activation of GTPase activity,GO:0097581~lamellipodium organization,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,GO:0030864~cortical actin cytoskeleton,GO:0032587~ruffle membrane,GO:0042995~cell projection,	GO:0003779~actin binding,GO:0003785~actin monomer binding,GO:0005096~GTPase activator activity,GO:0005543~phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0031267~small GTPase binding,	IPR013606:I-BAR_dom,IPR027267:AH/BAR_dom_sf,IPR030127:MTSS1/MTSS2,						KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:IMD,DOMAIN:WH2,REGION:Disordered,
Q03237	MYB proto-oncogene like 2(MYBL2)	Gallus gallus			GO:0000278~mitotic cell cycle,GO:0006355~regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,	IPR001005:SANT/Myb,IPR009057:Homeobox-like_sf,IPR015395:C-myb_C,IPR017930:Myb_dom,	gga04218:Cellular senescence,			SM00717:SANT,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0238~DNA-binding,		COMPBIAS:Polar residues,DNA_BIND:H-T-H motif,DOMAIN:HTH myb-type,DOMAIN:HTH myb-type 1,DOMAIN:HTH myb-type 2,DOMAIN:HTH myb-type 3,DOMAIN:Myb-like,REGION:Disordered,
Q7TPH6	MYC binding protein 2, E3 ubiquitin protein ligase(Mycbp2)	Mus musculus			GO:0007411~axon guidance,GO:0008045~motor neuron axon guidance,GO:0008582~regulation of synaptic growth at neuromuscular junction,GO:0016567~protein ubiquitination,GO:0021785~branchiomotor neuron axon guidance,GO:0021952~central nervous system projection neuron axonogenesis,GO:0031398~positive regulation of protein ubiquitination,GO:0032880~regulation of protein localization,GO:0032922~circadian regulation of gene expression,GO:0042177~negative regulation of protein catabolic process,GO:0048511~rhythmic process,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0050905~neuromuscular process,GO:0051493~regulation of cytoskeleton organization,GO:0070936~protein K48-linked ubiquitination,GO:1902667~regulation of axon guidance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,GO:0030424~axon,GO:0042995~cell projection,GO:0043231~intracellular membrane-bounded organelle,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000408:Reg_chr_condens,IPR001841:Znf_RING,IPR004939:APC_su10/DOC_dom,IPR008979:Galactose-bd-like_sf,IPR009091:RCC1/BLIP-II,IPR012983:PHR,IPR013083:Znf_RING/FYVE/PHD,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR017868:Filamin/ABP280_repeat-like,IPR038648:PHR_sf,				SM00184:RING,SM01337:APC10,	KW-0090~Biological rhythms,KW-0833~Ubl conjugation pathway,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0344~Guanine-nucleotide releasing factor,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DOC,DOMAIN:RING-type,MUTAGEN:HH->AA: Abolished guanosine exchange factor (GEF) activity for Ran.,REGION:Disordered,REGION:PHR domain 1,REGION:PHR domain 2,REGION:RAE1 binding,REGION:Tandem cysteine domain,REPEAT:Filamin,REPEAT:RCC1,REPEAT:RCC1 1,REPEAT:RCC1 2,REPEAT:RCC1 3,REPEAT:RCC1 4,REPEAT:RCC1 5,SITE:Important for catalysis,ZN_FING:RING-type; atypical,
O14770	Meis homeobox 2(MEIS2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001654~eye development,GO:0006355~regulation of transcription, DNA-templated,GO:0007420~brain development,GO:0008284~positive regulation of cell proliferation,GO:0008542~visual learning,GO:0009612~response to mechanical stimulus,GO:0009880~embryonic pattern specification,GO:0009887~animal organ morphogenesis,GO:0031016~pancreas development,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045931~positive regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070848~response to growth factor,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0048471~perinuclear region of cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR001356:Homeobox_dom,IPR008422:Homeobox_KN_domain,IPR009057:Homeobox-like_sf,IPR032453:PKNOX/Meis_N,		600987~Cleft palate, cardiac defects, and impaired intellectual development,		SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0371~Homeobox,		KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DNA_BIND:Homeobox,DNA_BIND:Homeobox; TALE-type,DOMAIN:Homeobox,DOMAIN:MEIS N-terminal,MUTAGEN:EKCE->NNGT: Impairs interaction with PBX1.,MUTAGEN:I->A: Impairs interaction with PBX1; when associated with A-154.,MUTAGEN:L->A: Impairs interaction with PBX1; when associated with 158-A-A-159.,MUTAGEN:L->A: Impairs interaction with PBX1; when associated with A-151.,MUTAGEN:L->A: Impairs interaction with PBX1; when associated with A-85. HELIX 285 297.,MUTAGEN:L->A: Impairs interaction with PBX1; when associated with A-88.,MUTAGEN:LL->AA: Impairs interaction with PBX1; when associated with A-161.,MUTAGEN:R->M: Impairs DNA binding and PBX1-dependent transcriptional activation. No effect on interaction with PBX1.,REGION:Disordered,REGION:Interaction with DNA,REGION:Required for interaction with PBX1,REGION:Transcriptional activation domain,
Q5RGJ8	N-acetylglucosamine-1-phosphate transferase subunits alpha and beta(gnptab)	Danio rerio			GO:0002063~chondrocyte development,GO:0007040~lysosome organization,GO:0016256~N-glycan processing to lysosome,GO:0046835~carbohydrate phosphorylation,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048703~embryonic viscerocranium morphogenesis,GO:0051216~cartilage development,GO:0060348~bone development,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0003976~UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,GO:0005509~calcium ion binding,GO:0016740~transferase activity,GO:0016772~transferase activity, transferring phosphorus-containing groups,GO:0046872~metal ion binding,	IPR000800:Notch_dom,IPR002048:EF_hand_dom,IPR010506:DMAP1-bd,IPR018247:EF_Hand_1_Ca_BS,IPR021520:Stealth_CR2,IPR031356:Stealth_CR4,IPR031357:Stealth_CR3,IPR031358:Stealth_CR1,IPR035993:Notch-like_dom_sf,IPR041536:GNPTAB_reg,IPR047141:Stealth,	dre04142:Lysosome,			SM00004:NL,SM01137:DMAP_binding,		KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:DMAP1-binding,DOMAIN:EF-hand,DOMAIN:LNR,MUTAGEN:C->S: Partial loss of function due to loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity toward some substrates.,MUTAGEN:C->Y: Partial loss of function due to loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity toward some substrates.,MUTAGEN:K->N: Loss of function due to loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity.,REGION:Disordered,REPEAT:LNR 1,REPEAT:LNR 2,SITE:Cleavage; by mbtps1,TRANSMEM:Helical,
P13913	N-acetyltransferase, pineal gland isozyme NAT-10(PNAT10)	Gallus gallus					GO:0004060~arylamine N-acetyltransferase activity,GO:0016407~acetyltransferase activity,	IPR001447:Arylamine_N-AcTrfase,IPR038765:Papain-like_cys_pep_sf,	gga00232:Caffeine metabolism,gga00983:Drug metabolism - other enzymes,gga01100:Metabolic pathways,										KW-0012~Acyltransferase,KW-0808~Transferase,		ACT_SITE:Acyl-thioester intermediate,
Q6IQ20	N-acyl phosphatidylethanolamine phospholipase D(NAPEPLD)	Homo sapiens			GO:0001523~retinoid metabolic process,GO:0001659~temperature homeostasis,GO:0009395~phospholipid catabolic process,GO:0048874~homeostasis of number of cells in a free-living population,GO:0050729~positive regulation of inflammatory response,GO:0070291~N-acylethanolamine metabolic process,GO:0070292~N-acylphosphatidylethanolamine metabolic process,GO:0090336~positive regulation of brown fat cell differentiation,	GO:0000139~Golgi membrane,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0031901~early endosome membrane,GO:0042622~photoreceptor outer segment membrane,GO:0043227~membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0008270~zinc ion binding,GO:0032052~bile acid binding,GO:0042802~identical protein binding,GO:0070290~N-acylphosphatidylethanolamine-specific phospholipase D activity,	IPR001279:Metallo-B-lactamas,IPR024884:NAPE-PLD,IPR036866:RibonucZ/Hydroxyglut_hydro,	hsa04723:Retrograde endocannabinoid signaling,		PIRSF038896:NAPE-PLD,		KW-0442~Lipid degradation,KW-0443~Lipid metabolism,KW-0595~Phospholipid degradation,KW-1208~Phospholipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0967~Endosome,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0007~Acetylation,	COMPBIAS:Polar residues,DOMAIN:Metallo-beta-lactamase,MUTAGEN:H->R: Loss of activity.,MUTAGEN:L->F: Loss of activity.,MUTAGEN:Q->S: Impairs homodimerization resulting in loss of activity; when associated with S-159.,MUTAGEN:R->A: Impairs binding to bile acids resulting in loss of activity.,MUTAGEN:Y->S: Impairs homodimerization resulting in loss of activity; when associated with S-158.,REGION:Disordered,
Q08CZ6	NAD kinase 2, mitochondrial(nadk2)	Xenopus tropicalis			GO:0006741~NADP biosynthetic process,GO:0016310~phosphorylation,GO:0019674~NAD metabolic process,	GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0003951~NAD+ kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0042803~protein homodimerization activity,	IPR002504:NADK,IPR012355:NADK2_mit,IPR016064:NAD/diacylglycerol_kinase_sf,IPR017437:ATP-NAD_kinase_PpnK-typ_C,IPR017438:ATP-NAD_kinase_N,	xtr00760:Nicotinate and nicotinamide metabolism,xtr01100:Metabolic pathways,xtr01240:Biosynthesis of cofactors,		PIRSF017565:Kin_ATP-NAD_euk,			KW-0496~Mitochondrion,			KW-0732~Signal,KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0520~NAD,KW-0521~NADP,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		TRANSIT:Mitochondrion,
Q5ZMA6	NAD synthetase 1(NADSYN1)	Gallus gallus			GO:0009435~NAD biosynthetic process,GO:0034627~'de novo' NAD biosynthetic process,	GO:0005737~cytoplasm,	GO:0003952~NAD+ synthase (glutamine-hydrolyzing) activity,GO:0004359~glutaminase activity,GO:0005524~ATP binding,	IPR003010:C-N_Hydrolase,IPR003694:NAD_synthase,IPR014445:Gln-dep_NAD_synthase,IPR014729:Rossmann-like_a/b/a_fold,IPR022310:NAD/GMP_synthase,IPR036526:C-N_Hydrolase_sf,	gga00760:Nicotinate and nicotinamide metabolism,gga01100:Metabolic pathways,gga01240:Biosynthesis of cofactors,		PIRSF006630:NADS_GAT,							KW-0067~ATP-binding,KW-0520~NAD,KW-0547~Nucleotide-binding,	KW-0436~Ligase,		ACT_SITE:For glutaminase activity,ACT_SITE:Nucleophile; for glutaminase activity,ACT_SITE:Proton acceptor; for glutaminase activity,DOMAIN:CN hydrolase,REGION:Ligase,
Q9R1J0	NAD(P) dependent steroid dehydrogenase-like(Nsdhl)	Mus musculus			GO:0001942~hair follicle development,GO:0006629~lipid metabolic process,GO:0006694~steroid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0007224~smoothened signaling pathway,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0016126~sterol biosynthetic process,GO:0060716~labyrinthine layer blood vessel development,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0016020~membrane,	GO:0000252~C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,GO:0003854~3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0047012~sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,	IPR002225:3Beta_OHSteriod_DH/Estase,IPR036291:NAD(P)-bd_dom_sf,	mmu00100:Steroid biosynthesis,mmu01100:Metabolic pathways,				KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0551~Lipid droplet,		KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0520~NAD,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,	ACT_SITE:Proton acceptor,DOMAIN:3-beta hydroxysteroid dehydrogenase/isomerase,MOTIF:Prevents secretion from ER,TRANSMEM:Helical,
A7YVD7	NADH:ubiquinone oxidoreductase complex assembly factor 6(NDUFAF6)	Bos taurus			GO:0009058~biosynthetic process,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,		IPR002060:Squ/phyt_synthse,IPR008949:Isoprenoid_synthase_dom_sf,	bta04714:Thermogenesis,					KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,				TRANSIT:Mitochondrion,
P28331	NADH:ubiquinone oxidoreductase core subunit S1(NDUFS1)	Homo sapiens			GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0008637~apoptotic mitochondrial changes,GO:0009060~aerobic respiration,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042773~ATP synthesis coupled electron transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,GO:0045333~cellular respiration,GO:0046034~ATP metabolic process,GO:0051881~regulation of mitochondrial membrane potential,GO:0072593~reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0016020~membrane,GO:0070469~respiratory chain,	GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051537~2 iron, 2 sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000283:NADH_UbQ_OxRdtase_75kDa_su_CS,IPR001041:2Fe-2S_ferredoxin-type,IPR006656:Mopterin_OxRdtase,IPR006963:Mopterin_OxRdtase_4Fe-4S_dom,IPR010228:NADH_UbQ_OxRdtase_Gsu,IPR015405:NDUFS1-like_C,IPR019574:NADH_UbQ_OxRdtase_Gsu_4Fe4S-bd,IPR036010:2Fe-2S_ferredoxin-like_sf,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04714:Thermogenesis,hsa04723:Retrograde endocannabinoid signaling,hsa04932:Non-alcoholic fatty liver disease,hsa05010:Alzheimer disease,hsa05012:Parkinson disease,hsa05014:Amyotrophic lateral sclerosis,hsa05016:Huntington disease,hsa05020:Prion disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05208:Chemical carcinogenesis - reactive oxygen species,hsa05415:Diabetic cardiomyopathy,	618226~Mitochondrial complex I deficiency, nuclear type 5,		SM00929:NADH-G_4Fe-4S_3,	KW-0249~Electron transport,KW-0679~Respiratory chain,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,		KW-0225~Disease variant,KW-1274~Primary mitochondrial disease,	KW-0809~Transit peptide,	KW-0001~2Fe-2S,KW-0004~4Fe-4S,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,KW-0520~NAD,KW-0830~Ubiquinone,	KW-0560~Oxidoreductase,KW-1278~Translocase,	KW-0007~Acetylation,	DOMAIN:2Fe-2S ferredoxin-type,DOMAIN:4Fe-4S His(Cys)3-ligated-type,DOMAIN:4Fe-4S Mo/W bis-MGD-type,DOMAIN:Molybdopterin oxidoreductase,DOMAIN:NADH-ubiquinone oxidoreductase 75 kDa subunit mitochondrial-like,TRANSIT:Mitochondrion,
Q8HXG6	NADH:ubiquinone oxidoreductase subunit A11(NDUFA11)	Bos taurus			GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,		IPR039205:NDUFA11,	bta00190:Oxidative phosphorylation,bta01100:Metabolic pathways,bta04714:Thermogenesis,bta04723:Retrograde endocannabinoid signaling,bta04932:Non-alcoholic fatty liver disease,bta05010:Alzheimer disease,bta05012:Parkinson disease,bta05014:Amyotrophic lateral sclerosis,bta05016:Huntington disease,bta05020:Prion disease,bta05022:Pathways of neurodegeneration - multiple diseases,bta05208:Chemical carcinogenesis - reactive oxygen species,bta05415:Diabetic cardiomyopathy,				KW-0249~Electron transport,KW-0679~Respiratory chain,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,	TRANSMEM:Helical,
Q02380	NADH:ubiquinone oxidoreductase subunit B5(NDUFB5)	Bos taurus			GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005747~mitochondrial respiratory chain complex I,		IPR019173:NADH_UbQ_OxRdtase_B5_su,	bta00190:Oxidative phosphorylation,bta01100:Metabolic pathways,bta04714:Thermogenesis,bta04723:Retrograde endocannabinoid signaling,bta04932:Non-alcoholic fatty liver disease,bta05010:Alzheimer disease,bta05012:Parkinson disease,bta05014:Amyotrophic lateral sclerosis,bta05016:Huntington disease,bta05020:Prion disease,bta05022:Pathways of neurodegeneration - multiple diseases,bta05208:Chemical carcinogenesis - reactive oxygen species,bta05415:Diabetic cardiomyopathy,				KW-0249~Electron transport,KW-0679~Respiratory chain,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSIT:Mitochondrion,TRANSMEM:Helical,
Q02367	NADH:ubiquinone oxidoreductase subunit B6(NDUFB6)	Bos taurus			GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042775~mitochondrial ATP synthesis coupled electron transport,	GO:0005654~nucleoplasm,GO:0005747~mitochondrial respiratory chain complex I,		IPR019174:NADH_DH_b-subcmplx_su6,	bta00190:Oxidative phosphorylation,bta01100:Metabolic pathways,bta04714:Thermogenesis,bta04723:Retrograde endocannabinoid signaling,bta04932:Non-alcoholic fatty liver disease,bta05010:Alzheimer disease,bta05012:Parkinson disease,bta05014:Amyotrophic lateral sclerosis,bta05016:Huntington disease,bta05020:Prion disease,bta05022:Pathways of neurodegeneration - multiple diseases,bta05208:Chemical carcinogenesis - reactive oxygen species,bta05415:Diabetic cardiomyopathy,				KW-0249~Electron transport,KW-0679~Respiratory chain,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,	TRANSMEM:Helical,
O43181	NADH:ubiquinone oxidoreductase subunit S4(NDUFS4)	Homo sapiens			GO:0001932~regulation of protein phosphorylation,GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0007420~brain development,GO:0009060~aerobic respiration,GO:0022900~electron transport chain,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042776~mitochondrial ATP synthesis coupled proton transport,GO:0045333~cellular respiration,GO:0048146~positive regulation of fibroblast proliferation,GO:0051591~response to cAMP,GO:0072593~reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0070469~respiratory chain,	GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR006885:NADH_UbQ_FeS_4_mit-like,IPR038532:NDUFS4-like_sf,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04714:Thermogenesis,hsa04723:Retrograde endocannabinoid signaling,hsa04932:Non-alcoholic fatty liver disease,hsa05010:Alzheimer disease,hsa05012:Parkinson disease,hsa05014:Amyotrophic lateral sclerosis,hsa05016:Huntington disease,hsa05020:Prion disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05208:Chemical carcinogenesis - reactive oxygen species,hsa05415:Diabetic cardiomyopathy,	252010~Mitochondrial complex I deficiency, nuclear type 1,			KW-0249~Electron transport,KW-0679~Respiratory chain,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,		KW-0225~Disease variant,KW-1274~Primary mitochondrial disease,	KW-0809~Transit peptide,	KW-0830~Ubiquinone,		KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,MUTAGEN:S->A: Loss of phosphorylation.,REGION:Disordered,TRANSIT:Mitochondrion,
Q9NPH5	NADPH oxidase 4(NOX4)	Homo sapiens			GO:0000902~cell morphogenesis,GO:0003015~heart process,GO:0006801~superoxide metabolic process,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0008285~negative regulation of cell proliferation,GO:0010467~gene expression,GO:0022900~electron transport chain,GO:0042554~superoxide anion generation,GO:0045453~bone resorption,GO:0050667~homocysteine metabolic process,GO:0051897~positive regulation of protein kinase B signaling,GO:0055007~cardiac muscle cell differentiation,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071333~cellular response to glucose stimulus,GO:0072593~reactive oxygen species metabolic process,GO:1903409~reactive oxygen species biosynthetic process,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0043020~NADPH oxidase complex,GO:0048471~perinuclear region of cytoplasm,GO:0097038~perinuclear endoplasmic reticulum,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0009055~electron carrier activity,GO:0016174~NAD(P)H oxidase activity,GO:0016175~superoxide-generating NADPH oxidase activity,GO:0016491~oxidoreductase activity,GO:0019826~oxygen sensor activity,GO:0020037~heme binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050664~oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,GO:0072341~modified amino acid binding,GO:1990782~protein tyrosine kinase binding,	IPR000778:Cyt_b245_heavy_chain,IPR013112:FAD-bd_8,IPR013121:Fe_red_NAD-bd_6,IPR013130:Fe3_Rdtase_TM_dom,IPR017927:FAD-bd_FR_type,IPR017938:Riboflavin_synthase-like_b-brl,IPR039261:FNR_nucleotide-bd,	hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04936:Alcoholic liver disease,hsa05010:Alzheimer disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05208:Chemical carcinogenesis - reactive oxygen species,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:FAD-binding FR-type,DOMAIN:Ferric oxidoreductase,DOMAIN:Ferric reductase NAD binding,MUTAGEN:C->V: Loss of H2O2 generation with predominant generation of superoxide.,MUTAGEN:H->Q: 50% reduction in H2O2 generation, without any effect on superoxide generation.,MUTAGEN:H->Q: Loss of H2O2 generation with predominant generation of superoxide.,MUTAGEN:H->Q: No effect on H2O2 or superoxide generation.,MUTAGEN:Missing: Loss of H2O2 generation with predominant generation of superoxide. No effect on localization to the endoplasmic reticulum.,MUTAGEN:Missing: Partial loss of catalytic activity. No effect on CYBA localization.,MUTAGEN:R->RGT: Partial loss of catalytic activity. No effect on CYBA localization.,REGION:E-loop; essential for H2O2 generating catalytic activity,REGION:Mediates interaction with TLR4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9ESJ4	NCK interacting protein with SH3 domain(Nckipsd)	Mus musculus			GO:0006897~endocytosis,GO:0010976~positive regulation of neuron projection development,	GO:0005634~nucleus,GO:0008180~COP9 signalosome,	GO:0017124~SH3 domain binding,GO:0071933~Arp2/3 complex binding,	IPR001452:SH3_domain,IPR018556:SPIN90/Ldb17_LRD,IPR030125:SPIN90/Ldb17,IPR035514:SPIN90_SH3,IPR036028:SH3-like_dom_sf,				SM00326:SH3,		KW-0539~Nucleus,			KW-0728~SH3 domain,KW-0729~SH3-binding,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:SH3,MOTIF:Nuclear localization signal,REGION:Disordered,
Q7SZC5	NDC1 transmembrane nucleoporin(ndc1)	Danio rerio			GO:0006999~nuclear pore organization,GO:0015031~protein transport,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0070762~nuclear pore transmembrane ring,	GO:0030674~protein binding, bridging,	IPR019049:Nucleoporin_prot_Ndc1/Nup,	dre03013:Nucleocytoplasmic transport,				KW-0509~mRNA transport,KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0472~Membrane,KW-0539~Nucleus,KW-0906~Nuclear pore complex,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Perinuclear space,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q6DRJ7	NDC80 kinetochore complex component(ndc80)	Danio rerio			GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,GO:1990758~mitotic sister chromatid biorientation,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0031262~Ndc80 complex,	GO:0008017~microtubule binding,	IPR005550:Kinetochore_Ndc80,IPR038273:Ndc80_sf,IPR040967:DUF5595,	dre04110:Cell cycle,				KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,			KW-0175~Coiled coil,
Q5ZLE9	NEDD4 binding protein 1(N4BP1)	Gallus gallus			GO:0001818~negative regulation of cytokine production,GO:0031397~negative regulation of protein ubiquitination,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0016605~PML body,	GO:0003729~mRNA binding,GO:0004540~ribonuclease activity,GO:0043130~ubiquitin binding,	IPR021869:RNase_Zc3h12_NYN,					KW-0391~Immunity,KW-0399~Innate immunity,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0540~Nuclease,KW-0694~RNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:KH-like,DOMAIN:RNase NYN,REGION:CoCUN,REGION:Disordered,
Q5NUA6	NFE2 like bZIP transcription factor 2(NFE2L2)	Bos taurus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010499~proteasomal ubiquitin-independent protein catabolic process,GO:0016567~protein ubiquitination,GO:0034599~cellular response to oxidative stress,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045088~regulation of innate immune response,GO:0045454~cell redox homeostasis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071498~cellular response to fluid shear stress,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR004826:bZIP_Maf,IPR004827:bZIP,IPR008917:TF_DNA-bd_sf,IPR046347:bZIP_sf,IPR047167:NFE2-like,	bta04141:Protein processing in endoplasmic reticulum,bta05012:Parkinson disease,bta05200:Pathways in cancer,bta05208:Chemical carcinogenesis - reactive oxygen species,bta05225:Hepatocellular carcinoma,bta05417:Lipid and atherosclerosis,bta05418:Fluid shear stress and atherosclerosis,			SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0971~Glycation,	CARBOHYD:N-linked (Glc) (glycation) arginine,CARBOHYD:N-linked (Glc) (glycation) lysine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:bZIP,MOTIF:DLG motif,MOTIF:ETGE motif,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,REGION:Mediates interaction with CHD6 and is necessary to activate transcription,
Q9Y4A8	NFE2 like bZIP transcription factor 3(NFE2L3)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR004826:bZIP_Maf,IPR004827:bZIP,IPR008917:TF_DNA-bd_sf,IPR046347:bZIP_sf,IPR047167:NFE2-like,				SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,DOMAIN:BZIP,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
P51955	NIMA related kinase 2(NEK2)	Homo sapiens			GO:0000278~mitotic cell cycle,GO:0001824~blastocyst development,GO:0006468~protein phosphorylation,GO:0007059~chromosome segregation,GO:0007088~regulation of mitotic nuclear division,GO:0016310~phosphorylation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0046602~regulation of mitotic centrosome separation,GO:0046777~protein autophosphorylation,GO:0051225~spindle assembly,GO:0051299~centrosome separation,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051973~positive regulation of telomerase activity,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0090307~mitotic spindle assembly,GO:1903126~negative regulation of centriole-centriole cohesion,GO:1904355~positive regulation of telomere capping,	GO:0000776~kinetochore,GO:0000794~condensed nuclear chromosome,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0030496~midbody,GO:0032991~macromolecular complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019903~protein phosphatase binding,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,		615565~Retinitis pigmentosa 67,		SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0469~Meiosis,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,		KW-0682~Retinitis pigmentosa,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,MUTAGEN:D->A: Loss of autophosphorylation.,MUTAGEN:K->R: Loss of kinase activity and of ability to activate NEK11. Loss of phosphorylation of CCDC102B.,MUTAGEN:S->A: Loss of kinase activity.,MUTAGEN:S->A: No effect on kinase activity.,MUTAGEN:S->D: Kinase activity increased by two fold.,MUTAGEN:S->D: Loss of kinase activity.,MUTAGEN:T->A: Kinase activity decreased by two fold.,MUTAGEN:T->A: Loss of kinase activity.,MUTAGEN:T->A: No effect on kinase activity.,MUTAGEN:T->E: Kinase activity increased by two fold.,MUTAGEN:T->E: Loss of kinase activity.,REGION:Interaction with CEP85,REGION:Interaction with PCNT,REGION:Interaction with SAV1 and STK3/MST2,REGION:Leucine-zipper,REGION:Necessary for interaction with MAD1L1,REGION:Required for microtubule binding and for localization to the centrosomes,
Q7RTR2	NLR family CARD domain containing 3(NLRC3)	Homo sapiens			GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032687~negative regulation of interferon-alpha production,GO:0032688~negative regulation of interferon-beta production,GO:0032715~negative regulation of interleukin-6 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0035556~intracellular signal transduction,GO:0042110~T cell activation,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045824~negative regulation of innate immune response,GO:0048147~negative regulation of fibroblast proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0051898~negative regulation of protein kinase B signaling,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:1900226~negative regulation of NLRP3 inflammasome complex assembly,GO:1901223~negative regulation of NIK/NF-kappaB signaling,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034451~centriolar satellite,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,	IPR001611:Leu-rich_rpt,IPR007111:NACHT_NTPase,IPR027417:P-loop_NTPase,IPR032675:LRR_dom_sf,IPR041075:NOD2_WH,IPR041267:NLRP_HD2,				SM00368:LRR_RI,		KW-0963~Cytoplasm,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			DOMAIN:NACHT,MOTIF:TRAF6-binding,MUTAGEN:SLQE->AAAA: Strong decrease of TRAF6-binding.,MUTAGEN:SVEE->AAAA: Almost no effect on TRAF6-binding.,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
Q5BLF0	NMD3 ribosome export adaptor(nmd3)	Danio rerio			GO:0000055~ribosomal large subunit export from nucleus,GO:0015031~protein transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0043023~ribosomal large subunit binding,	IPR007064:Nmd3_N,IPR039768:Nmd3,IPR048898:NMD3_OB,IPR048899:NMD_SH3,	dre03008:Ribosome biogenesis in eukaryotes,dre03013:Nucleocytoplasmic transport,				KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,							COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q9Y5B8	NME/NM23 family member 7(NME7)	Homo sapiens			GO:0006183~GTP biosynthetic process,GO:0006228~UTP biosynthetic process,GO:0006241~CTP biosynthetic process,GO:0010968~regulation of microtubule nucleation,GO:0016310~phosphorylation,	GO:0000931~gamma-tubulin large complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005879~axonemal microtubule,	GO:0004550~nucleoside diphosphate kinase activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008408~3'-5' exonuclease activity,GO:0046872~metal ion binding,	IPR001564:Nucleoside_diP_kinase,IPR006602:DM10_dom,IPR011410:NDPK7,IPR034907:NDK-like_dom,IPR035525:NDPk7A,IPR036850:NDK-like_dom_sf,IPR037993:NDPk7B,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,hsa01240:Biosynthesis of cofactors,		PIRSF036503:NDK7,	SM00562:NDK,SM00676:DM10,	KW-0546~Nucleotide metabolism,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		ACT_SITE:Pros-phosphohistidine intermediate,DOMAIN:DM10,
Q9WV84	NME/NM23 nucleoside diphosphate kinase 4(Nme4)	Mus musculus			GO:0006183~GTP biosynthetic process,GO:0006228~UTP biosynthetic process,GO:0006241~CTP biosynthetic process,GO:0006869~lipid transport,GO:0009117~nucleotide metabolic process,GO:0016310~phosphorylation,	GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0004550~nucleoside diphosphate kinase activity,GO:0005524~ATP binding,GO:0008289~lipid binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:1901612~cardiolipin binding,	IPR001564:Nucleoside_diP_kinase,IPR023005:Nucleoside_diP_kinase_AS,IPR034907:NDK-like_dom,IPR036850:NDK-like_dom_sf,	mmu00230:Purine metabolism,mmu00240:Pyrimidine metabolism,mmu00983:Drug metabolism - other enzymes,mmu01100:Metabolic pathways,mmu01232:Nucleotide metabolism,mmu01240:Biosynthesis of cofactors,			SM00562:NDK,	KW-0546~Nucleotide metabolism,	KW-0472~Membrane,KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0446~Lipid-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		ACT_SITE:Pros-phosphohistidine intermediate,DOMAIN:Nucleoside diphosphate kinase-like,TRANSIT:Mitochondrion,
Q7TS68	NOL1/NOP2/Sun domain family member 6(Nsun6)	Mus musculus			GO:0001510~RNA methylation,GO:0002946~tRNA C5-cytosine methylation,GO:0006400~tRNA modification,GO:0030488~tRNA methylation,GO:0032259~methylation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016428~tRNA (cytosine-5-)-methyltransferase activity,GO:0016740~transferase activity,	IPR001678:MeTrfase_RsmB/NOP2,IPR002478:PUA,IPR015947:PUA-like_sf,IPR023267:RCMT,IPR029063:SAM-dependent_MTases_sf,IPR036974:PUA_sf,				SM00359:PUA,		KW-0963~Cytoplasm,				KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0694~RNA-binding,KW-0808~Transferase,	KW-0007~Acetylation,	ACT_SITE:Nucleophile,DOMAIN:PUA,DOMAIN:SAM-dependent MTase RsmB/NOP-type,
Q96P11	NOP2/Sun RNA methyltransferase 5(NSUN5)	Homo sapiens			GO:0001510~RNA methylation,GO:0014003~oligodendrocyte development,GO:0021987~cerebral cortex development,GO:0022038~corpus callosum development,GO:0031641~regulation of myelination,GO:0045727~positive regulation of translation,GO:0050890~cognition,GO:0070475~rRNA base methylation,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0009383~rRNA (cytosine-C5-)-methyltransferase activity,	IPR001678:MeTrfase_RsmB/NOP2,IPR023267:RCMT,IPR029063:SAM-dependent_MTases_sf,IPR048889:NSUN5_RCM1_N,					KW-0698~rRNA processing,	KW-0539~Nucleus,		KW-0856~Williams-Beuren syndrome,		KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0694~RNA-binding,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,DOMAIN:SAM-dependent MTase RsmB/NOP-type,MUTAGEN:C->S: Abolished methyltransferase activity without affecting nucleolar localization; when associated with S-308.,MUTAGEN:C->S: Abolished methyltransferase activity without affecting nucleolar localization; when associated with S-359.,REGION:Disordered,
Q2PFW9	NOVA alternative splicing regulator 1(NOVA1)	Macaca fascicularis			GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0007399~nervous system development,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:1990825~sequence-specific mRNA binding,	IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR036612:KH_dom_type_1_sf,IPR047274:KH-I_NOVA_rpt3,IPR047275:KH-I_NOVA_rpt1,IPR047276:KH-I_NOVA_rpt2,				SM00322:KH,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0524~Neurogenesis,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0694~RNA-binding,		COMPBIAS:Basic and acidic residues,DOMAIN:K Homology,DOMAIN:KH 1,DOMAIN:KH 2,DOMAIN:KH 3,MOTIF:Bipartite nuclear localization signal,REGION:Disordered,REGION:Required for RNA binding,
Q6PAF4	NSE1 homolog, SMC5-SMC6 complex component L homeolog(nsmce1.L)	Xenopus laevis			GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0030915~Smc5-Smc6 complex,	GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,GO:0061630~ubiquitin protein ligase activity,	IPR011513:Nse1,IPR013083:Znf_RING/FYVE/PHD,IPR014857:Nse1_RING_C4HC3-type,IPR036388:WH-like_DNA-bd_sf,IPR046349:C1-like_sf,					KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0779~Telomere,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		DOMAIN:Non-structural maintenance of chromosomes element 1 RING C4HC3-type,REGION:Disordered,ZN_FING:RING-type; atypical,
P54921	NSF attachment protein alpha(Napa)	Rattus norvegicus			GO:0006886~intracellular protein transport,GO:0007420~brain development,GO:0010807~regulation of synaptic vesicle priming,GO:0016082~synaptic vesicle priming,GO:0016192~vesicle-mediated transport,GO:0030182~neuron differentiation,GO:0032781~positive regulation of ATPase activity,GO:0032984~macromolecular complex disassembly,GO:0035249~synaptic transmission, glutamatergic,GO:0035494~SNARE complex disassembly,GO:0045176~apical protein localization,GO:0061025~membrane fusion,	GO:0016020~membrane,GO:0031594~neuromuscular junction,GO:0043195~terminal bouton,GO:0048787~presynaptic active zone membrane,GO:0070044~synaptobrevin 2-SNAP-25-syntaxin-1a complex,GO:0098793~presynapse,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,	GO:0000149~SNARE binding,GO:0005483~soluble NSF attachment protein activity,GO:0005515~protein binding,GO:0019905~syntaxin binding,GO:0044877~macromolecular complex binding,	IPR000744:NSF_attach,IPR011990:TPR-like_helical_dom_sf,	rno04721:Synaptic vesicle cycle,				KW-0653~Protein transport,KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,
Q96IY1	NSL1 component of MIS12 kinetochore complex(NSL1)	Homo sapiens			GO:0000070~mitotic sister chromatid segregation,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0051301~cell division,	GO:0000444~MIS12/MIND type complex,GO:0000776~kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005829~cytosol,GO:0016607~nuclear speck,	GO:0005515~protein binding,	IPR013950:Mis14/Nsl1,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,						KW-0597~Phosphoprotein,
Q641K5	NUAK family, SNF1-like kinase, 1(Nuak1)	Mus musculus			GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007155~cell adhesion,GO:0016310~phosphorylation,GO:0030155~regulation of cell adhesion,GO:0032007~negative regulation of TOR signaling,GO:0035507~regulation of myosin-light-chain-phosphatase activity,GO:0035556~intracellular signal transduction,GO:0042149~cellular response to glucose starvation,GO:2000772~regulation of cellular senescence,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,GO:0031588~nucleotide-activated protein kinase complex,	GO:0000166~nucleotide binding,GO:0002039~p53 binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,				SM00220:S_TKc,	KW-0130~Cell adhesion,KW-0227~DNA damage,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Protein kinase,MOTIF:GILK motif,REGION:Disordered,
Q8TB37	NUBP iron-sulfur cluster assembly factor, mitochondrial(NUBPL)	Homo sapiens			GO:0007005~mitochondrion organization,GO:0016226~iron-sulfur cluster assembly,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0070584~mitochondrion morphogenesis,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000808:Mrp-like_CS,IPR019591:Mrp/NBP35_ATP-bd,IPR027417:P-loop_NTPase,IPR033756:YlxH/NBP35,IPR044304:NUBPL-like,		618242~Mitochondrial complex I deficiency, nuclear type 21,				KW-0496~Mitochondrion,		KW-0225~Disease variant,KW-1274~Primary mitochondrial disease,	KW-0732~Signal,KW-0809~Transit peptide,	KW-0004~4Fe-4S,KW-0067~ATP-binding,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,			MUTAGEN:C->A: Defect in complex I assembly; when associated with A-244.,MUTAGEN:C->A: Defect in complex I assembly; when associated with A-247.,TRANSIT:Mitochondrion,
Q9QZS3	NUMB endocytic adaptor protein(Numb)	Mus musculus			GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0007405~neuroblast proliferation,GO:0007409~axonogenesis,GO:0021670~lateral ventricle development,GO:0021849~neuroblast division in subventricular zone,GO:0030335~positive regulation of cell migration,GO:0030862~positive regulation of polarized epithelial cell differentiation,GO:0030900~forebrain development,GO:0034332~adherens junction organization,GO:0045664~regulation of neuron differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0050769~positive regulation of neurogenesis,GO:0050775~positive regulation of dendrite morphogenesis,GO:0060487~lung epithelial cell differentiation,GO:1903077~negative regulation of protein localization to plasma membrane,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0010008~endosome membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0030136~clathrin-coated vesicle,GO:0031410~cytoplasmic vesicle,GO:0043197~dendritic spine,GO:0045177~apical part of cell,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0045294~alpha-catenin binding,GO:0045296~cadherin binding,	IPR006020:PTB/PI_dom,IPR010449:Numb_domain,IPR011993:PH-like_dom_sf,IPR016698:Numb/numb-like,	mmu04330:Notch signaling pathway,		PIRSF017607:Numb/numb-like,	SM00462:PTB,	KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,					KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PID,REGION:Disordered,
Q9D035	Na+/K+ transporting ATPase interacting 1(Nkain1)	Mus musculus			GO:0002028~regulation of sodium ion transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0051117~ATPase binding,	IPR008516:Na/K-Atpase_Interacting,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TRANSMEM:Helical,
Q4FZG9	Ndufa4, mitochondrial complex associated like 2(Ndufa4l2)	Mus musculus				GO:0005751~mitochondrial respiratory chain complex IV,		IPR010530:B12D,	mmu00190:Oxidative phosphorylation,mmu01100:Metabolic pathways,mmu04714:Thermogenesis,mmu04723:Retrograde endocannabinoid signaling,mmu04932:Non-alcoholic fatty liver disease,mmu05010:Alzheimer disease,mmu05012:Parkinson disease,mmu05014:Amyotrophic lateral sclerosis,mmu05016:Huntington disease,mmu05020:Prion disease,mmu05022:Pathways of neurodegeneration - multiple diseases,mmu05208:Chemical carcinogenesis - reactive oxygen species,mmu05415:Diabetic cardiomyopathy,
Q6DGP4	Nedd4 family interacting protein 1, like(ndfip1l)	Danio rerio			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007034~vacuolar transport,GO:0030001~metal ion transport,GO:0031398~positive regulation of protein ubiquitination,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0050699~WW domain binding,	IPR019325:NEDD4/Bsd2,						KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				MOTIF:PPxY motif 1,MOTIF:PPxY motif 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q91431	Nuclear factor 7 S homeolog(xnf7.S)	Xenopus laevis			GO:0010468~regulation of gene expression,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000315:Znf_B-box,IPR000953:Chromo/chromo_shadow_dom,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003649:Bbox_C,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR016197:Chromo-like_dom_sf,IPR017907:Znf_RING_CS,IPR025995:Tudor-knot,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00298:CHROMO,SM00336:BBOX,SM00449:SPRY,SM00502:BBC,SM00589:PRY,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,DOMAIN:Tudor-knot,REGION:Disordered,ZN_FING:B box-type,ZN_FING:RING-type,
E9QBI7	OMA1 zinc metallopeptidase(oma1)	Danio rerio			GO:0002024~diet induced thermogenesis,GO:0006006~glucose metabolic process,GO:0006508~proteolysis,GO:0006515~misfolded or incompletely synthesized protein catabolic process,GO:0006629~lipid metabolic process,GO:0010637~negative regulation of mitochondrial fusion,GO:0016540~protein autoprocessing,GO:0031638~zymogen activation,GO:0033108~mitochondrial respiratory chain complex assembly,GO:0034982~mitochondrial protein processing,GO:0043065~positive regulation of apoptotic process,GO:0097009~energy homeostasis,GO:1903850~regulation of cristae formation,	GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0031966~mitochondrial membrane,	GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR001915:Peptidase_M48,						KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0068~Autocatalytic cleavage,KW-0865~Zymogen,KW-1015~Disulfide bond,	DOMAIN:Peptidase M48,REGION:Stress-sensor region,TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSIT:Mitochondrion,TRANSMEM:Helical,
Q6TLE6	ORAI calcium release-activated calcium modulator 1b(orai1b)	Danio rerio			GO:0002115~store-operated calcium entry,GO:0002250~adaptive immune response,GO:0002376~immune system process,GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:0045214~sarcomere organization,GO:0051928~positive regulation of calcium ion transport,GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005262~calcium channel activity,GO:0015279~store-operated calcium channel activity,	IPR012446:CRAC_channel,IPR038350:Orai_sf,	dre04020:Calcium signaling pathway,				KW-0109~Calcium transport,KW-0391~Immunity,KW-0406~Ion transport,KW-0813~Transport,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0107~Calcium channel,KW-0407~Ion channel,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8TE49	OTU deubiquitinase 7A(OTUD7A)	Homo sapiens			GO:0006508~proteolysis,GO:0035871~protein K11-linked deubiquitination,GO:0070536~protein K63-linked deubiquitination,GO:0071108~protein K48-linked deubiquitination,GO:0071947~protein deubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0008270~zinc ion binding,GO:0070530~K63-linked polyubiquitin binding,	IPR002653:Znf_A20,IPR003323:OTU_dom,IPR009060:UBA-like_sf,				SM00259:ZnF_A20,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0488~Methylation,KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:OTU,MOTIF:Nuclear localization signal,REGION:Catalytic,REGION:Disordered,REGION:TRAF-binding,ZN_FING:A20-type,
Q7ZU42	Obg-like ATPase 1(ola1)	Danio rerio				GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0043023~ribosomal large subunit binding,GO:0046872~metal ion binding,	IPR004095:TGS,IPR004396:ATPase_YchF/OLA1,IPR006073:GTP-bd,IPR012675:Beta-grasp_dom_sf,IPR012676:TGS-like,IPR013029:YchF_C,IPR023192:TGS-like_dom_sf,IPR027417:P-loop_NTPase,IPR031167:G_OBG,IPR041706:YchF_N,			PIRSF006641:CHP00092,			KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,		DOMAIN:OBG-type G,DOMAIN:TGS,MOTIF:Nuclear export signal,
P18749	Oocyte zinc finger protein XlCOF6 (ZO6_XENLA)	Xenopus laevis				GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q5ZLN7	PABIR family member 3(PABIR3)	Gallus gallus			GO:0030307~positive regulation of cell growth,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0044818~mitotic G2/M transition checkpoint,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004865~protein serine/threonine phosphatase inhibitor activity,	IPR026716:PBIR1/2/3,						KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0650~Protein phosphatase inhibitor,		COMPBIAS:Polar residues,REGION:Disordered,
Q1RMA6	PARP1 binding protein(parpbp)	Danio rerio			GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:2000042~negative regulation of double-strand break repair via homologous recombination,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,	IPR038932:PARPBP,					KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q96RG2	PAS domain containing serine/threonine kinase(PASK)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,GO:0043576~regulation of respiratory gaseous exchange,GO:0045719~negative regulation of glycogen biosynthetic process,GO:0045727~positive regulation of translation,GO:0046777~protein autophosphorylation,GO:0070092~regulation of glucagon secretion,GO:0097009~energy homeostasis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0035091~phosphatidylinositol binding,	IPR000014:PAS,IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR035965:PAS-like_dom_sf,				SM00091:PAS,SM00220:S_TKc,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0446~Lipid-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:PAS,DOMAIN:PAS 1,DOMAIN:PAS 2,DOMAIN:Protein kinase,MUTAGEN:A->K: Induces lower protein kinase activity and ability to autophosphorylate.,MUTAGEN:K->R: Loss of autophosphorylating activity.,MUTAGEN:R->A: Induces lower protein kinase activity.,MUTAGEN:R->K: Does not affect protein kinase activity.,MUTAGEN:T->A: Loss of catalytic activity (PubMed:11459942). According to another report, does not affect the protein kinase activity (PubMed:20943661). Does not affect protein translation.,MUTAGEN:T->A: Loss of catalytic activity. Does not affect protein translation.,MUTAGEN:Y->F: Induces lower protein kinase activity.,REGION:Disordered,
Q5HZL4	PCNA clamp associated factor S homeolog(pclaf.S)	Xenopus laevis			GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007098~centrosome cycle,GO:0009411~response to UV,GO:0019985~translesion synthesis,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0003682~chromatin binding,	IPR031444:PCNA-AF_dom,IPR040444:PCNA-AF,					KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,KW-0963~Cytoplasm,							COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PCNA-associated factor histone-like,MOTIF:D-box,MOTIF:Initiation motif,MOTIF:KEN box,MOTIF:PIP-box,REGION:Disordered,
Q3SYZ8	PDZ and LIM domain 3(PDLIM3)	Bos taurus			GO:0007507~heart development,GO:0030036~actin cytoskeleton organization,GO:0061061~muscle structure development,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005912~adherens junction,GO:0030018~Z disc,GO:0031941~filamentous actin,	GO:0003779~actin binding,GO:0046872~metal ion binding,GO:0051371~muscle alpha-actinin binding,	IPR001478:PDZ,IPR001781:Znf_LIM,IPR006643:Zasp-like_motif,IPR031847:PDLI1-4/Zasp-like_mid,IPR036034:PDZ_sf,				SM00132:LIM,SM00228:PDZ,SM00735:ZM,		KW-0963~Cytoplasm,			KW-0440~LIM domain,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:LIM zinc-binding,DOMAIN:PDZ,REGION:Disordered,
Q6DHU8	PDZ binding kinase(pbk)	Danio rerio			GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,		GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004708~MAP kinase kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR041989:PKc_TOPK,			PIRSF000654:Integrin-linked_kinase,	SM00220:S_TKc,						KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,
Q8N4B1	PH domain containing endocytic trafficking adaptor 1(PHETA1)	Homo sapiens			GO:0001881~receptor recycling,GO:0007032~endosome organization,GO:0042147~retrograde transport, endosome to Golgi,	GO:0005769~early endosome,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0030136~clathrin-coated vesicle,GO:0055037~recycling endosome,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR045188:Boi1/Boi2-like,				SM00233:PH,		KW-0333~Golgi apparatus,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,						KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,DOMAIN:PH,MOTIF:F&H,MUTAGEN:EI->AA: Loss of OCRL-binding.,MUTAGEN:F->A: Loss of OCRL-binding. Drastically reduces membrane targeting.,MUTAGEN:H->A: Loss of OCRL-binding.,REGION:Disordered,
Q92576	PHD finger protein 3(PHF3)	Homo sapiens			GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0048188~Set1C/COMPASS complex,	GO:0046872~metal ion binding,	IPR001965:Znf_PHD,IPR003618:TFIIS_cen_dom,IPR011011:Znf_FYVE_PHD,IPR012921:SPOC_C,IPR013083:Znf_RING/FYVE/PHD,IPR019786:Zinc_finger_PHD-type_CS,IPR019787:Znf_PHD-finger,IPR036575:TFIIS_cen_dom_sf,IPR037869:Spp1/CFP1,				SM00249:PHD,SM00510:TFS2M,		KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:PHD-type,DOMAIN:Spen paralogue and orthologue SPOC C-terminal,DOMAIN:TFIIS central,REGION:Disordered,ZN_FING:PHD-type,
P83871	PHD finger protein 5A(Phf5a)	Rattus norvegicus			GO:0000398~mRNA splicing, via spliceosome,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048863~stem cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0071005~U2-type precatalytic spliceosome,GO:0071011~precatalytic spliceosome,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,	IPR005345:PHF5,	rno03040:Spliceosome,		PIRSF016468:PHF5,		KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0747~Spliceosome,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Interaction with SF3B1 and SF3B3,REGION:Interaction with SF3B3,SITE:Interaction with RNA,SITE:Interaction with SF3B3,
Q9M2U3	PIF / Ping-Pong family of plant transposase(AT3G55350)	Arabidopsis thaliana				GO:0000118~histone deacetylase complex,GO:0005634~nucleus,	GO:0004518~nuclease activity,GO:0046872~metal ion binding,	IPR027806:HARBI1_dom,						KW-0539~Nucleus,				KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0540~Nuclease,		DOMAIN:DDE Tnp4,MOTIF:Nuclear localization signal,
Q28I85	POC1 centriolar protein A(poc1a)	Xenopus tropicalis			GO:0060271~cilium assembly,	GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005856~cytoskeleton,GO:0036064~ciliary basal body,		IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,				SM00320:WD40,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
A2AJ77	PR domain containing 12(Prdm12)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006479~protein methylation,GO:0010468~regulation of gene expression,GO:0019233~sensory perception of pain,GO:0022008~neurogenesis,GO:0031175~neuron projection development,GO:0032259~methylation,GO:0050965~detection of temperature stimulus involved in sensory perception of pain,GO:1900111~positive regulation of histone H3-K9 dimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:1990226~histone methyltransferase binding,	IPR001214:SET_dom,IPR013087:Znf_C2H2_type,IPR017126:Znf_PRDM12,IPR036236:Znf_C2H2_sf,IPR044406:PRDM12_PR/SET,IPR046341:SET_dom_sf,			PIRSF037163:PRDM12,	SM00317:SET,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0238~DNA-binding,KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:SET,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,
P57071	PR/SET domain 15(PRDM15)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032259~methylation,GO:0043409~negative regulation of MAPK cascade,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:2000035~regulation of stem cell division,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016604~nuclear body,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0008168~methyltransferase activity,GO:0046872~metal ion binding,GO:1990841~promoter-specific chromatin binding,	IPR001214:SET_dom,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,IPR044409:PRDM15_PR-SET,IPR046341:SET_dom_sf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0489~Methyltransferase,KW-0678~Repressor,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:C2H2-type,DOMAIN:SET,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q9Y3B1	PRELI domain containing 3B(PRELID3B)	Homo sapiens			GO:0015914~phospholipid transport,	GO:0005758~mitochondrial intermembrane space,	GO:1990050~phosphatidic acid transporter activity,	IPR006797:PRELI/MSF1_dom,IPR037365:Slowmo/Ups,												KW-0597~Phosphoprotein,	DOMAIN:PRELI/MSF1,
Q6P9U4	PRELI domain containing 3B(Prelid3b)	Rattus norvegicus			GO:0015914~phospholipid transport,	GO:0005758~mitochondrial intermembrane space,	GO:1990050~phosphatidic acid transporter activity,	IPR006797:PRELI/MSF1_dom,IPR037365:Slowmo/Ups,												KW-0597~Phosphoprotein,	DOMAIN:PRELI/MSF1,
Q13136	PTPRF interacting protein alpha 1(PPFIA1)	Homo sapiens			GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0050808~synapse organization,GO:0051497~negative regulation of stress fiber assembly,GO:0099072~regulation of postsynaptic specialization membrane neurotransmitter receptor levels,GO:1903077~negative regulation of protein localization to plasma membrane,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030424~axon,GO:0032991~macromolecular complex,GO:0048786~presynaptic active zone,GO:0097444~spine apparatus,GO:0098685~Schaffer collateral - CA1 synapse,	GO:0005515~protein binding,	IPR001660:SAM,IPR013761:SAM/pointed_sf,IPR029515:Liprin,IPR037620:Liprin-alpha_SAM_rpt_1,IPR037621:Liprin-alpha_SAM_rpt_2,IPR037622:Liprin-alpha_SAM_rpt_3,				SM00454:SAM,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SAM,DOMAIN:SAM 1,DOMAIN:SAM 2,DOMAIN:SAM 3,REGION:Disordered,
Q5NVI6	PTTG1 interacting protein(PTTG1IP)	Pongo abelii			GO:0006606~protein import into nucleus,GO:0031398~positive regulation of protein ubiquitination,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:1902254~negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0002039~p53 binding,	IPR016201:PSI,				SM00423:PSI,		KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:PSI,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9I9N6	PYD and CARD domain containing(pycard)	Danio rerio			GO:0002221~pattern recognition receptor signaling pathway,GO:0002376~immune system process,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0032731~positive regulation of interleukin-1 beta production,GO:0042742~defense response to bacterium,GO:0042981~regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045087~innate immune response,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,	GO:0005737~cytoplasm,GO:0061702~inflammasome complex,GO:0072558~NLRP1 inflammasome complex,GO:0072559~NLRP3 inflammasome complex,	GO:0005515~protein binding,GO:0032090~Pyrin domain binding,	IPR001315:CARD,IPR004020:DAPIN,IPR011029:DEATH-like_dom_sf,IPR033516:CARD8/ASC/NALP1_CARD,	dre04217:Necroptosis,dre04621:NOD-like receptor signaling pathway,dre04623:Cytosolic DNA-sensing pathway,dre04625:C-type lectin receptor signaling pathway,dre05132:Salmonella infection,			SM01289:PYRIN,	KW-0053~Apoptosis,KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,	KW-0963~Cytoplasm,KW-1271~Inflammasome,		KW-0043~Tumor suppressor,					DOMAIN:CARD,DOMAIN:Pyrin,MUTAGEN:D->A: Impairs inflammasome activity, but does not impair speck formation.,MUTAGEN:D->R: Abolishes speck formation and impairs inflammasome activity.,MUTAGEN:E->R: Defective speck formation and impairs inflammasome activity.,MUTAGEN:Q->A: Impairs inflammasome activity, but does not impair speck formation.,MUTAGEN:R->E: Abolishes speck formation and impairs inflammasome activity.,
P52186	Potassium inwardly rectifying channel subfamily J member 2(KCNJ2)	Gallus gallus			GO:0006813~potassium ion transport,GO:0034765~regulation of ion transmembrane transport,GO:0051289~protein homotetramerization,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0034702~ion channel complex,	GO:0005242~inward rectifier potassium channel activity,	IPR003271:K_chnl_inward-rec_Kir2.1,IPR013518:K_chnl_inward-rec_Kir_cyto,IPR013673:K_chnl_inward-rec_Kir_N,IPR014756:Ig_E-set,IPR016449:K_chnl_inward-rec_Kir,IPR040445:Kir_TM,IPR041647:IRK_C,			PIRSF005465:GIRK_kir,		KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0851~Voltage-gated channel,	KW-0449~Lipoprotein,KW-0519~Myristate,	DOMAIN:Inward rectifier potassium channel C-terminal,DOMAIN:Potassium channel inwardly rectifying Kir N-terminal,DOMAIN:Potassium channel inwardly rectifying transmembrane,INTRAMEM:Helical; Pore-forming; Name=H5,INTRAMEM:Pore-forming,LIPID:N-myristoyl glycine,MOTIF:PDZ-binding,MOTIF:Selectivity filter,REGION:Disordered,SITE:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=M1,TRANSMEM:Helical; Name=M2,
Q9NBX4	Probable RNA-directed DNA polymerase from transposon X-element(X-element\ORF2)	Drosophila melanogaster			GO:0006313~transposition, DNA-mediated,		GO:0003964~RNA-directed DNA polymerase activity,	IPR000477:RT_dom,IPR005135:Endo/exonuclease/phosphatase,IPR036691:Endo/exonu/phosph_ase_sf,IPR043502:DNA/RNA_pol_sf,											KW-0548~Nucleotidyltransferase,KW-0695~RNA-directed DNA polymerase,KW-0808~Transferase,		DOMAIN:Reverse transcriptase,REGION:Disordered,
Q4RSM6	Probable glutathione peroxidase 8(gpx8)	Tetraodon nigroviridis			GO:0006979~response to oxidative stress,	GO:0016020~membrane,	GO:0004602~glutathione peroxidase activity,	IPR000889:Glutathione_peroxidase,IPR013376:Glut_perox_Gpx7,IPR036249:Thioredoxin-like_sf,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0560~Oxidoreductase,KW-0575~Peroxidase,		TRANSMEM:Helical,
Q4RU86	Protein ALKAL-like(GSTENG00028908001)	Tetraodon nigroviridis				GO:0005576~extracellular region,	GO:0005125~cytokine activity,GO:0030298~receptor signaling protein tyrosine kinase activator activity,GO:0030971~receptor tyrosine kinase binding,	IPR029364:ALKL1/2,						KW-0964~Secreted,			KW-0732~Signal,
Q09490	Protein lgg-1(lgg-1)	Caenorhabditis elegans			GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0001778~plasma membrane repair,GO:0006914~autophagy,GO:0006995~cellular response to nitrogen starvation,GO:0008340~determination of adult lifespan,GO:0009408~response to heat,GO:0012501~programmed cell death,GO:0016236~macroautophagy,GO:0040024~dauer larval development,GO:0050830~defense response to Gram-positive bacterium,GO:0070266~necroptotic process,GO:0097237~cellular response to toxic substance,GO:0097352~autophagosome maturation,GO:0098792~xenophagy,GO:2000786~positive regulation of autophagosome assembly,	GO:0000407~pre-autophagosomal structure,GO:0000421~autophagosome membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005764~lysosome,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0030670~phagocytic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043202~lysosomal lumen,GO:0043204~perikaryon,	GO:0005515~protein binding,GO:0008429~phosphatidylethanolamine binding,GO:0031625~ubiquitin protein ligase binding,GO:0050811~GABA receptor binding,	IPR004241:Atg8-like,IPR029071:Ubiquitin-like_domsf,	cel04068:FoxO signaling pathway,cel04136:Autophagy - other,cel04137:Mitophagy - animal,cel04140:Autophagy - animal,cel04212:Longevity regulating pathway - worm,				KW-0072~Autophagy,	KW-0458~Lysosome,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,						KW-0449~Lipoprotein,	LIPID:Phosphatidylethanolamine amidated glycine,MUTAGEN:A->V: Does not rescue the degradation defect in the lgg-1 bp500 mutant.,MUTAGEN:D->A: Defective degradation of sepa-1-containing protein aggregates in embryos.,MUTAGEN:E->A: Mildly impaired membrane tethering activity and fusion in vitro.,MUTAGEN:G->A: Diffuse cytosolic localization in 500-cell embryos with no punctate pattern of distribution which is in contrast to wild-type. Not cleaved by atg-4.1 and atg-4.2. Does not rescue the protein degradation defect in the atg-4.1 bp501 mutant. Reduces lgg-2 lipidation and the accumulation of sqst-1-containing aggregates. Abolishes the interaction with atg-3.,MUTAGEN:K->A: Mildly impaired membrane tethering activity and fusion in vitro.,MUTAGEN:Missing: Impairs interaction with atg-3. Rescues the protein degradation defect in the atg-4.1 bp501 and atg-4.2 tm3948 single mutants. Does not rescue the lethal phenotype of the atg-4.1 bp501 and atg-4.2 tm3948 double mutant, but partially rescues the protein degradation defect.,MUTAGEN:Missing: In bp500; defective degradation of sepa-1-containing protein aggregates in comma stage embryos. Suppresses the lysosomal accumulation of ribosomal RNA and ribosomal proteins in the rnst-2 qx245 mutant.,MUTAGEN:R->C: In bp523; abolishes interaction with sqst-1 and impairs the interaction with epg-7, sepa-1 and unc-51. Defective degradation of sepa-1- and sqst-1-containing aggregates in embryos. No defects in lipidation or puncta formation.,MUTAGEN:RR->AA: Severely impaired membrane tethering activity and fusion in vitro. Does not rescue the degradation defect in the lgg-1 bp500 mutant.,MUTAGEN:W->G: Does not rescue the protein aggregate degradation defect in the lgg-1 bp500 mutant.,MUTAGEN:WA->GG: Impaired membrane tethering activity and fusion in vitro.,PROPEP:Removed in mature form,SITE:Cleavage,SITE:Required for interaction with sqst-1,SITE:Required for the interaction with unc-51,
P34528	Putative serine protease K12H4.7(K12H4.7)	Caenorhabditis elegans			GO:0006508~proteolysis,GO:0045087~innate immune response,		GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0016787~hydrolase activity,GO:0070008~serine-type exopeptidase activity,	IPR008758:Peptidase_S28,IPR029058:AB_hydrolase,IPR042269:Ser_carbopepase_S28_SKS,									KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,
Q80TM6	R3H domain containing 2(R3hdm2)	Mus musculus				GO:0005634~nucleus,	GO:0003676~nucleic acid binding,	IPR001374:R3H_dom,IPR024771:SUZ,IPR036867:R3H_dom_sf,				SM00393:R3H,		KW-0539~Nucleus,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:R3H,DOMAIN:SUZ,REGION:Disordered,
O18973	RAB guanine nucleotide exchange factor 1(RABGEF1)	Bos taurus			GO:0001933~negative regulation of protein phosphorylation,GO:0002686~negative regulation of leukocyte migration,GO:0006612~protein targeting to membrane,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007265~Ras protein signal transduction,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032715~negative regulation of interleukin-6 production,GO:0032764~negative regulation of mast cell cytokine production,GO:0038109~Kit signaling pathway,GO:0043303~mast cell degranulation,GO:0043305~negative regulation of mast cell degranulation,GO:0046580~negative regulation of Ras protein signal transduction,GO:0048261~negative regulation of receptor-mediated endocytosis,GO:0050728~negative regulation of inflammatory response,GO:0060368~regulation of Fc receptor mediated stimulatory signaling pathway,GO:0097531~mast cell migration,GO:0098935~dendritic transport,GO:1900235~negative regulation of Kit signaling pathway,	GO:0005730~nucleolus,GO:0005769~early endosome,GO:0005829~cytosol,GO:0030139~endocytic vesicle,GO:0030425~dendrite,GO:0055037~recycling endosome,	GO:0003677~DNA binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0008270~zinc ion binding,GO:0031267~small GTPase binding,GO:0061630~ubiquitin protein ligase activity,	IPR002653:Znf_A20,IPR003123:VPS9,IPR037191:VPS9_dom_sf,IPR041545:DUF5601,IPR045046:Vps9-like,	bta04137:Mitophagy - animal,			SM00167:VPS9,SM00259:ZnF_A20,	KW-0254~Endocytosis,KW-0653~Protein transport,KW-0813~Transport,KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:A20-type,DOMAIN:VPS9,MUTAGEN:A->D: Strongly reduced ubiquitin binding. Loss of ubiquitin binding; when associated with A-25.,MUTAGEN:L->D: Strongly reduced ubiquitin binding.,MUTAGEN:Y->A,P: Strongly reduced ubiquitin binding. Loss of ubiquitin binding; when associated with D-58. Loss of ubiquitin ligase activity; when associated with A-26.,MUTAGEN:Y->A,P: Strongly reduced ubiquitin binding. Loss of ubiquitin ligase activity; when associated with A-25.,REGION:Disordered,REGION:Interaction with ubiquitinated proteins,ZN_FING:A20-type,
Q6TNS7	RAB, member of RAS oncogene family-like 3(rabl3)	Danio rerio			GO:0001779~natural killer cell differentiation,GO:0006886~intracellular protein transport,GO:0030183~B cell differentiation,GO:0033077~T cell differentiation in thymus,GO:0046578~regulation of Ras protein signal transduction,GO:1903059~regulation of protein lipidation,	GO:0012505~endomembrane system,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0042803~protein homodimerization activity,	IPR027417:P-loop_NTPase,				SM00175:RAB,						KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			REGION:Small GTPase-like,
G3XA57	RAB11 family interacting protein 2 (class I)(Rab11fip2)	Mus musculus			GO:0006909~phagocytosis,GO:0015031~protein transport,GO:0030010~establishment of cell polarity,GO:0035669~TRAM-dependent toll-like receptor 4 signaling pathway,GO:0035773~insulin secretion involved in cellular response to glucose stimulus,GO:0043547~positive regulation of GTPase activity,GO:0045055~regulated exocytosis,GO:1903078~positive regulation of protein localization to plasma membrane,	GO:0001891~phagocytic cup,GO:0005654~nucleoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0055038~recycling endosome membrane,	GO:0019901~protein kinase binding,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR000008:C2_dom,IPR019018:Rab-bd_FIP-RBD,IPR035892:C2_domain_sf,IPR037245:FIP-RBD_C_sf,IPR037789:FIP_classI,	mmu04144:Endocytosis,			SM00239:C2,	KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:FIP-RBD,MOTIF:NPF 1,MOTIF:NPF 2,REGION:Disordered,REGION:Necessary for interaction with AP2A1, RAB11A, subcellular location, endocytosis activity and homooligomerization,REGION:Necessary for its cellular translocation to the plasma membrane,
Q9WTL2	RAB25, member RAS oncogene family(Rab25)	Mus musculus			GO:0003382~epithelial cell morphogenesis,GO:0006887~exocytosis,GO:0008284~positive regulation of cell proliferation,GO:0010634~positive regulation of epithelial cell migration,GO:0015031~protein transport,GO:0031268~pseudopodium organization,GO:0060627~regulation of vesicle-mediated transport,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031143~pseudopodium,GO:0031260~pseudopodium membrane,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0055037~recycling endosome,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0031489~myosin V binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,				SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,	KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0488~Methylation,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,
O00194	RAB27B, member RAS oncogene family(RAB27B)	Homo sapiens			GO:0006887~exocytosis,GO:0045921~positive regulation of exocytosis,GO:0048488~synaptic vesicle endocytosis,GO:0071985~multivesicular body sorting pathway,GO:0099641~anterograde axonal protein transport,	GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0005886~plasma membrane,GO:0016324~apical plasma membrane,GO:0030140~trans-Golgi network transport vesicle,GO:0030141~secretory granule,GO:0030672~synaptic vesicle membrane,GO:0031088~platelet dense granule membrane,GO:0032585~multivesicular body membrane,GO:0042470~melanosome,GO:0042589~zymogen granule membrane,GO:0070062~extracellular exosome,GO:0070382~exocytic vesicle,GO:1904115~axon cytoplasm,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0019904~protein domain specific binding,GO:0031489~myosin V binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR041837:Rab27a/b,	hsa04972:Pancreatic secretion,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,		KW-0472~Membrane,KW-0967~Endosome,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0488~Methylation,KW-0636~Prenylation,KW-1015~Disulfide bond,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,MUTAGEN:Q->L: GTP-locked. decreases interaction with DENND10.,MUTAGEN:T->N: GDP-locked. Increases interaction with DENND10. Disrupts late endocytic pathway homeostasis.,REGION:Disordered,
Q6NUV0	RAB3 GTPase activating protein subunit 1(rab3gap1)	Danio rerio			GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,	GO:0005096~GTPase activator activity,	IPR026147:Rab3GAP1_conserved,IPR045698:Rab3GAP1_C,IPR045700:Rab3GAP1,						KW-0256~Endoplasmic reticulum,KW-0963~Cytoplasm,					KW-0343~GTPase activation,		COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q9CZE3	RAB32, member RAS oncogene family(Rab32)	Mus musculus			GO:0006886~intracellular protein transport,GO:0007005~mitochondrion organization,GO:0016192~vesicle-mediated transport,GO:0019882~antigen processing and presentation,GO:0032438~melanosome organization,GO:0035646~endosome to melanosome transport,GO:0072657~protein localization to membrane,GO:0090382~phagosome maturation,GO:1903232~melanosome assembly,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0030670~phagocytic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0033162~melanosome membrane,GO:0042470~melanosome,GO:0044233~ER-mitochondrion membrane contact site,GO:0045335~phagocytic vesicle,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0030742~GTP-dependent protein binding,GO:0035650~AP-1 adaptor complex binding,GO:0035651~AP-3 adaptor complex binding,GO:0036461~BLOC-2 complex binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR030697:Rab29/Rab38/Rab32,				SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,		KW-0472~Membrane,KW-0496~Mitochondrion,KW-0968~Cytoplasmic vesicle,KW-1000~Mitochondrion outer membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0597~Phosphoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,MUTAGEN:Q->L: Inhibits the proper trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes.,MUTAGEN:V->A: Disrupts interaction with ANKRD27.,REGION:PKA-RII subunit binding domain,
Q5U316	RAB35, member RAS oncogene family(Rab35)	Rattus norvegicus			GO:0000281~mitotic cytokinesis,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016197~endosomal transport,GO:0019882~antigen processing and presentation,GO:0031175~neuron projection development,GO:0032456~endocytic recycling,GO:0032482~Rab protein signal transduction,GO:0036010~protein localization to endosome,GO:0048227~plasma membrane to endosome transport,GO:1990090~cellular response to nerve growth factor stimulus,	GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0010008~endosome membrane,GO:0030672~synaptic vesicle membrane,GO:0031253~cell projection membrane,GO:0042470~melanosome,GO:0045171~intercellular bridge,GO:0045334~clathrin-coated endocytic vesicle,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0019003~GDP binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR041815:Rab35,	rno04144:Endocytosis,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,SM00177:ARF,	KW-0653~Protein transport,KW-0813~Transport,	KW-0168~Coated pit,KW-0472~Membrane,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0597~Phosphoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,REGION:Disordered,
Q17QU4	RAB39B, member RAS oncogene family(RAB39B)	Bos taurus			GO:0006914~autophagy,GO:0010506~regulation of autophagy,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032482~Rab protein signal transduction,GO:0050808~synapse organization,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0043005~neuron projection,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0031489~myosin V binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR041818:Rab39,	bta04140:Autophagy - animal,bta05014:Amyotrophic lateral sclerosis,bta05022:Pathways of neurodegeneration - multiple diseases,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,	KW-0072~Autophagy,KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,
Q5ZHW4	RAB5B, member RAS oncogene family(RAB5B)	Gallus gallus			GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0030100~regulation of endocytosis,	GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0030139~endocytic vesicle,GO:0031901~early endosome membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,	gga04137:Mitophagy - animal,gga04144:Endocytosis,gga04145:Phagosome,gga04148:Efferocytosis,gga05132:Salmonella infection,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,	KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,REGION:Disordered,
P70550	RAB8B, member RAS oncogene family(Rab8b)	Rattus norvegicus			GO:0006904~vesicle docking involved in exocytosis,GO:0009306~protein secretion,GO:0017157~regulation of exocytosis,GO:0019882~antigen processing and presentation,GO:0031346~positive regulation of cell projection organization,GO:0032456~endocytic recycling,GO:0045046~protein import into peroxisome membrane,GO:0048210~Golgi vesicle fusion to target membrane,GO:0051461~positive regulation of corticotropin secretion,GO:0072659~protein localization to plasma membrane,	GO:0005768~endosome,GO:0005778~peroxisomal membrane,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0030140~trans-Golgi network transport vesicle,GO:0030670~phagocytic vesicle membrane,GO:0045335~phagocytic vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0051286~cell tip,GO:0098793~presynapse,	GO:0003924~GTPase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0030911~TPR domain binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,	rno04530:Tight junction,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,SM00177:ARF,	KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,TRANSMEM:Helical,
P51151	RAB9A, member RAS oncogene family(RAB9A)	Homo sapiens		h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery,	GO:0015031~protein transport,GO:0032482~Rab protein signal transduction,GO:0032880~regulation of protein localization,GO:0042147~retrograde transport, endosome to Golgi,GO:0045921~positive regulation of exocytosis,GO:0052403~negative regulation by host of symbiont catalytic activity,	GO:0000139~Golgi membrane,GO:0005764~lysosome,GO:0005770~late endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030133~transport vesicle,GO:0030670~phagocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0042470~melanosome,GO:0045335~phagocytic vesicle,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR041824:Rab9,	hsa05132:Salmonella infection,hsa05162:Measles,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,	KW-0653~Protein transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0597~Phosphoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,MUTAGEN:F->L: Loss of interaction with HPS4; when associated with L-66.,MUTAGEN:I->L: Loss of interaction with HPS4; when associated with L-66.,MUTAGEN:Q->L: Loss of interaction with HPS4; when associated with L-40 or L-44 or L-61.,MUTAGEN:W->L: Loss of interaction with HPS4; when associated with L-66.,
Q96D71	RALBP1 associated Eps domain containing 1(REPS1)	Homo sapiens			GO:0006897~endocytosis,GO:0016197~endosomal transport,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0043231~intracellular membrane-bounded organelle,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,	IPR000261:EH_dom,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,		617916~Neurodegeneration with brain iron accumulation 7,		SM00027:EH,		KW-0168~Coated pit,KW-0472~Membrane,		KW-0225~Disease variant,KW-0523~Neurodegeneration,	KW-0175~Coiled coil,KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:EF-hand,DOMAIN:EH,DOMAIN:EH 1,DOMAIN:EH 2,REGION:Disordered,REGION:Interaction with RALBP1,
Q640R7	RAP1B, member of RAS oncogene family(rap1b)	Xenopus tropicalis			GO:0007165~signal transduction,GO:0032486~Rap protein signal transduction,GO:0071320~cellular response to cAMP,GO:2000301~negative regulation of synaptic vesicle exocytosis,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070161~anchoring junction,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0019003~GDP binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR020849:Small_GTPase_Ras-type,IPR027417:P-loop_NTPase,IPR038851:Rap1,	xtr04010:MAPK signaling pathway,xtr04510:Focal adhesion,xtr04520:Adherens junction,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,
Q5R988	RAP2A, member of RAS oncogene family(RAP2A)	Pongo abelii			GO:0007165~signal transduction,GO:0008104~protein localization,GO:0030033~microvillus assembly,GO:0030036~actin cytoskeleton organization,GO:0030336~negative regulation of cell migration,GO:0031954~positive regulation of protein autophosphorylation,GO:0032486~Rap protein signal transduction,GO:0045184~establishment of protein localization,GO:0046328~regulation of JNK cascade,GO:0048814~regulation of dendrite morphogenesis,GO:0051963~regulation of synapse assembly,GO:0071466~cellular response to xenobiotic stimulus,GO:0072659~protein localization to plasma membrane,GO:0099072~regulation of postsynaptic specialization membrane neurotransmitter receptor levels,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0055038~recycling endosome membrane,GO:0098685~Schaffer collateral - CA1 synapse,	GO:0000287~magnesium ion binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR020849:Small_GTPase_Ras-type,IPR027417:P-loop_NTPase,IPR041840:Rap2,				SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,		KW-0472~Membrane,KW-0967~Endosome,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0564~Palmitate,KW-0636~Prenylation,KW-0832~Ubl conjugation,	LIPID:S-farnesyl cysteine,LIPID:S-palmitoyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,
P61227	RAP2B, member of RAS oncogene family(Rap2b)	Rattus norvegicus			GO:0030168~platelet activation,GO:0030336~negative regulation of cell migration,GO:0031954~positive regulation of protein autophosphorylation,GO:0032486~Rap protein signal transduction,GO:0061097~regulation of protein tyrosine kinase activity,GO:0070527~platelet aggregation,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0044291~cell-cell contact zone,GO:0045121~membrane raft,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0019904~protein domain specific binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR020849:Small_GTPase_Ras-type,IPR027417:P-loop_NTPase,IPR041840:Rap2,				SM00173:RAS,SM00174:RHO,SM00175:RAB,		KW-0472~Membrane,KW-0967~Endosome,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0564~Palmitate,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,LIPID:S-palmitoyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,
Q8IZ41	RAS and EF-hand domain containing(RASEF)	Homo sapiens			GO:0016192~vesicle-mediated transport,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0003924~GTPase activity,GO:0005509~calcium ion binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0042802~identical protein binding,	IPR001806:Small_GTPase,IPR002048:EF_hand_dom,IPR005225:Small_GTP-bd_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR027417:P-loop_NTPase,				SM00054:EFh,SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,	KW-0106~Calcium,KW-0342~GTP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,MUTAGEN:Q->L: Favors GTP association.,MUTAGEN:S->N: Impairs nucleotide binding and perinuclear localization.,REGION:Disordered,
O95267	RAS guanyl releasing protein 1(RASGRP1)	Homo sapiens			GO:0001934~positive regulation of protein phosphorylation,GO:0002437~inflammatory response to antigenic stimulus,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0030101~natural killer cell activation,GO:0030154~cell differentiation,GO:0032252~secretory granule localization,GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production,GO:0032729~positive regulation of interferon-gamma production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032825~positive regulation of natural killer cell differentiation,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0042098~T cell proliferation,GO:0042100~B cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0043303~mast cell degranulation,GO:0043406~positive regulation of MAP kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0046330~positive regulation of JNK cascade,GO:0046579~positive regulation of Ras protein signal transduction,GO:0047496~vesicle transport along microtubule,GO:0051896~regulation of protein kinase B signaling,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090630~activation of GTPase activity,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005509~calcium ion binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0019992~diacylglycerol binding,GO:0031210~phosphatidylcholine binding,GO:0042802~identical protein binding,	IPR000651:Ras-like_Gua-exchang_fac_N,IPR001895:RASGEF_cat_dom,IPR002048:EF_hand_dom,IPR002219:PE/DAG-bd,IPR008937:Ras-like_GEF,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR020454:DAG/PE-bd,IPR023578:Ras_GEF_dom_sf,IPR036964:RASGEF_cat_dom_sf,IPR046349:C1-like_sf,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04611:Platelet activation,hsa04660:T cell receptor signaling pathway,hsa05200:Pathways in cancer,hsa05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,	618534~Immunodeficiency 64,		SM00054:EFh,SM00109:C1,SM00147:RasGEF,SM00229:RasGEFN,	KW-0221~Differentiation,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0772~Systemic lupus erythematosus,	KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:N-terminal Ras-GEF,DOMAIN:Phorbol-ester/DAG-type,DOMAIN:Ras-GEF,MUTAGEN:DHDQD->AHAQA: Decrease of Ras activation indicated by decrease of ERK phosphorylation.,MUTAGEN:E->A: Decrease of Ras activation indicated by decrease of ERK phosphorylation.,MUTAGEN:F->D: Increase of Ras activation indicated by increase of ERK phosphorylation.,MUTAGEN:R->E: Loss of function; prevents Ras activation.,MUTAGEN:V->D: Increase of Ras activation indicated by increase of ERK phosphorylation.,MUTAGEN:Y->F: Loss of localization to the endoplasmic reticulum and the Golgi apparatus.,REGION:Disordered,REGION:PT region; mediates the BCR-dependent translocation to plasma membrane,REGION:Ras exchanger motif region; required for transforming activity,REGION:Suppress the PT region-mediated translocation to plasma membrane,ZN_FING:Phorbol-ester/DAG-type,
O95294	RAS protein activator like 1(RASAL1)	Homo sapiens			GO:0007165~signal transduction,GO:0030154~cell differentiation,GO:0035556~intracellular signal transduction,GO:0046580~negative regulation of Ras protein signal transduction,GO:0071277~cellular response to calcium ion,GO:1903861~positive regulation of dendrite extension,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,GO:0005543~phospholipid binding,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR001562:Znf_Btk_motif,IPR001849:PH_domain,IPR001936:RasGAP_dom,IPR008936:Rho_GTPase_activation_prot,IPR011993:PH-like_dom_sf,IPR023152:RasGAP_CS,IPR035892:C2_domain_sf,IPR037776:RASAL_RasGAP,IPR039360:Ras_GTPase,	hsa04014:Ras signaling pathway,			SM00107:BTK,SM00233:PH,SM00239:C2,SM00323:RasGAP,	KW-0221~Differentiation,				KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0343~GTPase activation,		DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:PH,DOMAIN:Ras-GAP,ZN_FING:Btk-type,
A1DZY4	RAS-like, family 11, member A(rasl11a)	Danio rerio			GO:0045943~positive regulation of transcription from RNA polymerase I promoter,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0016787~hydrolase activity,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,				SM00173:RAS,SM00174:RHO,SM00175:RAB,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,		REGION:Disordered,
Q969Z4	RELT TNF receptor(RELT)	Homo sapiens			GO:0006915~apoptotic process,GO:0097186~amelogenesis,	GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR022248:TNF_rcpt_RELT,IPR022333:TNFR_19-like,IPR034048:TNFRSF19L_N,	hsa04060:Cytokine-cytokine receptor interaction,	618386~Amelogenesis imperfecta, type IIIC,			KW-0053~Apoptosis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0986~Amelogenesis imperfecta,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,MOTIF:RFRV motif; mediates interaction with STK39,MUTAGEN:F->A: Loss of interaction with STK39.,REGION:Disordered,REPEAT:TNFR-Cys,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q2KI80	RELT like 2(RELL2)	Bos taurus			GO:0010811~positive regulation of cell-substrate adhesion,GO:1900745~positive regulation of p38MAPK cascade,	GO:0005886~plasma membrane,		IPR022248:TNF_rcpt_RELT,IPR042313:RELL2,	bta04060:Cytokine-cytokine receptor interaction,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,TRANSMEM:Helical,
Q6DGN0	RERG/RAS-like a(rergla)	Danio rerio					GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0016787~hydrolase activity,	IPR001806:Small_GTPase,IPR027417:P-loop_NTPase,				SM00173:RAS,SM00175:RAB,						KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,		REGION:Small GTPase-like,
Q4KWZ7	REV1, DNA directed polymerase(REV1)	Gallus gallus			GO:0002206~gene conversion of immunoglobulin genes,GO:0006302~double-strand break repair,GO:0042276~error-prone translesion synthesis,GO:0070987~error-free translesion synthesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0016779~nucleotidyltransferase activity,GO:0017125~deoxycytidyl transferase activity,GO:0046872~metal ion binding,	IPR001126:UmuC,IPR001357:BRCT_dom,IPR012112:REV1,IPR017961:DNA_pol_Y-fam_little_finger,IPR025527:HUWE1/Rev1_UBM,IPR031991:Rev1_C,IPR036420:BRCT_dom_sf,IPR036775:DNA_pol_Y-fam_lit_finger_sf,IPR038401:Rev1_C_sf,IPR043128:Rev_trsase/Diguanyl_cyclase,IPR043502:DNA/RNA_pol_sf,IPR047346:Rev1_UBM1/2,	gga03460:Fanconi anemia pathway,		PIRSF036573:REV1,	SM00292:BRCT,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0237~DNA synthesis,	KW-0539~Nucleus,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0238~DNA-binding,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:BRCT,DOMAIN:UmuC,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with target DNA,REGION:Protein interaction domain,SITE:Interaction with target DNA,
Q92546	RGP1 homolog, RAB6A GEF complex partner 1(RGP1)	Homo sapiens			GO:0042147~retrograde transport, endosome to Golgi,GO:0042177~negative regulation of protein catabolic process,GO:0043547~positive regulation of GTPase activity,	GO:0000139~Golgi membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0032588~trans-Golgi network membrane,GO:0032991~macromolecular complex,GO:0034066~RIC1-RGP1 guanyl-nucleotide exchange factor complex,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0031267~small GTPase binding,	IPR014848:Rgp1,						KW-0472~Membrane,KW-0963~Cytoplasm,					KW-0344~Guanine-nucleotide releasing factor,
Q4R698	RIB43A domain with coiled-coils 1(RIBC1)	Macaca fascicularis						IPR008805:RIB43A,									KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q8QFX1	RIMS binding protein 2(RIMBP2)	Gallus gallus			GO:0007274~neuromuscular synaptic transmission,	GO:0005886~plasma membrane,GO:0045202~synapse,	GO:0005515~protein binding,	IPR001452:SH3_domain,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR035753:RIM-BP_SH3_2,IPR035755:RIM-BP_SH3_3,IPR036028:SH3-like_dom_sf,IPR036116:FN3_sf,IPR040325:RIMBP1/2/3,				SM00060:FN3,SM00326:SH3,		KW-0472~Membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0728~SH3 domain,				COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:SH3,DOMAIN:SH3 1,DOMAIN:SH3 2,DOMAIN:SH3 3,REGION:Disordered,
P98175	RNA binding motif protein 10(RBM10)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000398~mRNA splicing, via spliceosome,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1905288~vascular associated smooth muscle cell apoptotic process,GO:1905461~positive regulation of vascular associated smooth muscle cell apoptotic process,GO:1990874~vascular smooth muscle cell proliferation,GO:2000204~negative regulation of ribosomal large subunit export from nucleus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016607~nuclear speck,GO:0032991~macromolecular complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0035198~miRNA binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000467:G_patch_dom,IPR000504:RRM_dom,IPR001876:Znf_RanBP2,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR013087:Znf_C2H2_type,IPR034992:RBM10_RRM2,IPR035618:RBM10_OCRE,IPR035979:RBD_domain_sf,IPR036443:Znf_RanBP2_sf,IPR041591:OCRE,		311900~TARP syndrome,		SM00360:RRM,SM00443:G_patch,SM00547:ZnF_RBZ,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,DOMAIN:G-patch,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RanBP2-type,REGION:Disordered,ZN_FING:C2H2-type; atypical,ZN_FING:RanBP2-type,
Q8C2Q3	RNA binding motif protein 14(Rbm14)	Mus musculus			GO:0000398~mRNA splicing, via spliceosome,GO:0002218~activation of innate immune response,GO:0002376~immune system process,GO:0006915~apoptotic process,GO:0007369~gastrulation,GO:0045087~innate immune response,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046600~negative regulation of centriole replication,GO:0060395~SMAD protein signal transduction,GO:0098534~centriole assembly,GO:1902151~regulation of response to DNA integrity checkpoint signaling,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:1990935~splicing factor binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034506:RBM14_RRM1,IPR034507:RBM14_RRM2,IPR035979:RBD_domain_sf,				SM00360:RRM,	KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,REGION:TRBP-interacting domain; interaction with STIL,
Q5ZJX4	RNA binding motif protein 38(RBM38)	Gallus gallus			GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0030154~cell differentiation,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR035979:RBD_domain_sf,				SM00360:RRM,	KW-0221~Differentiation,KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,		DOMAIN:RRM,
Q6IQ97	RNA binding motif protein 4.1(rbm4.1)	Danio rerio			GO:0000398~mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000504:RRM_dom,IPR001878:Znf_CCHC,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034897:RBM4_RRM1,IPR034898:RBM4_RRM2,IPR035979:RBD_domain_sf,				SM00343:ZnF_C2HC,SM00360:RRM,		KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	DOMAIN:CCHC-type,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,ZN_FING:CCHC-type,
Q5RBD3	RNA binding motif single stranded interacting protein 3(RBMS3)	Pongo abelii				GO:0005634~nucleus,GO:0005737~cytoplasm,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003729~mRNA binding,	IPR000504:RRM_dom,IPR002343:Hud_Sxl_RNA,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034406:RBMS3_RRM2,IPR035979:RBD_domain_sf,				SM00360:RRM,		KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,
Q6DH13	RNA binding protein, mRNA processing factor 2a(rbpms2a)	Danio rerio			GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0031290~retinal ganglion cell axon guidance,GO:0046660~female sex differentiation,GO:0048813~dendrite morphogenesis,GO:0051151~negative regulation of smooth muscle cell differentiation,GO:0090259~regulation of retinal ganglion cell axon guidance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0042803~protein homodimerization activity,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034787:RBPMS2_RRM,IPR035979:RBD_domain_sf,				SM00360:RRM,		KW-0963~Cytoplasm,					KW-0694~RNA-binding,		COMPBIAS:Polar residues,DOMAIN:RRM,REGION:Disordered,
Q6MFY5	RNA polymerase I subunit H(Polr1h)	Rattus norvegicus			GO:0006351~transcription, DNA-templated,GO:0006363~termination of RNA polymerase I transcription,	GO:0000428~DNA-directed RNA polymerase complex,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005736~DNA-directed RNA polymerase I complex,GO:0016020~membrane,	GO:0001054~RNA polymerase I activity,GO:0003676~nucleic acid binding,GO:0003899~DNA-directed 5'-3' RNA polymerase activity,GO:0008270~zinc ion binding,	IPR001222:Znf_TFIIS,IPR012164:Rpa12/Rpb9/Rpc10/TFS,IPR019761:DNA-dir_RNA_pol-M_15_CS,IPR034004:Zn_ribbon_RPA12_C,	rno03020:RNA polymerase,		PIRSF005586:RNApol_RpoM,	SM00440:ZnF_C2C2,	KW-0804~Transcription,	KW-0240~DNA-directed RNA polymerase,KW-0472~Membrane,KW-0539~Nucleus,KW-9994~DNA-directed RNA polymerase,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,			DOMAIN:TFIIS-type,TRANSMEM:Helical,ZN_FING:C4-type,ZN_FING:TFIIS-type,
P52435	RNA polymerase II subunit J(POLR2J)	Homo sapiens			GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,	GO:0000428~DNA-directed RNA polymerase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,	GO:0001055~RNA polymerase II activity,GO:0003677~DNA binding,GO:0003899~DNA-directed 5'-3' RNA polymerase activity,GO:0005515~protein binding,GO:0030275~LRR domain binding,GO:0046983~protein dimerization activity,	IPR008193:RNA_pol_Rpb11_13-16kDa_CS,IPR009025:RBP11-like_dimer,IPR022905:Rpo11-like,IPR024831:Uroplakin-3,IPR036603:RBP11-like,IPR037685:RBP11,	hsa03020:RNA polymerase,hsa03420:Nucleotide excision repair,hsa05016:Huntington disease,				KW-0804~Transcription,	KW-0240~DNA-directed RNA polymerase,KW-0539~Nucleus,KW-9994~DNA-directed RNA polymerase,						KW-0007~Acetylation,	DOMAIN:DNA-directed RNA polymerase RBP11-like dimerisation,
Q9H1D9	RNA polymerase III subunit F(POLR3F)	Homo sapiens			GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0006383~transcription from RNA polymerase III promoter,GO:0032728~positive regulation of interferon-beta production,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0051607~defense response to virus,	GO:0005654~nucleoplasm,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005829~cytosol,	GO:0003690~double-stranded DNA binding,GO:0003899~DNA-directed 5'-3' RNA polymerase activity,GO:0005515~protein binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR007832:RNA_pol_Rpc34,IPR016049:RNA_pol_Rpc34-like,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,	hsa03020:RNA polymerase,hsa04623:Cytosolic DNA-sensing pathway,	619872~Immunodeficiency 101 (varicella zoster virus-specific),	PIRSF028763:RNA_pol_Rpc34,		KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,	KW-0240~DNA-directed RNA polymerase,KW-0539~Nucleus,KW-9994~DNA-directed RNA polymerase,					KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MUTAGEN:ESE->KSK: Strongly impaired dsDNA-binding. No effect on interaction with POLR3C.,MUTAGEN:KAVK->EAVE: Strongly impaired dsDNA-binding. No effect on interaction with POLR3C.,
Q9Y535	RNA polymerase III subunit H(POLR3H)	Homo sapiens			GO:0006139~nucleobase-containing compound metabolic process,GO:0006351~transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006383~transcription from RNA polymerase III promoter,GO:0006384~transcription initiation from RNA polymerase III promoter,GO:0045087~innate immune response,GO:0051607~defense response to virus,	GO:0000428~DNA-directed RNA polymerase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005813~centrosome,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003899~DNA-directed 5'-3' RNA polymerase activity,GO:0005515~protein binding,	IPR004519:RNAP_E/RPC8,IPR005576:Rpb7-like_N,IPR012340:NA-bd_OB-fold,IPR013238:RNA_pol_III_Rbc25,IPR036898:RNA_pol_Rpb7-like_N_sf,IPR045113:Rpb7-like,	hsa03020:RNA polymerase,hsa04623:Cytosolic DNA-sensing pathway,				KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,	KW-0240~DNA-directed RNA polymerase,KW-0539~Nucleus,KW-9994~DNA-directed RNA polymerase,							COMPBIAS:Polar residues,DOMAIN:RNA polymerase Rpb7-like N-terminal,REGION:Disordered,
Q8IYK8	RRAD and GEM like GTPase 2(REM2)	Homo sapiens				GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0005246~calcium channel regulator activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR001806:Small_GTPase,IPR017358:RGK,IPR025662:Sigma_54_int_dom_ATP-bd_1,IPR027417:P-loop_NTPase,			PIRSF038017:GTP-binding_GEM,	SM00173:RAS,SM00174:RHO,SM00175:RAB,		KW-0472~Membrane,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,
Q01196	RUNX family transcription factor 1(RUNX1)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001503~ossification,GO:0002062~chondrocyte differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010755~regulation of plasminogen activation,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030182~neuron differentiation,GO:0030853~negative regulation of granulocyte differentiation,GO:0030854~positive regulation of granulocyte differentiation,GO:0032743~positive regulation of interleukin-2 production,GO:0032967~positive regulation of collagen biosynthetic process,GO:0043371~negative regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043378~positive regulation of CD8-positive, alpha-beta T cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048935~peripheral nervous system neuron development,GO:0051094~positive regulation of developmental process,GO:0060043~regulation of cardiac muscle cell proliferation,GO:0061026~cardiac muscle tissue regeneration,GO:0071425~hematopoietic stem cell proliferation,GO:1903055~positive regulation of extracellular matrix organization,GO:1905203~regulation of connective tissue replacement,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016513~core-binding factor complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001222~transcription corepressor binding,GO:0001223~transcription coactivator binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000040:AML1_Runt,IPR002893:Znf_MYND,IPR008967:p53-like_TF_DNA-bd_sf,IPR012346:p53/RUNT-type_TF_DNA-bd_sf,IPR013289:CBFA2T1/2/3,IPR013290:CBFA2T1,IPR013524:Runt_dom,IPR013711:RunxI_C_dom,IPR014896:NHR2,IPR016554:TF_Runt-rel_RUNX,IPR027384:Runx_central_dom_sf,	hsa04530:Tight junction,hsa04659:Th17 cell differentiation,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,	601399~Platelet disorder, familial, with associated myeloid malignancy,601626~Leukemia, acute myeloid,	PIRSF009374:TF_Runt-rel_RUNX,		KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,		KW-0225~Disease variant,KW-0656~Proto-oncogene,	KW-0175~Coiled coil,KW-0812~Transmembrane,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0868~Chloride,	KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:MYND-type,DOMAIN:NHR2-like,DOMAIN:Runt,MUTAGEN:A->T: Loss of heterodimerization. Disrupts interactionof AML1-MTG8/ETO with CBFB, no effect on AML1-MTG8/ETO-mediated transformation activity.,MUTAGEN:D->A: Strongly reduces DNA-binding.,MUTAGEN:G->R: Loss of heterodimerization and impaired phosphorylation.,MUTAGEN:K->A: Reduces DNA-binding.,MUTAGEN:K->A: Strongly reduces DNA-binding.,MUTAGEN:K->E: Strongly reduces DNA-binding, impaired phosphorylation and reduced EP300 phosphorylation induction.,MUTAGEN:M->V: Disrupts interaction of AML1-MTG8/ETO with CBFB, no effect on AML1-MTG8/ETO-mediated transformation activity.,MUTAGEN:Missing: No DNA-binding.,MUTAGEN:R->A: Strongly reduces DNA-binding.,MUTAGEN:S->A: Reduced phosphorylation.,MUTAGEN:S->A: Reduced phosphorylation; when associated with A-273.,MUTAGEN:S->G: Disrupts AML1-MTG8/ETO DNA-binding, decreases AML1-MTG8/ETO transforming activity.,MUTAGEN:S->R: Loss of heterodimerization and reduced EP300 phosphorylation induction.,MUTAGEN:T->A: No effect on DNA binding.,MUTAGEN:T->A: Reduced phosphorylation; when associated with A-276.,MUTAGEN:T->A: Strongly reduces DNA-binding.,REGION:Disordered,REGION:Interaction with DNA,REGION:Interaction with FOXP3,REGION:Interaction with KAT6A,REGION:Interaction with KAT6B,SITE:Breakpoint for translocation to form AML1-EAP in T-MDS and CML, to form type II MACROD1-RUNX1 fusion protein and to form RUNX1-CBFA2T2 in acute myeloid leukemia,SITE:Breakpoint for translocation to form AML1-EMV-1 (or AML1-EAP) in CML and T-MDS, to form AML1-MTG8 (ETO) in AML-M2, to form AML1-CBFA2T3 in therapy-related myeloid malignancies, to form AML1-MECOM in CML and to form type I MACROD1-RUNX1 fusion protein,
Q9CQK7	RWD domain containing 1(Rwdd1)	Mus musculus			GO:0002181~cytoplasmic translation,GO:0030521~androgen receptor signaling pathway,GO:0034599~cellular response to oxidative stress,GO:0071394~cellular response to testosterone stimulus,GO:2000825~positive regulation of androgen receptor activity,	GO:0005737~cytoplasm,GO:0005844~polysome,		IPR006575:RWD-domain,IPR016135:UBQ-conjugating_enzyme/RWD,IPR032378:ZC3H15/TMA46_C,IPR040213:GIR2-like,				SM00591:RWD,								KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,DOMAIN:RWD,REGION:Disordered,REGION:Interaction with DRG2,
Q6PBV4	RWD domain containing 3(rwdd3)	Danio rerio			GO:0033235~positive regulation of protein sumoylation,GO:1902073~positive regulation of hypoxia-inducible factor-1alpha signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR006575:RWD-domain,IPR016135:UBQ-conjugating_enzyme/RWD,IPR038840:RWDD3,				SM00591:RWD,		KW-0539~Nucleus,KW-0963~Cytoplasm,							DOMAIN:RWD,
Q9H0H5	Rac GTPase activating protein 1(RACGAP1)	Homo sapiens			GO:0000281~mitotic cytokinesis,GO:0000915~actomyosin contractile ring assembly,GO:0006811~ion transport,GO:0007165~signal transduction,GO:0007266~Rho protein signal transduction,GO:0007283~spermatogenesis,GO:0007405~neuroblast proliferation,GO:0008272~sulfate transport,GO:0030218~erythrocyte differentiation,GO:0032467~positive regulation of cytokinesis,GO:0045995~regulation of embryonic development,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051256~mitotic spindle midzone assembly,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,	GO:0001669~acrosomal vesicle,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0005829~cytosol,GO:0005874~microtubule,GO:0009898~cytoplasmic side of plasma membrane,GO:0030496~midbody,GO:0032154~cleavage furrow,GO:0051233~spindle midzone,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,GO:0090543~Flemming body,GO:0097149~centralspindlin complex,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008017~microtubule binding,GO:0019901~protein kinase binding,GO:0043014~alpha-tubulin binding,GO:0043015~gamma-tubulin binding,GO:0046872~metal ion binding,GO:0048487~beta-tubulin binding,	IPR000198:RhoGAP_dom,IPR002219:PE/DAG-bd,IPR008936:Rho_GTPase_activation_prot,IPR046349:C1-like_sf,		619789~Anemia, congenital dyserythropoietic, type IIIb, autosomal recessive,		SM00109:C1,SM00324:RhoGAP,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0221~Differentiation,KW-0406~Ion transport,KW-0744~Spermatogenesis,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0360~Hereditary hemolytic anemia,KW-1055~Congenital dyserythropoietic anemia,	KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0446~Lipid-binding,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0343~GTPase activation,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Phorbol-ester/DAG-type,DOMAIN:Rho-GAP,MUTAGEN:C->G: Cytokinesis failure.,MUTAGEN:F->A: Cytokinesis failure. Abolishes localization at the cell membrane.,MUTAGEN:F->G: Cytokinesis failure.,MUTAGEN:K->L: Cytokinesis failure. Abolishes localization at the cell membrane.,MUTAGEN:R->A: Abolishes GAP activity towards RAC1. Abolishes GAP activity towards CDC42 in prometaphase. Abolishes GAP activity towards RHOA. Induces multiple blebs during cytokinesis.,MUTAGEN:R->L: Cytokinesis failure. Abolishes localization at the cell membrane.,MUTAGEN:S->A: Does not inhibit interaction with ECT2. Strongly reduces phosphorylation, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-149; A-157 and A-164. Strongly reduces phosphorylation by PLK1, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-157; A-164 and A-214.,MUTAGEN:S->A: Does not inhibit interaction with ECT2. Strongly reduces phosphorylation, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-149; A-157 and A-170. Strongly reduces phosphorylation by PLK1, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-157; A-170 and A-214.,MUTAGEN:S->A: Does not inhibit interaction with ECT2. Strongly reduces phosphorylation, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-149; A-164 and A-170. Strongly reduces phosphorylation by PLK1, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-164; A-170 and A-214.,MUTAGEN:S->A: Does not inhibit interaction with ECT2. Strongly reduces phosphorylation, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-157; A-164 and A-170.,MUTAGEN:S->A: Strongly reduces phosphorylation by PLK1, inhibits interaction with ECT2 and cleavage furrow formation; when associated with A-157; A-164 and A-170.,MUTAGEN:W->A: More than 20-fold reduction in binding to ECT2.,REGION:Disordered,REGION:Interaction with SLC26A8,ZN_FING:Phorbol-ester/DAG-type,
B0UXH6	Ral GEF with PH domain and SH3 binding motif 1(ralgps1)	Danio rerio			GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,	IPR001849:PH_domain,IPR001895:RASGEF_cat_dom,IPR008937:Ras-like_GEF,IPR011993:PH-like_dom_sf,IPR023578:Ras_GEF_dom_sf,IPR036964:RASGEF_cat_dom_sf,				SM00147:RasGEF,SM00233:PH,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,					KW-0344~Guanine-nucleotide releasing factor,		COMPBIAS:Polar residues,DOMAIN:PH,DOMAIN:Ras-GEF,MOTIF:PXXP,REGION:Disordered,
Q99MK9	Ras association (RalGDS/AF-6) domain family member 1(Rassf1)	Mus musculus			GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007265~Ras protein signal transduction,GO:0031398~positive regulation of protein ubiquitination,GO:0050821~protein stabilization,GO:0051726~regulation of cell cycle,GO:1902806~regulation of cell cycle G1/S phase transition,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,	GO:0005515~protein binding,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000159:RA_dom,IPR002219:PE/DAG-bd,IPR011524:SARAH_dom,IPR029071:Ubiquitin-like_domsf,IPR033600:RASSF1_RA,IPR033614:RASSF1-6,IPR046349:C1-like_sf,	mmu04014:Ras signaling pathway,mmu04390:Hippo signaling pathway,mmu04392:Hippo signaling pathway - multiple species,mmu05200:Pathways in cancer,mmu05206:MicroRNAs in cancer,mmu05219:Bladder cancer,mmu05223:Non-small cell lung cancer,			SM00109:C1,SM00314:RA,	KW-0131~Cell cycle,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,	KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Phorbol-ester/DAG-type,DOMAIN:Ras-associating,DOMAIN:SARAH,REGION:Disordered,REGION:MOAP1-binding,REGION:Mediates interaction with E4F1,ZN_FING:Phorbol-ester/DAG-type,
A7UA95	Ras association and DIL domains(radil)	Danio rerio			GO:0001755~neural crest cell migration,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0034446~substrate adhesion-dependent cell spreading,	GO:0005874~microtubule,	GO:0051020~GTPase binding,	IPR000159:RA_dom,IPR000253:FHA_dom,IPR001478:PDZ,IPR002710:Dilute_dom,IPR008984:SMAD_FHA_dom_sf,IPR029071:Ubiquitin-like_domsf,IPR036034:PDZ_sf,IPR037983:CBD_Rasip1/Radil,	dre04520:Adherens junction,			SM00228:PDZ,SM00314:RA,SM01132:DIL,	KW-0130~Cell adhesion,						KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Dilute,DOMAIN:FHA,DOMAIN:PDZ,DOMAIN:Ras-associating,REGION:Disordered,
P50749	Ras association domain family member 2(RASSF2)	Homo sapiens			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0031954~positive regulation of protein autophosphorylation,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0045667~regulation of osteoblast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045860~positive regulation of protein kinase activity,GO:0046330~positive regulation of JNK cascade,GO:0046849~bone remodeling,GO:0048872~homeostasis of number of cells,GO:0050821~protein stabilization,GO:1901222~regulation of NIK/NF-kappaB signaling,GO:1901223~negative regulation of NIK/NF-kappaB signaling,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0032991~macromolecular complex,	GO:0004672~protein kinase activity,GO:0005515~protein binding,	IPR000159:RA_dom,IPR011524:SARAH_dom,IPR029071:Ubiquitin-like_domsf,IPR033614:RASSF1-6,IPR033618:RASSF2_RA,	hsa04392:Hippo signaling pathway - multiple species,			SM00314:RA,	KW-0131~Cell cycle,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,		KW-0043~Tumor suppressor,				KW-0597~Phosphoprotein,	DOMAIN:Ras-associating,DOMAIN:SARAH,REGION:Disordered,
Q75NR7	RecQ protein-like 4(Recql4)	Mus musculus			GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0001501~skeletal system development,GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006310~DNA recombination,GO:0007062~sister chromatid cohesion,GO:0008284~positive regulation of cell proliferation,GO:0032508~DNA duplex unwinding,GO:0043473~pigmentation,GO:0045875~negative regulation of sister chromatid cohesion,GO:0048705~skeletal system morphogenesis,GO:0061820~telomeric D-loop disassembly,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0000405~bubble DNA binding,GO:0003676~nucleic acid binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0009378~four-way junction helicase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0032357~oxidized purine DNA binding,GO:0043138~3'-5' DNA helicase activity,GO:0046872~metal ion binding,GO:0061821~telomeric D-loop binding,GO:1990814~DNA/DNA annealing activity,	IPR001650:Helicase_C,IPR001878:Znf_CCHC,IPR004589:DNA_helicase_ATP-dep_RecQ,IPR011545:DEAD/DEAH_box_helicase_dom,IPR014001:Helicase_ATP-bd,IPR021110:DNA_rep_checkpnt_protein,IPR027417:P-loop_NTPase,IPR036875:Znf_CCHC_sf,				SM00343:ZnF_C2HC,SM00487:DEXDc,SM00490:HELICc,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0347~Helicase,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:CCHC-type,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,REGION:Disordered,ZN_FING:CCHC-type,
Q69D48	Rh family B glycoprotein L homeolog(rhbg.L)	Xenopus laevis			GO:0072488~ammonium transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,	GO:0008519~ammonium transmembrane transporter activity,	IPR002229:RhesusRHD,IPR024041:NH4_transpt_AmtB-like_dom,IPR029020:Ammonium/urea_transptr,					KW-0813~Transport,KW-0924~Ammonia transport,	KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ammonium transporter AmtB-like,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q80Y19	Rho GTPase activating protein 11A(Arhgap11a)	Mus musculus			GO:0007165~signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005634~nucleus,GO:0005759~mitochondrial matrix,	GO:0005096~GTPase activator activity,	IPR000198:RhoGAP_dom,IPR008936:Rho_GTPase_activation_prot,IPR042869:ARHGAP11A/B,				SM00324:RhoGAP,		KW-0539~Nucleus,					KW-0343~GTPase activation,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Rho-GAP,REGION:Disordered,
Q5ZMM3	Rho GTPase activating protein 15(ARHGAP15)	Gallus gallus			GO:0007165~signal transduction,GO:0043087~regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0005096~GTPase activator activity,	IPR000198:RhoGAP_dom,IPR001849:PH_domain,IPR008936:Rho_GTPase_activation_prot,IPR011993:PH-like_dom_sf,				SM00233:PH,SM00324:RhoGAP,		KW-0472~Membrane,KW-0963~Cytoplasm,					KW-0343~GTPase activation,		COMPBIAS:Polar residues,DOMAIN:PH,DOMAIN:Rho-GAP,REGION:Disordered,
Q6INE5	Rho GTPase activating protein 19 L homeolog(arhgap19.L)	Xenopus laevis			GO:0007165~signal transduction,		GO:0005096~GTPase activator activity,	IPR000198:RhoGAP_dom,IPR008936:Rho_GTPase_activation_prot,IPR047941:ARHGAP19_RhoGAP,				SM00324:RhoGAP,							KW-0343~GTPase activation,		COMPBIAS:Polar residues,DOMAIN:Rho-GAP,REGION:Disordered,
Q6IFT4	Rho GTPase activating protein 20(Arhgap20)	Mus musculus			GO:0007165~signal transduction,GO:0035023~regulation of Rho protein signal transduction,		GO:0005096~GTPase activator activity,	IPR000159:RA_dom,IPR000198:RhoGAP_dom,IPR001849:PH_domain,IPR008936:Rho_GTPase_activation_prot,IPR011993:PH-like_dom_sf,IPR029071:Ubiquitin-like_domsf,IPR047886:ARHGAP20-like_RhoGAP,IPR047887:ARHGAP20_PH,IPR047888:ARHGAP20_RA,				SM00233:PH,SM00324:RhoGAP,							KW-0343~GTPase activation,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:PH,DOMAIN:Ras-associating,DOMAIN:Rho-GAP,REGION:Disordered,
Q5U2Z7	Rho GTPase activating protein 24(Arhgap24)	Rattus norvegicus			GO:0001525~angiogenesis,GO:0007165~signal transduction,GO:0016601~Rac protein signal transduction,GO:0030154~cell differentiation,GO:0035021~negative regulation of Rac protein signal transduction,GO:0035313~wound healing, spreading of epidermal cells,GO:0090630~activation of GTPase activity,GO:1900028~negative regulation of ruffle assembly,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0042995~cell projection,	GO:0005096~GTPase activator activity,	IPR000198:RhoGAP_dom,IPR001849:PH_domain,IPR008936:Rho_GTPase_activation_prot,IPR011993:PH-like_dom_sf,				SM00233:PH,SM00324:RhoGAP,	KW-0037~Angiogenesis,KW-0221~Differentiation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,			KW-0175~Coiled coil,		KW-0217~Developmental protein,KW-0343~GTPase activation,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PH,DOMAIN:Rho-GAP,REGION:Disordered,
Q91YM2	Rho GTPase activating protein 35(Arhgap35)	Mus musculus			GO:0001843~neural tube closure,GO:0007165~signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0007266~Rho protein signal transduction,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008360~regulation of cell shape,GO:0008361~regulation of cell size,GO:0010976~positive regulation of neuron projection development,GO:0016477~cell migration,GO:0021955~central nervous system neuron axonogenesis,GO:0030879~mammary gland development,GO:0030900~forebrain development,GO:0030950~establishment or maintenance of actin cytoskeleton polarity,GO:0031668~cellular response to extracellular stimulus,GO:0032956~regulation of actin cytoskeleton organization,GO:0035024~negative regulation of Rho protein signal transduction,GO:0043010~camera-type eye development,GO:0043116~negative regulation of vascular permeability,GO:0043547~positive regulation of GTPase activity,GO:0044319~wound healing, spreading of cells,GO:0045724~positive regulation of cilium assembly,GO:0050770~regulation of axonogenesis,GO:0097485~neuron projection guidance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0036064~ciliary basal body,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003924~GTPase activity,GO:0005096~GTPase activator activity,GO:0005525~GTP binding,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0032794~GTPase activating protein binding,GO:0044877~macromolecular complex binding,	IPR000198:RhoGAP_dom,IPR001806:Small_GTPase,IPR002713:FF_domain,IPR008936:Rho_GTPase_activation_prot,IPR027417:P-loop_NTPase,IPR032835:RhoGAP-FF1,IPR036517:FF_domain_sf,IPR039006:RhoGAP_pG2,IPR039007:pG1,IPR045786:RhoGAP_pG1_pG2,	mmu04510:Focal adhesion,mmu04611:Platelet activation,mmu04670:Leukocyte transendothelial migration,mmu04810:Regulation of actin cytoskeleton,			SM00324:RhoGAP,SM00441:FF,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,	KW-0342~GTP-binding,KW-0446~Lipid-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0343~GTPase activation,KW-0675~Receptor,KW-0678~Repressor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:FF,DOMAIN:FF 1,DOMAIN:FF 2,DOMAIN:FF 3,DOMAIN:FF 4,DOMAIN:PG1 pseudoGTPase,DOMAIN:PG2 pseudoGTPase,DOMAIN:Rho-GAP,DOMAIN:pG1 pseudoGTPase,DOMAIN:pG2 pseudoGTPase,MUTAGEN:L->Q: In ENU mutant Arhgap35-D34; mutant animals show hypodysplastic kidneys and neural tube closure defects; the number of ciliated cells and cilia average length are drastically reduced in the proximal tubules. Results in loss of activation of GTP hydrolysis.,MUTAGEN:S->A: Abolishes phosphorylation by GSK3B. Reduces phosphorylation by MAPK. Affects polarized cell migration. Increases RhoGAP catalytic activity.,MUTAGEN:S->A: Abolishes phosphorylation by GSK3B. Reduces phosphorylation by MAPK. No effect on polarized cell migration.,MUTAGEN:S->A: Reduces phosphorylation by GSK3B by 50%. No effect on polarized cell migration.,MUTAGEN:T->A: Abolishes phosphorylation by GSK3B. Reduces phosphorylation by MAPK. Affects polarized cell migration. Increases RhoGAP catalytic activity.,REGION:Disordered,REGION:Has GTPase activity, required for proper localization,REGION:Required for phospholipid binding and regulation of the substrate preference,
O77819	Rho associated coiled-coil containing protein kinase 1(ROCK1)	Oryctolagus cuniculus			GO:0000281~mitotic cytokinesis,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006996~organelle organization,GO:0007266~Rho protein signal transduction,GO:0016310~phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0030036~actin cytoskeleton organization,GO:0030334~regulation of cell migration,GO:0030866~cortical actin cytoskeleton organization,GO:0031032~actomyosin structure organization,GO:0032956~regulation of actin cytoskeleton organization,GO:0042326~negative regulation of phosphorylation,GO:0048598~embryonic morphogenesis,GO:0051451~myoblast migration,GO:0051894~positive regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0090521~glomerular visceral epithelial cell migration,GO:1901888~regulation of cell junction assembly,	GO:0000139~Golgi membrane,GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0010494~cytoplasmic stress granule,GO:0030027~lamellipodium,GO:0032059~bleb,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0031267~small GTPase binding,GO:0046872~metal ion binding,GO:0072518~Rho-dependent protein serine/threonine kinase activity,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR001849:PH_domain,IPR002219:PE/DAG-bd,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011072:HR1_rho-bd,IPR011993:PH-like_dom_sf,IPR015008:ROCK_Rho-bd_dom,IPR017441:Protein_kinase_ATP_BS,IPR020684:ROCK1/ROCK2,IPR037310:ROCK1_HR1,IPR046349:C1-like_sf,	ocu04022:cGMP-PKG signaling pathway,ocu04024:cAMP signaling pathway,ocu04062:Chemokine signaling pathway,ocu04071:Sphingolipid signaling pathway,ocu04270:Vascular smooth muscle contraction,ocu04350:TGF-beta signaling pathway,ocu04360:Axon guidance,ocu04510:Focal adhesion,ocu04520:Adherens junction,ocu04530:Tight junction,ocu04611:Platelet activation,ocu04670:Leukocyte transendothelial migration,ocu04810:Regulation of actin cytoskeleton,ocu04921:Oxytocin signaling pathway,ocu05135:Yersinia infection,ocu05163:Human cytomegalovirus infection,ocu05200:Pathways in cancer,ocu05205:Proteoglycans in cancer,ocu05206:MicroRNAs in cancer,		PIRSF037568:Rho_kinase,	SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,	KW-0053~Apoptosis,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:AGC-kinase C-terminal,DOMAIN:PH,DOMAIN:Phorbol-ester/DAG-type,DOMAIN:Protein kinase,DOMAIN:REM-1,DOMAIN:RhoBD,REGION:Auto-inhibitory,REGION:Disordered,REGION:Interaction with FHOD1,REGION:RHOA binding,REGION:SHROOM3 binding,SITE:Cleavage; by caspase-3,ZN_FING:Phorbol-ester/DAG-type,
Q6SA80	Rho family GTPase 3(Rnd3)	Rattus norvegicus			GO:0007015~actin filament organization,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0016477~cell migration,GO:0032956~regulation of actin cytoskeleton organization,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019901~protein kinase binding,	IPR001806:Small_GTPase,IPR003578:Small_GTPase_Rho,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR041843:RhoE,				SM00173:RAS,SM00174:RHO,SM00175:RAB,		KW-0472~Membrane,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0488~Methylation,KW-0636~Prenylation,	LIPID:S-farnesyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,
Q3UPH7	Rho guanine nucleotide exchange factor 40(Arhgef40)	Mus musculus				GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,	IPR000219:DH-domain,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,				SM00233:PH,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DH,DOMAIN:PH,REGION:Disordered,
O94844	Rho related BTB domain containing 1(RHOBTB1)	Homo sapiens			GO:0006897~endocytosis,GO:0007015~actin filament organization,GO:0007163~establishment or maintenance of cell polarity,GO:0007264~small GTPase mediated signal transduction,GO:0032488~Cdc42 protein signal transduction,	GO:0005886~plasma membrane,GO:0010008~endosome membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019901~protein kinase binding,	IPR000210:BTB/POZ_dom,IPR001806:Small_GTPase,IPR003578:Small_GTPase_Rho,IPR011333:SKP1/BTB/POZ_sf,IPR027417:P-loop_NTPase,	hsa04120:Ubiquitin mediated proteolysis,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00225:BTB,					KW-0677~Repeat,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			DOMAIN:BTB 1,DOMAIN:BTB 2,REGION:Disordered,REGION:Rho-like,
Q61599	Rho, GDP dissociation inhibitor beta(Arhgdib)	Mus musculus		m_caspasePathway:Caspase Cascade in Apoptosis,m_d4gdiPathway:D4-GDI Signaling Pathway,m_fasPathway:FAS signaling pathway ( CD95 ),m_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,m_tnfr1Pathway:TNFR1 Signaling Pathway,	GO:0007266~Rho protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:1901164~negative regulation of trophoblast cell migration,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005094~Rho GDP-dissociation inhibitor activity,GO:0005096~GTPase activator activity,GO:0031267~small GTPase binding,	IPR000406:Rho_GDI,IPR014756:Ig_E-set,IPR024792:RhoGDI_dom_sf,	mmu04722:Neurotrophin signaling pathway,mmu04962:Vasopressin-regulated water reabsorption,					KW-0963~Cytoplasm,					KW-0343~GTPase activation,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q9Z0Z3	S-phase kinase-associated protein 2(Skp2)	Mus musculus		m_g1Pathway:Cell Cycle: G1/S Check Point ,m_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,m_skp2e2fPathway:E2F1 Destruction Pathway,	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016310~phosphorylation,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0042981~regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045087~innate immune response,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051607~defense response to virus,GO:0051726~regulation of cell cycle,GO:0070936~protein K48-linked ubiquitination,GO:1902916~positive regulation of protein polyubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0042802~identical protein binding,	IPR001810:F-box_dom,IPR006553:Leu-rich_rpt_Cys-con_subtyp,IPR032675:LRR_dom_sf,IPR036047:F-box-like_dom_sf,	mmu04068:FoxO signaling pathway,mmu04110:Cell cycle,mmu04120:Ubiquitin mediated proteolysis,mmu04150:mTOR signaling pathway,mmu05169:Epstein-Barr virus infection,mmu05200:Pathways in cancer,mmu05203:Viral carcinogenesis,mmu05222:Small cell lung cancer,			SM00256:FBOX,SM00367:LRR_CC,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,		KW-0418~Kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	DOMAIN:F-box,MOTIF:Nuclear localization signal,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
P02639	S100 calcium binding protein A1(S100A1)	Bos taurus			GO:0008016~regulation of heart contraction,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016529~sarcoplasmic reticulum,	GO:0005509~calcium ion binding,GO:0044548~S100 protein binding,GO:0048306~calcium-dependent protein binding,	IPR001751:S100/CaBP7/8-like_CS,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR013787:S100_Ca-bd_sub,IPR018247:EF_Hand_1_Ca_BS,IPR028486:S100-A1,				SM00054:EFh,SM01394:S_100,		KW-0496~Mitochondrion,KW-0703~Sarcoplasmic reticulum,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0702~S-nitrosylation,	DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,
Q2EN75	S100 calcium binding protein A6(S100A6)	Sus scrofa			GO:0098586~cellular response to virus,	GO:0001726~ruffle,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005509~calcium ion binding,GO:0005523~tropomyosin binding,GO:0008270~zinc ion binding,GO:0042803~protein homodimerization activity,GO:0044548~S100 protein binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,	IPR001751:S100/CaBP7/8-like_CS,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR013787:S100_Ca-bd_sub,IPR018247:EF_Hand_1_Ca_BS,IPR034118:S-100A6,				SM00054:EFh,SM01394:S_100,		KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0007~Acetylation,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,
Q503K9	S100 calcium binding protein Z(s100z)	Danio rerio					GO:0005509~calcium ion binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,	IPR001751:S100/CaBP7/8-like_CS,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR013787:S100_Ca-bd_sub,IPR018247:EF_Hand_1_Ca_BS,IPR028490:S100Z,				SM00054:EFh,SM01394:S_100,					KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,			DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,
A1L244	SAC1 like phosphatidylinositide phosphatase b(sacm1lb)	Danio rerio			GO:0046856~phosphatidylinositol dephosphorylation,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0004438~phosphatidylinositol-3-phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0043812~phosphatidylinositol-4-phosphate phosphatase activity,	IPR002013:SAC_dom,	dre00562:Inositol phosphate metabolism,dre01100:Metabolic pathways,dre04070:Phosphatidylinositol signaling system,					KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,		DOMAIN:SAC,REGION:Essential for phosphatidylinositol-4-phosphate phosphatase activity,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q01826	SATB homeobox 1(SATB1)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0016605~PML body,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeobox_dom,IPR003350:CUT_dom,IPR009057:Homeobox-like_sf,IPR010982:Lambda_DNA-bd_dom_sf,IPR032355:CUTL,IPR032392:ULD,IPR038216:SATB_CUTL_sf,IPR038224:SATB_ULD_sf,IPR039673:SATB1/SATB2,		619228~Developmental delay with dysmorphic facies and dental anomalies,619229~den Hoed-de Boer-Voisin syndrome,		SM00389:HOX,SM01109:CUT,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0945~Host-virus interaction,	KW-0539~Nucleus,		KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0371~Homeobox,KW-0677~Repeat,		KW-0156~Chromatin regulator,KW-0238~DNA-binding,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:CUT 1,DNA_BIND:CUT 2,DNA_BIND:Homeobox,DOMAIN:CUTL,DOMAIN:ULD,MOTIF:Nuclear localization signal,MOTIF:Protein interaction,MUTAGEN:D->A: CASP6-resistant.,MUTAGEN:E->A: Normal nuclear localization.,MUTAGEN:FQN->AAA: Reduced interaction with matrix attachment region (MAR) DNA.,MUTAGEN:G->A: Impaired MAR-DNA-binding.,MUTAGEN:K->A,Q,R: No acetylation.,MUTAGEN:K->A: Loss of nuclear localization, cytoplasmic.,MUTAGEN:K->N: Impaired MAR-DNA-binding.,MUTAGEN:K->N: Reduced MAR-DNA-binding.,MUTAGEN:K->R: Loss of sumoylation.,MUTAGEN:K->R: Normal sumoylation.,MUTAGEN:N->A: Normal nuclear localization.,MUTAGEN:Q->A: Impaired MAR-DNA-binding.,MUTAGEN:R->A: Loss of nuclear localization, cytoplasmic.,MUTAGEN:R->A: Reduced interaction with matrix attachment region (MAR) DNA; when associated with A-646.,MUTAGEN:R->A: Reduced interaction with matrix attachment region (MAR) DNA; when associated with A-648.,MUTAGEN:R->N: Impaired MAR-DNA-binding.,MUTAGEN:R->N: Reduced MAR-DNA-binding.,MUTAGEN:S->A: Impaired MAR-DNA-binding.,MUTAGEN:S->A: No phosphorylation.,MUTAGEN:S->A: Slightly reduced MAR-DNA-binding.,REGION:Disordered,REGION:Nuclear matrix targeting sequence (NMTS),SITE:Cleavage; by caspases,
P21158	SDR family oxidoreductase(MXAN_RS06255)	Myxococcus xanthus DK 1622			GO:0030435~sporulation resulting in formation of a cellular spore,	GO:0005576~extracellular region,GO:0009279~cell outer membrane,		IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,					KW-0346~Stress response,KW-0749~Sporulation,	KW-0472~Membrane,KW-0964~Secreted,KW-0998~Cell outer membrane,	KW-0293~Fruiting body,
Q5R9C7	SEC11 homolog A, signal peptidase complex subunit(SEC11A)	Pongo abelii			GO:0006465~signal peptide processing,	GO:0005787~signal peptidase complex,GO:0016020~membrane,	GO:0004252~serine-type endopeptidase activity,	IPR001733:Peptidase_S26B,IPR015927:Peptidase_S24_S26A/B/C,IPR019533:Peptidase_S26,IPR019756:Pept_S26A_signal_pept_1_Ser-AS,IPR019758:Pept_S26A_signal_pept_1_CS,IPR036286:LexA/Signal_pep-like_sf,	pon03060:Protein export,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,		ACT_SITE:Charge relay system,DOMAIN:Peptidase S24/S26A/S26B/S26C,REGION:C-terminal short (CTS) helix,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q92503	SEC14 like lipid binding 1(SEC14L1)	Homo sapiens			GO:0015871~choline transport,GO:0039536~negative regulation of RIG-I signaling pathway,GO:0045087~innate immune response,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005758~mitochondrial intermembrane space,GO:0005794~Golgi apparatus,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0039552~RIG-I binding,	IPR001251:CRAL-TRIO_dom,IPR006797:PRELI/MSF1_dom,IPR009038:GOLD_dom,IPR011074:CRAL/TRIO_N_dom,IPR036273:CRAL/TRIO_N_dom_sf,IPR036598:GOLD_dom_sf,IPR036865:CRAL-TRIO_dom_sf,IPR037365:Slowmo/Ups,				SM00516:SEC14,SM01100:CRAL_TRIO_N,	KW-0391~Immunity,KW-0399~Innate immunity,	KW-0333~Golgi apparatus,KW-0963~Cytoplasm,					KW-0734~Signal transduction inhibitor,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:CRAL-TRIO,DOMAIN:GOLD,DOMAIN:PRELI/MSF1,REGION:Disordered,REGION:Required for interaction and inhibitory function toward RIGI,
Q99J08	SEC14-like lipid binding 2(Sec14l2)	Mus musculus			GO:0045542~positive regulation of cholesterol biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0008047~enzyme activator activity,GO:0008289~lipid binding,GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,	IPR001251:CRAL-TRIO_dom,IPR009038:GOLD_dom,IPR011074:CRAL/TRIO_N_dom,IPR036273:CRAL/TRIO_N_dom_sf,IPR036598:GOLD_dom_sf,IPR036865:CRAL-TRIO_dom_sf,				SM00516:SEC14,SM01100:CRAL_TRIO_N,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0446~Lipid-binding,	KW-0010~Activator,		DOMAIN:CRAL-TRIO,DOMAIN:GOLD,
O95487	SEC24 homolog B, COPII coat complex component(SEC24B)	Homo sapiens			GO:0001843~neural tube closure,GO:0003151~outflow tract morphogenesis,GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0021747~cochlear nucleus development,GO:0035909~aorta morphogenesis,GO:0060088~auditory receptor cell stereocilium organization,GO:0060463~lung lobe morphogenesis,GO:0060982~coronary artery morphogenesis,GO:0061156~pulmonary artery morphogenesis,GO:0090110~cargo loading into COPII-coated vesicle,GO:0090178~regulation of establishment of planar polarity involved in neural tube closure,GO:1901301~regulation of cargo loading into COPII-coated vesicle,	GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0012507~ER to Golgi transport vesicle membrane,GO:0030127~COPII vesicle coat,GO:0070971~endoplasmic reticulum exit site,	GO:0000149~SNARE binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR006895:Znf_Sec23_Sec24,IPR006896:Sec23/24_trunk_dom,IPR006900:Sec23/24_helical_dom,IPR007123:Gelsolin-like_dom,IPR012990:Sec23_24_beta_S,IPR029006:ADF-H/Gelsolin-like_dom_sf,IPR036174:Znf_Sec23_Sec24_sf,IPR036175:Sec23/24_helical_dom_sf,IPR036180:Gelsolin-like_dom_sf,IPR036465:vWFA_dom_sf,IPR041742:Sec24-like_trunk_dom,	hsa04141:Protein processing in endoplasmic reticulum,hsa05130:Pathogenic Escherichia coli infection,				KW-0653~Protein transport,KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,				KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Gelsolin-like,DOMAIN:Sec23/Sec24 beta-sandwich,DOMAIN:Sec23/Sec24 helical,DOMAIN:Sec23/Sec24 trunk,DOMAIN:Zinc finger Sec23/Sec24-type,MUTAGEN:R->A: Decreased ability to package the SNARE SEC22B cargo into COPII vesicles. Has no effect on other cargos packaging.,REGION:Disordered,REGION:Zinc finger-like,REPEAT:Gelsolin-like,
Q7SZU9	SEC61 translocon subunit gamma(sec61g)	Gadus morhua			GO:0006605~protein targeting,GO:0031204~posttranslational protein targeting to membrane, translocation,GO:0045047~protein targeting to ER,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0071261~Ssh1 translocon complex,	GO:0008320~protein transmembrane transporter activity,GO:0043022~ribosome binding,	IPR001901:Translocase_SecE/Sec61-g,IPR008158:Translocase_Sec61-g,IPR023391:Prot_translocase_SecE_dom_sf,					KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5BJI7	SET and MYND domain containing 2a(smyd2a)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0007507~heart development,GO:0007519~skeletal muscle tissue development,GO:0008285~negative regulation of cell proliferation,GO:0018026~peptidyl-lysine monomethylation,GO:0018027~peptidyl-lysine dimethylation,GO:0032259~methylation,GO:0033336~caudal fin development,GO:0043516~regulation of DNA damage response, signal transduction by p53 class mediator,GO:0060047~heart contraction,GO:0060297~regulation of sarcomere organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000993~RNA polymerase II core binding,GO:0008168~methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001214:SET_dom,IPR002893:Znf_MYND,IPR011990:TPR-like_helical_dom_sf,IPR046341:SET_dom_sf,	dre00310:Lysine degradation,dre01100:Metabolic pathways,			SM00317:SET,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0156~Chromatin regulator,KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:SET,ZN_FING:MYND-type,
Q9H7B4	SET and MYND domain containing 3(SMYD3)	Homo sapiens			GO:0006334~nucleosome assembly,GO:0014904~myotube cell development,GO:0032259~methylation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0045184~establishment of protein localization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071549~cellular response to dexamethasone stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000993~RNA polymerase II core binding,GO:0001162~RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001214:SET_dom,IPR002893:Znf_MYND,IPR011990:TPR-like_helical_dom_sf,IPR025805:Hist-Lys_N-MeTrfase_SMYD3,IPR044420:SMYD3_SET,IPR046341:SET_dom_sf,	hsa00310:Lysine degradation,hsa01100:Metabolic pathways,			SM00317:SET,		KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0156~Chromatin regulator,KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:MYND-type,DOMAIN:SET,REGION:C-terminal domain; essential for histone methyltransferase activity, nuclear localization and mediates interaction with HSP90AA1,TRANSMEM:Helical,ZN_FING:MYND-type,
C0H8I2	SET domain containing 6, protein lysine methyltransferase(setd6)	Salmo salar			GO:0018026~peptidyl-lysine monomethylation,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032259~methylation,GO:0050727~regulation of inflammatory response,	GO:0005634~nucleus,	GO:0005515~protein binding,GO:0016279~protein-lysine N-methyltransferase activity,	IPR001214:SET_dom,IPR011383:N-lys_methylase_SETD6,IPR015353:Rubisco_LSMT_subst-bd,IPR036464:Rubisco_LSMT_subst-bd_sf,IPR044430:SETD6_SET,IPR046341:SET_dom_sf,			PIRSF011771:RMS1_SET,			KW-0539~Nucleus,				KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:SET,
B0KWR6	SFI1 centrin binding protein(SFI1)	Callithrix jacchus				GO:0005737~cytoplasm,GO:0005814~centriole,	GO:0019902~phosphatase binding,							KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,				REGION:Disordered,REGION:Interaction with CETN2,REPEAT:HAT 1,REPEAT:HAT 2,REPEAT:HAT 3,REPEAT:HAT 4,REPEAT:HAT 5,REPEAT:HAT 6,
Q06AA1	SH2 domain containing 1A(SH2D1A)	Sus scrofa			GO:0002250~adaptive immune response,GO:0006959~humoral immune response,GO:0006968~cellular defense response,GO:0007267~cell-cell signaling,GO:0042267~natural killer cell mediated cytotoxicity,GO:0045087~innate immune response,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0050860~negative regulation of T cell receptor signaling pathway,	GO:0005737~cytoplasm,		IPR000980:SH2,IPR017289:SH2_prot_1A,IPR035876:SH2D1A_SH2,IPR036860:SH2_dom_sf,	ssc04650:Natural killer cell mediated cytotoxicity,		PIRSF037828:SH2_p1A,	SM00252:SH2,	KW-0391~Immunity,KW-0399~Innate immunity,KW-1064~Adaptive immunity,	KW-0963~Cytoplasm,			KW-0727~SH2 domain,			KW-0007~Acetylation,	DOMAIN:SH2,REGION:Disordered,REGION:Interaction with FYN SH3 domain,
Q9QZS8	SH2 domain containing 3C(Sh2d3c)	Mus musculus			GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0033138~positive regulation of peptidyl-serine phosphorylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0032587~ruffle membrane,GO:0042995~cell projection,	GO:0001784~phosphotyrosine binding,GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000980:SH2,IPR001895:RASGEF_cat_dom,IPR023578:Ras_GEF_dom_sf,IPR036860:SH2_dom_sf,IPR036964:RASGEF_cat_dom_sf,IPR044102:SH2_SHEP1/BCAR3/NSP1,				SM00147:RasGEF,SM00252:SH2,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0727~SH2 domain,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Ras-GEF,DOMAIN:SH2,MUTAGEN:Y->E: Abolishes interaction with NEDD9. Abolishes interaction with BCAR1. Abolishes phosphorylation of NEDD9. Abolishes promotion of migration and adhesion in T cells.,MUTAGEN:Y->E: Disrupts binding to BCAR1 and inhibits EGF-induced tyrosine phosphorylation.,REGION:Disordered,
A6NKC9	SH2 domain containing 7(SH2D7)	Homo sapiens				GO:0005737~cytoplasm,		IPR000980:SH2,IPR035885:SH2D7_SH2,IPR036860:SH2_dom_sf,				SM00252:SH2,					KW-0727~SH2 domain,				COMPBIAS:Polar residues,DOMAIN:SH2,REGION:Disordered,
A0JNJ1	SH3 and cysteine rich domain(STAC)	Bos taurus			GO:0003009~skeletal muscle contraction,GO:1901387~positive regulation of voltage-gated calcium channel activity,GO:1903078~positive regulation of protein localization to plasma membrane,GO:2001259~positive regulation of cation channel activity,	GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0042383~sarcolemma,	GO:0044325~ion channel binding,GO:0046872~metal ion binding,	IPR001452:SH3_domain,IPR002219:PE/DAG-bd,IPR035508:STAC1_SH3,IPR036028:SH3-like_dom_sf,IPR039688:STAC1/2/3,IPR046349:C1-like_sf,				SM00109:C1,SM00326:SH3,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0728~SH3 domain,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Polar residues,DOMAIN:SH3 1,DOMAIN:SH3 2,REGION:Disordered,ZN_FING:Phorbol-ester/DAG-type,
Q9H299	SH3 domain binding glutamate rich protein like 3(SH3BGRL3)	Homo sapiens			GO:0007010~cytoskeleton organization,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016604~nuclear body,GO:0032587~ruffle membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR006993:Glut_rich_SH3-bd,IPR036249:Thioredoxin-like_sf,			PIRSF008142:SH3-bind_E-rich_L,			KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,						KW-0007~Acetylation,KW-0325~Glycoprotein,	CARBOHYD:O-linked (GalNAc...) threonine,DOMAIN:Glutaredoxin,
O60239	SH3 domain binding protein 5(SH3BP5)	Homo sapiens			GO:0007165~signal transduction,GO:0035556~intracellular signal transduction,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016604~nuclear body,GO:0030659~cytoplasmic vesicle membrane,	GO:0004860~protein kinase inhibitor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,	IPR007940:SH3BP5,						KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0729~SH3-binding,		KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MUTAGEN:L->A: Loss of phosphorylation and binding by phospho-JNK; when associated with A-347.,MUTAGEN:L->A: Loss of phosphorylation and binding by phospho-JNK; when associated with A-349.,MUTAGEN:L->A: No change of phosphorylation or binding by phospho-JNK; when associated with A-434.,MUTAGEN:L->A: No change of phosphorylation or binding by phospho-JNK; when associated with A-436.,MUTAGEN:LE->AK: Loss of guanine nucleotide exchange factor activity.,MUTAGEN:LNQ->AAA: Loss of guanine nucleotide exchange factor activity.,REGION:Disordered,REGION:Sufficient for interaction with RAB11A and for guanine nucleotide exchange activity,
Q8AXU9	SH3 domain containing GRB2 like 3, endophilin A3(SH3GL3)	Gallus gallus			GO:0006897~endocytosis,GO:0016191~synaptic vesicle uncoating,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031901~early endosome membrane,GO:0098793~presynapse,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,GO:0008289~lipid binding,	IPR001452:SH3_domain,IPR004148:BAR_dom,IPR027267:AH/BAR_dom_sf,IPR032469:Endophilin-A3_BAR,IPR035824:Endophilin_A_SH3,IPR036028:SH3-like_dom_sf,	gga04144:Endocytosis,			SM00326:SH3,SM00721:BAR,	KW-0254~Endocytosis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0175~Coiled coil,KW-0728~SH3 domain,	KW-0446~Lipid-binding,			DOMAIN:BAR,DOMAIN:SH3,REGION:Interaction with ARC,REGION:Membrane-binding amphipathic helix,REGION:Required for dimerization upon membrane association,
Q5ZJ81	SH3 domain containing GRB2 like, endophilin B2(SH3GLB2)	Gallus gallus			GO:0006915~apoptotic process,GO:0061024~membrane organization,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0016020~membrane,	GO:0005515~protein binding,	IPR001452:SH3_domain,IPR004148:BAR_dom,IPR027267:AH/BAR_dom_sf,IPR028503:SH3GLB_SH3,IPR035640:Endophilin_B2_SH3,IPR036028:SH3-like_dom_sf,	gga04144:Endocytosis,			SM00326:SH3,SM00721:BAR,	KW-0053~Apoptosis,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1000~Mitochondrion outer membrane,			KW-0175~Coiled coil,KW-0728~SH3 domain,				DOMAIN:BAR,DOMAIN:SH3,REGION:Membrane-binding amphipathic helix,
Q96B97	SH3 domain containing kinase binding protein 1(SH3KBP1)	Homo sapiens		h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,	GO:0006897~endocytosis,GO:0006915~apoptotic process,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0050871~positive regulation of B cell activation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030139~endocytic vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0043005~neuron projection,GO:0045202~synapse,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0017124~SH3 domain binding,GO:0031625~ubiquitin protein ligase binding,	IPR001452:SH3_domain,IPR035770:CIN85_SH3_1,IPR035771:CIN85_SH3_2,IPR035772:CIN85_SH3_3,IPR036028:SH3-like_dom_sf,	hsa04144:Endocytosis,	300310~Immunodeficiency 61,		SM00326:SH3,	KW-0053~Apoptosis,KW-0254~Endocytosis,KW-0945~Host-virus interaction,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0770~Synapse,KW-0771~Synaptosome,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0728~SH3 domain,KW-0729~SH3-binding,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SH3,DOMAIN:SH3 1,DOMAIN:SH3 2,DOMAIN:SH3 3,REGION:Disordered,TRANSMEM:Helical,
Q925Q9	SH3 domain-containing kinase-binding protein 1(Sh3kbp1)	Rattus norvegicus			GO:0006897~endocytosis,GO:0006915~apoptotic process,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0008360~regulation of cell shape,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0042981~regulation of apoptotic process,GO:0050871~positive regulation of B cell activation,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0030139~endocytic vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0043005~neuron projection,GO:0045202~synapse,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0017124~SH3 domain binding,GO:0031625~ubiquitin protein ligase binding,	IPR001452:SH3_domain,IPR035770:CIN85_SH3_1,IPR035771:CIN85_SH3_2,IPR035772:CIN85_SH3_3,IPR036028:SH3-like_dom_sf,	rno04144:Endocytosis,			SM00326:SH3,	KW-0053~Apoptosis,KW-0254~Endocytosis,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0770~Synapse,KW-0771~Synaptosome,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0728~SH3 domain,KW-0729~SH3-binding,		KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SH3,DOMAIN:SH3 1,DOMAIN:SH3 2,DOMAIN:SH3 3,REGION:Disordered,
Q9WUZ7	SH3-binding domain glutamic acid-rich protein(Sh3bgr)	Mus musculus				GO:0005737~cytoplasm,	GO:0017124~SH3 domain binding,	IPR006993:Glut_rich_SH3-bd,IPR036249:Thioredoxin-like_sf,			PIRSF008142:SH3-bind_E-rich_L,						KW-0729~SH3-binding,				COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,MOTIF:SH3-binding,REGION:Disordered,
Q640F2	SHC SH2-domain binding protein 1 L homeolog(shcbp1.L)	Xenopus laevis			GO:0008543~fibroblast growth factor receptor signaling pathway,GO:2000177~regulation of neural precursor cell proliferation,	GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0030496~midbody,		IPR011050:Pectin_lyase_fold/virulence,IPR012334:Pectin_lyas_fold,IPR039448:Beta_helix,IPR045140:SHCBP1-like,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,				DOMAIN:Right handed beta helix,REPEAT:PbH1 1,REPEAT:PbH1 2,REPEAT:PbH1 3,
O70142	SHC adaptor protein 2(Shc2)	Rattus norvegicus			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0035556~intracellular signal transduction,	GO:0005886~plasma membrane,	GO:0030971~receptor tyrosine kinase binding,	IPR000980:SH2,IPR006019:PID_Shc-like,IPR006020:PTB/PI_dom,IPR011993:PH-like_dom_sf,IPR035676:SHC_SH2,IPR036860:SH2_dom_sf,	rno01521:EGFR tyrosine kinase inhibitor resistance,rno01522:Endocrine resistance,rno04012:ErbB signaling pathway,rno04014:Ras signaling pathway,rno04062:Chemokine signaling pathway,rno04072:Phospholipase D signaling pathway,rno04370:VEGF signaling pathway,rno04510:Focal adhesion,rno04650:Natural killer cell mediated cytotoxicity,rno04722:Neurotrophin signaling pathway,rno04910:Insulin signaling pathway,rno04915:Estrogen signaling pathway,rno04917:Prolactin signaling pathway,rno04926:Relaxin signaling pathway,rno04935:Growth hormone synthesis, secretion and action,rno05034:Alcoholism,rno05100:Bacterial invasion of epithelial cells,rno05214:Glioma,rno05220:Chronic myeloid leukemia,rno05224:Breast cancer,rno05225:Hepatocellular carcinoma,rno05226:Gastric cancer,			SM00252:SH2,SM00462:PTB,					KW-0727~SH2 domain,			KW-0597~Phosphoprotein,	DOMAIN:PID,DOMAIN:SH2,
Q6NSM8	SIK family kinase 3(sik3)	Danio rerio			GO:0000226~microtubule cytoskeleton organization,GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0050321~tau-protein kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015940:UBA,IPR017441:Protein_kinase_ATP_BS,IPR034672:SIK,				SM00165:UBA,SM00220:S_TKc,						KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,DOMAIN:UBA,REGION:Disordered,
Q3MHV6	SLAIN motif family member 2(SLAIN2)	Bos taurus			GO:0007020~microtubule nucleation,GO:0031116~positive regulation of microtubule polymerization,GO:0031122~cytoplasmic microtubule organization,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0015630~microtubule cytoskeleton,GO:0035371~microtubule plus-end,		IPR026179:Slain,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,SITE:Important for interaction with CLIP1,
Q9H5Y7	SLIT and NTRK like family member 6(SLITRK6)	Homo sapiens			GO:0001964~startle response,GO:0002088~lens development in camera-type eye,GO:0002093~auditory receptor cell morphogenesis,GO:0007409~axonogenesis,GO:0007416~synapse assembly,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0008344~adult locomotory behavior,GO:0021562~vestibulocochlear nerve development,GO:0031223~auditory behavior,GO:0035264~multicellular organism growth,GO:0051965~positive regulation of synapse assembly,GO:0060007~linear vestibuloocular reflex,GO:0060384~innervation,GO:0090102~cochlea development,GO:1905606~regulation of presynapse assembly,	GO:0005886~plasma membrane,GO:0009986~cell surface,		IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,IPR043326:Slitrk,	hsa04514:Cell adhesion molecules,	221200~Deafness and myopia,		SM00082:LRRCT,SM00365:LRR_SD22,SM00369:LRR_TYP,	KW-0716~Sensory transduction,KW-0844~Vision,KW-1009~Hearing,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0209~Deafness,	KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:LRRCT 1,DOMAIN:LRRCT 2,DOMAIN:LRRNT 1,DOMAIN:LRRNT 2,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
B0S6J3	SLIT-ROBO Rho GTPase activating protein 2(srgap2)	Danio rerio			GO:0007165~signal transduction,GO:0007399~nervous system development,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0043547~positive regulation of GTPase activity,GO:0046847~filopodium assembly,GO:0048468~cell development,GO:0048731~system development,GO:0048812~neuron projection morphogenesis,GO:0051014~actin filament severing,GO:0060996~dendritic spine development,GO:0072015~glomerular visceral epithelial cell development,GO:2001223~negative regulation of neuron migration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0044327~dendritic spine head,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0045335~phagocytic vesicle,	GO:0005096~GTPase activator activity,GO:0031267~small GTPase binding,GO:0042803~protein homodimerization activity,	IPR000198:RhoGAP_dom,IPR001060:FCH_dom,IPR001452:SH3_domain,IPR008936:Rho_GTPase_activation_prot,IPR027267:AH/BAR_dom_sf,IPR031160:F_BAR,IPR035648:srGAP1/2/3_SH3,IPR036028:SH3-like_dom_sf,				SM00055:FCH,SM00324:RhoGAP,SM00326:SH3,	KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0539~Nucleus,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0728~SH3 domain,		KW-0343~GTPase activation,		COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:F-BAR,DOMAIN:Rho-GAP,DOMAIN:SH3,REGION:Disordered,
O43295	SLIT-ROBO Rho GTPase activating protein 3(SRGAP3)	Homo sapiens			GO:0007165~signal transduction,GO:0030336~negative regulation of cell migration,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR000198:RhoGAP_dom,IPR001060:FCH_dom,IPR001452:SH3_domain,IPR008936:Rho_GTPase_activation_prot,IPR027267:AH/BAR_dom_sf,IPR031160:F_BAR,IPR035648:srGAP1/2/3_SH3,IPR036028:SH3-like_dom_sf,	hsa04360:Axon guidance,			SM00055:FCH,SM00324:RhoGAP,SM00326:SH3,					KW-0175~Coiled coil,KW-0728~SH3 domain,		KW-0343~GTPase activation,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:F-BAR,DOMAIN:Rho-GAP,DOMAIN:SH3,REGION:Disordered,
Q9W734	SMAD family member 6(SMAD6)	Gallus gallus			GO:0001657~ureteric bud development,GO:0003148~outflow tract septum morphogenesis,GO:0003180~aortic valve morphogenesis,GO:0003183~mitral valve morphogenesis,GO:0003184~pulmonary valve morphogenesis,GO:0003281~ventricular septum development,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006955~immune response,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007352~zygotic specification of dorsal/ventral axis,GO:0008285~negative regulation of cell proliferation,GO:0009653~anatomical structure morphogenesis,GO:0010693~negative regulation of alkaline phosphatase activity,GO:0030154~cell differentiation,GO:0030279~negative regulation of ossification,GO:0030509~BMP signaling pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0031589~cell-substrate adhesion,GO:0032331~negative regulation of chondrocyte differentiation,GO:0032496~response to lipopolysaccharide,GO:0032926~negative regulation of activin receptor signaling pathway,GO:0034616~response to laminar fluid shear stress,GO:0035904~aorta development,GO:0043066~negative regulation of apoptotic process,GO:0045444~fat cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0050767~regulation of neurogenesis,GO:0060392~negative regulation of SMAD protein import into nucleus,GO:0060395~SMAD protein signal transduction,GO:0060976~coronary vasculature development,GO:1902832~negative regulation of cell proliferation in dorsal spinal cord,GO:1902844~positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016604~nuclear body,GO:0071144~SMAD2-SMAD3 protein complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0031625~ubiquitin protein ligase binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0070410~co-SMAD binding,GO:0070411~I-SMAD binding,GO:0070412~R-SMAD binding,GO:0070698~type I activin receptor binding,	IPR001132:SMAD_dom_Dwarfin-type,IPR003619:MAD_homology1_Dwarfin-type,IPR008984:SMAD_FHA_dom_sf,IPR013019:MAD_homology_MH1,IPR013790:Dwarfin,IPR017855:SMAD-like_dom_sf,IPR036578:SMAD_MH1_sf,	gga04350:TGF-beta signaling pathway,			SM00523:DWA,SM00524:DWB,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:MH1,DOMAIN:MH2,REGION:Disordered,
Q9HCE7	SMAD specific E3 ubiquitin protein ligase 1(SMURF1)	Homo sapiens		h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,	GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006611~protein export from nucleus,GO:0007398~ectoderm development,GO:0016567~protein ubiquitination,GO:0030154~cell differentiation,GO:0030509~BMP signaling pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0032801~receptor catabolic process,GO:0032926~negative regulation of activin receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045773~positive regulation of axon extension,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0061736~engulfment of target by autophagosome,GO:0061753~substrate localization to autophagosome,GO:0071211~protein targeting to vacuole involved in autophagy,GO:0072659~protein localization to plasma membrane,GO:1903861~positive regulation of dendrite extension,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030424~axon,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0004842~ubiquitin-protein transferase activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0046332~SMAD binding,GO:0061630~ubiquitin protein ligase activity,GO:0070411~I-SMAD binding,GO:0070412~R-SMAD binding,GO:0070697~activin receptor binding,	IPR000008:C2_dom,IPR000569:HECT_dom,IPR001202:WW_dom,IPR024928:E3_ub_ligase_SMURF1,IPR035892:C2_domain_sf,IPR035983:Hect_E3_ubiquitin_ligase,IPR036020:WW_dom_sf,	hsa04120:Ubiquitin mediated proteolysis,hsa04137:Mitophagy - animal,hsa04144:Endocytosis,hsa04340:Hedgehog signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04520:Adherens junction,		PIRSF001569:E3_ub_ligase_SMURF1,	SM00119:HECTc,SM00239:C2,SM00456:WW,	KW-0221~Differentiation,KW-0833~Ubl conjugation pathway,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,		KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Glycyl thioester intermediate,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:C2,DOMAIN:HECT,DOMAIN:WW 1,DOMAIN:WW 2,MUTAGEN:C->A: Loss of enzyme activity, without abolishing FBXL15-mediated ubiquitination.,MUTAGEN:K->A: Fails to ubiquitinate RHOA; when associated with A-28.,MUTAGEN:K->A: Fails to ubiquitinate RHOA; when associated with A-85.,MUTAGEN:K->R: Abolishes FBXL15-mediated ubiquitination and degradation; when associated with R-350 and R-381. Abolishes FBXL15-mediated ubiquitination and degradation; when associated with R-381.,MUTAGEN:K->R: Abolishes FBXL15-mediated ubiquitination and degradation; when associated with R-350 and R-383. Abolishes FBXL15-mediated ubiquitination and degradation; when associated with R-383.,MUTAGEN:K->R: Abolishes FBXL15-mediated ubiquitination and degradation; when associated with R-381 and R-381.,REGION:Disordered,
Q6P5D8	SMC hinge domain containing 1(Smchd1)	Mus musculus			GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006325~chromatin organization,GO:0006974~cellular response to DNA damage stimulus,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0043584~nose development,GO:0045739~positive regulation of DNA repair,GO:0051276~chromosome organization,GO:0060818~inactivation of paternal X chromosome by genetic imprinting,GO:2000042~negative regulation of double-strand break repair via homologous recombination,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,	GO:0000781~chromosome, telomeric region,GO:0001740~Barr body,GO:0005634~nucleus,GO:0005694~chromosome,GO:0035861~site of double-strand break,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0042803~protein homodimerization activity,	IPR010935:SMC_hinge,IPR036277:SMC_hinge_sf,IPR036890:HATPase_C_sf,IPR038892:SMCHD1,				SM00968:SMC_hinge,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,					KW-0156~Chromatin regulator,KW-0238~DNA-binding,KW-0378~Hydrolase,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:SMC hinge,MUTAGEN:E->A: Abolishes ATPase activity.,MUTAGEN:GKFGG->AKFAA: Abolishes homodimerization.,MUTAGEN:R->G: Abolishes ability to bind DNA without altering the ability of the SMC hinge domain to mediate homodimerization.,REGION:ATPase activity domain,REGION:Disordered,
Q9NRH2	SNF related kinase(SNRK)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0016310~phosphorylation,GO:0030099~myeloid cell differentiation,GO:0035556~intracellular signal transduction,GO:0051301~cell division,	GO:0005634~nucleus,	GO:0000287~magnesium ion binding,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015940:UBA,IPR017441:Protein_kinase_ATP_BS,IPR030616:Aur-like,				SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Protein kinase,DOMAIN:UBA,MUTAGEN:T->A,E: Prevents phosphorylation and activation by STK11/LKB1 complex.,REGION:Disordered,
Q5RD69	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3(SPOCK3)	Pongo abelii			GO:0048856~anatomical structure development,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0005539~glycosaminoglycan binding,GO:0008191~metalloendopeptidase inhibitor activity,GO:0050840~extracellular matrix binding,	IPR000716:Thyroglobulin_1,IPR002350:Kazal_dom,IPR011992:EF-hand-dom_pair,IPR019577:SPARC/Testican_Ca-bd-dom,IPR036058:Kazal_dom_sf,IPR036857:Thyroglobulin_1_sf,				SM00211:TY,SM00280:KAZAL,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,	KW-0481~Metalloenzyme inhibitor,KW-0483~Metalloprotease inhibitor,KW-0646~Protease inhibitor,	KW-0325~Glycoprotein,KW-0357~Heparan sulfate,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:O-linked (Xyl...) (glycosaminoglycan) serine,COMPBIAS:Acidic residues,DOMAIN:Kazal-like,DOMAIN:SPARC/Testican calcium-binding,DOMAIN:Thyroglobulin type-1,REGION:Disordered,
Q503N2	SPC24 component of NDC80 kinetochore complex(spc24)	Danio rerio			GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0031262~Ndc80 complex,	GO:0008017~microtubule binding,	IPR013252:Ndc80_Spc24,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,			KW-0175~Coiled coil,
Q3UA16	SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae)(Spc25)	Mus musculus			GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007094~mitotic spindle assembly checkpoint,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005829~cytosol,GO:0031262~Ndc80 complex,		IPR013255:Spc25_C,IPR045143:Spc25,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	DOMAIN:Chromosome segregation protein Spc25 C-terminal,REGION:Disordered,REGION:Interaction with the C-terminus of SPBC24,REGION:Interaction with the N-terminus of SPBC24,REGION:Interaction with the NDC80-NUF2 subcomplex,
Q2T9X3	SPRY domain containing 7(SPRYD7)	Bos taurus					GO:0005515~protein binding,	IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR013320:ConA-like_dom_sf,IPR035766:SPRYD7,IPR043136:B30.2/SPRY_sf,				SM00449:SPRY,								KW-0007~Acetylation,	DOMAIN:B30.2/SPRY,
Q9D8T7	SRA stem-loop interacting RNA binding protein(Slirp)	Mus musculus			GO:0000961~negative regulation of mitochondrial RNA catabolic process,GO:0007005~mitochondrion organization,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007338~single fertilization,GO:0030317~flagellated sperm motility,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0070584~mitochondrion morphogenesis,	GO:0001669~acrosomal vesicle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0036126~sperm flagellum,GO:0048471~perinuclear region of cytoplasm,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0034046~poly(G) binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034152:SLIRP_RRM,IPR035979:RBD_domain_sf,				SM00360:RRM,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0496~Mitochondrion,KW-0539~Nucleus,			KW-0809~Transit peptide,		KW-0678~Repressor,KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	DOMAIN:RRM,TRANSIT:Mitochondrion,
Q62280	SS18, subunit of BAF chromatin remodeling complex(Ss18)	Mus musculus			GO:0000226~microtubule cytoskeleton organization,GO:0000902~cell morphogenesis,GO:0006338~chromatin remodeling,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007010~cytoskeleton organization,GO:0008284~positive regulation of cell proliferation,GO:0009410~response to xenobiotic stimulus,GO:0035556~intracellular signal transduction,GO:0045596~negative regulation of cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048013~ephrin receptor signaling pathway,GO:0097150~neuronal stem cell population maintenance,GO:1902459~positive regulation of stem cell population maintenance,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0015630~microtubule cytoskeleton,GO:0016514~SWI/SNF complex,GO:0071564~npBAF complex,	GO:0003713~transcription coactivator activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,	IPR007726:SS18_N,IPR044779:SS18,	mmu03082:ATP-dependent chromatin remodeling,mmu05202:Transcriptional misregulation in cancer,				KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0010~Activator,	KW-0007~Acetylation,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:SS18 N-terminal,MOTIF:SH2-binding,MOTIF:SH3-binding,REGION:2 X 13 AA imperfect tandem repeats,REGION:Disordered,REPEAT:1,REPEAT:2,
Q11200	ST3 beta-galactoside alpha-2,3-sialyltransferase 1(ST3GAL1)	Gallus gallus			GO:0006054~N-acetylneuraminate metabolic process,GO:0006486~protein glycosylation,GO:0006487~protein N-linked glycosylation,GO:0010706~ganglioside biosynthetic process via lactosylceramide,GO:0097503~sialylation,	GO:0005576~extracellular region,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0032580~Golgi cisterna membrane,	GO:0003836~beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,GO:0008373~sialyltransferase activity,	IPR001675:Glyco_trans_29,IPR012163:Sialyl_trans,IPR038578:GT29-like_sf,	gga00512:Mucin type O-glycan biosynthesis,gga00533:Glycosaminoglycan biosynthesis - keratan sulfate,gga00603:Glycosphingolipid biosynthesis - globo and isoglobo series,gga00604:Glycosphingolipid biosynthesis - ganglio series,gga01100:Metabolic pathways,		PIRSF005557:Sialyl_trans,			KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0964~Secreted,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q11205	ST3 beta-galactoside alpha-2,3-sialyltransferase 2(St3gal2)	Rattus norvegicus			GO:0006486~protein glycosylation,GO:0009101~glycoprotein biosynthetic process,GO:0009247~glycolipid biosynthetic process,GO:0009312~oligosaccharide biosynthetic process,GO:0010706~ganglioside biosynthetic process via lactosylceramide,GO:0010707~globoside biosynthetic process via lactosylceramide,GO:0030259~lipid glycosylation,GO:0097503~sialylation,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0032580~Golgi cisterna membrane,	GO:0003836~beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,GO:0008373~sialyltransferase activity,GO:0042803~protein homodimerization activity,GO:0047288~monosialoganglioside sialyltransferase activity,	IPR001675:Glyco_trans_29,IPR012163:Sialyl_trans,IPR038578:GT29-like_sf,	rno00512:Mucin type O-glycan biosynthesis,rno00533:Glycosaminoglycan biosynthesis - keratan sulfate,rno00603:Glycosphingolipid biosynthesis - globo and isoglobo series,rno00604:Glycosphingolipid biosynthesis - ganglio series,rno01100:Metabolic pathways,		PIRSF005557:Sialyl_trans,		KW-0443~Lipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0964~Secreted,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q68G12	ST3 beta-galactoside alpha-2,3-sialyltransferase 5(St3gal5)	Rattus norvegicus			GO:0006486~protein glycosylation,GO:0006629~lipid metabolic process,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0008373~sialyltransferase activity,GO:0047291~lactosylceramide alpha-2,3-sialyltransferase activity,	IPR001675:Glyco_trans_29,IPR012163:Sialyl_trans,IPR038578:GT29-like_sf,	rno00604:Glycosphingolipid biosynthesis - ganglio series,rno01100:Metabolic pathways,		PIRSF005557:Sialyl_trans,		KW-0443~Lipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
O46640	ST3A1(SULT3A1)	Oryctolagus cuniculus			GO:0051923~sulfation,	GO:0005737~cytoplasm,	GO:0008146~sulfotransferase activity,GO:0047685~amine sulfotransferase activity,	IPR000863:Sulfotransferase_dom,IPR027417:P-loop_NTPase,						KW-0963~Cytoplasm,					KW-0808~Transferase,		ACT_SITE:Proton acceptor,DOMAIN:Sulfotransferase,
Q9UJ37	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2(ST6GALNAC2)	Homo sapiens			GO:0006486~protein glycosylation,GO:0006493~protein O-linked glycosylation,GO:0016266~O-glycan processing,GO:0019082~viral protein processing,GO:1990743~protein sialylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0001665~alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,GO:0008373~sialyltransferase activity,	IPR001675:Glyco_trans_29,IPR012163:Sialyl_trans,IPR038578:GT29-like_sf,	hsa00512:Mucin type O-glycan biosynthesis,hsa01100:Metabolic pathways,		PIRSF005557:Sialyl_trans,			KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q969X2	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6(ST6GALNAC6)	Homo sapiens			GO:0001574~ganglioside biosynthetic process,GO:0006486~protein glycosylation,GO:0006677~glycosylceramide metabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0009100~glycoprotein metabolic process,GO:0009311~oligosaccharide metabolic process,GO:0009312~oligosaccharide biosynthetic process,GO:0009988~cell-cell recognition,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0001665~alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,GO:0005515~protein binding,GO:0008373~sialyltransferase activity,	IPR001675:Glyco_trans_29,IPR038578:GT29-like_sf,	hsa00604:Glycosphingolipid biosynthesis - ganglio series,hsa01100:Metabolic pathways,				KW-0443~Lipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0730~Sialic acid,	KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q687X5	STEAP4 metalloreductase(STEAP4)	Homo sapiens			GO:0006826~iron ion transport,GO:0015677~copper ion import,GO:0022900~electron transport chain,GO:0033212~iron assimilation,GO:0045444~fat cell differentiation,GO:0070207~protein homotrimerization,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0031901~early endosome membrane,GO:0070062~extracellular exosome,	GO:0008823~cupric reductase activity,GO:0009055~electron carrier activity,GO:0020037~heme binding,GO:0046872~metal ion binding,GO:0052851~ferric-chelate reductase (NADPH) activity,GO:0071949~FAD binding,	IPR013130:Fe3_Rdtase_TM_dom,IPR028939:P5C_Rdtase_cat_N,IPR036291:NAD(P)-bd_dom_sf,					KW-0249~Electron transport,KW-0406~Ion transport,KW-0410~Iron transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0186~Copper,KW-0274~FAD,KW-0285~Flavoprotein,KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,	BINDING:axial binding residue,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ferric oxidoreductase,DOMAIN:Pyrroline-5-carboxylate reductase catalytic N-terminal,MUTAGEN:S->Q: Strongly reduced enzyme activity. No effect on trimerization and on heme binding.,TRANSMEM:Helical,
B8JKF4	STN1 subunit of CST complex(stn1)	Danio rerio			GO:0000723~telomere maintenance,GO:0001944~vasculature development,GO:0010833~telomere maintenance via telomere lengthening,GO:0016233~telomere capping,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:1990879~CST complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0042162~telomeric DNA binding,GO:0043047~single-stranded telomeric DNA binding,	IPR012340:NA-bd_OB-fold,IPR014647:Stn1,IPR015253:CST_STN1_C,IPR018856:Stn1_N,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR040260:RFA2-like,IPR042082:CST_Stn1_wHTH1_sf,			PIRSF036950:UCP036950,			KW-0158~Chromosome,KW-0539~Nucleus,KW-0779~Telomere,					KW-0238~DNA-binding,		DNA_BIND:OB,REGION:Interaction with CTC1,REGION:Winged helix-turn-helix (wHTH) 1,REGION:Winged helix-turn-helix (wHTH) 2,
A7MBJ2	SUMO specific peptidase 7(SENP7)	Bos taurus			GO:0006508~proteolysis,GO:0016926~protein desumoylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0008234~cysteine-type peptidase activity,GO:0070139~SUMO-specific endopeptidase activity,	IPR003653:Peptidase_C48_C,IPR038765:Papain-like_cys_pep_sf,					KW-0391~Immunity,KW-0399~Innate immunity,KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Ubiquitin-like protease family profile,REGION:Disordered,REGION:Protease,
Q9EP97	SUMO/sentrin specific peptidase 3(Senp3)	Mus musculus			GO:0006508~proteolysis,GO:0016926~protein desumoylation,GO:0019538~protein metabolic process,GO:2000042~negative regulation of double-strand break repair via homologous recombination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0071339~MLL1 complex,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,GO:0016929~SUMO-specific protease activity,	IPR003653:Peptidase_C48_C,IPR038765:Papain-like_cys_pep_sf,IPR045577:SENP3_5_cons_dom,					KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,COMPBIAS:Acidic residues,DOMAIN:Ubiquitin-like protease family profile,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Protease,
Q6IQS6	SUMO1 activating enzyme subunit 1(sae1)	Danio rerio			GO:0016925~protein sumoylation,GO:0032446~protein modification by small protein conjugation,GO:0036211~protein modification process,GO:0060216~definitive hemopoiesis,GO:0061484~hematopoietic stem cell homeostasis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031510~SUMO activating enzyme complex,	GO:0008641~small protein activating enzyme activity,GO:0016874~ligase activity,GO:0019948~SUMO activating enzyme activity,	IPR000011:UBQ/SUMO-activ_enz_E1-like,IPR000594:ThiF_NAD_FAD-bd,IPR035985:Ubiquitin-activating_enz,IPR045886:ThiF/MoeB/HesA,	dre04120:Ubiquitin mediated proteolysis,				KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,					KW-0436~Ligase,		DOMAIN:THIF-type NAD/FAD binding fold,
P28606	SYNPCC7002_A1628	Synechococcus sp. PCC 7002					GO:0004407~histone deacetylase activity,	IPR000286:His_deacetylse,IPR023696:Ureohydrolase_dom_sf,IPR023801:His_deacetylse_dom,IPR037138:His_deacetylse_dom_sf,IPR044150:HDAC_classIV,											KW-0378~Hydrolase,
A2A9C3	SZT2 subunit of KICSTOR complex(Szt2)	Mus musculus			GO:0007417~central nervous system development,GO:0009791~post-embryonic development,GO:0021540~corpus callosum morphogenesis,GO:0031667~response to nutrient levels,GO:0034198~cellular response to amino acid starvation,GO:0042149~cellular response to glucose starvation,GO:0043473~pigmentation,GO:0061462~protein localization to lysosome,GO:1901668~regulation of superoxide dismutase activity,GO:1904262~negative regulation of TORC1 signaling,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005777~peroxisome,GO:0016020~membrane,GO:0061700~GATOR2 complex,GO:1990130~Iml1 complex,		IPR033228:SZT2,						KW-0458~Lysosome,KW-0472~Membrane,KW-0576~Peroxisome,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Mediates interaction with the GATOR1 complex,
O94901	Sad1 and UNC84 domain containing 1(SUN1)	Homo sapiens			GO:0001503~ossification,GO:0007129~synapsis,GO:0007283~spermatogenesis,GO:0009612~response to mechanical stimulus,GO:0021817~nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,GO:0051642~centrosome localization,GO:0070197~meiotic attachment of telomere to nuclear envelope,GO:0090292~nuclear matrix anchoring at nuclear membrane,	GO:0000781~chromosome, telomeric region,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0034993~LINC complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0005521~lamin binding,GO:0042802~identical protein binding,GO:0043495~protein anchor,	IPR012919:SUN_dom,IPR032680:SUN1_N,IPR040994:Sun_CC2,IPR045119:SUN1-5,					KW-0221~Differentiation,KW-0469~Meiosis,KW-0744~Spermatogenesis,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DISULFID:Interchain (with KASH domain-containing nesprins),DOMAIN:SUN,DOMAIN:SUN coiled coil,REGION:Disordered,REGION:EMD-binding,REGION:LMNA-binding,REGION:SYNE2-binding,REGION:Sufficient for interaction with SYNE1 and SYNE2,TOPO_DOM:Nuclear,TOPO_DOM:Perinuclear space,TRANSMEM:Helical,
Q92154	Schwann cell myelin protein(SMP)	Coturnix japonica			GO:0007155~cell adhesion,	GO:0016020~membrane,	GO:0030246~carbohydrate binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0430~Lectin,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like V-type,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q96GD3	Scm polycomb group protein homolog 1(SCMH1)	Homo sapiens			GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0009952~anterior/posterior pattern specification,GO:0031507~heterochromatin assembly,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0001673~male germ cell nucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0010369~chromocenter,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0042393~histone binding,	IPR001660:SAM,IPR004092:Mbt,IPR013761:SAM/pointed_sf,IPR021987:SLED,IPR033763:SCML2_RBR,IPR038348:SLED_sf,IPR047279:MBT_SCMH1_rpt1,IPR047280:MBT_SCMH1_rpt2,IPR047531:SAM_Scm-like,	hsa03083:Polycomb repressive complex,			SM00454:SAM,SM00561:MBT,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0217~Developmental protein,KW-0678~Repressor,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:Polycomb group protein RNA binding region,DOMAIN:SAM,DOMAIN:SLED,REGION:Disordered,REPEAT:MBT,REPEAT:MBT 1,REPEAT:MBT 2,
Q6BDS1	Spi-1 proto-oncogene(Spi1)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001944~vasculature development,GO:0002314~germinal center B cell differentiation,GO:0002316~follicular B cell differentiation,GO:0002320~lymphoid progenitor cell differentiation,GO:0002327~immature B cell differentiation,GO:0002357~defense response to tumor cell,GO:0002572~pro-T cell differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030098~lymphocyte differentiation,GO:0030154~cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030225~macrophage differentiation,GO:0030316~osteoclast differentiation,GO:0030851~granulocyte differentiation,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0036462~TRAIL-activated apoptotic signaling pathway,GO:0043011~myeloid dendritic cell differentiation,GO:0043314~negative regulation of neutrophil degranulation,GO:0045347~negative regulation of MHC class II biosynthetic process,GO:0045471~response to ethanol,GO:0045579~positive regulation of B cell differentiation,GO:0045646~regulation of erythrocyte differentiation,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060033~anatomical structure regression,GO:0070102~interleukin-6-mediated signaling pathway,GO:0071361~cellular response to ethanol,GO:0090402~oncogene-induced cell senescence,GO:0098508~endothelial to hematopoietic transition,GO:1900745~positive regulation of p38MAPK cascade,GO:1901223~negative regulation of NIK/NF-kappaB signaling,GO:1902262~apoptotic process involved in blood vessel morphogenesis,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904151~positive regulation of microglial cell mediated cytotoxicity,GO:1904178~negative regulation of adipose tissue development,GO:1904238~pericyte cell differentiation,GO:1905036~positive regulation of antifungal innate immune response,GO:1905453~regulation of myeloid progenitor cell differentiation,GO:2000529~positive regulation of myeloid dendritic cell chemotaxis,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001216~bacterial-type RNA polymerase transcriptional activator activity, sequence-specific DNA binding,GO:0001217~bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0051525~NFAT protein binding,GO:0060090~binding, bridging,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0097677~STAT family protein binding,	IPR000418:Ets_dom,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR046328:ETS_fam,	rno04380:Osteoclast differentiation,rno05166:Human T-cell leukemia virus 1 infection,rno05200:Pathways in cancer,rno05202:Transcriptional misregulation in cancer,rno05221:Acute myeloid leukemia,			SM00413:ETS,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0694~RNA-binding,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	BINDING:contacts bases in the GGAA sequence in the major groove,BINDING:contacts the phosphate backbone of the GGAA sequence in the minor groove upstream,BINDING:forms a salt bridge with the phosphate backbone of the opposite strand downstream of the GGAA core sequence,COMPBIAS:Basic and acidic residues,DNA_BIND:ETS,DOMAIN:ETS,MUTAGEN:G->A,S: No effect on transcriptional activation of CSF1R or FCER1A promoter.,MUTAGEN:S->A: No effect on transcriptional activation of CSF1R or FCER1A promoter.,REGION:Disordered,
A0A0G2L7I0	SprT-like N-terminal domain(sprtn)	Danio rerio			GO:0006281~DNA repair,GO:0006508~proteolysis,GO:0006974~cellular response to DNA damage stimulus,GO:0016540~protein autoprocessing,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0016787~hydrolase activity,GO:0031593~polyubiquitin binding,GO:0046872~metal ion binding,	IPR006640:SprT-like_domain,IPR006642:Rad18_UBZ4,IPR044245:Spartan,				SM00731:SprT,SM00734:ZnF_Rad18,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0068~Autocatalytic cleavage,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:SprT-like,MOTIF:Nuclear localization signal,MOTIF:PIP-box,MOTIF:SHP-box,REGION:Disordered,ZN_FING:UBZ4-type,
Q8R4L0	Src-like-adaptor 2(Sla2)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002250~adaptive immune response,GO:0002376~immune system process,GO:0042110~T cell activation,GO:0046854~phosphatidylinositol phosphorylation,GO:0050849~negative regulation of calcium-mediated signaling,GO:0050860~negative regulation of T cell receptor signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0035591~signaling adaptor activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,	IPR000980:SH2,IPR001452:SH3_domain,IPR035052:SLAP_SH2,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,IPR043539:Grb2-like,				SM00252:SH2,SM00326:SH3,	KW-0391~Immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0727~SH2 domain,KW-0728~SH3 domain,			KW-0449~Lipoprotein,KW-0519~Myristate,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:SH2,DOMAIN:SH3,LIPID:N-myristoyl glycine,MUTAGEN:G->A: Abolishes localization to membranes.,MUTAGEN:M->V: Abolishes isoform 2.,MUTAGEN:P->L: Does not affect its inhibitory function.,MUTAGEN:R->E: Abolishes interaction with ZAP70, and its inhibitory function.,REGION:Disordered,REGION:SLA C-terminal,
Q8N3R3	T cell activation inhibitor, mitochondrial(TCAIM)	Homo sapiens				GO:0005739~mitochondrion,		IPR027986:TCAIM,IPR027989:DUF4461,IPR028031:DUF4460,						KW-0496~Mitochondrion,			KW-0175~Coiled coil,				COMPBIAS:Polar residues,DOMAIN:DUF4460,REGION:Disordered,
O60806	T-box transcription factor 19(TBX19)	Homo sapiens			GO:0001707~mesoderm formation,GO:0001708~cell fate specification,GO:0003007~heart morphogenesis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009653~anatomical structure morphogenesis,GO:0021983~pituitary gland development,GO:0042127~regulation of cell proliferation,GO:0045595~regulation of cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000785~chromatin,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR001699:TF_T-box,IPR002070:TF_Brachyury,IPR008967:p53-like_TF_DNA-bd_sf,IPR018186:TF_T-box_CS,IPR036960:T-box_sf,IPR046360:T-box_DNA-bd,		201400~Adrenocorticotropic hormone deficiency,		SM00425:TBOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0225~Disease variant,			KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,		DNA_BIND:T-box,DOMAIN:T-box,REGION:Disordered,
Q6P0T2	TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor(taf8)	Danio rerio			GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005669~transcription factor TFIID complex,GO:0005737~cytoplasm,	GO:0046982~protein heterodimerization activity,	IPR006565:BTP,IPR009072:Histone-fold,IPR019473:TFIID_su8_C,IPR037818:TAF8,	dre03022:Basal transcription factors,			SM00576:BTP,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Histone-fold,MOTIF:Nuclear localization signal,REGION:Disordered,
Q3B7H2	TAM41 mitochondrial translocator assembly and maintenance homolog(tamm41)	Danio rerio			GO:0006629~lipid metabolic process,GO:0008654~phospholipid biosynthetic process,GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0032049~cardiolipin biosynthetic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0031314~extrinsic component of mitochondrial inner membrane,	GO:0004605~phosphatidate cytidylyltransferase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,	IPR015222:Tam41,			PIRSF028840:Mmp37,		KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0594~Phospholipid biosynthesis,KW-1208~Phospholipid metabolism,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,				KW-0460~Magnesium,	KW-0548~Nucleotidyltransferase,KW-0808~Transferase,
O73895	TAP binding protein(TAPBP)	Gallus gallus			GO:0002502~peptide antigen assembly with MHC class I protein complex,	GO:0016020~membrane,GO:0042824~MHC class I peptide loading complex,	GO:0023024~MHC class I protein complex binding,	IPR003006:Ig/MHC_CS,IPR003597:Ig_C1-set,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,	gga05168:Herpes simplex virus 1 infection,			SM00407:IGc1,SM00409:IG,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Ig-like,DOMAIN:Ig-like C1-type 1,DOMAIN:Ig-like C1-type 2,REGION:Disordered,SITE:May be involved in interaction with TAP,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q91WQ5	TATA-box binding protein associated factor 5 like(Taf5l)	Mus musculus			GO:0006282~regulation of DNA repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0043484~regulation of RNA splicing,GO:0045893~positive regulation of transcription, DNA-templated,GO:1904672~regulation of somatic stem cell population maintenance,	GO:0000123~histone acetyltransferase complex,GO:0000124~SAGA complex,GO:0005634~nucleus,GO:0016607~nuclear speck,GO:0033276~transcription factor TFTC complex,GO:0036464~cytoplasmic ribonucleoprotein granule,	GO:0003713~transcription coactivator activity,	IPR001680:WD40_rpt,IPR007582:TFIID_NTD2,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,IPR037264:TFIID_NTD2_sf,	mmu03022:Basal transcription factors,			SM00320:WD40,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0853~WD repeat,				DOMAIN:TFIID subunit TAF5 NTD2,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,
Q15573	TATA-box binding protein associated factor, RNA polymerase I subunit A(TAF1A)	Homo sapiens			GO:0006360~transcription from RNA polymerase I promoter,GO:0006366~transcription from RNA polymerase II promoter,	GO:0000120~RNA polymerase I transcription factor complex,GO:0005654~nucleoplasm,GO:0005668~RNA polymerase transcription factor SL1 complex,GO:0015630~microtubule cytoskeleton,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR016629:RNA_pol_I_TAF1A/TAFI48_chr,IPR039495:TAF1A,			PIRSF015161:TAFI48,		KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0238~DNA-binding,
Q9BXI6	TBC1 domain family member 10A(TBC1D10A)	Homo sapiens			GO:0042147~retrograde transport, endosome to Golgi,GO:0045862~positive regulation of proteolysis,GO:0090630~activation of GTPase activity,GO:0097202~activation of cysteine-type endopeptidase activity,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0070062~extracellular exosome,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0030165~PDZ domain binding,GO:0045296~cadherin binding,	IPR000195:Rab-GAP-TBC_dom,IPR035969:Rab-GAP_TBC_sf,				SM00164:TBC,		KW-0966~Cell projection,					KW-0343~GTPase activation,KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Rab-GAP TBC,MUTAGEN:D->A: Loss of activity. No effect on subcellular location.,MUTAGEN:L->LA: Loss of interaction with EBP50 and impaired subcellular localization.,MUTAGEN:R->K: Loss of activity. No effect on subcellular location.,REGION:Binding to the PDZ domain of EBP50,REGION:Disordered,SITE:Arginine finger,SITE:Glutamine finger,
Q8TBP0	TBC1 domain family member 16(TBC1D16)	Homo sapiens			GO:0001919~regulation of receptor recycling,GO:0090630~activation of GTPase activity,	GO:0005769~early endosome,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR000195:Rab-GAP-TBC_dom,IPR035969:Rab-GAP_TBC_sf,				SM00164:TBC,							KW-0343~GTPase activation,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Rab-GAP TBC,REGION:Disordered,
A1A5K6	TBC1 domain family member 24 L homeolog(tbc1d24.L)	Xenopus laevis				GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0045202~synapse,GO:0098793~presynapse,	GO:0005096~GTPase activator activity,	IPR000195:Rab-GAP-TBC_dom,IPR006571:TLDc_dom,IPR035969:Rab-GAP_TBC_sf,				SM00164:TBC,SM00584:TLDc,		KW-0472~Membrane,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,					KW-0343~GTPase activation,		COMPBIAS:Polar residues,DOMAIN:Rab-GAP TBC,DOMAIN:TLDc,REGION:Disordered,
A3KGB4	TBC1 domain family, member 8B(Tbc1d8b)	Mus musculus			GO:0003094~glomerular filtration,GO:0016192~vesicle-mediated transport,GO:0090630~activation of GTPase activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,GO:0005509~calcium ion binding,	IPR000195:Rab-GAP-TBC_dom,IPR002048:EF_hand_dom,IPR004182:GRAM,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,IPR035969:Rab-GAP_TBC_sf,IPR036012:TBC1D8B_PH-GRAM1,IPR036015:TBC1D8B_PH-GRAM2,				SM00164:TBC,SM00568:GRAM,		KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0343~GTPase activation,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EF-hand,DOMAIN:GRAM 1,DOMAIN:GRAM 2,DOMAIN:Rab-GAP TBC,REGION:Disordered,SITE:Arginine finger,SITE:Glutamine finger,
Q6NXR4	TELO2 interacting protein 2(TTI2)	Homo sapiens			GO:0050821~protein stabilization,GO:2000003~positive regulation of DNA damage checkpoint,	GO:0005634~nucleus,		IPR016024:ARM-type_fold,IPR018870:Tti2,		615541~Intellectual developmental disorder, autosomal recessive 39,						KW-0225~Disease variant,KW-0991~Intellectual disability,					REGION:Disordered,
A8C754	THADA, armadillo repeat containing(THADA)	Gallus gallus			GO:0002128~tRNA nucleoside ribose methylation,GO:0008033~tRNA processing,GO:0030488~tRNA methylation,	GO:0005829~cytosol,		IPR016024:ARM-type_fold,IPR019442:THADA/TRM732_DUF2428,					KW-0819~tRNA processing,								DOMAIN:DUF2428,
Q9BT49	THAP domain containing 7(THAP7)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0001222~transcription corepressor binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0035064~methylated histone binding,GO:0042393~histone binding,GO:0042802~identical protein binding,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,GO:0070577~lysine-acetylated histone binding,GO:0070742~C2H2 zinc finger domain binding,	IPR006612:THAP_Znf,IPR026519:THAP7,				SM00692:DM3,SM00980:THAP,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	MOTIF:HCFC1-binding motif (HBM),REGION:Disordered,ZN_FING:THAP-type,
Q8VE80	THO complex 3(Thoc3)	Mus musculus			GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,GO:0046784~viral mRNA export from host cell nucleus,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0000445~THO complex part of transcription export complex,GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR001680:WD40_rpt,IPR011659:PD40,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR020472:G-protein_beta_WD-40_rep,IPR024977:Apc4-like_WD40_dom,IPR036322:WD40_repeat_dom_sf,IPR040132:Tex1/THOC3,	mmu03013:Nucleocytoplasmic transport,mmu03040:Spliceosome,			SM00320:WD40,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0509~mRNA transport,KW-0813~Transport,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0853~WD repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,	REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,
Q13009	TIAM Rac1 associated GEF 1(TIAM1)	Homo sapiens			GO:0003300~cardiac muscle hypertrophy,GO:0007160~cell-matrix adhesion,GO:0007264~small GTPase mediated signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0016477~cell migration,GO:0016601~Rac protein signal transduction,GO:0030335~positive regulation of cell migration,GO:0032092~positive regulation of protein binding,GO:0042220~response to cocaine,GO:0048013~ephrin receptor signaling pathway,GO:0050772~positive regulation of axonogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0065003~macromolecular complex assembly,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0072657~protein localization to membrane,GO:0090630~activation of GTPase activity,GO:1904268~positive regulation of Schwann cell chemotaxis,GO:1904338~regulation of dopaminergic neuron differentiation,GO:1905274~regulation of modification of postsynaptic actin cytoskeleton,GO:1990138~neuron projection extension,GO:2000050~regulation of non-canonical Wnt signaling pathway,	GO:0005829~cytosol,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0032587~ruffle membrane,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0044291~cell-cell contact zone,GO:0044295~axonal growth cone,GO:0044304~main axon,GO:0045202~synapse,GO:0098978~glutamatergic synapse,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008289~lipid binding,GO:0019900~kinase binding,GO:0030971~receptor tyrosine kinase binding,	IPR000219:DH-domain,IPR001331:GDS_CDC24_CS,IPR001478:PDZ,IPR001849:PH_domain,IPR003116:RBD_dom,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR036034:PDZ_sf,IPR040655:TIAM1_CC-Ex,IPR043537:Tiam1/Tiam2/Sif,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04530:Tight junction,hsa04810:Regulation of actin cytoskeleton,hsa05205:Proteoglycans in cancer,	619908~Neurodevelopmental disorder with language delay and seizures,		SM00228:PDZ,SM00233:PH,SM00325:RhoGEF,SM00455:RBD,		KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,		KW-0887~Epilepsy,KW-0991~Intellectual disability,	KW-0175~Coiled coil,KW-0677~Repeat,	KW-0446~Lipid-binding,	KW-0344~Guanine-nucleotide releasing factor,	KW-0449~Lipoprotein,KW-0519~Myristate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:DH,DOMAIN:PDZ,DOMAIN:PH,DOMAIN:PH 1,DOMAIN:PH 2,DOMAIN:RBD,LIPID:N-myristoyl glycine,MUTAGEN:K->E: Strongly reduces affinity for SDC1.,MUTAGEN:K->R: Decreased ubiquitination and increased abundance.,REGION:Disordered,
Q9TTY1	TIMP metallopeptidase inhibitor 2(TIMP2)	Canis lupus familiaris			GO:0009725~response to hormone,GO:0010033~response to organic substance,GO:0010951~negative regulation of endopeptidase activity,GO:0034097~response to cytokine,GO:0051045~negative regulation of membrane protein ectodomain proteolysis,	GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0002020~protease binding,GO:0008191~metalloendopeptidase inhibitor activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001134:Netrin_domain,IPR001820:TIMP,IPR008993:TIMP-like_OB-fold,IPR027465:TIMP_C,IPR030490:TIMP_CS,				SM00206:NTR,		KW-0964~Secreted,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0481~Metalloenzyme inhibitor,KW-0483~Metalloprotease inhibitor,KW-0646~Protease inhibitor,	KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:NTR,REGION:Disordered,REGION:Involved in metalloproteinase-binding,SITE:Involved in metalloproteinase-binding,
A8WGS4	TLC domain containing 2(tlcd2)	Danio rerio			GO:0007009~plasma membrane organization,GO:0055091~phospholipid homeostasis,GO:0071709~membrane assembly,GO:0097035~regulation of membrane lipid distribution,	GO:0005886~plasma membrane,GO:0016020~membrane,		IPR006634:TLC-dom,				SM00724:TLC,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:TLC,TRANSMEM:Helical,
Q8TBR7	TLC domain containing 3A(TLCD3A)	Homo sapiens			GO:0055088~lipid homeostasis,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,	IPR006634:TLC-dom,				SM00724:TLC,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,DOMAIN:TLC,REGION:Disordered,TRANSMEM:Helical,
Q6PGS5	TLC domain containing 4 S homeolog(tlcd4.S)	Xenopus laevis				GO:0016020~membrane,		IPR006634:TLC-dom,				SM00724:TLC,		KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:TLC,TRANSMEM:Helical,
Q496Z2	TLR4 interactor with leucine-rich repeats(Tril)	Rattus norvegicus			GO:0002718~regulation of cytokine production involved in immune response,GO:0006954~inflammatory response,GO:0034142~toll-like receptor 4 signaling pathway,GO:0045087~innate immune response,	GO:0005615~extracellular space,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0046696~lipopolysaccharide receptor complex,	GO:0001530~lipopolysaccharide binding,	IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR003961:FN3_dom,IPR032675:LRR_dom_sf,IPR036116:FN3_sf,				SM00369:LRR_TYP,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,	KW-0472~Membrane,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:LRRCT,DOMAIN:LRRNT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9JJR8	TMEM9 domain family, member B(Tmem9b)	Mus musculus				GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0016020~membrane,GO:0031901~early endosome membrane,		IPR008853:TMEM9/TMEM9B,						KW-0458~Lysosome,KW-0472~Membrane,KW-0967~Endosome,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
Q59H18	TNNI3 interacting kinase(TNNI3K)	Homo sapiens			GO:0002027~regulation of heart rate,GO:0006468~protein phosphorylation,GO:0044238~primary metabolic process,GO:0055117~regulation of cardiac muscle contraction,GO:0071704~organic substance metabolic process,GO:0086069~bundle of His cell to Purkinje myocyte communication,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016772~transferase activity, transferring phosphorus-containing groups,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR002110:Ankyrin_rpt,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR036770:Ankyrin_rpt-contain_sf,		616117~Cardiac conduction disease with or without dilated cardiomyopathy,		SM00248:ANK,		KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,	KW-0040~ANK repeat,KW-0175~Coiled coil,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,MUTAGEN:K->R: Loss of autophosphorylation activity.,REGION:Disordered,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 10,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,
Q6DDV8	TPX2, microtubule-associated S homeolog(tpx2.S)	Xenopus laevis			GO:0007049~cell cycle,GO:0051301~cell division,GO:0060236~regulation of mitotic spindle organization,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,		IPR009675:TPX2_fam,IPR015128:Aurora-A-bd,IPR027329:TPX2_C,IPR027330:TPX2_central_dom,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:Aurora-A binding,DOMAIN:TPX2 C-terminal,DOMAIN:TPX2 central,REGION:Disordered,
Q6NRV0	TRAF interacting protein L homeolog(traip.L)	Xenopus laevis			GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0016567~protein ubiquitination,GO:0036297~interstrand cross-link repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0090734~site of DNA damage,	GO:0004842~ubiquitin-protein transferase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:1904931~MCM complex binding,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,				SM00184:RING,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		MOTIF:PIP-box,MUTAGEN:C->A: Abolished ability to mediate ubiquitination of mcm7.,MUTAGEN:Missing: Does not affect ability to mediate ubiquitination of mcm7.,MUTAGEN:R->C: Impaired ability to mediate ubiquitination of mcm7. Abolished ability to promote ubiquitination of covalent DNA-protein cross-links (DPCs).,REGION:Disordered,ZN_FING:RING-type; atypical,
O43734	TRAF3 interacting protein 2(TRAF3IP2)	Homo sapiens			GO:0001768~establishment of T cell polarity,GO:0001782~B cell homeostasis,GO:0001783~B cell apoptotic process,GO:0001822~kidney development,GO:0002230~positive regulation of defense response to virus by host,GO:0002269~leukocyte activation involved in inflammatory response,GO:0002334~transitional two stage B cell differentiation,GO:0002344~B cell affinity maturation,GO:0002447~eosinophil mediated immunity,GO:0006606~protein import into nucleus,GO:0006954~inflammatory response,GO:0006959~humoral immune response,GO:0007507~heart development,GO:0009410~response to xenobiotic stimulus,GO:0023019~signal transduction involved in regulation of gene expression,GO:0023035~CD40 signaling pathway,GO:0030217~T cell differentiation,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0035556~intracellular signal transduction,GO:0038173~interleukin-17A-mediated signaling pathway,GO:0042092~type 2 immune response,GO:0042119~neutrophil activation,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043588~skin development,GO:0048255~mRNA stabilization,GO:0048535~lymph node development,GO:0048536~spleen development,GO:0070254~mucus secretion,GO:0070534~protein K63-linked ubiquitination,GO:0072538~T-helper 17 type immune response,GO:0097400~interleukin-17-mediated signaling pathway,GO:1990959~eosinophil homeostasis,	GO:0005634~nucleus,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031410~cytoplasmic vesicle,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR013568:SEFIR_dom,	hsa04218:Cellular senescence,hsa04657:IL-17 signaling pathway,	614070~Psoriasis susceptibility 13,615527~Candidiasis, familial, 8,			KW-0395~Inflammatory response,KW-0833~Ubl conjugation pathway,	KW-0472~Membrane,		KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,		COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:SEFIR,MUTAGEN:L->G: Loss of E3 ubiquitin ligase activity.,MUTAGEN:L->R: Decreases E3 ubiquitin ligase activity.,MUTAGEN:P->G: Decreases E3 ubiquitin ligase activity.,MUTAGEN:V->R: Loss of E3 ubiquitin ligase activity.,REGION:Disordered,REGION:Mediates interaction with TRAF6,TRANSMEM:Helical,
Q8C0G2	TRAF3 interacting protein 3(Traf3ip3)	Mus musculus			GO:0002753~cytoplasmic pattern recognition receptor signaling pathway,GO:0032481~positive regulation of type I interferon production,GO:0032727~positive regulation of interferon-alpha production,GO:0032728~positive regulation of interferon-beta production,GO:0035457~cellular response to interferon-alpha,GO:0035458~cellular response to interferon-beta,GO:0043496~regulation of protein homodimerization activity,	GO:0000139~Golgi membrane,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031966~mitochondrial membrane,	GO:0044198~zf-TRAF domain binding,GO:0060090~binding, bridging,	IPR009003:Peptidase_S1_PA,IPR043504:Peptidase_S1_PA_chymotrypsin,						KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
Q9EP53	TSC complex subunit 1(Tsc1)	Mus musculus		m_mtorPathway:mTOR Signaling Pathway,	GO:0001822~kidney development,GO:0001843~neural tube closure,GO:0001952~regulation of cell-matrix adhesion,GO:0002250~adaptive immune response,GO:0006407~rRNA export from nucleus,GO:0006417~regulation of translation,GO:0006813~potassium ion transport,GO:0007160~cell-matrix adhesion,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008306~associative learning,GO:0008344~adult locomotory behavior,GO:0009267~cellular response to starvation,GO:0009790~embryo development,GO:0010977~negative regulation of neuron projection development,GO:0016239~positive regulation of macroautophagy,GO:0016242~negative regulation of macroautophagy,GO:0017148~negative regulation of translation,GO:0021766~hippocampus development,GO:0021987~cerebral cortex development,GO:0030030~cell projection organization,GO:0032007~negative regulation of TOR signaling,GO:0032780~negative regulation of ATPase activity,GO:0032868~response to insulin,GO:0036294~cellular response to decreased oxygen levels,GO:0042552~myelination,GO:0043379~memory T cell differentiation,GO:0043666~regulation of phosphoprotein phosphatase activity,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0046323~glucose import,GO:0050808~synapse organization,GO:0050821~protein stabilization,GO:0051492~regulation of stress fiber assembly,GO:0051496~positive regulation of stress fiber assembly,GO:0051726~regulation of cell cycle,GO:0051893~regulation of focal adhesion assembly,GO:0051894~positive regulation of focal adhesion assembly,GO:0055007~cardiac muscle cell differentiation,GO:0090630~activation of GTPase activity,GO:0090650~cellular response to oxygen-glucose deprivation,GO:1900408~negative regulation of cellular response to oxidative stress,GO:1904262~negative regulation of TORC1 signaling,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005938~cell cortex,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0030426~growth cone,GO:0032991~macromolecular complex,GO:0033596~TSC1-TSC2 complex,GO:0042995~cell projection,GO:0048471~perinuclear region of cytoplasm,GO:0101031~chaperone complex,	GO:0005515~protein binding,GO:0030544~Hsp70 protein binding,GO:0042030~ATPase inhibitor activity,GO:0051087~chaperone binding,GO:0051879~Hsp90 protein binding,	IPR007483:Hamartin,IPR016024:ARM-type_fold,	mmu04072:Phospholipase D signaling pathway,mmu04140:Autophagy - animal,mmu04150:mTOR signaling pathway,mmu04151:PI3K-Akt signaling pathway,mmu04152:AMPK signaling pathway,mmu04211:Longevity regulating pathway,mmu04218:Cellular senescence,mmu04714:Thermogenesis,mmu04910:Insulin signaling pathway,mmu05163:Human cytomegalovirus infection,mmu05165:Human papillomavirus infection,mmu05168:Herpes simplex virus 1 infection,mmu05231:Choline metabolism in cancer,					KW-0458~Lysosome,KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,	KW-0175~Coiled coil,		KW-0143~Chaperone,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Mediates interaction with WDR45B,
Q5PPI9	TTL family tubulin polyglutamylase complex subunit L1(Ttll1)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0002395~immune response in nasopharyngeal-associated lymphoid tissue,GO:0003351~epithelial cilium movement,GO:0007288~sperm axoneme assembly,GO:0018095~protein polyglutamylation,GO:0021702~cerebellar Purkinje cell differentiation,GO:0030317~flagellated sperm motility,GO:0035082~axoneme assembly,GO:0036211~protein modification process,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005929~cilium,GO:0031514~motile cilium,GO:0036064~ciliary basal body,	GO:0005524~ATP binding,GO:0015631~tubulin binding,GO:0016881~acid-amino acid ligase activity,GO:0046872~metal ion binding,GO:0070740~tubulin-glutamic acid ligase activity,	IPR004344:TTL/TTLL_fam,						KW-0206~Cytoskeleton,KW-0282~Flagellum,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,		DOMAIN:TTL,REGION:Disordered,SITE:Essential for specifying alpha-elongation versus initiation step of the polyglutamylase activity,
P42681	TXK tyrosine kinase(TXK)	Homo sapiens			GO:0001819~positive regulation of cytokine production,GO:0002250~adaptive immune response,GO:0006468~protein phosphorylation,GO:0007202~activation of phospholipase C activity,GO:0007229~integrin-mediated signaling pathway,GO:0010468~regulation of gene expression,GO:0010543~regulation of platelet activation,GO:0016310~phosphorylation,GO:0032729~positive regulation of interferon-gamma production,GO:0042246~tissue regeneration,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046777~protein autophosphorylation,GO:0050852~T cell receptor signaling pathway,GO:0060335~positive regulation of interferon-gamma-mediated signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR000719:Prot_kinase_dom,IPR000980:SH2,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001452:SH3_domain,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR035579:TXK_SH3,IPR035870:Txk_SH2,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,	hsa04670:Leukocyte transendothelial migration,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	KW-0391~Immunity,KW-0804~Transcription,KW-0805~Transcription regulation,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0727~SH2 domain,KW-0728~SH3 domain,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,DOMAIN:SH2,DOMAIN:SH3,MOTIF:Nuclear localization signal,MUTAGEN:K->A: Impairs kinase activity.,MUTAGEN:Y->A: Reduces expression levels if IFN-gamma.,REGION:Disordered,
Q6DRL4	TopBP1-interacting, checkpoint, and replication regulator(ticrr)	Danio rerio			GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007093~mitotic cell cycle checkpoint,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0010212~response to ionizing radiation,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0033314~mitotic DNA replication checkpoint,	GO:0005634~nucleus,	GO:0003682~chromatin binding,	IPR026153:Treslin,IPR032746:Treslin_N,	dre04110:Cell cycle,				KW-0131~Cell cycle,KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,							COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
F1QZ15	Tp53rk binding protein(tprkb)	Danio rerio			GO:0002949~tRNA threonylcarbamoyladenosine modification,GO:0008033~tRNA processing,	GO:0000408~EKC/KEOPS complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,		IPR013926:CGI121/TPRKB,IPR036504:CGI121/TPRKB_sf,					KW-0819~tRNA processing,	KW-0539~Nucleus,KW-0963~Cytoplasm,
P03934	Transposable element Tc1 transposase(tc1a)	Caenorhabditis elegans			GO:0006313~transposition, DNA-mediated,GO:0015074~DNA integration,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0004519~endonuclease activity,	IPR002492:Transposase_Tc1-like,IPR036397:RNaseH_sf,IPR038717:Tc1-like_DDE_dom,					KW-0229~DNA integration,KW-0233~DNA recombination,	KW-0539~Nucleus,					KW-0238~DNA-binding,KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,
O94941	U-box domain containing 5(UBOX5)	Homo sapiens			GO:0000209~protein polyubiquitination,GO:0016567~protein ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005925~focal adhesion,GO:0016604~nuclear body,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0034450~ubiquitin-ubiquitin ligase activity,GO:0046872~metal ion binding,	IPR001841:Znf_RING,IPR003613:Ubox_domain,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR039847:Ubox5,IPR039925:RNF37_RING-Ubox,IPR045696:Ubox5_N,	hsa04120:Ubiquitin mediated proteolysis,			SM00504:Ubox,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0488~Methylation,	DOMAIN:RING finger protein 37 N-terminal,DOMAIN:RING-type,DOMAIN:U-box,REGION:Disordered,ZN_FING:RING-type,
A1A4K8	U2 small nuclear RNA auxiliary factor 1(U2AF1)	Bos taurus			GO:0000398~mRNA splicing, via spliceosome,	GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0089701~U2AF,	GO:0003723~RNA binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0046872~metal ion binding,	IPR000504:RRM_dom,IPR000571:Znf_CCCH,IPR003954:RRM_dom_euk,IPR009145:U2AF_small,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR035979:RBD_domain_sf,	bta03040:Spliceosome,			SM00356:ZnF_C3H1,SM00360:RRM,SM00361:RRM_1,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,DOMAIN:C3H1-type,DOMAIN:RRM,REGION:Disordered,ZN_FING:C3H1-type,ZN_FING:C3H1-type 1,ZN_FING:C3H1-type 2,
Q6P3B2	UBA-like domain containing 1(Ubald1)	Mus musculus						IPR009060:UBA-like_sf,IPR039310:UBALD1/2,													COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,
Q64638	UDP glucuronosyltransferase family 1 member A5(Ugt1a5)	Rattus norvegicus			GO:0001889~liver development,GO:0014070~response to organic cyclic compound,GO:0032870~cellular response to hormone stimulus,GO:0052695~cellular glucuronidation,GO:0070640~vitamin D3 metabolic process,GO:0071361~cellular response to ethanol,GO:0071385~cellular response to glucocorticoid stimulus,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0008194~UDP-glycosyltransferase activity,GO:0015020~glucuronosyltransferase activity,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP_glucos_trans,IPR035595:UDP_glycos_trans_CS,	rno00040:Pentose and glucuronate interconversions,rno00053:Ascorbate and aldarate metabolism,rno00140:Steroid hormone biosynthesis,rno00830:Retinol metabolism,rno00860:Porphyrin metabolism,rno00980:Metabolism of xenobiotics by cytochrome P450,rno00982:Drug metabolism - cytochrome P450,rno00983:Drug metabolism - other enzymes,rno01100:Metabolic pathways,rno01240:Biosynthesis of cofactors,rno04976:Bile secretion,rno05204:Chemical carcinogenesis - DNA adducts,rno05207:Chemical carcinogenesis - receptor activation,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
Q63ZR6	UDP glycosyltransferase 3 family, polypeptide A2 L homeolog(ugt3a2.L)	Xenopus laevis				GO:0016020~membrane,	GO:0008194~UDP-glycosyltransferase activity,GO:0015020~glucuronosyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,	IPR002213:UDP_glucos_trans,IPR035595:UDP_glycos_trans_CS,						KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q7T3S5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5a(b3gnt5a)	Danio rerio			GO:0006486~protein glycosylation,GO:0006493~protein O-linked glycosylation,GO:0006629~lipid metabolic process,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0008457~beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0016758~transferase activity, transferring hexosyl groups,GO:0047256~lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,	IPR002659:Glyco_trans_31,	dre00601:Glycosphingolipid biosynthesis - lacto and neolacto series,dre01100:Metabolic pathways,				KW-0443~Lipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q91YN5	UDP-N-acetylglucosamine pyrophosphorylase 1(Uap1)	Mus musculus			GO:0006047~UDP-N-acetylglucosamine metabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,GO:0032481~positive regulation of type I interferon production,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0003977~UDP-N-acetylglucosamine diphosphorylase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,GO:0052630~UDP-N-acetylgalactosamine diphosphorylase activity,GO:0070569~uridylyltransferase activity,	IPR002618:UDPGP_fam,IPR029044:Nucleotide-diphossugar_trans,IPR039741:UDP-sugar_pyrophosphorylase,	mmu00520:Amino sugar and nucleotide sugar metabolism,mmu01100:Metabolic pathways,mmu01250:Biosynthesis of nucleotide sugars,				KW-0391~Immunity,KW-0399~Innate immunity,	KW-0963~Cytoplasm,					KW-0548~Nucleotidyltransferase,KW-0808~Transferase,
Q7ZWD4	UDP-N-acetylglucosamine pyrophosphorylase 1, like 1(uap1l1)	Danio rerio			GO:0006048~UDP-N-acetylglucosamine biosynthetic process,		GO:0003977~UDP-N-acetylglucosamine diphosphorylase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0070569~uridylyltransferase activity,	IPR002618:UDPGP_fam,IPR029044:Nucleotide-diphossugar_trans,IPR039741:UDP-sugar_pyrophosphorylase,	dre00520:Amino sugar and nucleotide sugar metabolism,dre01100:Metabolic pathways,dre01250:Biosynthesis of nucleotide sugars,										KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		MOTIF:Substrate binding,
Q7ZW63	UF2 component of NDC80 kinetochore complex(nuf2)	Danio rerio			GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007507~heart development,GO:0045132~meiotic chromosome segregation,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0051383~kinetochore organization,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0031262~Ndc80 complex,	GO:0008017~microtubule binding,GO:0044877~macromolecular complex binding,	IPR005549:Kinetochore_Nuf2_N,IPR038275:Nuf2_N_sf,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,			KW-0175~Coiled coil,
Q9NUQ7	UFM1 specific peptidase 2(UFSP2)	Homo sapiens			GO:0006508~proteolysis,GO:0033146~regulation of intracellular estrogen receptor signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,	GO:0005515~protein binding,GO:0071567~UFM1 hydrolase activity,	IPR012462:UfSP1/2_DUB_cat,IPR038765:Papain-like_cys_pep_sf,IPR049387:UfSP2-like_N,		142669~Hip dysplasia, Beukes type,617974~Spondyloepimetaphyseal dysplasia, Di Rocco type,620028~Developmental and epileptic encephalopathy 106,			KW-0833~Ubl conjugation pathway,	KW-0256~Endoplasmic reticulum,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0242~Dwarfism,KW-0887~Epilepsy,KW-0991~Intellectual disability,			KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0007~Acetylation,	DOMAIN:Ubiquitin-fold modifier 1 specific protease 2-like N-terminal,DOMAIN:UfSP1/2/DUB catalytic,MUTAGEN:C->S: Catalytically inactive.,
Q3TLD5	URI1, prefoldin-like chaperone(Uri1)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009615~response to virus,GO:0010923~negative regulation of phosphatase activity,GO:0071363~cellular response to growth factor stimulus,GO:0071383~cellular response to steroid hormone stimulus,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0030425~dendrite,GO:0042995~cell projection,GO:1990062~RPAP3/R2TP/prefoldin-like complex,	GO:0000993~RNA polymerase II core binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0004864~protein phosphatase inhibitor activity,GO:0019212~phosphatase inhibitor activity,GO:0051219~phosphoprotein binding,	IPR004127:Prefoldin_subunit_alpha,IPR009053:Prefoldin,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,		KW-0553~Oncogene,	KW-0732~Signal,		KW-0650~Protein phosphatase inhibitor,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q9Z1Z0	USO1 vesicle docking factor(Uso1)	Mus musculus			GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032252~secretory granule localization,GO:0045056~transcytosis,GO:0048211~Golgi vesicle docking,GO:0048280~vesicle fusion with Golgi apparatus,GO:0061025~membrane fusion,GO:1900076~regulation of cellular response to insulin stimulus,	GO:0000139~Golgi membrane,GO:0001650~fibrillar center,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0005829~cytosol,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR000225:Armadillo,IPR006953:Vesicle_Uso1_P115_head,IPR006955:Uso1_p115_C,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR041209:P115_Arm_rpt,				SM00185:ARM,	KW-0653~Protein transport,KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,REGION:Disordered,REGION:Globular head,REPEAT:ARM 1,REPEAT:ARM 10,REPEAT:ARM 11,REPEAT:ARM 12,REPEAT:ARM 2,REPEAT:ARM 3,REPEAT:ARM 4,REPEAT:ARM 5,REPEAT:ARM 6,REPEAT:ARM 7,REPEAT:ARM 8,REPEAT:ARM 9,
O75691	UTP20 small subunit processome component(UTP20)	Homo sapiens			GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000472~endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0008285~negative regulation of cell proliferation,GO:0042274~ribosomal small subunit biogenesis,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030686~90S preribosome,GO:0030688~preribosome, small subunit precursor,GO:0032040~small-subunit processome,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR011430:UTP20_N,IPR016024:ARM-type_fold,IPR046523:UTP20_C,					KW-0698~rRNA processing,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,MOTIF:Nuclear localization signal,MOTIF:Nucleolar localization signal,MUTAGEN:K->A: Decreases nucleolar localization.,MUTAGEN:K->A: Does not decrease nucleolar localization.,MUTAGEN:KK->AA: Inhibits nucleolar but not nuclear localization.,MUTAGEN:KKK->AAA: Inhibits nucleolar but not nuclear localization.,MUTAGEN:KKRK->AAAA: Inhibits nucleolar localization and decreases nuclear localization.,REGION:Disordered,REPEAT:HEAT 1,REPEAT:HEAT 2,
E7EXT2	UV-stimulated scaffold protein A(uvssa)	Danio rerio			GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009411~response to UV,GO:0016567~protein ubiquitination,	GO:0005694~chromosome,	GO:0000993~RNA polymerase II core binding,	IPR018610:UVSSA,IPR049408:UVSSA_N_a-solenoid_rpt,IPR049431:UVSSA_C,	dre03420:Nucleotide excision repair,				KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,			KW-0175~Coiled coil,			KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),REGION:Disordered,REGION:VHS-like,
D3YZF7	V-set and immunoglobulin domain containing 10 like(Vsig10l)	Mus musculus				GO:0005654~nucleoplasm,GO:0016020~membrane,		IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q0VCY1	VAMP associated protein A(VAPA)	Bos taurus			GO:0006686~sphingomyelin biosynthetic process,GO:0015914~phospholipid transport,GO:0019076~viral release from host cell,GO:0030301~cholesterol transport,GO:0031175~neuron projection development,GO:0035627~ceramide transport,GO:0044828~negative regulation by host of viral genome replication,GO:0044829~positive regulation by host of viral genome replication,GO:0061817~endoplasmic reticulum-plasma membrane tethering,GO:0070972~protein localization to endoplasmic reticulum,GO:0090114~COPII-coated vesicle budding,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0031982~vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0008017~microtubule binding,GO:0033149~FFAT motif binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR000535:MSP_dom,IPR008962:PapD-like_sf,IPR013783:Ig-like_fold,IPR016763:VAP,	bta04979:Cholesterol metabolism,		PIRSF019693:VAMP-associated,			KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DISULFID:Interchain,DOMAIN:MSP,REGION:Disordered,REGION:phosphorylated FFAT motif binding,SITE:Involved in binding the phosphorylated serine of the phospho-FFAT motif,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical; Anchor for type IV membrane protein,
Q3T178	VPS28 subunit of ESCRT-I(VPS28)	Bos taurus			GO:0015031~protein transport,GO:0031397~negative regulation of protein ubiquitination,GO:0032509~endosome transport via multivesicular body sorting pathway,GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,GO:0043328~protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,	GO:0000813~ESCRT I complex,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0031902~late endosome membrane,	GO:0044877~macromolecular complex binding,	IPR007143:Vps28,IPR017898:VPS28_N,IPR017899:VPS28_C,IPR037202:ESCRT_assembly_dom,IPR037206:VPS28_C_sf,IPR038358:VPS28_N_sf,	bta04144:Endocytosis,		PIRSF017535:VPS28,		KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0732~Signal,			KW-0007~Acetylation,	DOMAIN:VPS28 C-terminal,DOMAIN:VPS28 N-terminal,
Q8R5L3	VPS39 HOPS complex subunit(Vps39)	Mus musculus			GO:0006886~intracellular protein transport,GO:0006914~autophagy,GO:0008333~endosome to lysosome transport,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032456~endocytic recycling,GO:0034058~endosomal vesicle fusion,GO:1902774~late endosome to lysosome transport,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005770~late endosome,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0030123~AP-3 adaptor complex,GO:0030897~HOPS complex,GO:0031902~late endosome membrane,GO:0043231~intracellular membrane-bounded organelle,GO:1902501~lysosomal HOPS complex,	GO:0005515~protein binding,	IPR000547:Clathrin_H-chain/VPS_repeat,IPR001180:CNH_dom,IPR019452:VPS39/TGF_beta_rcpt-assoc_1,IPR019453:VPS39/TGF_beta_rcpt-assoc_2,IPR032914:Vam6/VPS39/TRAP1,IPR036322:WD40_repeat_dom_sf,	mmu04140:Autophagy - animal,mmu04148:Efferocytosis,mmu05132:Salmonella infection,			SM00036:CNH,	KW-0072~Autophagy,KW-0653~Protein transport,KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,							DOMAIN:CNH,REPEAT:CHCR,
Q155U0	VPS51 subunit of GARP complex(vps51)	Danio rerio			GO:0006869~lipid transport,GO:0007030~Golgi organization,GO:0007041~lysosomal transport,GO:0010517~regulation of phospholipase activity,GO:0015031~protein transport,GO:0032456~endocytic recycling,GO:0042147~retrograde transport, endosome to Golgi,GO:0044241~lipid digestion,GO:0048193~Golgi vesicle transport,	GO:0000938~GARP complex,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0055037~recycling endosome,GO:1990745~EARP complex,	GO:0031267~small GTPase binding,	IPR014812:Vps51,IPR016159:Cullin_repeat-like_dom_sf,					KW-0445~Lipid transport,KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0967~Endosome,			KW-0175~Coiled coil,				COMPBIAS:Polar residues,REGION:Disordered,
Q7ZUS1	VRK serine/threonine kinase 1(vrk1)	Danio rerio			GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007283~spermatogenesis,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0051301~cell division,GO:0061351~neural precursor cell proliferation,GO:0090166~Golgi disassembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005795~Golgi stack,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,				SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,		ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,DOMAIN:Protein kinase,REGION:Disordered,
O13046	WD repeat and HMG-box DNA binding protein 1 L homeolog(wdhd1.L)	Xenopus laevis				GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043229~intracellular organelle,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001680:WD40_rpt,IPR009071:HMG_box_dom,IPR013979:TIF_beta_prop-like,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR022100:Mcl1_mid,IPR036322:WD40_repeat_dom_sf,IPR036910:HMG_box_dom_sf,IPR048591:Ctf4-like_C,				SM00320:WD40,SM00398:HMG,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0853~WD repeat,		KW-0238~DNA-binding,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:HMG box,DOMAIN:HMG box,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q9XSC3	WD repeat domain 44(WDR44)	Bos taurus			GO:0060627~regulation of vesicle-mediated transport,GO:0061824~cytosolic ciliogenesis,GO:1902018~negative regulation of cilium assembly,	GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0031267~small GTPase binding,	IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,IPR040324:WDR44/Dgr2,				SM00320:WD40,		KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0677~Repeat,KW-0853~WD repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,MOTIF:FFAT-like motif,REGION:Binding activity,REGION:Disordered,REGION:Important for interaction with ARHGAP26 AND ARHGAP10,REGION:Important for interaction with RAB11A,REGION:Interaction with RAB11,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q6PJI9	WD repeat domain 59(WDR59)	Homo sapiens			GO:0031669~cellular response to nutrient levels,GO:0032008~positive regulation of TOR signaling,GO:0034198~cellular response to amino acid starvation,GO:1904262~negative regulation of TORC1 signaling,GO:1904263~positive regulation of TORC1 signaling,	GO:0005765~lysosomal membrane,GO:0005774~vacuolar membrane,GO:0005829~cytosol,GO:0035859~Seh1-associated complex,GO:0043231~intracellular membrane-bounded organelle,GO:0061700~GATOR2 complex,	GO:0005515~protein binding,GO:0035591~signaling adaptor activity,GO:0046872~metal ion binding,	IPR001680:WD40_rpt,IPR006575:RWD-domain,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016135:UBQ-conjugating_enzyme/RWD,IPR019775:WD40_repeat_CS,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,IPR039456:WDR59_mRING-H2-C3H3C2,	hsa04150:mTOR signaling pathway,			SM00320:WD40,SM00591:RWD,		KW-0458~Lysosome,KW-0472~Membrane,			KW-0677~Repeat,KW-0853~WD repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:RWD,MUTAGEN:CAIC->AAIA: Impaired amino-acid-mediated mTORC1 activation.,MUTAGEN:L->E: Abolished interaction with WDR24 and assembly of the GATOR2 complex; when associated with 728-E--E-732.,MUTAGEN:LLESL->ELESE: Abolished interaction with WDR24 and assembly of the GATOR2 complex; when associated with E-698.,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,REPEAT:WD 8,ZN_FING:C4-type,ZN_FING:RING-type; atypical,
Q5MNZ9	WD repeat domain, phosphoinositide interacting 1(WIPI1)	Homo sapiens			GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006497~protein lipidation,GO:0006914~autophagy,GO:0009267~cellular response to starvation,GO:0030242~pexophagy,GO:0034497~protein localization to pre-autophagosomal structure,GO:0044804~nucleophagy,GO:0048203~vesicle targeting, trans-Golgi to endosome,GO:0061723~glycophagy,GO:2000786~positive regulation of autophagosome assembly,	GO:0000139~Golgi membrane,GO:0000407~pre-autophagosomal structure,GO:0000421~autophagosome membrane,GO:0005737~cytoplasm,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0010008~endosome membrane,GO:0019898~extrinsic component of membrane,GO:0030136~clathrin-coated vesicle,GO:0034045~pre-autophagosomal structure membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0030331~estrogen receptor binding,GO:0030674~protein binding, bridging,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0050681~androgen receptor binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR036322:WD40_repeat_dom_sf,IPR048720:PROPPIN,	hsa04136:Autophagy - other,hsa04140:Autophagy - animal,hsa05010:Alzheimer disease,hsa05014:Amyotrophic lateral sclerosis,hsa05016:Huntington disease,hsa05017:Spinocerebellar ataxia,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05131:Shigellosis,			SM00320:WD40,	KW-0072~Autophagy,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,			KW-0677~Repeat,KW-0853~WD repeat,	KW-0446~Lipid-binding,			COMPBIAS:Polar residues,MOTIF:L/FRRG motif,MOTIF:Nuclear receptor interaction,MUTAGEN:G->A: Loss of binding to phosphoinositides and abolishes puncta formation.,MUTAGEN:H->A: Loss of binding to phosphoinositides and abolishes puncta formation.,MUTAGEN:R->A: Loss of binding to phosphoinositides and abolishes puncta formation.,MUTAGEN:RR->AA: Loss of binding to phosphoinositides, does not disrupt the MPR pathway.,MUTAGEN:S->A: Loss of binding to phosphoinositides and abolishes puncta formation.,MUTAGEN:T->A: Loss of binding to phosphoinositides and abolishes puncta formation.,REGION:Disordered,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q8QGV2	WEE1 G2 checkpoint kinase S homeolog(wee1.S)	Xenopus laevis			GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0016310~phosphorylation,GO:0045786~negative regulation of cell cycle,GO:0051301~cell division,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017164:Wee1-like_protein_kinase,IPR017441:Protein_kinase_ATP_BS,	xla04110:Cell cycle,		PIRSF037281:Wee1-like_protein_kinase,	SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0539~Nucleus,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Protein kinase,MUTAGEN:NIN->AAA: Impairs without abolishing ability to phosphorylate cdk1.,MUTAGEN:T->A: Abolishes kinase activity inhibition during M-phase. Does not affect ability to phosphorylate cdk1.,REGION:Disordered,
O95785	WIZ zinc finger(WIZ)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0030496~midbody,GO:0070062~extracellular exosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001222~transcription corepressor binding,GO:0005515~protein binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:1990226~histone methyltransferase binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,		KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:C2H2-type,REGION:Disordered,REGION:Interaction with CTBP1 and CTBP2 1,REGION:Interaction with CTBP1 and CTBP2 2,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q9H4A3	WNK lysine deficient protein kinase 1(WNK1)	Homo sapiens			GO:0002028~regulation of sodium ion transport,GO:0003084~positive regulation of systemic arterial blood pressure,GO:0006468~protein phosphorylation,GO:0006811~ion transport,GO:0006884~cell volume homeostasis,GO:0007165~signal transduction,GO:0007507~heart development,GO:0010507~negative regulation of autophagy,GO:0010766~negative regulation of sodium ion transport,GO:0010793~regulation of mRNA export from nucleus,GO:0010820~positive regulation of T cell chemotaxis,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0030644~cellular chloride ion homeostasis,GO:0031397~negative regulation of protein ubiquitination,GO:0033633~negative regulation of cell-cell adhesion mediated by integrin,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0034260~negative regulation of GTPase activity,GO:0035556~intracellular signal transduction,GO:0035725~sodium ion transmembrane transport,GO:0038116~chemokine (C-C motif) ligand 21 signaling pathway,GO:0045050~protein insertion into ER membrane by stop-transfer membrane-anchor sequence,GO:0045766~positive regulation of angiogenesis,GO:0048666~neuron development,GO:0050852~T cell receptor signaling pathway,GO:0055075~potassium ion homeostasis,GO:0055080~cation homeostasis,GO:0071474~cellular hyperosmotic response,GO:0090188~negative regulation of pancreatic juice secretion,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0097022~lymphocyte migration into lymph node,GO:1902305~regulation of sodium ion transmembrane transport,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903077~negative regulation of protein localization to plasma membrane,GO:1903490~positive regulation of mitotic cytokinesis,GO:1904062~regulation of cation transmembrane transport,GO:1904595~positive regulation of termination of RNA polymerase II transcription,GO:1990869~cellular response to chemokine,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0032991~macromolecular complex,GO:0043232~intracellular non-membrane-bounded organelle,GO:0072686~mitotic spindle,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,GO:0030295~protein kinase activator activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR024678:Kinase_OSR1/WNK_CCT,		201300~Neuropathy, hereditary sensory and autonomic, type II,614492~Pseudohypoaldosteronism, type IIC,		SM00220:S_TKc,		KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0523~Neurodegeneration,KW-0622~Neuropathy,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,KW-0868~Chloride,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Protein kinase,MOTIF:RFXV motif 1,MOTIF:RFXV motif 2,MOTIF:RFXV motif 3,MOTIF:RFXV motif 4,MUTAGEN:D->A,K: Abolished interaction with EMC2.,MUTAGEN:D->A,K: Does not affect interaction with EMC2.,MUTAGEN:D->A: Abolished serine/threonine-protein kinase activity.,MUTAGEN:D->K: Does not affect interaction with EMC2.,MUTAGEN:F->A: Slightly decreased binding to OXSR1/OSR1 and STK39/SPAK; when associated with A-1258. Abolished binding to OXSR1/OSR1 and STK39/SPAK; when associated with A-1258, A-1946 and A-1958.,MUTAGEN:F->A: Slightly decreased binding to OXSR1/OSR1 and STK39/SPAK; when associated with A-1860. Abolished binding to OXSR1/OSR1 and STK39/SPAK; when associated with A-1860, A-1946 and A-1958.,MUTAGEN:F->A: Slightly decreased binding to OXSR1/OSR1 and STK39/SPAK; when associated with A-1946. Abolished binding to OXSR1/OSR1 and STK39/SPAK; when associated with A-1258, A-1860 and A-1946.,MUTAGEN:F->A: Slightly decreased binding to OXSR1/OSR1 and STK39/SPAK; when associated with A-1958. Abolished binding to OXSR1/OSR1 and STK39/SPAK; when associated with A-1257, A-1860 and A-1958.,MUTAGEN:F->K: Abolished interaction with EMC2.,MUTAGEN:G->R,N,D,C,Q,H,I,L,K,M,F,P,S,T,W,Y,V: Does not affect binding to OXSR1/OSR1.,MUTAGEN:H->K: Does not affect interaction with EMC2.,MUTAGEN:K->M: Abolished serine/threonine-protein kinase activity. Does not affect ability to activate SGK1.,MUTAGEN:L->K: Abolished interaction with EMC2.,MUTAGEN:Missing: Abolished interaction with EMC2.,MUTAGEN:R->A,N,C,E,Q,H,I,L,K,M,F,S,T,W,Y,V: Does not affect binding to OXSR1/OSR1.,MUTAGEN:S->A: Decreased autophosphorylation, preventing activation of the serine/threonine-protein kinase activity.,MUTAGEN:V->E: Does not affect ability to phosphorylate OXSR1/OSR1.,MUTAGEN:W->K,L,A: Abolished interaction with EMC2.,REGION:Amphipathic alpha-helix,REGION:Autoinhibitory domain,REGION:Disordered,REGION:Interaction with KLHL3,
Q3UH66	WNK lysine deficient protein kinase 2(Wnk2)	Mus musculus			GO:0006468~protein phosphorylation,GO:0008285~negative regulation of cell proliferation,GO:0010766~negative regulation of sodium ion transport,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,GO:0046777~protein autophosphorylation,GO:0050801~ion homeostasis,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1903288~positive regulation of potassium ion import,GO:2000651~positive regulation of sodium ion transmembrane transporter activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019870~potassium channel inhibitor activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR024678:Kinase_OSR1/WNK_CCT,				SM00220:S_TKc,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Protein kinase,REGION:Disordered,
Q96S55	WRN helicase interacting protein 1(WRNIP1)	Homo sapiens			GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0032508~DNA duplex unwinding,GO:0045087~innate immune response,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008047~enzyme activator activity,GO:0016887~ATPase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR006642:Rad18_UBZ4,IPR008921:DNA_pol3_clamp-load_cplx_C,IPR021886:MgsA_C,IPR027417:P-loop_NTPase,IPR032423:AAA_assoc_2,IPR040539:Znf-WRNIP1_ubi,				SM00382:AAA,SM00734:ZnF_Rad18,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0235~DNA replication,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,DOMAIN:UBZ4-type,MUTAGEN:D->A: Loss of affinity for ubiquitin.,MUTAGEN:I->A: Loss of affinity for ubiquitin.,MUTAGEN:L->A: Loss of affinity for ubiquitin.,MUTAGEN:L->A: Normal affinity for ubiquitin.,MUTAGEN:N->A: Loss of affinity for ubiquitin.,MUTAGEN:P->A: Loss of affinity for ubiquitin.,MUTAGEN:P->A: Normal affinity for ubiquitin.,MUTAGEN:T->A: Loss of ATPase activity.,MUTAGEN:V->A: Reduced affinity for ubiquitin.,REGION:Disordered,ZN_FING:UBZ4-type,
B7ZSG3	WT1 transcription factor S homeolog(wt1.S)	Xenopus laevis			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0039004~specification of pronephric proximal tubule identity,GO:0048793~pronephros development,GO:0061440~kidney vasculature development,GO:0072013~glomus development,GO:1900207~negative regulation of pronephric nephron tubule development,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0010385~double-stranded methylated DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044729~hemi-methylated DNA-binding,GO:0046872~metal ion binding,	IPR000976:Wilms_tumour_N,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0879~Wnt signaling pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,	KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0694~RNA-binding,KW-9996~Developmental protein,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DOMAIN:C2H2-type,MOTIF:9aaTAD,MOTIF:KTS motif,REGION:Important for interaction with target DNA,SITE:Important for interaction with target DNA,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,
Q96G27	WW domain binding protein 1(WBP1)	Homo sapiens				GO:0016020~membrane,	GO:0005515~protein binding,GO:0050699~WW domain binding,	IPR021684:WBP1-like,						KW-0472~Membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Polar residues,COMPBIAS:Pro residues,MOTIF:PPxY motif 1,MOTIF:PPxY motif 2,MUTAGEN:Y->A: Abolishes interaction with WWOX.,REGION:Disordered,TRANSMEM:Helical,
O00308	WW domain containing E3 ubiquitin protein ligase 2(WWP2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006858~extracellular transport,GO:0010629~negative regulation of gene expression,GO:0016567~protein ubiquitination,GO:0032410~negative regulation of transporter activity,GO:0034765~regulation of ion transmembrane transport,GO:0036211~protein modification process,GO:0042391~regulation of membrane potential,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045746~negative regulation of Notch signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046718~viral entry into host cell,GO:0051224~negative regulation of protein transport,GO:0051865~protein autoubiquitination,GO:0070534~protein K63-linked ubiquitination,GO:1901016~regulation of potassium ion transmembrane transporter activity,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016874~ligase activity,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0061630~ubiquitin protein ligase activity,	IPR000008:C2_dom,IPR000569:HECT_dom,IPR001202:WW_dom,IPR024928:E3_ub_ligase_SMURF1,IPR035892:C2_domain_sf,IPR035983:Hect_E3_ubiquitin_ligase,IPR036020:WW_dom_sf,	hsa04120:Ubiquitin mediated proteolysis,		PIRSF001569:E3_ub_ligase_SMURF1,	SM00119:HECTc,SM00239:C2,SM00456:WW,	KW-0833~Ubl conjugation pathway,KW-0945~Host-virus interaction,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Glycyl thioester intermediate,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:HECT,DOMAIN:WW,DOMAIN:WW 1,DOMAIN:WW 2,DOMAIN:WW 3,DOMAIN:WW 4,MUTAGEN:C->A: Abolishes ubiquitination of POU5F1.,MUTAGEN:H->K: Does not affect FBXL15-mediated ubiquitination.,MUTAGEN:K->R: Does not affect FBXL15-mediated ubiquitination.,REGION:Disordered,
P46094	X-C motif chemokine receptor 1(XCR1)	Homo sapiens			GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0019722~calcium-mediated signaling,GO:0051209~release of sequestered calcium ion into cytosol,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,	GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,	IPR000276:GPCR_Rhodpsn,IPR005393:Chemokine_XCR1,IPR017452:GPCR_Rhodpsn_7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04061:Viral protein interaction with cytokine and cytokine receptor,hsa04062:Chemokine signaling pathway,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-1015~Disulfide bond,	DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q66I85	YJU2 splicing factor homolog B(yju2b)	Danio rerio			GO:0000398~mRNA splicing, via spliceosome,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005684~U2-type spliceosomal complex,GO:0071014~post-mRNA release spliceosomal complex,		IPR007590:Saf4/Yju2,						KW-0539~Nucleus,							REGION:Disordered,
Q8IY57	YY1 associated factor 2(YAF2)	Homo sapiens	61.Myc_network,		GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001876:Znf_RanBP2,IPR033774:YAF2_RYBP,IPR036443:Znf_RanBP2_sf,IPR039958:RYBP/YAF2,	hsa03083:Polycomb repressive complex,			SM00547:ZnF_RBZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RanBP2-type,REGION:Disordered,ZN_FING:RanBP2-type,
A5D7K7	Yip1 domain family member 7(YIPF7)	Bos taurus			GO:0006888~ER to Golgi vesicle-mediated transport,GO:0048280~vesicle fusion with Golgi apparatus,	GO:0005789~endoplasmic reticulum membrane,GO:0005802~trans-Golgi network,GO:0016020~membrane,		IPR006977:Yip1_dom,IPR045231:Yip1/4-like,						KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q05910	a disintegrin and metallopeptidase domain 8(Adam8)	Mus musculus			GO:0000902~cell morphogenesis,GO:0001525~angiogenesis,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002675~positive regulation of acute inflammatory response,GO:0002693~positive regulation of cellular extravasation,GO:0006508~proteolysis,GO:0006954~inflammatory response,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0022407~regulation of cell-cell adhesion,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0043534~blood vessel endothelial cell migration,GO:0045089~positive regulation of innate immune response,GO:0045670~regulation of osteoclast differentiation,GO:0045780~positive regulation of bone resorption,GO:0045785~positive regulation of cell adhesion,GO:0048247~lymphocyte chemotaxis,GO:0048729~tissue morphogenesis,GO:0050729~positive regulation of inflammatory response,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0051897~positive regulation of protein kinase B signaling,GO:0061025~membrane fusion,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0071456~cellular response to hypoxia,GO:0072675~osteoclast fusion,GO:0098609~cell-cell adhesion,GO:1901394~positive regulation of transforming growth factor beta1 activation,GO:2000309~positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,GO:2000391~positive regulation of neutrophil extravasation,GO:2000399~negative regulation of thymocyte aggregation,GO:2000406~positive regulation of T cell migration,GO:2000415~positive regulation of fibronectin-dependent thymocyte migration,GO:2000418~positive regulation of eosinophil migration,	GO:0002102~podosome,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0032010~phagolysosome,GO:0032127~dense core granule membrane,GO:0042581~specific granule,GO:0070820~tertiary granule,GO:0071133~alpha9-beta1 integrin-ADAM8 complex,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0050839~cell adhesion molecule binding,	IPR000742:EGF-like_dom,IPR001590:Peptidase_M12B,IPR001762:Disintegrin_dom,IPR002870:Peptidase_M12B_N,IPR006586:ADAM_Cys-rich,IPR018358:Disintegrin_CS,IPR024079:MetalloPept_cat_dom_sf,IPR034027:Reprolysin_adamalysin,IPR036436:Disintegrin_dom_sf,				SM00050:DISIN,SM00608:ACR,		KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0401~Integrin,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Disintegrin,DOMAIN:EGF-like,DOMAIN:Peptidase M12B,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q08C93	abhydrolase domain containing 12, lysophospholipase(abhd12)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006660~phosphatidylserine catabolic process,GO:0009395~phospholipid catabolic process,GO:0010842~retina layer formation,GO:0036269~swimming behavior,GO:0042552~myelination,GO:0043010~camera-type eye development,GO:0046464~acylglycerol catabolic process,GO:0048899~anterior lateral line development,GO:0048919~posterior lateral line neuromast development,GO:0052651~monoacylglycerol catabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004620~phospholipase activity,GO:0004622~lysophospholipase activity,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0047372~acylglycerol lipase activity,	IPR000073:AB_hydrolase_1,IPR029058:AB_hydrolase,					KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,	ACT_SITE:Charge relay system,ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8CJ27	abnormal spindle microtubule assembly(Aspm)	Mus musculus			GO:0001764~neuron migration,GO:0002052~positive regulation of neuroblast proliferation,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007283~spermatogenesis,GO:0007405~neuroblast proliferation,GO:0007420~brain development,GO:0008356~asymmetric cell division,GO:0008584~male gonad development,GO:0021873~forebrain neuroblast division,GO:0021987~cerebral cortex development,GO:0045665~negative regulation of neuron differentiation,GO:0045769~negative regulation of asymmetric cell division,GO:0048477~oogenesis,GO:0048589~developmental growth,GO:0051301~cell division,GO:0051445~regulation of meiotic cell cycle,GO:0051653~spindle localization,GO:0051661~maintenance of centrosome location,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0090306~spindle assembly involved in meiosis,GO:0097150~neuronal stem cell population maintenance,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016324~apical plasma membrane,GO:0030496~midbody,GO:0036449~microtubule minus-end,GO:0072687~meiotic spindle,GO:0097431~mitotic spindle pole,	GO:0005516~calmodulin binding,	IPR000048:IQ_motif_EF-hand-BS,IPR001715:CH_dom,IPR013783:Ig-like_fold,IPR016024:ARM-type_fold,IPR027417:P-loop_NTPase,IPR031549:ASH,IPR036872:CH_dom_sf,				SM00015:IQ,SM00033:CH,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0112~Calmodulin-binding,	KW-0597~Phosphoprotein,	DOMAIN:Calponin-homology (CH) 1,DOMAIN:Calponin-homology (CH) 2,DOMAIN:IQ 1,DOMAIN:IQ 10,DOMAIN:IQ 11,DOMAIN:IQ 12,DOMAIN:IQ 13,DOMAIN:IQ 14,DOMAIN:IQ 15,DOMAIN:IQ 16,DOMAIN:IQ 17,DOMAIN:IQ 18,DOMAIN:IQ 19,DOMAIN:IQ 2,DOMAIN:IQ 20,DOMAIN:IQ 21,DOMAIN:IQ 22,DOMAIN:IQ 23,DOMAIN:IQ 24,DOMAIN:IQ 25,DOMAIN:IQ 26,DOMAIN:IQ 27,DOMAIN:IQ 28,DOMAIN:IQ 29,DOMAIN:IQ 3,DOMAIN:IQ 30,DOMAIN:IQ 31,DOMAIN:IQ 32,DOMAIN:IQ 4,DOMAIN:IQ 5,DOMAIN:IQ 6,DOMAIN:IQ 7,DOMAIN:IQ 8,DOMAIN:IQ 9,MUTAGEN:F->A: Disrupts interaction with KATNA1:KATNB1.,MUTAGEN:F->A: Disrupts interaction with KATNA1:KATNB1; when associated with A-302.,MUTAGEN:F->A: Disrupts interaction with KATNA1:KATNB1; when associated with A-377.,REGION:Disordered,REGION:Sufficient for interaction with KATNA1:KATNB1,
A3QK15	acetoacetyl-CoA synthetase(aacs)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0032024~positive regulation of insulin secretion,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0030729~acetoacetate-CoA ligase activity,	IPR000873:AMP-dep_Synth/Lig_com,IPR005914:Acac_CoA_synth,IPR020845:AMP-binding_CS,IPR032387:ACAS_N,IPR042099:ANL_N_sf,IPR045851:AMP-bd_C_sf,	dre00280:Valine, leucine and isoleucine degradation,dre00650:Butanoate metabolism,dre01100:Metabolic pathways,				KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,
Q8BWT1	acetyl-CoA acyltransferase 2(Acaa2)	Mus musculus			GO:0006084~acetyl-CoA metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0071456~cellular response to hypoxia,GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1902109~negative regulation of mitochondrial membrane permeability involved in apoptotic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,	GO:0003985~acetyl-CoA C-acetyltransferase activity,GO:0003986~acetyl-CoA hydrolase activity,GO:0003988~acetyl-CoA C-acyltransferase activity,GO:0016290~palmitoyl-CoA hydrolase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,GO:0016787~hydrolase activity,GO:0047617~acyl-CoA hydrolase activity,GO:0102991~myristoyl-CoA hydrolase activity,	IPR002155:Thiolase,IPR016039:Thiolase-like,IPR020610:Thiolase_AS,IPR020613:Thiolase_CS,IPR020615:Thiolase_acyl_enz_int_AS,IPR020616:Thiolase_N,IPR020617:Thiolase_C,	mmu00062:Fatty acid elongation,mmu00071:Fatty acid degradation,mmu00280:Valine, leucine and isoleucine degradation,mmu01100:Metabolic pathways,mmu01212:Fatty acid metabolism,		PIRSF000429:Ac-CoA_Ac_transf,		KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0012~Acyltransferase,KW-0378~Hydrolase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Acyl-thioester intermediate,ACT_SITE:Proton acceptor,ACT_SITE:Proton donor/acceptor,DOMAIN:Thiolase C-terminal,DOMAIN:Thiolase N-terminal,REGION:Disordered,SITE:Increases nucleophilicity of active site Cys,TRANSIT:Mitochondrion; not cleaved,
O00763	acetyl-CoA carboxylase beta(ACACB)	Homo sapiens			GO:0006084~acetyl-CoA metabolic process,GO:0006098~pentose-phosphate shunt,GO:0006633~fatty acid biosynthetic process,GO:0007584~response to nutrient,GO:0009410~response to xenobiotic stimulus,GO:0010629~negative regulation of gene expression,GO:0010884~positive regulation of lipid storage,GO:0010906~regulation of glucose metabolic process,GO:0014070~response to organic cyclic compound,GO:0019395~fatty acid oxidation,GO:0031999~negative regulation of fatty acid beta-oxidation,GO:0046323~glucose import,GO:0046722~lactic acid secretion,GO:0051289~protein homotetramerization,GO:0060421~positive regulation of heart growth,GO:0072350~tricarboxylic acid metabolic process,GO:0090459~aspartate homeostasis,GO:0090461~glutamate homeostasis,GO:0097009~energy homeostasis,GO:1903242~regulation of cardiac muscle hypertrophy in response to stress,GO:2001295~malonyl-CoA biosynthetic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0016507~mitochondrial fatty acid beta-oxidation multienzyme complex,	GO:0003989~acetyl-CoA carboxylase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0009374~biotin binding,GO:0016874~ligase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000089:Biotin_lipoyl,IPR005479:CbamoylP_synth_lsu-like_ATP-bd,IPR005481:BC-like_N,IPR005482:Biotin_COase_C,IPR011053:Single_hybrid_motif,IPR011054:Rudment_hybrid_motif,IPR011761:ATP-grasp,IPR011762:COA_CT_N,IPR011763:COA_CT_C,IPR011764:Biotin_carboxylation_dom,IPR013537:AcCoA_COase_cen,IPR013815:ATP_grasp_subdomain_1,IPR016185:PreATP-grasp_dom_sf,IPR029045:ClpP/crotonase-like_dom_sf,IPR034733:AcCoA_carboxyl_beta,IPR049074:ACCA_BT,IPR049076:ACCA,	hsa00061:Fatty acid biosynthesis,hsa00620:Pyruvate metabolism,hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa04152:AMPK signaling pathway,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04936:Alcoholic liver disease,			SM00878:Biotin_carb_C,	KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0092~Biotin,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0436~Ligase,KW-0511~Multifunctional enzyme,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:ATP-grasp,DOMAIN:Biotin carboxylation,DOMAIN:Biotinyl-binding,DOMAIN:CoA carboxyltransferase C-terminal,DOMAIN:CoA carboxyltransferase N-terminal,MUTAGEN:E->A: Altered regulation of oligomerization by phosphorylation at S-222.,MUTAGEN:R->A: Loss of regulation of oligomerization by phosphorylation at S-222.,REGION:Carboxyltransferase,REGION:Disordered,TRANSIT:Mitochondrion,
Q5SWU9	acetyl-Coenzyme A carboxylase alpha(Acaca)	Mus musculus			GO:0001894~tissue homeostasis,GO:0006084~acetyl-CoA metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0008152~metabolic process,GO:0008610~lipid biosynthetic process,GO:0014070~response to organic cyclic compound,GO:0019538~protein metabolic process,GO:0051289~protein homotetramerization,GO:0055088~lipid homeostasis,GO:0071380~cellular response to prostaglandin E stimulus,GO:2001295~malonyl-CoA biosynthetic process,	GO:0001650~fibrillar center,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0003989~acetyl-CoA carboxylase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0009374~biotin binding,GO:0016874~ligase activity,GO:0019900~kinase binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000089:Biotin_lipoyl,IPR001882:Biotin_BS,IPR005479:CbamoylP_synth_lsu-like_ATP-bd,IPR005481:BC-like_N,IPR005482:Biotin_COase_C,IPR011053:Single_hybrid_motif,IPR011054:Rudment_hybrid_motif,IPR011761:ATP-grasp,IPR011762:COA_CT_N,IPR011763:COA_CT_C,IPR011764:Biotin_carboxylation_dom,IPR013537:AcCoA_COase_cen,IPR013815:ATP_grasp_subdomain_1,IPR016185:PreATP-grasp_dom_sf,IPR029045:ClpP/crotonase-like_dom_sf,IPR034733:AcCoA_carboxyl_beta,IPR049074:ACCA_BT,IPR049076:ACCA,	mmu00061:Fatty acid biosynthesis,mmu00620:Pyruvate metabolism,mmu00640:Propanoate metabolism,mmu01100:Metabolic pathways,mmu01212:Fatty acid metabolism,mmu04152:AMPK signaling pathway,mmu04910:Insulin signaling pathway,mmu04922:Glucagon signaling pathway,mmu04936:Alcoholic liver disease,			SM00878:Biotin_carb_C,	KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0092~Biotin,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0436~Ligase,KW-0511~Multifunctional enzyme,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:ATP-grasp,DOMAIN:Acetyl-CoA carboxylase central,DOMAIN:Biotin carboxylation,DOMAIN:Biotinyl-binding,DOMAIN:CoA carboxyltransferase C-terminal,DOMAIN:CoA carboxyltransferase N-terminal,REGION:Carboxyltransferase,
Q5ZKG5	acid phosphatase 1, soluble(ACP1)	Gallus gallus			GO:0006470~protein dephosphorylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0042383~sarcolemma,	GO:0003993~acid phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0004726~non-membrane spanning protein tyrosine phosphatase activity,	IPR002115:Tyr_Pase_low_mol_wt_mml,IPR017867:Tyr_phospatase_low_mol_wt,IPR023485:Ptyr_pPase,IPR036196:Ptyr_pPase_sf,	gga00730:Thiamine metabolism,gga00740:Riboflavin metabolism,gga01100:Metabolic pathways,gga04520:Adherens junction,			SM00226:LMWPc,		KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,DOMAIN:Phosphotyrosine protein phosphatase I,
Q98972	actin alpha 1, skeletal muscle b(acta1b)	Oryzias latipes				GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR004000:Actin,IPR004001:Actin_CS,IPR020902:Actin/actin-like_CS,IPR043129:ATPase_NBD,	ola04260:Cardiac muscle contraction,ola04261:Adrenergic signaling in cardiomyocytes,ola04814:Motor proteins,			SM00268:ACTIN,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0514~Muscle protein,	KW-0007~Acetylation,KW-0488~Methylation,KW-0558~Oxidation,
P62738	actin alpha 2, smooth muscle(Acta2)	Rattus norvegicus			GO:0006936~muscle contraction,GO:0008217~regulation of blood pressure,GO:0009615~response to virus,GO:0010628~positive regulation of gene expression,GO:0014829~vascular smooth muscle contraction,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072051~juxtaglomerular apparatus development,GO:0072144~glomerular mesangial cell development,GO:0090131~mesenchyme migration,GO:2000491~positive regulation of hepatic stellate cell activation,	GO:0001725~stress fiber,GO:0005604~basement membrane,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030485~smooth muscle contractile fiber,GO:0031514~motile cilium,GO:0032991~macromolecular complex,GO:0044297~cell body,	GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019901~protein kinase binding,	IPR004000:Actin,IPR004001:Actin_CS,IPR020902:Actin/actin-like_CS,IPR043129:ATPase_NBD,	rno04270:Vascular smooth muscle contraction,rno04371:Apelin signaling pathway,rno04814:Motor proteins,rno04926:Relaxin signaling pathway,			SM00268:ACTIN,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0514~Muscle protein,	KW-0007~Acetylation,KW-0488~Methylation,KW-0558~Oxidation,
O14639	actin binding LIM protein 1(ABLIM1)	Homo sapiens			GO:0007010~cytoskeleton organization,GO:0007601~visual perception,GO:0009887~animal organ morphogenesis,GO:0030032~lamellipodium assembly,GO:0060271~cilium assembly,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,	IPR001781:Znf_LIM,IPR003128:Villin_headpiece,IPR032402:AbLIM_anchor,IPR036886:Villin_headpiece_dom_sf,	hsa04360:Axon guidance,			SM00132:LIM,SM00153:VHP,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0009~Actin-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:HP,DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,DOMAIN:LIM zinc-binding 3,DOMAIN:LIM zinc-binding 4,DOMAIN:Putative adherens-junction anchoring,REGION:Disordered,
P62738	actin gamma 2, smooth muscle(Actg2)	Rattus norvegicus			GO:0006936~muscle contraction,GO:0008217~regulation of blood pressure,GO:0009615~response to virus,GO:0010628~positive regulation of gene expression,GO:0014829~vascular smooth muscle contraction,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072051~juxtaglomerular apparatus development,GO:0072144~glomerular mesangial cell development,GO:0090131~mesenchyme migration,GO:2000491~positive regulation of hepatic stellate cell activation,	GO:0001725~stress fiber,GO:0005604~basement membrane,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030485~smooth muscle contractile fiber,GO:0031514~motile cilium,GO:0032982~myosin filament,GO:0032991~macromolecular complex,GO:0044297~cell body,GO:0071944~cell periphery,	GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019901~protein kinase binding,	IPR004000:Actin,IPR004001:Actin_CS,IPR020902:Actin/actin-like_CS,IPR043129:ATPase_NBD,	rno04270:Vascular smooth muscle contraction,rno04814:Motor proteins,			SM00268:ACTIN,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0514~Muscle protein,	KW-0007~Acetylation,KW-0488~Methylation,KW-0558~Oxidation,
Q1LWJ6	actin related protein 2/3 complex inhibitor(arpin)	Danio rerio			GO:0030336~negative regulation of cell migration,GO:0033058~directional locomotion,GO:0051126~negative regulation of actin nucleation,	GO:0030027~lamellipodium,GO:0042995~cell projection,		IPR018889:Arpin,						KW-0966~Cell projection,							COMPBIAS:Polar residues,REGION:Disordered,
Q7SXW6	actin related protein 2a(actr2a)	Danio rerio			GO:0001501~skeletal system development,GO:0001755~neural crest cell migration,GO:0016310~phosphorylation,GO:0030902~hindbrain development,GO:0032924~activin receptor signaling pathway,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051216~cartilage development,GO:0071363~cellular response to growth factor stimulus,GO:1905168~positive regulation of double-strand break repair via homologous recombination,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005885~Arp2/3 protein complex,GO:0005886~plasma membrane,GO:0035861~site of double-strand break,GO:0042995~cell projection,GO:0048179~activin receptor complex,	GO:0000166~nucleotide binding,GO:0003779~actin binding,GO:0005524~ATP binding,GO:0017002~activin-activated receptor activity,GO:0046872~metal ion binding,GO:0048185~activin binding,GO:0051015~actin filament binding,	IPR000333:TGFB_receptor,IPR000472:Activin_recp,IPR000719:Prot_kinase_dom,IPR004000:Actin,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR020902:Actin/actin-like_CS,IPR043129:ATPase_NBD,IPR045860:Snake_toxin-like_sf,	dre04144:Endocytosis,dre04530:Tight junction,dre04810:Regulation of actin cytoskeleton,dre05132:Salmonella infection,			SM00268:ACTIN,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0009~Actin-binding,KW-0418~Kinase,KW-0675~Receptor,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,		DOMAIN:Protein kinase,TRANSMEM:Helical,
P62738	actin, alpha 1, skeletal muscle(Acta1)	Rattus norvegicus			GO:0006936~muscle contraction,GO:0008217~regulation of blood pressure,GO:0009612~response to mechanical stimulus,GO:0009615~response to virus,GO:0009991~response to extracellular stimulus,GO:0010628~positive regulation of gene expression,GO:0014829~vascular smooth muscle contraction,GO:0030240~skeletal muscle thin filament assembly,GO:0043503~skeletal muscle fiber adaptation,GO:0048545~response to steroid hormone,GO:0048741~skeletal muscle fiber development,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071417~cellular response to organonitrogen compound,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072051~juxtaglomerular apparatus development,GO:0072144~glomerular mesangial cell development,GO:0090131~mesenchyme migration,GO:2000491~positive regulation of hepatic stellate cell activation,	GO:0001725~stress fiber,GO:0005604~basement membrane,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005865~striated muscle thin filament,GO:0005884~actin filament,GO:0015629~actin cytoskeleton,GO:0030017~sarcomere,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030485~smooth muscle contractile fiber,GO:0031514~motile cilium,GO:0032991~macromolecular complex,GO:0044297~cell body,	GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019901~protein kinase binding,	IPR004000:Actin,IPR004001:Actin_CS,IPR020902:Actin/actin-like_CS,IPR043129:ATPase_NBD,	rno04814:Motor proteins,			SM00268:ACTIN,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0514~Muscle protein,	KW-0007~Acetylation,KW-0488~Methylation,KW-0558~Oxidation,	REGION:Interaction with alpha-actinin,
P62738	actin, alpha, cardiac muscle 1(Actc1)	Rattus norvegicus			GO:0006936~muscle contraction,GO:0007015~actin filament organization,GO:0008217~regulation of blood pressure,GO:0009410~response to xenobiotic stimulus,GO:0009615~response to virus,GO:0010628~positive regulation of gene expression,GO:0014829~vascular smooth muscle contraction,GO:0030048~actin filament-based movement,GO:0030240~skeletal muscle thin filament assembly,GO:0031032~actomyosin structure organization,GO:0033275~actin-myosin filament sliding,GO:0043066~negative regulation of apoptotic process,GO:0045471~response to ethanol,GO:0055003~cardiac myofibril assembly,GO:0055008~cardiac muscle tissue morphogenesis,GO:0060047~heart contraction,GO:0060048~cardiac muscle contraction,GO:0070252~actin-mediated cell contraction,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072051~juxtaglomerular apparatus development,GO:0072144~glomerular mesangial cell development,GO:0090131~mesenchyme migration,GO:2000491~positive regulation of hepatic stellate cell activation,	GO:0001725~stress fiber,GO:0005604~basement membrane,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0015629~actin cytoskeleton,GO:0030017~sarcomere,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030485~smooth muscle contractile fiber,GO:0031514~motile cilium,GO:0031674~I band,GO:0032991~macromolecular complex,GO:0044297~cell body,GO:0045202~synapse,GO:0098978~glutamatergic synapse,	GO:0000146~microfilament motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0017022~myosin binding,GO:0019901~protein kinase binding,	IPR004000:Actin,IPR004001:Actin_CS,IPR020902:Actin/actin-like_CS,IPR043129:ATPase_NBD,	rno04260:Cardiac muscle contraction,rno04261:Adrenergic signaling in cardiomyocytes,rno04814:Motor proteins,rno05410:Hypertrophic cardiomyopathy,rno05414:Dilated cardiomyopathy,			SM00268:ACTIN,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0514~Muscle protein,	KW-0007~Acetylation,KW-0488~Methylation,KW-0558~Oxidation,
Q90460	activated leukocyte cell adhesion molecule a(alcama)	Danio rerio			GO:0001947~heart looping,GO:0002250~adaptive immune response,GO:0002376~immune system process,GO:0007155~cell adhesion,GO:0007409~axonogenesis,GO:0010628~positive regulation of gene expression,GO:0010770~positive regulation of cell morphogenesis involved in differentiation,GO:0014033~neural crest cell differentiation,GO:0030182~neuron differentiation,GO:0048703~embryonic viscerocranium morphogenesis,GO:0060042~retina morphogenesis in camera-type eye,GO:0060536~cartilage morphogenesis,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0042995~cell projection,	GO:0042802~identical protein binding,	IPR003006:Ig/MHC_CS,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013162:CD80_C2-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,	dre04514:Cell adhesion molecules,			SM00406:IGv,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,KW-0391~Immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like V-type 1,DOMAIN:Ig-like V-type 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q08DA8	activating transcription factor 1(ATF1)	Bos taurus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0050896~response to stimulus,	GO:0005634~nucleus,GO:1990589~ATF4-CREB1 transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR001630:Leuzip_CREB,IPR003102:CREB1-like_pKID,IPR004827:bZIP,IPR046347:bZIP_sf,	bta04925:Aldosterone synthesis and secretion,bta05202:Transcriptional misregulation in cancer,			SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BZIP,DOMAIN:KID,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
Q7SXW6	activin A receptor type 2Aa(acvr2aa)	Danio rerio			GO:0001501~skeletal system development,GO:0001755~neural crest cell migration,GO:0006468~protein phosphorylation,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0016310~phosphorylation,GO:0030902~hindbrain development,GO:0032924~activin receptor signaling pathway,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051216~cartilage development,GO:0071363~cellular response to growth factor stimulus,GO:1905168~positive regulation of double-strand break repair via homologous recombination,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005885~Arp2/3 protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0035861~site of double-strand break,GO:0042995~cell projection,GO:0043235~receptor complex,GO:0048179~activin receptor complex,	GO:0000166~nucleotide binding,GO:0003779~actin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0017002~activin-activated receptor activity,GO:0038023~signaling receptor activity,GO:0046872~metal ion binding,GO:0048185~activin binding,	IPR000333:TGFB_receptor,IPR000472:Activin_recp,IPR000719:Prot_kinase_dom,IPR004000:Actin,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017194:Transform_growth_fac-b_typ-2,IPR020902:Actin/actin-like_CS,IPR043129:ATPase_NBD,IPR045860:Snake_toxin-like_sf,	dre04060:Cytokine-cytokine receptor interaction,dre04350:TGF-beta signaling pathway,		PIRSF037393:TGFRII,	SM00268:ACTIN,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0009~Actin-binding,KW-0418~Kinase,KW-0675~Receptor,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,TRANSMEM:Helical,
Q9H845	acyl-CoA dehydrogenase family member 9(ACAD9)	Homo sapiens			GO:0001676~long-chain fatty acid metabolic process,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0051791~medium-chain fatty acid metabolic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0030425~dendrite,GO:0031966~mitochondrial membrane,	GO:0003995~acyl-CoA dehydrogenase activity,GO:0004466~long-chain-acyl-CoA dehydrogenase activity,GO:0005515~protein binding,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0050660~flavin adenine dinucleotide binding,GO:0070991~medium-chain-acyl-CoA dehydrogenase activity,	IPR006089:Acyl-CoA_DH_CS,IPR006091:Acyl-CoA_Oxase/DH_mid-dom,IPR009075:AcylCo_DH/oxidase_C,IPR009100:AcylCoA_DH/oxidase_NM_dom_sf,IPR013786:AcylCoA_DH/ox_N,IPR036250:AcylCo_DH-like_C,IPR037069:AcylCoA_DH/ox_N_sf,IPR046373:Acyl-CoA_Oxase/DH_mid-dom_sf,		611126~Mitochondrial complex I deficiency, nuclear type 20,				KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,		KW-0225~Disease variant,KW-1274~Primary mitochondrial disease,	KW-0809~Transit peptide,	KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Acyl-CoA dehydrogenase/oxidase C-terminal,DOMAIN:Acyl-CoA dehydrogenase/oxidase N-terminal,DOMAIN:Acyl-CoA oxidase/dehydrogenase middle,MUTAGEN:E->Q: Loss of long-chain-acyl-CoA dehydrogenase activity. Does not affect mitochondrial complex I assembly.,REGION:Disordered,TRANSIT:Mitochondrion,
Q0P4F7	acyl-CoA synthetase family member 2(acsf2)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,	GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0031956~medium-chain fatty acid-CoA ligase activity,GO:0047760~butyrate-CoA ligase activity,	IPR000873:AMP-dep_Synth/Lig_com,IPR020845:AMP-binding_CS,IPR025110:AMP-bd_C,IPR042099:ANL_N_sf,IPR045851:AMP-bd_C_sf,					KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,		DOMAIN:AMP-binding enzyme C-terminal,DOMAIN:AMP-dependent synthetase/ligase,TRANSIT:Mitochondrion,
Q9NR19	acyl-CoA synthetase short chain family member 2(ACSS2)	Homo sapiens		h_cptPathway:Mitochondrial Carnitine Palmitoyltransferase (CPT) System,	GO:0006069~ethanol oxidation,GO:0006085~acetyl-CoA biosynthetic process,GO:0006629~lipid metabolic process,GO:0007616~long-term memory,GO:0008610~lipid biosynthetic process,GO:0019413~acetate biosynthetic process,GO:0019427~acetyl-CoA biosynthetic process from acetate,GO:0019542~propionate biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0003987~acetate-CoA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016208~AMP binding,GO:0050218~propionate-CoA ligase activity,	IPR000873:AMP-dep_Synth/Lig_com,IPR011904:Ac_CoA_lig,IPR020845:AMP-binding_CS,IPR025110:AMP-bd_C,IPR032387:ACAS_N,IPR042099:ANL_N_sf,IPR045851:AMP-bd_C_sf,	hsa00010:Glycolysis / Gluconeogenesis,hsa00620:Pyruvate metabolism,hsa00630:Glyoxylate and dicarboxylate metabolism,hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,				KW-0443~Lipid metabolism,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0010~Activator,KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:AMP-binding enzyme C-terminal,DOMAIN:AMP-dependent synthetase/ligase,DOMAIN:Acetyl-coenzyme A synthetase N-terminal,MOTIF:Nuclear localization signal,MUTAGEN:RR->AA: No effect on catalytic activity. Loss of interaction with KPNA1 and nuclear translocation upon glucose deprivation. Loss of ability to promote gene transcription for lysosomal biogenesis and autophagy.,MUTAGEN:S->A: No effect on catalytic activity. Loss of AMPK-mediated phosphorylation, interaction with KPNA1 and nuclear translocation upon glucose deprivation. Loss of ability to promote gene transcription for lysosomal biogenesis and autophagy.,MUTAGEN:T->A: Loss of catlytic activity but no effect on its nuclear translocation upon glucose deprivation. Loss of ability to promote gene transcription for lysosomal biogenesis and autophagy.,REGION:Disordered,REGION:Interaction with TFEB,
Q86TX2	acyl-CoA thioesterase 1(ACOT1)	Homo sapiens			GO:0000038~very long-chain fatty acid metabolic process,GO:0001676~long-chain fatty acid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006637~acyl-CoA metabolic process,	GO:0005829~cytosol,	GO:0016290~palmitoyl-CoA hydrolase activity,GO:0016790~thiolester hydrolase activity,GO:0047617~acyl-CoA hydrolase activity,GO:0052689~carboxylic ester hydrolase activity,GO:0052816~long-chain acyl-CoA hydrolase activity,GO:0102991~myristoyl-CoA hydrolase activity,	IPR006862:Thio_Ohase/aa_AcTrfase,IPR014940:BAAT_C,IPR016662:Acyl-CoA_thioEstase_long-chain,IPR029058:AB_hydrolase,IPR042490:Thio_Ohase/BAAT_N,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01100:Metabolic pathways,hsa04913:Ovarian steroidogenesis,		PIRSF016521:Acyl-CoA_hydro,		KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0719~Serine esterase,		ACT_SITE:Charge relay system,DOMAIN:Acyl-CoA thioester hydrolase/bile acid-CoA amino acid N-acetyltransferase,DOMAIN:BAAT/Acyl-CoA thioester hydrolase C-terminal,
O55137	acyl-CoA thioesterase 1(Acot1)	Mus musculus			GO:0000038~very long-chain fatty acid metabolic process,GO:0001676~long-chain fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006637~acyl-CoA metabolic process,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0016290~palmitoyl-CoA hydrolase activity,GO:0016787~hydrolase activity,GO:0016790~thiolester hydrolase activity,GO:0047617~acyl-CoA hydrolase activity,GO:0052689~carboxylic ester hydrolase activity,GO:0102991~myristoyl-CoA hydrolase activity,	IPR006862:Thio_Ohase/aa_AcTrfase,IPR014940:BAAT_C,IPR016662:Acyl-CoA_thioEstase_long-chain,IPR029058:AB_hydrolase,IPR042490:Thio_Ohase/BAAT_N,	mmu00062:Fatty acid elongation,mmu01040:Biosynthesis of unsaturated fatty acids,mmu01100:Metabolic pathways,mmu04913:Ovarian steroidogenesis,		PIRSF016521:Acyl-CoA_hydro,		KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0719~Serine esterase,	KW-0597~Phosphoprotein,	ACT_SITE:Charge relay system,DOMAIN:Acyl-CoA thioester hydrolase/bile acid-CoA amino acid N-acetyltransferase,DOMAIN:BAAT/Acyl-CoA thioester hydrolase C-terminal,MUTAGEN:D->A: Abolishes activity.,MUTAGEN:H->Q: Abolishes activity.,MUTAGEN:S->A: Abolishes activity.,MUTAGEN:S->C: Retains 2% of the initial activity; deacylation of the acyl-enzyme intermediate becomes rate-limiting.,REGION:Disordered,
Q8VHQ9	acyl-CoA thioesterase 11(Acot11)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006637~acyl-CoA metabolic process,GO:0009266~response to temperature stimulus,GO:0009409~response to cold,GO:0035556~intracellular signal transduction,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0008289~lipid binding,GO:0016290~palmitoyl-CoA hydrolase activity,GO:0016787~hydrolase activity,GO:0016790~thiolester hydrolase activity,GO:0047617~acyl-CoA hydrolase activity,GO:0052689~carboxylic ester hydrolase activity,GO:0052816~long-chain acyl-CoA hydrolase activity,GO:0102991~myristoyl-CoA hydrolase activity,	IPR002913:START_lipid-bd_dom,IPR006683:Thioestr_dom,IPR023393:START-like_dom_sf,IPR029069:HotDog_dom_sf,IPR033120:HOTDOG_ACOT,IPR040170:Cytosol_ACT,				SM00234:START,	KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0809~Transit peptide,		KW-0378~Hydrolase,KW-0719~Serine esterase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:HotDog ACOT-type,DOMAIN:HotDog ACOT-type 1,DOMAIN:HotDog ACOT-type 2,DOMAIN:START,REGION:Disordered,TRANSIT:Mitochondrion,
Q9CQR4	acyl-CoA thioesterase 13(Acot13)	Mus musculus			GO:0006629~lipid metabolic process,GO:0051289~protein homotetramerization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,	GO:0016290~palmitoyl-CoA hydrolase activity,GO:0016787~hydrolase activity,GO:0047617~acyl-CoA hydrolase activity,GO:0102991~myristoyl-CoA hydrolase activity,	IPR003736:PAAI_dom,IPR006683:Thioestr_dom,IPR029069:HotDog_dom_sf,IPR039298:ACOT13,					KW-0443~Lipid metabolism,	KW-0206~Cytoskeleton,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,	KW-0007~Acetylation,	DOMAIN:Thioesterase,
P00821	acylphosphatase 2(ACYP2)	Meleagris gallopavo					GO:0003998~acylphosphatase activity,	IPR001792:Acylphosphatase-like_dom,IPR017968:Acylphosphatase_CS,IPR020456:Acylphosphatase,IPR036046:Acylphosphatase-like_dom_sf,	mgp00620:Pyruvate metabolism,mgp01100:Metabolic pathways,										KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0318~Glutathionylation,KW-1015~Disulfide bond,	DISULFID:Interchain; alternate,DOMAIN:Acylphosphatase-like,
Q9BXS5	adaptor related protein complex 1 subunit mu 1(AP1M1)	Homo sapiens			GO:0006886~intracellular protein transport,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032438~melanosome organization,GO:0035646~endosome to melanosome transport,GO:0060155~platelet dense granule organization,GO:1903232~melanosome assembly,	GO:0000139~Golgi membrane,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030121~AP-1 adaptor complex,GO:0030131~clathrin adaptor complex,GO:0030136~clathrin-coated vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0030665~clathrin-coated vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0035579~specific granule membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0035615~clathrin adaptor activity,	IPR001392:Clathrin_mu,IPR011012:Longin-like_dom_sf,IPR018240:Clathrin_mu_CS,IPR022775:AP_mu_sigma_su,IPR028565:MHD,IPR036168:AP2_Mu_C_sf,	hsa04142:Lysosome,hsa05170:Human immunodeficiency virus 1 infection,		PIRSF005992:Clathrin_mu,		KW-0653~Protein transport,KW-0813~Transport,KW-0945~Host-virus interaction,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:AP complex mu/sigma subunit,DOMAIN:MHD,REGION:Disordered,
P56377	adaptor related protein complex 1 subunit sigma 2(AP1S2)	Homo sapiens			GO:0006886~intracellular protein transport,GO:0016192~vesicle-mediated transport,GO:0060155~platelet dense granule organization,GO:1903232~melanosome assembly,	GO:0000139~Golgi membrane,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005905~clathrin-coated pit,GO:0030117~membrane coat,GO:0030119~AP-type membrane coat adaptor complex,GO:0030121~AP-1 adaptor complex,GO:0030659~cytoplasmic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0035615~clathrin adaptor activity,	IPR000804:Clathrin_sm-chain_CS,IPR011012:Longin-like_dom_sf,IPR016635:AP_complex_ssu,IPR022775:AP_mu_sigma_su,IPR044733:AP1_sigma,	hsa04142:Lysosome,hsa05170:Human immunodeficiency virus 1 infection,	304340~Pettigrew syndrome,	PIRSF015588:AP_complex_sigma,		KW-0653~Protein transport,KW-0813~Transport,	KW-0168~Coated pit,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,		KW-0991~Intellectual disability,					DOMAIN:AP complex mu/sigma subunit,
Q9UEY8	adducin 3(ADD3)	Homo sapiens			GO:0007010~cytoskeleton organization,GO:0009410~response to xenobiotic stimulus,GO:0045907~positive regulation of vasoconstriction,GO:0051016~barbed-end actin filament capping,GO:0051495~positive regulation of cytoskeleton organization,	GO:0000794~condensed nuclear chromosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005911~cell-cell junction,GO:0005938~cell cortex,GO:0014069~postsynaptic density,GO:0016020~membrane,	GO:0005080~protein kinase C binding,GO:0005200~structural constituent of cytoskeleton,GO:0005516~calmodulin binding,GO:0051015~actin filament binding,	IPR001303:Aldolase_II/adducin_N,IPR036409:Aldolase_II/adducin_N_sf,		617008~Cerebral palsy, spastic quadriplegic, 3,		SM01007:Aldolase_II,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0225~Disease variant,			KW-0009~Actin-binding,KW-0112~Calmodulin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Class II aldolase/adducin N-terminal,REGION:Disordered,REGION:Interaction with calmodulin,SITE:Cleavage by asparagine endopeptidase (AEP),
P49892	adenosine A1 receptor(ADORA1)	Gallus gallus			GO:0001973~adenosine receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0045202~synapse,	GO:0001609~G-protein coupled adenosine receptor activity,	IPR000276:GPCR_Rhodpsn,IPR001068:Adeno_A1_rcpt,IPR001634:Adenosn_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	gga04080:Neuroactive ligand-receptor interaction,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,LIPID:S-palmitoyl cysteine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P29274	adenosine A2a receptor(ADORA2A)	Homo sapiens			GO:0001963~synaptic transmission, dopaminergic,GO:0001973~adenosine receptor signaling pathway,GO:0001975~response to amphetamine,GO:0006355~regulation of transcription, DNA-templated,GO:0006909~phagocytosis,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006968~cellular defense response,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007271~synaptic transmission, cholinergic,GO:0007417~central nervous system development,GO:0007596~blood coagulation,GO:0007600~sensory perception,GO:0007626~locomotory behavior,GO:0008015~blood circulation,GO:0008285~negative regulation of cell proliferation,GO:0009410~response to xenobiotic stimulus,GO:0010035~response to inorganic substance,GO:0014049~positive regulation of glutamate secretion,GO:0014057~positive regulation of acetylcholine secretion, neurotransmission,GO:0014061~regulation of norepinephrine secretion,GO:0014074~response to purine-containing compound,GO:0031000~response to caffeine,GO:0032230~positive regulation of synaptic transmission, GABAergic,GO:0035249~synaptic transmission, glutamatergic,GO:0035810~positive regulation of urine volume,GO:0042311~vasodilation,GO:0042755~eating behavior,GO:0043116~negative regulation of vascular permeability,GO:0043524~negative regulation of neuron apoptotic process,GO:0045938~positive regulation of circadian sleep/wake cycle, sleep,GO:0046636~negative regulation of alpha-beta T cell activation,GO:0048143~astrocyte activation,GO:0048812~neuron projection morphogenesis,GO:0050714~positive regulation of protein secretion,GO:0050728~negative regulation of inflammatory response,GO:0051881~regulation of mitochondrial membrane potential,GO:0051899~membrane depolarization,GO:0051924~regulation of calcium ion transport,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0060079~excitatory postsynaptic potential,GO:0060080~inhibitory postsynaptic potential,GO:0060134~prepulse inhibition,GO:0097190~apoptotic signaling pathway,GO:1900273~positive regulation of long-term synaptic potentiation,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0030673~axolemma,GO:0032279~asymmetric synapse,GO:0042734~presynaptic membrane,GO:0043025~neuronal cell body,GO:0045211~postsynaptic membrane,GO:0048786~presynaptic active zone,GO:0098978~glutamatergic synapse,	GO:0001609~G-protein coupled adenosine receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008289~lipid binding,GO:0019899~enzyme binding,GO:0031802~type 5 metabotropic glutamate receptor binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:0051393~alpha-actinin binding,	IPR000276:GPCR_Rhodpsn,IPR001513:Adeno_A2A_rcpt,IPR001634:Adenosn_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04270:Vascular smooth muscle contraction,hsa05012:Parkinson disease,hsa05034:Alcoholism,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
O13076	adenosine A2b receptor(ADORA2B)	Gallus gallus			GO:0001973~adenosine receptor signaling pathway,GO:0002882~positive regulation of chronic inflammatory response to non-antigenic stimulus,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010753~positive regulation of cGMP-mediated signaling,GO:0019934~cGMP-mediated signaling,GO:0031668~cellular response to extracellular stimulus,GO:0032722~positive regulation of chemokine production,GO:0032755~positive regulation of interleukin-6 production,GO:0042311~vasodilation,GO:0043303~mast cell degranulation,GO:0043306~positive regulation of mast cell degranulation,GO:0060087~relaxation of vascular smooth muscle,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098793~presynapse,GO:0098978~glutamatergic synapse,	GO:0001609~G-protein coupled adenosine receptor activity,GO:0004930~G-protein coupled receptor activity,	IPR000276:GPCR_Rhodpsn,IPR001435:Adeno_A2B_rcpt,IPR001634:Adenosn_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	gga04020:Calcium signaling pathway,gga04080:Neuroactive ligand-receptor interaction,gga04270:Vascular smooth muscle contraction,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,LIPID:S-palmitoyl cysteine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q6DG22	adenosine deaminase(ada)	Danio rerio			GO:0006154~adenosine catabolic process,GO:0009117~nucleotide metabolic process,GO:0009168~purine ribonucleoside monophosphate biosynthetic process,GO:0042110~T cell activation,GO:0043103~hypoxanthine salvage,GO:0046103~inosine biosynthetic process,GO:0060169~negative regulation of adenosine receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0060205~cytoplasmic vesicle lumen,GO:0070161~anchoring junction,	GO:0004000~adenosine deaminase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0019239~deaminase activity,GO:0046872~metal ion binding,GO:0046936~deoxyadenosine deaminase activity,	IPR001365:A_deaminase_dom,IPR006330:Ado/ade_deaminase,IPR006650:A/AMP_deam_AS,IPR028893:A_deaminase,IPR032466:Metal_Hydrolase,	dre00230:Purine metabolism,dre01100:Metabolic pathways,dre01232:Nucleotide metabolism,				KW-0546~Nucleotide metabolism,	KW-0458~Lysosome,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,		ACT_SITE:Proton donor,SITE:Important for catalytic activity,
P51400	adenosine deaminase, RNA-specific, B1(Adarb1)	Rattus norvegicus			GO:0006382~adenosine to inosine editing,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007274~neuromuscular synaptic transmission,GO:0008285~negative regulation of cell proliferation,GO:0016553~base conversion or substitution editing,GO:0016556~mRNA modification,GO:0021610~facial nerve morphogenesis,GO:0021618~hypoglossal nerve morphogenesis,GO:0021965~spinal cord ventral commissure morphogenesis,GO:0030336~negative regulation of cell migration,GO:0035264~multicellular organism growth,GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0045070~positive regulation of viral genome replication,GO:0050685~positive regulation of mRNA processing,GO:0050884~neuromuscular process controlling posture,GO:0051726~regulation of cell cycle,GO:0060384~innervation,GO:0060415~muscle tissue morphogenesis,GO:0061744~motor behavior,GO:0097049~motor neuron apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0045202~synapse,	GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003726~double-stranded RNA adenosine deaminase activity,GO:0004000~adenosine deaminase activity,GO:0005515~protein binding,GO:0008251~tRNA-specific adenosine deaminase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR002466:A_deamin,IPR014720:dsRBD_dom,IPR044458:ADAR2_DSRM_1,IPR044459:ADAR2_DSRM_2,				SM00358:DSRM,SM00552:ADEAMc,	KW-0507~mRNA processing,	KW-0539~Nucleus,			KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	ACT_SITE:Proton donor,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:A to I editase,DOMAIN:DRBM,DOMAIN:DRBM 1,DOMAIN:DRBM 2,MUTAGEN:K->A: Reduced RNA editing activity; when associated with A-128.,MUTAGEN:K->A: Reduced RNA editing activity; when associated with A-281.,MUTAGEN:M->A: Strongly reduced RNA editing activity.,MUTAGEN:SH->AA: Abolishes RNA editing activity.,MUTAGEN:VH->AA: Strongly reduced RNA editing activity.,REGION:Disordered,REGION:Interaction with substrate RNA,
Q01433	adenosine monophosphate deaminase 2(AMPD2)	Homo sapiens			GO:0006188~IMP biosynthetic process,GO:0032264~IMP salvage,GO:0046033~AMP metabolic process,GO:0052652~cyclic purine nucleotide metabolic process,GO:0097009~energy homeostasis,	GO:0005829~cytosol,	GO:0003876~AMP deaminase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR006329:AMPD,IPR006650:A/AMP_deam_AS,IPR032466:Metal_Hydrolase,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,	615686~Spastic paraplegia 63, autosomal recessive,615809~Pontocerebellar hypoplasia, type 9,	PIRSF001251:AMP_deaminase_met,		KW-0546~Nucleotide metabolism,			KW-0225~Disease variant,KW-0523~Neurodegeneration,KW-0890~Hereditary spastic paraplegia,		KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,REGION:Disordered,
O08739	adenosine monophosphate deaminase 3(Ampd3)	Mus musculus			GO:0006188~IMP biosynthetic process,GO:0006196~AMP catabolic process,GO:0009117~nucleotide metabolic process,GO:0009168~purine ribonucleoside monophosphate biosynthetic process,GO:0032264~IMP salvage,GO:0034101~erythrocyte homeostasis,GO:0046031~ADP metabolic process,GO:0046032~ADP catabolic process,GO:0046033~AMP metabolic process,GO:0046034~ATP metabolic process,GO:0046039~GTP metabolic process,GO:0097009~energy homeostasis,	GO:0005829~cytosol,	GO:0003876~AMP deaminase activity,GO:0016787~hydrolase activity,GO:0019239~deaminase activity,GO:0046872~metal ion binding,	IPR006329:AMPD,IPR006650:A/AMP_deam_AS,IPR032466:Metal_Hydrolase,	mmu00230:Purine metabolism,mmu01100:Metabolic pathways,mmu01232:Nucleotide metabolism,		PIRSF001251:AMP_deaminase_met,		KW-0546~Nucleotide metabolism,					KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q08462	adenylate cyclase 2(ADCY2)	Homo sapiens			GO:0006171~cAMP biosynthetic process,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0009190~cyclic nucleotide biosynthetic process,GO:0019933~cAMP-mediated signaling,GO:0035556~intracellular signal transduction,GO:1904322~cellular response to forskolin,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0045121~membrane raft,	GO:0000287~magnesium ion binding,GO:0004016~adenylate cyclase activity,GO:0005524~ATP binding,GO:0008179~adenylate cyclase binding,GO:0016849~phosphorus-oxygen lyase activity,GO:0030145~manganese ion binding,GO:0046872~metal ion binding,	IPR001054:A/G_cyclase,IPR009398:Adcy_conserved_dom,IPR018297:A/G_cyclase_CS,IPR029787:Nucleotide_cyclase,IPR030672:Adcy,IPR032628:AC_N,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa01522:Endocrine resistance,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04072:Phospholipase D signaling pathway,hsa04114:Oocyte meiosis,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04371:Apelin signaling pathway,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04714:Thermogenesis,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04727:GABAergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04925:Aldosterone synthesis and secretion,hsa04926:Relaxin signaling pathway,hsa04927:Cortisol synthesis and secretion,hsa04928:Parathyroid hormone synthesis, secretion and action,hsa04934:Cushing syndrome,hsa04935:Growth hormone synthesis, secretion and action,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,hsa05032:Morphine addiction,hsa05163:Human cytomegalovirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05200:Pathways in cancer,hsa05207:Chemical carcinogenesis - receptor activation,hsa05414:Dilated cardiomyopathy,		PIRSF039050:Ade_cyc,	SM00044:CYCc,	KW-0115~cAMP biosynthesis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0456~Lyase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Adenylate cyclase N-terminal,DOMAIN:Guanylate cyclase,REGION:Disordered,REGION:Interaction with GNAS,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
P26769	adenylate cyclase 2(Adcy2)	Rattus norvegicus			GO:0006171~cAMP biosynthetic process,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0019933~cAMP-mediated signaling,GO:0035556~intracellular signal transduction,GO:1904322~cellular response to forskolin,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0032991~macromolecular complex,GO:0045121~membrane raft,	GO:0000287~magnesium ion binding,GO:0004016~adenylate cyclase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008179~adenylate cyclase binding,GO:0030145~manganese ion binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR001054:A/G_cyclase,IPR009398:Adcy_conserved_dom,IPR018297:A/G_cyclase_CS,IPR029787:Nucleotide_cyclase,IPR030672:Adcy,IPR032628:AC_N,	rno00230:Purine metabolism,rno01100:Metabolic pathways,rno01522:Endocrine resistance,rno04015:Rap1 signaling pathway,rno04020:Calcium signaling pathway,rno04022:cGMP-PKG signaling pathway,rno04024:cAMP signaling pathway,rno04062:Chemokine signaling pathway,rno04072:Phospholipase D signaling pathway,rno04114:Oocyte meiosis,rno04211:Longevity regulating pathway,rno04213:Longevity regulating pathway - multiple species,rno04261:Adrenergic signaling in cardiomyocytes,rno04270:Vascular smooth muscle contraction,rno04371:Apelin signaling pathway,rno04540:Gap junction,rno04611:Platelet activation,rno04713:Circadian entrainment,rno04714:Thermogenesis,rno04723:Retrograde endocannabinoid signaling,rno04724:Glutamatergic synapse,rno04725:Cholinergic synapse,rno04727:GABAergic synapse,rno04750:Inflammatory mediator regulation of TRP channels,rno04911:Insulin secretion,rno04912:GnRH signaling pathway,rno04913:Ovarian steroidogenesis,rno04914:Progesterone-mediated oocyte maturation,rno04915:Estrogen signaling pathway,rno04916:Melanogenesis,rno04918:Thyroid hormone synthesis,rno04921:Oxytocin signaling pathway,rno04922:Glucagon signaling pathway,rno04923:Regulation of lipolysis in adipocytes,rno04925:Aldosterone synthesis and secretion,rno04926:Relaxin signaling pathway,rno04927:Cortisol synthesis and secretion,rno04928:Parathyroid hormone synthesis, secretion and action,rno04934:Cushing syndrome,rno04935:Growth hormone synthesis, secretion and action,rno04970:Salivary secretion,rno04971:Gastric acid secretion,rno04972:Pancreatic secretion,rno04976:Bile secretion,rno05032:Morphine addiction,rno05163:Human cytomegalovirus infection,rno05166:Human T-cell leukemia virus 1 infection,rno05200:Pathways in cancer,rno05207:Chemical carcinogenesis - receptor activation,rno05414:Dilated cardiomyopathy,		PIRSF039050:Ade_cyc,	SM00044:CYCc,	KW-0115~cAMP biosynthesis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0456~Lyase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Guanylate cyclase,MUTAGEN:S->A: Reduces activation by PKC. Abolishes activation by PKC; when associated with A-490.,MUTAGEN:S->A: Reduces activation by PKC. Abolishes activation by PKC; when associated with A-543.,MUTAGEN:S->D: Increases basal level of enzyme activity. Abolishes activation by PKC; when associated with D-490.,MUTAGEN:S->D: Increases basal level of enzyme activity. Abolishes activation by PKC; when associated with D-543.,REGION:Interaction with GNAS,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
P21932	adenylate cyclase 3(Adcy3)	Rattus norvegicus			GO:0006171~cAMP biosynthetic process,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007338~single fertilization,GO:0007340~acrosome reaction,GO:0007608~sensory perception of smell,GO:0008355~olfactory learning,GO:0030317~flagellated sperm motility,GO:0035556~intracellular signal transduction,GO:1904322~cellular response to forskolin,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0016020~membrane,GO:0060170~ciliary membrane,	GO:0004016~adenylate cyclase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008294~calcium- and calmodulin-responsive adenylate cyclase activity,GO:0046872~metal ion binding,	IPR001054:A/G_cyclase,IPR018297:A/G_cyclase_CS,IPR029787:Nucleotide_cyclase,IPR030672:Adcy,IPR032628:AC_N,	rno00230:Purine metabolism,rno01100:Metabolic pathways,rno01522:Endocrine resistance,rno04015:Rap1 signaling pathway,rno04020:Calcium signaling pathway,rno04022:cGMP-PKG signaling pathway,rno04024:cAMP signaling pathway,rno04062:Chemokine signaling pathway,rno04072:Phospholipase D signaling pathway,rno04114:Oocyte meiosis,rno04211:Longevity regulating pathway,rno04213:Longevity regulating pathway - multiple species,rno04261:Adrenergic signaling in cardiomyocytes,rno04270:Vascular smooth muscle contraction,rno04371:Apelin signaling pathway,rno04540:Gap junction,rno04611:Platelet activation,rno04713:Circadian entrainment,rno04714:Thermogenesis,rno04723:Retrograde endocannabinoid signaling,rno04724:Glutamatergic synapse,rno04725:Cholinergic synapse,rno04727:GABAergic synapse,rno04740:Olfactory transduction,rno04750:Inflammatory mediator regulation of TRP channels,rno04911:Insulin secretion,rno04912:GnRH signaling pathway,rno04913:Ovarian steroidogenesis,rno04914:Progesterone-mediated oocyte maturation,rno04915:Estrogen signaling pathway,rno04916:Melanogenesis,rno04918:Thyroid hormone synthesis,rno04921:Oxytocin signaling pathway,rno04923:Regulation of lipolysis in adipocytes,rno04925:Aldosterone synthesis and secretion,rno04926:Relaxin signaling pathway,rno04927:Cortisol synthesis and secretion,rno04928:Parathyroid hormone synthesis, secretion and action,rno04934:Cushing syndrome,rno04935:Growth hormone synthesis, secretion and action,rno04962:Vasopressin-regulated water reabsorption,rno04970:Salivary secretion,rno04971:Gastric acid secretion,rno04972:Pancreatic secretion,rno04976:Bile secretion,rno05032:Morphine addiction,rno05163:Human cytomegalovirus infection,rno05166:Human T-cell leukemia virus 1 infection,rno05200:Pathways in cancer,rno05207:Chemical carcinogenesis - receptor activation,rno05414:Dilated cardiomyopathy,		PIRSF039050:Ade_cyc,	SM00044:CYCc,	KW-0115~cAMP biosynthesis,KW-0552~Olfaction,KW-0716~Sensory transduction,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0112~Calmodulin-binding,KW-0456~Lyase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3),DOMAIN:Guanylate cyclase,MUTAGEN:K->R: Abolishes sumoylation. Abolishes location at cilia in the olfactory epithelium.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
O43306	adenylate cyclase 6(ADCY6)	Homo sapiens			GO:0003091~renal water homeostasis,GO:0006171~cAMP biosynthetic process,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007212~dopamine receptor signaling pathway,GO:0010977~negative regulation of neuron projection development,GO:0035556~intracellular signal transduction,GO:0035811~negative regulation of urine volume,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071870~cellular response to catecholamine stimulus,GO:0097746~regulation of blood vessel diameter,GO:1904117~cellular response to vasopressin,GO:1904322~cellular response to forskolin,	GO:0005886~plasma membrane,GO:0005929~cilium,GO:0016020~membrane,GO:0032420~stereocilium,	GO:0004016~adenylate cyclase activity,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,	IPR001054:A/G_cyclase,IPR009398:Adcy_conserved_dom,IPR018297:A/G_cyclase_CS,IPR029787:Nucleotide_cyclase,IPR030672:Adcy,IPR032628:AC_N,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa01522:Endocrine resistance,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04072:Phospholipase D signaling pathway,hsa04114:Oocyte meiosis,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04371:Apelin signaling pathway,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04714:Thermogenesis,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04727:GABAergic synapse,hsa04742:Taste transduction,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04926:Relaxin signaling pathway,hsa04927:Cortisol synthesis and secretion,hsa04928:Parathyroid hormone synthesis, secretion and action,hsa04934:Cushing syndrome,hsa04935:Growth hormone synthesis, secretion and action,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04962:Vasopressin-regulated water reabsorption,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,hsa05032:Morphine addiction,hsa05163:Human cytomegalovirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05200:Pathways in cancer,hsa05207:Chemical carcinogenesis - receptor activation,hsa05414:Dilated cardiomyopathy,	616287~Lethal congenital contracture syndrome 8,	PIRSF039050:Ade_cyc,	SM00044:CYCc,	KW-0115~cAMP biosynthesis,	KW-0472~Membrane,KW-0966~Cell projection,KW-0969~Cilium,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0456~Lyase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Adenylate cyclase N-terminal,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9DGG6	adenylate cyclase 9(ADCY9)	Gallus gallus			GO:0006171~cAMP biosynthetic process,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0009190~cyclic nucleotide biosynthetic process,GO:0035556~intracellular signal transduction,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004016~adenylate cyclase activity,GO:0005524~ATP binding,GO:0016849~phosphorus-oxygen lyase activity,GO:0046872~metal ion binding,	IPR001054:A/G_cyclase,IPR018297:A/G_cyclase_CS,IPR029787:Nucleotide_cyclase,	gga00230:Purine metabolism,gga01100:Metabolic pathways,gga04020:Calcium signaling pathway,gga04114:Oocyte meiosis,gga04261:Adrenergic signaling in cardiomyocytes,gga04270:Vascular smooth muscle contraction,gga04371:Apelin signaling pathway,gga04540:Gap junction,gga04912:GnRH signaling pathway,gga04914:Progesterone-mediated oocyte maturation,gga04916:Melanogenesis,			SM00044:CYCc,	KW-0115~cAMP biosynthesis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0456~Lyase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:Guanylate cyclase,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5R421	adenylate kinase 4(AK4)	Pongo abelii			GO:0002082~regulation of oxidative phosphorylation,GO:0006139~nucleobase-containing compound metabolic process,GO:0006172~ADP biosynthetic process,GO:0009188~ribonucleoside diphosphate biosynthetic process,GO:0016310~phosphorylation,GO:0046033~AMP metabolic process,GO:0046034~ATP metabolic process,GO:0046039~GTP metabolic process,GO:0071456~cellular response to hypoxia,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0043227~membrane-bounded organelle,	GO:0004017~adenylate kinase activity,GO:0004550~nucleoside diphosphate kinase activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0046899~nucleoside triphosphate adenylate kinase activity,	IPR000850:Adenylat/UMP-CMP_kin,IPR006259:Adenyl_kin_sub,IPR007862:Adenylate_kinase_lid-dom,IPR027417:P-loop_NTPase,IPR028585:AK4_mitochondrial,IPR028586:AK3/Ak4_mitochondrial,IPR033690:Adenylat_kinase_CS,IPR036193:ADK_active_lid_dom_sf,	pon00230:Purine metabolism,pon00730:Thiamine metabolism,pon01100:Metabolic pathways,pon01232:Nucleotide metabolism,pon01240:Biosynthesis of cofactors,					KW-0496~Mitochondrion,				KW-0067~ATP-binding,KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,	KW-0007~Acetylation,	DOMAIN:Adenylate kinase active site lid,REGION:LID,REGION:NMP,REGION:NMPbind,
A4IFD0	adenylate kinase 5(AK5)	Bos taurus			GO:0009142~nucleoside triphosphate biosynthetic process,GO:0016310~phosphorylation,GO:0046034~ATP metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004017~adenylate kinase activity,GO:0004550~nucleoside diphosphate kinase activity,GO:0005524~ATP binding,	IPR000850:Adenylat/UMP-CMP_kin,IPR006267:AK1/5,IPR027417:P-loop_NTPase,IPR033690:Adenylat_kinase_CS,	bta00230:Purine metabolism,bta00730:Thiamine metabolism,bta01100:Metabolic pathways,bta01232:Nucleotide metabolism,bta01240:Biosynthesis of cofactors,					KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		COMPBIAS:Polar residues,REGION:Adenylate kinase 1,REGION:Adenylate kinase 2,REGION:Disordered,REGION:LID 1,REGION:LID 2,REGION:NMP 1,REGION:NMP 2,
Q96M32	adenylate kinase 7(AK7)	Homo sapiens			GO:0016310~phosphorylation,GO:0030030~cell projection organization,GO:0046940~nucleoside monophosphate phosphorylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031514~motile cilium,	GO:0004017~adenylate kinase activity,GO:0004127~cytidylate kinase activity,GO:0004550~nucleoside diphosphate kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR000850:Adenylat/UMP-CMP_kin,IPR007858:Dpy-30_motif,IPR027417:P-loop_NTPase,IPR036291:NAD(P)-bd_dom_sf,IPR047499:DD_AK7,	hsa00230:Purine metabolism,hsa00730:Thiamine metabolism,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,hsa01240:Biosynthesis of cofactors,	617965~Spermatogenic failure 27,			KW-0970~Cilium biogenesis/degradation,	KW-0282~Flagellum,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,		KW-0225~Disease variant,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		REGION:Adenylate kinase,REGION:DPY-30,REGION:Disordered,REGION:LID,REGION:NMP,
B5DGM4	adenylosuccinate synthase 1(adss1)	Salmo salar			GO:0044208~'de novo' AMP biosynthetic process,GO:0046040~IMP metabolic process,	GO:0005737~cytoplasm,	GO:0000287~magnesium ion binding,GO:0004019~adenylosuccinate synthase activity,GO:0005525~GTP binding,	IPR001114:Adenylosuccinate_synthetase,IPR018220:Adenylosuccin_syn_GTP-bd,IPR027417:P-loop_NTPase,IPR027509:AdSS_1_vert,IPR033128:Adenylosuccin_syn_Lys_AS,IPR042109:Adenylosuccinate_synth_dom1,IPR042110:Adenylosuccinate_synth_dom2,IPR042111:Adenylosuccinate_synth_dom3,	sasa00230:Purine metabolism,sasa00250:Alanine, aspartate and glutamate metabolism,sasa01100:Metabolic pathways,sasa01232:Nucleotide metabolism,sasa01240:Biosynthesis of cofactors,			SM00788:Adenylsucc_synt,	KW-0658~Purine biosynthesis,	KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,		ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,BINDING:in other chain,COMPBIAS:Polar residues,REGION:Disordered,
Q7Z7M1	adhesion G protein-coupled receptor D2(ADGRD2)	Homo sapiens			GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,	GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000203:GPS,IPR000832:GPCR_2_secretin-like,IPR001759:Pentraxin-related,IPR013320:ConA-like_dom_sf,IPR017981:GPCR_2-like_7TM,IPR046338:GAIN_dom_sf,				SM00159:PTX,SM00303:GPS,		KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 2 profile 2,DOMAIN:GPS,DOMAIN:Pentraxin (PTX),REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
C6KFA3	adhesion G protein-coupled receptor G6(adgrg6)	Danio rerio			GO:0001503~ossification,GO:0007005~mitochondrion organization,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007507~heart development,GO:0014037~Schwann cell differentiation,GO:0019933~cAMP-mediated signaling,GO:0022011~myelination in peripheral nervous system,GO:0032290~peripheral nervous system myelin formation,GO:0042552~myelination,GO:0043583~ear development,GO:0048932~myelination of posterior lateral line nerve axons,GO:0060347~heart trabecula formation,GO:0060879~semicircular canal fusion,GO:1903670~regulation of sprouting angiogenesis,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005518~collagen binding,GO:0043236~laminin binding,GO:0050840~extracellular matrix binding,	IPR000203:GPS,IPR000832:GPCR_2_secretin-like,IPR000859:CUB_dom,IPR001759:Pentraxin-related,IPR013320:ConA-like_dom_sf,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR035914:Sperma_CUB_dom_sf,IPR046338:GAIN_dom_sf,				SM00042:CUB,SM00159:PTX,SM00303:GPS,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:CUB,DOMAIN:GPS,DOMAIN:Pentraxin (PTX),MOTIF:Stachel,MUTAGEN:Missing: In stl215; mutants developp swollen ears, fail to express mbp and do not myelinate peripheral axons.,REGION:Disordered,REGION:Inhibits receptor signaling in absence of type IV collagen,REGION:Mediates interaction with type IV collagen,SITE:Cleavage,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q8JZZ7	adhesion G protein-coupled receptor L2(Adgrl2)	Mus musculus			GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0009617~response to bacterium,GO:0050808~synapse organization,GO:0051965~positive regulation of synapse assembly,	GO:0016020~membrane,GO:0045211~postsynaptic membrane,GO:0098978~glutamatergic synapse,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0030165~PDZ domain binding,GO:0030246~carbohydrate binding,	IPR000203:GPS,IPR000832:GPCR_2_secretin-like,IPR000922:Lectin_gal-bd_dom,IPR001879:GPCR_2_extracellular_dom,IPR003112:Olfac-like_dom,IPR003334:GPCR_2_latrophilin_rcpt_C,IPR003924:GPCR_2_latrophilin,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR032471:GAIN_dom_N,IPR036445:GPCR_2_extracell_dom_sf,IPR043159:Lectin_gal-bd_sf,IPR046338:GAIN_dom_sf,				SM00008:HormR,SM00284:OLF,SM00303:GPS,		KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 2 profile 1,DOMAIN:G-protein coupled receptors family 2 profile 2,DOMAIN:GPCR family 2 latrophilin C-terminal,DOMAIN:GPS,DOMAIN:Olfactomedin-like,DOMAIN:SUEL-type lectin,REGION:Disordered,SITE:Cleavage,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
O97827	adhesion G protein-coupled receptor L3(ADGRL3)	Bos taurus			GO:0001764~neuron migration,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007416~synapse assembly,GO:0007420~brain development,GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0030424~axon,GO:0098978~glutamatergic synapse,	GO:0004930~G-protein coupled receptor activity,GO:0005509~calcium ion binding,GO:0030246~carbohydrate binding,	IPR000203:GPS,IPR000832:GPCR_2_secretin-like,IPR000922:Lectin_gal-bd_dom,IPR001879:GPCR_2_extracellular_dom,IPR003112:Olfac-like_dom,IPR003334:GPCR_2_latrophilin_rcpt_C,IPR003924:GPCR_2_latrophilin,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR032471:GAIN_dom_N,IPR036445:GPCR_2_extracell_dom_sf,IPR043159:Lectin_gal-bd_sf,IPR046338:GAIN_dom_sf,				SM00008:HormR,SM00284:OLF,SM00303:GPS,		KW-0472~Membrane,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0430~Lectin,KW-0479~Metal-binding,	KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 2 profile 1,DOMAIN:G-protein coupled receptors family 2 profile 2,DOMAIN:GPS,DOMAIN:Olfactomedin-like,DOMAIN:SUEL-type lectin,REGION:Disordered,REGION:Interaction with FLRT3,SITE:Cleavage,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q80TS3	adhesion G protein-coupled receptor L3(Adgrl3)	Mus musculus			GO:0001764~neuron migration,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007416~synapse assembly,GO:0031987~locomotion involved in locomotory behavior,GO:0042220~response to cocaine,GO:0050808~synapse organization,GO:0051965~positive regulation of synapse assembly,GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,GO:0098880~maintenance of postsynaptic specialization structure,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0030424~axon,GO:0042995~cell projection,GO:0045211~postsynaptic membrane,GO:0070161~anchoring junction,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098978~glutamatergic synapse,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR000203:GPS,IPR000832:GPCR_2_secretin-like,IPR000922:Lectin_gal-bd_dom,IPR001879:GPCR_2_extracellular_dom,IPR003112:Olfac-like_dom,IPR003334:GPCR_2_latrophilin_rcpt_C,IPR003924:GPCR_2_latrophilin,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR032471:GAIN_dom_N,IPR036445:GPCR_2_extracell_dom_sf,IPR043159:Lectin_gal-bd_sf,IPR046338:GAIN_dom_sf,				SM00008:HormR,SM00284:OLF,SM00303:GPS,		KW-0472~Membrane,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0430~Lectin,KW-0479~Metal-binding,	KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:G-protein coupled receptors family 2 profile 1,DOMAIN:G-protein coupled receptors family 2 profile 2,DOMAIN:GPS,DOMAIN:Olfactomedin-like,DOMAIN:SUEL-type lectin,MUTAGEN:D->A: Strongly reduces FLRT3 binding.,MUTAGEN:G->T: Abolishes interaction with FLRT2; when associated with N-324.,MUTAGEN:K->T: Strongly reduces FLRT2 binding; when associated with N-267.,MUTAGEN:P->N: Strongly reduces FLRT2 binding; when associated with T-246.,MUTAGEN:R->N: Abolishes interaction with FLRT2; when associated with T-294.,MUTAGEN:R->N: Abolishes interaction with FLRT2; when associated with T-326.,MUTAGEN:R->T: Abolishes interaction with FLRT2; when associated with N-292.,MUTAGEN:R->T: Strongly reduces FLRT2 binding; when associated with N-244.,MUTAGEN:T->N: Strongly reduces FLRT2 binding; when associated with T-269.,MUTAGEN:Y->A: Abolishes FLRT3 binding.,REGION:Disordered,REGION:Interaction with FLRT3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q86WK7	adhesion molecule with Ig like domain 3(AMIGO3)	Homo sapiens			GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007420~brain development,GO:0010977~negative regulation of neuron projection development,GO:0051965~positive regulation of synapse assembly,	GO:0016020~membrane,	GO:0044877~macromolecular complex binding,	IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR031283:AMIGO,IPR032675:LRR_dom_sf,IPR036179:Ig-like_dom_sf,				SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:LRRCT,DOMAIN:LRRNT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q90WY5	adrenoceptor alpha 2B(adra2b)	Danio rerio			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0071875~adrenergic receptor signaling pathway,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071881~adenylate cyclase-inhibiting adrenergic receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004936~alpha-adrenergic receptor activity,GO:0004938~alpha2-adrenergic receptor activity,GO:0051379~epinephrine binding,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,	dre04080:Neuroactive ligand-receptor interaction,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,LIPID:S-palmitoyl cysteine,REGION:Disordered,SITE:Implicated in catechol agonist binding,SITE:Implicated in ligand binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q5CZR5	aerolysin-like protein(aep1)	Danio rerio			GO:0001816~cytokine production,GO:0042742~defense response to bacterium,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0046930~pore complex,	GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,GO:0048030~disaccharide binding,	IPR001229:Jacalin-like_lectin_dom,IPR036404:Jacalin-like_lectin_dom_sf,						KW-0472~Membrane,KW-1003~Cell membrane,				KW-0430~Lectin,			DOMAIN:Jacalin-type lectin,MUTAGEN:D->A: Abolishes carbohydrate binding. Fails to homodimerize but can form higher-order oligomers; when associated with A-171; A-190; A-192 and A-246.,MUTAGEN:K->A: Fails to homodimerize but can form higher-order oligomers; when associated with A-135; A-171; A-190 and A-246.,MUTAGEN:K->A: Fails to homodimerize but can form higher-order oligomers; when associated with A-135; A-190; A-192 and A-246.,MUTAGEN:N->A: Fails to homodimerize but can form higher-order oligomers; when associated with A-135; A-171; A-190 and A-192.,MUTAGEN:S->A: Fails to homodimerize but can form higher-order oligomers; when associated with A-135; A-171; A-192 and A-246.,
Q6GQB5	akirin 2 S homeolog(akirin2.S)	Xenopus laevis			GO:0015031~protein transport,GO:0022008~neurogenesis,	GO:0005634~nucleus,	GO:0030674~protein binding, bridging,	IPR024132:Akirin,					KW-0653~Protein transport,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,	KW-0539~Nucleus,					KW-0217~Developmental protein,KW-0678~Repressor,KW-9996~Developmental protein,		MOTIF:Nuclear localization signal,MOTIF:SYVS motif,REGION:Disordered,
Q9BYV1	alanine--glyoxylate aminotransferase 2(AGXT2)	Homo sapiens			GO:0009436~glyoxylate catabolic process,GO:0019265~glycine biosynthetic process, by transamination of glyoxylate,GO:0019481~L-alanine catabolic process, by transamination,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:2001299~N(omega),N(omega)-dimethyl-L-arginine catabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0008453~alanine-glyoxylate transaminase activity,GO:0008483~transaminase activity,GO:0016223~beta-alanine-pyruvate transaminase activity,GO:0030170~pyridoxal phosphate binding,GO:0047305~(R)-3-amino-2-methylpropionate-pyruvate transaminase activity,	IPR005814:Aminotrans_3,IPR015421:PyrdxlP-dep_Trfase_major,IPR015422:PyrdxlP-dep_Trfase_small,IPR015424:PyrdxlP-dep_Trfase,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00260:Glycine, serine and threonine metabolism,hsa00270:Cysteine and methionine metabolism,hsa00280:Valine, leucine and isoleucine degradation,hsa01100:Metabolic pathways,hsa01210:2-Oxocarboxylic acid metabolism,	210100~Beta-aminoisobutyric acid, urinary excretion of,	PIRSF000521:Transaminase_4ab_Lys_Orn,			KW-0496~Mitochondrion,		KW-0225~Disease variant,	KW-0809~Transit peptide,	KW-0663~Pyridoxal phosphate,	KW-0032~Aminotransferase,KW-0808~Transferase,	KW-0007~Acetylation,	TRANSIT:Mitochondrion,
P31030	alanine--glyoxylate aminotransferase(AGXT)	Oryctolagus cuniculus			GO:0006563~L-serine metabolic process,GO:0019265~glycine biosynthetic process, by transamination of glyoxylate,GO:0046487~glyoxylate metabolic process,	GO:0005777~peroxisome,	GO:0004760~serine-pyruvate transaminase activity,GO:0008453~alanine-glyoxylate transaminase activity,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,	IPR000192:Aminotrans_V_dom,IPR015421:PyrdxlP-dep_Trfase_major,IPR015422:PyrdxlP-dep_Trfase_small,IPR015424:PyrdxlP-dep_Trfase,IPR020578:Aminotrans_V_PyrdxlP_BS,IPR024169:SP_NH2Trfase/AEP_transaminase,	ocu00250:Alanine, aspartate and glutamate metabolism,ocu00260:Glycine, serine and threonine metabolism,ocu00630:Glyoxylate and dicarboxylate metabolism,ocu01100:Metabolic pathways,ocu01200:Carbon metabolism,ocu01210:2-Oxocarboxylic acid metabolism,ocu04146:Peroxisome,		PIRSF000524:SPT,			KW-0576~Peroxisome,				KW-0663~Pyridoxal phosphate,	KW-0032~Aminotransferase,KW-0808~Transferase,	KW-0007~Acetylation,	MOTIF:Microbody targeting signal,
P26325	alcohol dehydrogenase 1(LOC115543782)	Gadus morhua			GO:0046294~formaldehyde catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004022~alcohol dehydrogenase (NAD) activity,GO:0004024~alcohol dehydrogenase activity, zinc-dependent,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0051903~S-(hydroxymethyl)glutathione dehydrogenase activity,	IPR002328:ADH_Zn_CS,IPR011032:GroES-like_sf,IPR013149:ADH-like_C,IPR013154:ADH-like_N,IPR020843:PKS_ER,IPR036291:NAD(P)-bd_dom_sf,				SM00829:PKS_ER,		KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0520~NAD,KW-0862~Zinc,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,	DOMAIN:Alcohol dehydrogenase-like C-terminal,DOMAIN:Alcohol dehydrogenase-like N-terminal,DOMAIN:Enoyl reductase (ER),
P81601	alcohol dehydrogenase class-3 chain L(LOC115543574)	Gadus morhua			GO:0006069~ethanol oxidation,GO:0046294~formaldehyde catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004022~alcohol dehydrogenase (NAD) activity,GO:0004024~alcohol dehydrogenase activity, zinc-dependent,GO:0008270~zinc ion binding,GO:0051903~S-(hydroxymethyl)glutathione dehydrogenase activity,	IPR002328:ADH_Zn_CS,IPR011032:GroES-like_sf,IPR013149:ADH-like_C,IPR013154:ADH-like_N,IPR014183:ADH_3,IPR020843:PKS_ER,IPR036291:NAD(P)-bd_dom_sf,				SM00829:PKS_ER,		KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0520~NAD,KW-0862~Zinc,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,	DOMAIN:Enoyl reductase (ER),SITE:Important for FDH activity and activation by fatty acids,
A6QR56	aldehyde dehydrogenase 16 family member A1(ALDH16A1)	Bos taurus					GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,	IPR011408:Aldehyde_DH,IPR015590:Aldehyde_DH_dom,IPR016161:Ald_DH/histidinol_DH,IPR016162:Ald_DH_N,IPR016163:Ald_DH_C,			PIRSF036490:Aldedh_dupl,										DOMAIN:Aldehyde dehydrogenase,
P53447	aldolase b, fructose-bisphosphate(aldob)	Sparus aurata			GO:0006096~glycolytic process,GO:0030388~fructose 1,6-bisphosphate metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034451~centriolar satellite,	GO:0004332~fructose-bisphosphate aldolase activity,GO:0061609~fructose-1-phosphate aldolase activity,	IPR000741:FBA_I,IPR013785:Aldolase_TIM,IPR029768:Aldolase_I_AS,					KW-0324~Glycolysis,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,				KW-0704~Schiff base,	KW-0456~Lyase,		ACT_SITE:Proton acceptor,ACT_SITE:Schiff-base intermediate with dihydroxyacetone-P,SITE:Necessary for preference for fructose 1,6-bisphosphate over fructose 1-phosphate,
Q2M2S8	alkB homolog 7(ALKBH7)	Bos taurus			GO:0006631~fatty acid metabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0010883~regulation of lipid storage,GO:1902445~regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,	GO:0005759~mitochondrial matrix,	GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR027450:AlkB-like,IPR032870:ALKBH7-like,IPR037151:AlkB-like_sf,					KW-1210~Necrosis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0408~Iron,KW-0479~Metal-binding,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,		TRANSIT:Mitochondrion,
P55008	allograft inflammatory factor 1(AIF1)	Homo sapiens			GO:0001774~microglial cell activation,GO:0006911~phagocytosis, engulfment,GO:0006954~inflammatory response,GO:0008284~positive regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0016601~Rac protein signal transduction,GO:0030041~actin filament polymerization,GO:0030046~parallel actin filament bundle assembly,GO:0030335~positive regulation of cell migration,GO:0032722~positive regulation of chemokine production,GO:0032755~positive regulation of interleukin-6 production,GO:0034599~cellular response to oxidative stress,GO:0042102~positive regulation of T cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050921~positive regulation of chemotaxis,GO:0051017~actin filament bundle assembly,GO:0051764~actin crosslink formation,GO:0071346~cellular response to interferon-gamma,GO:0071672~negative regulation of smooth muscle cell chemotaxis,GO:0071673~positive regulation of smooth muscle cell chemotaxis,GO:0071677~positive regulation of mononuclear cell migration,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090271~positive regulation of fibroblast growth factor production,GO:0097178~ruffle assembly,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:2000406~positive regulation of T cell migration,	GO:0001726~ruffle,GO:0001891~phagocytic cup,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005884~actin filament,GO:0030027~lamellipodium,GO:0032587~ruffle membrane,GO:0048471~perinuclear region of cytoplasm,GO:0097386~glial cell projection,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0051015~actin filament binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR042433:AIF1/AIF1L,IPR049025:AIF-1_EF_pair,						KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2; degenerate,REGION:Disordered,
Q9EQX4	allograft inflammatory factor 1-like(Aif1l)	Mus musculus			GO:0051017~actin filament bundle assembly,GO:0097178~ruffle assembly,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0032587~ruffle membrane,GO:0032991~macromolecular complex,GO:0042995~cell projection,	GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR042433:AIF1/AIF1L,IPR049025:AIF-1_EF_pair,						KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Allograft inflammatory factor 1-like EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2; degenerate,REGION:Disordered,
Q6GMK0	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B(mgat4b)	Danio rerio			GO:0006486~protein glycosylation,GO:0006487~protein N-linked glycosylation,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0016020~membrane,	GO:0008375~acetylglucosaminyltransferase activity,GO:0008454~alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0046872~metal ion binding,	IPR006759:Glyco_transf_54,	dre00510:N-Glycan biosynthesis,dre00513:Various types of N-glycan biosynthesis,dre01100:Metabolic pathways,					KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0175~Coiled coil,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,	KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q90744	alpha-N-acetylgalactosaminidase(NAGA)	Gallus gallus			GO:0005975~carbohydrate metabolic process,GO:0006629~lipid metabolic process,GO:0009311~oligosaccharide metabolic process,GO:0016139~glycoside catabolic process,GO:0046477~glycosylceramide catabolic process,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0016020~membrane,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004557~alpha-galactosidase activity,GO:0008456~alpha-N-acetylgalactosaminidase activity,	IPR000111:Glyco_hydro_27/36_CS,IPR002241:Glyco_hydro_27,IPR013780:Glyco_hydro_b,IPR013785:Aldolase_TIM,IPR017853:Glycoside_hydrolase_SF,IPR035373:Melibiase/NAGA_C,	gga00603:Glycosphingolipid biosynthesis - globo and isoglobo series,gga01100:Metabolic pathways,gga04142:Lysosome,				KW-0443~Lipid metabolism,	KW-0458~Lysosome,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0326~Glycosidase,KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Alpha galactosidase A C-terminal beta-sandwich,TRANSMEM:Helical,
O46640	amine sulfotransferase-like(LOC100338493)	Oryctolagus cuniculus			GO:0051923~sulfation,	GO:0005737~cytoplasm,	GO:0008146~sulfotransferase activity,GO:0047685~amine sulfotransferase activity,	IPR000863:Sulfotransferase_dom,IPR027417:P-loop_NTPase,						KW-0963~Cytoplasm,					KW-0808~Transferase,		ACT_SITE:Proton acceptor,DOMAIN:Sulfotransferase,
A8E657	aminoadipate-semialdehyde synthase(AASS)	Bos taurus			GO:0006554~lysine catabolic process,GO:0019878~lysine biosynthetic process via aminoadipic acid,GO:0033512~L-lysine catabolic process to acetyl-CoA via saccharopine,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0004753~saccharopine dehydrogenase activity,GO:0047130~saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,GO:0047131~saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,	IPR005097:Sacchrp_dh_NADP,IPR007698:AlaDH/PNT_NAD(H)-bd,IPR007886:AlaDH/PNT_N,IPR032095:Sacchrp_dh-like_C,IPR036291:NAD(P)-bd_dom_sf,	bta00310:Lysine degradation,bta01100:Metabolic pathways,			SM01002:AlaDh_PNT_C,SM01003:AlaDh_PNT_N,		KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0520~NAD,KW-0521~NADP,	KW-0511~Multifunctional enzyme,KW-0560~Oxidoreductase,	KW-0007~Acetylation,	REGION:Lysine-ketoglutarate reductase,REGION:Saccharopine dehydrogenase,TRANSIT:Mitochondrion,
Q3T004	amyloid P component, serum(APCS)	Bos taurus			GO:0044869~negative regulation by host of viral exo-alpha-sialidase activity,GO:0044871~negative regulation by host of viral glycoprotein metabolic process,GO:0045087~innate immune response,GO:0045656~negative regulation of monocyte differentiation,GO:0046597~negative regulation of viral entry into host cell,	GO:0005615~extracellular space,	GO:0001849~complement component C1q binding,GO:0005509~calcium ion binding,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,GO:0046790~virion binding,	IPR001759:Pentraxin-related,IPR013320:ConA-like_dom_sf,IPR030476:Pentaxin_CS,				SM00159:PTX,		KW-0034~Amyloid,KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0430~Lectin,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Pentraxin (PTX),
O19063	amyloid P component, serum(APCS)	Sus scrofa			GO:0044869~negative regulation by host of viral exo-alpha-sialidase activity,GO:0044871~negative regulation by host of viral glycoprotein metabolic process,GO:0045087~innate immune response,GO:0045656~negative regulation of monocyte differentiation,GO:0046597~negative regulation of viral entry into host cell,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0001849~complement component C1q binding,GO:0005509~calcium ion binding,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,GO:0046790~virion binding,GO:0046872~metal ion binding,	IPR001759:Pentraxin-related,IPR013320:ConA-like_dom_sf,IPR030476:Pentaxin_CS,				SM00159:PTX,		KW-0034~Amyloid,KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0430~Lectin,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Pentraxin (PTX),
P07629	amyloid P component, serum(Apcs)	Mesocricetus auratus			GO:0006953~acute-phase response,GO:0044869~negative regulation by host of viral exo-alpha-sialidase activity,GO:0044871~negative regulation by host of viral glycoprotein metabolic process,GO:0045087~innate immune response,GO:0045656~negative regulation of monocyte differentiation,GO:0046597~negative regulation of viral entry into host cell,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0001849~complement component C1q binding,GO:0005509~calcium ion binding,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,GO:0046790~virion binding,GO:0046872~metal ion binding,	IPR001759:Pentraxin-related,IPR013320:ConA-like_dom_sf,IPR030476:Pentaxin_CS,				SM00159:PTX,	KW-0011~Acute phase,	KW-0034~Amyloid,KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0430~Lectin,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Pentraxin (PTX),
P51693	amyloid beta precursor like protein 1(APLP1)	Homo sapiens		h_prionPathway:Prion Pathway,	GO:0006417~regulation of translation,GO:0006897~endocytosis,GO:0006915~apoptotic process,GO:0007155~cell adhesion,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0007417~central nervous system development,GO:0009887~animal organ morphogenesis,GO:0030198~extracellular matrix organization,GO:0030900~forebrain development,GO:0071874~cellular response to norepinephrine stimulus,	GO:0005604~basement membrane,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008201~heparin binding,GO:0031694~alpha-2A adrenergic receptor binding,GO:0031695~alpha-2B adrenergic receptor binding,GO:0031696~alpha-2C adrenergic receptor binding,GO:0042802~identical protein binding,GO:0046914~transition metal ion binding,	IPR008154:Amyloid_glyco_extra,IPR008155:Amyloid_glyco,IPR011178:Amyloid_glyco_Cu-bd,IPR015849:Amyloid_glyco_heparin-bd,IPR019543:APP_amyloid_C,IPR019744:APP_CUBD_CS,IPR019745:Amyloid_glyco_intracell_CS,IPR024329:Amyloid_glyco_E2_domain,IPR036176:E2_sf,IPR036454:Amyloid_glyco_heparin-bd_sf,IPR036669:Amyloid_Cu-bd_sf,				SM00006:A4_EXTRA,	KW-0053~Apoptosis,KW-0130~Cell adhesion,KW-0254~Endocytosis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0523~Neurodegeneration,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0186~Copper,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) serine,CARBOHYD:O-linked (GalNAc...) threonine,COMPBIAS:Basic and acidic residues,DOMAIN:E1,DOMAIN:E2,MOTIF:Basolateral sorting signal,MOTIF:Clathrin-binding,MOTIF:NPXY motif; contains endocytosis signal,MUTAGEN:H->A: Reduced affinity for heparin. Reduces homodimerization.,MUTAGEN:R->A: Strongly reduced affinity for heparin. Strongly reduced homodimerization.,PEPTIDE:C30,REGION:Collagen-binding,REGION:CuBD subdomain,REGION:Disordered,REGION:GFLD subdomain,REGION:Heparin-binding,REGION:Interaction with DAB1,REGION:Interaction with DAB2,REGION:O-glycosylated at three sites,SITE:Cleavage; by caspase-3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8R1C9	amyloid beta precursor protein binding family B member 3(Apbb3)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0043066~negative regulation of apoptotic process,GO:0050714~positive regulation of protein secretion,GO:1901988~negative regulation of cell cycle phase transition,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016604~nuclear body,	GO:0001540~beta-amyloid binding,GO:0008134~transcription factor binding,GO:0050750~low-density lipoprotein particle receptor binding,	IPR001202:WW_dom,IPR006020:PTB/PI_dom,IPR011993:PH-like_dom_sf,IPR036020:WW_dom_sf,IPR039576:APBB1/2/3,				SM00456:WW,SM00462:PTB,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,				DOMAIN:PID,DOMAIN:PID 1,DOMAIN:PID 2,DOMAIN:WW,REGION:Disordered,
O35460	angiopoietin 1(Angpt1)	Rattus norvegicus			GO:0001525~angiogenesis,GO:0001541~ovarian follicle development,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002040~sprouting angiogenesis,GO:0002092~positive regulation of receptor internalization,GO:0002719~negative regulation of cytokine production involved in immune response,GO:0007162~negative regulation of cell adhesion,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0010595~positive regulation of endothelial cell migration,GO:0010628~positive regulation of gene expression,GO:0014842~regulation of skeletal muscle satellite cell proliferation,GO:0030097~hemopoiesis,GO:0030210~heparin biosynthetic process,GO:0031100~animal organ regeneration,GO:0031398~positive regulation of protein ubiquitination,GO:0031589~cell-substrate adhesion,GO:0032680~regulation of tumor necrosis factor production,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033552~response to vitamin B3,GO:0034394~protein localization to cell surface,GO:0042308~negative regulation of protein import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0043116~negative regulation of vascular permeability,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043524~negative regulation of neuron apoptotic process,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0043627~response to estrogen,GO:0045785~positive regulation of cell adhesion,GO:0048014~Tie signaling pathway,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050918~positive chemotaxis,GO:0051402~neuron apoptotic process,GO:0051897~positive regulation of protein kinase B signaling,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0072012~glomerulus vasculature development,GO:0097421~liver regeneration,GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2000446~regulation of macrophage migration inhibitory factor signaling pathway,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0045121~membrane raft,	GO:0005102~receptor binding,GO:0030971~receptor tyrosine kinase binding,GO:0042802~identical protein binding,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR020837:Fibrinogen_CS,IPR036056:Fibrinogen-like_C,	rno04010:MAPK signaling pathway,rno04014:Ras signaling pathway,rno04015:Rap1 signaling pathway,rno04066:HIF-1 signaling pathway,rno04151:PI3K-Akt signaling pathway,rno05323:Rheumatoid arthritis,			SM00186:FBG,	KW-0037~Angiogenesis,KW-0221~Differentiation,	KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibrinogen C-terminal,
O77802	angiopoietin 2(ANGPT2)	Bos taurus			GO:0001525~angiogenesis,GO:0010467~gene expression,GO:0010812~negative regulation of cell-substrate adhesion,GO:0016525~negative regulation of angiogenesis,GO:0030154~cell differentiation,GO:0043537~negative regulation of blood vessel endothelial cell migration,GO:0048014~Tie signaling pathway,GO:0050928~negative regulation of positive chemotaxis,	GO:0005615~extracellular space,	GO:0030971~receptor tyrosine kinase binding,GO:0046872~metal ion binding,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR020837:Fibrinogen_CS,IPR036056:Fibrinogen-like_C,	bta04010:MAPK signaling pathway,bta04014:Ras signaling pathway,bta04015:Rap1 signaling pathway,bta04066:HIF-1 signaling pathway,bta04151:PI3K-Akt signaling pathway,bta05167:Kaposi sarcoma-associated herpesvirus infection,			SM00186:FBG,	KW-0037~Angiogenesis,KW-0221~Differentiation,	KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibrinogen C-terminal,REGION:Disordered,
O35608	angiopoietin 2(Angpt2)	Mus musculus			GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0001974~blood vessel remodeling,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007275~multicellular organism development,GO:0007281~germ cell development,GO:0007492~endoderm development,GO:0009612~response to mechanical stimulus,GO:0009749~response to glucose,GO:0010467~gene expression,GO:0010812~negative regulation of cell-substrate adhesion,GO:0014070~response to organic cyclic compound,GO:0014823~response to activity,GO:0016525~negative regulation of angiogenesis,GO:0030097~hemopoiesis,GO:0030154~cell differentiation,GO:0031100~animal organ regeneration,GO:0043537~negative regulation of blood vessel endothelial cell migration,GO:0045765~regulation of angiogenesis,GO:0045766~positive regulation of angiogenesis,GO:0048014~Tie signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0050928~negative regulation of positive chemotaxis,GO:0060135~maternal process involved in female pregnancy,GO:0071363~cellular response to growth factor stimulus,GO:0072012~glomerulus vasculature development,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0042995~cell projection,	GO:0005172~vascular endothelial growth factor receptor binding,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,GO:0046872~metal ion binding,GO:0048019~receptor antagonist activity,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR020837:Fibrinogen_CS,IPR036056:Fibrinogen-like_C,	mmu04010:MAPK signaling pathway,mmu04014:Ras signaling pathway,mmu04015:Rap1 signaling pathway,mmu04066:HIF-1 signaling pathway,mmu04151:PI3K-Akt signaling pathway,mmu05167:Kaposi sarcoma-associated herpesvirus infection,			SM00186:FBG,	KW-0037~Angiogenesis,KW-0221~Differentiation,	KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibrinogen C-terminal,
Q1RMR1	angiopoietin like 1(ANGPTL1)	Bos taurus			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,	GO:0005615~extracellular space,	GO:0005102~receptor binding,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR020837:Fibrinogen_CS,IPR036056:Fibrinogen-like_C,				SM00186:FBG,		KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibrinogen C-terminal,
Q2KJ51	angiopoietin like 4(ANGPTL4)	Bos taurus			GO:0001525~angiogenesis,GO:0006629~lipid metabolic process,GO:0043335~protein unfolding,GO:0070328~triglyceride homeostasis,GO:0072577~endothelial cell apoptotic process,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0004857~enzyme inhibitor activity,GO:0042802~identical protein binding,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR020837:Fibrinogen_CS,IPR036056:Fibrinogen-like_C,	bta03320:PPAR signaling pathway,bta04979:Cholesterol metabolism,			SM00186:FBG,	KW-0037~Angiogenesis,KW-0443~Lipid metabolism,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibrinogen C-terminal,REGION:Disordered,SITE:Cleavage,
Q86XS5	angiopoietin like 5(ANGPTL5)	Homo sapiens				GO:0005615~extracellular space,	GO:0005102~receptor binding,GO:0005515~protein binding,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR020837:Fibrinogen_CS,IPR036056:Fibrinogen-like_C,				SM00186:FBG,		KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibrinogen C-terminal,
Q640P2	angiopoietin-like 1(Angptl1)	Mus musculus			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005102~receptor binding,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR020837:Fibrinogen_CS,IPR036056:Fibrinogen-like_C,				SM00186:FBG,		KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibrinogen C-terminal,
Q9R045	angiopoietin-like 2(Angptl2)	Mus musculus				GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005102~receptor binding,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR020837:Fibrinogen_CS,IPR036056:Fibrinogen-like_C,				SM00186:FBG,		KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibrinogen C-terminal,REGION:Disordered,
Q9R182	angiopoietin-like 3(Angptl3)	Mus musculus			GO:0001525~angiogenesis,GO:0006071~glycerol metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006641~triglyceride metabolic process,GO:0006644~phospholipid metabolic process,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0008203~cholesterol metabolic process,GO:0009395~phospholipid catabolic process,GO:0009725~response to hormone,GO:0010519~negative regulation of phospholipase activity,GO:0019915~lipid storage,GO:0030335~positive regulation of cell migration,GO:0042632~cholesterol homeostasis,GO:0045766~positive regulation of angiogenesis,GO:0045834~positive regulation of lipid metabolic process,GO:0048844~artery morphogenesis,GO:0050996~positive regulation of lipid catabolic process,GO:0051005~negative regulation of lipoprotein lipase activity,GO:0055088~lipid homeostasis,GO:0055090~acylglycerol homeostasis,GO:0055091~phospholipid homeostasis,GO:0070328~triglyceride homeostasis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0009986~cell surface,GO:0030027~lamellipodium,GO:0042995~cell projection,	GO:0004857~enzyme inhibitor activity,GO:0004859~phospholipase inhibitor activity,GO:0005178~integrin binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR036056:Fibrinogen-like_C,	mmu04979:Cholesterol metabolism,			SM00186:FBG,	KW-0037~Angiogenesis,KW-0130~Cell adhesion,KW-0443~Lipid metabolism,	KW-0964~Secreted,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0732~Signal,		KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GlcNAc) threonine,COMPBIAS:Polar residues,DOMAIN:Fibrinogen C-terminal,MUTAGEN:R->A: Abolishes proteolytical cleavage.,REGION:Disordered,REGION:Required for inhibition of LPL lipase activity,REGION:Sufficient to inhibit LIPG/EL phospholipase activity,REGION:Sufficient to inhibit LPL lipase activity,
Q10751	angiotensin I converting enzyme(ACE)	Gallus gallus			GO:0001822~kidney development,GO:0002003~angiotensin maturation,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0003084~positive regulation of systemic arterial blood pressure,GO:0006508~proteolysis,GO:0008217~regulation of blood pressure,GO:0008283~cell proliferation,GO:0010814~substance P catabolic process,GO:0010815~bradykinin catabolic process,GO:0042445~hormone metabolic process,GO:0042447~hormone catabolic process,GO:0048167~regulation of synaptic plasticity,GO:0060319~primitive erythrocyte differentiation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004180~carboxypeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008241~peptidyl-dipeptidase activity,GO:0008270~zinc ion binding,GO:0031404~chloride ion binding,GO:0046872~metal ion binding,GO:0070573~metallodipeptidase activity,	IPR001548:Peptidase_M2,						KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor 1,ACT_SITE:Proton acceptor 2,ACT_SITE:Proton donor 1,ACT_SITE:Proton donor 2,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase M2 1,DOMAIN:Peptidase M2 2,REGION:Juxtamembrane stalk,SITE:Cleavage,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P30555	angiotensin II receptor type 1(AGTR1)	Sus scrofa			GO:0001822~kidney development,GO:0002034~regulation of blood vessel diameter by renin-angiotensin,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007266~Rho protein signal transduction,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0019229~regulation of vasoconstriction,GO:0019722~calcium-mediated signaling,GO:0046718~viral entry into host cell,GO:0051247~positive regulation of protein metabolic process,GO:0060326~cell chemotaxis,GO:1903589~positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0001596~angiotensin type I receptor activity,GO:0004945~angiotensin type II receptor activity,GO:0031711~bradykinin receptor binding,GO:0046982~protein heterodimerization activity,	IPR000190:ATII_AT1_rcpt,IPR000248:ATII_rcpt,IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,	ssc04020:Calcium signaling pathway,ssc04022:cGMP-PKG signaling pathway,ssc04072:Phospholipase D signaling pathway,ssc04080:Neuroactive ligand-receptor interaction,ssc04261:Adrenergic signaling in cardiomyocytes,ssc04270:Vascular smooth muscle contraction,ssc04371:Apelin signaling pathway,ssc04614:Renin-angiotensin system,ssc04924:Renin secretion,ssc04925:Aldosterone synthesis and secretion,ssc04927:Cortisol synthesis and secretion,ssc04933:AGE-RAGE signaling pathway in diabetic complications,ssc04934:Cushing syndrome,ssc05171:Coronavirus disease - COVID-19,ssc05200:Pathways in cancer,ssc05415:Diabetic cardiomyopathy,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,LIPID:S-palmitoyl cysteine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q801E2	anillin, actin binding protein L homeolog(anln.L)	Xenopus laevis			GO:0007049~cell cycle,GO:0051301~cell division,GO:1904172~positive regulation of bleb assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005938~cell cortex,GO:0032059~bleb,GO:0042995~cell projection,	GO:0003779~actin binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR012966:AHD,IPR031970:Anillin_N,IPR037840:PH_Anillin,				SM00233:PH,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,		KW-0009~Actin-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:PH,REGION:Disordered,REGION:Interaction with F-actin,REGION:Interactions with myh9 and myh10,
Q9NQW6	anillin, actin binding protein(ANLN)	Homo sapiens			GO:0000281~mitotic cytokinesis,GO:0000915~actomyosin contractile ring assembly,GO:0000921~septin ring assembly,GO:0002244~hematopoietic progenitor cell differentiation,GO:0007096~regulation of exit from mitosis,GO:0031106~septin ring organization,GO:0090521~glomerular visceral epithelial cell migration,GO:1904172~positive regulation of bleb assembly,	GO:0005654~nucleoplasm,GO:0005826~actomyosin contractile ring,GO:0005829~cytosol,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0030496~midbody,GO:0032059~bleb,	GO:0003779~actin binding,GO:0045296~cadherin binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR012966:AHD,IPR031970:Anillin_N,IPR037840:PH_Anillin,		616032~Focal segmental glomerulosclerosis 8,		SM00233:PH,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,		KW-0225~Disease variant,	KW-0175~Coiled coil,		KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),DOMAIN:Anillin N-terminal,DOMAIN:Anillin homology,DOMAIN:PH,MUTAGEN:L->A: Abrogates ubiquitin-mediated proteolysis; when associated with A-41.,MUTAGEN:R->A: Abrogates interaction with CD2AP.,MUTAGEN:R->A: Abrogates ubiquitin-mediated proteolysis; when associated with A-44.,REGION:Disordered,REGION:Interaction with CD2AP,REGION:Interaction with F-actin,REGION:Localization to the cleavage furrow,REGION:Nuclear localization,REGION:Required for ubiquitination,
P16157	ankyrin 1(ANK1)	Homo sapiens		h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,	GO:0006887~exocytosis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0010638~positive regulation of organelle organization,GO:0045199~maintenance of epithelial cell apical/basal polarity,GO:0051179~localization,GO:0072659~protein localization to plasma membrane,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0014731~spectrin-associated cytoskeleton,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016529~sarcoplasmic reticulum,GO:0030018~Z disc,GO:0030673~axolemma,GO:0031430~M band,GO:0042383~sarcolemma,GO:0043005~neuron projection,GO:0045211~postsynaptic membrane,	GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0019899~enzyme binding,GO:0019903~protein phosphatase binding,GO:0030507~spectrin binding,GO:0044325~ion channel binding,GO:0051117~ATPase binding,	IPR000488:Death_domain,IPR000906:ZU5_dom,IPR002110:Ankyrin_rpt,IPR011029:DEATH-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,IPR040745:Ankyrin_UPA,	hsa05205:Proteoglycans in cancer,	182900~Spherocytosis, type 1,		SM00005:DEATH,SM00218:ZU5,SM00248:ANK,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0703~Sarcoplasmic reticulum,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0250~Elliptocytosis,KW-0360~Hereditary hemolytic anemia,	KW-0040~ANK repeat,KW-0677~Repeat,KW-0732~Signal,			KW-0379~Hydroxylation,KW-0449~Lipoprotein,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Death,DOMAIN:ZU5,DOMAIN:ZU5 1,DOMAIN:ZU5 2,MUTAGEN:K->E: Abolishes interaction with OBSCN (in isoform Mu17).,MUTAGEN:R->G: Abolishes interaction with OBSCN (in isoform Mu17).,MUTAGEN:T->P: Abolishes interaction with OBSCN (in isoform Mu17).,REGION:55 kDa regulatory domain,REGION:89 kDa domain,REGION:Disordered,REGION:UPA domain,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 10,REPEAT:ANK 11,REPEAT:ANK 12,REPEAT:ANK 13,REPEAT:ANK 14,REPEAT:ANK 15,REPEAT:ANK 16,REPEAT:ANK 17,REPEAT:ANK 18,REPEAT:ANK 19,REPEAT:ANK 2,REPEAT:ANK 20,REPEAT:ANK 21,REPEAT:ANK 22,REPEAT:ANK 23,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,
Q12955	ankyrin 3(ANK3)	Homo sapiens			GO:0000281~mitotic cytokinesis,GO:0007009~plasma membrane organization,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007409~axonogenesis,GO:0007528~neuromuscular junction development,GO:0010628~positive regulation of gene expression,GO:0010650~positive regulation of cell communication by electrical coupling,GO:0010765~positive regulation of sodium ion transport,GO:0010960~magnesium ion homeostasis,GO:0019228~neuronal action potential,GO:0034112~positive regulation of homotypic cell-cell adhesion,GO:0043001~Golgi to plasma membrane protein transport,GO:0043266~regulation of potassium ion transport,GO:0045184~establishment of protein localization,GO:0045838~positive regulation of membrane potential,GO:0051179~localization,GO:0071286~cellular response to magnesium ion,GO:0071709~membrane assembly,GO:0072659~protein localization to plasma membrane,GO:0072660~maintenance of protein location in plasma membrane,GO:0090314~positive regulation of protein targeting to membrane,GO:0099612~protein localization to axon,GO:1900827~positive regulation of membrane depolarization during cardiac muscle cell action potential,GO:1902260~negative regulation of delayed rectifier potassium channel activity,GO:2000651~positive regulation of sodium ion transmembrane transporter activity,GO:2001259~positive regulation of cation channel activity,	GO:0005764~lysosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0009925~basal plasma membrane,GO:0009986~cell surface,GO:0014704~intercalated disc,GO:0014731~spectrin-associated cytoskeleton,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0016529~sarcoplasmic reticulum,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0030425~dendrite,GO:0031594~neuromuscular junction,GO:0033268~node of Ranvier,GO:0042383~sarcolemma,GO:0043005~neuron projection,GO:0043034~costamere,GO:0043194~axon initial segment,GO:0045211~postsynaptic membrane,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0030507~spectrin binding,GO:0030674~protein binding, bridging,GO:0044325~ion channel binding,GO:0045296~cadherin binding,	IPR000488:Death_domain,IPR000906:ZU5_dom,IPR002110:Ankyrin_rpt,IPR011029:DEATH-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,IPR037971:Ank3_Death,IPR040745:Ankyrin_UPA,	hsa05205:Proteoglycans in cancer,	615493~Intellectual developmental disorder, autosomal recessive 37,		SM00005:DEATH,SM00218:ZU5,SM00248:ANK,		KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0991~Intellectual disability,KW-1268~Autism spectrum disorder,	KW-0040~ANK repeat,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Death,DOMAIN:ZU5,DOMAIN:ZU5 1,DOMAIN:ZU5 2,REGION:Disordered,REGION:UPA domain,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 10,REPEAT:ANK 11,REPEAT:ANK 12,REPEAT:ANK 13,REPEAT:ANK 14,REPEAT:ANK 15,REPEAT:ANK 16,REPEAT:ANK 17,REPEAT:ANK 18,REPEAT:ANK 19,REPEAT:ANK 2,REPEAT:ANK 20,REPEAT:ANK 21,REPEAT:ANK 22,REPEAT:ANK 23,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,
Q9NU02	ankyrin repeat and EF-hand domain containing 1(ANKEF1)	Homo sapiens					GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002048:EF_hand_dom,IPR002110:Ankyrin_rpt,IPR011992:EF-hand-dom_pair,IPR036770:Ankyrin_rpt-contain_sf,				SM00248:ANK,					KW-0040~ANK repeat,KW-0677~Repeat,				DOMAIN:EF-hand,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,
Q08DV6	ankyrin repeat and SOCS box containing 3(ASB3)	Bos taurus			GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0005515~protein binding,	IPR001496:SOCS_box,IPR002110:Ankyrin_rpt,IPR036036:SOCS_box-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,IPR037329:ASB3_SOCS,				SM00248:ANK,SM00969:SOCS_box,	KW-0833~Ubl conjugation pathway,				KW-0040~ANK repeat,KW-0677~Repeat,				DOMAIN:SOCS box,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 10,REPEAT:ANK 11,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,
Q8C6Y6	ankyrin repeat and SOCS box-containing 14(Asb14)	Mus musculus			GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,GO:0042147~retrograde transport, endosome to Golgi,GO:0090160~Golgi to lysosome transport,	GO:0005829~cytosol,GO:0010008~endosome membrane,	GO:0031267~small GTPase binding,	IPR001496:SOCS_box,IPR002110:Ankyrin_rpt,IPR036036:SOCS_box-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,				SM00248:ANK,SM00253:SOCS,SM00969:SOCS_box,					KW-0040~ANK repeat,KW-0677~Repeat,				DOMAIN:SOCS box,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 10,REPEAT:ANK 11,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,
Q8VHS5	ankyrin repeat and SOCS box-containing 16(Asb16)	Mus musculus			GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,			IPR001496:SOCS_box,IPR002110:Ankyrin_rpt,IPR036036:SOCS_box-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,				SM00248:ANK,SM00969:SOCS_box,	KW-0833~Ubl conjugation pathway,				KW-0040~ANK repeat,KW-0677~Repeat,				DOMAIN:SOCS box,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,
Q8N957	ankyrin repeat and fibronectin type III domain containing 1(ANKFN1)	Homo sapiens			GO:0000132~establishment of mitotic spindle orientation,GO:0061172~regulation of establishment of bipolar cell polarity,	GO:0005819~spindle,		IPR002110:Ankyrin_rpt,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036770:Ankyrin_rpt-contain_sf,IPR039269:ANKFN1,				SM00060:FN3,SM00248:ANK,					KW-0040~ANK repeat,KW-0677~Repeat,				COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,REGION:Disordered,REGION:Highly conserved peptide sequence,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,
A0A8M9QN10	ankyrin repeat and fibronectin type III domain containing 1(ankfn1)	Danio rerio						IPR002110:Ankyrin_rpt,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036770:Ankyrin_rpt-contain_sf,IPR039269:ANKFN1,				SM00060:FN3,					KW-0040~ANK repeat,KW-0677~Repeat,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,REGION:Disordered,REGION:Highly conserved peptide sequence,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,
Q92625	ankyrin repeat and sterile alpha motif domain containing 1A(ANKS1A)	Homo sapiens			GO:0006929~substrate-dependent cell migration,GO:0016322~neuron remodeling,GO:0048013~ephrin receptor signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0043005~neuron projection,	GO:0005515~protein binding,GO:0046875~ephrin receptor binding,	IPR001660:SAM,IPR002110:Ankyrin_rpt,IPR006020:PTB/PI_dom,IPR011993:PH-like_dom_sf,IPR013761:SAM/pointed_sf,IPR036770:Ankyrin_rpt-contain_sf,IPR041880:SAM_ANKS1_repeat1,IPR041882:SAM_ANKS1_repeat2,				SM00248:ANK,SM00454:SAM,SM00462:PTB,		KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0040~ANK repeat,KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PID,DOMAIN:SAM,DOMAIN:SAM 1,DOMAIN:SAM 2,REGION:Disordered,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,
Q9WV06	ankyrin repeat domain 2(Ankrd2)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001817~regulation of cytokine production,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010832~negative regulation of myotube differentiation,GO:0014902~myotube differentiation,GO:0035914~skeletal muscle cell differentiation,GO:0035994~response to muscle stretch,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0045662~negative regulation of myoblast differentiation,GO:1902253~regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:2000291~regulation of myoblast proliferation,	GO:0000791~euchromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016528~sarcoplasm,GO:0016605~PML body,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0031674~I band,GO:0043231~intracellular membrane-bounded organelle,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0031432~titin binding,GO:0043422~protein kinase B binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,	IPR002110:Ankyrin_rpt,IPR036770:Ankyrin_rpt-contain_sf,				SM00248:ANK,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0040~ANK repeat,KW-0677~Repeat,			KW-0597~Phosphoprotein,	REGION:Disordered,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,
Q8N8A2	ankyrin repeat domain 44(ANKRD44)	Homo sapiens					GO:0005515~protein binding,	IPR002110:Ankyrin_rpt,IPR036770:Ankyrin_rpt-contain_sf,				SM00248:ANK,					KW-0040~ANK repeat,KW-0677~Repeat,				REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 10,REPEAT:ANK 11,REPEAT:ANK 12,REPEAT:ANK 13,REPEAT:ANK 14,REPEAT:ANK 15,REPEAT:ANK 16,REPEAT:ANK 17,REPEAT:ANK 18,REPEAT:ANK 19,REPEAT:ANK 2,REPEAT:ANK 20,REPEAT:ANK 21,REPEAT:ANK 22,REPEAT:ANK 23,REPEAT:ANK 24,REPEAT:ANK 25,REPEAT:ANK 26,REPEAT:ANK 27,REPEAT:ANK 28,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,
Q9ULJ7	ankyrin repeat domain containing 50(ANKRD50)	Homo sapiens			GO:0015031~protein transport,GO:0032456~endocytic recycling,	GO:0005768~endosome,	GO:0005515~protein binding,	IPR002110:Ankyrin_rpt,IPR036770:Ankyrin_rpt-contain_sf,IPR039323:ANKRD60,				SM00248:ANK,	KW-0653~Protein transport,KW-0813~Transport,	KW-0967~Endosome,			KW-0040~ANK repeat,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 10,REPEAT:ANK 11,REPEAT:ANK 12,REPEAT:ANK 13,REPEAT:ANK 14,REPEAT:ANK 15,REPEAT:ANK 16,REPEAT:ANK 17,REPEAT:ANK 18,REPEAT:ANK 19,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,
Q5REL2	annexin A1(ANXA1)	Pongo abelii			GO:0002250~adaptive immune response,GO:0002548~monocyte chemotaxis,GO:0002685~regulation of leukocyte migration,GO:0006909~phagocytosis,GO:0006954~inflammatory response,GO:0007166~cell surface receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0008360~regulation of cell shape,GO:0010165~response to X-ray,GO:0014839~myoblast migration involved in skeletal muscle regeneration,GO:0030036~actin cytoskeleton organization,GO:0030073~insulin secretion,GO:0030216~keratinocyte differentiation,GO:0030850~prostate gland development,GO:0031018~endocrine pancreas development,GO:0031340~positive regulation of vesicle fusion,GO:0031394~positive regulation of prostaglandin biosynthetic process,GO:0032355~response to estradiol,GO:0032508~DNA duplex unwinding,GO:0032652~regulation of interleukin-1 production,GO:0032717~negative regulation of interleukin-8 production,GO:0032743~positive regulation of interleukin-2 production,GO:0033031~positive regulation of neutrophil apoptotic process,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0042063~gliogenesis,GO:0042102~positive regulation of T cell proliferation,GO:0042119~neutrophil activation,GO:0043434~response to peptide hormone,GO:0045087~innate immune response,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0045629~negative regulation of T-helper 2 cell differentiation,GO:0045920~negative regulation of exocytosis,GO:0046632~alpha-beta T cell differentiation,GO:0046883~regulation of hormone secretion,GO:0050482~arachidonic acid secretion,GO:0050727~regulation of inflammatory response,GO:0070301~cellular response to hydrogen peroxide,GO:0070365~hepatocyte differentiation,GO:0070459~prolactin secretion,GO:0070555~response to interleukin-1,GO:0071385~cellular response to glucocorticoid stimulus,GO:0071621~granulocyte chemotaxis,GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis,GO:0090303~positive regulation of wound healing,GO:0097350~neutrophil clearance,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1900138~negative regulation of phospholipase A2 activity,	GO:0001533~cornified envelope,GO:0001891~phagocytic cup,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0031514~motile cilium,GO:0031901~early endosome membrane,GO:0042383~sarcolemma,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019834~phospholipase A2 inhibitor activity,GO:0048306~calcium-dependent protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001464:Annexin,IPR002388:ANX1,IPR018252:Annexin_repeat_CS,IPR018502:Annexin_repeat,IPR037104:Annexin_sf,				SM00335:ANX,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,KW-0966~Cell projection,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-0969~Cilium,KW-1003~Cell membrane,			KW-0041~Annexin,KW-0677~Repeat,	KW-0106~Calcium,KW-0111~Calcium/phospholipid-binding,KW-0479~Metal-binding,	KW-0593~Phospholipase A2 inhibitor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?),PEPTIDE:Annexin Ac2-26,REPEAT:Annexin 1,REPEAT:Annexin 2,REPEAT:Annexin 3,REPEAT:Annexin 4,SITE:Cleavage; by CTSG,
Q5R5A0	annexin A2(ANXA2)	Pongo abelii			GO:0001525~angiogenesis,GO:0001765~membrane raft assembly,GO:0001921~positive regulation of receptor recycling,GO:0002091~negative regulation of receptor internalization,GO:0006900~membrane budding,GO:0010756~positive regulation of plasminogen activation,GO:0031340~positive regulation of vesicle fusion,GO:0032804~negative regulation of low-density lipoprotein particle receptor catabolic process,GO:0036035~osteoclast development,GO:0044090~positive regulation of vacuole organization,GO:1905581~positive regulation of low-density lipoprotein particle clearance,GO:1905602~positive regulation of receptor-mediated endocytosis involved in cholesterol transport,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005811~lipid particle,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0030496~midbody,GO:0031902~late endosome membrane,GO:0031982~vesicle,GO:0045121~membrane raft,GO:0070062~extracellular exosome,GO:0098797~plasma membrane protein complex,GO:1990665~AnxA2-p11 complex,GO:1990667~PCSK9-AnxA2 complex,	GO:0001786~phosphatidylserine binding,GO:0002020~protease binding,GO:0004859~phospholipase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008092~cytoskeletal protein binding,GO:0019834~phospholipase A2 inhibitor activity,GO:0042802~identical protein binding,GO:0044548~S100 protein binding,GO:0046790~virion binding,GO:0048306~calcium-dependent protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001464:Annexin,IPR002389:ANX2,IPR018252:Annexin_repeat_CS,IPR018502:Annexin_repeat,IPR037104:Annexin_sf,	pon05132:Salmonella infection,			SM00335:ANX,		KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0041~Annexin,KW-0677~Repeat,	KW-0106~Calcium,KW-0111~Calcium/phospholipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,REGION:S100A10-binding site,REPEAT:Annexin 1,REPEAT:Annexin 2,REPEAT:Annexin 3,REPEAT:Annexin 4,
P07356	annexin A2(Anxa2)	Mus musculus			GO:0001525~angiogenesis,GO:0001765~membrane raft assembly,GO:0001921~positive regulation of receptor recycling,GO:0001934~positive regulation of protein phosphorylation,GO:0002091~negative regulation of receptor internalization,GO:0006900~membrane budding,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007589~body fluid secretion,GO:0010756~positive regulation of plasminogen activation,GO:0014823~response to activity,GO:0030199~collagen fibril organization,GO:0030324~lung development,GO:0031340~positive regulation of vesicle fusion,GO:0032804~negative regulation of low-density lipoprotein particle receptor catabolic process,GO:0036035~osteoclast development,GO:0042730~fibrinolysis,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0044090~positive regulation of vacuole organization,GO:0045921~positive regulation of exocytosis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,GO:0050767~regulation of neurogenesis,GO:0051099~positive regulation of binding,GO:0071229~cellular response to acid chemical,GO:0072659~protein localization to plasma membrane,GO:1904019~epithelial cell apoptotic process,GO:1905581~positive regulation of low-density lipoprotein particle clearance,GO:1905597~positive regulation of low-density lipoprotein particle receptor binding,GO:1905599~positive regulation of low-density lipoprotein receptor activity,GO:1905602~positive regulation of receptor-mediated endocytosis involved in cholesterol transport,GO:1905686~positive regulation of plasma membrane repair,	GO:0001533~cornified envelope,GO:0001725~stress fiber,GO:0001726~ruffle,GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0009986~cell surface,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016363~nuclear matrix,GO:0030054~cell junction,GO:0030496~midbody,GO:0031902~late endosome membrane,GO:0031982~vesicle,GO:0032991~macromolecular complex,GO:0035749~myelin sheath adaxonal region,GO:0042383~sarcolemma,GO:0042470~melanosome,GO:0043220~Schmidt-Lanterman incisure,GO:0044354~macropinosome,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0090575~RNA polymerase II transcription factor complex,GO:0098797~plasma membrane protein complex,GO:1990665~AnxA2-p11 complex,GO:1990667~PCSK9-AnxA2 complex,	GO:0001786~phosphatidylserine binding,GO:0002020~protease binding,GO:0004859~phospholipase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008092~cytoskeletal protein binding,GO:0019834~phospholipase A2 inhibitor activity,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0044548~S100 protein binding,GO:0044730~bone sialoprotein binding,GO:0046790~virion binding,GO:0048306~calcium-dependent protein binding,	IPR001464:Annexin,IPR002389:ANX2,IPR018252:Annexin_repeat_CS,IPR018502:Annexin_repeat,IPR037104:Annexin_sf,	mmu05132:Salmonella infection,			SM00335:ANX,		KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0041~Annexin,KW-0677~Repeat,	KW-0106~Calcium,KW-0111~Calcium/phospholipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,REGION:S100A10-binding site,REPEAT:Annexin 1,REPEAT:Annexin 2,REPEAT:Annexin 3,REPEAT:Annexin 4,
Q3SWX7	annexin A3(ANXA3)	Bos taurus			GO:0006909~phagocytosis,GO:0010595~positive regulation of endothelial cell migration,GO:0042742~defense response to bacterium,GO:0043312~neutrophil degranulation,GO:0045766~positive regulation of angiogenesis,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030670~phagocytic vesicle membrane,GO:0042581~specific granule,	GO:0004859~phospholipase inhibitor activity,GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019834~phospholipase A2 inhibitor activity,GO:0048306~calcium-dependent protein binding,	IPR001464:Annexin,IPR002390:ANX3,IPR018252:Annexin_repeat_CS,IPR018502:Annexin_repeat,IPR037104:Annexin_sf,				SM00335:ANX,					KW-0041~Annexin,KW-0677~Repeat,	KW-0106~Calcium,KW-0111~Calcium/phospholipid-binding,	KW-0593~Phospholipase A2 inhibitor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	REPEAT:Annexin 1,REPEAT:Annexin 2,REPEAT:Annexin 3,REPEAT:Annexin 4,
Q4V8U5	anoctamin 10a(ano10a)	Danio rerio			GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005254~chloride channel activity,	IPR007632:Anoctamin,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
P23352	anosmin 1(ANOS1)	Homo sapiens			GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0030182~neuron differentiation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0031012~extracellular matrix,	GO:0004252~serine-type endopeptidase activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0030414~peptidase inhibitor activity,	IPR003961:FN3_dom,IPR008197:WAP_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036645:Elafin-like_sf,IPR040957:Anosmin-1_Cys_box,IPR042447:Anosmin-1,		308700~Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1),		SM00060:FN3,SM00217:WAP,	KW-0130~Cell adhesion,KW-0145~Chemotaxis,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0956~Kallmann syndrome,KW-1016~Hypogonadotropic hypogonadism,	KW-0677~Repeat,KW-0732~Signal,		KW-0358~Heparin-binding,KW-0378~Hydrolase,KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:WAP,REGION:Disordered,
Q6NY34	anti-silencing function 1Bb histone chaperone(asf1bb)	Danio rerio			GO:0006325~chromatin organization,GO:0006335~DNA replication-dependent nucleosome assembly,	GO:0005634~nucleus,	GO:0042393~histone binding,	IPR006818:ASF1-like,IPR036747:ASF1-like_sf,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0143~Chaperone,KW-0156~Chromatin regulator,
P51910	apolipoprotein D(Apod)	Mus musculus			GO:0000302~response to reactive oxygen species,GO:0006006~glucose metabolic process,GO:0006629~lipid metabolic process,GO:0006869~lipid transport,GO:0007420~brain development,GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway,GO:0014012~peripheral nervous system axon regeneration,GO:0042246~tissue regeneration,GO:0042308~negative regulation of protein import into nucleus,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048678~response to axon injury,GO:0051895~negative regulation of focal adhesion assembly,GO:0060588~negative regulation of lipoprotein lipid oxidation,GO:0071638~negative regulation of monocyte chemotactic protein-1 production,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:2000098~negative regulation of smooth muscle cell-matrix adhesion,GO:2000405~negative regulation of T cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0022626~cytosolic ribosome,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0008289~lipid binding,GO:0015485~cholesterol binding,	IPR000566:Lipocln_cytosolic_FA-bd_dom,IPR002969:ApolipopD,IPR012674:Calycin,IPR022271:Lipocalin_ApoD,IPR022272:Lipocalin_CS,IPR026222:ApoD_vertbrte,			PIRSF036893:Lipocalin_ApoD,		KW-0813~Transport,	KW-0964~Secreted,			KW-0732~Signal,	KW-0446~Lipid-binding,		KW-0325~Glycoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,
P33703	apolipoprotein H(APOH)	Canis lupus familiaris			GO:0001937~negative regulation of endothelial cell proliferation,GO:0006641~triglyceride metabolic process,GO:0007597~blood coagulation, intrinsic pathway,GO:0010596~negative regulation of endothelial cell migration,GO:0016525~negative regulation of angiogenesis,GO:0030195~negative regulation of blood coagulation,GO:0031639~plasminogen activation,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0034392~negative regulation of smooth muscle cell apoptotic process,GO:0051918~negative regulation of fibrinolysis,	GO:0005576~extracellular region,GO:0009986~cell surface,GO:0034361~very-low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0042627~chylomicron,	GO:0005543~phospholipid binding,GO:0008201~heparin binding,GO:0042802~identical protein binding,GO:0060230~lipoprotein lipase activator activity,	IPR000436:Sushi_SCR_CCP_dom,IPR015104:Sushi_2,IPR035976:Sushi/SCR/CCP_sf,	cfa04979:Cholesterol metabolism,			SM00032:CCP,		KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,		KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) threonine,DOMAIN:Sushi,DOMAIN:Sushi 1,DOMAIN:Sushi 2,DOMAIN:Sushi 3,DOMAIN:Sushi 4,REGION:Sushi-like,
B2GUW6	apoptosis enhancing nuclease(Aen)	Rattus norvegicus			GO:0006259~DNA metabolic process,GO:0010212~response to ionizing radiation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031965~nuclear membrane,	GO:0003676~nucleic acid binding,GO:0004527~exonuclease activity,GO:0004529~exodeoxyribonuclease activity,	IPR012337:RNaseH-like_sf,IPR013520:Exonuclease_RNaseT/DNA_pol3,IPR036397:RNaseH_sf,IPR047021:REXO1/3/4-like,				SM00479:EXOIII,	KW-0053~Apoptosis,KW-0227~DNA damage,	KW-0539~Nucleus,					KW-0269~Exonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,DOMAIN:Exonuclease,MOTIF:Nuclear localization signal,MOTIF:Nucleolar localization signal,REGION:Disordered,
Q5R819	aquaporin 1 (Colton blood group)(AQP1)	Pongo abelii			GO:0003094~glomerular filtration,GO:0003097~renal water transport,GO:0006833~water transport,GO:0006884~cell volume homeostasis,GO:0006972~hyperosmotic response,GO:0009992~cellular water homeostasis,GO:0010761~fibroblast migration,GO:0010763~positive regulation of fibroblast migration,GO:0015670~carbon dioxide transport,GO:0015793~glycerol transport,GO:0019233~sensory perception of pain,GO:0019725~cellular homeostasis,GO:0019934~cGMP-mediated signaling,GO:0021670~lateral ventricle development,GO:0030157~pancreatic juice secretion,GO:0030185~nitric oxide transport,GO:0030950~establishment or maintenance of actin cytoskeleton polarity,GO:0033326~cerebrospinal fluid secretion,GO:0033363~secretory granule organization,GO:0034644~cellular response to UV,GO:0035377~transepithelial water transport,GO:0035378~carbon dioxide transmembrane transport,GO:0042060~wound healing,GO:0042476~odontogenesis,GO:0043066~negative regulation of apoptotic process,GO:0044241~lipid digestion,GO:0045766~positive regulation of angiogenesis,GO:0046878~positive regulation of saliva secretion,GO:0048146~positive regulation of fibroblast proliferation,GO:0048593~camera-type eye morphogenesis,GO:0050829~defense response to Gram-negative bacterium,GO:0051458~corticotropin secretion,GO:0051649~establishment of localization in cell,GO:0070295~renal water absorption,GO:0070301~cellular response to hydrogen peroxide,GO:0071241~cellular response to inorganic substance,GO:0071260~cellular response to mechanical stimulus,GO:0071280~cellular response to copper ion,GO:0071288~cellular response to mercury ion,GO:0071300~cellular response to retinoic acid,GO:0071320~cellular response to cAMP,GO:0071456~cellular response to hypoxia,GO:0071472~cellular response to salt stress,GO:0071474~cellular hyperosmotic response,GO:0071549~cellular response to dexamethasone stimulus,GO:0071732~cellular response to nitric oxide,GO:0072220~metanephric descending thin limb development,GO:0072230~metanephric proximal straight tubule development,GO:0072232~metanephric proximal convoluted tubule segment 2 development,GO:0072239~metanephric glomerulus vasculature development,GO:0072488~ammonium transmembrane transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005903~brush border,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030424~axon,GO:0031526~brush border membrane,GO:0031965~nuclear membrane,GO:0042383~sarcolemma,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0005223~intracellular cGMP activated cation channel activity,GO:0005267~potassium channel activity,GO:0005372~water transmembrane transporter activity,GO:0008519~ammonium transmembrane transporter activity,GO:0015168~glycerol transmembrane transporter activity,GO:0015250~water channel activity,GO:0022857~transmembrane transporter activity,GO:0030184~nitric oxide transmembrane transporter activity,GO:0035379~carbon dioxide transmembrane transporter activity,GO:0042802~identical protein binding,GO:0046875~ephrin receptor binding,	IPR000425:MIP,IPR022357:MIP_CS,IPR023271:Aquaporin-like,IPR023274:Aquaporin_1,IPR034294:Aquaporin_transptr,	pon04924:Renin secretion,pon04964:Proximal tubule bicarbonate reclamation,pon04976:Bile secretion,				KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,INTRAMEM:Helical; Name=Helix B,INTRAMEM:Helical; Name=Helix E,MOTIF:NPA 1,MOTIF:NPA 2,SITE:Hg(2+)-sensitive residue,SITE:Substrate discrimination,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=Helix 1,TRANSMEM:Helical; Name=Helix 2,TRANSMEM:Helical; Name=Helix 3,TRANSMEM:Helical; Name=Helix 4,TRANSMEM:Helical; Name=Helix 5,TRANSMEM:Helical; Name=Helix 6,
Q8CHJ2	aquaporin 12(Aqp12)	Mus musculus			GO:0055085~transmembrane transport,	GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0015267~channel activity,	IPR000425:MIP,IPR016697:Aquaporin_11/12,IPR023265:Aquaporin_12,IPR023271:Aquaporin-like,			PIRSF017529:Aquaporin_11/12,		KW-0813~Transport,	KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				MOTIF:NPA 1,MOTIF:NPA 2,REGION:Disordered,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
O54794	aquaporin 7(Aqp7)	Mus musculus			GO:0006833~water transport,GO:0015793~glycerol transport,GO:0015840~urea transport,GO:0055085~transmembrane transport,GO:0070295~renal water absorption,	GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005938~cell cortex,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031526~brush border membrane,GO:1990904~ribonucleoprotein complex,	GO:0015204~urea transmembrane transporter activity,GO:0015250~water channel activity,GO:0015254~glycerol channel activity,GO:0015265~urea channel activity,GO:0015267~channel activity,	IPR000425:MIP,IPR023271:Aquaporin-like,	mmu03320:PPAR signaling pathway,mmu04923:Regulation of lipolysis in adipocytes,				KW-0813~Transport,	KW-0472~Membrane,KW-0551~Lipid droplet,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	INTRAMEM:Discontinuously helical,MOTIF:NPA 1,MOTIF:NPA 2,SITE:Important for permeability to glycerol,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O43315	aquaporin 9(AQP9)	Homo sapiens			GO:0006833~water transport,GO:0006863~purine nucleobase transport,GO:0015722~canalicular bile acid transport,GO:0015793~glycerol transport,GO:0015837~amine transport,GO:0015855~pyrimidine nucleobase transport,GO:0048265~response to pain,GO:0071320~cellular response to cAMP,GO:0071918~urea transmembrane transport,GO:0072531~pyrimidine-containing compound transmembrane transport,GO:1904823~purine nucleobase transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005345~purine nucleobase transmembrane transporter activity,GO:0005350~pyrimidine nucleobase transmembrane transporter activity,GO:0005515~protein binding,GO:0015204~urea transmembrane transporter activity,GO:0015250~water channel activity,GO:0015254~glycerol channel activity,GO:0015265~urea channel activity,	IPR000425:MIP,IPR015685:Aquaporin_9,IPR022357:MIP_CS,IPR023271:Aquaporin-like,	hsa04613:Neutrophil extracellular trap formation,hsa04976:Bile secretion,				KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				INTRAMEM:Discontinuously helical,MOTIF:NPA 1,MOTIF:NPA 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
D3ZKX9	arachidonate lipoxygenase 3(Aloxe3)	Rattus norvegicus			GO:0006665~sphingolipid metabolic process,GO:0019233~sensory perception of pain,GO:0019369~arachidonic acid metabolic process,GO:0019372~lipoxygenase pathway,GO:0034440~lipid oxidation,GO:0035357~peroxisome proliferator activated receptor signaling pathway,GO:0043651~linoleic acid metabolic process,GO:0045444~fat cell differentiation,GO:0046513~ceramide biosynthetic process,GO:0051122~hepoxilin biosynthetic process,GO:0061436~establishment of skin barrier,	GO:0005737~cytoplasm,	GO:0005506~iron ion binding,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0050486~intramolecular transferase activity, transferring hydroxy groups,GO:0051120~hepoxilin A3 synthase activity,	IPR000907:LipOase,IPR001024:PLAT/LH2_dom,IPR001885:LipOase_mml,IPR013819:LipOase_C,IPR020833:LipOase_Fe_BS,IPR020834:LipOase_CS,IPR036226:LipOase_C_sf,IPR036392:PLAT/LH2_dom_sf,IPR042062:PLAT_LOX_verte,	rno00590:Arachidonic acid metabolism,rno01100:Metabolic pathways,			SM00308:LH2,	KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,				KW-0408~Iron,KW-0479~Metal-binding,	KW-0223~Dioxygenase,KW-0413~Isomerase,KW-0456~Lyase,KW-0560~Oxidoreductase,		DOMAIN:Lipoxygenase,DOMAIN:PLAT,
O88721	arginine vasopressin receptor 2(Avpr2)	Mus musculus			GO:0001992~regulation of systemic arterial blood pressure by vasopressin,GO:0003084~positive regulation of systemic arterial blood pressure,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0021537~telencephalon development,GO:0032609~interferon-gamma production,GO:0032870~cellular response to hormone stimulus,GO:0034097~response to cytokine,GO:0035811~negative regulation of urine volume,GO:0045777~positive regulation of blood pressure,GO:0045907~positive regulation of vasoconstriction,GO:1902533~positive regulation of intracellular signal transduction,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030139~endocytic vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0004930~G-protein coupled receptor activity,GO:0005000~vasopressin receptor activity,GO:0038023~signaling receptor activity,GO:0042277~peptide binding,	IPR000161:Vprsn_rcpt_V2,IPR000276:GPCR_Rhodpsn,IPR001817:Vasoprsn_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	mmu04072:Phospholipase D signaling pathway,mmu04080:Neuroactive ligand-receptor interaction,mmu04962:Vasopressin-regulated water reabsorption,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 1 profile,LIPID:S-palmitoyl cysteine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q0P5H7	arginyl-tRNA synthetase 2, mitochondrial(RARS2)	Bos taurus			GO:0006420~arginyl-tRNA aminoacylation,GO:0032543~mitochondrial translation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031966~mitochondrial membrane,	GO:0004814~arginine-tRNA ligase activity,GO:0005524~ATP binding,	IPR001278:Arg-tRNA-ligase,IPR001412:aa-tRNA-synth_I_CS,IPR008909:DALR_anticod-bd,IPR009080:tRNAsynth_Ia_anticodon-bd,IPR014729:Rossmann-like_a/b/a_fold,IPR035684:ArgRS_core,IPR036695:Arg-tRNA-synth_N_sf,	bta00970:Aminoacyl-tRNA biosynthesis,			SM00836:DALR_1,	KW-0648~Protein biosynthesis,	KW-0472~Membrane,KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,	KW-0007~Acetylation,	DOMAIN:DALR anticodon binding,MOTIF:'HIGH' region,TRANSIT:Mitochondrion,
E9QAU8	arkadia (RNF111) C-terminal like ring finger ubiquitin ligase 2C(Ark2c)	Mus musculus			GO:0000209~protein polyubiquitination,GO:0007409~axonogenesis,GO:0008045~motor neuron axon guidance,GO:0030163~protein catabolic process,GO:0030513~positive regulation of BMP signaling pathway,GO:0035136~forelimb morphogenesis,GO:0060173~limb development,GO:0060384~innervation,GO:0061061~muscle structure development,	GO:0005634~nucleus,GO:0032991~macromolecular complex,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR011016:Znf_RING-CH,IPR013083:Znf_RING/FYVE/PHD,IPR045191:MBR1/2-like,				SM00184:RING,SM00744:RINGv,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,			KW-0732~Signal,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,DOMAIN:RING-type,REGION:Disordered,REGION:Ubiquitin binding,ZN_FING:RING-type; atypical,
B0BNL6	arrestin domain containing 1(Arrdc1)	Rattus norvegicus			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006858~extracellular transport,GO:0015031~protein transport,GO:0016567~protein ubiquitination,GO:0045746~negative regulation of Notch signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,GO:1903561~extracellular vesicle,	GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:1990756~protein binding, bridging involved in substrate recognition for ubiquitination,GO:1990763~arrestin family protein binding,	IPR011021:Arrestin-like_N,IPR011022:Arrestin_C-like,IPR014752:Arrestin-like_C,IPR014756:Ig_E-set,				SM01017:Arrestin_C,		KW-0472~Membrane,KW-1003~Cell membrane,						KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:Arrestin C-terminal-like,MOTIF:PPxY motif 1,MOTIF:PPxY motif 2,REGION:Disordered,
Q6TXF1	arrestin domain containing 3(Arrdc3)	Rattus norvegicus			GO:0001659~temperature homeostasis,GO:0015031~protein transport,GO:0031649~heat generation,GO:0031651~negative regulation of heat generation,GO:0035332~positive regulation of hippo signaling,GO:0043588~skin development,GO:0060613~fat pad development,GO:0071878~negative regulation of adrenergic receptor signaling pathway,GO:0090327~negative regulation of locomotion involved in locomotory behavior,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,	GO:0031699~beta-3 adrenergic receptor binding,	IPR011021:Arrestin-like_N,IPR011022:Arrestin_C-like,IPR014752:Arrestin-like_C,IPR014756:Ig_E-set,				SM01017:Arrestin_C,		KW-0458~Lysosome,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,				COMPBIAS:Polar residues,DOMAIN:Arrestin C-terminal-like,MOTIF:PPxY motif 1,MOTIF:PPxY motif 2,REGION:Disordered,
Q7TPQ9	arrestin domain containing 3(Arrdc3)	Mus musculus			GO:0001659~temperature homeostasis,GO:0015031~protein transport,GO:0031649~heat generation,GO:0031651~negative regulation of heat generation,GO:0035332~positive regulation of hippo signaling,GO:0043588~skin development,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0060613~fat pad development,GO:0071878~negative regulation of adrenergic receptor signaling pathway,GO:0090327~negative regulation of locomotion involved in locomotory behavior,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0031699~beta-3 adrenergic receptor binding,	IPR011021:Arrestin-like_N,IPR011022:Arrestin_C-like,IPR014752:Arrestin-like_C,IPR014756:Ig_E-set,				SM01017:Arrestin_C,		KW-0458~Lysosome,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,				COMPBIAS:Polar residues,DOMAIN:Arrestin C-terminal-like,MOTIF:PPxY motif 1,MOTIF:PPxY motif 2,REGION:Disordered,
Q9I8T7	aryl hydrocarbon receptor nuclear translocator like(ARNTL)	Gallus gallus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007623~circadian rhythm,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0051775~response to redox state,GO:1901985~positive regulation of protein acetylation,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0034751~aryl hydrocarbon receptor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046983~protein dimerization activity,	IPR000014:PAS,IPR001067:Nuc_translocat,IPR001610:PAC,IPR011598:bHLH_dom,IPR013767:PAS_fold,IPR035965:PAS-like_dom_sf,IPR036638:HLH_DNA-bd_sf,				SM00086:PAC,SM00091:PAS,SM00353:HLH,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3),DOMAIN:BHLH,DOMAIN:PAC,DOMAIN:PAS,DOMAIN:PAS 1,DOMAIN:PAS 2,DOMAIN:bHLH,MOTIF:Nuclear export signal 1,MOTIF:Nuclear export signal 2,MOTIF:Nuclear localization signal,REGION:Disordered,SITE:Important for interaction with CLOCK,SITE:Interaction with E-box DNA,
Q95LD9	aryl hydrocarbon receptor(AHR)	Delphinapterus leucas			GO:0002819~regulation of adaptive immune response,GO:0002841~negative regulation of T cell mediated immune response to tumor cell,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0009410~response to xenobiotic stimulus,GO:0009636~response to toxic substance,GO:0019933~cAMP-mediated signaling,GO:0030888~regulation of B cell proliferation,GO:0032922~circadian regulation of gene expression,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0050728~negative regulation of inflammatory response,GO:0071219~cellular response to molecule of bacterial origin,GO:0071320~cellular response to cAMP,GO:1904322~cellular response to forskolin,GO:1904613~cellular response to 2,3,7,8-tetrachlorodibenzodioxine,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034751~aryl hydrocarbon receptor complex,GO:0034753~nuclear aryl hydrocarbon receptor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001094~TFIID-class transcription factor binding,GO:0001223~transcription coactivator binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0017025~TBP-class protein binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051879~Hsp90 protein binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0070888~E-box binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000014:PAS,IPR001610:PAC,IPR011598:bHLH_dom,IPR013655:PAS_fold_3,IPR013767:PAS_fold,IPR033348:AHR_bHLH,IPR035965:PAS-like_dom_sf,IPR036638:HLH_DNA-bd_sf,	dle04659:Th17 cell differentiation,dle04934:Cushing syndrome,dle05207:Chemical carcinogenesis - receptor activation,dle05208:Chemical carcinogenesis - reactive oxygen species,			SM00086:PAC,SM00091:PAS,SM00353:HLH,	KW-0090~Biological rhythms,KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,KW-0678~Repressor,	KW-0013~ADP-ribosylation,	DOMAIN:BHLH,DOMAIN:PAC,DOMAIN:PAS,DOMAIN:PAS 1,DOMAIN:PAS 2,DOMAIN:PAS fold-3,DOMAIN:bHLH,MOTIF:Nuclear export signal,MOTIF:Nuclear localization signal 1,MOTIF:Nuclear localization signal 2,REGION:Disordered,REGION:Required for maintaining the overall integrity of the AHR:ARNT heterodimer and its transcriptional activity,
Q9DG12	aryl-hydrocarbon receptor nuclear translocator 2(arnt2)	Danio rerio			GO:0001666~response to hypoxia,GO:0003208~cardiac ventricle morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0007411~axon guidance,GO:0007420~brain development,GO:0021536~diencephalon development,GO:0021591~ventricular system development,GO:0021979~hypothalamus cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048798~swim bladder inflation,GO:0071542~dopaminergic neuron differentiation,GO:0072576~liver morphogenesis,GO:0098609~cell-cell adhesion,GO:1902073~positive regulation of hypoxia-inducible factor-1alpha signaling pathway,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0034751~aryl hydrocarbon receptor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,	IPR000014:PAS,IPR001067:Nuc_translocat,IPR001610:PAC,IPR011598:bHLH_dom,IPR013767:PAS_fold,IPR035965:PAS-like_dom_sf,IPR036638:HLH_DNA-bd_sf,				SM00086:PAC,SM00091:PAS,SM00353:HLH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BHLH,DOMAIN:PAC,DOMAIN:PAS,DOMAIN:PAS 1,DOMAIN:PAS 2,DOMAIN:bHLH,REGION:Disordered,
Q7M370	arylacetamide deacetylase(AADAC)	Oryctolagus cuniculus			GO:0006629~lipid metabolic process,GO:0010898~positive regulation of triglyceride catabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004806~triglyceride lipase activity,GO:0016787~hydrolase activity,GO:0017171~serine hydrolase activity,GO:0019213~deacetylase activity,GO:0052689~carboxylic ester hydrolase activity,	IPR013094:AB_hydrolase_3,IPR017157:Arylacetamide_deacetylase,IPR029058:AB_hydrolase,IPR033140:Lipase_GDXG_put_SER_AS,			PIRSF037251:Arylacetamide_deacetylase,		KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Alpha/beta hydrolase fold-3,MOTIF:Involved in the stabilization of the negatively charged intermediate by the formation of the oxyanion hole,MUTAGEN:D->K: Inverted topology; when associated with I-3; Q-27 and Q-28, or with I-3; K-27 and K-28.,MUTAGEN:EE->KK,QQ: No effect on topology; when associated with K-24. Inverted topology; when associated with I-3 and K-24.,MUTAGEN:K->I: No effect on membrane topology. Inverted topology; when associated with N-24; Q-27 and Q-28, or with N-24; K-27 and K-28.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q7M370	arylacetamide deacetylase-like 2(LOC103350418)	Oryctolagus cuniculus			GO:0006629~lipid metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004806~triglyceride lipase activity,GO:0016787~hydrolase activity,GO:0019213~deacetylase activity,GO:0052689~carboxylic ester hydrolase activity,	IPR013094:AB_hydrolase_3,IPR017157:Arylacetamide_deacetylase,IPR029058:AB_hydrolase,IPR033140:Lipase_GDXG_put_SER_AS,			PIRSF037251:Arylacetamide_deacetylase,		KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Alpha/beta hydrolase fold-3,MOTIF:Involved in the stabilization of the negatively charged intermediate by the formation of the oxyanion hole,MUTAGEN:D->K: Inverted topology; when associated with I-3; Q-27 and Q-28, or with I-3; K-27 and K-28.,MUTAGEN:EE->KK,QQ: No effect on topology; when associated with K-24. Inverted topology; when associated with I-3 and K-24.,MUTAGEN:K->I: No effect on membrane topology. Inverted topology; when associated with N-24; Q-27 and Q-28, or with N-24; K-27 and K-28.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q7M370	arylacetamide deacetylase-like(LOC100348001)	Oryctolagus cuniculus			GO:0006629~lipid metabolic process,GO:0010898~positive regulation of triglyceride catabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004806~triglyceride lipase activity,GO:0016787~hydrolase activity,GO:0017171~serine hydrolase activity,GO:0019213~deacetylase activity,GO:0052689~carboxylic ester hydrolase activity,	IPR013094:AB_hydrolase_3,IPR017157:Arylacetamide_deacetylase,IPR029058:AB_hydrolase,IPR033140:Lipase_GDXG_put_SER_AS,			PIRSF037251:Arylacetamide_deacetylase,		KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Alpha/beta hydrolase fold-3,MOTIF:Involved in the stabilization of the negatively charged intermediate by the formation of the oxyanion hole,MUTAGEN:D->K: Inverted topology; when associated with I-3; Q-27 and Q-28, or with I-3; K-27 and K-28.,MUTAGEN:EE->KK,QQ: No effect on topology; when associated with K-24. Inverted topology; when associated with I-3 and K-24.,MUTAGEN:K->I: No effect on membrane topology. Inverted topology; when associated with N-24; Q-27 and Q-28, or with N-24; K-27 and K-28.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q7M370	arylacetamide deacetylase-like(LOC100349258)	Oryctolagus cuniculus			GO:0006629~lipid metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004806~triglyceride lipase activity,GO:0016787~hydrolase activity,GO:0019213~deacetylase activity,GO:0052689~carboxylic ester hydrolase activity,	IPR013094:AB_hydrolase_3,IPR017157:Arylacetamide_deacetylase,IPR029058:AB_hydrolase,IPR033140:Lipase_GDXG_put_SER_AS,			PIRSF037251:Arylacetamide_deacetylase,		KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Alpha/beta hydrolase fold-3,MOTIF:Involved in the stabilization of the negatively charged intermediate by the formation of the oxyanion hole,MUTAGEN:D->K: Inverted topology; when associated with I-3; Q-27 and Q-28, or with I-3; K-27 and K-28.,MUTAGEN:EE->KK,QQ: No effect on topology; when associated with K-24. Inverted topology; when associated with I-3 and K-24.,MUTAGEN:K->I: No effect on membrane topology. Inverted topology; when associated with N-24; Q-27 and Q-28, or with N-24; K-27 and K-28.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P51689	arylsulfatase D(ARSD)	Homo sapiens				GO:0005764~lysosome,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,	GO:0004065~arylsulfatase activity,GO:0008484~sulfuric ester hydrolase activity,GO:0046872~metal ion binding,	IPR000917:Sulfatase_N,IPR017850:Alkaline_phosphatase_core_sf,IPR024607:Sulfatase_CS,						KW-0458~Lysosome,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,	ACT_SITE:Nucleophile,BINDING:via 3-oxoalanine,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Sulfatase N-terminal,TRANSMEM:Helical,
Q32KI9	arylsulfatase i(Arsi)	Mus musculus				GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,	GO:0008484~sulfuric ester hydrolase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000917:Sulfatase_N,IPR017850:Alkaline_phosphatase_core_sf,IPR024607:Sulfatase_CS,IPR047115:ARSB,						KW-0256~Endoplasmic reticulum,KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,	ACT_SITE:Nucleophile,BINDING:via 3-oxoalanine,CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,
Q7L266	asparaginase and isoaspartyl peptidase 1(ASRGL1)	Homo sapiens			GO:0016540~protein autoprocessing,GO:0033345~asparagine catabolic process via L-aspartate,	GO:0001917~photoreceptor inner segment,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004067~asparaginase activity,GO:0008798~beta-aspartyl-peptidase activity,GO:0016787~hydrolase activity,	IPR000246:Peptidase_T2,IPR029055:Ntn_hydrolases_N,IPR033844:ASRGL1_meta,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa01100:Metabolic pathways,					KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,	KW-0007~Acetylation,KW-0068~Autocatalytic cleavage,	ACT_SITE:Nucleophile,COMPBIAS:Basic and acidic residues,MUTAGEN:T->A,C: Abolishes activation by autocleavage. Abolishes enzyme activity.,MUTAGEN:T->S: Strongly reduced enzyme activity.,REGION:Disordered,SITE:Cleavage; by autolysis,
Q5BKW9	asparaginase and isoaspartyl peptidase 1(asrgl1)	Danio rerio			GO:0006508~proteolysis,GO:0016540~protein autoprocessing,GO:0033345~asparagine catabolic process via L-aspartate,	GO:0001917~photoreceptor inner segment,GO:0005737~cytoplasm,	GO:0004067~asparaginase activity,GO:0008233~peptidase activity,GO:0008798~beta-aspartyl-peptidase activity,GO:0016787~hydrolase activity,	IPR000246:Peptidase_T2,IPR029055:Ntn_hydrolases_N,IPR033844:ASRGL1_meta,	dre00250:Alanine, aspartate and glutamate metabolism,dre01100:Metabolic pathways,					KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,	KW-0068~Autocatalytic cleavage,	ACT_SITE:Nucleophile,SITE:Cleavage; by autolysis,
O88202	asparaginase(Aspg)	Rattus norvegicus			GO:0006528~asparagine metabolic process,GO:0006644~phospholipid metabolic process,GO:0009066~aspartate family amino acid metabolic process,GO:0016042~lipid catabolic process,		GO:0003847~1-alkyl-2-acetylglycerophosphocholine esterase activity,GO:0004067~asparaginase activity,GO:0004622~lysophospholipase activity,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,	IPR002110:Ankyrin_rpt,IPR006033:AsnA_fam,IPR006034:Asparaginase/glutaminase-like,IPR027473:L-asparaginase_C,IPR027474:L-asparaginase_N,IPR027475:Asparaginase/glutaminase_AS2,IPR036152:Asp/glu_Ase-like_sf,IPR036770:Ankyrin_rpt-contain_sf,IPR037152:L-asparaginase_N_sf,IPR040919:Asparaginase_C,IPR041725:L-asparaginase_I,			PIRSF001220:L-ASNase_gatD,PIRSF500176:L_ASNase,	SM00248:ANK,SM00870:Asparaginase,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,				KW-0040~ANK repeat,KW-0677~Repeat,		KW-0012~Acyltransferase,KW-0378~Hydrolase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Acyl-ester intermediate,DOMAIN:Asparaginase/glutaminase,DOMAIN:Asparaginase/glutaminase C-terminal,DOMAIN:L-asparaginase N-terminal,REGION:Asparaginase,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,
Q2KJG3	asparaginyl-tRNA synthetase 1(NARS1)	Bos taurus			GO:0006421~asparaginyl-tRNA aminoacylation,GO:0016477~cell migration,GO:0021987~cerebral cortex development,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031090~organelle membrane,	GO:0003676~nucleic acid binding,GO:0004816~asparagine-tRNA ligase activity,GO:0005524~ATP binding,GO:0031728~CCR3 chemokine receptor binding,GO:0046983~protein dimerization activity,	IPR002312:Asp/Asn-tRNA-synth_IIb,IPR004364:Aa-tRNA-synt_II,IPR004365:NA-bd_OB_tRNA,IPR004522:Asn-tRNA-ligase,IPR006195:aa-tRNA-synth_II,IPR012340:NA-bd_OB-fold,IPR045864:aa-tRNA-synth_II/BPL/LPL,IPR048952:AsnRS_N,	bta00970:Aminoacyl-tRNA biosynthesis,				KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Aminoacyl-transfer RNA synthetases class-II family profile,REGION:Disordered,
Q6DHI0	aspartoacylase (aminocyclase) 3, tandem duplicate 1(acy3.1)	Danio rerio				GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,	GO:0004046~aminoacylase activity,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0046872~metal ion binding,	IPR007036:Aste_AspA,IPR016708:Aspartoacylase,			PIRSF018001:Aspartoacylase,			KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,
A8KB34	aspartoacylase(aspa)	Danio rerio				GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0019807~aspartoacylase activity,GO:0046872~metal ion binding,	IPR007036:Aste_AspA,IPR016708:Aspartoacylase,	dre00250:Alanine, aspartate and glutamate metabolism,dre00340:Histidine metabolism,dre01100:Metabolic pathways,		PIRSF018001:Aspartoacylase,			KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,
Q1LYL8	asteroid homolog 1a(aste1a)	Danio rerio						IPR026832:Asteroid,IPR029060:PIN-like_dom_sf,
Q9ULK2	ataxin 7 like 1(ATXN7L1)	Homo sapiens					GO:0005515~protein binding,	IPR013243:SCA7_dom,													COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SCA7,REGION:Disordered,
Q91819	aurora kinase A S homeolog(aurka.S)	Xenopus laevis			GO:0000212~meiotic spindle organization,GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007098~centrosome cycle,GO:0007100~mitotic centrosome separation,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0046777~protein autophosphorylation,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0090307~mitotic spindle assembly,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019894~kinesin binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR030611:AURKA,IPR030616:Aur-like,	xla04114:Oocyte meiosis,xla04914:Progesterone-mediated oocyte maturation,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Protein kinase,REGION:Activation segment,REGION:Disordered,
Q6NW76	aurora kinase B(aurkb)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000226~microtubule cytoskeleton organization,GO:0000281~mitotic cytokinesis,GO:0002903~negative regulation of B cell apoptotic process,GO:0006468~protein phosphorylation,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0009838~abscission,GO:0016310~phosphorylation,GO:0032465~regulation of cytokinesis,GO:0032466~negative regulation of cytokinesis,GO:0032467~positive regulation of cytokinesis,GO:0034501~protein localization to kinetochore,GO:0034644~cellular response to UV,GO:0036089~cleavage furrow formation,GO:0043687~post-translational protein modification,GO:0044878~mitotic cytokinesis checkpoint,GO:0051256~mitotic spindle midzone assembly,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005876~spindle microtubule,GO:0030496~midbody,GO:0031616~spindle pole centrosome,GO:0032133~chromosome passenger complex,GO:0051233~spindle midzone,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR030616:Aur-like,	dre03083:Polycomb repressive complex,dre04110:Cell cycle,			SM00220:S_TKc,	KW-0159~Chromosome partition,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-9996~Developmental protein,		ACT_SITE:Proton acceptor,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Protein kinase,REGION:Disordered,
Q3T0W7	autophagy related 12(ATG12)	Bos taurus			GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006501~C-terminal protein lipidation,GO:0044804~nucleophagy,GO:0045087~innate immune response,	GO:0005737~cytoplasm,GO:0034045~pre-autophagosomal structure membrane,GO:0034274~Atg12-Atg5-Atg16 complex,		IPR007242:Atg12,IPR029071:Ubiquitin-like_domsf,	bta04068:FoxO signaling pathway,bta04136:Autophagy - other,bta04140:Autophagy - animal,bta04621:NOD-like receptor signaling pathway,bta04622:RIG-I-like receptor signaling pathway,				KW-0072~Autophagy,KW-0391~Immunity,KW-0399~Innate immunity,KW-0833~Ubl conjugation pathway,	KW-0472~Membrane,KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor protein),REGION:Disordered,
Q5RE28	autophagy related 13(ATG13)	Pongo abelii			GO:0000045~autophagosome assembly,GO:0000423~macromitophagy,GO:0008285~negative regulation of cell proliferation,GO:0010508~positive regulation of autophagy,GO:0034497~protein localization to pre-autophagosomal structure,GO:0034727~piecemeal microautophagy of nucleus,GO:0098780~response to mitochondrial depolarisation,GO:1903059~regulation of protein lipidation,	GO:0000407~pre-autophagosomal structure,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0034045~pre-autophagosomal structure membrane,GO:1990316~ATG1/ULK1 kinase complex,	GO:0019901~protein kinase binding,GO:0043539~protein serine/threonine kinase activator activity,	IPR018731:Atg13_N,IPR036570:HORMA_dom_sf,IPR040182:ATG13,	pon04136:Autophagy - other,pon04140:Autophagy - animal,pon04211:Longevity regulating pathway,pon05010:Alzheimer disease,pon05014:Amyotrophic lateral sclerosis,pon05016:Huntington disease,pon05017:Spinocerebellar ataxia,pon05022:Pathways of neurodegeneration - multiple diseases,				KW-0072~Autophagy,	KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Autophagy-related protein 13 N-terminal,MOTIF:LIR,REGION:Disordered,
Q8CDJ3	autophagy related 14(Atg14)	Mus musculus			GO:0000045~autophagosome assembly,GO:0000423~macromitophagy,GO:0001932~regulation of protein phosphorylation,GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0006622~protein targeting to lysosome,GO:0006914~autophagy,GO:0008333~endosome to lysosome transport,GO:0009267~cellular response to starvation,GO:0010608~posttranscriptional regulation of gene expression,GO:0016236~macroautophagy,GO:0016240~autophagosome docking,GO:0016241~regulation of macroautophagy,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0042149~cellular response to glucose starvation,GO:0043491~protein kinase B signaling,GO:0045022~early endosome to late endosome transport,GO:0090207~regulation of triglyceride metabolic process,GO:0097352~autophagosome maturation,GO:0098780~response to mitochondrial depolarisation,	GO:0000407~pre-autophagosomal structure,GO:0000421~autophagosome membrane,GO:0005737~cytoplasm,GO:0005776~autophagosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005930~axoneme,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0034045~pre-autophagosomal structure membrane,GO:0035032~phosphatidylinositol 3-kinase complex, class III,GO:0044233~ER-mitochondrion membrane contact site,GO:0045335~phagocytic vesicle,GO:0097629~extrinsic component of omegasome membrane,GO:0097632~extrinsic component of pre-autophagosomal structure membrane,	GO:0005515~protein binding,GO:0043495~protein anchor,GO:0051020~GTPase binding,	IPR018791:UV_resistance/autophagy_Atg14,	mmu04140:Autophagy - animal,mmu05010:Alzheimer disease,mmu05014:Amyotrophic lateral sclerosis,mmu05016:Huntington disease,mmu05017:Spinocerebellar ataxia,mmu05022:Pathways of neurodegeneration - multiple diseases,mmu05167:Kaposi sarcoma-associated herpesvirus infection,				KW-0072~Autophagy,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	REGION:BATS,REGION:Disordered,
Q28ER3	baculoviral IAP repeat containing 5 like(birc5l)	Xenopus tropicalis			GO:0001944~vasculature development,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0031398~positive regulation of protein ubiquitination,GO:0043066~negative regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051301~cell division,GO:0051726~regulation of cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0030496~midbody,GO:0032133~chromosome passenger complex,	GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0046872~metal ion binding,GO:0046965~retinoid X receptor binding,GO:0061630~ubiquitin protein ligase activity,	IPR001370:BIR_rpt,	xtr04210:Apoptosis,			SM00238:BIR,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	REPEAT:BIR,
O35780	basic helix-loop-helix family, member e40(Bhlhe40)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0007623~circadian rhythm,GO:0009416~response to light stimulus,GO:0009952~anterior/posterior pattern specification,GO:0032922~circadian regulation of gene expression,GO:0042752~regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048168~regulation of neuronal synaptic plasticity,GO:0050767~regulation of neurogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016604~nuclear body,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0019904~protein domain specific binding,GO:0042803~protein homodimerization activity,GO:0043425~bHLH transcription factor binding,GO:0043426~MRF binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0070888~E-box binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR003650:Orange_dom,IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,	rno04710:Circadian rhythm,			SM00353:HLH,SM00511:ORANGE,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1, SUMO2 and SUMO3),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1, SUMO2 and SUMO3); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:BHLH,DOMAIN:Orange,DOMAIN:bHLH,REGION:Disordered,REGION:Essential for interaction with BMAL1, E-box binding and repressor activity against the CLOCK-BMAL1 heterodimer,REGION:Necessary for interaction with RXRA and repressor activity against RXRA,
Q64152	basic transcription factor 3(Btf3)	Mus musculus			GO:0001701~in utero embryonic development,GO:0015031~protein transport,GO:1905551~negative regulation of protein localization to endoplasmic reticulum,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005854~nascent polypeptide-associated complex,GO:0042788~polysomal ribosome,		IPR002715:Nas_poly-pep-assoc_cplx_dom,IPR038187:NAC_A/B_dom_sf,IPR039370:BTF3,				SM01407:NAC,	KW-0653~Protein transport,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0143~Chaperone,	KW-0488~Methylation,KW-0597~Phosphoprotein,	DOMAIN:NAC-A/B,REGION:Disordered,
O43825	beta-1,3-galactosyltransferase 2(B3GALT2)	Homo sapiens		h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,	GO:0006486~protein glycosylation,GO:0006493~protein O-linked glycosylation,GO:0006682~galactosylceramide biosynthetic process,GO:0009312~oligosaccharide biosynthetic process,	GO:0000139~Golgi membrane,GO:0016020~membrane,	GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0047275~glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,	IPR002659:Glyco_trans_31,IPR045821:B3GT2_N,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,				KW-0443~Lipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0464~Manganese,	KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P58158	beta-1,3-glucuronyltransferase 3(B3gat3)	Mus musculus			GO:0005975~carbohydrate metabolic process,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006486~protein glycosylation,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0043085~positive regulation of catalytic activity,GO:0050650~chondroitin sulfate proteoglycan biosynthetic process,GO:0050651~dermatan sulfate proteoglycan biosynthetic process,GO:0090316~positive regulation of intracellular protein transport,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0016020~membrane,	GO:0015018~galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,GO:0015020~glucuronosyltransferase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0072542~protein phosphatase activator activity,	IPR005027:Glyco_trans_43,IPR029044:Nucleotide-diphossugar_trans,	mmu00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,mmu00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,mmu01100:Metabolic pathways,					KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0464~Manganese,KW-0479~Metal-binding,	KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,REGION:Disordered,REGION:Interaction with galactose moiety of substrate glycoprotein,SITE:Interaction with galactose moiety of substrate glycoprotein,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
O60513	beta-1,4-galactosyltransferase 4(B4GALT4)	Homo sapiens			GO:0001572~lactosylceramide biosynthetic process,GO:0005975~carbohydrate metabolic process,GO:0006486~protein glycosylation,GO:0006643~membrane lipid metabolic process,GO:0018146~keratan sulfate biosynthetic process,GO:0070085~glycosylation,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0032580~Golgi cisterna membrane,	GO:0003945~N-acetyllactosamine synthase activity,GO:0005515~protein binding,GO:0008378~galactosyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0035250~UDP-galactosyltransferase activity,GO:0046872~metal ion binding,	IPR003859:Galactosyl_T,IPR027791:Galactosyl_T_C,IPR027995:Galactosyl_T_N,IPR029044:Nucleotide-diphossugar_trans,	hsa00533:Glycosaminoglycan biosynthesis - keratan sulfate,hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,				KW-0443~Lipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0964~Secreted,			KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0464~Manganese,KW-0479~Metal-binding,	KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Galactosyltransferase C-terminal,DOMAIN:Galactosyltransferase N-terminal,MUTAGEN:T->A: Has no impact on N-glycosylation.,MUTAGEN:T->A: Has no impact on localization to the Golgi apparatus. Decreases N-glycosylation. Impairs the catalytic activity. Impairs keratan sulfate biosynthesis; when associated with A-337.,MUTAGEN:T->A: Impairs localization to the Golgi apparatus. Abolishes N-glycosylation. Impairs the interaction with SLC35A/UGT1. Impairs the catalytic activity. Impairs keratan sulfate biosynthesis; when associated with A-222.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P56819	beta-secretase 1(Bace1)	Rattus norvegicus			GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0010288~response to lead ion,GO:0016485~protein processing,GO:0034205~beta-amyloid formation,GO:0042987~amyloid precursor protein catabolic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0050435~beta-amyloid metabolic process,GO:0050804~modulation of synaptic transmission,GO:0050966~detection of mechanical stimulus involved in sensory perception of pain,GO:0060134~prepulse inhibition,GO:0071280~cellular response to copper ion,GO:0071287~cellular response to manganese ion,GO:1904646~cellular response to beta-amyloid,	GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005771~multivesicular body,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0009986~cell surface,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0043025~neuronal cell body,GO:0045121~membrane raft,GO:0055037~recycling endosome,GO:0098686~hippocampal mossy fiber to CA3 synapse,GO:0098793~presynapse,	GO:0001540~beta-amyloid binding,GO:0004175~endopeptidase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0008233~peptidase activity,GO:0019899~enzyme binding,	IPR001461:Aspartic_peptidase_A1,IPR001969:Aspartic_peptidase_AS,IPR009119:BACE,IPR009120:BACE1,IPR021109:Peptidase_aspartic_dom_sf,IPR033121:PEPTIDASE_A1,IPR033874:Memapsin-like,	rno05010:Alzheimer disease,					KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0966~Cell projection,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0064~Aspartyl protease,KW-0378~Hydrolase,KW-0645~Protease,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0865~Zymogen,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Peptidase A1,LIPID:S-palmitoyl cysteine,MOTIF:DXXLL,REGION:Interaction with RTN3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q32LQ4	betaine-homocysteine methyltransferase(bhmt)	Danio rerio			GO:0003323~type B pancreatic cell development,GO:0006579~amino-acid betaine catabolic process,GO:0009086~methionine biosynthetic process,GO:0032259~methylation,GO:0055123~digestive system development,GO:0071267~L-methionine salvage,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0047150~betaine-homocysteine S-methyltransferase activity,	IPR003726:HCY_dom,IPR017226:Betaine-hCys_S-MeTrfase_BHMT,IPR036589:HCY_dom_sf,	dre00260:Glycine, serine and threonine metabolism,dre00270:Cysteine and methionine metabolism,dre01100:Metabolic pathways,		PIRSF037505:Betaine_HMT,			KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:Hcy-binding,
P07738	bisphosphoglycerate mutase(BPGM)	Homo sapiens			GO:0005975~carbohydrate metabolic process,GO:0006096~glycolytic process,GO:0006753~nucleoside phosphate metabolic process,GO:0007585~respiratory gaseous exchange,GO:0015671~oxygen transport,GO:0042832~defense response to protozoan,GO:0048821~erythrocyte development,GO:0060856~establishment of blood-brain barrier,GO:1901136~carbohydrate derivative catabolic process,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004082~bisphosphoglycerate mutase activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0016868~intramolecular transferase activity, phosphotransferases,GO:0046538~2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,	IPR001345:PG/BPGM_mutase_AS,IPR005952:Phosphogly_mut1,IPR013078:His_Pase_superF_clade-1,IPR029033:His_PPase_superfam,	hsa00010:Glycolysis / Gluconeogenesis,hsa00260:Glycine, serine and threonine metabolism,hsa01100:Metabolic pathways,	222800~Erythrocytosis, familial, 8,	PIRSF000709:6PFK_2-Ptase,	SM00855:PGAM,	KW-0324~Glycolysis,			KW-0225~Disease variant,KW-0360~Hereditary hemolytic anemia,KW-0985~Congenital erythrocytosis,			KW-0378~Hydrolase,KW-0413~Isomerase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0971~Glycation,	ACT_SITE:Proton donor/acceptor,ACT_SITE:Tele-phosphohistidine intermediate,CARBOHYD:N-linked (Glc) (glycation) lysine,CARBOHYD:N-linked (Glc) (glycation) lysine; in vitro,SITE:Not glycated,SITE:Transition state stabilizer,
P98063	bone morphogenetic protein 1(Bmp1)	Mus musculus			GO:0001503~ossification,GO:0006508~proteolysis,GO:0007275~multicellular organism development,GO:0009953~dorsal/ventral pattern formation,GO:0016485~protein processing,GO:0030154~cell differentiation,GO:0051216~cartilage development,GO:0061036~positive regulation of cartilage development,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0031982~vesicle,	GO:0004222~metalloendopeptidase activity,GO:0005125~cytokine activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR000859:CUB_dom,IPR001506:Peptidase_M12A,IPR001881:EGF-like_Ca-bd_dom,IPR006026:Peptidase_Metallo,IPR015446:BMP_1/tolloid-like,IPR018097:EGF_Ca-bd_CS,IPR024079:MetalloPept_cat_dom_sf,IPR034036:ZnMP_TLD/BMP1,IPR035914:Sperma_CUB_dom_sf,			PIRSF001199:BMP_1/tolloid-like,	SM00042:CUB,SM00179:EGF_CA,SM00181:EGF,SM00235:ZnMc,	KW-0221~Differentiation,KW-0891~Chondrogenesis,KW-0892~Osteogenesis,	KW-0272~Extracellular matrix,KW-0333~Golgi apparatus,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0202~Cytokine,KW-0217~Developmental protein,KW-0339~Growth factor,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,KW-9996~Developmental protein,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0488~Methylation,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:CUB,DOMAIN:CUB 1,DOMAIN:CUB 2,DOMAIN:CUB 3,DOMAIN:CUB 4,DOMAIN:CUB 5,DOMAIN:EGF-like,DOMAIN:EGF-like 1; calcium-binding,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:Peptidase M12A,REGION:Disordered,
O95393	bone morphogenetic protein 10(BMP10)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,	GO:0001822~kidney development,GO:0007155~cell adhesion,GO:0007512~adult heart development,GO:0010596~negative regulation of endothelial cell migration,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0010614~negative regulation of cardiac muscle hypertrophy,GO:0010628~positive regulation of gene expression,GO:0030308~negative regulation of cell growth,GO:0030336~negative regulation of cell migration,GO:0030509~BMP signaling pathway,GO:0032924~activin receptor signaling pathway,GO:0045214~sarcomere organization,GO:0045893~positive regulation of transcription, DNA-templated,GO:0055009~atrial cardiac muscle tissue morphogenesis,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0055015~ventricular cardiac muscle cell development,GO:0055117~regulation of cardiac muscle contraction,GO:0060038~cardiac muscle cell proliferation,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060298~positive regulation of sarcomere organization,GO:0060347~heart trabecula formation,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0061036~positive regulation of cartilage development,GO:1903242~regulation of cardiac muscle hypertrophy in response to stress,GO:2000138~positive regulation of cell proliferation involved in heart morphogenesis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0030018~Z disc,	GO:0005125~cytokine activity,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0031433~telethonin binding,GO:0033612~receptor serine/threonine kinase binding,	IPR001111:TGF-b_propeptide,IPR001839:TGF-b_C,IPR015615:TGF-beta-rel,IPR017948:TGFb_CS,IPR029034:Cystine-knot_cytokine,	hsa04060:Cytokine-cytokine receptor interaction,			SM00204:TGFB,	KW-0130~Cell adhesion,	KW-0964~Secreted,			KW-0732~Signal,		KW-0202~Cytokine,KW-0217~Developmental protein,KW-0339~Growth factor,KW-9996~Developmental protein,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,
Q04906	bone morphogenetic protein 6(Bmp6)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0001654~eye development,GO:0001822~kidney development,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001958~endochondral ossification,GO:0003323~type B pancreatic cell development,GO:0006879~cellular iron ion homeostasis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0010039~response to iron ion,GO:0010628~positive regulation of gene expression,GO:0014823~response to activity,GO:0030182~neuron differentiation,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0030539~male genitalia development,GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway,GO:0032026~response to magnesium ion,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032349~positive regulation of aldosterone biosynthetic process,GO:0032526~response to retinoic acid,GO:0043117~positive regulation of vascular permeability,GO:0045595~regulation of cell differentiation,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051216~cartilage development,GO:0051384~response to glucocorticoid,GO:0060348~bone development,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0060395~SMAD protein signal transduction,GO:0060586~multicellular organismal iron ion homeostasis,GO:0071260~cellular response to mechanical stimulus,GO:0071281~cellular response to iron ion,GO:0071773~cellular response to BMP stimulus,GO:1903392~negative regulation of adherens junction organization,GO:2000048~negative regulation of cell-cell adhesion mediated by cadherin,GO:2000860~positive regulation of aldosterone secretion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031982~vesicle,	GO:0005125~cytokine activity,GO:0008083~growth factor activity,GO:0046982~protein heterodimerization activity,GO:0070700~BMP receptor binding,	IPR001111:TGF-b_propeptide,IPR001839:TGF-b_C,IPR015615:TGF-beta-rel,IPR017948:TGFb_CS,IPR029034:Cystine-knot_cytokine,	rno04060:Cytokine-cytokine receptor interaction,rno04350:TGF-beta signaling pathway,rno04390:Hippo signaling pathway,rno04913:Ovarian steroidogenesis,			SM00204:TGFB,	KW-0221~Differentiation,KW-0891~Chondrogenesis,KW-0892~Osteogenesis,	KW-0964~Secreted,			KW-0732~Signal,		KW-0202~Cytokine,KW-0217~Developmental protein,KW-0339~Growth factor,KW-9996~Developmental protein,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DISULFID:Interchain,DOMAIN:TGF-beta family profile,REGION:Disordered,
P34820	bone morphogenetic protein 8b(BMP8B)	Homo sapiens			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0007165~signal transduction,GO:0030154~cell differentiation,GO:0051216~cartilage development,	GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0008083~growth factor activity,	IPR001111:TGF-b_propeptide,IPR001839:TGF-b_C,IPR015615:TGF-beta-rel,IPR017948:TGFb_CS,IPR029034:Cystine-knot_cytokine,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04714:Thermogenesis,			SM00204:TGFB,	KW-0221~Differentiation,KW-0891~Chondrogenesis,KW-0892~Osteogenesis,	KW-0964~Secreted,			KW-0732~Signal,		KW-0202~Cytokine,KW-0217~Developmental protein,KW-0339~Growth factor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,
O00238	bone morphogenetic protein receptor type 1B(BMPR1B)	Homo sapiens			GO:0001502~cartilage condensation,GO:0001550~ovarian cumulus expansion,GO:0001649~osteoblast differentiation,GO:0001654~eye development,GO:0002063~chondrocyte development,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0009953~dorsal/ventral pattern formation,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016310~phosphorylation,GO:0021953~central nervous system neuron differentiation,GO:0030166~proteoglycan biosynthetic process,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0031290~retinal ganglion cell axon guidance,GO:0032332~positive regulation of chondrocyte differentiation,GO:0042698~ovulation cycle,GO:0045669~positive regulation of osteoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0060041~retina development in camera-type eye,GO:0060350~endochondral bone morphogenesis,GO:0061036~positive regulation of cartilage development,GO:0071363~cellular response to growth factor stimulus,GO:0071773~cellular response to BMP stimulus,GO:0080090~regulation of primary metabolic process,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902731~negative regulation of chondrocyte proliferation,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043235~receptor complex,GO:0098802~plasma membrane receptor complex,GO:1990712~HFE-transferrin receptor complex,	GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004888~transmembrane signaling receptor activity,GO:0005025~transforming growth factor beta receptor activity, type I,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0036122~BMP binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0098821~BMP receptor activity,	IPR000333:TGFB_receptor,IPR000472:Activin_recp,IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR003605:GS_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR045860:Snake_toxin-like_sf,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04360:Axon guidance,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05418:Fluid shear stress and atherosclerosis,	112600~Brachydactyly, type A2,609441~Acromesomelic dysplasia 3,616849~Brachydactyly, type A1, D,		SM00220:S_TKc,SM00467:GS,	KW-0891~Chondrogenesis,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0242~Dwarfism,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,DOMAIN:Activin types I and II receptor,DOMAIN:GS,DOMAIN:Protein kinase,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8HZN9	bradykinin receptor B1(BDKRB1)	Sus scrofa			GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0009612~response to mechanical stimulus,GO:0019371~cyclooxygenase pathway,GO:0030593~neutrophil chemotaxis,GO:0060085~smooth muscle relaxation of the bladder outlet,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004947~bradykinin receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000496:Brdyknn_rcpt,IPR001186:Brdyknn_1_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	ssc04020:Calcium signaling pathway,ssc04080:Neuroactive ligand-receptor interaction,ssc04610:Complement and coagulation cascades,ssc04750:Inflammatory mediator regulation of TRP channels,ssc04810:Regulation of actin cytoskeleton,ssc05200:Pathways in cancer,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,LIPID:S-palmitoyl cysteine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q90ZY4	brain specific kinase 146(bsk146)	Danio rerio			GO:0016310~phosphorylation,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR016234:Ser/Thr_kinase_Sbk1,			PIRSF000566:Ser/Thr_PK_Sbk1,	SM00220:S_TKc,		KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,		ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,MUTAGEN:K->R: Loss of activity.,REGION:Disordered,
Q90ZY4	brain specific kinase 146-like(LOC791840)	Danio rerio			GO:0016310~phosphorylation,	GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR016234:Ser/Thr_kinase_Sbk1,			PIRSF000566:Ser/Thr_PK_Sbk1,	SM00220:S_TKc,		KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,		ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,MUTAGEN:K->R: Loss of activity.,REGION:Disordered,
Q9GKM4	branched chain amino acid transaminase 1(BCAT1)	Ovis aries			GO:0006629~lipid metabolic process,GO:0008652~cellular amino acid biosynthetic process,GO:0009082~branched-chain amino acid biosynthetic process,GO:0009098~leucine biosynthetic process,GO:0009099~valine biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0004084~branched-chain-amino-acid transaminase activity,GO:0050048~L-leucine:2-oxoglutarate aminotransferase activity,GO:0052654~L-leucine transaminase activity,GO:0052655~L-valine transaminase activity,GO:0052656~L-isoleucine transaminase activity,	IPR001544:Aminotrans_IV,IPR005786:B_amino_transII,IPR018300:Aminotrans_IV_CS,IPR033939:BCAT_family,IPR036038:Aminotransferase-like,IPR043131:BCAT-like_N,IPR043132:BCAT-like_C,	oas00270:Cysteine and methionine metabolism,oas00280:Valine, leucine and isoleucine degradation,oas00290:Valine, leucine and isoleucine biosynthesis,oas00770:Pantothenate and CoA biosynthesis,oas01100:Metabolic pathways,oas01210:2-Oxocarboxylic acid metabolism,oas01230:Biosynthesis of amino acids,oas01240:Biosynthesis of cofactors,		PIRSF006468:BCAT1,		KW-0028~Amino-acid biosynthesis,KW-0100~Branched-chain amino acid biosynthesis,KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,				KW-0663~Pyridoxal phosphate,	KW-0032~Aminotransferase,KW-0808~Transferase,		REGION:Disordered,
Q14667	bridge-like lipid transfer protein family member 2(BLTP2)	Homo sapiens				GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031966~mitochondrial membrane,	GO:0035091~phosphatidylinositol binding,	IPR019439:FMP27/BLTP2_N,IPR019441:FMP27/BLTP2/Hobbit_GFWDK_RBG,IPR019443:BLTP2/FMP27/Hobbit_C,IPR042314:TMEM121,IPR045167:Hobbit,IPR048872:BLTP2_RBG6,				SM01214:Fmp27_GFWDK,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:FMP27/BLTP2/Hobbit GFWDK motif-containing RBG unit,REGION:Disordered,REGION:Transmembrane domain,
Q13410	butyrophilin subfamily 1 member A1(BTN1A1)	Homo sapiens			GO:0001817~regulation of cytokine production,GO:0050852~T cell receptor signaling pathway,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0038023~signaling receptor activity,	IPR001870:B30.2/SPRY,IPR003599:Ig_sub,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013162:CD80_C2-set,IPR013320:ConA-like_dom_sf,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR037958:SPRY/PRY_BTN1/2,IPR043136:B30.2/SPRY_sf,				SM00406:IGv,SM00409:IG,SM00449:SPRY,SM00589:PRY,		KW-0472~Membrane,KW-0964~Secreted,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:B30.2/SPRY,DOMAIN:Ig-like,DOMAIN:Ig-like V-type 1,DOMAIN:Ig-like V-type 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q0IIP8	c-reactive protein, pentraxin-related 5(crp5)	Danio rerio			GO:0006953~acute-phase response,GO:0051607~defense response to virus,	GO:0005576~extracellular region,	GO:0015485~cholesterol binding,GO:0046872~metal ion binding,	IPR001759:Pentraxin-related,IPR013320:ConA-like_dom_sf,				SM00159:PTX,	KW-0011~Acute phase,	KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-1015~Disulfide bond,	DOMAIN:Pentraxin (PTX),
Q1LYG4	cAMP responsive element binding protein 3-like 3a(creb3l3a)	Danio rerio			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR004827:bZIP,IPR046347:bZIP_sf,	dre04261:Adrenergic signaling in cardiomyocytes,dre04916:Melanogenesis,			SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,SITE:Cleavage; by PS1,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q1LYG4	cAMP responsive element binding protein 3-like 3b(creb3l3b)	Danio rerio			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR004827:bZIP,IPR046347:bZIP_sf,	dre04261:Adrenergic signaling in cardiomyocytes,dre04916:Melanogenesis,			SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,SITE:Cleavage; by PS1,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q02930	cAMP responsive element binding protein 5(CREB5)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0035497~cAMP response element binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR004827:bZIP,IPR013087:Znf_C2H2_type,IPR016378:TF_CRE-BP1-typ,IPR036236:Znf_C2H2_sf,IPR046347:bZIP_sf,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04211:Longevity regulating pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04668:TNF signaling pathway,hsa04714:Thermogenesis,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04911:Insulin secretion,hsa04915:Estrogen signaling pathway,hsa04918:Thyroid hormone synthesis,hsa04922:Glucagon signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa04926:Relaxin signaling pathway,hsa04927:Cortisol synthesis and secretion,hsa04928:Parathyroid hormone synthesis, secretion and action,hsa04931:Insulin resistance,hsa04934:Cushing syndrome,hsa04935:Growth hormone synthesis, secretion and action,hsa04962:Vasopressin-regulated water reabsorption,hsa05016:Huntington disease,hsa05020:Prion disease,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05161:Hepatitis B,hsa05163:Human cytomegalovirus infection,hsa05165:Human papillomavirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05203:Viral carcinogenesis,hsa05207:Chemical carcinogenesis - receptor activation,hsa05215:Prostate cancer,		PIRSF003153:ATF2_CRE-BP1,	SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BZIP,DOMAIN:C2H2-type,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,ZN_FING:C2H2-type,
Q5VU97	cache domain containing 1(CACHD1)	Homo sapiens			GO:0006816~calcium ion transport,GO:0070588~calcium ion transmembrane transport,	GO:0005891~voltage-gated calcium channel complex,GO:0016020~membrane,	GO:0005245~voltage-gated calcium channel activity,	IPR002035:VWF_A,IPR029151:Sensor-like_sf,IPR036465:vWFA_dom_sf,					KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Cache 1,DOMAIN:Cache 2,DOMAIN:VWFA,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P55288	cadherin 11(Cdh11)	Mus musculus			GO:0000902~cell morphogenesis,GO:0007043~cell-cell junction assembly,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007275~multicellular organism development,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0021957~corticospinal tract morphogenesis,GO:0030336~negative regulation of cell migration,GO:0034332~adherens junction organization,GO:0044331~cell-cell adhesion mediated by cadherin,GO:0048041~focal adhesion assembly,GO:0050804~modulation of synaptic transmission,GO:0098609~cell-cell adhesion,GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0016020~membrane,GO:0016342~catenin complex,GO:0045202~synapse,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098978~glutamatergic synapse,	GO:0005509~calcium ion binding,GO:0045296~cadherin binding,GO:0046872~metal ion binding,	IPR000233:Cadherin_Y-type_LIR,IPR002126:Cadherin-like_dom,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,IPR027397:Catenin-bd_sf,IPR039808:Cadherin,				SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O88338	cadherin 16(Cdh16)	Mus musculus			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,	GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR002126:Cadherin-like_dom,IPR015919:Cadherin-like_sf,IPR039808:Cadherin,				SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,REGION:Disordered,REGION:Ectodomain G,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q90275	cadherin 2, type 1, N-cadherin (neuronal)(cdh2)	Danio rerio			GO:0000902~cell morphogenesis,GO:0001502~cartilage condensation,GO:0001755~neural crest cell migration,GO:0001756~somitogenesis,GO:0001764~neuron migration,GO:0001841~neural tube formation,GO:0007043~cell-cell junction assembly,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007158~neuron cell-cell adhesion,GO:0007275~multicellular organism development,GO:0007398~ectoderm development,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0007416~synapse assembly,GO:0007420~brain development,GO:0007422~peripheral nervous system development,GO:0008045~motor neuron axon guidance,GO:0009790~embryo development,GO:0010001~glial cell differentiation,GO:0010002~cardioblast differentiation,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0021511~spinal cord patterning,GO:0021535~cell migration in hindbrain,GO:0021577~hindbrain structural organization,GO:0021591~ventricular system development,GO:0021915~neural tube development,GO:0030154~cell differentiation,GO:0030901~midbrain development,GO:0030902~hindbrain development,GO:0030917~midbrain-hindbrain boundary development,GO:0034332~adherens junction organization,GO:0035118~embryonic pectoral fin morphogenesis,GO:0035142~dorsal fin morphogenesis,GO:0036342~post-anal tail morphogenesis,GO:0042246~tissue regeneration,GO:0042476~odontogenesis,GO:0042478~regulation of eye photoreceptor cell development,GO:0044331~cell-cell adhesion mediated by cadherin,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0048048~embryonic eye morphogenesis,GO:0048331~axial mesoderm structural organization,GO:0048332~mesoderm morphogenesis,GO:0048514~blood vessel morphogenesis,GO:0048699~generation of neurons,GO:0048752~semicircular canal morphogenesis,GO:0050770~regulation of axonogenesis,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0060030~dorsal convergence,GO:0060041~retina development in camera-type eye,GO:0060059~embryonic retina morphogenesis in camera-type eye,GO:0060088~auditory receptor cell stereocilium organization,GO:0060271~cilium assembly,GO:0060429~epithelium development,GO:0070285~pigment cell development,GO:0070654~sensory epithelium regeneration,GO:0071679~commissural neuron axon guidance,GO:0090248~cell migration involved in somitogenic axis elongation,GO:0097150~neuronal stem cell population maintenance,GO:0097475~motor neuron migration,GO:0098609~cell-cell adhesion,GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016342~catenin complex,GO:0030027~lamellipodium,GO:0030057~desmosome,GO:0042383~sarcolemma,GO:0042734~presynaptic membrane,GO:0043005~neuron projection,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0070161~anchoring junction,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0045296~cadherin binding,GO:0046872~metal ion binding,	IPR000233:Cadherin_Y-type_LIR,IPR002126:Cadherin-like_dom,IPR014868:Cadherin_pro_dom,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,IPR027397:Catenin-bd_sf,IPR039808:Cadherin,	dre04514:Cell adhesion molecules,			SM00112:CA,SM01055:Cadherin_pro,	KW-0130~Cell adhesion,KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,MUTAGEN:Missing: In pac(fr7); causes abnormal embryonic brain and tail morphogenesis.,MUTAGEN:Missing: In pac(tm101B); causes abnormal embryonic brain and tail morphogenesis.,MUTAGEN:R->E: Does not display significant adhesive activity alone but mediates cell adhesion with pcdh19.,MUTAGEN:W->A: Does not display significant adhesive activity alone but mediates cell adhesion with pcdh19.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q0P4Y4	calcitonin receptor like receptor(calcrl)	Xenopus tropicalis			GO:0001525~angiogenesis,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0001605~adrenomedullin receptor activity,GO:0001635~calcitonin gene-related peptide receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004948~calcitonin receptor activity,	IPR000832:GPCR_2_secretin-like,IPR001879:GPCR_2_extracellular_dom,IPR003287:GCPR_2_calcitonin_rcpt_fam,IPR003289:GPCR_2_CGRP1_rcpt,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR036445:GPCR_2_extracell_dom_sf,	xtr04080:Neuroactive ligand-receptor interaction,xtr04270:Vascular smooth muscle contraction,			SM00008:HormR,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 2 profile 1,DOMAIN:G-protein coupled receptors family 2 profile 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q68EK2	calcitonin receptor-like a(calcrla)	Danio rerio			GO:0001525~angiogenesis,GO:0001756~somitogenesis,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0048844~artery morphogenesis,GO:0055064~chloride ion homeostasis,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0001605~adrenomedullin receptor activity,GO:0001635~calcitonin gene-related peptide receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004948~calcitonin receptor activity,	IPR000832:GPCR_2_secretin-like,IPR001879:GPCR_2_extracellular_dom,IPR003287:GCPR_2_calcitonin_rcpt_fam,IPR003289:GPCR_2_CGRP1_rcpt,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR036445:GPCR_2_extracell_dom_sf,	dre04080:Neuroactive ligand-receptor interaction,dre04270:Vascular smooth muscle contraction,			SM00008:HormR,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
A2BGD5	calcium binding and coiled-coil domain 1a(calcoco1a)	Danio rerio			GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003713~transcription coactivator activity,	IPR012852:CALCOCO1-like,IPR041611:SKICH,						KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,				COMPBIAS:Polar residues,DOMAIN:Calcium binding and coiled-coil,DOMAIN:SKICH,REGION:Disordered,
Q9N1R0	calcium binding protein 1(CABP1)	Bos taurus			GO:0007601~visual perception,GO:0042308~negative regulation of protein import into nucleus,GO:0050896~response to stimulus,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0048471~perinuclear region of cytoplasm,	GO:0005246~calcium channel regulator activity,GO:0005509~calcium ion binding,GO:0008139~nuclear localization sequence binding,GO:0048306~calcium-dependent protein binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR043582:CaBP1/2/4/5,				SM00054:EFh,	KW-0716~Sensory transduction,KW-0844~Vision,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0770~Synapse,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0449~Lipoprotein,KW-0519~Myristate,KW-0564~Palmitate,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,LIPID:N-myristoyl glycine,LIPID:S-palmitoyl cysteine,REGION:Disordered,
Q6PHS9	calcium channel, voltage-dependent, alpha 2/delta subunit 2(Cacna2d2)	Mus musculus			GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:0007528~neuromuscular junction development,GO:0034220~ion transmembrane transport,GO:0035265~organ growth,GO:0040014~regulation of multicellular organism growth,GO:0046622~positive regulation of organ growth,GO:0055001~muscle cell development,GO:0060024~rhythmic synaptic transmission,GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0016020~membrane,GO:0034702~ion channel complex,	GO:0005245~voltage-gated calcium channel activity,GO:0005262~calcium channel activity,GO:0046872~metal ion binding,	IPR002035:VWF_A,IPR013608:VWA_N,IPR013680:VDCC_a2/dsu,IPR036465:vWFA_dom_sf,	mmu04010:MAPK signaling pathway,mmu04260:Cardiac muscle contraction,mmu04261:Adrenergic signaling in cardiomyocytes,mmu04921:Oxytocin signaling pathway,mmu05410:Hypertrophic cardiomyopathy,mmu05412:Arrhythmogenic right ventricular cardiomyopathy,mmu05414:Dilated cardiomyopathy,			SM00327:VWA,	KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,		KW-0225~Disease variant,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0107~Calcium channel,KW-0407~Ion channel,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DISULFID:Interchain (between alpha-2-2 and delta-2 chains),DOMAIN:Cache,DOMAIN:VWFA,MOTIF:MIDAS-like motif,MUTAGEN:D->A: Abolishes metal-binding and ability to regulate calcium current.,MUTAGEN:R->A: Induces a strong decrease in gabapentin-binding.,MUTAGEN:S->A: Abolishes metal-binding and ability to regulate calcium current.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q3UP38	calcium release activated channel regulator 2A(Cracr2a)	Mus musculus			GO:0002115~store-operated calcium entry,GO:0002250~adaptive immune response,GO:0002376~immune system process,GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:0016197~endosomal transport,GO:0032237~activation of store-operated calcium channel activity,GO:0034776~response to histamine,GO:0045063~T-helper 1 cell differentiation,GO:0046330~positive regulation of JNK cascade,GO:0051928~positive regulation of calcium ion transport,	GO:0000139~Golgi membrane,GO:0001772~immunological synapse,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031982~vesicle,GO:0032588~trans-Golgi network membrane,GO:0033093~Weibel-Palade body,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005509~calcium ion binding,GO:0005525~GTP binding,GO:0046872~metal ion binding,	IPR001806:Small_GTPase,IPR002048:EF_hand_dom,IPR005225:Small_GTP-bd_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR027417:P-loop_NTPase,				SM00054:EFh,SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,SM00177:ARF,	KW-0109~Calcium transport,KW-0391~Immunity,KW-0406~Ion transport,KW-0813~Transport,KW-1064~Adaptive immunity,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,	KW-0106~Calcium,KW-0342~GTP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0636~Prenylation,	COMPBIAS:Polar residues,DOMAIN:EF-hand,LIPID:S-geranylgeranyl cysteine,REGION:Disordered,REGION:Proline-rich domain (PRD) which mediates interaction with VAV1,
P54289	calcium voltage-gated channel auxiliary subunit alpha2delta 1(CACNA2D1)	Homo sapiens			GO:0006816~calcium ion transport,GO:0051924~regulation of calcium ion transport,GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization,GO:0060402~calcium ion transport into cytosol,GO:0061577~calcium ion transmembrane transport via high voltage-gated calcium channel,GO:0086002~cardiac muscle cell action potential involved in contraction,GO:0086048~membrane depolarization during bundle of His cell action potential,GO:0086091~regulation of heart rate by cardiac conduction,GO:0098703~calcium ion import across plasma membrane,GO:0098903~regulation of membrane repolarization during action potential,GO:1901843~positive regulation of high voltage-gated calcium channel activity,GO:1902514~regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,GO:1904646~cellular response to beta-amyloid,	GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0016020~membrane,GO:0016529~sarcoplasmic reticulum,GO:0034702~ion channel complex,GO:0070062~extracellular exosome,GO:0098992~neuronal dense core vesicle,GO:1990454~L-type voltage-gated calcium channel complex,	GO:0005245~voltage-gated calcium channel activity,GO:0005262~calcium channel activity,GO:0046872~metal ion binding,GO:0086007~voltage-gated calcium channel activity involved in cardiac muscle cell action potential,GO:0086057~voltage-gated calcium channel activity involved in bundle of His cell action potential,	IPR002035:VWF_A,IPR013608:VWA_N,IPR013680:VDCC_a2/dsu,IPR036465:vWFA_dom_sf,	hsa04010:MAPK signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04921:Oxytocin signaling pathway,hsa05410:Hypertrophic cardiomyopathy,hsa05412:Arrhythmogenic right ventricular cardiomyopathy,hsa05414:Dilated cardiomyopathy,	620149~Developmental and epileptic encephalopathy 110,		SM00327:VWA,	KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0991~Intellectual disability,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0107~Calcium channel,KW-0407~Ion channel,KW-0675~Receptor,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between alpha-2-1 and delta-1 chains),DOMAIN:Cache,DOMAIN:VWA N-terminal,DOMAIN:VWFA,DOMAIN:Voltage-dependent calcium channel alpha-2/delta subunit conserved region,MOTIF:MIDAS-like motif,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q7Z3S7	calcium voltage-gated channel auxiliary subunit alpha2delta 4(CACNA2D4)	Homo sapiens			GO:0006816~calcium ion transport,GO:0050908~detection of light stimulus involved in visual perception,GO:0070588~calcium ion transmembrane transport,	GO:0005891~voltage-gated calcium channel complex,GO:0016020~membrane,GO:0034702~ion channel complex,	GO:0005245~voltage-gated calcium channel activity,GO:0005262~calcium channel activity,GO:0046872~metal ion binding,	IPR002035:VWF_A,IPR013608:VWA_N,IPR013680:VDCC_a2/dsu,IPR036465:vWFA_dom_sf,	hsa04010:MAPK signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04921:Oxytocin signaling pathway,hsa05410:Hypertrophic cardiomyopathy,hsa05412:Arrhythmogenic right ventricular cardiomyopathy,hsa05414:Dilated cardiomyopathy,	610478~Retinal cone dystrophy 4,		SM00327:VWA,	KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0107~Calcium channel,KW-0407~Ion channel,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between alpha-2-4 and delta-4 chains),DOMAIN:Cache,DOMAIN:VWA N-terminal,DOMAIN:VWFA,DOMAIN:Voltage-dependent calcium channel alpha-2/delta subunit conserved region,MOTIF:MIDAS-like motif,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
D4A055	calcium voltage-gated channel auxiliary subunit beta 4(Cacnb4)	Rattus norvegicus			GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007528~neuromuscular junction development,GO:0007628~adult walking behavior,GO:0008285~negative regulation of cell proliferation,GO:0014051~gamma-aminobutyric acid secretion,GO:0019227~neuronal action potential propagation,GO:0035249~synaptic transmission, glutamatergic,GO:0042391~regulation of membrane potential,GO:0046058~cAMP metabolic process,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048541~Peyer's patch development,GO:0050852~T cell receptor signaling pathway,GO:0050877~neurological system process,GO:0050908~detection of light stimulus involved in visual perception,GO:0055001~muscle cell development,GO:0070588~calcium ion transmembrane transport,GO:0099509~regulation of presynaptic cytosolic calcium ion concentration,GO:1901385~regulation of voltage-gated calcium channel activity,GO:1904751~positive regulation of protein localization to nucleolus,GO:1990830~cellular response to leukemia inhibitory factor,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000300~regulation of synaptic vesicle exocytosis,	GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0016607~nuclear speck,GO:0045202~synapse,GO:0098793~presynapse,GO:0098978~glutamatergic synapse,	GO:0005245~voltage-gated calcium channel activity,GO:0005515~protein binding,GO:0008331~high voltage-gated calcium channel activity,GO:0019901~protein kinase binding,GO:0099626~voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,	IPR000584:VDCC_L_bsu,IPR001452:SH3_domain,IPR008145:GK/Ca_channel_bsu,IPR027417:P-loop_NTPase,IPR036028:SH3-like_dom_sf,IPR046937:CAB1-4_N_A-dom,	rno04010:MAPK signaling pathway,rno04260:Cardiac muscle contraction,rno04261:Adrenergic signaling in cardiomyocytes,rno04921:Oxytocin signaling pathway,rno05410:Hypertrophic cardiomyopathy,rno05412:Arrhythmogenic right ventricular cardiomyopathy,rno05414:Dilated cardiomyopathy,			SM00072:GuKc,					KW-0728~SH3 domain,			KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SH3,REGION:Disordered,
Q96NX5	calcium/calmodulin dependent protein kinase IG(CAMK1G)	Homo sapiens		h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_mitrPathway:Signal Dependent Regulation of Myogenesis by Corepressor MITR,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_pgc1aPathway:Regulation of PGC-1a,	GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005954~calcium- and calmodulin-dependent protein kinase complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,	hsa04020:Calcium signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa05214:Glioma,			SM00220:S_TKc,		KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0112~Calmodulin-binding,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0449~Lipoprotein,KW-0636~Prenylation,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,REGION:Autoinhibitory domain,REGION:Calmodulin-binding,REGION:Disordered,
Q13555	calcium/calmodulin dependent protein kinase II gamma(CAMK2G)	Homo sapiens		h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation,h_crebPathway:Transcription factor CREB and its extracellular signals,h_pgc1aPathway:Regulation of PGC-1a,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,	GO:0007399~nervous system development,GO:0010975~regulation of neuron projection development,GO:0014733~regulation of skeletal muscle adaptation,GO:0016310~phosphorylation,GO:0030073~insulin secretion,GO:0030154~cell differentiation,GO:0051924~regulation of calcium ion transport,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005954~calcium- and calmodulin-dependent protein kinase complex,GO:0016020~membrane,GO:0030666~endocytic vesicle membrane,GO:0033017~sarcoplasmic reticulum membrane,GO:0043005~neuron projection,GO:0043226~organelle,	GO:0004672~protein kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0004723~calcium-dependent protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013543:Ca/CaM-dep_prot_kinase-assoc,IPR017441:Protein_kinase_ATP_BS,IPR032710:NTF2-like_dom_sf,	hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04114:Oocyte meiosis,hsa04148:Efferocytosis,hsa04217:Necroptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04310:Wnt signaling pathway,hsa04360:Axon guidance,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04740:Olfactory transduction,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa04934:Cushing syndrome,hsa04971:Gastric acid secretion,hsa05012:Parkinson disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05031:Amphetamine addiction,hsa05152:Tuberculosis,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05214:Glioma,hsa05415:Diabetic cardiomyopathy,hsa05417:Lipid and atherosclerosis,	618522~Intellectual developmental disorder, autosomal dominant 59,		SM00220:S_TKc,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0703~Sarcoplasmic reticulum,		KW-0991~Intellectual disability,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0112~Calmodulin-binding,KW-0217~Developmental protein,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Calcium/calmodulin-dependent protein kinase II association-domain,DOMAIN:Protein kinase,REGION:Autoinhibitory domain,REGION:Calmodulin-binding,REGION:Disordered,
Q16566	calcium/calmodulin dependent protein kinase IV(CAMK4)	Homo sapiens	103.Ca2-calmodulin_PK_cascade,	h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_pgc1aPathway:Regulation of PGC-1a,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,	GO:0002250~adaptive immune response,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007616~long-term memory,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0033081~regulation of T cell differentiation in thymus,GO:0035556~intracellular signal transduction,GO:0043011~myeloid dendritic cell differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046777~protein autophosphorylation,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0009931~calcium-dependent protein serine/threonine kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,	hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04211:Longevity regulating pathway,hsa04371:Apelin signaling pathway,hsa04380:Osteoclast differentiation,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04921:Oxytocin signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05214:Glioma,			SM00220:S_TKc,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-1064~Adaptive immunity,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0106~Calcium,KW-0547~Nucleotide-binding,	KW-0112~Calmodulin-binding,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,CARBOHYD:O-linked (GlcNAc) serine,CARBOHYD:O-linked (GlcNAc) threonine,COMPBIAS:Basic and acidic residues,DOMAIN:Protein kinase,MUTAGEN:FN->DD: Fully active Ca2+/CaM-independent kinase; when associated with 309-A--A-312. Loss of interaction with PPP2CA/PPP2CB.,MUTAGEN:HMDT->DEDD: Fully active Ca2+/CaM-independent kinase; when associated with 320-A-A-321.,MUTAGEN:K->E: Loss of activity; dominant negative form.,MUTAGEN:S->A: Increases phosphorylation of CREB1 2-fold. Decreases total O-linked glycosylation 2-fold. Increases ATP-binding affinity.,MUTAGEN:S->A: Loss of activity.,MUTAGEN:T->A: Loss of activation by CaMKK1 or CaMKK2.,MUTAGEN:TS->AA: Loss of phosphorylation of CREB1.,REGION:Autoinhibitory domain,REGION:Calmodulin-binding,REGION:Disordered,REGION:PP2A-binding,
Q6DEH3	calcium/calmodulin-dependent protein kinase (CaM kinase) II delta 1(camk2d1)	Danio rerio			GO:0016310~phosphorylation,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043005~neuron projection,GO:0043226~organelle,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013543:Ca/CaM-dep_prot_kinase-assoc,IPR017441:Protein_kinase_ATP_BS,IPR032710:NTF2-like_dom_sf,	dre04012:ErbB signaling pathway,dre04020:Calcium signaling pathway,dre04114:Oocyte meiosis,dre04148:Efferocytosis,dre04217:Necroptosis,dre04261:Adrenergic signaling in cardiomyocytes,dre04310:Wnt signaling pathway,dre04912:GnRH signaling pathway,dre04916:Melanogenesis,			SM00220:S_TKc,		KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0112~Calmodulin-binding,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Protein kinase,REGION:Disordered,TRANSMEM:Helical,
Q8BW96	calcium/calmodulin-dependent protein kinase ID(Camk1d)	Mus musculus			GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0007399~nervous system development,GO:0008152~metabolic process,GO:0010976~positive regulation of neuron projection development,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032793~positive regulation of CREB transcription factor activity,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0050766~positive regulation of phagocytosis,GO:0050773~regulation of dendrite development,GO:0060267~positive regulation of respiratory burst,GO:0071622~regulation of granulocyte chemotaxis,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,				SM00220:S_TKc,	KW-0395~Inflammatory response,KW-0524~Neurogenesis,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0106~Calcium,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0112~Calmodulin-binding,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Proton acceptor,COMPBIAS:Basic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Protein kinase,MOTIF:Nuclear export signal,MUTAGEN:F->A: Constitutively active form; when associated with 289-A--A-292.,MUTAGEN:IHES->DEDD: Constitutively active form; when associated with A-301.,MUTAGEN:K->D: Catalytically inactive form.,REGION:Autoinhibitory domain,REGION:Calmodulin-binding,REGION:Disordered,
P13505	caldesmon 1(CALD1)	Meleagris gallopavo			GO:0001525~angiogenesis,GO:0006936~muscle contraction,GO:0051017~actin filament bundle assembly,GO:1903611~negative regulation of calcium-dependent ATPase activity,GO:1904530~negative regulation of actin filament binding,	GO:0001725~stress fiber,GO:0005884~actin filament,GO:0015629~actin cytoskeleton,GO:0030016~myofibril,	GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0017022~myosin binding,GO:0045159~myosin II binding,GO:0051015~actin filament binding,	IPR006017:Caldesmon,IPR006018:Caldesmon_LSP,	mgp04270:Vascular smooth muscle contraction,					KW-0206~Cytoskeleton,KW-0963~Cytoplasm,					KW-0009~Actin-binding,KW-0112~Calmodulin-binding,KW-0514~Muscle protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
P0DP35	calmodulin 1 (phosphorylase kinase, delta) homeolog L(calm1.L)	Xenopus laevis					GO:0005102~receptor binding,GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,	xla04020:Calcium signaling pathway,xla04070:Phosphatidylinositol signaling system,xla04114:Oocyte meiosis,xla04218:Cellular senescence,xla04261:Adrenergic signaling in cardiomyocytes,xla04270:Vascular smooth muscle contraction,xla04371:Apelin signaling pathway,xla04625:C-type lectin receptor signaling pathway,xla04744:Phototransduction,xla04910:Insulin signaling pathway,xla04912:GnRH signaling pathway,xla04916:Melanogenesis,			SM00054:EFh,					KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0007~Acetylation,KW-0488~Methylation,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,
P0DP35	calmodulin 1 (phosphorylase kinase, delta) homeolog S(calm1.S)	Xenopus laevis					GO:0005102~receptor binding,GO:0005509~calcium ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,	xla04020:Calcium signaling pathway,xla04070:Phosphatidylinositol signaling system,xla04114:Oocyte meiosis,xla04218:Cellular senescence,xla04261:Adrenergic signaling in cardiomyocytes,xla04270:Vascular smooth muscle contraction,xla04371:Apelin signaling pathway,xla04625:C-type lectin receptor signaling pathway,xla04744:Phototransduction,xla04910:Insulin signaling pathway,xla04912:GnRH signaling pathway,xla04916:Melanogenesis,			SM00054:EFh,					KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0007~Acetylation,KW-0488~Methylation,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,
P0DP35	calmodulin 2 (phosphorylase kinase, delta) homeolog L(calm2.L)	Xenopus laevis					GO:0005102~receptor binding,GO:0005509~calcium ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,	xla04020:Calcium signaling pathway,xla04070:Phosphatidylinositol signaling system,xla04114:Oocyte meiosis,xla04218:Cellular senescence,xla04261:Adrenergic signaling in cardiomyocytes,xla04270:Vascular smooth muscle contraction,xla04371:Apelin signaling pathway,xla04625:C-type lectin receptor signaling pathway,xla04744:Phototransduction,xla04910:Insulin signaling pathway,xla04912:GnRH signaling pathway,xla04916:Melanogenesis,			SM00054:EFh,					KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0007~Acetylation,KW-0488~Methylation,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,
P0DP35	calmodulin 2 (phosphorylase kinase, delta) homeolog S(calm2.S)	Xenopus laevis					GO:0005102~receptor binding,GO:0005509~calcium ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,	xla04020:Calcium signaling pathway,xla04070:Phosphatidylinositol signaling system,xla04114:Oocyte meiosis,xla04218:Cellular senescence,xla04261:Adrenergic signaling in cardiomyocytes,xla04270:Vascular smooth muscle contraction,xla04371:Apelin signaling pathway,xla04625:C-type lectin receptor signaling pathway,xla04744:Phototransduction,xla04910:Insulin signaling pathway,xla04912:GnRH signaling pathway,xla04916:Melanogenesis,			SM00054:EFh,					KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0007~Acetylation,KW-0488~Methylation,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,
Q9P1Y5	calmodulin regulated spectrin associated protein family member 3(CAMSAP3)	Homo sapiens			GO:0000076~DNA replication checkpoint,GO:0000226~microtubule cytoskeleton organization,GO:0001701~in utero embryonic development,GO:0003341~cilium movement,GO:0009792~embryo development ending in birth or egg hatching,GO:0030334~regulation of cell migration,GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity,GO:0031113~regulation of microtubule polymerization,GO:0031175~neuron projection development,GO:0033043~regulation of organelle organization,GO:0034453~microtubule anchoring,GO:0043111~replication fork arrest,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0045218~zonula adherens maintenance,GO:0051893~regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0090136~epithelial cell-cell adhesion,GO:0098840~protein transport along microtubule,GO:1903358~regulation of Golgi organization,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005915~zonula adherens,GO:0005930~axoneme,GO:0031298~replication fork protection complex,GO:0031514~motile cilium,GO:0036064~ciliary basal body,GO:0036449~microtubule minus-end,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0030507~spectrin binding,GO:0051011~microtubule minus-end binding,GO:0051015~actin filament binding,	IPR001715:CH_dom,IPR011033:PRC_barrel-like_sf,IPR014797:CKK_domain,IPR022613:CAMSAP-like_CH_dom,IPR031372:CAMSAP_CC1,IPR032940:CAMSAP,IPR036872:CH_dom_sf,IPR038209:CKK_dom_sf,				SM01051:CAMSAP_CKK,	KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:CKK,DOMAIN:Calponin-homology (CH),REGION:Disordered,
Q8C1B1	calmodulin regulated spectrin-associated protein family, member 2(Camsap2)	Mus musculus			GO:0000226~microtubule cytoskeleton organization,GO:0007026~negative regulation of microtubule depolymerization,GO:0031113~regulation of microtubule polymerization,GO:0031122~cytoplasmic microtubule organization,GO:0031175~neuron projection development,GO:0033043~regulation of organelle organization,GO:0050773~regulation of dendrite development,GO:0061564~axon development,GO:1903358~regulation of Golgi organization,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0036064~ciliary basal body,GO:0036449~microtubule minus-end,GO:0042995~cell projection,GO:1990752~microtubule end,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008017~microtubule binding,GO:0030507~spectrin binding,GO:0051011~microtubule minus-end binding,	IPR001715:CH_dom,IPR011033:PRC_barrel-like_sf,IPR014797:CKK_domain,IPR022613:CAMSAP-like_CH_dom,IPR031372:CAMSAP_CC1,IPR032940:CAMSAP,IPR036872:CH_dom_sf,IPR038209:CKK_dom_sf,				SM01051:CAMSAP_CKK,		KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:CKK,DOMAIN:Calponin-homology (CH),REGION:Disordered,REGION:MBD region,
Q07009	calpain 2(Capn2)	Rattus norvegicus			GO:0001666~response to hypoxia,GO:0001824~blastocyst development,GO:0006508~proteolysis,GO:0007520~myoblast fusion,GO:0007565~female pregnancy,GO:0009612~response to mechanical stimulus,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0016540~protein autoprocessing,GO:0030163~protein catabolic process,GO:0032675~regulation of interleukin-6 production,GO:0035458~cellular response to interferon-beta,GO:0042542~response to hydrogen peroxide,GO:0048266~behavioral response to pain,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0071222~cellular response to lipopolysaccharide,GO:0071230~cellular response to amino acid stimulus,GO:1901741~positive regulation of myoblast fusion,GO:2001247~positive regulation of phosphatidylcholine biosynthetic process,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0030425~dendrite,GO:0031143~pseudopodium,GO:0042995~cell projection,GO:0043025~neuronal cell body,GO:0045121~membrane raft,GO:0097038~perinuclear endoplasmic reticulum,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0008233~peptidase activity,GO:0019899~enzyme binding,GO:0044877~macromolecular complex binding,	IPR000169:Pept_cys_AS,IPR001300:Peptidase_C2_calpain_cat,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR022682:Calpain_domain_III,IPR022683:Calpain_III,IPR022684:Calpain_cysteine_protease,IPR033883:C2_III,IPR036213:Calpain_III_sf,IPR038765:Papain-like_cys_pep_sf,IPR042736:EFh_PEF_CAPN2,	rno04141:Protein processing in endoplasmic reticulum,rno04210:Apoptosis,rno04217:Necroptosis,rno04218:Cellular senescence,rno04510:Focal adhesion,rno05010:Alzheimer disease,rno05022:Pathways of neurodegeneration - multiple diseases,			SM00230:CysPc,SM00720:calpain_III,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0007~Acetylation,	DOMAIN:Calpain catalytic,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,MUTAGEN:C->S: Loss of activity.,MUTAGEN:E->S: 10% decrease in activity.,MUTAGEN:H->A: Loss of activity.,MUTAGEN:K->E: 84% decrease in activity.,MUTAGEN:K->E: 85% decrease in activity.,MUTAGEN:K->S: 12% decrease in activity.,MUTAGEN:K->S: 20% decrease in activity.,MUTAGEN:K->S: No effect.,MUTAGEN:N->A: Loss of activity.,MUTAGEN:R->A: Decreases catalytic activity.,MUTAGEN:W->Y: 95% decrease in activity.,PROPEP:Anchors to the small subunit,REGION:Domain III,REGION:Domain IV,REGION:Linker,
P20807	calpain 3(CAPN3)	Homo sapiens			GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0007517~muscle organ development,GO:0014718~positive regulation of satellite cell activation involved in skeletal muscle regeneration,GO:0014850~response to muscle activity,GO:0030163~protein catabolic process,GO:0030239~myofibril assembly,GO:0031648~protein destabilization,GO:0033234~negative regulation of protein sumoylation,GO:0043066~negative regulation of apoptotic process,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045214~sarcomere organization,GO:0045661~regulation of myoblast differentiation,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046716~muscle cell cellular homeostasis,GO:0050790~regulation of catalytic activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051592~response to calcium ion,GO:0061061~muscle structure development,GO:0065003~macromolecular complex assembly,GO:0070315~G1 to G0 transition involved in cell differentiation,GO:0071277~cellular response to calcium ion,GO:0071472~cellular response to salt stress,GO:0072657~protein localization to membrane,GO:0097264~self proteolysis,GO:1990092~calcium-dependent self proteolysis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030016~myofibril,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0032991~macromolecular complex,	GO:0003824~catalytic activity,GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008307~structural constituent of muscle,GO:0031402~sodium ion binding,GO:0031432~titin binding,GO:0042802~identical protein binding,GO:0055103~ligase regulator activity,GO:0060090~binding, bridging,	IPR000169:Pept_cys_AS,IPR001300:Peptidase_C2_calpain_cat,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR022682:Calpain_domain_III,IPR022683:Calpain_III,IPR022684:Calpain_cysteine_protease,IPR029531:CAPN3_PEF,IPR033883:C2_III,IPR036213:Calpain_III_sf,IPR038765:Papain-like_cys_pep_sf,		253600~Muscular dystrophy, limb-girdle, autosomal recessive 1,618129~Muscular dystrophy, limb-girdle, autosomal dominant 4,		SM00054:EFh,SM00230:CysPc,SM00720:calpain_III,		KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0947~Limb-girdle muscular dystrophy,	KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Calpain catalytic,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,DOMAIN:Peptidase C2 calpain,MUTAGEN:C->S: Loss of activity. No effect on CMYA5-binding. Does not degradate p53/TP53.,REGION:Disordered,REGION:Domain III,REGION:Domain IV,REGION:Linker,
O08688	calpain 5(Capn5)	Mus musculus			GO:0006508~proteolysis,	GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0045202~synapse,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,	IPR000008:C2_dom,IPR000169:Pept_cys_AS,IPR001300:Peptidase_C2_calpain_cat,IPR022682:Calpain_domain_III,IPR022683:Calpain_III,IPR022684:Calpain_cysteine_protease,IPR033883:C2_III,IPR033884:C2_Calpain,IPR035892:C2_domain_sf,IPR036213:Calpain_III_sf,IPR038765:Papain-like_cys_pep_sf,				SM00230:CysPc,SM00239:C2,SM00720:calpain_III,							KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,		DOMAIN:C2,DOMAIN:Calpain catalytic,REGION:Domain III,
Q08094	calponin 2(CNN2)	Sus scrofa			GO:0006909~phagocytosis,GO:0010628~positive regulation of gene expression,GO:0030097~hemopoiesis,GO:0031032~actomyosin structure organization,GO:0042060~wound healing,GO:0050765~negative regulation of phagocytosis,GO:0051649~establishment of localization in cell,GO:0051764~actin crosslink formation,GO:0070663~regulation of leukocyte proliferation,GO:1905517~macrophage migration,GO:1905522~negative regulation of macrophage migration,	GO:0005884~actin filament,	GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0008093~cytoskeletal adaptor activity,GO:0051015~actin filament binding,	IPR000557:Calponin_repeat,IPR001715:CH_dom,IPR001997:Calponin/LIMCH1,IPR003096:SM22_calponin,IPR036872:CH_dom_sf,				SM00033:CH,					KW-0677~Repeat,		KW-0009~Actin-binding,KW-0112~Calmodulin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Calponin-homology (CH),REGION:Disordered,REPEAT:Calponin-like 1,REPEAT:Calponin-like 2,REPEAT:Calponin-like 3,
P15253	calreticulin(CALR)	Oryctolagus cuniculus			GO:0006457~protein folding,GO:0050821~protein stabilization,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0009986~cell surface,GO:0016529~sarcoplasmic reticulum,GO:0033018~sarcoplasmic reticulum lumen,GO:0044194~cytolytic granule,GO:0060473~cortical granule,	GO:0005509~calcium ion binding,GO:0030246~carbohydrate binding,GO:0051082~unfolded protein binding,	IPR001580:Calret/calnex,IPR009033:Calreticulin/calnexin_P_dom_sf,IPR009169:Calreticulin,IPR013320:ConA-like_dom_sf,IPR018124:Calret/calnex_CS,	ocu04141:Protein processing in endoplasmic reticulum,ocu04145:Phagosome,ocu04148:Efferocytosis,ocu04612:Antigen processing and presentation,ocu05142:Chagas disease,ocu05163:Human cytomegalovirus infection,ocu05166:Human T-cell leukemia virus 1 infection,ocu05168:Herpes simplex virus 1 infection,ocu05169:Epstein-Barr virus infection,ocu05170:Human immunodeficiency virus 1 infection,		PIRSF002356:Calreticulin,			KW-0256~Endoplasmic reticulum,KW-0272~Extracellular matrix,KW-0458~Lysosome,KW-0703~Sarcoplasmic reticulum,KW-0963~Cytoplasm,KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0430~Lectin,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0143~Chaperone,	KW-0007~Acetylation,KW-0379~Hydroxylation,KW-1015~Disulfide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,MOTIF:Prevents secretion from ER,MUTAGEN:H->A: Loss of activity.,REGION:3 X approximate repeats,REGION:4 X approximate repeats,REGION:C-domain,REGION:Disordered,REGION:Interaction with PPIB,REGION:N-domain,REGION:P-domain,REPEAT:1-1,REPEAT:1-2,REPEAT:1-3,REPEAT:1-4,REPEAT:2-1,REPEAT:2-2,REPEAT:2-3,
B5X4E0	calumenin-B-like(LOC106573432)	Salmo salar				GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0033018~sarcoplasmic reticulum lumen,GO:0042470~melanosome,	GO:0005509~calcium ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,				SM00054:EFh,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0703~Sarcoplasmic reticulum,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,DOMAIN:EF-hand 5,DOMAIN:EF-hand 6,MOTIF:Prevents secretion from ER,
Q9GKT6	cannabinoid receptor interacting protein 1(CNRIP1)	Macaca fascicularis			GO:2000272~negative regulation of receptor activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0031718~type 1 cannabinoid receptor binding,	IPR029204:CNRIP1,													REGION:Disordered,
A3KNS2	canopy FGF signaling regulator 3(cnpy3)	Danio rerio			GO:0002376~immune system process,GO:0045087~innate immune response,	GO:0005783~endoplasmic reticulum,	GO:0005102~receptor binding,	IPR021852:DUF3456,					KW-0391~Immunity,KW-0399~Innate immunity,	KW-0256~Endoplasmic reticulum,			KW-0175~Coiled coil,KW-0732~Signal,		KW-0143~Chaperone,	KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,DOMAIN:Saposin B-type,REGION:Disordered,
Q9EQC0	carbohydrate sulfotransferase 1(Chst1)	Mus musculus			GO:0005975~carbohydrate metabolic process,GO:0006012~galactose metabolic process,GO:0006044~N-acetylglucosamine metabolic process,GO:0006790~sulfur compound metabolic process,GO:0006954~inflammatory response,GO:0018146~keratan sulfate biosynthetic process,GO:0042339~keratan sulfate metabolic process,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0016020~membrane,	GO:0001517~N-acetylglucosamine 6-O-sulfotransferase activity,GO:0008146~sulfotransferase activity,GO:0016740~transferase activity,GO:0045130~keratan sulfotransferase activity,	IPR000863:Sulfotransferase_dom,IPR016469:Carbohydrate_sulfotransferase,IPR027417:P-loop_NTPase,	mmu00533:Glycosaminoglycan biosynthesis - keratan sulfate,		PIRSF005883:Carbohydrate_sulfotransferase,		KW-0119~Carbohydrate metabolism,KW-0395~Inflammatory response,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Sulfotransferase,MOTIF:Cell attachment site,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q7LFX5	carbohydrate sulfotransferase 15(CHST15)	Homo sapiens			GO:0019319~hexose biosynthetic process,GO:0030206~chondroitin sulfate biosynthetic process,	GO:0000139~Golgi membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0016740~transferase activity,GO:0050656~3'-phosphoadenosine 5'-phosphosulfate binding,GO:0050659~N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,	IPR000863:Sulfotransferase_dom,IPR027417:P-loop_NTPase,	hsa00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,					KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P22748	carbonic anhydrase 4(CA4)	Homo sapiens			GO:0006730~one-carbon metabolic process,GO:0015701~bicarbonate transport,	GO:0005791~rough endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0030658~transport vesicle membrane,GO:0030667~secretory granule membrane,GO:0031526~brush border membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004089~carbonate dehydratase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001148:CA_dom,IPR018338:Carbonic_anhydrase_a-class_CS,IPR023561:Carbonic_anhydrase_a-class,IPR036398:CA_dom_sf,IPR041874:CA4/CA15,	hsa00910:Nitrogen metabolism,hsa01100:Metabolic pathways,hsa04964:Proximal tubule bicarbonate reclamation,			SM01057:Carb_anhydrase,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0682~Retinitis pigmentosa,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0456~Lyase,	KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,DOMAIN:Alpha-carbonic anhydrase,LIPID:GPI-anchor amidated serine,MUTAGEN:S->F: Loss of C-terminal domain removal and abolishes carbonate dehydratase activity.,PROPEP:Removed in mature form,TRANSMEM:Helical,
Q9Y2D0	carbonic anhydrase 5B(CA5B)	Homo sapiens			GO:0006730~one-carbon metabolic process,GO:0009617~response to bacterium,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004089~carbonate dehydratase activity,GO:0008270~zinc ion binding,	IPR001148:CA_dom,IPR018338:Carbonic_anhydrase_a-class_CS,IPR023561:Carbonic_anhydrase_a-class,IPR036398:CA_dom_sf,	hsa00910:Nitrogen metabolism,hsa01100:Metabolic pathways,			SM01057:Carb_anhydrase,		KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0456~Lyase,		DOMAIN:Alpha-carbonic anhydrase,TRANSIT:Mitochondrion,
Q5RCU5	carbonyl reductase 1(CBR1)	Pongo abelii			GO:0006629~lipid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0008211~glucocorticoid metabolic process,GO:0030855~epithelial cell differentiation,GO:0042373~vitamin K metabolic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005737~cytoplasm,	GO:0004090~carbonyl reductase (NADPH) activity,GO:0008106~alcohol dehydrogenase (NADP+) activity,GO:0016655~oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,GO:0047020~15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,GO:0047021~15-hydroxyprostaglandin dehydrogenase (NADP+) activity,GO:0050221~prostaglandin-E2 9-reductase activity,	IPR002347:SDR_fam,IPR020904:Sc_DH/Rdtase_CS,IPR036291:NAD(P)-bd_dom_sf,IPR045313:CBR1-like,	pon00590:Arachidonic acid metabolism,pon00790:Folate biosynthesis,pon00980:Metabolism of xenobiotics by cytochrome P450,pon01100:Metabolic pathways,pon05204:Chemical carcinogenesis - DNA adducts,pon05208:Chemical carcinogenesis - reactive oxygen species,				KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,				KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,
Q6P0H7	carbonyl reductase 4(cbr4)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0051290~protein heterotetramerization,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:1990204~oxidoreductase complex,	GO:0004316~3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,GO:0016491~oxidoreductase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0048038~quinone binding,	IPR002347:SDR_fam,IPR020904:Sc_DH/Rdtase_CS,IPR036291:NAD(P)-bd_dom_sf,	dre00061:Fatty acid biosynthesis,dre01100:Metabolic pathways,dre01212:Fatty acid metabolism,			SM00822:PKS_KR,	KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0496~Mitochondrion,				KW-0520~NAD,KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,
P30122	carboxyl ester lipase(CEL)	Bos taurus			GO:0007158~neuron cell-cell adhesion,GO:0007268~chemical synaptic transmission,GO:0030157~pancreatic juice secretion,GO:0030299~intestinal cholesterol absorption,GO:0046514~ceramide catabolic process,GO:0048488~synaptic vesicle endocytosis,GO:0050804~modulation of synaptic transmission,GO:0097104~postsynaptic membrane assembly,GO:0097105~presynaptic membrane assembly,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0045202~synapse,GO:0099634~postsynaptic specialization membrane,	GO:0004771~sterol esterase activity,GO:0004806~triglyceride lipase activity,GO:0008126~acetylesterase activity,GO:0016787~hydrolase activity,GO:0038023~signaling receptor activity,GO:0042043~neurexin family protein binding,GO:0050253~retinyl-palmitate esterase activity,	IPR002018:CarbesteraseB,IPR019819:Carboxylesterase_B_CS,IPR019826:Carboxylesterase_B_AS,IPR029058:AB_hydrolase,	bta00100:Steroid biosynthesis,bta00561:Glycerolipid metabolism,bta01100:Metabolic pathways,bta04972:Pancreatic secretion,bta04975:Fat digestion and absorption,				KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0964~Secreted,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0719~Serine esterase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Acyl-ester intermediate,ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Carboxylesterase type B,REGION:Disordered,
Q8BK48	carboxylesterase 2E(Ces2e)	Mus musculus			GO:0006693~prostaglandin metabolic process,	GO:0005783~endoplasmic reticulum,GO:0043231~intracellular membrane-bounded organelle,	GO:0016787~hydrolase activity,GO:0047376~all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity,GO:0050253~retinyl-palmitate esterase activity,GO:0052689~carboxylic ester hydrolase activity,GO:0102209~trans-permethrin hydrolase activity,	IPR002018:CarbesteraseB,IPR019819:Carboxylesterase_B_CS,IPR019826:Carboxylesterase_B_AS,IPR029058:AB_hydrolase,	mmu00983:Drug metabolism - other enzymes,					KW-0256~Endoplasmic reticulum,KW-0492~Microsome,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0719~Serine esterase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	ACT_SITE:Acyl-ester intermediate,ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,
P00731	carboxypeptidase A1(Cpa1)	Rattus norvegicus			GO:0006508~proteolysis,GO:0006691~leukotriene metabolic process,GO:0046686~response to cadmium ion,GO:0051603~proteolysis involved in cellular protein catabolic process,	GO:0005615~extracellular space,	GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,	IPR000834:Peptidase_M14,IPR003146:M14A_act_pep,IPR034248:CPA_M14_CPD,IPR036990:M14A-like_propep,	rno04972:Pancreatic secretion,rno04974:Protein digestion and absorption,			SM00631:Zn_pept,		KW-0964~Secreted,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,DOMAIN:Peptidase M14,DOMAIN:Peptidase M14 carboxypeptidase A,PROPEP:Activation peptide,
Q504N0	carboxypeptidase A2, pancreatic(Cpa2)	Mus musculus			GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000834:Peptidase_M14,IPR003146:M14A_act_pep,IPR034248:CPA_M14_CPD,IPR036990:M14A-like_propep,	mmu04972:Pancreatic secretion,mmu04974:Protein digestion and absorption,			SM00631:Zn_pept,		KW-0964~Secreted,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,DOMAIN:Peptidase M14,PROPEP:Activation peptide,
Q8N4T0	carboxypeptidase A6(CPA6)	Homo sapiens			GO:0006508~proteolysis,	GO:0005615~extracellular space,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,	IPR000834:Peptidase_M14,IPR003146:M14A_act_pep,IPR033843:CPAH,IPR036990:M14A-like_propep,		614417~Epilepsy, familial temporal lobe, 5,614418~Febrile seizures, familial, 11,		SM00631:Zn_pept,		KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,KW-0887~Epilepsy,	KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase M14,PROPEP:Activation peptide,
P15086	carboxypeptidase B1(CPB1)	Homo sapiens			GO:0006508~proteolysis,	GO:0005615~extracellular space,GO:0031410~cytoplasmic vesicle,	GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000834:Peptidase_M14,IPR003146:M14A_act_pep,IPR034253:CPB_M14_CPD,IPR036990:M14A-like_propep,	hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,			SM00631:Zn_pept,		KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,DOMAIN:Carboxypeptidase activation peptide,DOMAIN:Peptidase M14,DOMAIN:Peptidase M14 carboxypeptidase A,PROPEP:Activation peptide,
P15169	carboxypeptidase N subunit 1(CPN1)	Homo sapiens			GO:0006508~proteolysis,GO:0006518~peptide metabolic process,GO:0010815~bradykinin catabolic process,GO:0016485~protein processing,GO:0030163~protein catabolic process,GO:0051384~response to glucocorticoid,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0004181~metallocarboxypeptidase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000834:Peptidase_M14,IPR008969:CarboxyPept-like_regulatory,IPR033814:M14_CPN,		212070~Carboxypeptidase N deficiency,		SM00631:Zn_pept,		KW-0964~Secreted,		KW-0225~Disease variant,	KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,CARBOHYD:O-linked (GalNAc...) threonine,DOMAIN:Peptidase M14,DOMAIN:Peptidase M14 carboxypeptidase A,REGION:Disordered,
Q9DBB9	carboxypeptidase N, polypeptide 2(Cpn2)	Mus musculus				GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031012~extracellular matrix,		IPR000372:LRRNT,IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,				SM00013:LRRNT,SM00082:LRRCT,SM00364:LRR_BAC,SM00369:LRR_TYP,		KW-0964~Secreted,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:LRRCT,DOMAIN:LRRNT,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
B8JLQ9	carboxypeptidase O(cpo)	Danio rerio			GO:0006508~proteolysis,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0098552~side of membrane,	GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000834:Peptidase_M14,IPR033850:Carboxypeptidase_O,				SM00631:Zn_pept,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,	ACT_SITE:Proton donor/acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase M14,LIPID:GPI-anchor amidated asparagine,PROPEP:Removed in mature form,
Q6GQ29	carboxypeptidase Q L homeolog(cpq.L)	Xenopus laevis			GO:0006508~proteolysis,GO:0043171~peptide catabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,	GO:0004180~carboxypeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0016787~hydrolase activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0070573~metallodipeptidase activity,	IPR007484:Peptidase_M28,IPR039866:CPQ,						KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0964~Secreted,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,	ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase M28,
Q96SM3	carboxypeptidase X, M14 family member 1(CPXM1)	Homo sapiens			GO:0006518~peptide metabolic process,GO:0016485~protein processing,	GO:0005615~extracellular space,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,	IPR000421:FA58C,IPR000834:Peptidase_M14,IPR008969:CarboxyPept-like_regulatory,IPR008979:Galactose-bd-like_sf,				SM00231:FA58C,SM00631:Zn_pept,		KW-0964~Secreted,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:F5/8 type C,DOMAIN:Peptidase M14,REGION:Disordered,
Q8QGP3	carboxypeptidase Z(CPZ)	Gallus gallus			GO:0006508~proteolysis,GO:0006518~peptide metabolic process,GO:0016055~Wnt signaling pathway,GO:0016485~protein processing,	GO:0005615~extracellular space,	GO:0004181~metallocarboxypeptidase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000834:Peptidase_M14,IPR008969:CarboxyPept-like_regulatory,IPR020067:Frizzled_dom,IPR034239:M14_CPZ_CPD,IPR036790:Frizzled_dom_sf,				SM00063:FRI,SM00631:Zn_pept,	KW-0879~Wnt signaling pathway,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0121~Carboxypeptidase,KW-0217~Developmental protein,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:FZ,DOMAIN:Peptidase M14,
Q5U2V5	cardiolipin synthase 1(Crls1)	Rattus norvegicus			GO:0008654~phospholipid biosynthetic process,GO:0032049~cardiolipin biosynthetic process,GO:0097068~response to thyroxine,GO:1905711~response to phosphatidylethanolamine,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0031966~mitochondrial membrane,	GO:0016780~phosphotransferase activity, for other substituted phosphate groups,GO:0043337~CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,	IPR000462:CDP-OH_P_trans,IPR043130:CDP-OH_PTrfase_TM_dom,	rno00564:Glycerophospholipid metabolism,rno01100:Metabolic pathways,				KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0594~Phospholipid biosynthesis,KW-1208~Phospholipid metabolism,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,		REGION:Disordered,TRANSMEM:Helical,
P52826	carnitine O-acetyltransferase(CRAT)	Columba livia			GO:0019254~carnitine metabolic process, CoA-linked,GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase,GO:0046459~short-chain fatty acid metabolic process,GO:0051791~medium-chain fatty acid metabolic process,	GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0005783~endoplasmic reticulum,	GO:0003997~acyl-CoA oxidase activity,GO:0004092~carnitine O-acetyltransferase activity,GO:0008458~carnitine O-octanoyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR000542:Carn_acyl_trans,IPR023213:CAT-like_dom_sf,IPR039551:Cho/carn_acyl_trans,IPR042231:Cho/carn_acyl_trans_2,	clv04146:Peroxisome,				KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0576~Peroxisome,KW-0999~Mitochondrion inner membrane,					KW-0012~Acyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,	ACT_SITE:Proton acceptor,DOMAIN:Choline/carnitine acyltransferase,MOTIF:Microbody targeting signal,
P43155	carnitine O-acetyltransferase(CRAT)	Homo sapiens			GO:0006635~fatty acid beta-oxidation,GO:0019254~carnitine metabolic process, CoA-linked,GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase,GO:0046459~short-chain fatty acid metabolic process,GO:0051791~medium-chain fatty acid metabolic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,	GO:0003997~acyl-CoA oxidase activity,GO:0004092~carnitine O-acetyltransferase activity,GO:0008458~carnitine O-octanoyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR000542:Carn_acyl_trans,IPR023213:CAT-like_dom_sf,IPR039551:Cho/carn_acyl_trans,IPR042231:Cho/carn_acyl_trans_2,IPR042572:Carn_acyl_trans_N,	hsa04146:Peroxisome,	617917~Neurodegeneration with brain iron accumulation 8,			KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0576~Peroxisome,KW-0999~Mitochondrion inner membrane,		KW-0523~Neurodegeneration,			KW-0012~Acyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,	ACT_SITE:Proton acceptor,DOMAIN:Choline/carnitine acyltransferase,MOTIF:Microbody targeting signal,MUTAGEN:F->A: Increases the KM for carnitine 18-fold and reduces enzyme activity 100-fold.,MUTAGEN:F->Y: No effect.,MUTAGEN:R->Q: Increases the KM for carnitine 230-fold and reduces enzyme activity almost 100-fold.,MUTAGEN:T->A: Increases the KM for carnitine almost 70-fold and reduces enzyme activity 450-fold.,MUTAGEN:Y->A: Increases the KM for carnitine 100-fold.,MUTAGEN:Y->F: Increases the KM for carnitine 320-fold and reduces enzyme activity 10000-fold.,REGION:Disordered,
Q96KP4	carnosine dipeptidase 2(CNDP2)	Homo sapiens			GO:0006508~proteolysis,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004180~carboxypeptidase activity,GO:0016787~hydrolase activity,GO:0016805~dipeptidase activity,GO:0046872~metal ion binding,GO:0070573~metallodipeptidase activity,GO:0103046~alanylglutamate dipeptidase activity,	IPR001261:ArgE/DapE_CS,IPR002933:Peptidase_M20,IPR011650:Peptidase_M20_dimer,IPR017153:CNDP/DUG1,	hsa00330:Arginine and proline metabolism,hsa00340:Histidine metabolism,hsa00410:beta-Alanine metabolism,hsa01100:Metabolic pathways,		PIRSF037242:CNDP_dipeptidase,			KW-0963~Cytoplasm,				KW-0464~Manganese,KW-0479~Metal-binding,	KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,BINDING:in other chain,DOMAIN:Peptidase M20 dimerisation,REGION:Disordered,SITE:Important for catalytic activity,
Q9NQ79	cartilage acidic protein 1(CRTAC1)	Homo sapiens			GO:0007413~axonal fasciculation,	GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR011519:UnbV_ASPIC,IPR013517:FG-GAP,IPR018097:EGF_Ca-bd_CS,IPR027039:Crtac1,IPR028994:Integrin_alpha_N,				SM00179:EGF_CA,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:O-linked (GalNAc...) threonine,COMPBIAS:Polar residues,DOMAIN:ASPIC/UnbV,DOMAIN:EGF-like,DOMAIN:EGF-like calcium-binding,REGION:Disordered,REPEAT:FG-GAP 1; atypical,REPEAT:FG-GAP 2; atypical,REPEAT:FG-GAP 3; atypical,REPEAT:FG-GAP 4; atypical,
P21868	casein kinase 2 alpha 1(CSNK2A1)	Gallus gallus			GO:0006302~double-strand break repair,GO:0006468~protein phosphorylation,GO:0016055~Wnt signaling pathway,GO:0018105~peptidyl-serine phosphorylation,GO:0048511~rhythmic process,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005956~protein kinase CK2 complex,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR045216:CK2_alpha,	gga03008:Ribosome biogenesis in eukaryotes,gga04137:Mitophagy - animal,gga04310:Wnt signaling pathway,gga04520:Adherens junction,			SM00220:S_TKc,	KW-0090~Biological rhythms,KW-0879~Wnt signaling pathway,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,		ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,REGION:Disordered,REGION:Interaction with beta subunit,
A0A1D5PPP7	caspase 6(CASP6)	Gallus gallus			GO:0002218~activation of innate immune response,GO:0006309~apoptotic DNA fragmentation,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0016540~protein autoprocessing,GO:0030262~apoptotic nuclear changes,GO:0030263~apoptotic chromosome condensation,GO:0043065~positive regulation of apoptotic process,GO:0060545~positive regulation of necroptotic process,GO:0070269~pyroptosis,GO:0070306~lens fiber cell differentiation,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0097284~hepatocyte apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004197~cysteine-type endopeptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process,GO:0097200~cysteine-type endopeptidase activity involved in execution phase of apoptosis,	IPR001309:Pept_C14_p20,IPR002138:Pept_C14_p10,IPR002398:Pept_C14,IPR011600:Pept_C14_caspase,IPR015917:Pept_C14A,IPR029030:Caspase-like_dom_sf,IPR033139:Caspase_cys_AS,	gga04210:Apoptosis,		PIRSF038001:Caspase_ICE,	SM00115:CASc,	KW-0053~Apoptosis,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0068~Autocatalytic cleavage,KW-0865~Zymogen,	COMPBIAS:Polar residues,DOMAIN:Caspase family p10,DOMAIN:Caspase family p20,REGION:130's region,REGION:Disordered,REGION:Tri-arginine exosite,
Q9WUF3	caspase 8 associated protein 2(Casp8ap2)	Mus musculus			GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007049~cell cycle,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0036337~Fas signaling pathway,GO:0097190~apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016605~PML body,	GO:0002020~protease binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0032184~SUMO polymer binding,GO:0042802~identical protein binding,	IPR039674:FLASH,IPR049257:Gon4l/CASP8AP2_myb-like,					KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0010~Activator,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MOTIF:SUMO interaction motif 1 (SIM); mediates the binding to polysumoylated substrates,REGION:Disordered,REGION:NCOA2-binding,
Q96LW7	caspase recruitment domain family member 19(CARD19)	Homo sapiens			GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0031966~mitochondrial membrane,	GO:0050700~CARD domain binding,	IPR011029:DEATH-like_dom_sf,IPR042146:CARD_BinCARD,IPR043574:CARD19,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DISULFID:Redox-active,DOMAIN:CARD,MUTAGEN:L->A: Abolishes the NF-kappa-B inhibitory activity.,
Q9PT92	catalase(cat)	Danio rerio			GO:0006979~response to oxidative stress,GO:0042542~response to hydrogen peroxide,GO:0042744~hydrogen peroxide catabolic process,GO:0046688~response to copper ion,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,	GO:0004096~catalase activity,GO:0004601~peroxidase activity,GO:0016491~oxidoreductase activity,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR002226:Catalase_haem_BS,IPR010582:Catalase_immune_responsive,IPR011614:Catalase_core,IPR018028:Catalase,IPR020835:Catalase_sf,IPR024708:Catalase_AS,IPR024711:Catalase_clade1/3,IPR040333:Catalase_3,	dre00380:Tryptophan metabolism,dre00630:Glyoxylate and dicarboxylate metabolism,dre01100:Metabolic pathways,dre01200:Carbon metabolism,dre04068:FoxO signaling pathway,dre04146:Peroxisome,		PIRSF038928:Catalase_clade1-3,	SM01060:Catalase,	KW-0376~Hydrogen peroxide,	KW-0576~Peroxisome,				KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,KW-0521~NADP,	KW-0560~Oxidoreductase,KW-0575~Peroxidase,		BINDING:axial binding residue,COMPBIAS:Basic and acidic residues,DOMAIN:Catalase core,REGION:Disordered,
P30999	catenin delta 1(Ctnnd1)	Mus musculus			GO:0001738~morphogenesis of a polarized epithelium,GO:0001822~kidney development,GO:0007043~cell-cell junction assembly,GO:0007155~cell adhesion,GO:0007435~salivary gland morphogenesis,GO:0010954~positive regulation of protein processing,GO:0016055~Wnt signaling pathway,GO:0044331~cell-cell adhesion mediated by cadherin,GO:0050821~protein stabilization,GO:0051220~cytoplasmic sequestering of protein,GO:0060690~epithelial cell differentiation involved in salivary gland development,GO:0072102~glomerulus morphogenesis,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0098609~cell-cell adhesion,GO:0099072~regulation of postsynaptic specialization membrane neurotransmitter receptor levels,GO:1900086~positive regulation of peptidyl-tyrosine autophosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005915~zonula adherens,GO:0005923~bicellular tight junction,GO:0009986~cell surface,GO:0016020~membrane,GO:0016327~apicolateral plasma membrane,GO:0016342~catenin complex,GO:0016600~flotillin complex,GO:0030027~lamellipodium,GO:0030426~growth cone,GO:0030496~midbody,GO:0043197~dendritic spine,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098686~hippocampal mossy fiber to CA3 synapse,GO:0098831~presynaptic active zone cytoplasmic component,GO:0098978~glutamatergic synapse,GO:0099092~postsynaptic density, intracellular component,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0045296~cadherin binding,GO:0050839~cell adhesion molecule binding,GO:1990782~protein tyrosine kinase binding,	IPR000225:Armadillo,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR028435:Plakophilin/d_Catenin,	mmu04015:Rap1 signaling pathway,mmu04520:Adherens junction,mmu04670:Leukocyte transendothelial migration,			SM00185:ARM,	KW-0130~Cell adhesion,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MOTIF:Nuclear localization signal (NLS),MUTAGEN:KK->AA: Abolishes nuclear localization.,REGION:Disordered,REGION:Necessary and sufficient for interaction with CCDC85B,REPEAT:ARM,REPEAT:ARM 1,REPEAT:ARM 10,REPEAT:ARM 2,REPEAT:ARM 3,REPEAT:ARM 4,REPEAT:ARM 5,REPEAT:ARM 6,REPEAT:ARM 7,REPEAT:ARM 8,REPEAT:ARM 9,SITE:Essential for interaction with cadherins,
Q9UQB3	catenin delta 2(CTNND2)	Homo sapiens			GO:0007043~cell-cell junction assembly,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0016055~Wnt signaling pathway,GO:0050808~synapse organization,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0060997~dendritic spine morphogenesis,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0014069~postsynaptic density,GO:0030425~dendrite,GO:0043204~perikaryon,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0045296~cadherin binding,	IPR000225:Armadillo,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR028435:Plakophilin/d_Catenin,	hsa04310:Wnt signaling pathway,			SM00185:ARM,	KW-0130~Cell adhesion,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0879~Wnt signaling pathway,	KW-0539~Nucleus,KW-0965~Cell junction,KW-0966~Cell projection,		KW-0225~Disease variant,KW-1268~Autism spectrum disorder,KW-1269~Autism,	KW-0175~Coiled coil,KW-0677~Repeat,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,REPEAT:ARM,REPEAT:ARM 1,REPEAT:ARM 2,REPEAT:ARM 3,REPEAT:ARM 4,REPEAT:ARM 5,REPEAT:ARM 6,REPEAT:ARM 7,REPEAT:ARM 8,REPEAT:ARM 9,
Q5R6D1	cathepsin B(CTSB)	Pongo abelii			GO:0006508~proteolysis,GO:0006590~thyroid hormone generation,GO:0030574~collagen catabolic process,GO:0030855~epithelial cell differentiation,GO:0046697~decidualization,GO:0046718~viral entry into host cell,GO:0050790~regulation of catalytic activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0097067~cellular response to thyroid hormone stimulus,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0009897~external side of plasma membrane,GO:0016324~apical plasma membrane,GO:0042470~melanosome,GO:0048471~perinuclear region of cytoplasm,GO:1904090~peptidase inhibitor complex,	GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0005518~collagen binding,GO:0043394~proteoglycan binding,	IPR000169:Pept_cys_AS,IPR000668:Peptidase_C1A_C,IPR012599:Propeptide_C1A,IPR013128:Peptidase_C1A,IPR025660:Pept_his_AS,IPR025661:Pept_asp_AS,IPR038765:Papain-like_cys_pep_sf,	pon04140:Autophagy - animal,pon04142:Lysosome,pon04210:Apoptosis,pon04612:Antigen processing and presentation,pon04621:NOD-like receptor signaling pathway,pon04924:Renin secretion,			SM00645:Pept_C1,		KW-0458~Lysosome,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase C1A papain C-terminal,DOMAIN:Peptidase C1A propeptide,PROPEP:Activation peptide,
P83205	cathepsin B(CTSB)	Ovis aries			GO:0006508~proteolysis,GO:0006590~thyroid hormone generation,GO:0030574~collagen catabolic process,GO:0030855~epithelial cell differentiation,GO:0046697~decidualization,GO:0046718~viral entry into host cell,GO:0050790~regulation of catalytic activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0097067~cellular response to thyroid hormone stimulus,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0009897~external side of plasma membrane,GO:0016324~apical plasma membrane,GO:0042470~melanosome,GO:0048471~perinuclear region of cytoplasm,GO:1904090~peptidase inhibitor complex,	GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0005518~collagen binding,GO:0008234~cysteine-type peptidase activity,GO:0043394~proteoglycan binding,	IPR000169:Pept_cys_AS,IPR000668:Peptidase_C1A_C,IPR012599:Propeptide_C1A,IPR013128:Peptidase_C1A,IPR025660:Pept_his_AS,IPR025661:Pept_asp_AS,IPR038765:Papain-like_cys_pep_sf,	oas04140:Autophagy - animal,oas04142:Lysosome,oas04210:Apoptosis,oas04612:Antigen processing and presentation,oas04621:NOD-like receptor signaling pathway,oas04924:Renin secretion,			SM00645:Pept_C1,		KW-0458~Lysosome,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase C1A papain C-terminal,PROPEP:Activation peptide,
P53634	cathepsin C(CTSC)	Homo sapiens			GO:0001913~T cell mediated cytotoxicity,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0006955~immune response,GO:0010033~response to organic substance,GO:0031642~negative regulation of myelination,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:1903052~positive regulation of proteolysis involved in cellular protein catabolic process,GO:1903980~positive regulation of microglial cell activation,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005764~lysosome,GO:0005788~endoplasmic reticulum lumen,GO:0005813~centrosome,GO:0016020~membrane,GO:0030134~ER to Golgi transport vesicle,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0035578~azurophil granule lumen,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008234~cysteine-type peptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0016505~peptidase activator activity involved in apoptotic process,GO:0019902~phosphatase binding,GO:0031404~chloride ion binding,GO:0042802~identical protein binding,GO:0043621~protein self-association,GO:0051087~chaperone binding,	IPR000169:Pept_cys_AS,IPR000668:Peptidase_C1A_C,IPR013128:Peptidase_C1A,IPR014882:CathepsinC_exc,IPR025660:Pept_his_AS,IPR025661:Pept_asp_AS,IPR036496:CathepsinC_exc_dom_sf,IPR038765:Papain-like_cys_pep_sf,IPR039412:CatC,	hsa04142:Lysosome,hsa04210:Apoptosis,	170650~Periodontitis 1, juvenile,245000~Papillon-Lefevre syndrome,245010~Haim-Munk syndrome,		SM00645:Pept_C1,		KW-0458~Lysosome,		KW-0225~Disease variant,KW-1007~Palmoplantar keratoderma,	KW-0732~Signal,	KW-0868~Chloride,	KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cathepsin C exclusion,DOMAIN:Peptidase C1A papain C-terminal,REGION:Disordered,
O46427	cathepsin H(CTSH)	Sus scrofa			GO:0001656~metanephros development,GO:0001913~T cell mediated cytotoxicity,GO:0002764~immune response-regulating signaling pathway,GO:0006508~proteolysis,GO:0006955~immune response,GO:0008284~positive regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010813~neuropeptide catabolic process,GO:0010815~bradykinin catabolic process,GO:0010952~positive regulation of peptidase activity,GO:0030335~positive regulation of cell migration,GO:0031638~zymogen activation,GO:0031648~protein destabilization,GO:0032526~response to retinoic acid,GO:0033619~membrane protein proteolysis,GO:0043066~negative regulation of apoptotic process,GO:0043129~surfactant homeostasis,GO:0045766~positive regulation of angiogenesis,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060448~dichotomous subdivision of terminal units involved in lung branching,GO:0070371~ERK1 and ERK2 cascade,GO:0097067~cellular response to thyroid hormone stimulus,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005829~cytosol,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0097208~alveolar lamellar body,	GO:0004175~endopeptidase activity,GO:0004177~aminopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0030108~HLA-A specific activating MHC class I receptor activity,GO:0070324~thyroid hormone binding,	IPR000169:Pept_cys_AS,IPR000668:Peptidase_C1A_C,IPR013128:Peptidase_C1A,IPR013201:Prot_inhib_I29,IPR025660:Pept_his_AS,IPR025661:Pept_asp_AS,IPR038765:Papain-like_cys_pep_sf,IPR039417:Peptidase_C1A_papain-like,	ssc04142:Lysosome,ssc04210:Apoptosis,			SM00645:Pept_C1,SM00848:Inhibitor_I29,		KW-0458~Lysosome,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cathepsin propeptide inhibitor,DOMAIN:Peptidase C1A papain C-terminal,PEPTIDE:Cathepsin H mini chain,REGION:Disordered,
Q63918	caveolae associated 2(Cavin2)	Mus musculus			GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0097320~plasma membrane tubulation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0016020~membrane,GO:0045121~membrane raft,	GO:0001786~phosphatidylserine binding,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0008289~lipid binding,	IPR026752:Cavin_fam,						KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0446~Lipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Interaction with CAVIN1,REGION:Leucine-zipper,
P85125	caveolae associated protein 1(Cavin1)	Rattus norvegicus			GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0009303~rRNA transcription,GO:0009306~protein secretion,GO:2000147~positive regulation of cell motility,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0032991~macromolecular complex,GO:0043231~intracellular membrane-bounded organelle,GO:0045121~membrane raft,	GO:0005515~protein binding,GO:0042134~rRNA primary transcript binding,GO:0042802~identical protein binding,	IPR026752:Cavin_fam,					KW-0804~Transcription,KW-0805~Transcription regulation,KW-0806~Transcription termination,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0694~RNA-binding,KW-0699~rRNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,REGION:Disordered,REGION:Leucine-zipper 1,REGION:Leucine-zipper 2,REGION:Leucine-zipper 3,REGION:Nuclear export signal,REGION:Nuclear localization signal,REGION:Required for homotrimerization and for interaction with CAVIN2 and CAVIN3,
O95810	caveolae associated protein 2(CAVIN2)	Homo sapiens			GO:0097320~plasma membrane tubulation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0045121~membrane raft,	GO:0001786~phosphatidylserine binding,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,	IPR026752:Cavin_fam,						KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0446~Lipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MUTAGEN:I->E: Loss of localization in caveolae; when associated with E-86 or E-100.,MUTAGEN:L->E: Loss of localization in caveolae; when associated with E-86 or E-93.,MUTAGEN:L->E: Loss of localization in caveolae; when associated with E-93 or E-100.,REGION:Disordered,REGION:Interaction with CAVIN1,REGION:Leucine-zipper,
Q9YGM8	caveolin 1(cav1)	Takifugu rubripes			GO:0001756~somitogenesis,GO:0001937~negative regulation of endothelial cell proliferation,GO:0009953~dorsal/ventral pattern formation,GO:0031295~T cell costimulation,GO:0048884~neuromast development,GO:0050688~regulation of defense response to virus,GO:0060036~notochord cell vacuolation,GO:0060038~cardiac muscle cell proliferation,GO:0060338~regulation of type I interferon-mediated signaling pathway,GO:0061026~cardiac muscle tissue regeneration,GO:0061099~negative regulation of protein tyrosine kinase activity,GO:0070836~caveola assembly,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005901~caveola,GO:0031410~cytoplasmic vesicle,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0008013~beta-catenin binding,GO:0019901~protein kinase binding,GO:0044325~ion channel binding,GO:0060090~binding, bridging,	IPR001612:Caveolin,IPR018361:Caveolin_CS,	tru04144:Endocytosis,tru04510:Focal adhesion,					KW-0333~Golgi apparatus,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0449~Lipoprotein,KW-0564~Palmitate,	COMPBIAS:Basic and acidic residues,INTRAMEM:Helical,LIPID:S-palmitoyl cysteine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
Q8BLQ9	cell adhesion molecule 2(Cadm2)	Mus musculus			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0032809~neuronal cell body membrane,GO:0042995~cell projection,GO:0045202~synapse,	GO:0005515~protein binding,	IPR003585:Neurexin-like,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013162:CD80_C2-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00294:4.1m,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like V-type,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6DJ83	cell adhesion molecule 2(cadm2)	Xenopus tropicalis			GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,	GO:0016020~membrane,GO:0032809~neuronal cell body membrane,		IPR003585:Neurexin-like,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013106:Ig_V-set,IPR013162:CD80_C2-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,			PIRSF000615:TyrPK_CSF1-R,	SM00294:4.1m,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like V-type,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O70302	cell death-inducing DNA fragmentation factor, alpha subunit-like effector A(Cidea)	Mus musculus			GO:0001659~temperature homeostasis,GO:0001818~negative regulation of cytokine production,GO:0006629~lipid metabolic process,GO:0006915~apoptotic process,GO:0010890~positive regulation of sequestering of triglyceride,GO:0019915~lipid storage,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0032720~negative regulation of tumor necrosis factor production,GO:0035634~response to stilbenoid,GO:0042981~regulation of apoptotic process,GO:0050995~negative regulation of lipid catabolic process,GO:0070417~cellular response to cold,GO:1900118~negative regulation of execution phase of apoptosis,GO:1902510~regulation of apoptotic DNA fragmentation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005811~lipid particle,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0070300~phosphatidic acid binding,	IPR003508:CIDE-N_dom,IPR032936:CIDEA_N,	mmu04152:AMPK signaling pathway,			SM00266:CAD,	KW-0053~Apoptosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0551~Lipid droplet,					KW-0010~Activator,		DOMAIN:CIDE-N,MUTAGEN:FKAV->RKRR: Abolished localization to lipid droplets.,MUTAGEN:FKAVL->RAVRR: Abolished localization to lipid droplets.,MUTAGEN:K->A: Sustantial reduction in nuclear localization and loss of XDH induction; when associated with A-23.,MUTAGEN:K->A: Sustantial reduction in nuclear localization and loss of XDH induction; when associated with A-24.,MUTAGEN:K->R: Increased nuclear localization.,MUTAGEN:KAVLRNLLR->EAVLENLLE: Does not affect localization to lipid droplets but prevents lipid droplet fusion.,MUTAGEN:KAVLRNLLR->HAVLHNLLH: Does not affect localization to lipid droplets or ability to mediate lipid droplet fusion.,MUTAGEN:RNLLR->ANLLA: Abolished lipid transferase activity.,REGION:Amphipathic helix,
Q9JJ66	cell division cycle 20(Cdc20)	Mus musculus			GO:0000089~mitotic metaphase,GO:0007049~cell cycle,GO:0007064~mitotic sister chromatid cohesion,GO:0007094~mitotic spindle assembly checkpoint,GO:0007399~nervous system development,GO:0008284~positive regulation of cell proliferation,GO:0016567~protein ubiquitination,GO:0030154~cell differentiation,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0031915~positive regulation of synaptic plasticity,GO:0040020~regulation of meiotic nuclear division,GO:0044784~metaphase/anaphase transition of cell cycle,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0050773~regulation of dendrite development,GO:0051301~cell division,GO:0090129~positive regulation of synapse maturation,GO:0090307~mitotic spindle assembly,GO:1904668~positive regulation of ubiquitin protein ligase activity,GO:1905786~positive regulation of anaphase-promoting complex-dependent catabolic process,GO:1990949~metaphase/anaphase transition of meiosis I,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000922~spindle pole,GO:0005654~nucleoplasm,GO:0005680~anaphase-promoting complex,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0032991~macromolecular complex,GO:0033597~mitotic checkpoint complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0010997~anaphase-promoting complex binding,GO:0042826~histone deacetylase binding,GO:0097027~ubiquitin-protein transferase activator activity,GO:1990757~ubiquitin ligase activator activity,	IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR024977:Apc4-like_WD40_dom,IPR033010:Cdc20/Fizzy,IPR036322:WD40_repeat_dom_sf,	mmu04110:Cell cycle,mmu04114:Oocyte meiosis,mmu04120:Ubiquitin mediated proteolysis,mmu05166:Human T-cell leukemia virus 1 infection,mmu05203:Viral carcinogenesis,			SM00320:WD40,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0221~Differentiation,KW-0498~Mitosis,KW-0524~Neurogenesis,KW-0833~Ubl conjugation pathway,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0995~Kinetochore,			KW-0677~Repeat,KW-0853~WD repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Anaphase-promoting complex subunit 4-like WD40,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
P30305	cell division cycle 25B(CDC25B)	Homo sapiens		H_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_srcRPTPPathway:Activation of Src by Protein-tyrosine phosphatase alpha,	GO:0000086~G2/M transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001556~oocyte maturation,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007144~female meiosis I,GO:0008284~positive regulation of cell proliferation,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0032467~positive regulation of cytokinesis,GO:0045931~positive regulation of mitotic cell cycle,GO:0051301~cell division,GO:1902751~positive regulation of cell cycle G2/M phase transition,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR000751:MPI_Phosphatase,IPR001763:Rhodanese-like_dom,IPR036873:Rhodanese-like_dom_sf,	hsa04010:MAPK signaling pathway,hsa04110:Cell cycle,hsa04914:Progesterone-mediated oocyte maturation,hsa05206:MicroRNAs in cancer,			SM00450:RHOD,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Rhodanese,REGION:Disordered,
Q8CFN2	cell division cycle 42(Cdc42)	Rattus norvegicus			GO:0002040~sprouting angiogenesis,GO:0003015~heart process,GO:0003161~cardiac conduction system development,GO:0003253~cardiac neural crest cell migration involved in outflow tract morphogenesis,GO:0006897~endocytosis,GO:0006911~phagocytosis, engulfment,GO:0007015~actin filament organization,GO:0007030~Golgi organization,GO:0007088~regulation of mitotic nuclear division,GO:0007097~nuclear migration,GO:0007163~establishment or maintenance of cell polarity,GO:0007229~integrin-mediated signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0008104~protein localization,GO:0009653~anatomical structure morphogenesis,GO:0009749~response to glucose,GO:0010591~regulation of lamellipodium assembly,GO:0010592~positive regulation of lamellipodium assembly,GO:0017157~regulation of exocytosis,GO:0021762~substantia nigra development,GO:0030010~establishment of cell polarity,GO:0030036~actin cytoskeleton organization,GO:0030307~positive regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0031274~positive regulation of pseudopodium assembly,GO:0031333~negative regulation of protein complex assembly,GO:0032467~positive regulation of cytokinesis,GO:0032488~Cdc42 protein signal transduction,GO:0032956~regulation of actin cytoskeleton organization,GO:0034329~cell junction assembly,GO:0034332~adherens junction organization,GO:0035050~embryonic heart tube development,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0036336~dendritic cell migration,GO:0038189~neuropilin signaling pathway,GO:0043410~positive regulation of MAPK cascade,GO:0043525~positive regulation of neuron apoptotic process,GO:0044788~modulation by host of viral process,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0045740~positive regulation of DNA replication,GO:0046330~positive regulation of JNK cascade,GO:0046847~filopodium assembly,GO:0048549~positive regulation of pinocytosis,GO:0048664~neuron fate determination,GO:0051130~positive regulation of cellular component organization,GO:0051301~cell division,GO:0051489~regulation of filopodium assembly,GO:0051491~positive regulation of filopodium assembly,GO:0051492~regulation of stress fiber assembly,GO:0051496~positive regulation of stress fiber assembly,GO:0051647~nucleus localization,GO:0051649~establishment of localization in cell,GO:0051683~establishment of Golgi localization,GO:0051835~positive regulation of synapse structural plasticity,GO:0051897~positive regulation of protein kinase B signaling,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0060047~heart contraction,GO:0060501~positive regulation of epithelial cell proliferation involved in lung morphogenesis,GO:0060661~submandibular salivary gland formation,GO:0060997~dendritic spine morphogenesis,GO:0071346~cellular response to interferon-gamma,GO:0072384~organelle transport along microtubule,GO:0086101~endothelin receptor signaling pathway involved in heart process,GO:0090135~actin filament branching,GO:0090316~positive regulation of intracellular protein transport,GO:0099563~modification of synaptic structure,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0000139~Golgi membrane,GO:0000322~storage vacuole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0017119~Golgi transport complex,GO:0030141~secretory granule,GO:0030175~filopodium,GO:0030496~midbody,GO:0031252~cell leading edge,GO:0031256~leading edge membrane,GO:0031258~lamellipodium membrane,GO:0032991~macromolecular complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043227~membrane-bounded organelle,GO:0045177~apical part of cell,GO:0045335~phagocytic vesicle,GO:0051233~spindle midzone,GO:0071944~cell periphery,GO:0072686~mitotic spindle,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098978~glutamatergic synapse,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019901~protein kinase binding,GO:0030742~GTP-dependent protein binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0031996~thioesterase binding,GO:0032427~GBD domain binding,GO:0034191~apolipoprotein A-I receptor binding,GO:0042802~identical protein binding,GO:0051022~Rho GDP-dissociation inhibitor binding,GO:0061630~ubiquitin protein ligase activity,	IPR001806:Small_GTPase,IPR003578:Small_GTPase_Rho,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR037874:Cdc42,	rno04010:MAPK signaling pathway,rno04014:Ras signaling pathway,rno04015:Rap1 signaling pathway,rno04062:Chemokine signaling pathway,rno04144:Endocytosis,rno04360:Axon guidance,rno04370:VEGF signaling pathway,rno04510:Focal adhesion,rno04520:Adherens junction,rno04530:Tight junction,rno04660:T cell receptor signaling pathway,rno04666:Fc gamma R-mediated phagocytosis,rno04670:Leukocyte transendothelial migration,rno04722:Neurotrophin signaling pathway,rno04810:Regulation of actin cytoskeleton,rno04912:GnRH signaling pathway,rno04932:Non-alcoholic fatty liver disease,rno04933:AGE-RAGE signaling pathway in diabetic complications,rno05100:Bacterial invasion of epithelial cells,rno05132:Salmonella infection,rno05135:Yersinia infection,rno05165:Human papillomavirus infection,rno05200:Pathways in cancer,rno05203:Viral carcinogenesis,rno05205:Proteoglycans in cancer,rno05211:Renal cell carcinoma,rno05212:Pancreatic cancer,rno05417:Lipid and atherosclerosis,			SM00173:RAS,SM00174:RHO,SM00175:RAB,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,
Q9YHZ6	cell division cycle 45 L homeolog(cdc45.L)	Xenopus laevis			GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0071162~CMG complex,	GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR003874:CDC45,	xla04110:Cell cycle,				KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,							COMPBIAS:Acidic residues,REGION:Disordered,
Q8JZM7	cell division cycle 73, Paf1/RNA polymerase II complex component(Cdc73)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0001711~endodermal cell fate commitment,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006378~mRNA polyadenylation,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0019827~stem cell population maintenance,GO:0030177~positive regulation of Wnt signaling pathway,GO:0031124~mRNA 3'-end processing,GO:0031442~positive regulation of mRNA 3'-end processing,GO:0031648~protein destabilization,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0034402~recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,GO:0043066~negative regulation of apoptotic process,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048147~negative regulation of fibroblast proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0071222~cellular response to lipopolysaccharide,GO:1902808~positive regulation of cell cycle G1/S phase transition,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0016593~Cdc73/Paf1 complex,	GO:0000993~RNA polymerase II core binding,GO:0005515~protein binding,	IPR007852:Cdc73/Parafibromin,IPR031336:CDC73_C,IPR032041:Cdc73_N,IPR038103:CDC73_C_sf,					KW-0131~Cell cycle,KW-0804~Transcription,KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-0539~Nucleus,		KW-0043~Tumor suppressor,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with CTNNB1,REGION:Interaction with POLR2A and PAF1,TRANSMEM:Helical,
Q9D0M2	cell division cycle associated 7(Cdca7)	Mus musculus			GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0042127~regulation of cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,		IPR018866:Znf-4CXXC_R1,IPR040221:CDCA7/CDA7L,					KW-0053~Apoptosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with MYC,REGION:Mediates transcriptional activity,
Q5XLR4	cell division cycle associated 8(cdca8)	Danio rerio			GO:0000070~mitotic sister chromatid segregation,GO:0007049~cell cycle,GO:0007507~heart development,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0032133~chromosome passenger complex,GO:0051233~spindle midzone,		IPR018851:Borealin_N,IPR018867:Cell_div_borealin,IPR046466:Borealin_C,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,							COMPBIAS:Polar residues,DOMAIN:Borealin C-terminal,DOMAIN:Borealin N-terminal,REGION:Disordered,
P86347	cell division cycle associated 9(cdca9)	Danio rerio			GO:0000070~mitotic sister chromatid segregation,GO:0007049~cell cycle,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0032133~chromosome passenger complex,GO:0051233~spindle midzone,		IPR018851:Borealin_N,IPR018867:Cell_div_borealin,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,							COMPBIAS:Polar residues,DOMAIN:Borealin N-terminal,REGION:Disordered,
Q8BMJ7	cell growth regulator with ring finger domain 1(Cgrrf1)	Mus musculus			GO:0007049~cell cycle,GO:0030308~negative regulation of cell growth,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0046872~metal ion binding,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,				SM00184:RING,	KW-0131~Cell cycle,KW-0338~Growth arrest,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,			REGION:Disordered,TRANSMEM:Helical,ZN_FING:RING-type,
O00622	cellular communication network factor 1(CCN1)	Homo sapiens			GO:0001649~osteoblast differentiation,GO:0001934~positive regulation of protein phosphorylation,GO:0002041~intussusceptive angiogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003278~apoptotic process involved in heart morphogenesis,GO:0003281~ventricular septum development,GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0030501~positive regulation of bone mineralization,GO:0030513~positive regulation of BMP signaling pathway,GO:0033690~positive regulation of osteoblast proliferation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0044319~wound healing, spreading of cells,GO:0045597~positive regulation of cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045860~positive regulation of protein kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050793~regulation of developmental process,GO:0060413~atrial septum morphogenesis,GO:0060591~chondroblast differentiation,GO:0060710~chorio-allantoic fusion,GO:0060716~labyrinthine layer blood vessel development,GO:0061036~positive regulation of cartilage development,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0072593~reactive oxygen species metabolic process,GO:2000304~positive regulation of ceramide biosynthetic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,	GO:0000166~nucleotide binding,GO:0005178~integrin binding,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0019838~growth factor binding,GO:0050840~extracellular matrix binding,	IPR000867:IGFBP-like,IPR000884:TSP1_rpt,IPR001007:VWF_dom,IPR006207:Cys_knot_C,IPR006208:Glyco_hormone_CN,IPR009030:Growth_fac_rcpt_cys_sf,IPR012395:IGFBP_CNN,IPR017891:Insulin_GF-bd_Cys-rich_CS,IPR036383:TSP1_rpt_sf,IPR043973:TSP1_CCN,			PIRSF036495:IGFBP_rP_CNN,	SM00041:CT,SM00121:IB,SM00209:TSP1,SM00214:VWC,	KW-0130~Cell adhesion,KW-0145~Chemotaxis,	KW-0964~Secreted,			KW-0732~Signal,	KW-0547~Nucleotide-binding,	KW-0340~Growth factor binding,KW-0358~Heparin-binding,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Polar residues,DOMAIN:CTCK,DOMAIN:IGFBP N-terminal,DOMAIN:TSP type-1,DOMAIN:VWFC,REGION:Disordered,REGION:Heparin-binding,
Q5XK92	cellular inhibitor of PP2A L homeolog(cip2a.L)	Xenopus laevis			GO:0006974~cellular response to DNA damage stimulus,GO:0051276~chromosome organization,	GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0004864~protein phosphatase inhibitor activity,	IPR016024:ARM-type_fold,IPR042510:CIP2A,IPR048701:CIP2A_N,					KW-0227~DNA damage,	KW-0158~Chromosome,KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:CIP2A N-terminal,MOTIF:Nuclear export signal,TRANSMEM:Helical,
O75629	cellular repressor of E1A stimulated genes 1(CREG1)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006897~endocytosis,GO:0006914~autophagy,GO:0007042~lysosomal lumen acidification,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005667~transcription factor complex,GO:0005768~endosome,GO:0035578~azurophil granule lumen,GO:0070062~extracellular exosome,	GO:0003714~transcription corepressor activity,	IPR012349:Split_barrel_FMN-bd,IPR014631:CREG,			PIRSF036911:CREG,		KW-0341~Growth regulation,	KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,
Q8BGC9	cellular repressor of E1A-stimulated genes 2(Creg2)	Mus musculus				GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,		IPR012349:Split_barrel_FMN-bd,IPR014631:CREG,			PIRSF036911:CREG,			KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:N->Q: Abolishes N-glycosylation.,MUTAGEN:N->Q: N-glycosylated.,MUTAGEN:NSTGIPFFYMTAKDPAVADLVKN->QSTGIPFFYMTAKDPAVADLVKQ: Abolishes N-glycosylation.,REGION:Disordered,
Q6P3G4	centriole, cilia and spindle-associated protein b(ccsapb)	Danio rerio			GO:0000226~microtubule cytoskeleton organization,GO:0003341~cilium movement,GO:0007049~cell cycle,GO:0007420~brain development,GO:0007507~heart development,GO:0045995~regulation of embryonic development,GO:0048666~neuron development,GO:0051301~cell division,GO:0061371~determination of heart left/right asymmetry,GO:1901673~regulation of mitotic spindle assembly,GO:1990755~mitotic spindle microtubule depolymerization,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0030424~axon,GO:0035869~ciliary transition zone,GO:0036064~ciliary basal body,GO:0042995~cell projection,GO:0061673~mitotic spindle astral microtubule,GO:0072686~mitotic spindle,	GO:0008017~microtubule binding,	IPR029774:CSAP,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,			KW-0677~Repeat,		KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MOTIF:ST]-E-Y-X(3)-F motif 1; required for efficient microtubule binding and stabilization,MOTIF:ST]-E-Y-X(3)-F motif 2; required for efficient microtubule binding and stabilization,REGION:Disordered,
Q02224	centromere protein E(CENPE)	Homo sapiens			GO:0000278~mitotic cell cycle,GO:0007018~microtubule-based movement,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007079~mitotic chromosome movement towards spindle pole,GO:0007080~mitotic metaphase plate congression,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0045860~positive regulation of protein kinase activity,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0051382~kinetochore assembly,GO:0099606~microtubule plus-end directed mitotic chromosome migration,GO:0099607~lateral attachment of mitotic spindle microtubules to kinetochore,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000779~condensed chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005828~kinetochore microtubule,GO:0005829~cytosol,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0030496~midbody,GO:0043231~intracellular membrane-bounded organelle,GO:0045171~intercellular bridge,GO:0051233~spindle midzone,GO:0072686~mitotic spindle,GO:1990023~mitotic spindle midzone,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0043515~kinetochore binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	hsa04814:Motor proteins,	616051~Microcephaly 13, primary, autosomal recessive,		SM00129:KISc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0995~Kinetochore,		KW-0225~Disease variant,KW-0905~Primary microcephaly,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0505~Motor protein,KW-9996~Developmental protein,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:Kinesin motor,LIPID:S-farnesyl cysteine,PROPEP:Removed in mature form,REGION:Disordered,REGION:Globular autoinhibitory domain,REGION:Kinetochore-binding domain,
P49454	centromere protein F(CENPF)	Homo sapiens			GO:0000278~mitotic cell cycle,GO:0001822~kidney development,GO:0007059~chromosome segregation,GO:0007094~mitotic spindle assembly checkpoint,GO:0007517~muscle organ development,GO:0009410~response to xenobiotic stimulus,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0015031~protein transport,GO:0016202~regulation of striated muscle tissue development,GO:0021591~ventricular system development,GO:0030154~cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0051382~kinetochore assembly,GO:0071897~DNA biosynthetic process,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000785~chromatin,GO:0000922~spindle pole,GO:0000940~condensed chromosome outer kinetochore,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005930~axoneme,GO:0016363~nuclear matrix,GO:0030496~midbody,GO:0031965~nuclear membrane,GO:0036064~ciliary basal body,GO:0045120~pronucleus,GO:0048471~perinuclear region of cytoplasm,GO:0097539~ciliary transition fiber,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0042803~protein homodimerization activity,GO:0070840~dynein complex binding,	IPR018302:CenpF/LEK1_Rb-prot-bd,IPR018463:Centromere_CenpF_N,IPR019513:Centromere_CenpF_leu-rich_rpt,IPR043513:Cenp-F,		243605~Stromme syndrome,			KW-0131~Cell cycle,KW-0132~Cell division,KW-0221~Differentiation,KW-0237~DNA synthesis,KW-0498~Mitosis,KW-0517~Myogenesis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,		KW-0990~Primary ciliary dyskinesia,KW-1186~Ciliopathy,	KW-0175~Coiled coil,KW-0677~Repeat,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Centromere protein Cenp-F N-terminal,DOMAIN:Centromere protein Cenp-F leucine-rich repeat-containing,DOMAIN:Kinetochore protein Cenp-F/LEK1 Rb protein-binding,LIPID:S-farnesyl cysteine,MOTIF:Nuclear localization signal,PROPEP:Removed in mature form,REGION:2 X 177 AA tandem repeats,REGION:Disordered,REGION:Interaction with NDE1 and NDEL1,REGION:Interaction with SNAP25 and required for localization to the cytoplasm,REGION:Sufficient for centromere localization,REGION:Sufficient for nuclear localization,REGION:Sufficient for self-association,REPEAT:1,REPEAT:2,
Q8AYS7	centromere protein I(CENPI)	Gallus gallus			GO:0000070~mitotic sister chromatid segregation,GO:0034080~CENP-A containing nucleosome assembly,GO:0034508~centromere complex assembly,	GO:0000776~kinetochore,GO:0000939~condensed chromosome inner kinetochore,GO:0005634~nucleus,		IPR012485:CENP-I,						KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,							COMPBIAS:Basic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q9ESN5	centromere protein K(Cenpk)	Mus musculus			GO:0000070~mitotic sister chromatid segregation,GO:0007059~chromosome segregation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051382~kinetochore assembly,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000939~condensed chromosome inner kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0005515~protein binding,	IPR020993:Centromere_CenpK,						KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,			KW-0175~Coiled coil,
Q6DRD4	centromere protein L(cenpl)	Danio rerio				GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,		IPR025204:CENP-L,						KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,							REGION:Disordered,
Q5U4T8	centromere protein N L homeolog(cenpn.L)	Xenopus laevis			GO:0007059~chromosome segregation,GO:0034080~CENP-A containing nucleosome assembly,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,		IPR007902:Chl4/mis15/CENP-N,						KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,
Q28HU3	centromere protein O(cenpo)	Xenopus tropicalis			GO:0034508~centromere complex assembly,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0031511~Mis6-Sim4 complex,		IPR018464:CENP-O,						KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,			KW-0175~Coiled coil,
F1NPG5	centromere protein T(CENPT)	Gallus gallus			GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0051301~cell division,GO:0051382~kinetochore assembly,	GO:0000776~kinetochore,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR009072:Histone-fold,IPR028255:CENP-T,IPR032373:CENP-T_N,IPR035425:CENP-T/H4_C,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,					KW-0238~DNA-binding,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:CENP-T/Histone H4 histone fold,DOMAIN:Centromere kinetochore component CENP-T N-terminal,REGION:Disordered,REGION:Flexible stalk domain,
Q2Z1W2	centromere protein U(CENPU)	Gallus gallus				GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,		IPR025214:CENP-U,						KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,			KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MOTIF:Nuclear localization signal,REGION:Disordered,
Q9CXS4	centromere protein V(Cenpv)	Mus musculus			GO:0001667~ameboidal-type cell migration,GO:0007049~cell cycle,GO:0031508~pericentric heterochromatin assembly,GO:0032467~positive regulation of cytokinesis,GO:0033044~regulation of chromosome organization,GO:0034508~centromere complex assembly,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0030496~midbody,GO:0031965~nuclear membrane,GO:0051233~spindle midzone,	GO:0016846~carbon-sulfur lyase activity,GO:0046872~metal ion binding,	IPR006913:CENP-V/GFA,IPR011057:Mss4-like_sf,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,				KW-0479~Metal-binding,KW-0862~Zinc,		KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,DOMAIN:CENP-V/GFA,REGION:Disordered,
Q6A065	centrosomal protein 170(Cep170)	Mus musculus				GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,	GO:0005515~protein binding,	IPR000253:FHA_dom,IPR008984:SMAD_FHA_dom_sf,IPR029300:CEP170_C,				SM00240:FHA,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CEP170 C-terminal,DOMAIN:FHA,REGION:Disordered,REGION:Targeting to centrosomes,REGION:Targeting to microtubules,
Q498L0	centrosomal protein 170B S homeolog(cep170b.S)	Xenopus laevis				GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,		IPR000253:FHA_dom,IPR008984:SMAD_FHA_dom_sf,IPR029300:CEP170_C,				SM00240:FHA,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,							COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:FHA,REGION:Disordered,
A2RVA7	centrosomal protein 44kDa L homeolog(cep44.L)	Xenopus laevis			GO:0007098~centrosome cycle,GO:0007099~centriole replication,GO:0010457~centriole-centriole cohesion,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005856~cytoskeleton,GO:0030496~midbody,	GO:0008017~microtubule binding,	IPR029157:CEP44_CC,IPR033603:CEP44,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,DOMAIN:Centrosomal CEP44,REGION:Binds with microtubules and centrioles,REGION:Disordered,
Q8C0D9	centrosomal protein 68(Cep68)	Mus musculus			GO:0007098~centrosome cycle,GO:0010457~centriole-centriole cohesion,GO:0033365~protein localization to organelle,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0030054~cell junction,GO:0034451~centriolar satellite,	GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,							KW-0206~Cytoskeleton,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
P27545	ceramide synthase 1(Cers1)	Mus musculus			GO:0007420~brain development,GO:0030148~sphingolipid biosynthetic process,GO:0036146~cellular response to mycotoxin,GO:0046325~negative regulation of glucose import,GO:0046513~ceramide biosynthetic process,GO:0051974~negative regulation of telomerase activity,GO:0071466~cellular response to xenobiotic stimulus,GO:0071492~cellular response to UV-A,GO:0072721~cellular response to dithiothreitol,GO:1901526~positive regulation of macromitophagy,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0016410~N-acyltransferase activity,GO:0050291~sphingosine N-acyltransferase activity,	IPR006634:TLC-dom,IPR016439:Lag1/Lac1-like,	mmu00600:Sphingolipid metabolism,mmu01100:Metabolic pathways,mmu04071:Sphingolipid signaling pathway,			SM00724:TLC,	KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0007~Acetylation,	DOMAIN:TLC,MUTAGEN:D->N: Decreased ceramide synthase activity.,MUTAGEN:H->D: Decreased ceramide synthase activity.,MUTAGEN:K->L: Does not affect ceramide synthase activity.,MUTAGEN:L->E: Decreased ceramide synthase activity.,MUTAGEN:S->A: Does not affect ceramide synthase activity.,TRANSMEM:Helical,
Q3ZBF8	ceramide synthase 2(CERS2)	Bos taurus			GO:0019216~regulation of lipid metabolic process,GO:0046513~ceramide biosynthetic process,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0050291~sphingosine N-acyltransferase activity,	IPR001356:Homeobox_dom,IPR006634:TLC-dom,IPR009057:Homeobox-like_sf,IPR016439:Lag1/Lac1-like,	bta00600:Sphingolipid metabolism,bta01100:Metabolic pathways,bta04071:Sphingolipid signaling pathway,		PIRSF005225:LAG1_LAC1,	SM00724:TLC,	KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,			KW-0371~Homeobox,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0238~DNA-binding,KW-0808~Transferase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DNA_BIND:Homeobox,DOMAIN:Homeobox,DOMAIN:TLC,MOTIF:Last loop motif,REGION:Disordered,REGION:Homeobox-like,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q8N5B7	ceramide synthase 5(CERS5)	Homo sapiens			GO:0014003~oligodendrocyte development,GO:0030148~sphingolipid biosynthetic process,GO:0046513~ceramide biosynthetic process,	GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0050291~sphingosine N-acyltransferase activity,	IPR001356:Homeobox_dom,IPR006634:TLC-dom,IPR009057:Homeobox-like_sf,IPR016439:Lag1/Lac1-like,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04071:Sphingolipid signaling pathway,		PIRSF005225:LAG1_LAC1,	SM00724:TLC,	KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0746~Sphingolipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DNA_BIND:Homeobox,DOMAIN:Homeobox,DOMAIN:TLC,MOTIF:Last loop motif,MUTAGEN:CIFCYGIRFLWSS->IAGMAVIVD: Does not affect specificity toward acyl donor.,MUTAGEN:ESWEIIGPYAS->YPLELYPAFFG: Altered specificity toward acyl donor; generates C22-C24 ceramides instead of C16-ceramide.,MUTAGEN:H->D: Strongly decreased ceramide synthase activity.,MUTAGEN:L->E: Strongly decreased ceramide synthase activity.,MUTAGEN:L->M: Does not affect ceramide synthase activity.,MUTAGEN:N->Q: Reduced N-glycosylation.,MUTAGEN:S->A: Does not affect ceramide synthase activity.,MUTAGEN:SDVESSS->ADVEAAA: Decreased phosphorylation.,REGION:Disordered,REGION:Homeobox-like,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q6NZT2	cerebellar degeneration-related protein 2-like(cdr2l)	Danio rerio						IPR026079:CDR2,									KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,REGION:Disordered,
P50143	chaperonin containing TCP1 subunit 3 S homeolog(cct3.S)	Xenopus laevis			GO:0006457~protein folding,	GO:0005737~cytoplasm,GO:0005832~chaperonin-containing T-complex,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin_TCP-1_CS,IPR002423:Cpn60/GroEL/TCP-1,IPR012719:Chap_CCT_gamma,IPR017998:Chaperone_TCP-1,IPR027409:GroEL-like_apical_dom_sf,IPR027410:TCP-1-like_intermed_sf,IPR027413:GROEL-like_equatorial_sf,						KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-1015~Disulfide bond,	REGION:Disordered,
Q4R6V2	chaperonin containing TCP1 subunit 5(CCT5)	Macaca fascicularis			GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0009615~response to virus,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0050821~protein stabilization,GO:0061077~chaperone-mediated protein folding,GO:1904851~positive regulation of establishment of protein localization to telomere,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005832~chaperonin-containing T-complex,GO:0005874~microtubule,GO:0044297~cell body,	GO:0003730~mRNA 3'-UTR binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0031681~G-protein beta-subunit binding,GO:0048027~mRNA 5'-UTR binding,GO:0048487~beta-tubulin binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin_TCP-1_CS,IPR002423:Cpn60/GroEL/TCP-1,IPR012718:Chap_CCT_epsi,IPR017998:Chaperone_TCP-1,IPR027409:GroEL-like_apical_dom_sf,IPR027410:TCP-1-like_intermed_sf,IPR027413:GROEL-like_equatorial_sf,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),
P40227	chaperonin containing TCP1 subunit 6A(CCT6A)	Homo sapiens			GO:0006457~protein folding,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0050821~protein stabilization,GO:0061077~chaperone-mediated protein folding,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005832~chaperonin-containing T-complex,GO:0005874~microtubule,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0044183~protein binding involved in protein folding,GO:0051082~unfolded protein binding,GO:0071987~WD40-repeat domain binding,	IPR002194:Chaperonin_TCP-1_CS,IPR002423:Cpn60/GroEL/TCP-1,IPR012722:Chap_CCT_zeta,IPR017998:Chaperone_TCP-1,IPR027409:GroEL-like_apical_dom_sf,IPR027410:TCP-1-like_intermed_sf,IPR027413:GROEL-like_equatorial_sf,						KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),
Q3ZCI9	chaperonin containing TCP1 subunit 8(CCT8)	Bos taurus			GO:0006457~protein folding,	GO:0005813~centrosome,GO:0005832~chaperonin-containing T-complex,GO:0005929~cilium,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin_TCP-1_CS,IPR002423:Cpn60/GroEL/TCP-1,IPR012721:Chap_CCT_theta,IPR017998:Chaperone_TCP-1,IPR027409:GroEL-like_apical_dom_sf,IPR027410:TCP-1-like_intermed_sf,IPR027413:GROEL-like_equatorial_sf,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,
Q7ZW25	charged multivesicular body protein 2A(chmp2a)	Danio rerio			GO:0007034~vacuolar transport,GO:0010458~exit from mitosis,GO:0015031~protein transport,GO:0031468~nuclear envelope reassembly,GO:0032509~endosome transport via multivesicular body sorting pathway,GO:0045324~late endosome to vacuole transport,	GO:0000815~ESCRT III complex,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005771~multivesicular body,GO:0016020~membrane,GO:0031902~late endosome membrane,		IPR005024:Snf7_fam,	dre04144:Endocytosis,dre04217:Necroptosis,				KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,MOTIF:MIT-interacting motif,REGION:Disordered,
Q5F3A2	charged multivesicular body protein 2B(CHMP2B)	Gallus gallus			GO:0007034~vacuolar transport,GO:0015031~protein transport,GO:0032509~endosome transport via multivesicular body sorting pathway,GO:0045324~late endosome to vacuole transport,	GO:0000815~ESCRT III complex,GO:0005771~multivesicular body,GO:0005829~cytosol,GO:0031902~late endosome membrane,		IPR005024:Snf7_fam,	gga04144:Endocytosis,gga04217:Necroptosis,				KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0175~Coiled coil,				MOTIF:MIT-interacting motif,REGION:Disordered,
Q8AYC9	checkpoint kinase 1(CHEK1)	Gallus gallus			GO:0000077~DNA damage checkpoint,GO:0006281~DNA repair,GO:0006338~chromatin remodeling,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0016310~phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0035556~intracellular signal transduction,GO:0042770~signal transduction in response to DNA damage,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045839~negative regulation of mitotic nuclear division,GO:0046602~regulation of mitotic centrosome separation,	GO:0000785~chromatin,GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0035402~histone kinase activity (H3-T11 specific),	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR034670:Chk1_catalytic_dom,	gga04110:Cell cycle,gga04115:p53 signaling pathway,gga04218:Cellular senescence,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,REGION:Autoinhibitory region,REGION:Disordered,
Q9Z265	checkpoint kinase 2(Chek2)	Mus musculus		m_atmPathway:ATM Signaling Pathway,m_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,	GO:0000077~DNA damage checkpoint,GO:0000085~mitotic G2 phase,GO:0000086~G2/M transition of mitotic cell cycle,GO:0001934~positive regulation of protein phosphorylation,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007049~cell cycle,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010332~response to gamma radiation,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0030163~protein catabolic process,GO:0031573~intra-S DNA damage checkpoint,GO:0042176~regulation of protein catabolic process,GO:0042770~signal transduction in response to DNA damage,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0044773~mitotic DNA damage checkpoint,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046777~protein autophosphorylation,GO:0050821~protein stabilization,GO:0051301~cell division,GO:0070242~thymocyte apoptotic process,GO:0071480~cellular response to gamma radiation,GO:0090307~mitotic spindle assembly,GO:2000002~negative regulation of DNA damage checkpoint,GO:2000210~positive regulation of anoikis,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016605~PML body,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR000253:FHA_dom,IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR008984:SMAD_FHA_dom_sf,IPR011009:Kinase-like_dom_sf,	mmu04110:Cell cycle,mmu04115:p53 signaling pathway,mmu04218:Cellular senescence,mmu05166:Human T-cell leukemia virus 1 infection,			SM00220:S_TKc,SM00240:FHA,	KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0132~Cell division,KW-0227~DNA damage,KW-0234~DNA repair,KW-0498~Mitosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:FHA,DOMAIN:Protein kinase,MUTAGEN:Y->C: Does not inhibit cell survival upon DNA damage. Not phosphorylates p53/TP53.,REGION:Disordered,REGION:T-loop/activation segment,
B9VR26	chemerin chemokine-like receptor 1(CMKLR1)	Bos taurus			GO:0002430~complement receptor mediated signaling pathway,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010759~positive regulation of macrophage chemotaxis,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032695~negative regulation of interleukin-12 production,GO:0045600~positive regulation of fat cell differentiation,GO:0050848~regulation of calcium-mediated signaling,	GO:0005886~plasma membrane,	GO:0004875~complement receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0097003~adipokinetic hormone receptor activity,GO:0097004~adipokinetic hormone binding,	IPR000276:GPCR_Rhodpsn,IPR000826:Formyl_rcpt-rel,IPR002258:CML1,IPR017452:GPCR_Rhodpsn_7TM,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
A0A8V1ABE9	chicken D-serine dehydratase(CHDSD)	Gallus gallus			GO:0036088~D-serine catabolic process,	GO:0005737~cytoplasm,GO:0030425~dendrite,	GO:0008270~zinc ion binding,GO:0008721~D-serine ammonia-lyase activity,GO:0016829~lyase activity,GO:0030170~pyridoxal phosphate binding,	IPR001608:Ala_racemase_N,IPR026956:D-ser_dehydrat-like_dom,IPR029066:PLP-binding_barrel,IPR042208:D-ser_dehydrat-like_sf,	gga00260:Glycine, serine and threonine metabolism,gga00470:D-Amino acid metabolism,gga01100:Metabolic pathways,			SM01119:D-ser_dehydrat,		KW-0963~Cytoplasm,KW-0966~Cell projection,				KW-0479~Metal-binding,KW-0663~Pyridoxal phosphate,KW-0862~Zinc,	KW-0456~Lyase,		DOMAIN:D-serine dehydratase-like,REGION:Disordered,
Q7SYK0	chitinase domain containing 1(chid1)	Danio rerio			GO:0005975~carbohydrate metabolic process,	GO:0005576~extracellular region,GO:0005764~lysosome,GO:0012505~endomembrane system,	GO:0008061~chitin binding,GO:0070492~oligosaccharide binding,	IPR001223:Glyco_hydro18_cat,IPR011583:Chitinase_II,IPR017853:Glycoside_hydrolase_SF,IPR029070:Chitinase_insertion_sf,				SM00636:Glyco_18,		KW-0458~Lysosome,KW-0964~Secreted,			KW-0732~Signal,				DOMAIN:GH18,REGION:Disordered,
Q6RY07	chitinase, acidic(Chia)	Rattus norvegicus			GO:0000272~polysaccharide catabolic process,GO:0002376~immune system process,GO:0002532~production of molecular mediator involved in inflammatory response,GO:0005975~carbohydrate metabolic process,GO:0006032~chitin catabolic process,GO:0006915~apoptotic process,GO:0006955~immune response,GO:0032722~positive regulation of chemokine production,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0004568~chitinase activity,GO:0005129~granulocyte macrophage colony-stimulating factor receptor binding,GO:0008061~chitin binding,GO:0008083~growth factor activity,GO:0019900~kinase binding,	IPR000773:GM_colony-stim-fac,IPR001223:Glyco_hydro18_cat,IPR001579:Glyco_hydro_18_chit_AS,IPR002557:Chitin-bd_dom,IPR009079:4_helix_cytokine-like_core,IPR011583:Chitinase_II,IPR017853:Glycoside_hydrolase_SF,IPR029070:Chitinase_insertion_sf,IPR036508:Chitin-bd_dom_sf,	rno00520:Amino sugar and nucleotide sugar metabolism,rno01100:Metabolic pathways,			SM00040:CSF2,SM00494:ChtBD2,SM00636:Glyco_18,	KW-0053~Apoptosis,KW-0119~Carbohydrate metabolism,KW-0146~Chitin degradation,KW-0391~Immunity,KW-0395~Inflammatory response,KW-0624~Polysaccharide degradation,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0147~Chitin-binding,	KW-0326~Glycosidase,KW-0378~Hydrolase,	KW-1015~Disulfide bond,	ACT_SITE:Proton donor,COMPBIAS:Polar residues,DOMAIN:Chitin-binding type-2,DOMAIN:GH18,REGION:Disordered,TRANSMEM:Helical,
P51788	chloride voltage-gated channel 2(CLCN2)	Homo sapiens			GO:0006821~chloride transport,GO:0030324~lung development,GO:0032347~regulation of aldosterone biosynthetic process,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0060041~retina development in camera-type eye,GO:0060689~cell differentiation involved in salivary gland development,GO:0090425~acinar cell differentiation,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0034707~chloride channel complex,GO:0043204~perikaryon,	GO:0005247~voltage-gated chloride channel activity,	IPR001807:Cl-channel_volt-gated,IPR002244:Cl-channel-2,IPR014743:Cl-channel_core,IPR046342:CBS_dom_sf,	hsa04978:Mineral absorption,	605635~Hyperaldosteronism, familial, type II,607628~Epilepsy, idiopathic generalized, susceptibility to, 11,607628~Epilepsy, juvenile absence, susceptibility to, 2,607628~Epilepsy, juvenile myoclonic, susceptibility to, 8,615651~Leukoencephalopathy with ataxia,			KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0887~Epilepsy,	KW-0129~CBS domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0851~Voltage-gated channel,KW-0869~Chloride channel,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:CBS 1,DOMAIN:CBS 2,INTRAMEM:Helical,INTRAMEM:Note=Loop between two helices,MOTIF:Selectivity filter part_1,MOTIF:Selectivity filter part_2,MOTIF:Selectivity filter part_3,REGION:Disordered,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
Q3V6R6	cholesteryl ester transfer protein(CETP)	Gallus gallus			GO:0006641~triglyceride metabolic process,GO:0008203~cholesterol metabolic process,GO:0030301~cholesterol transport,GO:0034197~triglyceride transport,GO:0034372~very-low-density lipoprotein particle remodeling,GO:0034374~low-density lipoprotein particle remodeling,GO:0034375~high-density lipoprotein particle remodeling,GO:0042632~cholesterol homeostasis,GO:0043691~reverse cholesterol transport,GO:0046470~phosphatidylcholine metabolic process,GO:0055091~phospholipid homeostasis,GO:0070328~triglyceride homeostasis,	GO:0005615~extracellular space,GO:0034364~high-density lipoprotein particle,	GO:0005548~phospholipid transporter activity,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0017129~triglyceride binding,GO:0031210~phosphatidylcholine binding,	IPR001124:Lipid-bd_serum_glycop_C,IPR017130:Cholesteryl_ester_transfer,IPR017942:Lipid-bd_serum_glycop_N,IPR017943:Bactericidal_perm-incr_a/b_dom,			PIRSF037185:Cholesteryl_ester_transf,	SM00328:BPI1,SM00329:BPI2,	KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0445~Lipid transport,KW-0753~Steroid metabolism,KW-0813~Transport,KW-1207~Sterol metabolism,	KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Lipid-binding serum glycoprotein C-terminal,DOMAIN:Lipid-binding serum glycoprotein N-terminal,
Q6UPE0	choline dehydrogenase(Chdh)	Rattus norvegicus			GO:0019285~glycine betaine biosynthetic process from choline,	GO:0005743~mitochondrial inner membrane,	GO:0008812~choline dehydrogenase activity,GO:0050660~flavin adenine dinucleotide binding,	IPR000172:GMC_OxRdtase_N,IPR007867:GMC_OxRtase_C,IPR012132:GMC_OxRdtase,IPR036188:FAD/NAD-bd_sf,	rno00260:Glycine, serine and threonine metabolism,rno01100:Metabolic pathways,		PIRSF000137:Alcohol_oxidase,			KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,	KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,	ACT_SITE:Proton acceptor,TRANSIT:Mitochondrion,
P35790	choline kinase alpha(CHKA)	Homo sapiens			GO:0006629~lipid metabolic process,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0006656~phosphatidylcholine biosynthetic process,GO:0006657~CDP-choline pathway,GO:0006869~lipid transport,GO:0016310~phosphorylation,GO:0042149~cellular response to glucose starvation,GO:1905691~lipid particle disassembly,	GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005829~cytosol,	GO:0004103~choline kinase activity,GO:0004104~cholinesterase activity,GO:0004305~ethanolamine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,	IPR011009:Kinase-like_dom_sf,	hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa05231:Choline metabolism in cancer,	620023~Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures,			KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0594~Phospholipid biosynthesis,KW-1208~Phospholipid metabolism,	KW-0551~Lipid droplet,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0991~Intellectual disability,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,MUTAGEN:E->A: Does not affect interaction with PLIN2 and PLIN3.,MUTAGEN:IL->AA: Abolished interaction with PLIN2 and PLIN3.,MUTAGEN:K->Q: Mimics acetylation; promoting monomerization, leading to decreased choline kinase activity. Increased lipolysis of lipid droplets.,MUTAGEN:K->R: Abolished acetylation by KAT5, leading to prevent conversion into a tyrosine-protein kinase.,MUTAGEN:MVL->AAA: Does not affect interaction with PLIN2 and PLIN3.,MUTAGEN:S->A: Abolished phosphorylation by AMPK, preventing localization to lipid droplets and subsequent acetylation by KAT5.,MUTAGEN:S->D: Mimics phosphorylation; promoting localization to lipid droplets.,MUTAGEN:VMF->AAA: Does not affect interaction with PLIN2 and PLIN3.,REGION:Disordered,
P30372	cholinergic receptor muscarinic 2(CHRM2)	Gallus gallus			GO:0006940~regulation of smooth muscle contraction,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007197~adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0008016~regulation of heart contraction,GO:0009615~response to virus,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,	GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0098793~presynapse,GO:0098981~cholinergic synapse,	GO:0004993~G-protein coupled serotonin receptor activity,GO:0016907~G-protein coupled acetylcholine receptor activity,GO:1990763~arrestin family protein binding,	IPR000276:GPCR_Rhodpsn,IPR000995:Musac_Ach_rcpt,IPR001065:Musac_Ach_M2_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	gga04020:Calcium signaling pathway,gga04080:Neuroactive ligand-receptor interaction,gga04810:Regulation of actin cytoskeleton,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,MOTIF:Important for signaling,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P41984	cholinergic receptor muscarinic 3(CHRM3)	Bos taurus			GO:0003056~regulation of vascular smooth muscle contraction,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007197~adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0045987~positive regulation of smooth muscle contraction,GO:0046541~saliva secretion,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016323~basolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0030425~dendrite,GO:0045202~synapse,GO:0045211~postsynaptic membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004993~G-protein coupled serotonin receptor activity,GO:0016907~G-protein coupled acetylcholine receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000995:Musac_Ach_rcpt,IPR001183:Musac_Ach_M3_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	bta04020:Calcium signaling pathway,bta04080:Neuroactive ligand-receptor interaction,bta04725:Cholinergic synapse,bta04742:Taste transduction,bta04810:Regulation of actin cytoskeleton,bta04911:Insulin secretion,bta04970:Salivary secretion,bta04971:Gastric acid secretion,bta04972:Pancreatic secretion,bta05010:Alzheimer disease,bta05022:Pathways of neurodegeneration - multiple diseases,			SM01381:7TM_GPCR_Srsx,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 1 profile,MOTIF:Basolateral sorting signal,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q8N6G5	chondroitin sulfate N-acetylgalactosaminyltransferase 2(CSGALNACT2)	Homo sapiens			GO:0030166~proteoglycan biosynthetic process,GO:0030206~chondroitin sulfate biosynthetic process,GO:0050650~chondroitin sulfate proteoglycan biosynthetic process,GO:0050651~dermatan sulfate proteoglycan biosynthetic process,GO:0050652~dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,GO:0050653~chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0032580~Golgi cisterna membrane,	GO:0005515~protein binding,GO:0008376~acetylgalactosaminyltransferase activity,GO:0046872~metal ion binding,GO:0047237~glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,GO:0047238~glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,	IPR008428:Chond_GalNAc,IPR029044:Nucleotide-diphossugar_trans,	hsa00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,hsa01100:Metabolic pathways,					KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0175~Coiled coil,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,	KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q6ZQ11	chondroitin sulfate synthase 1(Chsy1)	Mus musculus			GO:0002063~chondrocyte development,GO:0009954~proximal/distal pattern formation,GO:0030206~chondroitin sulfate biosynthetic process,GO:0030279~negative regulation of ossification,GO:0031667~response to nutrient levels,GO:0045880~positive regulation of smoothened signaling pathway,GO:0051216~cartilage development,GO:0051923~sulfation,GO:0060349~bone morphogenesis,	GO:0005576~extracellular region,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0032580~Golgi cisterna membrane,	GO:0008376~acetylgalactosaminyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0046872~metal ion binding,GO:0047238~glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,GO:0050510~N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,	IPR008428:Chond_GalNAc,IPR029044:Nucleotide-diphossugar_trans,	mmu00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,mmu01100:Metabolic pathways,					KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0964~Secreted,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,	KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
A0JMK9	chromatin assembly factor 1, subunit A (p150)(chaf1a)	Danio rerio			GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,	GO:0005634~nucleus,GO:0033186~CAF-1 complex,		IPR022043:CAF1A,IPR029091:CAF1_p150_N,IPR029105:CAF1-p150_C2,					KW-0131~Cell cycle,KW-0227~DNA damage,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0539~Nucleus,					KW-0143~Chaperone,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Chromatin assembly factor 1 subunit p150 C-terminal,DOMAIN:Chromatin assembly factor 1 subunit p150 N-terminal,REGION:Disordered,
Q9D0N7	chromatin assembly factor 1, subunit B(Chaf1b)	Mus musculus			GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032991~macromolecular complex,GO:0033186~CAF-1 complex,	GO:0005515~protein binding,	IPR001632:Gprotein_B,IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR029129:CAF1_p60_C,IPR036322:WD40_repeat_dom_sf,IPR045145:PTHR15271,				SM00320:WD40,	KW-0131~Cell cycle,KW-0227~DNA damage,KW-0234~DNA repair,KW-0235~DNA replication,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0853~WD repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
O95931	chromobox 7(CBX7)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0031519~PcG protein complex,GO:0035102~PRC1 complex,	GO:0005515~protein binding,	IPR000953:Chromo/chromo_shadow_dom,IPR016197:Chromo-like_dom_sf,IPR017984:Chromo_dom_subgr,IPR023779:Chromodomain_CS,IPR023780:Chromo_domain,IPR033773:CBX7_C,IPR043000:CBX7,	hsa03083:Polycomb repressive complex,			SM00298:CHROMO,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0156~Chromatin regulator,KW-0678~Repressor,		DOMAIN:Chromo,MUTAGEN:F->D: Loss of interaction with RNF2.,MUTAGEN:F->D: Reduced interaction with RNF2.,MUTAGEN:K->A: Loss of cellular lifespan extension.,MUTAGEN:W->A: Loss of cellular lifespan extension.,REGION:Disordered,REGION:Required for cellular lifespan extension,
Q3L8U1	chromodomain helicase DNA binding protein 9(CHD9)	Homo sapiens			GO:0006338~chromatin remodeling,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,	IPR000330:SNF2_N,IPR000953:Chromo/chromo_shadow_dom,IPR001650:Helicase_C,IPR006576:BRK_domain,IPR014001:Helicase_ATP-bd,IPR016197:Chromo-like_dom_sf,IPR023780:Chromo_domain,IPR027417:P-loop_NTPase,IPR037259:BRK_sf,IPR038718:SNF2-like_sf,				SM00298:CHROMO,SM00487:DEXDc,SM00490:HELICc,SM00592:BRK,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0156~Chromatin regulator,KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BRK,DOMAIN:Chromo,DOMAIN:Chromo 1,DOMAIN:Chromo 2,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,MOTIF:LXXLL motif 1,MOTIF:LXXLL motif 2,MOTIF:LXXLL motif 3,MOTIF:LXXLL motif 4,MOTIF:LXXLL motif 5,REGION:A.T hook-like,REGION:Binds A/T-rich DNA,REGION:Disordered,
Q68DL7	chromosome 18 open reading frame 63(C18orf63)	Homo sapiens						IPR031643:DUF4708,													COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q9BZE7	chromosome 22 open reading frame 23(C22orf23)	Homo sapiens					GO:0005515~protein binding,	IPR007914:UPF0193,													REGION:Disordered,
P0CG11	chromosome transmission fidelity factor 8(CHTF8)	Bos taurus			GO:0006260~DNA replication,GO:0007064~mitotic sister chromatid cohesion,GO:0032508~DNA duplex unwinding,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0031390~Ctf18 RFC-like complex,	GO:0003677~DNA binding,	IPR018607:Ctf8,					KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0539~Nucleus,					KW-0238~DNA-binding,
P47796	chymotrypsin A(LOC115558460)	Gadus morhua			GO:0006508~proteolysis,GO:0007586~digestion,	GO:0005576~extracellular region,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR043504:Peptidase_S1_PA_chymotrypsin,				SM00020:Tryp_SPc,	KW-0222~Digestion,	KW-0964~Secreted,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,DOMAIN:Peptidase S1,
P08217	chymotrypsin like elastase 2A(CELA2A)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,	GO:0006508~proteolysis,GO:0032868~response to insulin,GO:0050796~regulation of insulin secretion,GO:0090330~regulation of platelet aggregation,GO:1901143~insulin catabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0036457~keratohyalin granule,	GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0017171~serine hydrolase activity,	IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR043504:Peptidase_S1_PA_chymotrypsin,	hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,	618620~Abdominal obesity-metabolic syndrome 4,		SM00020:Tryp_SPc,		KW-0964~Secreted,		KW-0219~Diabetes mellitus,KW-0225~Disease variant,KW-0550~Obesity,	KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,DOMAIN:Peptidase S1,PROPEP:Activation peptide,
B1H283	ciliary microtubule associated protein 2(Cimap2)	Rattus norvegicus			GO:0008284~positive regulation of cell proliferation,GO:1903862~positive regulation of oxidative phosphorylation,	GO:0005739~mitochondrion,	GO:0097177~mitochondrial ribosome binding,	IPR010736:SHIPPO-rpt,IPR033557:CIMAP2,
P51641	ciliary neurotrophic factor receptor(CNTFR)	Gallus gallus			GO:0019221~cytokine-mediated signaling pathway,GO:0070120~ciliary neurotrophic factor-mediated signaling pathway,	GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0070110~ciliary neurotrophic factor receptor complex,GO:0097059~CNTFR-CLCF1 complex,	GO:0004896~cytokine receptor activity,GO:0004897~ciliary neurotrophic factor receptor activity,GO:0019955~cytokine binding,	IPR003530:Hematopoietin_rcpt_L_F3_CS,IPR003598:Ig_sub2,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,	gga04060:Cytokine-cytokine receptor interaction,			SM00060:FN3,SM00408:IGc2,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,LIPID:GPI-anchor amidated aspartate,MOTIF:WSXWS motif,PROPEP:Removed in mature form,REGION:Disordered,TRANSMEM:Helical,
Q9H799	ciliogenesis and planar polarity effector complex subunit 1(CPLANE1)	Homo sapiens			GO:0001736~establishment of planar polarity,GO:0001822~kidney development,GO:0003281~ventricular septum development,GO:0021549~cerebellum development,GO:0042733~embryonic digit morphogenesis,GO:0060021~palate development,GO:0060271~cilium assembly,GO:0060976~coronary vasculature development,GO:1904491~protein localization to ciliary transition zone,	GO:0016020~membrane,GO:0035869~ciliary transition zone,		IPR028236:CPLANE1,IPR036322:WD40_repeat_dom_sf,		277170~Orofaciodigital syndrome VI,614615~Joubert syndrome 17,			KW-0970~Cilium biogenesis/degradation,	KW-0472~Membrane,KW-0966~Cell projection,		KW-0225~Disease variant,KW-0979~Joubert syndrome,KW-1186~Ciliopathy,	KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,TRANSMEM:Helical,
Q0VF96	cingulin like 1(CGNL1)	Homo sapiens			GO:0007015~actin filament organization,GO:0051058~negative regulation of small GTPase mediated signal transduction,GO:0051497~negative regulation of stress fiber assembly,	GO:0005923~bicellular tight junction,GO:0016459~myosin complex,GO:0032991~macromolecular complex,	GO:0005515~protein binding,	IPR002928:Myosin_tail,	hsa04530:Tight junction,					KW-0796~Tight junction,KW-0965~Cell junction,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MOTIF:ZIM,REGION:Disordered,REGION:Head,REGION:Tail,
Q3TQ03	circadian associated repressor of transcription(Ciart)	Mus musculus			GO:0032922~circadian regulation of gene expression,GO:0045475~locomotor rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,	GO:0005634~nucleus,GO:0016605~PML body,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0005515~protein binding,GO:0070888~E-box binding,	IPR031373:Ciart,					KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
E9PSL7	citron rho-interacting serine/threonine kinase(Cit)	Rattus norvegicus			GO:0000070~mitotic sister chromatid segregation,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000281~mitotic cytokinesis,GO:0001889~liver development,GO:0006996~organelle organization,GO:0007030~Golgi organization,GO:0007091~metaphase/anaphase transition of mitotic cell cycle,GO:0007283~spermatogenesis,GO:0008064~regulation of actin polymerization or depolymerization,GO:0016310~phosphorylation,GO:0016358~dendrite development,GO:0030517~negative regulation of axon extension,GO:0032467~positive regulation of cytokinesis,GO:0035331~negative regulation of hippo signaling,GO:0045665~negative regulation of neuron differentiation,GO:0048699~generation of neurons,GO:0050774~negative regulation of dendrite morphogenesis,GO:0051402~neuron apoptotic process,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005773~vacuole,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,GO:0030496~midbody,GO:0031985~Golgi cisterna,GO:0032154~cleavage furrow,GO:0043025~neuronal cell body,	GO:0001223~transcription coactivator binding,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0030165~PDZ domain binding,GO:0030291~protein serine/threonine kinase inhibitor activity,GO:0046872~metal ion binding,GO:0097110~scaffold protein binding,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR001180:CNH_dom,IPR001849:PH_domain,IPR002219:PE/DAG-bd,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011993:PH-like_dom_sf,IPR017405:Citron_Rho-interacting_kinase,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,IPR037708:CRIK_dom,IPR046349:C1-like_sf,			PIRSF038145:Citron_Rho-interacting_kinase,	SM00036:CNH,SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:AGC-kinase C-terminal,DOMAIN:CNH,DOMAIN:PH,DOMAIN:Phorbol-ester/DAG-type,DOMAIN:Protein kinase,REGION:Disordered,ZN_FING:Phorbol-ester/DAG-type,
Q68FD5	clathrin heavy chain(Cltc)	Mus musculus			GO:0000278~mitotic cell cycle,GO:0006886~intracellular protein transport,GO:0006898~receptor-mediated endocytosis,GO:0006914~autophagy,GO:0007030~Golgi organization,GO:0007049~cell cycle,GO:0016192~vesicle-mediated transport,GO:0031623~receptor internalization,GO:0033572~transferrin transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0048268~clathrin coat assembly,GO:0048488~synaptic vesicle endocytosis,GO:0051301~cell division,GO:0060236~regulation of mitotic spindle organization,GO:0072583~clathrin-dependent endocytosis,GO:0090307~mitotic spindle assembly,GO:1900126~negative regulation of hyaluronan biosynthetic process,GO:1903077~negative regulation of protein localization to plasma membrane,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0005768~endosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005905~clathrin-coated pit,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0030117~membrane coat,GO:0030118~clathrin coat,GO:0030130~clathrin coat of trans-Golgi network vesicle,GO:0030132~clathrin coat of coated pit,GO:0030136~clathrin-coated vesicle,GO:0030315~T-tubule,GO:0031410~cytoplasmic vesicle,GO:0031523~Myb complex,GO:0032991~macromolecular complex,GO:0042383~sarcolemma,GO:0042470~melanosome,GO:0043209~myelin sheath,GO:0045334~clathrin-coated endocytic vesicle,GO:0071439~clathrin complex,GO:0072686~mitotic spindle,GO:0098684~photoreceptor ribbon synapse,GO:0098835~presynaptic endocytic zone membrane,GO:0098850~extrinsic component of synaptic vesicle membrane,GO:1990498~mitotic spindle microtubule,	GO:0003725~double-stranded RNA binding,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030506~ankyrin binding,GO:0031072~heat shock protein binding,GO:0032051~clathrin light chain binding,GO:0042277~peptide binding,GO:0050750~low-density lipoprotein particle receptor binding,GO:0097718~disordered domain specific binding,GO:1990381~ubiquitin-specific protease binding,	IPR000547:Clathrin_H-chain/VPS_repeat,IPR011990:TPR-like_helical_dom_sf,IPR015348:Clathrin_H-chain_linker_core,IPR016024:ARM-type_fold,IPR016025:Clathrin_H-chain_N,IPR016341:Clathrin_heavy_chain,IPR022365:Clathrin_H-chain_propeller_rpt,	mmu04142:Lysosome,mmu04144:Endocytosis,mmu04721:Synaptic vesicle cycle,mmu04961:Endocrine and other factor-regulated calcium reabsorption,mmu05016:Huntington disease,mmu05100:Bacterial invasion of epithelial cells,		PIRSF002290:Clathrin_H_chain,	SM00299:CLH,	KW-0072~Autophagy,KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0168~Coated pit,KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Clathrin heavy chain linker core motif,REGION:Binding site for the uncoating ATPase, involved in lattice disassembly,REGION:Distal segment,REGION:Flexible linker,REGION:Globular terminal domain,REGION:Heavy chain arm,REGION:Involved in binding clathrin light chain,REGION:Proximal segment,REGION:Trimerization,REGION:WD40-like repeat 1,REGION:WD40-like repeat 2,REGION:WD40-like repeat 3,REGION:WD40-like repeat 4,REGION:WD40-like repeat 5,REGION:WD40-like repeat 6,REGION:WD40-like repeat 7,REPEAT:CHCR,REPEAT:CHCR 1,REPEAT:CHCR 2,REPEAT:CHCR 3,REPEAT:CHCR 4,REPEAT:CHCR 5,REPEAT:CHCR 6,REPEAT:CHCR 7,
O08585	clathrin light chain A(Clta)	Mus musculus		m_arapPathway:ADP-Ribosylation Factor,	GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0007049~cell cycle,GO:0016192~vesicle-mediated transport,GO:0048268~clathrin coat assembly,GO:0051301~cell division,GO:0072583~clathrin-dependent endocytosis,	GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0016020~membrane,GO:0030118~clathrin coat,GO:0030125~clathrin vesicle coat,GO:0030130~clathrin coat of trans-Golgi network vesicle,GO:0030132~clathrin coat of coated pit,GO:0030136~clathrin-coated vesicle,GO:0030672~synaptic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0071439~clathrin complex,GO:0098835~presynaptic endocytic zone membrane,GO:0098843~postsynaptic endocytic zone,GO:0098978~glutamatergic synapse,GO:0099631~postsynaptic endocytic zone cytoplasmic component,	GO:0005198~structural molecule activity,GO:0032050~clathrin heavy chain binding,GO:0042277~peptide binding,GO:0044877~macromolecular complex binding,GO:0051020~GTPase binding,	IPR000996:Clathrin_L-chain,	mmu04142:Lysosome,mmu04144:Endocytosis,mmu04721:Synaptic vesicle cycle,mmu04961:Endocrine and other factor-regulated calcium reabsorption,mmu05016:Huntington disease,mmu05100:Bacterial invasion of epithelial cells,				KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0168~Coated pit,KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,	KW-0106~Calcium,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Disordered,REGION:Involved in binding clathrin heavy chain,
P56745	claudin 1(Cldn1)	Rattus norvegicus			GO:0007155~cell adhesion,GO:0008065~establishment of blood-nerve barrier,GO:0009636~response to toxic substance,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:0030335~positive regulation of cell migration,GO:0032496~response to lipopolysaccharide,GO:0034331~cell junction maintenance,GO:0045216~cell-cell junction organization,GO:0045471~response to ethanol,GO:0046718~viral entry into host cell,GO:0051259~protein oligomerization,GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing,GO:0061436~establishment of skin barrier,GO:0061772~drug transport across blood-nerve barrier,GO:0070673~response to interleukin-18,GO:0070830~bicellular tight junction assembly,GO:0071284~cellular response to lead ion,GO:0071346~cellular response to interferon-gamma,GO:0071356~cellular response to tumor necrosis factor,GO:0071548~response to dexamethasone,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0090303~positive regulation of wound healing,GO:0090557~establishment of endothelial intestinal barrier,GO:0097421~liver regeneration,GO:1903348~positive regulation of bicellular tight junction assembly,GO:1903545~cellular response to butyrate,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0030054~cell junction,GO:0032991~macromolecular complex,GO:0070160~occluding junction,	GO:0001618~virus receptor activity,GO:0005198~structural molecule activity,GO:0042802~identical protein binding,	IPR003548:Claudin1,IPR004031:PMP22/EMP/MP20/Claudin,IPR006187:Claudin,IPR017974:Claudin_CS,	rno04514:Cell adhesion molecules,rno04530:Tight junction,rno04670:Leukocyte transendothelial migration,rno05160:Hepatitis C,					KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-1015~Disulfide bond,	REGION:Disordered,REGION:Interactions with TJP1, TJP2, TJP3 and PATJ,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q2KIY2	claudin 15(CLDN15)	Bos taurus			GO:0006811~ion transport,GO:0007155~cell adhesion,GO:0070830~bicellular tight junction assembly,	GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,	GO:0005198~structural molecule activity,	IPR004031:PMP22/EMP/MP20/Claudin,IPR006187:Claudin,IPR008094:Claudin15,IPR017974:Claudin_CS,	bta04514:Cell adhesion molecules,bta04530:Tight junction,bta04670:Leukocyte transendothelial migration,bta05160:Hepatitis C,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	REGION:Important for the formation of tight-junction strand-like structures,SITE:Important for Na(+)-selective paracellular ion transport,SITE:Important for the formation of tight-junction strand-like structures,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6BBL6	claudin 4(CLDN4)	Bos taurus			GO:0007155~cell adhesion,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:0022604~regulation of cell morphogenesis,GO:0030335~positive regulation of cell migration,GO:0061436~establishment of skin barrier,GO:0070293~renal absorption,GO:0070830~bicellular tight junction assembly,GO:0090303~positive regulation of wound healing,	GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0034707~chloride channel complex,	GO:0005198~structural molecule activity,GO:0005254~chloride channel activity,GO:0042802~identical protein binding,	IPR003550:Claudin4,IPR004031:PMP22/EMP/MP20/Claudin,IPR006187:Claudin,IPR017974:Claudin_CS,	bta04514:Cell adhesion molecules,bta04530:Tight junction,bta04670:Leukocyte transendothelial migration,bta05160:Hepatitis C,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	REGION:Interaction with EPHA2,REGION:Interactions with TJP1, TJP2 and TJP3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O35054	claudin 4(Cldn4)	Mus musculus			GO:0006811~ion transport,GO:0006821~chloride transport,GO:0007155~cell adhesion,GO:0007565~female pregnancy,GO:0007623~circadian rhythm,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:0022604~regulation of cell morphogenesis,GO:0030335~positive regulation of cell migration,GO:0032570~response to progesterone,GO:0034220~ion transmembrane transport,GO:0061436~establishment of skin barrier,GO:0070293~renal absorption,GO:0070830~bicellular tight junction assembly,GO:0090303~positive regulation of wound healing,GO:1905050~positive regulation of metallopeptidase activity,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0034707~chloride channel complex,GO:0070160~occluding junction,GO:0070161~anchoring junction,	GO:0005198~structural molecule activity,GO:0005254~chloride channel activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR003550:Claudin4,IPR004031:PMP22/EMP/MP20/Claudin,IPR006187:Claudin,IPR017974:Claudin_CS,	mmu04514:Cell adhesion molecules,mmu04530:Tight junction,mmu04670:Leukocyte transendothelial migration,mmu05160:Hepatitis C,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	MUTAGEN:D->N: No effect.,MUTAGEN:E->Q: No effect.,MUTAGEN:K->T: Abolishes ability to form paracellular chloride channel.,MUTAGEN:R->T: No effect.,REGION:Interaction with EPHA2,REGION:Interactions with TJP1, TJP2 and TJP3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P56748	claudin 8(CLDN8)	Homo sapiens			GO:0007155~cell adhesion,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:0070830~bicellular tight junction assembly,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0016323~basolateral plasma membrane,GO:0016327~apicolateral plasma membrane,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR004031:PMP22/EMP/MP20/Claudin,IPR006187:Claudin,IPR017974:Claudin_CS,	hsa04514:Cell adhesion molecules,hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05130:Pathogenic Escherichia coli infection,hsa05160:Hepatitis C,					KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0832~Ubl conjugation,	REGION:Disordered,REGION:Interactions with TJP1, TJP2 and TJP3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P14018	clusterin(CLU)	Coturnix japonica			GO:0042127~regulation of cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0050821~protein stabilization,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0031966~mitochondrial membrane,GO:0042583~chromaffin granule,		IPR000753:Clusterin-like,IPR016014:Clusterin_N,IPR016015:Clusterin_C,IPR016016:Clusterin,IPR033986:Clusterin_CS,			PIRSF002368:Clusterin,	SM00030:CLb,SM00035:CLa,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0732~Signal,		KW-0143~Chaperone,	KW-0325~Glycoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DISULFID:Interchain (between beta and alpha chains),DOMAIN:Clusterin C-terminal,DOMAIN:Clusterin N-terminal,REGION:Disordered,
Q6DC04	coactivator-associated arginine methyltransferase 1(carm1)	Danio rerio			GO:0006325~chromatin organization,GO:0032259~methylation,GO:0033146~regulation of intracellular estrogen receptor signaling pathway,GO:0045600~positive regulation of fat cell differentiation,GO:0048742~regulation of skeletal muscle fiber development,GO:0071932~replication fork reversal,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0043596~nuclear replication fork,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016274~protein-arginine N-methyltransferase activity,GO:0016740~transferase activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0035242~protein-arginine omega-N asymmetric methyltransferase activity,GO:0035642~histone methyltransferase activity (H3-R17 specific),GO:0070577~lysine-acetylated histone binding,GO:0070611~histone methyltransferase activity (H3-R2 specific),	IPR011993:PH-like_dom_sf,IPR020989:Histone-Arg_MeTrfase_N,IPR025799:Arg_MeTrfase,IPR029063:SAM-dependent_MTases_sf,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0949~S-adenosyl-L-methionine,	KW-0156~Chromatin regulator,KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:Histone-arginine methyltransferase CARM1 N-terminal,DOMAIN:SAM-dependent MTase PRMT-type,REGION:Transactivation domain,
B0BNA5	coactosin-like F-actin binding protein 1(Cotl1)	Rattus norvegicus			GO:0030833~regulation of actin filament polymerization,GO:0050832~defense response to fungus,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005884~actin filament,GO:0030427~site of polarized growth,GO:0030864~cortical actin cytoskeleton,	GO:0003779~actin binding,GO:0019899~enzyme binding,GO:0051015~actin filament binding,	IPR002108:ADF-H,IPR029006:ADF-H/Gelsolin-like_dom_sf,				SM00102:ADF,		KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0009~Actin-binding,KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:ADF-H,REGION:Flexible and important for F-actin binding,
O18806	coagulation factor VIII(F8)	Canis lupus dingo			GO:0006953~acute-phase response,GO:0007597~blood coagulation, intrinsic pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005507~copper ion binding,GO:0016491~oxidoreductase activity,	IPR000421:FA58C,IPR001117:Cu-oxidase_2nd,IPR008972:Cupredoxin,IPR008979:Galactose-bd-like_sf,IPR011706:Cu-oxidase_C,IPR011707:Cu-oxidase-like_N,IPR024715:Factor_5/8-like,IPR033138:Cu_oxidase_CS,	clud04610:Complement and coagulation cascades,		PIRSF000354:Factors_V_VIII,	SM00231:FA58C,	KW-0011~Acute phase,KW-0094~Blood coagulation,KW-0356~Hemostasis,	KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0765~Sulfation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:F5/8 type A 1,DOMAIN:F5/8 type A 2,DOMAIN:F5/8 type A 3,DOMAIN:F5/8 type C,DOMAIN:F5/8 type C 1,DOMAIN:F5/8 type C 2,DOMAIN:Plastocyanin-like 1,DOMAIN:Plastocyanin-like 2,DOMAIN:Plastocyanin-like 3,DOMAIN:Plastocyanin-like 4,DOMAIN:Plastocyanin-like 5,DOMAIN:Plastocyanin-like 6,REGION:B,REGION:Disordered,SITE:Cleavage (activation),SITE:Cleavage; by thrombin,
O18806	coagulation factor VIII(F8)	Canis lupus familiaris			GO:0006953~acute-phase response,GO:0007597~blood coagulation, intrinsic pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005507~copper ion binding,GO:0016491~oxidoreductase activity,	IPR000421:FA58C,IPR001117:Cu-oxidase_2nd,IPR008972:Cupredoxin,IPR008979:Galactose-bd-like_sf,IPR011706:Cu-oxidase_C,IPR011707:Cu-oxidase-like_N,IPR024715:Factor_5/8-like,IPR033138:Cu_oxidase_CS,	cfa04610:Complement and coagulation cascades,		PIRSF000354:Factors_V_VIII,	SM00231:FA58C,	KW-0011~Acute phase,KW-0094~Blood coagulation,KW-0356~Hemostasis,	KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0765~Sulfation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:F5/8 type A 1,DOMAIN:F5/8 type A 2,DOMAIN:F5/8 type A 3,DOMAIN:F5/8 type C,DOMAIN:F5/8 type C 1,DOMAIN:F5/8 type C 2,DOMAIN:Plastocyanin-like 1,DOMAIN:Plastocyanin-like 2,DOMAIN:Plastocyanin-like 3,DOMAIN:Plastocyanin-like 4,DOMAIN:Plastocyanin-like 5,DOMAIN:Plastocyanin-like 6,REGION:B,REGION:Disordered,SITE:Cleavage (activation),SITE:Cleavage; by thrombin,
O97507	coagulation factor XII(F12)	Sus scrofa			GO:0002542~Factor XII activation,GO:0006508~proteolysis,GO:0007596~blood coagulation,GO:0010756~positive regulation of plasminogen activation,GO:0016540~protein autoprocessing,GO:0030194~positive regulation of blood coagulation,GO:0031638~zymogen activation,GO:0042730~fibrinolysis,GO:0051788~response to misfolded protein,GO:0051919~positive regulation of fibrinolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005791~rough endoplasmic reticulum,	GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0008236~serine-type peptidase activity,	IPR000001:Kringle,IPR000083:Fibronectin_type1,IPR000562:FN_type2_dom,IPR000742:EGF-like_dom,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR001881:EGF-like_Ca-bd_dom,IPR009003:Peptidase_S1_PA,IPR013806:Kringle-like,IPR014394:Coagulation_fac_XII/HGFA,IPR018056:Kringle_CS,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR036943:FN_type2_sf,IPR038178:Kringle_sf,IPR043504:Peptidase_S1_PA_chymotrypsin,	ssc04610:Complement and coagulation cascades,		PIRSF001146:Factor_XII_HGFA,	SM00020:Tryp_SPc,SM00058:FN1,SM00059:FN2,SM00130:KR,SM00179:EGF_CA,SM00181:EGF,	KW-0094~Blood coagulation,KW-0280~Fibrinolysis,KW-0356~Hemostasis,	KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0420~Kringle,KW-0677~Repeat,KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Fuc) threonine,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:Fibronectin type-I,DOMAIN:Fibronectin type-II,DOMAIN:Kringle,DOMAIN:Peptidase S1,REGION:Disordered,
Q567E6	coenzyme Q10B(coq10b)	Danio rerio			GO:0006744~ubiquinone biosynthetic process,GO:0045333~cellular respiration,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0048039~ubiquinone binding,	IPR005031:COQ10_START,IPR023393:START-like_dom_sf,IPR044996:COQ10-like,						KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,				TRANSIT:Mitochondrion,
Q2KIQ4	coenzyme Q2, polyprenyltransferase(COQ2)	Bos taurus			GO:0006071~glycerol metabolic process,GO:0006744~ubiquinone biosynthetic process,GO:0008299~isoprenoid biosynthetic process,	GO:0005743~mitochondrial inner membrane,	GO:0002083~4-hydroxybenzoate decaprenyltransferase activity,GO:0008412~4-hydroxybenzoate octaprenyltransferase activity,GO:0047293~4-hydroxybenzoate nonaprenyltransferase activity,	IPR000537:UbiA_prenyltransferase,IPR006370:HB_polyprenyltransferase-like,IPR030470:UbiA_prenylTrfase_CS,IPR039653:Prenyltransferase,IPR044878:UbiA_sf,	bta00130:Ubiquinone and other terpenoid-quinone biosynthesis,bta01100:Metabolic pathways,bta01240:Biosynthesis of cofactors,				KW-0414~Isoprene biosynthesis,KW-0831~Ubiquinone biosynthesis,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,		TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSIT:Mitochondrion,TRANSMEM:Helical,
Q6PF54	coiled-coil and C2 domain containing 1B L homeolog(cc2d1b.L)	Xenopus laevis					GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,	IPR000008:C2_dom,IPR006608:CC2D1A/B_DM14,IPR035892:C2_domain_sf,IPR037772:C2_Freud,IPR039725:CC2D1A/B,				SM00239:C2,SM00685:DM14,					KW-0175~Coiled coil,				COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,REGION:Disordered,
P0CK98	coiled-coil domain 39 molecular ruler complex subunit(ccdc39)	Danio rerio			GO:0003341~cilium movement,GO:0007368~determination of left/right symmetry,GO:0036159~inner dynein arm assembly,GO:0060285~cilium-dependent cell motility,GO:0060287~epithelial cilium movement involved in determination of left/right asymmetry,GO:0070286~axonemal dynein complex assembly,	GO:0005576~extracellular region,GO:0005930~axoneme,		IPR033290:CCDC39,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,		KW-0990~Primary ciliary dyskinesia,KW-1186~Ciliopathy,	KW-0175~Coiled coil,				COMPBIAS:Polar residues,REGION:Disordered,
Q1LZ89	coiled-coil domain containing 106(CCDC106)	Bos taurus				GO:0005654~nucleoplasm,GO:0005829~cytosol,		IPR031591:CCDC106,						KW-0539~Nucleus,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,MOTIF:Bipartite nuclear localization signal,REGION:Disordered,
Q96EE4	coiled-coil domain containing 126(CCDC126)	Homo sapiens				GO:0005576~extracellular region,GO:0016020~membrane,		IPR027833:DUF4525,IPR042759:CCDC126,						KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,
Q28F39	coiled-coil domain containing 134(ccdc134)	Xenopus tropicalis				GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,	GO:0008430~selenium binding,	IPR007671:Selenoprotein-P_N,IPR026321:Coiled-coil_dom_con_pro_134,IPR037941:SeP,						KW-0256~Endoplasmic reticulum,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,				DOMAIN:Selenoprotein P N-terminal,MOTIF:Nuclear localization signal,REGION:Disordered,
Q8CAI1	coiled-coil domain containing 142(Ccdc142)	Mus musculus						IPR026700:CCDC142,									KW-0175~Coiled coil,				REGION:Disordered,
Q5RHZ2	coiled-coil domain containing 167(ccdc167)	Danio rerio				GO:0016020~membrane,		IPR028194:CCDC-167,						KW-0472~Membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
Q7T312	coiled-coil domain containing 25(ccdc25)	Danio rerio			GO:2000147~positive regulation of cell motility,	GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016020~membrane,	GO:0003677~DNA binding,	IPR008532:NFACT_RNA-bd,IPR039730:Jlp2/Ccd25,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:DNA-binding,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9BQI4	coiled-coil domain containing 3(CCDC3)	Homo sapiens			GO:0008610~lipid biosynthetic process,GO:0010629~negative regulation of gene expression,GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway,GO:0045600~positive regulation of fat cell differentiation,GO:0045833~negative regulation of lipid metabolic process,GO:0046889~positive regulation of lipid biosynthetic process,GO:0051055~negative regulation of lipid biosynthetic process,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,		IPR040311:CCDC3,						KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,
Q08CF3	coiled-coil domain containing 61(ccdc61)	Danio rerio			GO:0030030~cell projection organization,GO:0090307~mitotic spindle assembly,GO:0098534~centriole assembly,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0034451~centriolar satellite,GO:0036064~ciliary basal body,GO:0042995~cell projection,	GO:0042802~identical protein binding,						KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MUTAGEN:FD->EA: Abolishes dimerization.,REGION:Disordered,REGION:Head domain,
A7MC22	coiled-coil domain containing 69(ccdc69)	Danio rerio			GO:0051255~spindle midzone assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0030496~midbody,GO:0051233~spindle midzone,	GO:0008017~microtubule binding,							KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0449~Lipoprotein,KW-0519~Myristate,	COMPBIAS:Basic and acidic residues,LIPID:N-myristoyl glycine,REGION:Disordered,
Q90X49	coiled-coil domain containing 80(ccdc80)	Danio rerio			GO:0001756~somitogenesis,GO:0003073~regulation of systemic arterial blood pressure,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0005604~basement membrane,		IPR025232:DUF4174,						KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0732~Signal,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:DUF4174,REGION:Disordered,
Q0P485	coiled-coil domain containing 85C, a(ccdc85ca)	Danio rerio				GO:0005912~adherens junction,GO:0005923~bicellular tight junction,GO:0043296~apical junction complex,GO:0070161~anchoring junction,		IPR019359:CCDC85,						KW-0796~Tight junction,KW-0965~Cell junction,			KW-0175~Coiled coil,		KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q5XIB5	coiled-coil domain containing 86(Ccdc86)	Rattus norvegicus				GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,		IPR005579:Cgr1-like,IPR026570:CCDC86,						KW-0539~Nucleus,			KW-0175~Coiled coil,			KW-0164~Citrullination,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,
Q8WYQ3	coiled-coil-helix-coiled-coil-helix domain containing 10(CHCHD10)	Homo sapiens			GO:0006119~oxidative phosphorylation,GO:0007005~mitochondrion organization,GO:0030322~stabilization of membrane potential,GO:0031930~mitochondria-nucleus signaling pathway,GO:0051457~maintenance of protein location in nucleus,GO:0065003~macromolecular complex assembly,GO:0090144~mitochondrial nucleoid organization,GO:0099558~maintenance of synapse structure,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1903109~positive regulation of transcription from mitochondrial promoter,GO:1903852~positive regulation of cristae formation,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005758~mitochondrial intermembrane space,GO:0061617~MICOS complex,	GO:0005515~protein binding,	IPR010625:CHCH,	hsa05014:Amyotrophic lateral sclerosis,	615048~Spinal muscular atrophy, Jokela type,615911~Frontotemporal dementia and/or amyotrophic lateral sclerosis 2,616209~Myopathy, isolated mitochondrial, autosomal dominant,				KW-0496~Mitochondrion,		KW-0036~Amyotrophic lateral sclerosis,KW-0225~Disease variant,KW-0523~Neurodegeneration,	KW-0809~Transit peptide,			KW-1015~Disulfide bond,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:CHCH,MOTIF:Cx9C motif 1,MOTIF:Cx9C motif 2,REGION:Disordered,TRANSIT:Mitochondrion,
Q9DED4	cold inducible RNA binding protein S homeolog(cirbp.S)	Xenopus laevis			GO:0007369~gastrulation,GO:0009409~response to cold,GO:0009792~embryo development ending in birth or egg hatching,GO:0016477~cell migration,GO:0022008~neurogenesis,GO:0045727~positive regulation of translation,GO:0048255~mRNA stabilization,GO:0048793~pronephros development,GO:0060212~negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0043022~ribosome binding,	IPR000504:RRM_dom,IPR003954:RRM_dom_euk,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034278:RBM3/CIRBP_RRM,IPR035979:RBD_domain_sf,				SM00360:RRM,SM00361:RRM_1,	KW-0346~Stress response,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0217~Developmental protein,KW-0694~RNA-binding,KW-9996~Developmental protein,	KW-0488~Methylation,	COMPBIAS:Polar residues,DOMAIN:RRM,REGION:Disordered,
Q5RF83	cold inducible RNA binding protein(CIRBP)	Pongo abelii			GO:0009411~response to UV,GO:0030308~negative regulation of cell growth,GO:0034063~stress granule assembly,GO:0045727~positive regulation of translation,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0048255~mRNA stabilization,GO:0070417~cellular response to cold,GO:1902806~regulation of cell cycle G1/S phase transition,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0008266~poly(U) RNA binding,GO:0030371~translation repressor activity,GO:0070181~small ribosomal subunit rRNA binding,	IPR000504:RRM_dom,IPR003954:RRM_dom_euk,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034278:RBM3/CIRBP_RRM,IPR035979:RBD_domain_sf,				SM00360:RRM,SM00361:RRM_1,	KW-0346~Stress response,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:RRM,REGION:Disordered,
Q91YQ3	cold shock domain containing C2, RNA binding(Csdc2)	Mus musculus			GO:0006397~mRNA processing,GO:0043488~regulation of mRNA stability,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,	IPR002059:CSP_DNA-bd,IPR011129:CSD,IPR012340:NA-bd_OB-fold,IPR019844:CSD_1,				SM00357:CSP,	KW-0507~mRNA processing,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	DOMAIN:CSD,REGION:Disordered,
A8WGB1	collagen and calcium binding EGF domains 1(ccbe1)	Danio rerio			GO:0001525~angiogenesis,GO:0001945~lymph vessel development,GO:0001946~lymphangiogenesis,GO:0002040~sprouting angiogenesis,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0048845~venous blood vessel morphogenesis,GO:0048856~anatomical structure development,GO:0060855~venous endothelial cell migration involved in lymph vessel development,	GO:0005576~extracellular region,GO:0005581~collagen trimer,	GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR008160:Collagen,IPR018097:EGF_Ca-bd_CS,				SM00179:EGF_CA,SM00181:EGF,	KW-0037~Angiogenesis,	KW-0964~Secreted,			KW-0176~Collagen,KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Collagen-like 1,DOMAIN:Collagen-like 2,DOMAIN:EGF-like,DOMAIN:EGF-like; calcium-binding,MUTAGEN:D->E: In fof(hu3613); lacks the thoracic duct and the previously unidentified intersegmental (ISLVs) and dorsal longitudinal lymphatic vessels (DLLVs) but retains a seemingly normal blood vasculature. Mutants show edema, initiating in the lower intestine and around the eyes from 6 dpf. At 36 dpf, surviving mutants show severe edema.,REGION:Disordered,
Q6NVG7	collagen beta(1-O)galactosyltransferase 2(Colgalt2)	Mus musculus				GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0050211~procollagen galactosyltransferase activity,	IPR002654:Glyco_trans_25,IPR029044:Nucleotide-diphossugar_trans,	mmu00310:Lysine degradation,mmu00514:Other types of O-glycan biosynthesis,mmu01100:Metabolic pathways,					KW-0256~Endoplasmic reticulum,			KW-0732~Signal,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MOTIF:Prevents secretion from ER,REGION:Disordered,
P02457	collagen type I alpha 1 chain(COL1A1)	Gallus gallus			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001568~blood vessel development,GO:0001649~osteoblast differentiation,GO:0001957~intramembranous ossification,GO:0001958~endochondral ossification,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0009612~response to mechanical stimulus,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010812~negative regulation of cell-substrate adhesion,GO:0015031~protein transport,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030335~positive regulation of cell migration,GO:0032964~collagen biosynthetic process,GO:0034504~protein localization to nucleus,GO:0043588~skin development,GO:0043589~skin morphogenesis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048706~embryonic skeletal system development,GO:0060325~face morphogenesis,GO:0060346~bone trabecula formation,GO:0060351~cartilage development involved in endochondral bone morphogenesis,GO:0071230~cellular response to amino acid stimulus,GO:0071260~cellular response to mechanical stimulus,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005584~collagen type I trimer,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0002020~protease binding,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0048407~platelet-derived growth factor binding,	IPR000885:Fib_collagen_C,IPR001007:VWF_dom,IPR008160:Collagen,	gga04510:Focal adhesion,gga04512:ECM-receptor interaction,			SM00038:COLFI,SM00214:VWC,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Gal...) hydroxylysine; partial,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DISULFID:Interchain (with C-1254),DISULFID:Interchain (with C-1271),DOMAIN:Fibrillar collagen NC1,DOMAIN:VWFC,PROPEP:C-terminal propeptide,PROPEP:N-terminal propeptide,REGION:Disordered,SITE:Not glycosylated,
P02454	collagen type I alpha 1 chain(Col1a1)	Rattus norvegicus			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001568~blood vessel development,GO:0001649~osteoblast differentiation,GO:0001957~intramembranous ossification,GO:0001958~endochondral ossification,GO:0007584~response to nutrient,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0009410~response to xenobiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010812~negative regulation of cell-substrate adhesion,GO:0014070~response to organic cyclic compound,GO:0015031~protein transport,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030335~positive regulation of cell migration,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol,GO:0032868~response to insulin,GO:0032964~collagen biosynthetic process,GO:0034504~protein localization to nucleus,GO:0034505~tooth mineralization,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0042542~response to hydrogen peroxide,GO:0043434~response to peptide hormone,GO:0043588~skin development,GO:0043589~skin morphogenesis,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048545~response to steroid hormone,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0051591~response to cAMP,GO:0055093~response to hyperoxia,GO:0060325~face morphogenesis,GO:0060346~bone trabecula formation,GO:0060351~cartilage development involved in endochondral bone morphogenesis,GO:0071230~cellular response to amino acid stimulus,GO:0071260~cellular response to mechanical stimulus,GO:0071300~cellular response to retinoic acid,GO:0071306~cellular response to vitamin E,GO:0071333~cellular response to glucose stimulus,GO:0071356~cellular response to tumor necrosis factor,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1902617~response to fluoride,GO:1902618~cellular response to fluoride,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005584~collagen type I trimer,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030141~secretory granule,GO:0031012~extracellular matrix,	GO:0002020~protease binding,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0048407~platelet-derived growth factor binding,	IPR000885:Fib_collagen_C,IPR001007:VWF_dom,IPR008160:Collagen,	rno04151:PI3K-Akt signaling pathway,rno04510:Focal adhesion,rno04512:ECM-receptor interaction,rno04611:Platelet activation,rno04926:Relaxin signaling pathway,rno04933:AGE-RAGE signaling pathway in diabetic complications,rno04974:Protein digestion and absorption,rno05146:Amoebiasis,rno05165:Human papillomavirus infection,rno05205:Proteoglycans in cancer,rno05415:Diabetic cardiomyopathy,			SM00038:COLFI,SM00214:VWC,		KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Gal...) hydroxylysine; alternate,COMPBIAS:Pro residues,DISULFID:Interchain (with C-1254),DISULFID:Interchain (with C-1271),DOMAIN:Fibrillar collagen NC1,DOMAIN:VWFC,MOTIF:Cell attachment site,PROPEP:C-terminal propeptide,PROPEP:N-terminal propeptide,REGION:Disordered,REGION:Major antigenic determinant (of neutral salt-extracted rat skin collagen),REGION:Nonhelical region (C-terminal),REGION:Nonhelical region (N-terminal),REGION:Triple-helical region,TRANSMEM:Helical,
P08572	collagen type IV alpha 2 chain(COL4A2)	Homo sapiens		h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,h_amiPathway:Acute Myocardial Infarction,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,h_npp1Pathway:Regulators of Bone Mineralization,h_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,h_vitCBPathway:Vitamin C in the Brain,	GO:0001525~angiogenesis,GO:0006351~transcription, DNA-templated,GO:0014823~response to activity,GO:0016525~negative regulation of angiogenesis,GO:0030198~extracellular matrix organization,GO:0035987~endodermal cell differentiation,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005587~collagen type IV trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0060090~binding, bridging,	IPR001442:Collagen_IV_NC,IPR008160:Collagen,IPR016187:CTDL_fold,IPR019326:NDNF,IPR036954:Collagen_IV_NC_sf,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04926:Relaxin signaling pathway,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	614483~Brain small vessel disease 2,614519~Hemorrhage, intracerebral, susceptibility to,		SM00111:C4,	KW-0037~Angiogenesis,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,	KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,			KW-0102~Bromination,KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:Collagen IV NC1,PROPEP:N-terminal propeptide (7S domain),REGION:Disordered,REGION:Triple-helical region,
Q28084	collagen type IV alpha 3 chain(COL4A3)	Bos taurus			GO:0007155~cell adhesion,GO:0016525~negative regulation of angiogenesis,GO:0030198~extracellular matrix organization,GO:0032836~glomerular basement membrane development,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0072577~endothelial cell apoptotic process,GO:1905563~negative regulation of vascular endothelial cell proliferation,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005587~collagen type IV trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,	GO:0005178~integrin binding,GO:0005201~extracellular matrix structural constituent,GO:0030020~extracellular matrix structural constituent conferring tensile strength,	IPR001442:Collagen_IV_NC,IPR008160:Collagen,IPR016187:CTDL_fold,IPR036954:Collagen_IV_NC_sf,	bta04151:PI3K-Akt signaling pathway,bta04510:Focal adhesion,bta04512:ECM-receptor interaction,bta04926:Relaxin signaling pathway,bta04933:AGE-RAGE signaling pathway in diabetic complications,bta04974:Protein digestion and absorption,bta05146:Amoebiasis,bta05165:Human papillomavirus infection,bta05200:Pathways in cancer,bta05222:Small cell lung cancer,			SM00111:C4,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,			KW-0379~Hydroxylation,KW-1015~Disulfide bond,	COMPBIAS:Pro residues,CROSSLNK:S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-334),CROSSLNK:S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-452),DISULFID:Or C-261 with C-349,DISULFID:Or C-294 with C-352,DISULFID:Or C-371 with C-463,DISULFID:Or C-405 with C-466,DOMAIN:Collagen IV NC1,MOTIF:Cell attachment site,REGION:Disordered,REGION:Triple-helical region,
P15988	collagen type VI alpha 2 chain(COL6A2)	Gallus gallus			GO:0007155~cell adhesion,	GO:0005576~extracellular region,GO:0005581~collagen trimer,		IPR002035:VWF_A,IPR008160:Collagen,IPR036465:vWFA_dom_sf,	gga04510:Focal adhesion,gga04512:ECM-receptor interaction,			SM00327:VWA,	KW-0130~Cell adhesion,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0379~Hydroxylation,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:VWFA,DOMAIN:VWFA 1,DOMAIN:VWFA 2,DOMAIN:VWFA 3,MOTIF:Cell attachment site,REGION:Disordered,REGION:Interruption in collagenous region,REGION:Nonhelical region,REGION:Triple-helical region,
P12111	collagen type VI alpha 3 chain(COL6A3)	Homo sapiens			GO:0007155~cell adhesion,GO:0007517~muscle organ development,GO:0009411~response to UV,GO:0009749~response to glucose,GO:0043491~protein kinase B signaling,GO:0051402~neuron apoptotic process,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005589~collagen type VI trimer,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,GO:0042383~sarcolemma,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0030020~extracellular matrix structural constituent conferring tensile strength,	IPR002035:VWF_A,IPR002223:Kunitz_BPTI,IPR003961:FN3_dom,IPR008160:Collagen,IPR013783:Ig-like_fold,IPR020901:Prtase_inh_Kunz-CS,IPR036116:FN3_sf,IPR036465:vWFA_dom_sf,IPR036880:Kunitz_BPTI_sf,IPR041900:vWA_collagen_alpha3-VI-like,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04974:Protein digestion and absorption,hsa05165:Human papillomavirus infection,	616411~Dystonia 27,620726~Bethlem myopathy 1C,620728~Ullrich congenital muscular dystrophy 1C,		SM00131:KU,SM00327:VWA,	KW-0130~Cell adhesion,	KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,KW-0912~Congenital muscular dystrophy,KW-0947~Limb-girdle muscular dystrophy,KW-1023~Dystonia,	KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,		KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Gal...) hydroxylysine; alternate,COMPBIAS:Basic and acidic residues,DISULFID:Interchain,DOMAIN:BPTI/Kunitz inhibitor,DOMAIN:Collagen-like 1,DOMAIN:Collagen-like 2,DOMAIN:Collagen-like 3,DOMAIN:Collagen-like 4,DOMAIN:Collagen-like 5,DOMAIN:Fibronectin type-III,DOMAIN:VWFA,DOMAIN:VWFA 1,DOMAIN:VWFA 10,DOMAIN:VWFA 11,DOMAIN:VWFA 12,DOMAIN:VWFA 2,DOMAIN:VWFA 3,DOMAIN:VWFA 4,DOMAIN:VWFA 5,DOMAIN:VWFA 6,DOMAIN:VWFA 7,DOMAIN:VWFA 8,DOMAIN:VWFA 9,MOTIF:Cell attachment site,REGION:Disordered,REGION:Nonhelical region,REGION:Triple-helical region,SITE:Reactive bond,
Q99715	collagen type XII alpha 1 chain(COL12A1)	Homo sapiens			GO:0007155~cell adhesion,GO:0030199~collagen fibril organization,GO:0035987~endodermal cell differentiation,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005595~collagen type XII trimer,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0030020~extracellular matrix structural constituent conferring tensile strength,	IPR002035:VWF_A,IPR003961:FN3_dom,IPR008160:Collagen,IPR013320:ConA-like_dom_sf,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036465:vWFA_dom_sf,IPR048287:TSPN-like_N,	hsa04974:Protein digestion and absorption,	616470~Ullrich congenital muscular dystrophy 2,616471~Bethlem myopathy 2,		SM00060:FN3,SM00210:TSPN,SM00327:VWA,	KW-0130~Cell adhesion,	KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,KW-0912~Congenital muscular dystrophy,	KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Collagen-like 1,DOMAIN:Collagen-like 2,DOMAIN:Collagen-like 3,DOMAIN:Collagen-like 4,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 10,DOMAIN:Fibronectin type-III 11,DOMAIN:Fibronectin type-III 12,DOMAIN:Fibronectin type-III 13,DOMAIN:Fibronectin type-III 14,DOMAIN:Fibronectin type-III 15,DOMAIN:Fibronectin type-III 16,DOMAIN:Fibronectin type-III 17,DOMAIN:Fibronectin type-III 18,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,DOMAIN:Fibronectin type-III 7,DOMAIN:Fibronectin type-III 8,DOMAIN:Fibronectin type-III 9,DOMAIN:Laminin G-like,DOMAIN:VWFA,DOMAIN:VWFA 1,DOMAIN:VWFA 2,DOMAIN:VWFA 3,DOMAIN:VWFA 4,MOTIF:Cell attachment site,REGION:Disordered,REGION:Nonhelical region (NC1),REGION:Nonhelical region (NC2),REGION:Nonhelical region (NC3),REGION:Triple-helical region (COL1) with 2 imperfections,REGION:Triple-helical region (COL2) with 1 imperfection,
Q14993	collagen type XIX alpha 1 chain(COL19A1)	Homo sapiens			GO:0001501~skeletal system development,GO:0007155~cell adhesion,GO:0007519~skeletal muscle tissue development,GO:0030154~cell differentiation,GO:0030198~extracellular matrix organization,GO:0098609~cell-cell adhesion,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,	GO:0005201~extracellular matrix structural constituent,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0030674~protein binding, bridging,	IPR008160:Collagen,IPR013320:ConA-like_dom_sf,IPR048287:TSPN-like_N,	hsa04974:Protein digestion and absorption,			SM00210:TSPN,	KW-0130~Cell adhesion,KW-0221~Differentiation,KW-0517~Myogenesis,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0379~Hydroxylation,KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:Collagen-like 1,DOMAIN:Collagen-like 10,DOMAIN:Collagen-like 11,DOMAIN:Collagen-like 2,DOMAIN:Collagen-like 3,DOMAIN:Collagen-like 4,DOMAIN:Collagen-like 5,DOMAIN:Collagen-like 6,DOMAIN:Collagen-like 7,DOMAIN:Collagen-like 8,DOMAIN:Collagen-like 9,DOMAIN:Laminin G-like,MOTIF:Cell attachment site,REGION:Disordered,REGION:Triple-helical region 1 (COL1),REGION:Triple-helical region 2 (COL2),REGION:Triple-helical region 3 (COL3),REGION:Triple-helical region 4 (COL4),REGION:Triple-helical region 5 (COL5),REGION:Triple-helical region 6 (COL6),
P39060	collagen type XVIII alpha 1 chain(COL18A1)	Homo sapiens			GO:0001501~skeletal system development,GO:0001525~angiogenesis,GO:0001886~endothelial cell morphogenesis,GO:0007155~cell adhesion,GO:0007601~visual perception,GO:0008285~negative regulation of cell proliferation,GO:0009410~response to xenobiotic stimulus,GO:0009887~animal organ morphogenesis,GO:0030199~collagen fibril organization,GO:0030903~notochord development,GO:0051599~response to hydrostatic pressure,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0070062~extracellular exosome,	GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0046872~metal ion binding,	IPR008160:Collagen,IPR010363:DUF959_COL18_N,IPR010515:Collagenase_NC10/endostatin,IPR013320:ConA-like_dom_sf,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR020067:Frizzled_dom,IPR035523:Collagen_XVIII_Fz,IPR036790:Frizzled_dom_sf,IPR045463:XV/XVIII_trimerization_dom,IPR048287:TSPN-like_N,	hsa04974:Protein digestion and absorption,	267750~Knobloch syndrome, type 1,618880~Glaucoma, primary closed-angle,		SM00063:FRI,SM00210:TSPN,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0955~Glaucoma,	KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) threonine,CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Collagen type XV/XVIII trimerization,DOMAIN:Collagenase NC10/endostatin,DOMAIN:FZ,DOMAIN:Laminin G-like,MOTIF:Cell attachment site,REGION:Disordered,REGION:Non-collagenous domain 1 association domain,REGION:Non-collagenous domain 1 hinge region,REGION:Nonhelical region 1 (NC1),REGION:Nonhelical region 10 (NC10),REGION:Nonhelical region 11 (NC11),REGION:Nonhelical region 2 (NC2),REGION:Nonhelical region 3 (NC3),REGION:Nonhelical region 4 (NC4),REGION:Nonhelical region 5 (NC5),REGION:Nonhelical region 6 (NC6),REGION:Nonhelical region 7 (NC7),REGION:Nonhelical region 8 (NC8),REGION:Nonhelical region 9 (NC9),REGION:Triple-helical region 1 (COL1),REGION:Triple-helical region 10 (COL10),REGION:Triple-helical region 2 (COL2),REGION:Triple-helical region 3 (COL3),REGION:Triple-helical region 4 (COL4),REGION:Triple-helical region 5 (COL5),REGION:Triple-helical region 6 (COL6),REGION:Triple-helical region 7 (COL7),REGION:Triple-helical region 8 (COL8),REGION:Triple-helical region 9 (COL9),
O93484	collagen, type I, alpha 2(LOC100135811)	Oncorhynchus mykiss				GO:0005576~extracellular region,GO:0005581~collagen trimer,	GO:0005201~extracellular matrix structural constituent,GO:0046872~metal ion binding,	IPR000885:Fib_collagen_C,IPR008160:Collagen,	omy04510:Focal adhesion,omy04512:ECM-receptor interaction,			SM00038:COLFI,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Gal...) hydroxylysine; alternate,DOMAIN:Fibrillar collagen NC1,PROPEP:C-terminal propeptide,PROPEP:N-terminal propeptide,REGION:Disordered,
P02463	collagen, type IV, alpha 1(Col4a1)	Mus musculus		m_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,m_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,m_npp1Pathway:Regulators of Bone Mineralization,m_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,m_vitCBPathway:Vitamin C in the Brain,	GO:0001525~angiogenesis,GO:0001569~branching involved in blood vessel morphogenesis,GO:0007420~brain development,GO:0007528~neuromuscular junction development,GO:0030198~extracellular matrix organization,GO:0030855~epithelial cell differentiation,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0061304~retinal blood vessel morphogenesis,GO:0061333~renal tubule morphogenesis,GO:0071230~cellular response to amino acid stimulus,GO:0071711~basement membrane organization,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005587~collagen type IV trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0016020~membrane,	GO:0005201~extracellular matrix structural constituent,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0048407~platelet-derived growth factor binding,	IPR001442:Collagen_IV_NC,IPR008160:Collagen,IPR016187:CTDL_fold,IPR036954:Collagen_IV_NC_sf,	mmu04151:PI3K-Akt signaling pathway,mmu04510:Focal adhesion,mmu04512:ECM-receptor interaction,mmu04926:Relaxin signaling pathway,mmu04933:AGE-RAGE signaling pathway in diabetic complications,mmu04974:Protein digestion and absorption,mmu05146:Amoebiasis,mmu05165:Human papillomavirus infection,mmu05200:Pathways in cancer,mmu05222:Small cell lung cancer,			SM00111:C4,	KW-0037~Angiogenesis,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,CROSSLNK:S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1533),CROSSLNK:S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1651),DISULFID:Or C-1460 with C-1548,DISULFID:Or C-1493 with C-1551,DISULFID:Or C-1570 with C-1662,DISULFID:Or C-1604 with C-1665,DOMAIN:Collagen IV NC1,PROPEP:N-terminal propeptide (7S domain),REGION:Disordered,REGION:Triple-helical region,
O88207	collagen, type V, alpha 1(Col5a1)	Mus musculus			GO:0001568~blood vessel development,GO:0003007~heart morphogenesis,GO:0007155~cell adhesion,GO:0016477~cell migration,GO:0030199~collagen fibril organization,GO:0032964~collagen biosynthetic process,GO:0035313~wound healing, spreading of epidermal cells,GO:0035989~tendon development,GO:0043588~skin development,GO:0045112~integrin biosynthetic process,GO:0048592~eye morphogenesis,GO:0051128~regulation of cellular component organization,GO:0097435~supramolecular fiber organization,GO:1903225~negative regulation of endodermal cell differentiation,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005588~collagen type V trimer,GO:0005592~collagen type XI trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0043394~proteoglycan binding,GO:0048407~platelet-derived growth factor binding,	IPR000885:Fib_collagen_C,IPR001791:Laminin_G,IPR008160:Collagen,IPR013320:ConA-like_dom_sf,IPR048287:TSPN-like_N,	mmu04974:Protein digestion and absorption,			SM00038:COLFI,SM00210:TSPN,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,		KW-0358~Heparin-binding,	KW-0379~Hydroxylation,KW-0765~Sulfation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Fibrillar collagen NC1,DOMAIN:Laminin G-like,REGION:Disordered,REGION:Interrupted collagenous region,REGION:Nonhelical region,REGION:Triple-helical region,
Q3U962	collagen, type V, alpha 2(Col5a2)	Mus musculus			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0043588~skin development,GO:0048592~eye morphogenesis,GO:0071230~cellular response to amino acid stimulus,GO:1903225~negative regulation of endodermal cell differentiation,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005588~collagen type V trimer,GO:0005592~collagen type XI trimer,GO:0005615~extracellular space,	GO:0005201~extracellular matrix structural constituent,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0046332~SMAD binding,GO:0046872~metal ion binding,	IPR000885:Fib_collagen_C,IPR001007:VWF_dom,IPR008160:Collagen,	mmu04974:Protein digestion and absorption,			SM00038:COLFI,SM00214:VWC,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:Fibrillar collagen NC1,DOMAIN:VWFC,MOTIF:Cell attachment site,PROPEP:C-terminal propeptide,REGION:Disordered,
Q04857	collagen, type VI, alpha 1(Col6a1)	Mus musculus			GO:0000302~response to reactive oxygen species,GO:0000902~cell morphogenesis,GO:0001503~ossification,GO:0001942~hair follicle development,GO:0002023~reduction of food intake in response to dietary excess,GO:0003012~muscle system process,GO:0003016~respiratory system process,GO:0006096~glycolytic process,GO:0006099~tricarboxylic acid cycle,GO:0006103~2-oxoglutarate metabolic process,GO:0006112~energy reserve metabolic process,GO:0006468~protein phosphorylation,GO:0006497~protein lipidation,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006996~organelle organization,GO:0007005~mitochondrion organization,GO:0007155~cell adhesion,GO:0007338~single fertilization,GO:0007422~peripheral nervous system development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007623~circadian rhythm,GO:0008152~metabolic process,GO:0008219~cell death,GO:0008286~insulin receptor signaling pathway,GO:0008361~regulation of cell size,GO:0009410~response to xenobiotic stimulus,GO:0009411~response to UV,GO:0009611~response to wounding,GO:0009612~response to mechanical stimulus,GO:0009636~response to toxic substance,GO:0010467~gene expression,GO:0010657~muscle cell apoptotic process,GO:0014823~response to activity,GO:0014850~response to muscle activity,GO:0019226~transmission of nerve impulse,GO:0022011~myelination in peripheral nervous system,GO:0030199~collagen fibril organization,GO:0030262~apoptotic nuclear changes,GO:0030282~bone mineralization,GO:0030324~lung development,GO:0032496~response to lipopolysaccharide,GO:0032963~collagen metabolic process,GO:0033993~response to lipid,GO:0035987~endodermal cell differentiation,GO:0036022~limb joint morphogenesis,GO:0036293~response to decreased oxygen levels,GO:0043403~skeletal muscle tissue regeneration,GO:0043491~protein kinase B signaling,GO:0043588~skin development,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048265~response to pain,GO:0048286~lung alveolus development,GO:0048630~skeletal muscle tissue growth,GO:0048741~skeletal muscle fiber development,GO:0048771~tissue remodeling,GO:0048872~homeostasis of number of cells,GO:0050877~neurological system process,GO:0050954~sensory perception of mechanical stimulus,GO:0051216~cartilage development,GO:0051262~protein tetramerization,GO:0051402~neuron apoptotic process,GO:0051882~mitochondrial depolarization,GO:0055001~muscle cell development,GO:0060065~uterus development,GO:0060070~canonical Wnt signaling pathway,GO:0060348~bone development,GO:0060425~lung morphogenesis,GO:0060487~lung epithelial cell differentiation,GO:0060538~skeletal muscle organ development,GO:0060612~adipose tissue development,GO:0061061~muscle structure development,GO:0070341~fat cell proliferation,GO:0070836~caveola assembly,GO:0071230~cellular response to amino acid stimulus,GO:0071711~basement membrane organization,GO:0071965~multicellular organismal locomotion,GO:0072593~reactive oxygen species metabolic process,GO:0085029~extracellular matrix assembly,GO:0097009~energy homeostasis,GO:0098528~skeletal muscle fiber differentiation,GO:1901652~response to peptide,GO:1904026~regulation of collagen fibril organization,GO:1904583~response to polyamine macromolecule,GO:1904975~response to bleomycin,GO:1990542~mitochondrial transmembrane transport,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0016529~sarcoplasmic reticulum,GO:0030016~myofibril,GO:0031012~extracellular matrix,GO:0032991~macromolecular complex,GO:0042383~sarcolemma,GO:0097708~intracellular vesicle,	GO:0005515~protein binding,GO:0005518~collagen binding,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0048407~platelet-derived growth factor binding,	IPR002035:VWF_A,IPR008160:Collagen,IPR036465:vWFA_dom_sf,	mmu04151:PI3K-Akt signaling pathway,mmu04510:Focal adhesion,mmu04512:ECM-receptor interaction,mmu04974:Protein digestion and absorption,mmu05165:Human papillomavirus infection,			SM00327:VWA,	KW-0130~Cell adhesion,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0379~Hydroxylation,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:VWFA,DOMAIN:VWFA 1,DOMAIN:VWFA 2,DOMAIN:VWFA 3,MOTIF:Cell attachment site,REGION:C-terminal globular domain,REGION:Disordered,REGION:N-terminal globular domain,REGION:Triple-helical region,
Q8C6K9	collagen, type VI, alpha 6(Col6a6)	Mus musculus			GO:0007155~cell adhesion,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0031012~extracellular matrix,	GO:0030020~extracellular matrix structural constituent conferring tensile strength,	IPR002035:VWF_A,IPR008160:Collagen,IPR036465:vWFA_dom_sf,	mmu04151:PI3K-Akt signaling pathway,mmu04510:Focal adhesion,mmu04512:ECM-receptor interaction,mmu04974:Protein digestion and absorption,mmu05165:Human papillomavirus infection,			SM00327:VWA,	KW-0130~Cell adhesion,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0379~Hydroxylation,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:VWFA,DOMAIN:VWFA 1,DOMAIN:VWFA 2,DOMAIN:VWFA 3,DOMAIN:VWFA 4,DOMAIN:VWFA 5,DOMAIN:VWFA 6,DOMAIN:VWFA 7,DOMAIN:VWFA 8,DOMAIN:VWFA 9,MOTIF:Cell attachment site,REGION:Disordered,REGION:Nonhelical region,REGION:Triple-helical region,
Q00780	collagen, type VIII, alpha 1(Col8a1)	Mus musculus			GO:0001525~angiogenesis,GO:0001935~endothelial cell proliferation,GO:0007155~cell adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,GO:0035987~endodermal cell differentiation,GO:0048593~camera-type eye morphogenesis,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,	GO:0030020~extracellular matrix structural constituent conferring tensile strength,	IPR001073:C1q_dom,IPR008160:Collagen,IPR008983:Tumour_necrosis_fac-like_dom,	mmu04974:Protein digestion and absorption,			SM00110:C1Q,	KW-0037~Angiogenesis,KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,			KW-0379~Hydroxylation,	COMPBIAS:Pro residues,DOMAIN:C1q,REGION:Disordered,REGION:Nonhelical region (NC1),REGION:Nonhelical region (NC2),REGION:Triple-helical region (COL1),
A0MSJ1	collagen, type XXVII, alpha 1b(col27a1b)	Danio rerio			GO:0001501~skeletal system development,GO:0030198~extracellular matrix organization,GO:0030282~bone mineralization,GO:0048570~notochord morphogenesis,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,	GO:0005201~extracellular matrix structural constituent,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0046872~metal ion binding,	IPR000885:Fib_collagen_C,IPR008160:Collagen,IPR013320:ConA-like_dom_sf,IPR048287:TSPN-like_N,				SM00038:COLFI,SM00210:TSPN,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DISULFID:Interchain (with C-1268),DISULFID:Interchain (with C-1285),DOMAIN:Collagen-like 1,DOMAIN:Collagen-like 10,DOMAIN:Collagen-like 11,DOMAIN:Collagen-like 12,DOMAIN:Collagen-like 13,DOMAIN:Collagen-like 14,DOMAIN:Collagen-like 15,DOMAIN:Collagen-like 2,DOMAIN:Collagen-like 3,DOMAIN:Collagen-like 4,DOMAIN:Collagen-like 5,DOMAIN:Collagen-like 6,DOMAIN:Collagen-like 7,DOMAIN:Collagen-like 8,DOMAIN:Collagen-like 9,DOMAIN:Fibrillar collagen NC1,DOMAIN:Laminin G-like,DOMAIN:Thrombospondin-like N-terminal,PROPEP:C-terminal propeptide,PROPEP:N-terminal propeptide,REGION:Disordered,REGION:Triple-helical region,
Q8CF98	collectin sub-family member 10(Colec10)	Mus musculus			GO:0001867~complement activation, lectin pathway,GO:0006508~proteolysis,GO:0006952~defense response,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0009792~embryo development ending in birth or egg hatching,GO:1903028~positive regulation of opsonization,GO:1904888~cranial skeletal system development,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005771~multivesicular body,GO:0005794~Golgi apparatus,GO:0005829~cytosol,	GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0042056~chemoattractant activity,	IPR001304:C-type_lectin-like,IPR008160:Collagen,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR018378:C-type_lectin_CS,IPR033990:Collectin_CTLD,				SM00034:CLECT,		KW-0333~Golgi apparatus,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0176~Collagen,KW-0732~Signal,	KW-0106~Calcium,KW-0430~Lectin,KW-0465~Mannose-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:C-type lectin,DOMAIN:Collagen-like,REGION:Disordered,
Q5U3G1	collectin sub-family member 11(colec11)	Danio rerio			GO:0001755~neural crest cell migration,GO:0001867~complement activation, lectin pathway,GO:0002376~immune system process,GO:0019730~antimicrobial humoral response,GO:0032502~developmental process,GO:0045087~innate immune response,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,	GO:0003677~DNA binding,GO:0005509~calcium ion binding,GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0042806~fucose binding,GO:0046872~metal ion binding,GO:0070492~oligosaccharide binding,	IPR001304:C-type_lectin-like,IPR008160:Collagen,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR018378:C-type_lectin_CS,IPR033990:Collectin_CTLD,	dre04145:Phagosome,			SM00034:CLECT,	KW-0391~Immunity,KW-0399~Innate immunity,	KW-0964~Secreted,			KW-0175~Coiled coil,KW-0176~Collagen,KW-0732~Signal,	KW-0106~Calcium,KW-0430~Lectin,KW-0465~Mannose-binding,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-1015~Disulfide bond,	DOMAIN:C-type lectin,DOMAIN:Collagen-like,REGION:Disordered,
P08649	complement C4A(C4a)	Rattus norvegicus			GO:0006954~inflammatory response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0045087~innate immune response,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0045202~synapse,	GO:0001849~complement component C1q binding,GO:0004866~endopeptidase inhibitor activity,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin_domain,IPR001599:Macroglobln_a2,IPR001840:Anaphylatoxn_comp_syst_dom,IPR002890:MG2,IPR008930:Terpenoid_cyclase/PrenylTrfase,IPR008993:TIMP-like_OB-fold,IPR009048:A-macroglobulin_rcpt-bd,IPR011625:A2M_N_BRD,IPR011626:Alpha-macroglobulin_TED,IPR013783:Ig-like_fold,IPR018081:Anaphylatoxin_comp_syst,IPR018933:Netrin_module_non-TIMP,IPR019742:MacrogloblnA2_CS,IPR036595:A-macroglobulin_rcpt-bd_sf,IPR040839:MG4,IPR041555:MG3,IPR047565:Alpha-macroglob_thiol-ester_cl,IPR048847:C4_MG1,	rno04610:Complement and coagulation cascades,rno04936:Alcoholic liver disease,rno05133:Pertussis,rno05150:Staphylococcus aureus infection,rno05171:Coronavirus disease - COVID-19,rno05322:Systemic lupus erythematosus,			SM00104:ANATO,SM00643:C345C,SM01359:A2M_N_2,SM01360:A2M,SM01361:A2M_recep,SM01419:Thiol-ester_cl,	KW-0180~Complement pathway,KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,	KW-0770~Synapse,KW-0964~Secreted,KW-0966~Cell projection,			KW-0732~Signal,			KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0765~Sulfation,KW-0882~Thioester bond,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Isoglutamyl cysteine thioester (Cys-Gln),DOMAIN:Anaphylatoxin-like,DOMAIN:NTR,
Q811M5	complement C6(C6)	Rattus norvegicus			GO:0001701~in utero embryonic development,GO:0001970~positive regulation of activation of membrane attack complex,GO:0006955~immune response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0031640~killing of cells of other organism,GO:0043065~positive regulation of apoptotic process,GO:0045087~innate immune response,GO:0045766~positive regulation of angiogenesis,GO:0045917~positive regulation of complement activation,	GO:0005576~extracellular region,GO:0005579~membrane attack complex,GO:0005615~extracellular space,		IPR000436:Sushi_SCR_CCP_dom,IPR000884:TSP1_rpt,IPR001862:MAC_perforin,IPR002172:LDrepeatLR_classA_rpt,IPR002350:Kazal_dom,IPR003884:FacI_MAC,IPR020863:MACPF_CS,IPR020864:MACPF,IPR023415:LDLR_class-A_CS,IPR035976:Sushi/SCR/CCP_sf,IPR036055:LDL_receptor-like_sf,IPR036383:TSP1_rpt_sf,IPR048828:C6_KAZAL,IPR048831:C8A_B_C6_EGF-like,	rno04610:Complement and coagulation cascades,rno04810:Regulation of actin cytoskeleton,rno05020:Prion disease,rno05171:Coronavirus disease - COVID-19,rno05322:Systemic lupus erythematosus,			SM00032:CCP,SM00057:FIMAC,SM00192:LDLa,SM00209:TSP1,SM00457:MACPF,	KW-0180~Complement pathway,KW-0204~Cytolysis,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0473~Membrane attack complex,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:C-linked (Man) tryptophan,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Fuc...) serine,CARBOHYD:O-linked (Fuc...) threonine,DOMAIN:EGF-like,DOMAIN:Kazal-like,DOMAIN:Kazal-like 1,DOMAIN:Kazal-like 2,DOMAIN:LDL-receptor class A,DOMAIN:MACPF,DOMAIN:Sushi,DOMAIN:Sushi 1,DOMAIN:Sushi 2,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,REGION:C5B-binding domain,REGION:CCP 1,REGION:CCP 2,REGION:Factor I module (FIM) 1,REGION:Factor I module (FIM) 2,
Q9TUQ3	complement C7(C7)	Sus scrofa			GO:0006955~immune response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0031640~killing of cells of other organism,GO:0045087~innate immune response,	GO:0005576~extracellular region,GO:0005579~membrane attack complex,GO:0005615~extracellular space,	GO:0005515~protein binding,	IPR000436:Sushi_SCR_CCP_dom,IPR000884:TSP1_rpt,IPR001862:MAC_perforin,IPR002172:LDrepeatLR_classA_rpt,IPR003884:FacI_MAC,IPR020863:MACPF_CS,IPR020864:MACPF,IPR023415:LDLR_class-A_CS,IPR035976:Sushi/SCR/CCP_sf,IPR036055:LDL_receptor-like_sf,IPR036383:TSP1_rpt_sf,IPR040729:Kazal_3,IPR048825:C7_KAZAL,IPR048827:C7_FIM2_N,	ssc04610:Complement and coagulation cascades,ssc04810:Regulation of actin cytoskeleton,ssc05020:Prion disease,ssc05171:Coronavirus disease - COVID-19,ssc05322:Systemic lupus erythematosus,			SM00032:CCP,SM00057:FIMAC,SM00192:LDLa,SM00209:TSP1,SM00457:MACPF,	KW-0179~Complement alternate pathway,KW-0180~Complement pathway,KW-0204~Cytolysis,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0473~Membrane attack complex,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:C-linked (Man) tryptophan,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:LDL-receptor class A,DOMAIN:MACPF,DOMAIN:Sushi,DOMAIN:Sushi 1,DOMAIN:Sushi 2,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,REGION:CCP 1,REGION:CCP 2,REGION:Disordered,REGION:Factor I module (FIM) 1,REGION:Factor I module (FIM) 2,
P07357	complement C8 alpha chain(C8A)	Homo sapiens		h_alternativePathway:Alternative Complement Pathway,h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,h_lectinPathway:Lectin Induced Complement Pathway,	GO:0006955~immune response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0031640~killing of cells of other organism,GO:0045087~innate immune response,GO:0050778~positive regulation of immune response,	GO:0005576~extracellular region,GO:0005579~membrane attack complex,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0001848~complement binding,GO:0005515~protein binding,GO:0044877~macromolecular complex binding,	IPR000884:TSP1_rpt,IPR001862:MAC_perforin,IPR002172:LDrepeatLR_classA_rpt,IPR009030:Growth_fac_rcpt_cys_sf,IPR020863:MACPF_CS,IPR020864:MACPF,IPR023415:LDLR_class-A_CS,IPR036055:LDL_receptor-like_sf,IPR036383:TSP1_rpt_sf,IPR048831:C8A_B_C6_EGF-like,	hsa04610:Complement and coagulation cascades,hsa04810:Regulation of actin cytoskeleton,hsa05020:Prion disease,hsa05146:Amoebiasis,hsa05171:Coronavirus disease - COVID-19,hsa05322:Systemic lupus erythematosus,	613790~C8 deficiency, type I,		SM00192:LDLa,SM00209:TSP1,SM00457:MACPF,	KW-0179~Complement alternate pathway,KW-0180~Complement pathway,KW-0204~Cytolysis,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0472~Membrane,KW-0473~Membrane attack complex,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1134~Transmembrane beta strand,			KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:C-linked (Man) tryptophan,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (with C-60 in C8-gamma chain),DOMAIN:EGF-like,DOMAIN:LDL-receptor class A,DOMAIN:MACPF,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,REGION:Disordered,SITE:Not glycosylated,
P79755	complement component 9(c9)	Takifugu rubripes			GO:0001906~cell killing,GO:0006955~immune response,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0031640~killing of cells of other organism,GO:0045087~innate immune response,GO:0051260~protein homooligomerization,	GO:0005576~extracellular region,GO:0005579~membrane attack complex,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0044218~other organism cell membrane,	GO:0005515~protein binding,	IPR000884:TSP1_rpt,IPR001862:MAC_perforin,IPR002172:LDrepeatLR_classA_rpt,IPR020863:MACPF_CS,IPR020864:MACPF,IPR023415:LDLR_class-A_CS,IPR036055:LDL_receptor-like_sf,IPR036383:TSP1_rpt_sf,	tru04810:Regulation of actin cytoskeleton,			SM00192:LDLa,SM00209:TSP1,SM00457:MACPF,	KW-0179~Complement alternate pathway,KW-0180~Complement pathway,KW-0204~Cytolysis,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0472~Membrane,KW-0473~Membrane attack complex,KW-0964~Secreted,KW-1052~Target cell membrane,KW-1053~Target membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1134~Transmembrane beta strand,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:LDL-receptor class A,DOMAIN:MACPF,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,
Q14746	component of oligomeric golgi complex 2(COG2)	Homo sapiens			GO:0000301~retrograde transport, vesicle recycling within Golgi,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0015031~protein transport,GO:0070085~glycosylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0016020~membrane,GO:0017119~Golgi transport complex,GO:0032588~trans-Golgi network membrane,	GO:0005515~protein binding,GO:0044877~macromolecular complex binding,	IPR009316:COG2,IPR024602:COG_su2_N,IPR024603:COG_complex_COG2_C,		617395~Congenital disorder of glycosylation, type IIq,			KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,		KW-0225~Disease variant,KW-0900~Congenital disorder of glycosylation,					COMPBIAS:Polar residues,DOMAIN:COG complex component COG2 C-terminal,DOMAIN:Conserved oligomeric Golgi complex subunit 2 N-terminal,REGION:Disordered,
Q969H4	connector enhancer of kinase suppressor of Ras 1(CNKSR1)	Homo sapiens			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0016310~phosphorylation,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005938~cell cortex,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0030674~protein binding, bridging,	IPR001478:PDZ,IPR001660:SAM,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR013761:SAM/pointed_sf,IPR017874:CRIC_domain,IPR036034:PDZ_sf,				SM00233:PH,SM00454:SAM,		KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:CRIC,DOMAIN:PDZ,DOMAIN:PH,DOMAIN:SAM,MUTAGEN:W->A: No interaction with Rho.,REGION:Disordered,
Q8AXZ4	contactin 1a(cntn1a)	Danio rerio			GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0007420~brain development,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0098552~side of membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0098632~protein binding involved in cell-cell adhesion,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR005479:CbamoylP_synth_lsu-like_ATP-bd,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013151:Immunoglobulin,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,	dre04514:Cell adhesion molecules,			SM00060:FN3,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,LIPID:GPI-anchor amidated glycine,PROPEP:Removed in mature form,REGION:Disordered,
Q8IYJ1	copine family member 9(CPNE9)	Homo sapiens			GO:0030154~cell differentiation,GO:0071277~cellular response to calcium ion,GO:1903861~positive regulation of dendrite extension,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005544~calcium-dependent phospholipid binding,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR002035:VWF_A,IPR010734:Copine_C,IPR035892:C2_domain_sf,IPR036465:vWFA_dom_sf,IPR037768:C2B_Copine,IPR045052:Copine,				SM00239:C2,SM00327:VWA,	KW-0221~Differentiation,				KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:VWFA,REGION:Disordered,
Q6DK93	cornifelin, gene 1(cnfn.1)	Xenopus tropicalis				GO:0001533~cornified envelope,		IPR006461:PLAC_motif_containing,
Q9WUM3	coronin, actin binding protein 1B(Coro1b)	Mus musculus			GO:0007015~actin filament organization,GO:0016477~cell migration,GO:0030036~actin cytoskeleton organization,GO:0031529~ruffle organization,GO:0034316~negative regulation of Arp2/3 complex-mediated actin nucleation,GO:0035767~endothelial cell chemotaxis,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0042060~wound healing,GO:0051017~actin filament bundle assembly,GO:0070528~protein kinase C signaling,GO:0071672~negative regulation of smooth muscle cell chemotaxis,GO:0090135~actin filament branching,GO:1902463~protein localization to cell leading edge,GO:2000393~negative regulation of lamellipodium morphogenesis,GO:2000394~positive regulation of lamellipodium morphogenesis,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0048471~perinuclear region of cytoplasm,GO:0071944~cell periphery,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:0051015~actin filament binding,GO:0071933~Arp2/3 complex binding,	IPR001680:WD40_rpt,IPR015048:DUF1899,IPR015505:Coronin,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR036322:WD40_repeat_dom_sf,				SM00320:WD40,SM01166:DUF1899,SM01167:DUF1900,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:DUF1899,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,
B0R0D7	coronin, actin binding protein, 1Ca(coro1ca)	Danio rerio			GO:0001755~neural crest cell migration,GO:0007015~actin filament organization,GO:0016197~endosomal transport,GO:0090148~membrane fission,GO:0097750~endosome membrane tubulation,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0032587~ruffle membrane,GO:0042995~cell projection,	GO:0003779~actin binding,GO:0051015~actin filament binding,	IPR001680:WD40_rpt,IPR015048:DUF1899,IPR015505:Coronin,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR036322:WD40_repeat_dom_sf,				SM00320:WD40,SM01166:DUF1899,SM01167:DUF1900,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,		KW-0009~Actin-binding,		REGION:Disordered,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,
Q90812	corticotropin releasing hormone receptor 1(CRHR1)	Gallus gallus			GO:0007166~cell surface receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0051458~corticotropin secretion,GO:0071376~cellular response to corticotropin-releasing hormone stimulus,GO:2000852~regulation of corticosterone secretion,	GO:0005886~plasma membrane,GO:0043005~neuron projection,	GO:0004930~G-protein coupled receptor activity,GO:0008528~G-protein coupled peptide receptor activity,GO:0015056~corticotrophin-releasing factor receptor activity,GO:0043404~corticotropin-releasing hormone receptor activity,GO:0051424~corticotropin-releasing hormone binding,	IPR000832:GPCR_2_secretin-like,IPR001879:GPCR_2_extracellular_dom,IPR003051:GPCR_2_CRF_rcpt,IPR003052:GPCR_2_CRF1_rcpt,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR036445:GPCR_2_extracell_dom_sf,	gga04080:Neuroactive ligand-receptor interaction,			SM00008:HormR,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 2 profile 1,DOMAIN:G-protein coupled receptors family 2 profile 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P24722	creatine kinase, brain a(LOC100136767)	Oncorhynchus mykiss			GO:0016310~phosphorylation,GO:0046314~phosphocreatine biosynthetic process,		GO:0004111~creatine kinase activity,GO:0005524~ATP binding,	IPR000749:ATP-guanido_PTrfase,IPR014746:Gln_synth/guanido_kin_cat_dom,IPR022413:ATP-guanido_PTrfase_N,IPR022414:ATP-guanido_PTrfase_cat,IPR022415:ATP-guanido_PTrfase_AS,IPR036802:ATP-guanido_PTrfase_N_sf,	omy00330:Arginine and proline metabolism,omy01100:Metabolic pathways,									KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,DOMAIN:Phosphagen kinase C-terminal,DOMAIN:Phosphagen kinase N-terminal,REGION:Disordered,
Q8VHS2	crumbs family member 1, photoreceptor morphogenesis associated(Crb1)	Mus musculus			GO:0001974~blood vessel remodeling,GO:0007009~plasma membrane organization,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007601~visual perception,GO:0008104~protein localization,GO:0010001~glial cell differentiation,GO:0010467~gene expression,GO:0010842~retina layer formation,GO:0035845~photoreceptor cell outer segment organization,GO:0042462~eye photoreceptor cell development,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0045494~photoreceptor cell maintenance,GO:0048666~neuron development,GO:0050908~detection of light stimulus involved in visual perception,GO:0060041~retina development in camera-type eye,GO:0060042~retina morphogenesis in camera-type eye,GO:0060060~post-embryonic retina morphogenesis in camera-type eye,GO:0061024~membrane organization,GO:0061159~establishment of bipolar cell polarity involved in cell morphogenesis,GO:0071482~cellular response to light stimulus,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0032991~macromolecular complex,GO:0035003~subapical complex,GO:0042995~cell projection,GO:0043296~apical junction complex,GO:0045177~apical part of cell,GO:0070161~anchoring junction,GO:0097386~glial cell projection,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001791:Laminin_G,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR013032:EGF-like_CS,IPR013320:ConA-like_dom_sf,IPR018097:EGF_Ca-bd_CS,	mmu04390:Hippo signaling pathway,			SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0964~Secreted,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like 10,DOMAIN:EGF-like 11,DOMAIN:EGF-like 12,DOMAIN:EGF-like 13,DOMAIN:EGF-like 14,DOMAIN:EGF-like 15,DOMAIN:EGF-like 16; calcium-binding,DOMAIN:EGF-like 17,DOMAIN:EGF-like 18,DOMAIN:EGF-like 19; calcium-binding,DOMAIN:EGF-like 1; atypical,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,DOMAIN:EGF-like 9,DOMAIN:Laminin G,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G-like 2,DOMAIN:Laminin G-like 3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8QG60	cryptochrome circadian regulator 2(CRY2)	Gallus gallus			GO:0007623~circadian rhythm,GO:0009416~response to light stimulus,GO:0032922~circadian regulation of gene expression,GO:0042752~regulation of circadian rhythm,GO:0042754~negative regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0009881~photoreceptor activity,GO:0071949~FAD binding,	IPR002081:Cryptochrome/DNA_photolyase_1,IPR005101:Cryptochr/Photolyase_FAD-bd,IPR006050:DNA_photolyase_N,IPR014729:Rossmann-like_a/b/a_fold,IPR036134:Crypto/Photolyase_FAD-like_sf,IPR036155:Crypto/Photolyase_N_sf,					KW-0090~Biological rhythms,KW-0716~Sensory transduction,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0157~Chromophore,KW-0274~FAD,KW-0285~Flavoprotein,KW-0547~Nucleotide-binding,	KW-0600~Photoreceptor protein,KW-0675~Receptor,KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Photolyase/cryptochrome alpha/beta,REGION:Disordered,SITE:Electron transfer via tryptophanyl radical,
Q5R4S7	crystallin zeta(CRYZ)	Pongo abelii			GO:0042178~xenobiotic catabolic process,GO:0051289~protein homotetramerization,	GO:0005829~cytosol,	GO:0003730~mRNA 3'-UTR binding,GO:0003960~NADPH:quinone reductase activity,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0042802~identical protein binding,GO:0070402~NADPH binding,	IPR002364:Quin_OxRdtase/zeta-crystal_CS,IPR011032:GroES-like_sf,IPR013149:ADH-like_C,IPR013154:ADH-like_N,IPR020843:PKS_ER,IPR036291:NAD(P)-bd_dom_sf,				SM00829:PKS_ER,		KW-0963~Cytoplasm,				KW-0521~NADP,	KW-0560~Oxidoreductase,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Enoyl reductase (ER),
Q93034	cullin 5(CUL5)	Homo sapiens			GO:0000082~G1/S transition of mitotic cell cycle,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0038128~ERBB2 signaling pathway,GO:0070588~calcium ion transmembrane transport,GO:0097193~intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0031466~Cul5-RING ubiquitin ligase complex,GO:0090734~site of DNA damage,	GO:0004842~ubiquitin-protein transferase activity,GO:0005262~calcium channel activity,GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0031625~ubiquitin protein ligase binding,GO:0038023~signaling receptor activity,	IPR001373:Cullin_N,IPR016157:Cullin_CS,IPR016158:Cullin_homology,IPR016159:Cullin_repeat-like_dom_sf,IPR019559:Cullin_neddylation_domain,IPR036317:Cullin_homology_sf,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR045093:Cullin,	hsa04120:Ubiquitin mediated proteolysis,hsa05170:Human immunodeficiency virus 1 infection,			SM00182:CULLIN,SM00884:Cullin_Nedd8,	KW-0833~Ubl conjugation pathway,KW-0945~Host-virus interaction,	KW-0539~Nucleus,					KW-0675~Receptor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8),DOMAIN:Cullin N-terminal,DOMAIN:Cullin family profile,
Q24117	cut up(ctp)	Drosophila melanogaster			GO:0000132~establishment of mitotic spindle orientation,GO:0006914~autophagy,GO:0007017~microtubule-based process,GO:0007283~spermatogenesis,GO:0007290~spermatid nucleus elongation,GO:0007291~sperm individualization,GO:0007476~imaginal disc-derived wing morphogenesis,GO:0008407~chaeta morphogenesis,GO:0022416~chaeta development,GO:0034454~microtubule anchoring at centrosome,GO:0035071~salivary gland cell autophagic cell death,GO:0035220~wing disc development,GO:0048477~oogenesis,GO:0051017~actin filament bundle assembly,GO:1904801~positive regulation of neuron remodeling,	GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005868~cytoplasmic dynein complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0030286~dynein complex,GO:0032991~macromolecular complex,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0045505~dynein intermediate chain binding,GO:0051959~dynein light intermediate chain binding,GO:0097718~disordered domain specific binding,	IPR001372:Dynein_light_chain_typ-1/2,IPR019763:Dynein_light_1/2_CS,IPR037177:DLC_sf,	dme04814:Motor proteins,			SM01375:Dynein_light,	KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0243~Dynein,KW-0493~Microtubule,KW-0963~Cytoplasm,					KW-0505~Motor protein,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q9NTM9	cutC copper transporter(CUTC)	Homo sapiens			GO:0006825~copper ion transport,GO:0051262~protein tetramerization,GO:0055070~copper ion homeostasis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005507~copper ion binding,GO:0005515~protein binding,	IPR005627:CutC-like,IPR036822:CutC-like_dom_sf,						KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0186~Copper,KW-0479~Metal-binding,			MUTAGEN:C->A: Reduces copper binding. Reduces copper binding by 75%; when associated with A-31.,MUTAGEN:C->A: Reduces copper binding. Reduces copper binding by 75%; when associated with A-52.,
Q9I8P6	cutaneous T-cell lymphoma-associated antigen 1(CTAGE1)	Gallus gallus			GO:0001502~cartilage condensation,	GO:0005576~extracellular region,	GO:0005515~protein binding,	IPR001452:SH3_domain,IPR035554:Otoraplin_SH3,IPR036028:SH3-like_dom_sf,IPR042801:OTOR,				SM00326:SH3,		KW-0964~Secreted,			KW-0728~SH3 domain,KW-0732~Signal,			KW-1015~Disulfide bond,	DOMAIN:SH3,
P20248	cyclin A2(CCNA2)	Homo sapiens			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0006275~regulation of DNA replication,GO:0006351~transcription, DNA-templated,GO:0007265~Ras protein signal transduction,GO:0031100~animal organ regeneration,GO:0033762~response to glucagon,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0043687~post-translational protein modification,GO:0044320~cellular response to leptin stimulus,GO:0044772~mitotic cell cycle phase transition,GO:0044843~cell cycle G1/S phase transition,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048146~positive regulation of fibroblast proliferation,GO:0051301~cell division,GO:0071314~cellular response to cocaine,GO:0071373~cellular response to luteinizing hormone stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071456~cellular response to hypoxia,GO:0071732~cellular response to nitric oxide,GO:0090102~cochlea development,GO:1990314~cellular response to insulin-like growth factor stimulus,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0001939~female pronucleus,GO:0001940~male pronucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0097122~cyclin A2-CDK1 complex,GO:0097124~cyclin A2-CDK2 complex,	GO:0005515~protein binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR032447:Cyclin-A_N,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR046965:Cyclin_A/B-like,IPR048258:Cyclins_cyclin-box,	hsa04110:Cell cycle,hsa04152:AMPK signaling pathway,hsa04218:Cellular senescence,hsa04914:Progesterone-mediated oocyte maturation,hsa05161:Hepatitis B,hsa05165:Human papillomavirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05221:Acute myeloid leukemia,		PIRSF001771:Cyclin_A_B_D_E,	SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0195~Cyclin,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	REGION:Disordered,
Q92162	cyclin B1(ccnb1)	Carassius auratus			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0007080~mitotic metaphase plate congression,GO:0044772~mitotic cell cycle phase transition,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0097125~cyclin B1-CDK1 complex,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR046965:Cyclin_A/B-like,IPR048026:CCNB1_first_cyclin-box,IPR048258:Cyclins_cyclin-box,	caua04068:FoxO signaling pathway,caua04110:Cell cycle,caua04114:Oocyte meiosis,caua04115:p53 signaling pathway,caua04218:Cellular senescence,caua04914:Progesterone-mediated oocyte maturation,		PIRSF001771:Cyclin_A_B_D_E,	SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,						KW-0195~Cyclin,		DOMAIN:Cyclin C-terminal,DOMAIN:Cyclin-like,REGION:Disordered,
P39963	cyclin B3(CCNB3)	Gallus gallus			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0044772~mitotic cell cycle phase transition,GO:0051301~cell division,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR046965:Cyclin_A/B-like,IPR048258:Cyclins_cyclin-box,	gga04068:FoxO signaling pathway,gga04110:Cell cycle,gga04218:Cellular senescence,gga04914:Progesterone-mediated oocyte maturation,		PIRSF001771:Cyclin_A_B_D_E,	SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0539~Nucleus,					KW-0195~Cyclin,	KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:Cyclin C-terminal,DOMAIN:Cyclin-like,MOTIF:D-box,REGION:Disordered,
Q6DG03	cyclin D binding myb-like transcription factor 1(dmtf1)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,	IPR001005:SANT/Myb,IPR009057:Homeobox-like_sf,IPR017930:Myb_dom,IPR046775:DMTF1_N,				SM00717:SANT,	KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0043~Tumor suppressor,	KW-0677~Repeat,		KW-0010~Activator,KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:H-T-H motif,DOMAIN:HTH myb-type,DOMAIN:Myb-like,DOMAIN:Myb-like 1,DOMAIN:Myb-like 2,REGION:Disordered,
Q90459	cyclin D1(ccnd1)	Danio rerio			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0044772~mitotic cell cycle phase transition,GO:0048593~camera-type eye morphogenesis,GO:0051301~cell division,GO:0061074~regulation of neural retina development,GO:0070050~neuron cellular homeostasis,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0017053~transcriptional repressor complex,	GO:0003714~transcription corepressor activity,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR048258:Cyclins_cyclin-box,	dre04068:FoxO signaling pathway,dre04110:Cell cycle,dre04115:p53 signaling pathway,dre04218:Cellular senescence,dre04310:Wnt signaling pathway,dre04340:Hedgehog signaling pathway,dre04371:Apelin signaling pathway,dre04510:Focal adhesion,dre04530:Tight junction,			SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0195~Cyclin,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	DOMAIN:Cyclin C-terminal,DOMAIN:Cyclin-like,
P30280	cyclin D2(Ccnd2)	Mus musculus		m_cellcyclePathway:Cyclins and Cell Cycle Regulation,	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0001934~positive regulation of protein phosphorylation,GO:0007049~cell cycle,GO:0007616~long-term memory,GO:0008284~positive regulation of cell proliferation,GO:0008344~adult locomotory behavior,GO:0043066~negative regulation of apoptotic process,GO:0044772~mitotic cell cycle phase transition,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051301~cell division,GO:0051726~regulation of cell cycle,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0071481~cellular response to X-ray,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:2000726~negative regulation of cardiac muscle cell differentiation,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0097129~cyclin D2-CDK4 complex,	GO:0005515~protein binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0061575~cyclin-dependent protein serine/threonine kinase activator activity,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR048258:Cyclins_cyclin-box,	mmu04068:FoxO signaling pathway,mmu04110:Cell cycle,mmu04115:p53 signaling pathway,mmu04151:PI3K-Akt signaling pathway,mmu04218:Cellular senescence,mmu04310:Wnt signaling pathway,mmu04340:Hedgehog signaling pathway,mmu04390:Hippo signaling pathway,mmu04510:Focal adhesion,mmu04630:JAK-STAT signaling pathway,mmu04917:Prolactin signaling pathway,mmu05162:Measles,mmu05165:Human papillomavirus infection,mmu05166:Human T-cell leukemia virus 1 infection,mmu05169:Epstein-Barr virus infection,mmu05200:Pathways in cancer,mmu05202:Transcriptional misregulation in cancer,mmu05203:Viral carcinogenesis,mmu05206:MicroRNAs in cancer,			SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0195~Cyclin,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:Cyclin C-terminal,DOMAIN:Cyclin N-terminal,DOMAIN:Cyclin-like,REGION:Disordered,
Q6NYX6	cyclin F(ccnf)	Danio rerio			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0007049~cell cycle,GO:0010826~negative regulation of centrosome duplication,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0044772~mitotic cell cycle phase transition,GO:0051301~cell division,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005856~cytoskeleton,GO:0019005~SCF ubiquitin ligase complex,GO:0048471~perinuclear region of cytoplasm,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR001810:F-box_dom,IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036047:F-box-like_dom_sf,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR048258:Cyclins_cyclin-box,				SM00256:FBOX,SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0833~Ubl conjugation pathway,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0195~Cyclin,		COMPBIAS:Polar residues,DOMAIN:Cyclin N-terminal,DOMAIN:F-box,MOTIF:D box 1,MOTIF:Nuclear localization signal 1,MOTIF:Nuclear localization signal 2,REGION:Disordered,REGION:PEST,
Q3ZBL9	cyclin H(CCNH)	Bos taurus			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007049~cell cycle,	GO:0005634~nucleus,GO:0005675~holo TFIIH complex,GO:0070985~TFIIK complex,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR027081:CyclinH/Ccl1,IPR031658:Cyclin_C_2,IPR036915:Cyclin-like_sf,IPR043198:Cyclin/Ssn8,	bta03022:Basal transcription factors,bta03420:Nucleotide excision repair,bta04110:Cell cycle,			SM00385:CYCLIN,	KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0195~Cyclin,	KW-0597~Phosphoprotein,	DOMAIN:Cyclin-like,
Q9Z2V9	cyclin I(Ccni)	Mus musculus			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0044772~mitotic cell cycle phase transition,GO:0051726~regulation of cell cycle,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,				SM00385:CYCLIN,							KW-0195~Cyclin,		DOMAIN:Cyclin N-terminal,DOMAIN:Cyclin-like,REGION:Disordered,
Q5ZJH7	cyclin Pas1/PHO80 domain containing 1(CNPPD1)	Gallus gallus			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0016020~membrane,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,	IPR013922:Cyclin_PHO80-like,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,TRANSMEM:Helical,
Q6T8E9	cyclin T1(CCNT1)	Bos taurus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0043923~positive regulation by host of viral transcription,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0070691~P-TEFb complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0061575~cyclin-dependent protein serine/threonine kinase activator activity,GO:0070063~RNA polymerase binding,GO:0097322~7SK snRNA binding,	IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR043198:Cyclin/Ssn8,IPR047320:CYCLIN_CCNT1_rpt2,	bta03250:Viral life cycle - HIV-1,bta05202:Transcriptional misregulation in cancer,			SM00385:CYCLIN,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0945~Host-virus interaction,	KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0195~Cyclin,	KW-0007~Acetylation,KW-0013~ADP-ribosylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Cyclin N-terminal,DOMAIN:Cyclin-like,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Histidine-rich domain (HRD),
Q8NE01	cyclin and CBS domain divalent metal cation transport mediator 3(CNNM3)	Homo sapiens			GO:0006810~transport,GO:0006811~ion transport,GO:0010960~magnesium ion homeostasis,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0022857~transmembrane transporter activity,	IPR000644:CBS_dom,IPR002550:CNNM,IPR044751:Ion_transp-like_CBS,IPR045095:ACDP,IPR046342:CBS_dom_sf,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0129~CBS domain,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:CBS 1,DOMAIN:CBS 2,DOMAIN:CNNM transmembrane,REGION:Disordered,TRANSMEM:Helical,
O94921	cyclin dependent kinase 14(CDK14)	Homo sapiens			GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0016055~Wnt signaling pathway,GO:0016310~phosphorylation,GO:0051301~cell division,GO:0051726~regulation of cell cycle,GO:0060828~regulation of canonical Wnt signaling pathway,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0000308~cytoplasmic cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0004672~protein kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030332~cyclin binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,	hsa05202:Transcriptional misregulation in cancer,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,MUTAGEN:K->R: Abolishes protein kinase activity.,REGION:Disordered,
O14519	cyclin dependent kinase 2 associated protein 1(CDK2AP1)	Homo sapiens			GO:0001934~positive regulation of protein phosphorylation,GO:0006261~DNA-dependent DNA replication,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016581~NuRD complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0070182~DNA polymerase binding,	IPR017266:DOC_1/2,	hsa03082:ATP-dependent chromatin remodeling,		PIRSF037709:CDK2-associated_p2,		KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,		KW-0043~Tumor suppressor,				KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DISULFID:Interchain,MUTAGEN:C->A: Does not alter homodimerization.,REGION:Disordered,REGION:Interaction with CDK2AP2,
P46527	cyclin dependent kinase inhibitor 1B(CDKN1B)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,4.cyclins_&_p27_cell_cycle,62.G1-phase_progression_by_Myc,84.Ubiquitination_Pathways_Cell_Cycle,	h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_mcmPathway:CDK Regulation of DNA Replication,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0001890~placenta development,GO:0001934~positive regulation of protein phosphorylation,GO:0006813~potassium ion transport,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007096~regulation of exit from mitosis,GO:0007219~Notch signaling pathway,GO:0007507~heart development,GO:0007605~sensory perception of sound,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009410~response to xenobiotic stimulus,GO:0009749~response to glucose,GO:0016310~phosphorylation,GO:0030308~negative regulation of cell growth,GO:0030334~regulation of cell migration,GO:0031116~positive regulation of microtubule polymerization,GO:0032355~response to estradiol,GO:0033673~negative regulation of kinase activity,GO:0042326~negative regulation of phosphorylation,GO:0043200~response to amino acid,GO:0043434~response to peptide hormone,GO:0045732~positive regulation of protein catabolic process,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045740~positive regulation of DNA replication,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045930~negative regulation of mitotic cell cycle,GO:0046686~response to cadmium ion,GO:0048102~autophagic cell death,GO:0048839~inner ear development,GO:0051168~nuclear export,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051179~localization,GO:0051726~regulation of cell cycle,GO:0060255~regulation of macromolecule metabolic process,GO:0060767~epithelial cell proliferation involved in prostate gland development,GO:0060770~negative regulation of epithelial cell proliferation involved in prostate gland development,GO:0071236~cellular response to antibiotic,GO:0071285~cellular response to lithium ion,GO:0071407~cellular response to organic cyclic compound,GO:0071456~cellular response to hypoxia,GO:0080090~regulation of primary metabolic process,GO:0090398~cellular senescence,GO:1902746~regulation of lens fiber cell differentiation,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1904019~epithelial cell apoptotic process,GO:1904030~negative regulation of cyclin-dependent protein kinase activity,GO:1904036~negative regulation of epithelial cell apoptotic process,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1905179~negative regulation of cardiac muscle tissue regeneration,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,GO:0031464~Cul4A-RING E3 ubiquitin ligase complex,GO:0032991~macromolecular complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0004860~protein kinase inhibitor activity,GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0019914~cyclin-dependent protein kinase activating kinase regulator activity,GO:0030332~cyclin binding,GO:0030544~Hsp70 protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0044877~macromolecular complex binding,GO:0051087~chaperone binding,GO:0060090~binding, bridging,GO:1990757~ubiquitin ligase activator activity,	IPR003175:CDI_dom,IPR044898:CDI_dom_sf,	hsa01522:Endocrine resistance,hsa04012:ErbB signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04151:PI3K-Akt signaling pathway,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04934:Cushing syndrome,hsa05162:Measles,hsa05165:Human papillomavirus infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05215:Prostate cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05226:Gastric cancer,	610755~Multiple endocrine neoplasia, type IV,			KW-0131~Cell cycle,	KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0967~Endosome,		KW-0043~Tumor suppressor,			KW-0649~Protein kinase inhibitor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,DOMAIN:Cyclin-dependent kinase inhibitor,MOTIF:Nuclear localization signal,MUTAGEN:E->A,D,Q: Strongly reduced ubiquitination by a TRIM21-containing SCF(SKP2) complex.,MUTAGEN:S->A: Loss of phosphorylation by UHMK1. No translocation to the cytoplasm. Greater cell cycle arrest.,MUTAGEN:S->A: No change in PKB/AKT1-mediated phosphorylation.,MUTAGEN:S->D: Exported to the cytoplasm. Inhibits cell cycle arrest.,MUTAGEN:S->E: Increased stability in vivo and in vitro.,MUTAGEN:T->A,D: Abolishes PKB/AKT1-mediated phosphorylation. 46% cytoplasmic location. Greatly reduced binding to YWHAQ. Equally reduced binding; when associated with A-10 and A-187. No nuclear import; when associated with A-157. Completely abolishes PKB/AKT1-mediated phosphorylation and no cytoplasmic translocation; when associated with A-157.,MUTAGEN:T->A,D: No change in PKB/AKT1- nor UHMK1-mediated phosphorylation.,MUTAGEN:T->A: Abolishes phosphorylation-dependent ubiquitination.,MUTAGEN:T->A: Greatly reduced PKB/AKT1-mediated phosphorylation. Nuclear location. Inhibits cyclin E/CDK2 cell cycle progression. No effect on binding AKT1. Completely abolishes PKB/AKT1-mediated phosphorylation and no cytoplasmic translocation; when associated with A-198.,MUTAGEN:T->A: No change in PKB/AKT1-mediated phosphorylation.,MUTAGEN:Y->F: Abolishes LYN-mediated phosphorylation, reduces CDK2-mediated phosphorylation on T-187, has greater cell cycle arrest into S-phase, no effect on binding CDK2 complexes, reduced CDK4 binding and inhibits CDK4 enzyme activity. No nuclear translocation. No effect on in vitro phosphorylation of CDK4 by CCNH-CDK7. Completely abolishes CDK4 binding; when associated with F-89.,MUTAGEN:Y->F: No change in binding CDK4 and no inhibition of CDK4 activity. Translocates to nucleus. No effect on in vitro phosphorylation of CDK4 by CCNH-CDK7.,MUTAGEN:Y->F: No effect on binding CDK2 complexes, reduced CDK4 binding and greatly inhibits CDK4 enzyme activity. No nuclear translocation. Inhibits in vitro phosphorylation of CDK4 by CCNH-CDK7. Completely abolishes CDK4 binding; when associated with F-88.,REGION:Disordered,REGION:Interaction with CDK2,
P49918	cyclin dependent kinase inhibitor 1C(CDKN1C)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001822~kidney development,GO:0007049~cell cycle,GO:0007096~regulation of exit from mitosis,GO:0016310~phosphorylation,GO:0030099~myeloid cell differentiation,GO:0030325~adrenal gland development,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0033673~negative regulation of kinase activity,GO:0035264~multicellular organism growth,GO:0042326~negative regulation of phosphorylation,GO:0042551~neuron maturation,GO:0043010~camera-type eye development,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045930~negative regulation of mitotic cell cycle,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051726~regulation of cell cycle,GO:0055123~digestive system development,GO:0060065~uterus development,GO:0060255~regulation of macromolecule metabolic process,GO:0060669~embryonic placenta morphogenesis,GO:0071514~genetic imprinting,GO:0080090~regulation of primary metabolic process,GO:1902746~regulation of lens fiber cell differentiation,GO:1904030~negative regulation of cyclin-dependent protein kinase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004860~protein kinase inhibitor activity,GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0044877~macromolecular complex binding,	IPR003175:CDI_dom,IPR044898:CDI_dom_sf,	hsa04110:Cell cycle,	130650~Beckwith-Wiedemann syndrome,614732~IMAGE syndrome,			KW-0131~Cell cycle,	KW-0539~Nucleus,		KW-0043~Tumor suppressor,KW-0225~Disease variant,	KW-0677~Repeat,		KW-0649~Protein kinase inhibitor,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Cyclin-dependent kinase inhibitor,MOTIF:Nuclear localization signal,REGION:9 X 4 AA repeats of P-A-P-A,REGION:Disordered,REPEAT:1,REPEAT:2,REPEAT:3,REPEAT:4,REPEAT:5,REPEAT:6,REPEAT:7,REPEAT:8,REPEAT:9,
Q29RV0	cyclin dependent kinase inhibitor 2D(CDKN2D)	Bos taurus			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000731~DNA synthesis involved in DNA repair,GO:0007049~cell cycle,GO:0007605~sensory perception of sound,GO:0008285~negative regulation of cell proliferation,GO:0009411~response to UV,GO:0030308~negative regulation of cell growth,GO:0032526~response to retinoic acid,GO:0033280~response to vitamin D,GO:0042326~negative regulation of phosphorylation,GO:0048102~autophagic cell death,GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0097129~cyclin D2-CDK4 complex,	GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0019901~protein kinase binding,	IPR002110:Ankyrin_rpt,IPR036770:Ankyrin_rpt-contain_sf,	bta04068:FoxO signaling pathway,bta04110:Cell cycle,			SM00248:ANK,	KW-0131~Cell cycle,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,	KW-0040~ANK repeat,KW-0677~Repeat,			KW-0007~Acetylation,	REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,
Q16667	cyclin dependent kinase inhibitor 3(CDKN3)	Homo sapiens			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016301~kinase activity,GO:0017018~myosin phosphatase activity,	IPR000387:Tyr_Pase_dom,IPR003595:Tyr_Pase_cat,IPR008425:CDK_inhib_3,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR022778:CDKN3,IPR029021:Prot-tyrosine_phosphatase-like,			PIRSF037322:CDKN3,	SM00404:PTPc_motif,	KW-0131~Cell cycle,	KW-0963~Cytoplasm,		KW-0225~Disease variant,			KW-0378~Hydrolase,KW-0418~Kinase,KW-0808~Transferase,KW-0904~Protein phosphatase,		ACT_SITE:Phosphocysteine intermediate,DOMAIN:CDKN3,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,REGION:Disordered,REGION:Interaction with CDK2,
P51958	cyclin-dependent kinase 1(cdk1)	Carassius auratus			GO:0000086~G2/M transition of mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0016310~phosphorylation,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,	caua04110:Cell cycle,caua04114:Oocyte meiosis,caua04115:p53 signaling pathway,caua04218:Cellular senescence,caua04540:Gap junction,caua04914:Progesterone-mediated oocyte maturation,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,
P43450	cyclin-dependent kinase 2(cdk2)	Carassius auratus			GO:0000082~G1/S transition of mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0010468~regulation of gene expression,GO:0016310~phosphorylation,GO:0051301~cell division,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0030332~cyclin binding,GO:0097472~cyclin-dependent protein kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,	caua04068:FoxO signaling pathway,caua04110:Cell cycle,caua04114:Oocyte meiosis,caua04115:p53 signaling pathway,caua04218:Cellular senescence,caua04914:Progesterone-mediated oocyte maturation,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,
P21291	cysteine and glycine rich protein 1(CSRP1)	Homo sapiens			GO:0045214~sarcomere organization,GO:0060537~muscle tissue development,GO:0070527~platelet aggregation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0030018~Z disc,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008307~structural constituent of muscle,GO:0042805~actinin binding,GO:0046872~metal ion binding,	IPR001781:Znf_LIM,				SM00132:LIM,		KW-0539~Nucleus,			KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,MOTIF:Nuclear localization signal,
P19336	cysteine rich angiogenic inducer 61(CYR61)	Gallus gallus			GO:0001649~osteoblast differentiation,GO:0001934~positive regulation of protein phosphorylation,GO:0002041~intussusceptive angiogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003278~apoptotic process involved in heart morphogenesis,GO:0003281~ventricular septum development,GO:0007165~signal transduction,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0030501~positive regulation of bone mineralization,GO:0030513~positive regulation of BMP signaling pathway,GO:0033690~positive regulation of osteoblast proliferation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0044319~wound healing, spreading of cells,GO:0045669~positive regulation of osteoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060413~atrial septum morphogenesis,GO:0060591~chondroblast differentiation,GO:0061036~positive regulation of cartilage development,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0072593~reactive oxygen species metabolic process,GO:0098609~cell-cell adhesion,GO:2000304~positive regulation of ceramide biosynthetic process,	GO:0005576~extracellular region,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0019838~growth factor binding,GO:0050840~extracellular matrix binding,	IPR000867:IGFBP-like,IPR000884:TSP1_rpt,IPR001007:VWF_dom,IPR006207:Cys_knot_C,IPR006208:Glyco_hormone_CN,IPR009030:Growth_fac_rcpt_cys_sf,IPR012395:IGFBP_CNN,IPR017891:Insulin_GF-bd_Cys-rich_CS,IPR036383:TSP1_rpt_sf,IPR043973:TSP1_CCN,			PIRSF036495:IGFBP_rP_CNN,	SM00041:CT,SM00121:IB,SM00209:TSP1,SM00214:VWC,		KW-0964~Secreted,			KW-0732~Signal,		KW-0340~Growth factor binding,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DOMAIN:CTCK,DOMAIN:IGFBP N-terminal,DOMAIN:TSP type-1,DOMAIN:VWFC,REGION:Heparin-binding,
Q9DCT8	cysteine rich protein 2(Crip2)	Mus musculus			GO:0008284~positive regulation of cell proliferation,GO:0030097~hemopoiesis,	GO:0005938~cell cortex,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001781:Znf_LIM,				SM00132:LIM,					KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,
Q567Z6	cysteine-rich PDZ-binding protein(cript)	Danio rerio			GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0031122~cytoplasmic microtubule organization,	GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0030425~dendrite,	GO:0008017~microtubule binding,GO:0030165~PDZ domain binding,	IPR019367:PDZ-binding_CRIPT,					KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0747~Spliceosome,KW-0963~Cytoplasm,
Q4V9Y5	cysteine-rich secretory protein LCCL domain containing 2(crispld2)	Xenopus tropicalis				GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005539~glycosaminoglycan binding,	IPR001283:CRISP-related,IPR004043:LCCL,IPR014044:CAP_domain,IPR018244:Allrgn_V5/Tpx1_CS,IPR035940:CAP_sf,IPR036609:LCCL_sf,				SM00198:SCP,SM00603:LCCL,		KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,			KW-1015~Disulfide bond,	DOMAIN:LCCL,DOMAIN:LCCL 1,DOMAIN:LCCL 2,DOMAIN:SCP,REGION:Disordered,
Q2KIF8	cysteinyl-tRNA synthetase 2, mitochondrial(CARS2)	Bos taurus			GO:0006418~tRNA aminoacylation for protein translation,GO:0006423~cysteinyl-tRNA aminoacylation,	GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,	GO:0004812~aminoacyl-tRNA ligase activity,GO:0004817~cysteine-tRNA ligase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR009080:tRNAsynth_Ia_anticodon-bd,IPR014729:Rossmann-like_a/b/a_fold,IPR015803:Cys-tRNA-ligase,IPR024909:Cys-tRNA/MSH_ligase,IPR032678:tRNA-synt_1_cat_dom,	bta00970:Aminoacyl-tRNA biosynthesis,				KW-0648~Protein biosynthesis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,		DOMAIN:tRNA synthetases class I catalytic,MOTIF:'HIGH' region,MOTIF:'KIIK' region,MOTIF:'KMSKS' region,REGION:Disordered,TRANSIT:Mitochondrion,
Q5U3U4	cytidine and dCMP deaminase domain containing 1(cdadc1)	Danio rerio				GO:0005737~cytoplasm,	GO:0003824~catalytic activity,GO:0004126~cytidine deaminase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR002125:CMP_dCMP_dom,IPR015517:dCMP_deaminase-rel,IPR016192:APOBEC/CMP_deaminase_Zn-bd,IPR016193:Cytidine_deaminase-like,					KW-0545~Nucleotide biosynthesis,				KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,		ACT_SITE:Proton donor,COMPBIAS:Basic and acidic residues,DOMAIN:CMP/dCMP-type deaminase,DOMAIN:CMP/dCMP-type deaminase 1,DOMAIN:CMP/dCMP-type deaminase 2,REGION:Disordered,
P56389	cytidine deaminase(Cda)	Mus musculus			GO:0006248~CMP catabolic process,GO:0006249~dCMP catabolic process,GO:0009972~cytidine deamination,GO:0030308~negative regulation of cell growth,GO:0044206~UMP salvage,GO:0045980~negative regulation of nucleotide metabolic process,GO:0046898~response to cycloheximide,GO:0071217~cellular response to external biotic stimulus,	GO:0005829~cytosol,	GO:0001882~nucleoside binding,GO:0003824~catalytic activity,GO:0004126~cytidine deaminase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0019239~deaminase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0047844~deoxycytidine deaminase activity,	IPR002125:CMP_dCMP_dom,IPR006262:Cyt_deam_tetra,IPR016192:APOBEC/CMP_deaminase_Zn-bd,IPR016193:Cytidine_deaminase-like,	mmu00240:Pyrimidine metabolism,mmu00983:Drug metabolism - other enzymes,mmu01100:Metabolic pathways,mmu01232:Nucleotide metabolism,									KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,		ACT_SITE:Proton donor,DOMAIN:CMP/dCMP-type deaminase,
P51589	cytochrome P450 family 2 subfamily J member 2(CYP2J2)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,	GO:0006082~organic acid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006690~icosanoid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0008016~regulation of heart contraction,GO:0019373~epoxygenase P450 pathway,GO:0043651~linoleic acid metabolic process,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008392~arachidonic acid epoxygenase activity,GO:0008404~arachidonic acid 14,15-epoxygenase activity,GO:0008405~arachidonic acid 11,12-epoxygenase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0016853~isomerase activity,GO:0020037~heme binding,GO:0071614~linoleic acid epoxygenase activity,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR008071:Cyt_P450_E_grp-I_CYP2J-like,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa01100:Metabolic pathways,hsa04726:Serotonergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04913:Ovarian steroidogenesis,hsa05417:Lipid and atherosclerosis,				KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,				KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0413~Isomerase,KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,
Q9Y6A2	cytochrome P450 family 46 subfamily A member 1(CYP46A1)	Homo sapiens			GO:0006699~bile acid biosynthetic process,GO:0006707~cholesterol catabolic process,GO:0006805~xenobiotic metabolic process,GO:0007399~nervous system development,GO:0016125~sterol metabolic process,GO:0042448~progesterone metabolic process,GO:1900271~regulation of long-term synaptic potentiation,GO:1903044~protein localization to membrane raft,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0030425~dendrite,GO:0098793~presynapse,GO:0098794~postsynapse,	GO:0005506~iron ion binding,GO:0008395~steroid hydroxylase activity,GO:0020037~heme binding,GO:0033781~cholesterol 24-hydroxylase activity,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,IPR039983:CYP46A1,	hsa00120:Primary bile acid biosynthesis,				KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0770~Synapse,KW-0966~Cell projection,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,REGION:Disordered,TRANSMEM:Helical,
P22680	cytochrome P450 family 7 subfamily A member 1(CYP7A1)	Homo sapiens			GO:0006699~bile acid biosynthetic process,GO:0006707~cholesterol catabolic process,GO:0015721~bile acid and bile salt transport,GO:0016125~sterol metabolic process,GO:0032966~negative regulation of collagen biosynthetic process,GO:0038183~bile acid signaling pathway,GO:0042632~cholesterol homeostasis,GO:0045471~response to ethanol,GO:0045542~positive regulation of cholesterol biosynthetic process,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0070857~regulation of bile acid biosynthetic process,GO:0071333~cellular response to glucose stimulus,GO:0071397~cellular response to cholesterol,	GO:0005789~endoplasmic reticulum membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005506~iron ion binding,GO:0008123~cholesterol 7-alpha-monooxygenase activity,GO:0020037~heme binding,GO:0033782~24-hydroxycholesterol 7alpha-hydroxylase activity,	IPR001128:Cyt_P450,IPR002403:Cyt_P450_E_grp-IV,IPR017972:Cyt_P450_CS,IPR024204:Cyt_P450_CYP7A1-type,IPR030681:Cholesterol_7a_monooxygenase,IPR036396:Cyt_P450_sf,	hsa00120:Primary bile acid biosynthesis,hsa00140:Steroid hormone biosynthesis,hsa01100:Metabolic pathways,hsa03320:PPAR signaling pathway,hsa04976:Bile secretion,hsa04979:Cholesterol metabolism,		PIRSF000047:Cytochrome_CYPVIIA1,PIRSF500625:Cytochrome_CYP7A1,		KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,TRANSMEM:Helical,
P12938	cytochrome P450, family 2, subfamily d, polypeptide 3(Cyp2d3)	Rattus norvegicus			GO:0001889~liver development,GO:0006805~xenobiotic metabolic process,GO:0019369~arachidonic acid metabolic process,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR008069:Cyt_P450_E_grp-I_CYP2D-like,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	rno00140:Steroid hormone biosynthesis,rno04726:Serotonergic synapse,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,TRANSMEM:Helical,
P12938	cytochrome P450, family 2, subfamily d, polypeptide 5(Cyp2d5)	Rattus norvegicus			GO:0001889~liver development,GO:0006805~xenobiotic metabolic process,GO:0019369~arachidonic acid metabolic process,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR008069:Cyt_P450_E_grp-I_CYP2D-like,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	rno00140:Steroid hormone biosynthesis,rno04726:Serotonergic synapse,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,	BINDING:axial binding residue,CARBOHYD:O-linked (GlcNAc) serine,TRANSMEM:Helical,
P33267	cytochrome P450, family 2, subfamily f, polypeptide 2(Cyp2f2)	Mus musculus			GO:0006805~xenobiotic metabolic process,GO:0009636~response to toxic substance,GO:0018979~trichloroethylene metabolic process,GO:0019373~epoxygenase P450 pathway,GO:1901170~naphthalene catabolic process,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008392~arachidonic acid epoxygenase activity,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR017972:Cyt_P450_CS,IPR020469:Cyt_P450_CYP2_fam,IPR036396:Cyt_P450_sf,	mmu00980:Metabolism of xenobiotics by cytochrome P450,mmu05208:Chemical carcinogenesis - reactive oxygen species,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,				KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,
Q9CX98	cytochrome P450, family 2, subfamily u, polypeptide 1(Cyp2u1)	Mus musculus			GO:0006082~organic acid metabolic process,GO:0006629~lipid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0097267~omega-hydroxylase P450 pathway,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008395~steroid hydroxylase activity,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,GO:0046872~metal ion binding,GO:0052869~arachidonic acid omega-hydroxylase activity,GO:0102033~cytochrome P450 fatty acid omega-hydroxylase activity,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR008069:Cyt_P450_E_grp-I_CYP2D-like,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	mmu00071:Fatty acid degradation,mmu00590:Arachidonic acid metabolism,mmu01100:Metabolic pathways,				KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,TRANSMEM:Helical,
Q6EIG3	cytochrome P450, family 26, subfamily b, polypeptide 1(cyp26b1)	Danio rerio			GO:0006629~lipid metabolic process,GO:0016125~sterol metabolic process,GO:0021661~rhombomere 4 morphogenesis,GO:0030278~regulation of ossification,GO:0030902~hindbrain development,GO:0034653~retinoic acid catabolic process,GO:0035992~tendon formation,GO:0042476~odontogenesis,GO:0042573~retinoic acid metabolic process,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0060323~head morphogenesis,GO:0060349~bone morphogenesis,GO:0060363~cranial suture morphogenesis,GO:0060365~coronal suture morphogenesis,GO:0060536~cartilage morphogenesis,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008401~retinoic acid 4-hydroxylase activity,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0018471~4-chlorobenzaldehyde oxidase activity,GO:0018630~3,5-xylenol methylhydroxylase activity,GO:0018631~phenylacetate hydroxylase activity,GO:0018633~dimethyl sulfide monooxygenase activity,GO:0018634~alpha-pinene monooxygenase [NADH] activity,GO:0018636~phenanthrene 9,10-monooxygenase activity,GO:0018637~1-hydroxy-2-naphthoate hydroxylase activity,GO:0018638~toluene 4-monooxygenase activity,GO:0018639~xylene monooxygenase activity,GO:0018641~6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity,GO:0018642~chlorophenol 4-monooxygenase activity,GO:0018643~carbon disulfide oxygenase activity,GO:0018646~1-hydroxy-2-oxolimonene 1,2-monooxygenase activity,GO:0018647~phenanthrene 1,2-monooxygenase activity,GO:0018649~tetrahydrofuran hydroxylase activity,GO:0018650~styrene monooxygenase activity,GO:0018651~toluene-4-sulfonate monooxygenase activity,GO:0018653~3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity,GO:0018654~2-hydroxy-phenylacetate hydroxylase activity,GO:0018655~2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity,GO:0018656~phenanthrene 3,4-monooxygenase activity,GO:0019113~limonene monooxygenase activity,GO:0020037~heme binding,GO:0034526~2-methylnaphthalene hydroxylase activity,GO:0034534~1-methylnaphthalene hydroxylase activity,GO:0034560~bisphenol A hydroxylase A activity,GO:0034791~isobutylamine N-hydroxylase activity,GO:0034802~branched-chain dodecylbenzene sulfonate monooxygenase activity,GO:0034819~3-HSA hydroxylase activity,GO:0034894~4-hydroxypyridine-3-hydroxylase activity,GO:0043719~2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity,GO:0046872~metal ion binding,GO:0052872~tocotrienol omega-hydroxylase activity,GO:0080014~thalianol hydroxylase activity,	IPR001128:Cyt_P450,IPR002403:Cyt_P450_E_grp-IV,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	dre00830:Retinol metabolism,dre01100:Metabolic pathways,				KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,				KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,
A8WGA0	cytochrome P450, family 27, subfamily C, polypeptide 1(cyp27c1)	Danio rerio			GO:0006629~lipid metabolic process,GO:1901615~organic hydroxy compound metabolic process,	GO:0005739~mitochondrion,GO:0016020~membrane,	GO:0001972~retinoic acid binding,GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,GO:0046872~metal ion binding,GO:1904768~all-trans-retinol binding,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	dre00830:Retinol metabolism,				KW-0443~Lipid metabolism,	KW-0472~Membrane,				KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,
Q9WVK8	cytochrome P450, family 46, subfamily a, polypeptide 1(Cyp46a1)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006707~cholesterol catabolic process,GO:0006805~xenobiotic metabolic process,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0042448~progesterone metabolic process,GO:1900271~regulation of long-term synaptic potentiation,GO:1903044~protein localization to membrane raft,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043231~intracellular membrane-bounded organelle,GO:0045202~synapse,GO:0098793~presynapse,GO:0098794~postsynapse,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008395~steroid hydroxylase activity,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,GO:0033781~cholesterol 24-hydroxylase activity,GO:0046872~metal ion binding,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,IPR039983:CYP46A1,	mmu00120:Primary bile acid biosynthesis,				KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0770~Synapse,KW-0966~Cell projection,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,TRANSMEM:Helical,
P04839	cytochrome b-245 beta chain(CYBB)	Homo sapiens			GO:0006801~superoxide metabolic process,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007584~response to nutrient,GO:0009410~response to xenobiotic stimulus,GO:0022900~electron transport chain,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034220~ion transmembrane transport,GO:0042554~superoxide anion generation,GO:0045087~innate immune response,GO:0045730~respiratory burst,GO:0045766~positive regulation of angiogenesis,GO:0050665~hydrogen peroxide biosynthetic process,GO:0071276~cellular response to cadmium ion,GO:0071361~cellular response to ethanol,GO:0072593~reactive oxygen species metabolic process,GO:0097411~hypoxia-inducible factor-1alpha signaling pathway,GO:1904044~response to aldosterone,GO:1904845~cellular response to L-glutamine,GO:1990776~response to angiotensin,	GO:0005635~nuclear envelope,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0030670~phagocytic vesicle membrane,GO:0034702~ion channel complex,GO:0035579~specific granule membrane,GO:0043020~NADPH oxidase complex,GO:0043025~neuronal cell body,GO:0045335~phagocytic vesicle,GO:0070821~tertiary granule membrane,GO:0097038~perinuclear endoplasmic reticulum,	GO:0005515~protein binding,GO:0009055~electron carrier activity,GO:0016175~superoxide-generating NADPH oxidase activity,GO:0016491~oxidoreductase activity,GO:0020037~heme binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050664~oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,	IPR000778:Cyt_b245_heavy_chain,IPR013112:FAD-bd_8,IPR013121:Fe_red_NAD-bd_6,IPR013130:Fe3_Rdtase_TM_dom,IPR017927:FAD-bd_FR_type,IPR017938:Riboflavin_synthase-like_b-brl,IPR039261:FNR_nucleotide-bd,	hsa04066:HIF-1 signaling pathway,hsa04145:Phagosome,hsa04216:Ferroptosis,hsa04217:Necroptosis,hsa04613:Neutrophil extracellular trap formation,hsa04621:NOD-like receptor signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa05010:Alzheimer disease,hsa05020:Prion disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05140:Leishmaniasis,hsa05171:Coronavirus disease - COVID-19,hsa05415:Diabetic cardiomyopathy,hsa05417:Lipid and atherosclerosis,	300645~Immunodeficiency 34, mycobacteriosis, X-linked,306400~Chronic granulomatous disease, X-linked,			KW-0249~Electron transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0161~Chronic granulomatous disease,KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0274~FAD,KW-0285~Flavoprotein,KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,KW-0521~NADP,	KW-0407~Ion channel,KW-0560~Oxidoreductase,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	BINDING:axial binding residue,CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:FAD-binding FR-type,DOMAIN:Ferric oxidoreductase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5E965	cytochrome b-561 domain containing 2(CYB561D2)	Bos taurus				GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031982~vesicle,	GO:0016491~oxidoreductase activity,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR006593:Cyt_b561/ferric_Rdtase_TM,IPR045150:CYB561D1/2,				SM00665:B561,	KW-0249~Electron transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-1278~Translocase,		BINDING:axial binding residue,DOMAIN:Cytochrome b561,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q9GZY4	cytochrome c oxidase assembly factor 1(COA1)	Homo sapiens			GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0033617~mitochondrial respiratory chain complex IV assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,	IPR014807:Coa1,	hsa04714:Thermogenesis,					KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSMEM:Helical,
Q6DH88	cytochrome c oxidase assembly factor COX20(cox20)	Danio rerio			GO:0033617~mitochondrial respiratory chain complex IV assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,		IPR022533:Cox20,						KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSMEM:Helical,
O14548	cytochrome c oxidase subunit 7A2 like(COX7A2L)	Homo sapiens			GO:0002082~regulation of oxidative phosphorylation,GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,GO:0097250~mitochondrial respiratory chain supercomplex assembly,GO:1902600~hydrogen ion transmembrane transport,	GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005751~mitochondrial respiratory chain complex IV,	GO:0004129~cytochrome-c oxidase activity,	IPR003177:Cytc_oxidase_su7a_met,IPR017267:Cyt_c_oxidase_su7a-rel_mt,IPR036539:Cyt_c_oxidase_su7a_sf,IPR039297:COX7a,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04260:Cardiac muscle contraction,hsa04714:Thermogenesis,hsa04932:Non-alcoholic fatty liver disease,hsa05010:Alzheimer disease,hsa05012:Parkinson disease,hsa05014:Amyotrophic lateral sclerosis,hsa05016:Huntington disease,hsa05020:Prion disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05208:Chemical carcinogenesis - reactive oxygen species,hsa05415:Diabetic cardiomyopathy,		PIRSF037710:COX7A-rel_mt,			KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,	TRANSIT:Mitochondrion,TRANSMEM:Helical,
P00428	cytochrome c oxidase subunit Vb(COX5B)	Bos taurus			GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,	GO:0005740~mitochondrial envelope,GO:0005751~mitochondrial respiratory chain complex IV,GO:0045277~respiratory chain complex IV,	GO:0046872~metal ion binding,	IPR002124:Cyt_c_oxidase_su5b,IPR036972:Cyt_c_oxidase_su5b_sf,	bta00190:Oxidative phosphorylation,bta01100:Metabolic pathways,bta04260:Cardiac muscle contraction,bta04714:Thermogenesis,bta04932:Non-alcoholic fatty liver disease,bta05010:Alzheimer disease,bta05012:Parkinson disease,bta05014:Amyotrophic lateral sclerosis,bta05016:Huntington disease,bta05020:Prion disease,bta05022:Pathways of neurodegeneration - multiple diseases,bta05208:Chemical carcinogenesis - reactive oxygen species,bta05415:Diabetic cardiomyopathy,					KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,	TRANSIT:Mitochondrion,
Q91VY6	cytohesin 1 interacting protein(Cytip)	Mus musculus			GO:0030155~regulation of cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005938~cell cortex,		IPR001478:PDZ,IPR036034:PDZ_sf,				SM00228:PDZ,		KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0175~Coiled coil,				DOMAIN:PDZ,REGION:Interaction with CYTH1,
Q9UIA0	cytohesin 4(CYTH4)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,	GO:0032012~regulation of ARF protein signal transduction,	GO:0000139~Golgi membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0034451~centriolar satellite,GO:0045171~intercellular bridge,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008289~lipid binding,	IPR000904:Sec7_dom,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR023394:Sec7_C_sf,IPR035999:Sec7_dom_sf,	hsa04072:Phospholipase D signaling pathway,hsa04144:Endocytosis,hsa05130:Pathogenic Escherichia coli infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,			SM00222:Sec7,SM00233:PH,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,	KW-0446~Lipid-binding,	KW-0344~Guanine-nucleotide releasing factor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PH,DOMAIN:SEC7,REGION:C-terminal autoinhibitory region,REGION:Disordered,
Q5R414	cytoplasmic FMR1 interacting protein 2(CYFIP2)	Pongo abelii			GO:0000902~cell morphogenesis,GO:0006915~apoptotic process,GO:0007411~axon guidance,GO:0030031~cell projection assembly,GO:0030833~regulation of actin filament polymerization,GO:0045862~positive regulation of proteolysis,GO:0051388~positive regulation of neurotrophin TRK receptor signaling pathway,GO:0097202~activation of cysteine-type endopeptidase activity,GO:0097484~dendrite extension,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031209~SCAR complex,GO:0043005~neuron projection,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,	GO:0031267~small GTPase binding,	IPR008081:Cytoplasmic_FMR1-int,IPR009828:CYRIA/CYRIB_Rac1-bd,	pon04810:Regulation of actin cytoskeleton,pon05132:Salmonella infection,		PIRSF008153:FMR1_interacting,		KW-0053~Apoptosis,KW-0130~Cell adhesion,	KW-0539~Nucleus,KW-0770~Synapse,KW-0771~Synaptosome,KW-0963~Cytoplasm,						KW-0007~Acetylation,	DOMAIN:CYRIA/CYRIB Rac1 binding,
Q9Y2H9	cytoplasmic linker associated protein 1(CLASP1)	Homo sapiens			GO:0000226~microtubule cytoskeleton organization,GO:0001578~microtubule bundle formation,GO:0006468~protein phosphorylation,GO:0006903~vesicle targeting,GO:0007010~cytoskeleton organization,GO:0007020~microtubule nucleation,GO:0007026~negative regulation of microtubule depolymerization,GO:0007030~Golgi organization,GO:0007052~mitotic spindle organization,GO:0007163~establishment or maintenance of cell polarity,GO:0007420~brain development,GO:0010458~exit from mitosis,GO:0010470~regulation of gastrulation,GO:0010634~positive regulation of epithelial cell migration,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0030953~astral microtubule organization,GO:0031023~microtubule organizing center organization,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0031116~positive regulation of microtubule polymerization,GO:0034453~microtubule anchoring,GO:0035556~intracellular signal transduction,GO:0040001~establishment of mitotic spindle localization,GO:0045921~positive regulation of exocytosis,GO:0051128~regulation of cellular component organization,GO:0051294~establishment of spindle orientation,GO:0051301~cell division,GO:0051497~negative regulation of stress fiber assembly,GO:0051893~regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0090091~positive regulation of extracellular matrix disassembly,GO:0090162~establishment of epithelial cell polarity,GO:0090307~mitotic spindle assembly,GO:1903690~negative regulation of wound healing, spreading of epidermal cells,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0000776~kinetochore,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005828~kinetochore microtubule,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005876~spindle microtubule,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030981~cortical microtubule cytoskeleton,GO:0031592~centrosomal corona,GO:0035371~microtubule plus-end,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0045180~basal cortex,GO:0072686~mitotic spindle,	GO:0000287~magnesium ion binding,GO:0002162~dystroglycan binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0043515~kinetochore binding,GO:0051010~microtubule plus-end binding,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR001478:PDZ,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011989:ARM-like,IPR015022:MAST_pre-PK_dom,IPR016024:ARM-type_fold,IPR021133:HEAT_type_2,IPR023142:MAST_pre-PK_dom_sf,IPR024395:CLASP_N_dom,IPR034085:TOG,IPR036034:PDZ_sf,IPR037711:MAST,IPR041489:PDZ_6,IPR048491:XMAP215_CLASP_TOG,				SM00220:S_TKc,SM00228:PDZ,SM01349:TOG,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0995~Kinetochore,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0175~Coiled coil,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:AGC-kinase C-terminal,DOMAIN:Microtubule-associated serine/threonine-protein kinase pre-PK,DOMAIN:PDZ,DOMAIN:Protein kinase,DOMAIN:TOG,REGION:Disordered,REGION:Interaction with CLIP2,REGION:Interaction with PHLDB2 and RSN,REGION:Interaction with microtubules, MAPRE1 and MAPRE3,REGION:Localization to kinetochores,REPEAT:HEAT,REPEAT:HEAT 1,REPEAT:HEAT 2,REPEAT:HEAT 3,REPEAT:HEAT 4,REPEAT:HEAT 5,REPEAT:HEAT 6,REPEAT:HEAT 7,
Q9YGX5	cytoplasmic polyadenylation element binding protein 1b(cpeb1b)	Danio rerio			GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0031440~regulation of mRNA 3'-end processing,GO:0032869~cellular response to insulin stimulus,GO:0071230~cellular response to amino acid stimulus,GO:0071456~cellular response to hypoxia,GO:2000766~negative regulation of cytoplasmic translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0032991~macromolecular complex,GO:0043005~neuron projection,GO:0045202~synapse,GO:1990124~messenger ribonucleoprotein complex,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008135~translation factor activity, RNA binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0043022~ribosome binding,GO:0045182~translation regulator activity,GO:0046872~metal ion binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR032292:CEBP1_N,IPR032296:CEBP_ZZ,IPR034819:CPEB,IPR034977:CPEB1_RRM1,IPR035979:RBD_domain_sf,IPR038446:CEBP_ZZ_sf,	dre04114:Oocyte meiosis,dre04914:Progesterone-mediated oocyte maturation,			SM00360:RRM,	KW-0507~mRNA processing,KW-0810~Translation regulation,	KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0694~RNA-binding,		DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,
Q17RY0	cytoplasmic polyadenylation element binding protein 2(CPEB2)	Homo sapiens			GO:0002931~response to ischemia,GO:0006412~translation,GO:0032869~cellular response to insulin stimulus,GO:0034260~negative regulation of GTPase activity,GO:0034599~cellular response to oxidative stress,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0036294~cellular response to decreased oxygen levels,GO:0042149~cellular response to glucose starvation,GO:0043524~negative regulation of neuron apoptotic process,GO:0071230~cellular response to amino acid stimulus,GO:0071243~cellular response to arsenic-containing substance,GO:0071456~cellular response to hypoxia,GO:1900248~negative regulation of cytoplasmic translational elongation,GO:2000766~negative regulation of cytoplasmic translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0014069~postsynaptic density,GO:0030425~dendrite,GO:0030426~growth cone,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:1990124~messenger ribonucleoprotein complex,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005095~GTPase inhibitor activity,GO:0008135~translation factor activity, RNA binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0043022~ribosome binding,GO:0043023~ribosomal large subunit binding,GO:0043024~ribosomal small subunit binding,GO:0045182~translation regulator activity,GO:0046872~metal ion binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR032296:CEBP_ZZ,IPR034819:CPEB,IPR035979:RBD_domain_sf,IPR038446:CEBP_ZZ_sf,	hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,			SM00360:RRM,	KW-0810~Translation regulation,	KW-0256~Endoplasmic reticulum,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,REGION:RNA-binding,SITE:Important for the positionning of RRM1 relative to RRM2,SITE:RNA-binding,
Q17RY0	cytoplasmic polyadenylation element binding protein 3(CPEB3)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002931~response to ischemia,GO:0006412~translation,GO:0007616~long-term memory,GO:0017148~negative regulation of translation,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0036294~cellular response to decreased oxygen levels,GO:0042149~cellular response to glucose starvation,GO:0043524~negative regulation of neuron apoptotic process,GO:0045727~positive regulation of translation,GO:0048167~regulation of synaptic plasticity,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0060998~regulation of dendritic spine development,GO:0060999~positive regulation of dendritic spine development,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071230~cellular response to amino acid stimulus,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:1900248~negative regulation of cytoplasmic translational elongation,GO:2000766~negative regulation of cytoplasmic translation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030014~CCR4-NOT complex,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030496~midbody,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:0097440~apical dendrite,GO:1990124~messenger ribonucleoprotein complex,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008135~translation factor activity, RNA binding,GO:0035613~RNA stem-loop binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0043022~ribosome binding,GO:0045182~translation regulator activity,GO:0046872~metal ion binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR032296:CEBP_ZZ,IPR034819:CPEB,IPR035979:RBD_domain_sf,IPR038446:CEBP_ZZ_sf,	hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,			SM00360:RRM,	KW-0810~Translation regulation,	KW-0034~Amyloid,KW-0256~Endoplasmic reticulum,KW-0539~Nucleus,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0678~Repressor,KW-0694~RNA-binding,	KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,MUTAGEN:D->A: Does not impair RNA binding.,MUTAGEN:F->A,N: Abolishes RNA binding.,MUTAGEN:F->A: Reduced RNA binding.,MUTAGEN:F->Y: Does not impair RNA binding.,MUTAGEN:G->A: Does not impair RNA binding.,MUTAGEN:K->A: Does not impair RNA binding.,MUTAGEN:L->A: Abolishes nuclear export; when associated with A-349.,MUTAGEN:L->A: Abolishes nuclear export; when associated with A-353.,MUTAGEN:R->A: Does not impair RNA binding.,MUTAGEN:S->A: Does not impair RNA binding.,REGION:Disordered,REGION:RNA-binding,SITE:Cleavage; by CAPN2,SITE:Important for the positionning of RRM1 relative to RRM2,SITE:RNA-binding,SITE:Required for RNA-binding activity,
Q17RY0	cytoplasmic polyadenylation element binding protein 4(CPEB4)	Homo sapiens			GO:0002931~response to ischemia,GO:0006412~translation,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0036294~cellular response to decreased oxygen levels,GO:0042149~cellular response to glucose starvation,GO:0043524~negative regulation of neuron apoptotic process,GO:0071230~cellular response to amino acid stimulus,GO:2000766~negative regulation of cytoplasmic translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0014069~postsynaptic density,GO:0030425~dendrite,GO:0030426~growth cone,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:1990124~messenger ribonucleoprotein complex,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008135~translation factor activity, RNA binding,GO:0043022~ribosome binding,GO:0045182~translation regulator activity,GO:0046872~metal ion binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR032296:CEBP_ZZ,IPR034819:CPEB,IPR035979:RBD_domain_sf,IPR038446:CEBP_ZZ_sf,	hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,			SM00360:RRM,		KW-0256~Endoplasmic reticulum,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,REGION:RNA-binding,SITE:Important for the positionning of RRM1 relative to RRM2,SITE:RNA-binding,
A5PK21	cytoskeleton associated protein 2 like(CKAP2L)	Bos taurus				GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0072686~mitotic spindle,		IPR029197:CKAP2_C,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Cytoskeleton-associated protein 2 C-terminal,REGION:Disordered,
Q14008	cytoskeleton associated protein 5(CKAP5)	Homo sapiens			GO:0007019~microtubule depolymerization,GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007098~centrosome cycle,GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity,GO:0046785~microtubule polymerization,GO:0050658~RNA transport,GO:0051298~centrosome duplication,GO:0051301~cell division,GO:0090063~positive regulation of microtubule nucleation,	GO:0000776~kinetochore,GO:0000922~spindle pole,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0032991~macromolecular complex,GO:0035371~microtubule plus-end,GO:0043232~intracellular non-membrane-bounded organelle,GO:0099080~supramolecular complex,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0043021~ribonucleoprotein complex binding,GO:0045296~cadherin binding,GO:0051010~microtubule plus-end binding,	IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR021133:HEAT_type_2,IPR024395:CLASP_N_dom,IPR034085:TOG,IPR045110:XMAP215,IPR048491:XMAP215_CLASP_TOG,				SM01349:TOG,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0995~Kinetochore,			KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:TOG,MUTAGEN:L->A,R: Disrupts interaction with TACC3.,MUTAGEN:L->A: Abolishes localization to spindle microtubules, no effect on localization to centrosomes and kinetochores; when associated with A-1939.,MUTAGEN:L->A: Abolishes localization to spindle microtubules, no effect on localization to centrosomes and kinetochores; when associated with A-1942.,REGION:Disordered,REGION:Interaction with TACC3,REGION:TOG 1,REGION:TOG 2,REGION:TOG 3,REGION:TOG 4,REGION:TOG 5,REPEAT:HEAT 1,REPEAT:HEAT 10,REPEAT:HEAT 2,REPEAT:HEAT 3,REPEAT:HEAT 4,REPEAT:HEAT 5,REPEAT:HEAT 6,REPEAT:HEAT 7,REPEAT:HEAT 8,REPEAT:HEAT 9,
Q0V8A3	cytosolic arginine sensor for mTORC1 subunit 1(CASTOR1)	Bos taurus			GO:0034198~cellular response to amino acid starvation,GO:1903577~cellular response to L-arginine,GO:1904262~negative regulation of TORC1 signaling,GO:1904263~positive regulation of TORC1 signaling,	GO:0005829~cytosol,GO:0061700~GATOR2 complex,	GO:0034618~arginine binding,GO:0042802~identical protein binding,	IPR026249:CASTOR_fam,IPR027795:CASTOR_ACT_dom,IPR040778:CASTOR1_N,IPR045865:ACT-like_dom_sf,	bta04150:mTOR signaling pathway,					KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	DOMAIN:ACT 1,DOMAIN:ACT 2,
Q6DC53	cytosolic thiouridylase subunit 2 homolog (S. pombe)(ctu2)	Danio rerio			GO:0002098~tRNA wobble uridine modification,GO:0002143~tRNA wobble position uridine thiolation,GO:0008033~tRNA processing,GO:0032447~protein urmylation,GO:0034227~tRNA thio-modification,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000049~tRNA binding,GO:0016779~nucleotidyltransferase activity,GO:0016783~sulfurtransferase activity,	IPR014729:Rossmann-like_a/b/a_fold,IPR019407:CTU2,	dre04122:Sulfur relay system,				KW-0819~tRNA processing,	KW-0963~Cytoplasm,
Q5M9G0	dCMP deaminase(Dctd)	Rattus norvegicus			GO:0006220~pyrimidine nucleotide metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0043174~nucleoside salvage,	GO:0005737~cytoplasm,	GO:0003824~catalytic activity,GO:0004132~dCMP deaminase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,GO:0070694~deoxyribonucleoside 5'-monophosphate N-glycosidase activity,	IPR002125:CMP_dCMP_dom,IPR015517:dCMP_deaminase-rel,IPR016192:APOBEC/CMP_deaminase_Zn-bd,IPR016193:Cytidine_deaminase-like,IPR016473:dCMP_deaminase,IPR035105:Deoxycytidylate_deaminase_dom,	rno00240:Pyrimidine metabolism,rno01100:Metabolic pathways,rno01232:Nucleotide metabolism,		PIRSF006019:dCMP_deaminase,		KW-0545~Nucleotide biosynthesis,					KW-0479~Metal-binding,KW-0862~Zinc,	KW-0021~Allosteric enzyme,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton donor,DOMAIN:CMP/dCMP-type deaminase,
Q7T010	dCTP pyrophosphatase 1(dctpp1)	Danio rerio			GO:0006253~dCTP catabolic process,GO:0009143~nucleoside triphosphate catabolic process,GO:0032543~mitochondrial translation,GO:0042262~DNA protection,GO:0070681~glutaminyl-tRNAGln biosynthesis via transamidation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0030956~glutamyl-tRNA(Gln) amidotransferase complex,	GO:0000287~magnesium ion binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0047429~nucleoside-triphosphate diphosphatase activity,GO:0047840~dCTP diphosphatase activity,GO:0050567~glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,	IPR003789:Asn/Gln_tRNA_amidoTrase-B-like,IPR004413:GatB,IPR006075:Asn/Gln-tRNA_Trfase_suB/E_cat,IPR014746:Gln_synth/guanido_kin_cat_dom,IPR017959:Asn/Gln-tRNA_amidoTrfase_suB/E,IPR018027:Asn/Gln_amidotransferase,IPR023168:GatB_Yqey_C_2,IPR025984:DCTPP,	dre00240:Pyrimidine metabolism,dre01100:Metabolic pathways,dre01232:Nucleotide metabolism,			SM00845:GatB_Yqey,	KW-0648~Protein biosynthesis,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0436~Ligase,		COMPBIAS:Basic and acidic residues,REGION:Disordered,TRANSIT:Mitochondrion,
D4ACX8	dachsous cadherin-related 1(Dchs1)	Rattus norvegicus			GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0003007~heart morphogenesis,GO:0003183~mitral valve morphogenesis,GO:0003192~mitral valve formation,GO:0003273~cell migration involved in endocardial cushion formation,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007389~pattern specification process,GO:0009653~anatomical structure morphogenesis,GO:0016477~cell migration,GO:0021915~neural tube development,GO:0022008~neurogenesis,GO:0035329~hippo signaling,GO:0036342~post-anal tail morphogenesis,GO:0043931~ossification involved in bone maturation,GO:0048565~digestive tract development,GO:0072006~nephron development,GO:0072137~condensed mesenchymal cell proliferation,GO:0072659~protein localization to plasma membrane,GO:0090102~cochlea development,GO:0098609~cell-cell adhesion,GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,	GO:0005886~plasma membrane,GO:0016342~catenin complex,GO:0045177~apical part of cell,	GO:0005509~calcium ion binding,GO:0045296~cadherin binding,	IPR002126:Cadherin-like_dom,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,	rno04392:Hippo signaling pathway - multiple species,			SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 10,DOMAIN:Cadherin 11,DOMAIN:Cadherin 12,DOMAIN:Cadherin 13,DOMAIN:Cadherin 14,DOMAIN:Cadherin 15,DOMAIN:Cadherin 16,DOMAIN:Cadherin 17,DOMAIN:Cadherin 18,DOMAIN:Cadherin 19,DOMAIN:Cadherin 2,DOMAIN:Cadherin 20,DOMAIN:Cadherin 21,DOMAIN:Cadherin 22,DOMAIN:Cadherin 23,DOMAIN:Cadherin 24,DOMAIN:Cadherin 25,DOMAIN:Cadherin 26,DOMAIN:Cadherin 27,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,DOMAIN:Cadherin 7,DOMAIN:Cadherin 8,DOMAIN:Cadherin 9,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q2YDS1	damage-specific DNA binding protein 2(ddb2)	Danio rerio			GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009411~response to UV,GO:0016567~protein ubiquitination,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,GO:0090734~site of DNA damage,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,	IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR033312:DDB2,IPR036322:WD40_repeat_dom_sf,	dre03420:Nucleotide excision repair,dre04115:p53 signaling pathway,dre04120:Ubiquitin mediated proteolysis,			SM00320:WD40,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0677~Repeat,KW-0853~WD repeat,		KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,MOTIF:DWD box,REGION:Disordered,REGION:Photolesion recognition,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q9I9N0	death associated protein 1b(dap1b)	Danio rerio			GO:0006417~regulation of translation,GO:0010507~negative regulation of autophagy,GO:0034198~cellular response to amino acid starvation,GO:0097190~apoptotic signaling pathway,		GO:0030371~translation repressor activity,GO:0031369~translation initiation factor binding,GO:0043022~ribosome binding,GO:0070513~death domain binding,	IPR024130:DAP1/DAPL1,					KW-0810~Translation regulation,								COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q9I9N1	death-associated protein(dap)	Danio rerio			GO:0006417~regulation of translation,GO:0010507~negative regulation of autophagy,GO:0034198~cellular response to amino acid starvation,GO:0097190~apoptotic signaling pathway,		GO:0043022~ribosome binding,GO:0070513~death domain binding,	IPR024130:DAP1/DAPL1,					KW-0810~Translation regulation,								REGION:Disordered,
Q5JSL3	dedicator of cytokinesis 11(DOCK11)	Homo sapiens			GO:0001782~B cell homeostasis,GO:0002315~marginal zone B cell differentiation,GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051491~positive regulation of filopodium assembly,	GO:0005829~cytosol,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0031267~small GTPase binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR016024:ARM-type_fold,IPR021816:DOCK_C/D_N,IPR026791:DOCK,IPR027007:C2_DOCK-type_domain,IPR027357:DOCKER_dom,IPR035892:C2_domain_sf,IPR037809:C2_Dock-D,IPR043161:DOCK_C_lobe_A,IPR043162:DOCK_C_lobe_C,IPR046769:DOCKER_Lobe_A,IPR046770:DOCKER_Lobe_B,IPR046773:DOCKER_Lobe_C,		301109~Autoinflammatory disease, multisystem, with immune dysregulation, X-linked,		SM00233:PH,							KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:C2 DOCK-type,DOMAIN:DOCKER,DOMAIN:DOCKER Lobe C,DOMAIN:PH,REGION:Disordered,
Q96HP0	dedicator of cytokinesis 6(DOCK6)	Homo sapiens			GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR021816:DOCK_C/D_N,IPR026791:DOCK,IPR027007:C2_DOCK-type_domain,IPR027357:DOCKER_dom,IPR035892:C2_domain_sf,IPR037808:C2_Dock-C,IPR043161:DOCK_C_lobe_A,IPR043162:DOCK_C_lobe_C,IPR046769:DOCKER_Lobe_A,IPR046770:DOCKER_Lobe_B,IPR046773:DOCKER_Lobe_C,		614219~Adams-Oliver syndrome 2,				KW-0963~Cytoplasm,					KW-0344~Guanine-nucleotide releasing factor,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2 DOCK-type,DOMAIN:DOCKER,REGION:Disordered,
Q96N67	dedicator of cytokinesis 7(DOCK7)	Homo sapiens			GO:0000226~microtubule cytoskeleton organization,GO:0007264~small GTPase mediated signal transduction,GO:0007409~axonogenesis,GO:0022027~interkinetic nuclear migration,GO:0031175~neuron projection development,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0043547~positive regulation of GTPase activity,GO:0045200~establishment of neuroblast polarity,GO:0050767~regulation of neurogenesis,GO:0090630~activation of GTPase activity,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,	GO:0005925~focal adhesion,GO:0008180~COP9 signalosome,GO:0016020~membrane,GO:0030424~axon,GO:0030426~growth cone,GO:0043005~neuron projection,GO:0045178~basal part of cell,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0031267~small GTPase binding,	IPR021816:DOCK_C/D_N,IPR026791:DOCK,IPR027007:C2_DOCK-type_domain,IPR027357:DOCKER_dom,IPR035892:C2_domain_sf,IPR037808:C2_Dock-C,IPR043161:DOCK_C_lobe_A,IPR043162:DOCK_C_lobe_C,IPR046769:DOCKER_Lobe_A,IPR046770:DOCKER_Lobe_B,IPR046773:DOCKER_Lobe_C,		615859~Developmental and epileptic encephalopathy 23,			KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0966~Cell projection,		KW-0887~Epilepsy,	KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0344~Guanine-nucleotide releasing factor,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2 DOCK-type,DOMAIN:DOCKER,DOMAIN:Dedicator of cytokinesis C/D N-terminal,REGION:Disordered,TRANSMEM:Helical,
Q8R1A4	dedicator of cytokinesis 7(Dock7)	Mus musculus			GO:0000226~microtubule cytoskeleton organization,GO:0002244~hematopoietic progenitor cell differentiation,GO:0007264~small GTPase mediated signal transduction,GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0022027~interkinetic nuclear migration,GO:0030154~cell differentiation,GO:0031175~neuron projection development,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0043473~pigmentation,GO:0043547~positive regulation of GTPase activity,GO:0045200~establishment of neuroblast polarity,GO:0050767~regulation of neurogenesis,GO:0090630~activation of GTPase activity,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,	GO:0008180~COP9 signalosome,GO:0030424~axon,GO:0031594~neuromuscular junction,GO:0042995~cell projection,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0031267~small GTPase binding,	IPR021816:DOCK_C/D_N,IPR026791:DOCK,IPR027007:C2_DOCK-type_domain,IPR027357:DOCKER_dom,IPR035892:C2_domain_sf,IPR037808:C2_Dock-C,IPR043161:DOCK_C_lobe_A,IPR043162:DOCK_C_lobe_C,IPR046769:DOCKER_Lobe_A,IPR046770:DOCKER_Lobe_B,IPR046773:DOCKER_Lobe_C,					KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0966~Cell projection,			KW-0175~Coiled coil,		KW-0217~Developmental protein,KW-0344~Guanine-nucleotide releasing factor,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2 DOCK-type,DOMAIN:DOCKER,REGION:Disordered,
Q9BZ29	dedicator of cytokinesis 9(DOCK9)	Homo sapiens			GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005829~cytosol,GO:0012505~endomembrane system,GO:0016020~membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR016024:ARM-type_fold,IPR021816:DOCK_C/D_N,IPR026791:DOCK,IPR027007:C2_DOCK-type_domain,IPR027357:DOCKER_dom,IPR035892:C2_domain_sf,IPR037809:C2_Dock-D,IPR043161:DOCK_C_lobe_A,IPR043162:DOCK_C_lobe_C,IPR046769:DOCKER_Lobe_A,IPR046770:DOCKER_Lobe_B,IPR046773:DOCKER_Lobe_C,				SM00233:PH,		KW-0472~Membrane,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2 DOCK-type,DOMAIN:DOCKER,DOMAIN:PH,REGION:Disordered,REGION:Interaction with CDC42,
Q99L04	dehydrogenase/reductase 1(Dhrs1)	Mus musculus				GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,	GO:0004090~carbonyl reductase (NADPH) activity,GO:0016491~oxidoreductase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0047045~testosterone 17-beta-dehydrogenase (NADP+) activity,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,						KW-0256~Endoplasmic reticulum,				KW-0520~NAD,	KW-0560~Oxidoreductase,	KW-0488~Methylation,	ACT_SITE:Proton acceptor,
Q17QU7	dehydrogenase/reductase 13(DHRS13)	Bos taurus				GO:0005576~extracellular region,	GO:0016491~oxidoreductase activity,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,						KW-0964~Secreted,			KW-0732~Signal,	KW-0520~NAD,KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,REGION:Disordered,
Q6DI48	deltaA(dla)	Danio rerio			GO:0001525~angiogenesis,GO:0007154~cell communication,GO:0007219~Notch signaling pathway,GO:0007399~nervous system development,GO:0008593~regulation of Notch signaling pathway,GO:0009880~embryonic pattern specification,GO:0014032~neural crest cell development,GO:0021514~ventral spinal cord interneuron differentiation,GO:0021536~diencephalon development,GO:0022008~neurogenesis,GO:0030154~cell differentiation,GO:0030901~midbrain development,GO:0033504~floor plate development,GO:0045746~negative regulation of Notch signaling pathway,GO:0048468~cell development,GO:0048513~animal organ development,GO:0048731~system development,GO:0055016~hypochord development,GO:0060034~notochord cell differentiation,GO:0060113~inner ear receptor cell differentiation,	GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016020~membrane,	GO:0005112~Notch binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001774:DSL,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR011651:Notch_ligand_N,IPR013032:EGF-like_CS,IPR018097:EGF_Ca-bd_CS,	dre04330:Notch signaling pathway,			SM00051:DSL,SM00179:EGF_CA,SM00181:EGF,	KW-0037~Angiogenesis,KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0914~Notch signaling pathway,	KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:DSL,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,MUTAGEN:C->Y: In dla(dx2); excess numbers of early-specified neurons, reduced numbers of floorplate and hypochord cells, excess numbers of notochord cells.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8AW93	deltex 1 L homeolog(dtx1.L)	Xenopus laevis			GO:0007219~Notch signaling pathway,GO:0016567~protein ubiquitination,	GO:0005737~cytoplasm,	GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR004170:WWE-dom,IPR013083:Znf_RING/FYVE/PHD,IPR018123:WWE-dom_subgr,IPR018957:Znf_C3HC4_RING-type,IPR037197:WWE_dom_sf,IPR039396:Deltex_C,IPR039398:Deltex_fam,IPR039399:Deltex_C_sf,	xla04330:Notch signaling pathway,			SM00184:RING,SM00678:WWE,	KW-0833~Ubl conjugation pathway,KW-0914~Notch signaling pathway,	KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:RING-type,DOMAIN:WWE,DOMAIN:WWE 1,DOMAIN:WWE 2,REGION:Disordered,ZN_FING:RING-type,
Q6DH65	density-regulated protein(denr)	Danio rerio			GO:0001731~formation of translation preinitiation complex,GO:0002188~translation reinitiation,GO:0006412~translation,GO:0006413~translational initiation,		GO:0003729~mRNA binding,GO:0003743~translation initiation factor activity,	IPR001950:SUI1,IPR005873:DENR_eukaryotes,IPR036877:SUI1_dom_sf,IPR046447:DENR_C,IPR048517:DENR_N,					KW-0648~Protein biosynthesis,						KW-0396~Initiation factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:SUI1,REGION:Disordered,
P43346	deoxycytidine kinase(Dck)	Mus musculus			GO:0006139~nucleobase-containing compound metabolic process,GO:0006220~pyrimidine nucleotide metabolic process,GO:0009157~deoxyribonucleoside monophosphate biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0016310~phosphorylation,GO:0046092~deoxycytidine metabolic process,GO:1901135~carbohydrate derivative metabolic process,GO:1901293~nucleoside phosphate biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004136~deoxyadenosine kinase activity,GO:0004137~deoxycytidine kinase activity,GO:0004138~deoxyguanosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019136~deoxynucleoside kinase activity,GO:0032546~deoxyribonucleoside binding,GO:0032548~pyrimidine deoxyribonucleoside binding,GO:0042803~protein homodimerization activity,GO:0043771~cytidine kinase activity,	IPR002624:DCK/DGK,IPR027417:P-loop_NTPase,IPR031314:DNK_dom,	mmu00230:Purine metabolism,mmu00240:Pyrimidine metabolism,mmu01100:Metabolic pathways,mmu01232:Nucleotide metabolism,		PIRSF000705:DNK,			KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Deoxynucleoside kinase,
Q3B752	deoxythymidylate kinase (thymidylate kinase)(dtymk)	Danio rerio			GO:0006227~dUDP biosynthetic process,GO:0006233~dTDP biosynthetic process,GO:0006235~dTTP biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0016310~phosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0004550~nucleoside diphosphate kinase activity,GO:0004798~thymidylate kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR018094:Thymidylate_kinase,IPR018095:Thymidylate_kin_CS,IPR027417:P-loop_NTPase,IPR039430:Thymidylate_kin-like_dom,	dre00240:Pyrimidine metabolism,dre01100:Metabolic pathways,dre01232:Nucleotide metabolism,				KW-0545~Nucleotide biosynthesis,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,
Q9CQ43	deoxyuridine triphosphatase(Dut)	Mus musculus			GO:0001889~liver development,GO:0006226~dUMP biosynthetic process,GO:0006231~dTMP biosynthetic process,GO:0009117~nucleotide metabolic process,GO:0014070~response to organic cyclic compound,GO:0043254~regulation of protein complex assembly,GO:0046081~dUTP catabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,	GO:0000287~magnesium ion binding,GO:0004170~dUTP diphosphatase activity,GO:0016787~hydrolase activity,GO:0030547~receptor inhibitor activity,GO:0032556~pyrimidine deoxyribonucleotide binding,GO:0042802~identical protein binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0046872~metal ion binding,	IPR008181:dUTPase,IPR029054:dUTPase-like,IPR033704:dUTPase_trimeric,IPR036157:dUTPase-like_sf,	mmu00240:Pyrimidine metabolism,mmu00983:Drug metabolism - other enzymes,mmu01100:Metabolic pathways,mmu01232:Nucleotide metabolism,				KW-0546~Nucleotide metabolism,	KW-0539~Nucleus,			KW-0809~Transit peptide,	KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,
F1QSQ0	desmocollin 2 like(dsc2l)	Danio rerio			GO:0002159~desmosome assembly,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007507~heart development,GO:0055113~epiboly involved in gastrulation with mouth forming second,GO:0060027~convergent extension involved in gastrulation,GO:0060047~heart contraction,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030057~desmosome,GO:0070161~anchoring junction,	GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR000233:Cadherin_Y-type_LIR,IPR002126:Cadherin-like_dom,IPR009122:Desmosomal_cadherin,IPR014868:Cadherin_pro_dom,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,IPR027397:Catenin-bd_sf,IPR039808:Cadherin,				SM00112:CA,SM01055:Cadherin_pro,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9JIQ3	diablo, IAP-binding mitochondrial protein(Diablo)	Mus musculus		m_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,	GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0043065~positive regulation of apoptotic process,GO:0051402~neuron apoptotic process,GO:0097193~intrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0035631~CD40 receptor complex,	GO:0005515~protein binding,	IPR009062:Smac/DIABLO-like_sf,IPR015142:Smac_DIABLO,	mmu04210:Apoptosis,mmu04215:Apoptosis - multiple species,				KW-0053~Apoptosis,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,			KW-0809~Transit peptide,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,MOTIF:IAP-binding,REGION:Disordered,SITE:Cleavage; by PARL,TRANSIT:Mitochondrion,
P52429	diacylglycerol kinase epsilon(DGKE)	Homo sapiens			GO:0006654~phosphatidic acid biosynthetic process,GO:0006661~phosphatidylinositol biosynthetic process,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0016310~phosphorylation,GO:0030168~platelet activation,GO:0046339~diacylglycerol metabolic process,GO:0046486~glycerolipid metabolic process,GO:0046834~lipid phosphorylation,GO:0050804~modulation of synaptic transmission,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0098978~glutamatergic synapse,	GO:0004143~diacylglycerol kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0046872~metal ion binding,	IPR000756:Diacylglycerol_kin_accessory,IPR001206:Diacylglycerol_kinase_cat_dom,IPR002219:PE/DAG-bd,IPR016064:NAD/diacylglycerol_kinase_sf,IPR017438:ATP-NAD_kinase_N,IPR037607:DGK,IPR046349:C1-like_sf,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,hsa04072:Phospholipase D signaling pathway,hsa05231:Choline metabolism in cancer,	615008~Hemolytic uremic syndrome, atypical, susceptibility to, 7,615008~Nephrotic syndrome, type 7,		SM00045:DAGKa,SM00046:DAGKc,SM00109:C1,	KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-1068~Hemolytic uremic syndrome,	KW-0677~Repeat,KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0808~Transferase,		DOMAIN:DAGKc,DOMAIN:Phorbol-ester/DAG-type,MUTAGEN:L->I: Decreased diacylglycerol kinase activity toward 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol.,MUTAGEN:L->M: Decreased protein abundance and diacylglycerol kinase activity toward 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol.,MUTAGEN:L->S,A,G: Loss of diacylglycerol kinase activity toward 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol.,MUTAGEN:L->S: Loss of diacylglycerol kinase activity toward 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol.,MUTAGEN:P->G: Decreased diacylglycerol kinase activity toward 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol.,REGION:Disordered,TRANSMEM:Helical,ZN_FING:Phorbol-ester/DAG-type 1,ZN_FING:Phorbol-ester/DAG-type 2,
Q86XP1	diacylglycerol kinase eta(DGKH)	Homo sapiens			GO:0006654~phosphatidic acid biosynthetic process,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0016310~phosphorylation,GO:0030168~platelet activation,GO:0035556~intracellular signal transduction,GO:0043086~negative regulation of catalytic activity,GO:0046339~diacylglycerol metabolic process,GO:0046473~phosphatidic acid metabolic process,GO:0046486~glycerolipid metabolic process,GO:0046834~lipid phosphorylation,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0032991~macromolecular complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0004143~diacylglycerol kinase activity,GO:0005524~ATP binding,GO:0019900~kinase binding,GO:0032093~SAM domain binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000756:Diacylglycerol_kin_accessory,IPR001206:Diacylglycerol_kinase_cat_dom,IPR001660:SAM,IPR001849:PH_domain,IPR002219:PE/DAG-bd,IPR011993:PH-like_dom_sf,IPR013761:SAM/pointed_sf,IPR016064:NAD/diacylglycerol_kinase_sf,IPR017438:ATP-NAD_kinase_N,IPR037607:DGK,IPR046349:C1-like_sf,IPR047480:C1_DGKeta_rpt2,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,hsa04072:Phospholipase D signaling pathway,hsa05231:Choline metabolism in cancer,			SM00045:DAGKa,SM00046:DAGKc,SM00109:C1,SM00233:PH,SM00454:SAM,	KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:DAGKc,DOMAIN:PH,DOMAIN:Phorbol-ester/DAG-type,DOMAIN:SAM,MOTIF:PDZ-binding,MUTAGEN:W->G: Loss of homoligomerization and heterooligomerization but not diacylglycerol kinase activity.,REGION:Disordered,ZN_FING:Phorbol-ester/DAG-type 1,ZN_FING:Phorbol-ester/DAG-type 2,
Q9NSV4	diaphanous related formin 3(DIAPH3)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0007010~cytoskeleton organization,GO:0007026~negative regulation of microtubule depolymerization,GO:0007059~chromosome segregation,GO:0007229~integrin-mediated signaling pathway,GO:0007605~sensory perception of sound,GO:0010467~gene expression,GO:0016197~endosomal transport,GO:0030010~establishment of cell polarity,GO:0030030~cell projection organization,GO:0030036~actin cytoskeleton organization,GO:0030041~actin filament polymerization,GO:0030225~macrophage differentiation,GO:0034367~macromolecular complex remodeling,GO:0043131~erythrocyte enucleation,GO:0045010~actin nucleation,GO:0046785~microtubule polymerization,GO:0051017~actin filament bundle assembly,GO:0051764~actin crosslink formation,GO:0060113~inner ear receptor cell differentiation,GO:0060322~head development,GO:0071800~podosome assembly,	GO:0000813~ESCRT I complex,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005884~actin filament,GO:0031941~filamentous actin,GO:0032154~cleavage furrow,GO:0032432~actin filament bundle,GO:0097470~ribbon synapse,GO:1990427~stereocilia tip-link density,	GO:0003779~actin binding,GO:0008017~microtubule binding,GO:0031267~small GTPase binding,GO:0042803~protein homodimerization activity,GO:0045296~cadherin binding,	IPR010472:FH3_dom,IPR010473:GTPase-bd,IPR011989:ARM-like,IPR014767:DAD_dom,IPR014768:GBD/FH3_dom,IPR015425:FH2_Formin,IPR016024:ARM-type_fold,IPR042201:FH2_Formin_sf,IPR044933:DIA_GBD_sf,	hsa04810:Regulation of actin cytoskeleton,	609129~Auditory neuropathy, autosomal dominant 1,		SM00498:FH2,SM01139:Drf_FH3,SM01140:Drf_GBD,		KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0209~Deafness,KW-0622~Neuropathy,KW-1010~Non-syndromic deafness,	KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Pro residues,DOMAIN:DAD,DOMAIN:FH1,DOMAIN:FH2,DOMAIN:GBD/FH3,MOTIF:Nuclear export signal,MOTIF:Nuclear localization signal,REGION:Disordered,
Q9QUN9	dickkopf WNT signaling pathway inhibitor 3(Dkk3)	Mus musculus			GO:0007275~multicellular organism development,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030325~adrenal gland development,GO:0032348~negative regulation of aldosterone biosynthetic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000065~negative regulation of cortisol biosynthetic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0039706~co-receptor binding,GO:0048019~receptor antagonist activity,	IPR006796:Dickkopf_N,IPR039863:DKK-like,IPR047300:Dkk3_Cys2,IPR047301:Dkk3_N,					KW-0879~Wnt signaling pathway,	KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:DKK-type Cys-1,REGION:DKK-type Cys-2,
P04753	dihydrofolate reductase(Dhfr)	Mesocricetus auratus			GO:0006545~glycine biosynthetic process,GO:0006730~one-carbon metabolic process,GO:0031427~response to methotrexate,GO:0046452~dihydrofolate metabolic process,GO:0046653~tetrahydrofolate metabolic process,GO:0046654~tetrahydrofolate biosynthetic process,GO:0046655~folic acid metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003729~mRNA binding,GO:0004146~dihydrofolate reductase activity,GO:0050661~NADP binding,	IPR001796:DHFR_dom,IPR012259:DHFR,IPR017925:DHFR_CS,IPR024072:DHFR-like_dom_sf,	maua00670:One carbon pool by folate,maua00790:Folate biosynthesis,maua01100:Metabolic pathways,maua01240:Biosynthesis of cofactors,maua01523:Antifolate resistance,				KW-0487~Methotrexate resistance,KW-0554~One-carbon metabolism,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,				KW-0521~NADP,	KW-0560~Oxidoreductase,KW-0694~RNA-binding,	KW-0007~Acetylation,	DOMAIN:DHFR,REGION:Involved in methotrexate binding,
P00375	dihydrofolate reductase(Dhfr)	Mus musculus		m_g1Pathway:Cell Cycle: G1/S Check Point ,	GO:0006545~glycine biosynthetic process,GO:0006729~tetrahydrobiopterin biosynthetic process,GO:0006730~one-carbon metabolic process,GO:0031103~axon regeneration,GO:0031427~response to methotrexate,GO:0035094~response to nicotine,GO:0035999~tetrahydrofolate interconversion,GO:0046452~dihydrofolate metabolic process,GO:0046653~tetrahydrofolate metabolic process,GO:0046654~tetrahydrofolate biosynthetic process,GO:0046655~folic acid metabolic process,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:2000121~regulation of removal of superoxide radicals,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0004146~dihydrofolate reductase activity,GO:0005542~folic acid binding,GO:0016491~oxidoreductase activity,GO:0050661~NADP binding,GO:0051871~dihydrofolic acid binding,GO:0070402~NADPH binding,GO:1990825~sequence-specific mRNA binding,	IPR001796:DHFR_dom,IPR012259:DHFR,IPR017925:DHFR_CS,IPR024072:DHFR-like_dom_sf,	mmu00670:One carbon pool by folate,mmu00790:Folate biosynthesis,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,mmu01523:Antifolate resistance,				KW-0487~Methotrexate resistance,KW-0554~One-carbon metabolism,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,				KW-0521~NADP,	KW-0560~Oxidoreductase,KW-0694~RNA-binding,	KW-0007~Acetylation,	DOMAIN:DHFR,
O55096	dipeptidylpeptidase 3 like 1(Dpp3l1)	Rattus norvegicus			GO:0006508~proteolysis,GO:0030163~protein catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004177~aminopeptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR005317:Dipeptidyl-peptase3,IPR039461:Peptidase_M49,			PIRSF007828:Dipeptidyl-peptidase_III,			KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0031~Aminopeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0007~Acetylation,	MUTAGEN:C->A: 25% to 35% of wild-type activity.,MUTAGEN:C->E,G: Loss of activity.,MUTAGEN:E->A,D: Loss of activity.,MUTAGEN:H->Y: Loss of activity and zinc binding.,
O55096	dipeptidylpeptidase 3(Dpp3)	Rattus norvegicus			GO:0006508~proteolysis,GO:0030163~protein catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004177~aminopeptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR005317:Dipeptidyl-peptase3,IPR039461:Peptidase_M49,			PIRSF007828:Dipeptidyl-peptidase_III,			KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0031~Aminopeptidase,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0007~Acetylation,	MUTAGEN:C->A: 25% to 35% of wild-type activity.,MUTAGEN:C->E,G: Loss of activity.,MUTAGEN:E->A,D: Loss of activity.,MUTAGEN:H->Y: Loss of activity and zinc binding.,
Q8BWT5	disco interacting protein 2 homolog A(Dip2a)	Mus musculus			GO:0006085~acetyl-CoA biosynthetic process,GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0010629~negative regulation of gene expression,GO:0060997~dendritic spine morphogenesis,GO:2000758~positive regulation of peptidyl-lysine acetylation,	GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0042995~cell projection,GO:0043197~dendritic spine,GO:0045202~synapse,	GO:0003987~acetate-CoA ligase activity,GO:0005515~protein binding,GO:0016874~ligase activity,	IPR000873:AMP-dep_Synth/Lig_com,IPR010506:DMAP1-bd,IPR037337:Dip2-like_dom,IPR042099:ANL_N_sf,IPR045851:AMP-bd_C_sf,				SM01137:DMAP_binding,	KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,		KW-0217~Developmental protein,KW-0436~Ligase,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:AMP-dependent synthetase/ligase,DOMAIN:DMAP1-binding,MOTIF:PXXP motif; required for interaction with CTTN,MUTAGEN:PKRP->AKRA: Significantly reduced interaction with CTTN; when associated with 259-ANQA-262.,MUTAGEN:PNQP->ANQA: Significantly reduced interaction with CTTN; when associated with 235-AKRA-238.,REGION:Disordered,
Q5PYH7	discs, large homolog 2 (Drosophila)(dlg2)	Danio rerio			GO:0007268~chemical synaptic transmission,GO:0009790~embryo development,GO:0043113~receptor clustering,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0050808~synapse organization,GO:0097120~receptor localization to synapse,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0030424~axon,GO:0031594~neuromuscular junction,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043204~perikaryon,GO:0045202~synapse,GO:0098839~postsynaptic density membrane,	GO:0019900~kinase binding,	IPR001452:SH3_domain,IPR001478:PDZ,IPR004172:L27_dom,IPR008144:Guanylate_kin-like_dom,IPR008145:GK/Ca_channel_bsu,IPR015143:L27_1,IPR016313:DLG1-like,IPR019583:DLG1-4_PDZ_assoc,IPR019590:DLG1_PEST_dom,IPR020590:Guanylate_kinase_CS,IPR027417:P-loop_NTPase,IPR035759:DLG2_SH3,IPR036028:SH3-like_dom_sf,IPR036034:PDZ_sf,IPR036892:L27_dom_sf,	dre04530:Tight junction,		PIRSF001741:MAGUK_DLGH,	SM00072:GuKc,SM00228:PDZ,SM00326:SH3,SM00569:L27,SM01277:MAGUK_N_PEST,		KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0728~SH3 domain,			KW-0449~Lipoprotein,	COMPBIAS:Polar residues,DOMAIN:Guanylate kinase-like,DOMAIN:L27,DOMAIN:PDZ,DOMAIN:PDZ 1,DOMAIN:PDZ 2,DOMAIN:PDZ 3,DOMAIN:SH3,REGION:Disordered,
Q9Y4D1	dishevelled associated activator of morphogenesis 1(DAAM1)	Homo sapiens			GO:0030036~actin cytoskeleton organization,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031514~motile cilium,GO:0036064~ciliary basal body,GO:0048471~perinuclear region of cytoplasm,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,	IPR010472:FH3_dom,IPR010473:GTPase-bd,IPR011989:ARM-like,IPR014767:DAD_dom,IPR014768:GBD/FH3_dom,IPR015425:FH2_Formin,IPR016024:ARM-type_fold,IPR042201:FH2_Formin_sf,	hsa04310:Wnt signaling pathway,			SM00498:FH2,SM01139:Drf_FH3,SM01140:Drf_GBD,	KW-0879~Wnt signaling pathway,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:DAD,DOMAIN:FH1,DOMAIN:FH2,DOMAIN:Formin GTPase-binding,DOMAIN:GBD/FH3,MUTAGEN:I->A: Abolishes actin-binding.,REGION:Actin-binding,REGION:Disordered,
Q86T65	dishevelled associated activator of morphogenesis 2(DAAM2)	Homo sapiens			GO:0007368~determination of left/right symmetry,GO:0016055~Wnt signaling pathway,GO:0021516~dorsal spinal cord development,GO:0030036~actin cytoskeleton organization,GO:0030335~positive regulation of cell migration,GO:0030833~regulation of actin filament polymerization,GO:0032956~regulation of actin cytoskeleton organization,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0051489~regulation of filopodium assembly,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0090521~glomerular visceral epithelial cell migration,GO:2000050~regulation of non-canonical Wnt signaling pathway,	GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0031267~small GTPase binding,	IPR010472:FH3_dom,IPR010473:GTPase-bd,IPR011989:ARM-like,IPR014767:DAD_dom,IPR014768:GBD/FH3_dom,IPR015425:FH2_Formin,IPR016024:ARM-type_fold,IPR042201:FH2_Formin_sf,	hsa04310:Wnt signaling pathway,	619263~Nephrotic syndrome, type 24,		SM00498:FH2,SM01139:Drf_FH3,SM01140:Drf_GBD,	KW-0879~Wnt signaling pathway,			KW-0225~Disease variant,	KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,DOMAIN:DAD,DOMAIN:FH1,DOMAIN:FH2,DOMAIN:Formin GTPase-binding,DOMAIN:GBD/FH3,REGION:Disordered,
Q1RLQ5	divergent protein kinase domain 1Aa(dipk1aa)	Danio rerio				GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR022049:FAM69_kinase_dom,IPR029244:FAM69_N,				SM01299:PIP49_N,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-1015~Disulfide bond,	TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
A0JPE1	divergent protein kinase domain 1B(dipk1b)	Xenopus tropicalis				GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR011992:EF-hand-dom_pair,IPR022049:FAM69_kinase_dom,IPR029244:FAM69_N,				SM01299:PIP49_N,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-1015~Disulfide bond,	DOMAIN:FAM69 N-terminal,MOTIF:May mediate ER retention,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q0P6D2	divergent protein kinase domain 1C(DIPK1C)	Homo sapiens				GO:0005789~endoplasmic reticulum membrane,		IPR011009:Kinase-like_dom_sf,IPR022049:FAM69_kinase_dom,IPR029244:FAM69_N,				SM01299:PIP49_N,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-1015~Disulfide bond,	MOTIF:May mediate ER retention,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q99KE3	docking protein 4(Dok4)	Mus musculus			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007265~Ras protein signal transduction,GO:0007399~nervous system development,GO:0043410~positive regulation of MAPK cascade,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR001849:PH_domain,IPR002404:IRS_PTB,IPR011993:PH-like_dom_sf,IPR037816:DOK4/5/6_PH,				SM00233:PH,SM00310:PTBI,SM01244:IRS,								KW-0597~Phosphoprotein,	DOMAIN:IRS-type PTB,DOMAIN:PH,MOTIF:DKFBH motif,
Q6PKX4	docking protein 6(DOK6)	Homo sapiens			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007265~Ras protein signal transduction,GO:0043410~positive regulation of MAPK cascade,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR001849:PH_domain,IPR002404:IRS_PTB,IPR011993:PH-like_dom_sf,IPR037816:DOK4/5/6_PH,				SM00233:PH,SM00310:PTBI,SM01244:IRS,								KW-0597~Phosphoprotein,	DOMAIN:IRS-type PTB,DOMAIN:PH,MOTIF:DKFBH motif,REGION:Disordered,
P53453	dopamine receptor D2a(drd2a)	Takifugu rubripes			GO:0007195~adenylate cyclase-inhibiting dopamine receptor signaling pathway,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,GO:1903530~regulation of secretion by cell,GO:1904057~negative regulation of sensory perception of pain,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0042734~presynaptic membrane,GO:0045202~synapse,GO:0098978~glutamatergic synapse,	GO:0001591~dopamine neurotransmitter receptor activity, coupled via Gi/Go,GO:0004930~G-protein coupled receptor activity,GO:0004952~dopamine neurotransmitter receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000929:Dopamine_rcpt,IPR001922:Dopamine_D2_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	tru04080:Neuroactive ligand-receptor interaction,tru04540:Gap junction,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
A9LMC0	double PHD fingers 3(dpf3)	Danio rerio			GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-templated,GO:0007399~nervous system development,GO:0048644~muscle organ morphogenesis,GO:0055008~cardiac muscle tissue morphogenesis,	GO:0005634~nucleus,GO:0016514~SWI/SNF complex,GO:0071565~nBAF complex,	GO:0042393~histone binding,GO:0046872~metal ion binding,	IPR001965:Znf_PHD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR013087:Znf_C2H2_type,IPR019787:Znf_PHD-finger,IPR025750:DPF1-3_N,IPR036236:Znf_C2H2_sf,	dre03082:ATP-dependent chromatin remodeling,			SM00249:PHD,SM00355:ZnF_C2H2,	KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0156~Chromatin regulator,KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,DOMAIN:C2H2-type,DOMAIN:DPF1-3 N-terminal,DOMAIN:PHD-type,REGION:Disordered,ZN_FING:C2H2-type,ZN_FING:PHD-type 1,ZN_FING:PHD-type 2,
Q5DU00	doublecortin domain containing 2a(Dcdc2a)	Mus musculus			GO:0001764~neuron migration,GO:0007399~nervous system development,GO:0007605~sensory perception of sound,GO:0008542~visual learning,GO:0019228~neuronal action potential,GO:0030030~cell projection organization,GO:0030111~regulation of Wnt signaling pathway,GO:0035249~synaptic transmission, glutamatergic,GO:0035556~intracellular signal transduction,GO:0045880~positive regulation of smoothened signaling pathway,GO:0048813~dendrite morphogenesis,GO:0060271~cilium assembly,GO:1902017~regulation of cilium assembly,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0015630~microtubule cytoskeleton,GO:0034451~centriolar satellite,GO:0042995~cell projection,GO:0045202~synapse,GO:0060091~kinocilium,GO:0072686~mitotic spindle,	GO:0019894~kinesin binding,	IPR003533:Doublecortin_dom,IPR033036:DCDC2_DCX_dom2,IPR036572:Doublecortin_dom_sf,				SM00537:DCX,	KW-0524~Neurogenesis,KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Doublecortin,DOMAIN:Doublecortin 1,DOMAIN:Doublecortin 2,REGION:Disordered,
D2I3C6	doublecortin like kinase 2(DCLK2)	Ailuropoda melanoleuca			GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR003533:Doublecortin_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR036572:Doublecortin_dom_sf,				SM00220:S_TKc,SM00537:DCX,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Doublecortin,DOMAIN:Doublecortin 1,DOMAIN:Doublecortin 2,DOMAIN:Protein kinase,REGION:Disordered,
Q9C098	doublecortin like kinase 3(DCLK3)	Homo sapiens			GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0034504~protein localization to nucleus,GO:0035556~intracellular signal transduction,GO:1900181~negative regulation of protein localization to nucleus,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR003533:Doublecortin_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR036572:Doublecortin_dom_sf,				SM00220:S_TKc,SM00537:DCX,		KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,		ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:Doublecortin,DOMAIN:Protein kinase,REGION:Disordered,
Q16643	drebrin 1(DBN1)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0007015~actin filament organization,GO:0010643~cell communication by chemical coupling,GO:0010644~cell communication by electrical coupling,GO:0031915~positive regulation of synaptic plasticity,GO:0032507~maintenance of protein location in cell,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048699~generation of neurons,GO:0050773~regulation of dendrite development,GO:0051220~cytoplasmic sequestering of protein,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0061351~neural precursor cell proliferation,GO:1902685~positive regulation of receptor localization to synapse,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005921~gap junction,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030863~cortical cytoskeleton,GO:0042641~actomyosin,GO:0045211~postsynaptic membrane,GO:0098978~glutamatergic synapse,GO:0099524~postsynaptic cytosol,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0005522~profilin binding,GO:0045296~cadherin binding,	IPR002108:ADF-H,IPR029006:ADF-H/Gelsolin-like_dom_sf,				SM00102:ADF,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,		KW-0026~Alzheimer disease,KW-0523~Neurodegeneration,KW-1008~Amyloidosis,			KW-0009~Actin-binding,KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:ADF-H,MUTAGEN:C->Q: Decreased binding to ZMYND8.,MUTAGEN:R->D,G: Loss of binding to ZMYND8. Loss of ZMYND8 cytoplasmic localization.,REGION:Disordered,
Q6GM14	drebrin like S homeolog(dbnl.S)	Xenopus laevis				GO:0000139~Golgi membrane,GO:0001726~ruffle,GO:0002102~podosome,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0030425~dendrite,GO:0030665~clathrin-coated vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043204~perikaryon,GO:0045202~synapse,GO:0070161~anchoring junction,	GO:0003779~actin binding,	IPR001452:SH3_domain,IPR002108:ADF-H,IPR029006:ADF-H/Gelsolin-like_dom_sf,IPR035717:Drebrin-like_SH3,IPR036028:SH3-like_dom_sf,				SM00102:ADF,SM00326:SH3,	KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0728~SH3 domain,		KW-0009~Actin-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:ADF-H,DOMAIN:SH3,REGION:Disordered,
Q17QM8	dual specificity phosphatase 14(DUSP14)	Bos taurus			GO:0006470~protein dephosphorylation,GO:0016311~dephosphorylation,	GO:0005737~cytoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0017018~myosin phosphatase activity,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR016130:Tyr_Pase_AS,IPR020420:Atypical_DUSP_subfamB,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,				SM00195:DSPc,							KW-0378~Hydrolase,KW-0904~Protein phosphatase,		ACT_SITE:Phosphocysteine intermediate,DOMAIN:Tyrosine-protein phosphatase,
Q566R7	dual specificity phosphatase 22b(dusp22b)	Danio rerio			GO:0007165~signal transduction,GO:0016311~dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017018~myosin phosphatase activity,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,				SM00195:DSPc,		KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,		ACT_SITE:Phosphocysteine intermediate,DOMAIN:Tyrosine-protein phosphatase,
Q8BTR5	dual specificity phosphatase 28(Dusp28)	Mus musculus			GO:0006470~protein dephosphorylation,GO:0016311~dephosphorylation,		GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017018~myosin phosphatase activity,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,				SM00195:DSPc,							KW-0378~Hydrolase,KW-0904~Protein phosphatase,		ACT_SITE:Phosphocysteine intermediate,DOMAIN:Tyrosine-protein phosphatase,
Q29RA3	dual specificity phosphatase 29(dusp29)	Danio rerio			GO:0006470~protein dephosphorylation,GO:0016311~dephosphorylation,GO:0043409~negative regulation of MAPK cascade,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0033549~MAP kinase phosphatase activity,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR016130:Tyr_Pase_AS,IPR020405:Atypical_DUSP_subfamA,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,				SM00195:DSPc,		KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,		ACT_SITE:Phosphocysteine intermediate,DOMAIN:Tyrosine-protein phosphatase,
Q62767	dual specificity phosphatase 4(Dusp4)	Rattus norvegicus			GO:0001706~endoderm formation,GO:0016311~dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0043409~negative regulation of MAPK cascade,GO:0070373~negative regulation of ERK1 and ERK2 cascade,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0008330~protein tyrosine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0033550~MAP kinase tyrosine phosphatase activity,GO:1990439~MAP kinase threonine phosphatase activity,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR001763:Rhodanese-like_dom,IPR003595:Tyr_Pase_cat,IPR008343:MKP,IPR016130:Tyr_Pase_AS,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,IPR036873:Rhodanese-like_dom_sf,	rno04010:MAPK signaling pathway,rno04148:Efferocytosis,		PIRSF000939:MAPK_Ptase,	SM00195:DSPc,SM00404:PTPc_motif,SM00450:RHOD,		KW-0539~Nucleus,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,DOMAIN:Rhodanese,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,
Q0P5A1	dynactin subunit 3(DCTN3)	Bos taurus			GO:0007017~microtubule-based process,GO:0061640~cytoskeleton-dependent cytokinesis,	GO:0000776~kinetochore,GO:0005730~nucleolus,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005869~dynactin complex,GO:0030496~midbody,GO:0032154~cleavage furrow,GO:0048471~perinuclear region of cytoplasm,		IPR009991:DCTN3,	bta04814:Motor proteins,bta05014:Amyotrophic lateral sclerosis,bta05016:Huntington disease,bta05022:Pathways of neurodegeneration - multiple diseases,bta05132:Salmonella infection,				KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0995~Kinetochore,			KW-0175~Coiled coil,			KW-0007~Acetylation,
Q8WXX0	dynein axonemal heavy chain 7(DNAH7)	Homo sapiens			GO:0003341~cilium movement,GO:0036159~inner dynein arm assembly,GO:0060285~cilium-dependent cell motility,GO:0060294~cilium movement involved in cell motility,	GO:0005829~cytosol,GO:0005858~axonemal dynein complex,GO:0005874~microtubule,GO:0005929~cilium,GO:0036156~inner dynein arm,GO:0097729~9+2 motile cilium,	GO:0003777~microtubule motor activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0008569~ATP-dependent microtubule motor activity, minus-end-directed,GO:0016887~ATPase activity,GO:0045505~dynein intermediate chain binding,GO:0051959~dynein light intermediate chain binding,	IPR002048:EF_hand_dom,IPR003593:AAA+_ATPase,IPR004273:Dynein_heavy_D6_P-loop,IPR013602:Dynein_heavy_linker,IPR018247:EF_Hand_1_Ca_BS,IPR024317:Dynein_heavy_chain_D4_dom,IPR024743:Dynein_HC_stalk,IPR026983:DHC_fam,IPR027417:P-loop_NTPase,IPR035699:AAA_6,IPR035706:AAA_9,IPR041228:Dynein_C,IPR041466:Dynein_AAA5_ext,IPR041589:DNAH3_AAA_lid_1,IPR041658:AAA_lid_11,IPR042219:AAA_lid_11_sf,IPR042222:Dynein_2_N,IPR042228:Dynein_linker_3,IPR043157:Dynein_AAA1S,IPR043160:Dynein_C_barrel,	hsa04814:Motor proteins,hsa05014:Amyotrophic lateral sclerosis,hsa05016:Huntington disease,hsa05022:Pathways of neurodegeneration - multiple diseases,	620356~Ciliary dyskinesia, primary, 50,		SM00382:AAA,		KW-0206~Cytoskeleton,KW-0243~Dynein,KW-0282~Flagellum,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,		KW-0990~Primary ciliary dyskinesia,KW-1186~Ciliopathy,	KW-0175~Coiled coil,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,		COMPBIAS:Basic and acidic residues,REGION:AAA 1,REGION:AAA 2,REGION:AAA 3,REGION:AAA 4,REGION:AAA 5,REGION:AAA 6,REGION:Disordered,REGION:Stalk,REGION:Stem,
Q78P75	dynein light chain LC8-type 2(Dynll2)	Rattus norvegicus			GO:0007017~microtubule-based process,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005868~cytoplasmic dynein complex,GO:0005874~microtubule,GO:0014069~postsynaptic density,GO:0030286~dynein complex,GO:0031475~myosin V complex,GO:0097731~9+0 non-motile cilium,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:0045505~dynein intermediate chain binding,GO:0097110~scaffold protein binding,	IPR001372:Dynein_light_chain_typ-1/2,IPR019763:Dynein_light_1/2_CS,IPR037177:DLC_sf,	rno04814:Motor proteins,rno04962:Vasopressin-regulated water reabsorption,rno05132:Salmonella infection,			SM01375:Dynein_light,	KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0243~Dynein,KW-0493~Microtubule,KW-0963~Cytoplasm,					KW-0505~Motor protein,		SITE:Interaction with myosin V motor complex,
Q6DHB1	dynein, axonemal, light chain 1(dnal1)	Danio rerio			GO:0036158~outer dynein arm assembly,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0030286~dynein complex,GO:0042995~cell projection,	GO:0043014~alpha-tubulin binding,GO:0045504~dynein heavy chain binding,	IPR001611:Leu-rich_rpt,IPR025875:Leu-rich_rpt_4,IPR032675:LRR_dom_sf,	dre04814:Motor proteins,			SM00365:LRR_SD22,		KW-0206~Cytoskeleton,KW-0243~Dynein,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,		KW-0505~Motor protein,		DOMAIN:LRRCT,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,
Q5ZKM0	dystrobrevin binding protein 1(DTNBP1)	Gallus gallus			GO:0001956~positive regulation of neurotransmitter secretion,GO:0006469~negative regulation of protein kinase activity,GO:0007596~blood coagulation,GO:0008089~anterograde axonal transport,GO:0010628~positive regulation of gene expression,GO:0014059~regulation of dopamine secretion,GO:0030036~actin cytoskeleton organization,GO:0031175~neuron projection development,GO:0048490~anterograde synaptic vesicle transport,GO:0048812~neuron projection morphogenesis,GO:0048813~dendrite morphogenesis,GO:0060155~platelet dense granule organization,GO:0060159~regulation of dopamine receptor signaling pathway,GO:2000300~regulation of synaptic vesicle exocytosis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0014069~postsynaptic density,GO:0015630~microtubule cytoskeleton,GO:0016528~sarcoplasm,GO:0030424~axon,GO:0030426~growth cone,GO:0030496~midbody,GO:0030672~synaptic vesicle membrane,GO:0031083~BLOC-1 complex,GO:0033162~melanosome membrane,GO:0042383~sarcolemma,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098686~hippocampal mossy fiber to CA3 synapse,GO:0098978~glutamatergic synapse,GO:1904115~axon cytoplasm,		IPR007531:Dysbindin,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,				COMPBIAS:Polar residues,REGION:Disordered,
Q6NTY6	early growth response 1 S homeolog(egr1.S)	Xenopus laevis			GO:0006355~regulation of transcription, DNA-templated,GO:0032922~circadian regulation of gene expression,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0010385~double-stranded methylated DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044729~hemi-methylated DNA-binding,GO:0046872~metal ion binding,GO:1990841~promoter-specific chromatin binding,	IPR013087:Znf_C2H2_type,IPR021839:EGR1_C,IPR021849:EGR_N,IPR036236:Znf_C2H2_sf,	xla04371:Apelin signaling pathway,xla04912:GnRH signaling pathway,			SM00355:ZnF_C2H2,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,		DOMAIN:C2H2-type,REGION:Disordered,SITE:Interaction with DNA,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,
F1QC17	elastin microfibril interfacer 1a(emilin1a)	Danio rerio			GO:0030097~hemopoiesis,	GO:0005576~extracellular region,		IPR001073:C1q_dom,IPR008160:Collagen,IPR008983:Tumour_necrosis_fac-like_dom,IPR011489:EMI_domain,				SM00110:C1Q,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,			KW-1015~Disulfide bond,	DOMAIN:C1q,DOMAIN:Collagen-like,DOMAIN:EMI,REGION:Disordered,
Q7Z2Z2	elongation factor like GTPase 1(EFL1)	Homo sapiens			GO:0006414~translational elongation,GO:0042256~mature ribosome assembly,GO:0046039~GTP metabolic process,	GO:0005829~cytosol,GO:1990904~ribonucleoprotein complex,	GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0043022~ribosome binding,	IPR000640:EFG_V-like,IPR000795:T_Tr_GTP-bd_dom,IPR005225:Small_GTP-bd_dom,IPR009000:Transl_B-barrel_sf,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR027417:P-loop_NTPase,IPR035647:EFG_III/V,IPR041095:EFG_II,	hsa03008:Ribosome biogenesis in eukaryotes,	617941~Shwachman-Diamond syndrome 2,		SM00838:EFG_C,	KW-0648~Protein biosynthesis,KW-0690~Ribosome biogenesis,			KW-0225~Disease variant,		KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0251~Elongation factor,	KW-0007~Acetylation,	COMPBIAS:Basic and acidic residues,DOMAIN:Elongation factor EFG,DOMAIN:Tr-type G,DOMAIN:tr-type G,MUTAGEN:H->A: Loss of GTPase activity. Abolishes dissociation of EIF6 from 60S pre-ribosome subunits.,MUTAGEN:T->A: Loss of GTPase activity. Abolishes dissociation of EIF6 from 60S pre-ribosome subunits.,REGION:Disordered,
A1L251	endo-beta-N-acetylglucosaminidase(engase)	Danio rerio			GO:0006517~protein deglycosylation,GO:0008152~metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0016787~hydrolase activity,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0033925~mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,	IPR005201:Glyco_hydro_85,IPR032979:ENGase,	dre00511:Other glycan degradation,					KW-0963~Cytoplasm,					KW-0326~Glycosidase,KW-0378~Hydrolase,		COMPBIAS:Polar residues,DOMAIN:BRCT,DOMAIN:Glycoside hydrolase family 85,REGION:Disordered,
Q1LUM3	endonuclease, polyU-specific C(endouc)	Danio rerio				GO:0005576~extracellular region,	GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0016787~hydrolase activity,GO:0016829~lyase activity,GO:0046872~metal ion binding,	IPR018998:EndoU_C,IPR037227:EndoU-like,IPR039787:ENDOU,						KW-0964~Secreted,			KW-0732~Signal,	KW-0464~Manganese,KW-0479~Metal-binding,	KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0456~Lyase,KW-0540~Nuclease,KW-0694~RNA-binding,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EndoU,
Q9PTU6	endonuclease, polyU-specific(endou)	Paralichthys olivaceus			GO:0006955~immune response,	GO:0005576~extracellular region,	GO:0003723~RNA binding,GO:0004521~endoribonuclease activity,GO:0005044~scavenger receptor activity,GO:0016829~lyase activity,GO:0030247~polysaccharide binding,GO:0046872~metal ion binding,	IPR001212:Somatomedin_B_dom,IPR018998:EndoU_C,IPR020436:SMB_chordata,IPR036024:Somatomedin_B-like_dom_sf,IPR037227:EndoU-like,IPR039787:ENDOU,				SM00201:SO,		KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0464~Manganese,KW-0479~Metal-binding,	KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0456~Lyase,KW-0540~Nuclease,KW-0694~RNA-binding,	KW-1015~Disulfide bond,	DISULFID:Alternate,DOMAIN:EndoU,DOMAIN:SMB 1,DOMAIN:SMB 2,
A5PJN2	endoplasmic reticulum oxidoreductase 1 alpha(ERO1A)	Bos taurus			GO:0006457~protein folding,GO:0006979~response to oxidative stress,GO:0022417~protein maturation by protein folding,GO:0030198~extracellular matrix organization,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0034975~protein folding in endoplasmic reticulum,GO:0034976~response to endoplasmic reticulum stress,GO:0045454~cell redox homeostasis,GO:0050873~brown fat cell differentiation,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0051209~release of sequestered calcium ion into cytosol,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005796~Golgi lumen,GO:0030425~dendrite,	GO:0015035~protein disulfide oxidoreductase activity,GO:0016491~oxidoreductase activity,GO:0016972~thiol oxidase activity,GO:0071949~FAD binding,	IPR007266:Ero1,IPR037192:ERO1-like_sf,	bta04141:Protein processing in endoplasmic reticulum,bta05417:Lipid and atherosclerosis,		PIRSF017205:ERO1,		KW-0053~Apoptosis,KW-0249~Electron transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0964~Secreted,KW-0966~Cell projection,			KW-0676~Redox-active center,KW-0732~Signal,	KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Alternate,DISULFID:Redox-active,DISULFID:Redox-active; alternate,
Q8R2E9	endoplasmic reticulum oxidoreductase 1 beta(Ero1b)	Mus musculus			GO:0006888~ER to Golgi vesicle-mediated transport,GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,GO:0022417~protein maturation by protein folding,GO:0030070~insulin processing,GO:0030198~extracellular matrix organization,GO:0034975~protein folding in endoplasmic reticulum,GO:0042593~glucose homeostasis,GO:0045454~cell redox homeostasis,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0015035~protein disulfide oxidoreductase activity,GO:0015036~disulfide oxidoreductase activity,GO:0016491~oxidoreductase activity,GO:0016972~thiol oxidase activity,GO:0071949~FAD binding,	IPR007266:Ero1,IPR037192:ERO1-like_sf,	mmu04141:Protein processing in endoplasmic reticulum,		PIRSF017205:ERO1,		KW-0249~Electron transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0676~Redox-active center,KW-0732~Signal,	KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Alternate,DISULFID:Redox-active,DISULFID:Redox-active; alternate,MUTAGEN:C->A: Complete loss of disulfide oxidase activity in vitro.,
Q32L47	endoplasmic reticulum protein 27(ERP27)	Bos taurus			GO:0006457~protein folding,GO:0006986~response to unfolded protein,GO:0034976~response to endoplasmic reticulum stress,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,		IPR036249:Thioredoxin-like_sf,					KW-0834~Unfolded protein response,	KW-0256~Endoplasmic reticulum,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Thioredoxin,MOTIF:Prevents secretion from ER,REGION:PDIA3-binding site,
Q6UXG2	endosome-lysosome associated apoptosis and autophagy regulator 1(ELAPOR1)	Homo sapiens			GO:0000045~autophagosome assembly,GO:0009267~cellular response to starvation,GO:0044090~positive regulation of vacuole organization,GO:2000786~positive regulation of autophagosome assembly,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0031902~late endosome membrane,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,	IPR009011:Man6P_isomerase_rcpt-bd_dom_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR039181:EIG121-like,IPR044865:MRH_dom,				SM01411:Ephrin_rec_like,	KW-0072~Autophagy,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:MRH,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q3UZV7	endosome-lysosome associated apoptosis and autophagy regulator family member 2(Elapor2)	Mus musculus			GO:0030513~positive regulation of BMP signaling pathway,GO:0045684~positive regulation of epidermis development,GO:0051961~negative regulation of nervous system development,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0070700~BMP receptor binding,	IPR009011:Man6P_isomerase_rcpt-bd_dom_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR039181:EIG121-like,IPR044865:MRH_dom,				SM01411:Ephrin_rec_like,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:MRH,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P97682	endothelial cell-specific molecule 1(Esm1)	Rattus norvegicus			GO:0001525~angiogenesis,GO:0002040~sprouting angiogenesis,GO:0008284~positive regulation of cell proliferation,GO:1902204~positive regulation of hepatocyte growth factor receptor signaling pathway,	GO:0005576~extracellular region,	GO:0005171~hepatocyte growth factor receptor binding,GO:0005178~integrin binding,	IPR000867:IGFBP-like,IPR009030:Growth_fac_rcpt_cys_sf,IPR038850:ESM1,				SM00121:IB,	KW-0037~Angiogenesis,	KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine,COMPBIAS:Basic and acidic residues,DOMAIN:IGFBP N-terminal,REGION:Disordered,
Q95L55	endothelin receptor type A(EDNRA)	Ovis aries			GO:0000278~mitotic cell cycle,GO:0001569~branching involved in blood vessel morphogenesis,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0001974~blood vessel remodeling,GO:0001975~response to amphetamine,GO:0002027~regulation of heart rate,GO:0003094~glomerular filtration,GO:0003207~cardiac chamber formation,GO:0003220~left ventricular cardiac muscle tissue morphogenesis,GO:0003228~atrial cardiac muscle tissue development,GO:0003253~cardiac neural crest cell migration involved in outflow tract morphogenesis,GO:0003357~noradrenergic neuron differentiation,GO:0006874~cellular calcium ion homeostasis,GO:0007005~mitochondrion organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007585~respiratory gaseous exchange,GO:0008217~regulation of blood pressure,GO:0009611~response to wounding,GO:0010467~gene expression,GO:0010737~protein kinase A signaling,GO:0010827~regulation of glucose transport,GO:0014034~neural crest cell fate commitment,GO:0014824~artery smooth muscle contraction,GO:0016322~neuron remodeling,GO:0030202~heparin metabolic process,GO:0030878~thyroid gland development,GO:0034599~cellular response to oxidative stress,GO:0035050~embryonic heart tube development,GO:0035556~intracellular signal transduction,GO:0035904~aorta development,GO:0042310~vasoconstriction,GO:0042415~norepinephrine metabolic process,GO:0042474~middle ear morphogenesis,GO:0044751~cellular response to human chorionic gonadotropin stimulus,GO:0048484~enteric nervous system development,GO:0048485~sympathetic nervous system development,GO:0048675~axon extension,GO:0048706~embryonic skeletal system development,GO:0050905~neuromuscular process,GO:0055078~sodium ion homeostasis,GO:0060070~canonical Wnt signaling pathway,GO:0060324~face development,GO:0060385~axonogenesis involved in innervation,GO:0061028~establishment of endothelial barrier,GO:0061626~pharyngeal arch artery morphogenesis,GO:0070294~renal sodium ion absorption,GO:0070588~calcium ion transmembrane transport,GO:0071372~cellular response to follicle-stimulating hormone stimulus,GO:0071373~cellular response to luteinizing hormone stimulus,GO:0071806~protein transmembrane transport,GO:0072011~glomerular endothelium development,GO:0072112~glomerular visceral epithelial cell differentiation,GO:0086101~endothelin receptor signaling pathway involved in heart process,GO:0097018~renal albumin absorption,GO:0097084~vascular smooth muscle cell development,GO:0097152~mesenchymal cell apoptotic process,GO:0097492~sympathetic neuron axon guidance,GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance,GO:1903210~glomerular visceral epithelial cell apoptotic process,GO:1903537~meiotic cell cycle process involved in oocyte maturation,GO:1904888~cranial skeletal system development,GO:1905144~response to acetylcholine,GO:1905871~regulation of protein localization to cell leading edge,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004962~endothelin receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000499:Endthln_rcpt,IPR002175:ETA_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	oas04020:Calcium signaling pathway,oas04022:cGMP-PKG signaling pathway,oas04024:cAMP signaling pathway,oas04080:Neuroactive ligand-receptor interaction,oas04270:Vascular smooth muscle contraction,oas04924:Renin secretion,oas05200:Pathways in cancer,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q90328	endothelin receptor type B(EDNRB)	Coturnix japonica			GO:0007186~G-protein coupled receptor signaling pathway,GO:0008217~regulation of blood pressure,GO:0035556~intracellular signal transduction,GO:0042310~vasoconstriction,GO:0048484~enteric nervous system development,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004962~endothelin receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000499:Endthln_rcpt,IPR001112:ETB_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	cjo04020:Calcium signaling pathway,cjo04080:Neuroactive ligand-receptor interaction,cjo04916:Melanogenesis,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	DOMAIN:G-protein coupled receptors family 1 profile,LIPID:S-palmitoyl cysteine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q8BPU7	engulfment and cell motility 1(Elmo1)	Mus musculus			GO:0006909~phagocytosis,GO:0006911~phagocytosis, engulfment,GO:0006915~apoptotic process,GO:0007015~actin filament organization,GO:0016601~Rac protein signal transduction,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0048870~cell motility,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0032045~guanyl-nucleotide exchange factor complex,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,	IPR001849:PH_domain,IPR006816:ELMO_dom,IPR011989:ARM-like,IPR011993:PH-like_dom_sf,IPR016024:ARM-type_fold,IPR024574:ELMO_ARM,	mmu04062:Chemokine signaling pathway,mmu04148:Efferocytosis,mmu05100:Bacterial invasion of epithelial cells,mmu05132:Salmonella infection,mmu05135:Yersinia infection,				KW-0053~Apoptosis,KW-0581~Phagocytosis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0729~SH3-binding,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:ELMO,DOMAIN:PH,MOTIF:SH3-binding,
Q7TSV9	enkurin domain containing 1(Enkd1)	Mus musculus			GO:0000132~establishment of mitotic spindle orientation,GO:0030030~cell projection organization,GO:0044458~motile cilium assembly,GO:1905515~non-motile cilium assembly,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0015630~microtubule cytoskeleton,GO:0036064~ciliary basal body,GO:0042995~cell projection,GO:0097546~ciliary base,GO:0097731~9+0 non-motile cilium,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0043014~alpha-tubulin binding,	IPR027012:Enkurin_dom,					KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Enkurin,REGION:Disordered,
B5DGQ7	enolase 3, (beta, muscle)(eno3)	Salmo salar			GO:0006096~glycolytic process,	GO:0000015~phosphopyruvate hydratase complex,	GO:0000287~magnesium ion binding,GO:0004634~phosphopyruvate hydratase activity,	IPR000941:Enolase,IPR020809:Enolase_CS,IPR020810:Enolase_C,IPR020811:Enolase_N,IPR029017:Enolase-like_N,IPR036849:Enolase-like_C_sf,	sasa00010:Glycolysis / Gluconeogenesis,sasa01100:Metabolic pathways,sasa01200:Carbon metabolism,sasa01230:Biosynthesis of amino acids,sasa03018:RNA degradation,		PIRSF001400:Enolase,	SM01192:Enolase_C,SM01193:Enolase_N,	KW-0324~Glycolysis,	KW-0963~Cytoplasm,		KW-0020~Allergen,		KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0456~Lyase,		ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,DOMAIN:Enolase C-terminal TIM barrel,DOMAIN:Enolase N-terminal,
A0PJR5	enoyl CoA hydratase domain containing 3(echdc3)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,	GO:0005739~mitochondrion,	GO:0003824~catalytic activity,GO:0016836~hydro-lyase activity,	IPR001753:Enoyl-CoA_hydra/iso,IPR014748:Enoyl-CoA_hydra_C,IPR029045:ClpP/crotonase-like_dom_sf,					KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,				TRANSIT:Mitochondrion,
P79944	eomesodermin L homeolog(eomes.L)	Xenopus laevis			GO:0001706~endoderm formation,GO:0001707~mesoderm formation,GO:0006355~regulation of transcription, DNA-templated,GO:0007369~gastrulation,GO:0030154~cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR001699:TF_T-box,IPR008967:p53-like_TF_DNA-bd_sf,IPR018186:TF_T-box_CS,IPR032385:T-box_assoc,IPR036960:T-box_sf,IPR046360:T-box_DNA-bd,				SM00425:TBOX,	KW-0221~Differentiation,KW-0306~Gastrulation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DNA_BIND:T-box,DOMAIN:T-box,REGION:Disordered,REGION:Required for transcription activation,
Q91736	ephrin type-B receptor 1-B-like(LOC108718198)	Xenopus laevis			GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0030010~establishment of cell polarity,GO:0031589~cell-substrate adhesion,GO:0046328~regulation of JNK cascade,GO:0046777~protein autophosphorylation,GO:0048013~ephrin receptor signaling pathway,GO:0051965~positive regulation of synapse assembly,GO:0060326~cell chemotaxis,GO:0060996~dendritic spine development,GO:0060997~dendritic spine morphogenesis,GO:0070372~regulation of ERK1 and ERK2 cascade,	GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0031901~early endosome membrane,	GO:0005003~ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR001090:Ephrin_rcpt_lig-bd_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001426:Tyr_kinase_rcpt_V_CS,IPR001660:SAM,IPR003961:FN3_dom,IPR008266:Tyr_kinase_AS,IPR008979:Galactose-bd-like_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR011009:Kinase-like_dom_sf,IPR013761:SAM/pointed_sf,IPR013783:Ig-like_fold,IPR016257:Tyr_kinase_ephrin_rcpt,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR027936:Eph_TM,IPR034231:EphB1_rcpt_lig-bd,IPR036116:FN3_sf,IPR042819:EphB1_SAM,			PIRSF000666:TyrPK_ephrin_receptor,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:Ephrin_rec_like,	KW-0130~Cell adhesion,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0966~Cell projection,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Eph LBD,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Protein kinase,DOMAIN:SAM,MOTIF:PDZ-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P42566	epidermal growth factor receptor pathway substrate 15(EPS15)	Homo sapiens		h_ndkDynaminPathway:Endocytotic role of NDK, Phosphins and Dynamin,	GO:0001921~positive regulation of receptor recycling,GO:0006895~Golgi to endosome transport,GO:0006897~endocytosis,GO:0015031~protein transport,GO:0016050~vesicle organization,GO:0016197~endosomal transport,GO:0019065~receptor-mediated endocytosis of virus by host cell,GO:0032456~endocytic recycling,GO:0042127~regulation of cell proliferation,GO:0046718~viral entry into host cell,GO:0048268~clathrin coat assembly,GO:0098884~postsynaptic neurotransmitter receptor internalization,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016235~aggresome,GO:0016324~apical plasma membrane,GO:0030132~clathrin coat of coated pit,GO:0031901~early endosome membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0031593~polyubiquitin binding,GO:0045296~cadherin binding,	IPR000261:EH_dom,IPR002048:EF_hand_dom,IPR003903:UIM_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,	hsa04144:Endocytosis,			SM00027:EH,SM00054:EFh,SM00726:UIM,	KW-0254~Endocytosis,KW-0653~Protein transport,KW-0813~Transport,KW-0945~Host-virus interaction,	KW-0168~Coated pit,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,KW-1003~Cell membrane,		KW-0656~Proto-oncogene,	KW-0175~Coiled coil,KW-0677~Repeat,KW-0729~SH3-binding,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0675~Receptor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,DOMAIN:EH,DOMAIN:EH 1,DOMAIN:EH 2,DOMAIN:EH 3,DOMAIN:UIM 1,DOMAIN:UIM 2,MOTIF:SH3-binding,MUTAGEN:V->E: Loss of interaction with STON2 NPF motifs.,MUTAGEN:W->A: Loss of interaction with STON2 NPF motifs.,REGION:15 X 3 AA repeats of D-P-F,REGION:Disordered,REGION:Interaction with DAB2,REPEAT:1,REPEAT:10,REPEAT:11,REPEAT:12,REPEAT:13,REPEAT:14,REPEAT:15,REPEAT:2,REPEAT:3,REPEAT:4,REPEAT:5,REPEAT:6,REPEAT:7,REPEAT:8,REPEAT:9,
Q9WVJ9	epidermal growth factor-containing fibulin-like extracellular matrix protein 2(Efemp2)	Mus musculus			GO:0035904~aorta development,GO:0048251~elastic fiber assembly,GO:0060414~aorta smooth muscle tissue morphogenesis,GO:0060840~artery development,GO:0097084~vascular smooth muscle cell development,GO:1904026~regulation of collagen fibril organization,GO:1904028~positive regulation of collagen fibril organization,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1904831~positive regulation of aortic smooth muscle cell differentiation,GO:1905609~positive regulation of smooth muscle cell-matrix adhesion,	GO:0001527~microfibril,GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0071953~elastic fiber,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0030023~extracellular matrix constituent conferring elasticity,GO:0042803~protein homodimerization activity,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR013032:EGF-like_CS,IPR018097:EGF_Ca-bd_CS,IPR026823:cEGF,				SM00179:EGF_CA,SM00181:EGF,		KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like 1; atypical,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like calcium-binding,MUTAGEN:E->K: Knockin mutant mice are viable and survive into adulthood. Mice display abnormalities in multiple organ systems, including loose skin, bent forelimb, aortic aneurysm, tortuous artery, and pulmonary emphysema. In addition to elastic fiber abnormalities in the skin and large arteries, collagen fibrils are irregularly shaped, with many large fibrils in the dermis. Mice have large artery stiffness and systolic hypertension. Reduces protein secretion.,REGION:Disordered,SITE:Cleavage,SITE:Cleavage; by ELANE,SITE:Cleavage; by MMP2, MMP3, MMP7, MMP9, MMP12,
Q8R0W0	epiplakin 1(Eppk1)	Mus musculus			GO:0007010~cytoskeleton organization,GO:0010839~negative regulation of keratinocyte proliferation,GO:0030336~negative regulation of cell migration,GO:0030856~regulation of epithelial cell differentiation,GO:0042060~wound healing,GO:0045104~intermediate filament cytoskeleton organization,GO:0045109~intermediate filament organization,GO:0045110~intermediate filament bundle assembly,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051548~negative regulation of keratinocyte migration,GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing,GO:0061045~negative regulation of wound healing,GO:1905041~regulation of epithelium regeneration,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0030056~hemidesmosome,GO:0042995~cell projection,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,GO:0045178~basal part of cell,GO:0070161~anchoring junction,GO:0071944~cell periphery,GO:0097356~perinucleolar compartment,	GO:0005198~structural molecule activity,GO:0019215~intermediate filament binding,GO:1990254~keratin filament binding,	IPR001101:Plectin_repeat,IPR035915:Plakin_repeat_sf,IPR043197:Plakin,				SM00250:PLEC,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0796~Tight junction,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Interaction with KRT14,REGION:Interaction with KRT5,REPEAT:Plectin 1,REPEAT:Plectin 10,REPEAT:Plectin 11,REPEAT:Plectin 12,REPEAT:Plectin 13,REPEAT:Plectin 14,REPEAT:Plectin 15,REPEAT:Plectin 16,REPEAT:Plectin 17,REPEAT:Plectin 18,REPEAT:Plectin 19,REPEAT:Plectin 2,REPEAT:Plectin 20,REPEAT:Plectin 21,REPEAT:Plectin 22,REPEAT:Plectin 23,REPEAT:Plectin 24,REPEAT:Plectin 25,REPEAT:Plectin 26,REPEAT:Plectin 27,REPEAT:Plectin 28,REPEAT:Plectin 29,REPEAT:Plectin 3,REPEAT:Plectin 30,REPEAT:Plectin 31,REPEAT:Plectin 32,REPEAT:Plectin 33,REPEAT:Plectin 34,REPEAT:Plectin 35,REPEAT:Plectin 36,REPEAT:Plectin 37,REPEAT:Plectin 38,REPEAT:Plectin 39,REPEAT:Plectin 4,REPEAT:Plectin 40,REPEAT:Plectin 41,REPEAT:Plectin 42,REPEAT:Plectin 43,REPEAT:Plectin 44,REPEAT:Plectin 45,REPEAT:Plectin 46,REPEAT:Plectin 47,REPEAT:Plectin 48,REPEAT:Plectin 49,REPEAT:Plectin 5,REPEAT:Plectin 50,REPEAT:Plectin 51,REPEAT:Plectin 52,REPEAT:Plectin 53,REPEAT:Plectin 54,REPEAT:Plectin 55,REPEAT:Plectin 56,REPEAT:Plectin 57,REPEAT:Plectin 58,REPEAT:Plectin 59,REPEAT:Plectin 6,REPEAT:Plectin 60,REPEAT:Plectin 61,REPEAT:Plectin 62,REPEAT:Plectin 63,REPEAT:Plectin 64,REPEAT:Plectin 65,REPEAT:Plectin 66,REPEAT:Plectin 67,REPEAT:Plectin 68,REPEAT:Plectin 69,REPEAT:Plectin 7,REPEAT:Plectin 70,REPEAT:Plectin 71,REPEAT:Plectin 72,REPEAT:Plectin 73,REPEAT:Plectin 74,REPEAT:Plectin 75,REPEAT:Plectin 76,REPEAT:Plectin 8,REPEAT:Plectin 9,
Q9H8V3	epithelial cell transforming 2(ECT2)	Homo sapiens			GO:0000281~mitotic cytokinesis,GO:0000902~cell morphogenesis,GO:0007399~nervous system development,GO:0015031~protein transport,GO:0030154~cell differentiation,GO:0032147~activation of protein kinase activity,GO:0032467~positive regulation of cytokinesis,GO:0035556~intracellular signal transduction,GO:0042307~positive regulation of protein import into nucleus,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043547~positive regulation of GTPase activity,GO:0045666~positive regulation of neuron differentiation,GO:0045859~regulation of protein kinase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051260~protein homooligomerization,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0070301~cellular response to hydrogen peroxide,GO:0070830~bicellular tight junction assembly,GO:0071277~cellular response to calcium ion,GO:0071479~cellular response to ionizing radiation,GO:0090630~activation of GTPase activity,GO:2000431~regulation of cytokinesis, actomyosin contractile ring assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0005938~cell cortex,GO:0016604~nuclear body,GO:0030496~midbody,GO:0032154~cleavage furrow,GO:0072686~mitotic spindle,GO:0097149~centralspindlin complex,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0031267~small GTPase binding,GO:0042803~protein homodimerization activity,	IPR000219:DH-domain,IPR001331:GDS_CDC24_CS,IPR001357:BRCT_dom,IPR011993:PH-like_dom_sf,IPR026817:Ect2,IPR035899:DBL_dom_sf,IPR036420:BRCT_dom_sf,IPR049395:ECT2_PH,IPR049396:ECT2_BRCT0,				SM00292:BRCT,SM00325:RhoGEF,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0653~Protein transport,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0796~Tight junction,KW-0963~Cytoplasm,KW-0965~Cell junction,		KW-0553~Oncogene,	KW-0677~Repeat,		KW-0344~Guanine-nucleotide releasing factor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BRCT,DOMAIN:BRCT 1,DOMAIN:BRCT 2,DOMAIN:DH,DOMAIN:ECT2 BRCT0,DOMAIN:ECT2 PH,DOMAIN:PH,MOTIF:Nuclear localization signal,MUTAGEN:A->D: 2-fold increase in GEF activity.,MUTAGEN:C->K: More than 10-fold increase in GEF activity. Overexpression causes noticeable changes in interphase cell morphology such as cell rounding and formation of stress fibers, suggesting ectopic RHOA activation.,MUTAGEN:F->A: No effect on GEF activity but severely decreases ECT2 activation by RHOA. Localizes correctly but fails to rescue the cytokinesis defect caused by knockdown of endogenous ECT2 in contrast to the wild-type protein which rescues this defect.,MUTAGEN:K->A: Inhibits interaction with RACGAP1. Abolishes targeting to the central spindle.,MUTAGEN:KRR->AAA: Shows both nuclear and cytoplasmic localization and activates its transforming activity.,MUTAGEN:P->D: More than 10-fold increase in GEF activity. Overexpression causes noticeable changes in interphase cell morphology such as cell rounding and formation of stress fibers, suggesting ectopic RhoA activation.,MUTAGEN:P->S: Complete loss of GEF activity and failure to support cytokinesis.,MUTAGEN:PVQR->AAAA: Inhibits activation of the transforming activity.,MUTAGEN:R->C: Partially releases inhibition.,MUTAGEN:R->D: 2-fold increase in GEF activity.,MUTAGEN:R->Q: Complete loss of GEF activity and failure to support cytokinesis.,MUTAGEN:R->Q: Marked increase in GEF activity and rescues the cytokinesis defect caused by depletion of endogenous ECT2. When expressed in a cancer cell line, causes faster cell proliferation than the wild-type protein.,MUTAGEN:RKR->AKA: Shows both nuclear and cytoplasmic localization and activates its transforming activity.,MUTAGEN:T->A: Diminishes its phosphorylation status.,MUTAGEN:T->A: Diminishes its phosphorylation status. Reduces its interaction with PLK1 and Rho exchange activity. Does not change its subcellular localization. Does not inhibit anchorage-independent growth and invasion in cancer cells.,MUTAGEN:T->A: Does not inhibit its Rho exchange activity. Increases interaction with RACGAP1. Does not inhibit anchorage-independent growth and invasion in cancer cells.,MUTAGEN:T->A: Inhibits interaction with RACGAP1. Abolishes targeting to the central spindle.,MUTAGEN:T->A: Inhibits its phosphorylation and anchorage-independent growth and invasion in cancer cells. Does not inhibit its GEF activity.,MUTAGEN:T->D: Does not inhibit subcellular localization or homodimerization. Enhances its Rho exchange activity.,MUTAGEN:T->D: Does not reduce its interaction with PLK1, change its subcellular localization and Rho exchange activity.,MUTAGEN:W->A: 2-fold increase in GEF activity.,MUTAGEN:W->R: Inhibits homodimerization. Increases binding with RhoA and GEF activity.,MUTAGEN:Y->A: No effect on GEF activity but severely decreases ECT2 activation by RHOA. Fails to rescue the cytokinesis defect caused by knockdown of endogenous ECT2 in contrast to the wild-type protein which rescues this defect.,REGION:Disordered,
F1QIK8	epithelial membrane protein 2(emp2)	Danio rerio			GO:0003093~regulation of glomerular filtration,GO:0008284~positive regulation of cell proliferation,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,		IPR004031:PMP22/EMP/MP20/Claudin,IPR004032:PMP22_EMP_MP20,	dre04510:Focal adhesion,					KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,
P54852	epithelial membrane protein 3 (MAM blood group)(EMP3)	Homo sapiens			GO:0006915~apoptotic process,GO:0032060~bleb assembly,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,	IPR003934:EMP_3,IPR004031:PMP22/EMP/MP20/Claudin,IPR004032:PMP22_EMP_MP20,	hsa04350:TGF-beta signaling pathway,					KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TRANSMEM:Helical,
P07099	epoxide hydrolase 1(EPHX1)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,	GO:0006805~xenobiotic metabolic process,GO:0009636~response to toxic substance,GO:0014070~response to organic cyclic compound,GO:0019369~arachidonic acid metabolic process,GO:0019439~aromatic compound catabolic process,GO:0097176~epoxide metabolic process,	GO:0005789~endoplasmic reticulum membrane,	GO:0004301~epoxide hydrolase activity,GO:0005515~protein binding,GO:0008142~oxysterol binding,GO:0016787~hydrolase activity,GO:0033961~cis-stilbene-oxide hydrolase activity,	IPR000073:AB_hydrolase_1,IPR000639:Epox_hydrolase-like,IPR010497:Epoxide_hydro_N,IPR016292:Epoxide_hydrolase,IPR029058:AB_hydrolase,	hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa04976:Bile secretion,hsa05204:Chemical carcinogenesis - DNA adducts,hsa05207:Chemical carcinogenesis - receptor activation,hsa05208:Chemical carcinogenesis - reactive oxygen species,		PIRSF001112:Epoxide_hydrolase,		KW-0058~Aromatic hydrocarbons catabolism,KW-0216~Detoxification,KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0488~Methylation,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,DOMAIN:AB hydrolase-1,DOMAIN:Epoxide hydrolase N-terminal,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical; Signal-anchor for type III membrane protein,
Q9WV92	erythrocyte membrane protein band 4.1 like 3(Epb41l3)	Mus musculus			GO:0002175~protein localization to paranode region of axon,GO:0006915~apoptotic process,GO:0008360~regulation of cell shape,GO:0030865~cortical cytoskeleton organization,GO:0030866~cortical actin cytoskeleton organization,GO:0030913~paranodal junction assembly,GO:0031032~actomyosin structure organization,GO:0043217~myelin maintenance,GO:0048812~neuron projection morphogenesis,GO:0061564~axon development,GO:0071205~protein localization to juxtaparanode region of axon,GO:0072659~protein localization to plasma membrane,GO:1990227~paranodal junction maintenance,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030054~cell junction,GO:0030673~axolemma,GO:0033270~paranode region of axon,GO:0044224~juxtaparanode region of axon,GO:0070161~anchoring junction,	GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,	IPR000299:FERM_domain,IPR000798:Ez/rad/moesin-like,IPR007477:SAB_dom,IPR008379:Band_4.1_C,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR014847:FA,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019747:FERM_CS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR030691:Band4.1-L3_FERM_F1,IPR035963:FERM_2,			PIRSF002304:Membrane_skeletal_4_1,	SM00295:B41,SM01195:FA,SM01196:FERM_C,	KW-0053~Apoptosis,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-1003~Cell membrane,		KW-0043~Tumor suppressor,	KW-0732~Signal,		KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Band 4.1 C-terminal,DOMAIN:FERM,DOMAIN:SAB,REGION:C-terminal (CTD),REGION:Disordered,REGION:Hydrophilic,REGION:Spectrin--actin-binding,
Q5SPR8	establishment of sister chromatid cohesion N-acetyltransferase 2(esco2)	Danio rerio			GO:0000278~mitotic cell cycle,GO:0006275~regulation of DNA replication,GO:0007049~cell cycle,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0007507~heart development,GO:0031101~fin regeneration,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:1990523~bone regeneration,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0016407~acetyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,GO:0034915~2-methylhexanoyl-CoA C-acetyltransferase activity,GO:0034945~2,6-dimethyl-5-methylene-3-oxo-heptanoyl-CoA C-acetyltransferase activity,GO:0043806~keto acid formate lyase activity,GO:0046872~metal ion binding,GO:0061733~peptide-lysine-N-acetyltransferase activity,	IPR028005:AcTrfase_ESCO_Znf_dom,IPR028009:ESCO_Acetyltransf_dom,	dre04110:Cell cycle,				KW-0131~Cell cycle,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0012~Acyltransferase,KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:N-acetyltransferase ESCO acetyl-transferase,DOMAIN:N-acetyltransferase ESCO zinc-finger,REGION:Disordered,ZN_FING:CCHH-type,
Q9PVZ9	estrogen receptor 1(esr1)	Sparus aurata			GO:0006355~regulation of transcription, DNA-templated,GO:0043401~steroid hormone mediated signaling pathway,	GO:0005634~nucleus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005496~steroid binding,GO:0008270~zinc ion binding,GO:0030284~estrogen receptor activity,GO:0042562~hormone binding,GO:0043565~sequence-specific DNA binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001292:Estr_rcpt,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR013088:Znf_NHR/GATA,IPR024178:Est_rcpt/est-rel_rcp,IPR035500:NHR-like_dom_sf,IPR046944:Estr_rcpt_N,			PIRSF002527:ER-like_NR,PIRSF500101:ER-a,	SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0446~Lipid-binding,KW-0479~Metal-binding,KW-0754~Steroid-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0675~Receptor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,REGION:Disordered,REGION:Hinge,REGION:Modulating,ZN_FING:NR C4-type,
P62510	estrogen-related receptor gamma(Esrrg)	Rattus norvegicus			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0043401~steroid hormone mediated signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048384~retinoic acid receptor signaling pathway,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005496~steroid binding,GO:0008270~zinc ion binding,GO:0034056~estrogen response element binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0050682~AF-2 domain binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR003078:Retinoic_acid_rcpt,IPR013088:Znf_NHR/GATA,IPR024178:Est_rcpt/est-rel_rcp,IPR027289:Oest-rel_rcp,IPR035500:NHR-like_dom_sf,			PIRSF002527:ER-like_NR,PIRSF500939:ERR1-2-3,	SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,	KW-0007~Acetylation,	COMPBIAS:Polar residues,DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,REGION:Disordered,ZN_FING:NR C4-type,
Q28C91	ethylmalonyl-CoA decarboxylase 1(echdc1)	Xenopus tropicalis			GO:0006635~fatty acid beta-oxidation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0004492~methylmalonyl-CoA decarboxylase activity,GO:0016829~lyase activity,GO:0016831~carboxy-lyase activity,	IPR001753:Enoyl-CoA_hydra/iso,IPR018376:Enoyl-CoA_hyd/isom_CS,IPR029045:ClpP/crotonase-like_dom_sf,	xtr00640:Propanoate metabolism,xtr01100:Metabolic pathways,					KW-0963~Cytoplasm,					KW-0456~Lyase,
Q9CXC9	ets variant 5(Etv5)	Mus musculus		m_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007274~neuromuscular synaptic transmission,GO:0007626~locomotory behavior,GO:0030154~cell differentiation,GO:0034599~cellular response to oxidative stress,GO:0045666~positive regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048133~male germ-line stem cell asymmetric division,GO:0050807~regulation of synapse organization,GO:0060252~positive regulation of glial cell proliferation,GO:0060762~regulation of branching involved in mammary gland duct morphogenesis,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0045202~synapse,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000418:Ets_dom,IPR006715:ETS_PEA3_N,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR046328:ETS_fam,	mmu05202:Transcriptional misregulation in cancer,mmu05215:Prostate cancer,			SM00413:ETS,		KW-0539~Nucleus,					KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:ETS,DOMAIN:ETS,DOMAIN:PEA3-type ETS-domain transcription factor N-terminal,REGION:Disordered,
Q92005	eukaryotic translation elongation factor 1 alpha 1, like 1(eef1a1l1)	Danio rerio			GO:0006412~translation,GO:0006414~translational elongation,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0016787~hydrolase activity,	IPR000795:T_Tr_GTP-bd_dom,IPR004160:Transl_elong_EFTu/EF1A_C,IPR004161:EFTu-like_2,IPR004539:Transl_elong_EF1A_euk/arc,IPR009000:Transl_B-barrel_sf,IPR009001:Transl_elong_EF1A/Init_IF2_C,IPR027417:P-loop_NTPase,IPR031157:G_TR_CS,	dre03013:Nucleocytoplasmic transport,				KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0251~Elongation factor,KW-0378~Hydrolase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	DOMAIN:tr-type G,REGION:G1,REGION:G2,REGION:G3,REGION:G4,REGION:G5,
Q6PE25	eukaryotic translation elongation factor 1 gamma(eef1g)	Danio rerio			GO:0006412~translation,GO:0006414~translational elongation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003746~translation elongation factor activity,	IPR001662:EF1B_G_C,IPR004045:Glutathione_S-Trfase_N,IPR004046:GST_C,IPR010987:Glutathione-S-Trfase_C-like,IPR036249:Thioredoxin-like_sf,IPR036282:Glutathione-S-Trfase_C_sf,IPR036433:EF1B_G_C_sf,IPR040079:Glutathione_S-Trfase,				SM01183:EF1G,	KW-0648~Protein biosynthesis,						KW-0251~Elongation factor,		DOMAIN:EF-1-gamma C-terminal,DOMAIN:GST C-terminal,DOMAIN:GST N-terminal,REGION:Disordered,
Q6P3J5	eukaryotic translation elongation factor 2b(eef2b)	Danio rerio			GO:0006412~translation,GO:0006414~translational elongation,GO:0043009~chordate embryonic development,GO:0071466~cellular response to xenobiotic stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:1990904~ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0043022~ribosome binding,	IPR000640:EFG_V-like,IPR000795:T_Tr_GTP-bd_dom,IPR004161:EFTu-like_2,IPR005225:Small_GTP-bd_dom,IPR005517:Transl_elong_EFG/EF2_IV,IPR009000:Transl_B-barrel_sf,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR027417:P-loop_NTPase,IPR031157:G_TR_CS,IPR035647:EFG_III/V,IPR041095:EFG_II,				SM00838:EFG_C,SM00889:EFG_IV,	KW-0648~Protein biosynthesis,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0251~Elongation factor,KW-0378~Hydrolase,		DOMAIN:tr-type G,
P19525	eukaryotic translation initiation factor 2 alpha kinase 2(EIF2AK2)	Homo sapiens		h_eif2Pathway:Regulation of eIF2,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_ranklPathway:Bone Remodelling,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_tollPathway:Toll-Like Receptor Pathway,	GO:0001819~positive regulation of cytokine production,GO:0006412~translation,GO:0006468~protein phosphorylation,GO:0008285~negative regulation of cell proliferation,GO:0009615~response to virus,GO:0017148~negative regulation of translation,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0032722~positive regulation of chemokine production,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0033689~negative regulation of osteoblast proliferation,GO:0034198~cellular response to amino acid starvation,GO:0035455~response to interferon-alpha,GO:0036492~eiF2alpha phosphorylation in response to endoplasmic reticulum stress,GO:0043066~negative regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0045071~negative regulation of viral genome replication,GO:0046777~protein autophosphorylation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051607~defense response to virus,GO:1900225~regulation of NLRP3 inflammasome complex assembly,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1901532~regulation of hematopoietic progenitor cell differentiation,GO:1902033~regulation of hematopoietic stem cell proliferation,GO:1902036~regulation of hematopoietic stem cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019888~protein phosphatase regulator activity,GO:0042802~identical protein binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014720:dsRBD_dom,IPR017441:Protein_kinase_ATP_BS,IPR044452:EIF2AK2_DSRM_1,IPR044453:EIF2AK2_DSRM_2,	hsa04217:Necroptosis,hsa05010:Alzheimer disease,hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05165:Human papillomavirus infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05168:Herpes simplex virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05171:Coronavirus disease - COVID-19,hsa05203:Viral carcinogenesis,	618877~Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome,619687~Dystonia 33,		SM00220:S_TKc,SM00358:DSRM,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-1023~Dystonia,	KW-0677~Repeat,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0694~RNA-binding,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Proton acceptor,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15),DOMAIN:DRBM,DOMAIN:DRBM 1,DOMAIN:DRBM 2,DOMAIN:Protein kinase,MUTAGEN:A->E: Significant loss of activity; loss of dsRNA binding and dimerization.,MUTAGEN:D->V: 15-fold decrease in K3L binding affinity and thus resistance of mutated PKR to K3L inhibition.,MUTAGEN:F->S: Loss of PKR inhibition by HCMV protein TRS1.,MUTAGEN:I->T: No effect on PKR inhibition by HCMV protein TRS1.,MUTAGEN:I->V: No effect on PKR inhibition by HCMV protein TRS1.,MUTAGEN:K->A: Impairs dsRNA binding but not dimerization or activity.,MUTAGEN:K->R: Loss of activity.,MUTAGEN:K->R: No effect on PKR inhibition by HCMV protein TRS1.,MUTAGEN:Missing: Loss of activity.,MUTAGEN:Q->E: No effect on PKR inhibition by HCMV protein TRS1.,MUTAGEN:S->A: Moderate loss of activity; when associated with A-255 and A-258.,MUTAGEN:S->A: No effect on enzymatic activity; when associated with A-88; A-89 and A-90.,MUTAGEN:SK->AA: In FL-PKR-2AI; moderate loss of activity but no effect on dsRNA binding.,MUTAGEN:T->A: Loss of activity.,MUTAGEN:T->A: Moderate loss of activity.,MUTAGEN:T->A: Moderate loss of activity; when associated with A-242 and A-255.,MUTAGEN:T->A: No effect on enzymatic activity; when associated with A-83; A-88 and A-89.,MUTAGEN:T->A: No effect on enzymatic activity; when associated with A-83; A-88 and A-90.,MUTAGEN:T->A: No effect on enzymatic activity; when associated with A-83; A-89 and A-90.,MUTAGEN:T->A: Significant loss of activity and impairs autophosphorylation of T-451.,MUTAGEN:T->K: No effect on PKR inhibition by HCMV protein TRS1.,MUTAGEN:TK->AA: In FL-PKR-2AII; no effect on activity.,REGION:(Microbial infection) Interaction with HCV NS5A,REGION:2 X 13 AA approximate repeats,REGION:Dimerization,REGION:Disordered,REGION:Interaction with EIF2S1/EIF-2ALPHA,REGION:Interaction with TRAF5,REPEAT:1,REPEAT:2,
Q63184	eukaryotic translation initiation factor 2-alpha kinase 2(Eif2ak2)	Rattus norvegicus			GO:0001819~positive regulation of cytokine production,GO:0006412~translation,GO:0006468~protein phosphorylation,GO:0009612~response to mechanical stimulus,GO:0009615~response to virus,GO:0009636~response to toxic substance,GO:0010033~response to organic substance,GO:0016310~phosphorylation,GO:0017148~negative regulation of translation,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0032496~response to lipopolysaccharide,GO:0032722~positive regulation of chemokine production,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0033197~response to vitamin E,GO:0033689~negative regulation of osteoblast proliferation,GO:0034198~cellular response to amino acid starvation,GO:0035455~response to interferon-alpha,GO:0036492~eiF2alpha phosphorylation in response to endoplasmic reticulum stress,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043330~response to exogenous dsRNA,GO:0043410~positive regulation of MAPK cascade,GO:0045071~negative regulation of viral genome replication,GO:0046777~protein autophosphorylation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:1900225~regulation of NLRP3 inflammasome complex assembly,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1901532~regulation of hematopoietic progenitor cell differentiation,GO:1902033~regulation of hematopoietic stem cell proliferation,GO:1902036~regulation of hematopoietic stem cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0003725~double-stranded RNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0042802~identical protein binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014720:dsRBD_dom,IPR017441:Protein_kinase_ATP_BS,IPR044452:EIF2AK2_DSRM_1,IPR044453:EIF2AK2_DSRM_2,	rno04217:Necroptosis,rno05010:Alzheimer disease,rno05160:Hepatitis C,rno05162:Measles,rno05164:Influenza A,rno05165:Human papillomavirus infection,rno05167:Kaposi sarcoma-associated herpesvirus infection,rno05168:Herpes simplex virus 1 infection,rno05169:Epstein-Barr virus infection,rno05171:Coronavirus disease - COVID-19,rno05203:Viral carcinogenesis,			SM00220:S_TKc,SM00358:DSRM,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0694~RNA-binding,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Proton acceptor,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15),DOMAIN:DRBM,DOMAIN:DRBM 1,DOMAIN:DRBM 2,DOMAIN:Protein kinase,REGION:Interaction with TRAF5,
Q6PCR7	eukaryotic translation initiation factor 3, subunit 10 (theta)(eif3s10)	Danio rerio			GO:0001732~formation of cytoplasmic translation initiation complex,GO:0002188~translation reinitiation,GO:0006412~translation,GO:0006413~translational initiation,	GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0043614~multi-eIF complex,GO:0071540~eukaryotic translation initiation factor 3 complex, eIF3e,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003743~translation initiation factor activity,	IPR000717:PCI_dom,IPR027512:EIF3A,				SM00088:PINT,	KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0396~Initiation factor,KW-0694~RNA-binding,		COMPBIAS:Basic and acidic residues,DOMAIN:PCI,REGION:12 X 10 AA approximate tandem repeats of D-[DE]-[DE]-R-[GP]-[GPQT]-R-R-[GPS]-[ADFGIM],REGION:Disordered,REPEAT:1,REPEAT:10; approximate,REPEAT:11,REPEAT:12; approximate,REPEAT:2,REPEAT:3,REPEAT:4; truncated,REPEAT:5,REPEAT:6,REPEAT:7; truncated,REPEAT:8,REPEAT:9,
Q7T2A5	eukaryotic translation initiation factor 3, subunit 6 interacting protein(eif3s6ip)	Danio rerio			GO:0001732~formation of cytoplasmic translation initiation complex,GO:0006412~translation,GO:0006413~translational initiation,	GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,	GO:0003743~translation initiation factor activity,	IPR000717:PCI_dom,IPR011990:TPR-like_helical_dom_sf,IPR019382:eIF3l,					KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,					KW-0396~Initiation factor,		DOMAIN:PCI,
Q6PFQ2	eukaryotic translation initiation factor 3, subunit C(eif3c)	Danio rerio			GO:0001732~formation of cytoplasmic translation initiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0048856~anatomical structure development,	GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0031369~translation initiation factor binding,	IPR000717:PCI_dom,IPR008905:EIF3C_N_dom,IPR016024:ARM-type_fold,IPR027516:EIF3C,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,				SM00088:PINT,	KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,					KW-0396~Initiation factor,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PCI,REGION:Disordered,
Q5R7J9	eukaryotic translation initiation factor 4 gamma 2(EIF4G2)	Pongo abelii			GO:0006446~regulation of translational initiation,GO:0010507~negative regulation of autophagy,GO:0030307~positive regulation of cell growth,	GO:0005829~cytosol,GO:0016281~eukaryotic translation initiation factor 4F complex,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0008135~translation factor activity, RNA binding,	IPR003307:W2_domain,IPR003890:MIF4G-like_typ-3,IPR003891:Initiation_fac_eIF4g_MI,IPR016024:ARM-type_fold,IPR045208:IF4G,	pon05416:Viral myocarditis,			SM00515:eIF5C,SM00543:MIF4G,SM00544:MA3,	KW-0648~Protein biosynthesis,KW-0810~Translation regulation,						KW-0396~Initiation factor,KW-0678~Repressor,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:MI,DOMAIN:MIF4G,DOMAIN:W2,REGION:Disordered,
Q6NZJ6	eukaryotic translation initiation factor 4, gamma 1(Eif4g1)	Mus musculus			GO:0001662~behavioral fear response,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006446~regulation of translational initiation,GO:0009059~macromolecule biosynthetic process,GO:0010507~negative regulation of autophagy,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0030182~neuron differentiation,GO:0030307~positive regulation of cell growth,GO:0030324~lung development,GO:0031669~cellular response to nutrient levels,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0035278~miRNA mediated inhibition of translation,GO:0036493~positive regulation of translation in response to endoplasmic reticulum stress,GO:0045471~response to ethanol,GO:0045666~positive regulation of neuron differentiation,GO:0051247~positive regulation of protein metabolic process,GO:0097009~energy homeostasis,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1904377~positive regulation of protein localization to cell periphery,GO:1905537~positive regulation of eukaryotic translation initiation factor 4F complex assembly,GO:1905606~regulation of presynapse assembly,GO:1905612~positive regulation of mRNA cap binding,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005844~polysome,GO:0010494~cytoplasmic stress granule,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0098794~postsynapse,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008135~translation factor activity, RNA binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0042802~identical protein binding,	IPR003307:W2_domain,IPR003890:MIF4G-like_typ-3,IPR003891:Initiation_fac_eIF4g_MI,IPR016024:ARM-type_fold,IPR045208:IF4G,	mmu05416:Viral myocarditis,			SM00515:eIF5C,SM00543:MIF4G,SM00544:MA3,	KW-0648~Protein biosynthesis,KW-0810~Translation regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0396~Initiation factor,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:MI,DOMAIN:MIF4G,DOMAIN:W2,REGION:Disordered,REGION:EIF4A-binding,REGION:EIF4E-binding,REGION:Necessary but not sufficient for MKNK1-binding,REGION:PABPC1-binding,REGION:eIF3/EIF4A-binding,
Q6NX89	eukaryotic translation initiation factor 5A(eif5a)	Danio rerio			GO:0006412~translation,GO:0006413~translational initiation,GO:0006414~translational elongation,GO:0045901~positive regulation of translational elongation,GO:0045905~positive regulation of translational termination,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0003746~translation elongation factor activity,GO:0005515~protein binding,GO:0043022~ribosome binding,	IPR001884:IF5A-like,IPR008991:Translation_prot_SH3-like_sf,IPR012340:NA-bd_OB-fold,IPR014722:Rib_uL2_dom2,IPR019769:Trans_elong_IF5A_hypusine_site,IPR020189:Transl_elong_IF5A_C,IPR048670:IF5A-like_N,			PIRSF003025:eIF5A,	SM01376:eIF-5a,	KW-0648~Protein biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0251~Elongation factor,KW-0396~Initiation factor,KW-0694~RNA-binding,	KW-0385~Hypusine,
Q7ZVV1	excision repair cross-complementation group 3(ercc3)	Danio rerio			GO:0006265~DNA topological change,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,	GO:0000112~nucleotide-excision repair factor 3 complex,GO:0005634~nucleus,GO:0005675~holo TFIIH complex,GO:0097550~transcriptional preinitiation complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0043138~3'-5' DNA helicase activity,	IPR001161:XPB/Ssl2,IPR001650:Helicase_C,IPR006935:Helicase/UvrB_N,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR032438:ERCC3_RAD25_C,IPR032830:XPB/Ssl2_N,	dre03022:Basal transcription factors,dre03420:Nucleotide excision repair,			SM00487:DEXDc,SM00490:HELICc,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,		COMPBIAS:Basic and acidic residues,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEVH box,MOTIF:Nuclear localization signal,REGION:Disordered,
A2BGR3	excision repair cross-complementation group 6-like(ercc6l)	Danio rerio			GO:0007049~cell cycle,GO:0016539~intein-mediated protein splicing,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005694~chromosome,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0015616~DNA translocase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,	IPR000330:SNF2_N,IPR001650:Helicase_C,IPR006141:Intein_N,IPR014001:Helicase_ATP-bd,IPR019734:TPR_repeat,IPR027417:P-loop_NTPase,IPR038718:SNF2-like_sf,				SM00487:DEXDc,SM00490:HELICc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0995~Kinetochore,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,
Q2M3D2	exocyst complex component 3 like 2(EXOC3L2)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0006887~exocytosis,	GO:0000145~exocyst,	GO:0005515~protein binding,	IPR010326:EXOC3/Sec6,IPR042532:EXOC3/Sec6_C,									KW-0175~Coiled coil,				COMPBIAS:Pro residues,REGION:Disordered,
O60645	exocyst complex component 3(EXOC3)	Homo sapiens			GO:0000281~mitotic cytokinesis,GO:0006887~exocytosis,GO:0006904~vesicle docking involved in exocytosis,GO:0015031~protein transport,GO:0051601~exocyst localization,GO:0090148~membrane fission,GO:0090522~vesicle tethering involved in exocytosis,	GO:0000145~exocyst,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0030426~growth cone,GO:0030496~midbody,GO:0030667~secretory granule membrane,GO:0042734~presynaptic membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0000149~SNARE binding,GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR010326:EXOC3/Sec6,IPR042532:EXOC3/Sec6_C,					KW-0268~Exocytosis,KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0963~Cytoplasm,KW-0966~Cell projection,						KW-0007~Acetylation,
Q2KID0	exosome component 2(EXOSC2)	Bos taurus			GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0030307~positive regulation of cell growth,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034475~U4 snRNA 3'-end processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0071034~CUT catabolic process,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071038~nuclear polyadenylation-dependent tRNA catabolic process,GO:0071051~polyadenylation-dependent snoRNA 3'-end processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031090~organelle membrane,	GO:0003723~RNA binding,	IPR004088:KH_dom_type_1,IPR012340:NA-bd_OB-fold,IPR025721:Exosome_cplx_N_dom,IPR026699:Exosome_RNA_bind1/RRP40/RRP4,IPR036612:KH_dom_type_1_sf,IPR048565:RRP4_S1,	bta03018:RNA degradation,				KW-0698~rRNA processing,	KW-0271~Exosome,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	DOMAIN:Exosome complex component N-terminal,DOMAIN:K Homology,DOMAIN:RRP4 S1,DOMAIN:S1 motif,
Q3U7R1	extended synaptotagmin-like protein 1(Esyt1)	Mus musculus			GO:0006869~lipid transport,GO:0061817~endoplasmic reticulum-plasma membrane tethering,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008289~lipid binding,GO:0008429~phosphatidylethanolamine binding,GO:0031210~phosphatidylcholine binding,GO:0035091~phosphatidylinositol binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR031468:SMP_LBD,IPR035892:C2_domain_sf,IPR037733:Ext_Synaptotagmin_C2A,IPR037749:Ext_Synaptotagmin_C2B,IPR037752:C2C_KIAA1228,IPR039010:Synaptotagmin_SMP,				SM00239:C2,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0446~Lipid-binding,KW-0479~Metal-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:C2 3,DOMAIN:C2 4,DOMAIN:C2 5,DOMAIN:SMP-LTD,MUTAGEN:S->A: Abolished phosphorylation by CDK5.,REGION:Disordered,REGION:Required for phosphatidylinositol 4,5-bisphosphate-dependent location at the cell membrane,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
P60330	extra spindle pole bodies 1, separase(Espl1)	Mus musculus			GO:0000070~mitotic sister chromatid segregation,GO:0000212~meiotic spindle organization,GO:0000278~mitotic cell cycle,GO:0000280~nuclear division,GO:0006508~proteolysis,GO:0007059~chromosome segregation,GO:0007127~meiosis I,GO:0045143~homologous chromosome segregation,GO:0051307~meiotic chromosome separation,GO:0098813~nuclear chromosome segregation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0072686~mitotic spindle,	GO:0004197~cysteine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,	IPR005314:Peptidase_C50,IPR030397:SEPARIN_core_dom,	mmu04110:Cell cycle,mmu04114:Oocyte meiosis,mmu05166:Human T-cell leukemia virus 1 infection,				KW-0159~Chromosome partition,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0068~Autocatalytic cleavage,KW-0597~Phosphoprotein,	DOMAIN:Peptidase C50,REGION:Disordered,SITE:Cleavage; by autolysis,
P0C7U0	extracellular leucine rich repeat and fibronectin type III domain containing 1(ELFN1)	Homo sapiens			GO:0050808~synapse organization,	GO:0005615~extracellular space,GO:0016020~membrane,GO:0030425~dendrite,GO:0031012~extracellular matrix,GO:0060076~excitatory synapse,	GO:0004864~protein phosphatase inhibitor activity,	IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,				SM00082:LRRCT,SM00369:LRR_TYP,		KW-0472~Membrane,KW-0966~Cell projection,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0650~Protein phosphatase inhibitor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:Fibronectin type-III,DOMAIN:LRRCT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q61508	extracellular matrix protein 1(Ecm1)	Mus musculus			GO:0001503~ossification,GO:0001525~angiogenesis,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0002063~chondrocyte development,GO:0002828~regulation of type 2 immune response,GO:0003416~endochondral bone growth,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0010466~negative regulation of peptidase activity,GO:0030500~regulation of bone mineralization,GO:0030502~negative regulation of bone mineralization,GO:0031214~biomineral tissue development,GO:0045766~positive regulation of angiogenesis,GO:2000404~regulation of T cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0002020~protease binding,GO:0005134~interleukin-2 receptor binding,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,	IPR008605:ECM1,IPR020858:Serum_albumin-like,					KW-0037~Angiogenesis,KW-0091~Biomineralization,KW-0495~Mineral balance,KW-0892~Osteogenesis,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) (high mannose) asparagine,CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:2 X approximate repeats,REGION:Disordered,REPEAT:1,REPEAT:2,
Q8HYW0	family with sequence similarity 13 member A(FAM13A)	Bos taurus			GO:0007165~signal transduction,			IPR000198:RhoGAP_dom,IPR008936:Rho_GTPase_activation_prot,IPR039102:FAM13,				SM00324:RhoGAP,					KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Rho-GAP,REGION:Disordered,
Q9NYF5	family with sequence similarity 13 member B(FAM13B)	Homo sapiens			GO:0007165~signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,	GO:0005096~GTPase activator activity,	IPR000198:RhoGAP_dom,IPR008936:Rho_GTPase_activation_prot,IPR039102:FAM13,				SM00324:RhoGAP,					KW-0175~Coiled coil,		KW-0343~GTPase activation,		COMPBIAS:Polar residues,DOMAIN:Rho-GAP,REGION:Disordered,
Q0V7M8	family with sequence similarity 167 member A(FAM167A)	Bos taurus						IPR024280:FAM167,									KW-0175~Coiled coil,				REGION:Disordered,
Q8BGZ2	family with sequence similarity 168, member A(Fam168a)	Mus musculus			GO:1905053~positive regulation of base-excision repair,			IPR029247:FAM168A/MANI,												KW-0007~Acetylation,KW-0488~Methylation,	REGION:Disordered,
Q8CHT6	family with sequence similarity 169, member B(Fam169b)	Mus musculus						IPR029625:FAM169,													COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q8BR63	family with sequence similarity 177, member A(Fam177a)	Mus musculus						IPR028260:FAM177,									KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,
Q8IW50	family with sequence similarity 219 member A(FAM219A)	Homo sapiens						IPR029339:FAM219,												KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
F1QN48	family with sequence similarity 53 member B(fam53b)	Danio rerio			GO:0006606~protein import into nucleus,GO:0016055~Wnt signaling pathway,GO:0031101~fin regeneration,GO:0048675~axon extension,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005634~nucleus,		IPR029356:FAM53,					KW-0879~Wnt signaling pathway,	KW-0539~Nucleus,							COMPBIAS:Polar residues,MOTIF:Nuclear localization signal,MUTAGEN:KRRR->EGGG: Abolishes nuclear localization and beta-catenin (ctnnb1) import into the nucleus.,REGION:Disordered,
A4QP72	family with sequence similarity 83 member D(fam83d)	Danio rerio			GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0032006~regulation of TOR signaling,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:1902480~protein localization to mitotic spindle,GO:1902808~positive regulation of cell cycle G1/S phase transition,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0097431~mitotic spindle pole,	GO:0019901~protein kinase binding,	IPR012461:FAM83_N,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,							COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q96I24	far upstream element binding protein 3(FUBP3)	Homo sapiens			GO:0006351~transcription, DNA-templated,GO:0008298~intracellular mRNA localization,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0016020~membrane,GO:0043025~neuronal cell body,GO:0043198~dendritic shaft,	GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR036612:KH_dom_type_1_sf,				SM00322:KH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:KH 1,DOMAIN:KH 2,DOMAIN:KH 3,DOMAIN:KH 4,REGION:Disordered,
P08836	farnesyl diphosphate synthase(FDPS)	Gallus gallus			GO:0006695~cholesterol biosynthetic process,GO:0008299~isoprenoid biosynthetic process,GO:0033384~geranyl diphosphate biosynthetic process,GO:0045337~farnesyl diphosphate biosynthetic process,	GO:0005737~cytoplasm,	GO:0004161~dimethylallyltranstransferase activity,GO:0004337~geranyltranstransferase activity,GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,GO:0046872~metal ion binding,	IPR000092:Polyprenyl_synt,IPR008949:Isoprenoid_synthase_dom_sf,IPR033749:Polyprenyl_synt_CS,IPR039702:FPS1-like,	gga00900:Terpenoid backbone biosynthesis,gga01100:Metabolic pathways,gga05164:Influenza A,				KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0414~Isoprene biosynthesis,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0808~Transferase,		MUTAGEN:F->A: Alters selectivity towards product chain length, so that geranylgeranyl diphosphate is produced.,MUTAGEN:F->S: Alters selectivity towards product chain length, so that geranylfarnesyl diphosphate is produced.,SITE:Important for determining product chain length,
P97577	fasciculation and elongation protein zeta 1(Fez1)	Rattus norvegicus			GO:0007005~mitochondrion organization,GO:0010976~positive regulation of neuron projection development,GO:0021766~hippocampus development,GO:0030010~establishment of cell polarity,GO:0051654~establishment of mitochondrion localization,GO:0070584~mitochondrion morphogenesis,GO:0071363~cellular response to growth factor stimulus,GO:1902902~negative regulation of autophagosome assembly,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0042995~cell projection,GO:0043025~neuronal cell body,	GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0043015~gamma-tubulin binding,	IPR011680:FEZ,	rno03250:Viral life cycle - HIV-1,				KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,REGION:Disordered,
O08914	fatty acid amide hydrolase(Faah)	Mus musculus		m_cb1rPathway:Metabolism of Anandamide, an Endogenous Cannabinoid,	GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0009062~fatty acid catabolic process,GO:0016042~lipid catabolic process,GO:0045907~positive regulation of vasoconstriction,GO:0052651~monoacylglycerol catabolic process,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0031090~organelle membrane,	GO:0004040~amidase activity,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0017064~fatty acid amide hydrolase activity,GO:0042802~identical protein binding,GO:0047372~acylglycerol lipase activity,	IPR020556:Amidase_CS,IPR023631:Amidase_dom,IPR036928:AS_sf,	mmu04723:Retrograde endocannabinoid signaling,		PIRSF001221:Amidase_fungi,		KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	ACT_SITE:Acyl-ester intermediate,ACT_SITE:Charge relay system,DOMAIN:Amidase,REGION:Disordered,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
Q99P61	fatty acid binding protein 3(Fabp3)	Ictidomys tridecemlineatus			GO:0015908~fatty acid transport,GO:0042750~hibernation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005504~fatty acid binding,GO:0008289~lipid binding,	IPR000463:Fatty_acid-bd,IPR000566:Lipocln_cytosolic_FA-bd_dom,IPR012674:Calycin,IPR031259:ILBP,					KW-0813~Transport,KW-0909~Hibernation,	KW-0963~Cytoplasm,				KW-0446~Lipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Cytosolic fatty-acid binding proteins,
Q09139	fatty acid binding protein 7(FABP7)	Bos taurus			GO:0015908~fatty acid transport,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005504~fatty acid binding,	IPR000463:Fatty_acid-bd,IPR000566:Lipocln_cytosolic_FA-bd_dom,IPR012674:Calycin,IPR031259:ILBP,	bta03320:PPAR signaling pathway,				KW-0813~Transport,	KW-0963~Cytoplasm,				KW-0446~Lipid-binding,		KW-0007~Acetylation,
P12276	fatty acid synthase(FASN)	Gallus gallus			GO:0006089~lactate metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0032100~positive regulation of appetite,	GO:0005737~cytoplasm,	GO:0003697~single-stranded DNA binding,GO:0004312~fatty acid synthase activity,GO:0004313~[acyl-carrier-protein] S-acetyltransferase activity,GO:0004314~[acyl-carrier-protein] S-malonyltransferase activity,GO:0004315~3-oxoacyl-[acyl-carrier-protein] synthase activity,GO:0004316~3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,GO:0004317~3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,GO:0008659~(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity,GO:0008693~3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016295~myristoyl-[acyl-carrier-protein] hydrolase activity,GO:0016296~palmitoyl-[acyl-carrier-protein] hydrolase activity,GO:0016491~oxidoreductase activity,GO:0016787~hydrolase activity,GO:0016829~lyase activity,GO:0031177~phosphopantetheine binding,GO:0047117~enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,GO:0047450~crotonoyl-[acyl-carrier-protein] hydratase activity,GO:0047451~3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,	IPR001031:Thioesterase,IPR001227:Ac_transferase_dom_sf,IPR006162:Ppantetheine_attach_site,IPR009081:PP-bd_ACP,IPR011032:GroES-like_sf,IPR013149:ADH-like_C,IPR013968:PKS_KR,IPR014030:Ketoacyl_synth_N,IPR014031:Ketoacyl_synth_C,IPR014043:Acyl_transferase,IPR016035:Acyl_Trfase/lysoPLipase,IPR016036:Malonyl_transacylase_ACP-bd,IPR016039:Thiolase-like,IPR018201:Ketoacyl_synth_AS,IPR020806:PKS_PP-bd,IPR020807:PKS_DH,IPR020841:PKS_Beta-ketoAc_synthase_dom,IPR020843:PKS_ER,IPR029058:AB_hydrolase,IPR029063:SAM-dependent_MTases_sf,IPR032821:PKS_assoc,IPR036291:NAD(P)-bd_dom_sf,IPR036736:ACP-like_sf,IPR042104:PKS_dehydratase_sf,IPR049391:FAS_pseudo-KR,	gga00061:Fatty acid biosynthesis,gga01100:Metabolic pathways,gga01212:Fatty acid metabolism,gga04910:Insulin signaling pathway,			SM00822:PKS_KR,SM00823:PKS_PP,SM00825:PKS_KS,SM00826:PKS_DH,SM00827:PKS_AT,SM00829:PKS_ER,	KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,					KW-0520~NAD,KW-0521~NADP,KW-0663~Pyridoxal phosphate,	KW-0378~Hydrolase,KW-0456~Lyase,KW-0511~Multifunctional enzyme,KW-0560~Oxidoreductase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0596~Phosphopantetheine,KW-0597~Phosphoprotein,KW-0702~S-nitrosylation,	ACT_SITE:For acyl/malonyl transferase activity,ACT_SITE:For beta-ketoacyl synthase activity,ACT_SITE:For thioesterase activity,ACT_SITE:Proton acceptor; for dehydratase activity,ACT_SITE:Proton donor; for dehydratase activity,COMPBIAS:Polar residues,DOMAIN:Carrier,DOMAIN:Ketosynthase family 3 (KS3),DOMAIN:PKS/mFAS DH,REGION:Acyl and malonyl transferases,REGION:Beta-ketoacyl reductase,REGION:C-terminal hotdog fold,REGION:Disordered,REGION:Enoyl reductase,REGION:N-terminal hotdog fold,REGION:Thioesterase,
Q04791	fatty acyl-CoA hydrolase precursor, medium chain-like(LOC101790670)	Anas platyrhynchos			GO:0006633~fatty acid biosynthetic process,		GO:0016787~hydrolase activity,	IPR002018:CarbesteraseB,IPR019819:Carboxylesterase_B_CS,IPR019826:Carboxylesterase_B_AS,IPR029058:AB_hydrolase,	apla00983:Drug metabolism - other enzymes,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,				KW-0732~Signal,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Acyl-ester intermediate,ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Carboxylesterase type B,
Q7ZXF5	fatty acyl-CoA reductase 1 L homeolog(far1.L)	Xenopus laevis			GO:0006629~lipid metabolic process,GO:0008611~ether lipid biosynthetic process,GO:0010025~wax biosynthetic process,GO:1901568~fatty acid derivative metabolic process,	GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0016020~membrane,	GO:0016491~oxidoreductase activity,GO:0080019~fatty-acyl-CoA reductase (alcohol-forming) activity,	IPR013120:Far_NAD-bd,IPR026055:FAR,IPR033640:FAR_C,IPR036291:NAD(P)-bd_dom_sf,	xla04146:Peroxisome,				KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0472~Membrane,KW-0576~Peroxisome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0521~NADP,	KW-0560~Oxidoreductase,		DOMAIN:Fatty acyl-CoA reductase C-terminal,DOMAIN:Thioester reductase (TE),TOPO_DOM:Cytoplasmic,TOPO_DOM:Peroxisomal,TRANSMEM:Helical,
Q8K1B8	fermitin family member 3(Fermt3)	Mus musculus			GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0030335~positive regulation of cell migration,GO:0033622~integrin activation,GO:0033632~regulation of cell-cell adhesion mediated by integrin,GO:0034446~substrate adhesion-dependent cell spreading,GO:0070527~platelet aggregation,	GO:0002102~podosome,GO:0030055~cell-substrate junction,GO:0042995~cell projection,GO:0070161~anchoring junction,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008289~lipid binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR035963:FERM_2,IPR037837:PH_Kindlin/fermitin,IPR037843:Kindlin/fermitin,IPR040790:Kindlin_2_N,	mmu04611:Platelet activation,			SM00233:PH,SM00295:B41,	KW-0130~Cell adhesion,	KW-0965~Cell junction,KW-0966~Cell projection,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Band 4.1,DOMAIN:FERM,DOMAIN:Kindlin-2 N-terminal,DOMAIN:PH,MUTAGEN:Q->A: Impairs ability to activate integrins.,REGION:Disordered,
P49946	ferritin heavy subunit(LOC100136564)	Salmo salar			GO:0006826~iron ion transport,GO:0006879~cellular iron ion homeostasis,GO:0006880~intracellular sequestering of iron ion,	GO:0005737~cytoplasm,	GO:0004322~ferroxidase activity,GO:0008198~ferrous iron binding,GO:0008199~ferric iron binding,	IPR001519:Ferritin,IPR008331:Ferritin_DPS_dom,IPR009040:Ferritin-like_diiron,IPR009078:Ferritin-like_SF,IPR012347:Ferritin-like,IPR014034:Ferritin_CS,	sasa04216:Ferroptosis,sasa04217:Necroptosis,				KW-0409~Iron storage,					KW-0408~Iron,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,		DOMAIN:Ferritin-like diiron,
P98133	fibrillin 1(FBN1)	Bos taurus			GO:0001501~skeletal system development,GO:0007507~heart development,GO:0009653~anatomical structure morphogenesis,GO:0033627~cell adhesion mediated by integrin,GO:0035582~sequestering of BMP in extracellular matrix,GO:0035583~sequestering of TGFbeta in extracellular matrix,GO:0043010~camera-type eye development,GO:0048048~embryonic eye morphogenesis,GO:0048050~post-embryonic eye morphogenesis,GO:2001205~negative regulation of osteoclast development,	GO:0001527~microfibril,GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0005178~integrin binding,GO:0005179~hormone activity,GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0008201~heparin binding,GO:0042802~identical protein binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR013032:EGF-like_CS,IPR017878:TB_dom,IPR018097:EGF_Ca-bd_CS,IPR024731:EGF_dom,IPR026823:cEGF,IPR036773:TB_dom_sf,IPR040872:Fibrillin_U_N,IPR049388:FBN_EGF_N,	bta04350:TGF-beta signaling pathway,		PIRSF036312:Fibrillin,	SM00179:EGF_CA,SM00181:EGF,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0372~Hormone,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Glc) serine,COMPBIAS:Pro residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10; calcium-binding,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13; calcium-binding,DOMAIN:EGF-like 14; calcium-binding,DOMAIN:EGF-like 15; calcium-binding,DOMAIN:EGF-like 16; calcium-binding,DOMAIN:EGF-like 17; calcium-binding,DOMAIN:EGF-like 18; calcium-binding,DOMAIN:EGF-like 19; calcium-binding,DOMAIN:EGF-like 2,DOMAIN:EGF-like 20; calcium-binding,DOMAIN:EGF-like 21; calcium-binding,DOMAIN:EGF-like 22; calcium-binding,DOMAIN:EGF-like 23; calcium-binding,DOMAIN:EGF-like 24; calcium-binding,DOMAIN:EGF-like 25; calcium-binding,DOMAIN:EGF-like 26; calcium-binding,DOMAIN:EGF-like 27; calcium-binding,DOMAIN:EGF-like 28; calcium-binding,DOMAIN:EGF-like 29; calcium-binding,DOMAIN:EGF-like 3,DOMAIN:EGF-like 30; calcium-binding,DOMAIN:EGF-like 31; calcium-binding,DOMAIN:EGF-like 32; calcium-binding,DOMAIN:EGF-like 33; calcium-binding,DOMAIN:EGF-like 34; calcium-binding,DOMAIN:EGF-like 35; calcium-binding,DOMAIN:EGF-like 36; calcium-binding,DOMAIN:EGF-like 37; calcium-binding,DOMAIN:EGF-like 38; calcium-binding,DOMAIN:EGF-like 39; calcium-binding,DOMAIN:EGF-like 40; calcium-binding,DOMAIN:EGF-like 41; calcium-binding,DOMAIN:EGF-like 42; calcium-binding,DOMAIN:EGF-like 43; calcium-binding,DOMAIN:EGF-like 44; calcium-binding,DOMAIN:EGF-like 45; calcium-binding,DOMAIN:EGF-like 46; calcium-binding,DOMAIN:EGF-like 47; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:EGF-like 9; calcium-binding,DOMAIN:TB,DOMAIN:TB 1,DOMAIN:TB 2,DOMAIN:TB 3,DOMAIN:TB 4,DOMAIN:TB 5,DOMAIN:TB 6,DOMAIN:TB 7,DOMAIN:TB 8,DOMAIN:TB 9,MOTIF:Cell attachment site,REGION:C-terminal domain,REGION:Disordered,REGION:Fibrillin unique N-terminal (FUN) domain,REGION:Hybrid domain 1,REGION:Hybrid domain 2,REGION:Interaction with MFAP4,REGION:N-terminal domain,SITE:Cleavage; by furin,
Q9ERW3	fibroblast growth factor 13(Fgf13)	Rattus norvegicus			GO:0000165~MAPK cascade,GO:0001764~neuron migration,GO:0006814~sodium ion transport,GO:0007026~negative regulation of microtubule depolymerization,GO:0007165~signal transduction,GO:0007399~nervous system development,GO:0007611~learning or memory,GO:0007612~learning,GO:0007613~memory,GO:0021766~hippocampus development,GO:0021795~cerebral cortex cell migration,GO:0022008~neurogenesis,GO:0045200~establishment of neuroblast polarity,GO:0046785~microtubule polymerization,GO:0048671~negative regulation of collateral sprouting,GO:0048755~branching morphogenesis of a nerve,GO:0072659~protein localization to plasma membrane,GO:0098909~regulation of cardiac muscle cell action potential involved in regulation of contraction,GO:1904862~inhibitory synapse assembly,GO:1905150~regulation of voltage-gated sodium channel activity,GO:1905152~positive regulation of voltage-gated sodium channel activity,GO:1990834~response to odorant,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0014704~intercalated disc,GO:0016328~lateral plasma membrane,GO:0030175~filopodium,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0042383~sarcolemma,GO:0043005~neuron projection,	GO:0008017~microtubule binding,GO:0008083~growth factor activity,GO:0017080~sodium channel regulator activity,GO:0044325~ion channel binding,GO:0048487~beta-tubulin binding,	IPR002209:Fibroblast_GF_fam,IPR008996:IL1/FGF,				SM00442:FGF,	KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Mediates interaction with sodium channels,REGION:Mediates targeting to the nucleus,
O95750	fibroblast growth factor 19(FGF19)	Homo sapiens			GO:0001934~positive regulation of protein phosphorylation,GO:0007399~nervous system development,GO:0008284~positive regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0009887~animal organ morphogenesis,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030154~cell differentiation,GO:0030334~regulation of cell migration,GO:0046326~positive regulation of glucose import,GO:0046330~positive regulation of JNK cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070858~negative regulation of bile acid biosynthetic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0005104~fibroblast growth factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR002209:Fibroblast_GF_fam,IPR008996:IL1/FGF,IPR035444:FGF15/19/21,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05218:Melanoma,hsa05224:Breast cancer,hsa05226:Gastric cancer,		PIRSF037961:FGF-19_FGF-21,	SM00442:FGF,		KW-0964~Secreted,			KW-0732~Signal,		KW-0339~Growth factor,	KW-1015~Disulfide bond,
P13109	fibroblast growth factor 2(Fgf2)	Rattus norvegicus			GO:0001525~angiogenesis,GO:0001649~osteoblast differentiation,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001759~organ induction,GO:0001934~positive regulation of protein phosphorylation,GO:0001935~endothelial cell proliferation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002042~cell migration involved in sprouting angiogenesis,GO:0002052~positive regulation of neuroblast proliferation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006661~phosphatidylinositol biosynthetic process,GO:0007165~signal transduction,GO:0007405~neuroblast proliferation,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0009792~embryo development ending in birth or egg hatching,GO:0009887~animal organ morphogenesis,GO:0010001~glial cell differentiation,GO:0010595~positive regulation of endothelial cell migration,GO:0010628~positive regulation of gene expression,GO:0010764~negative regulation of fibroblast migration,GO:0014843~growth factor dependent regulation of skeletal muscle satellite cell proliferation,GO:0021762~substantia nigra development,GO:0021930~cerebellar granule cell precursor proliferation,GO:0021940~positive regulation of cerebellar granule cell precursor proliferation,GO:0030154~cell differentiation,GO:0030214~hyaluronan catabolic process,GO:0030324~lung development,GO:0032958~inositol phosphate biosynthetic process,GO:0038001~paracrine signaling,GO:0042060~wound healing,GO:0042491~auditory receptor cell differentiation,GO:0042660~positive regulation of cell fate specification,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043491~protein kinase B signaling,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0043537~negative regulation of blood vessel endothelial cell migration,GO:0043542~endothelial cell migration,GO:0045609~positive regulation of auditory receptor cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046668~regulation of retinal cell programmed cell death,GO:0048513~animal organ development,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048678~response to axon injury,GO:0048731~system development,GO:0048863~stem cell differentiation,GO:0048864~stem cell development,GO:0050673~epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050918~positive chemotaxis,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051726~regulation of cell cycle,GO:0051781~positive regulation of cell division,GO:0051897~positive regulation of protein kinase B signaling,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060070~canonical Wnt signaling pathway,GO:0060128~corticotropin hormone secreting cell differentiation,GO:0060129~thyroid-stimulating hormone-secreting cell differentiation,GO:0060563~neuroepithelial cell differentiation,GO:0060591~chondroblast differentiation,GO:0060644~mammary gland epithelial cell differentiation,GO:0060978~angiogenesis involved in coronary vascular morphogenesis,GO:0061045~negative regulation of wound healing,GO:0070371~ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071260~cellular response to mechanical stimulus,GO:0072089~stem cell proliferation,GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1902748~positive regulation of lens fiber cell differentiation,GO:1902913~positive regulation of neuroepithelial cell differentiation,GO:1903672~positive regulation of sprouting angiogenesis,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:1904977~lymphatic endothelial cell migration,GO:1905278~positive regulation of epithelial tube formation,GO:1905564~positive regulation of vascular endothelial cell proliferation,GO:2000544~regulation of endothelial cell chemotaxis to fibroblast growth factor,GO:2000546~positive regulation of endothelial cell chemotaxis to fibroblast growth factor,GO:2000573~positive regulation of DNA biosynthetic process,GO:2000647~negative regulation of stem cell proliferation,GO:2000648~positive regulation of stem cell proliferation,GO:2000738~positive regulation of stem cell differentiation,GO:2001028~positive regulation of endothelial cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005104~fibroblast growth factor receptor binding,GO:0005125~cytokine activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0019956~chemokine binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0042056~chemoattractant activity,GO:0042802~identical protein binding,GO:0090722~receptor-receptor interaction,	IPR002209:Fibroblast_GF_fam,IPR008996:IL1/FGF,	rno01521:EGFR tyrosine kinase inhibitor resistance,rno04010:MAPK signaling pathway,rno04014:Ras signaling pathway,rno04015:Rap1 signaling pathway,rno04020:Calcium signaling pathway,rno04151:PI3K-Akt signaling pathway,rno04550:Signaling pathways regulating pluripotency of stem cells,rno04810:Regulation of actin cytoskeleton,rno05167:Kaposi sarcoma-associated herpesvirus infection,rno05200:Pathways in cancer,rno05205:Proteoglycans in cancer,rno05207:Chemical carcinogenesis - receptor activation,rno05218:Melanoma,rno05224:Breast cancer,rno05226:Gastric cancer,			SM00442:FGF,	KW-0037~Angiogenesis,KW-0221~Differentiation,	KW-0539~Nucleus,KW-0964~Secreted,					KW-0217~Developmental protein,KW-0339~Growth factor,KW-0358~Heparin-binding,KW-0497~Mitogen,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),REGION:Disordered,REGION:Heparin-binding,SITE:Important for interaction with integrin,
P48805	fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene) L homeolog(fgf4.L)	Xenopus laevis			GO:0030154~cell differentiation,GO:0051781~positive regulation of cell division,GO:0080159~zygote elongation,	GO:0005576~extracellular region,GO:0016020~membrane,	GO:0008083~growth factor activity,	IPR002209:Fibroblast_GF_fam,IPR008996:IL1/FGF,	xla04010:MAPK signaling pathway,xla04020:Calcium signaling pathway,xla04810:Regulation of actin cytoskeleton,			SM00442:FGF,	KW-0221~Differentiation,	KW-0472~Membrane,KW-0964~Secreted,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0339~Growth factor,KW-0497~Mitogen,KW-9996~Developmental protein,		TRANSMEM:Helical,
P07589	fibronectin 1(FN1)	Bos taurus			GO:0001525~angiogenesis,GO:0001932~regulation of protein phosphorylation,GO:0006953~acute-phase response,GO:0007044~cell-substrate junction assembly,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007161~calcium-independent cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007399~nervous system development,GO:0007507~heart development,GO:0008360~regulation of cell shape,GO:0010628~positive regulation of gene expression,GO:0033622~integrin activation,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0042060~wound healing,GO:0045773~positive regulation of axon extension,GO:0048146~positive regulation of fibroblast proliferation,GO:0051702~interaction with symbiont,GO:0051897~positive regulation of protein kinase B signaling,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0071635~negative regulation of transforming growth factor beta production,GO:1901166~neural crest cell migration involved in autonomic nervous system development,GO:1904237~positive regulation of substrate-dependent cell migration, cell attachment to substrate,	GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0005178~integrin binding,GO:0008201~heparin binding,GO:0016504~peptidase activator activity,GO:0042802~identical protein binding,GO:0043394~proteoglycan binding,GO:0097718~disordered domain specific binding,	IPR000083:Fibronectin_type1,IPR000562:FN_type2_dom,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR013806:Kringle-like,IPR036116:FN3_sf,IPR036943:FN_type2_sf,	bta04151:PI3K-Akt signaling pathway,bta04510:Focal adhesion,bta04512:ECM-receptor interaction,bta04810:Regulation of actin cytoskeleton,bta04933:AGE-RAGE signaling pathway in diabetic complications,bta05100:Bacterial invasion of epithelial cells,bta05135:Yersinia infection,bta05146:Amoebiasis,bta05165:Human papillomavirus infection,bta05200:Pathways in cancer,bta05205:Proteoglycans in cancer,bta05222:Small cell lung cancer,			SM00058:FN1,SM00059:FN2,SM00060:FN3,	KW-0011~Acute phase,KW-0037~Angiogenesis,KW-0130~Cell adhesion,KW-0133~Cell shape,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,		KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-0558~Oxidation,KW-0597~Phosphoprotein,KW-0765~Sulfation,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) threonine,COMPBIAS:Basic and acidic residues,CROSSLNK:Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?),DISULFID:Interchain (with C-2458),DISULFID:Interchain (with C-2462),DOMAIN:Fibronectin type-I,DOMAIN:Fibronectin type-I 1,DOMAIN:Fibronectin type-I 10,DOMAIN:Fibronectin type-I 11,DOMAIN:Fibronectin type-I 12,DOMAIN:Fibronectin type-I 2,DOMAIN:Fibronectin type-I 3,DOMAIN:Fibronectin type-I 4,DOMAIN:Fibronectin type-I 5,DOMAIN:Fibronectin type-I 6,DOMAIN:Fibronectin type-I 7,DOMAIN:Fibronectin type-I 8,DOMAIN:Fibronectin type-I 9,DOMAIN:Fibronectin type-II,DOMAIN:Fibronectin type-II 1,DOMAIN:Fibronectin type-II 2,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 10,DOMAIN:Fibronectin type-III 11,DOMAIN:Fibronectin type-III 12,DOMAIN:Fibronectin type-III 13; extra domain A,DOMAIN:Fibronectin type-III 14,DOMAIN:Fibronectin type-III 15,DOMAIN:Fibronectin type-III 16,DOMAIN:Fibronectin type-III 17,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,DOMAIN:Fibronectin type-III 7,DOMAIN:Fibronectin type-III 8; extra domain B,DOMAIN:Fibronectin type-III 9,MOTIF:Cell attachment site,REGION:Binds to FBLN1,REGION:Cell-attachment,REGION:Collagen-binding,REGION:Critical for collagen binding,REGION:Disordered,REGION:Fibrin- and heparin-binding 1,REGION:Fibrin-binding 2,REGION:Heparin-binding 2,REGION:V region (type III connecting segment, IIICS),SITE:Important for superfibronectin formation,
P11722	fibronectin 1(FN1)	Gallus gallus			GO:0001932~regulation of protein phosphorylation,GO:0006929~substrate-dependent cell migration,GO:0006953~acute-phase response,GO:0007044~cell-substrate junction assembly,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007161~calcium-independent cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007399~nervous system development,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0008360~regulation of cell shape,GO:0010628~positive regulation of gene expression,GO:0016477~cell migration,GO:0031589~cell-substrate adhesion,GO:0033622~integrin activation,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0042060~wound healing,GO:0045176~apical protein localization,GO:0045773~positive regulation of axon extension,GO:0048041~focal adhesion assembly,GO:0048146~positive regulation of fibroblast proliferation,GO:0051702~interaction with symbiont,GO:0051897~positive regulation of protein kinase B signaling,GO:0060974~cell migration involved in heart formation,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0071635~negative regulation of transforming growth factor beta production,GO:0090245~axis elongation involved in somitogenesis,GO:1901166~neural crest cell migration involved in autonomic nervous system development,GO:1904237~positive regulation of substrate-dependent cell migration, cell attachment to substrate,	GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005604~basement membrane,GO:0005614~interstitial matrix,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0031012~extracellular matrix,GO:0045178~basal part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0099512~supramolecular fiber,	GO:0002020~protease binding,GO:0003677~DNA binding,GO:0005178~integrin binding,GO:0008201~heparin binding,GO:0016504~peptidase activator activity,GO:0042802~identical protein binding,GO:0043394~proteoglycan binding,	IPR000083:Fibronectin_type1,IPR000562:FN_type2_dom,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR013806:Kringle-like,IPR036116:FN3_sf,IPR036943:FN_type2_sf,	gga04510:Focal adhesion,gga04512:ECM-receptor interaction,gga04810:Regulation of actin cytoskeleton,			SM00058:FN1,SM00059:FN2,SM00060:FN3,	KW-0011~Acute phase,KW-0130~Cell adhesion,KW-0133~Cell shape,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,		KW-0238~DNA-binding,KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0765~Sulfation,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-I,DOMAIN:Fibronectin type-I 1,DOMAIN:Fibronectin type-I 10,DOMAIN:Fibronectin type-I 11,DOMAIN:Fibronectin type-I 12,DOMAIN:Fibronectin type-I 2,DOMAIN:Fibronectin type-I 3,DOMAIN:Fibronectin type-I 4,DOMAIN:Fibronectin type-I 5,DOMAIN:Fibronectin type-I 6,DOMAIN:Fibronectin type-I 7,DOMAIN:Fibronectin type-I 8,DOMAIN:Fibronectin type-I 9,DOMAIN:Fibronectin type-II,DOMAIN:Fibronectin type-II 1,DOMAIN:Fibronectin type-II 2,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 10,DOMAIN:Fibronectin type-III 11,DOMAIN:Fibronectin type-III 12,DOMAIN:Fibronectin type-III 13,DOMAIN:Fibronectin type-III 13; extra domain A,DOMAIN:Fibronectin type-III 14,DOMAIN:Fibronectin type-III 15,DOMAIN:Fibronectin type-III 16,DOMAIN:Fibronectin type-III 17,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,DOMAIN:Fibronectin type-III 7,DOMAIN:Fibronectin type-III 8,DOMAIN:Fibronectin type-III 8; extra domain B,DOMAIN:Fibronectin type-III 9,MOTIF:Cell attachment site,REGION:Cell-attachment,REGION:Collagen-binding,REGION:Disordered,REGION:Fibrin- and heparin-binding 1,REGION:Fibrin-binding 2,REGION:Heparin-binding 2,REGION:V region (type III connecting segment, IIICS),
Q2Q0I9	fibronectin type III domain containing 1(Fndc1)	Rattus norvegicus			GO:0001934~positive regulation of protein phosphorylation,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0051223~regulation of protein transport,GO:0071456~cellular response to hypoxia,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0031966~mitochondrial membrane,		IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR049109:TARSH/FNDC1_C,				SM00060:FN3,		KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,REGION:Disordered,
Q5VTL7	fibronectin type III domain containing 7(FNDC7)	Homo sapiens				GO:0005576~extracellular region,		IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,				SM00060:FN3,		KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,DOMAIN:Fibronectin type-III 7,DOMAIN:Fibronectin type-III 8,
P21333	filamin A(FLNA)	Homo sapiens			GO:0001525~angiogenesis,GO:0001837~epithelial to mesenchymal transition,GO:0001974~blood vessel remodeling,GO:0003007~heart morphogenesis,GO:0007195~adenylate cyclase-inhibiting dopamine receptor signaling pathway,GO:0007597~blood coagulation, intrinsic pathway,GO:0010572~positive regulation of platelet activation,GO:0010977~negative regulation of neuron projection development,GO:0016479~negative regulation of transcription from RNA polymerase I promoter,GO:0021943~formation of radial glial scaffolds,GO:0021987~cerebral cortex development,GO:0030036~actin cytoskeleton organization,GO:0030334~regulation of cell migration,GO:0032233~positive regulation of actin filament bundle assembly,GO:0034394~protein localization to cell surface,GO:0035855~megakaryocyte development,GO:0042177~negative regulation of protein catabolic process,GO:0042307~positive regulation of protein import into nucleus,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043066~negative regulation of apoptotic process,GO:0043113~receptor clustering,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0044319~wound healing, spreading of cells,GO:0045022~early endosome to late endosome transport,GO:0045184~establishment of protein localization,GO:0045216~cell-cell junction organization,GO:0048680~positive regulation of axon regeneration,GO:0050808~synapse organization,GO:0050821~protein stabilization,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051220~cytoplasmic sequestering of protein,GO:0051764~actin crosslink formation,GO:0060271~cilium assembly,GO:0070527~platelet aggregation,GO:0071526~semaphorin-plexin signaling pathway,GO:0072659~protein localization to plasma membrane,GO:0090042~tubulin deacetylation,GO:0090307~mitotic spindle assembly,GO:0097368~establishment of Sertoli cell barrier,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1901381~positive regulation of potassium ion transmembrane transport,GO:1902396~protein localization to bicellular tight junction,GO:1905000~regulation of membrane repolarization during atrial cardiac muscle cell action potential,GO:1905031~regulation of membrane repolarization during cardiac muscle cell action potential,GO:2000179~positive regulation of neural precursor cell proliferation,GO:2001046~positive regulation of integrin-mediated signaling pathway,GO:2001224~positive regulation of neuron migration,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030018~Z disc,GO:0030863~cortical cytoskeleton,GO:0031523~Myb complex,GO:0032432~actin filament bundle,GO:0043198~dendritic shaft,GO:0043204~perikaryon,GO:0044295~axonal growth cone,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0097440~apical dendrite,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,GO:1990779~glycoprotein Ib-IX-V complex,	GO:0001664~G-protein coupled receptor binding,GO:0003723~RNA binding,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0015459~potassium channel regulator activity,GO:0019900~kinase binding,GO:0031267~small GTPase binding,GO:0034988~Fc-gamma receptor I complex binding,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,GO:0045296~cadherin binding,GO:0046332~SMAD binding,GO:0051015~actin filament binding,GO:0051020~GTPase binding,	IPR001298:Filamin/ABP280_rpt,IPR001589:Actinin_actin-bd_CS,IPR001715:CH_dom,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR017868:Filamin/ABP280_repeat-like,IPR036872:CH_dom_sf,IPR044801:Filamin,	hsa04010:MAPK signaling pathway,hsa04510:Focal adhesion,hsa05132:Salmonella infection,hsa05205:Proteoglycans in cancer,	300048~Congenital short bowel syndrome,300048~Intestinal pseudoobstruction, neuronal,300049~Heterotopia, periventricular, 1,300244~Terminal osseous dysplasia,300321~FG syndrome 2,304120~Otopalatodigital syndrome, type II,305620~Frontometaphyseal dysplasia 1,309350~Melnick-Needles syndrome,311300~Otopalatodigital syndrome, type I,314400~Cardiac valvular dysplasia, X-linked,		SM00033:CH,SM00557:IG_FLMN,	KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,		KW-0209~Deafness,KW-0225~Disease variant,	KW-0677~Repeat,		KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Calponin-homology (CH),DOMAIN:Calponin-homology (CH) 1,DOMAIN:Calponin-homology (CH) 2,MUTAGEN:K->R: Abrogates ASB2alpha-mediated degradation without altering ASB2alpha binding; when associated with R-42 and R-135.,MUTAGEN:K->R: Abrogates ASB2alpha-mediated degradation without altering ASB2alpha binding; when associated with R-42 and R-43.,MUTAGEN:K->R: Abrogates ASB2alpha-mediated degradation without altering ASB2alpha binding; when associated with R-43 and R-135.,REGION:Actin-binding,REGION:Disordered,REGION:Hinge 1,REGION:Hinge 2,REGION:Interaction with furin,REGION:Self-association site, tail,REPEAT:Filamin,REPEAT:Filamin 1,REPEAT:Filamin 10,REPEAT:Filamin 11,REPEAT:Filamin 12,REPEAT:Filamin 13,REPEAT:Filamin 14,REPEAT:Filamin 15,REPEAT:Filamin 16,REPEAT:Filamin 17,REPEAT:Filamin 18,REPEAT:Filamin 19,REPEAT:Filamin 2,REPEAT:Filamin 20,REPEAT:Filamin 21,REPEAT:Filamin 22,REPEAT:Filamin 23,REPEAT:Filamin 24,REPEAT:Filamin 3,REPEAT:Filamin 4,REPEAT:Filamin 5,REPEAT:Filamin 6,REPEAT:Filamin 7,REPEAT:Filamin 8,REPEAT:Filamin 9,SITE:Cleavage; by calpain,
A1IGX5	fin bud initiation factor b(fibinb)	Danio rerio			GO:0035118~embryonic pectoral fin morphogenesis,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,		IPR026772:Fibin,						KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,
Q5I4H3	flap structure-specific endonuclease 1(fen1)	Xiphophorus maculatus			GO:0006284~base-excision repair,GO:0043137~DNA replication, removal of RNA primer,GO:0060041~retina development in camera-type eye,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,	GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0004523~RNA-DNA hybrid ribonuclease activity,GO:0008409~5'-3' exonuclease activity,GO:0017108~5'-flap endonuclease activity,GO:0030145~manganese ion binding,	IPR002421:5-3_exonuclease,IPR006084:XPG/Rad2,IPR006085:XPG_DNA_repair_N,IPR006086:XPG-I_dom,IPR008918:HhH2,IPR019974:XPG_CS,IPR023426:Flap_endonuc,IPR029060:PIN-like_dom_sf,IPR036279:5-3_exonuclease_C_sf,	xma03030:DNA replication,xma03410:Base excision repair,xma03450:Non-homologous end-joining,			SM00279:HhH2,SM00475:53EXOc,SM00484:XPGI,SM00485:XPGN,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0496~Mitochondrion,KW-0539~Nucleus,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0255~Endonuclease,KW-0269~Exonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,REGION:I-domain,REGION:Interaction with PCNA,REGION:N-domain,
Q8K2I3	flavin containing monooxygenase 2(Fmo2)	Mus musculus			GO:0006082~organic acid metabolic process,GO:0006739~NADP metabolic process,GO:0006805~xenobiotic metabolic process,GO:0009404~toxin metabolic process,GO:0046322~negative regulation of fatty acid oxidation,GO:0070995~NADPH oxidation,GO:0072592~oxygen metabolic process,GO:0097009~energy homeostasis,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0004499~N,N-dimethylaniline monooxygenase activity,GO:0016491~oxidoreductase activity,GO:0047822~hypotaurine dehydrogenase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR000960:Flavin_mOase,IPR002254:Flavin_mOase_2,IPR020946:Flavin_mOase-like,IPR036188:FAD/NAD-bd_sf,	mmu00430:Taurine and hypotaurine metabolism,mmu00982:Drug metabolism - cytochrome P450,mmu01100:Metabolic pathways,		PIRSF000332:FMO,			KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0274~FAD,KW-0285~Flavoprotein,KW-0460~Magnesium,KW-0521~NADP,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),TRANSMEM:Helical,
P97872	flavin containing monooxygenase 5(Fmo5)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0070995~NADPH oxidation,GO:0090181~regulation of cholesterol metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004031~aldehyde oxidase activity,GO:0004497~monooxygenase activity,GO:0004499~N,N-dimethylaniline monooxygenase activity,GO:0016174~NAD(P)H oxidase activity,GO:0016491~oxidoreductase activity,GO:0047822~hypotaurine dehydrogenase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR000960:Flavin_mOase,IPR002257:Flavin_mOase_5,IPR020946:Flavin_mOase-like,IPR036188:FAD/NAD-bd_sf,	mmu00430:Taurine and hypotaurine metabolism,mmu00982:Drug metabolism - cytochrome P450,mmu01100:Metabolic pathways,		PIRSF000332:FMO,		KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0274~FAD,KW-0285~Flavoprotein,KW-0521~NADP,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	TRANSMEM:Helical,
Q98TZ8	flotillin 2a(flot2a)	Danio rerio			GO:0007155~cell adhesion,GO:0045661~regulation of myoblast differentiation,GO:0072659~protein localization to plasma membrane,GO:1904086~regulation of epiboly involved in gastrulation with mouth forming second,GO:2000047~regulation of cell-cell adhesion mediated by cadherin,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016600~flotillin complex,GO:0030139~endocytic vesicle,GO:0031410~cytoplasmic vesicle,		IPR001107:Band_7,IPR027705:Flotillin_fam,IPR031905:Flotillin_C,IPR036013:Band_7/SPFH_dom_sf,	dre04910:Insulin signaling pathway,			SM00244:PHB,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0967~Endosome,			KW-0175~Coiled coil,			KW-0449~Lipoprotein,KW-0564~Palmitate,	DOMAIN:Band 7,LIPID:S-palmitoyl cysteine,
E7FGT5	focadhesin(focad)	Danio rerio			GO:0060147~regulation of posttranscriptional gene silencing,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0070161~anchoring junction,		IPR016024:ARM-type_fold,IPR021392:Focadhesin_C,IPR022542:FOCAD/RST1_DUF3730,IPR045163:Focadhesin/RST1,						KW-0963~Cytoplasm,KW-0965~Cell junction,							DOMAIN:DUF3730,DOMAIN:Focadhesin C-terminal,REGION:Disordered,
Q8TF40	folliculin interacting protein 1(FNIP1)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001783~B cell apoptotic process,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002327~immature B cell differentiation,GO:0002904~positive regulation of B cell apoptotic process,GO:0008285~negative regulation of cell proliferation,GO:0009267~cellular response to starvation,GO:0030183~B cell differentiation,GO:0031334~positive regulation of protein complex assembly,GO:0031929~TOR signaling,GO:0032007~negative regulation of TOR signaling,GO:0032008~positive regulation of TOR signaling,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:1904263~positive regulation of TORC1 signaling,GO:1905672~negative regulation of lysosome organization,GO:2000973~regulation of pro-B cell differentiation,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0019899~enzyme binding,GO:0042030~ATPase inhibitor activity,GO:0046872~metal ion binding,GO:0051087~chaperone binding,	IPR026156:FNIP_fam,IPR028084:FNIP_N_dom,IPR028085:FNIP_mid_dom,IPR028086:FNIP_C_dom,IPR037545:DENN_FNIP1/2,	hsa04150:mTOR signaling pathway,	619705~Immunodeficiency 93 and hypertrophic cardiomyopathy,				KW-0458~Lysosome,KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,		KW-0479~Metal-binding,KW-0862~Zinc,		KW-0325~Glycoprotein,KW-0558~Oxidation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CARBOHYD:O-linked (GlcNAc) serine; alternate,COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:UDENN FNIP1/2-type,DOMAIN:cDENN FNIP1/2-type,DOMAIN:dDENN FNIP1/2-type,DOMAIN:uDENN FNIP1/2-type,MOTIF:Cys degron,MUTAGEN:K->R: Impaired ubiquitination, leading to increased stability.,MUTAGEN:K->R: No effect on ubiquitination and protein stability.,MUTAGEN:S->A: Impaired phosphorylation by CK2 and interaction with HSP90AA1/Hsp90.,MUTAGEN:S->A: In SA5 mutant; Abolishes phosphorylation by AMPK, leading to activation of the non-canonical mTORC1 signaling; when associated with 230-A--A-232, A-261 and A-593.,MUTAGEN:S->A: In SA5 mutant; Abolishes phosphorylation by AMPK, leading to activation of the non-canonical mTORC1 signaling; when associated with A-220, 230-A--A-232 and A-261.,MUTAGEN:S->A: In SA5 mutant; Abolishes phosphorylation by AMPK, leading to activation of the non-canonical mTORC1 signaling; when associated with A-220, 230-A--A-232 and A-593.,MUTAGEN:SAS->AAA: In SA5 mutant; Abolishes phosphorylation by AMPK, leading to activation of the non-canonical mTORC1 signaling; when associated with A-220, A-261 and A-593.,MUTAGEN:SSDSALGDSES->EDEALGDEEE: Mimics phosphorylation status; leading to inhibit ATPase activity of HSP90AA1/Hsp90.,REGION:Disordered,REGION:Interaction with HSP90AA1,REGION:KY-finger,
Q8BFR2	follistatin-like 5(Fstl5)	Mus musculus			GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0030510~regulation of BMP signaling pathway,	GO:0005576~extracellular region,	GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR002048:EF_hand_dom,IPR002350:Kazal_dom,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR011044:Quino_amine_DH_bsu,IPR011992:EF-hand-dom_pair,IPR013783:Ig-like_fold,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR018247:EF_Hand_1_Ca_BS,IPR036058:Kazal_dom_sf,IPR036179:Ig-like_dom_sf,				SM00280:KAZAL,SM00408:IGc2,SM00409:IG,		KW-0964~Secreted,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:Ig-like,DOMAIN:Ig-like 1,DOMAIN:Ig-like 2,DOMAIN:Kazal-like,
A6H751	folylpolyglutamate synthase(FPGS)	Bos taurus			GO:0006536~glutamate metabolic process,GO:0006730~one-carbon metabolic process,GO:0046901~tetrahydrofolylpolyglutamate biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0004326~tetrahydrofolylpolyglutamate synthase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR001645:Folylpolyglutamate_synth,IPR013221:Mur_ligase_cen,IPR018109:Folylpolyglutamate_synth_CS,IPR023600:Folylpolyglutamate_synth_euk,IPR036565:Mur-like_cat_sf,IPR036615:Mur_ligase_C_dom_sf,	bta00790:Folate biosynthesis,bta01100:Metabolic pathways,bta01240:Biosynthesis of cofactors,bta01523:Antifolate resistance,		PIRSF038895:FPGS,		KW-0554~One-carbon metabolism,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0597~Phosphoprotein,	DOMAIN:Mur ligase central,REGION:Disordered,TRANSIT:Mitochondrion,
O42097	forkhead box A2(foxa2)	Oryzias latipes			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009653~anatomical structure morphogenesis,GO:0030154~cell differentiation,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0043565~sequence-specific DNA binding,	IPR001766:Fork_head_dom,IPR013638:Fork-head_N,IPR018122:TF_fork_head_CS_1,IPR018533:Forkhead_box_C,IPR030456:TF_fork_head_CS_2,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,				SM00339:FH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,		COMPBIAS:Polar residues,DNA_BIND:Fork-head,DOMAIN:Fork-head,REGION:Disordered,
A1L1S5	forkhead box F1(foxf1)	Danio rerio			GO:0002040~sprouting angiogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009887~animal organ morphogenesis,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001766:Fork_head_dom,IPR018122:TF_fork_head_CS_1,IPR030456:TF_fork_head_CS_2,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,				SM00339:FH,		KW-0539~Nucleus,					KW-0238~DNA-binding,		COMPBIAS:Polar residues,DNA_BIND:Fork-head,REGION:Disordered,
Q01167	forkhead box K2(FOXK2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001678~cellular glucose homeostasis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010507~negative regulation of autophagy,GO:0010906~regulation of glucose metabolic process,GO:0042594~response to starvation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061621~canonical glycolysis,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0043231~intracellular membrane-bounded organelle,	GO:0000287~magnesium ion binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000253:FHA_dom,IPR001766:Fork_head_dom,IPR008984:SMAD_FHA_dom_sf,IPR018122:TF_fork_head_CS_1,IPR030456:TF_fork_head_CS_2,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR047397:FH_FOXK2,IPR047398:FHA_FOXK2,	hsa03083:Polycomb repressive complex,			SM00240:FHA,SM00339:FH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:Fork-head,DOMAIN:FHA,DOMAIN:Fork-head,MUTAGEN:C->A: No effect on interaction with DVL2.,MUTAGEN:F->A: Abolishes interaction with DVL2 and SUDS3 as well as DVL2 nuclear translocation.,MUTAGEN:G->A: No effect on interaction with DVL2.,MUTAGEN:H->A: No effect on interaction with DVL2.,MUTAGEN:I->A: No effect on interaction with DVL2.,MUTAGEN:K->A: Decreases DNA-binding to 20%.,MUTAGEN:K->A: Decreases DNA-binding to 25%.,MUTAGEN:K->A: Decreases DNA-binding to 40%.,MUTAGEN:K->A: No effect on interaction with DVL2.,MUTAGEN:K->R: Abolished SUMOylation; when associated with R-527.,MUTAGEN:K->R: Abolished SUMOylation; when associated with R-633.,MUTAGEN:L->A: Abolishes interaction with DVL2 and SUDS3 as well as DVL2 nuclear translocation.,MUTAGEN:L->A: No effect on interaction with DVL2.,MUTAGEN:P->A: Highly reduces interaction with DVL2.,MUTAGEN:P->A: No effect on interaction with DVL2.,MUTAGEN:Q->A: No effect on interaction with DVL2.,MUTAGEN:R->A: Abolishes DNA-binding.,MUTAGEN:R->A: No effect on interaction with DVL2.,MUTAGEN:R->A: Reduced interaction with BAP1.,MUTAGEN:S->A: Decreased phosphorylation leading to increased stability of the protein; when associated with A-373.,MUTAGEN:S->A: Decreased phosphorylation leading to increased stability of the protein; when associated with A-428.,MUTAGEN:S->A: Decreases DNA-binding to 70%.,MUTAGEN:S->A: No effect on interaction with DVL2.,MUTAGEN:S->D: Phosphomimetic mutant; decreased phosphorylation leading to decreased stability of the protein; when associated with D-373.,MUTAGEN:S->D: Phosphomimetic mutant; decreased phosphorylation leading to decreased stability of the protein; when associated with D-428.,MUTAGEN:T->A: No effect on interaction with DVL2.,REGION:DNA-binding; major groove,REGION:DNA-binding; minor groove,REGION:Disordered,REGION:Required for interaction with DVL2 and SUDS3,
A3RK74	forkhead box O1 a(foxo1a)	Danio rerio			GO:0001945~lymph vessel development,GO:0006094~gluconeogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0048659~smooth muscle cell proliferation,GO:0048745~smooth muscle tissue development,GO:0051145~smooth muscle cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001766:Fork_head_dom,IPR030456:TF_fork_head_CS_2,IPR032067:FOXO-TAD,IPR032068:FOXO_KIX-bd,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR047408:FH_FOXO1,	dre04068:FoxO signaling pathway,dre04218:Cellular senescence,dre04910:Insulin signaling pathway,			SM00339:FH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0238~DNA-binding,		COMPBIAS:Polar residues,DNA_BIND:Fork-head,REGION:Disordered,
P0CF24	forkhead box P2(Foxp2)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007519~skeletal muscle tissue development,GO:0009791~post-embryonic development,GO:0010467~gene expression,GO:0021549~cerebellum development,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021757~caudate nucleus development,GO:0021758~putamen development,GO:0021987~cerebral cortex development,GO:0030324~lung development,GO:0030900~forebrain development,GO:0033574~response to testosterone,GO:0042297~vocal learning,GO:0043010~camera-type eye development,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048286~lung alveolus development,GO:0048745~smooth muscle tissue development,GO:0050679~positive regulation of epithelial cell proliferation,GO:0060013~righting reflex,GO:0060501~positive regulation of epithelial cell proliferation involved in lung morphogenesis,GO:0060502~epithelial cell proliferation involved in lung morphogenesis,GO:0071625~vocalization behavior,GO:0098582~innate vocalization behavior,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001221~transcription cofactor binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0050681~androgen receptor binding,	IPR001766:Fork_head_dom,IPR030456:TF_fork_head_CS_2,IPR032354:FOXP-CC,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR047412:FH_FOXP1_P2,				SM00339:FH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,		COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DNA_BIND:Fork-head,DOMAIN:Fork-head,REGION:CTBP1-binding,REGION:Disordered,REGION:Leucine-zipper,ZN_FING:C2H2-type,
Q4VYR7	forkhead box P4 S homeolog(foxp4.S)	Xenopus laevis			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001766:Fork_head_dom,IPR030456:TF_fork_head_CS_2,IPR032354:FOXP-CC,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR047414:FH_FOXP4,				SM00339:FH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,		COMPBIAS:Polar residues,DNA_BIND:Fork-head,DOMAIN:Fork-head,REGION:Disordered,REGION:Leucine-zipper,REGION:ctbp1-binding,ZN_FING:C2H2-type,
Q76LL6	formin homology 2 domain containing 3(Fhod3)	Mus musculus			GO:0030837~negative regulation of actin filament polymerization,GO:0030866~cortical actin cytoskeleton organization,GO:0045214~sarcomere organization,GO:0055003~cardiac myofibril assembly,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005865~striated muscle thin filament,GO:0030018~Z disc,	GO:0003779~actin binding,GO:0051015~actin filament binding,	IPR011989:ARM-like,IPR014767:DAD_dom,IPR014768:GBD/FH3_dom,IPR015425:FH2_Formin,IPR016024:ARM-type_fold,IPR041387:FHOD1_GBD_N,IPR042201:FH2_Formin_sf,				SM00498:FH2,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DAD,DOMAIN:FH1,DOMAIN:FH2,DOMAIN:GBD/FH3,REGION:Disordered,
Q9JL26	formin-like 1(Fmnl1)	Mus musculus			GO:0006929~substrate-dependent cell migration,GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0016043~cellular component organization,GO:0016477~cell migration,GO:0022604~regulation of cell morphogenesis,GO:0030036~actin cytoskeleton organization,GO:0030866~cortical actin cytoskeleton organization,GO:0051014~actin filament severing,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0045335~phagocytic vesicle,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0005522~profilin binding,GO:0031267~small GTPase binding,GO:0032794~GTPase activating protein binding,GO:0051015~actin filament binding,	IPR010472:FH3_dom,IPR010473:GTPase-bd,IPR011989:ARM-like,IPR014767:DAD_dom,IPR014768:GBD/FH3_dom,IPR015425:FH2_Formin,IPR016024:ARM-type_fold,IPR042201:FH2_Formin_sf,IPR043592:FMNL_animal,				SM00498:FH2,SM01139:Drf_FH3,SM01140:Drf_GBD,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0175~Coiled coil,			KW-0449~Lipoprotein,KW-0519~Myristate,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DAD,DOMAIN:FH2,DOMAIN:GBD/FH3,LIPID:N-myristoyl glycine,REGION:Disordered,
Q9WUH4	four and a half LIM domains 1(Fhl1)	Rattus norvegicus			GO:0003254~regulation of membrane depolarization,GO:0007517~muscle organ development,GO:0010972~negative regulation of G2/M transition of mitotic cell cycle,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,GO:0043268~positive regulation of potassium ion transport,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0044325~ion channel binding,GO:0046872~metal ion binding,	IPR001781:Znf_LIM,IPR042997:Fhl1,	rno04630:JAK-STAT signaling pathway,			SM00132:LIM,	KW-0221~Differentiation,	KW-0963~Cytoplasm,			KW-0440~LIM domain,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,DOMAIN:LIM zinc-binding 3,DOMAIN:LIM zinc-binding 4,ZN_FING:C4-type,
Q5ZEQ8	four-jointed box kinase 1(fjx1)	Xiphophorus maculatus			GO:0007267~cell-cell signaling,	GO:0005576~extracellular region,GO:0005615~extracellular space,		IPR024868:FJX1/FJ,						KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,
O89106	fragile histidine triad gene(Fhit)	Mus musculus			GO:0006163~purine nucleotide metabolic process,GO:0006260~DNA replication,GO:0006915~apoptotic process,GO:0015964~diadenosine triphosphate catabolic process,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0016151~nickel cation binding,GO:0016740~transferase activity,GO:0016787~hydrolase activity,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0043530~adenosine 5'-monophosphoramidase activity,GO:0047352~adenylylsulfate-ammonia adenylyltransferase activity,GO:0047627~adenylylsulfatase activity,GO:0047710~bis(5'-adenosyl)-triphosphatase activity,	IPR011146:HIT-like,IPR019808:Histidine_triad_CS,IPR036265:HIT-like_sf,IPR039383:FHIT,	mmu00230:Purine metabolism,mmu01100:Metabolic pathways,mmu05222:Small cell lung cancer,mmu05223:Non-small cell lung cancer,				KW-0053~Apoptosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0464~Manganese,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Tele-AMP-histidine intermediate,DOMAIN:HIT,MOTIF:Histidine triad motif,SITE:Important for induction of apoptosis,
Q9I9M5	frizzled class receptor 1 L homeolog(fzd1.L)	Xenopus laevis			GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0016055~Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,	IPR000539:Frizzled/Smoothened_7TM,IPR015526:Frizzled/SFRP,IPR017981:GPCR_2-like_7TM,IPR020067:Frizzled_dom,IPR036790:Frizzled_dom_sf,	xla04150:mTOR signaling pathway,xla04310:Wnt signaling pathway,xla04916:Melanogenesis,			SM00063:FRI,SM01330:Frizzled,	KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:FZ,DOMAIN:G-protein coupled receptors family 2 profile 2,MOTIF:Lys-Thr-X-X-X-Trp motif, mediates interaction with the PDZ domain of Dvl family members,MOTIF:PDZ-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q8WMU5	frizzled class receptor 6(FZD6)	Canis lupus familiaris			GO:0001843~neural tube closure,GO:0001942~hair follicle development,GO:0007399~nervous system development,GO:0030168~platelet activation,GO:0033278~cell proliferation in midbrain,GO:0035567~non-canonical Wnt signaling pathway,GO:0035880~embryonic nail plate morphogenesis,GO:0042472~inner ear morphogenesis,GO:0048105~establishment of body hair planar orientation,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0030659~cytoplasmic vesicle membrane,	GO:0004930~G-protein coupled receptor activity,GO:0017147~Wnt-protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0042813~Wnt-activated receptor activity,	IPR000539:Frizzled/Smoothened_7TM,IPR015526:Frizzled/SFRP,IPR017981:GPCR_2-like_7TM,IPR020067:Frizzled_dom,IPR026543:FZD6_7TM,IPR036790:Frizzled_dom_sf,IPR041770:FZ6_CRD,	cfa04150:mTOR signaling pathway,cfa04310:Wnt signaling pathway,cfa04390:Hippo signaling pathway,cfa04550:Signaling pathways regulating pluripotency of stem cells,cfa04916:Melanogenesis,cfa04934:Cushing syndrome,cfa05010:Alzheimer disease,cfa05022:Pathways of neurodegeneration - multiple diseases,cfa05165:Human papillomavirus infection,cfa05200:Pathways in cancer,cfa05205:Proteoglycans in cancer,cfa05217:Basal cell carcinoma,cfa05224:Breast cancer,cfa05225:Hepatocellular carcinoma,cfa05226:Gastric cancer,			SM00063:FRI,SM01330:Frizzled,	KW-0524~Neurogenesis,KW-0879~Wnt signaling pathway,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:FZ,DOMAIN:G-protein coupled receptors family 2 profile 2,MOTIF:Lys-Thr-X-X-X-Trp motif, mediates interaction with the PDZ domain of Dvl family members,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q9PUK8	frizzled class receptor 7 L homeolog(fzd7.L)	Xenopus laevis			GO:0001707~mesoderm formation,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007258~JUN phosphorylation,GO:0008104~protein localization,GO:0009950~dorsal/ventral axis specification,GO:0016055~Wnt signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048729~tissue morphogenesis,GO:0060027~convergent extension involved in gastrulation,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,	GO:0005576~extracellular region,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0045545~syndecan binding,	IPR000539:Frizzled/Smoothened_7TM,IPR015526:Frizzled/SFRP,IPR017981:GPCR_2-like_7TM,IPR020067:Frizzled_dom,IPR036790:Frizzled_dom_sf,IPR042742:Frizzled-7_CRD,	xla04150:mTOR signaling pathway,xla04310:Wnt signaling pathway,xla04916:Melanogenesis,			SM00063:FRI,SM01330:Frizzled,	KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:FZ,DOMAIN:G-protein coupled receptors family 2 profile 2,MOTIF:Lys-Thr-X-X-X-Trp motif, mediates interaction with the PDZ domain of Dvl family members,MOTIF:PDZ-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
O93274	frizzled class receptor 8 L homeolog(fzd8.L)	Xenopus laevis			GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0016055~Wnt signaling pathway,GO:0035776~pronephric proximal tubule development,GO:0035777~pronephric distal tubule development,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060070~canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,	IPR000539:Frizzled/Smoothened_7TM,IPR015526:Frizzled/SFRP,IPR017981:GPCR_2-like_7TM,IPR020067:Frizzled_dom,IPR036790:Frizzled_dom_sf,IPR041776:FZ8_CRD,	xla04150:mTOR signaling pathway,xla04310:Wnt signaling pathway,xla04916:Melanogenesis,			SM00063:FRI,SM01330:Frizzled,	KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:FZ,DOMAIN:G-protein coupled receptors family 2 profile 2,MOTIF:Lys-Thr-X-X-X-Trp motif, mediates interaction with the PDZ domain of Dvl family members,MOTIF:PDZ-binding,REGION:Disordered,REGION:Wnt-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
O93274	frizzled class receptor 8 S homeolog(fzd8.S)	Xenopus laevis			GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0016055~Wnt signaling pathway,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060070~canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,	IPR000539:Frizzled/Smoothened_7TM,IPR015526:Frizzled/SFRP,IPR017981:GPCR_2-like_7TM,IPR020067:Frizzled_dom,IPR036790:Frizzled_dom_sf,IPR041776:FZ8_CRD,	xla04150:mTOR signaling pathway,xla04310:Wnt signaling pathway,xla04916:Melanogenesis,			SM00063:FRI,SM01330:Frizzled,	KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:FZ,DOMAIN:G-protein coupled receptors family 2 profile 2,MOTIF:Lys-Thr-X-X-X-Trp motif, mediates interaction with the PDZ domain of Dvl family members,MOTIF:PDZ-binding,REGION:Disordered,REGION:Wnt-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P00636	fructose-bisphosphatase 1(FBP1)	Sus scrofa			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0005986~sucrose biosynthetic process,GO:0006000~fructose metabolic process,GO:0006002~fructose 6-phosphate metabolic process,GO:0006094~gluconeogenesis,GO:0006111~regulation of gluconeogenesis,GO:0016311~dephosphorylation,GO:0030308~negative regulation of cell growth,GO:0030388~fructose 1,6-bisphosphate metabolic process,GO:0045820~negative regulation of glycolytic process,GO:0046580~negative regulation of Ras protein signal transduction,GO:0071286~cellular response to magnesium ion,GO:0071466~cellular response to xenobiotic stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0016208~AMP binding,GO:0016787~hydrolase activity,GO:0042132~fructose 1,6-bisphosphate 1-phosphatase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0048029~monosaccharide binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,	IPR000146:FBPase_class-1,IPR020548:Fructose_bisphosphatase_AS,IPR028343:FBPtase,IPR033391:FBPase_N,IPR044015:FBPase_C_dom,	ssc00010:Glycolysis / Gluconeogenesis,ssc00030:Pentose phosphate pathway,ssc00051:Fructose and mannose metabolism,ssc01100:Metabolic pathways,ssc01200:Carbon metabolism,ssc04152:AMPK signaling pathway,ssc04910:Insulin signaling pathway,ssc04922:Glucagon signaling pathway,		PIRSF000904:FBPtase_SBPase,PIRSF500210:FBPtase,		KW-0119~Carbohydrate metabolism,KW-0312~Gluconeogenesis,					KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0021~Allosteric enzyme,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Fructose-1-6-bisphosphatase class 1 C-terminal,DOMAIN:Fructose-1-6-bisphosphatase class I N-terminal,MUTAGEN:A->L: Destabilizes the inactive T-state and promotes transition to the R-state.,
Q7SX99	fumarate hydratase(fh)	Danio rerio			GO:0000050~urea cycle,GO:0000821~regulation of arginine metabolic process,GO:0006099~tricarboxylic acid cycle,GO:0006106~fumarate metabolic process,GO:0006108~malate metabolic process,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0045239~tricarboxylic acid cycle enzyme complex,	GO:0003824~catalytic activity,GO:0004333~fumarate hydratase activity,GO:0016829~lyase activity,	IPR000362:Fumarate_lyase_fam,IPR005677:Fum_hydII,IPR008948:L-Aspartase-like,IPR018951:Fumarase_C_C,IPR020557:Fumarate_lyase_CS,IPR022761:Fumarate_lyase_N,IPR024083:Fumarase/histidase_N,	dre00020:Citrate cycle (TCA cycle),dre00620:Pyruvate metabolism,dre01100:Metabolic pathways,dre01200:Carbon metabolism,				KW-0227~DNA damage,KW-0234~DNA repair,KW-0816~Tricarboxylic acid cycle,	KW-0158~Chromosome,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0809~Transit peptide,		KW-0456~Lyase,		ACT_SITE:Proton donor/acceptor,BINDING:in site B,SITE:Important for catalytic activity,TRANSIT:Mitochondrion,
Q2HJ98	fumarylacetoacetate hydrolase domain containing 1(FAHD1)	Bos taurus			GO:0006090~pyruvate metabolic process,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0008948~oxaloacetate decarboxylase activity,GO:0018773~acetylpyruvate hydrolase activity,GO:0034545~fumarylpyruvate hydrolase activity,GO:0046872~metal ion binding,GO:0047621~acylpyruvate hydrolase activity,	IPR011234:Fumarylacetoacetase-like_C,IPR036663:Fumarylacetoacetase_C_sf,	bta00350:Tyrosine metabolism,bta01100:Metabolic pathways,					KW-0496~Mitochondrion,KW-0963~Cytoplasm,			KW-0809~Transit peptide,	KW-0106~Calcium,KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0456~Lyase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Fumarylacetoacetase-like C-terminal,TRANSIT:Mitochondrion,
Q99999	galactose-3-O-sulfotransferase 1(GAL3ST1)	Homo sapiens			GO:0006487~protein N-linked glycosylation,GO:0006665~sphingolipid metabolic process,GO:0006681~galactosylceramide metabolic process,GO:0006682~galactosylceramide biosynthetic process,GO:0007283~spermatogenesis,GO:0009247~glycolipid biosynthetic process,GO:0042552~myelination,GO:0046486~glycerolipid metabolic process,	GO:0000139~Golgi membrane,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0001733~galactosylceramide sulfotransferase activity,GO:0008146~sulfotransferase activity,	IPR009729:Gal-3-0_sulfotransfrase,IPR027417:P-loop_NTPase,	hsa00565:Ether lipid metabolism,hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,				KW-0443~Lipid metabolism,KW-0746~Sphingolipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P19019	gamma-aminobutyric acid type A receptor beta3 subunit(GABRB3)	Gallus gallus			GO:0007165~signal transduction,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007268~chemical synaptic transmission,GO:0034220~ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0050877~neurological system process,GO:1902476~chloride transmembrane transport,GO:1904862~inhibitory synapse assembly,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0034707~chloride channel complex,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005254~chloride channel activity,GO:0022851~GABA-gated chloride ion channel activity,GO:0030594~neurotransmitter receptor activity,	IPR002289:GABAAb_rcpt,IPR006028:GABAA/Glycine_rcpt,IPR006029:Neurotrans-gated_channel_TM,IPR006201:Neur_channel,IPR006202:Neur_chan_lig-bd,IPR018000:Neurotransmitter_ion_chnl_CS,IPR036719:Neuro-gated_channel_TM_sf,IPR036734:Neur_chan_lig-bd_sf,IPR038050:Neuro_actylchol_rec,	gga04080:Neuroactive ligand-receptor interaction,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0675~Receptor,KW-0869~Chloride channel,KW-1071~Ligand-gated ion channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Neurotransmitter-gated ion-channel ligand-binding,DOMAIN:Neurotransmitter-gated ion-channel transmembrane,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q99928	gamma-aminobutyric acid type A receptor subunit gamma3(GABRG3)	Homo sapiens			GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0009410~response to xenobiotic stimulus,GO:0050877~neurological system process,GO:0051932~synaptic transmission, GABAergic,GO:0060078~regulation of postsynaptic membrane potential,GO:1902476~chloride transmembrane transport,GO:1904862~inhibitory synapse assembly,	GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0032590~dendrite membrane,GO:0034707~chloride channel complex,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0098794~postsynapse,GO:0098982~GABA-ergic synapse,GO:1902495~transmembrane transporter complex,GO:1902711~GABA-A receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005237~inhibitory extracellular ligand-gated ion channel activity,GO:0005254~chloride channel activity,GO:0008503~benzodiazepine receptor activity,GO:0022851~GABA-gated chloride ion channel activity,GO:1904315~transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,	IPR005437:GABRG-1/4,IPR005440:GABBAg3_rcpt,IPR006028:GABAA/Glycine_rcpt,IPR006029:Neurotrans-gated_channel_TM,IPR006201:Neur_channel,IPR006202:Neur_chan_lig-bd,IPR018000:Neurotransmitter_ion_chnl_CS,IPR036719:Neuro-gated_channel_TM_sf,IPR036734:Neur_chan_lig-bd_sf,IPR038050:Neuro_actylchol_rec,	hsa04080:Neuroactive ligand-receptor interaction,hsa04723:Retrograde endocannabinoid signaling,hsa04727:GABAergic synapse,hsa05032:Morphine addiction,hsa05033:Nicotine addiction,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Neurotransmitter-gated ion-channel ligand-binding,DOMAIN:Neurotransmitter-gated ion-channel transmembrane,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q0II76	gamma-aminobutyric acid type A receptor subunit rho2(GABRR2)	Bos taurus			GO:0007165~signal transduction,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007601~visual perception,GO:0034220~ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0050877~neurological system process,GO:1902476~chloride transmembrane transport,	GO:0016020~membrane,GO:0034707~chloride channel complex,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005254~chloride channel activity,GO:0030594~neurotransmitter receptor activity,	IPR006028:GABAA/Glycine_rcpt,IPR006029:Neurotrans-gated_channel_TM,IPR006201:Neur_channel,IPR006202:Neur_chan_lig-bd,IPR008057:GABAAa_rho_rcpt,IPR008059:GABAAa_rho2_rcpt,IPR018000:Neurotransmitter_ion_chnl_CS,IPR036719:Neuro-gated_channel_TM_sf,IPR036734:Neur_chan_lig-bd_sf,IPR038050:Neuro_actylchol_rec,	bta04080:Neuroactive ligand-receptor interaction,bta04723:Retrograde endocannabinoid signaling,bta04727:GABAergic synapse,bta05032:Morphine addiction,bta05033:Nicotine addiction,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9QZU7	gamma-butyrobetaine hydroxylase 1(Bbox1)	Rattus norvegicus			GO:0045329~carnitine biosynthetic process,	GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0005506~iron ion binding,GO:0008270~zinc ion binding,GO:0008336~gamma-butyrobetaine dioxygenase activity,GO:0042802~identical protein binding,GO:0051213~dioxygenase activity,	IPR003819:TauD/TfdA-like,IPR010376:GBBH-like_N,IPR012775:GBBH-like,IPR038492:GBBH-like_N_sf,IPR042098:TauD-like_sf,	rno00310:Lysine degradation,rno01100:Metabolic pathways,				KW-0124~Carnitine biosynthesis,	KW-0963~Cytoplasm,				KW-0408~Iron,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	DOMAIN:Gamma-butyrobetaine hydroxylase-like N-terminal,DOMAIN:TauD/TfdA-like,
Q7T047	gap junction protein alpha 13.2(gja13.2)	Danio rerio			GO:0007154~cell communication,GO:0007267~cell-cell signaling,	GO:0005886~plasma membrane,GO:0005921~gap junction,GO:0005922~connexin complex,GO:0016020~membrane,GO:0070161~anchoring junction,	GO:0005243~gap junction channel activity,	IPR000500:Connexin,IPR013092:Connexin_N,IPR017990:Connexin_CS,IPR019570:Connexin_CCC,IPR038359:Connexin_N_sf,				SM00037:CNX,SM01089:Connexin_CCC,		KW-0303~Gap junction,KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-1015~Disulfide bond,	DOMAIN:Connexin N-terminal,DOMAIN:Gap junction protein cysteine-rich,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O57474	gap junction protein alpha 1b(gja1b)	Danio rerio			GO:0007154~cell communication,GO:0007267~cell-cell signaling,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0010644~cell communication by electrical coupling,GO:0030154~cell differentiation,GO:0031101~fin regeneration,GO:0033333~fin development,GO:0033334~fin morphogenesis,GO:0033338~medial fin development,GO:0035050~embryonic heart tube development,GO:0035143~caudal fin morphogenesis,GO:0035162~embryonic hemopoiesis,GO:0060047~heart contraction,GO:0060272~embryonic skeletal joint morphogenesis,GO:0060349~bone morphogenesis,GO:0070121~Kupffer's vesicle development,GO:0098868~bone growth,GO:0099111~microtubule-based transport,	GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0005921~gap junction,GO:0005922~connexin complex,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0070161~anchoring junction,	GO:0005243~gap junction channel activity,GO:0005515~protein binding,GO:0022832~voltage-gated channel activity,GO:0022857~transmembrane transporter activity,GO:0055077~gap junction hemi-channel activity,	IPR000500:Connexin,IPR002261:Connexin43,IPR013092:Connexin_N,IPR013124:Connexin43_C,IPR017990:Connexin_CS,IPR019570:Connexin_CCC,IPR034634:Connexin_C,IPR035091:Alpha_helix_dom_sf,IPR038359:Connexin_N_sf,	dre04540:Gap junction,			SM00037:CNX,SM01089:Connexin_CCC,	KW-0221~Differentiation,	KW-0303~Gap junction,KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MUTAGEN:F->I: In shf(j7e3); short fin ray segments.,MUTAGEN:F->V: In shf(j7e1); short fin ray segments.,MUTAGEN:P->S: In shf(j7e2); short fin ray segments.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q92052	gap junction protein gamma 1(gjc1)	Danio rerio			GO:0007154~cell communication,GO:0007267~cell-cell signaling,	GO:0005886~plasma membrane,GO:0005921~gap junction,GO:0005922~connexin complex,GO:0016020~membrane,GO:0070161~anchoring junction,	GO:0005243~gap junction channel activity,	IPR000500:Connexin,IPR013092:Connexin_N,IPR017990:Connexin_CS,IPR019570:Connexin_CCC,IPR038359:Connexin_N_sf,				SM00037:CNX,SM01089:Connexin_CCC,		KW-0303~Gap junction,KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Connexin N-terminal,DOMAIN:Gap junction protein cysteine-rich,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q92052	gap junction protein gamma 4b(gjc4b)	Danio rerio			GO:0007154~cell communication,GO:0007267~cell-cell signaling,	GO:0005886~plasma membrane,GO:0005921~gap junction,GO:0005922~connexin complex,GO:0016020~membrane,GO:0070161~anchoring junction,	GO:0005243~gap junction channel activity,	IPR000500:Connexin,IPR013092:Connexin_N,IPR017990:Connexin_CS,IPR019570:Connexin_CCC,IPR038359:Connexin_N_sf,				SM00037:CNX,SM01089:Connexin_CCC,		KW-0303~Gap junction,KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Connexin N-terminal,DOMAIN:Gap junction protein cysteine-rich,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P57678	gem nuclear organelle associated protein 4(GEMIN4)	Homo sapiens			GO:0000387~spliceosomal snRNP assembly,GO:0006364~rRNA processing,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015030~Cajal body,GO:0016020~membrane,GO:0016604~nuclear body,GO:0030532~small nuclear ribonucleoprotein complex,GO:0032797~SMN complex,GO:0034719~SMN-Sm protein complex,GO:0070062~extracellular exosome,GO:0097504~Gemini of coiled bodies,	GO:0005515~protein binding,GO:0043021~ribonucleoprotein complex binding,	IPR033265:GEMIN4,		617913~Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities,			KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,				KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Leucine-zipper,
Q9H840	gem nuclear organelle associated protein 7(GEMIN7)	Homo sapiens			GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016604~nuclear body,GO:0032797~SMN complex,GO:0034719~SMN-Sm protein complex,GO:0097504~Gemini of coiled bodies,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR020338:SMN_gemin7,IPR024642:SUZ-C,IPR047575:Sm,					KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:SUZ-C,DOMAIN:Sm,
O75496	geminin DNA replication inhibitor(GMNN)	Homo sapiens			GO:0006275~regulation of DNA replication,GO:0007346~regulation of mitotic cell cycle,GO:0008156~negative regulation of DNA replication,GO:0009887~animal organ morphogenesis,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0035563~positive regulation of chromatin binding,GO:0045786~negative regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0071163~DNA replication preinitiation complex assembly,GO:2000104~negative regulation of DNA-dependent DNA replication,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0017053~transcriptional repressor complex,	GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,	IPR022786:Geminin/Multicilin,		616835~Meier-Gorlin syndrome 6,			KW-0131~Cell cycle,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0242~Dwarfism,	KW-0175~Coiled coil,		KW-0236~DNA replication inhibitor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Homeodomain binding,REGION:Necessary and sufficient for interaction with IDAS and CDT1,
P62916	general transcription factor IIB(Gtf2b)	Rattus norvegicus			GO:0001174~transcriptional start site selection at RNA polymerase II promoter,GO:0006338~chromatin remodeling,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006473~protein acetylation,GO:0010467~gene expression,GO:0019083~viral transcription,GO:0051123~RNA polymerase II transcriptional preinitiation complex assembly,GO:0051177~meiotic sister chromatid cohesion,GO:0051225~spindle assembly,GO:0051276~chromosome organization,GO:0070897~DNA-templated transcriptional preinitiation complex assembly,GO:1990114~RNA Polymerase II core complex assembly,	GO:0000776~kinetochore,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005694~chromosome,GO:0016604~nuclear body,GO:0032153~cell division site,GO:0032993~protein-DNA complex,GO:0042585~germinal vesicle,GO:0090575~RNA polymerase II transcription factor complex,GO:0097550~transcriptional preinitiation complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000993~RNA polymerase II core binding,GO:0003677~DNA binding,GO:0004402~histone acetyltransferase activity,GO:0008270~zinc ion binding,GO:0016407~acetyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0017025~TBP-class protein binding,GO:0046966~thyroid hormone receptor binding,GO:1990841~promoter-specific chromatin binding,	IPR000812:TFIIB,IPR013137:Znf_TFIIB,IPR013150:TFIIB_cyclin,IPR013763:Cyclin-like_dom,IPR023486:TFIIB_CS,IPR036915:Cyclin-like_sf,	rno03022:Basal transcription factors,rno05017:Spinocerebellar ataxia,rno05203:Viral carcinogenesis,			SM00385:CYCLIN,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0012~Acyltransferase,KW-0238~DNA-binding,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Cyclin-like,DOMAIN:TFIIB-type,REGION:Core promoter DNA-binding,REGION:Necessary for TATA box-bound TBP complex formation,REPEAT:1,REPEAT:2,ZN_FING:TFIIB-type,
Q5RDC3	general transcription factor IIIC subunit 2(GTF3C2)	Pongo abelii			GO:0006383~transcription from RNA polymerase III promoter,	GO:0000127~transcription factor TFIIIC complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000995~transcription factor activity, core RNA polymerase III binding,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR036322:WD40_repeat_dom_sf,				SM00320:WD40,	KW-0804~Transcription,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0853~WD repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,
Q6ZMI3	gliomedin(GLDN)	Homo sapiens			GO:0007165~signal transduction,GO:0032528~microvillus organization,GO:0034113~heterotypic cell-cell adhesion,GO:0045162~clustering of voltage-gated sodium channels,	GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0030424~axon,	GO:0086080~protein binding involved in heterotypic cell-cell adhesion,	IPR003112:Olfac-like_dom,IPR008160:Collagen,		617194~Lethal congenital contracture syndrome 11,		SM00284:OLF,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0964~Secreted,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0176~Collagen,KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:Collagen-like 1,DOMAIN:Collagen-like 2,DOMAIN:Olfactomedin-like,REGION:Disordered,SITE:Cleavage; by BMP1,SITE:Cleavage; by furin-like protease,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q8K3I9	glucocorticoid induced transcript 1(Glcci1)	Mus musculus				GO:0005737~cytoplasm,		IPR026642:Glcci1/FAM117,									KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,
Q17QL1	glucosamine-6-phosphate deaminase 2(GNPDA2)	Bos taurus			GO:0005975~carbohydrate metabolic process,GO:0006043~glucosamine catabolic process,GO:0006044~N-acetylglucosamine metabolic process,GO:0006046~N-acetylglucosamine catabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,GO:0019262~N-acetylneuraminate catabolic process,	GO:0005737~cytoplasm,	GO:0004342~glucosamine-6-phosphate deaminase activity,GO:0016853~isomerase activity,GO:0042802~identical protein binding,	IPR004547:Glucosamine6P_isomerase,IPR006148:Glc/Gal-6P_isomerase,IPR018321:Glucosamine6P_isomerase_CS,IPR037171:NagB/RpiA_transferase-like,	bta00520:Amino sugar and nucleotide sugar metabolism,bta01100:Metabolic pathways,				KW-0119~Carbohydrate metabolism,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0378~Hydrolase,KW-0413~Isomerase,	KW-0597~Phosphoprotein,	ACT_SITE:For ring-opening step,ACT_SITE:Proton acceptor; for enolization step,ACT_SITE:Proton acceptor; for ring-opening step,DOMAIN:Glucosamine/galactosamine-6-phosphate isomerase,
Q5RAL9	glucosamine-phosphate N-acetyltransferase 1(GNPNAT1)	Pongo abelii			GO:0006048~UDP-N-acetylglucosamine biosynthetic process,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0010008~endosome membrane,	GO:0004343~glucosamine 6-phosphate N-acetyltransferase activity,GO:0042802~identical protein binding,GO:0048029~monosaccharide binding,	IPR000182:GNAT_dom,IPR016181:Acyl_CoA_acyltransferase,IPR039143:GNPNAT1-like,	pon00520:Amino sugar and nucleotide sugar metabolism,pon01100:Metabolic pathways,pon01250:Biosynthesis of nucleotide sugars,					KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0967~Endosome,					KW-0012~Acyltransferase,KW-0808~Transferase,		DOMAIN:N-acetyltransferase,
O19133	glucose-6-phosphatase catalytic subunit 1(G6PC1)	Canis lupus dingo			GO:0005980~glycogen catabolic process,GO:0006094~gluconeogenesis,GO:0006641~triglyceride metabolic process,GO:0008202~steroid metabolic process,GO:0010468~regulation of gene expression,GO:0015760~glucose-6-phosphate transport,GO:0035264~multicellular organism growth,GO:0042593~glucose homeostasis,GO:0042632~cholesterol homeostasis,GO:0046415~urate metabolic process,GO:0051156~glucose 6-phosphate metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004346~glucose-6-phosphatase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0042301~phosphate ion binding,	IPR000326:P_Acid_Pase_2/haloperoxidase,IPR016275:Glucose-6-phosphatase,IPR036938:P_Acid_Pase_2/haloperoxi_sf,	clud00010:Glycolysis / Gluconeogenesis,clud00052:Galactose metabolism,clud00500:Starch and sucrose metabolism,clud01100:Metabolic pathways,clud04068:FoxO signaling pathway,clud04151:PI3K-Akt signaling pathway,clud04152:AMPK signaling pathway,clud04910:Insulin signaling pathway,clud04920:Adipocytokine signaling pathway,clud04922:Glucagon signaling pathway,clud04931:Insulin resistance,clud04973:Carbohydrate digestion and absorption,		PIRSF000905:Glucose-6-phosphatase,	SM00014:acidPPc,	KW-0312~Gluconeogenesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Phosphatidic acid phosphatase type 2/haloperoxidase,MOTIF:Prevents secretion from ER,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
O19133	glucose-6-phosphatase catalytic subunit 1(G6PC1)	Canis lupus familiaris			GO:0005980~glycogen catabolic process,GO:0006094~gluconeogenesis,GO:0006641~triglyceride metabolic process,GO:0008202~steroid metabolic process,GO:0010468~regulation of gene expression,GO:0015760~glucose-6-phosphate transport,GO:0035264~multicellular organism growth,GO:0042593~glucose homeostasis,GO:0042632~cholesterol homeostasis,GO:0046415~urate metabolic process,GO:0051156~glucose 6-phosphate metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004346~glucose-6-phosphatase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0042301~phosphate ion binding,	IPR000326:P_Acid_Pase_2/haloperoxidase,IPR016275:Glucose-6-phosphatase,IPR036938:P_Acid_Pase_2/haloperoxi_sf,	cfa00010:Glycolysis / Gluconeogenesis,cfa00052:Galactose metabolism,cfa00500:Starch and sucrose metabolism,cfa01100:Metabolic pathways,cfa04068:FoxO signaling pathway,cfa04151:PI3K-Akt signaling pathway,cfa04152:AMPK signaling pathway,cfa04910:Insulin signaling pathway,cfa04920:Adipocytokine signaling pathway,cfa04922:Glucagon signaling pathway,cfa04931:Insulin resistance,cfa04973:Carbohydrate digestion and absorption,		PIRSF000905:Glucose-6-phosphatase,	SM00014:acidPPc,	KW-0312~Gluconeogenesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Phosphatidic acid phosphatase type 2/haloperoxidase,MOTIF:Prevents secretion from ER,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q5ZKI6	glucoside xylosyltransferase 1(GXYLT1)	Gallus gallus			GO:0016266~O-glycan processing,	GO:0016020~membrane,	GO:0008194~UDP-glycosyltransferase activity,GO:0035252~UDP-xylosyltransferase activity,	IPR002495:Glyco_trans_8,IPR029044:Nucleotide-diphossugar_trans,	gga00514:Other types of O-glycan biosynthesis,					KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
A0PJZ3	glucoside xylosyltransferase 2(GXYLT2)	Homo sapiens			GO:0016266~O-glycan processing,	GO:0016020~membrane,	GO:0035252~UDP-xylosyltransferase activity,	IPR002495:Glyco_trans_8,IPR029044:Nucleotide-diphossugar_trans,	hsa00514:Other types of O-glycan biosynthesis,					KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P48508	glutamate cysteine ligase, modifier subunit(Gclm)	Rattus norvegicus			GO:0006534~cysteine metabolic process,GO:0006536~glutamate metabolic process,GO:0006749~glutathione metabolic process,GO:0006750~glutathione biosynthetic process,GO:0006979~response to oxidative stress,GO:0007584~response to nutrient,GO:0008637~apoptotic mitochondrial changes,GO:0009410~response to xenobiotic stimulus,GO:0014823~response to activity,GO:0035229~positive regulation of glutamate-cysteine ligase activity,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0035733~hepatic stellate cell activation,GO:0043524~negative regulation of neuron apoptotic process,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0044752~response to human chorionic gonadotropin,GO:0051409~response to nitrosative stress,GO:0051900~regulation of mitochondrial depolarization,GO:0071333~cellular response to glucose stimulus,GO:0071372~cellular response to follicle-stimulating hormone stimulus,GO:0097069~cellular response to thyroxine stimulus,GO:0097746~regulation of blood vessel diameter,GO:1990830~cellular response to leukemia inhibitory factor,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0017109~glutamate-cysteine ligase complex,	GO:0004357~glutamate-cysteine ligase activity,GO:0016874~ligase activity,GO:0030234~enzyme regulator activity,GO:0035226~glutamate-cysteine ligase catalytic subunit binding,GO:0044877~macromolecular complex binding,	IPR023210:NADP_OxRdtase_dom,IPR032963:Gclm,IPR036812:NADP_OxRdtase_dom_sf,	rno00270:Cysteine and methionine metabolism,rno00480:Glutathione metabolism,rno01100:Metabolic pathways,rno01240:Biosynthesis of cofactors,rno04216:Ferroptosis,				KW-0317~Glutathione biosynthesis,						KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:NADP-dependent oxidoreductase,
Q7Z429	glutamate ionotropic receptor NMDA type subunit associated protein 1(GRINA)	Homo sapiens			GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0005515~protein binding,GO:0044325~ion channel binding,	IPR006214:Bax_inhibitor_1-related,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,		COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,TRANSMEM:Helical,
P31422	glutamate metabotropic receptor 3(Grm3)	Rattus norvegicus			GO:0007186~G-protein coupled receptor signaling pathway,GO:0007196~adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,GO:0007216~G-protein coupled glutamate receptor signaling pathway,GO:0010467~gene expression,GO:0019233~sensory perception of pain,GO:0050804~modulation of synaptic transmission,GO:0051966~regulation of synaptic transmission, glutamatergic,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030424~axon,GO:0042734~presynaptic membrane,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0045211~postsynaptic membrane,GO:0097449~astrocyte projection,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,	GO:0001641~group II metabotropic glutamate receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005246~calcium channel regulator activity,GO:0097110~scaffold protein binding,	IPR000162:GPCR_3_mtglu_rcpt,IPR000337:GPCR_3,IPR001234:GPCR_3_mGluR3,IPR001828:ANF_lig-bd_rcpt,IPR011500:GPCR_3_9-Cys_dom,IPR017978:GPCR_3_C,IPR017979:GPCR_3_CS,IPR028082:Peripla_BP_I,IPR038550:GPCR_3_9-Cys_sf,	rno04072:Phospholipase D signaling pathway,rno04080:Neuroactive ligand-receptor interaction,rno04724:Glutamatergic synapse,rno05030:Cocaine addiction,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 3 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q8HZM5	glutamate-ammonia ligase(GLUL)	Canis lupus dingo			GO:0001525~angiogenesis,GO:0006542~glutamine biosynthetic process,GO:0008283~cell proliferation,GO:0009267~cellular response to starvation,GO:0009749~response to glucose,GO:0010594~regulation of endothelial cell migration,GO:0018345~protein palmitoylation,GO:0042254~ribosome biogenesis,GO:1903670~regulation of sprouting angiogenesis,GO:1904749~regulation of protein localization to nucleolus,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0044297~cell body,GO:0097386~glial cell projection,	GO:0004356~glutamate-ammonia ligase activity,GO:0005524~ATP binding,GO:0019706~protein-cysteine S-palmitoyltransferase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR008146:Gln_synth_cat_dom,IPR008147:Gln_synt_N,IPR014746:Gln_synth/guanido_kin_cat_dom,IPR027302:Gln_synth_N_conserv_site,IPR027303:Gln_synth_gly_rich_site,IPR036651:Gln_synt_N_sf,	clud00220:Arginine biosynthesis,clud00250:Alanine, aspartate and glutamate metabolism,clud00630:Glyoxylate and dicarboxylate metabolism,clud00910:Nitrogen metabolism,clud01100:Metabolic pathways,clud01230:Biosynthesis of amino acids,clud04217:Necroptosis,clud04724:Glutamatergic synapse,clud04727:GABAergic synapse,			SM01230:Gln-synt_C,	KW-0037~Angiogenesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,DOMAIN:GS beta-grasp,DOMAIN:GS catalytic,REGION:Disordered,
Q8HZM5	glutamate-ammonia ligase(GLUL)	Canis lupus familiaris			GO:0001525~angiogenesis,GO:0006542~glutamine biosynthetic process,GO:0008283~cell proliferation,GO:0009267~cellular response to starvation,GO:0009749~response to glucose,GO:0010594~regulation of endothelial cell migration,GO:0018345~protein palmitoylation,GO:0042254~ribosome biogenesis,GO:1903670~regulation of sprouting angiogenesis,GO:1904749~regulation of protein localization to nucleolus,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0044297~cell body,GO:0097386~glial cell projection,	GO:0004356~glutamate-ammonia ligase activity,GO:0005524~ATP binding,GO:0019706~protein-cysteine S-palmitoyltransferase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR008146:Gln_synth_cat_dom,IPR008147:Gln_synt_N,IPR014746:Gln_synth/guanido_kin_cat_dom,IPR027302:Gln_synth_N_conserv_site,IPR027303:Gln_synth_gly_rich_site,IPR036651:Gln_synt_N_sf,	cfa00220:Arginine biosynthesis,cfa00250:Alanine, aspartate and glutamate metabolism,cfa00630:Glyoxylate and dicarboxylate metabolism,cfa00910:Nitrogen metabolism,cfa01100:Metabolic pathways,cfa01230:Biosynthesis of amino acids,cfa04217:Necroptosis,cfa04724:Glutamatergic synapse,cfa04727:GABAergic synapse,			SM01230:Gln-synt_C,	KW-0037~Angiogenesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,DOMAIN:GS beta-grasp,DOMAIN:GS catalytic,REGION:Disordered,
P00504	glutamic-oxaloacetic transaminase 1(GOT1)	Gallus gallus			GO:0006094~gluconeogenesis,GO:0006103~2-oxoglutarate metabolic process,GO:0006107~oxaloacetate metabolic process,GO:0006114~glycerol biosynthetic process,GO:0006531~aspartate metabolic process,GO:0006532~aspartate biosynthetic process,GO:0006533~aspartate catabolic process,GO:0006536~glutamate metabolic process,GO:0007219~Notch signaling pathway,GO:0019550~glutamate catabolic process to aspartate,GO:0019551~glutamate catabolic process to 2-oxoglutarate,GO:0032869~cellular response to insulin stimulus,GO:0051384~response to glucocorticoid,GO:0055089~fatty acid homeostasis,	GO:0005829~cytosol,	GO:0004069~L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004609~phosphatidylserine decarboxylase activity,GO:0030170~pyridoxal phosphate binding,GO:0047801~L-cysteine:2-oxoglutarate aminotransferase activity,	IPR000796:Asp_trans,IPR004838:NHTrfase_class1_PyrdxlP-BS,IPR004839:Aminotransferase_I/II,IPR015421:PyrdxlP-dep_Trfase_major,IPR015422:PyrdxlP-dep_Trfase_small,IPR015424:PyrdxlP-dep_Trfase,	gga00220:Arginine biosynthesis,gga00250:Alanine, aspartate and glutamate metabolism,gga00270:Cysteine and methionine metabolism,gga00330:Arginine and proline metabolism,gga00350:Tyrosine metabolism,gga00360:Phenylalanine metabolism,gga00400:Phenylalanine, tyrosine and tryptophan biosynthesis,gga01100:Metabolic pathways,gga01200:Carbon metabolism,gga01210:2-Oxocarboxylic acid metabolism,gga01230:Biosynthesis of amino acids,				KW-0028~Amino-acid biosynthesis,	KW-0963~Cytoplasm,				KW-0663~Pyridoxal phosphate,	KW-0032~Aminotransferase,KW-0808~Transferase,	KW-0007~Acetylation,
O94925	glutaminase(GLS)	Homo sapiens		h_argininecPathway:Catabolic Pathways for Arginine , Histidine, Glutamate, Glutamine, and Proline,	GO:0001967~suckling behavior,GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0006537~glutamate biosynthetic process,GO:0006541~glutamine metabolic process,GO:0006543~glutamine catabolic process,GO:0007268~chemical synaptic transmission,GO:0051289~protein homotetramerization,GO:0090461~glutamate homeostasis,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0045202~synapse,	GO:0004359~glutaminase activity,GO:0005515~protein binding,	IPR002110:Ankyrin_rpt,IPR012338:Beta-lactam/transpept-like,IPR015868:Glutaminase,IPR036770:Ankyrin_rpt-contain_sf,IPR041541:Glutaminase_EF-hand,	hsa00220:Arginine biosynthesis,hsa00250:Alanine, aspartate and glutamate metabolism,hsa00470:D-Amino acid metabolism,hsa01100:Metabolic pathways,hsa04724:Glutamatergic synapse,hsa04727:GABAergic synapse,hsa04964:Proximal tubule bicarbonate reclamation,hsa05206:MicroRNAs in cancer,hsa05230:Central carbon metabolism in cancer,	618328~Developmental and epileptic encephalopathy 71,618339~Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development,618412~Global developmental delay, progressive ataxia, and elevated glutamine,		SM00248:ANK,		KW-0496~Mitochondrion,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0898~Cataract,	KW-0040~ANK repeat,KW-0677~Repeat,KW-0809~Transit peptide,		KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Glutaminase EF-hand,MUTAGEN:F->S: No effect on catalytic activity. Loss of inhibition by BPTES; when associated with Y-318.,MUTAGEN:F->Y: No effect on catalytic activity. Loss of inhibition by BPTES; when associated with S-322.,MUTAGEN:K->A: Loss of enzyme activity.,MUTAGEN:L->A: Decreased enzyme activity.,MUTAGEN:S->A: Loss of enzyme activity.,MUTAGEN:Y->A: Decreased enzyme activity.,MUTAGEN:Y->A: Loss of enzyme activity.,MUTAGEN:Y->L: No effect on catalytic activity. Loss of inhibition by BPTES.,REGION:Disordered,REGION:Highly mobile activation loop,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,SITE:Cleavage; by MPP,TRANSIT:Mitochondrion,
P82808	glutamine fructose-6-phosphate transaminase 1(Gfpt1)	Rattus norvegicus			GO:0006002~fructose 6-phosphate metabolic process,GO:0006042~glucosamine biosynthetic process,GO:0006047~UDP-N-acetylglucosamine metabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,GO:0006487~protein N-linked glycosylation,GO:0006541~glutamine metabolic process,GO:0009744~response to sucrose,GO:0032868~response to insulin,GO:0032869~cellular response to insulin stimulus,GO:0032922~circadian regulation of gene expression,GO:0045719~negative regulation of glycogen biosynthetic process,GO:1901137~carbohydrate derivative biosynthetic process,		GO:0004360~glutamine-fructose-6-phosphate transaminase (isomerizing) activity,GO:0016597~amino acid binding,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,GO:0097367~carbohydrate derivative binding,	IPR001347:SIS_dom,IPR005855:GFAT,IPR017932:GATase_2_dom,IPR029055:Ntn_hydrolases_N,IPR035466:GlmS/AgaS_SIS,IPR035490:GlmS/FrlB_SIS,IPR046348:SIS_dom_sf,IPR047084:GFAT_N,	rno00250:Alanine, aspartate and glutamate metabolism,rno00520:Amino sugar and nucleotide sugar metabolism,rno01100:Metabolic pathways,rno01250:Biosynthesis of nucleotide sugars,rno04931:Insulin resistance,rno05415:Diabetic cardiomyopathy,				KW-0090~Biological rhythms,				KW-0315~Glutamine amidotransferase,KW-0677~Repeat,		KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:For GATase activity,DOMAIN:Glutamine amidotransferase type-2,DOMAIN:SIS,DOMAIN:SIS 1,DOMAIN:SIS 2,REGION:Isomerase,
Q8HZM5	glutamine synthetase-like(LOC112655053)	Canis lupus dingo			GO:0001525~angiogenesis,GO:0006542~glutamine biosynthetic process,GO:0008283~cell proliferation,GO:0009267~cellular response to starvation,GO:0009749~response to glucose,GO:0010594~regulation of endothelial cell migration,GO:0018345~protein palmitoylation,GO:0042254~ribosome biogenesis,GO:1903670~regulation of sprouting angiogenesis,GO:1904749~regulation of protein localization to nucleolus,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0044297~cell body,GO:0097386~glial cell projection,	GO:0004356~glutamate-ammonia ligase activity,GO:0005524~ATP binding,GO:0019706~protein-cysteine S-palmitoyltransferase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR008146:Gln_synth_cat_dom,IPR008147:Gln_synt_N,IPR014746:Gln_synth/guanido_kin_cat_dom,IPR027302:Gln_synth_N_conserv_site,IPR027303:Gln_synth_gly_rich_site,IPR036651:Gln_synt_N_sf,	clud00220:Arginine biosynthesis,clud00250:Alanine, aspartate and glutamate metabolism,clud00630:Glyoxylate and dicarboxylate metabolism,clud00910:Nitrogen metabolism,clud01100:Metabolic pathways,clud01230:Biosynthesis of amino acids,clud04217:Necroptosis,clud04724:Glutamatergic synapse,clud04727:GABAergic synapse,			SM01230:Gln-synt_C,	KW-0037~Angiogenesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	DOMAIN:GS beta-grasp,DOMAIN:GS catalytic,
Q8HZM5	glutamine synthetase-like(LOC612295)	Canis lupus familiaris			GO:0001525~angiogenesis,GO:0006542~glutamine biosynthetic process,GO:0008283~cell proliferation,GO:0009267~cellular response to starvation,GO:0009749~response to glucose,GO:0010594~regulation of endothelial cell migration,GO:0018345~protein palmitoylation,GO:0042254~ribosome biogenesis,GO:1903670~regulation of sprouting angiogenesis,GO:1904749~regulation of protein localization to nucleolus,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0044297~cell body,GO:0097386~glial cell projection,	GO:0004356~glutamate-ammonia ligase activity,GO:0005524~ATP binding,GO:0019706~protein-cysteine S-palmitoyltransferase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR008146:Gln_synth_cat_dom,IPR008147:Gln_synt_N,IPR014746:Gln_synth/guanido_kin_cat_dom,IPR027302:Gln_synth_N_conserv_site,IPR027303:Gln_synth_gly_rich_site,IPR036651:Gln_synt_N_sf,	cfa00220:Arginine biosynthesis,cfa00250:Alanine, aspartate and glutamate metabolism,cfa00630:Glyoxylate and dicarboxylate metabolism,cfa00910:Nitrogen metabolism,cfa01100:Metabolic pathways,cfa01230:Biosynthesis of amino acids,cfa04217:Necroptosis,cfa04724:Glutamatergic synapse,cfa04727:GABAergic synapse,			SM01230:Gln-synt_C,	KW-0037~Angiogenesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	DOMAIN:GS beta-grasp,DOMAIN:GS catalytic,
Q8BH73	glutaminyl-peptide cyclotransferase-like(Qpctl)	Mus musculus			GO:0017186~peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0008270~zinc ion binding,GO:0016603~glutaminyl-peptide cyclotransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0046872~metal ion binding,	IPR007484:Peptidase_M28,IPR037457:M28_QC,IPR040234:QC/QCL,						KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0012~Acyltransferase,KW-0808~Transferase,	KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,TRANSMEM:Helical,
P47897	glutaminyl-tRNA synthetase 1(QARS1)	Homo sapiens			GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006425~glutaminyl-tRNA aminoacylation,GO:0006469~negative regulation of protein kinase activity,GO:0007420~brain development,GO:0032873~negative regulation of stress-activated MAPK cascade,GO:0043039~tRNA aminoacylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0032991~macromolecular complex,	GO:0004812~aminoacyl-tRNA ligase activity,GO:0004819~glutamine-tRNA ligase activity,GO:0004860~protein kinase inhibitor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR000924:Glu/Gln-tRNA-synth,IPR001412:aa-tRNA-synth_I_CS,IPR004514:Gln-tRNA-synth,IPR007638:Gln-tRNA-synth_Ib_RNA-bd_2,IPR007639:Gln-tRNA-synth_Ib_RNA-bd_N,IPR011035:Ribosomal_bL25/Gln-tRNA_synth,IPR014729:Rossmann-like_a/b/a_fold,IPR020056:Rbsml_bL25/Gln-tRNA_synth_N,IPR020058:Glu/Gln-tRNA-synth_Ib_cat-dom,IPR020059:Glu/Gln-tRNA-synth_Ib_codon-bd,IPR020061:Glu_tRNA_lig_a-bdl,IPR042558:Gln-tRNA-synth_Ib_RNA-bd_N_1,IPR042559:Gln-tRNA-synth_Ib_RNA-bd_N_2,IPR049437:tRNA-synt_1c_C2,	hsa00970:Aminoacyl-tRNA biosynthesis,hsa01100:Metabolic pathways,	615760~Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy,			KW-0648~Protein biosynthesis,	KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0905~Primary microcephaly,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Glutaminyl-tRNA synthetase class Ib non-specific RNA-binding,DOMAIN:Glutamyl/glutaminyl-tRNA synthetase class Ib anti-codon binding,DOMAIN:Glutamyl/glutaminyl-tRNA synthetase class Ib catalytic,DOMAIN:tRNA synthetases class I (E and Q) anti-codon binding,MOTIF:'HIGH' region,MOTIF:'KMSKS' region,MUTAGEN:H->A: Decreases catalytic efficiency about 60-fold.,TRANSMEM:Helical,
Q8CGC7	glutamyl-prolyl-tRNA synthetase 1(Eprs1)	Mus musculus			GO:0006412~translation,GO:0006417~regulation of translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006424~glutamyl-tRNA aminoacylation,GO:0006433~prolyl-tRNA aminoacylation,GO:0008152~metabolic process,GO:0017148~negative regulation of translation,GO:0032869~cellular response to insulin stimulus,GO:0043039~tRNA aminoacylation,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0071346~cellular response to interferon-gamma,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0097452~GAIT complex,GO:1990904~ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004818~glutamate-tRNA ligase activity,GO:0004827~proline-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0035613~RNA stem-loop binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0051020~GTPase binding,	IPR000738:WHEP-TRS_dom,IPR000924:Glu/Gln-tRNA-synth,IPR001412:aa-tRNA-synth_I_CS,IPR002314:aa-tRNA-synt_IIb,IPR004046:GST_C,IPR004154:Anticodon-bd,IPR004499:Pro-tRNA-ligase_IIa_arc-type,IPR004526:Glu-tRNA-synth_arc/euk,IPR006195:aa-tRNA-synth_II,IPR009068:uS15_NS1_RNA-bd_sf,IPR011035:Ribosomal_bL25/Gln-tRNA_synth,IPR014729:Rossmann-like_a/b/a_fold,IPR016061:Pro-tRNA_ligase_II_C,IPR017449:Pro-tRNA_synth_II,IPR020056:Rbsml_bL25/Gln-tRNA_synth_N,IPR020058:Glu/Gln-tRNA-synth_Ib_cat-dom,IPR020059:Glu/Gln-tRNA-synth_Ib_codon-bd,IPR033721:ProRS_core_arch_euk,IPR036282:Glutathione-S-Trfase_C_sf,IPR036621:Anticodon-bd_dom_sf,IPR042450:EEF1E1,IPR045864:aa-tRNA-synth_II/BPL/LPL,IPR049437:tRNA-synt_1c_C2,	mmu00860:Porphyrin metabolism,mmu00970:Aminoacyl-tRNA biosynthesis,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,			SM00946:ProRS-C_1,SM00991:WHEP-TRS,	KW-0648~Protein biosynthesis,KW-0810~Translation regulation,	KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,KW-0511~Multifunctional enzyme,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Aminoacyl-transfer RNA synthetases class-II family profile,DOMAIN:Glutamyl/glutaminyl-tRNA synthetase class Ib catalytic,DOMAIN:Glutathione S-transferase C-terminal,DOMAIN:WHEP-TRS,DOMAIN:WHEP-TRS 1,DOMAIN:WHEP-TRS 2,DOMAIN:WHEP-TRS 3,MOTIF:'HIGH' region,MOTIF:'KMSKS' region,MUTAGEN:S->A: Loss of function in translation inhibition. Loss of interaction with SLC27A1. Mutant mice have no apparent developmental defect but display reduced adiposity associated with decreased insulin levels and adipocytes size. They also display increased lipolysis and fatty acid beta-oxidation and an extended lifespan. Adipocytes display decreased insulin-stimulated long-chain fatty acid uptake.,MUTAGEN:S->D: Constitutively active in translation inhibition (phosphomimetic). Mutant mice have no apparent developmental defect and do not display overt phenotype related to adiposity or lifespan.,REGION:3 X 57 AA approximate repeats,REGION:Disordered,REGION:Glutamate--tRNA ligase,REGION:Proline--tRNA ligase,
Q7T010	glutamyl-tRNA(Gln) amidotransferase, subunit B(gatb)	Danio rerio			GO:0006253~dCTP catabolic process,GO:0006412~translation,GO:0032543~mitochondrial translation,GO:0042262~DNA protection,GO:0070681~glutaminyl-tRNAGln biosynthesis via transamidation,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0030956~glutamyl-tRNA(Gln) amidotransferase complex,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0003824~catalytic activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0016884~carbon-nitrogen ligase activity, with glutamine as amido-N-donor,GO:0047840~dCTP diphosphatase activity,GO:0050567~glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,	IPR003789:Asn/Gln_tRNA_amidoTrase-B-like,IPR004413:GatB,IPR006075:Asn/Gln-tRNA_Trfase_suB/E_cat,IPR014746:Gln_synth/guanido_kin_cat_dom,IPR017959:Asn/Gln-tRNA_amidoTrfase_suB/E,IPR018027:Asn/Gln_amidotransferase,IPR023168:GatB_Yqey_C_2,IPR025984:DCTPP,	dre00970:Aminoacyl-tRNA biosynthesis,dre01100:Metabolic pathways,			SM00845:GatB_Yqey,	KW-0648~Protein biosynthesis,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0436~Ligase,		COMPBIAS:Basic and acidic residues,REGION:Disordered,TRANSIT:Mitochondrion,
Q32L67	glutaredoxin 2(GLRX2)	Bos taurus				GO:0005739~mitochondrion,	GO:0015035~protein disulfide oxidoreductase activity,GO:0046872~metal ion binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR002109:Glutaredoxin,IPR011899:Glutaredoxin_euk/vir,IPR014025:Glutaredoxin_subgr,IPR036249:Thioredoxin-like_sf,					KW-0249~Electron transport,KW-0813~Transport,	KW-0496~Mitochondrion,			KW-0676~Redox-active center,KW-0809~Transit peptide,	KW-0001~2Fe-2S,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,		KW-0318~Glutathionylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	BINDING:in inactive form,DISULFID:Redox-active; alternate,DOMAIN:Glutaredoxin,TRANSIT:Mitochondrion,
P78417	glutathione S-transferase omega 1(GSTO1)	Homo sapiens			GO:0006749~glutathione metabolic process,GO:0010880~regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0014810~positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,GO:0019852~L-ascorbic acid metabolic process,GO:0042178~xenobiotic catabolic process,GO:0060315~negative regulation of ryanodine-sensitive calcium-release channel activity,GO:0060316~positive regulation of ryanodine-sensitive calcium-release channel activity,GO:0071243~cellular response to arsenic-containing substance,GO:0098869~cellular oxidant detoxification,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0045174~glutathione dehydrogenase (ascorbate) activity,GO:0050610~methylarsonate reductase activity,	IPR004045:Glutathione_S-Trfase_N,IPR004046:GST_C,IPR005442:GST_omega,IPR010987:Glutathione-S-Trfase_C-like,IPR036249:Thioredoxin-like_sf,IPR036282:Glutathione-S-Trfase_C_sf,IPR040079:Glutathione_S-Trfase,IPR045073:Omega/Tau-like,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa01524:Platinum drug resistance,hsa05200:Pathways in cancer,hsa05204:Chemical carcinogenesis - DNA adducts,hsa05207:Chemical carcinogenesis - receptor activation,hsa05208:Chemical carcinogenesis - reactive oxygen species,hsa05225:Hepatocellular carcinoma,hsa05418:Fluid shear stress and atherosclerosis,					KW-0963~Cytoplasm,					KW-0560~Oxidoreductase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,DOMAIN:GST C-terminal,DOMAIN:GST N-terminal,MUTAGEN:C->A: Loss of activity.,
Q6DDT5	glutathione S-transferase, C-terminal domain containing L homeolog(gstcd.L)	Xenopus laevis				GO:0005737~cytoplasm,	GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,	IPR025714:Methyltranfer_dom,IPR029063:SAM-dependent_MTases_sf,IPR036282:Glutathione-S-Trfase_C_sf,						KW-0963~Cytoplasm,							DOMAIN:GST C-terminal,DOMAIN:Methyltransferase,
P48774	glutathione S-transferase, mu 5(Gstm5)	Mus musculus			GO:0006749~glutathione metabolic process,GO:0018916~nitrobenzene metabolic process,GO:0042178~xenobiotic catabolic process,GO:0043627~response to estrogen,GO:0070458~cellular detoxification of nitrogen compound,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0035686~sperm fibrous sheath,GO:0045171~intercellular bridge,	GO:0004364~glutathione transferase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043295~glutathione binding,	IPR003081:GST_mu,IPR004045:Glutathione_S-Trfase_N,IPR004046:GST_C,IPR010987:Glutathione-S-Trfase_C-like,IPR036249:Thioredoxin-like_sf,IPR036282:Glutathione-S-Trfase_C_sf,IPR040079:Glutathione_S-Trfase,	mmu00480:Glutathione metabolism,mmu00980:Metabolism of xenobiotics by cytochrome P450,mmu00982:Drug metabolism - cytochrome P450,mmu00983:Drug metabolism - other enzymes,mmu01100:Metabolic pathways,mmu01524:Platinum drug resistance,mmu05200:Pathways in cancer,mmu05204:Chemical carcinogenesis - DNA adducts,mmu05207:Chemical carcinogenesis - receptor activation,mmu05208:Chemical carcinogenesis - reactive oxygen species,mmu05225:Hepatocellular carcinoma,mmu05418:Fluid shear stress and atherosclerosis,					KW-0963~Cytoplasm,					KW-0808~Transferase,	KW-0597~Phosphoprotein,	DOMAIN:GST C-terminal,DOMAIN:GST N-terminal,
P36968	glutathione peroxidase 4(GPX4)	Sus scrofa			GO:0006325~chromatin organization,GO:0006979~response to oxidative stress,GO:0007283~spermatogenesis,GO:0019369~arachidonic acid metabolic process,GO:0019372~lipoxygenase pathway,GO:0051258~protein polymerization,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0032991~macromolecular complex,	GO:0004601~peroxidase activity,GO:0004602~glutathione peroxidase activity,GO:0042802~identical protein binding,GO:0047066~phospholipid-hydroperoxide glutathione peroxidase activity,	IPR000889:Glutathione_peroxidase,IPR013766:Thioredoxin_domain,IPR029759:GPX_AS,IPR029760:GPX_CS,IPR036249:Thioredoxin-like_sf,	ssc00480:Glutathione metabolism,ssc00590:Arachidonic acid metabolism,ssc01100:Metabolic pathways,ssc04216:Ferroptosis,		PIRSF000303:Glutathion_perox,		KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,			KW-0732~Signal,KW-0809~Transit peptide,		KW-0217~Developmental protein,KW-0560~Oxidoreductase,KW-0575~Peroxidase,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic residues,DOMAIN:Thioredoxin,NON_STD:Selenocysteine,REGION:Disordered,TRANSIT:Mitochondrion,
Q5XIZ6	glycerol-3-phosphate dehydrogenase 1 like(gpd1l)	Danio rerio			GO:0005975~carbohydrate metabolic process,GO:0006072~glycerol-3-phosphate metabolic process,GO:0046168~glycerol-3-phosphate catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0009331~glycerol-3-phosphate dehydrogenase complex,	GO:0016491~oxidoreductase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0042803~protein homodimerization activity,GO:0047952~glycerol-3-phosphate dehydrogenase [NAD(P)+] activity,GO:0051287~NAD binding,	IPR006109:G3P_DH_NAD-dep_C,IPR006168:G3P_DH_NAD-dep,IPR008927:6-PGluconate_DH-like_C_sf,IPR011128:G3P_DH_NAD-dep_N,IPR013328:6PGD_dom2,IPR017751:G3P_DH_NAD-dep_euk,IPR036291:NAD(P)-bd_dom_sf,	dre00564:Glycerophospholipid metabolism,		PIRSF000114:Glycerol-3-P_dh,			KW-0963~Cytoplasm,				KW-0520~NAD,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,
Q9JL56	glycerophosphodiester phosphodiesterase 1(Gde1)	Mus musculus			GO:0006580~ethanolamine metabolic process,GO:0006629~lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0007186~G-protein coupled receptor signaling pathway,GO:0070291~N-acylethanolamine metabolic process,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,	GO:0004622~lysophospholipase activity,GO:0008081~phosphoric diester hydrolase activity,GO:0008889~glycerophosphodiester phosphodiesterase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0047395~glycerophosphoinositol glycerophosphodiesterase activity,	IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR030395:GP_PDE_dom,					KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:GP-PDE,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q3KTM2	glycerophosphodiester phosphodiesterase domain containing 5(GDPD5)	Gallus gallus			GO:0006629~lipid metabolic process,GO:0007399~nervous system development,GO:0045666~positive regulation of neuron differentiation,	GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0030426~growth cone,GO:0048471~perinuclear region of cytoplasm,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0008081~phosphoric diester hydrolase activity,GO:0008889~glycerophosphodiester phosphodiesterase activity,GO:0047389~glycerophosphocholine phosphodiesterase activity,	IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR030395:GP_PDE_dom,					KW-0443~Lipid metabolism,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:GP-PDE,MUTAGEN:APML->GAHD: Catalytically inactive mutant. Abolishes ability to remove the GPI-anchor of RECK.,MUTAGEN:C->S: Enhances the ability to promote motor neuron differentiation. Retains the ability to bind PRDX1; loss the ability to form a mixed-disulfide with PRDX1; loss the ability to be reduced by PRDX1; when associated with S-25.,MUTAGEN:C->S: Enhances the ability to promote motor neuron differentiation. Retains the ability to bind PRDX1; loss the ability to form a mixed-disulfide with PRDX1; loss the ability to be reduced by PRDX1; when associated with S-576.,MUTAGEN:C->S: Retains the ability to bind PRDX1; forms a mixed-disulfide with PRDX1; can be reduced by PRDX1; promote motor neuron differentiation as the wild type; when associated with S-15.,MUTAGEN:C->S: Retains the ability to bind PRDX1; forms a mixed-disulfide with PRDX1; can be reduced by PRDX1; promote motor neuron differentiation as the wild type; when associated with S-18.,MUTAGEN:H->A: Abolishes the ability to promote motor neuron differentiation.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9QXF8	glycine N-methyltransferase(Gnmt)	Mus musculus			GO:0005977~glycogen metabolic process,GO:0006111~regulation of gluconeogenesis,GO:0006544~glycine metabolic process,GO:0006555~methionine metabolic process,GO:0006730~one-carbon metabolic process,GO:0032259~methylation,GO:0046498~S-adenosylhomocysteine metabolic process,GO:0046500~S-adenosylmethionine metabolic process,GO:0051289~protein homotetramerization,GO:0071704~organic substance metabolic process,GO:1901052~sarcosine metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034708~methyltransferase complex,	GO:0005542~folic acid binding,GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016594~glycine binding,GO:0016740~transferase activity,GO:0017174~glycine N-methyltransferase activity,GO:0042802~identical protein binding,GO:1904047~S-adenosyl-L-methionine binding,	IPR014369:Gly/Sar_N_MeTrfase,IPR025714:Methyltranfer_dom,IPR029063:SAM-dependent_MTases_sf,	mmu00260:Glycine, serine and threonine metabolism,mmu00270:Cysteine and methionine metabolism,mmu01100:Metabolic pathways,		PIRSF000385:Gly_N-mtase,			KW-0963~Cytoplasm,				KW-0290~Folate-binding,KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Methyltransferase,
Q0VCM4	glycogen phosphorylase L(PYGL)	Bos taurus			GO:0005977~glycogen metabolic process,GO:0005980~glycogen catabolic process,GO:0009617~response to bacterium,GO:0042593~glucose homeostasis,GO:0070266~necroptotic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0002060~purine nucleobase binding,GO:0005524~ATP binding,GO:0005536~glucose binding,GO:0008184~glycogen phosphorylase activity,GO:0016208~AMP binding,GO:0030170~pyridoxal phosphate binding,GO:0032052~bile acid binding,GO:0042802~identical protein binding,	IPR000811:Glyco_trans_35,IPR011833:Glycg_phsphrylas,IPR035090:Pyridoxal_P_attach_site,	bta00500:Starch and sucrose metabolism,bta01100:Metabolic pathways,bta04217:Necroptosis,bta04910:Insulin signaling pathway,bta04922:Glucagon signaling pathway,bta04931:Insulin resistance,		PIRSF000460:Pprylas_GlgP,		KW-0119~Carbohydrate metabolism,KW-0321~Glycogen metabolism,	KW-0963~Cytoplasm,				KW-0547~Nucleotide-binding,KW-0663~Pyridoxal phosphate,	KW-0021~Allosteric enzyme,KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Disordered,SITE:Involved in the association of subunits,SITE:May be involved in allosteric control,
P13834	glycogen synthase 1(GYS1)	Oryctolagus cuniculus			GO:0005978~glycogen biosynthetic process,GO:0007507~heart development,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016234~inclusion body,GO:0098723~skeletal muscle myofibril,	GO:0004373~glycogen (starch) synthase activity,GO:0019901~protein kinase binding,GO:0061547~glycogen synthase activity, transferring glucose-1-phosphate,	IPR008631:Glycogen_synth,	ocu00500:Starch and sucrose metabolism,ocu01100:Metabolic pathways,ocu04151:PI3K-Akt signaling pathway,ocu04152:AMPK signaling pathway,ocu04910:Insulin signaling pathway,ocu04922:Glucagon signaling pathway,ocu04931:Insulin resistance,ocu05415:Diabetic cardiomyopathy,				KW-0320~Glycogen biosynthesis,						KW-0021~Allosteric enzyme,KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	BINDING:in other chain,COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MUTAGEN:S->A: Does not affect PASK-mediated phosphorylation.,MUTAGEN:S->A: Loss of an inhibitory phosphorylation site. Abolishes phosphorylation by DYRK2.Abolishes PASK-mediated phosphorylation.,REGION:Disordered,
Q86YW7	glycoprotein hormone subunit beta 5(GPHB5)	Homo sapiens			GO:0002155~regulation of thyroid hormone mediated signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0005179~hormone activity,GO:0005515~protein binding,GO:0031531~thyrotropin-releasing hormone receptor binding,GO:0046982~protein heterodimerization activity,	IPR001545:Gonadotropin_bsu,IPR006208:Glyco_hormone_CN,IPR029034:Cystine-knot_cytokine,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,			SM00068:GHB,		KW-0964~Secreted,			KW-0732~Signal,		KW-0372~Hormone,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Glycoprotein hormone subunit beta,
Q9CPU0	glyoxalase 1(Glo1)	Mus musculus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006749~glutathione metabolic process,GO:0009438~methylglyoxal metabolic process,GO:0019243~methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,GO:0030316~osteoclast differentiation,GO:0043066~negative regulation of apoptotic process,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0004462~lactoylglutathione lyase activity,GO:0008270~zinc ion binding,GO:0016829~lyase activity,GO:0046872~metal ion binding,	IPR004360:Glyas_Fos-R_dOase_dom,IPR004361:Glyoxalase_1,IPR018146:Glyoxalase_1_CS,IPR029068:Glyas_Bleomycin-R_OHBP_Dase,IPR037523:VOC,	mmu00620:Pyruvate metabolism,mmu01100:Metabolic pathways,									KW-0479~Metal-binding,KW-0862~Zinc,	KW-0456~Lyase,	KW-0007~Acetylation,KW-0318~Glutathionylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton donor/acceptor,BINDING:in other chain,DOMAIN:Glyoxalase/fosfomycin resistance/dioxygenase,DOMAIN:VOC,REGION:Disordered,
Q663W4	glyoxylate/hydroxypyruvate reductase GhrB(ghrB)	Yersinia pseudotuberculosis IP 32953				GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0008465~glycerate dehydrogenase activity,GO:0016618~hydroxypyruvate reductase activity,GO:0030267~glyoxylate reductase (NADP) activity,GO:0051287~NAD binding,	IPR006139:D-isomer_2_OHA_DH_cat_dom,IPR006140:D-isomer_DH_NAD-bd,IPR023756:Glyo/OHPyrv_Rdtase_B,IPR029752:D-isomer_DH_CS1,IPR029753:D-isomer_DH_CS,IPR036291:NAD(P)-bd_dom_sf,						KW-0963~Cytoplasm,				KW-0520~NAD,KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton donor,
P50593	glypican 1(GPC1)	Gallus gallus			GO:0009966~regulation of signal transduction,GO:0016477~cell migration,GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway,GO:1902723~negative regulation of skeletal muscle satellite cell proliferation,GO:1902724~positive regulation of skeletal muscle satellite cell proliferation,GO:1902725~negative regulation of satellite cell differentiation,GO:1902726~positive regulation of skeletal muscle satellite cell differentiation,GO:1905475~regulation of protein localization to membrane,	GO:0005576~extracellular region,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0045202~synapse,GO:0098552~side of membrane,	GO:0017134~fibroblast growth factor binding,	IPR001863:Glypican,IPR019803:Glypican_CS,						KW-0472~Membrane,KW-0964~Secreted,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0357~Heparan sulfate,KW-0449~Lipoprotein,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Xyl...) (heparan sulfate) serine,LIPID:GPI-anchor amidated glycine,PROPEP:Removed in mature form,REGION:Disordered,
P78333	glypican 5(GPC5)	Homo sapiens			GO:0016477~cell migration,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1905475~regulation of protein localization to membrane,	GO:0005576~extracellular region,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0043202~lysosomal lumen,GO:0098552~side of membrane,	GO:0005515~protein binding,	IPR001863:Glypican,IPR019803:Glypican_CS,						KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0357~Heparan sulfate,KW-0449~Lipoprotein,KW-0654~Proteoglycan,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Xyl...) (glycosaminoglycan) serine,COMPBIAS:Basic and acidic residues,PROPEP:Removed in mature form,REGION:Disordered,
Q5RE54	glypican 6(GPC6)	Pongo abelii			GO:0009966~regulation of signal transduction,GO:0016477~cell migration,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0043202~lysosomal lumen,GO:0045202~synapse,GO:0098552~side of membrane,		IPR001863:Glypican,IPR019803:Glypican_CS,						KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0357~Heparan sulfate,KW-0449~Lipoprotein,KW-0654~Proteoglycan,	LIPID:GPI-anchor amidated serine,PROPEP:Removed in mature form,REGION:Disordered,
Q535K8	gon-4 like(Gon4l)	Rattus norvegicus			GO:0006355~regulation of transcription, DNA-templated,GO:0030183~B cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016604~nuclear body,	GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,	IPR001005:SANT/Myb,IPR003822:PAH,IPR009057:Homeobox-like_sf,IPR036600:PAH_sf,IPR049257:Gon4l/CASP8AP2_myb-like,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0678~Repressor,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:Myb-like,DOMAIN:PAH 1,DOMAIN:PAH 2,REGION:Disordered,REGION:Required for interaction with YY1, SIN3A and HDAC1, and transcriptional repression activity,
Q5M7R9	grainyhead like transcription factor 2(grhl2)	Xenopus tropicalis			GO:0001843~neural tube closure,GO:0003382~epithelial cell morphogenesis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0007420~brain development,GO:0021915~neural tube development,GO:0034329~cell junction assembly,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051973~positive regulation of telomerase activity,GO:0070830~bicellular tight junction assembly,	GO:0005634~nucleus,GO:0005911~cell-cell junction,GO:0016020~membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001161~intronic transcription regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR007604:CP2,IPR040167:TF_CP2-like,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,		COMPBIAS:Polar residues,DOMAIN:Grh/CP2 DB,REGION:Disordered,REGION:Transcription activation,SITE:Important for activation of transcription,
P28799	granulin precursor(GRN)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,	GO:0002265~astrocyte activation involved in immune response,GO:0002282~microglial cell activation involved in immune response,GO:0007040~lysosome organization,GO:0007041~lysosomal transport,GO:0007042~lysosomal lumen acidification,GO:0007165~signal transduction,GO:0010595~positive regulation of endothelial cell migration,GO:0030335~positive regulation of cell migration,GO:0043524~negative regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0045766~positive regulation of angiogenesis,GO:0048680~positive regulation of axon regeneration,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050727~regulation of inflammatory response,GO:0050821~protein stabilization,GO:0060266~negative regulation of respiratory burst involved in inflammatory response,GO:1900426~positive regulation of defense response to bacterium,GO:1902564~negative regulation of neutrophil activation,GO:1903334~positive regulation of protein folding,GO:1903979~negative regulation of microglial cell activation,GO:1905247~positive regulation of aspartic-type peptidase activity,GO:1905673~positive regulation of lysosome organization,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005770~late endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0035578~azurophil granule lumen,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0051087~chaperone binding,	IPR000118:Granulin,IPR037277:Granulin_sf,IPR039036:Granulin_fam,		607485~Aphasia, primary progressive,607485~Frontotemporal lobar degeneration with ubiquitin-positive inclusions,614706~Ceroid lipofuscinosis, neuronal, 11,		SM00277:GRAN,		KW-0458~Lysosome,KW-0964~Secreted,		KW-0523~Neurodegeneration,KW-0525~Neuronal ceroid lipofuscinosis,	KW-0677~Repeat,KW-0732~Signal,		KW-0202~Cytokine,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Granulins,PEPTIDE:Granulin-1,PEPTIDE:Granulin-2,PEPTIDE:Granulin-3,PEPTIDE:Granulin-4,PEPTIDE:Granulin-5,PEPTIDE:Granulin-6,PEPTIDE:Granulin-7,PEPTIDE:Paragranulin,REGION:Disordered,
P18291	granzyme B(Gzmb)	Rattus norvegicus			GO:0001913~T cell mediated cytotoxicity,GO:0006508~proteolysis,GO:0017148~negative regulation of translation,GO:0031640~killing of cells of other organism,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042742~defense response to bacterium,GO:0051402~neuron apoptotic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051604~protein maturation,GO:0060545~positive regulation of necroptotic process,GO:0070269~pyroptosis,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0043231~intracellular membrane-bounded organelle,GO:0044194~cytolytic granule,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR043504:Peptidase_S1_PA_chymotrypsin,	rno04210:Apoptosis,rno04650:Natural killer cell mediated cytotoxicity,rno04940:Type I diabetes mellitus,rno05202:Transcriptional misregulation in cancer,rno05320:Autoimmune thyroid disease,rno05330:Allograft rejection,rno05332:Graft-versus-host disease,			SM00020:Tryp_SPc,	KW-0053~Apoptosis,KW-0204~Cytolysis,	KW-0458~Lysosome,KW-0964~Secreted,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase S1,MUTAGEN:N->Q: Decreased secretion without affecting the protease activity.,MUTAGEN:R->A: Does not affect the protease activity.,MUTAGEN:R->E: Decreased activity for acidic amino acids at position P3, whereas the activity against basic amino is increased.,PROPEP:Activation peptide,SITE:Mediates preference for Asp-containing substrates,
P20718	granzyme H(GZMH)	Homo sapiens			GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0031640~killing of cells of other organism,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0044194~cytolytic granule,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR043504:Peptidase_S1_PA_chymotrypsin,				SM00020:Tryp_SPc,	KW-0204~Cytolysis,	KW-0458~Lysosome,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase S1,PROPEP:Activation peptide,REGION:Mediates the preference for acidic residues at the P3' and P4' sites,
P49863	granzyme K(GZMK)	Homo sapiens			GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0030141~secretory granule,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR043504:Peptidase_S1_PA_chymotrypsin,				SM00020:Tryp_SPc,		KW-0964~Secreted,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,DOMAIN:Peptidase S1,PROPEP:Activation peptide,
Q01721	growth arrest specific 1(Gas1)	Mus musculus			GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007224~smoothened signaling pathway,GO:0007411~axon guidance,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008589~regulation of smoothened signaling pathway,GO:0009953~dorsal/ventral pattern formation,GO:0010955~negative regulation of protein processing,GO:0012501~programmed cell death,GO:0021587~cerebellum morphogenesis,GO:0021904~dorsal/ventral neural tube patterning,GO:0030308~negative regulation of cell growth,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0042473~outer ear morphogenesis,GO:0042474~middle ear morphogenesis,GO:0042476~odontogenesis,GO:0042733~embryonic digit morphogenesis,GO:0043010~camera-type eye development,GO:0043066~negative regulation of apoptotic process,GO:0045165~cell fate commitment,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045930~negative regulation of mitotic cell cycle,GO:0048589~developmental growth,GO:0048592~eye morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048706~embryonic skeletal system development,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051726~regulation of cell cycle,GO:0060021~palate development,GO:0060628~regulation of ER to Golgi vesicle-mediated transport,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0098552~side of membrane,	GO:0005515~protein binding,GO:0008142~oxysterol binding,	IPR016017:GDNF/GAS1,IPR039596:GAS1,	mmu04340:Hedgehog signaling pathway,			SM00907:GDNF,	KW-0131~Cell cycle,KW-0338~Growth arrest,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:GDNF/GAS1,LIPID:GPI-anchor amidated serine,PROPEP:Removed in mature form,REGION:Disordered,
P11862	growth arrest specific 2(Gas2)	Mus musculus		m_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,	GO:0001544~initiation of primordial ovarian follicle growth,GO:0001547~antral ovarian follicle growth,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0008360~regulation of cell shape,GO:0008593~regulation of Notch signaling pathway,GO:0030728~ovulation,GO:0051726~regulation of cell cycle,GO:0051764~actin crosslink formation,GO:0071711~basement membrane organization,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0016020~membrane,	GO:0008017~microtubule binding,GO:0008093~cytoskeletal adaptor activity,GO:0051015~actin filament binding,	IPR001715:CH_dom,IPR003108:GAR_dom,IPR036534:GAR_dom_sf,IPR036872:CH_dom_sf,				SM00033:CH,SM00243:GAS2,	KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0133~Cell shape,KW-0338~Growth arrest,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Calponin-homology (CH),DOMAIN:GAR,MUTAGEN:D->A: Abolishes proteolytic processing.,REGION:Disordered,SITE:Cleavage; by a caspase during apoptosis,
O60861	growth arrest specific 7(GAS7)	Homo sapiens			GO:0030041~actin filament polymerization,GO:0048812~neuron projection morphogenesis,	GO:0005737~cytoplasm,GO:0005884~actin filament,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0051015~actin filament binding,	IPR001060:FCH_dom,IPR001202:WW_dom,IPR001452:SH3_domain,IPR027267:AH/BAR_dom_sf,IPR031160:F_BAR,IPR036020:WW_dom_sf,IPR036028:SH3-like_dom_sf,IPR037957:GAS7_F-BAR,				SM00055:FCH,SM00326:SH3,SM00456:WW,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0963~Cytoplasm,		KW-0656~Proto-oncogene,	KW-0175~Coiled coil,KW-0728~SH3 domain,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:F-BAR,DOMAIN:SH3,DOMAIN:WW,REGION:Disordered,
Q60780	growth arrest specific 7(Gas7)	Mus musculus			GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0008360~regulation of cell shape,GO:0030041~actin filament polymerization,GO:0030154~cell differentiation,GO:0030182~neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0051017~actin filament bundle assembly,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005884~actin filament,GO:0005886~plasma membrane,	GO:0042802~identical protein binding,GO:0051015~actin filament binding,	IPR001060:FCH_dom,IPR001202:WW_dom,IPR001452:SH3_domain,IPR027267:AH/BAR_dom_sf,IPR031160:F_BAR,IPR036020:WW_dom_sf,IPR036028:SH3-like_dom_sf,IPR037957:GAS7_F-BAR,				SM00055:FCH,SM00326:SH3,SM00456:WW,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:F-BAR,DOMAIN:SH3,DOMAIN:WW,REGION:Disordered,
Q90375	growth hormone receptor(GHR)	Columba livia			GO:0006897~endocytosis,GO:0019221~cytokine-mediated signaling pathway,GO:0046427~positive regulation of JAK-STAT cascade,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0060396~growth hormone receptor signaling pathway,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0070195~growth hormone receptor complex,	GO:0004896~cytokine receptor activity,GO:0004903~growth hormone receptor activity,GO:0017046~peptide hormone binding,GO:0019838~growth factor binding,GO:0019955~cytokine binding,	IPR003528:Long_hematopoietin_rcpt_CS,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR015152:Growth/epo_recpt_lig-bind,IPR025871:GHBP,IPR036116:FN3_sf,	clv04060:Cytokine-cytokine receptor interaction,clv04080:Neuroactive ligand-receptor interaction,			SM00060:FN3,	KW-0254~Endocytosis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,MOTIF:Box 1 motif,MOTIF:UbE motif,MOTIF:WSXWS motif,REGION:Disordered,REGION:Required for JAK2 binding,SITE:Required for endocytosis and down-regulation,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q02643	growth hormone releasing hormone receptor(GHRHR)	Homo sapiens			GO:0007166~cell surface receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007595~lactation,GO:0008284~positive regulation of cell proliferation,GO:0008340~determination of adult lifespan,GO:0019933~cAMP-mediated signaling,GO:0030252~growth hormone secretion,GO:0032868~response to insulin,GO:0032869~cellular response to insulin stimulus,GO:0033143~regulation of intracellular steroid hormone receptor signaling pathway,GO:0040018~positive regulation of multicellular organism growth,GO:0042445~hormone metabolic process,GO:0043567~regulation of insulin-like growth factor receptor signaling pathway,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0043627~response to estrogen,GO:0048469~cell maturation,GO:0048609~multicellular organismal reproductive process,GO:0051246~regulation of protein metabolic process,GO:0051384~response to glucocorticoid,GO:0051649~establishment of localization in cell,GO:0060124~positive regulation of growth hormone secretion,GO:0060133~somatotropin secreting cell development,	GO:0005637~nuclear inner membrane,GO:0005640~nuclear outer membrane,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0030141~secretory granule,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0008528~G-protein coupled peptide receptor activity,GO:0016520~growth hormone-releasing hormone receptor activity,GO:0017046~peptide hormone binding,GO:0019838~growth factor binding,	IPR000832:GPCR_2_secretin-like,IPR001879:GPCR_2_extracellular_dom,IPR003288:GPCR_2_GHRH_rcpt,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR036445:GPCR_2_extracell_dom_sf,	hsa04080:Neuroactive ligand-receptor interaction,hsa04935:Growth hormone synthesis, secretion and action,	618157~Growth hormone deficiency, isolated, type IV,		SM00008:HormR,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0242~Dwarfism,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 2 profile 1,DOMAIN:G-protein coupled receptors family 2 profile 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q02153	guanylate cyclase 1 soluble subunit beta 1(GUCY1B1)	Homo sapiens		h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,	GO:0006182~cGMP biosynthetic process,GO:0007263~nitric oxide mediated signal transduction,GO:0008015~blood circulation,GO:0019934~cGMP-mediated signaling,GO:0035556~intracellular signal transduction,GO:0038060~nitric oxide-cGMP-mediated signaling pathway,GO:0070482~response to oxygen levels,GO:0071732~cellular response to nitric oxide,GO:0099555~trans-synaptic signaling by nitric oxide, modulating synaptic transmission,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0008074~guanylate cyclase complex, soluble,GO:0098831~presynaptic active zone cytoplasmic component,GO:0098978~glutamatergic synapse,	GO:0004016~adenylate cyclase activity,GO:0004383~guanylate cyclase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0020037~heme binding,GO:0038023~signaling receptor activity,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0047805~cytidylate cyclase activity,GO:0051879~Hsp90 protein binding,	IPR001054:A/G_cyclase,IPR011644:Heme_NO-bd,IPR011645:HNOB_dom_associated,IPR018297:A/G_cyclase_CS,IPR024096:NO_sig/Golgi_transp_ligand-bd,IPR029787:Nucleotide_cyclase,IPR038158:H-NOX_domain_sf,IPR042463:HNOB_dom_associated_sf,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa04022:cGMP-PKG signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04730:Long-term depression,hsa04921:Oxytocin signaling pathway,hsa04924:Renin secretion,hsa04970:Salivary secretion,			SM00044:CYCc,	KW-0141~cGMP biosynthesis,	KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0456~Lyase,		BINDING:proximal binding residue,DOMAIN:Guanylate cyclase,REGION:Disordered,
Q5SDA5	guanylate cyclase 2f(Gucy2f)	Mus musculus			GO:0006182~cGMP biosynthetic process,GO:0006468~protein phosphorylation,GO:0007168~receptor guanylyl cyclase signaling pathway,GO:0007601~visual perception,GO:0009190~cyclic nucleotide biosynthetic process,GO:0019934~cGMP-mediated signaling,GO:0035556~intracellular signal transduction,GO:0050896~response to stimulus,GO:0050908~detection of light stimulus involved in visual perception,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0001653~peptide receptor activity,GO:0004016~adenylate cyclase activity,GO:0004383~guanylate cyclase activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0016829~lyase activity,GO:0016849~phosphorus-oxygen lyase activity,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,	IPR000719:Prot_kinase_dom,IPR001054:A/G_cyclase,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001828:ANF_lig-bd_rcpt,IPR011009:Kinase-like_dom_sf,IPR018297:A/G_cyclase_CS,IPR028082:Peripla_BP_I,IPR029787:Nucleotide_cyclase,	mmu00230:Purine metabolism,mmu01100:Metabolic pathways,mmu04744:Phototransduction,			SM00044:CYCc,	KW-0141~cGMP biosynthesis,KW-0716~Sensory transduction,KW-0844~Vision,	KW-0472~Membrane,KW-0966~Cell projection,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0456~Lyase,	KW-1015~Disulfide bond,	DISULFID:Interchain,DOMAIN:Guanylate cyclase,DOMAIN:Protein kinase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P79880	guanylate cyclase activator 1A(GUCA1A)	Gallus gallus			GO:0007601~visual perception,GO:0007602~phototransduction,GO:0031284~positive regulation of guanylate cyclase activity,GO:0071277~cellular response to calcium ion,	GO:0001917~photoreceptor inner segment,	GO:0005509~calcium ion binding,GO:0008048~calcium sensitive guanylate cyclase activator activity,GO:0030249~guanylate cyclase regulator activity,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR028846:Recoverin,	gga04744:Phototransduction,			SM00054:EFh,	KW-0716~Sensory transduction,KW-0844~Vision,				KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0449~Lipoprotein,KW-0519~Myristate,	DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,LIPID:N-myristoyl glycine,
Q6DRM0	guided entry of tail-anchored proteins factor 1(get1)	Danio rerio			GO:0001964~startle response,GO:0007507~heart development,GO:0007605~sensory perception of sound,GO:0010996~response to auditory stimulus,GO:0060041~retina development in camera-type eye,GO:0071816~tail-anchored membrane protein insertion into ER membrane,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043529~GET complex,	GO:0043495~protein anchor,	IPR028945:Get1,IPR029012:Helix_hairpin_bin_sf,	dre03060:Protein export,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Interaction with GET3/TRC40,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q5BJJ5	haloacid dehalogenase-like hydrolase domain containing 2(hdhd2)	Danio rerio			GO:0016311~dephosphorylation,		GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0046872~metal ion binding,	IPR006355:LHPP/HDHD2,IPR006357:HAD-SF_hydro_IIA,IPR023214:HAD_sf,IPR036412:HAD-like_sf,										KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,
Q96MB7	harbinger transposase derived 1(HARBI1)	Homo sapiens				GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0034451~centriolar satellite,	GO:0004518~nuclease activity,GO:0046872~metal ion binding,	IPR026103:HARBI1_animal,IPR027806:HARBI1_dom,						KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0540~Nuclease,		DOMAIN:DDE Tnp4,
Q6AZB8	harbinger transposase derived 1(harbi1)	Danio rerio				GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004518~nuclease activity,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0046872~metal ion binding,	IPR026103:HARBI1_animal,IPR027806:HARBI1_dom,						KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0540~Nuclease,		DOMAIN:DDE Tnp4,
P57102	heart and neural crest derivatives expressed 2(hand2)	Danio rerio			GO:0001947~heart looping,GO:0003007~heart morphogenesis,GO:0003142~cardiogenic plate morphogenesis,GO:0003144~embryonic heart tube formation,GO:0003342~proepicardium development,GO:0003357~noradrenergic neuron differentiation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0010002~cardioblast differentiation,GO:0030859~polarized epithelial cell differentiation,GO:0030878~thyroid gland development,GO:0035051~cardiocyte differentiation,GO:0035118~embryonic pectoral fin morphogenesis,GO:0048485~sympathetic nervous system development,GO:0048703~embryonic viscerocranium morphogenesis,GO:0055007~cardiac muscle cell differentiation,GO:0060047~heart contraction,GO:0071908~determination of intestine left/right asymmetry,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046983~protein dimerization activity,	IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,				SM00353:HLH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,DOMAIN:BHLH,DOMAIN:bHLH,REGION:Disordered,
P08108	heat shock protein 8(hspa8)	Oncorhynchus mykiss			GO:0009408~response to heat,GO:0016192~vesicle-mediated transport,GO:0034620~cellular response to unfolded protein,GO:0042026~protein refolding,GO:0046686~response to cadmium ion,GO:0046688~response to copper ion,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:1903842~response to arsenite ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,GO:0051787~misfolded protein binding,	IPR013126:Hsp_70_fam,IPR018181:Heat_shock_70_CS,IPR029047:HSP70_peptide-bd_sf,IPR029048:HSP70_C_sf,IPR043129:ATPase_NBD,	omy03040:Spliceosome,omy04010:MAPK signaling pathway,omy04141:Protein processing in endoplasmic reticulum,omy04144:Endocytosis,				KW-0346~Stress response,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			REGION:Disordered,
P41148	heat shock protein 90 beta family member 1(HSP90B1)	Canis lupus familiaris			GO:0001666~response to hypoxia,GO:0006457~protein folding,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0030970~retrograde protein transport, ER to cytosol,GO:0031247~actin rod assembly,GO:0043066~negative regulation of apoptotic process,GO:0071318~cellular response to ATP,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0030496~midbody,GO:0032991~macromolecular complex,GO:0033018~sarcoplasmic reticulum lumen,GO:0042470~melanosome,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019903~protein phosphatase binding,GO:0050750~low-density lipoprotein particle receptor binding,GO:0051082~unfolded protein binding,	IPR001404:Hsp90_fam,IPR003594:HATPase_C,IPR019805:Heat_shock_protein_90_CS,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR020575:Hsp90_N,IPR036890:HATPase_C_sf,IPR037196:HSP90_C,	cfa04141:Protein processing in endoplasmic reticulum,cfa04151:PI3K-Akt signaling pathway,cfa04657:IL-17 signaling pathway,cfa04915:Estrogen signaling pathway,cfa04918:Thyroid hormone synthesis,cfa05132:Salmonella infection,cfa05200:Pathways in cancer,cfa05207:Chemical carcinogenesis - receptor activation,cfa05215:Prostate cancer,cfa05417:Lipid and atherosclerosis,cfa05418:Fluid shear stress and atherosclerosis,		PIRSF002583:Hsp90,	SM00387:HATPase_c,		KW-0256~Endoplasmic reticulum,KW-0703~Sarcoplasmic reticulum,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DISULFID:Interchain,DOMAIN:Histidine kinase/HSP90-like ATPase,MOTIF:Prevents secretion from ER,MUTAGEN:E->A: Loss of ATPase activity.,MUTAGEN:R->A: Reduces ATPase activity by 85%.,REGION:Disordered,SITE:Important for ATP hydrolysis,
Q95M18	heat shock protein 90 beta family member 1(HSP90B1)	Bos taurus			GO:0001666~response to hypoxia,GO:0006457~protein folding,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0030970~retrograde protein transport, ER to cytosol,GO:0031247~actin rod assembly,GO:0043066~negative regulation of apoptotic process,GO:0071318~cellular response to ATP,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0030496~midbody,GO:0032991~macromolecular complex,GO:0033018~sarcoplasmic reticulum lumen,GO:0042470~melanosome,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019903~protein phosphatase binding,GO:0050750~low-density lipoprotein particle receptor binding,GO:0051082~unfolded protein binding,	IPR001404:Hsp90_fam,IPR003594:HATPase_C,IPR019805:Heat_shock_protein_90_CS,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR020575:Hsp90_N,IPR036890:HATPase_C_sf,IPR037196:HSP90_C,	bta04141:Protein processing in endoplasmic reticulum,bta04151:PI3K-Akt signaling pathway,bta04657:IL-17 signaling pathway,bta04915:Estrogen signaling pathway,bta04918:Thyroid hormone synthesis,bta05132:Salmonella infection,bta05200:Pathways in cancer,bta05207:Chemical carcinogenesis - receptor activation,bta05215:Prostate cancer,bta05417:Lipid and atherosclerosis,bta05418:Fluid shear stress and atherosclerosis,		PIRSF002583:Hsp90,	SM00387:HATPase_c,		KW-0256~Endoplasmic reticulum,KW-0703~Sarcoplasmic reticulum,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,DISULFID:Interchain,MOTIF:Prevents secretion from ER,REGION:Disordered,SITE:Important for ATP hydrolysis,
O57521	heat shock protein 90, alpha (cytosolic), class B member 1(hsp90ab1)	Danio rerio			GO:0001568~blood vessel development,GO:0006457~protein folding,GO:0007517~muscle organ development,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034605~cellular response to heat,GO:0043627~response to estrogen,GO:0050821~protein stabilization,GO:0050900~leukocyte migration,GO:0051726~regulation of cell cycle,GO:1901389~negative regulation of transforming growth factor beta activation,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0032991~macromolecular complex,GO:0034751~aryl hydrocarbon receptor complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0046983~protein dimerization activity,GO:0051082~unfolded protein binding,GO:0097718~disordered domain specific binding,	IPR001404:Hsp90_fam,IPR003594:HATPase_C,IPR019805:Heat_shock_protein_90_CS,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR020575:Hsp90_N,IPR036890:HATPase_C_sf,IPR037196:HSP90_C,	dre04141:Protein processing in endoplasmic reticulum,dre04217:Necroptosis,dre04621:NOD-like receptor signaling pathway,dre04914:Progesterone-mediated oocyte maturation,dre05132:Salmonella infection,		PIRSF002583:Hsp90,	SM00387:HATPase_c,	KW-0346~Stress response,KW-0517~Myogenesis,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,MOTIF:TPR repeat-binding,REGION:Disordered,
Q0VCX2	heat shock protein family A (Hsp70) member 5(HSPA5)	Bos taurus			GO:0006983~ER overload response,GO:0021589~cerebellum structural organization,GO:0021680~cerebellar Purkinje cell layer development,GO:0030335~positive regulation of cell migration,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031204~posttranslational protein targeting to membrane, translocation,GO:0031333~negative regulation of protein complex assembly,GO:0031398~positive regulation of protein ubiquitination,GO:0034620~cellular response to unfolded protein,GO:0035437~maintenance of protein localization in endoplasmic reticulum,GO:0042026~protein refolding,GO:0042149~cellular response to glucose starvation,GO:0043066~negative regulation of apoptotic process,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0071353~cellular response to interleukin-4,GO:1903895~negative regulation of IRE1-mediated unfolded protein response,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008180~COP9 signalosome,GO:0009986~cell surface,GO:0016020~membrane,GO:0030496~midbody,GO:0034663~endoplasmic reticulum chaperone complex,GO:0042470~melanosome,GO:0043231~intracellular membrane-bounded organelle,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019904~protein domain specific binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0043022~ribosome binding,GO:0044183~protein binding involved in protein folding,GO:0051082~unfolded protein binding,GO:0051787~misfolded protein binding,	IPR013126:Hsp_70_fam,IPR018181:Heat_shock_70_CS,IPR029047:HSP70_peptide-bd_sf,IPR029048:HSP70_C_sf,IPR042050:BIP_NBD,IPR043129:ATPase_NBD,	bta03060:Protein export,bta04141:Protein processing in endoplasmic reticulum,bta04612:Antigen processing and presentation,bta04918:Thyroid hormone synthesis,bta05012:Parkinson disease,bta05014:Amyotrophic lateral sclerosis,bta05020:Prion disease,bta05022:Pathways of neurodegeneration - multiple diseases,bta05417:Lipid and atherosclerosis,					KW-0256~Endoplasmic reticulum,KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0944~Nitration,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MOTIF:Prevents secretion from ER,REGION:Disordered,REGION:Interdomain linker,REGION:Nucleotide-binding (NBD),REGION:Required for interaction with KIAA1324,REGION:Substrate-binding (SBD),
Q5R511	heat shock protein family A (Hsp70) member 9(HSPA9)	Pongo abelii			GO:0006457~protein folding,GO:0006611~protein export from nucleus,GO:0016226~iron-sulfur cluster assembly,GO:0030218~erythrocyte differentiation,GO:0045646~regulation of erythrocyte differentiation,GO:0045647~negative regulation of erythrocyte differentiation,GO:1902037~negative regulation of hematopoietic stem cell differentiation,GO:1903707~negative regulation of hemopoiesis,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0042645~mitochondrial nucleoid,	GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,GO:0051082~unfolded protein binding,	IPR012725:Chaperone_DnaK,IPR013126:Hsp_70_fam,IPR018181:Heat_shock_70_CS,IPR029047:HSP70_peptide-bd_sf,IPR029048:HSP70_C_sf,IPR043129:ATPase_NBD,	pon03018:RNA degradation,pon05152:Tuberculosis,					KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0732~Signal,KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Interaction with FXN and ISCU,REGION:Interaction with NFS1,TRANSIT:Mitochondrion,
A4IGP0	heat shock protein nuclear import factor hikeshi(hikeshi)	Xenopus tropicalis			GO:0006606~protein import into nucleus,GO:0015031~protein transport,GO:0034605~cellular response to heat,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0030544~Hsp70 protein binding,GO:0061608~nuclear import signal receptor activity,	IPR008493:Hikeshi-like_N,IPR031318:OPI10,IPR048364:Hikeshi-like_C,					KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,							DOMAIN:Hikeshi-like C-terminal,DOMAIN:Hikeshi-like N-terminal,
Q96QV1	hedgehog interacting protein(HHIP)	Homo sapiens			GO:0007165~signal transduction,GO:0007405~neuroblast proliferation,GO:0009953~dorsal/ventral pattern formation,GO:0009968~negative regulation of signal transduction,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0045879~negative regulation of smoothened signaling pathway,GO:0048705~skeletal system morphogenesis,GO:0060441~epithelial tube branching involved in lung morphogenesis,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0060170~ciliary membrane,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0097108~hedgehog family protein binding,	IPR000742:EGF-like_dom,IPR011041:Quinoprot_gluc/sorb_DH,IPR011042:6-blade_b-propeller_TolB-like,IPR012938:Glc/Sorbosone_DH,IPR013111:EGF_extracell,IPR018143:Folate_rcpt-like,	hsa04024:cAMP signaling pathway,hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,			SM00181:EGF,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,MUTAGEN:D->A,R: Abolishes SHH binding.,MUTAGEN:D->A: Abolishes SHH binding.,MUTAGEN:E->A: Abolishes SHH binding.,MUTAGEN:M->A: Abolishes SHH binding.,REGION:Interaction with SHH zinc binding site,
P42694	helicase with zinc finger(HELZ)	Homo sapiens			GO:0035194~posttranscriptional gene silencing by RNA,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,GO:0043186~P granule,	GO:0003723~RNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000571:Znf_CCCH,IPR006935:Helicase/UvrB_N,IPR011990:TPR-like_helical_dom_sf,IPR014016:UvrD-like_ATP-bd,IPR027417:P-loop_NTPase,IPR036855:Znf_CCCH_sf,IPR041677:DNA2/NAM7_AAA_11,IPR041679:DNA2/NAM7-like_C,IPR045055:DNA2/NAM7-like,IPR047187:SF1_C_Upf1,				SM00356:ZnF_C3H1,	KW-0945~Host-virus interaction,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0347~Helicase,KW-0378~Hydrolase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:C3H1-type,MOTIF:DEAA box,REGION:Disordered,TRANSMEM:Helical,ZN_FING:C3H1-type,
Q8TDG4	helicase, POLQ like(HELQ)	Homo sapiens			GO:0000724~double-strand break repair via homologous recombination,GO:0010792~DNA double-strand break processing involved in repair via single-strand annealing,GO:0032508~DNA duplex unwinding,GO:0045003~double-strand break repair via synthesis-dependent strand annealing,GO:0097681~double-strand break repair via alternative nonhomologous end joining,GO:1905168~positive regulation of double-strand break repair via homologous recombination,	GO:0005634~nucleus,GO:0090734~site of DNA damage,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:1990518~single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,	IPR001650:Helicase_C,IPR011545:DEAD/DEAH_box_helicase_dom,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR036390:WH_DNA-bd_sf,IPR046931:HTH_61,IPR048960:POLQ-like_helical,				SM00487:DEXDc,SM00490:HELICc,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,MUTAGEN:D->A: Abolished ATPase and DNA helicase activity.,MUTAGEN:K->M: Abolishes ATPase and DNA helicase activity.,MUTAGEN:YK->SD: Abolished double-stranded DNA-binding.,REGION:Disordered,
Q56A36	hematopoietic SH2 domain containing(hsh2d)	Danio rerio			GO:0007165~signal transduction,	GO:0005737~cytoplasm,		IPR000980:SH2,IPR035047:HSH2D_SH2,IPR036860:SH2_dom_sf,				SM00252:SH2,					KW-0727~SH2 domain,				COMPBIAS:Polar residues,DOMAIN:SH2,REGION:Disordered,
Q8CFY5	heme A:farnesyltransferase cytochrome c oxidase assembly factor 10(Cox10)	Mus musculus			GO:0000266~mitochondrial fission,GO:0006629~lipid metabolic process,GO:0006783~heme biosynthetic process,GO:0006784~heme a biosynthetic process,GO:0007005~mitochondrion organization,GO:0008535~respiratory chain complex IV assembly,GO:0009060~aerobic respiration,GO:0017004~cytochrome complex assembly,GO:0018343~protein farnesylation,GO:0048034~heme O biosynthetic process,	GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0031966~mitochondrial membrane,GO:0070069~cytochrome complex,	GO:0004311~farnesyltranstransferase activity,GO:0008495~protoheme IX farnesyltransferase activity,GO:0016740~transferase activity,GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,	IPR000537:UbiA_prenyltransferase,IPR006369:Protohaem_IX_farnesylTrfase,IPR016315:Protohaem_IX_farnesylTrfase_mt,IPR030470:UbiA_prenylTrfase_CS,IPR044878:UbiA_sf,	mmu00190:Oxidative phosphorylation,mmu00860:Porphyrin metabolism,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,mmu04714:Thermogenesis,		PIRSF001773:COX10,		KW-0350~Heme biosynthesis,KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0496~Mitochondrion,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,		REGION:Disordered,TRANSIT:Mitochondrion,TRANSMEM:Helical,
P23711	heme oxygenase 2(Hmox2)	Rattus norvegicus			GO:0001666~response to hypoxia,GO:0006788~heme oxidation,GO:0006979~response to oxidative stress,GO:0042167~heme catabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004392~heme oxygenase (decyclizing) activity,GO:0005515~protein binding,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR002051:Haem_Oase,IPR016053:Haem_Oase-like,IPR016084:Haem_Oase-like_multi-hlx,IPR018207:Haem_oxygenase_CS,	rno00860:Porphyrin metabolism,rno01100:Metabolic pathways,rno04978:Mineral absorption,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	BINDING:axial binding residue,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:HRM 1,REPEAT:HRM 2,SITE:Important for catalytic activity,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
Q96RW7	hemicentin 1(HMCN1)	Homo sapiens			GO:0007049~cell cycle,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007601~visual perception,GO:0009617~response to bacterium,GO:0030036~actin cytoskeleton organization,GO:0051301~cell division,GO:0071711~basement membrane organization,	GO:0005604~basement membrane,GO:0005737~cytoplasm,GO:0005912~adherens junction,GO:0005927~muscle tendon junction,GO:0005938~cell cortex,GO:0032154~cleavage furrow,GO:0070062~extracellular exosome,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR000884:TSP1_rpt,IPR001881:EGF-like_Ca-bd_dom,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR006605:G2_nidogen/fibulin_G2F,IPR007110:Ig-like_dom,IPR009017:GFP,IPR009030:Growth_fac_rcpt_cys_sf,IPR013098:Ig_I-set,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR018097:EGF_Ca-bd_CS,IPR026823:cEGF,IPR036179:Ig-like_dom_sf,IPR036383:TSP1_rpt_sf,IPR036465:vWFA_dom_sf,		603075~Macular degeneration, age-related, 1,		SM00179:EGF_CA,SM00181:EGF,SM00209:TSP1,SM00406:IGv,SM00408:IGc2,SM00409:IG,SM00682:G2F,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0716~Sensory transduction,KW-0844~Vision,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0963~Cytoplasm,KW-0964~Secreted,KW-0965~Cell junction,		KW-0225~Disease variant,KW-0913~Age-related macular degeneration,	KW-0245~EGF-like domain,KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like 1; calcium-binding,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 10,DOMAIN:Ig-like C2-type 11,DOMAIN:Ig-like C2-type 12,DOMAIN:Ig-like C2-type 13,DOMAIN:Ig-like C2-type 14,DOMAIN:Ig-like C2-type 15,DOMAIN:Ig-like C2-type 16,DOMAIN:Ig-like C2-type 17,DOMAIN:Ig-like C2-type 18,DOMAIN:Ig-like C2-type 19,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 20,DOMAIN:Ig-like C2-type 21,DOMAIN:Ig-like C2-type 22,DOMAIN:Ig-like C2-type 23,DOMAIN:Ig-like C2-type 24,DOMAIN:Ig-like C2-type 25,DOMAIN:Ig-like C2-type 26,DOMAIN:Ig-like C2-type 27,DOMAIN:Ig-like C2-type 28,DOMAIN:Ig-like C2-type 29,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 30,DOMAIN:Ig-like C2-type 31,DOMAIN:Ig-like C2-type 32,DOMAIN:Ig-like C2-type 33,DOMAIN:Ig-like C2-type 34,DOMAIN:Ig-like C2-type 35,DOMAIN:Ig-like C2-type 36,DOMAIN:Ig-like C2-type 37,DOMAIN:Ig-like C2-type 38,DOMAIN:Ig-like C2-type 39,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 40,DOMAIN:Ig-like C2-type 41,DOMAIN:Ig-like C2-type 42,DOMAIN:Ig-like C2-type 43,DOMAIN:Ig-like C2-type 44,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,DOMAIN:Ig-like C2-type 7,DOMAIN:Ig-like C2-type 8,DOMAIN:Ig-like C2-type 9,DOMAIN:Nidogen G2 beta-barrel,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,DOMAIN:TSP type-1 5,DOMAIN:TSP type-1 6,DOMAIN:VWFA,
D3YXG0	hemicentin 1(Hmcn1)	Mus musculus			GO:0007049~cell cycle,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0009617~response to bacterium,GO:0030036~actin cytoskeleton organization,GO:0051301~cell division,GO:0071711~basement membrane organization,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005737~cytoplasm,GO:0005912~adherens junction,GO:0005927~muscle tendon junction,GO:0005938~cell cortex,GO:0030054~cell junction,GO:0032154~cleavage furrow,GO:0070161~anchoring junction,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR000884:TSP1_rpt,IPR001881:EGF-like_Ca-bd_dom,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR006605:G2_nidogen/fibulin_G2F,IPR007110:Ig-like_dom,IPR009017:GFP,IPR009030:Growth_fac_rcpt_cys_sf,IPR013098:Ig_I-set,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR018097:EGF_Ca-bd_CS,IPR026823:cEGF,IPR036179:Ig-like_dom_sf,IPR036383:TSP1_rpt_sf,IPR036465:vWFA_dom_sf,				SM00179:EGF_CA,SM00181:EGF,SM00209:TSP1,SM00406:IGv,SM00408:IGc2,SM00409:IG,SM00682:G2F,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0963~Cytoplasm,KW-0964~Secreted,KW-0965~Cell junction,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:O-linked (GalNAc...) threonine,DOMAIN:EGF-like,DOMAIN:EGF-like 1; calcium-binding,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 10,DOMAIN:Ig-like C2-type 11,DOMAIN:Ig-like C2-type 12,DOMAIN:Ig-like C2-type 13,DOMAIN:Ig-like C2-type 14,DOMAIN:Ig-like C2-type 15,DOMAIN:Ig-like C2-type 16,DOMAIN:Ig-like C2-type 17,DOMAIN:Ig-like C2-type 18,DOMAIN:Ig-like C2-type 19,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 20,DOMAIN:Ig-like C2-type 21,DOMAIN:Ig-like C2-type 22,DOMAIN:Ig-like C2-type 23,DOMAIN:Ig-like C2-type 24,DOMAIN:Ig-like C2-type 25,DOMAIN:Ig-like C2-type 26,DOMAIN:Ig-like C2-type 27,DOMAIN:Ig-like C2-type 28,DOMAIN:Ig-like C2-type 29,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 30,DOMAIN:Ig-like C2-type 31,DOMAIN:Ig-like C2-type 32,DOMAIN:Ig-like C2-type 33,DOMAIN:Ig-like C2-type 34,DOMAIN:Ig-like C2-type 35,DOMAIN:Ig-like C2-type 36,DOMAIN:Ig-like C2-type 37,DOMAIN:Ig-like C2-type 38,DOMAIN:Ig-like C2-type 39,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 40,DOMAIN:Ig-like C2-type 41,DOMAIN:Ig-like C2-type 42,DOMAIN:Ig-like C2-type 43,DOMAIN:Ig-like C2-type 44,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,DOMAIN:Ig-like C2-type 7,DOMAIN:Ig-like C2-type 8,DOMAIN:Ig-like C2-type 9,DOMAIN:Nidogen G2 beta-barrel,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,DOMAIN:TSP type-1 5,DOMAIN:TSP type-1 6,DOMAIN:VWFA,
P02001	hemoglobin alpha, subunit D(HBAD)	Gallus gallus			GO:0015671~oxygen transport,GO:0042744~hydrogen peroxide catabolic process,GO:0098869~cellular oxidant detoxification,	GO:0005833~hemoglobin complex,GO:0031838~haptoglobin-hemoglobin complex,GO:0072562~blood microparticle,	GO:0004601~peroxidase activity,GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0031720~haptoglobin binding,GO:0043177~organic acid binding,	IPR000971:Globin,IPR002338:Hemoglobin_a-typ,IPR002339:Hemoglobin_pi,IPR009050:Globin-like_sf,IPR012292:Globin/Proto,					KW-0561~Oxygen transport,KW-0813~Transport,					KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,			BINDING:distal binding residue,BINDING:proximal binding residue,COMPBIAS:Polar residues,DOMAIN:Globin family profile,REGION:Disordered,
P84610	hemoglobin subunit beta-1(LOC115560866)	Gadus morhua			GO:0015671~oxygen transport,GO:0042744~hydrogen peroxide catabolic process,	GO:0005833~hemoglobin complex,GO:0031838~haptoglobin-hemoglobin complex,GO:0072562~blood microparticle,	GO:0004601~peroxidase activity,GO:0005344~oxygen transporter activity,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0031720~haptoglobin binding,GO:0043177~organic acid binding,GO:0046872~metal ion binding,	IPR000971:Globin,IPR002337:Hemoglobin_b,IPR009050:Globin-like_sf,IPR012292:Globin/Proto,					KW-0561~Oxygen transport,KW-0813~Transport,					KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,			BINDING:distal binding residue,BINDING:proximal binding residue,DOMAIN:Globin family profile,
Q6PHG2	hemopexin a(hpxa)	Danio rerio			GO:0006879~cellular iron ion homeostasis,GO:0015886~heme transport,GO:0071391~cellular response to estrogen stimulus,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0015232~heme transporter activity,GO:0046872~metal ion binding,	IPR000585:Hemopexin-like_dom,IPR016358:Hemopexin,IPR018487:Hemopexin-like_repeat,IPR036375:Hemopexin-like_dom_sf,			PIRSF002551:Hemopexin_chordata,	SM00120:HX,	KW-0813~Transport,	KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,		KW-0325~Glycoprotein,	BINDING:axial binding residue,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,REPEAT:Hemopexin 5,REPEAT:Hemopexin 6,REPEAT:Hemopexin 7,REPEAT:Hemopexin 8,
Q76KB1	heparan sulfate 2-O-sulfotransferase 1(HS2ST1)	Gallus gallus			GO:0010467~gene expression,GO:0015014~heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,GO:0015015~heparan sulfate proteoglycan biosynthetic process, enzymatic modification,GO:0030202~heparin metabolic process,GO:0060676~ureteric bud formation,	GO:0000139~Golgi membrane,GO:0016020~membrane,	GO:0004394~heparan sulfate 2-O-sulfotransferase activity,GO:0008146~sulfotransferase activity,GO:0042802~identical protein binding,	IPR005331:Sulfotransferase,IPR007734:Heparan_SO4_2-O-STrfase,IPR027417:P-loop_NTPase,	gga00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,					KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:H->A: Complete loss of activity; when associated with Ala-140.,MUTAGEN:H->A: Complete loss of activity; when associated with Ala-142.,MUTAGEN:H->A: Preferentially transfers sulfates to IdoA units.,MUTAGEN:R->A: Less than 10% activity toward polysaccharide substrates.,MUTAGEN:R->A: Only transfers sulfates to GlcA moieties within the polysaccharide.,MUTAGEN:Y->A: Preferentially transfers sulfates to IdoA units.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P98160	heparan sulfate proteoglycan 2(HSPG2)	Homo sapiens			GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0001938~positive regulation of endothelial cell proliferation,GO:0006629~lipid metabolic process,GO:0006898~receptor-mediated endocytosis,GO:0006954~inflammatory response,GO:0007162~negative regulation of cell adhesion,GO:0007224~smoothened signaling pathway,GO:0007420~brain development,GO:0007566~embryo implantation,GO:0008285~negative regulation of cell proliferation,GO:0009410~response to xenobiotic stimulus,GO:0016525~negative regulation of angiogenesis,GO:0030154~cell differentiation,GO:0031100~animal organ regeneration,GO:0072359~circulatory system development,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,GO:0098797~plasma membrane protein complex,	GO:0001540~beta-amyloid binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030021~extracellular matrix structural constituent conferring compression resistance,GO:0050750~low-density lipoprotein particle receptor binding,GO:0070052~collagen V binding,	IPR000034:Laminin_IV,IPR000082:SEA_dom,IPR000742:EGF-like_dom,IPR001791:Laminin_G,IPR001881:EGF-like_Ca-bd_dom,IPR002049:LE_dom,IPR002172:LDrepeatLR_classA_rpt,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013106:Ig_V-set,IPR013320:ConA-like_dom_sf,IPR013783:Ig-like_fold,IPR023415:LDLR_class-A_CS,IPR036055:LDL_receptor-like_sf,IPR036179:Ig-like_dom_sf,	hsa04512:ECM-receptor interaction,hsa05161:Hepatitis B,hsa05205:Proteoglycans in cancer,	224410~Dyssegmental dysplasia, Silverman-Handmaker type,255800~Schwartz-Jampel syndrome, type 1,		SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,SM00192:LDLa,SM00200:SEA,SM00281:LamB,SM00282:LamG,SM00406:IGv,SM00408:IGc2,SM00409:IG,	KW-0037~Angiogenesis,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,	KW-0245~EGF-like domain,KW-0393~Immunoglobulin domain,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0357~Heparan sulfate,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) threonine,CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine,CARBOHYD:O-linked (Xyl...) (heparan sulfate) serine,COMPBIAS:Pro residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 10,DOMAIN:Ig-like C2-type 11,DOMAIN:Ig-like C2-type 12,DOMAIN:Ig-like C2-type 13,DOMAIN:Ig-like C2-type 14,DOMAIN:Ig-like C2-type 15,DOMAIN:Ig-like C2-type 16,DOMAIN:Ig-like C2-type 17,DOMAIN:Ig-like C2-type 18,DOMAIN:Ig-like C2-type 19,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 20,DOMAIN:Ig-like C2-type 21,DOMAIN:Ig-like C2-type 22,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,DOMAIN:Ig-like C2-type 7,DOMAIN:Ig-like C2-type 8,DOMAIN:Ig-like C2-type 9,DOMAIN:LDL-receptor class A 1,DOMAIN:LDL-receptor class A 2,DOMAIN:LDL-receptor class A 3,DOMAIN:LDL-receptor class A 4,DOMAIN:Laminin EGF-like,DOMAIN:Laminin EGF-like 10,DOMAIN:Laminin EGF-like 11,DOMAIN:Laminin EGF-like 1; first part,DOMAIN:Laminin EGF-like 1; second part,DOMAIN:Laminin EGF-like 2,DOMAIN:Laminin EGF-like 3,DOMAIN:Laminin EGF-like 4; truncated,DOMAIN:Laminin EGF-like 5; first part,DOMAIN:Laminin EGF-like 5; second part,DOMAIN:Laminin EGF-like 6,DOMAIN:Laminin EGF-like 7,DOMAIN:Laminin EGF-like 8,DOMAIN:Laminin EGF-like 9; first part,DOMAIN:Laminin EGF-like 9; second part,DOMAIN:Laminin G,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G-like 2,DOMAIN:Laminin G-like 3,DOMAIN:Laminin IV type A,DOMAIN:Laminin IV type A 1,DOMAIN:Laminin IV type A 2,DOMAIN:Laminin IV type A 3,DOMAIN:SEA,MUTAGEN:D->A: Retains proper folding. Reduced calcium ion binding.,MUTAGEN:D->I: Abolishes BMP1-mediated cleavage of endorepellin.,MUTAGEN:N->A: Retains proper folding. Reduced calcium ion binding.,REGION:Disordered,REGION:Mediates motor neuron attachment,SITE:Cleavage; by BMP1,
Q9ESG5	heparan sulfate-glucosamine 3-sulfotransferase 1(Hs3st1)	Rattus norvegicus			GO:0006024~glycosaminoglycan biosynthetic process,GO:0015012~heparan sulfate proteoglycan biosynthetic process,	GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,	GO:0008146~sulfotransferase activity,GO:0008467~[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,	IPR000863:Sulfotransferase_dom,IPR027417:P-loop_NTPase,IPR037359:NST/OST,	rno00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,					KW-0333~Golgi apparatus,			KW-0732~Signal,		KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:For sulfotransferase activity,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Sulfotransferase,
Q9Y251	heparanase(HPSE)	Homo sapiens			GO:0006029~proteoglycan metabolic process,GO:0007160~cell-matrix adhesion,GO:0010033~response to organic substance,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0030194~positive regulation of blood coagulation,GO:0030200~heparan sulfate proteoglycan catabolic process,GO:0030202~heparin metabolic process,GO:0033690~positive regulation of osteoblast proliferation,GO:0051797~regulation of hair follicle development,GO:0051798~positive regulation of hair follicle development,GO:0051897~positive regulation of protein kinase B signaling,GO:0060055~angiogenesis involved in wound healing,GO:0061028~establishment of endothelial barrier,GO:0061042~vascular wound healing,GO:0071806~protein transmembrane transport,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0035580~specific granule lumen,GO:0043202~lysosomal lumen,GO:0043231~intracellular membrane-bounded organelle,GO:0045121~membrane raft,	GO:0004566~beta-glucuronidase activity,GO:0005515~protein binding,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0030305~heparanase activity,GO:0045545~syndecan binding,	IPR005199:Glyco_hydro_79,IPR017853:Glycoside_hydrolase_SF,	hsa00531:Glycosaminoglycan degradation,hsa01100:Metabolic pathways,hsa05205:Proteoglycans in cancer,				KW-0130~Cell adhesion,	KW-0458~Lysosome,KW-0472~Membrane,KW-0539~Nucleus,KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0460~Magnesium,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:A->K: Abolishes processing, secretion and enzyme activity.,MUTAGEN:A->K: No effect on processing, secretion nor enzyme activity.,MUTAGEN:C->A: Abolishes processing, secretion and enzyme activity.,MUTAGEN:D->A: Strong decrease in heparanase activity.,MUTAGEN:E->A: Loss of heparanase activity.,MUTAGEN:E->A: Loss of heparanase activity. No effect on HPSE-mediated cell adhesion.,MUTAGEN:E->A: No reduction in heparanase activity.,MUTAGEN:F->R: Abolishes processing, secretion and enzyme activity.,MUTAGEN:F->R: No effect on processing nor secretion. No enzyme activity detected.,MUTAGEN:I->D: Abolishes processing, secretion and enzyme activity.,MUTAGEN:K->A: No association with GS-modified heparin; when associated with K-158.,MUTAGEN:K->A: No effect on processing, secretion nor enzyme activity.,MUTAGEN:K->A: Two-fold increase in the level of secretion upon addition of GS-modified heparin. No association with GS-modified heparin; when associated with K-161.,MUTAGEN:K->E: No effect on processing nor secretion. No enzyme activity detected.,MUTAGEN:N->A: No effect on processing, secretion nor enzyme activity.,MUTAGEN:N->Q: Faster electrophoretic migration typical of a size reduction and important decrease of secretion. Larger size reduction; when associated with Q-162; Q-200; Q-217; Q-238 and Q-459.,MUTAGEN:N->Q: Faster electrophoretic migration typical of a size reduction and important decrease of secretion. Larger size reduction; when associated with Q-178; Q-200; Q-217; Q-238 and Q-459.,MUTAGEN:N->Q: Faster electrophoretic migration typical of a size reduction and partial decrease in secretion. Larger size reduction; when associated with Q-162; Q-178; Q-200; Q-238 and Q-459.,MUTAGEN:N->Q: Faster electrophoretic migration typical of a size reduction and partial decrease in secretion. Larger size reduction; when associated with Q-162; Q-178; Q-217; Q-238 and Q-459.,MUTAGEN:N->Q: Faster electrophoretic migration typical of a size reduction. Larger size reduction and important decrease of secretion; when associated with Q-162; Q-178; Q-200; Q-217 and Q-238.,MUTAGEN:N->Q: Faster electrophoretic migration typical of a size reduction. Larger size reduction and important decrease of secretion; when associated with Q-162; Q-178; Q-200; Q-217 and Q-459.,MUTAGEN:P->G: No effect on processing nor secretion. No enzyme activity detected.,MUTAGEN:R->A: No effect on processing, secretion nor enzyme activity.,MUTAGEN:S->K: No effect on processing nor secretion. No enzyme activity detected.,MUTAGEN:V->A: No effect on processing, secretion nor enzyme activity.,MUTAGEN:V->K: Abolishes processing, secretion and enzyme activity.,MUTAGEN:V->R: Abolishes processing, secretion and enzyme activity.,MUTAGEN:Y->A,E: Alteration of the correct processing of heparanase which results in the cleavage at an upstream site in the linker peptide and no activation of proheparanase.,MUTAGEN:Y->A: No effect on processing nor secretion. No enzyme activity detected.,MUTAGEN:Y->V: Normal processing.,PROPEP:Linker peptide,REGION:Required for heterodimerization with the heparanase 8 kDa subunit,REGION:Required for transferring proheparanase to the Golgi apparatus, secretion and subsequent enzyme activity and for enhancement of PKB/AKT1 phosphorylation,
Q5QNS5	hepatitis A virus cellular receptor 1(Havcr1)	Mus musculus			GO:0006911~phagocytosis, engulfment,GO:0009611~response to wounding,GO:0032496~response to lipopolysaccharide,GO:0033005~positive regulation of mast cell activation,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0009986~cell surface,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0031514~motile cilium,GO:0045335~phagocytic vesicle,	GO:0001618~virus receptor activity,GO:0001786~phosphatidylserine binding,GO:0005515~protein binding,	IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,	mmu03264:Virion - Flavivirus,mmu04148:Efferocytosis,			SM00409:IG,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Ig-like,DOMAIN:Ig-like V-type,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q867B7	hepatocyte growth factor(HGF)	Canis lupus dingo			GO:0000902~cell morphogenesis,GO:0001889~liver development,GO:0001934~positive regulation of protein phosphorylation,GO:0006508~proteolysis,GO:0014856~skeletal muscle cell proliferation,GO:0030335~positive regulation of cell migration,GO:0032715~negative regulation of interleukin-6 production,GO:0032733~positive regulation of interleukin-10 production,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0043066~negative regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0050673~epithelial cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051450~myoblast proliferation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060326~cell chemotaxis,GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:1900744~regulation of p38MAPK cascade,GO:1901299~negative regulation of hydrogen peroxide-mediated programmed cell death,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,GO:0005102~receptor binding,GO:0008083~growth factor activity,GO:0042056~chemoattractant activity,GO:0042802~identical protein binding,	IPR000001:Kringle,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR003609:Pan_app,IPR009003:Peptidase_S1_PA,IPR013806:Kringle-like,IPR018056:Kringle_CS,IPR024174:HGF/MST1,IPR027284:Hepatocyte_GF,IPR038178:Kringle_sf,IPR043504:Peptidase_S1_PA_chymotrypsin,	clud01521:EGFR tyrosine kinase inhibitor resistance,clud04010:MAPK signaling pathway,clud04014:Ras signaling pathway,clud04015:Rap1 signaling pathway,clud04020:Calcium signaling pathway,clud04151:PI3K-Akt signaling pathway,clud04510:Focal adhesion,clud05144:Malaria,clud05200:Pathways in cancer,clud05205:Proteoglycans in cancer,clud05208:Chemical carcinogenesis - reactive oxygen species,clud05211:Renal cell carcinoma,clud05218:Melanoma,clud05223:Non-small cell lung cancer,clud05225:Hepatocellular carcinoma,clud05226:Gastric cancer,		PIRSF001152:HGF_MST1,PIRSF500183:Hepatocyte_GF,	SM00020:Tryp_SPc,SM00130:KR,SM00473:PAN_AP,					KW-0420~Kringle,KW-0677~Repeat,KW-0732~Signal,		KW-0339~Growth factor,KW-0721~Serine protease homolog,	KW-0325~Glycoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between alpha and beta chains),DOMAIN:Apple,DOMAIN:Kringle,DOMAIN:Kringle 1,DOMAIN:Kringle 2,DOMAIN:Kringle 3,DOMAIN:Kringle 4,DOMAIN:PAN,DOMAIN:Peptidase S1,
Q867B7	hepatocyte growth factor(HGF)	Canis lupus familiaris			GO:0000902~cell morphogenesis,GO:0001889~liver development,GO:0001934~positive regulation of protein phosphorylation,GO:0006508~proteolysis,GO:0014856~skeletal muscle cell proliferation,GO:0030335~positive regulation of cell migration,GO:0032715~negative regulation of interleukin-6 production,GO:0032733~positive regulation of interleukin-10 production,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0043066~negative regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0050673~epithelial cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051450~myoblast proliferation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060326~cell chemotaxis,GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:1900744~regulation of p38MAPK cascade,GO:1901299~negative regulation of hydrogen peroxide-mediated programmed cell death,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,GO:0005102~receptor binding,GO:0008083~growth factor activity,GO:0042056~chemoattractant activity,GO:0042802~identical protein binding,	IPR000001:Kringle,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR003609:Pan_app,IPR009003:Peptidase_S1_PA,IPR013806:Kringle-like,IPR018056:Kringle_CS,IPR024174:HGF/MST1,IPR027284:Hepatocyte_GF,IPR038178:Kringle_sf,IPR043504:Peptidase_S1_PA_chymotrypsin,	cfa01521:EGFR tyrosine kinase inhibitor resistance,cfa04010:MAPK signaling pathway,cfa04014:Ras signaling pathway,cfa04015:Rap1 signaling pathway,cfa04020:Calcium signaling pathway,cfa04151:PI3K-Akt signaling pathway,cfa04510:Focal adhesion,cfa05144:Malaria,cfa05200:Pathways in cancer,cfa05205:Proteoglycans in cancer,cfa05208:Chemical carcinogenesis - reactive oxygen species,cfa05211:Renal cell carcinoma,cfa05218:Melanoma,cfa05223:Non-small cell lung cancer,cfa05225:Hepatocellular carcinoma,cfa05226:Gastric cancer,		PIRSF001152:HGF_MST1,PIRSF500183:Hepatocyte_GF,	SM00020:Tryp_SPc,SM00130:KR,SM00473:PAN_AP,					KW-0420~Kringle,KW-0677~Repeat,KW-0732~Signal,		KW-0339~Growth factor,KW-0721~Serine protease homolog,	KW-0325~Glycoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between alpha and beta chains),DOMAIN:Apple,DOMAIN:Kringle,DOMAIN:Kringle 1,DOMAIN:Kringle 2,DOMAIN:Kringle 3,DOMAIN:Kringle 4,DOMAIN:PAN,DOMAIN:Peptidase S1,
Q91766	hepatocyte nuclear factor 4 alpha S homeolog(hnf4a.S)	Xenopus laevis			GO:0006355~regulation of transcription, DNA-templated,GO:0042752~regulation of circadian rhythm,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048511~rhythmic process,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000003:Retinoid-X_rcpt/HNF4,IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR013088:Znf_NHR/GATA,IPR035500:NHR-like_dom_sf,				SM00399:ZnF_C4,SM00430:HOLI,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,KW-0678~Repressor,		DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,MOTIF:9aaTAD,REGION:Disordered,ZN_FING:NR C4-type,
Q14103	heterogeneous nuclear ribonucleoprotein D(HNRNPD)	Homo sapiens			GO:0001889~liver development,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0006401~RNA catabolic process,GO:0010468~regulation of gene expression,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010629~negative regulation of gene expression,GO:0021549~cerebellum development,GO:0032204~regulation of telomere maintenance,GO:0042752~regulation of circadian rhythm,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0045727~positive regulation of translation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051592~response to calcium ion,GO:0051602~response to electrical stimulus,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0070934~CRD-mediated mRNA stabilization,GO:0071230~cellular response to amino acid stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071732~cellular response to nitric oxide,GO:0097167~circadian regulation of translation,GO:1900152~negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:1901355~response to rapamycin,GO:1904355~positive regulation of telomere capping,GO:1904383~response to sodium phosphate,GO:1904586~cellular response to putrescine,GO:1905663~positive regulation of telomerase RNA reverse transcriptase activity,GO:1990828~hepatocyte dedifferentiation,GO:2000767~positive regulation of cytoplasmic translation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0098978~glutamatergic synapse,GO:1990904~ribonucleoprotein complex,	GO:0003680~AT DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0042162~telomeric DNA binding,GO:0042826~histone deacetylase binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR012956:CARG-binding_factor_N,IPR035979:RBD_domain_sf,				SM00360:RRM,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0238~DNA-binding,KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:CARG-binding factor N-terminal,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,
O35737	heterogeneous nuclear ribonucleoprotein H1(Hnrnph1)	Mus musculus			GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0043484~regulation of RNA splicing,GO:0098761~cellular response to interleukin-7,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0071013~catalytic step 2 spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042802~identical protein binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR012996:Znf_CHHC,IPR035979:RBD_domain_sf,				SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,			KW-0677~Repeat,		KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,REGION:2 X 16 AA Gly-rich approximate repeats,REGION:2 X 19 AA perfect repeats,REPEAT:1-1,REPEAT:1-2,REPEAT:2-1,REPEAT:2-2,
Q5ZIQ3	heterogeneous nuclear ribonucleoprotein K like(HNRNPKL)	Gallus gallus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048024~regulation of mRNA splicing, via spliceosome,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:1990904~ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,	IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR012987:ROK_N,IPR036612:KH_dom_type_1_sf,	gga03040:Spliceosome,			SM00322:KH,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:K Homology,DOMAIN:KH 1,DOMAIN:KH 2,DOMAIN:KH 3,DOMAIN:ROK N-terminal,REGION:2 X 22 AA approximate repeats,REGION:2 X 6 AA approximate repeats,REGION:5 X 4 AA repeats of G-X-G-G,REGION:Disordered,REGION:RNA-binding RGG-box,REPEAT:1-1,REPEAT:1-2,REPEAT:2-1,REPEAT:2-2,REPEAT:3-1,REPEAT:3-2,REPEAT:3-3,REPEAT:3-4,REPEAT:3-5,
Q5ZIQ3	heterogeneous nuclear ribonucleoprotein K(HNRNPK)	Gallus gallus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048024~regulation of mRNA splicing, via spliceosome,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:1990904~ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,	IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR012987:ROK_N,IPR036612:KH_dom_type_1_sf,	gga03040:Spliceosome,			SM00322:KH,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:K Homology,DOMAIN:KH 1,DOMAIN:KH 2,DOMAIN:KH 3,DOMAIN:ROK N-terminal,REGION:2 X 22 AA approximate repeats,REGION:2 X 6 AA approximate repeats,REGION:5 X 4 AA repeats of G-X-G-G,REGION:Disordered,REGION:RNA-binding RGG-box,REPEAT:1-1,REPEAT:1-2,REPEAT:2-1,REPEAT:2-2,REPEAT:3-1,REPEAT:3-2,REPEAT:3-3,REPEAT:3-4,REPEAT:3-5,
P19367	hexokinase 1(HK1)	Homo sapiens		h_glycolysisPathway:Glycolysis Pathway,	GO:0001678~cellular glucose homeostasis,GO:0002720~positive regulation of cytokine production involved in immune response,GO:0005975~carbohydrate metabolic process,GO:0006002~fructose 6-phosphate metabolic process,GO:0006006~glucose metabolic process,GO:0006013~mannose metabolic process,GO:0006096~glycolytic process,GO:0006954~inflammatory response,GO:0019318~hexose metabolic process,GO:0032731~positive regulation of interleukin-1 beta production,GO:0045087~innate immune response,GO:0046835~carbohydrate phosphorylation,GO:0051156~glucose 6-phosphate metabolic process,GO:0061621~canonical glycolysis,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0045121~membrane raft,	GO:0004340~glucokinase activity,GO:0004396~hexokinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005536~glucose binding,GO:0008865~fructokinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0019158~mannokinase activity,GO:0042834~peptidoglycan binding,GO:0047931~glucosamine kinase activity,	IPR001312:Hexokinase,IPR019807:Hexokinase_BS,IPR022672:Hexokinase_N,IPR022673:Hexokinase_C,IPR043129:ATPase_NBD,	hsa00010:Glycolysis / Gluconeogenesis,hsa00051:Fructose and mannose metabolism,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa00524:Neomycin, kanamycin and gentamicin biosynthesis,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,hsa01250:Biosynthesis of nucleotide sugars,hsa04066:HIF-1 signaling pathway,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04973:Carbohydrate digestion and absorption,hsa05131:Shigellosis,hsa05230:Central carbon metabolism in cancer,	235700~Hemolytic anemia due to hexokinase deficiency,605285~Neuropathy, hereditary motor and sensory, Russe type,617460~Retinitis pigmentosa 79,618547~Neurodevelopmental disorder with visual defects and brain anomalies,			KW-0324~Glycolysis,KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1000~Mitochondrion outer membrane,		KW-0144~Charcot-Marie-Tooth disease,KW-0225~Disease variant,KW-0523~Neurodegeneration,KW-0622~Neuropathy,KW-0682~Retinitis pigmentosa,KW-0991~Intellectual disability,	KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0418~Kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Hexokinase 1,DOMAIN:Hexokinase 2,DOMAIN:Hexokinase C-terminal,DOMAIN:Hexokinase N-terminal,REGION:Disordered,REGION:Hexokinase large subdomain 1,REGION:Hexokinase large subdomain 2,REGION:Hexokinase small subdomain 1,REGION:Hexokinase small subdomain 2,REGION:Mitochondrial-binding peptide (MBP),
P07746	high mobility group box 1a(hmgb1a)	Oncorhynchus mykiss			GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0008301~DNA binding, bending,	IPR009057:Homeobox-like_sf,IPR009071:HMG_box_dom,IPR017967:HMG_boxA_CS,IPR036388:WH-like_DNA-bd_sf,IPR036910:HMG_box_dom_sf,				SM00398:HMG,		KW-0158~Chromosome,KW-0539~Nucleus,			KW-0677~Repeat,		KW-0238~DNA-binding,		COMPBIAS:Acidic residues,DNA_BIND:HMG box,DNA_BIND:HMG box 1,DNA_BIND:HMG box 2,DOMAIN:HMG box,REGION:Disordered,
B5FZ84	hippocalcin like 1(HPCAL1)	Taeniopygia guttata			GO:0003073~regulation of systemic arterial blood pressure,GO:0019722~calcium-mediated signaling,		GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0015631~tubulin binding,GO:0030276~clathrin binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR028846:Recoverin,				SM00054:EFh,					KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0449~Lipoprotein,KW-0519~Myristate,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,LIPID:N-myristoyl glycine,
Q8TCT9	histocompatibility minor 13(HM13)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0006465~signal peptide processing,GO:0033619~membrane protein proteolysis,GO:0034599~cellular response to oxidative stress,GO:1904211~membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005791~rough endoplasmic reticulum,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0036513~Derlin-1 retrotranslocation complex,GO:0098553~lumenal side of endoplasmic reticulum membrane,GO:0098554~cytoplasmic side of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0031625~ubiquitin protein ligase binding,GO:0042500~aspartic endopeptidase activity, intramembrane cleaving,GO:0042803~protein homodimerization activity,	IPR006639:Preselin/SPP,IPR007369:Peptidase_A22B_SPP,				SM00730:PSN,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,MOTIF:PAL,MUTAGEN:D->A: Abolishes proteolysis of PSEN1.,MUTAGEN:D->A: No effect on inhibitor binding; abolishes catalytic activity. Abolishes proteolysis of PSEN1. Abolishes proteolysis of XBP1 isoform 1 and increases interaction with XBP1 isoform 1.,MUTAGEN:G->A: No effect on proteolysis of PSEN1.,MUTAGEN:N->Q: Abolishes N-glycosylation; when associated with Q-10.,MUTAGEN:N->Q: Abolishes N-glycosylation; when associated with Q-20.,MUTAGEN:P->L: Abolishes proteolysis of PSEN1.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q803H4	histone H3-like centromeric protein A(cenpa)	Danio rerio				GO:0000775~chromosome, centromeric region,GO:0000786~nucleosome,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0030527~structural constituent of chromatin,GO:0046982~protein heterodimerization activity,	IPR000164:Histone_H3/CENP-A,IPR007125:Histone_H2A/H2B/H3,IPR009072:Histone-fold,				SM00428:H3,		KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0544~Nucleosome core,					KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic residues,REGION:Disordered,REGION:H3-like,
O42227	histone deacetylase 1 S homeolog(hdac1.S)	Xenopus laevis			GO:0006325~chromatin organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004407~histone deacetylase activity,GO:0016787~hydrolase activity,GO:0033558~protein deacetylase activity,GO:0046872~metal ion binding,	IPR000286:His_deacetylse,IPR003084:His_deacetylse_1,IPR023696:Ureohydrolase_dom_sf,IPR023801:His_deacetylse_dom,IPR037138:His_deacetylse_dom_sf,	xla03082:ATP-dependent chromatin remodeling,xla03083:Polycomb repressive complex,xla04110:Cell cycle,xla04330:Notch signaling pathway,xla04350:TGF-beta signaling pathway,		PIRSF037913:His_deacetylse_1,		KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,	KW-0156~Chromatin regulator,KW-0378~Hydrolase,KW-0678~Repressor,		ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,DOMAIN:Histone deacetylase,MUTAGEN:H->A: Abolishes histone deacetylase activity.,REGION:Disordered,REGION:Histone deacetylase,
Q92769	histone deacetylase 2(HDAC2)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_etsPathway:METS affect on Macrophage Differentiation,h_mef2dPathway:Role of MEF2D in T-cell Apoptosis,h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001975~response to amphetamine,GO:0003300~cardiac muscle hypertrophy,GO:0006338~chromatin remodeling,GO:0008284~positive regulation of cell proliferation,GO:0009410~response to xenobiotic stimulus,GO:0009913~epidermal cell differentiation,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0010977~negative regulation of neuron projection development,GO:0016358~dendrite development,GO:0030336~negative regulation of cell migration,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031000~response to caffeine,GO:0031507~heterochromatin assembly,GO:0032496~response to lipopolysaccharide,GO:0032732~positive regulation of interleukin-1 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032922~circadian regulation of gene expression,GO:0032967~positive regulation of collagen biosynthetic process,GO:0034605~cellular response to heat,GO:0035094~response to nicotine,GO:0036211~protein modification process,GO:0042220~response to cocaine,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0042659~regulation of cell fate specification,GO:0042733~embryonic digit morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045347~negative regulation of MHC class II biosynthetic process,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048149~behavioral response to ethanol,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0055093~response to hyperoxia,GO:0060789~hair follicle placode formation,GO:0061000~negative regulation of dendritic spine development,GO:0061029~eyelid development in camera-type eye,GO:0061198~fungiform papilla formation,GO:0070301~cellular response to hydrogen peroxide,GO:0071300~cellular response to retinoic acid,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1902437~positive regulation of male mating behavior,GO:1902455~negative regulation of stem cell population maintenance,GO:1902459~positive regulation of stem cell population maintenance,GO:1903351~cellular response to dopamine,GO:1904645~response to beta-amyloid,GO:2000273~positive regulation of receptor activity,GO:2000736~regulation of stem cell differentiation,GO:2000757~negative regulation of peptidyl-lysine acetylation,	GO:0000118~histone deacetylase complex,GO:0000781~chromosome, telomeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0032991~macromolecular complex,GO:0035098~ESC/E(Z) complex,GO:0070822~Sin3-type complex,	GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031072~heat shock protein binding,GO:0031492~nucleosomal DNA binding,GO:0033558~protein deacetylase activity,GO:0042393~histone binding,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,GO:0051059~NF-kappaB binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:1990841~promoter-specific chromatin binding,	IPR000286:His_deacetylse,IPR003084:His_deacetylse_1,IPR023696:Ureohydrolase_dom_sf,IPR023801:His_deacetylse_dom,IPR037138:His_deacetylse_dom_sf,	hsa03082:ATP-dependent chromatin remodeling,hsa03083:Polycomb repressive complex,hsa04110:Cell cycle,hsa04213:Longevity regulating pathway - multiple species,hsa04330:Notch signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04613:Neutrophil extracellular trap formation,hsa04919:Thyroid hormone signaling pathway,hsa05016:Huntington disease,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05165:Human papillomavirus infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05220:Chronic myeloid leukemia,		PIRSF037913:His_deacetylse_1,		KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,	KW-0156~Chromatin regulator,KW-0378~Hydrolase,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0702~S-nitrosylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Histone deacetylase,REGION:Disordered,REGION:Histone deacetylase,TRANSMEM:Helical,
Q9Z2V5	histone deacetylase 6(Hdac6)	Mus musculus		m_ranbp2Pathway:Sumoylation by RanBP2 Regulates Transcriptional Repression,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000209~protein polyubiquitination,GO:0001975~response to amphetamine,GO:0006325~chromatin organization,GO:0006476~protein deacetylation,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006515~misfolded or incompletely synthesized protein catabolic process,GO:0006886~intracellular protein transport,GO:0007015~actin filament organization,GO:0007026~negative regulation of microtubule depolymerization,GO:0007519~skeletal muscle tissue development,GO:0010634~positive regulation of epithelial cell migration,GO:0010821~regulation of mitochondrion organization,GO:0014902~myotube differentiation,GO:0016241~regulation of macroautophagy,GO:0019896~axonal transport of mitochondrion,GO:0031333~negative regulation of protein complex assembly,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032418~lysosome localization,GO:0032984~macromolecular complex disassembly,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034983~peptidyl-lysine deacetylation,GO:0035601~protein deacylation,GO:0035902~response to immobilization stress,GO:0035967~cellular response to topologically incorrect protein,GO:0043131~erythrocyte enucleation,GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,GO:0043242~negative regulation of protein complex disassembly,GO:0045598~regulation of fat cell differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045861~negative regulation of proteolysis,GO:0048668~collateral sprouting,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050775~positive regulation of dendrite morphogenesis,GO:0051412~response to corticosterone,GO:0051646~mitochondrion localization,GO:0051788~response to misfolded protein,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0060997~dendritic spine morphogenesis,GO:0061523~cilium disassembly,GO:0061734~parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,GO:0070201~regulation of establishment of protein localization,GO:0070301~cellular response to hydrogen peroxide,GO:0070842~aggresome assembly,GO:0070845~polyubiquitinated misfolded protein transport,GO:0070846~Hsp90 deacetylation,GO:0070848~response to growth factor,GO:0071218~cellular response to misfolded protein,GO:0071374~cellular response to parathyroid hormone stimulus,GO:0071548~response to dexamethasone,GO:0090042~tubulin deacetylation,GO:0090044~positive regulation of tubulin deacetylation,GO:0098779~positive regulation of macromitophagy in response to mitochondrial depolarization,GO:1900409~positive regulation of cellular response to oxidative stress,GO:1901984~negative regulation of protein acetylation,GO:1904056~positive regulation of cholangiocyte proliferation,GO:2000273~positive regulation of receptor activity,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0015630~microtubule cytoskeleton,GO:0016234~inclusion body,GO:0016235~aggresome,GO:0030424~axon,GO:0030425~dendrite,GO:0031252~cell leading edge,GO:0032991~macromolecular complex,GO:0036064~ciliary basal body,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0048471~perinuclear region of cytoplasm,GO:1904115~axon cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001222~transcription corepressor binding,GO:0003779~actin binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008017~microtubule binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0031593~polyubiquitin binding,GO:0031625~ubiquitin protein ligase binding,GO:0033558~protein deacetylase activity,GO:0042826~histone deacetylase binding,GO:0042903~tubulin deacetylase activity,GO:0043014~alpha-tubulin binding,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,GO:0048156~tau protein binding,GO:0048487~beta-tubulin binding,GO:0051787~misfolded protein binding,GO:0051879~Hsp90 protein binding,GO:0070840~dynein complex binding,	IPR000286:His_deacetylse,IPR001607:Znf_UBP,IPR013083:Znf_RING/FYVE/PHD,IPR017320:Histone_deAcase_II_euk,IPR023696:Ureohydrolase_dom_sf,IPR023801:His_deacetylse_dom,IPR037138:His_deacetylse_dom_sf,	mmu04613:Neutrophil extracellular trap formation,mmu05014:Amyotrophic lateral sclerosis,mmu05034:Alcoholism,mmu05203:Viral carcinogenesis,			SM00290:ZnF_UBP,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0009~Actin-binding,KW-0156~Chromatin regulator,KW-0378~Hydrolase,KW-0678~Repressor,	KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:1,ACT_SITE:2,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Histone deacetylase,DOMAIN:UBP-type,REGION:Disordered,REGION:Histone deacetylase 1,REGION:Histone deacetylase 2,REGION:Ubiquitin binding,ZN_FING:UBP-type,
Q8WUI4	histone deacetylase 7(HDAC7)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0006338~chromatin remodeling,GO:0006476~protein deacetylation,GO:0007043~cell-cell junction assembly,GO:0016925~protein sumoylation,GO:0032703~negative regulation of interleukin-2 production,GO:0045668~negative regulation of osteoblast differentiation,GO:0050684~regulation of mRNA processing,GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis,GO:1901223~negative regulation of NIK/NF-kappaB signaling,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0004407~histone deacetylase activity,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0019789~SUMO transferase activity,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0033558~protein deacetylase activity,GO:0046872~metal ion binding,GO:0071889~14-3-3 protein binding,	IPR000286:His_deacetylse,IPR017320:Histone_deAcase_II_euk,IPR023696:Ureohydrolase_dom_sf,IPR023801:His_deacetylse_dom,IPR037138:His_deacetylse_dom_sf,IPR046949:HDAC4/5/7/9,	hsa04613:Neutrophil extracellular trap formation,hsa05034:Alcoholism,hsa05203:Viral carcinogenesis,		PIRSF037911:HDAC_II_euk,		KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0156~Chromatin regulator,KW-0378~Hydrolase,KW-0678~Repressor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Histone deacetylase,MOTIF:Nuclear export signal,MUTAGEN:H->A: Enhanced deacetylase activity.,MUTAGEN:H->F: Enhanced deacetylase activity.,MUTAGEN:H->Y: 6000 fold increase in deacetylase activity.,MUTAGEN:L->A: Abolishes phosphorylation at S-155.,MUTAGEN:S->A: Abolishes nuclear export; when associated with A-155; A-358 and A-486.,MUTAGEN:S->A: Abolishes nuclear export; when associated with A-181; A-358 and A-486. Abolishes phosphorylation by MARK2 and MARK3, interaction with 14-3-3 and localization to the cytoplasm.,MUTAGEN:S->A: Abolishes nuclear export; when associated with A-192; A-1118 and A-358.,MUTAGEN:S->A: Abolishes nuclear export; when associated with A-192; A-1118 and A-486.,REGION:Disordered,REGION:Histone deacetylase,REGION:Interaction with MEF2A,REGION:Interaction with MEF2C,REGION:Interaction with SIN3A,REGION:Transcription repression 1,REGION:Transcription repression 2,SITE:Contributes to catalysis,
Q5F339	holocytochrome c synthase(HCCS)	Gallus gallus			GO:0018063~cytochrome c-heme linkage,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,	GO:0004408~holocytochrome-c synthase activity,GO:0046872~metal ion binding,	IPR000511:Holocyt_c/c1_synthase,	gga00860:Porphyrin metabolism,gga01100:Metabolic pathways,					KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0456~Lyase,		COMPBIAS:Polar residues,REGION:Disordered,REPEAT:HRM 1,REPEAT:HRM 2,
Q8IX15	homeobox and leucine zipper encoding(HOMEZ)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001356:Homeobox_dom,IPR009057:Homeobox-like_sf,IPR024578:Homez_homeobox_dom,				SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0371~Homeobox,KW-0677~Repeat,		KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:Homeobox,DNA_BIND:Homeobox 1,DNA_BIND:Homeobox 2,DNA_BIND:Homeobox 3,DOMAIN:Homeobox,MOTIF:Nuclear localization signal,REGION:Disordered,
P19367	hook microtubule tethering protein 1(HOOK1)	Homo sapiens			GO:0001678~cellular glucose homeostasis,GO:0002720~positive regulation of cytokine production involved in immune response,GO:0005975~carbohydrate metabolic process,GO:0006002~fructose 6-phosphate metabolic process,GO:0006006~glucose metabolic process,GO:0006013~mannose metabolic process,GO:0006096~glycolytic process,GO:0006954~inflammatory response,GO:0007030~Golgi organization,GO:0007032~endosome organization,GO:0007040~lysosome organization,GO:0008333~endosome to lysosome transport,GO:0015031~protein transport,GO:0019318~hexose metabolic process,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0031122~cytoplasmic microtubule organization,GO:0032731~positive regulation of interleukin-1 beta production,GO:0045022~early endosome to late endosome transport,GO:0045087~innate immune response,GO:0046835~carbohydrate phosphorylation,GO:0051156~glucose 6-phosphate metabolic process,GO:0061621~canonical glycolysis,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,GO:1905198~manchette assembly,GO:1905719~protein localization to perinuclear region of cytoplasm,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0030897~HOPS complex,GO:0045121~membrane raft,GO:0070695~FHF complex,	GO:0003779~actin binding,GO:0004340~glucokinase activity,GO:0004396~hexokinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005536~glucose binding,GO:0008017~microtubule binding,GO:0008865~fructokinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0019158~mannokinase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0042834~peptidoglycan binding,GO:0047931~glucosamine kinase activity,GO:0051959~dynein light intermediate chain binding,	IPR001312:Hexokinase,IPR001715:CH_dom,IPR008636:Hook_C,IPR019807:Hexokinase_BS,IPR022672:Hexokinase_N,IPR022673:Hexokinase_C,IPR036872:CH_dom_sf,IPR043129:ATPase_NBD,IPR043936:HOOK_N,					KW-0221~Differentiation,KW-0324~Glycolysis,KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,KW-0653~Protein transport,KW-0744~Spermatogenesis,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0493~Microtubule,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1000~Mitochondrion outer membrane,		KW-0144~Charcot-Marie-Tooth disease,KW-0225~Disease variant,KW-0523~Neurodegeneration,KW-0622~Neuropathy,KW-0682~Retinitis pigmentosa,KW-0991~Intellectual disability,	KW-0175~Coiled coil,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0217~Developmental protein,KW-0418~Kinase,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Calponin-homology (CH),DOMAIN:HOOK N-terminal,DOMAIN:Hexokinase 1,DOMAIN:Hexokinase 2,DOMAIN:Hexokinase C-terminal,DOMAIN:Hexokinase N-terminal,DOMAIN:Hook C-terminal,MUTAGEN:EE->AA: Abrogates interaction with AKTIP, VPS16, VPS18, VPS39 and VPS41, AP4M1, FHIP1B, decreases interaction with HOOK2 but does not affect interaction withHOOK3; when associated with 669-A-A-670.,MUTAGEN:WY->AA: Abrogates interaction with AKTIP, VPS16, VPS18, VPS39 and VPS41, AP4M1, FHIP1B, decreases interaction with HOOK2 but does not affect interaction withHOOK3; when associated with 661-A-A-662.,REGION:Disordered,REGION:Hexokinase large subdomain 1,REGION:Hexokinase large subdomain 2,REGION:Hexokinase small subdomain 1,REGION:Hexokinase small subdomain 2,REGION:Mitochondrial-binding peptide (MBP),REGION:Sufficient for homodimerization, interaction wit HOOK2, HOOK3 and AP4M1,REGION:Sufficient for interaction with AKTIP and VPS18,REGION:Sufficient for interaction with microtubules,
Q9D968	host cell factor C2(Hcfc2)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0034139~regulation of toll-like receptor 3 signaling pathway,GO:1902615~immune response involved in response to exogenous dsRNA,GO:1903025~regulation of RNA polymerase II regulatory region sequence-specific DNA binding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016604~nuclear body,GO:0035097~histone methyltransferase complex,GO:0044665~MLL1/2 complex,GO:0048188~Set1C/COMPASS complex,GO:0071339~MLL1 complex,	GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,	IPR003961:FN3_dom,IPR006652:Kelch_1,IPR013783:Ig-like_fold,IPR015915:Kelch-typ_b-propeller,IPR036116:FN3_sf,IPR043536:HCF1/2,	mmu03083:Polycomb repressive complex,mmu05168:Herpes simplex virus 1 infection,			SM00060:FN3,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0880~Kelch repeat,				COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,REGION:Disordered,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,
O00291	huntingtin interacting protein 1(HIP1)	Homo sapiens			GO:0006897~endocytosis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007015~actin filament organization,GO:0030100~regulation of endocytosis,GO:0030154~cell differentiation,GO:0042981~regulation of apoptotic process,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048268~clathrin coat assembly,GO:0050821~protein stabilization,GO:0051897~positive regulation of protein kinase B signaling,GO:0097190~apoptotic signaling pathway,GO:0099637~neurotransmitter receptor transport,GO:2000588~positive regulation of platelet-derived growth factor receptor-beta signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0030136~clathrin-coated vesicle,GO:0030665~clathrin-coated vesicle membrane,GO:0042734~presynaptic membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0045211~postsynaptic membrane,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098793~presynapse,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,	GO:0003779~actin binding,GO:0005154~epidermal growth factor receptor binding,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0030276~clathrin binding,GO:0032051~clathrin light chain binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0035091~phosphatidylinositol binding,GO:0035254~glutamate receptor binding,GO:0035612~AP-2 adaptor complex binding,GO:0035615~clathrin adaptor activity,GO:0042803~protein homodimerization activity,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0046982~protein heterodimerization activity,GO:0051015~actin filament binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR002558:ILWEQ_dom,IPR008942:ENTH_VHS,IPR011417:ANTH_dom,IPR013809:ENTH,IPR030224:Sla2_fam,IPR032422:HIP1_clath-bd,IPR035964:I/LWEQ_dom_sf,	hsa05016:Huntington disease,hsa05022:Pathways of neurodegeneration - multiple diseases,			SM00273:ENTH,SM00307:ILWEQ,	KW-0053~Apoptosis,KW-0221~Differentiation,KW-0254~Endocytosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,		KW-0523~Neurodegeneration,	KW-0175~Coiled coil,		KW-0009~Actin-binding,KW-0010~Activator,	KW-0597~Phosphoprotein,	DOMAIN:ENTH,DOMAIN:Huntingtin-interacting protein 1 clathrin-binding,DOMAIN:I/LWEQ,MUTAGEN:F->G: Abolishes HIP1-induced cell death.,MUTAGEN:K->E: Abolishes 3-phosphoinositide-binding; when associated with E-56.,MUTAGEN:K->E: Abolishes 3-phosphoinositide-binding; when associated with E-58.,MUTAGEN:R->E: Reduces AR-induced nuclear translocation.,REGION:Disordered,REGION:Important for actin binding,REGION:pDED,
Q9CR41	huntingtin interacting protein K(Hypk)	Mus musculus			GO:0043066~negative regulation of apoptotic process,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,GO:0032991~macromolecular complex,	GO:0005515~protein binding,GO:0044183~protein binding involved in protein folding,	IPR038922:HYPK_UBA,IPR044034:NAC-like_UBA,						KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Nascent polypeptide-associated complex subunit alpha-like UBA,REGION:Disordered,REGION:Required for association with the NAA10-NAA15 complex,
Q80WM5	hyaluronan and proteoglycan link protein 3(Hapln3)	Mus musculus			GO:0001501~skeletal system development,GO:0002052~positive regulation of neuroblast proliferation,GO:0007155~cell adhesion,GO:0007417~central nervous system development,GO:0010001~glial cell differentiation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0045202~synapse,GO:0072534~perineuronal net,	GO:0005540~hyaluronic acid binding,	IPR000538:Link_dom,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR036179:Ig-like_dom_sf,				SM00406:IGv,SM00409:IG,SM00445:LINK,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,	KW-0373~Hyaluronic acid,		KW-1015~Disulfide bond,	COMPBIAS:Polar residues,DOMAIN:Ig-like,DOMAIN:Ig-like V-type,DOMAIN:Link,DOMAIN:Link 1,DOMAIN:Link 2,REGION:Disordered,
P97779	hyaluronan-mediated motility receptor(Hmmr)	Rattus norvegicus			GO:0006898~receptor-mediated endocytosis,GO:0007010~cytoskeleton organization,GO:0007267~cell-cell signaling,GO:0030214~hyaluronan catabolic process,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0009986~cell surface,GO:0015630~microtubule cytoskeleton,	GO:0005540~hyaluronic acid binding,GO:0038024~cargo receptor activity,	IPR026203:IHABP,IPR031794:HMMR_C,	rno04512:ECM-receptor interaction,					KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,	KW-0373~Hyaluronic acid,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Hyaluronan-mediated motility receptor C-terminal,REGION:Disordered,REGION:Hyaluronic acid-binding,REGION:Required for interaction with FAM83D,
Q8C131	hydrocarboxylic acid receptor 1(Hcar1)	Mus musculus			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0050995~negative regulation of lipid catabolic process,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043229~intracellular organelle,	GO:0004930~G-protein coupled receptor activity,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,	mmu04024:cAMP signaling pathway,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P00348	hydroxyacyl-CoA dehydrogenase(HADH)	Sus scrofa			GO:0006631~fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0050796~regulation of insulin secretion,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003857~3-hydroxyacyl-CoA dehydrogenase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0042802~identical protein binding,GO:0070403~NAD+ binding,	IPR006108:3HC_DH_C,IPR006176:3-OHacyl-CoA_DH_NAD-bd,IPR006180:3-OHacyl-CoA_DH_CS,IPR008927:6-PGluconate_DH-like_C_sf,IPR013328:6PGD_dom2,IPR022694:3-OHacyl-CoA_DH,IPR036291:NAD(P)-bd_dom_sf,	ssc00062:Fatty acid elongation,ssc00071:Fatty acid degradation,ssc00280:Valine, leucine and isoleucine degradation,ssc00310:Lysine degradation,ssc00380:Tryptophan metabolism,ssc00650:Butanoate metabolism,ssc01100:Metabolic pathways,ssc01212:Fatty acid metabolism,		PIRSF000105:HCDH,		KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0520~NAD,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0379~Hydroxylation,	DOMAIN:3-hydroxyacyl-CoA dehydrogenase C-terminal,DOMAIN:3-hydroxyacyl-CoA dehydrogenase NAD binding,REGION:Disordered,SITE:Important for catalytic activity,TRANSIT:Mitochondrion,
Q8TDS4	hydroxycarboxylic acid receptor 2(HCAR2)	Homo sapiens			GO:0001781~neutrophil apoptotic process,GO:0007186~G-protein coupled receptor signaling pathway,GO:0033031~positive regulation of neutrophil apoptotic process,GO:0050995~negative regulation of lipid catabolic process,GO:0070165~positive regulation of adiponectin secretion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030054~cell junction,	GO:0004930~G-protein coupled receptor activity,GO:0070553~nicotinic acid receptor activity,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,	hsa04024:cAMP signaling pathway,				KW-0053~Apoptosis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q7T3H9	hydroxypyruvate isomerase(hyi)	Danio rerio			GO:0046487~glyoxylate metabolic process,		GO:0008903~hydroxypyruvate isomerase activity,GO:0016853~isomerase activity,	IPR013022:Xyl_isomerase-like_TIM-brl,IPR026040:HyI-like,IPR036237:Xyl_isomerase-like_sf,	dre00630:Glyoxylate and dicarboxylate metabolism,dre01100:Metabolic pathways,		PIRSF006241:HyI,								KW-0413~Isomerase,		ACT_SITE:Proton donor/acceptor,DOMAIN:Xylose isomerase-like TIM barrel,
O02691	hydroxysteroid 17-beta dehydrogenase 10(HSD17B10)	Bos taurus			GO:0006550~isoleucine catabolic process,GO:0006631~fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0006699~bile acid biosynthetic process,GO:0008207~C21-steroid hormone metabolic process,GO:0008209~androgen metabolic process,GO:0008210~estrogen metabolic process,GO:0051289~protein homotetramerization,GO:0070901~mitochondrial tRNA methylation,GO:0097745~mitochondrial tRNA 5'-end processing,GO:1990180~mitochondrial tRNA 3'-end processing,	GO:0005739~mitochondrion,GO:0030678~mitochondrial ribonuclease P complex,GO:0042645~mitochondrial nucleoid,	GO:0000049~tRNA binding,GO:0003857~3-hydroxyacyl-CoA dehydrogenase activity,GO:0004303~estradiol 17-beta-dehydrogenase activity,GO:0008709~cholate 7-alpha-dehydrogenase activity,GO:0030283~testosterone dehydrogenase [NAD(P)] activity,GO:0044594~17-beta-hydroxysteroid dehydrogenase (NAD+) activity,GO:0047015~3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,GO:0047035~testosterone dehydrogenase (NAD+) activity,GO:0047044~androstan-3-alpha,17-beta-diol dehydrogenase activity,	IPR002347:SDR_fam,IPR020904:Sc_DH/Rdtase_CS,IPR036291:NAD(P)-bd_dom_sf,	bta00280:Valine, leucine and isoleucine degradation,bta01100:Metabolic pathways,bta05010:Alzheimer disease,bta05022:Pathways of neurodegeneration - multiple diseases,			SM00822:PKS_KR,	KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-0819~tRNA processing,	KW-0496~Mitochondrion,KW-1135~Mitochondrion nucleoid,				KW-0520~NAD,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,	ACT_SITE:Proton acceptor,
Q6P5L8	hydroxysteroid dehydrogenase like 2(hsdl2)	Danio rerio				GO:0005739~mitochondrion,GO:0005777~peroxisome,	GO:0016491~oxidoreductase activity,	IPR002347:SDR_fam,IPR003033:SCP2_sterol-bd_dom,IPR036291:NAD(P)-bd_dom_sf,IPR036527:SCP2_sterol-bd_dom_sf,						KW-0576~Peroxisome,				KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,DOMAIN:SCP2,
Q90W33	hypermethylated in cancer 2(hic2)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ_dom,IPR011333:SKP1/BTB/POZ_sf,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00225:BTB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BTB,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,
Q55EX9	hypothetical protein(DDB_G0268948)	Dictyostelium discoideum AX4			GO:0032259~methylation,	GO:0045335~phagocytic vesicle,	GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016740~transferase activity,	IPR013216:Methyltransf_11,IPR029063:SAM-dependent_MTases_sf,										KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,
Q98SW2	hypoxia inducible factor 1 subunit alpha(hif1a)	Oncorhynchus mykiss			GO:0001678~cellular glucose homeostasis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0071456~cellular response to hypoxia,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046983~protein dimerization activity,	IPR000014:PAS,IPR001321:HIF-1_alpha,IPR001610:PAC,IPR011598:bHLH_dom,IPR013655:PAS_fold_3,IPR014887:HIF-1_CTAD,IPR021537:HIF_alpha-like,IPR035965:PAS-like_dom_sf,IPR036638:HLH_DNA-bd_sf,	omy04137:Mitophagy - animal,omy04140:Autophagy - animal,omy04148:Efferocytosis,			SM00086:PAC,SM00091:PAS,SM00353:HLH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0379~Hydroxylation,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:BHLH,DOMAIN:PAC,DOMAIN:PAS,DOMAIN:PAS 1,DOMAIN:PAS 2,DOMAIN:bHLH,MOTIF:Nuclear localization signal,REGION:Disordered,
Q6NV04	ilvB (bacterial acetolactate synthase)-like(ilvbl)	Danio rerio			GO:0001561~fatty acid alpha-oxidation,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0009097~isoleucine biosynthetic process,GO:0009099~valine biosynthetic process,GO:0048701~embryonic cranial skeleton morphogenesis,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005948~acetolactate synthase complex,GO:0016020~membrane,	GO:0000287~magnesium ion binding,GO:0003824~catalytic activity,GO:0003984~acetolactate synthase activity,GO:0016829~lyase activity,GO:0016832~aldehyde-lyase activity,GO:0030976~thiamine pyrophosphate binding,GO:0046872~metal ion binding,GO:0050660~flavin adenine dinucleotide binding,	IPR000399:TPP-bd_CS,IPR011766:TPP_enzyme_TPP-bd,IPR012000:Thiamin_PyroP_enz_cen_dom,IPR012001:Thiamin_PyroP_enz_TPP-bd_dom,IPR029035:DHS-like_NAD/FAD-binding_dom,IPR029061:THDP-binding,IPR045229:TPP_enz,					KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0460~Magnesium,KW-0479~Metal-binding,KW-0786~Thiamine pyrophosphate,	KW-0456~Lyase,		DOMAIN:Thiamine pyrophosphate enzyme N-terminal TPP-binding,DOMAIN:Thiamine pyrophosphate enzyme TPP-binding,DOMAIN:Thiamine pyrophosphate enzyme central,REGION:Thiamine pyrophosphate binding,TRANSMEM:Helical,
A0A075B6H7	immunoglobulin kappa variable 3-7 (non-functional)(IGKV3-7)	Homo sapiens			GO:0002250~adaptive immune response,GO:0002377~immunoglobulin production,GO:0006955~immune response,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0019814~immunoglobulin complex,		IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00406:IGv,SM00409:IG,	KW-0391~Immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,KW-1280~Immunoglobulin,			KW-0393~Immunoglobulin domain,KW-0732~Signal,			KW-1015~Disulfide bond,	DOMAIN:Ig-like,
Q9EPL8	importin 7(Ipo7)	Mus musculus			GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0015031~protein transport,GO:0045087~innate immune response,GO:0045668~negative regulation of osteoblast differentiation,GO:1900182~positive regulation of protein localization to nucleus,GO:1901331~positive regulation of odontoblast differentiation,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0031267~small GTPase binding,GO:0042393~histone binding,GO:0046332~SMAD binding,	IPR001494:Importin-beta_N,IPR011989:ARM-like,IPR013713:XPO2_central,IPR016024:ARM-type_fold,	mmu03013:Nucleocytoplasmic transport,			SM00913:IBN_N,	KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,DOMAIN:Importin N-terminal,REGION:Disordered,
Q8R0V5	indoleamine 2,3-dioxygenase 2(Ido2)	Mus musculus			GO:0002376~immune system process,GO:0006569~tryptophan catabolic process,GO:0019441~tryptophan catabolic process to kynurenine,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,	GO:0005737~cytoplasm,	GO:0004833~tryptophan 2,3-dioxygenase activity,GO:0016491~oxidoreductase activity,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0020037~heme binding,GO:0033754~indoleamine 2,3-dioxygenase activity,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR000898:Indolamine_dOase,IPR037217:Trp/Indoleamine_2_3_dOase-like,	mmu00380:Tryptophan metabolism,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,mmu05143:African trypanosomiasis,				KW-0391~Immunity,KW-0823~Tryptophan catabolism,					KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,		BINDING:proximal binding residue,
P27093	inhibin beta B subunit(INHBB)	Gallus gallus			GO:0009267~cellular response to starvation,GO:0009611~response to wounding,GO:0030509~BMP signaling pathway,GO:0032686~negative regulation of hepatocyte growth factor production,GO:0032869~cellular response to insulin stimulus,GO:0032924~activin receptor signaling pathway,GO:0044320~cellular response to leptin stimulus,GO:0045444~fat cell differentiation,GO:0046676~negative regulation of insulin secretion,GO:0046881~positive regulation of follicle-stimulating hormone secretion,GO:0046882~negative regulation of follicle-stimulating hormone secretion,GO:0048513~animal organ development,GO:0048599~oocyte development,GO:0060279~positive regulation of ovulation,GO:0060395~SMAD protein signal transduction,GO:0097190~apoptotic signaling pathway,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0048471~perinuclear region of cytoplasm,GO:0071944~cell periphery,	GO:0005125~cytokine activity,GO:0005179~hormone activity,GO:0008083~growth factor activity,GO:0042803~protein homodimerization activity,	IPR000381:INHBB_C,IPR001111:TGF-b_propeptide,IPR001839:TGF-b_C,IPR006311:TAT_signal,IPR015615:TGF-beta-rel,IPR017948:TGFb_CS,IPR029034:Cystine-knot_cytokine,	gga04060:Cytokine-cytokine receptor interaction,gga04350:TGF-beta signaling pathway,			SM00204:TGFB,		KW-0964~Secreted,			KW-0732~Signal,		KW-0339~Growth factor,KW-0372~Hormone,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,DOMAIN:TGF-beta family profile,REGION:Disordered,
Q9H160	inhibitor of growth family member 2(ING2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007141~male meiosis I,GO:0007165~signal transduction,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0030317~flagellated sperm motility,GO:0030336~negative regulation of cell migration,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048133~male germ-line stem cell asymmetric division,GO:0072520~seminiferous tubule development,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1902455~negative regulation of stem cell population maintenance,GO:1902459~positive regulation of stem cell population maintenance,GO:2000772~regulation of cellular senescence,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0016580~Sin3 complex,GO:0016602~CCAAT-binding factor complex,GO:0070822~Sin3-type complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0035033~histone deacetylase regulator activity,GO:0035064~methylated histone binding,GO:0035091~phosphatidylinositol binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,	IPR001965:Znf_PHD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR019786:Zinc_finger_PHD-type_CS,IPR019787:Znf_PHD-finger,IPR024610:ING_N_histone-binding,IPR028651:ING_fam,IPR042019:ING2_PHD,				SM00249:PHD,SM01408:ING,	KW-0341~Growth regulation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0156~Chromatin regulator,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),DOMAIN:Inhibitor of growth protein N-terminal histone-binding,DOMAIN:PHD-type,REGION:Disordered,REGION:PBR,SITE:Histone H3K4me3 binding,ZN_FING:PHD-type,
Q3KP66	innate immunity activator(INAVA)	Homo sapiens			GO:0002221~pattern recognition receptor signaling pathway,GO:0002720~positive regulation of cytokine production involved in immune response,GO:0031398~positive regulation of protein ubiquitination,GO:0032494~response to peptidoglycan,GO:0032495~response to muramyl dipeptide,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032733~positive regulation of interleukin-10 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0034334~adherens junction maintenance,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043410~positive regulation of MAPK cascade,GO:0045087~innate immune response,GO:0060729~intestinal epithelial structure maintenance,GO:0070431~nucleotide-binding oligomerization domain containing 2 signaling pathway,GO:1903409~reactive oxygen species biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016604~nuclear body,	GO:0005515~protein binding,	IPR021774:CUPID,IPR043447:CCDC120/INAVA,		618077~Inflammatory bowel disease 29,			KW-0391~Immunity,KW-0399~Innate immunity,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0175~Coiled coil,				COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Cytohesin Ubiquitin Protein Inducing,MOTIF:Nuclear localization signal (NLS) 1,MOTIF:Nuclear localization signal (NLS) 2,MOTIF:Nuclear localization signal (NLS) 3,MUTAGEN:KPRK->AAAA: No effect on nuclear translocation upon induction by MDP. Abolishes nuclear translocation upon induction by MDP and slightly decreases NOD2-induced AP-1 and NF-kappaB activation and IL6 secretion; when associated with 164-A--A-170 and 423-A--A-426.,MUTAGEN:PKVRRRI->AAAAAAA: No effect on nuclear translocation upon induction by MDP. Abolishes nuclear translocation upon induction by MDP and slightly decreases NOD2-induced AP-1 and NF-kappaB activation and IL6 secretion; when associated with 335-A--A-338 and 423-A--A-426.,MUTAGEN:RRRP->AAAA: No effect on nuclear translocation upon induction by MDP. Abolishes nuclear translocation upon induction by MDP and slightly decreases NOD2-induced AP-1 and NF-kappaB activation and IL6 secretion; when associated with 164-A--A-170 and 335-A--A-338.,MUTAGEN:S->A: Decreases interaction with YWHAQ, cellular signaling pathway activation and cytokine secretion.,REGION:Disordered,
Q7TN12	innate immunity activator(Inava)	Mus musculus			GO:0002221~pattern recognition receptor signaling pathway,GO:0002376~immune system process,GO:0002720~positive regulation of cytokine production involved in immune response,GO:0031398~positive regulation of protein ubiquitination,GO:0032494~response to peptidoglycan,GO:0032495~response to muramyl dipeptide,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032733~positive regulation of interleukin-10 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0034334~adherens junction maintenance,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043410~positive regulation of MAPK cascade,GO:0045087~innate immune response,GO:0060729~intestinal epithelial structure maintenance,GO:0070431~nucleotide-binding oligomerization domain containing 2 signaling pathway,GO:1903409~reactive oxygen species biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016604~nuclear body,		IPR021774:CUPID,IPR043447:CCDC120/INAVA,					KW-0391~Immunity,KW-0399~Innate immunity,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Cytohesin Ubiquitin Protein Inducing,MOTIF:Nuclear localization signal (NLS) 1,MOTIF:Nuclear localization signal (NLS) 2,MOTIF:Nuclear localization signal (NLS) 3,REGION:Disordered,
Q32N93	inner centromere protein S homeolog(incenp.S)	Xenopus laevis			GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0030496~midbody,GO:0032133~chromosome passenger complex,GO:0043232~intracellular non-membrane-bounded organelle,	GO:0019901~protein kinase binding,	IPR005635:Inner_centromere_prot_ARK-bd,IPR022006:INCENP_N,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Chromosome passenger complex (CPC) protein INCENP N-terminal,DOMAIN:Inner centromere protein ARK-binding,REGION:Disordered,REGION:IN box,REGION:SAH,
Q28I39	inner mitochondrial membrane peptidase subunit 1(immp1l)	Xenopus tropicalis			GO:0006465~signal peptide processing,GO:0006508~proteolysis,GO:0006627~protein processing involved in protein targeting to mitochondrion,GO:0030030~cell projection organization,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0042720~mitochondrial inner membrane peptidase complex,	GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0016787~hydrolase activity,	IPR000223:Pept_S26A_signal_pept_1,IPR011677:Tectonic_dom,IPR019533:Peptidase_S26,IPR036286:LexA/Signal_pep-like_sf,IPR040354:Tectonic,	xtr03060:Protein export,				KW-0970~Cilium biogenesis/degradation,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,	KW-0325~Glycoprotein,	DOMAIN:Peptidase S26,DOMAIN:Tectonic,TRANSMEM:Helical,
Q14643	inositol 1,4,5-trisphosphate receptor type 1(ITPR1)	Homo sapiens			GO:0000902~cell morphogenesis,GO:0001666~response to hypoxia,GO:0006816~calcium ion transport,GO:0007165~signal transduction,GO:0007207~phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,GO:0009791~post-embryonic development,GO:0010506~regulation of autophagy,GO:0019722~calcium-mediated signaling,GO:0032024~positive regulation of insulin secretion,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0042045~epithelial fluid transport,GO:0050849~negative regulation of calcium-mediated signaling,GO:0050882~voluntary musculoskeletal movement,GO:0051209~release of sequestered calcium ion into cytosol,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0099105~ion channel modulating, G-protein coupled receptor signaling pathway,GO:0099566~regulation of postsynaptic cytosolic calcium ion concentration,	GO:0005637~nuclear inner membrane,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005955~calcineurin complex,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016529~sarcoplasmic reticulum,GO:0030658~transport vesicle membrane,GO:0030667~secretory granule membrane,GO:0031088~platelet dense granule membrane,GO:0031094~platelet dense tubular network,GO:0031095~platelet dense tubular network membrane,GO:0048471~perinuclear region of cytoplasm,GO:0098685~Schaffer collateral - CA1 synapse,	GO:0005216~ion channel activity,GO:0005220~inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0015085~calcium ion transmembrane transporter activity,GO:0015278~calcium-release channel activity,GO:0019855~calcium channel inhibitor activity,GO:0019904~protein domain specific binding,GO:0035091~phosphatidylinositol binding,GO:0070679~inositol 1,4,5 trisphosphate binding,	IPR000493:InsP3_rcpt,IPR000699:RIH_dom,IPR005821:Ion_trans_dom,IPR013662:RIH_assoc-dom,IPR014821:Ins145_P3_rcpt,IPR015925:Ryanodine_IP3_receptor,IPR016024:ARM-type_fold,IPR016093:MIR_motif,IPR035910:RyR/IP3R_RIH_dom_sf,IPR036300:MIR_dom_sf,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04114:Oocyte meiosis,hsa04140:Autophagy - animal,hsa04210:Apoptosis,hsa04218:Cellular senescence,hsa04270:Vascular smooth muscle contraction,hsa04371:Apelin signaling pathway,hsa04380:Osteoclast differentiation,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04621:NOD-like receptor signaling pathway,hsa04625:C-type lectin receptor signaling pathway,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04927:Cortisol synthesis and secretion,hsa04928:Parathyroid hormone synthesis, secretion and action,hsa04929:GnRH secretion,hsa04934:Cushing syndrome,hsa04935:Growth hormone synthesis, secretion and action,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa05010:Alzheimer disease,hsa05012:Parkinson disease,hsa05016:Huntington disease,hsa05017:Spinocerebellar ataxia,hsa05020:Prion disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05131:Shigellosis,hsa05163:Human cytomegalovirus infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05170:Human immunodeficiency virus 1 infection,hsa05205:Proteoglycans in cancer,hsa05417:Lipid and atherosclerosis,	117360~Spinocerebellar ataxia 29, congenital nonprogressive,206700~Gillespie syndrome,606658~Spinocerebellar ataxia 15,		SM00472:MIR,	KW-0053~Apoptosis,KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,		KW-0225~Disease variant,KW-0523~Neurodegeneration,KW-0950~Spinocerebellar ataxia,KW-0991~Intellectual disability,	KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0107~Calcium channel,KW-0407~Ion channel,KW-0675~Receptor,KW-1071~Ligand-gated ion channel,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Ion transport,DOMAIN:MIR,DOMAIN:MIR 1,DOMAIN:MIR 2,DOMAIN:MIR 3,DOMAIN:MIR 4,DOMAIN:MIR 5,DOMAIN:RIH,DOMAIN:RyR/IP3R Homology associated,LIPID:S-palmitoyl cysteine,MUTAGEN:K->A: Abolishes interaction with AHCYL1.,MUTAGEN:K->Q: Abolishes interaction with AHCYL1.,MUTAGEN:P->L: Creates a dileucine motif and recruits clathrin.,MUTAGEN:R->A: Abolishes interaction with AHCYL1.,MUTAGEN:R->Q: Abolishes interaction with AHCYL1.,MUTAGEN:R->Q: No effect on interaction with AHCYL1.,MUTAGEN:T->A: No effect on interaction with AHCYL1.,MUTAGEN:Y->A: Abolishes interaction with AHCYL1.,REGION:Disordered,REGION:Interaction with ERP44,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q2I6J0	inositol polyphosphate phosphatase-like 1b(inppl1b)	Danio rerio			GO:0002376~immune system process,GO:0006629~lipid metabolic process,GO:0007155~cell adhesion,GO:0043569~negative regulation of insulin-like growth factor receptor signaling pathway,GO:0046856~phosphatidylinositol dephosphorylation,GO:0050776~regulation of immune response,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0042995~cell projection,	GO:0003779~actin binding,GO:0004445~inositol-polyphosphate 5-phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017124~SH3 domain binding,GO:0034485~phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,	IPR000300:IPPc,IPR000980:SH2,IPR001660:SAM,IPR013761:SAM/pointed_sf,IPR036691:Endo/exonu/phosph_ase_sf,IPR036860:SH2_dom_sf,	dre00562:Inositol phosphate metabolism,dre01100:Metabolic pathways,dre04070:Phosphatidylinositol signaling system,dre04910:Insulin signaling pathway,			SM00128:IPPc,SM00252:SH2,	KW-0130~Cell adhesion,KW-0391~Immunity,KW-0443~Lipid metabolism,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0727~SH2 domain,KW-0729~SH3-binding,		KW-0009~Actin-binding,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:SAM,DOMAIN:SH2,MOTIF:NPXY motif,REGION:Disordered,
Q96PE3	inositol polyphosphate-4-phosphatase type I A(INPP4A)	Homo sapiens			GO:0006661~phosphatidylinositol biosynthetic process,GO:0007165~signal transduction,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0043647~inositol phosphate metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0031901~early endosome membrane,GO:0031965~nuclear membrane,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,GO:0016316~phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,GO:0017161~inositol-1,3,4-trisphosphate 4-phosphatase activity,GO:0052828~inositol-3,4-bisphosphate 4-phosphatase activity,	IPR000008:C2_dom,IPR035892:C2_domain_sf,IPR039034:INPP4,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,				KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0539~Nucleus,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,DOMAIN:C2,MUTAGEN:C->S: Does not rescue the wortmannin-induced dilation of endosomes due to accumulation of (PtdIns(3,4)P2).,MUTAGEN:D->N: Complete loss of lipid phosphatase activity.,TRANSMEM:Helical,
Q9ES52	inositol polyphosphate-5-phosphatase D(Inpp5d)	Mus musculus			GO:0002376~immune system process,GO:0006629~lipid metabolic process,GO:0006915~apoptotic process,GO:0008340~determination of adult lifespan,GO:0009968~negative regulation of signal transduction,GO:0016064~immunoglobulin mediated immune response,GO:0030853~negative regulation of granulocyte differentiation,GO:0030889~negative regulation of B cell proliferation,GO:0032715~negative regulation of interleukin-6 production,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0045579~positive regulation of B cell differentiation,GO:0045621~positive regulation of lymphocyte differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045656~negative regulation of monocyte differentiation,GO:0045659~negative regulation of neutrophil differentiation,GO:0045671~negative regulation of osteoclast differentiation,GO:0045779~negative regulation of bone resorption,GO:0046856~phosphatidylinositol dephosphorylation,GO:0050776~regulation of immune response,GO:0050777~negative regulation of immune response,GO:0050869~negative regulation of B cell activation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030863~cortical cytoskeleton,GO:0045121~membrane raft,	GO:0003824~catalytic activity,GO:0004439~phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,GO:0004445~inositol-polyphosphate 5-phosphatase activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017124~SH3 domain binding,GO:0030487~inositol-4,5-bisphosphate 5-phosphatase activity,GO:0034485~phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,GO:0052658~inositol-1,4,5-trisphosphate 5-phosphatase activity,GO:0052659~inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,	IPR000300:IPPc,IPR000980:SH2,IPR036691:Endo/exonu/phosph_ase_sf,IPR036860:SH2_dom_sf,	mmu00562:Inositol phosphate metabolism,mmu01100:Metabolic pathways,mmu04070:Phosphatidylinositol signaling system,mmu04662:B cell receptor signaling pathway,mmu04664:Fc epsilon RI signaling pathway,mmu04666:Fc gamma R-mediated phagocytosis,			SM00128:IPPc,SM00252:SH2,	KW-0053~Apoptosis,KW-0391~Immunity,KW-0443~Lipid metabolism,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0727~SH2 domain,KW-0729~SH3-binding,		KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SH2,MOTIF:NPXY motif 1,MOTIF:NPXY motif 2,MOTIF:SH3-binding 1,MOTIF:SH3-binding 2,MOTIF:SH3-binding 3,MUTAGEN:D->G: Loss of function.,MUTAGEN:Y->F: Strongly impairs function, tyrosine phosphorylation, subcellular location and interaction with DOK1; when associated with F-1021.,MUTAGEN:Y->F: Strongly impairs function, tyrosine phosphorylation, subcellular location and interaction with DOK1; when associated with F-918.,REGION:Disordered,REGION:Interaction with DAB2,
P23677	inositol-trisphosphate 3-kinase A(ITPKA)	Homo sapiens			GO:0006020~inositol metabolic process,GO:0007165~signal transduction,GO:0016310~phosphorylation,GO:0030036~actin cytoskeleton organization,GO:0032958~inositol phosphate biosynthetic process,GO:0046854~phosphatidylinositol phosphorylation,GO:0048167~regulation of synaptic plasticity,GO:0051592~response to calcium ion,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0071277~cellular response to calcium ion,GO:0097062~dendritic spine maintenance,GO:0098885~modification of postsynaptic actin cytoskeleton,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0043197~dendritic spine,GO:0098871~postsynaptic actin cytoskeleton,GO:0098978~glutamatergic synapse,	GO:0004683~calmodulin-dependent protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008440~inositol-1,4,5-trisphosphate 3-kinase activity,GO:0016301~kinase activity,GO:0031267~small GTPase binding,GO:0051765~inositol tetrakisphosphate kinase activity,	IPR005522:IPK,IPR038286:IPK_sf,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04070:Phosphatidylinositol signaling system,					KW-0206~Cytoskeleton,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0112~Calmodulin-binding,KW-0418~Kinase,KW-0808~Transferase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,MUTAGEN:D->A,N: Decreases to 12% of kinase activity.,MUTAGEN:D->A: Loss of kinase activity.,MUTAGEN:K->A: Decreases to 80% of kinase activity.,MUTAGEN:K->A: Loss of kinase activity.,MUTAGEN:R->D,A: Loss of kinase activity.,MUTAGEN:W->A: Decreases to 44% of kinase activity.,REGION:Calmodulin-binding,REGION:Disordered,REGION:Required for cytoskeleton location,
Q8AV61	insulin induced gene 1(insig1)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006695~cholesterol biosynthetic process,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0032869~cellular response to insulin stimulus,GO:0032933~SREBP signaling pathway,GO:0036316~SREBP-SCAP complex retention in endoplasmic reticulum,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0032937~SREBP-SCAP-Insig complex,	GO:0008142~oxysterol binding,GO:0008289~lipid binding,	IPR025929:INSIG_fam,					KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0446~Lipid-binding,			MOTIF:KxHxx,SITE:Required for the recognition of 25-hydroxycholesterol,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q5RB68	insulin like growth factor 2 mRNA binding protein 2(IGF2BP2)	Pongo abelii			GO:0006417~regulation of translation,GO:0007399~nervous system development,GO:0010468~regulation of gene expression,GO:0017148~negative regulation of translation,GO:0051028~mRNA transport,GO:0070934~CRD-mediated mRNA stabilization,GO:0097009~energy homeostasis,	GO:0000932~P-body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0010494~cytoplasmic stress granule,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0048027~mRNA 5'-UTR binding,GO:0090079~translation regulator activity, nucleic acid binding,GO:1990247~N6-methyladenosine-containing RNA binding,	IPR000504:RRM_dom,IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034843:IGF2BP2_RRM1,IPR035979:RBD_domain_sf,IPR036612:KH_dom_type_1_sf,				SM00322:KH,SM00360:RRM,	KW-0509~mRNA transport,KW-0810~Translation regulation,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	DOMAIN:KH 1,DOMAIN:KH 2,DOMAIN:KH 3,DOMAIN:KH 4,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,
P24854	insulin like growth factor binding protein 4(IGFBP4)	Sus scrofa			GO:0000165~MAPK cascade,GO:0001558~regulation of cell growth,GO:0010906~regulation of glucose metabolic process,GO:0043410~positive regulation of MAPK cascade,GO:0043567~regulation of insulin-like growth factor receptor signaling pathway,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0044342~type B pancreatic cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005520~insulin-like growth factor binding,GO:0031994~insulin-like growth factor I binding,GO:0031995~insulin-like growth factor II binding,	IPR000716:Thyroglobulin_1,IPR000867:IGFBP-like,IPR009030:Growth_fac_rcpt_cys_sf,IPR017891:Insulin_GF-bd_Cys-rich_CS,IPR022321:IGFBP_1-6_chordata,IPR022327:IGFBP-4,IPR036857:Thyroglobulin_1_sf,				SM00121:IB,SM00211:TY,		KW-0964~Secreted,			KW-0732~Signal,		KW-0340~Growth factor binding,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:IGFBP N-terminal,DOMAIN:Thyroglobulin type-1,REGION:Disordered,
Q9Y4H2	insulin receptor substrate 2(IRS2)	Homo sapiens			GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002903~negative regulation of B cell apoptotic process,GO:0006006~glucose metabolic process,GO:0007165~signal transduction,GO:0007420~brain development,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0009749~response to glucose,GO:0010631~epithelial cell migration,GO:0010634~positive regulation of epithelial cell migration,GO:0010748~negative regulation of plasma membrane long-chain fatty acid transport,GO:0010907~positive regulation of glucose metabolic process,GO:0019216~regulation of lipid metabolic process,GO:0030879~mammary gland development,GO:0030890~positive regulation of B cell proliferation,GO:0032000~positive regulation of fatty acid beta-oxidation,GO:0032024~positive regulation of insulin secretion,GO:0032869~cellular response to insulin stimulus,GO:0033673~negative regulation of kinase activity,GO:0044342~type B pancreatic cell proliferation,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0046326~positive regulation of glucose import,GO:0051897~positive regulation of protein kinase B signaling,GO:0055088~lipid homeostasis,GO:0071333~cellular response to glucose stimulus,GO:1904692~positive regulation of type B pancreatic cell proliferation,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005158~insulin receptor binding,GO:0005515~protein binding,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0071889~14-3-3 protein binding,	IPR001849:PH_domain,IPR002404:IRS_PTB,IPR011993:PH-like_dom_sf,IPR039011:IRS,	hsa04022:cGMP-PKG signaling pathway,hsa04068:FoxO signaling pathway,hsa04140:Autophagy - animal,hsa04152:AMPK signaling pathway,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04935:Growth hormone synthesis, secretion and action,hsa05010:Alzheimer disease,hsa05206:MicroRNAs in cancer,	125853~Diabetes mellitus, noninsulin-dependent,		SM00233:PH,SM00310:PTBI,SM01244:IRS,		KW-0963~Cytoplasm,					KW-0675~Receptor,KW-0807~Transducer,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:IRS-type PTB,DOMAIN:PH,MOTIF:YXXM motif 1,MOTIF:YXXM motif 2,MOTIF:YXXM motif 3,MOTIF:YXXM motif 4,MOTIF:YXXM motif 5,MOTIF:YXXM motif 6,MOTIF:YXXM motif 7,REGION:Disordered,
B3F211	insulin-like growth factor binding protein 2b(igfbp2b)	Danio rerio			GO:0001525~angiogenesis,GO:0002040~sprouting angiogenesis,GO:0007507~heart development,GO:0008156~negative regulation of DNA replication,GO:0008285~negative regulation of cell proliferation,GO:0043567~regulation of insulin-like growth factor receptor signaling pathway,GO:0048640~negative regulation of developmental growth,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005520~insulin-like growth factor binding,GO:0019838~growth factor binding,GO:0031994~insulin-like growth factor I binding,GO:0031995~insulin-like growth factor II binding,	IPR000716:Thyroglobulin_1,IPR000867:IGFBP-like,IPR009030:Growth_fac_rcpt_cys_sf,IPR012210:IGFBP-2,IPR017891:Insulin_GF-bd_Cys-rich_CS,IPR022321:IGFBP_1-6_chordata,IPR036857:Thyroglobulin_1_sf,				SM00121:IB,SM00211:TY,	KW-0341~Growth regulation,	KW-0964~Secreted,			KW-0732~Signal,		KW-0217~Developmental protein,KW-0340~Growth factor binding,KW-9996~Developmental protein,	KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,DOMAIN:IGFBP N-terminal,DOMAIN:Thyroglobulin type-1,MOTIF:Cell attachment site,REGION:Disordered,
Q07079	insulin-like growth factor binding protein 5(Igfbp5)	Mus musculus			GO:0001558~regulation of cell growth,GO:0001649~osteoblast differentiation,GO:0007565~female pregnancy,GO:0014912~negative regulation of smooth muscle cell migration,GO:0017148~negative regulation of translation,GO:0030336~negative regulation of cell migration,GO:0031069~hair follicle morphogenesis,GO:0035556~intracellular signal transduction,GO:0040008~regulation of growth,GO:0042593~glucose homeostasis,GO:0043567~regulation of insulin-like growth factor receptor signaling pathway,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0043569~negative regulation of insulin-like growth factor receptor signaling pathway,GO:0044342~type B pancreatic cell proliferation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045926~negative regulation of growth,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048286~lung alveolus development,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0051146~striated muscle cell differentiation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060056~mammary gland involution,GO:0060416~response to growth hormone,GO:0071320~cellular response to cAMP,GO:0071407~cellular response to organic cyclic compound,GO:1901862~negative regulation of muscle tissue development,GO:1904205~negative regulation of skeletal muscle hypertrophy,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016942~insulin-like growth factor binding protein complex,GO:0042567~insulin-like growth factor ternary complex,	GO:0001968~fibronectin binding,GO:0005520~insulin-like growth factor binding,GO:0019838~growth factor binding,GO:0031994~insulin-like growth factor I binding,GO:0031995~insulin-like growth factor II binding,	IPR000716:Thyroglobulin_1,IPR000867:IGFBP-like,IPR009030:Growth_fac_rcpt_cys_sf,IPR012213:IGFBP-5,IPR017891:Insulin_GF-bd_Cys-rich_CS,IPR022321:IGFBP_1-6_chordata,IPR036857:Thyroglobulin_1_sf,				SM00121:IB,SM00211:TY,		KW-0964~Secreted,			KW-0732~Signal,		KW-0340~Growth factor binding,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,DOMAIN:IGFBP N-terminal,DOMAIN:Thyroglobulin type-1,REGION:Disordered,
Q5NVC3	integral membrane protein 2C(ITM2C)	Pongo abelii			GO:0010977~negative regulation of neuron projection development,GO:0030182~neuron differentiation,GO:0042985~negative regulation of amyloid precursor protein biosynthetic process,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0001540~beta-amyloid binding,	IPR007084:BRICHOS_dom,IPR040145:ITM2,				SM01039:BRICHOS,		KW-0458~Lysosome,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:BRICHOS,PEPTIDE:CT-BRI3,SITE:Cleavage; by furin,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q1LXC9	integrator complex subunit 3(ints3)	Danio rerio			GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0010212~response to ionizing radiation,GO:0044818~mitotic G2/M transition checkpoint,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0070876~SOSS complex,		IPR019333:INTS3_N,IPR045334:INTS3,					KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,							COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q00651	integrin alpha 4(Itga4)	Mus musculus		m_lymphocytePathway:Adhesion Molecules on Lymphocyte,m_monocytePathway:Monocyte and its Surface Molecules,	GO:0001974~blood vessel remodeling,GO:0002687~positive regulation of leukocyte migration,GO:0003366~cell-matrix adhesion involved in ameboidal cell migration,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007159~leukocyte cell-cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007507~heart development,GO:0016477~cell migration,GO:0033627~cell adhesion mediated by integrin,GO:0033631~cell-cell adhesion mediated by integrin,GO:0034113~heterotypic cell-cell adhesion,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0043113~receptor clustering,GO:0045906~negative regulation of vasoconstriction,GO:0050901~leukocyte tethering or rolling,GO:0050904~diapedesis,GO:0060324~face development,GO:0060385~axonogenesis involved in innervation,GO:0060485~mesenchyme development,GO:0060710~chorio-allantoic fusion,GO:0061032~visceral serous pericardium development,GO:0071345~cellular response to cytokine stimulus,GO:0072678~T cell migration,GO:0090074~negative regulation of protein homodimerization activity,GO:0098609~cell-cell adhesion,GO:0098657~import into cell,GO:1903039~positive regulation of leukocyte cell-cell adhesion,GO:1903238~positive regulation of leukocyte tethering or rolling,GO:1904646~cellular response to beta-amyloid,GO:1904738~vascular associated smooth muscle cell migration,GO:1905351~pericyte cell migration,GO:1905564~positive regulation of vascular endothelial cell proliferation,GO:1990138~neuron projection extension,GO:1990771~clathrin-dependent extracellular exosome endocytosis,GO:2000353~positive regulation of endothelial cell apoptotic process,GO:2000406~positive regulation of T cell migration,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0030426~growth cone,GO:0034669~integrin alpha4-beta7 complex,GO:0043025~neuronal cell body,	GO:0001968~fibronectin binding,GO:0003823~antigen binding,GO:0005178~integrin binding,GO:0019960~C-X3-C chemokine binding,GO:0046872~metal ion binding,GO:0050839~cell adhesion molecule binding,GO:1990405~protein antigen binding,	IPR000413:Integrin_alpha,IPR013517:FG-GAP,IPR013519:Int_alpha_beta-p,IPR013649:Integrin_alpha_Ig-like_1,IPR018184:Integrin_alpha_C_CS,IPR028994:Integrin_alpha_N,IPR032695:Integrin_dom_sf,IPR048285:Integrin_alpha_Ig-like_2,IPR048286:Integrin_alpha_Ig-like_3,	mmu04151:PI3K-Akt signaling pathway,mmu04510:Focal adhesion,mmu04512:ECM-receptor interaction,mmu04514:Cell adhesion molecules,mmu04640:Hematopoietic cell lineage,mmu04670:Leukocyte transendothelial migration,mmu04672:Intestinal immune network for IgA production,mmu04810:Regulation of actin cytoskeleton,mmu05135:Yersinia infection,mmu05140:Leishmaniasis,mmu05165:Human papillomavirus infection,mmu05410:Hypertrophic cardiomyopathy,mmu05412:Arrhythmogenic right ventricular cardiomyopathy,mmu05414:Dilated cardiomyopathy,			SM00191:Int_alpha,	KW-0130~Cell adhesion,	KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0401~Integrin,KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Integrin alpha first immunoglubulin-like,DOMAIN:Integrin alpha second immunoglobulin-like,DOMAIN:Integrin alpha third immunoglobulin-like,MOTIF:GFFKR motif,MOTIF:SG1,REPEAT:FG-GAP,REPEAT:FG-GAP 1,REPEAT:FG-GAP 2,REPEAT:FG-GAP 3,REPEAT:FG-GAP 4,REPEAT:FG-GAP 5,REPEAT:FG-GAP 6,REPEAT:FG-GAP 7,SITE:Cleavage,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9DF58	integrin linked kinase(ILK)	Gallus gallus			GO:0000902~cell morphogenesis,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001934~positive regulation of protein phosphorylation,GO:0003151~outflow tract morphogenesis,GO:0006468~protein phosphorylation,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0010761~fibroblast migration,GO:0016310~phosphorylation,GO:0021675~nerve development,GO:0022011~myelination in peripheral nervous system,GO:0030030~cell projection organization,GO:0030513~positive regulation of BMP signaling pathway,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034446~substrate adhesion-dependent cell spreading,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043491~protein kinase B signaling,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0045669~positive regulation of osteoblast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0061351~neural precursor cell proliferation,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030017~sarcomere,GO:0030027~lamellipodium,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR002110:Ankyrin_rpt,IPR011009:Kinase-like_dom_sf,IPR035692:PK_ILK,IPR036770:Ankyrin_rpt-contain_sf,	gga03320:PPAR signaling pathway,gga04510:Focal adhesion,		PIRSF000654:Integrin-linked_kinase,	SM00248:ANK,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0040~ANK repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	DOMAIN:Protein kinase,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,
P56199	integrin subunit alpha 1(ITGA1)	Homo sapiens			GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0030593~neutrophil chemotaxis,GO:0032516~positive regulation of phosphoprotein phosphatase activity,GO:0033627~cell adhesion mediated by integrin,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042311~vasodilation,GO:0043410~positive regulation of MAPK cascade,GO:0043525~positive regulation of neuron apoptotic process,GO:0045123~cellular extravasation,GO:0048812~neuron projection morphogenesis,GO:0098609~cell-cell adhesion,	GO:0001669~acrosomal vesicle,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0034665~integrin alpha1-beta1 complex,GO:0043204~perikaryon,GO:0045178~basal part of cell,GO:0070062~extracellular exosome,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0019903~protein phosphatase binding,GO:0046872~metal ion binding,GO:0098639~collagen binding involved in cell-matrix adhesion,	IPR000413:Integrin_alpha,IPR002035:VWF_A,IPR013517:FG-GAP,IPR013519:Int_alpha_beta-p,IPR013649:Integrin_alpha_Ig-like_1,IPR018184:Integrin_alpha_C_CS,IPR028994:Integrin_alpha_N,IPR032695:Integrin_dom_sf,IPR036465:vWFA_dom_sf,IPR048285:Integrin_alpha_Ig-like_2,IPR048286:Integrin_alpha_Ig-like_3,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04640:Hematopoietic cell lineage,hsa04810:Regulation of actin cytoskeleton,hsa05165:Human papillomavirus infection,hsa05410:Hypertrophic cardiomyopathy,hsa05412:Arrhythmogenic right ventricular cardiomyopathy,hsa05414:Dilated cardiomyopathy,			SM00191:Int_alpha,SM00327:VWA,	KW-0130~Cell adhesion,	KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0401~Integrin,KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:VWFA,MOTIF:GFFKR motif,REGION:Disordered,REPEAT:FG-GAP,REPEAT:FG-GAP 1,REPEAT:FG-GAP 2,REPEAT:FG-GAP 3,REPEAT:FG-GAP 4,REPEAT:FG-GAP 5,REPEAT:FG-GAP 6,REPEAT:FG-GAP 7,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P17301	integrin subunit alpha 2(ITGA2)	Homo sapiens			GO:0001666~response to hypoxia,GO:0002687~positive regulation of leukocyte migration,GO:0006929~substrate-dependent cell migration,GO:0006971~hypotonic response,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007565~female pregnancy,GO:0007596~blood coagulation,GO:0009410~response to xenobiotic stimulus,GO:0009887~animal organ morphogenesis,GO:0010634~positive regulation of epithelial cell migration,GO:0014075~response to amine,GO:0014850~response to muscle activity,GO:0014911~positive regulation of smooth muscle cell migration,GO:0030879~mammary gland development,GO:0031346~positive regulation of cell projection organization,GO:0031589~cell-substrate adhesion,GO:0032967~positive regulation of collagen biosynthetic process,GO:0033591~response to L-ascorbic acid,GO:0033627~cell adhesion mediated by integrin,GO:0038065~collagen-activated signaling pathway,GO:0043589~skin morphogenesis,GO:0045727~positive regulation of translation,GO:0045785~positive regulation of cell adhesion,GO:0045987~positive regulation of smooth muscle contraction,GO:0046718~viral entry into host cell,GO:0048041~focal adhesion assembly,GO:0048333~mesodermal cell differentiation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050927~positive regulation of positive chemotaxis,GO:0050966~detection of mechanical stimulus involved in sensory perception of pain,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0070365~hepatocyte differentiation,GO:0071107~response to parathyroid hormone,GO:0071260~cellular response to mechanical stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0034666~integrin alpha2-beta1 complex,GO:0043679~axon terminus,GO:0045178~basal part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0001540~beta-amyloid binding,GO:0001618~virus receptor activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0038064~collagen receptor activity,GO:0043236~laminin binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0098639~collagen binding involved in cell-matrix adhesion,	IPR000413:Integrin_alpha,IPR002035:VWF_A,IPR013517:FG-GAP,IPR013519:Int_alpha_beta-p,IPR018184:Integrin_alpha_C_CS,IPR028994:Integrin_alpha_N,IPR032695:Integrin_dom_sf,IPR036465:vWFA_dom_sf,IPR048285:Integrin_alpha_Ig-like_2,IPR048286:Integrin_alpha_Ig-like_3,	hsa03271:Virion - Rotavirus,hsa04145:Phagosome,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04611:Platelet activation,hsa04640:Hematopoietic cell lineage,hsa04810:Regulation of actin cytoskeleton,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05222:Small cell lung cancer,hsa05410:Hypertrophic cardiomyopathy,hsa05412:Arrhythmogenic right ventricular cardiomyopathy,hsa05414:Dilated cardiomyopathy,			SM00191:Int_alpha,SM00327:VWA,	KW-0130~Cell adhesion,KW-0945~Host-virus interaction,	KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0401~Integrin,KW-0675~Receptor,KW-1183~Host cell receptor for virus entry,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:VWFA,MOTIF:GFFKR motif,MUTAGEN:E->A: Significant reduction of RAB21-binding; when associated with A-1160; A-1161 and A-1165.,MUTAGEN:F->A: No significant reduction of RAB21-binding by co-immunoprecipitation assay; when associated with A-1160 and A-1162.,MUTAGEN:K->A: No effect on RAB21-binding. Significant reduction of RAB21-binding; when associated with A-1161. Shows defective cytokinesis on collagen, but not on fibronectin; when associated with A-1161.,MUTAGEN:K->A: No significant reduction of RAB21-binding by co-immunoprecipitation assay; when associated with A-1159 and A-1160.,MUTAGEN:K->A: Significant reduction of RAB21-binding; when associated with A-1160; A-1161 and A-1164.,MUTAGEN:K->P: Markedly weakens RAB21-binding. Shows defective cytokinesis on collagen, but not on fibronectin.,MUTAGEN:R->A: Significant reduction of RAB21-binding; when associated with A-1160. Shows defective cytokinesis on collagen, but not on fibronectin; when associated with A-1160.,REGION:Interaction with HPS5,REPEAT:FG-GAP,REPEAT:FG-GAP 1,REPEAT:FG-GAP 2,REPEAT:FG-GAP 3,REPEAT:FG-GAP 4,REPEAT:FG-GAP 5,REPEAT:FG-GAP 6,REPEAT:FG-GAP 7,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P11215	integrin subunit alpha M(ITGAM)	Homo sapiens	37.Akt-PKB_Effector_of_P13K_in_Vivo,8.MonocytesIFNF_IL4,	h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_monocytePathway:Monocyte and its Surface Molecules,h_neutrophilPathway:Neutrophil and Its Surface Molecules,	GO:0001774~microglial cell activation,GO:0002430~complement receptor mediated signaling pathway,GO:0002931~response to ischemia,GO:0006898~receptor-mediated endocytosis,GO:0006911~phagocytosis, engulfment,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0009612~response to mechanical stimulus,GO:0010668~ectodermal cell differentiation,GO:0030900~forebrain development,GO:0032355~response to estradiol,GO:0032930~positive regulation of superoxide anion generation,GO:0033627~cell adhesion mediated by integrin,GO:0034113~heterotypic cell-cell adhesion,GO:0043315~positive regulation of neutrophil degranulation,GO:0045087~innate immune response,GO:0045963~negative regulation of dopamine metabolic process,GO:0090314~positive regulation of protein targeting to membrane,GO:0097242~beta-amyloid clearance,GO:0098609~cell-cell adhesion,GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,GO:1904151~positive regulation of microglial cell mediated cytotoxicity,GO:1904643~response to curcumin,GO:2000363~positive regulation of prostaglandin-E synthase activity,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0034688~integrin alphaM-beta2 complex,GO:0035579~specific granule membrane,GO:0044853~plasma membrane raft,GO:0070062~extracellular exosome,GO:0070821~tertiary granule membrane,	GO:0001540~beta-amyloid binding,GO:0001851~complement component C3b binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0031072~heat shock protein binding,GO:0038024~cargo receptor activity,GO:0046872~metal ion binding,	IPR000413:Integrin_alpha,IPR002035:VWF_A,IPR013517:FG-GAP,IPR013519:Int_alpha_beta-p,IPR013649:Integrin_alpha_Ig-like_1,IPR018184:Integrin_alpha_C_CS,IPR028994:Integrin_alpha_N,IPR032695:Integrin_dom_sf,IPR036465:vWFA_dom_sf,IPR048285:Integrin_alpha_Ig-like_2,IPR048633:ITGAX-like_Ig_3,	hsa04015:Rap1 signaling pathway,hsa04145:Phagosome,hsa04514:Cell adhesion molecules,hsa04610:Complement and coagulation cascades,hsa04613:Neutrophil extracellular trap formation,hsa04640:Hematopoietic cell lineage,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05146:Amoebiasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05202:Transcriptional misregulation in cancer,hsa05221:Acute myeloid leukemia,			SM00191:Int_alpha,SM00327:VWA,	KW-0130~Cell adhesion,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0772~Systemic lupus erythematosus,	KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0401~Integrin,KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Integrin alpha-X-like third Ig-like,DOMAIN:VWFA,MOTIF:GFFKR motif,REGION:Disordered,REPEAT:FG-GAP,REPEAT:FG-GAP 1,REPEAT:FG-GAP 2,REPEAT:FG-GAP 3,REPEAT:FG-GAP 4,REPEAT:FG-GAP 5,REPEAT:FG-GAP 6,REPEAT:FG-GAP 7,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O14713	integrin subunit beta 1 binding protein 1(ITGB1BP1)	Homo sapiens	66.Prot_Interac_w_integrin_domains,		GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis,GO:0006469~negative regulation of protein kinase activity,GO:0006933~negative regulation of cell adhesion involved in substrate-bound cell migration,GO:0007160~cell-matrix adhesion,GO:0007219~Notch signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010595~positive regulation of endothelial cell migration,GO:0010764~negative regulation of fibroblast migration,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:0031214~biomineral tissue development,GO:0032091~negative regulation of protein binding,GO:0032148~activation of protein kinase B activity,GO:0033622~integrin activation,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0035148~tube formation,GO:0035556~intracellular signal transduction,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0043087~regulation of GTPase activity,GO:0043113~receptor clustering,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045747~positive regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051451~myoblast migration,GO:0051496~positive regulation of stress fiber assembly,GO:0051781~positive regulation of cell division,GO:0051894~positive regulation of focal adhesion assembly,GO:0051895~negative regulation of focal adhesion assembly,GO:0051897~positive regulation of protein kinase B signaling,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0072659~protein localization to plasma membrane,GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis,GO:0090314~positive regulation of protein targeting to membrane,GO:0090315~negative regulation of protein targeting to membrane,GO:0097746~regulation of blood vessel diameter,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:2001044~regulation of integrin-mediated signaling pathway,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016604~nuclear body,GO:0030027~lamellipodium,GO:0034451~centriolar satellite,GO:0048471~perinuclear region of cytoplasm,GO:0071944~cell periphery,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR006020:PTB/PI_dom,IPR011993:PH-like_dom_sf,IPR019517:Integrin-bd_ICAP-1,				SM00462:PTB,	KW-0037~Angiogenesis,KW-0091~Biomineralization,KW-0130~Cell adhesion,KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0914~Notch signaling pathway,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,					KW-0401~Integrin,KW-0497~Mitogen,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:PID,MOTIF:Nuclear localization signal,MUTAGEN:C->D: Reduces KRIT1 and ITGB1 binding.,MUTAGEN:D->A: Abolishes KRIT1 binding; when associated with A-96.,MUTAGEN:I->A: Abolishes ITGB1 binding.,MUTAGEN:I->R: Reduces KRIT1 binding. No effect on ITGB1 binding.,MUTAGEN:KK->AA: Abolishes nuclear import and transcriptional activity.,MUTAGEN:L->A: Abolishes ITGB1 binding.,MUTAGEN:L->A: Reduces ITGB1 binding.,MUTAGEN:L->Q: No effect on ITGB1 binding.,MUTAGEN:LYLII->AYAA: Reduces KRIT1 and ITGB1 binding.,MUTAGEN:Q->A: Abolishes KRIT1 binding; when associated with A-93.,MUTAGEN:T->A: Stimulates cell spreading on fibronectin to a similar extent as inhibition of CaMKII.,MUTAGEN:T->D: Changes in cell spreading.,MUTAGEN:T->D: Strong defect in cell spreading.,MUTAGEN:Y->T: Abolishes ITGB1 binding.,REGION:Disordered,REGION:Interaction with ITGB1,REGION:Interaction with KRIT1,
Q9GLY5	inter-alpha-trypsin inhibitor heavy chain 3(ITIH3)	Oryctolagus cuniculus			GO:0030212~hyaluronan metabolic process,	GO:0005576~extracellular region,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR002035:VWF_A,IPR010600:ITI_HC_C,IPR013694:VIT,IPR036465:vWFA_dom_sf,				SM00327:VWA,SM00609:VIT,		KW-0964~Secreted,			KW-0732~Signal,		KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,KW-0654~Proteoglycan,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:VIT,DOMAIN:VWFA,
Q8TCB0	interferon induced protein 44(IFI44)	Homo sapiens			GO:0006955~immune response,GO:0009615~response to virus,GO:0009617~response to bacterium,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR006571:TLDc_dom,IPR027417:P-loop_NTPase,						KW-0963~Cytoplasm,							DOMAIN:TLDc,
Q15306	interferon regulatory factor 4(IRF4)	Homo sapiens	79.B_cell_Activation,	h_pcafPathway:The information-processing pathway at the IFN-beta enhancer,	GO:0002376~immune system process,GO:0006338~chromatin remodeling,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032733~positive regulation of interleukin-10 production,GO:0032736~positive regulation of interleukin-13 production,GO:0032743~positive regulation of interleukin-2 production,GO:0032753~positive regulation of interleukin-4 production,GO:0034122~negative regulation of toll-like receptor signaling pathway,GO:0042110~T cell activation,GO:0042832~defense response to protozoan,GO:0043011~myeloid dendritic cell differentiation,GO:0045622~regulation of T-helper cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0072540~T-helper 17 cell lineage commitment,	GO:0000785~chromatin,GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR001346:Interferon_reg_fact_DNA-bd_dom,IPR008984:SMAD_FHA_dom_sf,IPR017855:SMAD-like_dom_sf,IPR019471:Interferon_reg_factor-3,IPR019817:Interferon_reg_fac_CS,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,	hsa04659:Th17 cell differentiation,	611724~Skin/hair/eye pigmentation, variation in, 8,		SM00348:IRF,SM01243:IRF-3,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	DNA_BIND:IRF tryptophan pentad repeat,DOMAIN:IRF tryptophan pentad repeat,DOMAIN:Interferon regulatory factor-3,
Q02556	interferon regulatory factor 8(IRF8)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002273~plasmacytoid dendritic cell differentiation,GO:0002314~germinal center B cell differentiation,GO:0002316~follicular B cell differentiation,GO:0002376~immune system process,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006909~phagocytosis,GO:0006914~autophagy,GO:0006955~immune response,GO:0030099~myeloid cell differentiation,GO:0032479~regulation of type I interferon production,GO:0032729~positive regulation of interferon-gamma production,GO:0032735~positive regulation of interleukin-12 production,GO:0042742~defense response to bacterium,GO:0042832~defense response to protozoan,GO:0043065~positive regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071222~cellular response to lipopolysaccharide,GO:0071346~cellular response to interferon-gamma,GO:0097028~dendritic cell differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR001346:Interferon_reg_fact_DNA-bd_dom,IPR008984:SMAD_FHA_dom_sf,IPR017855:SMAD-like_dom_sf,IPR019471:Interferon_reg_factor-3,IPR019817:Interferon_reg_fac_CS,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,	hsa05133:Pertussis,	226990~Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive,614893~Immunodeficiency 32A, mycobacteriosis, autosomal dominant,		SM00348:IRF,SM01243:IRF-3,	KW-0072~Autophagy,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,			KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,	KW-0832~Ubl conjugation,	DNA_BIND:IRF tryptophan pentad repeat,DOMAIN:IRF tryptophan pentad repeat,DOMAIN:Interferon regulatory factor-3,MUTAGEN:K->H: In resting macrophages, no effect on cytoplasmic subcellular localization. Decreased nuclear subcellular localization upon IFN-gamma induction. Partial loss of IRF1-dependent transcriptional activator activity.,MUTAGEN:K->Q: In resting macrophages, no effect on cytoplasmic subcellular localization. Loss of nuclear subcellular localization upon IFN-gamma induction. Loss of IRF1-dependent transcriptional activator activity.,MUTAGEN:K->R: In resting macrophages, no effect on cytoplasmic subcellular localization. No effect on nuclear subcellular localization upon IFN-gamma induction. No effect on transcriptional activator activity. No effect on IRF1-dependent transcriptional activator activity.,
Q01638	interleukin 1 receptor like 1(IL1RL1)	Homo sapiens			GO:0002826~negative regulation of T-helper 1 type immune response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0030225~macrophage differentiation,GO:0032689~negative regulation of interferon-gamma production,GO:0032722~positive regulation of chemokine production,GO:0032754~positive regulation of interleukin-5 production,GO:0038172~interleukin-33-mediated signaling pathway,GO:0043032~positive regulation of macrophage activation,GO:0050729~positive regulation of inflammatory response,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,	GO:0002113~interleukin-33 binding,GO:0002114~interleukin-33 receptor activity,GO:0004896~cytokine receptor activity,GO:0004908~interleukin-1 receptor activity,GO:0005515~protein binding,GO:0050135~NAD(P)+ nucleosidase activity,GO:0061809~NAD+ nucleotidase, cyclic ADP-ribose generating,	IPR000157:TIR_dom,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR004074:IL-1_rcpt_I/II-typ,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR015621:IL-1_rcpt_fam,IPR035897:Toll_tir_struct_dom_sf,IPR036179:Ig-like_dom_sf,	hsa04060:Cytokine-cytokine receptor interaction,			SM00255:TIR,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0520~NAD,	KW-0378~Hydrolase,KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:TIR,REGION:Flexible linker,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P27931	interleukin 1 receptor, type II(Il1r2)	Mus musculus			GO:0006954~inflammatory response,GO:0010955~negative regulation of protein processing,GO:0016485~protein processing,GO:0032690~negative regulation of interleukin-1 alpha production,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:2000660~negative regulation of interleukin-1-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004908~interleukin-1 receptor activity,GO:0004910~interleukin-1, Type II, blocking receptor activity,GO:0019966~interleukin-1 binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR004074:IL-1_rcpt_I/II-typ,IPR004077:IL-1_rcpt_II-typ,IPR007110:Ig-like_dom,IPR013151:Immunoglobulin,IPR013783:Ig-like_fold,IPR015621:IL-1_rcpt_fam,IPR036179:Ig-like_dom_sf,IPR041416:IL-1RAcP-like_ig,	mmu04060:Cytokine-cytokine receptor interaction,mmu04640:Hematopoietic cell lineage,mmu05146:Amoebiasis,mmu05166:Human T-cell leukemia virus 1 infection,mmu05202:Transcriptional misregulation in cancer,mmu05215:Prostate cancer,mmu05418:Fluid shear stress and atherosclerosis,			SM00408:IGc2,SM00409:IG,	KW-0395~Inflammatory response,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P97378	interleukin 12 receptor, beta 2(Il12rb2)	Mus musculus		m_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,m_nktPathway:Selective expression of chemokine receptors during T-cell polarization,m_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,m_th1th2Pathway:Th1/Th2 Differentiation,	GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0032609~interferon-gamma production,GO:0032729~positive regulation of interferon-gamma production,GO:0034097~response to cytokine,GO:0035722~interleukin-12-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0019901~protein kinase binding,GO:0019955~cytokine binding,	IPR003529:Hematopoietin_rcpt_Gp130_CS,IPR003961:FN3_dom,IPR010457:IgC2-like_lig-bd,IPR013783:Ig-like_fold,IPR036116:FN3_sf,	mmu04060:Cytokine-cytokine receptor interaction,mmu04630:JAK-STAT signaling pathway,mmu04658:Th1 and Th2 cell differentiation,mmu05200:Pathways in cancer,mmu05321:Inflammatory bowel disease,			SM00060:FN3,		KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,MOTIF:Box 1 motif,MOTIF:WSXWS motif,MUTAGEN:Y->F: No loss of IL12-induced STAT4 activation nor T-cell proliferation. No effect on IFN-gamma production.,MUTAGEN:Y->F: No loss of IL12-induced STAT4 activation. Greatly reduced IL12-induced T-cell proliferation and IFN-gamma production.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q61098	interleukin 18 receptor 1(Il18r1)	Mus musculus		m_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,m_nktPathway:Selective expression of chemokine receptors during T-cell polarization,m_th1th2Pathway:Th1/Th2 Differentiation,	GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0030101~natural killer cell activation,GO:0032609~interferon-gamma production,GO:0032729~positive regulation of interferon-gamma production,GO:0035655~interleukin-18-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0045063~T-helper 1 cell differentiation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:2000556~positive regulation of T-helper 1 cell cytokine production,	GO:0016020~membrane,GO:0045092~interleukin-18 receptor complex,	GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0042007~interleukin-18 binding,GO:0042008~interleukin-18 receptor activity,GO:0050135~NAD(P)+ nucleosidase activity,GO:0061809~NAD+ nucleotidase, cyclic ADP-ribose generating,	IPR000157:TIR_dom,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR015621:IL-1_rcpt_fam,IPR035897:Toll_tir_struct_dom_sf,IPR036179:Ig-like_dom_sf,IPR041416:IL-1RAcP-like_ig,	mmu04060:Cytokine-cytokine receptor interaction,mmu04061:Viral protein interaction with cytokine and cytokine receptor,mmu04668:TNF signaling pathway,mmu05321:Inflammatory bowel disease,			SM00255:TIR,SM00409:IG,	KW-0395~Inflammatory response,	KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0520~NAD,	KW-0378~Hydrolase,KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Immunoglobulin subtype,DOMAIN:TIR,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9NZM3	intersectin 2(ITSN2)	Homo sapiens			GO:0006897~endocytosis,GO:0016197~endosomal transport,GO:0030154~cell differentiation,GO:1903861~positive regulation of dendrite extension,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0042734~presynaptic membrane,GO:0070062~extracellular exosome,GO:0097708~intracellular vesicle,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0060090~binding, bridging,	IPR000008:C2_dom,IPR000219:DH-domain,IPR000261:EH_dom,IPR001452:SH3_domain,IPR001849:PH_domain,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,IPR018247:EF_Hand_1_Ca_BS,IPR035737:Intersectin-2_SH3_1,IPR035738:Intersectin-2_SH3_2,IPR035739:Intersectin-2_SH3_3,IPR035740:Intersectin-2_SH3_4,IPR035741:Intersectin-2_SH3_5,IPR035892:C2_domain_sf,IPR035899:DBL_dom_sf,IPR036028:SH3-like_dom_sf,				SM00027:EH,SM00054:EFh,SM00233:PH,SM00239:C2,SM00325:RhoGEF,SM00326:SH3,	KW-0221~Differentiation,KW-0254~Endocytosis,KW-0945~Host-virus interaction,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0728~SH3 domain,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:DH,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EH,DOMAIN:EH 1,DOMAIN:EH 2,DOMAIN:PH,DOMAIN:SH3,DOMAIN:SH3 1,DOMAIN:SH3 2,DOMAIN:SH3 3,DOMAIN:SH3 4,DOMAIN:SH3 5,REGION:Disordered,
K7NA32	intracellular-type I interferon receptor(LOC101268957)	Oncorhynchus mykiss			GO:0001934~positive regulation of protein phosphorylation,GO:0060337~type I interferon signaling pathway,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004904~interferon receptor activity,GO:0004905~type I interferon receptor activity,GO:0005515~protein binding,	IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR015373:Interferon/interleukin_rcp_dom,IPR036116:FN3_sf,	omy04060:Cytokine-cytokine receptor interaction,					KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A7YE96	intraflagellar transport 70(ift70)	Danio rerio			GO:0001736~establishment of planar polarity,GO:0007155~cell adhesion,GO:0007368~determination of left/right symmetry,GO:0018095~protein polyglutamylation,GO:0030030~cell projection organization,GO:0036372~opsin transport,GO:0042073~intraciliary transport,GO:0060271~cilium assembly,	GO:0005737~cytoplasm,GO:0005879~axonemal microtubule,GO:0005929~cilium,GO:0030992~intraciliary transport particle B,GO:0031514~motile cilium,GO:0042995~cell projection,	GO:0051015~actin filament binding,GO:0070738~tubulin-glycine ligase activity,	IPR011990:TPR-like_helical_dom_sf,IPR013105:TPR_2,IPR019734:TPR_repeat,IPR036723:Alpha-catenin/vinculin-like_sf,IPR039941:TT30,				SM00028:TPR,	KW-0970~Cilium biogenesis/degradation,	KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,				REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,
Q7ZV26	ints3 and nabp interacting protein(inip)	Danio rerio			GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0010212~response to ionizing radiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0070876~SOSS complex,		IPR031821:SOSSC,					KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,
E7FCN8	inturned planar cell polarity protein(intu)	Danio rerio			GO:0001736~establishment of planar polarity,GO:0007399~nervous system development,GO:0008589~regulation of smoothened signaling pathway,GO:0016192~vesicle-mediated transport,GO:0030030~cell projection organization,GO:0060173~limb development,GO:0060271~cilium assembly,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005929~cilium,GO:0009986~cell surface,GO:0042995~cell projection,		IPR001478:PDZ,IPR036034:PDZ_sf,IPR039151:INTU,IPR043987:CCZ1/INTU/HSP4_longin_1,IPR043988:CCZ1/INTU_longin_2,IPR043989:CCZ1/INTU/HSP4_longin_3,					KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,					KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:PDZ,REGION:Disordered,
Q27J81	inverted formin 2(INF2)	Homo sapiens			GO:0030036~actin cytoskeleton organization,GO:0030041~actin filament polymerization,GO:0090140~regulation of mitochondrial fission,	GO:0005884~actin filament,GO:0048471~perinuclear region of cytoplasm,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0031267~small GTPase binding,	IPR003124:WH2_dom,IPR010472:FH3_dom,IPR010473:GTPase-bd,IPR011989:ARM-like,IPR014768:GBD/FH3_dom,IPR015425:FH2_Formin,IPR016024:ARM-type_fold,IPR042201:FH2_Formin_sf,		613237~Glomerulosclerosis, focal segmental, 5,614455~Charcot-Marie-Tooth disease, dominant intermediate E,		SM00498:FH2,SM01139:Drf_FH3,SM01140:Drf_GBD,		KW-0963~Cytoplasm,		KW-0144~Charcot-Marie-Tooth disease,KW-0225~Disease variant,KW-0523~Neurodegeneration,KW-0622~Neuropathy,	KW-0175~Coiled coil,		KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:FH2,DOMAIN:Formin GTPase-binding,DOMAIN:GBD/FH3,DOMAIN:WH2,REGION:Disordered,
Q9D6R2	isocitrate dehydrogenase 3 (NAD+) alpha(Idh3a)	Mus musculus			GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006103~2-oxoglutarate metabolic process,GO:0006734~NADH metabolic process,	GO:0005739~mitochondrion,GO:0005962~mitochondrial isocitrate dehydrogenase complex (NAD+),GO:0043209~myelin sheath,	GO:0000287~magnesium ion binding,GO:0004449~isocitrate dehydrogenase (NAD+) activity,GO:0016491~oxidoreductase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0046872~metal ion binding,GO:0051287~NAD binding,	IPR004434:Isocitrate_DH_NAD,IPR019818:IsoCit/isopropylmalate_DH_CS,IPR024084:IsoPropMal-DH-like_dom,	mmu00020:Citrate cycle (TCA cycle),mmu01100:Metabolic pathways,mmu01200:Carbon metabolism,mmu01210:2-Oxocarboxylic acid metabolism,mmu01230:Biosynthesis of amino acids,			SM01329:Iso_dh,	KW-0816~Tricarboxylic acid cycle,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0520~NAD,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Isopropylmalate dehydrogenase-like,MUTAGEN:E->K: Homozygous mutant mice exhibit retinal degeneration.,SITE:Critical for catalysis,TRANSIT:Mitochondrion,
P70404	isocitrate dehydrogenase 3 (NAD+), gamma(Idh3g)	Mus musculus			GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006103~2-oxoglutarate metabolic process,GO:0006734~NADH metabolic process,GO:0045926~negative regulation of growth,	GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005962~mitochondrial isocitrate dehydrogenase complex (NAD+),	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004449~isocitrate dehydrogenase (NAD+) activity,GO:0005524~ATP binding,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0046872~metal ion binding,GO:0051287~NAD binding,	IPR004434:Isocitrate_DH_NAD,IPR019818:IsoCit/isopropylmalate_DH_CS,IPR024084:IsoPropMal-DH-like_dom,	mmu00020:Citrate cycle (TCA cycle),mmu01100:Metabolic pathways,mmu01200:Carbon metabolism,mmu01210:2-Oxocarboxylic acid metabolism,mmu01230:Biosynthesis of amino acids,			SM01329:Iso_dh,	KW-0816~Tricarboxylic acid cycle,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Isopropylmalate dehydrogenase-like,TRANSIT:Mitochondrion,
P41252	isoleucyl-tRNA synthetase 1(IARS1)	Homo sapiens			GO:0001649~osteoblast differentiation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006428~isoleucyl-tRNA aminoacylation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0002161~aminoacyl-tRNA editing activity,GO:0004822~isoleucine-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0051020~GTPase binding,	IPR001412:aa-tRNA-synth_I_CS,IPR002300:aa-tRNA-synth_Ia,IPR002301:Ile-tRNA-ligase,IPR009008:Val/Leu/Ile-tRNA-synth_edit,IPR009080:tRNAsynth_Ia_anticodon-bd,IPR013155:M/V/L/I-tRNA-synth_anticd-bd,IPR014729:Rossmann-like_a/b/a_fold,IPR023586:Ile-tRNA-ligase_type2,IPR033709:Anticodon_Ile_ABEc,	hsa00970:Aminoacyl-tRNA biosynthesis,	617093~Growth retardation, impaired intellectual development, hypotonia, and hepatopathy,			KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0991~Intellectual disability,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Aminoacyl-tRNA synthetase class Ia,DOMAIN:Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase anticodon-binding,MOTIF:'HIGH' region,MOTIF:'KMSKS' region,
O35586	isopentenyl-diphosphate Delta-isomerase 1(LOC121135697)	Mesocricetus auratus			GO:0006695~cholesterol biosynthetic process,GO:0008299~isoprenoid biosynthetic process,GO:0009240~isopentenyl diphosphate biosynthetic process,GO:0050992~dimethylallyl diphosphate biosynthetic process,	GO:0005737~cytoplasm,GO:0005777~peroxisome,	GO:0004452~isopentenyl-diphosphate delta-isomerase activity,GO:0046872~metal ion binding,	IPR000086:NUDIX_hydrolase_dom,IPR011876:IsopentenylPP_isomerase_typ1,IPR015797:NUDIX_hydrolase-like_dom_sf,	maua00900:Terpenoid backbone biosynthesis,maua01100:Metabolic pathways,		PIRSF018427:Isopntndiph_ism,		KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0414~Isoprene biosynthesis,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0576~Peroxisome,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0413~Isomerase,	KW-0007~Acetylation,	DOMAIN:Nudix hydrolase,MOTIF:Microbody targeting signal,
O35586	isopentenyl-diphosphate delta isomerase 1(Idi1)	Mesocricetus auratus			GO:0006695~cholesterol biosynthetic process,GO:0008299~isoprenoid biosynthetic process,GO:0009240~isopentenyl diphosphate biosynthetic process,GO:0050992~dimethylallyl diphosphate biosynthetic process,	GO:0005737~cytoplasm,GO:0005777~peroxisome,	GO:0004452~isopentenyl-diphosphate delta-isomerase activity,GO:0046872~metal ion binding,	IPR000086:NUDIX_hydrolase_dom,IPR011876:IsopentenylPP_isomerase_typ1,IPR015797:NUDIX_hydrolase-like_dom_sf,	maua00900:Terpenoid backbone biosynthesis,maua01100:Metabolic pathways,		PIRSF018427:Isopntndiph_ism,		KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0414~Isoprene biosynthesis,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0576~Peroxisome,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0413~Isomerase,	KW-0007~Acetylation,	DOMAIN:Nudix hydrolase,MOTIF:Microbody targeting signal,
Q5RBD5	isovaleryl-CoA dehydrogenase(IVD)	Pongo abelii			GO:0006552~leucine catabolic process,GO:0009083~branched-chain amino acid catabolic process,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003995~acyl-CoA dehydrogenase activity,GO:0004085~butyryl-CoA dehydrogenase activity,GO:0008470~isovaleryl-CoA dehydrogenase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0042802~identical protein binding,GO:0050660~flavin adenine dinucleotide binding,	IPR006089:Acyl-CoA_DH_CS,IPR006091:Acyl-CoA_Oxase/DH_mid-dom,IPR009075:AcylCo_DH/oxidase_C,IPR009100:AcylCoA_DH/oxidase_NM_dom_sf,IPR013786:AcylCoA_DH/ox_N,IPR034183:IVD,IPR036250:AcylCo_DH-like_C,IPR037069:AcylCoA_DH/ox_N_sf,IPR046373:Acyl-CoA_Oxase/DH_mid-dom_sf,	pon00280:Valine, leucine and isoleucine degradation,pon01100:Metabolic pathways,					KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,	ACT_SITE:Proton acceptor,DOMAIN:Acyl-CoA dehydrogenase/oxidase C-terminal,DOMAIN:Acyl-CoA dehydrogenase/oxidase N-terminal,DOMAIN:Acyl-CoA oxidase/dehydrogenase middle,REGION:Disordered,TRANSIT:Mitochondrion,
Q803A0	jade family PHD finger 1(jade1)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0060828~regulation of canonical Wnt signaling pathway,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0042995~cell projection,	GO:0046872~metal ion binding,	IPR001965:Znf_PHD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR019542:Enhancer_polycomb-like_N,IPR019786:Zinc_finger_PHD-type_CS,IPR019787:Znf_PHD-finger,IPR034732:EPHD,IPR039546:Jade-1_PHD,				SM00249:PHD,	KW-0053~Apoptosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PHD-type,REGION:Disordered,ZN_FING:C2HC pre-PHD-type,ZN_FING:PHD-type 1,ZN_FING:PHD-type 2,
P0C870	jumonji domain containing 7(JMJD7)	Homo sapiens			GO:0006508~proteolysis,GO:0018126~protein hydroxylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004175~endopeptidase activity,GO:0004177~aminopeptidase activity,GO:0004497~monooxygenase activity,GO:0005515~protein binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0035064~methylated histone binding,GO:0046872~metal ion binding,	IPR003347:JmjC_dom,IPR014710:RmlC-like_jellyroll,IPR041667:Cupin_8,				SM00558:JmjC,		KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0408~Iron,KW-0479~Metal-binding,	KW-0031~Aminopeptidase,KW-0378~Hydrolase,KW-0503~Monooxygenase,KW-0560~Oxidoreductase,KW-0645~Protease,	KW-1015~Disulfide bond,	DISULFID:Interchain,DOMAIN:JmjC,MUTAGEN:C->A: Impairs homodimer formation.,MUTAGEN:D->A: Loss of peptidase activity toward methylated histones and reduced anchorage-independent growth of transformed cells; when associated with A-180 and A-277.,MUTAGEN:H->A: Loss of peptidase activity toward methylated histones and reduced anchorage-independent growth of transformed cells; when associated with A-180 and A-277.,MUTAGEN:H->A: Loss of peptidase activity toward methylated histones and reduced anchorage-independent growth of transformed cells; when associated with A-180 and A-277. Impairs L-lysine (3S)-hydroxylase activity. Impairs the interaction with DRG1 and DRG2.,
Q96S16	jumonji domain containing 8(JMJD8)	Homo sapiens			GO:0006110~regulation of glycolytic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:1903302~regulation of pyruvate kinase activity,GO:1903672~positive regulation of sprouting angiogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0005515~protein binding,	IPR003347:JmjC_dom,IPR041667:Cupin_8,						KW-0256~Endoplasmic reticulum,KW-0963~Cytoplasm,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:JmjC,REGION:Disordered,
A3KPA0	junctional adhesion molecule 3b(jam3b)	Danio rerio			GO:0007155~cell adhesion,GO:0007520~myoblast fusion,GO:0016477~cell migration,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0030057~desmosome,GO:0044291~cell-cell contact zone,GO:0070161~anchoring junction,GO:0098636~protein complex involved in cell adhesion,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0098632~protein binding involved in cell-cell adhesion,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR042974:JAM-C,	dre04514:Cell adhesion molecules,dre04530:Tight junction,			SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-1015~Disulfide bond,	DOMAIN:Ig-like C2-type,DOMAIN:Ig-like V-type,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9GKY7	junctophilin 2(JPH2)	Oryctolagus cuniculus				GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016529~sarcoplasmic reticulum,GO:0030314~junctional membrane complex,GO:0033017~sarcoplasmic reticulum membrane,	GO:0001786~phosphatidylserine binding,GO:0003677~DNA binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0070273~phosphatidylinositol-4-phosphate binding,GO:0070300~phosphatidic acid binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR003409:MORN,IPR017191:Junctophilin,			PIRSF037387:Junctophilin,	SM00698:MORN,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0703~Sarcoplasmic reticulum,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0678~Repressor,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,MOTIF:Bipartite nuclear localization signal,MOTIF:Nuclear localization signal,REGION:Disordered,REPEAT:MORN 1,REPEAT:MORN 2,REPEAT:MORN 3,REPEAT:MORN 4,REPEAT:MORN 5,REPEAT:MORN 6,REPEAT:MORN 7,REPEAT:MORN 8,SITE:Cleavage; by calpain,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical; Anchor for type IV membrane protein,
O60229	kalirin RhoGEF kinase(KALRN)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007528~neuromuscular junction development,GO:0007595~lactation,GO:0007613~memory,GO:0008344~adult locomotory behavior,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0035176~social behavior,GO:0035556~intracellular signal transduction,GO:0042711~maternal behavior,GO:0046959~habituation,GO:0048013~ephrin receptor signaling pathway,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0060125~negative regulation of growth hormone secretion,GO:0060137~maternal process involved in parturition,GO:0061003~positive regulation of dendritic spine morphogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0019898~extrinsic component of membrane,GO:0070062~extracellular exosome,	GO:0004674~protein serine/threonine kinase activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000219:DH-domain,IPR000719:Prot_kinase_dom,IPR001251:CRAL-TRIO_dom,IPR001452:SH3_domain,IPR001849:PH_domain,IPR002017:Spectrin_repeat,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011993:PH-like_dom_sf,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR017441:Protein_kinase_ATP_BS,IPR018159:Spectrin/alpha-actinin,IPR028570:Kalirin_TRIO_SH3_1,IPR035899:DBL_dom_sf,IPR036028:SH3-like_dom_sf,IPR036116:FN3_sf,IPR036865:CRAL-TRIO_dom_sf,IPR047053:Kalirin_TRIO_SH3_2,IPR047054:Kalirin_TRIO_PH_1,				SM00060:FN3,SM00150:SPEC,SM00220:S_TKc,SM00233:PH,SM00325:RhoGEF,SM00326:SH3,SM00408:IGc2,SM00409:IG,SM00516:SEC14,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0728~SH3 domain,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0344~Guanine-nucleotide releasing factor,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CRAL-TRIO,DOMAIN:DH,DOMAIN:DH 1,DOMAIN:DH 2,DOMAIN:Fibronectin type-III,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:PH,DOMAIN:PH 1,DOMAIN:PH 2,DOMAIN:Protein kinase,DOMAIN:SH3,DOMAIN:SH3 1,DOMAIN:SH3 2,MUTAGEN:K->A: Loss of autophosphorylation.,REGION:Disordered,REPEAT:Spectrin 1,REPEAT:Spectrin 2,REPEAT:Spectrin 3,REPEAT:Spectrin 4,REPEAT:Spectrin 5,REPEAT:Spectrin 6,REPEAT:Spectrin 7,REPEAT:Spectrin 8,REPEAT:Spectrin 9,
P52293	karyopherin subunit alpha 2(Kpna2)	Mus musculus		m_ranMSPathway:Role of Ran in mitotic spindle regulation,	GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing protein import into nucleus,GO:0075506~entry of viral genome into host nucleus through nuclear pore complex via importin,GO:0099527~postsynapse to nucleus signaling pathway,GO:1903902~positive regulation of viral life cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0014069~postsynaptic density,GO:0031965~nuclear membrane,GO:0042564~NLS-dependent protein nuclear import complex,GO:0043657~host cell,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0042826~histone deacetylase binding,GO:0061608~nuclear import signal receptor activity,	IPR000225:Armadillo,IPR002652:Importin-a_IBB,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR024931:Importin_alpha,IPR032413:Arm_3,IPR036975:Importin-a_IBB_sf,	mmu03013:Nucleocytoplasmic transport,mmu05164:Influenza A,mmu05207:Chemical carcinogenesis - receptor activation,		PIRSF005673:Importin_alpha,	SM00185:ARM,	KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:IBB,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:NLS binding site (major),REGION:NLS binding site (minor),REPEAT:ARM,REPEAT:ARM 10; atypical,REPEAT:ARM 1; truncated,REPEAT:ARM 2,REPEAT:ARM 3,REPEAT:ARM 4,REPEAT:ARM 5,REPEAT:ARM 6,REPEAT:ARM 7,REPEAT:ARM 8,REPEAT:ARM 9,
Q5U3S1	katanin p60 subunit A-like 1(katnal1)	Danio rerio			GO:0007283~spermatogenesis,GO:0051013~microtubule severing,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008568~microtubule-severing ATPase activity,GO:0016853~isomerase activity,GO:0016887~ATPase activity,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR003960:ATPase_AAA_CS,IPR015415:Spast_Vps4_C,IPR027417:P-loop_NTPase,IPR028594:Katnal1_chordates,IPR028596:KATNA1,IPR041569:AAA_lid_3,IPR048611:KATNA1_MIT,IPR048612:KTNA1_AAA_dom,				SM00382:AAA,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0413~Isomerase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,REGION:Disordered,
Q80YG3	kelch domain containing 1(Klhdc1)	Mus musculus			GO:0016567~protein ubiquitination,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031466~Cul5-RING ubiquitin ligase complex,	GO:1990756~protein binding, bridging involved in substrate recognition for ubiquitination,	IPR006652:Kelch_1,IPR011043:Gal_Oxase/kelch_b-propeller,IPR015915:Kelch-typ_b-propeller,					KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0880~Kelch repeat,				REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,REPEAT:Kelch 6,
Q8BNW9	kelch repeat and BTB (POZ) domain containing 11(Kbtbd11)	Mus musculus						IPR000210:BTB/POZ_dom,IPR006652:Kelch_1,IPR011333:SKP1/BTB/POZ_sf,IPR015915:Kelch-typ_b-propeller,				SM00225:BTB,SM00612:Kelch,					KW-0677~Repeat,KW-0880~Kelch repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BTB,REGION:Disordered,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,
Q8CE33	kelch-like 11(Klhl11)	Mus musculus						IPR000210:BTB/POZ_dom,IPR006652:Kelch_1,IPR011333:SKP1/BTB/POZ_sf,IPR011705:BACK,IPR015915:Kelch-typ_b-propeller,				SM00225:BTB,SM00612:Kelch,SM00875:BACK,	KW-0833~Ubl conjugation pathway,				KW-0677~Repeat,KW-0732~Signal,KW-0880~Kelch repeat,			KW-0597~Phosphoprotein,	DOMAIN:BACK,DOMAIN:BTB,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,
Q8K430	kelch-like family member 17(Klhl17)	Rattus norvegicus			GO:0016567~protein ubiquitination,GO:0030036~actin cytoskeleton organization,	GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0032839~dendrite cytoplasm,GO:0043025~neuronal cell body,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,GO:0031208~POZ domain binding,GO:0051015~actin filament binding,GO:0060090~binding, bridging,	IPR000210:BTB/POZ_dom,IPR006652:Kelch_1,IPR011043:Gal_Oxase/kelch_b-propeller,IPR011333:SKP1/BTB/POZ_sf,IPR011705:BACK,IPR015915:Kelch-typ_b-propeller,IPR017096:BTB-kelch_protein,			PIRSF037037:Kelch-like_protein_gigaxonin,	SM00225:BTB,SM00612:Kelch,SM00875:BACK,	KW-0833~Ubl conjugation pathway,	KW-0770~Synapse,			KW-0677~Repeat,KW-0880~Kelch repeat,		KW-0009~Actin-binding,		COMPBIAS:Pro residues,DOMAIN:BACK,DOMAIN:BTB,MUTAGEN:Missing: No interaction with PDZK1.,REGION:Disordered,REGION:Interaction with F-actin,REGION:Interaction with PDZK1,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,REPEAT:Kelch 6,
Q6NYM1	kelch-like family member 21(klhl21)	Danio rerio			GO:0007049~cell cycle,GO:0016567~protein ubiquitination,GO:0032465~regulation of cytokinesis,GO:0035853~chromosome passenger complex localization to spindle midzone,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005827~polar microtubule,GO:0005856~cytoskeleton,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ_dom,IPR006652:Kelch_1,IPR011333:SKP1/BTB/POZ_sf,IPR011705:BACK,IPR015915:Kelch-typ_b-propeller,IPR017096:BTB-kelch_protein,IPR030577:BTB/POZ_KLHL21,IPR047069:KLHL21_BACK,			PIRSF037037:Kelch-like_protein_gigaxonin,	SM00225:BTB,SM00612:Kelch,SM00875:BACK,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0833~Ubl conjugation pathway,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0880~Kelch repeat,				DOMAIN:BACK,DOMAIN:BTB,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,REPEAT:Kelch 6,
Q1LYM6	kelch-like family member 38a(klhl38a)	Danio rerio						IPR000210:BTB/POZ_dom,IPR006652:Kelch_1,IPR011333:SKP1/BTB/POZ_sf,IPR011705:BACK,IPR015915:Kelch-typ_b-propeller,IPR017096:BTB-kelch_protein,IPR030568:KLHL38_BACK,			PIRSF037037:Kelch-like_protein_gigaxonin,	SM00225:BTB,SM00612:Kelch,SM00875:BACK,					KW-0677~Repeat,KW-0880~Kelch repeat,				DOMAIN:BACK,DOMAIN:BTB,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,REPEAT:Kelch 6,
Q02974	ketohexokinase(Khk)	Rattus norvegicus			GO:0006000~fructose metabolic process,GO:0006001~fructose catabolic process,GO:0009744~response to sucrose,GO:0009749~response to glucose,GO:0009750~response to fructose,GO:0010043~response to zinc ion,GO:0016052~carbohydrate catabolic process,GO:0032868~response to insulin,GO:0046835~carbohydrate phosphorylation,GO:0061624~fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,GO:0070873~regulation of glycogen metabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004454~ketohexokinase activity,GO:0005524~ATP binding,	IPR011611:PfkB_dom,IPR029056:Ribokinase-like,IPR034093:KHK,	rno00051:Fructose and mannose metabolism,rno01100:Metabolic pathways,				KW-0119~Carbohydrate metabolism,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		DOMAIN:Carbohydrate kinase PfkB,
Q7T163	kinase D-interacting substrate 220b(kidins220b)	Danio rerio			GO:0007399~nervous system development,GO:0016310~phosphorylation,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005770~late endosome,GO:0016020~membrane,GO:0031902~late endosome membrane,	GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019887~protein kinase regulator activity,GO:0030165~PDZ domain binding,	IPR002110:Ankyrin_rpt,IPR011646:KAP_P-loop,IPR036770:Ankyrin_rpt-contain_sf,				SM00248:ANK,	KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0040~ANK repeat,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0418~Kinase,KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,DOMAIN:KAP NTPase,MOTIF:PDZ-binding,REGION:Disordered,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 10,REPEAT:ANK 11,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q92845	kinesin associated protein 3(KIFAP3)	Homo sapiens			GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0007165~signal transduction,GO:0007405~neuroblast proliferation,GO:0007406~negative regulation of neuroblast proliferation,GO:0008104~protein localization,GO:0010659~cardiac muscle cell apoptotic process,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0044782~cilium organization,GO:0046587~positive regulation of calcium-dependent cell-cell adhesion,GO:0065003~macromolecular complex assembly,GO:0070242~thymocyte apoptotic process,GO:0070244~negative regulation of thymocyte apoptotic process,GO:0072383~plus-end-directed vesicle transport along microtubule,	GO:0000794~condensed nuclear chromosome,GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0015630~microtubule cytoskeleton,GO:0016939~kinesin II complex,GO:0032391~photoreceptor connecting cilium,GO:0035869~ciliary transition zone,GO:0036064~ciliary basal body,GO:0097542~ciliary tip,GO:1990075~periciliary membrane compartment,	GO:0005515~protein binding,GO:0019894~kinesin binding,GO:0019903~protein phosphatase binding,	IPR000225:Armadillo,IPR008658:KAP3,IPR011989:ARM-like,IPR016024:ARM-type_fold,	hsa04814:Motor proteins,			SM00185:ARM,SM01297:KAP,					KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,REPEAT:ARM 1,REPEAT:ARM 2,REPEAT:ARM 3,REPEAT:ARM 4,REPEAT:ARM 5,
B2GU58	kinesin family member 11(kif11)	Xenopus tropicalis			GO:0007018~microtubule-based movement,GO:0007049~cell cycle,GO:0051301~cell division,GO:0090307~mitotic spindle assembly,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,	GO:0000166~nucleotide binding,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0019901~protein kinase binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR025901:Kinesin-assoc_MT-bd_dom,IPR027417:P-loop_NTPase,IPR036961:Kinesin_motor_dom_sf,IPR047149:KIF11-like,IPR047241:KIF11-like_kin_motor_dom,	xtr04814:Motor proteins,			SM00129:KISc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Kinesin motor,REGION:Disordered,
Q15058	kinesin family member 14(KIF14)	Homo sapiens			GO:0001558~regulation of cell growth,GO:0007018~microtubule-based movement,GO:0007080~mitotic metaphase plate congression,GO:0008284~positive regulation of cell proliferation,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0021685~cerebellar granular layer structural organization,GO:0021693~cerebellar Purkinje cell layer structural organization,GO:0021695~cerebellar cortex development,GO:0021766~hippocampus development,GO:0021772~olfactory bulb development,GO:0021846~cell proliferation in forebrain,GO:0021987~cerebral cortex development,GO:0030155~regulation of cell adhesion,GO:0030334~regulation of cell migration,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031641~regulation of myelination,GO:0032147~activation of protein kinase activity,GO:0032467~positive regulation of cytokinesis,GO:0032487~regulation of Rap protein signal transduction,GO:0033624~negative regulation of integrin activation,GO:0034446~substrate adhesion-dependent cell spreading,GO:0043066~negative regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045184~establishment of protein localization,GO:0051301~cell division,GO:1903429~regulation of cell maturation,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0051233~spindle midzone,GO:0090543~Flemming body,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,GO:0015631~tubulin binding,GO:0016887~ATPase activity,GO:0019901~protein kinase binding,GO:0030165~PDZ domain binding,	IPR000253:FHA_dom,IPR001752:Kinesin_motor_dom,IPR008984:SMAD_FHA_dom_sf,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR032405:Kinesin_assoc,IPR036961:Kinesin_motor_dom_sf,	hsa04814:Motor proteins,	616258~Meckel syndrome 12,617914~Microcephaly 20, primary, autosomal recessive,		SM00129:KISc,SM00240:FHA,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0905~Primary microcephaly,KW-0981~Meckel syndrome,KW-1186~Ciliopathy,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:FHA,DOMAIN:Kinesin motor,REGION:Disordered,REGION:Required for CIT-binding,REGION:Required for PRC1-binding,REGION:Required for microtubule-binding with high affinity,
Q91785	kinesin family member 15 L homeolog(kif15.L)	Xenopus laevis			GO:0007018~microtubule-based movement,	GO:0000922~spindle pole,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR031794:HMMR_C,IPR036961:Kinesin_motor_dom_sf,IPR044986:KIF15/KIN-12,	xla04814:Motor proteins,			SM00129:KISc,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,		COMPBIAS:Polar residues,DOMAIN:Kinesin motor,MUTAGEN:L->K: Inhibits its targeting to microtubule minus ends.,REGION:Disordered,REGION:Necessary for its targeting to microtubule minus ends,
Q8NI77	kinesin family member 18A(KIF18A)	Homo sapiens			GO:0000070~mitotic sister chromatid segregation,GO:0007018~microtubule-based movement,GO:0007019~microtubule depolymerization,GO:0007080~mitotic metaphase plate congression,GO:0007140~male meiosis,GO:0015031~protein transport,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0071392~cellular response to estradiol stimulus,GO:0072520~seminiferous tubule development,	GO:0000776~kinetochore,GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005828~kinetochore microtubule,GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005901~caveola,GO:0015630~microtubule cytoskeleton,GO:0061673~mitotic spindle astral microtubule,GO:1990023~mitotic spindle midzone,	GO:0003777~microtubule motor activity,GO:0003779~actin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,GO:0016887~ATPase activity,GO:0051010~microtubule plus-end binding,GO:0070463~tubulin-dependent ATPase activity,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	hsa04814:Motor proteins,			SM00129:KISc,	KW-0653~Protein transport,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Kinesin motor,REGION:Disordered,
O95235	kinesin family member 20A(KIF20A)	Homo sapiens			GO:0000281~mitotic cytokinesis,GO:0001578~microtubule bundle formation,GO:0007018~microtubule-based movement,GO:0015031~protein transport,GO:0032465~regulation of cytokinesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005819~spindle,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0030496~midbody,GO:0045171~intercellular bridge,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,GO:0019901~protein kinase binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,IPR047149:KIF11-like,	hsa04814:Motor proteins,	619433~Cardiomyopathy, familial restrictive, 6,		SM00129:KISc,	KW-0653~Protein transport,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0493~Microtubule,KW-0963~Cytoplasm,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Kinesin motor,MUTAGEN:S->A: Impairs phosphorylation by PLK1 and recruitment of PLK1 to the spindle.,REGION:Disordered,REGION:Globular,
Q96Q89	kinesin family member 20B(KIF20B)	Homo sapiens			GO:0001843~neural tube closure,GO:0007018~microtubule-based movement,GO:0007049~cell cycle,GO:0007088~regulation of mitotic nuclear division,GO:0008284~positive regulation of cell proliferation,GO:0032467~positive regulation of cytokinesis,GO:0035372~protein localization to microtubule,GO:0048812~neuron projection morphogenesis,GO:0051301~cell division,GO:0051726~regulation of cell cycle,GO:0090316~positive regulation of intracellular protein transport,GO:1903438~positive regulation of mitotic cytokinetic process,GO:2000114~regulation of establishment of cell polarity,GO:2001224~positive regulation of neuron migration,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0030426~growth cone,GO:0030496~midbody,GO:0045171~intercellular bridge,GO:0048471~perinuclear region of cytoplasm,GO:0051233~spindle midzone,GO:0070938~contractile ring,GO:0097431~mitotic spindle pole,GO:1990023~mitotic spindle midzone,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,GO:0016887~ATPase activity,GO:0042803~protein homodimerization activity,GO:0050699~WW domain binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR036961:Kinesin_motor_dom_sf,IPR047149:KIF11-like,	hsa04814:Motor proteins,			SM00129:KISc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,		KW-0553~Oncogene,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Kinesin motor,REGION:Disordered,REGION:Interaction with PIN1,REGION:Necessary and sufficient for interaction with SHTN1,
Q80WE4	kinesin family member 20B(Kif20b)	Mus musculus			GO:0001843~neural tube closure,GO:0007018~microtubule-based movement,GO:0007049~cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0032467~positive regulation of cytokinesis,GO:0035372~protein localization to microtubule,GO:0048812~neuron projection morphogenesis,GO:0051301~cell division,GO:0070201~regulation of establishment of protein localization,GO:0090316~positive regulation of intracellular protein transport,GO:1903438~positive regulation of mitotic cytokinetic process,GO:2000114~regulation of establishment of cell polarity,GO:2001222~regulation of neuron migration,GO:2001224~positive regulation of neuron migration,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0030426~growth cone,GO:0030496~midbody,GO:0042995~cell projection,GO:0045171~intercellular bridge,GO:0048471~perinuclear region of cytoplasm,GO:0051233~spindle midzone,GO:0070938~contractile ring,GO:0097431~mitotic spindle pole,GO:1990023~mitotic spindle midzone,	GO:0000166~nucleotide binding,GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,GO:0016887~ATPase activity,GO:0042803~protein homodimerization activity,GO:0050699~WW domain binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR036961:Kinesin_motor_dom_sf,IPR047149:KIF11-like,	mmu04814:Motor proteins,			SM00129:KISc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,		KW-0553~Oncogene,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Kinesin motor,MUTAGEN:R->A: Reduces interaction with SHTN1; when associated with F-1047.,MUTAGEN:Y->F: Reduces interaction with SHTN1; when associated with A-1048.,REGION:Disordered,REGION:Interaction with PIN1,REGION:Necessary and sufficient for interaction with SHTN1,
Q9QXL2	kinesin family member 21A(Kif21a)	Mus musculus			GO:0007018~microtubule-based movement,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0030424~axon,GO:0030425~dendrite,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,GO:0071532~ankyrin repeat binding,	IPR001680:WD40_rpt,IPR001752:Kinesin_motor_dom,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036322:WD40_repeat_dom_sf,IPR036961:Kinesin_motor_dom_sf,	mmu04814:Motor proteins,			SM00129:KISc,SM00320:WD40,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Kinesin motor,REGION:Disordered,REGION:Interaction with KANK1 and KANK2,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
O75037	kinesin family member 21B(KIF21B)	Homo sapiens			GO:0007018~microtubule-based movement,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0030425~dendrite,GO:0030426~growth cone,GO:0031410~cytoplasmic vesicle,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,	IPR001680:WD40_rpt,IPR001752:Kinesin_motor_dom,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036322:WD40_repeat_dom_sf,IPR036961:Kinesin_motor_dom_sf,	hsa04814:Motor proteins,			SM00129:KISc,SM00320:WD40,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Kinesin motor,REGION:Disordered,REGION:Interaction with TRIM3,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
A8WFU8	kinesin family member 22(kif22)	Danio rerio			GO:0001756~somitogenesis,GO:0001966~thigmotaxis,GO:0007018~microtubule-based movement,GO:0007409~axonogenesis,GO:0007420~brain development,GO:0021952~central nervous system projection neuron axonogenesis,GO:0048592~eye morphogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,	IPR001752:Kinesin_motor_dom,IPR010994:RuvA_2-like,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	dre04814:Motor proteins,dre04914:Progesterone-mediated oocyte maturation,			SM00129:KISc,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0505~Motor protein,	KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,DOMAIN:Kinesin motor,REGION:Disordered,
Q02241	kinesin family member 23(KIF23)	Homo sapiens			GO:0000022~mitotic spindle elongation,GO:0000281~mitotic cytokinesis,GO:0007018~microtubule-based movement,GO:0032467~positive regulation of cytokinesis,GO:0051256~mitotic spindle midzone assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005925~focal adhesion,GO:0030496~midbody,GO:0045171~intercellular bridge,GO:0072686~mitotic spindle,GO:0090543~Flemming body,GO:0097149~centralspindlin complex,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR032384:Kif23_Arf-bd,IPR036961:Kinesin_motor_dom_sf,IPR038105:Kif23_Arf-bd_sf,	hsa04814:Motor proteins,hsa05206:MicroRNAs in cancer,	105600~Anemia, congenital dyserythropoietic, type IIIA,		SM00129:KISc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0360~Hereditary hemolytic anemia,KW-1055~Congenital dyserythropoietic anemia,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Kinesin motor,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with ARF6,
Q52KG5	kinesin family member 26A(Kif26a)	Mus musculus			GO:0001560~regulation of cell growth by extracellular stimulus,GO:0009968~negative regulation of signal transduction,GO:0010975~regulation of neuron projection development,GO:0021987~cerebral cortex development,GO:0048484~enteric nervous system development,GO:2001222~regulation of neuron migration,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,	IPR001752:Kinesin_motor_dom,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	mmu04814:Motor proteins,			SM00129:KISc,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Kinesin motor,REGION:Disordered,
Q91636	kinesin family member 2C S homeolog(kif2c.S)	Xenopus laevis			GO:0007018~microtubule-based movement,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0035371~microtubule plus-end,	GO:0000166~nucleotide binding,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	xla04814:Motor proteins,			SM00129:KISc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			COMPBIAS:Polar residues,DOMAIN:Kinesin motor,REGION:Disordered,REGION:Globular,REGION:Negative regulator of microtubule-binding,
P79955	kinesin family member C1 L homeolog(kifc1.L)	Xenopus laevis			GO:0007018~microtubule-based movement,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,	GO:0000166~nucleotide binding,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	xla04814:Motor proteins,			SM00129:KISc,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Kinesin motor,REGION:Disordered,REGION:Globular,
P50748	kinetochore associated 1(KNTC1)	Homo sapiens			GO:0000070~mitotic sister chromatid segregation,GO:0007094~mitotic spindle assembly checkpoint,GO:0007096~regulation of exit from mitosis,GO:0051301~cell division,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0065003~macromolecular complex assembly,GO:1903394~protein localization to kinetochore involved in kinetochore assembly,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005828~kinetochore microtubule,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:1990423~RZZ complex,	GO:0005515~protein binding,GO:0031267~small GTPase binding,	IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019527:RZZ-complex_KNTC1/ROD_C,IPR036322:WD40_repeat_dom_sf,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,						KW-0597~Phosphoprotein,	DOMAIN:RZZ complex subunit KNTC1/ROD C-terminal,
Q96J84	kirre like nephrin family adhesion molecule 1(KIRREL1)	Homo sapiens			GO:0001933~negative regulation of protein phosphorylation,GO:0003094~glomerular filtration,GO:0030838~positive regulation of actin filament polymerization,GO:0045217~cell-cell junction maintenance,GO:0097017~renal protein absorption,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0031253~cell projection membrane,GO:0043198~dendritic shaft,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0017022~myosin binding,GO:0050839~cell adhesion molecule binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013162:CD80_C2-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,		619201~Nephrotic syndrome, type 23,		SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,MOTIF:Cell attachment site,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q80W68	kirre like nephrin family adhesion molecule 1(Kirrel1)	Mus musculus			GO:0001933~negative regulation of protein phosphorylation,GO:0003094~glomerular filtration,GO:0030838~positive regulation of actin filament polymerization,GO:0045217~cell-cell junction maintenance,GO:0097017~renal protein absorption,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0031253~cell projection membrane,GO:0043198~dendritic shaft,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0017022~myosin binding,GO:0050839~cell adhesion molecule binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013162:CD80_C2-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,MOTIF:Cell attachment site,MUTAGEN:P->S: No effect on interaction with NPHS2.,MUTAGEN:Y->A: Inhibits interaction with NPHS2.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8IZU9	kirre like nephrin family adhesion molecule 3(KIRREL3)	Homo sapiens			GO:0001764~neuron migration,GO:0002121~inter-male aggressive behavior,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007416~synapse assembly,GO:0021740~principal sensory nucleus of trigeminal nerve development,GO:0021766~hippocampus development,GO:0030097~hemopoiesis,GO:0048812~neuron projection morphogenesis,GO:0072102~glomerulus morphogenesis,GO:0098609~cell-cell adhesion,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043198~dendritic shaft,	GO:0005515~protein binding,GO:0050839~cell adhesion molecule binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013162:CD80_C2-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q96MU8	kringle containing transmembrane protein 1(KREMEN1)	Homo sapiens			GO:0006915~apoptotic process,GO:0007154~cell communication,GO:0007275~multicellular organism development,GO:0016055~Wnt signaling pathway,GO:0030279~negative regulation of ossification,GO:0048681~negative regulation of axon regeneration,GO:0060173~limb development,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043025~neuronal cell body,	GO:0005515~protein binding,	IPR000001:Kringle,IPR000859:CUB_dom,IPR002889:WSC_carb-bd,IPR013806:Kringle-like,IPR017076:Kremen,IPR018056:Kringle_CS,IPR035914:Sperma_CUB_dom_sf,IPR038178:Kringle_sf,		617392~Ectodermal dysplasia 13, hair/tooth type,	PIRSF036961:Kremen,	SM00042:CUB,SM00130:KR,SM00321:WSC,	KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0038~Ectodermal dysplasia,KW-0225~Disease variant,	KW-0420~Kringle,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:CUB,DOMAIN:Kringle,DOMAIN:WSC,REGION:Essential for apoptotic activity,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9PVK4	lactate dehydrogenase Ba(ldhba)	Danio rerio			GO:0006089~lactate metabolic process,GO:0006090~pyruvate metabolic process,GO:0019752~carboxylic acid metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003824~catalytic activity,GO:0004459~L-lactate dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,	IPR001236:Lactate/malate_DH_N,IPR001557:L-lactate/malate_DH,IPR011304:L-lactate_DH,IPR015955:Lactate_DH/Glyco_Ohase_4_C,IPR018177:L-lactate_DH_AS,IPR022383:Lactate/malate_DH_C,IPR036291:NAD(P)-bd_dom_sf,	dre00010:Glycolysis / Gluconeogenesis,dre00270:Cysteine and methionine metabolism,dre00620:Pyruvate metabolism,dre00640:Propanoate metabolism,dre01100:Metabolic pathways,		PIRSF000102:Lac_mal_DH,			KW-0963~Cytoplasm,				KW-0520~NAD,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,
Q16787	laminin subunit alpha 3(LAMA3)	Homo sapiens		h_agrPathway:Agrin in Postsynaptic Differentiation,	GO:0007155~cell adhesion,GO:0008544~epidermis development,GO:0030155~regulation of cell adhesion,GO:0030334~regulation of cell migration,GO:0031581~hemidesmosome assembly,GO:0035987~endodermal cell differentiation,GO:0045995~regulation of embryonic development,GO:0098609~cell-cell adhesion,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005608~laminin-3 complex,GO:0005610~laminin-5 complex,GO:0005783~endoplasmic reticulum,GO:0005912~adherens junction,GO:0016020~membrane,GO:0030056~hemidesmosome,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,	IPR000034:Laminin_IV,IPR000742:EGF-like_dom,IPR001791:Laminin_G,IPR002049:LE_dom,IPR008211:Laminin_N,IPR009254:Laminin_aI,IPR010307:Laminin_dom_II,IPR013320:ConA-like_dom_sf,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	245660~Epidermolysis bullosa, junctional 2C, laryngoonychocutaneous,619783~Epidermolysis bullosa, junctional 2A, intermediate,619784~Epidermolysis bullosa, junctional 2B, severe,		SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,SM00281:LamB,SM00282:LamG,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,KW-0263~Epidermolysis bullosa,	KW-0175~Coiled coil,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,DOMAIN:Laminin EGF-like,DOMAIN:Laminin EGF-like 1,DOMAIN:Laminin EGF-like 10,DOMAIN:Laminin EGF-like 11,DOMAIN:Laminin EGF-like 12,DOMAIN:Laminin EGF-like 13,DOMAIN:Laminin EGF-like 14,DOMAIN:Laminin EGF-like 15; truncated,DOMAIN:Laminin EGF-like 2,DOMAIN:Laminin EGF-like 3,DOMAIN:Laminin EGF-like 4,DOMAIN:Laminin EGF-like 5,DOMAIN:Laminin EGF-like 6,DOMAIN:Laminin EGF-like 7,DOMAIN:Laminin EGF-like 8,DOMAIN:Laminin EGF-like 9,DOMAIN:Laminin G,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G-like 2,DOMAIN:Laminin G-like 3,DOMAIN:Laminin G-like 4,DOMAIN:Laminin G-like 5,DOMAIN:Laminin IV type A,DOMAIN:Laminin N-terminal,MOTIF:Cell attachment site,REGION:Disordered,REGION:Domain II and I,REGION:Domain III A,REGION:Domain III B,REGION:Domain IV 1 (domain IV B),REGION:Domain V,
Q16363	laminin subunit alpha 4(LAMA4)	Homo sapiens		h_agrPathway:Agrin in Postsynaptic Differentiation,	GO:0001568~blood vessel development,GO:0007155~cell adhesion,GO:0030155~regulation of cell adhesion,GO:0030334~regulation of cell migration,GO:0045995~regulation of embryonic development,GO:0050873~brown fat cell differentiation,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0016020~membrane,GO:0031594~neuromuscular junction,GO:0043083~synaptic cleft,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005201~extracellular matrix structural constituent,	IPR000742:EGF-like_dom,IPR001791:Laminin_G,IPR002049:LE_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR009254:Laminin_aI,IPR010307:Laminin_dom_II,IPR013320:ConA-like_dom_sf,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05143:African trypanosomiasis,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	615235~Cardiomyopathy, dilated, 1JJ,		SM00180:EGF_Lam,SM00181:EGF,SM00282:LamG,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,	KW-0175~Coiled coil,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine,DISULFID:Interchain,DOMAIN:Laminin EGF-like,DOMAIN:Laminin EGF-like 1,DOMAIN:Laminin EGF-like 2,DOMAIN:Laminin EGF-like 3,DOMAIN:Laminin EGF-like 4; truncated,DOMAIN:Laminin G,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G-like 2,DOMAIN:Laminin G-like 3,DOMAIN:Laminin G-like 4,DOMAIN:Laminin G-like 5,MOTIF:Cell attachment site,REGION:Disordered,REGION:Domain II and I,
P07942	laminin subunit beta 1(LAMB1)	Homo sapiens		h_prionPathway:Prion Pathway,	GO:0007155~cell adhesion,GO:0021812~neuronal-glial interaction involved in cerebral cortex radial glia guided migration,GO:0030335~positive regulation of cell migration,GO:0031175~neuron projection development,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0042476~odontogenesis,GO:0045785~positive regulation of cell adhesion,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051149~positive regulation of muscle cell differentiation,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005606~laminin-1 complex,GO:0005607~laminin-2 complex,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0043257~laminin-8 complex,GO:0043259~laminin-10 complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0098637~protein complex involved in cell-matrix adhesion,	GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,	IPR000742:EGF-like_dom,IPR002049:LE_dom,IPR008211:Laminin_N,IPR013015:Laminin_IV_B,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	615191~Lissencephaly 5,		SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0451~Lissencephaly,	KW-0175~Coiled coil,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DISULFID:Interchain,DOMAIN:Laminin EGF-like,DOMAIN:Laminin EGF-like 1,DOMAIN:Laminin EGF-like 10,DOMAIN:Laminin EGF-like 11,DOMAIN:Laminin EGF-like 12,DOMAIN:Laminin EGF-like 13,DOMAIN:Laminin EGF-like 2,DOMAIN:Laminin EGF-like 3,DOMAIN:Laminin EGF-like 4,DOMAIN:Laminin EGF-like 5; truncated,DOMAIN:Laminin EGF-like 6,DOMAIN:Laminin EGF-like 7,DOMAIN:Laminin EGF-like 8,DOMAIN:Laminin EGF-like 9,DOMAIN:Laminin IV type B,DOMAIN:Laminin N-terminal,REGION:Disordered,REGION:Domain I,REGION:Domain II,REGION:Domain alpha,
Q13751	laminin subunit beta 3(LAMB3)	Homo sapiens			GO:0007155~cell adhesion,GO:0008544~epidermis development,GO:0035987~endodermal cell differentiation,GO:0050873~brown fat cell differentiation,	GO:0005576~extracellular region,GO:0005610~laminin-5 complex,	GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0044877~macromolecular complex binding,	IPR000742:EGF-like_dom,IPR002049:LE_dom,IPR008211:Laminin_N,IPR008979:Galactose-bd-like_sf,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	104530~Amelogenesis imperfecta, type IA,226650~Epidermolysis bullosa, junctional 1A, intermediate,226700~Epidermolysis bullosa, junctional 1B, severe,		SM00136:LamNT,SM00180:EGF_Lam,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,KW-0263~Epidermolysis bullosa,KW-0986~Amelogenesis imperfecta,	KW-0175~Coiled coil,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,DOMAIN:Laminin EGF-like,DOMAIN:Laminin EGF-like 1,DOMAIN:Laminin EGF-like 2,DOMAIN:Laminin EGF-like 3,DOMAIN:Laminin EGF-like 4,DOMAIN:Laminin EGF-like 5,DOMAIN:Laminin EGF-like 6,DOMAIN:Laminin N-terminal,REGION:Domain I,REGION:Domain II,REGION:Domain alpha,
Q9Y6N6	laminin subunit gamma 3(LAMC3)	Homo sapiens			GO:0000902~cell morphogenesis,GO:0007155~cell adhesion,GO:0007601~visual perception,GO:0014002~astrocyte development,GO:0060041~retina development in camera-type eye,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0005198~structural molecule activity,	IPR000034:Laminin_IV,IPR000742:EGF-like_dom,IPR002049:LE_dom,IPR008211:Laminin_N,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	614115~Cortical malformations, occipital,		SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,SM00281:LamB,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,	KW-0175~Coiled coil,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Laminin EGF-like,DOMAIN:Laminin EGF-like 1,DOMAIN:Laminin EGF-like 10,DOMAIN:Laminin EGF-like 11,DOMAIN:Laminin EGF-like 2,DOMAIN:Laminin EGF-like 3,DOMAIN:Laminin EGF-like 4,DOMAIN:Laminin EGF-like 5; first part,DOMAIN:Laminin EGF-like 5; second part,DOMAIN:Laminin EGF-like 6,DOMAIN:Laminin EGF-like 7,DOMAIN:Laminin EGF-like 8,DOMAIN:Laminin EGF-like 9,DOMAIN:Laminin IV type A,DOMAIN:Laminin N-terminal,MOTIF:Cell attachment site,REGION:Disordered,REGION:Domain II and I,
Q0P3X8	late endosomal/lysosomal adaptor, MAPK and MTOR activator 4(lamtor4)	Danio rerio			GO:0008361~regulation of cell size,GO:0032008~positive regulation of TOR signaling,GO:0061462~protein localization to lysosome,GO:0071230~cellular response to amino acid stimulus,GO:1904263~positive regulation of TORC1 signaling,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0071986~Ragulator complex,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0060090~binding, bridging,	IPR034601:LAMTOR4,	dre04150:mTOR signaling pathway,					KW-0458~Lysosome,						KW-0597~Phosphoprotein,
Q00918	latent transforming growth factor beta binding protein 1(Ltbp1)	Rattus norvegicus			GO:0003281~ventricular septum development,GO:0032967~positive regulation of collagen biosynthetic process,GO:0035583~sequestering of TGFbeta in extracellular matrix,GO:0035904~aorta development,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0060976~coronary vasculature development,GO:0071260~cellular response to mechanical stimulus,GO:0071305~cellular response to vitamin D,GO:0071374~cellular response to parathyroid hormone stimulus,GO:1901388~regulation of transforming growth factor beta activation,	GO:0001527~microfibril,GO:0005576~extracellular region,GO:0030425~dendrite,GO:0031012~extracellular matrix,GO:0032991~macromolecular complex,GO:0038045~large latent transforming growth factor-beta complex,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0005509~calcium ion binding,GO:0050431~transforming growth factor beta binding,GO:0050436~microfibril binding,GO:0060090~binding, bridging,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR017878:TB_dom,IPR018097:EGF_Ca-bd_CS,IPR036773:TB_dom_sf,	rno04350:TGF-beta signaling pathway,		PIRSF036312:Fibrillin,	SM00179:EGF_CA,SM00181:EGF,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,		KW-0340~Growth factor binding,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Glc) serine,DISULFID:Interchain (with C-33 in TGFB1); in linked form,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10; calcium-binding,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13; calcium-binding,DOMAIN:EGF-like 14; calcium-binding,DOMAIN:EGF-like 15; calcium-binding,DOMAIN:EGF-like 16; calcium-binding,DOMAIN:EGF-like 17,DOMAIN:EGF-like 18; calcium-binding,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:EGF-like 9; calcium-binding,DOMAIN:TB,DOMAIN:TB 1,DOMAIN:TB 2,DOMAIN:TB 3,DOMAIN:TB 4,REGION:8-Cys3 region,REGION:C-terminal domain,REGION:Disordered,SITE:Cleavage,
Q8K4G1	latent transforming growth factor beta binding protein 4(Ltbp4)	Mus musculus			GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0046879~hormone secretion,GO:0048251~elastic fiber assembly,	GO:0001527~microfibril,GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0019838~growth factor binding,GO:0050431~transforming growth factor beta binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR013032:EGF-like_CS,IPR017878:TB_dom,IPR018097:EGF_Ca-bd_CS,IPR036773:TB_dom_sf,				SM00179:EGF_CA,SM00181:EGF,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,		KW-0340~Growth factor binding,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DISULFID:Interchain (with C-33 in TGFB1); in linked form,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10; calcium-binding,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13; calcium-binding,DOMAIN:EGF-like 14; calcium-binding,DOMAIN:EGF-like 15,DOMAIN:EGF-like 16,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:EGF-like 9; calcium-binding,DOMAIN:TB,DOMAIN:TB 1,DOMAIN:TB 2,DOMAIN:TB 3,DOMAIN:TB 4,REGION:Disordered,
A0A0G2K0D3	leiomodin 1(Lmod1)	Rattus norvegicus			GO:0006936~muscle contraction,GO:0007015~actin filament organization,GO:0030239~myofibril assembly,GO:0030838~positive regulation of actin filament polymerization,GO:0045010~actin nucleation,GO:0051694~pointed-end actin filament capping,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005865~striated muscle thin filament,GO:0005884~actin filament,GO:0030016~myofibril,GO:0030017~sarcomere,	GO:0003779~actin binding,GO:0005523~tropomyosin binding,	IPR003124:WH2_dom,IPR004934:TMOD,IPR032675:LRR_dom_sf,				SM00246:WH2,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:WH2,REGION:5 X 4 AA approximate tandem repeats,REGION:8 X approximate tandem repeats,REGION:Disordered,REPEAT:1,REPEAT:2,REPEAT:3,REPEAT:4,REPEAT:5,REPEAT:6,REPEAT:7,REPEAT:8,
Q5XGB9	leucine aminopeptidase 3(lap3)	Xenopus tropicalis			GO:0006508~proteolysis,GO:0019538~protein metabolic process,	GO:0005737~cytoplasm,	GO:0004177~aminopeptidase activity,GO:0004180~carboxypeptidase activity,GO:0008233~peptidase activity,GO:0016787~hydrolase activity,GO:0030145~manganese ion binding,GO:0046872~metal ion binding,GO:0070006~metalloaminopeptidase activity,	IPR000819:Peptidase_M17_C,IPR008283:Peptidase_M17_N,IPR011356:Leucine_aapep/pepB,IPR023042:Peptidase_M17_leu_NH2_pept,IPR043472:Macro_dom-like,	xtr00330:Arginine and proline metabolism,xtr00480:Glutathione metabolism,xtr01100:Metabolic pathways,					KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0031~Aminopeptidase,KW-0378~Hydrolase,KW-0645~Protease,		DOMAIN:Cytosol aminopeptidase,
Q8K2P1	leucine rich adaptor protein 1-like(Lurap1l)	Mus musculus			GO:0009966~regulation of signal transduction,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,			IPR037443:LURAP1,IPR039499:LURA1/LRA25,												KW-0007~Acetylation,	COMPBIAS:Polar residues,REGION:Disordered,
Q28C74	leucine rich pentatricopeptide repeat containing(lrpprc)	Xenopus tropicalis			GO:0070129~regulation of mitochondrial translation,	GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,	IPR002885:Pentatricopeptide_rpt,IPR011990:TPR-like_helical_dom_sf,IPR016024:ARM-type_fold,IPR033443:PPR_long,IPR033490:LRP130,					KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,	KW-0496~Mitochondrion,KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0809~Transit peptide,		KW-0238~DNA-binding,KW-0694~RNA-binding,		DOMAIN:Pentacotripeptide-repeat region of PRORP,REGION:RNA-binding,REPEAT:PPR,REPEAT:PPR 1,REPEAT:PPR 10,REPEAT:PPR 11,REPEAT:PPR 12,REPEAT:PPR 13,REPEAT:PPR 14,REPEAT:PPR 15,REPEAT:PPR 2,REPEAT:PPR 3,REPEAT:PPR 4,REPEAT:PPR 5,REPEAT:PPR 6,REPEAT:PPR 7,REPEAT:PPR 8,REPEAT:PPR 9,TRANSIT:Mitochondrion,
Q6GQU6	leucine rich repeat and Ig domain containing 3(Lingo3)	Mus musculus				GO:0005615~extracellular space,GO:0016020~membrane,GO:0031012~extracellular matrix,		IPR000372:LRRNT,IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR032675:LRR_dom_sf,IPR036179:Ig-like_dom_sf,				SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like C2-type,DOMAIN:LRRCT,DOMAIN:LRRNT,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8N6Y2	leucine rich repeat containing 17(LRRC17)	Homo sapiens	92.Ancient_Host_Defense_Pathways,		GO:0001503~ossification,GO:0045671~negative regulation of osteoclast differentiation,GO:0048539~bone marrow development,	GO:0005615~extracellular space,GO:0031012~extracellular matrix,		IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,				SM00082:LRRCT,SM00365:LRR_SD22,SM00369:LRR_TYP,	KW-0892~Osteogenesis,	KW-0964~Secreted,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,				DOMAIN:LRRCT,DOMAIN:LRRCT 1,DOMAIN:LRRCT 2,DOMAIN:LRRNT,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,
Q50LG9	leucine rich repeat containing 24(LRRC24)	Homo sapiens			GO:0051965~positive regulation of synapse assembly,	GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031012~extracellular matrix,		IPR000372:LRRNT,IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR032675:LRR_dom_sf,IPR036179:Ig-like_dom_sf,				SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:LRRCT,DOMAIN:LRRNT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,TRANSMEM:Helical,
Q5RF01	leucine rich repeat containing 32(LRRC32)	Pongo abelii			GO:0001818~negative regulation of cytokine production,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0010628~positive regulation of gene expression,GO:0046007~negative regulation of activated T cell proliferation,GO:1901388~regulation of transforming growth factor beta activation,GO:1901398~regulation of transforming growth factor beta3 activation,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0050431~transforming growth factor beta binding,	IPR000372:LRRNT,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,	pon04350:TGF-beta signaling pathway,			SM00013:LRRNT,SM00364:LRR_BAC,SM00368:LRR_RI,SM00369:LRR_TYP,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0340~Growth factor binding,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (with C-33 in TGFB1); in linked form,DOMAIN:LRRCT,DOMAIN:LRRNT,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 18,REPEAT:LRR 19,REPEAT:LRR 2,REPEAT:LRR 20,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8IUZ0	leucine rich repeat containing 49(LRRC49)	Homo sapiens				GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0034451~centriolar satellite,		IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR025875:Leu-rich_rpt_4,IPR032675:LRR_dom_sf,				SM00365:LRR_SD22,SM00369:LRR_TYP,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0433~Leucine-rich repeat,KW-0677~Repeat,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:LRRCT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,
Q3KQF4	leucine rich repeat containing 69 L homeolog(lrrc69.L)	Xenopus laevis						IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,				SM00364:LRR_BAC,SM00369:LRR_TYP,					KW-0433~Leucine-rich repeat,KW-0677~Repeat,				REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
Q96NW7	leucine rich repeat containing 7(LRRC7)	Homo sapiens			GO:0009790~embryo development,GO:0010976~positive regulation of neuron projection development,GO:0043113~receptor clustering,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0098609~cell-cell adhesion,GO:0098887~neurotransmitter receptor transport, endosome to postsynaptic membrane,GO:0098968~neurotransmitter receptor transport postsynaptic membrane to endosome,	GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0014069~postsynaptic density,GO:0016323~basolateral plasma membrane,GO:0035580~specific granule lumen,GO:0043194~axon initial segment,GO:0045211~postsynaptic membrane,	GO:0005515~protein binding,	IPR001478:PDZ,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,IPR036034:PDZ_sf,				SM00228:PDZ,SM00364:LRR_BAC,SM00365:LRR_SD22,SM00369:LRR_TYP,		KW-0770~Synapse,KW-0963~Cytoplasm,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,			KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:PDZ,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
A0N0X6	leucine rich repeat neuronal 1(LRRN1)	Bos taurus				GO:0005615~extracellular space,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0005515~protein binding,	IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR032675:LRR_dom_sf,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,				SM00082:LRRCT,SM00365:LRR_SD22,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-III,DOMAIN:Ig-like C2-type,DOMAIN:LRRCT,DOMAIN:LRRNT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O75325	leucine rich repeat neuronal 2(LRRN2)	Homo sapiens			GO:0007155~cell adhesion,GO:0007165~signal transduction,	GO:0005615~extracellular space,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0038023~signaling receptor activity,	IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR032675:LRR_dom_sf,IPR036179:Ig-like_dom_sf,				SM00082:LRRCT,SM00365:LRR_SD22,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like C2-type,DOMAIN:LRRCT,DOMAIN:LRRNT,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q86UE6	leucine rich repeat transmembrane neuronal 1(LRRTM1)	Homo sapiens			GO:0002091~negative regulation of receptor internalization,GO:0007626~locomotory behavior,GO:0031623~receptor internalization,GO:0035418~protein localization to synapse,GO:0035640~exploration behavior,GO:0050808~synapse organization,GO:0051649~establishment of localization in cell,GO:0051965~positive regulation of synapse assembly,GO:0060291~long-term synaptic potentiation,GO:1905606~regulation of presynapse assembly,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0030424~axon,GO:0030426~growth cone,GO:0031012~extracellular matrix,GO:0060076~excitatory synapse,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,GO:0099634~postsynaptic specialization membrane,		IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,				SM00369:LRR_TYP,		KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:LRRCT,DOMAIN:LRRNT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6AYL8	leucine-rich repeats and IQ motif containing 3(Lrriq3)	Rattus norvegicus						IPR000048:IQ_motif_EF-hand-BS,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR025875:Leu-rich_rpt_4,IPR032675:LRR_dom_sf,				SM00369:LRR_TYP,					KW-0175~Coiled coil,KW-0433~Leucine-rich repeat,KW-0677~Repeat,				DOMAIN:IQ,DOMAIN:LRRCT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,
Q8BTN6	leukocyte receptor cluster (LRC) member 9(Leng9)	Mus musculus					GO:0046872~metal ion binding,	IPR000571:Znf_CCCH,IPR009097:Cyclic_Pdiesterase,IPR019510:AKAP7-like_phosphoesterase,IPR040459:MJ1316,IPR041367:Znf-CCCH_4,IPR042653:Leng9,				SM00356:ZnF_C3H1,					KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Polar residues,REGION:Disordered,ZN_FING:C3H1-type,
Q15722	leukotriene B4 receptor(LTB4R)	Homo sapiens			GO:0006936~muscle contraction,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0061737~leukotriene signaling pathway,	GO:0005886~plasma membrane,	GO:0000166~nucleotide binding,GO:0001632~leukotriene B4 receptor activity,GO:0004974~leukotriene receptor activity,GO:0008528~G-protein coupled peptide receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000826:Formyl_rcpt-rel,IPR003981:Leukotriene_B4_rcpt,IPR003983:Leukotriene_B4_typ-1_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	hsa04080:Neuroactive ligand-receptor interaction,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 1 profile,MUTAGEN:S->A: No effect on affinity for leukotriene B4 or on desensitization by GRK6.,MUTAGEN:T->P,A: No effect on affinity for leukotriene B4, induces resistance to desensitization by GRK6, but minor effect on phosphorylation by GRK6.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
O60711	leupaxin(LPXN)	Homo sapiens			GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0034446~substrate adhesion-dependent cell spreading,GO:0043542~endothelial cell migration,GO:0050859~negative regulation of B cell receptor signaling pathway,GO:0065003~macromolecular complex assembly,	GO:0002102~podosome,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0042995~cell projection,GO:0048471~perinuclear region of cytoplasm,	GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001781:Znf_LIM,IPR017305:Tgfb1i1/Leupaxin/TGFB1I1,			PIRSF037881:Leupaxin,	SM00132:LIM,	KW-0130~Cell adhesion,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,DOMAIN:LIM zinc-binding 3,DOMAIN:LIM zinc-binding 4,MOTIF:LD motif 1,MOTIF:LD motif 2,MOTIF:LD motif 3,REGION:Disordered,
Q98919	limbic system-associated membrane protein(LSAMP)	Gallus gallus			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0050808~synapse organization,	GO:0005886~plasma membrane,GO:0030424~axon,GO:0043025~neuronal cell body,GO:0098552~side of membrane,	GO:0008046~axon guidance receptor activity,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,LIPID:GPI-anchor amidated asparagine,PROPEP:Removed in mature form,
Q3U3R4	lipase maturation factor 1(Lmf1)	Mus musculus			GO:0006486~protein glycosylation,GO:0006641~triglyceride metabolic process,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0009306~protein secretion,GO:0034382~chylomicron remnant clearance,GO:0051006~positive regulation of lipoprotein lipase activity,GO:0051604~protein maturation,GO:0090181~regulation of cholesterol metabolic process,GO:0090207~regulation of triglyceride metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0005515~protein binding,	IPR009613:LMF,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0143~Chaperone,		REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q0P4Y8	lipase maturation factor 2(lmf2)	Xenopus tropicalis			GO:0051604~protein maturation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR009613:LMF,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TRANSMEM:Helical,
Q14693	lipin 1(LPIN1)	Homo sapiens			GO:0006642~triglyceride mobilization,GO:0006654~phosphatidic acid biosynthetic process,GO:0007077~mitotic nuclear envelope disassembly,GO:0009062~fatty acid catabolic process,GO:0019432~triglyceride biosynthetic process,GO:0031100~animal organ regeneration,GO:0031642~negative regulation of myelination,GO:0032869~cellular response to insulin stimulus,GO:0045740~positive regulation of DNA replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046473~phosphatidic acid metabolic process,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008195~phosphatidate phosphatase activity,	IPR007651:Lipin_N,IPR013209:LNS2,IPR026058:LIPIN,IPR031315:LNS2/PITP,IPR031703:Lipin_mid,IPR036412:HAD-like_sf,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04150:mTOR signaling pathway,hsa04936:Alcoholic liver disease,	268200~Myoglobinuria, acute recurrent, autosomal recessive,		SM00775:LNS2,	KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DOMAIN:Lipin N-terminal,DOMAIN:Lipin middle,DOMAIN:Lipin/Ned1/Smp2 (LNS2),MOTIF:DXDXT motif,MOTIF:LXXIL motif,MOTIF:Nuclear localization signal,MUTAGEN:K->R: Decreased acetylation by KAT5.,REGION:C-LIP,REGION:Disordered,REGION:N-LIP,
P11602	lipoprotein lipase(LPL)	Gallus gallus			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0010886~positive regulation of cholesterol storage,GO:0010890~positive regulation of sequestering of triglyceride,GO:0019433~triglyceride catabolic process,GO:0032722~positive regulation of chemokine production,GO:0034371~chylomicron remodeling,GO:0034372~very-low-density lipoprotein particle remodeling,GO:0042632~cholesterol homeostasis,GO:0045600~positive regulation of fat cell differentiation,GO:0055096~low-density lipoprotein particle mediated signaling,GO:0070328~triglyceride homeostasis,GO:1904179~positive regulation of adipose tissue development,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0034361~very-low-density lipoprotein particle,GO:0042627~chylomicron,GO:1902494~catalytic complex,	GO:0004465~lipoprotein lipase activity,GO:0004620~phospholipase activity,GO:0004806~triglyceride lipase activity,GO:0005102~receptor binding,GO:0005509~calcium ion binding,GO:0008201~heparin binding,GO:0008970~phosphatidylcholine 1-acylhydrolase activity,GO:0034185~apolipoprotein binding,GO:0042803~protein homodimerization activity,GO:0043395~heparan sulfate proteoglycan binding,GO:0046872~metal ion binding,GO:0052739~phosphatidylserine 1-acylhydrolase activity,GO:0052740~1-acyl-2-lysophosphatidylserine acylhydrolase activity,GO:0071813~lipoprotein particle binding,	IPR000734:TAG_lipase,IPR001024:PLAT/LH2_dom,IPR002330:Lipo_Lipase,IPR013818:Lipase,IPR016272:Lipase_LIPH,IPR029058:AB_hydrolase,IPR033906:Lipase_N,IPR036392:PLAT/LH2_dom_sf,	gga00561:Glycerolipid metabolism,gga03320:PPAR signaling pathway,		PIRSF000865:Lipoprotein_lipase_LIPH,	SM00308:LH2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0162~Chylomicron,KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0850~VLDL,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0358~Heparin-binding,KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0944~Nitration,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) (complex) asparagine,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Lipase,DOMAIN:PLAT,MUTAGEN:K->N: No change in heparin-binding activity nor in specific enzymatic activity. Reduced heparin-binding activity and decreased specific enzymatic activity; when associated with N-441.,MUTAGEN:K->N: Reduced heparin-binding ability and some decrease in specific enzymatic activity.,MUTAGEN:K->N: Reduced heparin-binding ability. Almost complete loss of heparin binding and greatly reduced specific enzymatic activity; when associated with N-430 and N-432.,MUTAGEN:K->N: Reduced heparin-binding activity and decreased specific enzymatic activity. No further reduction of heparin-binding nor of specific enzymatic activity; when associated with N-440.,MUTAGEN:K->Q: Some loss of heparin-binding ability; when associated with Q-306 and Q-309.,MUTAGEN:R->N: Reduced heparin-binding ability and some reduction in specific enzymatic activity. Almost complete loss of heparin binding and greatly reduced specific enzymatic activity; when associated with N-432 and N-434.,MUTAGEN:R->N: Reduced heparin-binding ability. Almost complete loss of heparin binding and greatly reduced specific enzymatic activity; when associated with N-430 and N-434.,MUTAGEN:R->Q: Some loss of heparin-binding ability; when associated with Q-306 and Q-307.,MUTAGEN:R->Q: Some loss of heparin-binding ability; when associated with Q-307 and Q-309.,REGION:Disordered,REGION:Essential for determining substrate specificity,REGION:Important for heparin binding,REGION:Important for interaction with lipoprotein particles,REGION:Interaction with GPIHBP1,
Q5SZI1	low density lipoprotein receptor class A domain containing 2(LDLRAD2)	Homo sapiens				GO:0016020~membrane,		IPR002172:LDrepeatLR_classA_rpt,IPR035914:Sperma_CUB_dom_sf,IPR036055:LDL_receptor-like_sf,				SM00192:LDLa,		KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:LDL-receptor class A,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O15550	lysine demethylase 6A(KDM6A)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0001843~neural tube closure,GO:0003007~heart morphogenesis,GO:0003016~respiratory system process,GO:0006338~chromatin remodeling,GO:0007507~heart development,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0032525~somite rostral/caudal axis specification,GO:0035264~multicellular organism growth,GO:0036211~protein modification process,GO:0045793~positive regulation of cell size,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048333~mesodermal cell differentiation,GO:0048570~notochord morphogenesis,GO:0071305~cellular response to vitamin D,GO:0071456~cellular response to hypoxia,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1903298~negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,GO:1904385~cellular response to angiotensin,GO:1990859~cellular response to endothelin,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0031490~chromatin DNA binding,GO:0032452~histone demethylase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0071558~histone demethylase activity (H3-K27 specific),	IPR001440:TPR_1,IPR003347:JmjC_dom,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR046941:KDM6_GATAL_sf,IPR048560:KDM6A_B-like_GATAL,IPR048562:KDM6A_B-like_C-hel,	hsa05202:Transcriptional misregulation in cancer,	300867~Kabuki syndrome 2,		SM00028:TPR,SM00558:JmjC,		KW-0539~Nucleus,		KW-0991~Intellectual disability,	KW-0677~Repeat,KW-0802~TPR repeat,	KW-0408~Iron,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0156~Chromatin regulator,KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:JmjC,DOMAIN:Lysine-specific demethylase 6A/B-like GATA-like,MUTAGEN:H->A: Abolishes histone demethylase activity.,REGION:Disordered,REGION:Interaction with SUPT6H,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,
Q2YDJ8	lysine methyltransferase 5A(KMT5A)	Bos taurus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0018026~peptidyl-lysine monomethylation,GO:0043516~regulation of DNA damage response, signal transduction by p53 class mediator,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005700~polytene chromosome,	GO:0005515~protein binding,GO:0016279~protein-lysine N-methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0042799~histone methyltransferase activity (H4-K20 specific),	IPR001214:SET_dom,IPR016858:KMT5A-like,IPR046341:SET_dom_sf,IPR047266:KMT5A-like_SET,	bta00310:Lysine degradation,bta01100:Metabolic pathways,		PIRSF027717:Histone_H4-K20_mtfrase,	SM00317:SET,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,				KW-0949~S-adenosyl-L-methionine,	KW-0156~Chromatin regulator,KW-0489~Methyltransferase,KW-0678~Repressor,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:SET,REGION:Disordered,
Q28EG9	lysine-rich coiled-coil 1(krcc1)	Xenopus tropicalis				GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR003604:Matrin/U1-like-C_Znf_C2H2,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,SM00451:ZnF_U1,		KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:Matrin-type 1,ZN_FING:Matrin-type 2,ZN_FING:Matrin-type 3,ZN_FING:Matrin-type 4,
Q8BMC0	lysophosphatidic acid receptor 6(Lpar6)	Mus musculus			GO:0001835~blastocyst hatching,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0035025~positive regulation of Rho protein signal transduction,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,GO:0070915~lysophosphatidic acid receptor activity,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,	mmu04072:Phospholipase D signaling pathway,mmu04080:Neuroactive ligand-receptor interaction,mmu04151:PI3K-Akt signaling pathway,mmu05200:Pathways in cancer,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,LIPID:S-palmitoyl cysteine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q1LWG4	lysophosphatidylcholine acyltransferase 1(lpcat1)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0008654~phospholipid biosynthetic process,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005811~lipid particle,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0005509~calcium ion binding,GO:0008374~O-acyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0042171~lysophosphatidic acid acyltransferase activity,GO:0047159~1-alkenylglycerophosphocholine O-acyltransferase activity,GO:0047184~1-acylglycerophosphocholine O-acyltransferase activity,GO:0047192~1-alkylglycerophosphocholine O-acetyltransferase activity,GO:0050200~plasmalogen synthase activity,	IPR002048:EF_hand_dom,IPR002123:Plipid/glycerol_acylTrfase,IPR011992:EF-hand-dom_pair,IPR045252:LPCAT1-like,	dre00564:Glycerophospholipid metabolism,dre00565:Ether lipid metabolism,dre01100:Metabolic pathways,			SM00563:PlsC,	KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0594~Phospholipid biosynthesis,KW-1208~Phospholipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0551~Lipid droplet,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0012~Acyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand,MOTIF:Di-lysine motif,MOTIF:HXXXXD motif,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q5U1W4	lysosomal protein transmembrane 4 beta(Laptm4b)	Rattus norvegicus			GO:0007032~endosome organization,GO:0032509~endosome transport via multivesicular body sorting pathway,GO:0032911~negative regulation of transforming growth factor beta1 production,GO:0097213~regulation of lysosomal membrane permeability,GO:1905166~negative regulation of lysosomal protein catabolic process,GO:1905671~regulation of lysosome organization,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031902~late endosome membrane,GO:0032585~multivesicular body membrane,GO:0042995~cell projection,GO:0097487~multivesicular body, internal vesicle,	GO:0019900~kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0097001~ceramide binding,GO:1902936~phosphatidylinositol bisphosphate binding,	IPR004687:LAPTM4/5,	rno04142:Lysosome,				KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,KW-0966~Cell projection,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0832~Ubl conjugation,	REGION:Required for NEDD4 interaction,TRANSMEM:Helical,
P16636	lysyl oxidase(Lox)	Rattus norvegicus			GO:0001568~blood vessel development,GO:0001649~osteoblast differentiation,GO:0001932~regulation of protein phosphorylation,GO:0007507~heart development,GO:0009410~response to xenobiotic stimulus,GO:0009725~response to hormone,GO:0010468~regulation of gene expression,GO:0016202~regulation of striated muscle tissue development,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0018057~peptidyl-lysine oxidation,GO:0018158~protein oxidation,GO:0030199~collagen fibril organization,GO:0030282~bone mineralization,GO:0030324~lung development,GO:0035791~platelet-derived growth factor receptor-beta signaling pathway,GO:0035904~aorta development,GO:0035905~ascending aorta development,GO:0035906~descending aorta development,GO:0042981~regulation of apoptotic process,GO:0043491~protein kinase B signaling,GO:0045652~regulation of megakaryocyte differentiation,GO:0046716~muscle cell cellular homeostasis,GO:0048251~elastic fiber assembly,GO:0048514~blood vessel morphogenesis,GO:0048545~response to steroid hormone,GO:0055001~muscle cell development,GO:0060326~cell chemotaxis,GO:0061448~connective tissue development,GO:0071310~cellular response to organic substance,GO:0071897~DNA biosynthetic process,GO:1900120~regulation of receptor binding,GO:1903010~regulation of bone development,GO:1990869~cellular response to chemokine,GO:2000586~regulation of platelet-derived growth factor receptor-beta signaling pathway,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0004720~protein-lysine 6-oxidase activity,GO:0005507~copper ion binding,GO:0005518~collagen binding,GO:0036094~small molecule binding,GO:0060090~binding, bridging,	IPR001695:Lysyl_oxidase,IPR019828:Lysyl_oxidase_CS,						KW-0964~Secreted,			KW-0732~Signal,	KW-0186~Copper,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-0765~Sulfation,KW-0801~TPQ,KW-0886~LTQ,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Lysine tyrosylquinone (Lys-Tyr),PROPEP:Removed by BMP1,REGION:Disordered,REGION:Lysyl-oxidase like,SITE:Cleavage; by ADAMTS2 and ADAMTS14,
A1L1V4	lysyl oxidase-like 2a(loxl2a)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0001837~epithelial to mesenchymal transition,GO:0001935~endothelial cell proliferation,GO:0002040~sprouting angiogenesis,GO:0006325~chromatin organization,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0018057~peptidyl-lysine oxidation,GO:0030199~collagen fibril organization,GO:0032332~positive regulation of chondrocyte differentiation,GO:0043542~endothelial cell migration,GO:0045892~negative regulation of transcription, DNA-templated,GO:0070828~heterochromatin organization,GO:1902455~negative regulation of stem cell population maintenance,	GO:0000785~chromatin,GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,	GO:0004720~protein-lysine 6-oxidase activity,GO:0005044~scavenger receptor activity,GO:0005507~copper ion binding,GO:0005509~calcium ion binding,GO:0016491~oxidoreductase activity,GO:0016641~oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,GO:0046872~metal ion binding,	IPR001190:SRCR,IPR001695:Lysyl_oxidase,IPR017448:SRCR-like_dom,IPR019828:Lysyl_oxidase_CS,IPR036772:SRCR-like_dom_sf,				SM00202:SR,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0084~Basement membrane,KW-0158~Chromosome,KW-0256~Endoplasmic reticulum,KW-0272~Extracellular matrix,KW-0539~Nucleus,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0186~Copper,KW-0479~Metal-binding,	KW-0156~Chromatin regulator,KW-0560~Oxidoreductase,KW-0678~Repressor,	KW-0325~Glycoprotein,KW-0801~TPQ,KW-0886~LTQ,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Lysine tyrosylquinone (Lys-Tyr),DOMAIN:SRCR 1,DOMAIN:SRCR 2,DOMAIN:SRCR 3,DOMAIN:SRCR 4,REGION:Lysyl-oxidase like,
B8A4W9	lysyl oxidase-like 3b(loxl3b)	Danio rerio			GO:0006954~inflammatory response,GO:0018057~peptidyl-lysine oxidation,GO:0021510~spinal cord development,GO:0030199~collagen fibril organization,GO:0030324~lung development,GO:0048703~embryonic viscerocranium morphogenesis,GO:0060021~palate development,GO:0061053~somite development,GO:1905590~fibronectin fibril organization,GO:2000329~negative regulation of T-helper 17 cell lineage commitment,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0001968~fibronectin binding,GO:0004720~protein-lysine 6-oxidase activity,GO:0005044~scavenger receptor activity,GO:0005507~copper ion binding,GO:0016491~oxidoreductase activity,GO:0016641~oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,GO:0046872~metal ion binding,	IPR001190:SRCR,IPR001695:Lysyl_oxidase,IPR017448:SRCR-like_dom,IPR019828:Lysyl_oxidase_CS,IPR036772:SRCR-like_dom_sf,				SM00202:SR,		KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0186~Copper,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-0801~TPQ,KW-0886~LTQ,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Lysine tyrosylquinone (Lys-Tyr),DOMAIN:SRCR,DOMAIN:SRCR 1,DOMAIN:SRCR 2,DOMAIN:SRCR 3,DOMAIN:SRCR 4,DOMAIN:SRCR 5,
Q99MN1	lysyl-tRNA synthetase 1(Kars1)	Mus musculus			GO:0002276~basophil activation involved in immune response,GO:0002863~positive regulation of inflammatory response to antigenic stimulus,GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006430~lysyl-tRNA aminoacylation,GO:0010165~response to X-ray,GO:0015966~diadenosine tetraphosphate biosynthetic process,GO:0043032~positive regulation of macrophage activation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0070371~ERK1 and ERK2 cascade,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003877~ATP adenylyltransferase activity,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004824~lysine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016597~amino acid binding,GO:0016740~transferase activity,GO:0016874~ligase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0097110~scaffold protein binding,	IPR002313:Lys-tRNA-ligase_II,IPR004364:Aa-tRNA-synt_II,IPR004365:NA-bd_OB_tRNA,IPR006195:aa-tRNA-synth_II,IPR012340:NA-bd_OB-fold,IPR018149:Lys-tRNA-synth_II_C,IPR034762:Lys-tRNA-ligase_II_bac/euk,IPR044136:Lys-tRNA-ligase_II_N,IPR045864:aa-tRNA-synth_II/BPL/LPL,	mmu00970:Aminoacyl-tRNA biosynthesis,		PIRSF039101:LysRS2,		KW-0648~Protein biosynthesis,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Aminoacyl-transfer RNA synthetases class-II family profile,REGION:Disordered,
Q02874	macroH2A.1 histone(Macroh2a1)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002082~regulation of oxidative phosphorylation,GO:0006281~DNA repair,GO:0006334~nucleosome assembly,GO:0007549~dosage compensation,GO:0019216~regulation of lipid metabolic process,GO:0034184~positive regulation of maintenance of mitotic sister chromatid cohesion,GO:0040029~regulation of gene expression, epigenetic,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045815~positive regulation of gene expression, epigenetic,GO:0070828~heterochromatin organization,GO:0071169~establishment of protein localization to chromatin,GO:1901837~negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:1902688~regulation of NAD metabolic process,GO:1902750~negative regulation of cell cycle G2/M phase transition,GO:1902882~regulation of response to oxidative stress,GO:1902883~negative regulation of response to oxidative stress,GO:1902884~positive regulation of response to oxidative stress,GO:1903226~positive regulation of endodermal cell differentiation,GO:1904815~negative regulation of protein localization to chromosome, telomeric region,	GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0000793~condensed chromosome,GO:0001740~Barr body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005721~pericentric heterochromatin,GO:0005730~nucleolus,GO:0090734~site of DNA damage,	GO:0000182~rDNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0010385~double-stranded methylated DNA binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030291~protein serine/threonine kinase inhibitor activity,GO:0030527~structural constituent of chromatin,GO:0031490~chromatin DNA binding,GO:0031492~nucleosomal DNA binding,GO:0046982~protein heterodimerization activity,GO:0072570~ADP-D-ribose binding,GO:1990841~promoter-specific chromatin binding,	IPR002119:Histone_H2A,IPR002589:Macro_dom,IPR007125:Histone_H2A/H2B/H3,IPR009072:Histone-fold,IPR021171:Core_histone_macro-H2A,IPR032454:Histone_H2A_C,IPR035796:Macro_H2A,IPR043472:Macro_dom-like,	rno03082:ATP-dependent chromatin remodeling,rno04217:Necroptosis,rno04613:Neutrophil extracellular trap formation,rno05034:Alcoholism,rno05322:Systemic lupus erythematosus,		PIRSF037942:Core_histone_macro-H2A,	SM00414:H2A,SM00506:A1pp,		KW-0158~Chromosome,KW-0539~Nucleus,KW-0544~Nucleosome core,					KW-0156~Chromatin regulator,KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,DOMAIN:Histone H2A,DOMAIN:Histone H2A C-terminal,DOMAIN:Histone H2A/H2B/H3,DOMAIN:Macro,REGION:Disordered,
Q9P0M6	macroH2A.2 histone(MACROH2A2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006334~nucleosome assembly,GO:0007420~brain development,GO:0007549~dosage compensation,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0070828~heterochromatin organization,GO:0071169~establishment of protein localization to chromatin,GO:1901837~negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,	GO:0000781~chromosome, telomeric region,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0001740~Barr body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0070062~extracellular exosome,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0030527~structural constituent of chromatin,GO:0031490~chromatin DNA binding,GO:0031492~nucleosomal DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone_H2A,IPR002589:Macro_dom,IPR007125:Histone_H2A/H2B/H3,IPR009072:Histone-fold,IPR021171:Core_histone_macro-H2A,IPR032454:Histone_H2A_C,IPR035796:Macro_H2A,IPR043472:Macro_dom-like,	hsa03082:ATP-dependent chromatin remodeling,hsa04217:Necroptosis,hsa04613:Neutrophil extracellular trap formation,hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,		PIRSF037942:Core_histone_macro-H2A,	SM00414:H2A,SM00506:A1pp,		KW-0158~Chromosome,KW-0539~Nucleus,KW-0544~Nucleosome core,					KW-0156~Chromatin regulator,KW-0238~DNA-binding,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Histone H2A,DOMAIN:Histone H2A C-terminal,DOMAIN:Histone H2A/H2B/H3,DOMAIN:Macro,REGION:Disordered,
Q2M385	macrophage expressed 1(MPEG1)	Homo sapiens			GO:0002250~adaptive immune response,GO:0002468~dendritic cell antigen processing and presentation,GO:0002478~antigen processing and presentation of exogenous peptide antigen,GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I,GO:0042742~defense response to bacterium,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0055085~transmembrane transport,	GO:0005576~extracellular region,GO:0030659~cytoplasmic vesicle membrane,GO:0030670~phagocytic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0045335~phagocytic vesicle,GO:0061474~phagolysosome membrane,	GO:0022829~wide pore channel activity,	IPR020864:MACPF,IPR039707:MPEG1,		619223~Immunodeficiency 77,		SM00457:MACPF,	KW-0391~Immunity,KW-0399~Innate immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,		KW-0225~Disease variant,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,KW-1134~Transmembrane beta strand,			KW-0325~Glycoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:MACPF,REGION:P2,SITE:Cleavage; by LGMN,SITE:Cleavage; by trypsin,TRANSMEM:Beta stranded,TRANSMEM:Helical,
P26927	macrophage stimulating 1(MST1)	Homo sapiens		h_mspPathway:Msp/Ron Receptor Signaling Pathway,	GO:0006508~proteolysis,GO:0007283~spermatogenesis,GO:0007566~embryo implantation,GO:0010628~positive regulation of gene expression,GO:0010758~regulation of macrophage chemotaxis,GO:0030317~flagellated sperm motility,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0036211~protein modification process,GO:0043065~positive regulation of apoptotic process,GO:0045721~negative regulation of gluconeogenesis,GO:0046425~regulation of JAK-STAT cascade,GO:0060763~mammary duct terminal end bud growth,GO:0071346~cellular response to interferon-gamma,GO:0071456~cellular response to hypoxia,GO:1904036~negative regulation of epithelial cell apoptotic process,GO:2000479~regulation of cAMP-dependent protein kinase activity,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005773~vacuole,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,GO:0035173~histone kinase activity,	IPR000001:Kringle,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR003609:Pan_app,IPR009003:Peptidase_S1_PA,IPR013806:Kringle-like,IPR018056:Kringle_CS,IPR024174:HGF/MST1,IPR038178:Kringle_sf,IPR043504:Peptidase_S1_PA_chymotrypsin,IPR043575:MSP_HGFL,	hsa04020:Calcium signaling pathway,		PIRSF001152:HGF_MST1,PIRSF500185:MSP_HGFL,	SM00020:Tryp_SPc,SM00130:KR,SM00473:PAN_AP,		KW-0964~Secreted,			KW-0420~Kringle,KW-0677~Repeat,KW-0732~Signal,		KW-0721~Serine protease homolog,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between alpha and beta chains),DOMAIN:Apple,DOMAIN:Kringle,DOMAIN:Kringle 1,DOMAIN:Kringle 2,DOMAIN:Kringle 3,DOMAIN:Kringle 4,DOMAIN:PAN,DOMAIN:Peptidase S1,
Q8NDA8	maestro heat like repeat family member 1(MROH1)	Homo sapiens				GO:0005737~cytoplasm,		IPR000357:HEAT,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR021133:HEAT_type_2,IPR045206:Maestro_heat-like_prot,IPR048465:Maestro_HEAT_rpt,									KW-0677~Repeat,				REPEAT:HEAT,REPEAT:HEAT 1,REPEAT:HEAT 2,REPEAT:HEAT 3,REPEAT:HEAT 4,REPEAT:HEAT 5,REPEAT:HEAT 6,REPEAT:HEAT 7,
Q32LQ6	major facilitator superfamily domain containing 1(mfsd1)	Danio rerio			GO:0050821~protein stabilization,GO:0055085~transmembrane transport,GO:0061462~protein localization to lysosome,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0016020~membrane,	GO:0022857~transmembrane transporter activity,GO:0042803~protein homodimerization activity,	IPR011701:MFS,IPR020846:MFS_dom,IPR036259:MFS_trans_sf,					KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				MOTIF:Dileucine internalization motif,REGION:Disordered,TRANSMEM:Helical,
Q4V8E5	major facilitator superfamily domain containing 3(Mfsd3)	Rattus norvegicus			GO:0055085~transmembrane transport,	GO:0016020~membrane,	GO:0022857~transmembrane transporter activity,	IPR004752:AmpG_permease/AT-1,IPR011701:MFS,IPR036259:MFS_trans_sf,					KW-0813~Transport,	KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
Q1KKV8	major facilitator superfamily domain containing 5(mfsd5)	Takifugu rubripes			GO:0006811~ion transport,GO:0015689~molybdate ion transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0015098~molybdate ion transmembrane transporter activity,	IPR008509:MOT2/MFSD5,IPR036259:MFS_trans_sf,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
P21145	mal, T cell differentiation protein(MAL)	Homo sapiens		h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,	GO:0001766~membrane raft polarization,GO:0002175~protein localization to paranode region of axon,GO:0006915~apoptotic process,GO:0007417~central nervous system development,GO:0022010~central nervous system myelination,GO:0030154~cell differentiation,GO:0042552~myelination,GO:0045176~apical protein localization,GO:0098737~protein insertion into plasma membrane,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005783~endoplasmic reticulum,GO:0016324~apical plasma membrane,GO:0043220~Schmidt-Lanterman incisure,GO:0044853~plasma membrane raft,GO:0045121~membrane raft,GO:0120003~hinge region between urothelial plaques of apical plasma membrane,	GO:0005515~protein binding,GO:0008289~lipid binding,GO:0016505~peptidase activator activity involved in apoptotic process,GO:0019911~structural constituent of myelin sheath,	IPR008253:Marvel,IPR013295:MAL,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0449~Lipoprotein,	DOMAIN:MARVEL,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O43451	maltase-glucoamylase(MGAM)	Homo sapiens			GO:0000025~maltose catabolic process,GO:0005975~carbohydrate metabolic process,GO:0005983~starch catabolic process,GO:1901027~dextrin catabolic process,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,GO:0070821~tertiary granule membrane,GO:0101003~ficolin-1-rich granule membrane,	GO:0003824~catalytic activity,GO:0004339~glucan 1,4-alpha-glucosidase activity,GO:0004558~alpha-1,4-glucosidase activity,GO:0005515~protein binding,GO:0016160~amylase activity,GO:0030246~carbohydrate binding,GO:0032450~maltose alpha-glucosidase activity,GO:0090599~alpha-glucosidase activity,	IPR000322:Glyco_hydro_31_TIM,IPR000519:P_trefoil_dom,IPR011013:Gal_mutarotase_sf_dom,IPR013780:Glyco_hydro_b,IPR017853:Glycoside_hydrolase_SF,IPR017957:P_trefoil_CS,IPR017994:P_trefoil_chordata,IPR025887:Glyco_hydro_31_N_dom,IPR030458:Glyco_hydro_31_AS,IPR030459:Glyco_hydro_31_CS,IPR044913:P_trefoil_dom_sf,IPR048395:Glyco_hydro_31_C,	hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa01100:Metabolic pathways,hsa04973:Carbohydrate digestion and absorption,			SM00018:PD,		KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0326~Glycosidase,KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,	KW-0325~Glycoprotein,KW-0765~Sulfation,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:P-type,DOMAIN:P-type 1,DOMAIN:P-type 2,DOMAIN:P-type 3,MUTAGEN:D->A: Loss of alpha-1,4-glucosidase activity toward maltose.,MUTAGEN:Missing: Decreases alpha-1,4-glucosidase activity toward long oligomaltose substrates having four to seven D-glucose residues.,MUTAGEN:Y->W: Decreases alpha-1,4-glucosidase activity toward maltose.,REGION:Disordered,REGION:Glucoamylase,REGION:Maltase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q3SZI0	mannose phosphate isomerase(MPI)	Bos taurus			GO:0005975~carbohydrate metabolic process,GO:0009298~GDP-mannose biosynthetic process,GO:0061611~mannose to fructose-6-phosphate metabolic process,	GO:0005829~cytosol,	GO:0004476~mannose-6-phosphate isomerase activity,GO:0008270~zinc ion binding,	IPR001250:Man6P_Isoase-1,IPR011051:RmlC_Cupin_sf,IPR014710:RmlC-like_jellyroll,IPR016305:Mannose-6-P_Isomerase,IPR018050:Pmannose_isomerase-type1_CS,IPR046456:PMI_typeI_C,IPR046457:PMI_typeI_cat,IPR046458:PMI_typeI_hel,	bta00051:Fructose and mannose metabolism,bta00520:Amino sugar and nucleotide sugar metabolism,bta01100:Metabolic pathways,bta01240:Biosynthesis of cofactors,bta01250:Biosynthesis of nucleotide sugars,		PIRSF001480:Mannose-6-phosphate_isomerase,			KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0413~Isomerase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,
Q9UBG0	mannose receptor C type 2(MRC2)	Homo sapiens			GO:0001649~osteoblast differentiation,GO:0006897~endocytosis,GO:0030574~collagen catabolic process,	GO:0005925~focal adhesion,GO:0016020~membrane,	GO:0005515~protein binding,GO:0005518~collagen binding,GO:0030246~carbohydrate binding,GO:0038023~signaling receptor activity,	IPR000562:FN_type2_dom,IPR000772:Ricin_B_lectin,IPR001304:C-type_lectin-like,IPR013806:Kringle-like,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR018378:C-type_lectin_CS,IPR033989:CD209-like_CTLD,IPR035992:Ricin_B-like_lectins,IPR036943:FN_type2_sf,	hsa04145:Phagosome,hsa05152:Tuberculosis,			SM00034:CLECT,SM00059:FN2,SM00458:RICIN,	KW-0254~Endocytosis,	KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0430~Lectin,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CARBOHYD:N-linked (GlcNAc...) (complex) asparagine,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),DOMAIN:C-type lectin,DOMAIN:C-type lectin 1,DOMAIN:C-type lectin 2,DOMAIN:C-type lectin 3,DOMAIN:C-type lectin 4,DOMAIN:C-type lectin 5,DOMAIN:C-type lectin 6,DOMAIN:C-type lectin 7,DOMAIN:C-type lectin 8,DOMAIN:Fibronectin type-II,DOMAIN:Ricin B-type lectin,MUTAGEN:E->A: Increased cell surface distribution.,MUTAGEN:LV->AA: Reduction of endocytotic activity; distribution almost restricted to the cell surface.,MUTAGEN:N->D: Reduced sugar-binding activity.,MUTAGEN:Y->A: No alteration of distribution and trafficking.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q61830	mannose receptor, C type 1(Mrc1)	Mus musculus			GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0071222~cellular response to lipopolysaccharide,GO:0071346~cellular response to interferon-gamma,GO:0071353~cellular response to interleukin-4,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016020~membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0038023~signaling receptor activity,GO:0038024~cargo receptor activity,	IPR000562:FN_type2_dom,IPR000772:Ricin_B_lectin,IPR001304:C-type_lectin-like,IPR013806:Kringle-like,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR018378:C-type_lectin_CS,IPR035992:Ricin_B-like_lectins,IPR036943:FN_type2_sf,	mmu04145:Phagosome,mmu05152:Tuberculosis,			SM00034:CLECT,SM00059:FN2,SM00458:RICIN,	KW-0254~Endocytosis,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0430~Lectin,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:C-type lectin,DOMAIN:C-type lectin 1,DOMAIN:C-type lectin 2,DOMAIN:C-type lectin 3,DOMAIN:C-type lectin 4,DOMAIN:C-type lectin 5,DOMAIN:C-type lectin 6,DOMAIN:C-type lectin 7,DOMAIN:C-type lectin 8,DOMAIN:Fibronectin type-II,DOMAIN:Ricin B-type lectin,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P24668	mannose-6-phosphate receptor, cation dependent(M6pr)	Mus musculus			GO:0006622~protein targeting to lysosome,GO:0006886~intracellular protein transport,GO:0007041~lysosomal transport,GO:0033299~secretion of lysosomal enzymes,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:1905394~retromer complex binding,	IPR000296:Man-6-P_rcpt_cation_dep,IPR009011:Man6P_isomerase_rcpt-bd_dom_sf,IPR028927:Man-6-P_rcpt,IPR044865:MRH_dom,	mmu04142:Lysosome,mmu04145:Phagosome,mmu05132:Salmonella infection,				KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:MRH,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q91W89	mannosidase, alpha, class 2C, member 1(Man2c1)	Mus musculus			GO:0005975~carbohydrate metabolic process,GO:0006013~mannose metabolic process,GO:0008152~metabolic process,GO:0009313~oligosaccharide catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0004559~alpha-mannosidase activity,GO:0016787~hydrolase activity,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR000602:Glyco_hydro_38_N,IPR011013:Gal_mutarotase_sf_dom,IPR011330:Glyco_hydro/deAcase_b/a-brl,IPR011682:Glyco_hydro_38_C,IPR015341:Glyco_hydro_38_cen,IPR027291:Glyco_hydro_38_N_sf,IPR028995:Glyco_hydro_57/38_cen_sf,IPR037094:Glyco_hydro_38_cen_sf,IPR041147:GH38_C,	mmu00511:Other glycan degradation,			SM00872:Alpha-mann_mid,		KW-0963~Cytoplasm,				KW-0170~Cobalt,KW-0479~Metal-binding,	KW-0326~Glycosidase,KW-0378~Hydrolase,		ACT_SITE:Nucleophile,DOMAIN:Glycoside hydrolase family 38 N-terminal,DOMAIN:Glycoside hydrolase family 38 central,DOMAIN:Glycosyl hydrolase family 38 C-terminal,DOMAIN:Glycosyl hydrolases family 38 C-terminal beta sandwich,REGION:Disordered,
Q80UM7	mannosyl-oligosaccharide glucosidase(Mogs)	Mus musculus		m_eradPathway:ERassociated degradation (ERAD) Pathway,	GO:0005975~carbohydrate metabolic process,GO:0006487~protein N-linked glycosylation,GO:0008152~metabolic process,GO:0009311~oligosaccharide metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004573~mannosyl-oligosaccharide glucosidase activity,GO:0016787~hydrolase activity,GO:0016798~hydrolase activity, acting on glycosyl bonds,	IPR004888:Glycoside_hydrolase_63,IPR008928:6-hairpin_glycosidase_sf,IPR012341:6hp_glycosidase-like_sf,IPR031335:Glyco_hydro_63_C,IPR031631:Glyco_hydro_63N,IPR038518:Glyco_hydro_63N_sf,	mmu00510:N-Glycan biosynthesis,mmu01100:Metabolic pathways,mmu04141:Protein processing in endoplasmic reticulum,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0326~Glycosidase,KW-0378~Hydrolase,	KW-0325~Glycoprotein,	ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Glycosyl hydrolase family 63 C-terminal,DOMAIN:Glycosyl hydrolase family 63 N-terminal,MOTIF:Endoplasmic reticulum targeting,REGION:Disordered,REGION:Required for endoplasmic reticulum targeting,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P46013	marker of proliferation Ki-67(MKI67)	Homo sapiens			GO:0007049~cell cycle,GO:0007088~regulation of mitotic nuclear division,GO:0008283~cell proliferation,GO:0051983~regulation of chromosome segregation,GO:1902275~regulation of chromatin organization,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016604~nuclear body,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000253:FHA_dom,IPR008984:SMAD_FHA_dom_sf,IPR012568:KI67R,IPR029334:PP1-bd,				SM00240:FHA,SM01295:K167R,	KW-0131~Cell cycle,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:FHA,DOMAIN:PP1-binding,REGION:16 X 122 AA approximate repeats,REGION:Disordered,REPEAT:K167R 1,REPEAT:K167R 10,REPEAT:K167R 11,REPEAT:K167R 12,REPEAT:K167R 13,REPEAT:K167R 14,REPEAT:K167R 15,REPEAT:K167R 16,REPEAT:K167R 2,REPEAT:K167R 3,REPEAT:K167R 4,REPEAT:K167R 5,REPEAT:K167R 6,REPEAT:K167R 7,REPEAT:K167R 8,REPEAT:K167R 9,
A5D7F6	mastermind like transcriptional coactivator 2(MAML2)	Bos taurus			GO:0007219~Notch signaling pathway,GO:0007221~positive regulation of transcription of Notch receptor target,	GO:0005654~nucleoplasm,GO:0016607~nuclear speck,	GO:0003713~transcription coactivator activity,	IPR019082:Mastermind-like_N,IPR046369:MAML1-3,IPR046370:MAML_N_sf,	bta04330:Notch signaling pathway,bta04658:Th1 and Th2 cell differentiation,bta05165:Human papillomavirus infection,			SM01275:MamL-1,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0914~Notch signaling pathway,	KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0010~Activator,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Neurogenic mastermind-like N-terminal,REGION:Disordered,
F1QGZ6	maternal embryonic leucine zipper kinase(melk)	Danio rerio			GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0008016~regulation of heart contraction,GO:0008283~cell proliferation,GO:0016310~phosphorylation,GO:0030097~hemopoiesis,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0046777~protein autophosphorylation,GO:0048821~erythrocyte development,GO:0061351~neural precursor cell proliferation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0008289~lipid binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR001772:KA1_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR028375:KA1/Ssp2_C,IPR034673:MELK,IPR048637:MELK_UBA,				SM00220:S_TKc,	KW-0053~Apoptosis,KW-0131~Cell cycle,	KW-0472~Membrane,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0446~Lipid-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:KA1,DOMAIN:Protein kinase,REGION:Autoinhibitory region,REGION:Disordered,REGION:UBA-like,
Q11005	matrix metallopeptidase 11 L homeolog(mmp11.L)	Xenopus laevis			GO:0006508~proteolysis,GO:0030574~collagen catabolic process,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000585:Hemopexin-like_dom,IPR001818:Pept_M10_metallopeptidase,IPR006026:Peptidase_Metallo,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR021158:Pept_M10A_Zn_BS,IPR021190:Pept_M10A,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036375:Hemopexin-like_dom_sf,			PIRSF001191:Peptidase_M10A_matrix,	SM00120:HX,SM00235:ZnMc,	KW-0177~Collagen degradation,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,DOMAIN:Peptidase metallopeptidase,PROPEP:Activation peptide,REGION:Disordered,REPEAT:Hemopexin,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,
O62806	matrix metallopeptidase 13(MMP13)	Oryctolagus cuniculus			GO:0001958~endochondral ossification,GO:0003417~growth plate cartilage development,GO:0006508~proteolysis,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0030282~bone mineralization,GO:0030574~collagen catabolic process,GO:0060349~bone morphogenesis,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005509~calcium ion binding,GO:0005518~collagen binding,GO:0008270~zinc ion binding,	IPR000585:Hemopexin-like_dom,IPR001818:Pept_M10_metallopeptidase,IPR002477:Peptidoglycan-bd-like,IPR006026:Peptidase_Metallo,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR021158:Pept_M10A_Zn_BS,IPR021190:Pept_M10A,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036365:PGBD-like_sf,IPR036375:Hemopexin-like_dom_sf,	ocu04657:IL-17 signaling pathway,ocu04926:Relaxin signaling pathway,ocu04928:Parathyroid hormone synthesis, secretion and action,		PIRSF001191:Peptidase_M10A_matrix,	SM00120:HX,SM00235:ZnMc,	KW-0177~Collagen degradation,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase metallopeptidase,MOTIF:Cysteine switch,PROPEP:Activation peptide,REGION:Disordered,REGION:Interaction with TIMP2,REGION:Interaction with collagen,REPEAT:Hemopexin,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,
P50281	matrix metallopeptidase 14(MMP14)	Homo sapiens		h_reckPathway:Inhibition of Matrix Metalloproteinases,	GO:0001501~skeletal system development,GO:0001525~angiogenesis,GO:0001541~ovarian follicle development,GO:0001666~response to hypoxia,GO:0001935~endothelial cell proliferation,GO:0001958~endochondral ossification,GO:0006508~proteolysis,GO:0006979~response to oxidative stress,GO:0008584~male gonad development,GO:0009612~response to mechanical stimulus,GO:0010831~positive regulation of myotube differentiation,GO:0010954~positive regulation of protein processing,GO:0014070~response to organic cyclic compound,GO:0016485~protein processing,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0030307~positive regulation of cell growth,GO:0030324~lung development,GO:0030335~positive regulation of cell migration,GO:0030574~collagen catabolic process,GO:0031638~zymogen activation,GO:0035987~endodermal cell differentiation,GO:0035988~chondrocyte proliferation,GO:0043615~astrocyte cell migration,GO:0043627~response to estrogen,GO:0045579~positive regulation of B cell differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048771~tissue remodeling,GO:0048870~cell motility,GO:0051895~negative regulation of focal adhesion assembly,GO:0060322~head development,GO:0097094~craniofacial suture morphogenesis,GO:1903076~regulation of protein localization to plasma membrane,GO:1905523~positive regulation of macrophage migration,GO:1990834~response to odorant,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005796~Golgi lumen,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0031410~cytoplasmic vesicle,GO:0042470~melanosome,GO:0044354~macropinosome,GO:0045111~intermediate filament cytoskeleton,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0070006~metalloaminopeptidase activity,	IPR000585:Hemopexin-like_dom,IPR001818:Pept_M10_metallopeptidase,IPR002477:Peptidoglycan-bd-like,IPR006026:Peptidase_Metallo,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR021158:Pept_M10A_Zn_BS,IPR021190:Pept_M10A,IPR021805:Pept_M10A_metallopeptidase_C,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036365:PGBD-like_sf,IPR036366:PGBDSf,IPR036375:Hemopexin-like_dom_sf,	hsa04668:TNF signaling pathway,hsa04912:GnRH signaling pathway,hsa04928:Parathyroid hormone synthesis, secretion and action,	277950~Winchester syndrome,	PIRSF001191:Peptidase_M10A_matrix,	SM00120:HX,SM00235:ZnMc,		KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,DOMAIN:Peptidase metallopeptidase,DOMAIN:Peptidoglycan binding-like,MOTIF:Cysteine switch,PROPEP:Activation peptide,REGION:Disordered,REPEAT:Hemopexin,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P51511	matrix metallopeptidase 15(MMP15)	Homo sapiens			GO:0006508~proteolysis,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0032355~response to estradiol,GO:0035987~endodermal cell differentiation,GO:0036211~protein modification process,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0008270~zinc ion binding,GO:0070006~metalloaminopeptidase activity,	IPR000585:Hemopexin-like_dom,IPR001818:Pept_M10_metallopeptidase,IPR002477:Peptidoglycan-bd-like,IPR006026:Peptidase_Metallo,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR021158:Pept_M10A_Zn_BS,IPR021190:Pept_M10A,IPR021805:Pept_M10A_metallopeptidase_C,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036365:PGBD-like_sf,IPR036375:Hemopexin-like_dom_sf,	hsa04928:Parathyroid hormone synthesis, secretion and action,		PIRSF001191:Peptidase_M10A_matrix,	SM00120:HX,SM00235:ZnMc,		KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:Peptidase M10 metallopeptidase,DOMAIN:Peptidase metallopeptidase,MOTIF:Cysteine switch,REGION:Disordered,REPEAT:Hemopexin,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,SIGNAL:Or 45,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9JHI0	matrix metallopeptidase 19(Mmp19)	Mus musculus			GO:0001525~angiogenesis,GO:0006508~proteolysis,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0098552~side of membrane,	GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000585:Hemopexin-like_dom,IPR001818:Pept_M10_metallopeptidase,IPR002477:Peptidoglycan-bd-like,IPR006026:Peptidase_Metallo,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR021190:Pept_M10A,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036365:PGBD-like_sf,IPR036375:Hemopexin-like_dom_sf,			PIRSF001191:Peptidase_M10A_matrix,	SM00120:HX,SM00235:ZnMc,	KW-0037~Angiogenesis,KW-0177~Collagen degradation,KW-0221~Differentiation,	KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase metallopeptidase,LIPID:GPI-anchor amidated aspartate,MOTIF:Cysteine switch,PROPEP:Removed in mature form,REGION:Disordered,REPEAT:Hemopexin,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,
P08253	matrix metallopeptidase 2(MMP2)	Homo sapiens		h_reckPathway:Inhibition of Matrix Metalloproteinases,	GO:0001525~angiogenesis,GO:0001541~ovarian follicle development,GO:0001542~ovulation from ovarian follicle,GO:0001553~luteinization,GO:0001666~response to hypoxia,GO:0001955~blood vessel maturation,GO:0001957~intramembranous ossification,GO:0006508~proteolysis,GO:0007162~negative regulation of cell adhesion,GO:0007507~heart development,GO:0007566~embryo implantation,GO:0007567~parturition,GO:0009410~response to xenobiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0014012~peripheral nervous system axon regeneration,GO:0014823~response to activity,GO:0019538~protein metabolic process,GO:0022617~extracellular matrix disassembly,GO:0030163~protein catabolic process,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0030574~collagen catabolic process,GO:0032526~response to retinoic acid,GO:0034614~cellular response to reactive oxygen species,GO:0035094~response to nicotine,GO:0035987~endodermal cell differentiation,GO:0042542~response to hydrogen peroxide,GO:0043065~positive regulation of apoptotic process,GO:0043627~response to estrogen,GO:0045906~negative regulation of vasoconstriction,GO:0048013~ephrin receptor signaling pathway,GO:0048246~macrophage chemotaxis,GO:0048771~tissue remodeling,GO:0051602~response to electrical stimulus,GO:0055093~response to hyperoxia,GO:0060325~face morphogenesis,GO:0060346~bone trabecula formation,GO:0060740~prostate gland epithelium morphogenesis,GO:0071230~cellular response to amino acid stimulus,GO:0071347~cellular response to interleukin-1,GO:0071392~cellular response to estradiol stimulus,GO:0071492~cellular response to UV-A,GO:0071498~cellular response to fluid shear stress,GO:1903378~positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1904645~response to beta-amyloid,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0030017~sarcomere,GO:0031012~extracellular matrix,	GO:0001968~fibronectin binding,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000562:FN_type2_dom,IPR000585:Hemopexin-like_dom,IPR001818:Pept_M10_metallopeptidase,IPR006026:Peptidase_Metallo,IPR013806:Kringle-like,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR021158:Pept_M10A_Zn_BS,IPR021190:Pept_M10A,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036365:PGBD-like_sf,IPR036375:Hemopexin-like_dom_sf,IPR036943:FN_type2_sf,	hsa01522:Endocrine resistance,hsa04670:Leukocyte transendothelial migration,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04926:Relaxin signaling pathway,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05219:Bladder cancer,hsa05415:Diabetic cardiomyopathy,hsa05418:Fluid shear stress and atherosclerosis,	259600~Multicentric osteolysis, nodulosis, and arthropathy,	PIRSF001191:Peptidase_M10A_matrix,	SM00059:FN2,SM00120:HX,SM00235:ZnMc,	KW-0037~Angiogenesis,KW-0177~Collagen degradation,	KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0068~Autocatalytic cleavage,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-II,DOMAIN:Fibronectin type-II 1,DOMAIN:Fibronectin type-II 2,DOMAIN:Fibronectin type-II 3,DOMAIN:Peptidase M10 metallopeptidase,DOMAIN:Peptidase metallopeptidase,MOTIF:Cysteine switch,PROPEP:Activation peptide,REGION:Collagen-binding,REGION:Collagenase-like 1,REGION:Collagenase-like 2,REGION:Required for inhibitor TIMP2 binding,REPEAT:Hemopexin,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,
P50757	matrix metallopeptidase 2(MMP2)	Oryctolagus cuniculus			GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0006508~proteolysis,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0048771~tissue remodeling,GO:0048856~anatomical structure development,GO:0050896~response to stimulus,GO:0071492~cellular response to UV-A,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008270~zinc ion binding,	IPR000562:FN_type2_dom,IPR000585:Hemopexin-like_dom,IPR001818:Pept_M10_metallopeptidase,IPR002477:Peptidoglycan-bd-like,IPR006026:Peptidase_Metallo,IPR013806:Kringle-like,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR021158:Pept_M10A_Zn_BS,IPR021190:Pept_M10A,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036365:PGBD-like_sf,IPR036375:Hemopexin-like_dom_sf,IPR036943:FN_type2_sf,	ocu01522:Endocrine resistance,ocu04670:Leukocyte transendothelial migration,ocu04912:GnRH signaling pathway,ocu04915:Estrogen signaling pathway,ocu04926:Relaxin signaling pathway,ocu04933:AGE-RAGE signaling pathway in diabetic complications,ocu05200:Pathways in cancer,ocu05205:Proteoglycans in cancer,ocu05219:Bladder cancer,ocu05415:Diabetic cardiomyopathy,ocu05418:Fluid shear stress and atherosclerosis,		PIRSF001191:Peptidase_M10A_matrix,	SM00059:FN2,SM00120:HX,SM00235:ZnMc,	KW-0037~Angiogenesis,KW-0177~Collagen degradation,	KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0539~Nucleus,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0068~Autocatalytic cleavage,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-II,DOMAIN:Fibronectin type-II 1,DOMAIN:Fibronectin type-II 2,DOMAIN:Fibronectin type-II 3,MOTIF:Cysteine switch,PROPEP:Activation peptide,REGION:Collagen-binding,REGION:Collagenase-like 1,REGION:Collagenase-like 2,REGION:Disordered,REGION:Required for inhibitor TIMP2 binding,REPEAT:Hemopexin,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,
O75900	matrix metallopeptidase 23B(MMP23B)	Homo sapiens			GO:0000003~reproduction,GO:0006508~proteolysis,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,	GO:0005615~extracellular space,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR001818:Pept_M10_metallopeptidase,IPR003582:ShKT_dom,IPR003599:Ig_sub,IPR006026:Peptidase_Metallo,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR021190:Pept_M10A,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036179:Ig-like_dom_sf,				SM00235:ZnMc,SM00254:ShKT,SM00409:IG,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:Peptidase M10 metallopeptidase,DOMAIN:Peptidase metallopeptidase,DOMAIN:ShKT,MUTAGEN:R->G: Abolishes processing of soluble form.,REGION:Disordered,SITE:Cleavage; by furin-like protease,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q90WI4	matrix remodeling associated 8(MXRA8)	Gallus gallus			GO:0007155~cell adhesion,GO:0030154~cell differentiation,GO:0060857~establishment of glial blood-brain barrier,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,		IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR042472:MXRA8,				SM00406:IGv,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like V-type 1,DOMAIN:Ig-like V-type 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6DIN3	mbt domain containing 1(mbtd1)	Xenopus tropicalis			GO:0000724~double-strand break repair via homologous recombination,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0035267~NuA4 histone acetyltransferase complex,	GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0035064~methylated histone binding,GO:0042393~histone binding,GO:0046872~metal ion binding,	IPR002035:VWF_A,IPR004092:Mbt,IPR008930:Terpenoid_cyclase/PrenylTrfase,IPR012313:Znf_FCS,IPR013694:VIT,IPR036465:vWFA_dom_sf,IPR038603:Znf_FCS_sf,				SM00327:VWA,SM00561:MBT,SM00609:VIT,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0156~Chromatin regulator,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:FCS-type,DOMAIN:VIT,DOMAIN:VWFA,REGION:Disordered,REPEAT:MBT,REPEAT:MBT 1,REPEAT:MBT 2,REPEAT:MBT 3,REPEAT:MBT 4,ZN_FING:FCS-type,
O60244	mediator complex subunit 14(MED14)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0035019~somatic stem cell population maintenance,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051123~RNA polymerase II transcriptional preinitiation complex assembly,GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0016592~mediator complex,GO:0070847~core mediator complex,	GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0042809~vitamin D receptor binding,	IPR013947:Mediator_Med14,	hsa04919:Thyroid hormone signaling pathway,				KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0010~Activator,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,MOTIF:LXXLL motif 1,MOTIF:LXXLL motif 2,REGION:Disordered,REGION:Interaction with SREBF1,REGION:Interaction with STAT2,
Q7ZVN7	mediator complex subunit 15(med15)	Danio rerio			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016592~mediator complex,	GO:0003712~transcription cofactor activity,	IPR019087:Med15_N,IPR036529:KIX_dom_sf,IPR048385:Med15_central,IPR048386:Med15_C,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0010~Activator,		COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:ARC105/Med15 mediator subunit C-terminal,DOMAIN:ARC105/Med15 mediator subunit central,DOMAIN:Mediator of RNA polymerase II transcription subunit 15 N-terminal,REGION:Disordered,
Q5RKN3	mediator complex subunit 28(med28)	Danio rerio				GO:0005634~nucleus,GO:0016592~mediator complex,		IPR021640:Mediator_Med28,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0010~Activator,		COMPBIAS:Pro residues,REGION:Disordered,
Q5XGY9	meiotic nuclear division protein 1 homolog(LOC108699336)	Xenopus laevis			GO:0007131~reciprocal meiotic recombination,	GO:0005634~nucleus,	GO:0003690~double-stranded DNA binding,	IPR005647:Mnd1,IPR040453:Mnd1_HTH,IPR040661:LZ3wCH,			PIRSF026991:Mnd1,		KW-0233~DNA recombination,KW-0469~Meiosis,	KW-0539~Nucleus,			KW-0175~Coiled coil,				DOMAIN:Leucine zipper with capping helix,DOMAIN:Mnd1 HTH,
Q9BV36	melanophilin(MLPH)	Homo sapiens			GO:0006886~intracellular protein transport,GO:0032402~melanosome transport,	GO:0030425~dendrite,GO:0030864~cortical actin cytoskeleton,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0017022~myosin binding,GO:0030674~protein binding, bridging,GO:0031267~small GTPase binding,GO:0046872~metal ion binding,	IPR006788:Myrip/Melanophilin,IPR010911:Rab_BD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR037442:Melanophilin_FYVE-rel_dom,IPR041282:FYVE_2,		609227~Griscelli syndrome, type 3,				KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Rab effector MyRIP/Melanophilin,DOMAIN:RabBD,MUTAGEN:E->A: Abolishes RAB27A binding.,MUTAGEN:R->A: Decreases RAB27A binding.,REGION:Disordered,ZN_FING:FYVE-type,
P08582	melanotransferrin(MELTF)	Homo sapiens			GO:0006826~iron ion transport,GO:0010756~positive regulation of plasminogen activation,GO:0090091~positive regulation of extracellular matrix disassembly,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005788~endoplasmic reticulum lumen,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,GO:0098552~side of membrane,	GO:0005506~iron ion binding,GO:0005515~protein binding,	IPR001156:Transferrin-like_dom,IPR016357:Transferrin,IPR018195:Transferrin_Fe_BS,			PIRSF002549:Transferrin,	SM00094:TR_FER,	KW-0406~Ion transport,KW-0410~Iron transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,	KW-0408~Iron,KW-0479~Metal-binding,KW-0862~Zinc,		KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Transferrin-like,DOMAIN:Transferrin-like 1,DOMAIN:Transferrin-like 2,LIPID:GPI-anchor amidated cysteine,PROPEP:Removed in mature form,REGION:Antigenic epitope,REGION:Disordered,
Q5F488	membrane associated guanylate kinase, WW and PDZ domain containing 3(MAGI3)	Gallus gallus			GO:0007165~signal transduction,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0045202~synapse,	GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001202:WW_dom,IPR001478:PDZ,IPR008144:Guanylate_kin-like_dom,IPR008145:GK/Ca_channel_bsu,IPR020590:Guanylate_kinase_CS,IPR027417:P-loop_NTPase,IPR036020:WW_dom_sf,IPR036034:PDZ_sf,				SM00072:GuKc,SM00228:PDZ,SM00456:WW,		KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Guanylate kinase-like,DOMAIN:PDZ,DOMAIN:PDZ 1,DOMAIN:PDZ 2,DOMAIN:PDZ 3,DOMAIN:PDZ 4,DOMAIN:PDZ 5,DOMAIN:PDZ 6,DOMAIN:WW,DOMAIN:WW 1,DOMAIN:WW 2,REGION:Disordered,
Q14703	membrane bound transcription factor peptidase, site 1(MBTPS1)	Homo sapiens		h_s1pPathway:SREBP control of lipid synthesis,	GO:0006508~proteolysis,GO:0007040~lysosome organization,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0008203~cholesterol metabolic process,GO:0016485~protein processing,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031293~membrane protein intracellular domain proteolysis,GO:0034976~response to endoplasmic reticulum stress,GO:0036500~ATF6-mediated unfolded protein response,GO:0045540~regulation of cholesterol biosynthetic process,GO:0051604~protein maturation,GO:0060627~regulation of vesicle-mediated transport,	GO:0000139~Golgi membrane,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0016020~membrane,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,	IPR000209:Peptidase_S8/S53_dom,IPR015500:Peptidase_S8_subtilisin-rel,IPR022398:Peptidase_S8_His-AS,IPR023828:Peptidase_S8_Ser-AS,IPR034185:Site-1_peptidase_cat_dom,IPR036852:Peptidase_S8/S53_dom_sf,	hsa04141:Protein processing in endoplasmic reticulum,	618392~Spondyloepiphyseal dysplasia, Kondo-Fu type,			KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,		KW-0225~Disease variant,KW-0242~Dwarfism,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0068~Autocatalytic cleavage,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0865~Zymogen,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Peptidase S8,DOMAIN:Peptidase S8/S53,MUTAGEN:H->A: Abolishes serine protease activity.,MUTAGEN:S->A: Abolishes serine protease activity. Does not promote FAM20C kinase activity.,REGION:Disordered,SITE:Cleavage; by autolysis,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
D3YWE6	meningioma 1(Mn1)	Mus musculus			GO:0001957~intramembranous ossification,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0033689~negative regulation of osteoblast proliferation,GO:0070564~positive regulation of vitamin D receptor signaling pathway,GO:1902806~regulation of cell cycle G1/S phase transition,	GO:0005634~nucleus,		IPR037644:MN1,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0043~Tumor suppressor,			KW-0010~Activator,KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,
Q802G6	methionine sulfoxide reductase B1a(msrb1a)	Danio rerio			GO:0002376~immune system process,GO:0030041~actin filament polymerization,GO:0030091~protein repair,GO:0045087~innate immune response,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,	GO:0003779~actin binding,GO:0016491~oxidoreductase activity,GO:0033743~peptide-methionine (R)-S-oxide reductase activity,GO:0033745~L-methionine-(R)-S-oxide reductase activity,GO:0046872~metal ion binding,	IPR002579:Met_Sox_Rdtase_MsrB_dom,IPR011057:Mss4-like_sf,					KW-0391~Immunity,KW-0399~Innate immunity,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0560~Oxidoreductase,		ACT_SITE:Nucleophile,DOMAIN:MsrB,NON_STD:Selenocysteine,
Q9UIS9	methyl-CpG binding domain protein 1(MBD1)	Homo sapiens			GO:0006366~transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0009410~response to xenobiotic stimulus,GO:0010629~negative regulation of gene expression,GO:0030182~neuron differentiation,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol,GO:0042220~response to cocaine,GO:0044030~regulation of DNA methylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048712~negative regulation of astrocyte differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008327~methyl-CpG binding,GO:0010385~double-stranded methylated DNA binding,GO:0045322~unmethylated CpG binding,	IPR001739:Methyl_CpG_DNA-bd,IPR002857:Znf_CXXC,IPR016177:DNA-bd_dom_sf,				SM00391:MBD,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:CXXC-type,DOMAIN:MBD,MOTIF:Nuclear localization signal,MUTAGEN:D->A: Strongly reduces binding to methylated DNA.,MUTAGEN:F->A: Disrupts tertiary structure and abolishes DNA binding.,MUTAGEN:I->R: Abolishes interaction with ATF7IP and subsequent transcription repression activity.,MUTAGEN:K->A: Strongly reduces binding to methylated DNA.,MUTAGEN:R->A,K: Abolishes binding to methylated DNA.,MUTAGEN:R->A: Strongly reduces binding to methylated DNA.,MUTAGEN:R->K: No loss of binding to methylated DNA.,MUTAGEN:S->A: Reduces binding to methylated DNA.,MUTAGEN:Y->A,F: Strongly reduces binding to methylated DNA.,MUTAGEN:Y->A: No loss of binding to methylated DNA.,REGION:Disordered,REGION:Transcriptional repression domain (TRD),ZN_FING:CXXC-type 1,ZN_FING:CXXC-type 2,ZN_FING:CXXC-type 3,
Q5ZKA5	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase(MTHFD2)	Gallus gallus			GO:0006730~one-carbon metabolic process,GO:0035999~tetrahydrofolate interconversion,	GO:0005739~mitochondrion,	GO:0000287~magnesium ion binding,GO:0004477~methenyltetrahydrofolate cyclohydrolase activity,GO:0004487~methylenetetrahydrofolate dehydrogenase (NAD+) activity,GO:0004488~methylenetetrahydrofolate dehydrogenase (NADP+) activity,GO:0016787~hydrolase activity,GO:0042301~phosphate ion binding,	IPR000672:THF_DH/CycHdrlase,IPR020630:THF_DH/CycHdrlase_cat_dom,IPR020631:THF_DH/CycHdrlase_NAD-bd_dom,IPR020867:THF_DH/CycHdrlase_CS,IPR036291:NAD(P)-bd_dom_sf,IPR046346:Aminoacid_DH-like_N_sf,	gga00670:One carbon pool by folate,gga01100:Metabolic pathways,gga01240:Biosynthesis of cofactors,				KW-0554~One-carbon metabolism,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0460~Magnesium,KW-0520~NAD,KW-0521~NADP,	KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0560~Oxidoreductase,		DOMAIN:Tetrahydrofolate dehydrogenase/cyclohydrolase NAD(P)-binding,DOMAIN:Tetrahydrofolate dehydrogenase/cyclohydrolase catalytic,TRANSIT:Mitochondrion,
Q96PE7	methylmalonyl-CoA epimerase(MCEE)	Homo sapiens			GO:0019626~short-chain fatty acid catabolic process,GO:0046491~L-methylmalonyl-CoA metabolic process,	GO:0005759~mitochondrial matrix,	GO:0004493~methylmalonyl-CoA epimerase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR004360:Glyas_Fos-R_dOase_dom,IPR017515:MeMalonyl-CoA_epimerase,IPR029068:Glyas_Bleomycin-R_OHBP_Dase,IPR037523:VOC,	hsa00280:Valine, leucine and isoleucine degradation,hsa00630:Glyoxylate and dicarboxylate metabolism,hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,	251120~Methylmalonyl-CoA epimerase deficiency,				KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0170~Cobalt,KW-0479~Metal-binding,	KW-0413~Isomerase,	KW-0007~Acetylation,	DOMAIN:Glyoxalase/fosfomycin resistance/dioxygenase,DOMAIN:VOC,TRANSIT:Mitochondrion,
A6QP81	methyltransferase 21C, AARS1 lysine(METTL21C)	Bos taurus			GO:0006479~protein methylation,GO:0018022~peptidyl-lysine methylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032991~macromolecular complex,	GO:0016279~protein-lysine N-methyltransferase activity,GO:0031072~heat shock protein binding,	IPR019410:Methyltransf_16,IPR029063:SAM-dependent_MTases_sf,						KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		REGION:Disordered,
Q9BUU2	methyltransferase 22, Kin17 lysine(METTL22)	Homo sapiens			GO:0006338~chromatin remodeling,GO:0006479~protein methylation,GO:0032259~methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0032991~macromolecular complex,	GO:0005515~protein binding,GO:0008276~protein methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0031072~heat shock protein binding,GO:0042054~histone methyltransferase activity,	IPR019410:Methyltransf_16,IPR029063:SAM-dependent_MTases_sf,IPR038899:METTL22,						KW-0539~Nucleus,				KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,
B1WB06	methyltransferase like 24(mettl24)	Xenopus tropicalis			GO:0032259~methylation,	GO:0005576~extracellular region,GO:0005886~plasma membrane,	GO:0005524~ATP binding,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0016887~ATPase activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR005292:MRP,IPR011527:ABC1_TM_dom,IPR017871:ABC_transporter-like_CS,IPR025714:Methyltranfer_dom,IPR026913:METTL24,IPR027417:P-loop_NTPase,IPR036640:ABC1_TM_sf,				SM00382:AAA,	KW-0813~Transport,	KW-0472~Membrane,KW-0964~Secreted,			KW-0732~Signal,KW-0812~Transmembrane,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0489~Methyltransferase,KW-0808~Transferase,		COMPBIAS:Polar residues,DOMAIN:ABC transmembrane type-1,DOMAIN:ABC transporter,DOMAIN:Methyltransferase,REGION:Disordered,TRANSMEM:Helical,
A1L3F4	mex-3 RNA binding family member B S homeolog(mex3b.S)	Xenopus laevis				GO:0000932~P-body,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0046872~metal ion binding,	IPR001841:Znf_RING,IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR013083:Znf_RING/FYVE/PHD,IPR036612:KH_dom_type_1_sf,IPR047226:KH-I_MEX3_rpt2,IPR047227:MEX3,IPR047228:KH-I_MEX3_rpt1,				SM00184:RING,SM00322:KH,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0694~RNA-binding,		DOMAIN:KH 1,DOMAIN:KH 2,DOMAIN:RING-type,REGION:Disordered,ZN_FING:RING-type,
Q5IFK1	microcephalin 1(MCPH1)	Macaca fascicularis			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000132~establishment of mitotic spindle orientation,GO:0000278~mitotic cell cycle,GO:0021987~cerebral cortex development,GO:0046605~regulation of centrosome cycle,GO:0050727~regulation of inflammatory response,GO:0060348~bone development,GO:0060623~regulation of chromosome condensation,GO:0071539~protein localization to centrosome,GO:0097150~neuronal stem cell population maintenance,	GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0042802~identical protein binding,	IPR001357:BRCT_dom,IPR022047:Microcephalin-like,IPR029504:Microcephalin_mammal,IPR036420:BRCT_dom_sf,				SM00292:BRCT,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BRCT,DOMAIN:BRCT 1,DOMAIN:BRCT 2,DOMAIN:BRCT 3,REGION:Disordered,
O75121	microfibril associated protein 3 like(MFAP3L)	Homo sapiens				GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030054~cell junction,	GO:0005515~protein binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:Immunoglobulin I-set,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P55918	microfibril associated protein 4(MFAP4)	Bos taurus			GO:0007155~cell adhesion,GO:0048251~elastic fiber assembly,	GO:0005615~extracellular space,GO:0071953~elastic fiber,		IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR036056:Fibrinogen-like_C,				SM00186:FBG,	KW-0130~Cell adhesion,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibrinogen C-terminal,MOTIF:Cell attachment site,
P10620	microsomal glutathione S-transferase 1(MGST1)	Homo sapiens			GO:0034635~glutathione transport,GO:0071449~cellular response to lipid hydroperoxide,GO:0098869~cellular oxidant detoxification,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005778~peroxisomal membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0035577~azurophil granule membrane,	GO:0004364~glutathione transferase activity,GO:0004602~glutathione peroxidase activity,GO:0005515~protein binding,	IPR001129:Membr-assoc_MAPEG,IPR023352:MAPEG-like_dom_sf,IPR040162:MGST1-like,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa01524:Platinum drug resistance,hsa05200:Pathways in cancer,hsa05204:Chemical carcinogenesis - DNA adducts,hsa05207:Chemical carcinogenesis - receptor activation,hsa05208:Chemical carcinogenesis - reactive oxygen species,hsa05225:Hepatocellular carcinoma,hsa05418:Fluid shear stress and atherosclerosis,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0007~Acetylation,	TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
O08678	microtubule affinity regulating kinase 1(Mark1)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0001764~neuron migration,GO:0006468~protein phosphorylation,GO:0007010~cytoskeleton organization,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0010975~regulation of neuron projection development,GO:0016055~Wnt signaling pathway,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,GO:0050773~regulation of dendrite development,GO:0051654~establishment of mitochondrion localization,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030425~dendrite,	GO:0000287~magnesium ion binding,GO:0001786~phosphatidylserine binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0050321~tau-protein kinase activity,GO:0070300~phosphatidic acid binding,	IPR000719:Prot_kinase_dom,IPR001772:KA1_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015940:UBA,IPR017441:Protein_kinase_ATP_BS,IPR028375:KA1/Ssp2_C,				SM00165:UBA,SM00220:S_TKc,	KW-0879~Wnt signaling pathway,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0446~Lipid-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:KA1,DOMAIN:Protein kinase,DOMAIN:UBA,MUTAGEN:K->R: Loss of kinase activity.,MUTAGEN:S->A,E: Loss of activity.,MUTAGEN:S->A: Loss of kinase activity.,MUTAGEN:T->A: Abolishes activation of serine/threonine-protein kinase activity and only basal activity remains.,MUTAGEN:T->A: Loss of kinase activity.,MUTAGEN:T->E: Induces an increase of the basal serine/threonine-protein kinase activity.,REGION:Disordered,
P27448	microtubule affinity regulating kinase 3(MARK3)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032092~positive regulation of protein binding,GO:0035331~negative regulation of hippo signaling,GO:0035556~intracellular signal transduction,GO:0036289~peptidyl-serine autophosphorylation,GO:1900181~negative regulation of protein localization to nucleus,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0048156~tau protein binding,GO:0050321~tau-protein kinase activity,	IPR000719:Prot_kinase_dom,IPR001772:KA1_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015940:UBA,IPR017441:Protein_kinase_ATP_BS,IPR028375:KA1/Ssp2_C,		618283~Visual impairment and progressive phthisis bulbi,		SM00165:UBA,SM00220:S_TKc,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0732~Signal,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:KA1,DOMAIN:Protein kinase,DOMAIN:UBA,MUTAGEN:T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.,REGION:Disordered,
E7F9T0	microtubule associated monooxygenase, calponin and LIM domain containing 1(mical1)	Danio rerio			GO:0019417~sulfur oxidation,GO:0030042~actin filament depolymerization,GO:0048513~animal organ development,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0010008~endosome membrane,GO:0030496~midbody,	GO:0003779~actin binding,GO:0004497~monooxygenase activity,GO:0016174~NAD(P)H oxidase activity,GO:0016491~oxidoreductase activity,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0046872~metal ion binding,GO:0071949~FAD binding,	IPR001715:CH_dom,IPR001781:Znf_LIM,IPR002938:FAD-bd,IPR022735:bMERB_dom,IPR036188:FAD/NAD-bd_sf,IPR036872:CH_dom_sf,				SM00033:CH,SM00132:LIM,SM01203:DUF3585,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0175~Coiled coil,KW-0440~LIM domain,	KW-0274~FAD,KW-0285~Flavoprotein,KW-0479~Metal-binding,KW-0521~NADP,KW-0862~Zinc,	KW-0009~Actin-binding,KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BMERB,DOMAIN:Calponin-homology (CH),DOMAIN:FAD-binding,DOMAIN:LIM zinc-binding,DOMAIN:bMERB,REGION:Disordered,REGION:Monooxygenase domain,
Q9Y2H9	microtubule associated serine/threonine kinase 1(MAST1)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0007010~cytoskeleton organization,GO:0007420~brain development,GO:0018105~peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043005~neuron projection,GO:0043025~neuronal cell body,	GO:0000287~magnesium ion binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR001478:PDZ,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015022:MAST_pre-PK_dom,IPR023142:MAST_pre-PK_dom_sf,IPR036034:PDZ_sf,IPR037711:MAST,IPR041489:PDZ_6,		618273~Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations,		SM00220:S_TKc,SM00228:PDZ,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0991~Intellectual disability,		KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:AGC-kinase C-terminal,DOMAIN:Microtubule-associated serine/threonine-protein kinase pre-PK,DOMAIN:PDZ,DOMAIN:Protein kinase,REGION:Disordered,
Q6AX33	microtubule associated serine/threonine kinase 3 L homeolog(mast3.L)	Xenopus laevis			GO:0016310~phosphorylation,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR001478:PDZ,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015022:MAST_pre-PK_dom,IPR023142:MAST_pre-PK_dom_sf,IPR036034:PDZ_sf,IPR037711:MAST,IPR041489:PDZ_6,				SM00220:S_TKc,SM00228:PDZ,		KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:AGC-kinase C-terminal,DOMAIN:PDZ,DOMAIN:Protein kinase,REGION:Disordered,
Q6DBX4	microtubule associated serine/threonine kinase-like(mastl)	Danio rerio			GO:0000086~G2/M transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0002574~thrombocyte differentiation,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032515~negative regulation of phosphoprotein phosphatase activity,GO:0035556~intracellular signal transduction,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0032154~cleavage furrow,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0051721~protein phosphatase 2A binding,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,				SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:AGC-kinase C-terminal,DOMAIN:Protein kinase,REGION:Disordered,
A0JMQ7	microtubule associated tumor suppressor 1a(mtus1a)	Danio rerio			GO:0007049~cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0008017~microtubule binding,						KW-0131~Cell cycle,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,TRANSMEM:Helical,
Q5XIT1	microtubule-associated protein, RP/EB family, member 3(Mapre3)	Rattus norvegicus			GO:0007049~cell cycle,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0031113~regulation of microtubule polymerization,GO:0035372~protein localization to microtubule,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0015630~microtubule cytoskeleton,GO:0030496~midbody,GO:0035371~microtubule plus-end,GO:0048471~perinuclear region of cytoplasm,GO:0051233~spindle midzone,GO:1905721~mitotic spindle astral microtubule end,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0051010~microtubule plus-end binding,	IPR001715:CH_dom,IPR004953:EB1_C,IPR027328:MAPRE,IPR036133:EB1_C_sf,IPR036872:CH_dom_sf,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DOMAIN:Calponin-homology (CH),DOMAIN:EB1 C-terminal,REGION:APC-binding,REGION:DCTN1-binding,REGION:Disordered,
Q9NU22	midasin AAA ATPase 1(MDN1)	Homo sapiens			GO:0000027~ribosomal large subunit assembly,GO:0000055~ribosomal large subunit export from nucleus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0016020~membrane,GO:0030687~preribosome, large subunit precursor,GO:0045111~intermediate filament cytoskeleton,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR002035:VWF_A,IPR003593:AAA+_ATPase,IPR011704:ATPase_dyneun-rel_AAA,IPR012099:Midasin,IPR027417:P-loop_NTPase,IPR036465:vWFA_dom_sf,IPR040848:AAA_lid_7,IPR041190:Midasin_AAA_lid_5,IPR048617:MDN1_AAA_lid_4,	hsa03008:Ribosome biogenesis in eukaryotes,		PIRSF010340:Midasin,	SM00327:VWA,SM00382:AAA,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:VWFA,REGION:AAA-ATPase protomer 1,REGION:AAA-ATPase protomer 2,REGION:AAA-ATPase protomer 3,REGION:AAA-ATPase protomer 4,REGION:AAA-ATPase protomer 5,REGION:AAA-ATPase protomer 6,REGION:Disordered,REGION:Linker,
P48530	midkine S homeolog(mdk.S)	Xenopus laevis			GO:0007399~nervous system development,GO:0007528~neuromuscular junction development,GO:0009617~response to bacterium,GO:0042742~defense response to bacterium,GO:0050896~response to stimulus,GO:0051781~positive regulation of cell division,	GO:0005576~extracellular region,	GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0043395~heparan sulfate proteoglycan binding,	IPR000762:Midkine_heparin-bd_GF,IPR020089:PTN/MK_N_dom,IPR020090:PTN/MK_C_dom,IPR020091:PTN/MK_diS_sf,IPR020092:PTN_MK_heparin-bd_GF_CS,IPR037122:PTN/MK_N_dom_sf,IPR038130:PTN/MK_C_dom_sf,				SM00193:PTN,		KW-0964~Secreted,			KW-0732~Signal,		KW-0044~Antibiotic,KW-0217~Developmental protein,KW-0339~Growth factor,KW-0358~Heparin-binding,KW-0497~Mitogen,KW-0929~Antimicrobial,KW-9996~Developmental protein,	KW-1015~Disulfide bond,	DOMAIN:Pleiotrophin/Midkine C-terminal,DOMAIN:Pleiotrophin/Midkine N-terminal,
O15344	midline 1(MID1)	Homo sapiens			GO:0000226~microtubule cytoskeleton organization,GO:0007026~negative regulation of microtubule depolymerization,GO:0007389~pattern specification process,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0035372~protein localization to microtubule,GO:0070507~regulation of microtubule cytoskeleton organization,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005881~cytoplasmic microtubule,GO:0016020~membrane,GO:0034451~centriolar satellite,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0051219~phosphoprotein binding,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003649:Bbox_C,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR003961:FN3_dom,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR013783:Ig-like_fold,IPR017903:COS_domain,IPR017907:Znf_RING_CS,IPR027370:Znf-RING_euk,IPR027727:MID1_Bbox2_Zfn,IPR036116:FN3_sf,IPR040859:Midline-1_COS,IPR043136:B30.2/SPRY_sf,IPR047095:MID1_Bbox1_Zfn,	hsa04120:Ubiquitin mediated proteolysis,	300000~Opitz GBBB syndrome,		SM00060:FN3,SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00502:BBC,	KW-0833~Ubl conjugation pathway,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0493~Microtubule,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0175~Coiled coil,KW-0677~Repeat,KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:COS,DOMAIN:Fibronectin type-III,DOMAIN:RING-type,REGION:Disordered,TRANSMEM:Helical,ZN_FING:B box-type 1,ZN_FING:B box-type 2,ZN_FING:RING-type,
Q6NYU6	midnolin(midn)	Danio rerio				GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,		IPR000626:Ubiquitin-like_dom,IPR029071:Ubiquitin-like_domsf,IPR039336:Midnolin,				SM00213:UBQ,		KW-0539~Nucleus,KW-0963~Cytoplasm,							COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Ubiquitin-like,REGION:Disordered,
F1QDI9	minichromosome maintenance 9 homologous recombination repair factor(mcm9)	Danio rerio			GO:0000724~double-strand break repair via homologous recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0032508~DNA duplex unwinding,	GO:0005634~nucleus,GO:0042555~MCM complex,GO:0097362~MCM8-MCM9 complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,	IPR001208:MCM_dom,IPR003593:AAA+_ATPase,IPR012340:NA-bd_OB-fold,IPR027417:P-loop_NTPase,IPR031327:MCM,IPR033762:MCM_OB,IPR041562:MCM_lid,				SM00350:MCM,SM00382:AAA,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:MCM,DOMAIN:MCM AAA-lid,REGION:Disordered,
Q6DIH3	minichromosome maintenance complex component 2(mcm2)	Xenopus tropicalis			GO:0000727~double-strand break repair via break-induced replication,GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0006807~nitrogen compound metabolic process,GO:0007049~cell cycle,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0032508~DNA duplex unwinding,GO:0044238~primary metabolic process,GO:0071704~organic substance metabolic process,GO:1902975~mitotic DNA replication initiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0042555~MCM complex,GO:0071162~CMG complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003697~single-stranded DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0043138~3'-5' DNA helicase activity,GO:0046872~metal ion binding,	IPR001208:MCM_dom,IPR008045:MCM2,IPR012340:NA-bd_OB-fold,IPR018525:MCM_CS,IPR027417:P-loop_NTPase,IPR027925:MCM_N,IPR031327:MCM,IPR033762:MCM_OB,IPR041562:MCM_lid,	xtr03030:DNA replication,xtr04110:Cell cycle,			SM00350:MCM,	KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:MCM,MOTIF:Arginine finger,REGION:Disordered,ZN_FING:C4-type,
P30664	minichromosome maintenance complex component 4 L homeolog(mcm4.L)	Xenopus laevis			GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0006279~premeiotic DNA replication,GO:0007049~cell cycle,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0032508~DNA duplex unwinding,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0042555~MCM complex,GO:0071162~CMG complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0003697~single-stranded DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0046872~metal ion binding,	IPR001208:MCM_dom,IPR008047:MCM_4,IPR012340:NA-bd_OB-fold,IPR018525:MCM_CS,IPR027417:P-loop_NTPase,IPR027925:MCM_N,IPR031327:MCM,IPR033762:MCM_OB,IPR041562:MCM_lid,	xla03030:DNA replication,xla04110:Cell cycle,			SM00350:MCM,	KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,		COMPBIAS:Polar residues,DOMAIN:MCM,MOTIF:Arginine finger,REGION:Disordered,ZN_FING:C4-type,
Q561P5	minichromosome maintenance complex component 5(mcm5)	Xenopus tropicalis			GO:0000727~double-strand break repair via break-induced replication,GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0032508~DNA duplex unwinding,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0042555~MCM complex,GO:0071162~CMG complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003688~DNA replication origin binding,GO:0003697~single-stranded DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0043138~3'-5' DNA helicase activity,	IPR001208:MCM_dom,IPR008048:MCM5,IPR012340:NA-bd_OB-fold,IPR018525:MCM_CS,IPR027417:P-loop_NTPase,IPR027925:MCM_N,IPR031327:MCM,IPR033762:MCM_OB,IPR041562:MCM_lid,	xtr03030:DNA replication,xtr04110:Cell cycle,			SM00350:MCM,	KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,		DOMAIN:MCM,MOTIF:Arginine finger,
Q14566	minichromosome maintenance complex component 6(MCM6)	Homo sapiens		h_mcmPathway:CDK Regulation of DNA Replication,	GO:0000727~double-strand break repair via break-induced replication,GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:1902969~mitotic DNA replication,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0042555~MCM complex,GO:0071162~CMG complex,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042802~identical protein binding,GO:1990518~single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,	IPR001208:MCM_dom,IPR008049:MCM6,IPR012340:NA-bd_OB-fold,IPR018525:MCM_CS,IPR027417:P-loop_NTPase,IPR027925:MCM_N,IPR031327:MCM,IPR033762:MCM_OB,IPR041024:Mcm6_C,IPR041562:MCM_lid,	hsa03030:DNA replication,hsa04110:Cell cycle,	223100~Lactase persistence/nonpersistence,		SM00350:MCM,	KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,		KW-0225~Disease variant,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	DOMAIN:MCM,MOTIF:Arginine finger,MUTAGEN:E->A,D: Impairs interaction with CTD1.,MUTAGEN:L->A: Impairs interaction with CTD1.,
Q4R7G8	mitochondrial E3 ubiquitin protein ligase 1(MUL1)	Macaca fascicularis			GO:0000209~protein polyubiquitination,GO:0000266~mitochondrial fission,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006996~organelle organization,GO:0010637~negative regulation of mitochondrial fusion,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,GO:0030308~negative regulation of cell growth,GO:0031648~protein destabilization,GO:0033235~positive regulation of protein sumoylation,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045824~negative regulation of innate immune response,GO:0050689~negative regulation of defense response to virus by host,GO:0050821~protein stabilization,GO:0051646~mitochondrion localization,GO:0051881~regulation of mitochondrial membrane potential,GO:0051898~negative regulation of protein kinase B signaling,GO:0060339~negative regulation of type I interferon-mediated signaling pathway,GO:0071360~cellular response to exogenous dsRNA,GO:0071650~negative regulation of chemokine (C-C motif) ligand 5 production,GO:0090141~positive regulation of mitochondrial fission,GO:1901028~regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1903861~positive regulation of dendrite extension,GO:1904925~positive regulation of mitophagy in response to mitochondrial depolarization,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005777~peroxisome,GO:0016020~membrane,GO:0030424~axon,GO:0043025~neuronal cell body,	GO:0002039~p53 binding,GO:0004842~ubiquitin-protein transferase activity,GO:0019789~SUMO transferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,IPR022170:MUL1-like,	mcf04137:Mitophagy - animal,				KW-0833~Ubl conjugation pathway,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0576~Peroxisome,KW-1000~Mitochondrion outer membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:RING-type,TOPO_DOM:Cytoplasmic,TOPO_DOM:Mitochondrial intermembrane,TRANSMEM:Helical,ZN_FING:RING-type,
Q96AQ8	mitochondrial calcium uniporter regulator 1(MCUR1)	Homo sapiens			GO:0006851~mitochondrial calcium ion transport,GO:0036444~mitochondrial calcium uptake,GO:0051561~positive regulation of mitochondrial calcium ion concentration,GO:0070509~calcium ion import,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0005515~protein binding,	IPR024461:CCDC90-like,					KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,			TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSMEM:Helical,
A4IG32	mitochondrial calcium uptake 1(micu1)	Danio rerio			GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:0006851~mitochondrial calcium ion transport,GO:0036444~mitochondrial calcium uptake,GO:0051560~mitochondrial calcium ion homeostasis,GO:0051561~positive regulation of mitochondrial calcium ion concentration,GO:0070509~calcium ion import,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0016020~membrane,GO:0031966~mitochondrial membrane,GO:1990246~uniplex complex,	GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR039800:MICU1/2/3,				SM00054:EFh,	KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,DISULFID:Interchain (with C-413 in micu2),DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,REGION:C-helix region,REGION:Disordered,REGION:Polybasic region,TOPO_DOM:Mitochondrial intermembrane,TRANSIT:Mitochondrion,TRANSMEM:Helical,
Q08BD8	mitochondrial fission regulator 2(mtfr2)	Danio rerio			GO:0000266~mitochondrial fission,GO:0009060~aerobic respiration,	GO:0005739~mitochondrion,		IPR007972:Mtfr1,						KW-0496~Mitochondrion,			KW-0175~Coiled coil,				COMPBIAS:Polar residues,REGION:Disordered,
Q5TZ51	mitochondrial inner membrane protein MPV17(mpv17)	Danio rerio			GO:0001889~liver development,GO:0006225~UDP biosynthetic process,GO:0010821~regulation of mitochondrion organization,GO:0034614~cellular response to reactive oxygen species,GO:0048066~developmental pigmentation,GO:0048742~regulation of skeletal muscle fiber development,GO:0050935~iridophore differentiation,GO:0090207~regulation of triglyceride metabolic process,GO:1901858~regulation of mitochondrial DNA metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0015267~channel activity,	IPR007248:Mpv17_PMP22,	dre04146:Peroxisome,					KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				SITE:Determines ion selectivity,TRANSMEM:Helical,
Q6IN84	mitochondrial rRNA methyltransferase 1(MRM1)	Homo sapiens			GO:0000154~rRNA modification,GO:0000451~rRNA 2'-O-methylation,GO:0031167~rRNA methylation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008173~RNA methyltransferase activity,GO:0016435~rRNA (guanine) methyltransferase activity,GO:0070039~rRNA (guanosine-2'-O-)-methyltransferase activity,	IPR001537:SpoU_MeTrfase,IPR004441:rRNA_MeTrfase_TrmH,IPR013123:SpoU_subst-bd,IPR029026:tRNA_m1G_MTases_N,IPR029028:Alpha/beta_knot_MTases,IPR029064:Ribosomal_eL30-like_sf,IPR047182:MRM1,IPR047261:MRM1_MeTrfase_dom,				SM00967:SpoU_sub_bind,	KW-0698~rRNA processing,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:tRNA/rRNA methyltransferase SpoU type,REGION:Disordered,TRANSIT:Mitochondrion,
Q9HC36	mitochondrial rRNA methyltransferase 3(MRM3)	Homo sapiens			GO:0000451~rRNA 2'-O-methylation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0042802~identical protein binding,GO:0070039~rRNA (guanosine-2'-O-)-methyltransferase activity,	IPR001537:SpoU_MeTrfase,IPR013123:SpoU_subst-bd,IPR029026:tRNA_m1G_MTases_N,IPR029028:Alpha/beta_knot_MTases,IPR029064:Ribosomal_eL30-like_sf,				SM00967:SpoU_sub_bind,	KW-0698~rRNA processing,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:RNA 2-O ribose methyltransferase substrate binding,REGION:Disordered,TRANSIT:Mitochondrion,
Q5U4Z8	mitochondrial ribosomal protein L20 L homeolog(mrpl20.L)	Xenopus laevis			GO:0006412~translation,	GO:0005739~mitochondrion,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,	IPR005813:Ribosomal_bL20,IPR035566:Ribosomal_protein_bL20_C,	xla03010:Ribosome,					KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,		TRANSIT:Mitochondrion,
Q68EV6	mitochondrial ribosomal protein L28 L homeolog(mrpl28.L)	Xenopus laevis				GO:0005739~mitochondrion,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,	IPR026569:Ribosomal_bL28,IPR034704:Ribosomal_bL28/bL31-like_sf,	xla03010:Ribosome,					KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,		TRANSIT:Mitochondrion,
B5XAM2	mitochondrial ribosomal protein L58(mrpl58)	Salmo salar			GO:0070126~mitochondrial translational termination,	GO:0005739~mitochondrion,GO:0005762~mitochondrial large ribosomal subunit,	GO:0003747~translation release factor activity,GO:0004045~aminoacyl-tRNA hydrolase activity,GO:0016150~translation release factor activity, codon nonspecific,	IPR000352:Pep_chain_release_fac_I,					KW-0648~Protein biosynthesis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0378~Hydrolase,KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,		DOMAIN:Prokaryotic-type class I peptide chain release factors,TRANSIT:Mitochondrion,
P82911	mitochondrial ribosomal protein S11(MRPS11)	Bos taurus			GO:0000028~ribosomal small subunit assembly,GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006412~translation,GO:0032543~mitochondrial translation,GO:0043043~peptide biosynthetic process,	GO:0005743~mitochondrial inner membrane,GO:0005763~mitochondrial small ribosomal subunit,GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,GO:0048027~mRNA 5'-UTR binding,GO:0070181~small ribosomal subunit rRNA binding,	IPR001971:Ribosomal_uS11,IPR018102:Ribosomal_uS11_CS,IPR036967:Ribosomal_uS11_sf,	bta03010:Ribosome,					KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,		REGION:Disordered,TRANSIT:Mitochondrion,
P82916	mitochondrial ribosomal protein S17(MRPS17)	Bos taurus			GO:0006412~translation,GO:0032543~mitochondrial translation,	GO:0005743~mitochondrial inner membrane,GO:0005763~mitochondrial small ribosomal subunit,GO:0005840~ribosome,GO:0031090~organelle membrane,	GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,	IPR000266:Ribosomal_uS17,IPR012340:NA-bd_OB-fold,IPR039193:Ribosomal_uS17m_metazoa,	bta03010:Ribosome,					KW-0496~Mitochondrion,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0694~RNA-binding,KW-0699~rRNA-binding,
Q502C1	mitochondrial ribosomal protein S24(mrps24)	Danio rerio			GO:0032543~mitochondrial translation,	GO:0005739~mitochondrion,GO:0005763~mitochondrial small ribosomal subunit,GO:0005840~ribosome,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,	IPR026146:Ribosomal_uS3m,						KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,		TRANSIT:Mitochondrion,
Q9D2R8	mitochondrial ribosomal protein S33(Mrps33)	Mus musculus			GO:0032543~mitochondrial translation,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005763~mitochondrial small ribosomal subunit,GO:0005840~ribosome,GO:1990904~ribonucleoprotein complex,		IPR013219:Ribosomal_mS33,						KW-0496~Mitochondrion,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0007~Acetylation,	COMPBIAS:Basic residues,REGION:Disordered,
Q9P0P8	mitochondrial transcription rescue factor 1(MTRES1)	Homo sapiens			GO:0072344~rescue of stalled ribosome,GO:1903108~regulation of transcription from mitochondrial promoter,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043023~ribosomal large subunit binding,						KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,DOMAIN:S4 RNA-binding,MUTAGEN:D->A: Decreased RNA-binding; when associated with A-143; A-149: A-156 and A-158. Does not rescue diminished mitochondrial transcription induced by EtBr; when associated with A-143; A-149: A-156 and A-158.,MUTAGEN:K->A: Decreased RNA-binding; when associated with A-143; A-145: A-149 and A-156. Does not rescue diminished mitochondrial transcription induced by EtBr; when associated with A-143; A-145: A-149 and A-156.,MUTAGEN:K->A: Decreased RNA-binding; when associated with A-143; A-145: A-156 and A-158. Does not rescue diminished mitochondrial transcription induced by EtBr; when associated with A-143; A-149: A-156 and A-158.,MUTAGEN:R->A: Decreased RNA-binding; when associated with A-143; A-145: A-149 and A-158. Does not rescue diminished mitochondrial transcription induced by EtBr; when associated with A-143; A-145: A-149 and A-158.,MUTAGEN:R->A: Decreased RNA-binding; when associated with A-145; A-149: A-156 and A-158. Does not rescue diminished mitochondrial transcription induced by EtBr; when associated with A-145; A-149: A-156 and A-158.,REGION:Disordered,TRANSIT:Mitochondrion,
Q99551	mitochondrial transcription termination factor 1(MTERF1)	Homo sapiens			GO:0006353~DNA-templated transcription, termination,GO:0006355~regulation of transcription, DNA-templated,GO:0006393~termination of mitochondrial transcription,GO:0032392~DNA geometric change,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0042645~mitochondrial nucleoid,	GO:0003676~nucleic acid binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR003690:MTERF,IPR038538:MTERF_sf,				SM00733:Mterf,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0806~Transcription termination,	KW-0496~Mitochondrion,			KW-0677~Repeat,KW-0809~Transit peptide,		KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	MUTAGEN:F->A: Reduces affinity for cognate DNA; when associated with A-162 and A-288.,MUTAGEN:R->A: Reduces affinity for cognate DNA; when associated with A-243 and A-288.,MUTAGEN:R->A: Reduces transcription termination.,MUTAGEN:R->A: Strongly reduces affinity for DNA. Strongly reduces transcription termination.,MUTAGEN:R->A: Strongly reduces affinity for cognate DNA. Strongly reduces transcription termination.,MUTAGEN:R->A: Strongly reduces transcription termination.,MUTAGEN:Y->A: Reduces affinity for cognate DNA; when associated with A-162 and A-243.,REGION:Interaction with DNA,SITE:Interaction with DNA,TRANSIT:Mitochondrion,
Q32KZ1	mitochondrial translational initiation factor 3(MTIF3)	Bos taurus			GO:0032790~ribosome disassembly,GO:0070124~mitochondrial translational initiation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003743~translation initiation factor activity,GO:0008135~translation factor activity, RNA binding,GO:0043022~ribosome binding,GO:0043024~ribosomal small subunit binding,	IPR001288:Translation_initiation_fac_3,IPR019814:Translation_initiation_fac_3_N,IPR019815:Translation_initiation_fac_3_C,IPR036787:T_IF-3_N_sf,IPR036788:T_IF-3_C_sf,					KW-0648~Protein biosynthesis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0396~Initiation factor,		DOMAIN:Translation initiation factor 3 C-terminal,DOMAIN:Translation initiation factor 3 N-terminal,PROPEP:Removed in mature form,REGION:Disordered,TRANSIT:Mitochondrion,
O42376	mitogen-activated protein kinase 12a(mapk12a)	Danio rerio			GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004707~MAP kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR003527:MAP_kinase_CS,IPR008352:MAPK_p38-like,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,	dre04010:MAPK signaling pathway,dre04068:FoxO signaling pathway,dre04114:Oocyte meiosis,dre04148:Efferocytosis,dre04218:Cellular senescence,dre04261:Adrenergic signaling in cardiomyocytes,dre04370:VEGF signaling pathway,dre04620:Toll-like receptor signaling pathway,dre04621:NOD-like receptor signaling pathway,dre04622:RIG-I-like receptor signaling pathway,dre04625:C-type lectin receptor signaling pathway,dre04912:GnRH signaling pathway,dre04914:Progesterone-mediated oocyte maturation,dre05132:Salmonella infection,			SM00220:S_TKc,	KW-0346~Stress response,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,MOTIF:TXY,
Q13164	mitogen-activated protein kinase 7(MAPK7)	Homo sapiens	100.MAPK_signaling_cascades,	h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_mapkPathway:MAPKinase Signaling Pathway,	GO:0000165~MAPK cascade,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0016310~phosphorylation,GO:0019933~cAMP-mediated signaling,GO:0030154~cell differentiation,GO:0033173~calcineurin-NFAT signaling cascade,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0034392~negative regulation of smooth muscle cell apoptotic process,GO:0035556~intracellular signal transduction,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0045765~regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050728~negative regulation of inflammatory response,GO:0051247~positive regulation of protein metabolic process,GO:0051344~negative regulation of cyclic-nucleotide phosphodiesterase activity,GO:0060761~negative regulation of response to cytokine stimulus,GO:0070301~cellular response to hydrogen peroxide,GO:0070885~negative regulation of calcineurin-NFAT signaling cascade,GO:0071363~cellular response to growth factor stimulus,GO:0071499~cellular response to laminar fluid shear stress,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0016605~PML body,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004707~MAP kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0051019~mitogen-activated protein kinase binding,	IPR000719:Prot_kinase_dom,IPR003527:MAP_kinase_CS,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,	hsa04010:MAPK signaling pathway,hsa04540:Gap junction,hsa04657:IL-17 signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05206:MicroRNAs in cancer,hsa05418:Fluid shear stress and atherosclerosis,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0221~Differentiation,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Protein kinase,MOTIF:Nuclear localization signal,MOTIF:TXY,MUTAGEN:TEY->AEF: Loss activation by MAP2K5.,REGION:Disordered,REGION:May not be required for kinase activity; required to stimulate MEF2C activity,REGION:Necessary for oligomerization,REGION:Required for binding to MAP2K5,REGION:Required for cytoplasmic targeting,TRANSMEM:Helical,
Q9ERE9	mitogen-activated protein kinase 8 interacting protein 2(Mapk8ip2)	Mus musculus			GO:0000165~MAPK cascade,GO:0001662~behavioral fear response,GO:0007254~JNK cascade,GO:0007617~mating behavior,GO:0010469~regulation of receptor activity,GO:0016310~phosphorylation,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0035176~social behavior,GO:0046328~regulation of JNK cascade,GO:0046958~nonassociative learning,GO:0048813~dendrite morphogenesis,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0060079~excitatory postsynaptic potential,GO:2000310~regulation of NMDA receptor activity,GO:2000311~regulation of AMPA receptor activity,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0014069~postsynaptic density,GO:0032991~macromolecular complex,GO:0043025~neuronal cell body,	GO:0005078~MAP-kinase scaffold activity,GO:0005515~protein binding,GO:0008432~JUN kinase binding,GO:0016301~kinase activity,GO:0019894~kinesin binding,GO:0019901~protein kinase binding,GO:0030295~protein kinase activator activity,GO:0044877~macromolecular complex binding,	IPR001452:SH3_domain,IPR006020:PTB/PI_dom,IPR011993:PH-like_dom_sf,IPR035637:JIP2_SH3,IPR047178:JIP1_scaffold,	mmu04010:MAPK signaling pathway,			SM00326:SH3,SM00462:PTB,		KW-0963~Cytoplasm,			KW-0728~SH3 domain,		KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:PID,DOMAIN:SH3,REGION:Disordered,REGION:JNK-binding domain (JBD),REGION:Necessary for interaction with FGF13,
Q5TCX8	mitogen-activated protein kinase kinase kinase 21(MAP3K21)	Homo sapiens			GO:0000165~MAPK cascade,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0046777~protein autophosphorylation,	GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004706~JUN kinase kinase kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001452:SH3_domain,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR016231:MLK1-4,IPR017441:Protein_kinase_ATP_BS,IPR036028:SH3-like_dom_sf,	hsa04010:MAPK signaling pathway,		PIRSF000556:MAPKKK9_11,	SM00220:S_TKc,SM00326:SH3,					KW-0677~Repeat,KW-0728~SH3 domain,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Protein kinase,DOMAIN:SH3,REGION:Disordered,REGION:Leucine-zipper 1,REGION:Leucine-zipper 2,
Q13257	mitotic arrest deficient 2 like 1(MAD2L1)	Homo sapiens			GO:0000070~mitotic sister chromatid segregation,GO:0000132~establishment of mitotic spindle orientation,GO:0007094~mitotic spindle assembly checkpoint,GO:0042177~negative regulation of protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0045930~negative regulation of mitotic cell cycle,GO:0051301~cell division,GO:0051660~establishment of centrosome localization,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,GO:1904667~negative regulation of ubiquitin protein ligase activity,	GO:0000776~kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0033597~mitotic checkpoint complex,GO:0044615~nuclear pore nuclear basket,GO:0048471~perinuclear region of cytoplasm,GO:0072686~mitotic spindle,GO:1990728~mitotic spindle assembly checkpoint MAD1-MAD2 complex,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR003511:HORMA_dom,IPR036570:HORMA_dom_sf,IPR045091:Mad2-like,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,hsa05166:Human T-cell leukemia virus 1 infection,				KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:HORMA,MUTAGEN:F->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,MUTAGEN:H->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,MUTAGEN:L->A: Leads to formation of the closed conformation; when associated with A-133.,MUTAGEN:L->A: Leads to formation the closed conformation and homodimerization. Reduces binding to MAD1L1.,MUTAGEN:R->A: Prevents aggregation and promotes formation of monomeric protein that slowly interconverts between the open and closed conformation.,MUTAGEN:S->A: Abolishes phosphorylation on serine residues; when associated with A-170 and A-178.,MUTAGEN:S->A: Reduces phosphorylation on serine residues; when associated with A-170. Abolishes phosphorylation on serine residues; when associated with A-170 and A-195.,MUTAGEN:S->A: Reduces phosphorylation on serine residues; when associated with A-178. Abolishes phosphorylation on serine residues; when associated with A-178 and A-195.,MUTAGEN:S->D: Abolishes interaction with MAD1L1 and reduces interaction with CDC20; when associated with D-170 and D-195.,MUTAGEN:S->D: Abolishes interaction with MAD1L1 and reduces interaction with CDC20; when associated with D-178 and D-195.,MUTAGEN:S->D: Binds to the N and C-terminus of MAD1L1. Abolishes interaction with MAD1L1 and reduces interaction with CDC20; when associated with D-170 and D-178.,MUTAGEN:T->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,MUTAGEN:V->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,MUTAGEN:W->A: Prevents interaction with CDC20 and leads to formation of the closed conformation; when associated with A-133.,MUTAGEN:Y->A: Leads to formation of the closed conformation; when associated with A-133.,MUTAGEN:Y->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,REGION:Required for assuming the closed conformation and for interaction with CDC20,
P26038	moesin(MSN)	Homo sapiens			GO:0001771~immunological synapse formation,GO:0007010~cytoskeleton organization,GO:0007159~leukocyte cell-cell adhesion,GO:0008360~regulation of cell shape,GO:0008361~regulation of cell size,GO:0010628~positive regulation of gene expression,GO:0022612~gland morphogenesis,GO:0022614~membrane to membrane docking,GO:0042098~T cell proliferation,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0045732~positive regulation of protein catabolic process,GO:0050900~leukocyte migration,GO:0061028~establishment of endothelial barrier,GO:0070489~T cell aggregation,GO:0071394~cellular response to testosterone stimulus,GO:0071803~positive regulation of podosome assembly,GO:0072678~T cell migration,GO:1902115~regulation of organelle assembly,GO:1902966~positive regulation of protein localization to early endosome,GO:2000401~regulation of lymphocyte migration,GO:2000643~positive regulation of early endosome to late endosome transport,	GO:0001931~uropod,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030175~filopodium,GO:0031143~pseudopodium,GO:0031528~microvillus membrane,GO:0031982~vesicle,GO:0042995~cell projection,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0071944~cell periphery,GO:0072562~blood microparticle,	GO:0003725~double-stranded RNA binding,GO:0003779~actin binding,GO:0005102~receptor binding,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0050839~cell adhesion molecule binding,	IPR000299:FERM_domain,IPR000798:Ez/rad/moesin-like,IPR008954:Moesin_tail_sf,IPR011174:ERM,IPR011259:ERM_C_dom,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019747:FERM_CS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR035963:FERM_2,IPR041789:ERM_FERM_C,IPR046810:ERM_helical,	hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,hsa05162:Measles,hsa05205:Proteoglycans in cancer,	300988~Immunodeficiency 50,	PIRSF002305:ERM,	SM00295:B41,SM01196:FERM_C,	KW-0945~Host-virus interaction,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0225~Disease variant,				KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0702~S-nitrosylation,	COMPBIAS:Basic and acidic residues,DOMAIN:FERM,MOTIF:[IL]-x-C-x-x-[DE] motif,MUTAGEN:E->M: Inhibits S-nitrosylation of Cys-117; when associated with M-115.,MUTAGEN:I->M: Inhibits S-nitrosylation of Cys-117; when associated with M-120.,MUTAGEN:T->A: Abolishes phosphorylation by STK10.,MUTAGEN:T->D: Completely abolishes the interaction between N- and C-terminal domains.,MUTAGEN:T->D: Phosphomimetic mutant.,MUTAGEN:Y->R: Impairs phosphorylation by STK10.,REGION:Disordered,
Q8IYA7	mohawk homeobox(MKX)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007517~muscle organ development,GO:0048468~cell development,	GO:0000785~chromatin,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,	IPR001356:Homeobox_dom,IPR008422:Homeobox_KN_domain,IPR009057:Homeobox-like_sf,IPR017970:Homeobox_CS,				SM00389:HOX,		KW-0539~Nucleus,			KW-0371~Homeobox,		KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DNA_BIND:Homeobox,DNA_BIND:Homeobox; TALE-type,DOMAIN:Homeobox,REGION:Disordered,
Q9NZB8	molybdenum cofactor synthesis 1(MOCS1)	Homo sapiens			GO:0006777~Mo-molybdopterin cofactor biosynthetic process,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0019008~molybdopterin synthase complex,	GO:0005525~GTP binding,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0061798~GTP 3',8'-cyclase activity,GO:0061799~cyclic pyranopterin monophosphate synthase activity,GO:1904047~S-adenosyl-L-methionine binding,	IPR000385:MoaA_NifB_PqqE_Fe-S-bd_CS,IPR002820:Mopterin_CF_biosynth-C_dom,IPR006638:Elp3/MiaA/NifB-like_rSAM,IPR007197:rSAM,IPR010505:MoaA_twitch,IPR013483:MoaA,IPR013785:Aldolase_TIM,IPR023045:MoaC,IPR036522:MoaC_sf,IPR047594:MoaC_bact/euk,	hsa00790:Folate biosynthesis,hsa01100:Metabolic pathways,hsa01240:Biosynthesis of cofactors,	252150~Molybdenum cofactor deficiency A,		SM00729:Elp3,	KW-0501~Molybdenum cofactor biosynthesis,			KW-0225~Disease variant,		KW-0004~4Fe-4S,KW-0342~GTP-binding,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0949~S-adenosyl-L-methionine,	KW-0456~Lyase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:For molybdenum cofactor biosynthesis protein C activity,COMPBIAS:Polar residues,DOMAIN:Molybdenum cofactor biosynthesis protein A-like twitch,DOMAIN:Radical SAM core,MUTAGEN:C->S: Impairs precursor Z synthesis.,REGION:Disordered,REGION:Molybdenum cofactor biosynthesis protein A,REGION:Molybdenum cofactor biosynthesis protein C,
O96033	molybdenum cofactor synthesis 2(MOCS2)	Homo sapiens			GO:0006777~Mo-molybdopterin cofactor biosynthetic process,GO:0032324~molybdopterin cofactor biosynthetic process,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0019008~molybdopterin synthase complex,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0030366~molybdopterin synthase activity,	IPR003448:Mopterin_biosynth_MoaE,IPR003749:ThiS/MoaD-like,IPR012675:Beta-grasp_dom_sf,IPR016155:Mopterin_synth/thiamin_S_b,IPR028887:MOCS2A_euk,IPR028888:MOCS2B_euk,IPR036563:MoaE_sf,IPR044672:MOCS2A,	hsa00790:Folate biosynthesis,hsa01100:Metabolic pathways,hsa01240:Biosynthesis of cofactors,hsa04122:Sulfur relay system,	252160~Molybdenum cofactor deficiency B,			KW-0501~Molybdenum cofactor biosynthesis,	KW-0963~Cytoplasm,		KW-0225~Disease variant,		KW-0547~Nucleotide-binding,	KW-0808~Transferase,	KW-0597~Phosphoprotein,
B5FXU9	molybdenum cofactor synthesis 2(MOCS2)	Taeniopygia guttata			GO:0006777~Mo-molybdopterin cofactor biosynthetic process,	GO:0005829~cytosol,GO:0019008~molybdopterin synthase complex,	GO:0000166~nucleotide binding,GO:0030366~molybdopterin synthase activity,	IPR003448:Mopterin_biosynth_MoaE,IPR003749:ThiS/MoaD-like,IPR012675:Beta-grasp_dom_sf,IPR016155:Mopterin_synth/thiamin_S_b,IPR028887:MOCS2A_euk,IPR028888:MOCS2B_euk,IPR036563:MoaE_sf,IPR044672:MOCS2A,	tgu00790:Folate biosynthesis,tgu01100:Metabolic pathways,tgu01240:Biosynthesis of cofactors,tgu04122:Sulfur relay system,				KW-0501~Molybdenum cofactor biosynthesis,	KW-0963~Cytoplasm,					KW-0808~Transferase,		REGION:Disordered,
Q2KHS5	monoacylglycerol O-acyltransferase 2, gene 2 L homeolog(mogat2.2.L)	Xenopus laevis			GO:0006071~glycerol metabolic process,GO:0006629~lipid metabolic process,GO:0006640~monoacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,GO:1990578~perinuclear endoplasmic reticulum membrane,	GO:0003846~2-acylglycerol O-acyltransferase activity,GO:0004144~diacylglycerol O-acyltransferase activity,GO:0008374~O-acyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR007130:DAGAT,	xla00561:Glycerolipid metabolism,xla01100:Metabolic pathways,				KW-0319~Glycerol metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0012~Acyltransferase,KW-0808~Transferase,		TRANSMEM:Helical,
P49253	monoamine oxidase(LOC100136729)	Oncorhynchus mykiss				GO:0005741~mitochondrial outer membrane,	GO:0008131~primary amine oxidase activity,GO:0016491~oxidoreductase activity,GO:0097621~monoamine oxidase activity,	IPR001613:Flavin_amine_oxidase,IPR002937:Amino_oxidase,IPR036188:FAD/NAD-bd_sf,	omy00260:Glycine, serine and threonine metabolism,omy00330:Arginine and proline metabolism,omy00340:Histidine metabolism,omy00350:Tyrosine metabolism,omy00360:Phenylalanine metabolism,omy00380:Tryptophan metabolism,omy00982:Drug metabolism - cytochrome P450,omy01100:Metabolic pathways,					KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,		SITE:Important for catalytic activity,TOPO_DOM:Cytoplasmic,TOPO_DOM:Mitochondrial intermembrane,TRANSMEM:Helical; Anchor for type IV membrane protein,
Q9CWP6	motile sperm domain containing 2(Mospd2)	Mus musculus			GO:0006935~chemotaxis,GO:0051260~protein homooligomerization,GO:0090023~positive regulation of neutrophil chemotaxis,GO:0090026~positive regulation of monocyte chemotaxis,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0044232~organelle membrane contact site,	GO:0033149~FFAT motif binding,	IPR000535:MSP_dom,IPR001251:CRAL-TRIO_dom,IPR008962:PapD-like_sf,IPR013783:Ig-like_fold,IPR036273:CRAL/TRIO_N_dom_sf,IPR036865:CRAL-TRIO_dom_sf,				SM00516:SEC14,	KW-0145~Chemotaxis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,DOMAIN:CRAL-TRIO,DOMAIN:MSP,REGION:Disordered,REGION:Required for FFAT motif binding and phosphorylated FFAT motif binding,SITE:Required for FFAT motif binding,SITE:Required for phosphorylated FFAT motif binding,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
A4IIK1	multifunctional ROCO family signaling regulator 1(mfhas1)	Xenopus tropicalis			GO:0002376~immune system process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0009966~regulation of signal transduction,GO:0045087~innate immune response,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0005525~GTP binding,	IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR020859:ROC_dom,IPR027417:P-loop_NTPase,IPR032171:COR,IPR032675:LRR_dom_sf,IPR036388:WH-like_DNA-bd_sf,				SM00364:LRR_BAC,SM00369:LRR_TYP,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,	KW-0963~Cytoplasm,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			DOMAIN:Roc,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
D4ABL6	multiple C2 and transmembrane domain containing 1(Mctp1)	Rattus norvegicus			GO:0030336~negative regulation of cell migration,GO:0045806~negative regulation of endocytosis,GO:0046928~regulation of neurotransmitter secretion,GO:0048168~regulation of neuronal synaptic plasticity,GO:1902883~negative regulation of response to oxidative stress,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0030672~synaptic vesicle membrane,GO:0055037~recycling endosome,	GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR035892:C2_domain_sf,				SM00239:C2,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0770~Synapse,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,			COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:C2 3,REGION:Disordered,TRANSMEM:Helical,
Q6DN12	multiple C2 and transmembrane domain containing 2(MCTP2)	Homo sapiens			GO:0019722~calcium-mediated signaling,GO:0046928~regulation of neurotransmitter secretion,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030672~synaptic vesicle membrane,	GO:0005509~calcium ion binding,	IPR000008:C2_dom,IPR013583:MCTP_C,IPR035892:C2_domain_sf,				SM00239:C2,		KW-0472~Membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:C2 3,REGION:Disordered,TRANSMEM:Helical,
Q80V70	multiple EGF-like-domains 6(Megf6)	Mus musculus				GO:0005576~extracellular region,	GO:0005044~scavenger receptor activity,GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR002049:LE_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR011489:EMI_domain,IPR013032:EGF-like_CS,IPR013111:EGF_extracell,IPR018097:EGF_Ca-bd_CS,IPR026823:cEGF,IPR042635:MEGF10/SREC1/2-like,				SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,		KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like 10,DOMAIN:EGF-like 11,DOMAIN:EGF-like 12,DOMAIN:EGF-like 13,DOMAIN:EGF-like 14,DOMAIN:EGF-like 15,DOMAIN:EGF-like 16,DOMAIN:EGF-like 17,DOMAIN:EGF-like 18,DOMAIN:EGF-like 19,DOMAIN:EGF-like 1; calcium-binding,DOMAIN:EGF-like 20,DOMAIN:EGF-like 21,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,DOMAIN:EGF-like 9,DOMAIN:EMI,
O43347	musashi RNA binding protein 1(MSI1)	Homo sapiens			GO:0006417~regulation of translation,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0009725~response to hormone,GO:0030855~epithelial cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005844~polysome,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008266~poly(U) RNA binding,GO:0042802~identical protein binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034126:MSI_RRM2,IPR035979:RBD_domain_sf,	hsa03015:mRNA surveillance pathway,			SM00360:RRM,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,
Q96LU7	myelin regulatory factor like(MYRFL)	Homo sapiens			GO:0016540~protein autoprocessing,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR008967:p53-like_TF_DNA-bd_sf,IPR024061:NDT80_DNA-bd_dom,IPR025719:MYRF_C2,IPR026932:MYRF_ICA,IPR030392:S74_ICA,IPR037141:NDT80_DNA-bd_dom_sf,						KW-0472~Membrane,			KW-0175~Coiled coil,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0238~DNA-binding,		COMPBIAS:Polar residues,DNA_BIND:NDT80,DOMAIN:Myelin gene regulatory factor C-terminal,DOMAIN:Myelin gene regulatory factor ICA,DOMAIN:NDT80,DOMAIN:Peptidase S74,REGION:Disordered,TRANSMEM:Helical,
Q9CPT4	myeloid derived growth factor(Mydgf)	Mus musculus			GO:0001525~angiogenesis,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0006915~apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051897~positive regulation of protein kinase B signaling,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,		IPR018887:MYDGF,					KW-0037~Angiogenesis,KW-0053~Apoptosis,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0964~Secreted,			KW-0732~Signal,
Q63ZU3	myeloid-associated differentiation marker L homeolog(myadm.L)	Xenopus laevis				GO:0016020~membrane,		IPR008253:Marvel,IPR047123:MYADM-like,						KW-0472~Membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:MARVEL,DOMAIN:MARVEL 1,DOMAIN:MARVEL 2,TRANSMEM:Helical,
Q4V8T0	myo-inositol oxygenase(miox)	Danio rerio			GO:0019310~inositol catabolic process,	GO:0005737~cytoplasm,	GO:0005506~iron ion binding,GO:0008199~ferric iron binding,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0050113~inositol oxygenase activity,	IPR007828:Inositol_oxygenase,	dre00053:Ascorbate and aldarate metabolism,dre00562:Inositol phosphate metabolism,dre01100:Metabolic pathways,dre01250:Biosynthesis of nucleotide sugars,					KW-0963~Cytoplasm,				KW-0408~Iron,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,
Q9NZM1	myoferlin(MYOF)	Homo sapiens			GO:0001778~plasma membrane repair,GO:0006936~muscle contraction,GO:0008015~blood circulation,GO:0046928~regulation of neurotransmitter secretion,	GO:0005635~nuclear envelope,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0030672~synaptic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031965~nuclear membrane,GO:0034451~centriolar satellite,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,	IPR000008:C2_dom,IPR006614:Peroxin/Ferlin,IPR012560:Ferlin_A-domain,IPR012561:Ferlin_B-domain,IPR012968:FerIin_dom,IPR032362:Ferlin_C,IPR035892:C2_domain_sf,IPR037720:C2B_Ferlin,IPR037721:Ferlin,IPR037722:C2C_Ferlin,IPR037723:C2D_Ferlin,IPR037724:C2E_Ferlin,IPR037725:C2F_Ferlin,IPR037726:C2A_Ferlin,		619366~Angioedema, hereditary, 7,		SM00239:C2,SM00693:DysFN,SM00694:DysFC,SM01200:FerA,SM01201:FerB,SM01202:FerI,		KW-0472~Membrane,KW-0539~Nucleus,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:C2 3,DOMAIN:C2 4,DOMAIN:C2 5,DOMAIN:C2 6,DOMAIN:C2 7,MUTAGEN:NPF->SPL: Reduces interaction with EHD2.,REGION:Disordered,REGION:Necessary for interaction with EHD2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O43795	myosin IB(MYO1B)	Homo sapiens			GO:0006892~post-Golgi vesicle-mediated transport,GO:0006897~endocytosis,GO:0007015~actin filament organization,GO:0030048~actin filament-based movement,GO:0030050~vesicle transport along actin filament,GO:0051017~actin filament bundle assembly,	GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005903~brush border,GO:0010008~endosome membrane,GO:0015629~actin cytoskeleton,GO:0016459~myosin complex,GO:0030175~filopodium,GO:0031982~vesicle,GO:0032588~trans-Golgi network membrane,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0071944~cell periphery,	GO:0000146~microfilament motor activity,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0045296~cadherin binding,GO:0051015~actin filament binding,	IPR000048:IQ_motif_EF-hand-BS,IPR001609:Myosin_head_motor_dom,IPR010926:Myosin_TH1,IPR011993:PH-like_dom_sf,IPR027417:P-loop_NTPase,IPR036072:MYSc_Myo1,IPR036961:Kinesin_motor_dom_sf,	hsa04814:Motor proteins,hsa05130:Pathogenic Escherichia coli infection,			SM00015:IQ,SM00242:MYSc,					KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0009~Actin-binding,KW-0112~Calmodulin-binding,KW-0505~Motor protein,KW-0518~Myosin,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:IQ 1,DOMAIN:IQ 2,DOMAIN:IQ 3,DOMAIN:IQ 4,DOMAIN:IQ 5,DOMAIN:IQ 6,DOMAIN:Myosin motor,DOMAIN:TH1,REGION:Actin-binding,
Q8WXR4	myosin IIIB(MYO3B)	Homo sapiens			GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0030832~regulation of actin filament length,GO:0050896~response to stimulus,GO:0051491~positive regulation of filopodium assembly,GO:0090103~cochlea morphogenesis,	GO:0001917~photoreceptor inner segment,GO:0005737~cytoplasm,GO:0016459~myosin complex,GO:0032426~stereocilium tip,GO:0032433~filopodium tip,	GO:0000146~microfilament motor activity,GO:0003774~motor activity,GO:0003779~actin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000048:IQ_motif_EF-hand-BS,IPR000719:Prot_kinase_dom,IPR001609:Myosin_head_motor_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR027417:P-loop_NTPase,IPR036083:MYSc_Myo3,IPR036961:Kinesin_motor_dom_sf,	hsa04814:Motor proteins,			SM00015:IQ,SM00220:S_TKc,SM00242:MYSc,	KW-0716~Sensory transduction,KW-0844~Vision,KW-1009~Hearing,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0009~Actin-binding,KW-0418~Kinase,KW-0505~Motor protein,KW-0518~Myosin,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,		ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:IQ 1,DOMAIN:IQ 2,DOMAIN:Myosin motor,DOMAIN:Protein kinase,REGION:Actin-binding,REGION:Disordered,
Q90339	myosin heavy chain, fast skeletal muscle-like(LOC109084063)	Cyprinus carpio			GO:0048731~system development,	GO:0016459~myosin complex,GO:0030016~myofibril,GO:0032982~myosin filament,	GO:0003774~motor activity,GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0051015~actin filament binding,	IPR000048:IQ_motif_EF-hand-BS,IPR001609:Myosin_head_motor_dom,IPR002928:Myosin_tail,IPR004009:Myosin_N,IPR008989:Myosin_S1_N,IPR014751:XRCC4-like_C,IPR027417:P-loop_NTPase,IPR036961:Kinesin_motor_dom_sf,				SM00242:MYSc,		KW-0787~Thick filament,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0009~Actin-binding,KW-0112~Calmodulin-binding,KW-0505~Motor protein,KW-0514~Muscle protein,KW-0518~Myosin,	KW-0488~Methylation,	COMPBIAS:Polar residues,DOMAIN:IQ,DOMAIN:Myosin N-terminal SH3-like,DOMAIN:Myosin motor,REGION:Actin-binding,REGION:Disordered,REGION:Hinge,
Q28824	myosin light chain kinase(MYLK)	Bos taurus			GO:0006468~protein phosphorylation,GO:0014820~tonic smooth muscle contraction,GO:0016310~phosphorylation,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0030027~lamellipodium,GO:0032154~cleavage furrow,	GO:0003779~actin binding,GO:0004687~myosin light chain kinase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR015725:MLCK1_kinase_dom,IPR017441:Protein_kinase_ATP_BS,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,	bta04020:Calcium signaling pathway,bta04022:cGMP-PKG signaling pathway,bta04270:Vascular smooth muscle contraction,bta04371:Apelin signaling pathway,bta04510:Focal adhesion,bta04611:Platelet activation,bta04810:Regulation of actin cytoskeleton,bta04921:Oxytocin signaling pathway,bta04971:Gastric acid secretion,			SM00060:FN3,SM00220:S_TKc,SM00408:IGc2,SM00409:IG,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0009~Actin-binding,KW-0112~Calmodulin-binding,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Protein kinase,REGION:16 X 12 AA tandem repeats,REGION:Actin-binding (calcium/calmodulin-insensitive),REGION:Actin-binding (calcium/calmodulin-sensitive),REGION:Calmodulin-binding,REGION:Disordered,REPEAT:1,REPEAT:10,REPEAT:11,REPEAT:12,REPEAT:13,REPEAT:14,REPEAT:15,REPEAT:16,REPEAT:2,REPEAT:3,REPEAT:4,REPEAT:5,REPEAT:6,REPEAT:7,REPEAT:8,REPEAT:9,
P10587	myosin, heavy chain 11, smooth muscle(MYH11)	Gallus gallus			GO:0006939~smooth muscle contraction,GO:0030239~myofibril assembly,GO:0030241~skeletal muscle myosin thick filament assembly,GO:0031032~actomyosin structure organization,GO:0048251~elastic fiber assembly,GO:0055013~cardiac muscle cell development,	GO:0005737~cytoplasm,GO:0005859~muscle myosin complex,GO:0016459~myosin complex,GO:0016460~myosin II complex,GO:0030016~myofibril,GO:0032982~myosin filament,	GO:0000146~microfilament motor activity,GO:0000287~magnesium ion binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008307~structural constituent of muscle,GO:0032027~myosin light chain binding,GO:0043531~ADP binding,GO:0045159~myosin II binding,GO:0051015~actin filament binding,	IPR000048:IQ_motif_EF-hand-BS,IPR001609:Myosin_head_motor_dom,IPR002928:Myosin_tail,IPR004009:Myosin_N,IPR008989:Myosin_S1_N,IPR014751:XRCC4-like_C,IPR027417:P-loop_NTPase,IPR036961:Kinesin_motor_dom_sf,	gga04270:Vascular smooth muscle contraction,gga04530:Tight junction,gga04810:Regulation of actin cytoskeleton,gga04814:Motor proteins,			SM00015:IQ,SM00242:MYSc,		KW-0787~Thick filament,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0009~Actin-binding,KW-0112~Calmodulin-binding,KW-0505~Motor protein,KW-0514~Muscle protein,KW-0518~Myosin,	KW-0488~Methylation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:IQ,DOMAIN:Myosin N-terminal SH3-like,DOMAIN:Myosin motor,REGION:Actin-binding,REGION:Disordered,REGION:Rodlike tail (S2 and LMM domains),
Q13496	myotubularin 1(MTM1)	Homo sapiens			GO:0000045~autophagosome assembly,GO:0006470~protein dephosphorylation,GO:0006661~phosphatidylinositol biosynthetic process,GO:0007005~mitochondrion organization,GO:0008333~endosome to lysosome transport,GO:0015031~protein transport,GO:0016311~dephosphorylation,GO:0031929~TOR signaling,GO:0032007~negative regulation of TOR signaling,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043491~protein kinase B signaling,GO:0044088~regulation of vacuole organization,GO:0045109~intermediate filament organization,GO:0046716~muscle cell cellular homeostasis,GO:0046856~phosphatidylinositol dephosphorylation,GO:0048311~mitochondrion distribution,GO:0048630~skeletal muscle tissue growth,GO:0048633~positive regulation of skeletal muscle tissue growth,GO:0051898~negative regulation of protein kinase B signaling,GO:0070584~mitochondrion morphogenesis,GO:1902902~negative regulation of autophagosome assembly,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030175~filopodium,GO:0031674~I band,	GO:0004438~phosphatidylinositol-3-phosphatase activity,GO:0004721~phosphoprotein phosphatase activity,GO:0005515~protein binding,GO:0019215~intermediate filament binding,GO:0035091~phosphatidylinositol binding,GO:0052629~phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,	IPR000387:Tyr_Pase_dom,IPR003595:Tyr_Pase_cat,IPR004182:GRAM,IPR010569:Myotubularin-like_Pase_dom,IPR011993:PH-like_dom_sf,IPR016130:Tyr_Pase_AS,IPR029021:Prot-tyrosine_phosphatase-like,IPR030564:Myotubularin_fam,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,	Myopathy, centronuclear, X-linked 310400~Myopathy, centronuclear, X-linked 310400,		SM00404:PTPc_motif,SM00568:GRAM,	KW-0443~Lipid metabolism,KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0967~Endosome,KW-1003~Cell membrane,		KW-0225~Disease variant,			KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:GRAM,DOMAIN:Myotubularin phosphatase,DOMAIN:Tyrosine specific protein phosphatases,MUTAGEN:C->A: No effect on subcellular location.,MUTAGEN:C->S: Lacks activity toward PI3P. Does not affect interaction with DES or MTMR12.,MUTAGEN:D->A: Does not affect interaction with DES.,MUTAGEN:D->A: Localizes to plasma membrane extensions. Does not affect interaction with DES.,MUTAGEN:D->A: No effect on subcellular location.,MUTAGEN:D->A: Produces an unstable protein.,MUTAGEN:E->A: Produces an unstable protein.,MUTAGEN:H->A: Disrupts interaction with DES. Does not affect lipid phosphatase activity.,MUTAGEN:K->A: Disrupts interaction with DES.,MUTAGEN:K->A: Disrupts interaction with DES. Does not affect lipid phosphatase activity.,MUTAGEN:K->A: Reduced response to PI5P.,MUTAGEN:Missing: Reduces MTMR12 protein levels in myotubes.,MUTAGEN:R->A: Loss of activity.,MUTAGEN:S->A: Disrupts interaction with DES. Does not affect lipid phosphatase activity.,MUTAGEN:S->D: Does not affect interaction with DES.,MUTAGEN:Y->A: Disrupts interaction with DES. Does not affect lipid phosphatase activity.,REGION:Disordered,
A2BGG1	myotubularin related protein 12(mtmr12)	Danio rerio			GO:0007626~locomotory behavior,GO:0048741~skeletal muscle fiber development,	GO:0005737~cytoplasm,GO:0016529~sarcoplasmic reticulum,GO:0030017~sarcomere,		IPR010569:Myotubularin-like_Pase_dom,IPR011993:PH-like_dom_sf,IPR022587:MTMR12-like_C,IPR029021:Prot-tyrosine_phosphatase-like,IPR030564:Myotubularin_fam,						KW-0703~Sarcoplasmic reticulum,KW-0963~Cytoplasm,							DOMAIN:Myotubularin phosphatase,REGION:Disordered,
A7MB43	myotubularin related protein 9(MTMR9)	Bos taurus			GO:0010507~negative regulation of autophagy,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0032587~ruffle membrane,GO:0048471~perinuclear region of cytoplasm,		IPR010569:Myotubularin-like_Pase_dom,IPR011993:PH-like_dom_sf,IPR029021:Prot-tyrosine_phosphatase-like,IPR030564:Myotubularin_fam,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:GRAM,DOMAIN:Myotubularin phosphatase,
Q5RFA0	negative elongation factor complex member C/D(NELFCD)	Pongo abelii			GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0032021~NELF complex,	GO:0003723~RNA binding,	IPR006942:TH1,	pon03250:Viral life cycle - HIV-1,				KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0678~Repressor,KW-0694~RNA-binding,		COMPBIAS:Acidic residues,REGION:Disordered,
Q6AXL3	negative regulator of reactive oxygen species(nrros)	Danio rerio			GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0014005~microglia development,GO:0035583~sequestering of TGFbeta in extracellular matrix,GO:0036364~transforming growth factor beta1 activation,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0019838~growth factor binding,	IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR026906:LRR_5,IPR032675:LRR_dom_sf,	dre04350:TGF-beta signaling pathway,			SM00364:LRR_BAC,SM00369:LRR_TYP,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0340~Growth factor binding,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (with C-? in TGFB1); in linked form,DOMAIN:LRRCT,DOMAIN:LRRNT,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 18,REPEAT:LRR 19,REPEAT:LRR 2,REPEAT:LRR 20,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
B0DOB4	nephronophthisis 4, gene 2 L homeolog(nphp4.2.L)	Xenopus laevis			GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0097730~non-motile cilium,		IPR029775:NPHP4,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,							COMPBIAS:Basic and acidic residues,REGION:Disordered,REGION:Sufficient for basal bodies localization,
Q96CW9	netrin G2(NTNG2)	Homo sapiens			GO:0007409~axonogenesis,GO:0010975~regulation of neuron projection development,GO:0050804~modulation of synaptic transmission,GO:0099560~synaptic membrane adhesion,GO:1905606~regulation of presynapse assembly,GO:2001222~regulation of neuron migration,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0030424~axon,GO:0048787~presynaptic active zone membrane,GO:0098552~side of membrane,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,	IPR000742:EGF-like_dom,IPR002049:LE_dom,IPR008211:Laminin_N,	hsa04360:Axon guidance,hsa04514:Cell adhesion molecules,	618718~Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia,		SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0991~Intellectual disability,KW-1268~Autism spectrum disorder,	KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Laminin EGF-like 1,DOMAIN:Laminin EGF-like 2,DOMAIN:Laminin EGF-like 3,DOMAIN:Laminin N-terminal,LIPID:GPI-anchor amidated glycine,PROPEP:Removed in mature form,REGION:NGL discriminant loop I,REGION:NGL discriminant loop II,REGION:NGL discriminant loop III,
O76050	neuralized E3 ubiquitin protein ligase 1(NEURL1)	Homo sapiens			GO:0006417~regulation of translation,GO:0006513~protein monoubiquitination,GO:0007219~Notch signaling pathway,GO:0007288~sperm axoneme assembly,GO:0007399~nervous system development,GO:0007519~skeletal muscle tissue development,GO:0007595~lactation,GO:0008285~negative regulation of cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0045746~negative regulation of Notch signaling pathway,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0051491~positive regulation of filopodium assembly,GO:0060999~positive regulation of dendritic spine development,GO:0071230~cellular response to amino acid stimulus,GO:0090129~positive regulation of synapse maturation,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0048471~perinuclear region of cytoplasm,GO:0097440~apical dendrite,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0045183~translation factor activity, non-nucleic acid binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR006573:NHR_dom,IPR013083:Znf_RING/FYVE/PHD,IPR037962:Neuralized,IPR043136:B30.2/SPRY_sf,				SM00588:NEUZ,	KW-0810~Translation regulation,KW-0833~Ubl conjugation pathway,KW-0914~Notch signaling pathway,	KW-0472~Membrane,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0043~Tumor suppressor,	KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0449~Lipoprotein,KW-0519~Myristate,	DOMAIN:NHR,DOMAIN:NHR 1,DOMAIN:NHR 2,DOMAIN:RING-type,LIPID:N-myristoyl glycine,REGION:Disordered,ZN_FING:RING-type,
Q0MW30	neuralized E3 ubiquitin protein ligase 1B(Neurl1b)	Mus musculus			GO:0007219~Notch signaling pathway,GO:0016567~protein ubiquitination,GO:0070086~ubiquitin-dependent endocytosis,	GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,	GO:0005515~protein binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR006573:NHR_dom,IPR013083:Znf_RING/FYVE/PHD,IPR037962:Neuralized,IPR043136:B30.2/SPRY_sf,				SM00588:NEUZ,	KW-0833~Ubl conjugation pathway,KW-0914~Notch signaling pathway,	KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:NHR,DOMAIN:NHR 1,DOMAIN:NHR 2,DOMAIN:RING-type,REGION:Disordered,ZN_FING:RING-type,
O35569	neuregulin 2(Nrg2)	Rattus norvegicus			GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007399~nervous system development,GO:0035556~intracellular signal transduction,GO:0038130~ERBB4 signaling pathway,GO:0038133~ERBB2-ERBB3 signaling pathway,GO:0038138~ERBB4-ERBB4 signaling pathway,GO:0048513~animal organ development,GO:0051963~regulation of synapse assembly,GO:0090128~regulation of synapse maturation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,	GO:0005006~epidermal growth factor-activated receptor activity,GO:0005102~receptor binding,GO:0005154~epidermal growth factor receptor binding,GO:0008083~growth factor activity,GO:0043125~ErbB-3 class receptor binding,GO:0048018~receptor agonist activity,GO:1990631~ErbB-4 class receptor binding,	IPR000742:EGF-like_dom,IPR002154:Neuregulin_C,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR040180:Neuregulin,	rno01521:EGFR tyrosine kinase inhibitor resistance,rno04012:ErbB signaling pathway,rno05014:Amyotrophic lateral sclerosis,			SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0393~Immunoglobulin domain,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0339~Growth factor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:EGF-like,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Note=Internal signal sequence,
A1XQX0	neurexin 1a(nrxn1a)	Danio rerio			GO:0002040~sprouting angiogenesis,GO:0007155~cell adhesion,GO:0048856~anatomical structure development,	GO:0016020~membrane,	GO:0046872~metal ion binding,	IPR000742:EGF-like_dom,IPR001791:Laminin_G,IPR003585:Neurexin-like,IPR013320:ConA-like_dom_sf,IPR027789:Syndecan/Neurexin_dom,	dre04514:Cell adhesion molecules,			SM00181:EGF,SM00282:LamG,SM00294:4.1m,	KW-0130~Cell adhesion,	KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:Laminin G,DOMAIN:Laminin G-like,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G-like 2,DOMAIN:Laminin G-like 3,DOMAIN:Laminin G-like 4,DOMAIN:Laminin G-like 5,DOMAIN:Laminin G-like 6,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q08BN9	neurexophilin and PC-esterase domain family, member 3(nxpe3)	Danio rerio				GO:0005576~extracellular region,		IPR014756:Ig_E-set,IPR026845:NXPH/NXPE,						KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,
A9JTH1	neurocalcin delta a(ncalda)	Danio rerio			GO:0019722~calcium-mediated signaling,		GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0015631~tubulin binding,GO:0046872~metal ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR028846:Recoverin,				SM00054:EFh,					KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0449~Lipoprotein,KW-0519~Myristate,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,LIPID:N-myristoyl glycine,
Q640K1	neurochondrin S homeolog(ncdn.S)	Xenopus laevis			GO:0031175~neuron projection development,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043025~neuronal cell body,GO:0045202~synapse,GO:0098794~postsynapse,		IPR008709:Neurochondrin,						KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,
Q7Z628	neuroepithelial cell transforming 1(NET1)	Homo sapiens			GO:0001558~regulation of cell growth,GO:0007165~signal transduction,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051451~myoblast migration,GO:0070301~cellular response to hydrogen peroxide,GO:0071479~cellular response to ionizing radiation,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000219:DH-domain,IPR001331:GDS_CDC24_CS,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR037853:Net1_PH,				SM00233:PH,SM00325:RhoGEF,		KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0656~Proto-oncogene,			KW-0344~Guanine-nucleotide releasing factor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:PH,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Necessary for nuclear localization,
P35331	neuronal cell adhesion molecule(NRCAM)	Gallus gallus			GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007158~neuron cell-cell adhesion,GO:0007411~axon guidance,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0045162~clustering of voltage-gated sodium channels,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0030424~axon,	GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0030506~ankyrin binding,GO:0046982~protein heterodimerization activity,GO:0050839~cell adhesion molecule binding,GO:0098632~protein binding involved in cell-cell adhesion,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR021623:LAP2alpha_C,IPR026966:Neurofascin/L1/NrCAM_C,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,	gga04514:Cell adhesion molecules,			SM00060:FN3,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9Z0J8	neuronal growth regulator 1(Negr1)	Rattus norvegicus			GO:0007155~cell adhesion,GO:0007626~locomotory behavior,GO:0007631~feeding behavior,GO:0010976~positive regulation of neuron projection development,GO:0031175~neuron projection development,GO:0051963~regulation of synapse assembly,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0098552~side of membrane,		IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,	rno04514:Cell adhesion molecules,			SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,LIPID:GPI-anchor amidated glycine,PROPEP:Removed in mature form,
P47971	neuronal pentraxin 1(Nptx1)	Rattus norvegicus			GO:0006839~mitochondrial transport,GO:0035865~cellular response to potassium ion,GO:0043653~mitochondrial fragmentation involved in apoptotic process,GO:0060385~axonogenesis involved in innervation,GO:0071333~cellular response to glucose stimulus,GO:0097107~postsynaptic density assembly,GO:0099645~neurotransmitter receptor localization to postsynaptic specialization membrane,	GO:0005783~endoplasmic reticulum,GO:0030133~transport vesicle,GO:0043083~synaptic cleft,GO:0098978~glutamatergic synapse,	GO:0046872~metal ion binding,	IPR001759:Pentraxin-related,IPR013320:ConA-like_dom_sf,IPR030476:Pentaxin_CS,				SM00159:PTX,		KW-0256~Endoplasmic reticulum,KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Pentraxin (PTX),REGION:Disordered,
Q8MJV4	neuropeptide B(NPB)	Bos taurus			GO:0007186~G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007631~feeding behavior,	GO:0005576~extracellular region,	GO:0001664~G-protein coupled receptor binding,	IPR013297:Neuropept_BW_pre,IPR013298:Neuropept_B_pre,	bta04080:Neuroactive ligand-receptor interaction,					KW-0964~Secreted,			KW-0732~Signal,		KW-0527~Neuropeptide,	KW-0102~Bromination,KW-0165~Cleavage on pair of basic residues,	PEPTIDE:Neuropeptide B-29,
Q8QFX6	neuropilin 1a(nrp1a)	Danio rerio			GO:0001525~angiogenesis,GO:0001570~vasculogenesis,GO:0001666~response to hypoxia,GO:0001755~neural crest cell migration,GO:0001775~cell activation,GO:0001944~vasculature development,GO:0002040~sprouting angiogenesis,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0007508~larval heart development,GO:0008045~motor neuron axon guidance,GO:0009611~response to wounding,GO:0010595~positive regulation of endothelial cell migration,GO:0030154~cell differentiation,GO:0030900~forebrain development,GO:0030947~regulation of vascular endothelial growth factor receptor signaling pathway,GO:0032101~regulation of response to external stimulus,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0045765~regulation of angiogenesis,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048538~thymus development,GO:0048675~axon extension,GO:0050770~regulation of axonogenesis,GO:0051216~cartilage development,GO:0051491~positive regulation of filopodium assembly,GO:0060055~angiogenesis involved in wound healing,GO:0071678~olfactory bulb axon guidance,GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis,GO:0090259~regulation of retinal ganglion cell axon guidance,	GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030424~axon,	GO:0005021~vascular endothelial growth factor-activated receptor activity,GO:0008201~heparin binding,GO:0017154~semaphorin receptor activity,GO:0038085~vascular endothelial growth factor binding,GO:0046872~metal ion binding,	IPR000421:FA58C,IPR000859:CUB_dom,IPR000998:MAM_dom,IPR008979:Galactose-bd-like_sf,IPR013320:ConA-like_dom_sf,IPR014648:Neuropilin,IPR022579:Neuropilin_C,IPR035914:Sperma_CUB_dom_sf,			PIRSF036960:Neuropilin,	SM00042:CUB,SM00137:MAM,SM00231:FA58C,	KW-0037~Angiogenesis,KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-0358~Heparin-binding,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0357~Heparan sulfate,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine; alternate,CARBOHYD:O-linked (Xyl...) (heparan sulfate) serine; alternate,DOMAIN:CUB,DOMAIN:CUB 1,DOMAIN:CUB 2,DOMAIN:F5/8 type C,DOMAIN:F5/8 type C 1,DOMAIN:F5/8 type C 2,DOMAIN:MAM,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9Y639	neuroplastin(NPTN)	Homo sapiens			GO:0001818~negative regulation of cytokine production,GO:0001934~positive regulation of protein phosphorylation,GO:0006874~cellular calcium ion homeostasis,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010976~positive regulation of neuron projection development,GO:0045743~positive regulation of fibroblast growth factor receptor signaling pathway,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0060291~long-term synaptic potentiation,GO:1902683~regulation of receptor localization to synapse,GO:1904861~excitatory synapse assembly,	GO:0001772~immunological synapse,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0042734~presynaptic membrane,	GO:0005105~type 1 fibroblast growth factor receptor binding,GO:0005515~protein binding,GO:0050839~cell adhesion molecule binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR037448:Zig-8,			PIRSF000615:TyrPK_CSF1-R,	SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like 1,DOMAIN:Ig-like 2,DOMAIN:Ig-like 3,REGION:Disordered,REGION:Narpin; mediates binding with FGFR1 and has antidepressant-like activity,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O77775	neutrophil cytosolic factor 2(NCF2)	Bos taurus			GO:0006909~phagocytosis,GO:0042554~superoxide anion generation,GO:0045730~respiratory burst,	GO:0005737~cytoplasm,GO:0043020~NADPH oxidase complex,	GO:0005515~protein binding,GO:0016176~superoxide-generating NADPH oxidase activator activity,	IPR000270:PB1_dom,IPR001440:TPR_1,IPR001452:SH3_domain,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR034885:PB1_P67,IPR034889:NCF2_SH3,IPR035546:p67phox_SH3_1,IPR036028:SH3-like_dom_sf,	bta04145:Phagosome,bta04380:Osteoclast differentiation,bta04613:Neutrophil extracellular trap formation,bta04670:Leukocyte transendothelial migration,bta05020:Prion disease,bta05140:Leishmaniasis,bta05208:Chemical carcinogenesis - reactive oxygen species,bta05415:Diabetic cardiomyopathy,bta05417:Lipid and atherosclerosis,bta05418:Fluid shear stress and atherosclerosis,			SM00028:TPR,SM00326:SH3,SM00666:PB1,		KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0728~SH3 domain,KW-0802~TPR repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:PB1,DOMAIN:SH3,DOMAIN:SH3 1,DOMAIN:SH3 2,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
P97369	neutrophil cytosolic factor 4(Ncf4)	Mus musculus			GO:0006909~phagocytosis,GO:0042554~superoxide anion generation,GO:0045730~respiratory burst,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0043020~NADPH oxidase complex,	GO:0005515~protein binding,GO:0008289~lipid binding,GO:0016176~superoxide-generating NADPH oxidase activator activity,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0035091~phosphatidylinositol binding,	IPR000270:PB1_dom,IPR000919:p40phox,IPR001452:SH3_domain,IPR001683:PX_dom,IPR034853:PB1_P40,IPR034912:PX_p40phox,IPR035541:p40phox_SH3,IPR036028:SH3-like_dom_sf,IPR036871:PX_dom_sf,	mmu04145:Phagosome,mmu04380:Osteoclast differentiation,mmu04613:Neutrophil extracellular trap formation,mmu04670:Leukocyte transendothelial migration,mmu05020:Prion disease,mmu05140:Leishmaniasis,mmu05415:Diabetic cardiomyopathy,mmu05417:Lipid and atherosclerosis,			SM00312:PX,SM00326:SH3,SM00666:PB1,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0728~SH3 domain,	KW-0446~Lipid-binding,		KW-0597~Phosphoprotein,	DOMAIN:PB1,DOMAIN:PX,DOMAIN:SH3,
Q9Z2J4	nexilin (F actin binding protein)(Nexn)	Rattus norvegicus			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007411~axon guidance,GO:0009617~response to bacterium,GO:0030334~regulation of cell migration,GO:0051493~regulation of cytoskeleton organization,GO:0070593~dendrite self-avoidance,	GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0030018~Z disc,GO:0030055~cell-substrate junction,GO:0030424~axon,	GO:0008307~structural constituent of muscle,GO:0051015~actin filament binding,GO:0098632~protein binding involved in cell-cell adhesion,	IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR043204:Basigin-like,				SM00409:IG,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0965~Cell junction,			KW-0175~Coiled coil,KW-0393~Immunoglobulin domain,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Ig-like,REGION:Disordered,
Q9NPI5	nicotinamide riboside kinase 2(NMRK2)	Homo sapiens			GO:0009435~NAD biosynthetic process,GO:0016310~phosphorylation,GO:0019674~NAD metabolic process,GO:0045662~negative regulation of myoblast differentiation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,GO:0050262~ribosylnicotinamide kinase activity,GO:0061769~ribosylnicotinate kinase activity,	IPR027417:P-loop_NTPase,	hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				KW-0662~Pyridine nucleotide biosynthesis,					KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		ACT_SITE:Proton acceptor,MUTAGEN:D->A: Loss of activity.,MUTAGEN:E->A: Loss of activity.,REGION:Disordered,
Q14112	nidogen 2(NID2)	Homo sapiens			GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0071711~basement membrane organization,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005518~collagen binding,	IPR000033:LDLR_classB_rpt,IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000716:Thyroglobulin_1,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR003886:NIDO_dom,IPR006605:G2_nidogen/fibulin_G2F,IPR009017:GFP,IPR009030:Growth_fac_rcpt_cys_sf,IPR011042:6-blade_b-propeller_TolB-like,IPR018097:EGF_Ca-bd_CS,IPR024731:EGF_dom,IPR026823:cEGF,IPR036857:Thyroglobulin_1_sf,				SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00211:TY,SM00539:NIDO,SM00682:G2F,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-0488~Methylation,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:NIDO,DOMAIN:Nidogen G2 beta-barrel,DOMAIN:Thyroglobulin type-1,DOMAIN:Thyroglobulin type-1 1,DOMAIN:Thyroglobulin type-1 2,REGION:Disordered,REPEAT:LDL-receptor class B,REPEAT:LDL-receptor class B 1,REPEAT:LDL-receptor class B 2,REPEAT:LDL-receptor class B 3,REPEAT:LDL-receptor class B 4,REPEAT:LDL-receptor class B 5,
Q8N4C6	ninein(NIN)	Homo sapiens			GO:0008104~protein localization,GO:0010457~centriole-centriole cohesion,GO:0021540~corpus callosum morphogenesis,GO:0021957~corticospinal tract morphogenesis,GO:0034454~microtubule anchoring at centrosome,GO:0048668~collateral sprouting,GO:0050772~positive regulation of axonogenesis,GO:0051642~centrosome localization,GO:0090222~centrosome-templated microtubule nucleation,	GO:0000242~pericentriolar material,GO:0000922~spindle pole,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005813~centrosome,GO:0005814~centriole,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0044295~axonal growth cone,GO:0045177~apical part of cell,GO:0072686~mitotic spindle,GO:0097431~mitotic spindle pole,GO:0097539~ciliary transition fiber,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019900~kinase binding,GO:0051011~microtubule minus-end binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,		614851~Seckel syndrome 7,				KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0242~Dwarfism,KW-0991~Intellectual disability,	KW-0175~Coiled coil,KW-0677~Repeat,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0597~Phosphoprotein,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,DOMAIN:EF-hand 5,REGION:Disordered,REGION:Important for interaction with CEP170,
O55125	nipsnap homolog 1(Nipsnap1)	Mus musculus			GO:0019233~sensory perception of pain,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0097060~synaptic membrane,	GO:0005515~protein binding,	IPR011008:Dimeric_a/b-barrel,IPR012577:NIPSNAP,												KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:NIPSNAP,
Q9PU58	nipsnap homolog 2(nipsnap2)	Danio rerio				GO:0005737~cytoplasm,GO:0005739~mitochondrion,		IPR011008:Dimeric_a/b-barrel,IPR012577:NIPSNAP,						KW-0963~Cytoplasm,
Q5RAA9	nipsnap homolog 3A(NIPSNAP3A)	Pongo abelii				GO:0005739~mitochondrion,GO:0005829~cytosol,		IPR011008:Dimeric_a/b-barrel,IPR012577:NIPSNAP,						KW-0963~Cytoplasm,			KW-0732~Signal,			KW-0007~Acetylation,	DOMAIN:NIPSNAP,
Q4VBV9	nitrilase family, member 2(nit2)	Danio rerio			GO:0006107~oxaloacetate metabolic process,GO:0006528~asparagine metabolic process,GO:0006541~glutamine metabolic process,GO:0006807~nitrogen compound metabolic process,	GO:0005737~cytoplasm,	GO:0016787~hydrolase activity,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0050152~omega-amidase activity,	IPR003010:C-N_Hydrolase,IPR036526:C-N_Hydrolase_sf,IPR045254:Nit1/2_C-N_Hydrolase,	dre00250:Alanine, aspartate and glutamate metabolism,dre01100:Metabolic pathways,					KW-0963~Cytoplasm,					KW-0378~Hydrolase,		ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,DOMAIN:CN hydrolase,
Q9Z1J3	nitrogen fixation gene 1 (S. cerevisiae)(Nfs1)	Mus musculus			GO:0006777~Mo-molybdopterin cofactor biosynthetic process,GO:0016226~iron-sulfur cluster assembly,GO:0018283~iron incorporation into metallo-sulfur cluster,GO:0032324~molybdopterin cofactor biosynthetic process,GO:0043545~molybdopterin cofactor metabolic process,GO:0044571~[2Fe-2S] cluster assembly,GO:0044572~[4Fe-4S] cluster assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005813~centrosome,GO:0005829~cytosol,GO:0099128~mitochondrial iron-sulfur cluster assembly complex,GO:1990229~iron-sulfur cluster assembly complex,	GO:0016740~transferase activity,GO:0030170~pyridoxal phosphate binding,GO:0031071~cysteine desulfurase activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,	IPR000192:Aminotrans_V_dom,IPR010240:Cys_deSase_IscS,IPR015421:PyrdxlP-dep_Trfase_major,IPR015422:PyrdxlP-dep_Trfase_small,IPR015424:PyrdxlP-dep_Trfase,IPR016454:Cysteine_dSase,IPR020578:Aminotrans_V_PyrdxlP_BS,	mmu00730:Thiamine metabolism,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,mmu04122:Sulfur relay system,		PIRSF005572:NifS,		KW-0501~Molybdenum cofactor biosynthesis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,KW-0663~Pyridoxal phosphate,KW-0862~Zinc,	KW-0808~Transferase,		ACT_SITE:Cysteine persulfide intermediate,BINDING:via persulfide group,DOMAIN:Aminotransferase class V,TRANSIT:Mitochondrion,
Q9YHY6	non-SMC condensin I complex subunit D2 S homeolog(ncapd2.S)	Xenopus laevis			GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0007076~mitotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR007673:Condensin_cplx_su1,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR024324:Condensin_cplx_su1_N,IPR026971:CND1/NCAPD3,IPR032682:Cnd1_C,			PIRSF017127:Condensin_D2,		KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Condensin complex subunit 1 C-terminal,DOMAIN:Condensin complex subunit 1 N-terminal,MOTIF:Bipartite nuclear localization signal,REGION:Disordered,REGION:Interaction with XCAP-E and XCAP-C,
Q9YHB5	non-SMC condensin I complex subunit G L homeolog(ncapg.L)	Xenopus laevis			GO:0007049~cell cycle,GO:0007076~mitotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051301~cell division,	GO:0000796~condensin complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,		IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR025977:Cnd3_C,IPR027165:CND3,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,DOMAIN:Nuclear condensin complex subunit 3 C-terminal,REGION:Disordered,REPEAT:HEAT 1,REPEAT:HEAT 10,REPEAT:HEAT 2,REPEAT:HEAT 3,REPEAT:HEAT 4,REPEAT:HEAT 5,REPEAT:HEAT 6,REPEAT:HEAT 7,REPEAT:HEAT 8,REPEAT:HEAT 9,
O13067	non-SMC condensin I complex subunit H S homeolog(ncaph.S)	Xenopus laevis			GO:0007049~cell cycle,GO:0007076~mitotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051301~cell division,	GO:0000796~condensin complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,		IPR022816:Condensin_barren_su2,			PIRSF017126:Condensin_H,		KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,	REGION:Disordered,
Q6GN08	non-SMC condensin II complex subunit D3 L homeolog(ncapd3.L)	Xenopus laevis			GO:0007049~cell cycle,GO:0007076~mitotic chromosome condensation,GO:0010032~meiotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051301~cell division,	GO:0000779~condensed chromosome, centromeric region,GO:0000796~condensin complex,GO:0005634~nucleus,	GO:0005515~protein binding,	IPR011989:ARM-like,IPR012371:NCAPD3,IPR016024:ARM-type_fold,IPR026971:CND1/NCAPD3,IPR032682:Cnd1_C,			PIRSF036508:Condns_HCP-6,		KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0539~Nucleus,			KW-0677~Repeat,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Condensin complex subunit 1 C-terminal,REGION:Disordered,REPEAT:HEAT 1,REPEAT:HEAT 2,REPEAT:HEAT 3,
Q2TAW0	non-SMC condensin II complex subunit G2 L homeolog(ncapg2.L)	Xenopus laevis			GO:0007049~cell cycle,GO:0030261~chromosome condensation,GO:0051301~cell division,	GO:0005634~nucleus,		IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR024741:Condensin2_G2,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0539~Nucleus,							COMPBIAS:Acidic residues,REGION:Disordered,REPEAT:HEAT,
Q5RH01	non-SMC condensin II complex, subunit H2(ncaph2)	Danio rerio			GO:0010032~meiotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051306~mitotic sister chromatid separation,	GO:0000796~condensin complex,GO:0005634~nucleus,	GO:0003682~chromatin binding,	IPR009378:H2_N,IPR031737:CNDH2_C,IPR031739:Ncaph2,					KW-0226~DNA condensation,	KW-0539~Nucleus,							REGION:Disordered,
Q5F2E7	nuclear FMR1 interacting protein 2(Nufip2)	Mus musculus				GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0010494~cytoplasmic stress granule,GO:0016604~nuclear body,GO:0042788~polysomal ribosome,	GO:0003723~RNA binding,	IPR032747:NUFIP2,						KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,
P49321	nuclear autoantigenic sperm protein(NASP)	Homo sapiens			GO:0001824~blastocyst development,GO:0006260~DNA replication,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0007049~cell cycle,GO:0008584~male gonad development,GO:0015031~protein transport,GO:0033574~response to testosterone,GO:0034080~CENP-A containing nucleosome assembly,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032991~macromolecular complex,	GO:0005515~protein binding,GO:0042393~histone binding,GO:0044877~macromolecular complex binding,	IPR011990:TPR-like_helical_dom_sf,IPR019544:Tetratricopeptide_SHNi-TPR_dom,IPR019734:TPR_repeat,				SM00028:TPR,	KW-0131~Cell cycle,KW-0235~DNA replication,KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),DOMAIN:Tetratricopeptide SHNi-TPR,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Histone-binding,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
Q2T9P4	nuclear autoantigenic sperm protein(NASP)	Bos taurus			GO:0001824~blastocyst development,GO:0006260~DNA replication,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0007049~cell cycle,GO:0015031~protein transport,GO:0034080~CENP-A containing nucleosome assembly,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0042393~histone binding,	IPR011990:TPR-like_helical_dom_sf,IPR019544:Tetratricopeptide_SHNi-TPR_dom,IPR019734:TPR_repeat,				SM00028:TPR,	KW-0131~Cell cycle,KW-0235~DNA replication,KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,KW-0802~TPR repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),DOMAIN:Tetratricopeptide SHNi-TPR,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Histone-binding,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
Q60591	nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2(Nfatc2)	Mus musculus		m_bcrPathway:BCR Signaling Pathway,m_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,m_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,m_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,m_gata3Pathway:GATA3 participate in activating the Th2 cytokine genes expression,m_gpcrPathway:Signaling Pathway from G-Protein Families,m_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),m_mef2dPathway:Role of MEF2D in T-cell Apoptosis,m_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),m_tcrPathway:T Cell Receptor Signaling Pathway,m_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001816~cytokine production,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006974~cellular response to DNA damage stimulus,GO:0009410~response to xenobiotic stimulus,GO:0010035~response to inorganic substance,GO:0010467~gene expression,GO:0010628~positive regulation of gene expression,GO:0014904~myotube cell development,GO:0016477~cell migration,GO:0030890~positive regulation of B cell proliferation,GO:0033173~calcineurin-NFAT signaling cascade,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050853~B cell receptor signaling pathway,GO:0051216~cartilage development,GO:0071277~cellular response to calcium ion,GO:0098781~ncRNA transcription,GO:1901741~positive regulation of myoblast fusion,GO:1905064~negative regulation of vascular smooth muscle cell differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0035976~transcription factor AP-1 complex,GO:1990904~ribonucleoprotein complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019902~phosphatase binding,GO:0043565~sequence-specific DNA binding,GO:0060090~binding, bridging,GO:0071889~14-3-3 protein binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR002909:IPT_dom,IPR008366:NFAT,IPR008967:p53-like_TF_DNA-bd_sf,IPR011539:RHD_DNA_bind_dom,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR032397:RHD_dimer,IPR037059:RHD_DNA_bind_dom_sf,	mmu04020:Calcium signaling pathway,mmu04022:cGMP-PKG signaling pathway,mmu04148:Efferocytosis,mmu04218:Cellular senescence,mmu04310:Wnt signaling pathway,mmu04360:Axon guidance,mmu04370:VEGF signaling pathway,mmu04380:Osteoclast differentiation,mmu04625:C-type lectin receptor signaling pathway,mmu04650:Natural killer cell mediated cytotoxicity,mmu04658:Th1 and Th2 cell differentiation,mmu04659:Th17 cell differentiation,mmu04660:T cell receptor signaling pathway,mmu04662:B cell receptor signaling pathway,mmu04921:Oxytocin signaling pathway,mmu05135:Yersinia infection,mmu05161:Hepatitis B,mmu05163:Human cytomegalovirus infection,mmu05166:Human T-cell leukemia virus 1 infection,mmu05167:Kaposi sarcoma-associated herpesvirus infection,mmu05170:Human immunodeficiency virus 1 infection,mmu05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,mmu05417:Lipid and atherosclerosis,			SM00429:IPT,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:RHD,MOTIF:Nuclear localization signal,MUTAGEN:E->A: Decrease in binding to DNA.,MUTAGEN:E->A: Lowers dephosphorylation.,MUTAGEN:H->A: No change in binding to DNA.,MUTAGEN:R->A: Decrease in binding to DNA.,MUTAGEN:R->A: Induces aberrant nuclear localization of the phosphorylated form.,MUTAGEN:R->A: Lowers dephosphorylation.,MUTAGEN:T->A: No change in binding to DNA.,MUTAGEN:T->A: No dephosphorylation.,MUTAGEN:T->C: No change in binding to DNA and confers DNA-binding sensitivity to sulfhydryl modifications.,MUTAGEN:Y->A: Decrease in binding to DNA.,REGION:3 X approximate SP repeats,REGION:Calcineurin-binding,REGION:Disordered,REGION:Required for cytoplasmic retention of the phosphorylated form,REGION:Transactivation domain A (TAD-A),REPEAT:1,REPEAT:2,REPEAT:3; approximate,
D3Z9H7	nuclear factor of activated T-cells 4(Nfatc4)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001569~branching involved in blood vessel morphogenesis,GO:0001816~cytokine production,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0007616~long-term memory,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0030178~negative regulation of Wnt signaling pathway,GO:0031547~brain-derived neurotrophic factor receptor signaling pathway,GO:0032760~positive regulation of tumor necrosis factor production,GO:0033173~calcineurin-NFAT signaling cascade,GO:0034644~cellular response to UV,GO:0035886~vascular smooth muscle cell differentiation,GO:0043524~negative regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0045333~cellular respiration,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048167~regulation of synaptic plasticity,GO:0048813~dendrite morphogenesis,GO:0050774~negative regulation of dendrite morphogenesis,GO:0051402~neuron apoptotic process,GO:0060074~synapse maturation,GO:0060291~long-term synaptic potentiation,GO:0071285~cellular response to lithium ion,GO:0097084~vascular smooth muscle cell development,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904637~cellular response to ionomycin,GO:2000297~negative regulation of synapse maturation,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR002909:IPT_dom,IPR008366:NFAT,IPR008967:p53-like_TF_DNA-bd_sf,IPR011539:RHD_DNA_bind_dom,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR032397:RHD_dimer,IPR037059:RHD_DNA_bind_dom_sf,	rno04020:Calcium signaling pathway,rno04022:cGMP-PKG signaling pathway,rno04148:Efferocytosis,rno04218:Cellular senescence,rno04310:Wnt signaling pathway,rno04360:Axon guidance,rno04625:C-type lectin receptor signaling pathway,rno04921:Oxytocin signaling pathway,rno05161:Hepatitis B,rno05163:Human cytomegalovirus infection,rno05166:Human T-cell leukemia virus 1 infection,rno05167:Kaposi sarcoma-associated herpesvirus infection,rno05170:Human immunodeficiency virus 1 infection,			SM00429:IPT,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:IPT/TIG,DOMAIN:RHD,MOTIF:Nuclear localization signal,REGION:2 approximate SP repeats,REGION:Calcineurin-binding,REGION:Disordered,REPEAT:SP 1,REPEAT:SP 2; approximate,
Q5ZL67	nuclear factor, erythroid 2 like 1(NFE2L1)	Gallus gallus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008203~cholesterol metabolic process,	GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008289~lipid binding,	IPR004826:bZIP_Maf,IPR004827:bZIP,IPR008917:TF_DNA-bd_sf,IPR019525:Nrf1_NLS/DNA-bd_dimer,IPR039142:NRF1/Ewg,IPR047167:NFE2-like,				SM00338:BRLZ,	KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-0804~Transcription,KW-0805~Transcription regulation,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0446~Lipid-binding,	KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:Nuclear respiratory factor 1 NLS/DNA-binding dimerisation,DOMAIN:bZIP,MOTIF:Nuclear localization signal,REGION:Basic motif,REGION:Cholesterol recognition/amino acid consensus (CRAC) region,REGION:Disordered,REGION:Leucine-zipper,SITE:Cleavage,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q14980	nuclear mitotic apparatus protein 1(NUMA1)	Homo sapiens		h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_ranMSPathway:Role of Ran in mitotic spindle regulation,	GO:0000132~establishment of mitotic spindle orientation,GO:0001578~microtubule bundle formation,GO:0006997~nucleus organization,GO:0030513~positive regulation of BMP signaling pathway,GO:0030953~astral microtubule organization,GO:0031116~positive regulation of microtubule polymerization,GO:0032388~positive regulation of intracellular transport,GO:0045618~positive regulation of keratinocyte differentiation,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051798~positive regulation of hair follicle development,GO:0051984~positive regulation of chromosome segregation,GO:0055048~anastral spindle assembly,GO:0060236~regulation of mitotic spindle organization,GO:0090235~regulation of metaphase plate congression,GO:1902365~positive regulation of protein localization to spindle pole body,GO:1902846~positive regulation of mitotic spindle elongation,GO:1904778~positive regulation of protein localization to cell cortex,GO:1905820~positive regulation of chromosome separation,GO:1905832~positive regulation of spindle assembly,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016328~lateral plasma membrane,GO:0016363~nuclear matrix,GO:0030425~dendrite,GO:0031616~spindle pole centrosome,GO:0032991~macromolecular complex,GO:0035371~microtubule plus-end,GO:0036449~microtubule minus-end,GO:0043025~neuronal cell body,GO:0055028~cortical microtubule,GO:0061673~mitotic spindle astral microtubule,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,GO:0097427~microtubule bundle,GO:0097431~mitotic spindle pole,GO:0097575~lateral cell cortex,GO:0099738~cell cortex region,GO:1905720~cytoplasmic microtubule bundle,GO:1990023~mitotic spindle midzone,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0015631~tubulin binding,GO:0019904~protein domain specific binding,GO:0035091~phosphatidylinositol binding,GO:0044877~macromolecular complex binding,GO:0051010~microtubule plus-end binding,GO:0051011~microtubule minus-end binding,GO:0070840~dynein complex binding,GO:0097718~disordered domain specific binding,	IPR048724:NuMA_N_HOOK,IPR048726:NuMA_LGNBD,		612376~Leukemia, acute promyelocytic, somatic,			KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,	KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,	KW-0446~Lipid-binding,		KW-0007~Acetylation,KW-0013~ADP-ribosylation,KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CARBOHYD:O-linked (GlcNAc) serine; alternate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Nuclear mitotic apparatus protein 1 N-terminal hook,MOTIF:Nuclear localization signal,MOTIF:Tankyrase-binding domain,MUTAGEN:E->A: Abolishes interaction with GPSM2.,MUTAGEN:K->E: Abolishes nuclear localization.,MUTAGEN:R->G: No effect on nuclear localization.,MUTAGEN:S->A: Abolishes association with the mitotic spindle. Increases premature accumulation at the cell cortex during metaphase; when associated with A-2015 and A-2055.,MUTAGEN:T->A: Abolishes association with the mitotic spindle.,MUTAGEN:T->A: Abolishes association with the mitotic spindle. Increases premature accumulation at the cell cortex during metaphase; when associated with A-2055 and A-2087.,MUTAGEN:T->A: Increases premature accumulation at the cell membrane of the polar cortical region in prophase and metaphase. Reduces association with the mitotic spindle. Increased randomization of spindle orientation. Increases premature accumulation at the cell cortex during metaphase; when associated with A-2015 and A-2087.,MUTAGEN:T->D: Increases localization at the spindle poles. Decreases localization at the cell cortex.,MUTAGEN:T->E: Absence of cell membrane association even in anaphase. Increased localization at spindle poles and chromosome congression defects. Does not localize to the cortex in either metaphase or anaphase. Increased randomization of spindle orientation.,REGION:4.1-binding domain,REGION:Disordered,REGION:GPSM2-binding domain,REGION:Head (Globular),REGION:Membrane-binding domain 1,REGION:Membrane-binding domain 2,REGION:Tail (Globular),REGION:Tubulin-binding domain,
Q98TW1	nuclear receptor coactivator 2(ncoa2)	Danio rerio			GO:0006355~regulation of transcription, DNA-templated,GO:0019216~regulation of lipid metabolic process,GO:0030099~myeloid cell differentiation,GO:0030851~granulocyte differentiation,GO:0032870~cellular response to hormone stimulus,GO:0043009~chordate embryonic development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0060215~primitive hemopoiesis,	GO:0005634~nucleus,	GO:0003713~transcription coactivator activity,GO:0016922~ligand-dependent nuclear receptor binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0046966~thyroid hormone receptor binding,GO:0046983~protein dimerization activity,	IPR000014:PAS,IPR009110:Nuc_rcpt_coact,IPR010011:NCO_DUF1518,IPR011598:bHLH_dom,IPR013767:PAS_fold,IPR014920:Nuc_rcpt_coact_Ncoa-typ,IPR014935:SRC/p160_LXXLL,IPR017426:Nuclear_rcpt_coactivator,IPR028822:NCOA2_bHLH,IPR032565:NCOA2/3_DUF4927,IPR035965:PAS-like_dom_sf,IPR036638:HLH_DNA-bd_sf,IPR037077:Nuc_rcpt_coact_Ncoa_int_sf,			PIRSF038181:Nuclear_receptor_coactivator,	SM00091:PAS,SM00353:HLH,SM01151:DUF1518,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0010~Activator,KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:BHLH,DOMAIN:PAS,DOMAIN:bHLH,MOTIF:LLXXLXXXL motif,MOTIF:LXXLL motif 1,MOTIF:LXXLL motif 2,MOTIF:LXXLL motif 3,REGION:Disordered,
Q9Y618	nuclear receptor corepressor 2(NCOR2)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor,h_etsPathway:METS affect on Macrophage Differentiation,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0007595~lactation,GO:0010243~response to organonitrogen compound,GO:0010565~regulation of cellular ketone metabolic process,GO:0021549~cerebellum development,GO:0032355~response to estradiol,GO:0044849~estrous cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0060766~negative regulation of androgen receptor signaling pathway,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0017053~transcriptional repressor complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005112~Notch binding,GO:0005515~protein binding,GO:0035259~glucocorticoid receptor binding,GO:0042826~histone deacetylase binding,GO:0046965~retinoid X receptor binding,	IPR001005:SANT/Myb,IPR009057:Homeobox-like_sf,IPR017884:SANT_dom,IPR017930:Myb_dom,IPR031557:N-CoR_GPS2_interact,	hsa04330:Notch signaling pathway,hsa05169:Epstein-Barr virus infection,			SM00717:SANT,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0238~DNA-binding,KW-0675~Receptor,KW-0678~Repressor,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:HTH myb-type,DOMAIN:Myb-like,DOMAIN:N-CoR GPS2-interacting,DOMAIN:SANT,DOMAIN:SANT 1,DOMAIN:SANT 2,MOTIF:CORNR box of ID1,MOTIF:CORNR box of ID2,MUTAGEN:HRIL->AEIA: Abolishes interaction with TBL1X.,MUTAGEN:R->A: Abolishes interaction with the apo LBD of RARA. Restores some interaction on the addition of inverse agonist BMS493.,MUTAGEN:T->G: Abolishes interaction with the apo LBD of RARA. Restores some interaction on the addition of inverse agonist BMS493.,MUTAGEN:V->P: Abolishes interaction with the apo LBD of RARA. No change on interaction on the addition of inverse agonist BMS493.,REGION:Disordered,REGION:Interaction with SIN3A/B,REGION:Required for interaction with RARA in the absence of its ligand,
P49116	nuclear receptor subfamily 2 group C member 2(NR2C2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0007399~nervous system development,GO:0030154~cell differentiation,GO:0030522~intracellular receptor signaling pathway,GO:0040019~positive regulation of embryonic development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048856~anatomical structure development,	GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR013088:Znf_NHR/GATA,IPR033544:NR0B1/2,IPR035500:NHR-like_dom_sf,IPR048245:NR2C1/2-like_DBD,IPR048246:NR2C1/2-like_LBD,				SM00399:ZnF_C4,SM00430:HOLI,	KW-0221~Differentiation,KW-0744~Spermatogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,MUTAGEN:I->N: Reduces interaction with JAZF1.,REGION:Disordered,ZN_FING:NR C4-type,
O00482	nuclear receptor subfamily 5 group A member 2(NR5A2)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008206~bile acid metabolic process,GO:0009755~hormone-mediated signaling pathway,GO:0009792~embryo development ending in birth or egg hatching,GO:0009888~tissue development,GO:0030522~intracellular receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042592~homeostatic process,GO:0042632~cholesterol homeostasis,GO:0045070~positive regulation of viral genome replication,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061113~pancreas morphogenesis,GO:0090425~acinar cell differentiation,GO:0097720~calcineurin-mediated signaling,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001221~transcription cofactor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR013088:Znf_NHR/GATA,IPR016355:NR5_fam,IPR035500:NHR-like_dom_sf,	hsa04950:Maturity onset diabetes of the young,		PIRSF002530:Nuc_orph_FTZ-F1,	SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0446~Lipid-binding,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,MOTIF:FTZ-F1 box,MUTAGEN:F->A: Slightly reduced DNA binding. Strongly reduced transactivation; when associated with A-96 and A-172.,MUTAGEN:F->W: Reduced phospholipid binding. Strongly reduced transactivation; when associated with W-416.,MUTAGEN:GP->VA: Reduced DNA binding. Loss of transactivation.,MUTAGEN:I->W: Reduced phospholipid binding. Strongly reduced transactivation; when associated with W-342.,MUTAGEN:K->R: Impaired ability to act as an anti-inflammatory role during the hepatic acute phase response.,MUTAGEN:Y->A: Slightly reduced DNA binding. Strongly reduced transactivation; when associated with A-168 and A-172.,MUTAGEN:Y->A: Slightly reduced DNA binding. Strongly reduced transactivation; when associated with A-96 and A-168.,REGION:Disordered,ZN_FING:NR C4-type,
Q6ZNB6	nuclear transcription factor, X-box binding like 1(NFXL1)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0016020~membrane,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,	IPR000967:Znf_NFX1,IPR001841:Znf_RING,IPR034078:NFX1_fam,				SM00438:ZnF_NFX,		KW-0472~Membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RING-type,REGION:Disordered,TRANSMEM:Helical,ZN_FING:NF-X1-type 1,ZN_FING:NF-X1-type 10,ZN_FING:NF-X1-type 2,ZN_FING:NF-X1-type 3,ZN_FING:NF-X1-type 4,ZN_FING:NF-X1-type 5,ZN_FING:NF-X1-type 6,ZN_FING:NF-X1-type 7,ZN_FING:NF-X1-type 8,ZN_FING:NF-X1-type 9,ZN_FING:RING-type; atypical,
P61972	nuclear transport factor 2(Nutf2)	Rattus norvegicus			GO:0006606~protein import into nucleus,GO:0006611~protein export from nucleus,GO:0006913~nucleocytoplasmic transport,GO:0015031~protein transport,GO:0042307~positive regulation of protein import into nucleus,GO:0051028~mRNA transport,GO:0090204~protein localization to nuclear pore,GO:1904046~negative regulation of vascular endothelial growth factor production,	GO:0005634~nucleus,GO:0005637~nuclear inner membrane,GO:0005640~nuclear outer membrane,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,GO:0044613~nuclear pore central transport channel,	GO:0005515~protein binding,GO:0017056~structural constituent of nuclear pore,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0061608~nuclear import signal receptor activity,	IPR002075:NTF2_dom,IPR018222:Nuclear_transport_factor_2_euk,IPR032710:NTF2-like_dom_sf,IPR045875:NTF2,					KW-0509~mRNA transport,KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0472~Membrane,KW-0539~Nucleus,KW-0906~Nuclear pore complex,KW-0963~Cytoplasm,						KW-0007~Acetylation,	DOMAIN:NTF2,MUTAGEN:D->A,N: No effect on interaction with GDP-bound RAN. Increases GDP-bound RAN nuclear import. Increased interaction with nucleoporins and localization to the nuclear pore complex. Inhibits the nuclear import of nuclear localization signal-containing proteins.,MUTAGEN:D->N: Decreased interaction with GDP-bound RAN. No effect on interaction with nucleoporins. No effect on proteins nuclear import.,MUTAGEN:D->N: No effect on interaction with GDP-bound RAN. No effect on interaction with nucleoporins. No effect on proteins nuclear import.,MUTAGEN:DED->NEN: Loss of interaction with GDP-bound RAN. No effect on interaction with nucleoporins. Loss of proteins nuclear import.,MUTAGEN:E->D: Loss of interaction with GDP-bound RAN. Loss of GDP-bound RAN nuclear import.,MUTAGEN:E->K: Loss of interaction with GDP-bound RAN. No effect on interaction with nucleoporins. Loss of GDP-bound RAN and other proteins nuclear import.,MUTAGEN:H->A: Loss of interaction with GDP-bound RAN. No effect on interaction with nucleoporins. Decreased proteins nuclear import.,MUTAGEN:I->A: No effect on homodimerization. Decreased interaction with GDP-bound RAN. Loss of interaction with nucleoporins and localization to the nuclear pore complex.,MUTAGEN:I->Q: No effect on homodimerization. Loss of interaction with GDP-bound RAN. Decreased interaction with nucleoporins and localization to the nuclear pore complex.,MUTAGEN:M->E: Decreased homodimerization.,MUTAGEN:M->E: Loss of homodimerization. Decreased interaction with GDP-bound RAN. Decreased interaction with nucleoporins. Decreased localization to the nuclear pore complex.,MUTAGEN:Missing: Decreased interaction with GDP-bound RAN. No effect on interaction with nucleoporins. No effect on proteins nuclear import.,MUTAGEN:Missing: Loss of interaction with GDP-bound RAN. No effect on interaction with nucleoporins. Decreased proteins nuclear import.,MUTAGEN:W->A: No effect on interaction with GDP-bound RAN. Decreased interaction with nucleoporins. Decreased localization to the nuclear pore complex. Decreased GDP-bound RAN and other proteins nuclear import.,MUTAGEN:Y->A: Loss of interaction with GDP-bound RAN. Loss of GDP-bound RAN nuclear import.,
P80303	nucleobindin 2(NUCB2)	Homo sapiens			GO:0007264~small GTPase mediated signal transduction,	GO:0005615~extracellular space,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0001965~G-protein alpha-subunit binding,GO:0003677~DNA binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR040250:Nucleobindin,				SM00054:EFh,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0238~DNA-binding,KW-0344~Guanine-nucleotide releasing factor,	KW-0165~Cleavage on pair of basic residues,KW-0597~Phosphoprotein,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,MOTIF:GBA,REGION:Binds to necdin,REGION:Disordered,
A1L2F3	nucleolar and spindle associated protein 1(nusap1)	Danio rerio			GO:0000226~microtubule cytoskeleton organization,GO:0000281~mitotic cytokinesis,GO:0001755~neural crest cell migration,GO:0007049~cell cycle,GO:0007076~mitotic chromosome condensation,GO:0040001~establishment of mitotic spindle localization,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0072686~mitotic spindle,	GO:0003677~DNA binding,GO:0008017~microtubule binding,	IPR026756:NuSAP,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,REGION:Disordered,
Q567G6	nucleolus and neural progenitor protein(nepro)	Danio rerio			GO:0045665~negative regulation of neuron differentiation,GO:0045747~positive regulation of Notch signaling pathway,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,		IPR027951:Nepro_N,						KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:Nucleolus and neural progenitor protein-like N-terminal,REGION:Disordered,REGION:Nuclear localization signal,TRANSMEM:Helical,
Q8TEM1	nucleoporin 210(NUP210)	Homo sapiens		h_npcPathway:Mechanism of Protein Import into the Nucleus,	GO:0006913~nucleocytoplasmic transport,GO:0015031~protein transport,GO:0051028~mRNA transport,	GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0005515~protein binding,	IPR003343:Big_2,IPR008964:Invasin/intimin_cell_adhesion,IPR045197:NUP210-like,	hsa03013:Nucleocytoplasmic transport,hsa05014:Amyotrophic lateral sclerosis,			SM00635:BID_2,	KW-0509~mRNA transport,KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0906~Nuclear pore complex,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:BIG2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Perinuclear space,TRANSMEM:Helical,
Q8NFH4	nucleoporin 37(NUP37)	Homo sapiens			GO:0006913~nucleocytoplasmic transport,GO:0007059~chromosome segregation,GO:0015031~protein transport,GO:0051028~mRNA transport,GO:0051301~cell division,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0031080~nuclear pore outer ring,	GO:0005515~protein binding,	IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR036322:WD40_repeat_dom_sf,IPR037626:NUP37,	hsa03013:Nucleocytoplasmic transport,hsa05014:Amyotrophic lateral sclerosis,	618179~Microcephaly 24, primary, autosomal recessive,		SM00320:WD40,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,KW-0509~mRNA transport,KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0906~Nuclear pore complex,KW-0995~Kinetochore,		KW-0225~Disease variant,KW-0905~Primary microcephaly,	KW-0677~Repeat,KW-0853~WD repeat,				REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q6P298	nucleotide binding protein 1 (MinD homolog, E. coli)(nubp1)	Danio rerio			GO:0016226~iron-sulfur cluster assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000808:Mrp-like_CS,IPR019591:Mrp/NBP35_ATP-bd,IPR027417:P-loop_NTPase,IPR028601:NUBP1/Nbp35,IPR033756:YlxH/NBP35,						KW-0963~Cytoplasm,				KW-0004~4Fe-4S,KW-0067~ATP-binding,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,			REGION:Disordered,
Q3B7Q7	nucleotide binding protein 2 (MinD homolog, E. coli)(nubp2)	Danio rerio			GO:0016226~iron-sulfur cluster assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR019591:Mrp/NBP35_ATP-bd,IPR027417:P-loop_NTPase,IPR028600:NUBP2/Cfd1_eukaryotes,IPR033756:YlxH/NBP35,						KW-0963~Cytoplasm,				KW-0004~4Fe-4S,KW-0067~ATP-binding,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,
A0A024RBG1	nudix hydrolase 4B(NUDT4B)	Homo sapiens			GO:0071543~diphosphoinositol polyphosphate metabolic process,GO:1901907~diadenosine pentaphosphate catabolic process,GO:1901909~diadenosine hexaphosphate catabolic process,GO:1901911~adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000298~endopolyphosphatase activity,GO:0003723~RNA binding,GO:0008486~diphosphoinositol-polyphosphate diphosphatase activity,GO:0016462~pyrophosphatase activity,GO:0034431~bis(5'-adenosyl)-hexaphosphatase activity,GO:0034432~bis(5'-adenosyl)-pentaphosphatase activity,GO:0046872~metal ion binding,	IPR000086:NUDIX_hydrolase_dom,IPR015797:NUDIX_hydrolase-like_dom_sf,IPR020084:NUDIX_hydrolase_CS,IPR047198:DDP-like_NUDIX,						KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0694~RNA-binding,		ACT_SITE:Proton acceptor,DOMAIN:Nudix hydrolase,MOTIF:Nudix box,
P0C024	nudix hydrolase 7(NUDT7)	Homo sapiens			GO:0009132~nucleoside diphosphate metabolic process,GO:0015938~coenzyme A catabolic process,GO:0036114~medium-chain fatty-acyl-CoA catabolic process,GO:0044580~butyryl-CoA catabolic process,GO:0046356~acetyl-CoA catabolic process,GO:0050873~brown fat cell differentiation,GO:1901289~succinyl-CoA catabolic process,GO:1902858~propionyl-CoA metabolic process,GO:1902859~propionyl-CoA catabolic process,GO:2001294~malonyl-CoA catabolic process,	GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0010945~CoA pyrophosphatase activity,GO:0030145~manganese ion binding,GO:0030515~snoRNA binding,	IPR000059:NUDIX_hydrolase_NudL_CS,IPR000086:NUDIX_hydrolase_dom,IPR015797:NUDIX_hydrolase-like_dom_sf,IPR045121:CoAse,	hsa04146:Peroxisome,					KW-0576~Peroxisome,				KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0694~RNA-binding,		DOMAIN:Nudix hydrolase,MOTIF:Microbody targeting signal,MOTIF:Nudix box,SITE:Important for coenzyme A binding,
Q5VST9	obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF(OBSCN)	Homo sapiens			GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0016310~phosphorylation,GO:0036309~protein localization to M-band,GO:0045214~sarcomere organization,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0014704~intercalated disc,GO:0016604~nuclear body,GO:0030016~myofibril,GO:0030018~Z disc,GO:0031430~M band,GO:0042383~sarcolemma,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008307~structural constituent of muscle,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0030506~ankyrin binding,GO:0031432~titin binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0045296~cadherin binding,GO:0046872~metal ion binding,GO:0070273~phosphatidylinositol-4-phosphate binding,	IPR000048:IQ_motif_EF-hand-BS,IPR000219:DH-domain,IPR000719:Prot_kinase_dom,IPR001452:SH3_domain,IPR001849:PH_domain,IPR003006:Ig/MHC_CS,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR008266:Tyr_kinase_AS,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011993:PH-like_dom_sf,IPR013098:Ig_I-set,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR017441:Protein_kinase_ATP_BS,IPR035526:Obscurin_SH3,IPR035899:DBL_dom_sf,IPR036028:SH3-like_dom_sf,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,IPR043204:Basigin-like,		620235~Rhabdomyolysis, susceptibility to, 1,		SM00015:IQ,SM00060:FN3,SM00220:S_TKc,SM00233:PH,SM00325:RhoGEF,SM00406:IGv,SM00408:IGc2,SM00409:IG,	KW-0221~Differentiation,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0175~Coiled coil,KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0728~SH3 domain,	KW-0067~ATP-binding,KW-0446~Lipid-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0112~Calmodulin-binding,KW-0217~Developmental protein,KW-0418~Kinase,KW-0514~Muscle protein,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DH,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:IQ,DOMAIN:Ig-like,DOMAIN:Ig-like 1,DOMAIN:Ig-like 10,DOMAIN:Ig-like 11,DOMAIN:Ig-like 12,DOMAIN:Ig-like 13,DOMAIN:Ig-like 14,DOMAIN:Ig-like 15,DOMAIN:Ig-like 16,DOMAIN:Ig-like 17,DOMAIN:Ig-like 18,DOMAIN:Ig-like 19,DOMAIN:Ig-like 2,DOMAIN:Ig-like 20,DOMAIN:Ig-like 21,DOMAIN:Ig-like 22,DOMAIN:Ig-like 23,DOMAIN:Ig-like 24,DOMAIN:Ig-like 25,DOMAIN:Ig-like 26,DOMAIN:Ig-like 27,DOMAIN:Ig-like 28,DOMAIN:Ig-like 29,DOMAIN:Ig-like 3,DOMAIN:Ig-like 30,DOMAIN:Ig-like 31,DOMAIN:Ig-like 32,DOMAIN:Ig-like 33,DOMAIN:Ig-like 34,DOMAIN:Ig-like 35,DOMAIN:Ig-like 36,DOMAIN:Ig-like 37,DOMAIN:Ig-like 38,DOMAIN:Ig-like 39,DOMAIN:Ig-like 4,DOMAIN:Ig-like 40,DOMAIN:Ig-like 41,DOMAIN:Ig-like 42,DOMAIN:Ig-like 43,DOMAIN:Ig-like 44,DOMAIN:Ig-like 45,DOMAIN:Ig-like 46,DOMAIN:Ig-like 47,DOMAIN:Ig-like 48,DOMAIN:Ig-like 49,DOMAIN:Ig-like 5,DOMAIN:Ig-like 50,DOMAIN:Ig-like 51,DOMAIN:Ig-like 52,DOMAIN:Ig-like 53,DOMAIN:Ig-like 54,DOMAIN:Ig-like 55,DOMAIN:Ig-like 6,DOMAIN:Ig-like 7,DOMAIN:Ig-like 8,DOMAIN:Ig-like 9,DOMAIN:Immunoglobulin V-set,DOMAIN:PH,DOMAIN:Protein kinase,DOMAIN:Protein kinase 1,DOMAIN:Protein kinase 2,DOMAIN:SH3,MUTAGEN:R->A: Reduced binding to phosphatidylinositol 3,4-bisphosphate.,MUTAGEN:R->A: Reduced binding to phosphatidylinositol 4,5-bisphosphate.,REGION:Disordered,
Q6VZZ7	opsin 5(Opn5)	Mus musculus			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007601~visual perception,GO:0007602~phototransduction,GO:0007604~phototransduction, UV,GO:0043153~entrainment of circadian clock by photoperiod,GO:0050896~response to stimulus,GO:0071482~cellular response to light stimulus,GO:0071492~cellular response to UV-A,GO:1990384~hyaloid vascular plexus regression,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005502~11-cis retinal binding,GO:0008020~G-protein coupled photoreceptor activity,GO:0009881~photoreceptor activity,	IPR000276:GPCR_Rhodpsn,IPR002962:Peropsin,IPR017452:GPCR_Rhodpsn_7TM,IPR027430:Retinal_BS,					KW-0716~Sensory transduction,KW-0844~Vision,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0157~Chromophore,	KW-0297~G-protein coupled receptor,KW-0600~Photoreceptor protein,KW-0675~Receptor,KW-0681~Retinal protein,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,LIPID:S-palmitoyl cysteine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q9Y5N6	origin recognition complex subunit 6(ORC6)	Homo sapiens		h_mcmPathway:CDK Regulation of DNA Replication,	GO:0006260~DNA replication,GO:0006270~DNA replication initiation,	GO:0000808~origin recognition complex,GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005664~nuclear origin of replication recognition complex,GO:0005829~cytosol,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR008721:ORC6,IPR020529:ORC6_met/pln,	hsa04110:Cell cycle,	613803~Meier-Gorlin syndrome 3,			KW-0235~DNA replication,	KW-0539~Nucleus,		KW-0225~Disease variant,KW-0242~Dwarfism,			KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MUTAGEN:K->A: Abolished DNA binding.,MUTAGEN:Q->A: Abolished DNA binding.,MUTAGEN:R->A: Abolished DNA binding.,REGION:Disordered,
P27117	ornithine decarboxylase 1(ODC1)	Bos taurus			GO:0009615~response to virus,GO:0033387~putrescine biosynthetic process from ornithine,GO:0042176~regulation of protein catabolic process,	GO:0005737~cytoplasm,	GO:0004586~ornithine decarboxylase activity,GO:0042803~protein homodimerization activity,	IPR000183:Orn/DAP/Arg_de-COase,IPR002433:Orn_de-COase,IPR009006:Ala_racemase/Decarboxylase_C,IPR022643:De-COase2_C,IPR022644:De-COase2_N,IPR022653:De-COase2_pyr-phos_BS,IPR022657:De-COase2_CS,IPR029066:PLP-binding_barrel,	bta00330:Arginine and proline metabolism,bta00480:Glutathione metabolism,bta01100:Metabolic pathways,bta04148:Efferocytosis,				KW-0620~Polyamine biosynthesis,					KW-0663~Pyridoxal phosphate,	KW-0210~Decarboxylase,KW-0456~Lyase,	KW-0597~Phosphoprotein,KW-0702~S-nitrosylation,	ACT_SITE:Proton donor,ACT_SITE:Proton donor; shared with dimeric partner,BINDING:in other chain,DOMAIN:Orn/DAP/Arg decarboxylase 2 C-terminal,DOMAIN:Orn/DAP/Arg decarboxylase 2 N-terminal,SITE:Stacks against the aromatic ring of pyridoxal phosphate and stabilizes reaction intermediates,
Q1L9A2	outer mitochondrial membrane lipid metabolism regulator OPA3(opa3)	Danio rerio			GO:0007626~locomotory behavior,GO:0019216~regulation of lipid metabolic process,GO:0031413~regulation of buoyancy,GO:0050881~musculoskeletal movement,	GO:0005739~mitochondrion,		IPR010754:OPA3-like,						KW-0496~Mitochondrion,			KW-0175~Coiled coil,
Q8BGA9	oxidase assembly 1-like(Oxa1l)	Mus musculus			GO:0009060~aerobic respiration,GO:0032780~negative regulation of ATPase activity,GO:0032979~protein insertion into mitochondrial membrane from inner side,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0033615~mitochondrial proton-transporting ATP synthase complex assembly,GO:0051262~protein tetramerization,GO:0051354~negative regulation of oxidoreductase activity,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0032991~macromolecular complex,	GO:0032977~membrane insertase activity,GO:0042803~protein homodimerization activity,GO:0097177~mitochondrial ribosome binding,	IPR001708:YidC/ALB3/OXA1/COX18,IPR028055:YidC/Oxa/ALB_C,	mmu03060:Protein export,					KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Membrane insertase YidC/Oxa/ALB C-terminal,REGION:Disordered,TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSIT:Mitochondrion,TRANSMEM:Helical,
Q863I2	oxidative stress responsive kinase 1(OXSR1)	Sus scrofa			GO:0006468~protein phosphorylation,GO:0010820~positive regulation of T cell chemotaxis,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,GO:0046777~protein autophosphorylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR000719:Prot_kinase_dom,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR024678:Kinase_OSR1/WNK_CCT,				SM00220:S_TKc,		KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,DOMAIN:Protein kinase,REGION:Disordered,
A3KP77	oxidoreductase NAD-binding domain containing 1(oxnad1)	Danio rerio					GO:0016491~oxidoreductase activity,	IPR001433:OxRdtase_FAD/NAD-bd,IPR017927:FAD-bd_FR_type,IPR017938:Riboflavin_synthase-like_b-brl,IPR039261:FNR_nucleotide-bd,										KW-0520~NAD,	KW-0560~Oxidoreductase,		DOMAIN:FAD-binding FR-type,
Q8AXB4	p21 protein (Cdc42/Rac)-activated kinase 3 L homeolog(pak3.L)	Xenopus laevis			GO:0007049~cell cycle,GO:0007406~negative regulation of neuroblast proliferation,GO:0016310~phosphorylation,GO:0021990~neural plate formation,GO:0030154~cell differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0051726~regulation of cell cycle,GO:0071570~cement gland development,GO:0090017~anterior neural plate formation,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,	IPR000095:CRIB_dom,IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR033923:PAK_BD,IPR035063:STK_PAK3,IPR036936:CRIB_dom_sf,	xla04012:ErbB signaling pathway,xla04510:Focal adhesion,xla04810:Regulation of actin cytoskeleton,xla05132:Salmonella infection,			SM00220:S_TKc,SM00285:PBD,	KW-0131~Cell cycle,KW-0221~Differentiation,KW-0338~Growth arrest,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-9996~Developmental protein,		ACT_SITE:Proton acceptor,COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CRIB,DOMAIN:Protein kinase,REGION:Autoregulatory region,REGION:Disordered,REGION:GTPase-binding,REGION:Linker,
Q9HB75	p53-induced death domain protein 1(PIDD1)	Homo sapiens			GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007165~signal transduction,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0016540~protein autoprocessing,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0051092~positive regulation of NF-kappaB transcription factor activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:1905369~endopeptidase complex,	GO:0004175~endopeptidase activity,GO:0005123~death receptor binding,GO:0005515~protein binding,	IPR000488:Death_domain,IPR000906:ZU5_dom,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR011029:DEATH-like_dom_sf,IPR019502:Peptidase_S68_pidd,IPR032675:LRR_dom_sf,	hsa04064:NF-kappa B signaling pathway,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,	619827~Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly,		SM00005:DEATH,SM00364:LRR_BAC,SM00369:LRR_TYP,	KW-0053~Apoptosis,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0433~Leucine-rich repeat,KW-0677~Repeat,		KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Death,DOMAIN:ZU5,DOMAIN:ZU5 1,DOMAIN:ZU5 2,MUTAGEN:D->K: Partial loss of complex assembly with CRADD.,MUTAGEN:E->K: No effect on complex assembly with CRADD.,MUTAGEN:F->A: Loss of the proteolytic cleavage producing PIDD-CC.,MUTAGEN:F->D: Loss of complex assembly with CRADD. Loss of PIDDosome assembly. Loss of CASP2 activation.,MUTAGEN:F->H,W: Loss of the proteolytic cleavage producing PIDD-C.,MUTAGEN:F->H: Loss of the proteolytic cleavage producing PIDD-CC.,MUTAGEN:H->Q: Loss of the proteolytic cleavage producing PIDD-C.,MUTAGEN:L->A: No effect on complex assembly with CRADD.,MUTAGEN:L->E: Loss of complex assembly with CRADD.,MUTAGEN:Q->A: Partial loss of complex assembly with CRADD.,MUTAGEN:R->A: Loss of complex assembly with CRADD. Loss of PIDDosome assembly. Loss of CASP2 activation.,MUTAGEN:R->A: Partial loss of complex assembly with CRADD.,MUTAGEN:R->E: Loss of complex assembly with CRADD.,MUTAGEN:R->E: Partial loss of complex assembly with CRADD. Decreased PIDDosome assembly. Decreased CASP2 activation.,MUTAGEN:S->A: Loss of the proteolytic cleavage producing PIDD-C. Unable to translocate to the nucleus upon DNA damage. No effect on the ability to activate CASP2. Complete loss of proteolytic cleavage; when associated with A-588.,MUTAGEN:S->A: Loss of the proteolytic cleavage producing PIDD-CC. Loss of interaction with CRADD and of the ability to activate CASP2. No effect on translocation to the nucleus upon DNA damage. Complete loss of proteolytic cleavage; when associated with A-446.,MUTAGEN:S->C: No effect on the proteolytic cleavage producing PIDD-C.,MUTAGEN:S->C: No effect on the proteolytic cleavage producing PIDD-CC.,MUTAGEN:Y->A: Loss of complex assembly with CRADD. Loss of PIDDosome assembly. Loss of CASP2 activation.,REGION:Disordered,REGION:Peptidase S68,REGION:UPA domain,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,SITE:Cleavage; by autolysis,
Q8WX93	palladin, cytoskeletal associated protein(PALLD)	Homo sapiens			GO:0003334~keratinocyte development,GO:0003382~epithelial cell morphogenesis,GO:0007010~cytoskeleton organization,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007411~axon guidance,GO:0016477~cell migration,GO:0030036~actin cytoskeleton organization,GO:0070593~dendrite self-avoidance,	GO:0001725~stress fiber,GO:0001726~ruffle,GO:0002102~podosome,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0030018~Z disc,GO:0030027~lamellipodium,GO:0030424~axon,GO:0030426~growth cone,GO:0060076~excitatory synapse,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0051371~muscle alpha-actinin binding,GO:0098632~protein binding involved in cell-cell adhesion,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR033017:Palladin_C,IPR036179:Ig-like_dom_sf,IPR043204:Basigin-like,		606856~Pancreatic cancer, susceptibility to, 1,		SM00408:IGc2,SM00409:IG,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,REGION:Disordered,REGION:Interaction with ACTN,REGION:Interaction with EPS8,REGION:Interaction with EZR,REGION:Interaction with LASP1,REGION:Interaction with SORBS2, SPIN90 and SRC,REGION:Interaction with SORBS2, SPIN90, SRC and PFN1,REGION:Interaction with VASP,
P06857	pancreatic lipase related protein 1(PNLIPRP1)	Canis lupus familiaris			GO:0006629~lipid metabolic process,GO:0016042~lipid catabolic process,	GO:0005576~extracellular region,	GO:0004806~triglyceride lipase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0052689~carboxylic ester hydrolase activity,	IPR000734:TAG_lipase,IPR001024:PLAT/LH2_dom,IPR002331:Lipase_panc,IPR013818:Lipase,IPR016272:Lipase_LIPH,IPR029058:AB_hydrolase,IPR033906:Lipase_N,IPR036392:PLAT/LH2_dom_sf,	cfa00561:Glycerolipid metabolism,cfa01100:Metabolic pathways,cfa04972:Pancreatic secretion,cfa04975:Fat digestion and absorption,		PIRSF000865:Lipoprotein_lipase_LIPH,	SM00308:LH2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:PLAT,MUTAGEN:A->P: Removes steric hindrance and restores lipase activity; when associated with A-196.,MUTAGEN:V->A: Removes steric hindrance and restores lipase activity; when associated with P-198.,
Q9EPX2	papilin, proteoglycan-like sulfated glycoprotein(Papln)	Mus musculus			GO:0010466~negative regulation of peptidase activity,GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0005604~basement membrane,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005201~extracellular matrix structural constituent,GO:0030414~peptidase inhibitor activity,	IPR000884:TSP1_rpt,IPR002223:Kunitz_BPTI,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR010294:ADAMTS_spacer1,IPR010909:PLAC,IPR013098:Ig_I-set,IPR013106:Ig_V-set,IPR013151:Immunoglobulin,IPR013273:ADAMTS/ADAMTS-like,IPR013783:Ig-like_fold,IPR020901:Prtase_inh_Kunz-CS,IPR036179:Ig-like_dom_sf,IPR036383:TSP1_rpt_sf,IPR036880:Kunitz_BPTI_sf,IPR045371:ADAMTS_CR_3,				SM00131:KU,SM00209:TSP1,SM00406:IGv,SM00408:IGc2,SM00409:IG,		KW-0964~Secreted,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,		KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-1015~Disulfide bond,	COMPBIAS:Polar residues,DOMAIN:BPTI/Kunitz inhibitor,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:PLAC,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,DOMAIN:TSP type-1 5,REGION:Disordered,
P37967	para-nitrobenzyl esterase (intracellular esterase B)(pnbA)	Bacillus subtilis subsp. subtilis str. 168					GO:0004104~cholinesterase activity,	IPR000997:Cholinesterase,IPR002018:CarbesteraseB,IPR019819:Carboxylesterase_B_CS,IPR019826:Carboxylesterase_B_AS,IPR029058:AB_hydrolase,											KW-0378~Hydrolase,KW-0719~Serine esterase,	KW-0597~Phosphoprotein,	ACT_SITE:Acyl-ester intermediate,ACT_SITE:Charge relay system,DOMAIN:Carboxylesterase type B,
O42266	parapinopsin a(parapinopsina)	Ictalurus punctatus			GO:0007186~G-protein coupled receptor signaling pathway,GO:0007601~visual perception,GO:0007602~phototransduction,	GO:0001750~photoreceptor outer segment,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,GO:0009881~photoreceptor activity,	IPR000276:GPCR_Rhodpsn,IPR001760:Opsin,IPR017452:GPCR_Rhodpsn_7TM,IPR027430:Retinal_BS,					KW-0716~Sensory transduction,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0157~Chromophore,	KW-0297~G-protein coupled receptor,KW-0600~Photoreceptor protein,KW-0675~Receptor,KW-0681~Retinal protein,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,LIPID:S-palmitoyl cysteine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
O60260	parkin RBR E3 ubiquitin protein ligase(PRKN)	Homo sapiens		h_parkinPathway:Role of Parkin in the Ubiquitin-Proteasomal Pathway,h_parkinsonsPathway:Alpha-synuclein and Parkin-mediated proteolysis in Parkinson's disease,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000209~protein polyubiquitination,GO:0000266~mitochondrial fission,GO:0000422~mitophagy,GO:0000423~macromitophagy,GO:0001933~negative regulation of protein phosphorylation,GO:0001964~startle response,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0006914~autophagy,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007417~central nervous system development,GO:0007612~learning,GO:0008344~adult locomotory behavior,GO:0010498~proteasomal protein catabolic process,GO:0010506~regulation of autophagy,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010636~positive regulation of mitochondrial fusion,GO:0010637~negative regulation of mitochondrial fusion,GO:0010821~regulation of mitochondrion organization,GO:0010906~regulation of glucose metabolic process,GO:0010994~free ubiquitin chain polymerization,GO:0014059~regulation of dopamine secretion,GO:0016236~macroautophagy,GO:0016567~protein ubiquitination,GO:0030163~protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032092~positive regulation of protein binding,GO:0032232~negative regulation of actin filament bundle assembly,GO:0032368~regulation of lipid transport,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0033132~negative regulation of glucokinase activity,GO:0034599~cellular response to oxidative stress,GO:0034620~cellular response to unfolded protein,GO:0034976~response to endoplasmic reticulum stress,GO:0035249~synaptic transmission, glutamatergic,GO:0035519~protein K29-linked ubiquitination,GO:0036503~ERAD pathway,GO:0042053~regulation of dopamine metabolic process,GO:0042415~norepinephrine metabolic process,GO:0042417~dopamine metabolic process,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043388~positive regulation of DNA binding,GO:0043524~negative regulation of neuron apoptotic process,GO:0044314~protein K27-linked ubiquitination,GO:0044828~negative regulation by host of viral genome replication,GO:0045732~positive regulation of protein catabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046329~negative regulation of JNK cascade,GO:0046676~negative regulation of insulin secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0050821~protein stabilization,GO:0051582~positive regulation of neurotransmitter uptake,GO:0051583~dopamine uptake involved in synaptic transmission,GO:0051865~protein autoubiquitination,GO:0051881~regulation of mitochondrial membrane potential,GO:0060544~regulation of necroptotic process,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0061734~parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,GO:0070050~neuron cellular homeostasis,GO:0070534~protein K63-linked ubiquitination,GO:0070585~protein localization to mitochondrion,GO:0070842~aggresome assembly,GO:0070936~protein K48-linked ubiquitination,GO:0070979~protein K11-linked ubiquitination,GO:0071287~cellular response to manganese ion,GO:0085020~protein K6-linked ubiquitination,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090141~positive regulation of mitochondrial fission,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:0097237~cellular response to toxic substance,GO:0098779~positive regulation of macromitophagy in response to mitochondrial depolarization,GO:0099074~mitochondrion to lysosome transport,GO:1900242~regulation of synaptic vesicle endocytosis,GO:1900407~regulation of cellular response to oxidative stress,GO:1901526~positive regulation of macromitophagy,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1902254~negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:1902283~negative regulation of primary amine oxidase activity,GO:1902530~positive regulation of protein linear polyubiquitination,GO:1902803~regulation of synaptic vesicle transport,GO:1903214~regulation of protein targeting to mitochondrion,GO:1903265~positive regulation of tumor necrosis factor-mediated signaling pathway,GO:1903351~cellular response to dopamine,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903382~negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903542~negative regulation of exosomal secretion,GO:1903599~positive regulation of mitophagy,GO:1903861~positive regulation of dendrite extension,GO:1904049~negative regulation of spontaneous neurotransmitter secretion,GO:1905281~positive regulation of retrograde transport, endosome to Golgi,GO:1905366~negative regulation of intralumenal vesicle formation,GO:1905477~positive regulation of protein localization to membrane,GO:1990000~amyloid fibril formation,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000378~negative regulation of reactive oxygen species metabolic process,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0016235~aggresome,GO:0016607~nuclear speck,GO:0032991~macromolecular complex,GO:0043005~neuron projection,GO:0048471~perinuclear region of cytoplasm,GO:0097413~Lewy body,GO:0098793~presynapse,GO:0099073~mitochondrion-derived vesicle,GO:1990452~Parkin-FBXW7-Cul1 ubiquitin ligase complex,	GO:0001664~G-protein coupled receptor binding,GO:0003714~transcription corepressor activity,GO:0003779~actin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,GO:0016874~ligase activity,GO:0017124~SH3 domain binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030165~PDZ domain binding,GO:0030544~Hsp70 protein binding,GO:0031072~heat shock protein binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042826~histone deacetylase binding,GO:0043130~ubiquitin binding,GO:0043274~phospholipase binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0051087~chaperone binding,GO:0061630~ubiquitin protein ligase activity,GO:0097602~cullin family protein binding,GO:1990381~ubiquitin-specific protease binding,GO:1990444~F-box domain binding,	IPR000626:Ubiquitin-like_dom,IPR002867:IBR_dom,IPR003977:Parkin,IPR015496:Ubiquilin,IPR019956:Ubiquitin_dom,IPR029071:Ubiquitin-like_domsf,IPR031127:E3_UB_ligase_RBR,IPR041170:Znf-RING_14,IPR041565:Parkin_Znf-RING,IPR044066:TRIAD_supradom,IPR047534:BRcat_RBR_parkin,IPR047535:RING-HC_RBR_parkin,IPR047536:Rcat_RBR_parkin,	hsa04120:Ubiquitin mediated proteolysis,hsa04137:Mitophagy - animal,hsa04141:Protein processing in endoplasmic reticulum,hsa05012:Parkinson disease,hsa05014:Amyotrophic lateral sclerosis,hsa05022:Pathways of neurodegeneration - multiple diseases,	167000~Ovarian cancer, somatic,211980~Adenocarcinoma of lung, somatic,600116~Parkinson disease, juvenile, type 2,	PIRSF037880:Parkin,	SM00213:UBQ,SM00647:IBR,	KW-0072~Autophagy,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1000~Mitochondrion outer membrane,		KW-0225~Disease variant,KW-0523~Neurodegeneration,KW-0907~Parkinson disease,KW-0908~Parkinsonism,	KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0436~Ligase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0702~S-nitrosylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15),DOMAIN:RING-type,DOMAIN:Ubiquitin-like,MUTAGEN:C->A: Impairs the ability of self-ubiquitination and to ubiquitinate SNCAIP.,MUTAGEN:C->A: Impairs the ability to ubiquitinate SNCAIP.,MUTAGEN:C->A: Loss of activity.,MUTAGEN:C->S: Impairs folding of IBR domain.,MUTAGEN:C->S: Impairs protein folding.,MUTAGEN:C->S: Impairs the ability to ubiquitinate target proteins. No effect on translocation to mitochondria.,MUTAGEN:C->S: Loss of mitochondrial localization.,MUTAGEN:E->Q,A: Impaired activity.,MUTAGEN:G->D: Loss of self-ubiquitination.,MUTAGEN:G->E: Reduced self-ubiquitination.,MUTAGEN:H->N,A: Impaired activity.,MUTAGEN:K->N: Loss of activity towards MIRO1.,MUTAGEN:S->A: Loss of phosphorylation. Undergoes autoubiquitination in the presence of phosphorylated ubiquitin.,MUTAGEN:S->E: Phosphomimetic mutant; still requires PINK1 for activation. PRKN is activated in presence of phosphorylated ubiquitin.,MUTAGEN:T->A: Loss of phosphorylation. Reduced mitochondrial localization; when associated with A-175.,MUTAGEN:T->A: Loss of phosphorylation. Reduced mitochondrial localization; when associated with A-217.,MUTAGEN:T->E: Phosphomimetic mutant. Mostly localizes to the mitochondria; when associated with E-175.,MUTAGEN:T->E: Phosphomimetic mutant. Mostly localizes to the mitochondria; when associated with E-217.,MUTAGEN:T->N: Loss of activity and self-ubiquitination. Loss of monoubiquitination resulting in an increase in apoptosis. No effect on polyubiquitination or mitophagy.,MUTAGEN:W->A: Decreased autoinhibition and increased E3 activity.,REGION:Disordered,REGION:Necessary for PINK1-dependent localization to mitochondria,REGION:REP,REGION:SYT11 binding 1,REGION:SYT11 binding 2,REGION:TRIAD supradomain,ZN_FING:IBR-type,ZN_FING:RING-type 0; atypical,ZN_FING:RING-type 1,ZN_FING:RING-type 2; atypical,
P0C548	patatin-like phospholipase domain containing 2(Pnpla2)	Rattus norvegicus			GO:0006651~diacylglycerol biosynthetic process,GO:0010891~negative regulation of sequestering of triglyceride,GO:0010898~positive regulation of triglyceride catabolic process,GO:0016042~lipid catabolic process,GO:0019433~triglyceride catabolic process,GO:0019915~lipid storage,GO:0034389~lipid particle organization,GO:0042572~retinol metabolic process,GO:0044242~cellular lipid catabolic process,GO:0055088~lipid homeostasis,GO:1905691~lipid particle disassembly,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004623~phospholipase A2 activity,GO:0004806~triglyceride lipase activity,GO:0005515~protein binding,GO:0016411~acylglycerol O-acyltransferase activity,GO:0050253~retinyl-palmitate esterase activity,GO:0051264~mono-olein transacylation activity,GO:0051265~diolein transacylation activity,	IPR002641:PNPLA_dom,IPR016035:Acyl_Trfase/lysoPLipase,IPR033562:PLPL,IPR033903:PNPLA2,	rno00561:Glycerolipid metabolism,rno01100:Metabolic pathways,rno04714:Thermogenesis,rno04923:Regulation of lipolysis in adipocytes,				KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0551~Lipid droplet,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:PNPLA,MOTIF:DGA/G,MOTIF:GXGXXG,MOTIF:GXSXG,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q7ZWC4	pelota mRNA surveillance and ribosome rescue factor(pelo)	Danio rerio			GO:0007049~cell cycle,GO:0032790~ribosome disassembly,GO:0051301~cell division,GO:0070481~nuclear-transcribed mRNA catabolic process, non-stop decay,GO:0070651~nonfunctional rRNA decay,GO:0070966~nuclear-transcribed mRNA catabolic process, no-go decay,GO:0071025~RNA surveillance,GO:0072344~rescue of stalled ribosome,	GO:0005737~cytoplasm,GO:1990533~Dom34-Hbs1 complex,	GO:0043022~ribosome binding,GO:0046872~metal ion binding,	IPR004405:Transl-rel_pelota,IPR005140:eRF1_1_Pelota,IPR005141:eRF1_2,IPR005142:eRF1_3,IPR029064:Ribosomal_eL30-like_sf,IPR038069:Pelota/DOM34_N,IPR042226:eFR1_2_sf,	dre03015:mRNA surveillance pathway,			SM01194:eRF1_1,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0963~Cytoplasm,				KW-0479~Metal-binding,
Q08BB2	peptidase M20 domain containing 1, tandem duplicate 2(pm20d1.2)	Danio rerio			GO:0006508~proteolysis,GO:0006520~cellular amino acid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006807~nitrogen compound metabolic process,GO:0022904~respiratory electron transport chain,GO:0043604~amide biosynthetic process,GO:0043605~cellular amide catabolic process,GO:0044255~cellular lipid metabolic process,GO:0097009~energy homeostasis,GO:1990845~adaptive thermogenesis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0004046~aminoacylase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0016787~hydrolase activity,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0016829~lyase activity,GO:0046872~metal ion binding,	IPR002933:Peptidase_M20,IPR011650:Peptidase_M20_dimer,IPR017141:Pept_M20_carboxypep,IPR036264:Bact_exopeptidase_dim_dom,IPR047177:Pept_M20A,			PIRSF037217:Carboxypeptidase_S,			KW-0964~Secreted,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0456~Lyase,KW-0645~Protease,	KW-0325~Glycoprotein,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase M20 dimerisation,
Q6DIV5	peptidase domain containing associated with muscle regeneration 1(pamr1)	Xenopus tropicalis			GO:0006508~proteolysis,	GO:0005576~extracellular region,	GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR000436:Sushi_SCR_CCP_dom,IPR000742:EGF-like_dom,IPR000859:CUB_dom,IPR001254:Trypsin_dom,IPR001881:EGF-like_Ca-bd_dom,IPR009003:Peptidase_S1_PA,IPR035914:Sperma_CUB_dom_sf,IPR035976:Sushi/SCR/CCP_sf,IPR043504:Peptidase_S1_PA_chymotrypsin,				SM00020:Tryp_SPc,SM00032:CCP,SM00042:CUB,SM00179:EGF_CA,SM00181:EGF,		KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,		KW-0721~Serine protease homolog,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:CUB,DOMAIN:EGF-like,DOMAIN:Peptidase S1,DOMAIN:Sushi,DOMAIN:Sushi 1,DOMAIN:Sushi 2,
P20717	peptidyl arginine deiminase 2(Padi2)	Rattus norvegicus			GO:0006338~chromatin remodeling,GO:0021762~substantia nigra development,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0045815~positive regulation of gene expression, epigenetic,GO:0070100~negative regulation of chemokine-mediated signaling pathway,GO:1901624~negative regulation of lymphocyte chemotaxis,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0000791~euchromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004668~protein-arginine deiminase activity,GO:0005509~calcium ion binding,GO:0030331~estrogen receptor binding,GO:0042803~protein homodimerization activity,	IPR004303:PAD,IPR008972:Cupredoxin,IPR013530:PAD_C,IPR013732:PAD_N,IPR013733:Prot_Arg_deaminase_cen_dom,IPR036556:PAD_central_sf,IPR038685:PAD_N_sf,			PIRSF001247:Protein-arginine_deiminase,			KW-0963~Cytoplasm,				KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,		ACT_SITE:Nucleophile,DOMAIN:Protein-arginine deiminase (PAD) N-terminal,DOMAIN:Protein-arginine deiminase (PAD) central,DOMAIN:Protein-arginine deiminase C-terminal,
Q9D0W5	peptidylprolyl isomerase (cyclophilin)-like 1(Ppil1)	Mus musculus			GO:0000398~mRNA splicing, via spliceosome,GO:0000413~protein peptidyl-prolyl isomerization,GO:0006397~mRNA processing,GO:0006457~protein folding,GO:0008380~RNA splicing,GO:1990403~embryonic brain development,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0016020~membrane,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0016018~cyclosporin A binding,GO:0016853~isomerase activity,GO:0097718~disordered domain specific binding,	IPR002130:Cyclophilin-type_PPIase_dom,IPR020892:Cyclophilin-type_PPIase_CS,IPR024936:Cyclophilin-type_PPIase,IPR029000:Cyclophilin-like_dom_sf,IPR044666:Cyclophilin_A-like,	mmu03040:Spliceosome,		PIRSF001467:Peptidylpro_ismrse,		KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0472~Membrane,KW-0539~Nucleus,KW-0747~Spliceosome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0413~Isomerase,KW-0697~Rotamase,	KW-0597~Phosphoprotein,	DOMAIN:PPIase cyclophilin-type,MUTAGEN:R->A: Loss of isomerase activity. No phenotype when introduced in mice, animals are viable and fertile with no microcephaly or defective cortical lamination; no splicing defect.,TRANSMEM:Helical,
Q9UNP9	peptidylprolyl isomerase E(PPIE)	Homo sapiens			GO:0000398~mRNA splicing, via spliceosome,GO:0000413~protein peptidyl-prolyl isomerization,GO:0006355~regulation of transcription, DNA-templated,GO:0006457~protein folding,GO:0045070~positive regulation of viral genome replication,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0034774~secretory granule lumen,GO:0043231~intracellular membrane-bounded organelle,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1904813~ficolin-1-rich granule lumen,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0016018~cyclosporin A binding,	IPR000504:RRM_dom,IPR002130:Cyclophilin-type_PPIase_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR016304:PPIE,IPR020892:Cyclophilin-type_PPIase_CS,IPR029000:Cyclophilin-like_dom_sf,IPR034168:PPIE_RRM,IPR035979:RBD_domain_sf,	hsa03040:Spliceosome,		PIRSF001475:PPI_cyclophilin_E,	SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,					KW-0413~Isomerase,KW-0694~RNA-binding,KW-0697~Rotamase,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:PPIase cyclophilin-type,DOMAIN:RRM,MUTAGEN:E->A: Slightly decreased affinity for KMT2A.,MUTAGEN:F->A: Expected to disrupt proline isomerase activity. Abolishes inhibition of KMT2A activity; when associated with A-191.,MUTAGEN:F->A: Impairs protein folding.,MUTAGEN:F->A: Strongly decreased affinity for KMT2A. Decreased affinity for RNA.,MUTAGEN:F->D: Abolishes interaction with KMT2A. Abolishes inhibition of KMT2A activity.,MUTAGEN:FM->EE: Expected to disrupt peptidylproline binding. Decreases interaction with KMT2A. Abolishes inhibition of KMT2A activity.,MUTAGEN:K->A: No effect on interaction with KMT2A.,MUTAGEN:L->A: Decreased affinity for KMT2A.,MUTAGEN:Missing: Abolishes interaction with KMT2A.,MUTAGEN:R->A: Expected to disrupt proline isomerase activity. Abolishes inhibition of KMT2A activity; when associated with A-196.,MUTAGEN:R->A: No effect on interaction with KMT2A.,MUTAGEN:Y->A: Decreased affinity for RNA.,REGION:Disordered,
O15534	period circadian regulator 1(PER1)	Homo sapiens		h_circadianPathway:Circadian Rhythms,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002028~regulation of sodium ion transport,GO:0006338~chromatin remodeling,GO:0007623~circadian rhythm,GO:0009649~entrainment of circadian clock,GO:0010608~posttranscriptional regulation of gene expression,GO:0032922~circadian regulation of gene expression,GO:0042634~regulation of hair cycle,GO:0042752~regulation of circadian rhythm,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043153~entrainment of circadian clock by photoperiod,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046329~negative regulation of JNK cascade,GO:0051591~response to cAMP,GO:0097167~circadian regulation of translation,GO:1900015~regulation of cytokine production involved in inflammatory response,GO:1900744~regulation of p38MAPK cascade,GO:2000323~negative regulation of glucocorticoid receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001222~transcription corepressor binding,GO:0005515~protein binding,GO:0019900~kinase binding,GO:0031490~chromatin DNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0070888~E-box binding,	IPR000014:PAS,IPR013655:PAS_fold_3,IPR022728:Period_circadian-like_C,IPR035965:PAS-like_dom_sf,IPR048814:Per1-3_PAS-A,	hsa04710:Circadian rhythm,hsa04713:Circadian entrainment,			SM00091:PAS,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:PAC,DOMAIN:PAS,DOMAIN:PAS 1,DOMAIN:PAS 2,DOMAIN:Period circadian protein homolog 1-3 PAS-A,MOTIF:LXXLL,MOTIF:Nuclear export signal 1,MOTIF:Nuclear export signal 2,MOTIF:Nuclear export signal 3,MOTIF:Nuclear localization signal,MUTAGEN:FLSRF->ALSRA: Strongly decreases interaction with BTRC and FBXW11.,MUTAGEN:SEYT->AEYA: No effect on interaction with BTRC and FBXW11.,MUTAGEN:SVVSVTSQCSFSS->AVVAVTAQCAFAA: No effect on interaction with BTRC and FBXW11.,MUTAGEN:TSGCSS->AAGCSA: Strongly decreases interaction with BTRC and FBXW11 and inhibits degradation promoted by CSNK1E.,REGION:CRY binding domain,REGION:Disordered,REGION:Interaction with BTRC,REGION:Required for phosphorylation by CSNK1E,
Q5RAZ3	peripheral myelin protein 22(PMP22)	Pongo abelii			GO:0007049~cell cycle,GO:0032288~myelin assembly,GO:0051726~regulation of cell cycle,	GO:0005886~plasma membrane,		IPR003936:PMP22,IPR004031:PMP22/EMP/MP20/Claudin,IPR004032:PMP22_EMP_MP20,					KW-0131~Cell cycle,KW-0338~Growth arrest,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0832~Ubl conjugation,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A4IGL7	peroxidasin(pxdn)	Xenopus tropicalis			GO:0001525~angiogenesis,GO:0006979~response to oxidative stress,GO:0007155~cell adhesion,GO:0042744~hydrogen peroxide catabolic process,GO:0051260~protein homooligomerization,GO:0070207~protein homotrimerization,GO:0070831~basement membrane assembly,GO:0071711~basement membrane organization,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0009986~cell surface,GO:0031012~extracellular matrix,	GO:0004601~peroxidase activity,GO:0016491~oxidoreductase activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR000372:LRRNT,IPR000483:Cys-rich_flank_reg_C,IPR001007:VWF_dom,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR010255:Haem_peroxidase_sf,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR019791:Haem_peroxidase_animal,IPR032675:LRR_dom_sf,IPR034824:Peroxidasin_peroxidase,IPR034828:Peroxidasin_Ig-like4,IPR036179:Ig-like_dom_sf,IPR037120:Haem_peroxidase_sf_animal,IPR047018:Peroxidasin_Ig-like3,				SM00013:LRRNT,SM00082:LRRCT,SM00214:VWC,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,	KW-0376~Hydrogen peroxide,	KW-0084~Basement membrane,KW-0256~Endoplasmic reticulum,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0175~Coiled coil,KW-0393~Immunoglobulin domain,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,KW-0575~Peroxidase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,BINDING:axial binding residue,BINDING:covalent,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (with C-1304); in homotrimer,DISULFID:Interchain (with C-726); in homotrimer,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:LRRCT,DOMAIN:LRRNT,DOMAIN:VWFC,REGION:Required in homotrimerization,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,SITE:Cleavage; by FURIN,SITE:Transition state stabilizer,
O08807	peroxiredoxin 4(Prdx4)	Mus musculus			GO:0006979~response to oxidative stress,GO:0007283~spermatogenesis,GO:0008584~male gonad development,GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,GO:0022417~protein maturation by protein folding,GO:0030198~extracellular matrix organization,GO:0033554~cellular response to stress,GO:0042744~hydrogen peroxide catabolic process,GO:0045454~cell redox homeostasis,GO:0072593~reactive oxygen species metabolic process,GO:2000255~negative regulation of male germ cell proliferation,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005790~smooth endoplasmic reticulum,GO:0005829~cytosol,	GO:0004601~peroxidase activity,GO:0005515~protein binding,GO:0008379~thioredoxin peroxidase activity,GO:0016209~antioxidant activity,GO:0016491~oxidoreductase activity,GO:0042802~identical protein binding,GO:0051920~peroxiredoxin activity,GO:0060090~binding, bridging,	IPR000866:AhpC/TSA,IPR013766:Thioredoxin_domain,IPR019479:Peroxiredoxin_C,IPR036249:Thioredoxin-like_sf,						KW-0256~Endoplasmic reticulum,KW-0963~Cytoplasm,			KW-0676~Redox-active center,KW-0732~Signal,		KW-0049~Antioxidant,KW-0560~Oxidoreductase,KW-0575~Peroxidase,	KW-1015~Disulfide bond,	ACT_SITE:Cysteine sulfenic acid (-SOH) intermediate,DISULFID:Interchain (with C-127); in linked form,DISULFID:Interchain (with C-248); in linked form,DOMAIN:Thioredoxin,REGION:Disordered,
P30044	peroxiredoxin 5(PRDX5)	Homo sapiens			GO:0006954~inflammatory response,GO:0006979~response to oxidative stress,GO:0016480~negative regulation of transcription from RNA polymerase III promoter,GO:0032967~positive regulation of collagen biosynthetic process,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0042744~hydrogen peroxide catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0045454~cell redox homeostasis,GO:0051354~negative regulation of oxidoreductase activity,GO:0060785~regulation of apoptosis involved in tissue homeostasis,GO:0070995~NADPH oxidation,GO:0098869~cellular oxidant detoxification,GO:2001057~reactive nitrogen species metabolic process,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0001016~RNA polymerase III regulatory region DNA binding,GO:0004601~peroxidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008379~thioredoxin peroxidase activity,GO:0016209~antioxidant activity,GO:0042802~identical protein binding,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0072541~peroxynitrite reductase activity,	IPR013740:Redoxin,IPR013766:Thioredoxin_domain,IPR036249:Thioredoxin-like_sf,IPR037944:PRX5-like,	hsa04146:Peroxisome,					KW-0496~Mitochondrion,KW-0576~Peroxisome,KW-0963~Cytoplasm,			KW-0676~Redox-active center,KW-0809~Transit peptide,		KW-0049~Antioxidant,KW-0560~Oxidoreductase,KW-0575~Peroxidase,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Cysteine sulfenic acid (-SOH) intermediate,DISULFID:Redox-active,DOMAIN:Thioredoxin,LIPID:S-palmitoyl cysteine,MOTIF:Microbody targeting signal,MUTAGEN:C->S: Loss of antioxidant activity. Loss of S-palmitoylation.,MUTAGEN:C->S: Loss of antioxidant activity. No change in S-palmitoylation levels.,MUTAGEN:C->S: No change in antioxidant activity. No change in S-palmitoylation levels.,TRANSIT:Mitochondrion,
Q9BRX8	peroxiredoxin like 2A(PRXL2A)	Homo sapiens			GO:0045670~regulation of osteoclast differentiation,GO:0098869~cellular oxidant detoxification,	GO:0005576~extracellular region,GO:0005737~cytoplasm,	GO:0016209~antioxidant activity,	IPR032801:PXL2A/B/C,						KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0676~Redox-active center,		KW-0049~Antioxidant,		ACT_SITE:Redox-active,MUTAGEN:C->G: Decrease of about 125% in antioxidant activity in TNFSF11-stimulated osteoclasts and reduced inhibition of TNFSF11-induced osteoclast formation.,MUTAGEN:C->G: Decrease of about 38% in antioxidant activity in TNFSF11-stimulated osteoclasts and reduced inhibition of TNFSF11-induced osteoclast formation. Does not change anti-inflammatory properties.,REGION:Thioredoxin fold,
B5X9L9	peroxiredoxin like 2B(prxl2b)	Salmo salar			GO:0001516~prostaglandin biosynthetic process,	GO:0005829~cytosol,	GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,	IPR013766:Thioredoxin_domain,IPR032801:PXL2A/B/C,IPR036249:Thioredoxin-like_sf,	sasa00590:Arachidonic acid metabolism,sasa01100:Metabolic pathways,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0643~Prostaglandin biosynthesis,KW-0644~Prostaglandin metabolism,	KW-0963~Cytoplasm,				KW-0521~NADP,	KW-0560~Oxidoreductase,		DOMAIN:Thioredoxin,
Q99MZ7	peroxisomal trans-2-enoyl-CoA reductase(Pecr)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0030497~fatty acid elongation,GO:0033306~phytol metabolic process,	GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005102~receptor binding,GO:0016491~oxidoreductase activity,GO:0019166~trans-2-enoyl-CoA reductase (NADPH) activity,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,	mmu04146:Peroxisome,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0576~Peroxisome,				KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,MOTIF:Microbody targeting signal,
Q07869	peroxisome proliferator activated receptor alpha(PPARA)	Homo sapiens		h_bArrestinPathway:-arrestins in GPCR Desensitization,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,h_pgc1aPathway:Regulation of PGC-1a,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_pparPathway:Basic mechanism of action of PPARa, PPARb(d) and PPARg and effects on gene expression,h_tollPathway:Toll-Like Receptor Pathway,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0006094~gluconeogenesis,GO:0006631~fatty acid metabolic process,GO:0007507~heart development,GO:0007584~response to nutrient,GO:0008544~epidermis development,GO:0009267~cellular response to starvation,GO:0009755~hormone-mediated signaling pathway,GO:0010565~regulation of cellular ketone metabolic process,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010883~regulation of lipid storage,GO:0010887~negative regulation of cholesterol storage,GO:0010891~negative regulation of sequestering of triglyceride,GO:0014070~response to organic cyclic compound,GO:0019217~regulation of fatty acid metabolic process,GO:0030154~cell differentiation,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030522~intracellular receptor signaling pathway,GO:0032000~positive regulation of fatty acid beta-oxidation,GO:0032099~negative regulation of appetite,GO:0032868~response to insulin,GO:0032922~circadian regulation of gene expression,GO:0035095~behavioral response to nicotine,GO:0042060~wound healing,GO:0042157~lipoprotein metabolic process,GO:0042752~regulation of circadian rhythm,GO:0043401~steroid hormone mediated signaling pathway,GO:0045471~response to ethanol,GO:0045722~positive regulation of gluconeogenesis,GO:0045776~negative regulation of blood pressure,GO:0045820~negative regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045923~positive regulation of fatty acid metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046209~nitric oxide metabolic process,GO:0046321~positive regulation of fatty acid oxidation,GO:0046889~positive regulation of lipid biosynthetic process,GO:0050728~negative regulation of inflammatory response,GO:0051898~negative regulation of protein kinase B signaling,GO:0061052~negative regulation of cell growth involved in cardiac muscle cell development,GO:0070166~enamel mineralization,GO:0071332~cellular response to fructose stimulus,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903427~negative regulation of reactive oxygen species biosynthetic process,GO:1903944~negative regulation of hepatocyte apoptotic process,GO:1904189~positive regulation of transformation of host cell by virus,GO:2000191~regulation of fatty acid transport,GO:2000272~negative regulation of receptor activity,GO:2001171~positive regulation of ATP biosynthetic process,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001216~bacterial-type RNA polymerase transcriptional activator activity, sequence-specific DNA binding,GO:0001223~transcription coactivator binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0019902~phosphatase binding,GO:0019904~protein domain specific binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0043565~sequence-specific DNA binding,GO:0044877~macromolecular complex binding,GO:0051525~NFAT protein binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0097371~MDM2/MDM4 family protein binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR003074:1Cnucl_rcpt,IPR003076:PPAR-alpha,IPR013088:Znf_NHR/GATA,IPR035500:NHR-like_dom_sf,	hsa03320:PPAR signaling pathway,hsa04024:cAMP signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04936:Alcoholic liver disease,hsa05160:Hepatitis C,hsa05207:Chemical carcinogenesis - receptor activation,hsa05415:Diabetic cardiomyopathy,			SM00399:ZnF_C4,SM00430:HOLI,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0446~Lipid-binding,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,		DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,MUTAGEN:A->T: No effect on heterodimerization with RXRA nor on DNA binding.,MUTAGEN:C->G: Prevents DNA binding but no effect on heterodimerization with RXRA.,MUTAGEN:D->A: Reduced heterodimerization with RXRA. Reduced DNA binding.,MUTAGEN:L->R: Abolishes heterodimerization with RXRA, DNA binding and transactivation activity.,MUTAGEN:L->R: Abolishes heterodimerization with RXRA. No DNA binding.,MUTAGEN:L->R: No effect on heterodimerization with RXRA nor on DNA binding and transactivation activity.,REGION:Required for heterodimerization with RXRA,SITE:Essential for heterodimerization with RXRA,ZN_FING:NR C4-type,
Q96KR7	phosphatase and actin regulator 3(PHACTR3)	Homo sapiens			GO:0030036~actin cytoskeleton organization,	GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,	GO:0003779~actin binding,GO:0004864~protein phosphatase inhibitor activity,GO:0005515~protein binding,	IPR004018:RPEL_repeat,				SM00707:RPEL,		KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0009~Actin-binding,KW-0650~Protein phosphatase inhibitor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Required for PP1CA binding and inhibition of PP1 activity,REPEAT:RPEL,REPEAT:RPEL 1,REPEAT:RPEL 2,REPEAT:RPEL 3,REPEAT:RPEL 4,
F1QIC4	phosphatase and actin regulator 4a(phactr4a)	Danio rerio			GO:0001755~neural crest cell migration,GO:0001843~neural tube closure,GO:0007266~Rho protein signal transduction,GO:0007399~nervous system development,GO:0030036~actin cytoskeleton organization,GO:0043085~positive regulation of catalytic activity,GO:0048484~enteric nervous system development,GO:0051726~regulation of cell cycle,GO:0061386~closure of optic fissure,GO:2001045~negative regulation of integrin-mediated signaling pathway,	GO:0005737~cytoplasm,GO:0030027~lamellipodium,GO:0042995~cell projection,	GO:0003779~actin binding,GO:0008157~protein phosphatase 1 binding,GO:0072542~protein phosphatase activator activity,	IPR004018:RPEL_repeat,				SM00707:RPEL,	KW-0524~Neurogenesis,	KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,		KW-0009~Actin-binding,KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,REPEAT:RPEL,REPEAT:RPEL 1,REPEAT:RPEL 2,REPEAT:RPEL 3,
Q6PEI3	phosphatase and actin regulator 4b(phactr4b)	Danio rerio			GO:0001755~neural crest cell migration,GO:0001843~neural tube closure,GO:0007266~Rho protein signal transduction,GO:0007399~nervous system development,GO:0030036~actin cytoskeleton organization,GO:0043085~positive regulation of catalytic activity,GO:0048484~enteric nervous system development,GO:0051726~regulation of cell cycle,GO:0061386~closure of optic fissure,GO:2001045~negative regulation of integrin-mediated signaling pathway,	GO:0005737~cytoplasm,GO:0030027~lamellipodium,GO:0042995~cell projection,	GO:0003779~actin binding,GO:0008157~protein phosphatase 1 binding,GO:0072542~protein phosphatase activator activity,	IPR004018:RPEL_repeat,				SM00707:RPEL,	KW-0524~Neurogenesis,	KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,		KW-0009~Actin-binding,KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,REPEAT:RPEL,REPEAT:RPEL 1,REPEAT:RPEL 2,REPEAT:RPEL 3,
P70669	phosphate regulating endopeptidase homolog, X-linked(Phex)	Mus musculus			GO:0006508~proteolysis,GO:0016485~protein processing,GO:0019637~organophosphate metabolic process,GO:0030282~bone mineralization,GO:0030324~lung development,GO:0031214~biomineral tissue development,GO:0042476~odontogenesis,GO:0060348~bone development,GO:0060416~response to growth hormone,GO:0071305~cellular response to vitamin D,GO:0071374~cellular response to parathyroid hormone stimulus,GO:1904383~response to sodium phosphate,GO:1990418~response to insulin-like growth factor stimulus,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000718:Peptidase_M13,IPR008753:Peptidase_M13_N,IPR018497:Peptidase_M13_C,IPR024079:MetalloPept_cat_dom_sf,IPR042089:Peptidase_M13_dom_2,					KW-0091~Biomineralization,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase M13,DOMAIN:Peptidase M13 C-terminal,DOMAIN:Peptidase M13 N-terminal,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q9UKL6	phosphatidylcholine transfer protein(PCTP)	Homo sapiens			GO:0006869~lipid transport,GO:0015914~phospholipid transport,	GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008289~lipid binding,GO:0008525~phosphatidylcholine transporter activity,GO:0031210~phosphatidylcholine binding,	IPR002913:START_lipid-bd_dom,IPR023393:START-like_dom_sf,IPR041950:STARD2_START,				SM00234:START,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0963~Cytoplasm,				KW-0446~Lipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:START,MUTAGEN:C->A: Reduces activity by 20%.,
E9Q3L2	phosphatidylinositol 4-kinase alpha(Pi4ka)	Mus musculus			GO:0006629~lipid metabolic process,GO:0016310~phosphorylation,GO:0044788~modulation by host of viral process,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030660~Golgi-associated vesicle membrane,	GO:0000166~nucleotide binding,GO:0004430~1-phosphatidylinositol 4-kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000403:PI3/4_kinase_cat_dom,IPR001263:PI3K_accessory_dom,IPR011009:Kinase-like_dom_sf,IPR015433:PI_Kinase,IPR016024:ARM-type_fold,IPR018936:PI3/4_kinase_CS,IPR036940:PI3/4_kinase_cat_sf,IPR042236:PI3K_accessory_sf,IPR045495:PI4K_N,	mmu00562:Inositol phosphate metabolism,mmu01100:Metabolic pathways,mmu04070:Phosphatidylinositol signaling system,			SM00145:PI3Ka,SM00146:PI3Kc,	KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	DOMAIN:PI3K/PI4K catalytic,DOMAIN:PI4-kinase N-terminal,DOMAIN:PIK helical,REGION:Activation loop,REGION:Catalytic loop,REGION:Disordered,REGION:G-loop,
O55012	phosphatidylinositol binding clathrin assembly protein(Picalm)	Rattus norvegicus			GO:0006879~cellular iron ion homeostasis,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0006900~membrane budding,GO:0007409~axonogenesis,GO:0007611~learning or memory,GO:0010629~negative regulation of gene expression,GO:0016185~synaptic vesicle budding from presynaptic endocytic zone membrane,GO:0016188~synaptic vesicle maturation,GO:0016192~vesicle-mediated transport,GO:0016197~endosomal transport,GO:0030097~hemopoiesis,GO:0030100~regulation of endocytosis,GO:0031623~receptor internalization,GO:0032880~regulation of protein localization,GO:0035459~cargo loading into vesicle,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048261~negative regulation of receptor-mediated endocytosis,GO:0048268~clathrin coat assembly,GO:0048488~synaptic vesicle endocytosis,GO:0048813~dendrite morphogenesis,GO:0050772~positive regulation of axonogenesis,GO:0051223~regulation of protein transport,GO:0060586~multicellular organismal iron ion homeostasis,GO:0072583~clathrin-dependent endocytosis,GO:0097494~regulation of vesicle size,GO:0097753~membrane bending,GO:1900242~regulation of synaptic vesicle endocytosis,GO:1900244~positive regulation of synaptic vesicle endocytosis,GO:1902004~positive regulation of beta-amyloid formation,GO:1902803~regulation of synaptic vesicle transport,GO:1902959~regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902961~positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902963~negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,GO:1903077~negative regulation of protein localization to plasma membrane,GO:1903861~positive regulation of dendrite extension,GO:2000009~negative regulation of protein localization to cell surface,GO:2000331~regulation of terminal button organization,GO:2000809~positive regulation of synaptic vesicle clustering,	GO:0005634~nucleus,GO:0005768~endosome,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0008021~synaptic vesicle,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030132~clathrin coat of coated pit,GO:0030136~clathrin-coated vesicle,GO:0031982~vesicle,GO:0042734~presynaptic membrane,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070381~endosome to plasma membrane transport vesicle,GO:0097418~neurofibrillary tangle,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098688~parallel fiber to Purkinje cell synapse,GO:0098794~postsynapse,GO:0098894~extrinsic component of presynaptic endocytic zone membrane,	GO:0000149~SNARE binding,GO:0005515~protein binding,GO:0005545~1-phosphatidylinositol binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0017124~SH3 domain binding,GO:0030276~clathrin binding,GO:0031267~small GTPase binding,GO:0032050~clathrin heavy chain binding,GO:0042802~identical protein binding,GO:0048156~tau protein binding,GO:0050750~low-density lipoprotein particle receptor binding,	IPR008942:ENTH_VHS,IPR011417:ANTH_dom,IPR013809:ENTH,IPR014712:ANTH_dom_sf,IPR045192:AP180-like,				SM00273:ENTH,	KW-0254~Endocytosis,	KW-0168~Coated pit,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:ENTH,REGION:Disordered,REGION:Interaction with PIMREG,
Q5R6L8	phosphatidylinositol glycan anchor biosynthesis class K(PIGK)	Pongo abelii			GO:0006508~proteolysis,GO:0016255~attachment of GPI anchor to protein,	GO:0042765~GPI-anchor transamidase complex,	GO:0003923~GPI-anchor transamidase activity,	IPR001096:Peptidase_C13,IPR028361:GPI_transamidase,	pon00563:Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,pon01100:Metabolic pathways,		PIRSF019663:Legumain,PIRSF500138:GPI8,		KW-0337~GPI-anchor biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,DISULFID:Interchain (with C-186 in PIGT),REGION:Essential for GPI attachment,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
P48739	phosphatidylinositol transfer protein beta(PITPNB)	Homo sapiens			GO:0006629~lipid metabolic process,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006997~nucleus organization,GO:0015914~phospholipid transport,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,	GO:0005515~protein binding,GO:0008525~phosphatidylcholine transporter activity,GO:0008526~phosphatidylinositol transporter activity,GO:0031210~phosphatidylcholine binding,GO:0035091~phosphatidylinositol binding,	IPR001666:PI_transfer,IPR023393:START-like_dom_sf,					KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,				KW-0446~Lipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	MUTAGEN:C->A: No effect on phosphatidylinositol transfer activity.,MUTAGEN:C->T,A: Loss of phosphatidylcholine transfer activity but no effect on phosphatidylinositol transfer activity. Not inhibited by N-ethylmaleimide. Fails to rescue the retrograde transport defect from the Golgi to endoplasmic reticulum in PITPNB-deficient cells.,MUTAGEN:K->A: Loss of phosphatidylinositol transfer activity but no effect on phosphatidylcholine transfer activity. Fails to rescue the retrograde transport defect from the Golgi to endoplasmic reticulum in PITPNB-deficient cells.,MUTAGEN:N->F: Loss of phosphatidylinositol transfer activity but no effect on phosphatidylcholine transfer activity. Fails to rescue the retrograde transport defect from the Golgi to endoplasmic reticulum in PITPNB-deficient cells.,MUTAGEN:WW->AA: Loss of phosphatidylinositol transfer activity. Fails to rescue the retrograde transport defect from the Golgi to endoplasmic reticulum in PITPNB-deficient cells.,
Q70Z35	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2(PREX2)	Homo sapiens			GO:0007186~G-protein coupled receptor signaling pathway,GO:0008344~adult locomotory behavior,GO:0023051~regulation of signaling,GO:0035556~intracellular signal transduction,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0048813~dendrite morphogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,	IPR000219:DH-domain,IPR000591:DEP_dom,IPR001331:GDS_CDC24_CS,IPR001478:PDZ,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR036034:PDZ_sf,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR037367:Rex2_DEP_1,				SM00049:DEP,SM00228:PDZ,SM00233:PH,SM00325:RhoGEF,					KW-0677~Repeat,		KW-0344~Guanine-nucleotide releasing factor,		DOMAIN:DEP,DOMAIN:DEP 1,DOMAIN:DEP 2,DOMAIN:DH,DOMAIN:PDZ,DOMAIN:PDZ 1,DOMAIN:PDZ 2,DOMAIN:PH,REGION:Disordered,
Q5T9C9	phosphatidylinositol-4-phosphate 5-kinase like 1(PIP5KL1)	Homo sapiens			GO:0001933~negative regulation of protein phosphorylation,GO:0010917~negative regulation of mitochondrial membrane potential,GO:0016310~phosphorylation,GO:0030336~negative regulation of cell migration,GO:0043065~positive regulation of apoptotic process,GO:0046854~phosphatidylinositol phosphorylation,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0042995~cell projection,	GO:0005524~ATP binding,GO:0016308~1-phosphatidylinositol-4-phosphate 5-kinase activity,	IPR002498:PInositol-4-P-5-kinase_core,IPR023610:PInositol-4-P-5-kinase,IPR027484:PInositol-4-P-5-kinase_N,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04144:Endocytosis,			SM00330:PIPKc,	KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		DOMAIN:PIPK,
P34024	phosphatidylinositol-specific phospholipase c(plcA)	Listeria monocytogenes EGD-e			GO:0006629~lipid metabolic process,GO:0016042~lipid catabolic process,	GO:0005576~extracellular region,GO:0005737~cytoplasm,	GO:0004436~phosphatidylinositol diacylglycerol-lyase activity,GO:0008081~phosphoric diester hydrolase activity,	IPR000909:PLipase_C_PInositol-sp_X_dom,IPR017946:PLC-like_Pdiesterase_TIM-brl,	lmo00562:Inositol phosphate metabolism,lmo01100:Metabolic pathways,			SM00148:PLCXc,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,KW-0843~Virulence,	KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0732~Signal,		KW-0456~Lyase,		ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,DOMAIN:PI-PLC X-box,DOMAIN:Phosphatidylinositol-specific phospholipase C X,
Q803C9	phosphatidylserine synthase 1a(ptdss1a)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006659~phosphatidylserine biosynthetic process,GO:0008654~phospholipid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0016740~transferase activity,	IPR004277:PSS,	dre00564:Glycerophospholipid metabolism,dre01100:Metabolic pathways,				KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0594~Phospholipid biosynthesis,KW-1208~Phospholipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,		REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q14432	phosphodiesterase 3A(PDE3A)	Homo sapiens		h_no1Pathway:Actions of Nitric Oxide in the Heart,	GO:0001556~oocyte maturation,GO:0006629~lipid metabolic process,GO:0007186~G-protein coupled receptor signaling pathway,GO:0009410~response to xenobiotic stimulus,GO:0019933~cAMP-mediated signaling,GO:0019934~cGMP-mediated signaling,GO:0040020~regulation of meiotic nuclear division,GO:0043066~negative regulation of apoptotic process,GO:0043116~negative regulation of vascular permeability,GO:0043117~positive regulation of vascular permeability,GO:0043401~steroid hormone mediated signaling pathway,GO:0043951~negative regulation of cAMP-mediated signaling,GO:0060282~positive regulation of oocyte development,GO:0060700~regulation of ribonuclease activity,GO:0071321~cellular response to cGMP,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0097190~apoptotic signaling pathway,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0004119~cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,GO:0005515~protein binding,GO:0030284~estrogen receptor activity,GO:0046872~metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,GO:0099130~estrogen binding,	IPR002073:PDEase_catalytic_dom,IPR003607:HD/PDEase_dom,IPR023174:PDEase_CS,IPR036971:PDEase_catalytic_dom_sf,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04924:Renin secretion,hsa05032:Morphine addiction,	112410~Hypertension and brachydactyly syndrome,		SM00471:HDc,		KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0114~cAMP,KW-0140~cGMP,KW-0464~Manganese,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Proton donor,COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:PDEase,MUTAGEN:F->D,A: Loss of interaction with SLFN12.,MUTAGEN:N->R: Loss of interaction with SLFN12.,REGION:Disordered,REGION:Interaction with SLFN12,TRANSMEM:Helical,
P14646	phosphodiesterase 4B(Pde4b)	Rattus norvegicus			GO:0001780~neutrophil homeostasis,GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0019933~cAMP-mediated signaling,GO:0030593~neutrophil chemotaxis,GO:0032729~positive regulation of interferon-gamma production,GO:0032743~positive regulation of interleukin-2 production,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0071222~cellular response to lipopolysaccharide,GO:0071466~cellular response to xenobiotic stimulus,GO:0071872~cellular response to epinephrine stimulus,GO:0071878~negative regulation of adrenergic receptor signaling pathway,GO:0086004~regulation of cardiac muscle cell contraction,GO:1901898~negative regulation of relaxation of cardiac muscle,GO:1902514~regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,	GO:0000930~gamma-tubulin complex,GO:0005634~nucleus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005891~voltage-gated calcium channel complex,GO:0008021~synaptic vesicle,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030018~Z disc,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,GO:0060076~excitatory synapse,GO:0071944~cell periphery,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0005246~calcium channel regulator activity,GO:0016787~hydrolase activity,GO:0030552~cAMP binding,GO:0043015~gamma-tubulin binding,GO:0044325~ion channel binding,GO:0046872~metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,	IPR002073:PDEase_catalytic_dom,IPR003607:HD/PDEase_dom,IPR023088:PDEase,IPR023174:PDEase_CS,IPR036971:PDEase_catalytic_dom_sf,IPR040844:PDE4_UCR,	rno00230:Purine metabolism,rno01100:Metabolic pathways,rno04024:cAMP signaling pathway,rno04928:Parathyroid hormone synthesis, secretion and action,rno05032:Morphine addiction,			SM00471:HDc,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,				KW-0114~cAMP,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton donor,COMPBIAS:Basic and acidic residues,DOMAIN:PDEase,DOMAIN:Phosphodiesterase 4 upstream conserved regions (UCR),REGION:Disordered,
Q5VU43	phosphodiesterase 4D interacting protein(PDE4DIP)	Homo sapiens			GO:0007098~centrosome cycle,GO:0030036~actin cytoskeleton organization,GO:0030953~astral microtubule organization,GO:0065003~macromolecular complex assembly,GO:0090063~positive regulation of microtubule nucleation,GO:1903358~regulation of Golgi organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0030016~myofibril,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0060090~binding, bridging,	IPR005454:Profilin1/2/3_vertebrate,IPR010630:Olduvai_dom,IPR012943:Cnn_1N,IPR036140:PFN_sf,IPR040947:SMYLE_N,				SM01148:DUF1220,		KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Centrosomin N-terminal motif 1,DOMAIN:Olduvai,REGION:Disordered,SITE:Breakpoint for insertion to form PDE4DIP-PDGFRB fusion protein,
Q8QZV1	phosphodiesterase 9A(Pde9a)	Rattus norvegicus			GO:0007165~signal transduction,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0019933~cAMP-mediated signaling,GO:0046068~cGMP metabolic process,GO:0046069~cGMP catabolic process,GO:1900273~positive regulation of long-term synaptic potentiation,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005654~nucleoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0032587~ruffle membrane,GO:0042383~sarcolemma,GO:0043204~perikaryon,GO:0048471~perinuclear region of cytoplasm,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,	IPR002073:PDEase_catalytic_dom,IPR003607:HD/PDEase_dom,IPR023088:PDEase,IPR023174:PDEase_CS,IPR036971:PDEase_catalytic_dom_sf,	rno00230:Purine metabolism,rno01100:Metabolic pathways,			SM00471:HDc,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,				KW-0140~cGMP,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton donor,COMPBIAS:Basic and acidic residues,DOMAIN:PDEase,REGION:Disordered,
Q01813	phosphofructokinase, platelet(PFKP)	Homo sapiens		h_ptdinsPathway:Phosphoinositides and their downstream targets.,	GO:0006002~fructose 6-phosphate metabolic process,GO:0016310~phosphorylation,GO:0030388~fructose 1,6-bisphosphate metabolic process,GO:0061621~canonical glycolysis,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005945~6-phosphofructokinase complex,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003872~6-phosphofructokinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016208~AMP binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:0045296~cadherin binding,GO:0046872~metal ion binding,GO:0048029~monosaccharide binding,GO:0070095~fructose-6-phosphate binding,	IPR000023:Phosphofructokinase_dom,IPR009161:6-Pfructokinase_euk,IPR015912:Phosphofructokinase_CS,IPR022953:ATP_PFK,IPR035966:PKF_sf,IPR041914:PFK_vert-type,	hsa00010:Glycolysis / Gluconeogenesis,hsa00030:Pentose phosphate pathway,hsa00051:Fructose and mannose metabolism,hsa00052:Galactose metabolism,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,hsa01230:Biosynthesis of amino acids,hsa03018:RNA degradation,hsa04066:HIF-1 signaling pathway,hsa04152:AMPK signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04922:Glucagon signaling pathway,hsa05230:Central carbon metabolism in cancer,		PIRSF000533:ATP_PFK_euk,		KW-0324~Glycolysis,	KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0418~Kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,BINDING:in other chain,CARBOHYD:O-linked (GlcNAc) serine,DOMAIN:Phosphofructokinase,MUTAGEN:S->A: Decreased interaction with ATG4B.,REGION:C-terminal regulatory PFK domain 2,REGION:Interdomain linker,REGION:N-terminal catalytic PFK domain 1,
Q86VP3	phosphofurin acidic cluster sorting protein 2(PACS2)	Homo sapiens			GO:0000045~autophagosome assembly,GO:0006915~apoptotic process,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0034497~protein localization to pre-autophagosomal structure,GO:0072659~protein localization to plasma membrane,GO:1990456~mitochondrion-ER tethering,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,	GO:0005515~protein binding,GO:0044325~ion channel binding,	IPR019381:Phosphofurin_acidic_CS-1,		618067~Developmental and epileptic encephalopathy 66,			KW-0053~Apoptosis,KW-0945~Host-virus interaction,	KW-0256~Endoplasmic reticulum,KW-0496~Mitochondrion,		KW-0225~Disease variant,KW-0887~Epilepsy,				KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q8WYR1	phosphoinositide-3-kinase regulatory subunit 5(PIK3R5)	Homo sapiens	101.Gprot_coupled_Rec_MAP_Kinase,		GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0016310~phosphorylation,GO:0043406~positive regulation of MAP kinase activity,GO:0043491~protein kinase B signaling,GO:0046488~phosphatidylinositol metabolic process,GO:0051897~positive regulation of protein kinase B signaling,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0005943~phosphatidylinositol 3-kinase complex, class IA,GO:0005944~phosphatidylinositol 3-kinase complex, class IB,GO:0016020~membrane,GO:0034451~centriolar satellite,	GO:0016301~kinase activity,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,	IPR019522:PIK3R5/6,	hsa04022:cGMP-PKG signaling pathway,hsa04062:Chemokine signaling pathway,hsa04072:Phospholipase D signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04371:Apelin signaling pathway,hsa04611:Platelet activation,hsa04725:Cholinergic synapse,hsa04921:Oxytocin signaling pathway,hsa05145:Toxoplasmosis,hsa05167:Kaposi sarcoma-associated herpesvirus infection,	615217~Ataxia-oculomotor apraxia 3,				KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0523~Neurodegeneration,			KW-0418~Kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,REGION:Heterodimerization,REGION:Interaction with beta-gamma G protein dimers,
Q6NYZ4	phospholipase A1 member A(pla1a)	Danio rerio			GO:0006629~lipid metabolic process,GO:0016042~lipid catabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0008970~phosphatidylcholine 1-acylhydrolase activity,GO:0016298~lipase activity,GO:0016787~hydrolase activity,GO:0052689~carboxylic ester hydrolase activity,	IPR000734:TAG_lipase,IPR013818:Lipase,IPR016272:Lipase_LIPH,IPR029058:AB_hydrolase,IPR033906:Lipase_N,	dre00564:Glycerophospholipid metabolism,		PIRSF000865:Lipoprotein_lipase_LIPH,		KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0964~Secreted,			KW-0732~Signal,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) asparagine,
Q9NZ20	phospholipase A2 group III(PLA2G3)	Homo sapiens			GO:0001675~acrosome assembly,GO:0002532~production of molecular mediator involved in inflammatory response,GO:0006644~phospholipid metabolic process,GO:0006658~phosphatidylserine metabolic process,GO:0007288~sperm axoneme assembly,GO:0010629~negative regulation of gene expression,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0010976~positive regulation of neuron projection development,GO:0019372~lipoxygenase pathway,GO:0031394~positive regulation of prostaglandin biosynthetic process,GO:0032308~positive regulation of prostaglandin secretion,GO:0034374~low-density lipoprotein particle remodeling,GO:0034375~high-density lipoprotein particle remodeling,GO:0042116~macrophage activation,GO:0043303~mast cell degranulation,GO:0043524~negative regulation of neuron apoptotic process,GO:0046337~phosphatidylethanolamine metabolic process,GO:0046470~phosphatidylcholine metabolic process,GO:0046471~phosphatidylglycerol metabolic process,GO:0046473~phosphatidic acid metabolic process,GO:0046488~phosphatidylinositol metabolic process,GO:0048469~cell maturation,GO:0050482~arachidonic acid secretion,GO:0060271~cilium assembly,GO:0060376~positive regulation of mast cell differentiation,GO:1900017~positive regulation of cytokine production involved in inflammatory response,GO:1900222~negative regulation of beta-amyloid clearance,GO:1903595~positive regulation of histamine secretion by mast cell,GO:2001135~regulation of endocytic recycling,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005814~centriole,GO:0005886~plasma membrane,GO:0055037~recycling endosome,	GO:0046872~metal ion binding,GO:0047498~calcium-dependent phospholipase A2 activity,	IPR016090:PLipase_A2_dom,IPR033113:PLipase_A2_His_AS,IPR036444:PLipase_A2_dom_sf,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04014:Ras signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04972:Pancreatic secretion,hsa04975:Fat digestion and absorption,				KW-0443~Lipid metabolism,KW-0467~Mast cell degranulation,KW-0970~Cilium biogenesis/degradation,KW-1208~Phospholipid metabolism,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0964~Secreted,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic residues,MUTAGEN:H->Q: Impairs PGE2 synthesis. Impairs PGD2 synthesis. Impairs mast cell degranulation. Impairs neurite outgrowth.,MUTAGEN:N->S: Loss of glycosylation.,REGION:Disordered,REGION:Phospholipase A2-like,
Q64GA5	phospholipase A2, group IVC (cytosolic, calcium-independent)(Pla2g4c)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006663~platelet activating factor biosynthetic process,GO:0009395~phospholipid catabolic process,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0046475~glycerophospholipid catabolic process,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005938~cell cortex,GO:0031966~mitochondrial membrane,	GO:0004620~phospholipase activity,GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008374~O-acyltransferase activity,GO:0016740~transferase activity,GO:0016787~hydrolase activity,GO:0047498~calcium-dependent phospholipase A2 activity,GO:0047499~calcium-independent phospholipase A2 activity,	IPR002642:LysoPLipase_cat_dom,IPR016035:Acyl_Trfase/lysoPLipase,	mmu00564:Glycerophospholipid metabolism,mmu00565:Ether lipid metabolism,mmu00590:Arachidonic acid metabolism,mmu00591:Linoleic acid metabolism,mmu00592:alpha-Linolenic acid metabolism,mmu01100:Metabolic pathways,mmu04010:MAPK signaling pathway,mmu04014:Ras signaling pathway,mmu04072:Phospholipase D signaling pathway,mmu04217:Necroptosis,mmu04270:Vascular smooth muscle contraction,mmu04370:VEGF signaling pathway,mmu04611:Platelet activation,mmu04664:Fc epsilon RI signaling pathway,mmu04666:Fc gamma R-mediated phagocytosis,mmu04724:Glutamatergic synapse,mmu04726:Serotonergic synapse,mmu04730:Long-term depression,mmu04750:Inflammatory mediator regulation of TRP channels,mmu04912:GnRH signaling pathway,mmu04913:Ovarian steroidogenesis,mmu04921:Oxytocin signaling pathway,mmu05231:Choline metabolism in cancer,			SM00022:PLAc,	KW-0443~Lipid metabolism,KW-1208~Phospholipid metabolism,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0808~Transferase,		ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,DOMAIN:PLA2c,REGION:Disordered,
Q99P27	phospholipase A2, group XIIB(Pla2g12b)	Mus musculus			GO:0006644~phospholipid metabolic process,GO:0016042~lipid catabolic process,GO:0034374~low-density lipoprotein particle remodeling,GO:0042632~cholesterol homeostasis,GO:0050482~arachidonic acid secretion,GO:0070328~triglyceride homeostasis,	GO:0005576~extracellular region,	GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR010711:PLA2G12,IPR036444:PLipase_A2_dom_sf,	mmu00564:Glycerophospholipid metabolism,mmu00565:Ether lipid metabolism,mmu00590:Arachidonic acid metabolism,mmu00591:Linoleic acid metabolism,mmu00592:alpha-Linolenic acid metabolism,mmu01100:Metabolic pathways,mmu04014:Ras signaling pathway,mmu04270:Vascular smooth muscle contraction,mmu04972:Pancreatic secretion,mmu04975:Fat digestion and absorption,					KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,
Q06HQ7	phospholipase B1(PLB1)	Monodelphis domestica			GO:0006644~phospholipid metabolic process,GO:2000344~positive regulation of acrosome reaction,	GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,	GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0004806~triglyceride lipase activity,GO:0050253~retinyl-palmitate esterase activity,	IPR001087:GDSL,IPR008265:Lipase_GDSL_AS,IPR035547:Phospholipase_B,IPR036514:SGNH_hydro_sf,IPR038885:PLB1,	mdo00564:Glycerophospholipid metabolism,mdo00565:Ether lipid metabolism,mdo00590:Arachidonic acid metabolism,mdo00591:Linoleic acid metabolism,mdo00592:alpha-Linolenic acid metabolism,mdo01100:Metabolic pathways,mdo04977:Vitamin digestion and absorption,				KW-0443~Lipid metabolism,KW-1208~Phospholipid metabolism,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:4 X 308-326 AA approximate repeats,REGION:Necessary for membrane localization,REPEAT:1,REPEAT:2,REPEAT:3,REPEAT:4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P10687	phospholipase C beta 1(Plcb1)	Rattus norvegicus			GO:0000086~G2/M transition of mitotic cell cycle,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007207~phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007215~glutamate receptor signaling pathway,GO:0007612~learning,GO:0007613~memory,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0010243~response to organonitrogen compound,GO:0016042~lipid catabolic process,GO:0021987~cerebral cortex development,GO:0031161~phosphatidylinositol catabolic process,GO:0032024~positive regulation of insulin secretion,GO:0032735~positive regulation of interleukin-12 production,GO:0032957~inositol trisphosphate metabolic process,GO:0034284~response to monosaccharide,GO:0035556~intracellular signal transduction,GO:0035722~interleukin-12-mediated signaling pathway,GO:0035723~interleukin-15-mediated signaling pathway,GO:0040019~positive regulation of embryonic development,GO:0043434~response to peptide hormone,GO:0045444~fat cell differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046330~positive regulation of JNK cascade,GO:0046488~phosphatidylinositol metabolic process,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048639~positive regulation of developmental growth,GO:0051209~release of sequestered calcium ion into cytosol,GO:0060466~activation of meiosis involved in egg activation,GO:0070498~interleukin-1-mediated signaling pathway,GO:0080154~regulation of fertilization,GO:0099105~ion channel modulating, G-protein coupled receptor signaling pathway,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1902618~cellular response to fluoride,GO:1903140~regulation of establishment of endothelial barrier,GO:1904117~cellular response to vasopressin,GO:1904637~cellular response to ionomycin,GO:1905631~cellular response to glyceraldehyde,GO:2000344~positive regulation of acrosome reaction,GO:2000438~negative regulation of monocyte extravasation,GO:2000560~positive regulation of CD24 biosynthetic process,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0031965~nuclear membrane,GO:0032991~macromolecular complex,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,GO:0099524~postsynaptic cytosol,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0005096~GTPase activator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005521~lamin binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0019899~enzyme binding,GO:0042802~identical protein binding,	IPR000008:C2_dom,IPR000909:PLipase_C_PInositol-sp_X_dom,IPR001192:PI-PLC_fam,IPR001711:PLipase_C_Pinositol-sp_Y,IPR009535:PLC-beta_CS,IPR011992:EF-hand-dom_pair,IPR014815:PLC-beta_C,IPR015359:PLC_EF-hand-like,IPR016280:PLC-beta,IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR028400:PLC-beta1_EF,IPR035892:C2_domain_sf,IPR037862:PLC-beta_PH,IPR042531:PLC-beta_C_sf,	rno00562:Inositol phosphate metabolism,rno01100:Metabolic pathways,rno04015:Rap1 signaling pathway,rno04020:Calcium signaling pathway,rno04022:cGMP-PKG signaling pathway,rno04062:Chemokine signaling pathway,rno04070:Phosphatidylinositol signaling system,rno04071:Sphingolipid signaling pathway,rno04072:Phospholipase D signaling pathway,rno04261:Adrenergic signaling in cardiomyocytes,rno04270:Vascular smooth muscle contraction,rno04310:Wnt signaling pathway,rno04371:Apelin signaling pathway,rno04540:Gap junction,rno04611:Platelet activation,rno04613:Neutrophil extracellular trap formation,rno04621:NOD-like receptor signaling pathway,rno04713:Circadian entrainment,rno04720:Long-term potentiation,rno04723:Retrograde endocannabinoid signaling,rno04724:Glutamatergic synapse,rno04725:Cholinergic synapse,rno04726:Serotonergic synapse,rno04728:Dopaminergic synapse,rno04730:Long-term depression,rno04742:Taste transduction,rno04750:Inflammatory mediator regulation of TRP channels,rno04911:Insulin secretion,rno04912:GnRH signaling pathway,rno04915:Estrogen signaling pathway,rno04916:Melanogenesis,rno04918:Thyroid hormone synthesis,rno04919:Thyroid hormone signaling pathway,rno04921:Oxytocin signaling pathway,rno04922:Glucagon signaling pathway,rno04924:Renin secretion,rno04925:Aldosterone synthesis and secretion,rno04926:Relaxin signaling pathway,rno04927:Cortisol synthesis and secretion,rno04928:Parathyroid hormone synthesis, secretion and action,rno04929:GnRH secretion,rno04933:AGE-RAGE signaling pathway in diabetic complications,rno04934:Cushing syndrome,rno04935:Growth hormone synthesis, secretion and action,rno04961:Endocrine and other factor-regulated calcium reabsorption,rno04970:Salivary secretion,rno04971:Gastric acid secretion,rno04972:Pancreatic secretion,rno04973:Carbohydrate digestion and absorption,rno05010:Alzheimer disease,rno05016:Huntington disease,rno05017:Spinocerebellar ataxia,rno05022:Pathways of neurodegeneration - multiple diseases,rno05142:Chagas disease,rno05143:African trypanosomiasis,rno05146:Amoebiasis,rno05163:Human cytomegalovirus infection,rno05200:Pathways in cancer,rno05415:Diabetic cardiomyopathy,rno05417:Lipid and atherosclerosis,		PIRSF000956:PLC-beta,	SM00148:PLCXc,SM00149:PLCYc,SM00239:C2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0807~Transducer,	KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:PI-PLC X-box,DOMAIN:PI-PLC Y-box,LIPID:S-palmitoyl cysteine,REGION:Disordered,
Q8N3E9	phospholipase C delta 3(PLCD3)	Homo sapiens			GO:0001525~angiogenesis,GO:0006629~lipid metabolic process,GO:0016042~lipid catabolic process,GO:0035556~intracellular signal transduction,GO:0042127~regulation of cell proliferation,GO:0060716~labyrinthine layer blood vessel development,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0032154~cleavage furrow,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR000909:PLipase_C_PInositol-sp_X_dom,IPR001192:PI-PLC_fam,IPR001711:PLipase_C_Pinositol-sp_Y,IPR001849:PH_domain,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR018247:EF_Hand_1_Ca_BS,IPR035892:C2_domain_sf,IPR039504:PLC-delta3_EF-hand,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04919:Thyroid hormone signaling pathway,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa05131:Shigellosis,			SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0807~Transducer,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,DOMAIN:C2,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:PH,DOMAIN:PI-PLC X-box,DOMAIN:PI-PLC Y-box,REGION:Disordered,REGION:Substrate binding,
Q32NH8	phospholipase C delta 4 L homeolog(plcd4.L)	Xenopus laevis			GO:0006629~lipid metabolic process,GO:0007165~signal transduction,GO:0016042~lipid catabolic process,GO:0035556~intracellular signal transduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0005509~calcium ion binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR000909:PLipase_C_PInositol-sp_X_dom,IPR001192:PI-PLC_fam,IPR001711:PLipase_C_Pinositol-sp_Y,IPR001849:PH_domain,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,IPR015359:PLC_EF-hand-like,IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR018247:EF_Hand_1_Ca_BS,IPR035892:C2_domain_sf,	xla00562:Inositol phosphate metabolism,xla01100:Metabolic pathways,xla04020:Calcium signaling pathway,xla04070:Phosphatidylinositol signaling system,			SM00054:EFh,SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0807~Transducer,		COMPBIAS:Acidic residues,DOMAIN:C2,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:PH,DOMAIN:PI-PLC X-box,DOMAIN:PI-PLC Y-box,MOTIF:GBA,MOTIF:PDZ-binding,REGION:Disordered,REGION:Substrate binding,
A5D6R3	phospholipase C, delta 3a(plcd3a)	Danio rerio			GO:0006629~lipid metabolic process,GO:0007165~signal transduction,GO:0016042~lipid catabolic process,GO:0035556~intracellular signal transduction,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0032154~cleavage furrow,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0005509~calcium ion binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR000909:PLipase_C_PInositol-sp_X_dom,IPR001192:PI-PLC_fam,IPR001711:PLipase_C_Pinositol-sp_Y,IPR001849:PH_domain,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR018247:EF_Hand_1_Ca_BS,IPR035892:C2_domain_sf,IPR039504:PLC-delta3_EF-hand,	dre00562:Inositol phosphate metabolism,dre01100:Metabolic pathways,dre04020:Calcium signaling pathway,dre04070:Phosphatidylinositol signaling system,			SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0807~Transducer,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:C2,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:PH,DOMAIN:PI-PLC X-box,DOMAIN:PI-PLC Y-box,REGION:Disordered,REGION:Substrate binding,
Q62077	phospholipase C, gamma 1(Plcg1)	Mus musculus		m_bcrPathway:BCR Signaling Pathway,m_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,m_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,m_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,m_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,m_cxcr4Pathway:CXCR4 Signaling Pathway,m_egfPathway:EGF Signaling Pathway,m_epoPathway:EPO Signaling Pathway,m_erk5Pathway:Role of Erk5 in Neuronal Survival,m_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,m_ghPathway:Growth Hormone Signaling Pathway,m_gpcrPathway:Signaling Pathway from G-Protein Families,m_ionPathway:Ion Channel and Phorbal Esters Signaling Pathway,m_ngfPathway:Nerve growth factor pathway (NGF),m_pdgfPathway:PDGF Signaling Pathway,m_plcPathway:Phospholipase C Signaling Pathway,m_ptdinsPathway:Phosphoinositides and their downstream targets.,m_pyk2Pathway:Links between Pyk2 and Map Kinases,m_tcrPathway:T Cell Receptor Signaling Pathway,m_tpoPathway:TPO Signaling Pathway,m_trkaPathway:Trka Receptor Signaling Pathway,m_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,	GO:0001701~in utero embryonic development,GO:0006629~lipid metabolic process,GO:0006816~calcium ion transport,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0009395~phospholipid catabolic process,GO:0010243~response to organonitrogen compound,GO:0010634~positive regulation of epithelial cell migration,GO:0016042~lipid catabolic process,GO:0016477~cell migration,GO:0019722~calcium-mediated signaling,GO:0031161~phosphatidylinositol catabolic process,GO:0032957~inositol trisphosphate metabolic process,GO:0032959~inositol trisphosphate biosynthetic process,GO:0035556~intracellular signal transduction,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045766~positive regulation of angiogenesis,GO:0046488~phosphatidylinositol metabolic process,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050804~modulation of synaptic transmission,GO:0050852~T cell receptor signaling pathway,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0071364~cellular response to epidermal growth factor stimulus,GO:1904643~response to curcumin,GO:1905564~positive regulation of vascular endothelial cell proliferation,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0008180~COP9 signalosome,GO:0030027~lamellipodium,GO:0030136~clathrin-coated vesicle,GO:0032587~ruffle membrane,GO:0042995~cell projection,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098978~glutamatergic synapse,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004629~phospholipase C activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005158~insulin receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016787~hydrolase activity,GO:0019901~protein kinase binding,GO:0030971~receptor tyrosine kinase binding,GO:0035254~glutamate receptor binding,GO:0046872~metal ion binding,GO:0050429~calcium-dependent phospholipase C activity,GO:0051219~phosphoprotein binding,	IPR000008:C2_dom,IPR000909:PLipase_C_PInositol-sp_X_dom,IPR000980:SH2,IPR001192:PI-PLC_fam,IPR001452:SH3_domain,IPR001711:PLipase_C_Pinositol-sp_Y,IPR001849:PH_domain,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,IPR016279:PLC-gamma,IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR018247:EF_Hand_1_Ca_BS,IPR035023:PLC-gamma_C-SH2,IPR035024:PLC-gamma_N-SH2,IPR035724:PLCgamma1_SH3,IPR035892:C2_domain_sf,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,	mmu00562:Inositol phosphate metabolism,mmu01100:Metabolic pathways,mmu01521:EGFR tyrosine kinase inhibitor resistance,mmu04012:ErbB signaling pathway,mmu04014:Ras signaling pathway,mmu04015:Rap1 signaling pathway,mmu04020:Calcium signaling pathway,mmu04062:Chemokine signaling pathway,mmu04064:NF-kappa B signaling pathway,mmu04066:HIF-1 signaling pathway,mmu04070:Phosphatidylinositol signaling system,mmu04072:Phospholipase D signaling pathway,mmu04360:Axon guidance,mmu04370:VEGF signaling pathway,mmu04613:Neutrophil extracellular trap formation,mmu04650:Natural killer cell mediated cytotoxicity,mmu04658:Th1 and Th2 cell differentiation,mmu04659:Th17 cell differentiation,mmu04660:T cell receptor signaling pathway,mmu04664:Fc epsilon RI signaling pathway,mmu04666:Fc gamma R-mediated phagocytosis,mmu04670:Leukocyte transendothelial migration,mmu04722:Neurotrophin signaling pathway,mmu04750:Inflammatory mediator regulation of TRP channels,mmu04919:Thyroid hormone signaling pathway,mmu04933:AGE-RAGE signaling pathway in diabetic complications,mmu04935:Growth hormone synthesis, secretion and action,mmu05012:Parkinson disease,mmu05022:Pathways of neurodegeneration - multiple diseases,mmu05135:Yersinia infection,mmu05167:Kaposi sarcoma-associated herpesvirus infection,mmu05170:Human immunodeficiency virus 1 infection,mmu05171:Coronavirus disease - COVID-19,mmu05200:Pathways in cancer,mmu05205:Proteoglycans in cancer,mmu05206:MicroRNAs in cancer,mmu05214:Glioma,mmu05223:Non-small cell lung cancer,mmu05225:Hepatocellular carcinoma,mmu05231:Choline metabolism in cancer,mmu05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,mmu05417:Lipid and atherosclerosis,		PIRSF000952:PLC-gamma,	SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,SM00252:SH2,SM00326:SH3,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0966~Cell projection,			KW-0677~Repeat,KW-0727~SH2 domain,KW-0728~SH3 domain,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0807~Transducer,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	DOMAIN:C2,DOMAIN:EF-hand,DOMAIN:PH,DOMAIN:PH 1,DOMAIN:PH 2; first part,DOMAIN:PH 2; second part,DOMAIN:PI-PLC X-box,DOMAIN:PI-PLC Y-box,DOMAIN:SH2,DOMAIN:SH2 1,DOMAIN:SH2 2,DOMAIN:SH3,REGION:Disordered,
Q3SZE3	phospholipid phosphatase 3(PLPP3)	Bos taurus			GO:0001568~blood vessel development,GO:0001702~gastrulation with mouth forming second,GO:0001933~negative regulation of protein phosphorylation,GO:0006644~phospholipid metabolic process,GO:0006670~sphingosine metabolic process,GO:0006672~ceramide metabolic process,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007165~signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0010595~positive regulation of endothelial cell migration,GO:0022409~positive regulation of cell-cell adhesion,GO:0030111~regulation of Wnt signaling pathway,GO:0033631~cell-cell adhesion mediated by integrin,GO:0034109~homotypic cell-cell adhesion,GO:0042060~wound healing,GO:0046839~phospholipid dephosphorylation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050821~protein stabilization,GO:0060020~Bergmann glial cell differentiation,GO:0060070~canonical Wnt signaling pathway,GO:1902068~regulation of sphingolipid mediated signaling pathway,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0045121~membrane raft,GO:0070971~endoplasmic reticulum exit site,	GO:0005178~integrin binding,GO:0008195~phosphatidate phosphatase activity,GO:0042392~sphingosine-1-phosphate phosphatase activity,	IPR000326:P_Acid_Pase_2/haloperoxidase,IPR036938:P_Acid_Pase_2/haloperoxi_sf,IPR043216:PA_PP_rel,	bta00561:Glycerolipid metabolism,bta00564:Glycerophospholipid metabolism,bta00565:Ether lipid metabolism,bta00600:Sphingolipid metabolism,bta01100:Metabolic pathways,bta04072:Phospholipase D signaling pathway,bta04666:Fc gamma R-mediated phagocytosis,bta04975:Fat digestion and absorption,bta05231:Choline metabolism in cancer,			SM00014:acidPPc,	KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,ACT_SITE:Proton donors,CARBOHYD:N-linked (GlcNAc...) asparagine,MOTIF:Dityrosine basolateral targeting motif,MOTIF:Integrin-binding motif,REGION:Mediates interaction with CTNND1,REGION:Phosphatase sequence motif I,REGION:Phosphatase sequence motif II,REGION:Phosphatase sequence motif III,SITE:Stabilizes the active site histidine for nucleophilic attack,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P55058	phospholipid transfer protein(PLTP)	Homo sapiens			GO:0006629~lipid metabolic process,GO:0006869~lipid transport,GO:0010189~vitamin E biosynthetic process,GO:0010875~positive regulation of cholesterol efflux,GO:0015914~phospholipid transport,GO:0015918~sterol transport,GO:0030317~flagellated sperm motility,GO:0034375~high-density lipoprotein particle remodeling,GO:0035627~ceramide transport,GO:0046836~glycolipid transport,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0034364~high-density lipoprotein particle,	GO:0008035~high-density lipoprotein particle binding,GO:0008289~lipid binding,GO:0008429~phosphatidylethanolamine binding,GO:0008525~phosphatidylcholine transporter activity,GO:0008526~phosphatidylinositol transporter activity,GO:0019992~diacylglycerol binding,GO:0030169~low-density lipoprotein particle binding,GO:0031210~phosphatidylcholine binding,GO:0034189~very-low-density lipoprotein particle binding,GO:0070300~phosphatidic acid binding,GO:0097001~ceramide binding,GO:1901611~phosphatidylglycerol binding,GO:1904121~phosphatidylethanolamine transporter activity,GO:1990050~phosphatidic acid transporter activity,	IPR001124:Lipid-bd_serum_glycop_C,IPR017942:Lipid-bd_serum_glycop_N,IPR017943:Bactericidal_perm-incr_a/b_dom,IPR017954:Lipid-bd_serum_glycop_CS,IPR030675:BPI/LBP,IPR032942:BPI/LBP/Plunc,	hsa03320:PPAR signaling pathway,hsa04979:Cholesterol metabolism,		PIRSF002417:Lipid_binding_protein,	SM00328:BPI1,SM00329:BPI2,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) (complex) asparagine,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Lipid-binding serum glycoprotein C-terminal,DOMAIN:Lipid-binding serum glycoprotein N-terminal,MUTAGEN:M->E: Significant reduction in HDL-binding and absence of lipid transfer activity.,MUTAGEN:N->A: Increased nuclear localization; when associated with A-64; A-117 and A-143.,MUTAGEN:N->A: Increased nuclear localization; when associated with A-64; A-94 and A-117.,MUTAGEN:N->A: Increased nuclear localization; when associated with A-64; A-94 and A-143.,MUTAGEN:N->A: Increased nuclear localization; when associated with A-94; A-117 and A-143.,MUTAGEN:S->A: Significant reduction in phospholipid transfer activity. Increased secretion.,MUTAGEN:S->A: Significant reduction in phospholipid transfer activity. No effect on secretion.,MUTAGEN:S->A: Significant reduction in phospholipid transfer activity. Reduced secretion.,
Q9D0M1	phosphoribosyl pyrophosphate synthetase-associated protein 1(Prpsap1)	Mus musculus			GO:0006015~5-phosphoribose 1-diphosphate biosynthetic process,GO:0006164~purine nucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,	GO:0002189~ribose phosphate diphosphokinase complex,GO:0005737~cytoplasm,GO:0032991~macromolecular complex,	GO:0000287~magnesium ion binding,GO:0004749~ribose phosphate diphosphokinase activity,GO:0005524~ATP binding,GO:0019900~kinase binding,GO:0030234~enzyme regulator activity,GO:0042802~identical protein binding,	IPR000836:PRibTrfase_dom,IPR005946:Rib-P_diPkinase,IPR029057:PRTase-like,IPR029099:Pribosyltran_N,				SM01400:Pribosyltran_N,	KW-0545~Nucleotide biosynthesis,							KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Ribose-phosphate pyrophosphokinase N-terminal,
Q5SUR0	phosphoribosylformylglycinamidine synthase (FGAR amidotransferase)(Pfas)	Mus musculus			GO:0006164~purine nucleotide biosynthetic process,GO:0006177~GMP biosynthetic process,GO:0006189~'de novo' IMP biosynthetic process,GO:0006541~glutamine metabolic process,GO:0009410~response to xenobiotic stimulus,GO:0044208~'de novo' AMP biosynthetic process,GO:0097065~anterior head development,GO:0097294~'de novo' XMP biosynthetic process,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0004642~phosphoribosylformylglycinamidine synthase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR010073:PurL_large,IPR010918:PurM-like_C_dom,IPR029062:Class_I_gatase-like,IPR036604:PurS-like_sf,IPR036676:PurM-like_C_sf,IPR036921:PurM-like_N_sf,IPR040707:FGAR-AT_N,IPR041609:PurL_linker,	mmu00230:Purine metabolism,mmu01100:Metabolic pathways,			SM01211:GATase_5,	KW-0658~Purine biosynthesis,	KW-0963~Cytoplasm,			KW-0315~Glutamine amidotransferase,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,COMPBIAS:Polar residues,DOMAIN:Glutamine amidotransferase type-1,DOMAIN:Phosphoribosylformylglycinamidine synthase N-terminal,DOMAIN:Phosphoribosylformylglycinamidine synthase linker,DOMAIN:PurM-like C-terminal,REGION:Disordered,
Q9W6R1	phosphorylase kinase, alpha 2 (liver)(phka2)	Takifugu rubripes			GO:0005977~glycogen metabolic process,	GO:0005886~plasma membrane,GO:0005964~phosphorylase kinase complex,	GO:0005516~calmodulin binding,	IPR008734:PHK_A/B_su,IPR008928:6-hairpin_glycosidase_sf,IPR011613:GH15-like,IPR012341:6hp_glycosidase-like_sf,IPR045583:KPBA/B_C,	tru04020:Calcium signaling pathway,tru04910:Insulin signaling pathway,				KW-0119~Carbohydrate metabolism,KW-0321~Glycogen metabolism,	KW-0472~Membrane,KW-1003~Cell membrane,					KW-0112~Calmodulin-binding,	KW-0449~Lipoprotein,KW-0597~Phosphoprotein,KW-0636~Prenylation,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DOMAIN:GH15-like,DOMAIN:Phosphorylase b kinase regulatory subunit alpha/beta C-terminal,LIPID:S-farnesyl cysteine,REGION:Calmodulin-binding,REGION:Disordered,
Q5U3U0	phytanoyl-CoA dioxygenase domain containing 1(phyhd1)	Danio rerio					GO:0016491~oxidoreductase activity,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR008775:Phytyl_CoA_dOase-like,										KW-0408~Iron,KW-0479~Metal-binding,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,
Q9QY23	plakophilin 3(Pkp3)	Mus musculus			GO:0002159~desmosome assembly,GO:0007043~cell-cell junction assembly,GO:0007155~cell adhesion,GO:0010628~positive regulation of gene expression,GO:0072659~protein localization to plasma membrane,GO:0098609~cell-cell adhesion,GO:1902373~negative regulation of mRNA catabolic process,	GO:0001533~cornified envelope,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005914~spot adherens junction,GO:0030054~cell junction,GO:0030057~desmosome,GO:0070161~anchoring junction,GO:1990124~messenger ribonucleoprotein complex,	GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0045294~alpha-catenin binding,GO:0045296~cadherin binding,GO:0050839~cell adhesion molecule binding,	IPR000225:Armadillo,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR028435:Plakophilin/d_Catenin,				SM00185:ARM,	KW-0130~Cell adhesion,	KW-0539~Nucleus,KW-0965~Cell junction,			KW-0677~Repeat,			KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,REPEAT:ARM 1,REPEAT:ARM 2,REPEAT:ARM 3,REPEAT:ARM 4,REPEAT:ARM 5,REPEAT:ARM 6,REPEAT:ARM 7,REPEAT:ARM 8,
Q9Y342	plasmolipin(PLLP)	Homo sapiens			GO:0034220~ion transmembrane transport,GO:0042552~myelination,	GO:0016020~membrane,GO:0043218~compact myelin,	GO:0005515~protein binding,GO:0019911~structural constituent of myelin sheath,	IPR008253:Marvel,IPR013295:MAL,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0407~Ion channel,	KW-0597~Phosphoprotein,	DOMAIN:MARVEL,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q15102	platelet activating factor acetylhydrolase 1b catalytic subunit 3(PAFAH1B3)	Homo sapiens			GO:0006629~lipid metabolic process,GO:0007283~spermatogenesis,GO:0007399~nervous system development,GO:0016042~lipid catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0008247~1-alkyl-2-acetylglycerophosphocholine esterase complex,GO:0016020~membrane,	GO:0003847~1-alkyl-2-acetylglycerophosphocholine esterase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044877~macromolecular complex binding,GO:0046982~protein heterodimerization activity,GO:0047179~platelet-activating factor acetyltransferase activity,	IPR013830:SGNH_hydro,IPR036514:SGNH_hydro_sf,	hsa00565:Ether lipid metabolism,hsa01100:Metabolic pathways,				KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,					KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:SGNH hydrolase-type esterase,REGION:Disordered,
Q9GZP0	platelet derived growth factor D(PDGFD)	Homo sapiens			GO:0008284~positive regulation of cell proliferation,GO:0030335~positive regulation of cell migration,GO:0031954~positive regulation of protein autophosphorylation,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0043406~positive regulation of MAP kinase activity,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048146~positive regulation of fibroblast proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0051781~positive regulation of cell division,GO:0051897~positive regulation of protein kinase B signaling,GO:0070301~cellular response to hydrogen peroxide,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071230~cellular response to amino acid stimulus,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071673~positive regulation of smooth muscle cell chemotaxis,GO:0072126~positive regulation of glomerular mesangial cell proliferation,GO:2000439~positive regulation of monocyte extravasation,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,	GO:0005161~platelet-derived growth factor receptor binding,GO:0008083~growth factor activity,	IPR000072:PDGF/VEGF_dom,IPR000859:CUB_dom,IPR029034:Cystine-knot_cytokine,IPR035914:Sperma_CUB_dom_sf,	hsa01521:EGFR tyrosine kinase inhibitor resistance,hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04072:Phospholipase D signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04810:Regulation of actin cytoskeleton,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05231:Choline metabolism in cancer,			SM00042:CUB,		KW-0964~Secreted,		KW-0656~Proto-oncogene,	KW-0732~Signal,		KW-0217~Developmental protein,KW-0339~Growth factor,KW-0497~Mitogen,KW-9996~Developmental protein,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,DOMAIN:CUB,MUTAGEN:R->A: Abolishes cleavage into active form; when associated with A-247.,MUTAGEN:R->A: Abolishes cleavage into active form; when associated with A-249.,SITE:Cleavage,
A1L390	pleckstrin homology and RhoGEF domain containing G3(PLEKHG3)	Homo sapiens			GO:0030334~regulation of cell migration,GO:0051056~regulation of small GTPase mediated signal transduction,GO:2000114~regulation of establishment of cell polarity,	GO:0005829~cytosol,GO:0005856~cytoskeleton,	GO:0003779~actin binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0031267~small GTPase binding,	IPR000219:DH-domain,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR043324:PH_PLEKHG1_G2_G3,				SM00233:PH,SM00325:RhoGEF,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,						KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:PH,REGION:Disordered,
Q96PX9	pleckstrin homology and RhoGEF domain containing G4B(PLEKHG4B)	Homo sapiens			GO:0007411~axon guidance,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0019898~extrinsic component of membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000219:DH-domain,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR036865:CRAL-TRIO_dom_sf,				SM00233:PH,SM00325:RhoGEF,									COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:PH,REGION:Disordered,
Q6IQ23	pleckstrin homology domain containing A7(PLEKHA7)	Homo sapiens			GO:0042311~vasodilation,GO:0044331~cell-cell adhesion mediated by cadherin,GO:0045218~zonula adherens maintenance,GO:0046931~pore complex assembly,GO:0090136~epithelial cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0005915~zonula adherens,GO:0030054~cell junction,GO:0046930~pore complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0070097~delta-catenin binding,	IPR001202:WW_dom,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR036020:WW_dom_sf,IPR040392:PKHA4-7_PH,				SM00233:PH,SM00456:WW,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0965~Cell junction,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:PH,DOMAIN:WW,DOMAIN:WW 1,DOMAIN:WW 2,REGION:Disordered,REGION:Interaction with CTNND1,
Q8TD55	pleckstrin homology domain containing O2(PLEKHO2)	Homo sapiens			GO:0071888~macrophage apoptotic process,	GO:0005576~extracellular region,GO:1904813~ficolin-1-rich granule lumen,		IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR043448:PKHO1/2,				SM00233:PH,					KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	DOMAIN:PH,REGION:Disordered,
Q7TQG1	pleckstrin homology domain containing, family A member 6(Plekha6)	Mus musculus						IPR001202:WW_dom,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR036020:WW_dom_sf,IPR040392:PKHA4-7_PH,				SM00233:PH,SM00456:WW,					KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:PH,DOMAIN:WW,REGION:Disordered,
Q9QZC7	pleckstrin homology domain containing, family B (evectins) member 2(Plekhb2)	Mus musculus			GO:0045595~regulation of cell differentiation,	GO:0005768~endosome,GO:0016020~membrane,GO:0055038~recycling endosome membrane,	GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR039680:PLEKHB1/2,				SM00233:PH,		KW-0472~Membrane,KW-0967~Endosome,							DOMAIN:PH,
Q8R0J1	pleckstrin homology domain containing, family G (with RhoGef domain) member 6(Plekhg6)	Mus musculus				GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005902~microvillus,GO:0030054~cell junction,GO:0032154~cleavage furrow,GO:0042995~cell projection,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,	IPR000219:DH-domain,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR042918:PLEKHG6,				SM00233:PH,SM00325:RhoGEF,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,					KW-0343~GTPase activation,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:PH,REGION:Disordered,
Q00IB7	pleckstrin homology domain containing, family H (with MyTH4 domain) member 1(plekhh1)	Danio rerio			GO:0001569~branching involved in blood vessel morphogenesis,GO:0048514~blood vessel morphogenesis,	GO:0005856~cytoskeleton,		IPR000299:FERM_domain,IPR000857:MyTH4_dom,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR035963:FERM_2,IPR038185:MyTH4_dom_sf,				SM00139:MyTH4,SM00233:PH,SM00295:B41,					KW-0175~Coiled coil,KW-0677~Repeat,		KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:FERM,DOMAIN:MyTH4,DOMAIN:PH 1,DOMAIN:PH 2,REGION:Disordered,
Q80TQ5	pleckstrin homology domain containing, family M (with RUN domain) member 2(Plekhm2)	Mus musculus			GO:0007030~Golgi organization,GO:0032418~lysosome localization,GO:0032880~regulation of protein localization,GO:0042267~natural killer cell mediated cytotoxicity,GO:1902774~late endosome to lysosome transport,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0044754~autolysosome,	GO:0019894~kinesin binding,	IPR001849:PH_domain,IPR004012:Run_dom,IPR011993:PH-like_dom_sf,IPR037213:Run_dom_sf,IPR047327:RUN_PLEKHM2,	mmu05132:Salmonella infection,			SM00233:PH,SM00593:RUN,		KW-0458~Lysosome,KW-0472~Membrane,KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:PH,DOMAIN:RUN,REGION:Disordered,REGION:Interaction with KIF5B,
Q86UU1	pleckstrin homology like domain family B member 1(PHLDB1)	Homo sapiens			GO:0010470~regulation of gastrulation,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0070507~regulation of microtubule cytoskeleton organization,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0045171~intercellular bridge,GO:0045180~basal cortex,	GO:0005515~protein binding,	IPR000253:FHA_dom,IPR001849:PH_domain,IPR008984:SMAD_FHA_dom_sf,IPR011993:PH-like_dom_sf,IPR018136:Aconitase_4Fe-4S_BS,IPR037810:PHLDB1/2/3_PH,		620639~Osteogenesis imperfecta, type XXIII,		SM00233:PH,					KW-0175~Coiled coil,			KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:FHA,DOMAIN:PH,REGION:Disordered,
Q86SQ0	pleckstrin homology like domain family B member 2(PHLDB2)	Homo sapiens			GO:0000226~microtubule cytoskeleton organization,GO:0010470~regulation of gastrulation,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0016477~cell migration,GO:0030010~establishment of cell polarity,GO:0045184~establishment of protein localization,GO:0051497~negative regulation of stress fiber assembly,GO:0051895~negative regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:1903690~negative regulation of wound healing, spreading of epidermal cells,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031252~cell leading edge,GO:0045111~intermediate filament cytoskeleton,GO:0045180~basal cortex,	GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR037810:PHLDB1/2/3_PH,				SM00233:PH,		KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PH,MUTAGEN:KR->AA: Loss of binding to PtdIns(3,4,5)P3.,REGION:Disordered,TRANSMEM:Helical,
B5XG43	pleckstrin homology-like domain, family A, member 2(phlda2)	Salmo salar			GO:0043065~positive regulation of apoptotic process,	GO:0005737~cytoplasm,GO:0016020~membrane,	GO:1901981~phosphatidylinositol phosphate binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR042832:PHLA1/2/3,				SM00233:PH,		KW-0472~Membrane,KW-0963~Cytoplasm,							DOMAIN:PH,REGION:Disordered,
Q8AW35	pleckstrin homology-like domain, family A, member 3(phlda3)	Danio rerio			GO:0006915~apoptotic process,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043065~positive regulation of apoptotic process,GO:0051898~negative regulation of protein kinase B signaling,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,GO:1901981~phosphatidylinositol phosphate binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR042832:PHLA1/2/3,				SM00233:PH,	KW-0053~Apoptosis,	KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,					DOMAIN:PH,
Q6Q308	pleckstrin(PLEK)	Canis lupus dingo			GO:0002244~hematopoietic progenitor cell differentiation,GO:0006904~vesicle docking involved in exocytosis,GO:0007229~integrin-mediated signaling pathway,GO:0010572~positive regulation of platelet activation,GO:0010920~negative regulation of inositol phosphate biosynthetic process,GO:0030036~actin cytoskeleton organization,GO:0030836~positive regulation of actin filament depolymerization,GO:0030845~phospholipase C-inhibiting G-protein coupled receptor signaling pathway,GO:0030866~cortical actin cytoskeleton organization,GO:0031529~ruffle organization,GO:0032233~positive regulation of actin filament bundle assembly,GO:0033625~positive regulation of integrin activation,GO:0035556~intracellular signal transduction,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0046488~phosphatidylinositol metabolic process,GO:0060305~regulation of cell diameter,GO:0070493~thrombin-activated receptor signaling pathway,GO:0070527~platelet aggregation,GO:0070528~protein kinase C signaling,GO:0070560~protein secretion by platelet,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0032587~ruffle membrane,	GO:0005080~protein kinase C binding,GO:0042803~protein homodimerization activity,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,	IPR000591:DEP_dom,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR037370:Pleckstrin,IPR037371:PLEK_DEP,				SM00049:DEP,SM00233:PH,					KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:DEP,DOMAIN:PH,DOMAIN:PH 1,DOMAIN:PH 2,
Q6Q308	pleckstrin(PLEK)	Canis lupus familiaris			GO:0002244~hematopoietic progenitor cell differentiation,GO:0006904~vesicle docking involved in exocytosis,GO:0007229~integrin-mediated signaling pathway,GO:0010572~positive regulation of platelet activation,GO:0010920~negative regulation of inositol phosphate biosynthetic process,GO:0030036~actin cytoskeleton organization,GO:0030836~positive regulation of actin filament depolymerization,GO:0030845~phospholipase C-inhibiting G-protein coupled receptor signaling pathway,GO:0030866~cortical actin cytoskeleton organization,GO:0031529~ruffle organization,GO:0032233~positive regulation of actin filament bundle assembly,GO:0033625~positive regulation of integrin activation,GO:0035556~intracellular signal transduction,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0046488~phosphatidylinositol metabolic process,GO:0060305~regulation of cell diameter,GO:0070493~thrombin-activated receptor signaling pathway,GO:0070527~platelet aggregation,GO:0070528~protein kinase C signaling,GO:0070560~protein secretion by platelet,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0032587~ruffle membrane,	GO:0005080~protein kinase C binding,GO:0042803~protein homodimerization activity,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,	IPR000591:DEP_dom,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR037370:Pleckstrin,IPR037371:PLEK_DEP,				SM00049:DEP,SM00233:PH,					KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:DEP,DOMAIN:PH,DOMAIN:PH 1,DOMAIN:PH 2,
Q9QXS1	plectin(Plec)	Mus musculus			GO:0000902~cell morphogenesis,GO:0002522~leukocyte migration involved in immune response,GO:0003334~keratinocyte development,GO:0006469~negative regulation of protein kinase activity,GO:0006997~nucleus organization,GO:0007005~mitochondrion organization,GO:0007015~actin filament organization,GO:0007519~skeletal muscle tissue development,GO:0007584~response to nutrient,GO:0008104~protein localization,GO:0010467~gene expression,GO:0010761~fibroblast migration,GO:0010818~T cell chemotaxis,GO:0014866~skeletal myofibril assembly,GO:0019226~transmission of nerve impulse,GO:0022011~myelination in peripheral nervous system,GO:0022904~respiratory electron transport chain,GO:0030036~actin cytoskeleton organization,GO:0030216~keratinocyte differentiation,GO:0031581~hemidesmosome assembly,GO:0031668~cellular response to extracellular stimulus,GO:0032094~response to food,GO:0032287~peripheral nervous system myelin maintenance,GO:0034332~adherens junction organization,GO:0035264~multicellular organism growth,GO:0042060~wound healing,GO:0043114~regulation of vascular permeability,GO:0043588~skin development,GO:0043933~macromolecular complex subunit organization,GO:0045104~intermediate filament cytoskeleton organization,GO:0045109~intermediate filament organization,GO:0045214~sarcomere organization,GO:0045445~myoblast differentiation,GO:0048741~skeletal muscle fiber development,GO:0048870~cell motility,GO:0055013~cardiac muscle cell development,GO:0061436~establishment of skin barrier,GO:0070584~mitochondrion morphogenesis,GO:0071260~cellular response to mechanical stimulus,GO:0071464~cellular response to hydrostatic pressure,GO:0071498~cellular response to fluid shear stress,GO:2000689~actomyosin contractile ring assembly actin filament organization,GO:2000983~regulation of ATP citrate synthase activity,	GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0005903~brush border,GO:0005925~focal adhesion,GO:0009925~basal plasma membrane,GO:0016324~apical plasma membrane,GO:0016528~sarcoplasm,GO:0030016~myofibril,GO:0030018~Z disc,GO:0030056~hemidesmosome,GO:0030424~axon,GO:0030425~dendrite,GO:0042383~sarcolemma,GO:0043209~myelin sheath,GO:0043292~contractile fiber,GO:0045111~intermediate filament cytoskeleton,GO:0048471~perinuclear region of cytoplasm,GO:0070161~anchoring junction,GO:0071944~cell periphery,	GO:0002162~dystroglycan binding,GO:0003779~actin binding,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0008307~structural constituent of muscle,GO:0030506~ankyrin binding,GO:0043621~protein self-association,GO:0051015~actin filament binding,	IPR001101:Plectin_repeat,IPR001452:SH3_domain,IPR001589:Actinin_actin-bd_CS,IPR001715:CH_dom,IPR002017:Spectrin_repeat,IPR005326:Plectin_eS10_N,IPR018159:Spectrin/alpha-actinin,IPR035915:Plakin_repeat_sf,IPR036388:WH-like_DNA-bd_sf,IPR036872:CH_dom_sf,IPR041573:Desmoplakin_Spectrin-like,IPR041615:Desmoplakin_SH3,IPR043197:Plakin,				SM00033:CH,SM00150:SPEC,SM00250:PLEC,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0965~Cell junction,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0728~SH3 domain,		KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Calponin-homology (CH),DOMAIN:Calponin-homology (CH) 1,DOMAIN:Calponin-homology (CH) 2,DOMAIN:SH3,REGION:4 X 4 AA tandem repeats of G-S-R-X,REGION:Actin-binding,REGION:Binding to intermediate filaments,REGION:Central fibrous rod domain,REGION:Disordered,REGION:Globular 1,REGION:Globular 2,REGION:Required for efficient interaction with KRT5 and KRT14 heterodimers,REGION:Required for interaction with intermediate filament proteins,REGION:Required for interaction with type2 keratins, DES and VIM,REPEAT:Plectin 1,REPEAT:Plectin 10,REPEAT:Plectin 11,REPEAT:Plectin 12,REPEAT:Plectin 13,REPEAT:Plectin 14,REPEAT:Plectin 15,REPEAT:Plectin 16,REPEAT:Plectin 17,REPEAT:Plectin 18,REPEAT:Plectin 19,REPEAT:Plectin 2,REPEAT:Plectin 20,REPEAT:Plectin 21,REPEAT:Plectin 22,REPEAT:Plectin 23,REPEAT:Plectin 24,REPEAT:Plectin 25,REPEAT:Plectin 26,REPEAT:Plectin 27,REPEAT:Plectin 28,REPEAT:Plectin 29,REPEAT:Plectin 3,REPEAT:Plectin 30,REPEAT:Plectin 31,REPEAT:Plectin 32,REPEAT:Plectin 33,REPEAT:Plectin 4,REPEAT:Plectin 5,REPEAT:Plectin 6,REPEAT:Plectin 7,REPEAT:Plectin 8,REPEAT:Plectin 9,REPEAT:Spectrin 1,REPEAT:Spectrin 2,REPEAT:Spectrin 3,REPEAT:Spectrin 4,
P70206	plexin A1(Plxna1)	Mus musculus			GO:0007162~negative regulation of cell adhesion,GO:0008360~regulation of cell shape,GO:0014910~regulation of smooth muscle cell migration,GO:0021628~olfactory nerve formation,GO:0021828~gonadotrophin-releasing hormone neuronal migration to the hypothalamus,GO:0030334~regulation of cell migration,GO:0043087~regulation of GTPase activity,GO:0050772~positive regulation of axonogenesis,GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching,GO:0071526~semaphorin-plexin signaling pathway,GO:0097485~neuron projection guidance,GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance,GO:1990138~neuron projection extension,	GO:0002116~semaphorin receptor complex,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0017154~semaphorin receptor activity,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR002909:IPT_dom,IPR008936:Rho_GTPase_activation_prot,IPR013548:Plexin_cytoplasmic_RasGAP_dom,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR031148:Plexin,IPR036352:Semap_dom_sf,IPR041019:TIG1_plexin,IPR041362:TIG2_plexin,IPR042744:Plexin-A1_Sema,IPR046800:Plexin_RBD,	mmu04360:Axon guidance,			SM00423:PSI,SM00429:IPT,SM00630:Sema,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:IPT/TIG,DOMAIN:IPT/TIG 1,DOMAIN:IPT/TIG 2,DOMAIN:IPT/TIG 3,DOMAIN:IPT/TIG 4,DOMAIN:Sema,MUTAGEN:KRK->AAA: Loss of interaction with FARP2.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
B0S5N4	plexin A3(plxna3)	Danio rerio			GO:0003205~cardiac chamber development,GO:0007162~negative regulation of cell adhesion,GO:0007411~axon guidance,GO:0008045~motor neuron axon guidance,GO:0008360~regulation of cell shape,GO:0030334~regulation of cell migration,GO:0043087~regulation of GTPase activity,GO:0048675~axon extension,GO:0048696~regulation of collateral sprouting in absence of injury,GO:0048755~branching morphogenesis of a nerve,GO:0050772~positive regulation of axonogenesis,GO:0060272~embryonic skeletal joint morphogenesis,GO:0071526~semaphorin-plexin signaling pathway,GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance,	GO:0002116~semaphorin receptor complex,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0017154~semaphorin receptor activity,GO:0042802~identical protein binding,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR002909:IPT_dom,IPR008936:Rho_GTPase_activation_prot,IPR013548:Plexin_cytoplasmic_RasGAP_dom,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR031148:Plexin,IPR036352:Semap_dom_sf,IPR041019:TIG1_plexin,IPR041362:TIG2_plexin,IPR046800:Plexin_RBD,				SM00423:PSI,SM00429:IPT,SM00630:Sema,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:IPT/TIG 1,DOMAIN:IPT/TIG 2,DOMAIN:IPT/TIG 3,DOMAIN:IPT/TIG 4,DOMAIN:Sema,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O60486	plexin C1(PLXNC1)	Homo sapiens			GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0008360~regulation of cell shape,GO:0030334~regulation of cell migration,GO:0043087~regulation of GTPase activity,GO:0050772~positive regulation of axonogenesis,GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance,GO:1905806~regulation of synapse disassembly,	GO:0002116~semaphorin receptor complex,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0017154~semaphorin receptor activity,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR002909:IPT_dom,IPR008936:Rho_GTPase_activation_prot,IPR013548:Plexin_cytoplasmic_RasGAP_dom,IPR013783:Ig-like_fold,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR031148:Plexin,IPR036352:Semap_dom_sf,IPR041853:Plexin-C1_Sema,IPR046800:Plexin_RBD,	hsa04360:Axon guidance,			SM00423:PSI,SM00429:IPT,SM00630:Sema,		KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Plexin cytoplasmic RasGAP,DOMAIN:Plexin cytoplasmic RhoGTPase-binding,DOMAIN:Sema,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P62205	polo like kinase 1(plk1)	Xenopus tropicalis			GO:0000278~mitotic cell cycle,GO:0006099~tricarboxylic acid cycle,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0016310~phosphorylation,GO:0051301~cell division,GO:0071168~protein localization to chromatin,	GO:0000776~kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0030496~midbody,	GO:0000166~nucleotide binding,GO:0004591~oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0030976~thiamine pyrophosphate binding,	IPR000719:Prot_kinase_dom,IPR000959:POLO_box_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011603:2oxoglutarate_DH_E1,IPR017441:Protein_kinase_ATP_BS,IPR031717:KGD_C,IPR032106:2-oxogl_dehyd_N,IPR033695:POLO_box_2,IPR033701:POLO_box_1,IPR033702:PLK1_cat,IPR036947:POLO_box_dom_sf,IPR042179:KGD_C_sf,	xtr04068:FoxO signaling pathway,xtr04110:Cell cycle,xtr04114:Oocyte meiosis,xtr04914:Progesterone-mediated oocyte maturation,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,KW-0786~Thiamine pyrophosphate,	KW-0418~Kinase,KW-0560~Oxidoreductase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:2-oxoglutarate dehydrogenase E1 component N-terminal,DOMAIN:Multifunctional 2-oxoglutarate metabolism enzyme C-terminal,DOMAIN:POLO box 1,DOMAIN:POLO box 2,DOMAIN:Protein kinase,MOTIF:D-box that targets the protein for proteasomal degradation in anaphase,REGION:Activation loop,REGION:Disordered,REGION:Important for interaction with phosphorylated proteins,REGION:Linker,
Q13310	poly(A) binding protein cytoplasmic 4(PABPC4)	Homo sapiens			GO:0006396~RNA processing,GO:0006401~RNA catabolic process,GO:0006412~translation,GO:0007596~blood coagulation,GO:0043488~regulation of mRNA stability,GO:0061515~myeloid cell development,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,	IPR000504:RRM_dom,IPR002004:PABP_HYD,IPR003954:RRM_dom_euk,IPR006515:PABP_1234,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034364:PABP_RRM1,IPR035979:RBD_domain_sf,IPR036053:PABP-dom,IPR045305:RRM2_I_PABPs,	hsa03015:mRNA surveillance pathway,hsa03018:RNA degradation,			SM00360:RRM,SM00361:RRM_1,SM00517:PolyA,		KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:PABC,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,DOMAIN:RRM 4,REGION:Disordered,
F1QB54	poly(A) binding protein, cytoplasmic 1a(pabpc1a)	Danio rerio			GO:0006397~mRNA processing,GO:0006412~translation,GO:0006417~regulation of translation,GO:0007507~heart development,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,	IPR000504:RRM_dom,IPR002004:PABP_HYD,IPR003954:RRM_dom_euk,IPR006515:PABP_1234,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034364:PABP_RRM1,IPR035979:RBD_domain_sf,IPR036053:PABP-dom,IPR045305:RRM2_I_PABPs,	dre03015:mRNA surveillance pathway,dre03018:RNA degradation,			SM00360:RRM,SM00361:RRM_1,SM00517:PolyA,	KW-0507~mRNA processing,KW-0648~Protein biosynthesis,KW-0810~Translation regulation,	KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,		DOMAIN:PABC,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,DOMAIN:RRM 4,
Q9UKK3	poly(ADP-ribose) polymerase family member 4(PARP4)	Homo sapiens			GO:0006281~DNA repair,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0009410~response to xenobiotic stimulus,GO:0036211~protein modification process,GO:0051972~regulation of telomerase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0016020~membrane,GO:0070062~extracellular exosome,GO:1990904~ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0005515~protein binding,GO:0016779~nucleotidyltransferase activity,GO:0019899~enzyme binding,GO:1990404~protein ADP-ribosylase activity,	IPR001357:BRCT_dom,IPR002035:VWF_A,IPR004102:Poly(ADP-ribose)pol_reg_dom,IPR012317:Poly(ADP-ribose)pol_cat_dom,IPR013694:VIT,IPR031273:PARP4,IPR036420:BRCT_dom_sf,IPR036465:vWFA_dom_sf,IPR036616:Poly(ADP-ribose)pol_reg_dom_sf,	hsa03410:Base excision repair,hsa04210:Apoptosis,			SM00292:BRCT,SM00327:VWA,SM00609:VIT,		KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0520~NAD,	KW-0328~Glycosyltransferase,KW-0548~Nucleotidyltransferase,KW-0687~Ribonucleoprotein,KW-0808~Transferase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:BRCT,DOMAIN:PARP alpha-helical,DOMAIN:PARP catalytic,DOMAIN:VIT,DOMAIN:VWFA,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with the major vault protein,
Q64028	polyhomeotic 1(Phc1)	Mus musculus			GO:0006338~chromatin remodeling,GO:0007275~multicellular organism development,GO:0045892~negative regulation of transcription, DNA-templated,GO:0071300~cellular response to retinoic acid,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0001739~sex chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0031519~PcG protein complex,GO:0032991~macromolecular complex,GO:0035102~PRC1 complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042393~histone binding,GO:0046872~metal ion binding,	IPR001660:SAM,IPR012313:Znf_FCS,IPR013761:SAM/pointed_sf,IPR038603:Znf_FCS_sf,	mmu03083:Polycomb repressive complex,			SM00454:SAM,		KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:FCS-type,DOMAIN:SAM,REGION:Disordered,ZN_FING:FCS-type,
Q9DE46	polymerase (DNA directed), alpha 1, catalytic subunit S homeolog(pola1.S)	Xenopus laevis			GO:0006260~DNA replication,GO:0006269~DNA replication, synthesis of RNA primer,GO:0006270~DNA replication initiation,GO:0006271~DNA strand elongation involved in DNA replication,GO:0006272~leading strand elongation,GO:0006273~lagging strand elongation,GO:0006303~double-strand break repair via nonhomologous end joining,GO:1902975~mitotic DNA replication initiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005658~alpha DNA polymerase:primase complex,GO:0005730~nucleolus,GO:0016363~nuclear matrix,GO:0031981~nuclear lumen,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,	IPR006133:DNA-dir_DNA_pol_B_exonuc,IPR006134:DNA-dir_DNA_pol_B_multi_dom,IPR006172:DNA-dir_DNA_pol_B,IPR012337:RNaseH-like_sf,IPR015088:Znf_DNA-dir_DNA_pol_B_alpha,IPR017964:DNA-dir_DNA_pol_B_CS,IPR023211:DNA_pol_palm_dom_sf,IPR024647:DNA_pol_a_cat_su_N,IPR036397:RNaseH_sf,IPR038256:Pol_alpha_znc_sf,IPR042087:DNA_pol_B_thumb,IPR043502:DNA/RNA_pol_sf,IPR045846:POLBc_alpha,	xla03030:DNA replication,			SM00486:POLBc,	KW-0235~DNA replication,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0239~DNA-directed DNA polymerase,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,DOMAIN:DNA polymerase alpha catalytic subunit N-terminal,DOMAIN:DNA-directed DNA polymerase family B exonuclease,DOMAIN:DNA-directed DNA polymerase family B multifunctional,DOMAIN:Zinc finger DNA-directed DNA polymerase family B alpha,MOTIF:CysB motif,REGION:DNA-binding,REGION:Disordered,ZN_FING:CysA-type,
Q6R3M4	polymerase (DNA directed), iota(Poli)	Mus musculus			GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0019985~translesion synthesis,GO:0071494~cellular response to UV-C,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,GO:0016607~nuclear speck,GO:0036464~cytoplasmic ribonucleoprotein granule,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,	IPR001126:UmuC,IPR017961:DNA_pol_Y-fam_little_finger,IPR024728:PolY_HhH_motif,IPR036775:DNA_pol_Y-fam_lit_finger_sf,IPR043128:Rev_trsase/Diguanyl_cyclase,IPR043502:DNA/RNA_pol_sf,	mmu03460:Fanconi anemia pathway,		PIRSF036603:DPol_eta,		KW-0227~DNA damage,KW-0234~DNA repair,KW-0235~DNA replication,KW-0237~DNA synthesis,	KW-0539~Nucleus,				KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0704~Schiff base,	KW-0238~DNA-binding,KW-0239~DNA-directed DNA polymerase,KW-0515~Mutator protein,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:UmuC,MOTIF:Ubiquitin-binding 1 (UBM1),MOTIF:Ubiquitin-binding 2 (UBM2),MUTAGEN:L->A: Impairs ubiquitin binding and post-translation modification via ubiquitination; when associated with A-509. Abolishes ubiquitin binding and localization to nuclear foci after UV-induced DNA damage but does not affect catalytic activity; when associated with A-508, A-693 and A-694.,MUTAGEN:L->A: Impairs ubiquitin binding and post-translation modification via ubiquitination; when associated with A-694. Abolishes ubiquitin binding and localization to nuclear foci after UV-induced DNA damage but does not affect catalytic activity; when associated with A-508, A-509 and A-694.,MUTAGEN:Missing: Abolishes ubiquitin binding and localization to nuclear foci after UV-induced DNA damage.,MUTAGEN:P->A: Impairs ubiquitin binding and post-translation modification via ubiquitination; when associated with A-508. Abolishes ubiquitin binding and localization to nuclear foci after UV-induced DNA damage but does not affect catalytic activity; when associated with A-509, A-693 and A-694.,MUTAGEN:P->A: Impairs ubiquitin binding and post-translation modification via ubiquitination; when associated with A-693. Abolishes ubiquitin binding and localization to nuclear foci after UV-induced DNA damage but does not affect catalytic activity; when associated with A-508, A-509 and A-693.,REGION:DNA-binding,REGION:Disordered,
Q8IUC8	polypeptide N-acetylgalactosaminyltransferase 13(GALNT13)	Homo sapiens			GO:0006493~protein O-linked glycosylation,GO:0016266~O-glycan processing,GO:0018242~protein O-linked glycosylation via serine,GO:0018243~protein O-linked glycosylation via threonine,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0016740~transferase activity,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR000772:Ricin_B_lectin,IPR001173:Glyco_trans_2-like,IPR029044:Nucleotide-diphossugar_trans,IPR035992:Ricin_B-like_lectins,IPR045885:GalNAc-T,	hsa00512:Mucin type O-glycan biosynthesis,hsa00514:Other types of O-glycan biosynthesis,hsa01100:Metabolic pathways,			SM00458:RICIN,		KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0430~Lectin,KW-0464~Manganese,KW-0479~Metal-binding,	KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Glycosyltransferase 2-like,DOMAIN:Ricin B lectin,DOMAIN:Ricin B-type lectin,REGION:Catalytic subdomain A,REGION:Catalytic subdomain B,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q9BVG4	polysaccharide biosynthesis domain containing 1(PBDC1)	Homo sapiens					GO:0005515~protein binding,	IPR008476:PBDC1_metazoa/fungi,IPR023139:PBDC1-like_dom_sf,												KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q3UUQ7	post-GPI attachment to proteins 1(Pgap1)	Mus musculus			GO:0006505~GPI anchor metabolic process,GO:0006506~GPI anchor biosynthetic process,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007605~sensory perception of sound,GO:0009880~embryonic pattern specification,GO:0009948~anterior/posterior axis specification,GO:0015031~protein transport,GO:0021871~forebrain regionalization,GO:0060322~head development,GO:1902953~positive regulation of ER to Golgi vesicle-mediated transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0050185~phosphatidylinositol deacylase activity,	IPR012908:PGAP1-like,IPR029058:AB_hydrolase,IPR039529:PGAP1/BST1,	mmu00563:Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,mmu01100:Metabolic pathways,				KW-0653~Protein transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q7T321	potassium channel modulatory factor 1(kcmf1)	Danio rerio			GO:0099536~synaptic signaling,	GO:0005886~plasma membrane,GO:0045202~synapse,	GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,	IPR000433:Znf_ZZ,IPR008598:Di19_Zn-bd,IPR013087:Znf_C2H2_type,IPR043145:Znf_ZZ_sf,				SM00291:ZnF_ZZ,SM00355:ZnF_C2H2,	KW-0833~Ubl conjugation pathway,				KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		COMPBIAS:Polar residues,REGION:Disordered,ZN_FING:C2H2-type,ZN_FING:ZZ-type,
Q6WVG3	potassium channel tetramerisation domain containing 12(Kctd12)	Mus musculus			GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0051260~protein homooligomerization,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043235~receptor complex,GO:0045202~synapse,GO:0045211~postsynaptic membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000210:BTB/POZ_dom,IPR003131:T1-type_BTB,IPR011333:SKP1/BTB/POZ_sf,				SM00225:BTB,		KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:BTB,DOMAIN:Potassium channel tetramerisation-type BTB,REGION:Disordered,
Q96CX2	potassium channel tetramerization domain containing 12(KCTD12)	Homo sapiens			GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0034220~ion transmembrane transport,GO:0051260~protein homooligomerization,	GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043235~receptor complex,GO:0045211~postsynaptic membrane,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000210:BTB/POZ_dom,IPR003131:T1-type_BTB,IPR011333:SKP1/BTB/POZ_sf,				SM00225:BTB,	KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,					KW-0407~Ion channel,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:BTB,DOMAIN:Potassium channel tetramerisation-type BTB,REGION:Disordered,
Q6DC02	potassium channel tetramerization domain containing 15b(kctd15b)	Danio rerio			GO:0007420~brain development,GO:0014033~neural crest cell differentiation,GO:0051260~protein homooligomerization,GO:0060037~pharyngeal system development,GO:0060070~canonical Wnt signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,		IPR000210:BTB/POZ_dom,IPR003131:T1-type_BTB,IPR011333:SKP1/BTB/POZ_sf,IPR045904:KCTD15_T1-type_BTB,IPR048595:KCTD1-15-like_C,				SM00225:BTB,		KW-0539~Nucleus,					KW-0217~Developmental protein,KW-9996~Developmental protein,		DOMAIN:BTB,
Q9NXV2	potassium channel tetramerization domain containing 5(KCTD5)	Homo sapiens			GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051260~protein homooligomerization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:0097602~cullin family protein binding,	IPR000210:BTB/POZ_dom,IPR003131:T1-type_BTB,IPR011333:SKP1/BTB/POZ_sf,				SM00225:BTB,	KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:BTB,REGION:Disordered,
Q6DG99	potassium channel tetramerization domain containing 6b(kctd6b)	Danio rerio			GO:0016567~protein ubiquitination,GO:0051260~protein homooligomerization,			IPR000210:BTB/POZ_dom,IPR003131:T1-type_BTB,IPR011333:SKP1/BTB/POZ_sf,				SM00225:BTB,	KW-0833~Ubl conjugation pathway,								DOMAIN:BTB,
Q99712	potassium inwardly rectifying channel subfamily J member 15(KCNJ15)	Homo sapiens			GO:0006813~potassium ion transport,GO:0034765~regulation of ion transmembrane transport,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0034702~ion channel complex,	GO:0005242~inward rectifier potassium channel activity,GO:0005515~protein binding,	IPR003270:K_chnl_inward-rec_Kir1.3,IPR013518:K_chnl_inward-rec_Kir_cyto,IPR014756:Ig_E-set,IPR016449:K_chnl_inward-rec_Kir,IPR040445:Kir_TM,IPR041647:IRK_C,	hsa04971:Gastric acid secretion,		PIRSF005465:GIRK_kir,		KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0851~Voltage-gated channel,		DOMAIN:Inward rectifier potassium channel C-terminal,DOMAIN:Potassium channel inwardly rectifying transmembrane,INTRAMEM:Helical; Pore-forming; Name=H5,INTRAMEM:Pore-forming,MOTIF:Selectivity filter,REGION:Disordered,SITE:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=M1,TRANSMEM:Helical; Name=M2,
Q8R454	potassium two pore domain channel subfamily K member 1(Kcnk1)	Cavia porcellus			GO:0030322~stabilization of membrane potential,GO:0035725~sodium ion transmembrane transport,GO:0060075~regulation of resting membrane potential,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0030425~dendrite,GO:0034705~potassium channel complex,GO:0043204~perikaryon,GO:0055037~recycling endosome,GO:0097060~synaptic membrane,GO:1902937~inward rectifier potassium channel complex,	GO:0005242~inward rectifier potassium channel activity,GO:0005267~potassium channel activity,GO:0005272~sodium channel activity,GO:0015271~outward rectifier potassium channel activity,GO:0022841~potassium ion leak channel activity,GO:0042802~identical protein binding,	IPR001779:2pore_dom_K_chnl_TWIK1,IPR003092:2pore_dom_K_chnl_TASK,IPR003280:2pore_dom_K_chnl,IPR005408:2pore_dom_K_chnl_TWIK,IPR013099:K_chnl_dom,			PIRSF038061:K_channel_subfamily_K_type,		KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,	KW-0325~Glycoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DISULFID:Interchain,DOMAIN:Potassium channel,INTRAMEM:Helical; Name=Pore helix 1,INTRAMEM:Helical; Name=Pore helix 2,REGION:Important for intracellular retention in recycling endosomes,REGION:Selectivity filter 1,REGION:Selectivity filter 2,SITE:Important for increased permeability to Na(+) when K(+) levels are subphysiological,SITE:Part of a hydrophobic barrier that is stochastically dewetted and limits ion permeability,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O95279	potassium two pore domain channel subfamily K member 5(KCNK5)	Homo sapiens			GO:0006813~potassium ion transport,GO:0030322~stabilization of membrane potential,GO:0060075~regulation of resting membrane potential,GO:0071805~potassium ion transmembrane transport,GO:0097623~potassium ion export across plasma membrane,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0034702~ion channel complex,	GO:0005267~potassium channel activity,GO:0005515~protein binding,GO:0015271~outward rectifier potassium channel activity,GO:0022841~potassium ion leak channel activity,	IPR003092:2pore_dom_K_chnl_TASK,IPR003280:2pore_dom_K_chnl,IPR013099:K_chnl_dom,	hsa04742:Taste transduction,hsa04974:Protein digestion and absorption,				KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DISULFID:Interchain,DOMAIN:Potassium channel,INTRAMEM:Pore-forming; Name=Pore-forming 1,INTRAMEM:Pore-forming; Name=Pore-forming 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
Q9JL58	potassium two pore domain channel subfamily K member 9(Kcnk9)	Cavia porcellus			GO:0030322~stabilization of membrane potential,GO:0071805~potassium ion transmembrane transport,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005249~voltage-gated potassium channel activity,GO:0005267~potassium channel activity,GO:0015271~outward rectifier potassium channel activity,GO:0022841~potassium ion leak channel activity,	IPR003092:2pore_dom_K_chnl_TASK,IPR003280:2pore_dom_K_chnl,IPR005407:KCNK9,IPR013099:K_chnl_dom,	cpoc04925:Aldosterone synthesis and secretion,		PIRSF038061:K_channel_subfamily_K_type,		KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Potassium channel,INTRAMEM:Pore-forming; Name=Pore-forming 1,INTRAMEM:Pore-forming; Name=Pore-forming 2,MUTAGEN:H->N,Y: Reduces sensitivity to alterations in external pH.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9Y2W7	potassium voltage-gated channel interacting protein 3(KCNIP3)	Homo sapiens		h_dreamPathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0071805~potassium ion transmembrane transport,GO:0072659~protein localization to plasma membrane,GO:1901379~regulation of potassium ion transmembrane transport,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005267~potassium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0015459~potassium channel regulator activity,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR028846:Recoverin,				SM00054:EFh,	KW-0053~Apoptosis,KW-0406~Ion transport,KW-0633~Potassium transport,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,KW-0678~Repressor,KW-0851~Voltage-gated channel,	KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),DOMAIN:EF-hand,DOMAIN:EF-hand 1; degenerate,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,LIPID:S-palmitoyl cysteine,MUTAGEN:D->A: Abolishes cleavage by caspase-3.,REGION:Disordered,REGION:Interaction with KCND2,
Q5RC10	potassium voltage-gated channel modifier subfamily V member 1(KCNV1)	Pongo abelii			GO:0051260~protein homooligomerization,GO:0071805~potassium ion transmembrane transport,	GO:0008076~voltage-gated potassium channel complex,GO:0016020~membrane,GO:0045171~intercellular bridge,	GO:0005249~voltage-gated potassium channel activity,GO:0005515~protein binding,	IPR000210:BTB/POZ_dom,IPR003131:T1-type_BTB,IPR003968:K_chnl_volt-dep_Kv,IPR003970:K_chnl_volt-dep_Kv8.1,IPR005821:Ion_trans_dom,IPR011333:SKP1/BTB/POZ_sf,IPR027359:Volt_channel_dom_sf,				SM00225:BTB,	KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,KW-0851~Voltage-gated channel,		DOMAIN:BTB,MOTIF:Selectivity filter,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=Segment S1,TRANSMEM:Helical; Name=Segment S2,TRANSMEM:Helical; Name=Segment S3,TRANSMEM:Helical; Name=Segment S5,TRANSMEM:Helical; Name=Segment S6,TRANSMEM:Helical; Voltage-sensor; Name=Segment S4,
Q7Z628	pre-mRNA processing factor 38B(PRPF38B)	Homo sapiens			GO:0000398~mRNA splicing, via spliceosome,GO:0001558~regulation of cell growth,GO:0006397~mRNA processing,GO:0007165~signal transduction,GO:0008380~RNA splicing,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051451~myoblast migration,GO:0070301~cellular response to hydrogen peroxide,GO:0071479~cellular response to ionizing radiation,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0071011~precatalytic spliceosome,	GO:0003723~RNA binding,GO:0005085~guanyl-nucleotide exchange factor activity,	IPR000219:DH-domain,IPR001331:GDS_CDC24_CS,IPR001849:PH_domain,IPR005037:PRP38,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR037853:Net1_PH,	hsa03040:Spliceosome,			SM00233:PH,SM00325:RhoGEF,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,		KW-0656~Proto-oncogene,	KW-0175~Coiled coil,		KW-0344~Guanine-nucleotide releasing factor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:PH,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Necessary for nuclear localization,
Q99N48	predicted gene, 29721(Gm29721)	Mus musculus			GO:0006886~intracellular protein transport,GO:0006887~exocytosis,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070382~exocytic vesicle,	GO:0005543~phospholipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008270~zinc ion binding,GO:0031267~small GTPase binding,GO:0042043~neurexin family protein binding,	IPR000008:C2_dom,IPR010911:Rab_BD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR035892:C2_domain_sf,IPR041282:FYVE_2,IPR043567:SYTL1-5_C2B,				SM00239:C2,		KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0677~Repeat,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:RabBD,MUTAGEN:EE->QQ: Binds phospholipids only in the absence of divalent cations.,MUTAGEN:KRK->QQQ: Binds phospholipids only in the absence of divalent cations.,REGION:Disordered,
P45878	predicted gene, 51400(Gm51400)	Mus musculus			GO:0061077~chaperone-mediated protein folding,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,	IPR001179:PPIase_FKBP_dom,IPR044609:FKBP2/11,IPR046357:PPIase_dom_sf,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,		KW-0413~Isomerase,KW-0697~Rotamase,		DOMAIN:PPIase FKBP-type,MOTIF:Prevents secretion from ER,REGION:Disordered,
Q5D016	prefoldin subunit 1(pfdn1)	Danio rerio			GO:0006457~protein folding,	GO:0005737~cytoplasm,GO:0016272~prefoldin complex,	GO:0044183~protein binding involved in protein folding,GO:0051082~unfolded protein binding,	IPR002777:PFD_beta-like,IPR009053:Prefoldin,											KW-0143~Chaperone,
Q32PL8	primase and polymerase (DNA-directed)(primpol)	Danio rerio			GO:0006264~mitochondrial DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009411~response to UV,GO:0019985~translesion synthesis,GO:0031297~replication fork processing,GO:0042276~error-prone translesion synthesis,GO:0043504~mitochondrial DNA repair,	GO:0000428~DNA-directed RNA polymerase complex,GO:0005634~nucleus,GO:0005657~replication fork,GO:0005694~chromosome,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003896~DNA primase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0030145~manganese ion binding,GO:0046872~metal ion binding,	IPR044917:PRIMPOL,					KW-0227~DNA damage,KW-0234~DNA repair,KW-0804~Transcription,	KW-0158~Chromosome,KW-0240~DNA-directed RNA polymerase,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-9994~DNA-directed RNA polymerase,				KW-0464~Manganese,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0239~DNA-directed DNA polymerase,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,MOTIF:Zinc knuckle motif,REGION:Disordered,
Q9R0B9	procollagen lysine, 2-oxoglutarate 5-dioxygenase 2(Plod2)	Mus musculus			GO:0001666~response to hypoxia,GO:0017185~peptidyl-lysine hydroxylation,GO:0046947~hydroxylysine biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0030867~rough endoplasmic reticulum membrane,	GO:0005506~iron ion binding,GO:0008475~procollagen-lysine 5-dioxygenase activity,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0031418~L-ascorbic acid binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR001006:Procol_lys_dOase,IPR005123:Oxoglu/Fe-dep_dioxygenase,IPR006620:Pro_4_hyd_alph,IPR029044:Nucleotide-diphossugar_trans,IPR044861:IPNS-like_FE2OG_OXY,	mmu00310:Lysine degradation,mmu01100:Metabolic pathways,			SM00702:P4Hc,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,	KW-0408~Iron,KW-0479~Metal-binding,KW-0847~Vitamin C,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fe2OG dioxygenase,REGION:Disordered,
Q5U367	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3(Plod3)	Rattus norvegicus			GO:0001701~in utero embryonic development,GO:0001886~endothelial cell morphogenesis,GO:0006493~protein O-linked glycosylation,GO:0008104~protein localization,GO:0017185~peptidyl-lysine hydroxylation,GO:0021915~neural tube development,GO:0030199~collagen fibril organization,GO:0032870~cellular response to hormone stimulus,GO:0032963~collagen metabolic process,GO:0042311~vasodilation,GO:0046947~hydroxylysine biosynthetic process,GO:0048730~epidermis morphogenesis,GO:0060425~lung morphogenesis,GO:0070831~basement membrane assembly,	GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,	GO:0005506~iron ion binding,GO:0008475~procollagen-lysine 5-dioxygenase activity,GO:0031418~L-ascorbic acid binding,GO:0033823~procollagen glucosyltransferase activity,GO:0036094~small molecule binding,GO:0046872~metal ion binding,GO:0050211~procollagen galactosyltransferase activity,	IPR001006:Procol_lys_dOase,IPR005123:Oxoglu/Fe-dep_dioxygenase,IPR006620:Pro_4_hyd_alph,IPR029044:Nucleotide-diphossugar_trans,IPR044861:IPNS-like_FE2OG_OXY,	rno00310:Lysine degradation,rno00514:Other types of O-glycan biosynthesis,rno01100:Metabolic pathways,			SM00702:P4Hc,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0964~Secreted,			KW-0176~Collagen,KW-0732~Signal,	KW-0408~Iron,KW-0464~Manganese,KW-0479~Metal-binding,KW-0847~Vitamin C,	KW-0223~Dioxygenase,KW-0328~Glycosyltransferase,KW-0511~Multifunctional enzyme,KW-0560~Oxidoreductase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fe2OG dioxygenase,REGION:Accessory region,REGION:Important for dimerization,REGION:Required for glycosyltransferase activity,
P07737	profilin 1(PFN1)	Homo sapiens		h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_rhoPathway:Rho cell motility signaling pathway,	GO:0001843~neural tube closure,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010634~positive regulation of epithelial cell migration,GO:0030036~actin cytoskeleton organization,GO:0030833~regulation of actin filament polymerization,GO:0030837~negative regulation of actin filament polymerization,GO:0030838~positive regulation of actin filament polymerization,GO:0032232~negative regulation of actin filament bundle assembly,GO:0032233~positive regulation of actin filament bundle assembly,GO:0032781~positive regulation of ATPase activity,GO:0050804~modulation of synaptic transmission,GO:0050821~protein stabilization,GO:0051497~negative regulation of stress fiber assembly,GO:0060074~synapse maturation,GO:0098885~modification of postsynaptic actin cytoskeleton,GO:1900029~positive regulation of ruffle assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0016020~membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,GO:0098978~glutamatergic synapse,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0001784~phosphotyrosine binding,GO:0003723~RNA binding,GO:0003779~actin binding,GO:0003785~actin monomer binding,GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0031267~small GTPase binding,GO:0045296~cadherin binding,GO:0070064~proline-rich region binding,	IPR005454:Profilin1/2/3_vertebrate,IPR005455:PFN_euk,IPR027310:Profilin_CS,IPR036140:PFN_sf,IPR048278:PFN,	hsa04015:Rap1 signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05014:Amyotrophic lateral sclerosis,hsa05131:Shigellosis,hsa05132:Salmonella infection,	614808~Amyotrophic lateral sclerosis 18,		SM00392:PROF,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0036~Amyotrophic lateral sclerosis,KW-0225~Disease variant,KW-0523~Neurodegeneration,			KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,REGION:Disordered,
Q9EPC6	profilin 2(Pfn2)	Rattus norvegicus			GO:0010633~negative regulation of epithelial cell migration,GO:0030036~actin cytoskeleton organization,GO:0030833~regulation of actin filament polymerization,GO:0030837~negative regulation of actin filament polymerization,GO:0030838~positive regulation of actin filament polymerization,GO:0032233~positive regulation of actin filament bundle assembly,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0044087~regulation of cellular component biogenesis,GO:0050804~modulation of synaptic transmission,GO:0050821~protein stabilization,GO:0051496~positive regulation of stress fiber assembly,GO:0098885~modification of postsynaptic actin cytoskeleton,GO:1900028~negative regulation of ruffle assembly,GO:2000300~regulation of synaptic vesicle exocytosis,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0043195~terminal bouton,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098793~presynapse,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,	GO:0003779~actin binding,GO:0003785~actin monomer binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0016887~ATPase activity,	IPR005454:Profilin1/2/3_vertebrate,IPR005455:PFN_euk,IPR027310:Profilin_CS,IPR036140:PFN_sf,IPR048278:PFN,	rno04015:Rap1 signaling pathway,rno04810:Regulation of actin cytoskeleton,rno05014:Amyotrophic lateral sclerosis,rno05132:Salmonella infection,			SM00392:PROF,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,					KW-0009~Actin-binding,	KW-0007~Acetylation,
Q7ZVH1	progestin and adipoQ receptor family member Va(paqr5a)	Danio rerio			GO:0030154~cell differentiation,GO:0048477~oogenesis,	GO:0016020~membrane,	GO:0005496~steroid binding,GO:0008289~lipid binding,GO:0038023~signaling receptor activity,	IPR004254:AdipoR/HlyIII-related,					KW-0221~Differentiation,KW-0896~Oogenesis,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0446~Lipid-binding,KW-0754~Steroid-binding,	KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,		TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
A7MB10	programmed cell death 11(PDCD11)	Bos taurus			GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0031090~organelle membrane,GO:0032040~small-subunit processome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0051059~NF-kappaB binding,	IPR003029:S1_domain,IPR003107:HAT,IPR008847:Suf,IPR011990:TPR-like_helical_dom_sf,IPR012340:NA-bd_OB-fold,IPR045209:Rrp5,IPR048058:Rrp5_S1_rpt_hs11_sc8,IPR048059:Rrp5_S1_rpt_hs1_sc1,				SM00316:S1,SM00386:HAT,	KW-0698~rRNA processing,	KW-0539~Nucleus,			KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:S1 motif,DOMAIN:S1 motif 1,DOMAIN:S1 motif 10,DOMAIN:S1 motif 11,DOMAIN:S1 motif 12,DOMAIN:S1 motif 13,DOMAIN:S1 motif 2,DOMAIN:S1 motif 3,DOMAIN:S1 motif 4,DOMAIN:S1 motif 5,DOMAIN:S1 motif 6,DOMAIN:S1 motif 7,DOMAIN:S1 motif 8,DOMAIN:S1 motif 9,REGION:Disordered,REPEAT:HAT 1,REPEAT:HAT 2,REPEAT:HAT 3,REPEAT:HAT 4,
Q53EL6	programmed cell death 4(PDCD4)	Homo sapiens			GO:0006915~apoptotic process,GO:0009725~response to hormone,GO:0030509~BMP signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0043279~response to alkaloid,GO:0043508~negative regulation of JUN kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050729~positive regulation of inflammatory response,GO:0060940~epithelial to mesenchymal transition involved in cardiac fibroblast development,GO:0071222~cellular response to lipopolysaccharide,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1904761~negative regulation of myofibroblast differentiation,GO:1905064~negative regulation of vascular smooth muscle cell differentiation,GO:1905461~positive regulation of vascular associated smooth muscle cell apoptotic process,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR003891:Initiation_fac_eIF4g_MI,IPR016024:ARM-type_fold,IPR039778:PDCD4,	hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,			SM00544:MA3,	KW-0053~Apoptosis,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,	KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:MI,DOMAIN:MI 1,DOMAIN:MI 2,MOTIF:Nuclear localization signal,MOTIF:Phosphodegron,MUTAGEN:D->A: Reduced interaction with EIF4A1. Strongly reduced inhibition of translation.,MUTAGEN:D->A: Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation.,MUTAGEN:D->A: Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation. Reduced inhibition of EIF4A1 helicase activity.,MUTAGEN:E->A: No effect on inhibition of EIF4A1 and on inhibition of translation.,MUTAGEN:E->A: Reduced inhibition of EIF4A1 helicase activity.,MUTAGEN:E->A: Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.,MUTAGEN:E->A: Reduced interaction with EIF4A1.,MUTAGEN:F->A: Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation.,MUTAGEN:H->A: Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation.,MUTAGEN:H->A: Strongly reduced interaction with EIF4A1.,MUTAGEN:L->A: No effect on inhibition of EIF4A1 and on inhibition of translation; when associated with A-333.,MUTAGEN:L->A: Strongly reduced interaction with EIF4A1. Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.,MUTAGEN:M->A: No effect on inhibition of EIF4A1 and on inhibition of translation; when associated with A-340.,MUTAGEN:P->A: Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.,MUTAGEN:P->A: Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation.,MUTAGEN:S->A: Loss of phosphorylation site, and loss of nuclear accumulation. Abolishes phosphorylation by PKB; when associated with A-67.,MUTAGEN:S->A: Loss of phosphorylation site. Reduces interaction with BTRC. Abolishes phosphorylation by PKB; when associated with A-457.,MUTAGEN:S->A: Strongly reduced interaction with BTRC. Strongly reduced ubiquitination.,REGION:Disordered,
Q7ZZC6	proliferation associated nuclear element(pane1)	Danio rerio				GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,		IPR020987:Centromere_Cenp-M,IPR027417:P-loop_NTPase,						KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,
P50580	proliferation-associated 2G4(Pa2g4)	Mus musculus			GO:0006364~rRNA processing,GO:0006417~regulation of translation,GO:0043066~negative regulation of apoptotic process,GO:0045597~positive regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0031625~ubiquitin protein ligase binding,	IPR000994:Pept_M24,IPR004545:PA2G4,IPR018349:Pept_M24A_MAP2_BS,IPR036005:Creatinase/aminopeptidase-like,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR047113:PA2G4/ARX1,					KW-0698~rRNA processing,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0810~Translation regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0678~Repressor,KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Peptidase M24,MUTAGEN:KKEKEMKK->SSSSSSSS: No effect on RNA-binding.,REGION:Disordered,REGION:Interaction with RNA,REGION:Necessary for nucleolar localization,REGION:RNA-binding,
Q9GKN8	proline and arginine rich end leucine rich repeat protein(PRELP)	Bos taurus			GO:0090398~cellular senescence,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008201~heparin binding,	IPR000372:LRRNT,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR025875:Leu-rich_rpt_4,IPR032675:LRR_dom_sf,				SM00013:LRRNT,SM00364:LRR_BAC,SM00369:LRR_TYP,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,		KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-0357~Heparan sulfate,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:LRRNT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
E9PYL2	proline rich 12(Prr12)	Mus musculus				GO:0005634~nucleus,GO:0014069~postsynaptic density,GO:0043005~neuron projection,GO:0045202~synapse,	GO:0003677~DNA binding,	IPR025451:DUF4211,						KW-0539~Nucleus,KW-0770~Synapse,KW-0771~Synaptosome,					KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DUF4211,REGION:Disordered,
Q6DBU1	proline rich 15 like a(prr15la)	Danio rerio						IPR028237:PRR15,													COMPBIAS:Polar residues,REGION:Disordered,
Q6MZQ0	proline rich 5 like(PRR5L)	Homo sapiens			GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0009968~negative regulation of signal transduction,GO:0010762~regulation of fibroblast migration,GO:0034599~cellular response to oxidative stress,GO:0038203~TORC2 signaling,GO:0043491~protein kinase B signaling,GO:0051897~positive regulation of protein kinase B signaling,GO:0061014~positive regulation of mRNA catabolic process,GO:0090316~positive regulation of intracellular protein transport,	GO:0031932~TORC2 complex,	GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR013745:Bit61/PRR5,	hsa04150:mTOR signaling pathway,										KW-0734~Signal transduction inhibitor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	REGION:Disordered,
Q6PAQ9	proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane)(Prrg3)	Mus musculus				GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,	GO:0005509~calcium ion binding,	IPR000294:GLA_domain,IPR017857:Coagulation_fac-like_Gla_dom,IPR035972:GLA-like_dom_SF,				SM00069:GLA,		KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0301~Gamma-carboxyglutamic acid,KW-1015~Disulfide bond,	COMPBIAS:Polar residues,DOMAIN:Gla,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9BZD6	proline rich and Gla domain 4(PRRG4)	Homo sapiens				GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0050699~WW domain binding,	IPR000294:GLA_domain,IPR017857:Coagulation_fac-like_Gla_dom,IPR035972:GLA-like_dom_SF,				SM00069:GLA,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0165~Cleavage on pair of basic residues,KW-0301~Gamma-carboxyglutamic acid,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DOMAIN:Gla,MOTIF:LPXY motif; mediates binding to WW domain-containing proteins,MOTIF:PPXY motif; mediates binding to WW domain-containing proteins,MUTAGEN:Y->A: Reduced binding to MAGI1, MAGI3, NEDD4, NEDD4L, WWTR1 and YAP1.,MUTAGEN:Y->A: Reduced binding to MAGI1. No effect on binding to MAGI3, NEDD4, NEDD4L, WWTR1 or YAP1.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5RAG8	prolyl 4-hydroxylase subunit alpha 1(P4HA1)	Pongo abelii			GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0004656~procollagen-proline 4-dioxygenase activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0031418~L-ascorbic acid binding,GO:0042802~identical protein binding,	IPR005123:Oxoglu/Fe-dep_dioxygenase,IPR006620:Pro_4_hyd_alph,IPR011990:TPR-like_helical_dom_sf,IPR013547:Pro_4_hyd_alph_N,IPR019734:TPR_repeat,IPR044862:Pro_4_hyd_alph_FE2OG_OXY,IPR045054:P4HA-like,	pon00330:Arginine and proline metabolism,pon01100:Metabolic pathways,			SM00702:P4Hc,		KW-0256~Endoplasmic reticulum,			KW-0732~Signal,KW-0802~TPR repeat,	KW-0408~Iron,KW-0479~Metal-binding,KW-0847~Vitamin C,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fe2OG dioxygenase,REPEAT:TPR,
Q5ZLK5	prolyl 4-hydroxylase subunit alpha 2(P4HA2)	Gallus gallus			GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0004656~procollagen-proline 4-dioxygenase activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0031418~L-ascorbic acid binding,	IPR005123:Oxoglu/Fe-dep_dioxygenase,IPR006620:Pro_4_hyd_alph,IPR011990:TPR-like_helical_dom_sf,IPR013547:Pro_4_hyd_alph_N,IPR044862:Pro_4_hyd_alph_FE2OG_OXY,IPR045054:P4HA-like,	gga00330:Arginine and proline metabolism,gga01100:Metabolic pathways,			SM00702:P4Hc,		KW-0256~Endoplasmic reticulum,			KW-0732~Signal,KW-0802~TPR repeat,	KW-0408~Iron,KW-0479~Metal-binding,KW-0847~Vitamin C,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fe2OG dioxygenase,DOMAIN:Prolyl 4-hydroxylase alpha subunit,REPEAT:TPR,
Q9NXG6	prolyl 4-hydroxylase, transmembrane(P4HTM)	Homo sapiens			GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,GO:0045646~regulation of erythrocyte differentiation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004656~procollagen-proline 4-dioxygenase activity,GO:0005506~iron ion binding,GO:0005509~calcium ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0031418~L-ascorbic acid binding,GO:0046872~metal ion binding,	IPR002048:EF_hand_dom,IPR005123:Oxoglu/Fe-dep_dioxygenase,IPR006620:Pro_4_hyd_alph,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR044862:Pro_4_hyd_alph_FE2OG_OXY,IPR045054:P4HA-like,		618493~Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities,		SM00702:P4Hc,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0991~Intellectual disability,	KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0408~Iron,KW-0479~Metal-binding,KW-0847~Vitamin C,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:Fe2OG dioxygenase,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q9W735	prominin 1a(prom1a)	Danio rerio				GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005929~cilium,GO:0009986~cell surface,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0031528~microvillus membrane,GO:0042995~cell projection,GO:0071914~prominosome,	GO:0015485~cholesterol binding,	IPR008795:Prominin,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
Q91ZA3	propionyl-Coenzyme A carboxylase, alpha polypeptide(Pcca)	Mus musculus			GO:0006629~lipid metabolic process,GO:0016042~lipid catabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:1902494~catalytic complex,	GO:0000166~nucleotide binding,GO:0004658~propionyl-CoA carboxylase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0019899~enzyme binding,GO:0046872~metal ion binding,	IPR000089:Biotin_lipoyl,IPR001882:Biotin_BS,IPR005479:CbamoylP_synth_lsu-like_ATP-bd,IPR005481:BC-like_N,IPR005482:Biotin_COase_C,IPR011053:Single_hybrid_motif,IPR011054:Rudment_hybrid_motif,IPR011761:ATP-grasp,IPR011764:Biotin_carboxylation_dom,IPR013815:ATP_grasp_subdomain_1,IPR016185:PreATP-grasp_dom_sf,IPR041265:PCC_BT,	mmu00280:Valine, leucine and isoleucine degradation,mmu00630:Glyoxylate and dicarboxylate metabolism,mmu00640:Propanoate metabolism,mmu01100:Metabolic pathways,mmu01200:Carbon metabolism,			SM00878:Biotin_carb_C,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0092~Biotin,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:ATP-grasp,DOMAIN:Biotin carboxylation,DOMAIN:Biotinyl-binding,DOMAIN:Lipoyl-binding,DOMAIN:Propionyl-coenzyme A carboxylase BT,TRANSIT:Mitochondrion,
P29122	proprotein convertase subtilisin/kexin type 6(PCSK6)	Homo sapiens			GO:0006508~proteolysis,GO:0007354~zygotic determination of anterior/posterior axis, embryo,GO:0007368~determination of left/right symmetry,GO:0009100~glycoprotein metabolic process,GO:0016485~protein processing,GO:0016486~peptide hormone processing,GO:0030510~regulation of BMP signaling pathway,GO:0032902~nerve growth factor production,GO:0032940~secretion by cell,GO:0034369~plasma lipoprotein particle remodeling,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,	GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0048406~nerve growth factor binding,	IPR000209:Peptidase_S8/S53_dom,IPR000742:EGF-like_dom,IPR002884:P_dom,IPR006212:Furin_repeat,IPR008979:Galactose-bd-like_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR010909:PLAC,IPR015500:Peptidase_S8_subtilisin-rel,IPR022398:Peptidase_S8_His-AS,IPR023827:Peptidase_S8_Asp-AS,IPR023828:Peptidase_S8_Ser-AS,IPR032778:GF_recep_IV,IPR032815:S8_pro-domain,IPR034182:Kexin/furin,IPR036852:Peptidase_S8/S53_dom_sf,IPR038466:S8_pro-domain_sf,				SM00181:EGF,SM00261:FU,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:Growth factor receptor,DOMAIN:P/Homo B,DOMAIN:PLAC,DOMAIN:Peptidase S8,DOMAIN:Peptidase S8 pro-domain,DOMAIN:Peptidase S8/S53,MOTIF:Cell attachment site,REGION:CRM (Cys-rich motif),REGION:Disordered,REPEAT:FU 1,REPEAT:FU 2,REPEAT:FU 3,REPEAT:FU 4,REPEAT:FU 5,SITE:Cleavage; by autolysis,
Q63415	proprotein convertase subtilisin/kexin type 6(Pcsk6)	Rattus norvegicus			GO:0006508~proteolysis,GO:0007354~zygotic determination of anterior/posterior axis, embryo,GO:0007368~determination of left/right symmetry,GO:0009100~glycoprotein metabolic process,GO:0016485~protein processing,GO:0016486~peptide hormone processing,GO:0032902~nerve growth factor production,GO:0032940~secretion by cell,	GO:0005615~extracellular space,GO:0009986~cell surface,GO:0016020~membrane,	GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008201~heparin binding,GO:0048406~nerve growth factor binding,	IPR000209:Peptidase_S8/S53_dom,IPR000742:EGF-like_dom,IPR002884:P_dom,IPR006212:Furin_repeat,IPR008979:Galactose-bd-like_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR010909:PLAC,IPR015500:Peptidase_S8_subtilisin-rel,IPR022398:Peptidase_S8_His-AS,IPR023827:Peptidase_S8_Asp-AS,IPR023828:Peptidase_S8_Ser-AS,IPR032778:GF_recep_IV,IPR032815:S8_pro-domain,IPR034182:Kexin/furin,IPR036852:Peptidase_S8/S53_dom_sf,IPR038466:S8_pro-domain_sf,				SM00181:EGF,SM00261:FU,					KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:P/Homo B,DOMAIN:PLAC,DOMAIN:Peptidase S8,MOTIF:Cell attachment site,REGION:CRM (Cys-rich motif),REGION:Disordered,REPEAT:FU 1,REPEAT:FU 2,REPEAT:FU 3,REPEAT:FU 4,REPEAT:FU 5,SITE:Cleavage; by autolysis,
G1TGF1	prostaglandin E synthase 3(LOC100351480)	Oryctolagus cuniculus			GO:0001516~prostaglandin biosynthetic process,GO:0006457~protein folding,GO:0007004~telomere maintenance via telomerase,GO:0051131~chaperone-mediated protein complex assembly,GO:0051973~positive regulation of telomerase activity,GO:1905323~telomerase holoenzyme complex assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0050220~prostaglandin-E synthase activity,GO:0051087~chaperone binding,GO:0051879~Hsp90 protein binding,GO:0070182~DNA polymerase binding,	IPR007052:CS_dom,IPR008978:HSP20-like_chaperone,IPR045250:p23-like,	ocu00590:Arachidonic acid metabolism,ocu01100:Metabolic pathways,ocu05207:Chemical carcinogenesis - receptor activation,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0643~Prostaglandin biosynthesis,KW-0644~Prostaglandin metabolism,	KW-0963~Cytoplasm,					KW-0143~Chaperone,KW-0413~Isomerase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:CS,MOTIF:PXLE motif,REGION:Disordered,SITE:Cleavage; by caspase-7,
G1TGF1	prostaglandin E synthase 3(LOC100355572)	Oryctolagus cuniculus			GO:0001516~prostaglandin biosynthetic process,GO:0006457~protein folding,GO:0007004~telomere maintenance via telomerase,GO:0051131~chaperone-mediated protein complex assembly,GO:0051973~positive regulation of telomerase activity,GO:1905323~telomerase holoenzyme complex assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0050220~prostaglandin-E synthase activity,GO:0051087~chaperone binding,GO:0051879~Hsp90 protein binding,GO:0070182~DNA polymerase binding,	IPR007052:CS_dom,IPR008978:HSP20-like_chaperone,IPR045250:p23-like,	ocu00590:Arachidonic acid metabolism,ocu01100:Metabolic pathways,ocu05207:Chemical carcinogenesis - receptor activation,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0643~Prostaglandin biosynthesis,KW-0644~Prostaglandin metabolism,	KW-0963~Cytoplasm,					KW-0143~Chaperone,KW-0413~Isomerase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:CS,MOTIF:PXLE motif,REGION:Disordered,SITE:Cleavage; by caspase-7,
F1RE08	prostaglandin I2 (prostacyclin) synthase(ptgis)	Danio rerio			GO:0001516~prostaglandin biosynthetic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006693~prostaglandin metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008116~prostaglandin-I synthase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016829~lyase activity,GO:0016853~isomerase activity,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR001128:Cyt_P450,IPR002403:Cyt_P450_E_grp-IV,IPR024204:Cyt_P450_CYP7A1-type,IPR036396:Cyt_P450_sf,	dre00590:Arachidonic acid metabolism,dre01100:Metabolic pathways,		PIRSF000047:Cytochrome_CYPVIIA1,		KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0643~Prostaglandin biosynthesis,KW-0644~Prostaglandin metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0413~Isomerase,KW-0456~Lyase,		BINDING:axial binding residue,TRANSMEM:Helical,
O62664	prostaglandin-endoperoxide synthase 1(PTGS1)	Bos taurus			GO:0001516~prostaglandin biosynthetic process,GO:0006979~response to oxidative stress,GO:0019371~cyclooxygenase pathway,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0043005~neuron projection,	GO:0004601~peroxidase activity,GO:0004666~prostaglandin-endoperoxide synthase activity,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR000742:EGF-like_dom,IPR010255:Haem_peroxidase_sf,IPR019791:Haem_peroxidase_animal,IPR037120:Haem_peroxidase_sf_animal,	bta00590:Arachidonic acid metabolism,bta01100:Metabolic pathways,bta04611:Platelet activation,bta04726:Serotonergic synapse,bta04923:Regulation of lipolysis in adipocytes,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0643~Prostaglandin biosynthesis,KW-0644~Prostaglandin metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0245~EGF-like domain,KW-0732~Signal,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,KW-0575~Peroxidase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:For cyclooxygenase activity,ACT_SITE:Proton acceptor,BINDING:axial binding residue,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,REGION:Disordered,SITE:Aspirin-acetylated serine,
P31579	protease(lce)	Oryzias latipes			GO:0006508~proteolysis,	GO:0042588~zymogen granule,	GO:0004222~metalloendopeptidase activity,GO:0008270~zinc ion binding,	IPR001506:Peptidase_M12A,IPR006026:Peptidase_Metallo,IPR024079:MetalloPept_cat_dom_sf,IPR034039:ZnMP_hatching_enz,				SM00235:ZnMc,		KW-0968~Cytoplasmic vesicle,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase M12A,PROPEP:Activation peptide,
O35047	proteasome (prosome, macropain) 26S subunit, ATPase 3, interacting protein(Psmc3ip)	Mus musculus			GO:0000709~meiotic joint molecule formation,GO:0006310~DNA recombination,GO:0007129~synapsis,GO:0007131~reciprocal meiotic recombination,GO:0010774~meiotic strand invasion involved in reciprocal meiotic recombination,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051321~meiotic cell cycle,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0030331~estrogen receptor binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0035259~glucocorticoid receptor binding,GO:0044877~macromolecular complex binding,GO:0046966~thyroid hormone receptor binding,GO:0050681~androgen receptor binding,GO:0050692~DBD domain binding,	IPR010776:Hop2_WH_dom,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR040661:LZ3wCH,					KW-0233~DNA recombination,KW-0469~Meiosis,	KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0238~DNA-binding,		DOMAIN:Homologous-pairing protein 2 winged helix,DOMAIN:Leucine zipper with capping helix,MUTAGEN:E->P: Alters PSMC3/MND1 formation.,REGION:DNA-binding,
O35593	proteasome (prosome, macropain) 26S subunit, non-ATPase, 14(Psmd14)	Mus musculus			GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006508~proteolysis,GO:0006974~cellular response to DNA damage stimulus,GO:0016579~protein deubiquitination,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045471~response to ethanol,GO:0061136~regulation of proteasomal protein catabolic process,GO:0070536~protein K63-linked deubiquitination,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0008541~proteasome regulatory particle, lid subcomplex,GO:0022624~proteasome accessory complex,GO:0031597~cytosolic proteasome complex,GO:0032991~macromolecular complex,	GO:0004175~endopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0061133~endopeptidase activator activity,GO:0070628~proteasome binding,	IPR000555:JAMM/MPN+_dom,IPR037518:MPN,	mmu03050:Proteasome,mmu05010:Alzheimer disease,mmu05012:Parkinson disease,mmu05014:Amyotrophic lateral sclerosis,mmu05016:Huntington disease,mmu05017:Spinocerebellar ataxia,mmu05020:Prion disease,mmu05022:Pathways of neurodegeneration - multiple diseases,mmu05169:Epstein-Barr virus infection,			SM00232:JAB_MPN,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0647~Proteasome,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0597~Phosphoprotein,	DOMAIN:MPN,MOTIF:JAMM motif,
Q6DG91	proteasome (prosome, macropain) assembly chaperone 1(psmg1)	Danio rerio			GO:0043248~proteasome assembly,GO:0051131~chaperone-mediated protein complex assembly,GO:0080129~proteasome core complex assembly,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,	GO:0070628~proteasome binding,	IPR016565:Proteasome_assmbl_chp_1,			PIRSF010076:Psome_chaperone-1,			KW-0256~Endoplasmic reticulum,KW-0963~Cytoplasm,					KW-0143~Chaperone,
P21670	proteasome 20S subunit alpha 4(Psma4)	Rattus norvegicus			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0000502~proteasome complex,GO:0000932~P-body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0019773~proteasome core complex, alpha-subunit complex,GO:0043231~intracellular membrane-bounded organelle,		IPR000426:Proteasome_asu_N,IPR001353:Proteasome_sua/b,IPR016050:Proteasome_bsu_CS,IPR023332:Proteasome_alpha-type,IPR029055:Ntn_hydrolases_N,	rno03050:Proteasome,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05017:Spinocerebellar ataxia,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,			SM00948:Proteasome_A_N,		KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Proteasome alpha-type subunits,REGION:Disordered,
P28072	proteasome 20S subunit beta 6(PSMB6)	Homo sapiens		h_mhcPathway:Antigen Processing and Presentation,	GO:0010498~proteasomal protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0019774~proteasome core complex, beta-subunit complex,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0004298~threonine-type endopeptidase activity,GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR000243:Pept_T1A_subB,IPR001353:Proteasome_sua/b,IPR016050:Proteasome_bsu_CS,IPR023333:Proteasome_suB-type,IPR029055:Ntn_hydrolases_N,	hsa03050:Proteasome,hsa05010:Alzheimer disease,hsa05012:Parkinson disease,hsa05014:Amyotrophic lateral sclerosis,hsa05016:Huntington disease,hsa05017:Spinocerebellar ataxia,hsa05020:Prion disease,hsa05022:Pathways of neurodegeneration - multiple diseases,				KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,KW-0888~Threonine protease,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0865~Zymogen,	ACT_SITE:Nucleophile,PROPEP:Removed in mature form,REGION:Disordered,
Q9JHW0	proteasome 20S subunit beta 7(Psmb7)	Rattus norvegicus			GO:0010498~proteasomal protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0016604~nuclear body,GO:0019774~proteasome core complex, beta-subunit complex,	GO:0004175~endopeptidase activity,GO:0004298~threonine-type endopeptidase activity,	IPR000243:Pept_T1A_subB,IPR001353:Proteasome_sua/b,IPR016050:Proteasome_bsu_CS,IPR023333:Proteasome_suB-type,IPR024689:Proteasome_bsu_C,IPR029055:Ntn_hydrolases_N,	rno03050:Proteasome,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05017:Spinocerebellar ataxia,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,					KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,KW-0888~Threonine protease,	KW-0865~Zymogen,	ACT_SITE:Nucleophile,COMPBIAS:Polar residues,DOMAIN:Proteasome beta subunit C-terminal,PROPEP:Removed in mature form,REGION:Disordered,
P55036	proteasome 26S subunit ubiquitin receptor, non-ATPase 4(PSMD4)	Homo sapiens			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0008540~proteasome regulatory particle, base subcomplex,GO:0022624~proteasome accessory complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0031593~polyubiquitin binding,GO:0042802~identical protein binding,GO:0060090~binding, bridging,	IPR002035:VWF_A,IPR003903:UIM_dom,IPR027040:PSMD4,IPR036465:vWFA_dom_sf,	hsa03050:Proteasome,hsa05010:Alzheimer disease,hsa05012:Parkinson disease,hsa05014:Amyotrophic lateral sclerosis,hsa05016:Huntington disease,hsa05017:Spinocerebellar ataxia,hsa05020:Prion disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05169:Epstein-Barr virus infection,			SM00327:VWA,SM00726:UIM,		KW-0647~Proteasome,			KW-0677~Repeat,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:UIM 1,DOMAIN:UIM 2,DOMAIN:VWFA,REGION:Disordered,REGION:Essential for ubiquitin-binding,REGION:Interaction with UBQLN1,
Q63569	proteasome 26S subunit, ATPase 3(Psmc3)	Rattus norvegicus			GO:0001824~blastocyst development,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043921~modulation by host of viral transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1901800~positive regulation of proteasomal protein catabolic process,	GO:0000502~proteasome complex,GO:0000932~P-body,GO:0005634~nucleus,GO:0008540~proteasome regulatory particle, base subcomplex,GO:0022624~proteasome accessory complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0036402~proteasome-activating ATPase activity,GO:0042802~identical protein binding,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR003960:ATPase_AAA_CS,IPR012340:NA-bd_OB-fold,IPR027417:P-loop_NTPase,IPR032501:Prot_ATP_ID_OB_2nd,IPR041569:AAA_lid_3,	rno03050:Proteasome,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05017:Spinocerebellar ataxia,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05169:Epstein-Barr virus infection,			SM00382:AAA,		KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:AAA+ ATPase,
P84169	proteasome 26S subunit, non-ATPase 13(PSMD13)	Gallus gallus			GO:0006511~ubiquitin-dependent protein catabolic process,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005829~cytosol,GO:0008541~proteasome regulatory particle, lid subcomplex,GO:0022624~proteasome accessory complex,	GO:0005198~structural molecule activity,	IPR000717:PCI_dom,IPR035298:PSMD13,IPR036390:WH_DNA-bd_sf,	gga03050:Proteasome,			SM00088:PINT,		KW-0647~Proteasome,							COMPBIAS:Pro residues,DOMAIN:PCI,REGION:Disordered,
Q9BT73	proteasome assembly chaperone 3(PSMG3)	Homo sapiens			GO:0043248~proteasome assembly,GO:0051131~chaperone-mediated protein complex assembly,	GO:0032991~macromolecular complex,	GO:0005515~protein binding,GO:0044877~macromolecular complex binding,GO:0060090~binding, bridging,	IPR018788:Proteasome_assmbl_chp_3,											KW-0143~Chaperone,	KW-0007~Acetylation,
O73817	proteasome subunit C10-11(LOC100135869)	Oncorhynchus mykiss			GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005839~proteasome core complex,GO:0019774~proteasome core complex, beta-subunit complex,		IPR001353:Proteasome_sua/b,IPR016050:Proteasome_bsu_CS,IPR023333:Proteasome_suB-type,IPR029055:Ntn_hydrolases_N,IPR033811:Proteasome_beta_3,	omy03050:Proteasome,					KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,
Q9Z2U1	proteasome subunit alpha 5(Psma5)	Mus musculus			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0019773~proteasome core complex, alpha-subunit complex,		IPR000426:Proteasome_asu_N,IPR001353:Proteasome_sua/b,IPR023332:Proteasome_alpha-type,IPR029055:Ntn_hydrolases_N,IPR033812:Proteasome_alpha_type_5,	mmu03050:Proteasome,mmu05010:Alzheimer disease,mmu05012:Parkinson disease,mmu05014:Amyotrophic lateral sclerosis,mmu05016:Huntington disease,mmu05017:Spinocerebellar ataxia,mmu05020:Prion disease,mmu05022:Pathways of neurodegeneration - multiple diseases,			SM00948:Proteasome_A_N,		KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:O-linked (GlcNAc) serine,DOMAIN:Proteasome alpha-type subunits,
O73672	proteasome subunit alpha type-2(LOC113091586)	Carassius auratus			GO:0006511~ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005839~proteasome core complex,GO:0019773~proteasome core complex, alpha-subunit complex,		IPR000426:Proteasome_asu_N,IPR001353:Proteasome_sua/b,IPR023332:Proteasome_alpha-type,IPR029055:Ntn_hydrolases_N,	caua03050:Proteasome,			SM00948:Proteasome_A_N,		KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Proteasome alpha-type subunits,
Q9PTW9	proteasome subunit alpha type-7(LOC113037774)	Carassius auratus			GO:0006511~ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005839~proteasome core complex,GO:0019773~proteasome core complex, alpha-subunit complex,		IPR000426:Proteasome_asu_N,IPR001353:Proteasome_sua/b,IPR023332:Proteasome_alpha-type,IPR029055:Ntn_hydrolases_N,	caua03050:Proteasome,			SM00948:Proteasome_A_N,		KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,			KW-0175~Coiled coil,				DOMAIN:Proteasome alpha-type subunits,
P28024	proteasome subunit beta 4 L homeolog(psmb4.L)	Xenopus laevis			GO:0051603~proteolysis involved in cellular protein catabolic process,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005839~proteasome core complex,GO:0019774~proteasome core complex, beta-subunit complex,		IPR001353:Proteasome_sua/b,IPR016050:Proteasome_bsu_CS,IPR016295:Proteasome_beta4,IPR023333:Proteasome_suB-type,IPR029055:Ntn_hydrolases_N,	xla03050:Proteasome,		PIRSF001213:Psome_endopept_beta,			KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,							ACT_SITE:Nucleophile,
Q28278	protein C, inactivator of coagulation factors Va and VIIIa(PROC)	Canis lupus familiaris			GO:0006508~proteolysis,GO:0007596~blood coagulation,GO:0030195~negative regulation of blood coagulation,GO:0043066~negative regulation of apoptotic process,GO:0050728~negative regulation of inflammatory response,GO:0050819~negative regulation of coagulation,GO:1903142~positive regulation of establishment of endothelial barrier,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,	GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000294:GLA_domain,IPR000742:EGF-like_dom,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR001881:EGF-like_Ca-bd_dom,IPR009003:Peptidase_S1_PA,IPR009030:Growth_fac_rcpt_cys_sf,IPR012224:Pept_S1A_FX,IPR017857:Coagulation_fac-like_Gla_dom,IPR018097:EGF_Ca-bd_CS,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR035972:GLA-like_dom_SF,IPR043504:Peptidase_S1_PA_chymotrypsin,	cfa04610:Complement and coagulation cascades,		PIRSF001143:Factor_X,	SM00020:Tryp_SPc,SM00069:GLA,SM00179:EGF_CA,SM00181:EGF,	KW-0094~Blood coagulation,KW-0356~Hemostasis,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0165~Cleavage on pair of basic residues,KW-0301~Gamma-carboxyglutamic acid,KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between light and heavy chains),DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:Gla,DOMAIN:Peptidase S1,
Q28278	protein C, inactivator of coagulation factors Va and VIIIa(PROC)	Canis lupus dingo			GO:0006508~proteolysis,GO:0007596~blood coagulation,GO:0030195~negative regulation of blood coagulation,GO:0043066~negative regulation of apoptotic process,GO:0050728~negative regulation of inflammatory response,GO:0050819~negative regulation of coagulation,GO:1903142~positive regulation of establishment of endothelial barrier,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,	GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000294:GLA_domain,IPR000742:EGF-like_dom,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR001881:EGF-like_Ca-bd_dom,IPR009003:Peptidase_S1_PA,IPR009030:Growth_fac_rcpt_cys_sf,IPR012224:Pept_S1A_FX,IPR017857:Coagulation_fac-like_Gla_dom,IPR018097:EGF_Ca-bd_CS,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR035972:GLA-like_dom_SF,IPR043504:Peptidase_S1_PA_chymotrypsin,	clud04610:Complement and coagulation cascades,		PIRSF001143:Factor_X,	SM00020:Tryp_SPc,SM00069:GLA,SM00179:EGF_CA,SM00181:EGF,	KW-0094~Blood coagulation,KW-0356~Hemostasis,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0165~Cleavage on pair of basic residues,KW-0301~Gamma-carboxyglutamic acid,KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between light and heavy chains),DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:Gla,DOMAIN:Peptidase S1,
Q5RAA9	protein NipSnap homolog 3B(LOC100439866)	Pongo abelii				GO:0005739~mitochondrion,GO:0005829~cytosol,		IPR011008:Dimeric_a/b-barrel,IPR012577:NIPSNAP,						KW-0963~Cytoplasm,			KW-0732~Signal,			KW-0007~Acetylation,	DOMAIN:NIPSNAP,
Q91ZW2	protein O-fucosyltransferase 1(Pofut1)	Mus musculus			GO:0001525~angiogenesis,GO:0001756~somitogenesis,GO:0005975~carbohydrate metabolic process,GO:0006004~fucose metabolic process,GO:0006493~protein O-linked glycosylation,GO:0007219~Notch signaling pathway,GO:0007399~nervous system development,GO:0007507~heart development,GO:0008593~regulation of Notch signaling pathway,GO:0036066~protein O-linked fucosylation,	GO:0005783~endoplasmic reticulum,GO:0016020~membrane,	GO:0008417~fucosyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0046922~peptide-O-fucosyltransferase activity,	IPR019378:GDP-Fuc_O-FucTrfase,IPR039922:POFUT1,	mmu00514:Other types of O-glycan biosynthesis,				KW-0119~Carbohydrate metabolism,KW-0294~Fucose metabolism,KW-0914~Notch signaling pathway,	KW-0256~Endoplasmic reticulum,			KW-0732~Signal,	KW-0464~Manganese,	KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,MOTIF:Prevents secretion from ER,REGION:Disordered,
Q922R8	protein disulfide isomerase associated 6(Pdia6)	Mus musculus			GO:0030168~platelet activation,GO:0034976~response to endoplasmic reticulum stress,GO:0070527~platelet aggregation,GO:1903895~negative regulation of IRE1-mediated unfolded protein response,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005790~smooth endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0034663~endoplasmic reticulum chaperone complex,GO:0042470~melanosome,	GO:0003756~protein disulfide isomerase activity,GO:0015035~protein disulfide oxidoreductase activity,GO:0016853~isomerase activity,	IPR005788:PDI_thioredoxin-like_dom,IPR013766:Thioredoxin_domain,IPR017937:Thioredoxin_CS,IPR036249:Thioredoxin-like_sf,IPR044569:PDIA6-like,	mmu04141:Protein processing in endoplasmic reticulum,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0676~Redox-active center,KW-0677~Repeat,KW-0732~Signal,		KW-0143~Chaperone,KW-0413~Isomerase,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Acidic residues,DISULFID:Redox-active,DOMAIN:Thioredoxin,DOMAIN:Thioredoxin 1,DOMAIN:Thioredoxin 2,MOTIF:Prevents secretion from ER,REGION:Disordered,
Q13131	protein kinase AMP-activated catalytic subunit alpha 1(PRKAA1)	Homo sapiens		h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_leptinPathway:Reversal of Insulin Resistance by Leptin,	GO:0001666~response to hypoxia,GO:0006006~glucose metabolic process,GO:0006338~chromatin remodeling,GO:0006468~protein phosphorylation,GO:0006633~fatty acid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0006914~autophagy,GO:0007165~signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0008610~lipid biosynthetic process,GO:0009411~response to UV,GO:0009631~cold acclimation,GO:0010332~response to gamma radiation,GO:0010508~positive regulation of autophagy,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014823~response to activity,GO:0015721~bile acid and bile salt transport,GO:0016055~Wnt signaling pathway,GO:0016310~phosphorylation,GO:0019395~fatty acid oxidation,GO:0031000~response to caffeine,GO:0031669~cellular response to nutrient levels,GO:0032007~negative regulation of TOR signaling,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0034599~cellular response to oxidative stress,GO:0035556~intracellular signal transduction,GO:0038183~bile acid signaling pathway,GO:0042149~cellular response to glucose starvation,GO:0042593~glucose homeostasis,GO:0042752~regulation of circadian rhythm,GO:0043066~negative regulation of apoptotic process,GO:0043627~response to estrogen,GO:0045542~positive regulation of cholesterol biosynthetic process,GO:0045821~positive regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046318~negative regulation of glucosylceramide biosynthetic process,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0048511~rhythmic process,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0050995~negative regulation of lipid catabolic process,GO:0055089~fatty acid homeostasis,GO:0060627~regulation of vesicle-mediated transport,GO:0061744~motor behavior,GO:0061762~CAMKK-AMPK signaling cascade,GO:0070050~neuron cellular homeostasis,GO:0070301~cellular response to hydrogen peroxide,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0071277~cellular response to calcium ion,GO:0071333~cellular response to glucose stimulus,GO:0071361~cellular response to ethanol,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071456~cellular response to hypoxia,GO:0071466~cellular response to xenobiotic stimulus,GO:0097009~energy homeostasis,GO:1903109~positive regulation of transcription from mitochondrial promoter,GO:1903829~positive regulation of cellular protein localization,GO:1903944~negative regulation of hepatocyte apoptotic process,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:1904179~positive regulation of adipose tissue development,GO:1904262~negative regulation of TORC1 signaling,GO:1904428~negative regulation of tubulin deacetylation,GO:1905691~lipid particle disassembly,GO:1990044~protein localization to lipid particle,GO:2000758~positive regulation of peptidyl-lysine acetylation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016324~apical plasma membrane,GO:0016607~nuclear speck,GO:0030424~axon,GO:0030425~dendrite,GO:0031588~nucleotide-activated protein kinase complex,GO:0043025~neuronal cell body,	GO:0003682~chromatin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004679~AMP-activated protein kinase activity,GO:0004691~cAMP-dependent protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,GO:0047322~[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,GO:0048156~tau protein binding,GO:0050321~tau-protein kinase activity,GO:0050405~[acetyl-CoA carboxylase] kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR028375:KA1/Ssp2_C,IPR028797:PRKAA1_UBA,IPR032270:AMPK_C,IPR039137:AMPKA1_C,IPR049020:PRKAA1/2_AID,	hsa04068:FoxO signaling pathway,hsa04140:Autophagy - animal,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04371:Apelin signaling pathway,hsa04530:Tight junction,hsa04710:Circadian rhythm,hsa04714:Thermogenesis,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04936:Alcoholic liver disease,hsa05410:Hypertrophic cardiomyopathy,hsa05418:Fluid shear stress and atherosclerosis,			SM00220:S_TKc,	KW-0072~Autophagy,KW-0090~Biological rhythms,KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0879~Wnt signaling pathway,KW-0945~Host-virus interaction,KW-1207~Sterol metabolism,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0156~Chromatin regulator,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,MUTAGEN:V->G,Q: Activates the kinase activity.,REGION:AIS,REGION:Disordered,
P54646	protein kinase AMP-activated catalytic subunit alpha 2(PRKAA2)	Homo sapiens		h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_leptinPathway:Reversal of Insulin Resistance by Leptin,	GO:0006338~chromatin remodeling,GO:0006468~protein phosphorylation,GO:0006633~fatty acid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0006914~autophagy,GO:0007165~signal transduction,GO:0008610~lipid biosynthetic process,GO:0010508~positive regulation of autophagy,GO:0010629~negative regulation of gene expression,GO:0014850~response to muscle activity,GO:0016055~Wnt signaling pathway,GO:0016239~positive regulation of macroautophagy,GO:0016241~regulation of macroautophagy,GO:0016310~phosphorylation,GO:0031331~positive regulation of cellular catabolic process,GO:0031669~cellular response to nutrient levels,GO:0032007~negative regulation of TOR signaling,GO:0034599~cellular response to oxidative stress,GO:0035556~intracellular signal transduction,GO:0042149~cellular response to glucose starvation,GO:0042593~glucose homeostasis,GO:0042752~regulation of circadian rhythm,GO:0043066~negative regulation of apoptotic process,GO:0045821~positive regulation of glycolytic process,GO:0048511~rhythmic process,GO:0055089~fatty acid homeostasis,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0071277~cellular response to calcium ion,GO:0071333~cellular response to glucose stimulus,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071466~cellular response to xenobiotic stimulus,GO:0097009~energy homeostasis,GO:1903829~positive regulation of cellular protein localization,GO:1903944~negative regulation of hepatocyte apoptotic process,GO:1904262~negative regulation of TORC1 signaling,GO:1904428~negative regulation of tubulin deacetylation,GO:1905691~lipid particle disassembly,GO:1990044~protein localization to lipid particle,GO:2000758~positive regulation of peptidyl-lysine acetylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0030424~axon,GO:0030425~dendrite,GO:0031588~nucleotide-activated protein kinase complex,GO:0043025~neuronal cell body,	GO:0003682~chromatin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004679~AMP-activated protein kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0046872~metal ion binding,GO:0047322~[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,GO:0050405~[acetyl-CoA carboxylase] kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR028375:KA1/Ssp2_C,IPR028783:PRKAA2,IPR032270:AMPK_C,IPR039148:AMPKA2_C,IPR049020:PRKAA1/2_AID,	hsa04068:FoxO signaling pathway,hsa04140:Autophagy - animal,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04371:Apelin signaling pathway,hsa04530:Tight junction,hsa04710:Circadian rhythm,hsa04714:Thermogenesis,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04936:Alcoholic liver disease,hsa05410:Hypertrophic cardiomyopathy,hsa05418:Fluid shear stress and atherosclerosis,			SM00220:S_TKc,	KW-0072~Autophagy,KW-0090~Biological rhythms,KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0879~Wnt signaling pathway,KW-1207~Sterol metabolism,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0156~Chromatin regulator,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,MUTAGEN:K->R: Complete loss of kinase activity.,MUTAGEN:T->A: Loss of ARF6 activation. Loss of interaction with ACSS2.,MUTAGEN:T->D: Phosphomimetic mutant.,REGION:AIS,REGION:Disordered,TRANSMEM:Helical,
Q9UGJ0	protein kinase AMP-activated non-catalytic subunit gamma 2(PRKAG2)	Homo sapiens		h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_leptinPathway:Reversal of Insulin Resistance by Leptin,	GO:0005977~glycogen metabolic process,GO:0006110~regulation of glycolytic process,GO:0006468~protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0006633~fatty acid biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0016126~sterol biosynthetic process,GO:0016310~phosphorylation,GO:0019217~regulation of fatty acid metabolic process,GO:0031669~cellular response to nutrient levels,GO:0035556~intracellular signal transduction,GO:0045860~positive regulation of protein kinase activity,GO:0046320~regulation of fatty acid oxidation,GO:0046324~regulation of glucose import,GO:0050790~regulation of catalytic activity,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0031588~nucleotide-activated protein kinase complex,	GO:0004679~AMP-activated protein kinase activity,GO:0004862~cAMP-dependent protein kinase inhibitor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008603~cAMP-dependent protein kinase regulator activity,GO:0008607~phosphorylase kinase regulator activity,GO:0016208~AMP binding,GO:0016301~kinase activity,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0030295~protein kinase activator activity,GO:0043531~ADP binding,	IPR000644:CBS_dom,IPR046342:CBS_dom_sf,	hsa04068:FoxO signaling pathway,hsa04152:AMPK signaling pathway,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04371:Apelin signaling pathway,hsa04530:Tight junction,hsa04710:Circadian rhythm,hsa04714:Thermogenesis,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04936:Alcoholic liver disease,hsa05410:Hypertrophic cardiomyopathy,	194200~Wolff-Parkinson-White syndrome,261740~Glycogen storage disease of heart, lethal congenital,600858~Cardiomyopathy, hypertrophic 6,		SM00116:CBS,	KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0472~Membrane,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,KW-0322~Glycogen storage disease,	KW-0129~CBS domain,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CBS,DOMAIN:CBS 1,DOMAIN:CBS 2,DOMAIN:CBS 3,DOMAIN:CBS 4,MOTIF:AMPK pseudosubstrate,MUTAGEN:V->S: Induces phosphorylation by AMPK.,REGION:Disordered,TRANSMEM:Helical,
Q9WVE8	protein kinase C and casein kinase substrate in neurons 2(Pacsin2)	Mus musculus			GO:0006897~endocytosis,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0030036~actin cytoskeleton organization,GO:0030100~regulation of endocytosis,GO:0036010~protein localization to endosome,GO:0045806~negative regulation of endocytosis,GO:0048858~cell projection morphogenesis,GO:0050804~modulation of synaptic transmission,GO:0070836~caveola assembly,GO:0072584~caveolin-mediated endocytosis,GO:0097320~plasma membrane tubulation,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0031410~cytoplasmic vesicle,GO:0032587~ruffle membrane,GO:0034451~centriolar satellite,GO:0042995~cell projection,GO:0043231~intracellular membrane-bounded organelle,GO:0055038~recycling endosome membrane,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008092~cytoskeletal protein binding,GO:0008289~lipid binding,GO:0042802~identical protein binding,GO:0070300~phosphatidic acid binding,	IPR001060:FCH_dom,IPR001452:SH3_domain,IPR027267:AH/BAR_dom_sf,IPR031160:F_BAR,IPR035743:PACSIN1/PACSIN2_SH3,IPR036028:SH3-like_dom_sf,IPR037453:PACSIN2_F-BAR,				SM00055:FCH,SM00326:SH3,	KW-0254~Endocytosis,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0728~SH3 domain,	KW-0446~Lipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:F-BAR,DOMAIN:SH3,MOTIF:NPF1,MOTIF:NPF2,MOTIF:NPF3,MUTAGEN:D->K: Slight increase in affinity for membranes. Increases membrane tubulation activity.,MUTAGEN:K->E: Decreases affinity for membranes.,MUTAGEN:MM->TT: Nearly abolishes membrane tubulation activity.,MUTAGEN:P->L: Loss of DNM1-, SYNJ1- and WASL-binding.,MUTAGEN:R->D: Slight decrease in affinity for membranes. Nearly abolishes membrane tubulation activity.,MUTAGEN:S->D: Reduced membrane-binding affinity.,MUTAGEN:S->E: Reduced membrane-binding affinity.,REGION:Disordered,
Q04759	protein kinase C theta(PRKCQ)	Homo sapiens		h_keratinocytePathway:Keratinocyte Differentiation,	GO:0001558~regulation of cell growth,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006509~membrane protein ectodomain proteolysis,GO:0006954~inflammatory response,GO:0007411~axon guidance,GO:0018105~peptidyl-serine phosphorylation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0032740~positive regulation of interleukin-17 production,GO:0032743~positive regulation of interleukin-2 production,GO:0032753~positive regulation of interleukin-4 production,GO:0035556~intracellular signal transduction,GO:0035739~CD4-positive, alpha-beta T cell proliferation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050870~positive regulation of T cell activation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051973~positive regulation of telomerase activity,GO:0060326~cell chemotaxis,GO:0070233~negative regulation of T cell apoptotic process,GO:0090330~regulation of platelet aggregation,GO:1904355~positive regulation of telomere capping,GO:2000318~positive regulation of T-helper 17 type immune response,GO:2000563~positive regulation of CD4-positive, alpha-beta T cell proliferation,GO:2000570~positive regulation of T-helper 2 cell activation,	GO:0001772~immunological synapse,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016235~aggresome,GO:0034451~centriolar satellite,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR002219:PE/DAG-bd,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014376:Prot_kin_PKC_delta,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,IPR020454:DAG/PE-bd,IPR027264:PKC_theta,IPR034668:nPKC_theta,IPR035892:C2_domain_sf,IPR046349:C1-like_sf,	hsa04064:NF-kappa B signaling pathway,hsa04140:Autophagy - animal,hsa04270:Vascular smooth muscle contraction,hsa04658:Th1 and Th2 cell differentiation,hsa04659:Th17 cell differentiation,hsa04660:T cell receptor signaling pathway,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04920:Adipocytokine signaling pathway,hsa04931:Insulin resistance,hsa05131:Shigellosis,hsa05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,		PIRSF000551:PKC_delta,PIRSF501105:Protein_kin_C_theta,	SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,	KW-0391~Immunity,KW-0395~Inflammatory response,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:AGC-kinase C-terminal,DOMAIN:C2,DOMAIN:Protein kinase,MUTAGEN:A->E: Constitutively active form.,MUTAGEN:K->A,E: Loss of kinase activity.,MUTAGEN:S->A: Reduction in kinase activity.,MUTAGEN:T->A: Loss of kinase activity.,MUTAGEN:T->A: Loss of transactivation of the IL2 promoter and translocation to the plasma membrane. No effect on kinase activity.,MUTAGEN:Y->F: Loss of function in T-cells proliferation. No effect on kinase activity.,ZN_FING:Phorbol-ester/DAG-type 1,ZN_FING:Phorbol-ester/DAG-type 2,
Q05513	protein kinase C zeta(PRKCZ)	Homo sapiens		h_ptdinsPathway:Phosphoinositides and their downstream targets.,	GO:0000226~microtubule cytoskeleton organization,GO:0001954~positive regulation of cell-matrix adhesion,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007616~long-term memory,GO:0008284~positive regulation of cell proliferation,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0018105~peptidyl-serine phosphorylation,GO:0030010~establishment of cell polarity,GO:0031333~negative regulation of protein complex assembly,GO:0032733~positive regulation of interleukin-10 production,GO:0032736~positive regulation of interleukin-13 production,GO:0032753~positive regulation of interleukin-4 production,GO:0032754~positive regulation of interleukin-5 production,GO:0032869~cellular response to insulin stimulus,GO:0035556~intracellular signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0047496~vesicle transport along microtubule,GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051222~positive regulation of protein transport,GO:0051899~membrane depolarization,GO:0060081~membrane hyperpolarization,GO:0060291~long-term synaptic potentiation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070528~protein kinase C signaling,GO:0072659~protein localization to plasma membrane,GO:1990138~neuron projection extension,GO:2000463~positive regulation of excitatory postsynaptic potential,GO:2000553~positive regulation of T-helper 2 cell cytokine production,	GO:0001725~stress fiber,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0016363~nuclear matrix,GO:0030054~cell junction,GO:0031252~cell leading edge,GO:0031982~vesicle,GO:0035748~myelin sheath abaxonal region,GO:0043203~axon hillock,GO:0045179~apical cortex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0070160~occluding junction,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098978~glutamatergic synapse,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015459~potassium channel regulator activity,GO:0019901~protein kinase binding,GO:0043274~phospholipase binding,GO:0043560~insulin receptor substrate binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0071889~14-3-3 protein binding,	IPR000270:PB1_dom,IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR002219:PE/DAG-bd,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR012233:PKC,IPR015727:Protein_Kinase_C_mu-related,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,IPR020454:DAG/PE-bd,IPR034662:aPKC_zeta,IPR034877:PB1_aPKC,IPR046349:C1-like_sf,IPR047314:C1_aPKC_zeta,	hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04144:Endocytosis,hsa04360:Axon guidance,hsa04390:Hippo signaling pathway,hsa04530:Tight junction,hsa04611:Platelet activation,hsa04910:Insulin signaling pathway,hsa04926:Relaxin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa05165:Human papillomavirus infection,hsa05415:Diabetic cardiomyopathy,hsa05418:Fluid shear stress and atherosclerosis,		PIRSF000554:PKC_zeta,	SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00666:PB1,	KW-0395~Inflammatory response,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0967~Endosome,			KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,DOMAIN:AGC-kinase C-terminal,DOMAIN:PB1,DOMAIN:Phorbol-ester/DAG-type,DOMAIN:Protein kinase,MUTAGEN:D->A: Loss of interaction with SQSTM1 and PARD6B.,MUTAGEN:K->A: No effect on interaction with SQSTM1 and PARD6B.,REGION:Disordered,REGION:Interaction with SQSTM1,ZN_FING:Phorbol-ester/DAG-type,
P05696	protein kinase C, alpha(Prkca)	Rattus norvegicus			GO:0000302~response to reactive oxygen species,GO:0001525~angiogenesis,GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002026~regulation of the force of heart contraction,GO:0002062~chondrocyte differentiation,GO:0002159~desmosome assembly,GO:0006338~chromatin remodeling,GO:0006874~cellular calcium ion homeostasis,GO:0006915~apoptotic process,GO:0006937~regulation of muscle contraction,GO:0007155~cell adhesion,GO:0007611~learning or memory,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009612~response to mechanical stimulus,GO:0009636~response to toxic substance,GO:0010595~positive regulation of endothelial cell migration,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0014070~response to organic cyclic compound,GO:0016310~phosphorylation,GO:0017148~negative regulation of translation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0021955~central nervous system neuron axonogenesis,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway,GO:0032355~response to estradiol,GO:0034351~negative regulation of glial cell apoptotic process,GO:0035556~intracellular signal transduction,GO:0042221~response to chemical,GO:0043409~negative regulation of MAPK cascade,GO:0043434~response to peptide hormone,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0043687~post-translational protein modification,GO:0045184~establishment of protein localization,GO:0045471~response to ethanol,GO:0045651~positive regulation of macrophage differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045780~positive regulation of bone resorption,GO:0045785~positive regulation of cell adhesion,GO:0045921~positive regulation of exocytosis,GO:0045931~positive regulation of mitotic cell cycle,GO:0046325~negative regulation of glucose import,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0046716~muscle cell cellular homeostasis,GO:0047484~regulation of response to osmotic stress,GO:0048259~regulation of receptor-mediated endocytosis,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048863~stem cell differentiation,GO:0050729~positive regulation of inflammatory response,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050930~induction of positive chemotaxis,GO:0051412~response to corticosterone,GO:0051965~positive regulation of synapse assembly,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070555~response to interleukin-1,GO:0071322~cellular response to carbohydrate stimulus,GO:0090330~regulation of platelet aggregation,GO:0097193~intrinsic apoptotic signaling pathway,GO:2000300~regulation of synaptic vesicle exocytosis,GO:2000707~positive regulation of dense core granule biogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0031966~mitochondrial membrane,GO:0032991~macromolecular complex,GO:0035866~alphav-beta3 integrin-PKCalpha complex,GO:0036064~ciliary basal body,GO:0043025~neuronal cell body,GO:0044305~calyx of Held,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0099523~presynaptic cytosol,GO:1990917~ooplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0004698~calcium-dependent protein kinase C activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0019899~enzyme binding,GO:0035403~histone kinase activity (H3-T6 specific),	IPR000008:C2_dom,IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR002219:PE/DAG-bd,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014375:Protein_kinase_C_a/b/g,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,IPR020454:DAG/PE-bd,IPR034663:cPKC_alpha,IPR035892:C2_domain_sf,IPR046349:C1-like_sf,	rno01521:EGFR tyrosine kinase inhibitor resistance,rno04010:MAPK signaling pathway,rno04012:ErbB signaling pathway,rno04014:Ras signaling pathway,rno04015:Rap1 signaling pathway,rno04020:Calcium signaling pathway,rno04066:HIF-1 signaling pathway,rno04070:Phosphatidylinositol signaling system,rno04071:Sphingolipid signaling pathway,rno04072:Phospholipase D signaling pathway,rno04150:mTOR signaling pathway,rno04151:PI3K-Akt signaling pathway,rno04261:Adrenergic signaling in cardiomyocytes,rno04270:Vascular smooth muscle contraction,rno04310:Wnt signaling pathway,rno04360:Axon guidance,rno04370:VEGF signaling pathway,rno04510:Focal adhesion,rno04540:Gap junction,rno04613:Neutrophil extracellular trap formation,rno04650:Natural killer cell mediated cytotoxicity,rno04664:Fc epsilon RI signaling pathway,rno04666:Fc gamma R-mediated phagocytosis,rno04670:Leukocyte transendothelial migration,rno04713:Circadian entrainment,rno04720:Long-term potentiation,rno04723:Retrograde endocannabinoid signaling,rno04724:Glutamatergic synapse,rno04725:Cholinergic synapse,rno04726:Serotonergic synapse,rno04727:GABAergic synapse,rno04728:Dopaminergic synapse,rno04730:Long-term depression,rno04750:Inflammatory mediator regulation of TRP channels,rno04911:Insulin secretion,rno04912:GnRH signaling pathway,rno04916:Melanogenesis,rno04918:Thyroid hormone synthesis,rno04919:Thyroid hormone signaling pathway,rno04921:Oxytocin signaling pathway,rno04925:Aldosterone synthesis and secretion,rno04926:Relaxin signaling pathway,rno04928:Parathyroid hormone synthesis, secretion and action,rno04929:GnRH secretion,rno04933:AGE-RAGE signaling pathway in diabetic complications,rno04935:Growth hormone synthesis, secretion and action,rno04960:Aldosterone-regulated sodium reabsorption,rno04961:Endocrine and other factor-regulated calcium reabsorption,rno04970:Salivary secretion,rno04971:Gastric acid secretion,rno04972:Pancreatic secretion,rno05017:Spinocerebellar ataxia,rno05022:Pathways of neurodegeneration - multiple diseases,rno05031:Amphetamine addiction,rno05032:Morphine addiction,rno05143:African trypanosomiasis,rno05146:Amoebiasis,rno05161:Hepatitis B,rno05163:Human cytomegalovirus infection,rno05164:Influenza A,rno05170:Human immunodeficiency virus 1 infection,rno05171:Coronavirus disease - COVID-19,rno05200:Pathways in cancer,rno05205:Proteoglycans in cancer,rno05206:MicroRNAs in cancer,rno05207:Chemical carcinogenesis - receptor activation,rno05214:Glioma,rno05223:Non-small cell lung cancer,rno05225:Hepatocellular carcinoma,rno05231:Choline metabolism in cancer,rno05415:Diabetic cardiomyopathy,rno05417:Lipid and atherosclerosis,		PIRSF000550:PKC_alpha,	SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00239:C2,	KW-0037~Angiogenesis,KW-0053~Apoptosis,KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:AGC-kinase C-terminal,DOMAIN:C2,DOMAIN:Phorbol-ester/DAG-type,DOMAIN:Protein kinase,MUTAGEN:K->A: Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with S-195; A-209 and A-245.,MUTAGEN:K->A: Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with S-195; A-211 and A-245.,MUTAGEN:W->A: Reduced phosphatidylinositol 4,5-bisphosphate recognition and impaired membrane docking. Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with S-195; A-209 and A-211.,MUTAGEN:Y->S: Reduced phosphatidylinositol 4,5-bisphosphate recognition and impaired membrane docking. Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with A-209; A-211 and A-245.,ZN_FING:Phorbol-ester/DAG-type 1,ZN_FING:Phorbol-ester/DAG-type 2,
O94806	protein kinase D3(PRKD3)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0016310~phosphorylation,GO:0030148~sphingolipid biosynthetic process,GO:0035556~intracellular signal transduction,GO:0036211~protein modification process,GO:0089700~protein kinase D signaling,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR001849:PH_domain,IPR002219:PE/DAG-bd,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011993:PH-like_dom_sf,IPR015727:Protein_Kinase_C_mu-related,IPR017441:Protein_kinase_ATP_BS,IPR020454:DAG/PE-bd,IPR046349:C1-like_sf,	hsa04015:Rap1 signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa05208:Chemical carcinogenesis - reactive oxygen species,		PIRSF000552:PKC_mu_nu_D2,	SM00109:C1,SM00220:S_TKc,SM00233:PH,		KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PH,DOMAIN:Phorbol-ester/DAG-type,DOMAIN:Protein kinase,MUTAGEN:I->V: Slight increase in ability to bind DAG, no effect on phorbol-ester binding.,MUTAGEN:K->W: Increased ability to bind DAG, no effect on phorbol-ester binding.,MUTAGEN:P->G: No effect on ability to bind phorbol ester, increase in ability to bind DAG.,MUTAGEN:P->G: No effect on ability to bind phorbol ester, loss of ability to bind DAG, reduced DAG-induced membrane translocation.,MUTAGEN:T->A: Slight loss in ability to bind DAG and phorbol-ester.,MUTAGEN:T->A: Slight loss in ability to bind DAG and phorbol-ester; when associated with F-158.,MUTAGEN:Y->F: Slight loss in ability to bind DAG and phorbol-ester.,MUTAGEN:Y->F: Slight loss in ability to bind DAG and phorbol-ester; when associated with A-156.,REGION:Disordered,ZN_FING:Phorbol-ester/DAG-type 1,ZN_FING:Phorbol-ester/DAG-type 2,
P00516	protein kinase cGMP-dependent 1(PRKG1)	Bos taurus			GO:0001764~neuron migration,GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0016358~dendrite development,GO:0019934~cGMP-mediated signaling,GO:0030900~forebrain development,GO:0043087~regulation of GTPase activity,GO:0048668~collateral sprouting,GO:0060087~relaxation of vascular smooth muscle,GO:0090331~negative regulation of platelet aggregation,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1904753~negative regulation of vascular associated smooth muscle cell migration,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0004692~cGMP-dependent protein kinase activity,GO:0005246~calcium channel regulator activity,GO:0005524~ATP binding,GO:0030553~cGMP binding,GO:0042802~identical protein binding,	IPR000595:cNMP-bd_dom,IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR002374:cGMP_dep_kinase,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014710:RmlC-like_jellyroll,IPR017441:Protein_kinase_ATP_BS,IPR018488:cNMP-bd_CS,IPR018490:cNMP-bd_dom_sf,IPR031831:PKcGMP_CC,IPR035014:STKc_cGK,	bta04022:cGMP-PKG signaling pathway,bta04270:Vascular smooth muscle contraction,bta04540:Gap junction,bta04611:Platelet activation,bta04713:Circadian entrainment,bta04714:Thermogenesis,bta04730:Long-term depression,bta04740:Olfactory transduction,bta04923:Regulation of lipolysis in adipocytes,bta04970:Salivary secretion,		PIRSF000559:cGMP-dep_kinase,	SM00100:cNMP,SM00133:S_TK_X,SM00220:S_TKc,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0114~cAMP,KW-0116~cAMP-binding,KW-0140~cGMP,KW-0142~cGMP-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DISULFID:Interchain,DOMAIN:AGC-kinase C-terminal,DOMAIN:Cyclic nucleotide-binding,DOMAIN:Protein kinase,REGION:Autoinhibitory domain,REGION:Disordered,REGION:Leucine-zipper,REGION:Required for dimerization,REGION:cGMP-binding, high affinity,REGION:cGMP-binding, low affinity,SITE:Cleavage,
Q13237	protein kinase cGMP-dependent 2(PRKG2)	Homo sapiens		h_no1Pathway:Actions of Nitric Oxide in the Heart,h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,	GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0016310~phosphorylation,GO:0032332~positive regulation of chondrocyte differentiation,GO:0046146~tetrahydrobiopterin metabolic process,GO:0072659~protein localization to plasma membrane,GO:1903829~positive regulation of cellular protein localization,GO:2001226~negative regulation of chloride transport,	GO:0005829~cytosol,GO:0016324~apical plasma membrane,GO:0031965~nuclear membrane,	GO:0004672~protein kinase activity,GO:0004692~cGMP-dependent protein kinase activity,GO:0005524~ATP binding,GO:0030553~cGMP binding,GO:0042802~identical protein binding,GO:0051019~mitogen-activated protein kinase binding,	IPR000595:cNMP-bd_dom,IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR002374:cGMP_dep_kinase,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014710:RmlC-like_jellyroll,IPR017441:Protein_kinase_ATP_BS,IPR018488:cNMP-bd_CS,IPR018490:cNMP-bd_dom_sf,IPR035014:STKc_cGK,	hsa04022:cGMP-PKG signaling pathway,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04714:Thermogenesis,hsa04730:Long-term depression,hsa04740:Olfactory transduction,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04970:Salivary secretion,	619636~Acromesomelic dysplasia 4,619638~Spondylometaphyseal dysplasia, Pagnamenta type,	PIRSF000559:cGMP-dep_kinase,	SM00100:cNMP,SM00133:S_TK_X,SM00220:S_TKc,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0242~Dwarfism,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0140~cGMP,KW-0142~cGMP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0449~Lipoprotein,KW-0519~Myristate,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:AGC-kinase C-terminal,DOMAIN:Cyclic nucleotide-binding,DOMAIN:Protein kinase,LIPID:N-myristoyl glycine,MUTAGEN:D->A: Reduces cGMP binding affinity; when associated with A-415.,MUTAGEN:R->A: Reduces cGMP binding affinity; when associated with A-412.,REGION:Disordered,REGION:cGMP-binding, high affinity; cAMP-binding, low affinity,REGION:cGMP-binding, high affinity; cAMP-binding, moderate affinity,
B9ENE7	protein mago nashi homolog(LOC106584057)	Salmo salar			GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0035145~exon-exon junction complex,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,	IPR004023:Mago_nashi,IPR036605:Mago_nashi_sf,	sasa03013:Nucleocytoplasmic transport,sasa03015:mRNA surveillance pathway,sasa03040:Spliceosome,				KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0509~mRNA transport,KW-0810~Translation regulation,KW-0813~Transport,KW-0866~Nonsense-mediated mRNA decay,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,
Q6GLQ4	protein phosphatase 1 regulatory subunit 10 S homeolog(ppp1r10.S)	Xenopus laevis				GO:0005634~nucleus,	GO:0004864~protein phosphatase inhibitor activity,GO:0046872~metal ion binding,	IPR000571:Znf_CCCH,IPR003617:TFIIS/CRSP70_N_sub,IPR017923:TFIIS_N,IPR035441:TFIIS/LEDGF_dom_sf,				SM00356:ZnF_C3H1,SM00509:TFS2N,		KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0650~Protein phosphatase inhibitor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:C3H1-type,DOMAIN:TFIIS N-terminal,MOTIF:PP1-binding motif,REGION:Disordered,ZN_FING:C3H1-type,
O14974	protein phosphatase 1 regulatory subunit 12A(PPP1R12A)	Homo sapiens			GO:0000278~mitotic cell cycle,GO:0006470~protein dephosphorylation,GO:0007098~centrosome cycle,GO:0007165~signal transduction,GO:0030155~regulation of cell adhesion,GO:0035507~regulation of myosin-light-chain-phosphatase activity,GO:0035508~positive regulation of myosin-light-chain-phosphatase activity,GO:0043086~negative regulation of catalytic activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046822~regulation of nucleocytoplasmic transport,GO:0071466~cellular response to xenobiotic stimulus,	GO:0000776~kinetochore,GO:0001725~stress fiber,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0030018~Z disc,GO:0031672~A band,GO:0043292~contractile fiber,GO:0072357~PTW/PP1 phosphatase complex,	GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0019208~phosphatase regulator activity,GO:0019901~protein kinase binding,GO:0071889~14-3-3 protein binding,	IPR002110:Ankyrin_rpt,IPR017401:MYPT1/MYPT2/Mbs85,IPR031775:PRKG1_interact,IPR036770:Ankyrin_rpt-contain_sf,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04510:Focal adhesion,hsa04611:Platelet activation,hsa04810:Regulation of actin cytoskeleton,hsa04921:Oxytocin signaling pathway,hsa05205:Proteoglycans in cancer,	618820~Genitourinary and/or/brain malformation syndrome,	PIRSF038141:PP1_12ABC_vert,	SM00248:ANK,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0040~ANK repeat,KW-0175~Coiled coil,KW-0677~Repeat,			KW-0379~Hydroxylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:cGMP-dependent protein kinase interacting,MOTIF:KVKF motif,MUTAGEN:L->A: Loss of binding to PRKG1; when associated with A-1007.,MUTAGEN:L->A: Loss of binding to PRKG1; when associated with A-1014.,MUTAGEN:L->A: Loss of binding to PRKG1; when associated with A-1021.,MUTAGEN:L->A: Loss of binding to PRKG1; when associated with A-1028.,MUTAGEN:S->A: Abolishes binding to the POLO box domains of PLK1.,MUTAGEN:S->A: Abolishes phosphorylation by NUAK1 and interaction with 14-3-3; when associated with A-445 and A-472.,MUTAGEN:S->A: Abolishes phosphorylation by NUAK1 and interaction with 14-3-3; when associated with A-445 and A-910.,MUTAGEN:S->A: Abolishes phosphorylation by NUAK1 and interaction with 14-3-3; when associated with A-472 and A-910.,REGION:Disordered,REGION:Interaction with ROCK2,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,
Q90623	protein phosphatase 1 regulatory subunit 12A(PPP1R12A)	Gallus gallus			GO:0000278~mitotic cell cycle,GO:0007098~centrosome cycle,GO:0007165~signal transduction,GO:0030155~regulation of cell adhesion,GO:0035507~regulation of myosin-light-chain-phosphatase activity,GO:0035508~positive regulation of myosin-light-chain-phosphatase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046822~regulation of nucleocytoplasmic transport,GO:0071466~cellular response to xenobiotic stimulus,	GO:0000776~kinetochore,GO:0001725~stress fiber,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0030018~Z disc,GO:0031672~A band,GO:0072357~PTW/PP1 phosphatase complex,	GO:0004857~enzyme inhibitor activity,GO:0019208~phosphatase regulator activity,GO:0019901~protein kinase binding,GO:0071889~14-3-3 protein binding,	IPR002110:Ankyrin_rpt,IPR017401:MYPT1/MYPT2/Mbs85,IPR031775:PRKG1_interact,IPR036770:Ankyrin_rpt-contain_sf,	gga04270:Vascular smooth muscle contraction,gga04510:Focal adhesion,gga04810:Regulation of actin cytoskeleton,		PIRSF038141:PP1_12ABC_vert,	SM00248:ANK,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0040~ANK repeat,KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:cGMP-dependent protein kinase interacting,MUTAGEN:T->A: Reduces phosphorylation. Reduces phosphorylation on serine and threonine residues by 80%; when associated with A-695.,MUTAGEN:T->A: Reduces phosphorylation. Reduces phosphorylation on serine and threonine residues by 80%; when associated with A-850.,REGION:Disordered,REGION:Important for interaction with PPP1CB,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,
Q8K3F3	protein phosphatase 1, regulatory (inhibitor) subunit 14B(Ppp1r14b)	Rattus norvegicus			GO:0042325~regulation of phosphorylation,GO:0045087~innate immune response,	GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0004864~protein phosphatase inhibitor activity,GO:0004865~protein serine/threonine phosphatase inhibitor activity,GO:0019212~phosphatase inhibitor activity,GO:0019888~protein phosphatase regulator activity,	IPR008025:CPI-17,IPR036658:CPI-17_sf,						KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0650~Protein phosphatase inhibitor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q803M0	protein phosphatase 1, regulatory subunit 3B(ppp1r3b)	Danio rerio			GO:0005975~carbohydrate metabolic process,GO:0005977~glycogen metabolic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0005981~regulation of glycogen catabolic process,	GO:0000164~protein phosphatase type 1 complex,	GO:0008157~protein phosphatase 1 binding,GO:0019888~protein phosphatase regulator activity,GO:2001069~glycogen binding,	IPR005036:CBM21_dom,IPR017434:Pase-1_reg-su_3B/C/D_met,IPR030682:PP1_3B,IPR038175:CBM21_dom_sf,	dre04910:Insulin signaling pathway,		PIRSF038207:PP1_GT_animal,PIRSF500814:PP1_GL,		KW-0119~Carbohydrate metabolism,KW-0321~Glycogen metabolism,								DOMAIN:CBM21,
Q6P950	protein phosphatase 1, regulatory subunit 3Cb(ppp1r3cb)	Danio rerio			GO:0005975~carbohydrate metabolic process,GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0005979~regulation of glycogen biosynthetic process,	GO:0000164~protein phosphatase type 1 complex,	GO:0008157~protein phosphatase 1 binding,GO:0019903~protein phosphatase binding,GO:2001069~glycogen binding,	IPR005036:CBM21_dom,IPR017434:Pase-1_reg-su_3B/C/D_met,IPR030683:PP1_3C,IPR038175:CBM21_dom_sf,	dre04910:Insulin signaling pathway,		PIRSF038207:PP1_GT_animal,PIRSF500813:PP1_PTG,		KW-0119~Carbohydrate metabolism,KW-0321~Glycogen metabolism,								DOMAIN:CBM21,
Q80TL0	protein phosphatase 1E (PP2C domain containing)(Ppm1e)	Mus musculus			GO:0006469~negative regulation of protein kinase activity,GO:0006470~protein dephosphorylation,GO:0035970~peptidyl-threonine dephosphorylation,GO:0051496~positive regulation of stress fiber assembly,GO:0071222~cellular response to lipopolysaccharide,GO:0071466~cellular response to xenobiotic stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0032991~macromolecular complex,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0016787~hydrolase activity,GO:0017018~myosin phosphatase activity,GO:0043169~cation binding,GO:0046872~metal ion binding,	IPR000222:PP2C_BS,IPR001932:PPM-type_phosphatase-like_dom,IPR015655:PP2C,IPR036457:PPM-type-like_dom_sf,				SM00332:PP2Cc,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:PPM-type phosphatase,REGION:7 X 2 AA tandem repeats of P-E,REGION:Disordered,REPEAT:1,REPEAT:2,REPEAT:3,REPEAT:4; approximate,REPEAT:5,REPEAT:6,REPEAT:7,
Q06190	protein phosphatase 2 regulatory subunit B''alpha(PPP2R3A)	Homo sapiens			GO:0001754~eye photoreceptor cell differentiation,GO:0001756~somitogenesis,GO:0006470~protein dephosphorylation,GO:0007525~somatic muscle development,GO:0045732~positive regulation of protein catabolic process,GO:0061053~somite development,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090249~regulation of cell motility involved in somitogenic axis elongation,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000159~protein phosphatase type 2A complex,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0019888~protein phosphatase regulator activity,GO:0030674~protein binding, bridging,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR041534:EF-hand_13,IPR048855:P2R3A_B_D_EF-hand,	hsa03015:mRNA surveillance pathway,hsa04071:Sphingolipid signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04660:T cell receptor signaling pathway,hsa04728:Dopaminergic synapse,hsa05165:Human papillomavirus infection,								KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,			COMPBIAS:Pro residues,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:PP2A regulatory subunit B'' EF-hand,DOMAIN:Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha/beta/delta EF-hand,REGION:Disordered,
Q6NY64	protein phosphatase 2, regulatory subunit B, alpha b(ppp2r2ab)	Danio rerio			GO:0000278~mitotic cell cycle,GO:0007520~myoblast fusion,GO:0010458~exit from mitosis,GO:0051301~cell division,GO:0072554~blood vessel lumenization,	GO:0000159~protein phosphatase type 2A complex,GO:0005829~cytosol,	GO:0019888~protein phosphatase regulator activity,	IPR000009:PP2A_PR55,IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR018067:PP2A_PR55_CS,IPR036322:WD40_repeat_dom_sf,	dre03015:mRNA surveillance pathway,dre04261:Adrenergic signaling in cardiomyocytes,dre04530:Tight junction,		PIRSF037309:PP2A_PR55,	SM00320:WD40,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0853~WD repeat,				REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q6NY64	protein phosphatase 2, regulatory subunit B, delta(ppp2r2d)	Danio rerio			GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0007520~myoblast fusion,GO:0010458~exit from mitosis,GO:0051301~cell division,GO:0072554~blood vessel lumenization,	GO:0000159~protein phosphatase type 2A complex,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0019888~protein phosphatase regulator activity,	IPR000009:PP2A_PR55,IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR018067:PP2A_PR55_CS,IPR036322:WD40_repeat_dom_sf,	dre03015:mRNA surveillance pathway,dre04261:Adrenergic signaling in cardiomyocytes,dre04530:Tight junction,		PIRSF037309:PP2A_PR55,	SM00320:WD40,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0853~WD repeat,				REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q64620	protein phosphatase 6, catalytic subunit(Ppp6c)	Rattus norvegicus			GO:0000082~G1/S transition of mitotic cell cycle,GO:0045087~innate immune response,GO:0045824~negative regulation of innate immune response,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004722~protein serine/threonine phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0046872~metal ion binding,	IPR004843:Calcineurin-like_PHP_ApaH,IPR006186:Ser/Thr-sp_prot-phosphatase,IPR029052:Metallo-depent_PP-like,IPR047129:PPA2-like,				SM00156:PP2Ac,	KW-0131~Cell cycle,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,				KW-0464~Manganese,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0007~Acetylation,	ACT_SITE:Proton donor,DOMAIN:Serine/threonine specific protein phosphatases,
Q5SGD2	protein phosphatase, Mg2+/Mn2+ dependent 1L(PPM1L)	Homo sapiens			GO:0000165~MAPK cascade,GO:0006470~protein dephosphorylation,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0030148~sphingolipid biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0004722~protein serine/threonine phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0046872~metal ion binding,	IPR000222:PP2C_BS,IPR001932:PPM-type_phosphatase-like_dom,IPR015655:PP2C,IPR036457:PPM-type-like_dom_sf,				SM00331:PP2C_SIG,SM00332:PP2Cc,		KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0904~Protein phosphatase,		DOMAIN:PPM-type phosphatase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O43663	protein regulator of cytokinesis 1(PRC1)	Homo sapiens			GO:0000022~mitotic spindle elongation,GO:0000226~microtubule cytoskeleton organization,GO:0008284~positive regulation of cell proliferation,GO:0032465~regulation of cytokinesis,GO:0051256~mitotic spindle midzone assembly,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005876~spindle microtubule,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,GO:0030496~midbody,GO:0045171~intercellular bridge,GO:0070938~contractile ring,GO:1990023~mitotic spindle midzone,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0019894~kinesin binding,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,	IPR007145:MAP65_Ase1_PRC1,					KW-0131~Cell cycle,KW-0132~Cell division,	KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0553~Oncogene,	KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	MUTAGEN:ST->AA: Impairs binding to the POLO box domains of PLK1, preventing phosphorylation by PLK1 and recruitment of PLK1 to the spindle.,MUTAGEN:ST->AA: Weakly reduces binding to the POLO box domains of PLK1.,MUTAGEN:T->A: No effect. Abolishes CDK1-mediated phosphorylation, leading to prematurely recruit PLK1 to the spindle during prometaphase and blocking mitotic progression; when associated with A-481.,MUTAGEN:T->A: No effect. Reduces in vitro cyclin E-CDK2 phosphorylation and causes extensive bundling of microtubules to the mitotic spindle; when associated with A-470.,REGION:Dimerization,REGION:Disordered,REGION:Required for the interaction with KIF4A,REGION:Spectrin-fold,REGION:Unstructured, Arg/Lys rich,SITE:Tubulin binding,
A2VDT1	protein tyrosine phosphatase 4A3(PTP4A3)	Bos taurus			GO:0006355~regulation of transcription, DNA-templated,GO:0006470~protein dephosphorylation,GO:0007219~Notch signaling pathway,GO:0016311~dephosphorylation,GO:0043117~positive regulation of vascular permeability,GO:0043542~endothelial cell migration,GO:1900746~regulation of vascular endothelial growth factor signaling pathway,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1904951~positive regulation of establishment of protein localization,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005886~plasma membrane,	GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,	IPR000242:PTP_cat,IPR000387:Tyr_Pase_dom,IPR003595:Tyr_Pase_cat,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,				SM00404:PTPc_motif,		KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,		KW-0656~Proto-oncogene,			KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0636~Prenylation,KW-1015~Disulfide bond,	ACT_SITE:Phosphocysteine intermediate,ACT_SITE:Proton donor,DOMAIN:Tyrosine-protein phosphatase,LIPID:S-farnesyl cysteine,PROPEP:Removed in mature form,
P23467	protein tyrosine phosphatase receptor type B(PTPRB)	Homo sapiens		h_spryPathway:Sprouty regulation of tyrosine kinase signals,	GO:0001525~angiogenesis,GO:0006470~protein dephosphorylation,GO:0006796~phosphate-containing compound metabolic process,GO:0008347~glial cell migration,GO:0016311~dephosphorylation,GO:0036211~protein modification process,GO:1990264~peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,	GO:0005886~plasma membrane,GO:0035579~specific granule membrane,GO:0043235~receptor complex,GO:0070821~tertiary granule membrane,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0045296~cadherin binding,	IPR000242:PTP_cat,IPR000387:Tyr_Pase_dom,IPR000772:Ricin_B_lectin,IPR003595:Tyr_Pase_cat,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR016130:Tyr_Pase_AS,IPR029021:Prot-tyrosine_phosphatase-like,IPR035992:Ricin_B-like_lectins,IPR036116:FN3_sf,IPR041201:PTPRJ_TM,	hsa04520:Adherens junction,			SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,	KW-0037~Angiogenesis,	KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0430~Lectin,	KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 10,DOMAIN:Fibronectin type-III 11,DOMAIN:Fibronectin type-III 12,DOMAIN:Fibronectin type-III 13,DOMAIN:Fibronectin type-III 14,DOMAIN:Fibronectin type-III 15,DOMAIN:Fibronectin type-III 16,DOMAIN:Fibronectin type-III 17,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,DOMAIN:Fibronectin type-III 7,DOMAIN:Fibronectin type-III 8,DOMAIN:Fibronectin type-III 9,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A4IFW2	protein tyrosine phosphatase receptor type Fb(ptprfb)	Danio rerio			GO:0007155~cell adhesion,GO:0016043~cellular component organization,GO:0016311~dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0097374~sensory neuron axon guidance,GO:0099560~synaptic membrane adhesion,	GO:0016020~membrane,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008201~heparin binding,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,	IPR000242:PTP_cat,IPR000387:Tyr_Pase_dom,IPR003595:Tyr_Pase_cat,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR016130:Tyr_Pase_AS,IPR029021:Prot-tyrosine_phosphatase-like,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,	dre04514:Cell adhesion molecules,dre04520:Adherens junction,dre04910:Insulin signaling pathway,			SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0358~Heparin-binding,KW-0378~Hydrolase,KW-0675~Receptor,KW-0904~Protein phosphatase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Phosphocysteine intermediate,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,DOMAIN:Fibronectin type-III 7,DOMAIN:Fibronectin type-III 8,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,DOMAIN:Tyrosine-protein phosphatase 1,DOMAIN:Tyrosine-protein phosphatase 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q16827	protein tyrosine phosphatase receptor type O(PTPRO)	Homo sapiens			GO:0000902~cell morphogenesis,GO:0002548~monocyte chemotaxis,GO:0003093~regulation of glomerular filtration,GO:0003105~negative regulation of glomerular filtration,GO:0006470~protein dephosphorylation,GO:0007411~axon guidance,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010977~negative regulation of neuron projection development,GO:0016311~dephosphorylation,GO:0030032~lamellipodium assembly,GO:0032835~glomerulus development,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0036060~slit diaphragm assembly,GO:0050807~regulation of synapse organization,GO:0072112~glomerular visceral epithelial cell differentiation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090260~negative regulation of retinal ganglion cell axon guidance,GO:1990264~peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0030027~lamellipodium,GO:0030424~axon,GO:0030426~growth cone,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,GO:0098839~postsynaptic density membrane,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0016791~phosphatase activity,GO:0017147~Wnt-protein binding,GO:0042803~protein homodimerization activity,GO:0045296~cadherin binding,	IPR000242:PTP_cat,IPR000387:Tyr_Pase_dom,IPR003595:Tyr_Pase_cat,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR016130:Tyr_Pase_AS,IPR029021:Prot-tyrosine_phosphatase-like,IPR036116:FN3_sf,IPR042996:PTPRO,		614196~Nephrotic syndrome, type 6,		SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,		KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0675~Receptor,KW-0904~Protein phosphatase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,DOMAIN:Fibronectin type-III 7,DOMAIN:Fibronectin type-III 8,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
B3DK56	protein tyrosine phosphatase receptor type Ub(ptprub)	Danio rerio			GO:0001757~somite specification,GO:0006470~protein dephosphorylation,GO:0007155~cell adhesion,GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway,GO:0016311~dephosphorylation,GO:0030154~cell differentiation,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070161~anchoring junction,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,	IPR000242:PTP_cat,IPR000387:Tyr_Pase_dom,IPR000998:MAM_dom,IPR003595:Tyr_Pase_cat,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR013320:ConA-like_dom_sf,IPR013783:Ig-like_fold,IPR016130:Tyr_Pase_AS,IPR029021:Prot-tyrosine_phosphatase-like,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,				SM00060:FN3,SM00137:MAM,SM00194:PTPc,SM00404:PTPc_motif,SM00409:IG,	KW-0130~Cell adhesion,KW-0221~Differentiation,	KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0378~Hydrolase,KW-0675~Receptor,KW-0904~Protein phosphatase,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Phosphocysteine intermediate,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Ig-like C2-type,DOMAIN:MAM,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,DOMAIN:Tyrosine-protein phosphatase 1,DOMAIN:Tyrosine-protein phosphatase 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q62728	protein tyrosine phosphatase, non-receptor type 21(Ptpn21)	Rattus norvegicus			GO:0007010~cytoskeleton organization,GO:0016311~dephosphorylation,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0004725~protein tyrosine phosphatase activity,	IPR000242:PTP_cat,IPR000299:FERM_domain,IPR000387:Tyr_Pase_dom,IPR003595:Tyr_Pase_cat,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR014392:PTP_non-rcpt_14/21,IPR016130:Tyr_Pase_AS,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019747:FERM_CS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029021:Prot-tyrosine_phosphatase-like,IPR029071:Ubiquitin-like_domsf,IPR035963:FERM_2,IPR041782:PTPN14/21_FERM_C,			PIRSF000934:Tyr-Ptase_nr14,	SM00194:PTPc,SM00295:B41,SM00404:PTPc_motif,SM01196:FERM_C,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0675~Receptor,KW-0904~Protein phosphatase,	KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,COMPBIAS:Polar residues,DOMAIN:FERM,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,REGION:Disordered,
Q8BUM3	protein tyrosine phosphatase, non-receptor type 7(Ptpn7)	Mus musculus			GO:0006470~protein dephosphorylation,GO:0016311~dephosphorylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0009898~cytoplasmic side of plasma membrane,GO:0015630~microtubule cytoskeleton,GO:0072686~mitotic spindle,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,	IPR000242:PTP_cat,IPR000387:Tyr_Pase_dom,IPR003595:Tyr_Pase_cat,IPR008356:Tyr_Pase_KIM-con,IPR016130:Tyr_Pase_AS,IPR029021:Prot-tyrosine_phosphatase-like,	mmu04010:MAPK signaling pathway,			SM00194:PTPc,SM00404:PTPc_motif,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0675~Receptor,KW-0904~Protein phosphatase,	KW-0558~Oxidation,KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,REGION:Disordered,REGION:Interaction with MAP kinases,
Q641Z2	protein tyrosine phosphatase, non-receptor type 9(Ptpn9)	Rattus norvegicus			GO:0006470~protein dephosphorylation,GO:0010977~negative regulation of neuron projection development,GO:0016311~dephosphorylation,GO:1903078~positive regulation of protein localization to plasma membrane,	GO:0005737~cytoplasm,GO:0044306~neuron projection terminus,	GO:0004725~protein tyrosine phosphatase activity,	IPR000242:PTP_cat,IPR000387:Tyr_Pase_dom,IPR001251:CRAL-TRIO_dom,IPR003595:Tyr_Pase_cat,IPR016130:Tyr_Pase_AS,IPR029021:Prot-tyrosine_phosphatase-like,IPR036273:CRAL/TRIO_N_dom_sf,IPR036865:CRAL-TRIO_dom_sf,				SM00194:PTPc,SM00404:PTPc_motif,SM00516:SEC14,		KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0675~Receptor,KW-0904~Protein phosphatase,	KW-0007~Acetylation,	ACT_SITE:Phosphocysteine intermediate,DOMAIN:CRAL-TRIO,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,REGION:Disordered,
Q8BSS9	protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2(Ppfia2)	Mus musculus			GO:0050808~synapse organization,GO:0060998~regulation of dendritic spine development,GO:0061001~regulation of dendritic spine morphogenesis,GO:0099519~dense core granule cytoskeletal transport,GO:2000300~regulation of synaptic vesicle exocytosis,	GO:0005737~cytoplasm,GO:0008021~synaptic vesicle,GO:0009986~cell surface,GO:0030424~axon,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043197~dendritic spine,GO:0045202~synapse,GO:0048786~presynaptic active zone,GO:0098978~glutamatergic synapse,GO:0099523~presynaptic cytosol,GO:0099572~postsynaptic specialization,	GO:0005515~protein binding,GO:0044877~macromolecular complex binding,	IPR001660:SAM,IPR013761:SAM/pointed_sf,IPR029515:Liprin,IPR037620:Liprin-alpha_SAM_rpt_1,IPR037621:Liprin-alpha_SAM_rpt_2,IPR037622:Liprin-alpha_SAM_rpt_3,				SM00454:SAM,		KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SAM,DOMAIN:SAM 1,DOMAIN:SAM 2,DOMAIN:SAM 3,REGION:Disordered,
P22061	protein-L-isoaspartate (D-aspartate) O-methyltransferase(PCMT1)	Homo sapiens			GO:0006479~protein methylation,GO:0030091~protein repair,GO:0032259~methylation,GO:0036211~protein modification process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0004719~protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR000682:PCMT,IPR029063:SAM-dependent_MTases_sf,						KW-0963~Cytoplasm,				KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,
A0JMP0	protein-glucosylgalactosylhydroxylysine glucosidase(pgghg)	Danio rerio			GO:0005975~carbohydrate metabolic process,GO:0008152~metabolic process,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0016787~hydrolase activity,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0047402~protein-glucosylgalactosylhydroxylysine glucosidase activity,	IPR005195:Glyco_hydro_65_M,IPR008928:6-hairpin_glycosidase_sf,IPR012341:6hp_glycosidase-like_sf,											KW-0326~Glycosidase,KW-0378~Hydrolase,		ACT_SITE:Proton donor,
Q92954	proteoglycan 4(PRG4)	Homo sapiens			GO:0006897~endocytosis,GO:0006955~immune response,	GO:0005615~extracellular space,	GO:0005044~scavenger receptor activity,GO:0030021~extracellular matrix structural constituent conferring compression resistance,GO:0030247~polysaccharide binding,	IPR000585:Hemopexin-like_dom,IPR001212:Somatomedin_B_dom,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR020436:SMB_chordata,IPR036024:Somatomedin_B-like_dom_sf,IPR036375:Hemopexin-like_dom_sf,		208250~Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,		SM00120:HX,SM00201:SO,		KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) serine,CARBOHYD:O-linked (GalNAc...) threonine,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DISULFID:Alternate,DOMAIN:SMB,DOMAIN:SMB 1,DOMAIN:SMB 2,REGION:59 X 8 AA repeats of K-X-P-X-P-T-T-X,REGION:Disordered,REPEAT:1,REPEAT:10,REPEAT:11; approximate,REPEAT:12,REPEAT:13,REPEAT:14,REPEAT:15,REPEAT:16; approximate,REPEAT:17,REPEAT:18; approximate,REPEAT:19; approximate,REPEAT:20,REPEAT:21,REPEAT:22,REPEAT:23,REPEAT:24; approximate,REPEAT:25,REPEAT:26; approximate,REPEAT:27,REPEAT:28,REPEAT:29,REPEAT:2; approximate,REPEAT:3,REPEAT:30,REPEAT:31,REPEAT:32,REPEAT:33; approximate,REPEAT:34,REPEAT:35; approximate,REPEAT:36; approximate,REPEAT:37; approximate,REPEAT:38; approximate,REPEAT:39,REPEAT:40,REPEAT:41,REPEAT:42; approximate,REPEAT:43; approximate,REPEAT:44,REPEAT:45; approximate,REPEAT:46; approximate,REPEAT:47; approximate,REPEAT:48; approximate,REPEAT:49,REPEAT:4; approximate,REPEAT:5,REPEAT:50,REPEAT:51; approximate,REPEAT:52,REPEAT:53; approximate,REPEAT:54; approximate,REPEAT:55; approximate,REPEAT:56; approximate,REPEAT:57,REPEAT:58,REPEAT:59; approximate,REPEAT:6; approximate,REPEAT:7,REPEAT:8,REPEAT:9,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,SITE:Cleavage; by subtilisin-like proprotein convertase 4,
Q08174	protocadherin 1(PCDH1)	Homo sapiens			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0030054~cell junction,GO:0043231~intracellular membrane-bounded organelle,	GO:0005509~calcium ion binding,	IPR002126:Cadherin-like_dom,IPR013164:Cadherin_N,IPR013585:Protocadherin,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,				SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,DOMAIN:Cadherin 7,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q71M42	protocadherin 11 X-linked(PCDH11X)	Pan troglodytes			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,	GO:0005886~plasma membrane,	GO:0005509~calcium ion binding,	IPR002126:Cadherin-like_dom,IPR013164:Cadherin_N,IPR013585:Protocadherin,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,				SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,DOMAIN:Cadherin 7,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O14917	protocadherin 17(PCDH17)	Homo sapiens			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0030534~adult behavior,GO:0050805~negative regulation of synaptic transmission,GO:0099560~synaptic membrane adhesion,GO:1904071~presynaptic active zone assembly,GO:2000807~regulation of synaptic vesicle clustering,	GO:0016020~membrane,GO:0042734~presynaptic membrane,GO:0045211~postsynaptic membrane,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002126:Cadherin-like_dom,IPR013164:Cadherin_N,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,				SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,MOTIF:Cell attachment site,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
F8W3X3	protocadherin 19(pcdh19)	Danio rerio			GO:0001841~neural tube formation,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007399~nervous system development,GO:0007601~visual perception,GO:0048854~brain morphogenesis,GO:0060079~excitatory postsynaptic potential,GO:0098609~cell-cell adhesion,GO:0098908~regulation of neuronal action potential,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0098794~postsynapse,	GO:0005509~calcium ion binding,GO:0042802~identical protein binding,GO:0045296~cadherin binding,GO:0046872~metal ion binding,	IPR002126:Cadherin-like_dom,IPR013164:Cadherin_N,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,				SM00112:CA,	KW-0130~Cell adhesion,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,MUTAGEN:D->N: Does not affect interaction with cdh2 or adhesion activity.,MUTAGEN:E->K: Does not affect melting temperature. Abolishes homophilic interactions.,MUTAGEN:L->P: Does not affect interaction with cdh2 or adhesion activity.,MUTAGEN:L->R: Does not affect interaction with cdh2 or adhesion activity.,MUTAGEN:N->NSEN: Dramatically reduced adhesion.,MUTAGEN:N->S: Does not affect folding but reduces melting temperature.,MUTAGEN:R->E: Does not abolish homophilic interactions.,MUTAGEN:T->R: Abolishes homophilic interactions.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9Y5I4	protocadherin alpha subfamily C, 2(PCDHAC2)	Homo sapiens			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007399~nervous system development,GO:0036515~serotonergic neuron axon guidance,	GO:0005886~plasma membrane,	GO:0005509~calcium ion binding,	IPR002126:Cadherin-like_dom,IPR013164:Cadherin_N,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,IPR031904:Cadherin_CBD,IPR032455:Cadherin_C,				SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,REGION:4 X 4 AA repeats of P-X-X-P,REGION:Disordered,REPEAT:PXXP 1,REPEAT:PXXP 2,REPEAT:PXXP 3,REPEAT:PXXP 4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q7SY31	proton activated chloride channel 1(pacc1)	Danio rerio			GO:0006811~ion transport,GO:0006821~chloride transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0034707~chloride channel complex,	GO:0005254~chloride channel activity,GO:0061797~pH-gated chloride channel activity,	IPR029366:TMEM206,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,		COMPBIAS:Basic and acidic residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9WU56	pseudouridine synthase 1(Pus1)	Mus musculus			GO:0001522~pseudouridine synthesis,GO:0006397~mRNA processing,GO:0008033~tRNA processing,GO:0008380~RNA splicing,GO:0009451~RNA modification,GO:0031119~tRNA pseudouridine synthesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1990481~mRNA pseudouridine synthesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0043231~intracellular membrane-bounded organelle,	GO:0000049~tRNA binding,GO:0002153~steroid receptor RNA activator RNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0009982~pseudouridine synthase activity,GO:0016853~isomerase activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,	IPR001406:PsdUridine_synth_TruA,IPR020094:TruA/RsuA/RluB/E/F_N,IPR020095:PsdUridine_synth_TruA_C,IPR020097:PsdUridine_synth_TruA_a/b_dom,IPR020103:PsdUridine_synth_cat_dom_sf,IPR041708:PUS1/PUS2-like,					KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0819~tRNA processing,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0809~Transit peptide,		KW-0413~Isomerase,	KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,COMPBIAS:Basic and acidic residues,DOMAIN:Pseudouridine synthase I TruA alpha/beta,REGION:Disordered,TRANSIT:Mitochondrion,
Q9DG45	pterin-4 alpha-carbinolamine dehydratase 2(PCBD2)	Gallus gallus			GO:0006729~tetrahydrobiopterin biosynthetic process,		GO:0008124~4-alpha-hydroxytetrahydrobiopterin dehydratase activity,	IPR001533:Pterin_deHydtase,IPR036428:PCD_sf,	gga00790:Folate biosynthesis,gga01100:Metabolic pathways,				KW-0783~Tetrahydrobiopterin biosynthesis,						KW-0456~Lyase,
Q80U58	pumilio RNA-binding family member 2(Pum2)	Mus musculus			GO:0001501~skeletal system development,GO:0001942~hair follicle development,GO:0006417~regulation of translation,GO:0007005~mitochondrion organization,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0022904~respiratory electron transport chain,GO:0034063~stress granule assembly,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0043488~regulation of mRNA stability,GO:0048687~positive regulation of sprouting of injured axon,GO:0051276~chromosome organization,GO:0051983~regulation of chromosome segregation,GO:0060612~adipose tissue development,GO:1900246~positive regulation of RIG-I signaling pathway,GO:1904580~regulation of intracellular mRNA localization,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0035198~miRNA binding,	IPR001313:Pumilio_RNA-bd_rpt,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR033133:PUM-HD,IPR033712:Pumilio_RNA-bd,	mmu05017:Spinocerebellar ataxia,			SM00025:Pumilio,	KW-0810~Translation regulation,	KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PUM-HD,REGION:Adenine-nucleotide binding in RNA target,REGION:Disordered,REGION:Guanine-nucleotide binding in RNA target,REGION:Interaction with SNAPIN,REGION:Non-specific-nucleotide binding in RNA target,REGION:Uracil-nucleotide binding in RNA target,REPEAT:Pumilio,REPEAT:Pumilio 1,REPEAT:Pumilio 2,REPEAT:Pumilio 3,REPEAT:Pumilio 4,REPEAT:Pumilio 5,REPEAT:Pumilio 6,REPEAT:Pumilio 7,REPEAT:Pumilio 8,
P00491	purine nucleoside phosphorylase(PNP)	Homo sapiens			GO:0000255~allantoin metabolic process,GO:0006139~nucleobase-containing compound metabolic process,GO:0006148~inosine catabolic process,GO:0006149~deoxyinosine catabolic process,GO:0006157~deoxyadenosine catabolic process,GO:0006166~purine ribonucleoside salvage,GO:0006204~IMP catabolic process,GO:0006738~nicotinamide riboside catabolic process,GO:0006955~immune response,GO:0009116~nucleoside metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009410~response to xenobiotic stimulus,GO:0032743~positive regulation of interleukin-2 production,GO:0034418~urate biosynthetic process,GO:0042102~positive regulation of T cell proliferation,GO:0043101~purine-containing compound salvage,GO:0046059~dAMP catabolic process,GO:0046638~positive regulation of alpha-beta T cell differentiation,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034774~secretory granule lumen,GO:0070062~extracellular exosome,GO:1904813~ficolin-1-rich granule lumen,	GO:0001882~nucleoside binding,GO:0002060~purine nucleobase binding,GO:0004731~purine-nucleoside phosphorylase activity,GO:0005515~protein binding,GO:0042301~phosphate ion binding,GO:0042802~identical protein binding,GO:0047975~guanosine phosphorylase activity,	IPR000845:Nucleoside_phosphorylase_d,IPR011268:Purine_phosphorylase,IPR011270:Pur_Nuc_Pase_Ino/Guo-sp,IPR018099:Purine_phosphorylase-2_CS,IPR035994:Nucleoside_phosphorylase_sf,	hsa00230:Purine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,	613179~Immunodeficiency due to purine nucleoside phosphorylase deficiency,	PIRSF000477:PurNPase,		KW-0660~Purine salvage,	KW-0963~Cytoplasm,		KW-0225~Disease variant,			KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Nucleoside phosphorylase,MUTAGEN:E->A,Q: Severe loss of catalytic activity.,MUTAGEN:H->W: Reduces catalytic activity towards inosine.,MUTAGEN:N->A: Reduces catalytic activity.,MUTAGEN:N->D: Reduces catalytic activity towards inosine, hypoxanthine, guanosine and guanine. Increases catalytic activity towards adenosine and adenine.,REGION:Disordered,SITE:Important for substrate specificity,
P55859	purine nucleoside phosphorylase(PNP)	Bos taurus			GO:0006166~purine ribonucleoside salvage,GO:0009116~nucleoside metabolic process,	GO:0005737~cytoplasm,	GO:0004731~purine-nucleoside phosphorylase activity,GO:0047975~guanosine phosphorylase activity,	IPR000845:Nucleoside_phosphorylase_d,IPR011268:Purine_phosphorylase,IPR011270:Pur_Nuc_Pase_Ino/Guo-sp,IPR018099:Purine_phosphorylase-2_CS,IPR035994:Nucleoside_phosphorylase_sf,	bta00230:Purine metabolism,bta00760:Nicotinate and nicotinamide metabolism,bta01100:Metabolic pathways,bta01232:Nucleotide metabolism,		PIRSF000477:PurNPase,		KW-0660~Purine salvage,	KW-0963~Cytoplasm,					KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Nucleoside phosphorylase,SITE:Important for substrate specificity,
Q6PHK6	purine-rich element binding protein Bb(purbb)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0032422~purine-rich negative regulatory element binding,	IPR006628:PUR-bd_fam,				SM00712:PUR,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0238~DNA-binding,	KW-0007~Acetylation,	REGION:Disordered,
P41231	purinergic receptor P2Y2(P2RY2)	Homo sapiens		h_ionPathway:Ion Channel and Phorbal Esters Signaling Pathway,	GO:0006873~cellular ion homeostasis,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0035589~G-protein coupled purinergic nucleotide receptor signaling pathway,GO:0070257~positive regulation of mucus secretion,GO:0071318~cellular response to ATP,GO:0097746~regulation of blood vessel diameter,	GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0031686~A1 adenosine receptor binding,GO:0038023~signaling receptor activity,GO:0045028~G-protein coupled purinergic nucleotide receptor activity,GO:0045030~UTP-activated nucleotide receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000356:P2Y2_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	hsa04080:Neuroactive ligand-receptor interaction,hsa04148:Efferocytosis,hsa04750:Inflammatory mediator regulation of TRP channels,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P34275	putative acyl-CoA dehydrogenase 6(acdh-6)	Caenorhabditis elegans			GO:0006552~leucine catabolic process,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,	GO:0005737~cytoplasm,	GO:0003995~acyl-CoA dehydrogenase activity,GO:0008470~isovaleryl-CoA dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0050660~flavin adenine dinucleotide binding,	IPR006089:Acyl-CoA_DH_CS,IPR006091:Acyl-CoA_Oxase/DH_mid-dom,IPR009075:AcylCo_DH/oxidase_C,IPR009100:AcylCoA_DH/oxidase_NM_dom_sf,IPR013786:AcylCoA_DH/ox_N,IPR036250:AcylCo_DH-like_C,IPR037069:AcylCoA_DH/ox_N_sf,IPR046373:Acyl-CoA_Oxase/DH_mid-dom_sf,			PIRSF016578:HsaA,							KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,
O76387	putative peptidyl-tRNA hydrolase 2(C24G6.8)	Caenorhabditis elegans				GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004045~aminoacyl-tRNA hydrolase activity,GO:0016787~hydrolase activity,	IPR002833:PTH2,IPR009060:UBA-like_sf,IPR015940:UBA,IPR023476:Pep_tRNA_hydro_II_dom_sf,											KW-0378~Hydrolase,		COMPBIAS:Polar residues,DOMAIN:UBA,REGION:Disordered,
Q6ZTK2	putative uncharacterized protein LOC400499(LOC400499)	Homo sapiens					GO:0005319~lipid transporter activity,	IPR001747:Vitellogenin_N,IPR001846:VWF_type-D,IPR011030:Lipovitellin_superhlx_dom,IPR014853:VWF/SSPO/ZAN-like_Cys-rich_dom,IPR015255:Vitellinogen_open_b-sht,IPR015816:Vitellinogen_b-sht_N,IPR015817:Vitellinogen_open_b-sht_sub1,IPR015819:Lipid_transp_b-sht_shell,IPR048484:LOC400499-like,				SM00638:LPD_N,SM01169:DUF1943,	KW-0445~Lipid transport,KW-0813~Transport,				KW-0732~Signal,				DOMAIN:VWFD,DOMAIN:Vitellogenin,REGION:Disordered,
Q66HY8	pyridoxal-dependent decarboxylase domain containing 1(pdxdc1)	Danio rerio			GO:0019752~carboxylic acid metabolic process,	GO:0043231~intracellular membrane-bounded organelle,	GO:0003824~catalytic activity,GO:0016829~lyase activity,GO:0016830~carbon-carbon lyase activity,GO:0016831~carboxy-lyase activity,GO:0030170~pyridoxal phosphate binding,GO:0043728~2-keto-4-methylthiobutyrate aminotransferase activity,	IPR002129:PyrdxlP-dep_de-COase,IPR015421:PyrdxlP-dep_Trfase_major,IPR015424:PyrdxlP-dep_Trfase,									KW-0175~Coiled coil,	KW-0663~Pyridoxal phosphate,	KW-0210~Decarboxylase,KW-0456~Lyase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q15118	pyruvate dehydrogenase kinase 1(PDK1)	Homo sapiens			GO:0006006~glucose metabolic process,GO:0006468~protein phosphorylation,GO:0008283~cell proliferation,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0010510~regulation of acetyl-CoA biosynthetic process from pyruvate,GO:0010906~regulation of glucose metabolic process,GO:0016310~phosphorylation,GO:0097411~hypoxia-inducible factor-1alpha signaling pathway,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005967~mitochondrial pyruvate dehydrogenase complex,	GO:0004672~protein kinase activity,GO:0004740~pyruvate dehydrogenase (acetyl-transferring) kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR003594:HATPase_C,IPR005467:His_kinase_dom,IPR018955:BCDHK/PDK_N,IPR036784:AK/P_DHK_N_sf,IPR036890:HATPase_C_sf,IPR039028:BCKD/PDK,	hsa04066:HIF-1 signaling pathway,hsa05230:Central carbon metabolism in cancer,			SM00387:HATPase_c,		KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,KW-0670~Pyruvate,	KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	DOMAIN:Branched-chain alpha-ketoacid dehydrogenase kinase/Pyruvate dehydrogenase kinase N-terminal,DOMAIN:Histidine kinase,TRANSIT:Mitochondrion,
O00391	quiescin sulfhydryl oxidase 1(QSOX1)	Homo sapiens			GO:0006457~protein folding,GO:0008285~negative regulation of cell proliferation,GO:0016242~negative regulation of macroautophagy,GO:0085029~extracellular matrix assembly,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0031093~platelet alpha granule lumen,GO:0035580~specific granule lumen,GO:0043231~intracellular membrane-bounded organelle,GO:0045171~intercellular bridge,GO:0070062~extracellular exosome,GO:1904724~tertiary granule lumen,	GO:0003756~protein disulfide isomerase activity,GO:0016971~flavin-linked sulfhydryl oxidase activity,GO:0071949~FAD binding,	IPR013766:Thioredoxin_domain,IPR017905:ERV/ALR_sulphydryl_oxidase,IPR036249:Thioredoxin-like_sf,IPR036774:ERV/ALR_sulphydryl_oxid_sf,IPR039798:Sulfhydryl_oxidase,IPR040986:QSOX_FAD-bd_dom,IPR041269:QSOX_Trx1,IPR042568:QSOX_FAD-bd_sf,						KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0964~Secreted,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) (complex) asparagine,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Redox-active,DOMAIN:ERV/ALR sulfhydryl oxidase,DOMAIN:Thioredoxin,MUTAGEN:C->S: Loss of activity.,MUTAGEN:C->S: No effect. Reduces activity by 70%; when associated with S-512.,MUTAGEN:C->S: Reduces activity by 40%. Reduces activity by 70%; when associated with S-509.,MUTAGEN:C->S: Reduces activity by 93%.,MUTAGEN:C->S: Reduces activity by 96%.,MUTAGEN:CGHC->AGHA: Loss of catalytic activity. Cannot prevent cell detachment after depletion of the endogenous protein.,MUTAGEN:H->A: Decreased protein stability and catalytic activity; when associated with S-119 or T-119.,MUTAGEN:N->Q: Loss of glycosylation site.,MUTAGEN:N->Q: Loss of glycosylation site. Abolishes secretion. No effect on catalytic activity.,MUTAGEN:P->S,T: Loss of catalytic activity. Decreased protein stability and catalytic activity; when associated with A-72.,MUTAGEN:TTVAPTT->ANVAPVA: Decreased O-glycosylation.,REGION:Disordered,TRANSMEM:Helical,
Q9NZL6	ral guanine nucleotide dissociation stimulator like 1(RGL1)	Homo sapiens			GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000159:RA_dom,IPR000651:Ras-like_Gua-exchang_fac_N,IPR001895:RASGEF_cat_dom,IPR008937:Ras-like_GEF,IPR019804:Ras_G-nucl-exch_fac_CS,IPR023578:Ras_GEF_dom_sf,IPR029071:Ubiquitin-like_domsf,IPR030748:RGL1_RA,IPR036964:RASGEF_cat_dom_sf,	hsa04014:Ras signaling pathway,			SM00147:RasGEF,SM00229:RasGEFN,SM00314:RA,							KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:N-terminal Ras-GEF,DOMAIN:Ras-GEF,DOMAIN:Ras-associating,REGION:Disordered,
Q5REY6	ras homolog family member A(RHOA)	Pongo abelii			GO:0000902~cell morphogenesis,GO:0001764~neuron migration,GO:0001822~kidney development,GO:0001998~angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,GO:0002363~alpha-beta T cell lineage commitment,GO:0003100~regulation of systemic arterial blood pressure by endothelin,GO:0003189~aortic valve formation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007160~cell-matrix adhesion,GO:0007264~small GTPase mediated signal transduction,GO:0007266~Rho protein signal transduction,GO:0007519~skeletal muscle tissue development,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010975~regulation of neuron projection development,GO:0016477~cell migration,GO:0021795~cerebral cortex cell migration,GO:0021861~forebrain radial glial cell differentiation,GO:0030036~actin cytoskeleton organization,GO:0030334~regulation of cell migration,GO:0030521~androgen receptor signaling pathway,GO:0031122~cytoplasmic microtubule organization,GO:0032467~positive regulation of cytokinesis,GO:0033144~negative regulation of intracellular steroid hormone receptor signaling pathway,GO:0033688~regulation of osteoblast proliferation,GO:0034329~cell junction assembly,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035385~Roundabout signaling pathway,GO:0036089~cleavage furrow formation,GO:0038027~apolipoprotein A-I-mediated signaling pathway,GO:0042476~odontogenesis,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043149~stress fiber assembly,GO:0043297~apical junction assembly,GO:0043366~beta selection,GO:0043542~endothelial cell migration,GO:0043931~ossification involved in bone maturation,GO:0044319~wound healing, spreading of cells,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0045666~positive regulation of neuron differentiation,GO:0045792~negative regulation of cell size,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0050919~negative chemotaxis,GO:0051496~positive regulation of stress fiber assembly,GO:0061430~bone trabecula morphogenesis,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0071222~cellular response to lipopolysaccharide,GO:0071526~semaphorin-plexin signaling pathway,GO:0071803~positive regulation of podosome assembly,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis,GO:0090307~mitotic spindle assembly,GO:0090324~negative regulation of oxidative phosphorylation,GO:0097049~motor neuron apoptotic process,GO:0097498~endothelial tube lumen extension,GO:1902766~skeletal muscle satellite cell migration,GO:1903427~negative regulation of reactive oxygen species biosynthetic process,GO:1903673~mitotic cleavage furrow formation,GO:1904695~positive regulation of vascular smooth muscle contraction,GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell,GO:1905274~regulation of modification of postsynaptic actin cytoskeleton,GO:1990869~cellular response to chemokine,GO:2000177~regulation of neural precursor cell proliferation,GO:2000406~positive regulation of T cell migration,GO:2000672~negative regulation of motor neuron apoptotic process,	GO:0005634~nucleus,GO:0005768~endosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005938~cell cortex,GO:0009898~cytoplasmic side of plasma membrane,GO:0030027~lamellipodium,GO:0030496~midbody,GO:0032154~cleavage furrow,GO:0032587~ruffle membrane,GO:0043197~dendritic spine,GO:0043296~apical junction complex,GO:0098978~glutamatergic synapse,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017022~myosin binding,GO:0019901~protein kinase binding,	IPR001806:Small_GTPase,IPR003578:Small_GTPase_Rho,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,	pon04014:Ras signaling pathway,pon04015:Rap1 signaling pathway,pon04022:cGMP-PKG signaling pathway,pon04024:cAMP signaling pathway,pon04062:Chemokine signaling pathway,pon04071:Sphingolipid signaling pathway,pon04072:Phospholipase D signaling pathway,pon04144:Endocytosis,pon04150:mTOR signaling pathway,pon04270:Vascular smooth muscle contraction,pon04310:Wnt signaling pathway,pon04350:TGF-beta signaling pathway,pon04360:Axon guidance,pon04510:Focal adhesion,pon04520:Adherens junction,pon04530:Tight junction,pon04611:Platelet activation,pon04621:NOD-like receptor signaling pathway,pon04625:C-type lectin receptor signaling pathway,pon04660:T cell receptor signaling pathway,pon04670:Leukocyte transendothelial migration,pon04722:Neurotrophin signaling pathway,pon04810:Regulation of actin cytoskeleton,pon04921:Oxytocin signaling pathway,pon04928:Parathyroid hormone synthesis, secretion and action,pon04972:Pancreatic secretion,pon05100:Bacterial invasion of epithelial cells,pon05132:Salmonella infection,pon05133:Pertussis,pon05135:Yersinia infection,pon05152:Tuberculosis,pon05163:Human cytomegalovirus infection,pon05200:Pathways in cancer,pon05203:Viral carcinogenesis,pon05205:Proteoglycans in cancer,pon05206:MicroRNAs in cancer,pon05210:Colorectal cancer,pon05417:Lipid and atherosclerosis,pon05418:Fluid shear stress and atherosclerosis,			SM00173:RAS,SM00174:RHO,SM00175:RAB,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0656~Proto-oncogene,		KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,REGION:Switch II region; involved in RAP1GDS1 binding,
Q6NVC5	ras homolog family member T1a(rhot1a)	Danio rerio			GO:0007005~mitochondrion organization,GO:0007015~actin filament organization,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0019725~cellular homeostasis,GO:0047497~mitochondrion transport along microtubule,GO:0097345~mitochondrial outer membrane permeabilization,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005509~calcium ion binding,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR001806:Small_GTPase,IPR002048:EF_hand_dom,IPR003578:Small_GTPase_Rho,IPR005225:Small_GTP-bd_dom,IPR011992:EF-hand-dom_pair,IPR013566:EF_hand_assoc_1,IPR013567:EF_hand_assoc_2,IPR018247:EF_Hand_1_Ca_BS,IPR020860:MIRO_dom,IPR021181:Miro,IPR027417:P-loop_NTPase,	dre04137:Mitophagy - animal,		PIRSF037488:Mt_Rho_GTPase,	SM00054:EFh,SM00173:RAS,SM00174:RHO,SM00175:RAB,		KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0342~GTP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,		DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:Miro,DOMAIN:Miro 1,DOMAIN:Miro 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Mitochondrial intermembrane,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
Q7L0Q8	ras homolog family member U(RHOU)	Homo sapiens			GO:0000082~G1/S transition of mitotic cell cycle,GO:0006897~endocytosis,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007163~establishment or maintenance of cell polarity,GO:0008360~regulation of cell shape,GO:0016601~Rac protein signal transduction,GO:0032488~Cdc42 protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000139~Golgi membrane,GO:0002102~podosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0010008~endosome membrane,GO:0042995~cell projection,	GO:0003924~GTPase activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,	IPR001806:Small_GTPase,IPR003578:Small_GTPase_Rho,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,				SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,		KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,	LIPID:S-palmitoyl cysteine,MUTAGEN:C->S: Loss of subcellular location to plasma and intracellular membranes.,MUTAGEN:C->S: No effect on subcellular location.,MUTAGEN:F->A: Loss of binding to PAK3; when associated with S-81 and C-86.,MUTAGEN:F->C: Loss of PAK3-binding; when associated with S-81 and A-83. No effect on ARHGAP30-binding.,MUTAGEN:F->G: Loss of ARHGAP30-binding.,MUTAGEN:P->G: No effect on ARHGAP30-binding.,MUTAGEN:Q->L: Constitutively active. Results in increased rates of stress fiber dissolution and cell migration. No effect on ARHGAP30-binding.,MUTAGEN:T->N: Loss of GTP-binding and localization to focal adhesions. No effect on ARHGAP30-binding.,MUTAGEN:T->S: Loss of binding to PAK3; when associated with A-83 and C-86.,REGION:Disordered,
P80601	reactive intermediate imine deaminase A homolog(RIDA)	Capra hircus			GO:0006402~mRNA catabolic process,GO:0006629~lipid metabolic process,GO:0017148~negative regulation of translation,GO:0061157~mRNA destabilization,GO:1901565~organonitrogen compound catabolic process,	GO:0005634~nucleus,GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,GO:0005829~cytosol,	GO:0003729~mRNA binding,GO:0016892~endoribonuclease activity, producing 3'-phosphomonoesters,GO:0019239~deaminase activity,	IPR006056:RidA,IPR006175:YjgF/YER057c/UK114,IPR019897:RidA_CS,IPR035959:RutC-like_sf,					KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0576~Peroxisome,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,
P52758	reactive intermediate imine deaminase A homolog(RIDA)	Homo sapiens			GO:0006402~mRNA catabolic process,GO:0006629~lipid metabolic process,GO:0017148~negative regulation of translation,GO:0019518~L-threonine catabolic process to glycine,GO:0061157~mRNA destabilization,GO:1901565~organonitrogen compound catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0016892~endoribonuclease activity, producing 3'-phosphomonoesters,GO:0019239~deaminase activity,	IPR006056:RidA,IPR006175:YjgF/YER057c/UK114,IPR019897:RidA_CS,IPR035959:RutC-like_sf,					KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0576~Peroxisome,KW-0963~Cytoplasm,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,
Q00765	receptor accessory protein 5(REEP5)	Homo sapiens			GO:0007029~endoplasmic reticulum organization,GO:0032386~regulation of intracellular transport,GO:0090158~endoplasmic reticulum membrane organization,	GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0033017~sarcoplasmic reticulum membrane,GO:0071782~endoplasmic reticulum tubular network,	GO:0005515~protein binding,	IPR004345:TB2_DP1_HVA22,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0703~Sarcoplasmic reticulum,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,		REGION:Required for dimerization and maintaining endoplasmic reticulum morphology,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q9JJ74	receptor activity modifying protein 1(Ramp1)	Rattus norvegicus			GO:0001525~angiogenesis,GO:0006816~calcium ion transport,GO:0006886~intracellular protein transport,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0015031~protein transport,GO:0031623~receptor internalization,GO:0032870~cellular response to hormone stimulus,GO:0060050~positive regulation of protein glycosylation,GO:0072659~protein localization to plasma membrane,GO:0097647~amylin receptor signaling pathway,GO:1990408~calcitonin gene-related peptide receptor signaling pathway,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0043235~receptor complex,GO:1990406~CGRP receptor complex,	GO:0001635~calcitonin gene-related peptide receptor activity,GO:0001664~G-protein coupled receptor binding,GO:0015026~coreceptor activity,GO:0097643~amylin receptor activity,GO:1990407~calcitonin gene-related peptide binding,	IPR006985:RAMP,IPR038126:RAMP_sf,	rno04270:Vascular smooth muscle contraction,				KW-0813~Transport,	KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-1015~Disulfide bond,	TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O60896	receptor activity modifying protein 3(RAMP3)	Homo sapiens			GO:0001921~positive regulation of receptor recycling,GO:0006816~calcium ion transport,GO:0006886~intracellular protein transport,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010739~positive regulation of protein kinase A signaling,GO:0015031~protein transport,GO:0031623~receptor internalization,GO:0032870~cellular response to hormone stimulus,GO:0038041~cross-receptor inhibition within G-protein coupled receptor heterodimer,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0050850~positive regulation of calcium-mediated signaling,GO:0051897~positive regulation of protein kinase B signaling,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071392~cellular response to estradiol stimulus,GO:0072659~protein localization to plasma membrane,GO:0086103~G-protein coupled receptor signaling pathway involved in heart process,GO:0097647~amylin receptor signaling pathway,GO:1903078~positive regulation of protein localization to plasma membrane,GO:1904645~response to beta-amyloid,GO:1990410~adrenomedullin receptor signaling pathway,	GO:0005764~lysosome,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0043235~receptor complex,GO:1903143~adrenomedullin receptor complex,	GO:0001540~beta-amyloid binding,GO:0001605~adrenomedullin receptor activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0097643~amylin receptor activity,	IPR006985:RAMP,IPR038126:RAMP_sf,	hsa04270:Vascular smooth muscle contraction,				KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P78509	reelin(RELN)	Homo sapiens		h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development,h_reelinPathway:Reelin Signaling Pathway,	GO:0000902~cell morphogenesis,GO:0001764~neuron migration,GO:0001934~positive regulation of protein phosphorylation,GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0007616~long-term memory,GO:0007626~locomotory behavior,GO:0008306~associative learning,GO:0010001~glial cell differentiation,GO:0010976~positive regulation of neuron projection development,GO:0016358~dendrite development,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021511~spinal cord patterning,GO:0021517~ventral spinal cord development,GO:0021766~hippocampus development,GO:0021800~cerebral cortex tangential migration,GO:0021819~layer formation in cerebral cortex,GO:0032008~positive regulation of TOR signaling,GO:0032793~positive regulation of CREB transcription factor activity,GO:0035418~protein localization to synapse,GO:0038026~reelin-mediated signaling pathway,GO:0045664~regulation of neuron differentiation,GO:0045860~positive regulation of protein kinase activity,GO:0048265~response to pain,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050795~regulation of behavior,GO:0050804~modulation of synaptic transmission,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051897~positive regulation of protein kinase B signaling,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0060025~regulation of synaptic activity,GO:0060291~long-term synaptic potentiation,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0090129~positive regulation of synapse maturation,GO:0097114~NMDA glutamate receptor clustering,GO:0097119~postsynaptic density protein 95 clustering,GO:0097120~receptor localization to synapse,GO:0097477~lateral motor column neuron migration,GO:1900273~positive regulation of long-term synaptic potentiation,GO:1902078~positive regulation of lateral motor column neuron migration,GO:1904936~interneuron migration,GO:2000310~regulation of NMDA receptor activity,GO:2000463~positive regulation of excitatory postsynaptic potential,GO:2000969~positive regulation of AMPA receptor activity,GO:2001222~regulation of neuron migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0031012~extracellular matrix,GO:0043005~neuron projection,	GO:0008236~serine-type peptidase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0070325~lipoprotein particle receptor binding,GO:0070326~very-low-density lipoprotein particle receptor binding,	IPR000742:EGF-like_dom,IPR002861:Reeler_dom,IPR013111:EGF_extracell,IPR034968:Reelin,IPR036278:Sialidase_sf,IPR041161:EGF_Tenascin,IPR042307:Reeler_sf,IPR049419:Reelin_subrepeat-B,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05017:Spinocerebellar ataxia,hsa05165:Human papillomavirus infection,	257320~Lissencephaly 2 (Norman-Roberts type),616436~Epilepsy, familial temporal lobe, 7,		SM00181:EGF,	KW-0130~Cell adhesion,	KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,KW-0451~Lissencephaly,KW-0887~Epilepsy,	KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,DOMAIN:Reelin,REGION:Disordered,REPEAT:BNR 1,REPEAT:BNR 10,REPEAT:BNR 11,REPEAT:BNR 12,REPEAT:BNR 13,REPEAT:BNR 14,REPEAT:BNR 15,REPEAT:BNR 16,REPEAT:BNR 2,REPEAT:BNR 3,REPEAT:BNR 4,REPEAT:BNR 5,REPEAT:BNR 6,REPEAT:BNR 7,REPEAT:BNR 8,REPEAT:BNR 9,
Q5SVD0	refilin B(Rflnb)	Mus musculus			GO:0001837~epithelial to mesenchymal transition,GO:0030036~actin cytoskeleton organization,GO:0048705~skeletal system morphogenesis,GO:0061181~regulation of chondrocyte development,GO:0061182~negative regulation of chondrocyte development,GO:0061572~actin filament bundle organization,GO:1900158~negative regulation of bone mineralization involved in bone maturation,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0032432~actin filament bundle,	GO:0031005~filamin binding,	IPR028215:Refilin,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,	REGION:Disordered,
Q9JIR4	regulating synaptic membrane exocytosis 1(Rims1)	Rattus norvegicus			GO:0006836~neurotransmitter transport,GO:0006886~intracellular protein transport,GO:0006887~exocytosis,GO:0007269~neurotransmitter secretion,GO:0010628~positive regulation of gene expression,GO:0010808~positive regulation of synaptic vesicle priming,GO:0016081~synaptic vesicle docking,GO:0016082~synaptic vesicle priming,GO:0030154~cell differentiation,GO:0031632~positive regulation of synaptic vesicle fusion to presynaptic membrane,GO:0042391~regulation of membrane potential,GO:0048167~regulation of synaptic plasticity,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048790~maintenance of presynaptic active zone structure,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0050806~positive regulation of synaptic transmission,GO:0060291~long-term synaptic potentiation,GO:0060478~acrosomal vesicle exocytosis,GO:0061669~spontaneous neurotransmitter secretion,GO:0065003~macromolecular complex assembly,GO:0097151~positive regulation of inhibitory postsynaptic potential,GO:0099525~presynaptic dense core vesicle exocytosis,GO:1903861~positive regulation of dendrite extension,GO:2000300~regulation of synaptic vesicle exocytosis,GO:2000463~positive regulation of excitatory postsynaptic potential,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0031982~vesicle,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0045202~synapse,GO:0048788~cytoskeleton of presynaptic active zone,GO:0060077~inhibitory synapse,GO:0098831~presynaptic active zone cytoplasmic component,GO:0098891~extrinsic component of presynaptic active zone membrane,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,	GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0031267~small GTPase binding,GO:0044325~ion channel binding,GO:0046872~metal ion binding,GO:0098882~structural constituent of presynaptic active zone,	IPR000008:C2_dom,IPR001478:PDZ,IPR010911:Rab_BD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR017455:Znf_FYVE-rel,IPR035892:C2_domain_sf,IPR036034:PDZ_sf,IPR039032:Rim-like,IPR041282:FYVE_2,	rno04721:Synaptic vesicle cycle,rno04723:Retrograde endocannabinoid signaling,			SM00228:PDZ,SM00239:C2,	KW-0221~Differentiation,KW-0268~Exocytosis,KW-0532~Neurotransmitter transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:FYVE-type,DOMAIN:PDZ,DOMAIN:RabBD,REGION:Disordered,ZN_FING:FYVE-type,
Q9NS28	regulator of G protein signaling 18(RGS18)	Homo sapiens			GO:0007186~G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR016137:RGS,IPR024066:RGS_subdom1/3,IPR036305:RGS_sf,IPR044926:RGS_subdomain_2,				SM00315:RGS,		KW-0963~Cytoplasm,					KW-0734~Signal transduction inhibitor,	KW-0597~Phosphoprotein,	DOMAIN:RGS,REGION:Disordered,
Q5RJA1	regulatory factor X, 6(rfx6)	Danio rerio			GO:0003309~type B pancreatic cell differentiation,GO:0003310~pancreatic A cell differentiation,GO:0003311~pancreatic D cell differentiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0031018~endocrine pancreas development,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0042593~glucose homeostasis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048856~anatomical structure development,GO:0050796~regulation of insulin secretion,GO:0090104~pancreatic epsilon cell differentiation,	GO:0005634~nucleus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR003150:DNA-bd_RFX,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR039779:RFX-like,					KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		DNA_BIND:RFX-type winged-helix,DOMAIN:RFX-type winged-helix,
P17560	renin binding protein(RENBP)	Sus scrofa			GO:0005975~carbohydrate metabolic process,GO:0006044~N-acetylglucosamine metabolic process,GO:0006051~N-acetylmannosamine metabolic process,GO:0019262~N-acetylneuraminate catabolic process,		GO:0016853~isomerase activity,GO:0030414~peptidase inhibitor activity,GO:0042802~identical protein binding,GO:0050121~N-acylglucosamine 2-epimerase activity,	IPR008928:6-hairpin_glycosidase_sf,IPR010819:AGE/CE,IPR012341:6hp_glycosidase-like_sf,IPR034116:AGE_dom,	ssc00520:Amino sugar and nucleotide sugar metabolism,ssc01100:Metabolic pathways,										KW-0413~Isomerase,		MUTAGEN:L->D: Fails to bind renin or to form a dimer.,REGION:Disordered,REGION:Leucine-zipper,SITE:Important for enzyme activity,
Q05B83	replication factor C subunit 2(RFC2)	Bos taurus			GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0032508~DNA duplex unwinding,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0005634~nucleus,GO:0005663~DNA replication factor C complex,GO:0031390~Ctf18 RFC-like complex,	GO:0003677~DNA binding,GO:0003689~DNA clamp loader activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR008921:DNA_pol3_clamp-load_cplx_C,IPR013748:Rep_factorC_C,IPR027417:P-loop_NTPase,IPR047854:RFC_lid,	bta03030:DNA replication,bta03410:Base excision repair,bta03420:Nucleotide excision repair,bta03430:Mismatch repair,			SM00382:AAA,	KW-0235~DNA replication,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:AAA+ ATPase,REGION:Disordered,
Q9CQ71	replication protein A3(Rpa3)	Mus musculus			GO:0000724~double-strand break repair via homologous recombination,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006298~mismatch repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007346~regulation of mitotic cell cycle,GO:0042127~regulation of cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0035861~site of double-strand break,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,	IPR012340:NA-bd_OB-fold,IPR013970:Rfa2,	mmu03030:DNA replication,mmu03420:Nucleotide excision repair,mmu03430:Mismatch repair,mmu03440:Homologous recombination,mmu03460:Fanconi anemia pathway,				KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0539~Nucleus,						KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),
P07949	ret proto-oncogene(RET)	Homo sapiens			GO:0000165~MAPK cascade,GO:0001657~ureteric bud development,GO:0001755~neural crest cell migration,GO:0001838~embryonic epithelial tube formation,GO:0006468~protein phosphorylation,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007158~neuron cell-cell adhesion,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007275~multicellular organism development,GO:0007411~axon guidance,GO:0007497~posterior midgut development,GO:0009410~response to xenobiotic stimulus,GO:0010628~positive regulation of gene expression,GO:0010976~positive regulation of neuron projection development,GO:0014042~positive regulation of neuron maturation,GO:0016310~phosphorylation,GO:0030155~regulation of cell adhesion,GO:0030335~positive regulation of cell migration,GO:0033141~positive regulation of peptidyl-serine phosphorylation of STAT protein,GO:0033619~membrane protein proteolysis,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0033674~positive regulation of kinase activity,GO:0035799~ureter maturation,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,GO:0042551~neuron maturation,GO:0043410~positive regulation of MAPK cascade,GO:0045793~positive regulation of cell size,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048265~response to pain,GO:0048484~enteric nervous system development,GO:0050770~regulation of axonogenesis,GO:0051897~positive regulation of protein kinase B signaling,GO:0060041~retina development in camera-type eye,GO:0060384~innervation,GO:0061146~Peyer's patch morphogenesis,GO:0071300~cellular response to retinoic acid,GO:0072300~positive regulation of metanephric glomerulus development,GO:0097021~lymphocyte migration into lymphoid organs,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043235~receptor complex,GO:0098797~plasma membrane protein complex,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0038023~signaling receptor activity,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR002126:Cadherin-like_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015919:Cadherin-like_sf,IPR016249:Tyr_kinase_Ret_rcpt,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR040667:Ret_CLD3,IPR041163:Ret_CLD1,IPR041317:RET_CLD4,	hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa05200:Pathways in cancer,hsa05216:Thyroid cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,	142623~Hirschsprung disease, protection against,142623~Hirschsprung disease, susceptibility to, 1,155240~Medullary thyroid carcinoma,162300~Multiple endocrine neoplasia IIB,171300~Pheochromocytoma,171400~Multiple endocrine neoplasia IIA,	PIRSF000631:TyrPK_receptor_Ret,	SM00219:TyrKc,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0367~Hirschsprung disease,KW-0656~Proto-oncogene,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cadherin,DOMAIN:Protein kinase,DOMAIN:Ret cadherin like,MUTAGEN:D->N: Impaired cleavage by caspase-3 and loss of induced cell death.,MUTAGEN:K->R: Loss of kinase activity. No effect on interaction with and dissociation from CBLC and CD2AP.,MUTAGEN:Missing: Loss of induced cell death, but increased cell aggregation.,MUTAGEN:Y->F: Abolishes GFRAL-mediated MAPK1/MAPK2 phosphorylation.,REGION:Disordered,SITE:Breakpoint for translocation to form PCM1-RET; RET-CCDC6; RET-GOLGA5; RET-TRIM24 and RET-TRIM33 oncogenes,SITE:Breakpoint for translocation to form the TRIM27/RET oncogene,SITE:Cleavage; by caspase-3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O93434	reticulocalbin 1, EF-hand calcium binding domain(rcn1)	Takifugu rubripes				GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0005509~calcium ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR027241:Rcn1,				SM00054:EFh,		KW-0256~Endoplasmic reticulum,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,DOMAIN:EF-hand 5,DOMAIN:EF-hand 6,MOTIF:Prevents secretion from ER,
Q91392	retinoic acid receptor gamma a(rarga)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001889~liver development,GO:0006355~regulation of transcription, DNA-templated,GO:0009755~hormone-mediated signaling pathway,GO:0030154~cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048384~retinoic acid receptor signaling pathway,GO:0060037~pharyngeal system development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR003078:Retinoic_acid_rcpt,IPR013088:Znf_NHR/GATA,IPR035500:NHR-like_dom_sf,IPR047158:NR_LBD_RAR,IPR047159:NR_DBD_RAR,				SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0675~Receptor,		COMPBIAS:Acidic residues,DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,REGION:Disordered,REGION:Hinge,REGION:Modulating,ZN_FING:NR C4-type,
A2T929	retinoid X receptor, alpha a(rxraa)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0030154~cell differentiation,GO:0032526~response to retinoic acid,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048384~retinoic acid receptor signaling pathway,GO:0048856~anatomical structure development,	GO:0005634~nucleus,GO:0090575~RNA polymerase II transcription factor complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0044323~retinoic acid-responsive element binding,GO:0046872~metal ion binding,	IPR000003:Retinoid-X_rcpt/HNF4,IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR013088:Znf_NHR/GATA,IPR021780:Nuc_recep-AF1,IPR035500:NHR-like_dom_sf,	dre03320:PPAR signaling pathway,dre04148:Efferocytosis,dre04920:Adipocytokine signaling pathway,			SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0675~Receptor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,REGION:AF-2,REGION:Disordered,REGION:Hinge,REGION:Modulating,REGION:Nuclear localization signal,REGION:Required for nuclear export,ZN_FING:NR C4-type,
Q8TCX5	rhophilin Rho GTPase binding protein 1(RHPN1)	Homo sapiens			GO:0006508~proteolysis,GO:0007165~signal transduction,GO:0051497~negative regulation of stress fiber assembly,	GO:0005829~cytosol,	GO:0005515~protein binding,	IPR001478:PDZ,IPR004328:BRO1_dom,IPR011072:HR1_rho-bd,IPR036034:PDZ_sf,IPR036274:HR1_rpt_sf,IPR038499:BRO1_sf,IPR042715:Rhophilin-1_BRO1,IPR047138:RHPN1_2,				SM00228:PDZ,SM00742:Hr1,SM01041:BRO1,					KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:BRO1,DOMAIN:PDZ,DOMAIN:REM-1,REGION:Disordered,
Q5XIZ9	rhotekin 2(rtkn2)	Danio rerio			GO:0007165~signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0030097~hemopoiesis,			IPR001849:PH_domain,IPR011072:HR1_rho-bd,IPR011993:PH-like_dom_sf,IPR012966:AHD,				SM00233:PH,					KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PH,DOMAIN:REM-1,REGION:Disordered,
Q8IY67	ribonucleoprotein, PTB binding 1(RAVER1)	Homo sapiens				GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034633:RAVER1_RRM1,IPR034635:RAVER1_RRM3,IPR035979:RBD_domain_sf,				SM00360:RRM,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with PTBP1,
P79732	ribonucleotide reductase M1 polypeptide(rrm1)	Danio rerio			GO:0006260~DNA replication,GO:0008152~metabolic process,GO:0009263~deoxyribonucleotide biosynthetic process,	GO:0005737~cytoplasm,GO:0005971~ribonucleoside-diphosphate reductase complex,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0004748~ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,GO:0005524~ATP binding,GO:0016491~oxidoreductase activity,	IPR000788:RNR_lg_C,IPR005144:ATP-cone_dom,IPR008926:RNR_R1-su_N,IPR013346:NrdE_NrdA_C,IPR013509:RNR_lsu_N,IPR039718:Rrm1,	dre00230:Purine metabolism,dre00240:Pyrimidine metabolism,dre00480:Glutathione metabolism,dre00983:Drug metabolism - other enzymes,dre01100:Metabolic pathways,dre01232:Nucleotide metabolism,				KW-0215~Deoxyribonucleotide synthesis,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0560~Oxidoreductase,	KW-1015~Disulfide bond,	ACT_SITE:Cysteine radical intermediate,ACT_SITE:Proton acceptor,DISULFID:Redox-active,DOMAIN:ATP-cone,REGION:Disordered,SITE:Important for electron transfer,SITE:Important for hydrogen atom transfer,SITE:Interacts with thioredoxin/glutaredoxin,
P79733	ribonucleotide reductase M2 polypeptide(rrm2)	Danio rerio			GO:0006260~DNA replication,GO:0009263~deoxyribonucleotide biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004748~ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR000358:RNR_small_fam,IPR009078:Ferritin-like_SF,IPR012348:RNR-like,IPR030475:RNR_small_AS,IPR033909:RNR_small,	dre00230:Purine metabolism,dre00240:Pyrimidine metabolism,dre00480:Glutathione metabolism,dre00983:Drug metabolism - other enzymes,dre01100:Metabolic pathways,dre01232:Nucleotide metabolism,dre04115:p53 signaling pathway,		PIRSF000355:NrdB,		KW-0215~Deoxyribonucleotide synthesis,	KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0408~Iron,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	REGION:Disordered,TRANSMEM:Helical,
P79733	ribonucleotide reductase regulatory subunit M2(LOC100330864)	Danio rerio			GO:0006260~DNA replication,GO:0009263~deoxyribonucleotide biosynthetic process,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0004748~ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR000358:RNR_small_fam,IPR009078:Ferritin-like_SF,IPR012348:RNR-like,IPR030475:RNR_small_AS,IPR033909:RNR_small,	dre00230:Purine metabolism,dre00240:Pyrimidine metabolism,dre00480:Glutathione metabolism,dre00983:Drug metabolism - other enzymes,dre01100:Metabolic pathways,dre01232:Nucleotide metabolism,dre04115:p53 signaling pathway,		PIRSF000355:NrdB,		KW-0215~Deoxyribonucleotide synthesis,	KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0408~Iron,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	REGION:Disordered,TRANSMEM:Helical,
A2TLM1	ribose 5-phosphate isomerase A(RPIA)	Sus scrofa			GO:0006014~D-ribose metabolic process,GO:0009052~pentose-phosphate shunt, non-oxidative branch,	GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,	GO:0004751~ribose-5-phosphate isomerase activity,GO:0042802~identical protein binding,	IPR004788:Ribose5P_isomerase_type_A,IPR020672:Ribose5P_isomerase_typA_subgr,IPR037171:NagB/RpiA_transferase-like,	ssc00030:Pentose phosphate pathway,ssc01100:Metabolic pathways,ssc01200:Carbon metabolism,ssc01230:Biosynthesis of amino acids,										KW-0413~Isomerase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,
P39023	ribosomal protein L3(RPL3)	Homo sapiens			GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0071353~cellular response to interleukin-4,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0032991~macromolecular complex,GO:0070062~extracellular exosome,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,	IPR000597:Ribosomal_uL3,IPR009000:Transl_B-barrel_sf,IPR019926:Ribosomal_uL3_CS,IPR044892:Ribosomal_L3_dom_3_arc_sf,IPR045077:L3_arc_euk,	hsa03010:Ribosome,hsa05171:Coronavirus disease - COVID-19,					KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,MUTAGEN:RGLR->AGLA: No effect on methylation by METTL18.,REGION:Disordered,
P61928	ribosomal protein L37 like 2(Rpl37l2)	Rattus norvegicus			GO:0006412~translation,GO:1901798~positive regulation of signal transduction by p53 class mediator,	GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0045202~synapse,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019838~growth factor binding,GO:0019843~rRNA binding,GO:0046872~metal ion binding,GO:0097371~MDM2/MDM4 family protein binding,GO:1990948~ubiquitin ligase inhibitor activity,	IPR001569:Ribosomal_eL37,IPR011331:Ribosomal_eL37/eL43,IPR011332:Ribosomal_zn-bd,IPR018267:Ribosomal_eL37_CS,						KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0694~RNA-binding,KW-0699~rRNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	TRANSMEM:Helical,ZN_FING:C4-type,
P61928	ribosomal protein L37 like 4(Rpl37l4)	Rattus norvegicus			GO:0006412~translation,GO:1901798~positive regulation of signal transduction by p53 class mediator,	GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0045202~synapse,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019838~growth factor binding,GO:0019843~rRNA binding,GO:0046872~metal ion binding,GO:0097371~MDM2/MDM4 family protein binding,GO:1990948~ubiquitin ligase inhibitor activity,	IPR001569:Ribosomal_eL37,IPR011331:Ribosomal_eL37/eL43,IPR011332:Ribosomal_zn-bd,IPR018267:Ribosomal_eL37_CS,						KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0694~RNA-binding,KW-0699~rRNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Disordered,TRANSMEM:Helical,ZN_FING:C4-type,
P61928	ribosomal protein L37(Rpl37)	Rattus norvegicus			GO:0006412~translation,GO:1901798~positive regulation of signal transduction by p53 class mediator,	GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0045202~synapse,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019838~growth factor binding,GO:0019843~rRNA binding,GO:0046872~metal ion binding,GO:0097371~MDM2/MDM4 family protein binding,GO:1990948~ubiquitin ligase inhibitor activity,	IPR001569:Ribosomal_eL37,IPR011331:Ribosomal_eL37/eL43,IPR011332:Ribosomal_zn-bd,IPR018267:Ribosomal_eL37_CS,						KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0694~RNA-binding,KW-0699~rRNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	TRANSMEM:Helical,ZN_FING:C4-type,
P61928	ribosomal protein L37-like 1(Rpl37l1)	Rattus norvegicus			GO:0006412~translation,GO:1901798~positive regulation of signal transduction by p53 class mediator,	GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0045202~synapse,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019838~growth factor binding,GO:0019843~rRNA binding,GO:0046872~metal ion binding,GO:0097371~MDM2/MDM4 family protein binding,GO:1990948~ubiquitin ligase inhibitor activity,	IPR001569:Ribosomal_eL37,IPR011331:Ribosomal_eL37/eL43,IPR011332:Ribosomal_zn-bd,IPR018267:Ribosomal_eL37_CS,	rno03010:Ribosome,rno05171:Coronavirus disease - COVID-19,					KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0694~RNA-binding,KW-0699~rRNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	TRANSMEM:Helical,ZN_FING:C4-type,
P63174	ribosomal protein L38(Rpl38)	Rattus norvegicus			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0006417~regulation of translation,GO:0007605~sensory perception of sound,GO:0022618~ribonucleoprotein complex assembly,GO:0034463~90S preribosome assembly,GO:0042474~middle ear morphogenesis,GO:0048318~axial mesoderm development,	GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0014069~postsynaptic density,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0033291~eukaryotic 80S initiation complex,GO:0042788~polysomal ribosome,GO:0045202~synapse,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,	IPR002675:Ribosomal_eL38,IPR038464:Ribosomal_eL38_sf,	rno03010:Ribosome,rno05171:Coronavirus disease - COVID-19,					KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0007~Acetylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,
P63174	ribosomal protein L38, pseudogene 8(Rpl38-ps8)	Rattus norvegicus			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0006417~regulation of translation,GO:0007605~sensory perception of sound,GO:0022618~ribonucleoprotein complex assembly,GO:0034463~90S preribosome assembly,GO:0042474~middle ear morphogenesis,GO:0048318~axial mesoderm development,	GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0014069~postsynaptic density,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0033291~eukaryotic 80S initiation complex,GO:0042788~polysomal ribosome,GO:0045202~synapse,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,	IPR002675:Ribosomal_eL38,IPR038464:Ribosomal_eL38_sf,	rno03010:Ribosome,rno05171:Coronavirus disease - COVID-19,					KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0007~Acetylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,
Q02878	ribosomal protein L6(RPL6)	Homo sapiens			GO:0000027~ribosomal large subunit assembly,GO:0002181~cytoplasmic translation,GO:0006355~regulation of transcription, DNA-templated,GO:0006412~translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005791~rough endoplasmic reticulum,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0042788~polysomal ribosome,GO:1990904~ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR000915:60S_ribosomal_eL6,IPR005568:Ribosomal_uL6_N,IPR008991:Translation_prot_SH3-like_sf,IPR014722:Rib_uL2_dom2,IPR041997:Ribosomal_eL6_KOW,	hsa03010:Ribosome,hsa05171:Coronavirus disease - COVID-19,					KW-0256~Endoplasmic reticulum,KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Large ribosomal subunit protein uL6 N-terminal,REGION:Disordered,
Q6DKI1	ribosomal protein L7 like 1(RPL7L1)	Homo sapiens			GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001825~blastocyst formation,	GO:0005730~nucleolus,GO:0022625~cytosolic large ribosomal subunit,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,	IPR005998:Ribosomal_uL30_euk,IPR012988:Ribosomal_uL30_N_euk,IPR016082:Ribosomal_uL30_ferredoxin-like,IPR018038:Ribosomal_uL30_CS,IPR035808:Ribosomal_uL30_euk_arc,IPR036919:Ribo_uL30_ferredoxin-like_sf,IPR039699:Ribosomal_uL30,											KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Large ribosomal subunit protein uL30 N-terminal eukaryotes,DOMAIN:Large ribosomal subunit protein uL30-like ferredoxin-like fold,REGION:Disordered,
P62282	ribosomal protein S11(Rps11)	Rattus norvegicus			GO:0001649~osteoblast differentiation,GO:0006412~translation,GO:0042274~ribosomal small subunit biogenesis,	GO:0005730~nucleolus,GO:0005840~ribosome,GO:0016020~membrane,GO:0022626~cytosolic ribosome,GO:0022627~cytosolic small ribosomal subunit,GO:0032040~small-subunit processome,GO:0045202~synapse,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,	IPR000266:Ribosomal_uS17,IPR012340:NA-bd_OB-fold,IPR019979:Ribosomal_uS17_CS,IPR028333:Ribosomal_uS17_arc/euk,IPR032440:Ribosomal_uS17_N,	rno03010:Ribosome,rno05171:Coronavirus disease - COVID-19,					KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0694~RNA-binding,KW-0699~rRNA-binding,	KW-0007~Acetylation,KW-0164~Citrullination,KW-0449~Lipoprotein,KW-0488~Methylation,KW-0564~Palmitate,KW-0597~Phosphoprotein,	DOMAIN:Small ribosomal subunit protein uS17 N-terminal,LIPID:S-palmitoyl cysteine,
P46405	ribosomal protein S12(RPS12)	Sus scrofa			GO:0006412~translation,GO:0042274~ribosomal small subunit biogenesis,	GO:0005730~nucleolus,GO:0005840~ribosome,GO:0022627~cytosolic small ribosomal subunit,GO:0032040~small-subunit processome,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,	IPR000530:Ribosomal_eS12,IPR004038:Ribosomal_eL8/eL30/eS12/Gad45,IPR029064:Ribosomal_eL30-like_sf,IPR047860:Ribosomal_eS12_CS,	ssc03010:Ribosome,ssc05171:Coronavirus disease - COVID-19,					KW-0539~Nucleus,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0007~Acetylation,	DOMAIN:Ribosomal protein eL8/eL30/eS12/Gadd45,
P99027	ribosomal protein lateral stalk subunit P2(Rplp2)	Mus musculus			GO:0002181~cytoplasmic translation,GO:0002182~cytoplasmic translational elongation,GO:0006414~translational elongation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0022625~cytosolic large ribosomal subunit,GO:0045202~synapse,GO:0098793~presynapse,GO:0098794~postsynapse,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0005506~iron ion binding,GO:0043021~ribonucleoprotein complex binding,	IPR027534:Ribosomal_P1/P2,IPR038716:P1/P2_N_sf,IPR044076:Ribosomal_P2,	mmu03010:Ribosome,mmu05171:Coronavirus disease - COVID-19,										KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Disordered,
Q3UV31	ring finger 223(Rnf223)	Mus musculus			GO:0016567~protein ubiquitination,	GO:0016020~membrane,	GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR027370:Znf-RING_euk,				SM00184:RING,		KW-0472~Membrane,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Polar residues,DOMAIN:RING-type,REGION:Disordered,TRANSMEM:Helical,ZN_FING:RING-type,
Q66J69	ring finger protein 1 S homeolog(ring1.S)	Xenopus laevis			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0016567~protein ubiquitination,GO:0040029~regulation of gene expression, epigenetic,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0031519~PcG protein complex,GO:0035102~PRC1 complex,GO:0071339~MLL1 complex,	GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR032443:RAWUL,IPR043540:RING1/RING2,	xla03083:Polycomb repressive complex,			SM00184:RING,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0678~Repressor,KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RING-type,REGION:Disordered,REGION:Interaction with HIP2,REGION:Interaction with nucleosomes via an acidic patch on histone H2A and histone H2B,ZN_FING:RING-type,
Q8BP31	ring finger protein 122(Rnf122)	Mus musculus			GO:0010917~negative regulation of mitochondrial membrane potential,GO:0043065~positive regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051865~protein autoubiquitination,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,				SM00184:RING,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,			DOMAIN:RING-type,TRANSMEM:Helical,ZN_FING:RING-type; atypical,
Q91YL2	ring finger protein 126(Rnf126)	Mus musculus			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0016567~protein ubiquitination,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042147~retrograde transport, endosome to Golgi,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,GO:0070534~protein K63-linked ubiquitination,GO:0070936~protein K48-linked ubiquitination,GO:0071629~ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,IPR039525:RNF126-like_zinc-ribbon,IPR039571:RNF126_RING-H2,				SM00184:RING,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RING-type,MUTAGEN:C->A: Loss of E3 ubiquitin protein ligase activity.,MUTAGEN:C->A: Loss of interaction with EGFR and FLT3. No effect on E3 ubiquitin protein ligase activity but alters specificity for 'Lys-48'-linked chains; when associated with A-13.,MUTAGEN:C->A: Loss of interaction with EGFR and FLT3. No effect on E3 ubiquitin protein ligase activity but alters specificity for 'Lys-48'-linked chains; when associated with A-16.,REGION:Disordered,REGION:Required for interaction with BAG6,REGION:Sufficient for interaction with AICDA,ZN_FING:C4-type,ZN_FING:RING-type,
F1RB95	ring finger protein 14(rnf14)	Danio rerio			GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0072344~rescue of stalled ribosome,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0031624~ubiquitin conjugating enzyme binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR002867:IBR_dom,IPR006575:RWD-domain,IPR013083:Znf_RING/FYVE/PHD,IPR016135:UBQ-conjugating_enzyme/RWD,IPR017907:Znf_RING_CS,IPR031127:E3_UB_ligase_RBR,IPR031128:RNF14_RING-HC_Zfn,IPR044066:TRIAD_supradom,IPR047548:Rcat_RBR_RNF14,				SM00591:RWD,SM00647:IBR,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,DOMAIN:RWD,REGION:Disordered,REGION:TRIAD supradomain,ZN_FING:IBR-type,ZN_FING:RING-type 1,ZN_FING:RING-type 2; atypical,ZN_FING:RING-type 3,
Q6IV56	ring finger protein 141(rnf141)	Danio rerio			GO:0051865~protein autoubiquitination,		GO:0004842~ubiquitin-protein transferase activity,GO:0046872~metal ion binding,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR043400:RING-HC_RNF141,IPR047126:RNF141-like,				SM00184:RING,					KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			DOMAIN:RING-type,ZN_FING:RING-type,
Q7ZW78	ring finger protein 181(rnf181)	Danio rerio			GO:0016567~protein ubiquitination,	GO:0005737~cytoplasm,	GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,				SM00184:RING,	KW-0833~Ubl conjugation pathway,				KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		REGION:Disordered,ZN_FING:RING-type; atypical,
A0A0R4I9Y1	ring finger protein 213b(rnf213b)	Danio rerio			GO:0002040~sprouting angiogenesis,GO:0002376~immune system process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0019216~regulation of lipid metabolic process,GO:0042742~defense response to bacterium,GO:0070534~protein K63-linked ubiquitination,GO:0098792~xenophagy,GO:2000051~negative regulation of non-canonical Wnt signaling pathway,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR003593:AAA+_ATPase,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR027417:P-loop_NTPase,IPR031248:RNF213,IPR046439:ZF_RZ_dom,				SM00184:RING,SM00382:AAA,	KW-0037~Angiogenesis,KW-0391~Immunity,KW-0443~Lipid metabolism,KW-0833~Ubl conjugation pathway,	KW-0551~Lipid droplet,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0808~Transferase,		ACT_SITE:Nucleophile; for E3 ubiquitin-lipopolysaccharide ligase activity,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RING-type,DOMAIN:RZ-type,REGION:Disordered,ZN_FING:RING-type,ZN_FING:RZ-type,
Q96EP0	ring finger protein 31(RNF31)	Homo sapiens			GO:0000209~protein polyubiquitination,GO:0006508~proteolysis,GO:0019538~protein metabolic process,GO:0023035~CD40 signaling pathway,GO:0042742~defense response to bacterium,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050852~T cell receptor signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060546~negative regulation of necroptotic process,GO:0097039~protein linear polyubiquitination,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:1904417~positive regulation of xenophagy,	GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0035631~CD40 receptor complex,GO:0071797~LUBAC complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031625~ubiquitin protein ligase binding,GO:0036435~K48-linked polyubiquitin binding,GO:0042802~identical protein binding,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,GO:0070530~K63-linked polyubiquitin binding,GO:1990450~linear polyubiquitin binding,	IPR001876:Znf_RanBP2,IPR002867:IBR_dom,IPR009060:UBA-like_sf,IPR013083:Znf_RING/FYVE/PHD,IPR015940:UBA,IPR017907:Znf_RING_CS,IPR018997:PUB_domain,IPR026254:RNF31-like,IPR032065:RNF31-UBA,IPR036339:PUB-like_dom_sf,IPR036443:Znf_RanBP2_sf,IPR040641:RNF31_PUB,IPR041031:RNF31_C,IPR044066:TRIAD_supradom,IPR047539:UBA_RNF31,IPR047540:BRcat_RBR_RNF31-like,IPR047541:RNF31_RBR_mRING-HC-like,IPR047542:Rcat_RBR_RNF31-like,IPR047543:Bbox1_RNF31-like,	hsa04217:Necroptosis,hsa04621:NOD-like receptor signaling pathway,hsa05131:Shigellosis,	620632~Immunodeficiency 115 with autoinflammation,		SM00547:ZnF_RBZ,SM00647:IBR,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:E3 ubiquitin-protein ligase RNF31 PUB,DOMAIN:PUB,DOMAIN:RING-type,DOMAIN:RNF31 C-terminal,DOMAIN:RanBP2-type,DOMAIN:UBA,MUTAGEN:C->A: Abolished E3 ubiquitin-protein ligase activity and ability to promote formation of the bacterial ubiquitin coat; when associated with A-935 and A-983.,MUTAGEN:C->S: Abolishes polyubiquitination activity of LUBAC; when associated with S-699.,MUTAGEN:C->S: Abolishes polyubiquitination activity of LUBAC; when associated with S-702.,MUTAGEN:C->S: Abolishes polyubiquitination activity of LUBAC; when associated with S-871.,MUTAGEN:C->S: Abolishes polyubiquitination activity of LUBAC; when associated with S-874.,MUTAGEN:D->A: Abolished E3 ubiquitin-protein ligase activity and ability to promote formation of the bacterial ubiquitin coat; when associated with A-885 and A-935.,MUTAGEN:D->A: Abolishes cleavage by caspase.,MUTAGEN:K->E: Reduced interaction with OTULIN.,MUTAGEN:K->R: Reduced ubiquitination; when associated with R-735 and R-783.,MUTAGEN:K->R: Reduced ubiquitination; when associated with R-735 and R-875.,MUTAGEN:K->R: Reduced ubiquitination; when associated with R-783 and R-875.,MUTAGEN:N->A: Abolished interaction with SPATA2.,MUTAGEN:N->A: Reduced interaction with OTULIN.,MUTAGEN:N->D: Abolished interaction with OTULIN.,MUTAGEN:N->R: Does not affect interaction with OTULIN.,MUTAGEN:R->A: Abolished E3 ubiquitin-protein ligase activity and ability to promote formation of the bacterial ubiquitin coat; when associated with A-885 and A-983.,MUTAGEN:T->A: Decreased ubiquitin-binding and ability to promote formation of the bacterial ubiquitin coat.,MUTAGEN:V->A: Reduced interaction with OTULIN.,MUTAGEN:Y->A: Abolished interaction with OTULIN.,MUTAGEN:Y->F: Reduced interaction with OTULIN.,REGION:Disordered,REGION:Interaction with RBCK1,REGION:LDD domain,REGION:Polyubiquitin-binding,REGION:TRIAD supradomain,SITE:Cleavage; by caspase,ZN_FING:IBR-type,ZN_FING:RING-type 1,ZN_FING:RING-type 2; atypical,ZN_FING:RanBP2-type 1,ZN_FING:RanBP2-type 2,ZN_FING:RanBP2-type 3,
Q9IA88	salt inducible kinase 1(SIK1)	Gallus gallus			GO:0000226~microtubule cytoskeleton organization,GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,GO:0046626~regulation of insulin receptor signaling pathway,	GO:0005737~cytoplasm,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0050321~tau-protein kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015940:UBA,IPR017090:Ser/Thr_kinase_SIK1/2,IPR017441:Protein_kinase_ATP_BS,IPR034672:SIK,			PIRSF037014:Ser/Thr_PK_SNF1-like,	SM00220:S_TKc,		KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,DOMAIN:UBA,REGION:Disordered,
Q9IA88	salt inducible kinase 2(SIK2)	Gallus gallus			GO:0000226~microtubule cytoskeleton organization,GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,GO:0046626~regulation of insulin receptor signaling pathway,	GO:0005737~cytoplasm,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0050321~tau-protein kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015940:UBA,IPR017090:Ser/Thr_kinase_SIK1/2,IPR017441:Protein_kinase_ATP_BS,IPR034672:SIK,			PIRSF037014:Ser/Thr_PK_SNF1-like,	SM00220:S_TKc,		KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,DOMAIN:UBA,REGION:Disordered,
P97281	sarcoglycan delta(Sgcd)	Mesocricetus auratus			GO:0048738~cardiac muscle tissue development,GO:0060047~heart contraction,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0016012~sarcoglycan complex,GO:0042383~sarcolemma,		IPR006875:Sarcoglycan,IPR039972:Sarcoglycan_gamma/delta/zeta,	maua05410:Hypertrophic cardiomyopathy,maua05412:Arrhythmogenic right ventricular cardiomyopathy,maua05414:Dilated cardiomyopathy,maua05416:Viral myocarditis,					KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0122~Cardiomyopathy,	KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q14BN4	sarcolemma associated protein(SLMAP)	Homo sapiens			GO:0006936~muscle contraction,GO:0072659~protein localization to plasma membrane,GO:1900825~regulation of membrane depolarization during cardiac muscle cell action potential,GO:1902305~regulation of sodium ion transmembrane transport,GO:1905150~regulation of voltage-gated sodium channel activity,	GO:0005790~smooth endoplasmic reticulum,GO:0005813~centrosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0042383~sarcolemma,	GO:0005515~protein binding,GO:0031267~small GTPase binding,	IPR000253:FHA_dom,IPR008984:SMAD_FHA_dom_sf,				SM00240:FHA,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:FHA,REGION:Disordered,REGION:Necessary for targeting to centrosomes,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
P27615	scavenger receptor class B, member 2(Scarb2)	Rattus norvegicus			GO:0006622~protein targeting to lysosome,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007605~sensory perception of sound,GO:0010467~gene expression,GO:0010976~positive regulation of neuron projection development,GO:0015917~aminophospholipid transport,GO:0043470~regulation of carbohydrate catabolic process,GO:0099638~endosome to plasma membrane protein transport,GO:1905123~regulation of glucosylceramidase activity,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030666~endocytic vesicle membrane,GO:0043202~lysosomal lumen,	GO:0001786~phosphatidylserine binding,GO:0005044~scavenger receptor activity,GO:0015485~cholesterol binding,GO:0019899~enzyme binding,GO:0031210~phosphatidylcholine binding,GO:0038024~cargo receptor activity,GO:0042803~protein homodimerization activity,GO:0051087~chaperone binding,	IPR002159:CD36_fam,IPR005429:LimpII,	rno04142:Lysosome,					KW-0458~Lysosome,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Important for interaction with GBA1,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
P0DPB3	schwannomin interacting protein 1(SCHIP1)	Homo sapiens			GO:0035332~positive regulation of hippo signaling,GO:0051494~negative regulation of cytoskeleton organization,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016604~nuclear body,GO:0030054~cell junction,GO:0043194~axon initial segment,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR015649:SCHIP_1_C,IPR029362:IQCJ-SCHIP1_N,IPR039045:SCHIP_1,						KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Fusion protein IQCJ-SCHIP1 N-terminal,DOMAIN:IQ,DOMAIN:Schwannomin interacting protein 1 C-terminal,REGION:Disordered,REGION:Required for interaction with ankyrins,
Q5ZIV9	scinderin(SCIN)	Gallus gallus			GO:0007417~central nervous system development,GO:0008154~actin polymerization or depolymerization,GO:0030031~cell projection assembly,GO:0032330~regulation of chondrocyte differentiation,GO:0051014~actin filament severing,GO:0051016~barbed-end actin filament capping,	GO:0002102~podosome,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0042995~cell projection,GO:0070161~anchoring junction,	GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,	IPR007122:Villin/Gelsolin,IPR007123:Gelsolin-like_dom,IPR029006:ADF-H/Gelsolin-like_dom_sf,IPR036180:Gelsolin-like_dom_sf,	gga04810:Regulation of actin cytoskeleton,			SM00262:GEL,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0009~Actin-binding,KW-0117~Actin capping,		COMPBIAS:Basic and acidic residues,DOMAIN:Gelsolin-like,REGION:Actin-severing,REGION:Ca(2+)-dependent actin binding,REGION:Disordered,REPEAT:Gelsolin-like 1,REPEAT:Gelsolin-like 2,REPEAT:Gelsolin-like 3,REPEAT:Gelsolin-like 4,REPEAT:Gelsolin-like 5,REPEAT:Gelsolin-like 6,
Q642G2	sclerostin domain containing 1(Sostdc1)	Rattus norvegicus			GO:0007389~pattern specification process,GO:0007566~embryo implantation,GO:0010454~negative regulation of cell fate commitment,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030509~BMP signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0031069~hair follicle morphogenesis,GO:0042475~odontogenesis of dentin-containing tooth,GO:0045165~cell fate commitment,GO:0045662~negative regulation of myoblast differentiation,GO:0060070~canonical Wnt signaling pathway,GO:0060648~mammary gland bud morphogenesis,GO:0072148~epithelial cell fate commitment,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000016~negative regulation of determination of dorsal identity,	GO:0005615~extracellular space,GO:0016020~membrane,	GO:0036122~BMP binding,GO:0098821~BMP receptor activity,	IPR006207:Cys_knot_C,IPR008835:Sclerostin/SOSTDC1,IPR029034:Cystine-knot_cytokine,					KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-0964~Secreted,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic residues,DOMAIN:CTCK,REGION:Disordered,TRANSMEM:Helical,
Q0VFG3	secretagogin, EF-hand calcium binding protein(scgn)	Xenopus tropicalis			GO:0099509~regulation of presynaptic cytosolic calcium ion concentration,GO:1900271~regulation of long-term synaptic potentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030425~dendrite,GO:0043195~terminal bouton,GO:0045202~synapse,	GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR035798:EFh_SCGN,				SM00054:EFh,		KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,			DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,DOMAIN:EF-hand 5,DOMAIN:EF-hand 6,
O93390	secreted protein acidic and cysteine rich(SPARC)	Coturnix japonica			GO:0001937~negative regulation of endothelial cell proliferation,GO:0010595~positive regulation of endothelial cell migration,GO:0016525~negative regulation of angiogenesis,GO:0022604~regulation of cell morphogenesis,GO:0048856~anatomical structure development,	GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0009986~cell surface,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0031092~platelet alpha granule membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0050840~extracellular matrix binding,	IPR001999:Osteonectin_CS,IPR002350:Kazal_dom,IPR003645:Fol_N,IPR011992:EF-hand-dom_pair,IPR015369:Follistatin/Osteonectin_EGF,IPR018247:EF_Hand_1_Ca_BS,IPR019577:SPARC/Testican_Ca-bd-dom,IPR036058:Kazal_dom_sf,IPR037641:SPARC_FS,				SM00274:FOLN,SM00280:KAZAL,		KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0186~Copper,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand,DOMAIN:Follistatin-like,DOMAIN:Kazal-like,
P47872	secretin receptor(SCTR)	Homo sapiens			GO:0002024~diet induced thermogenesis,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0009992~cellular water homeostasis,GO:0031667~response to nutrient levels,GO:0032098~regulation of appetite,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0048167~regulation of synaptic plasticity,	GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,GO:0008528~G-protein coupled peptide receptor activity,GO:0015055~secretin receptor activity,GO:0017046~peptide hormone binding,	IPR000832:GPCR_2_secretin-like,IPR001879:GPCR_2_extracellular_dom,IPR002144:GPCR_2_secretin_rcpt,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR036445:GPCR_2_extracell_dom_sf,IPR047037:Secretin_7TM,	hsa04080:Neuroactive ligand-receptor interaction,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,			SM00008:HormR,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 2 profile 1,DOMAIN:G-protein coupled receptors family 2 profile 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q6P0C7	secretory carrier membrane protein 5a(scamp5a)	Danio rerio			GO:0001819~positive regulation of cytokine production,GO:0006887~exocytosis,GO:0015031~protein transport,GO:0045956~positive regulation of calcium ion-dependent exocytosis,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030672~synaptic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0032588~trans-Golgi network membrane,GO:0045202~synapse,GO:0055038~recycling endosome membrane,		IPR007273:SCAMP,					KW-0268~Exocytosis,KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0770~Synapse,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P16581	selectin E(SELE)	Homo sapiens		h_lymphocytePathway:Adhesion Molecules on Lymphocyte,h_monocytePathway:Monocyte and its Surface Molecules,h_neutrophilPathway:Neutrophil and Its Surface Molecules,	GO:0002092~positive regulation of receptor internalization,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002687~positive regulation of leukocyte migration,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007159~leukocyte cell-cell adhesion,GO:0007202~activation of phospholipase C activity,GO:0019722~calcium-mediated signaling,GO:0030029~actin filament-based process,GO:0032496~response to lipopolysaccharide,GO:0034097~response to cytokine,GO:0034612~response to tumor necrosis factor,GO:0050727~regulation of inflammatory response,GO:0050901~leukocyte tethering or rolling,GO:0070555~response to interleukin-1,GO:1903238~positive regulation of leukocyte tethering or rolling,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005905~clathrin-coated pit,GO:0009897~external side of plasma membrane,GO:0030863~cortical cytoskeleton,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0033691~sialic acid binding,GO:0043274~phospholipase binding,GO:0046872~metal ion binding,GO:0070492~oligosaccharide binding,	IPR000436:Sushi_SCR_CCP_dom,IPR000742:EGF-like_dom,IPR001304:C-type_lectin-like,IPR002396:Selectin_superfamily,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR018378:C-type_lectin_CS,IPR033991:Selectin_CTLD,IPR035976:Sushi/SCR/CCP_sf,	hsa04514:Cell adhesion molecules,hsa04668:TNF signaling pathway,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05417:Lipid and atherosclerosis,hsa05418:Fluid shear stress and atherosclerosis,			SM00032:CCP,SM00034:CLECT,SM00181:EGF,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0430~Lectin,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:C-type lectin,DOMAIN:EGF-like,DOMAIN:Sushi,DOMAIN:Sushi 1,DOMAIN:Sushi 2,DOMAIN:Sushi 3,DOMAIN:Sushi 4,DOMAIN:Sushi 5,DOMAIN:Sushi 6,MUTAGEN:E->D: Decreased adhesion to cells expressing SELPLG.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q7ZW38	selenophosphate synthetase 1(sephs1)	Danio rerio			GO:0016260~selenocysteine biosynthetic process,GO:0016310~phosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0000166~nucleotide binding,GO:0004756~selenide, water dikinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR004536:SPS/SelD,IPR010918:PurM-like_C_dom,IPR016188:PurM-like_N,IPR036676:PurM-like_C_sf,IPR036921:PurM-like_N_sf,	dre00450:Selenocompound metabolism,dre01100:Metabolic pathways,		PIRSF036407:Selenphspht_syn,			KW-0472~Membrane,KW-0539~Nucleus,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0711~Selenium,	KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	BINDING:in other chain,SITE:Important for catalytic activity,
Q1LVN8	selenoprotein O1(selenoo1)	Danio rerio				GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,GO:0070733~protein adenylyltransferase activity,	IPR003846:SelO,						KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		ACT_SITE:Proton acceptor,NON_STD:Selenocysteine,REGION:Disordered,TRANSIT:Mitochondrion,
Q62179	sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B(Sema4b)	Mus musculus			GO:0001755~neural crest cell migration,GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0098839~postsynaptic density membrane,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,GO:0030215~semaphorin receptor binding,GO:0045499~chemorepellent activity,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR027231:Semaphorin,IPR036352:Semap_dom_sf,	mmu04360:Axon guidance,			SM00423:PSI,SM00630:Sema,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like C2-type,DOMAIN:PSI,DOMAIN:Sema,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9WUH7	sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G(Sema4g)	Mus musculus			GO:0001755~neural crest cell migration,GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0030215~semaphorin receptor binding,GO:0045499~chemorepellent activity,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR027231:Semaphorin,IPR036179:Ig-like_dom_sf,IPR036352:Semap_dom_sf,	mmu04360:Axon guidance,			SM00409:IG,SM00423:PSI,SM00630:Sema,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:Ig-like C2-type,DOMAIN:PSI,DOMAIN:Sema,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9NS98	semaphorin 3G(SEMA3G)	Homo sapiens			GO:0001755~neural crest cell migration,GO:0007411~axon guidance,GO:0030335~positive regulation of cell migration,GO:0030517~negative regulation of axon extension,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0030215~semaphorin receptor binding,GO:0045499~chemorepellent activity,	IPR001627:Semap_dom,IPR007110:Ig-like_dom,IPR013151:Immunoglobulin,IPR013783:Ig-like_fold,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR027231:Semaphorin,IPR036179:Ig-like_dom_sf,IPR036352:Semap_dom_sf,	hsa04360:Axon guidance,			SM00423:PSI,SM00630:Sema,		KW-0964~Secreted,			KW-0393~Immunoglobulin domain,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like C2-type,DOMAIN:Sema,
Q9YHX4	semaphorin 4e(sema4e)	Danio rerio			GO:0001755~neural crest cell migration,GO:0007411~axon guidance,GO:0030335~positive regulation of cell migration,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0030215~semaphorin receptor binding,GO:0045499~chemorepellent activity,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR027231:Semaphorin,IPR036179:Ig-like_dom_sf,IPR036352:Semap_dom_sf,				SM00423:PSI,SM00630:Sema,		KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:PSI,DOMAIN:Sema,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8NFY4	semaphorin 6D(SEMA6D)	Homo sapiens			GO:0001755~neural crest cell migration,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0014909~smooth muscle cell migration,GO:0014911~positive regulation of smooth muscle cell migration,GO:0014912~negative regulation of smooth muscle cell migration,GO:0021591~ventricular system development,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0030517~negative regulation of axon extension,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,	GO:0030215~semaphorin receptor binding,GO:0045499~chemorepellent activity,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR027231:Semaphorin,IPR036352:Semap_dom_sf,	hsa04360:Axon guidance,			SM00423:PSI,SM00630:Sema,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PSI,DOMAIN:Sema,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P28661	septin 4(Septin4)	Mus musculus			GO:0001764~neuron migration,GO:0007049~cell cycle,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007420~brain development,GO:0017157~regulation of exocytosis,GO:0030154~cell differentiation,GO:0030317~flagellated sperm motility,GO:0030382~sperm mitochondrion organization,GO:0031398~positive regulation of protein ubiquitination,GO:0043065~positive regulation of apoptotic process,GO:0048240~sperm capacitation,GO:0048515~spermatid differentiation,GO:0048729~tissue morphogenesis,GO:0051301~cell division,GO:0061484~hematopoietic stem cell homeostasis,GO:0061640~cytoskeleton-dependent cytokinesis,GO:2000647~negative regulation of stem cell proliferation,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005929~cilium,GO:0005940~septin ring,GO:0008021~synaptic vesicle,GO:0015630~microtubule cytoskeleton,GO:0030424~axon,GO:0030425~dendrite,GO:0031105~septin complex,GO:0031410~cytoplasmic vesicle,GO:0031514~motile cilium,GO:0032153~cell division site,GO:0036126~sperm flagellum,GO:0042995~cell projection,GO:0043204~perikaryon,GO:0043209~myelin sheath,GO:0043679~axon terminus,GO:0045202~synapse,GO:0097227~sperm annulus,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0042802~identical protein binding,GO:0060090~binding, bridging,	IPR016491:Septin,IPR027417:P-loop_NTPase,IPR027979:DUF4655,IPR030379:G_SEPTIN_dom,	mmu04210:Apoptosis,mmu04215:Apoptosis - multiple species,		PIRSF006698:Septin,		KW-0131~Cell cycle,KW-0132~Cell division,KW-0221~Differentiation,KW-0744~Spermatogenesis,	KW-0282~Flagellum,KW-0496~Mitochondrion,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-0969~Cilium,			KW-0175~Coiled coil,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Septin-type G,REGION:Disordered,REGION:G1 motif,REGION:G3 motif,REGION:G4 motif,SITE:Important for dimerization,
Q05519	serine and arginine rich splicing factor 11(SRSF11)	Homo sapiens			GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034447:RRM_SRSF11,IPR035979:RBD_domain_sf,				SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:RRM,REGION:10 X 8 AA approximate repeats of R-R-S-R-S-R-S-R,REGION:Disordered,REPEAT:1,REPEAT:10,REPEAT:2,REPEAT:3,REPEAT:4,REPEAT:5,REPEAT:6,REPEAT:7,REPEAT:8,REPEAT:9,
Q5R1W5	serine and arginine rich splicing factor 2(SRSF2)	Pan troglodytes			GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005681~spliceosomal complex,GO:0005829~cytosol,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0036002~pre-mRNA binding,	IPR000504:RRM_dom,IPR003954:RRM_dom_euk,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR035979:RBD_domain_sf,	ptr03040:Spliceosome,ptr05168:Herpes simplex virus 1 infection,			SM00360:RRM,SM00361:RRM_1,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,					KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,DOMAIN:RRM,REGION:Disordered,
Q13247	serine and arginine rich splicing factor 6(SRSF6)	Homo sapiens			GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006376~mRNA splice site selection,GO:0010837~regulation of keratinocyte proliferation,GO:0032868~response to insulin,GO:0045617~negative regulation of keratinocyte differentiation,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0060501~positive regulation of epithelial cell proliferation involved in lung morphogenesis,GO:0061041~regulation of wound healing,GO:2000675~negative regulation of type B pancreatic cell apoptotic process,	GO:0005654~nucleoplasm,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034511:SRSF6_RRM1,IPR035979:RBD_domain_sf,	hsa03040:Spliceosome,hsa05168:Herpes simplex virus 1 infection,			SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0678~Repressor,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,MUTAGEN:S->A: Abolishes regulatory effect of DYRK1A on alternative splicing of MAPT/Tau exon 10.,MUTAGEN:S->A: No effect on regulation of alternative splicing of MAPT/Tau exon 10 by DYRK1A.,REGION:Disordered,
O43278	serine peptidase inhibitor, Kunitz type 1(SPINT1)	Homo sapiens			GO:0001843~neural tube closure,GO:0008544~epidermis development,GO:0030198~extracellular matrix organization,GO:0045687~positive regulation of glial cell differentiation,GO:0060429~epithelium development,GO:0060670~branching involved in labyrinthine layer morphogenesis,GO:0060674~placenta blood vessel development,GO:0071773~cellular response to BMP stimulus,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR002172:LDrepeatLR_classA_rpt,IPR002223:Kunitz_BPTI,IPR011106:MANSC_N,IPR013783:Ig-like_fold,IPR013980:MANSC_dom,IPR020901:Prtase_inh_Kunz-CS,IPR023415:LDLR_class-A_CS,IPR036055:LDL_receptor-like_sf,IPR036880:Kunitz_BPTI_sf,	hsa05202:Transcriptional misregulation in cancer,hsa05215:Prostate cancer,			SM00131:KU,SM00192:LDLa,SM00765:MANEC,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BPTI/Kunitz inhibitor,DOMAIN:BPTI/Kunitz inhibitor 1,DOMAIN:BPTI/Kunitz inhibitor 2,DOMAIN:LDL-receptor class A,DOMAIN:MANSC,REGION:Disordered,SITE:Reactive bond,TRANSMEM:Helical,
Q9D6X6	serine protease 23(Prss23)	Mus musculus			GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,	GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0016787~hydrolase activity,	IPR001254:Trypsin_dom,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR043504:Peptidase_S1_PA_chymotrypsin,						KW-0964~Secreted,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase S1,
Q91XS8	serine/threonine kinase 17b(Stk17b)	Rattus norvegicus			GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0012501~programmed cell death,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0046777~protein autophosphorylation,GO:2000271~positive regulation of fibroblast apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0090543~Flemming body,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR042763:ST17B_STKc,				SM00220:S_TKc,	KW-0053~Apoptosis,	KW-0472~Membrane,KW-0539~Nucleus,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Protein kinase,MUTAGEN:K->A: Inhibits kinase activity.,REGION:Disordered,
A4K2M3	serine/threonine kinase 4(STK4)	Papio anubis			GO:0000902~cell morphogenesis,GO:0001569~branching involved in blood vessel morphogenesis,GO:0001841~neural tube formation,GO:0003157~endocardium development,GO:0006468~protein phosphorylation,GO:0006606~protein import into nucleus,GO:0006915~apoptotic process,GO:0007417~central nervous system development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0016310~phosphorylation,GO:0030216~keratinocyte differentiation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0035265~organ growth,GO:0035329~hippo signaling,GO:0035556~intracellular signal transduction,GO:0043408~regulation of MAPK cascade,GO:0045600~positive regulation of fat cell differentiation,GO:0046621~negative regulation of organ growth,GO:0050673~epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050821~protein stabilization,GO:0051262~protein tetramerization,GO:0060070~canonical Wnt signaling pathway,GO:0060215~primitive hemopoiesis,GO:0060706~cell differentiation involved in embryonic placenta development,GO:0060800~regulation of cell differentiation involved in embryonic placenta development,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097284~hepatocyte apoptotic process,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1903945~positive regulation of hepatocyte apoptotic process,GO:1904237~positive regulation of substrate-dependent cell migration, cell attachment to substrate,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016604~nuclear body,GO:0032991~macromolecular complex,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,	IPR000719:Prot_kinase_dom,IPR011009:Kinase-like_dom_sf,IPR011524:SARAH_dom,IPR017441:Protein_kinase_ATP_BS,IPR024205:Mst1_SARAH_domain,IPR036674:p53_tetramer_sf,	panu04010:MAPK signaling pathway,panu04014:Ras signaling pathway,panu04068:FoxO signaling pathway,panu05200:Pathways in cancer,panu05223:Non-small cell lung cancer,			SM00220:S_TKc,	KW-0053~Apoptosis,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,DOMAIN:SARAH,REGION:Disordered,SITE:Cleavage; by caspase-3,
Q6J9G0	serine/threonine/tyrosine kinase 1(STYK1)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0042981~regulation of apoptotic process,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,						KW-0472~Membrane,		KW-0656~Proto-oncogene,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,		ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,REGION:Disordered,TRANSMEM:Helical,
Q5I0S8	serpin family B member 1(serpinb1)	Xenopus tropicalis			GO:0010951~negative regulation of endopeptidase activity,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0045211~postsynaptic membrane,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0004970~ionotropic glutamate receptor activity,GO:0030414~peptidase inhibitor activity,	IPR000215:Serpin_fam,IPR000240:Serpin_B9/Maspin,IPR001320:Iontro_rcpt_C,IPR001508:Iono_Glu_rcpt_met,IPR001638:Solute-binding_3/MltF_N,IPR001828:ANF_lig-bd_rcpt,IPR015683:Ionotropic_Glu_rcpt,IPR019594:Glu/Gly-bd,IPR023795:Serpin_CS,IPR023796:Serpin_dom,IPR028082:Peripla_BP_I,IPR036186:Serpin_sf,IPR042178:Serpin_sf_1,IPR042185:Serpin_sf_2,				SM00079:PBPe,SM00093:SERPIN,SM00918:Lig_chan-Glu_bd,	KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0770~Synapse,KW-0963~Cytoplasm,			KW-0732~Signal,		KW-0407~Ion channel,KW-0646~Protease inhibitor,KW-0675~Receptor,KW-0722~Serine protease inhibitor,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0832~Ubl conjugation,	DOMAIN:Ionotropic glutamate receptor C-terminal,DOMAIN:Ionotropic glutamate receptor L-glutamate and glycine-binding,DOMAIN:Serpin,SITE:Reactive bond,TRANSMEM:Helical,
P47776	serpin family D member 1(SERPIND1)	Oryctolagus cuniculus			GO:0007596~blood coagulation,GO:0010951~negative regulation of endopeptidase activity,	GO:0005615~extracellular space,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0008201~heparin binding,	IPR000215:Serpin_fam,IPR023795:Serpin_CS,IPR023796:Serpin_dom,IPR033831:HCII_serpin_dom,IPR036186:Serpin_sf,IPR042178:Serpin_sf_1,IPR042185:Serpin_sf_2,	ocu04610:Complement and coagulation cascades,			SM00093:SERPIN,	KW-0094~Blood coagulation,KW-0356~Hemostasis,				KW-0677~Repeat,KW-0732~Signal,		KW-0358~Heparin-binding,KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,KW-0765~Sulfation,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Serpin,REGION:2 X 11 AA approximate repeats, Asp/Glu-rich (acidic) (hirudin-like),REGION:Glycosaminoglycan-binding site,REPEAT:1,REPEAT:2,SITE:Reactive bond,
P05121	serpin family E member 1(SERPINE1)	Homo sapiens		h_fibrinolysisPathway:Fibrinolysis Pathway,h_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,	GO:0001525~angiogenesis,GO:0010469~regulation of receptor activity,GO:0010757~negative regulation of plasminogen activation,GO:0010951~negative regulation of endopeptidase activity,GO:0014912~negative regulation of smooth muscle cell migration,GO:0030194~positive regulation of blood coagulation,GO:0030195~negative regulation of blood coagulation,GO:0030336~negative regulation of cell migration,GO:0032757~positive regulation of interleukin-8 production,GO:0033629~negative regulation of cell adhesion mediated by integrin,GO:0035491~positive regulation of leukotriene production involved in inflammatory response,GO:0042730~fibrinolysis,GO:0045766~positive regulation of angiogenesis,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0050729~positive regulation of inflammatory response,GO:0050829~defense response to Gram-negative bacterium,GO:0051918~negative regulation of fibrinolysis,GO:0061044~negative regulation of vascular wound healing,GO:0061045~negative regulation of wound healing,GO:0071222~cellular response to lipopolysaccharide,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090399~replicative senescence,GO:0097187~dentinogenesis,GO:1901331~positive regulation of odontoblast differentiation,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000098~negative regulation of smooth muscle cell-matrix adhesion,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,GO:0097180~serine protease inhibitor complex,GO:1904090~peptidase inhibitor complex,	GO:0002020~protease binding,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0005515~protein binding,	IPR000215:Serpin_fam,IPR023795:Serpin_CS,IPR023796:Serpin_dom,IPR036186:Serpin_sf,IPR042178:Serpin_sf_1,IPR042185:Serpin_sf_2,	hsa04066:HIF-1 signaling pathway,hsa04115:p53 signaling pathway,hsa04218:Cellular senescence,hsa04371:Apelin signaling pathway,hsa04390:Hippo signaling pathway,hsa04610:Complement and coagulation cascades,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa05142:Chagas disease,	613329~Plasminogen activator inhibitor-1 deficiency,Transcription of plasminogen activator inhibitor, modulator of~Transcription of plasminogen activator inhibitor, modulator of,		SM00093:SERPIN,		KW-0964~Secreted,			KW-0732~Signal,		KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Serpin,MUTAGEN:G->C: Increased half-life of the active form when associated with C-197.,MUTAGEN:Q->C: Increased half-life of the active form when associated with C-355.,SITE:Reactive bond,
Q95121	serpin family F member 1(SERPINF1)	Bos taurus			GO:0010951~negative regulation of endopeptidase activity,GO:0016525~negative regulation of angiogenesis,GO:0050769~positive regulation of neurogenesis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0042470~melanosome,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR000215:Serpin_fam,IPR023795:Serpin_CS,IPR023796:Serpin_dom,IPR033832:PEDF_serpin_dom,IPR036186:Serpin_sf,IPR042178:Serpin_sf_1,IPR042185:Serpin_sf_2,	bta04310:Wnt signaling pathway,			SM00093:SERPIN,		KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,
P13731	serpin family H member 1(SERPINH1)	Gallus gallus			GO:0010951~negative regulation of endopeptidase activity,GO:0030199~collagen fibril organization,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005518~collagen binding,	IPR000215:Serpin_fam,IPR023795:Serpin_CS,IPR023796:Serpin_dom,IPR033830:Serpin_H1_serpin_dom,IPR036186:Serpin_sf,IPR042178:Serpin_sf_1,IPR042185:Serpin_sf_2,				SM00093:SERPIN,	KW-0346~Stress response,	KW-0256~Endoplasmic reticulum,			KW-0732~Signal,		KW-0143~Chaperone,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Serpin,MOTIF:Prevents secretion from ER,SITE:Reactive bond homolog,
Q90935	serpin family I member 1(SERPINI1)	Gallus gallus			GO:0010951~negative regulation of endopeptidase activity,	GO:0005615~extracellular space,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0060205~cytoplasmic vesicle lumen,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR000215:Serpin_fam,IPR023795:Serpin_CS,IPR023796:Serpin_dom,IPR036186:Serpin_sf,IPR042178:Serpin_sf_1,IPR042185:Serpin_sf_2,				SM00093:SERPIN,		KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,			KW-0732~Signal,		KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Serpin,MUTAGEN:RM->EP: Loss of protease inhibitor activity.,SITE:Reactive bond,
B0UYL8	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 3(serpine3)	Danio rerio			GO:0043010~camera-type eye development,	GO:0005615~extracellular space,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR000215:Serpin_fam,IPR023795:Serpin_CS,IPR023796:Serpin_dom,IPR031172:Serpin_E3,IPR036186:Serpin_sf,IPR042178:Serpin_sf_1,IPR042185:Serpin_sf_2,				SM00093:SERPIN,		KW-0964~Secreted,			KW-0732~Signal,		KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,SITE:Reactive bond,
Q66I22	serrate RNA effector molecule homolog (Arabidopsis)(srrt)	Danio rerio			GO:0006397~mRNA processing,GO:0031047~gene silencing by RNA,GO:0031053~primary miRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016604~nuclear body,		IPR007042:SERRATE/Ars2_C,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR021933:SERRATE/Ars2_N,IPR039727:SE/Ars2,					KW-0804~Transcription,KW-0805~Transcription regulation,KW-0943~RNA-mediated gene silencing,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0010~Activator,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DOMAIN:SERRATE/Ars2 C-terminal,REGION:Disordered,
Q9HBY8	serum/glucocorticoid regulated kinase 2(SGK2)	Homo sapiens			GO:0001558~regulation of cell growth,GO:0006468~protein phosphorylation,GO:0006979~response to oxidative stress,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032411~positive regulation of transporter activity,GO:0035556~intracellular signal transduction,GO:0042127~regulation of cell proliferation,	GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015459~potassium channel regulator activity,GO:0017080~sodium channel regulator activity,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,	hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,			SM00133:S_TK_X,SM00220:S_TKc,		KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:AGC-kinase C-terminal,DOMAIN:Protein kinase,MOTIF:Nuclear localization signal,MUTAGEN:S->D: Increased activation.,REGION:Disordered,
Q9N0F3	seryl-tRNA synthetase 2, mitochondrial(SARS2)	Bos taurus			GO:0006434~seryl-tRNA aminoacylation,GO:0070158~mitochondrial seryl-tRNA aminoacylation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0000049~tRNA binding,GO:0004828~serine-tRNA ligase activity,GO:0005524~ATP binding,	IPR002314:aa-tRNA-synt_IIb,IPR002317:Ser-tRNA-ligase_type_1,IPR006195:aa-tRNA-synth_II,IPR010978:tRNA-bd_arm,IPR033729:SerRS_core,IPR042103:SerRS_1_N_sf,IPR045864:aa-tRNA-synth_II/BPL/LPL,	bta00970:Aminoacyl-tRNA biosynthesis,		PIRSF001529:Ser-tRNA-synth_IIa,		KW-0648~Protein biosynthesis,	KW-0496~Mitochondrion,			KW-0175~Coiled coil,KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,	KW-0007~Acetylation,	COMPBIAS:Polar residues,DOMAIN:Aminoacyl-transfer RNA synthetases class-II family profile,REGION:Disordered,TRANSIT:Mitochondrion,
Q6ZNX1	shieldin complex subunit 3(SHLD3)	Homo sapiens			GO:0002208~somatic diversification of immunoglobulins involved in immune response,GO:0006281~DNA repair,GO:0043247~telomere maintenance in response to DNA damage,GO:0045830~positive regulation of isotype switching,GO:2000042~negative regulation of double-strand break repair via homologous recombination,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,	GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0035861~site of double-strand break,	GO:0005515~protein binding,	IPR039996:Shieldin_RINN1,					KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,							MUTAGEN:PKRSPP->AKRSPA: Fails to interact with MAD2L2.,REGION:Disordered,REGION:Sufficient for interaction with MAD2L2,
A7MC48	shisa family member 9(shisa9)	Xenopus tropicalis			GO:0048172~regulation of short-term neuronal synaptic plasticity,GO:2000311~regulation of AMPA receptor activity,	GO:0005886~plasma membrane,GO:0008328~ionotropic glutamate receptor complex,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0032281~AMPA glutamate receptor complex,GO:0032591~dendritic spine membrane,GO:0042995~cell projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,		IPR026910:Shisa,						KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
B3DFW5	short transmembrane mitochondrial protein 1(stmp1)	Danio rerio			GO:0002376~immune system process,GO:0032731~positive regulation of interleukin-1 beta production,GO:0034551~mitochondrial respiratory chain complex III assembly,GO:0045087~innate immune response,GO:0097250~mitochondrial respiratory chain supercomplex assembly,GO:1900227~positive regulation of NLRP3 inflammasome complex assembly,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005758~mitochondrial intermembrane space,GO:0016020~membrane,		IPR027854:STMP1,					KW-0391~Immunity,KW-0399~Innate immunity,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,KW-1000~Mitochondrion outer membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
Q8AV57	sidekick cell adhesion molecule 2(SDK2)	Gallus gallus			GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007416~synapse assembly,GO:0010842~retina layer formation,GO:0060219~camera-type eye photoreceptor cell differentiation,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0045202~synapse,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 10,DOMAIN:Fibronectin type-III 11,DOMAIN:Fibronectin type-III 12,DOMAIN:Fibronectin type-III 13,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Fibronectin type-III 5,DOMAIN:Fibronectin type-III 6,DOMAIN:Fibronectin type-III 7,DOMAIN:Fibronectin type-III 8,DOMAIN:Fibronectin type-III 9,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,MOTIF:PDZ-binding,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9H9B4	sideroflexin 1(SFXN1)	Homo sapiens			GO:0006730~one-carbon metabolic process,GO:0006826~iron ion transport,GO:0006865~amino acid transport,GO:0015808~L-alanine transport,GO:0015825~L-serine transport,GO:0030218~erythrocyte differentiation,GO:0034220~ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0015075~ion transmembrane transporter activity,GO:0015180~L-alanine transmembrane transporter activity,GO:0015194~L-serine transmembrane transporter activity,GO:0022889~serine transmembrane transporter activity,	IPR004686:Mtc,					KW-0029~Amino-acid transport,KW-0554~One-carbon metabolism,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,	TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSMEM:Helical,
Q5EA43	sideroflexin 2(SFXN2)	Bos taurus			GO:0006811~ion transport,GO:0006865~amino acid transport,GO:1990542~mitochondrial transmembrane transport,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0031966~mitochondrial membrane,	GO:0015075~ion transmembrane transporter activity,GO:0022889~serine transmembrane transporter activity,	IPR004686:Mtc,					KW-0029~Amino-acid transport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,KW-1000~Mitochondrion outer membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,	TRANSMEM:Helical,
Q9CUS9	signal peptide peptidase 3(Sppl3)	Mus musculus			GO:0006465~signal peptide processing,GO:0006508~proteolysis,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0032092~positive regulation of protein binding,GO:0033619~membrane protein proteolysis,GO:0035307~positive regulation of protein dephosphorylation,GO:0050852~T cell receptor signaling pathway,GO:0070886~positive regulation of calcineurin-NFAT signaling cascade,	GO:0005783~endoplasmic reticulum,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0031090~organelle membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043229~intracellular organelle,GO:0043231~intracellular membrane-bounded organelle,GO:0098553~lumenal side of endoplasmic reticulum membrane,GO:0098554~cytoplasmic side of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0016787~hydrolase activity,GO:0042500~aspartic endopeptidase activity, intramembrane cleaving,GO:0042803~protein homodimerization activity,	IPR006639:Preselin/SPP,IPR007369:Peptidase_A22B_SPP,				SM00730:PSN,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,		MOTIF:PAL,MUTAGEN:D->A: Does not inhibit NFAT-induced transcription activation.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q8IX30	signal peptide, CUB domain and EGF like domain containing 3(SCUBE3)	Homo sapiens			GO:0007165~signal transduction,GO:0030513~positive regulation of BMP signaling pathway,GO:0045669~positive regulation of osteoblast differentiation,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0036122~BMP binding,GO:0042802~identical protein binding,GO:0070700~BMP receptor binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR000859:CUB_dom,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR011641:Tyr-kin_ephrin_A/B_rcpt-like,IPR018097:EGF_Ca-bd_CS,IPR024731:EGF_dom,IPR026823:cEGF,IPR035914:Sperma_CUB_dom_sf,		619184~Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies,		SM00042:CUB,SM00179:EGF_CA,SM00181:EGF,SM01411:Ephrin_rec_like,		KW-0964~Secreted,		KW-0225~Disease variant,KW-0242~Dwarfism,	KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:CUB,DOMAIN:EGF-like 1; calcium-binding,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:EGF-like 9; calcium-binding,
O76094	signal recognition particle 72(SRP72)	Homo sapiens			GO:0006614~SRP-dependent cotranslational protein targeting to membrane,	GO:0005783~endoplasmic reticulum,GO:0005786~signal recognition particle, endoplasmic reticulum targeting,GO:0005829~cytosol,GO:0048500~signal recognition particle,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0005047~signal recognition particle binding,GO:0005515~protein binding,GO:0008312~7S RNA binding,GO:0030911~TPR domain binding,GO:0043022~ribosome binding,	IPR011990:TPR-like_helical_dom_sf,IPR013699:Signal_recog_part_SRP72_RNA-bd,IPR019734:TPR_repeat,IPR026270:SRP72,IPR031545:SRP72_TPR-like,	hsa03060:Protein export,	614675~Bone marrow failure syndrome 1,	PIRSF038922:SRP72,	SM00028:TPR,		KW-0256~Endoplasmic reticulum,KW-0733~Signal recognition particle,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0802~TPR repeat,		KW-0687~Ribonucleoprotein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Signal recognition particle SRP72 subunit RNA-binding,MUTAGEN:D->E: Reduced interaction with SRP68.,MUTAGEN:I->A: Loss of interaction with SRP72; when associated with A-598 in SRP68.,MUTAGEN:KK->AA: Diminished RNA binding.,MUTAGEN:KKKKKK->AAAAAA: Loss of RNA binding.,MUTAGEN:M->A: Does not affect RNA binding.,MUTAGEN:Missing: Loss of interaction with SRP68.,MUTAGEN:P->A: Strongly reduced RNA binding.,MUTAGEN:PM->AA: Diminished RNA binding.,MUTAGEN:RE->AA: Diminished RNA binding.,MUTAGEN:RG->AA: No impact on RNA binding.,MUTAGEN:RK->AA: No impact on RNA binding.,MUTAGEN:RS->AA: Loss of RNA binding.,MUTAGEN:V->I: Reduced interaction with SRP68.,MUTAGEN:V->I: Reduced interaction with SRP68. Diminished localization to endoplasmic reticulum.,MUTAGEN:VR->AA: Stronger interaction with SRP68.,MUTAGEN:WL->AA: Loss of RNA binding.,MUTAGEN:Y->C: Loss of interaction with SRP68. Diminished localization to endoplasmic reticulum.,MUTAGEN:YY->AA: Diminished RNA binding.,REGION:Disordered,REGION:RNA-binding,REGION:Required for interaction with SRP68,REGION:Required for the interaction with the SRP68/7SL RNA complex,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,
Q07984	signal sequence receptor subunit 4(Ssr4)	Rattus norvegicus				GO:0005783~endoplasmic reticulum,GO:0005784~Sec61 translocon complex,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,		IPR008855:TRAP-delta,	rno04141:Protein processing in endoplasmic reticulum,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q9UGK3	signal transducing adaptor family member 2(STAP2)	Homo sapiens				GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0035591~signaling adaptor activity,	IPR000980:SH2,IPR011993:PH-like_dom_sf,IPR035878:STAP2_SH2,IPR036860:SH2_dom_sf,IPR039111:STAP1/STAP2,						KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0727~SH2 domain,			KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,DOMAIN:PH,DOMAIN:SH2,MUTAGEN:Y->F: Decrease in tyrosine phosphorylation.,MUTAGEN:Y->F: Loss of tyrosine phosphorylation.,MUTAGEN:Y->F: Small decrease in tyrosine phosphorylation.,REGION:Disordered,
P0CD95	similar to human chromosome 17 open reading frame 67(C10h17orf67)	Rattus norvegicus				GO:0005576~extracellular region,		IPR027870:DUF4543,						KW-0964~Secreted,			KW-0732~Signal,				REGION:Disordered,
A7XYJ6	sine oculis binding protein homolog (Drosophila) b(sobpb)	Danio rerio			GO:0048513~animal organ development,	GO:0005634~nucleus,	GO:0046872~metal ion binding,	IPR026092:RAI2/SOBP,									KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,ZN_FING:FCS-type 1,ZN_FING:FCS-type 2,
Q9D032	single-stranded DNA binding protein 3(Ssbp3)	Mus musculus			GO:0002244~hematopoietic progenitor cell differentiation,GO:0008284~positive regulation of cell proliferation,GO:0021501~prechordal plate formation,GO:0021547~midbrain-hindbrain boundary initiation,GO:0030154~cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048382~mesendoderm development,GO:0060322~head development,GO:0060323~head morphogenesis,GO:0065003~macromolecular complex assembly,GO:2000744~positive regulation of anterior head development,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0032991~macromolecular complex,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR006594:LisH,IPR008116:SSDP_DNA-bd,				SM00667:LisH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:LisH,REGION:Disordered,
Q5XIS1	slingshot protein phosphatase 3(Ssh3)	Rattus norvegicus			GO:0016311~dephosphorylation,GO:0030036~actin cytoskeleton organization,GO:0030837~negative regulation of actin filament polymerization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0003779~actin binding,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0017018~myosin phosphatase activity,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR014876:DEK_C,IPR016130:Tyr_Pase_AS,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,IPR043587:Phosphatase_SSH-like,	rno04360:Axon guidance,rno04810:Regulation of actin cytoskeleton,			SM00195:DSPc,		KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DEK-C,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,REGION:Disordered,
O88279	slit guidance ligand 1(Slit1)	Rattus norvegicus			GO:0007097~nuclear migration,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0008045~motor neuron axon guidance,GO:0016043~cellular component organization,GO:0021510~spinal cord development,GO:0021772~olfactory bulb development,GO:0022028~tangential migration from the subventricular zone to the olfactory bulb,GO:0022029~telencephalon cell migration,GO:0030154~cell differentiation,GO:0031290~retinal ganglion cell axon guidance,GO:0033563~dorsal/ventral axon guidance,GO:0048812~neuron projection morphogenesis,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0048846~axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0051964~negative regulation of synapse assembly,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0048495~Roundabout binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000372:LRRNT,IPR000483:Cys-rich_flank_reg_C,IPR000742:EGF-like_dom,IPR001611:Leu-rich_rpt,IPR001791:Laminin_G,IPR001881:EGF-like_Ca-bd_dom,IPR003591:Leu-rich_rpt_typical-subtyp,IPR003645:Fol_N,IPR006207:Cys_knot_C,IPR009030:Growth_fac_rcpt_cys_sf,IPR013032:EGF-like_CS,IPR013320:ConA-like_dom_sf,IPR018097:EGF_Ca-bd_CS,IPR032675:LRR_dom_sf,	rno04360:Axon guidance,			SM00013:LRRNT,SM00041:CT,SM00082:LRRCT,SM00179:EGF_CA,SM00181:EGF,SM00274:FOLN,SM00282:LamG,SM00364:LRR_BAC,SM00365:LRR_SD22,SM00369:LRR_TYP,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:CTCK,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,DOMAIN:EGF-like 9,DOMAIN:LRRCT 1,DOMAIN:LRRCT 2,DOMAIN:LRRCT 3,DOMAIN:LRRCT 4,DOMAIN:LRRNT,DOMAIN:LRRNT 2,DOMAIN:LRRNT 3,DOMAIN:LRRNT 4,DOMAIN:Laminin G,DOMAIN:Laminin G-like,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 18,REPEAT:LRR 19,REPEAT:LRR 2,REPEAT:LRR 20,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
O88280	slit guidance ligand 3(Slit3)	Rattus norvegicus			GO:0003180~aortic valve morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0008285~negative regulation of cell proliferation,GO:0009887~animal organ morphogenesis,GO:0010629~negative regulation of gene expression,GO:0021510~spinal cord development,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,GO:0032870~cellular response to hormone stimulus,GO:0035385~Roundabout signaling pathway,GO:0048846~axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0051414~response to cortisol,GO:0060412~ventricular septum morphogenesis,GO:0061364~apoptotic process involved in luteolysis,GO:0070100~negative regulation of chemokine-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005509~calcium ion binding,GO:0008201~heparin binding,GO:0048495~Roundabout binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000372:LRRNT,IPR000483:Cys-rich_flank_reg_C,IPR000742:EGF-like_dom,IPR001611:Leu-rich_rpt,IPR001791:Laminin_G,IPR001881:EGF-like_Ca-bd_dom,IPR003591:Leu-rich_rpt_typical-subtyp,IPR006207:Cys_knot_C,IPR009030:Growth_fac_rcpt_cys_sf,IPR013320:ConA-like_dom_sf,IPR018097:EGF_Ca-bd_CS,IPR032675:LRR_dom_sf,	rno04360:Axon guidance,			SM00013:LRRNT,SM00041:CT,SM00082:LRRCT,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,SM00364:LRR_BAC,SM00365:LRR_SD22,SM00368:LRR_RI,SM00369:LRR_TYP,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:CTCK,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,DOMAIN:EGF-like 9,DOMAIN:LRRCT 1,DOMAIN:LRRCT 2,DOMAIN:LRRCT 3,DOMAIN:LRRCT 4,DOMAIN:LRRNT,DOMAIN:LRRNT 2,DOMAIN:LRRNT 3,DOMAIN:LRRNT 4,DOMAIN:Laminin G,DOMAIN:Laminin G-like,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 18,REPEAT:LRR 19,REPEAT:LRR 2,REPEAT:LRR 20,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
Q7T2D0	small G protein signaling modulator 3(sgsm3)	Danio rerio			GO:0090630~activation of GTPase activity,		GO:0005096~GTPase activator activity,	IPR000195:Rab-GAP-TBC_dom,IPR001452:SH3_domain,IPR004012:Run_dom,IPR035833:SGSM3_SH3,IPR035969:Rab-GAP_TBC_sf,IPR036028:SH3-like_dom_sf,IPR037213:Run_dom_sf,				SM00164:TBC,SM00326:SH3,SM00593:RUN,					KW-0175~Coiled coil,KW-0728~SH3 domain,				DOMAIN:RUN,DOMAIN:Rab-GAP TBC,DOMAIN:SH3,
Q96EQ0	small glutamine rich tetratricopeptide repeat co-chaperone beta(SGTB)	Homo sapiens			GO:0006620~posttranslational protein targeting to membrane,GO:0051260~protein homooligomerization,GO:0051291~protein heterooligomerization,	GO:0016020~membrane,GO:0072380~TRC complex,	GO:0005515~protein binding,GO:0030544~Hsp70 protein binding,GO:0042802~identical protein binding,GO:0060090~binding, bridging,	IPR001440:TPR_1,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR032374:SGTA_dimer,IPR047150:SGT,				SM00028:TPR,					KW-0677~Repeat,KW-0802~TPR repeat,		KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:SGTA homodimerisation,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,
Q2KIK3	small integral membrane protein 14(SMIM14)	Bos taurus				GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,		IPR000477:RT_dom,IPR020309:Uncharacterised_CD034/YQF4,IPR043502:DNA/RNA_pol_sf,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:Reverse transcriptase,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q8BP86	small nuclear RNA activating complex, polypeptide 4(Snapc4)	Mus musculus			GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0042796~snRNA transcription from RNA polymerase III promoter,	GO:0005634~nucleus,GO:0019185~snRNA-activating protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000995~transcription factor activity, core RNA polymerase III binding,GO:0001006~RNA polymerase III type 3 promoter sequence-specific DNA binding,GO:0003677~DNA binding,	IPR001005:SANT/Myb,IPR009057:Homeobox-like_sf,IPR017884:SANT_dom,IPR017930:Myb_dom,				SM00717:SANT,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DNA_BIND:H-T-H motif,DOMAIN:HTH myb-type,DOMAIN:HTH myb-type 1,DOMAIN:HTH myb-type 2,DOMAIN:HTH myb-type 3,DOMAIN:Myb-like,DOMAIN:Myb-like 1,DOMAIN:Myb-like 2,DOMAIN:SANT,REGION:Disordered,REGION:SNAPC2-binding,REGION:SNAPC5-binding,
P62315	small nuclear ribonucleoprotein D1(Snrpd1)	Mus musculus			GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005684~U2-type spliceosomal complex,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071005~U2-type precatalytic spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR027141:LSm4/Sm_D1/D3,IPR034102:Sm_D1,IPR047575:Sm,	mmu03040:Spliceosome,mmu05322:Systemic lupus erythematosus,			SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0687~Ribonucleoprotein,	KW-0488~Methylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Sm,REGION:Disordered,REGION:Required for interaction with SMN1,REGION:Sufficient for interaction with CLNS1A,
P62317	small nuclear ribonucleoprotein D2(Snrpd2)	Mus musculus			GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005684~U2-type spliceosomal complex,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030532~small nuclear ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071005~U2-type precatalytic spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR027248:Sm_D2,IPR047575:Sm,	mmu03040:Spliceosome,			SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Sm,REGION:Disordered,
P62309	small nuclear ribonucleoprotein polypeptide G(Snrpg)	Mus musculus			GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005684~U2-type spliceosomal complex,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034709~methylosome,GO:0034719~SMN-Sm protein complex,GO:0043186~P granule,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071004~U2-type prespliceosome,GO:0071005~U2-type precatalytic spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR034098:Sm_G,IPR044641:Lsm7/SmG-like,IPR047575:Sm,	mmu03040:Spliceosome,		PIRSF037188:U6_snRNA_Lsm7,	SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,		DOMAIN:Sm,
Q6GPW2	small ubiquitin-like modifier 2 S homeolog(sumo2.S)	Xenopus laevis				GO:0005634~nucleus,		IPR000626:Ubiquitin-like_dom,IPR022617:Rad60/SUMO-like_dom,IPR029071:Ubiquitin-like_domsf,	xla03013:Nucleocytoplasmic transport,			SM00213:UBQ,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,						KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DOMAIN:Ubiquitin-like,
P61959	small ubiquitin-like modifier 2(Sumo2)	Rattus norvegicus			GO:0008104~protein localization,GO:0016925~protein sumoylation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0033235~positive regulation of protein sumoylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0016605~PML body,	GO:0005515~protein binding,GO:0019789~SUMO transferase activity,GO:0031386~protein tag,GO:0031625~ubiquitin protein ligase binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0046965~retinoid X receptor binding,	IPR000626:Ubiquitin-like_dom,IPR022617:Rad60/SUMO-like_dom,IPR029071:Ubiquitin-like_domsf,	rno03013:Nucleocytoplasmic transport,rno05418:Fluid shear stress and atherosclerosis,			SM00213:UBQ,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,						KW-0007~Acetylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,CROSSLNK:Peptide (Met-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Rad60/SUMO-like,DOMAIN:Ubiquitin-like,
Q9Z172	small ubiquitin-like modifier 3(Sumo3)	Mus musculus		m_sumoPathway:Basic Mechanisms of SUMOylation,	GO:0016925~protein sumoylation,GO:0034504~protein localization to nucleus,GO:0043392~negative regulation of DNA binding,GO:1900180~regulation of protein localization to nucleus,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016604~nuclear body,GO:0016605~PML body,	GO:0019789~SUMO transferase activity,GO:0031386~protein tag,GO:0044389~ubiquitin-like protein ligase binding,	IPR000626:Ubiquitin-like_dom,IPR022617:Rad60/SUMO-like_dom,IPR029071:Ubiquitin-like_domsf,	mmu03013:Nucleocytoplasmic transport,mmu05418:Fluid shear stress and atherosclerosis,			SM00213:UBQ,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Rad60/SUMO-like,DOMAIN:Ubiquitin-like,REGION:Disordered,
P53814	smoothelin(SMTN)	Homo sapiens			GO:0006939~smooth muscle contraction,GO:0007517~muscle organ development,GO:0030036~actin cytoskeleton organization,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0031941~filamentous actin,	GO:0003779~actin binding,GO:0008307~structural constituent of muscle,	IPR001715:CH_dom,IPR022189:SMTN,IPR036872:CH_dom_sf,				SM00033:CH,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Calponin-homology (CH),DOMAIN:Smoothelin,REGION:Disordered,
Q5RH73	smoothened, frizzled class receptor(smo)	Danio rerio			GO:0001570~vasculogenesis,GO:0001839~neural plate morphogenesis,GO:0001933~negative regulation of protein phosphorylation,GO:0001947~heart looping,GO:0003231~cardiac ventricle development,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007224~smoothened signaling pathway,GO:0007389~pattern specification process,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007417~central nervous system development,GO:0007517~muscle organ development,GO:0009880~embryonic pattern specification,GO:0009952~anterior/posterior pattern specification,GO:0010002~cardioblast differentiation,GO:0014003~oligodendrocyte development,GO:0014033~neural crest cell differentiation,GO:0021508~floor plate formation,GO:0021520~spinal cord motor neuron cell fate specification,GO:0021522~spinal cord motor neuron differentiation,GO:0021523~somatic motor neuron differentiation,GO:0021536~diencephalon development,GO:0021537~telencephalon development,GO:0021587~cerebellum morphogenesis,GO:0021782~glial cell development,GO:0021798~forebrain dorsal/ventral pattern formation,GO:0021984~adenohypophysis development,GO:0021986~habenula development,GO:0030182~neuron differentiation,GO:0030239~myofibril assembly,GO:0030900~forebrain development,GO:0030902~hindbrain development,GO:0031016~pancreas development,GO:0031017~exocrine pancreas development,GO:0031018~endocrine pancreas development,GO:0031076~embryonic camera-type eye development,GO:0031290~retinal ganglion cell axon guidance,GO:0032474~otolith morphogenesis,GO:0035143~caudal fin morphogenesis,GO:0035270~endocrine system development,GO:0035479~angioblast cell migration from lateral mesoderm to midline,GO:0035912~dorsal aorta morphogenesis,GO:0042472~inner ear morphogenesis,GO:0042693~muscle cell fate commitment,GO:0043113~receptor clustering,GO:0045880~positive regulation of smoothened signaling pathway,GO:0048557~embryonic digestive tract morphogenesis,GO:0048663~neuron fate commitment,GO:0048702~embryonic neurocranium morphogenesis,GO:0048703~embryonic viscerocranium morphogenesis,GO:0048741~skeletal muscle fiber development,GO:0048745~smooth muscle tissue development,GO:0048752~semicircular canal morphogenesis,GO:0048794~swim bladder development,GO:0048795~swim bladder morphogenesis,GO:0048839~inner ear development,GO:0051216~cartilage development,GO:0055002~striated muscle cell development,GO:0060041~retina development in camera-type eye,GO:0060844~arterial endothelial cell fate commitment,GO:0060896~neural plate pattern specification,GO:0060956~endocardial cell differentiation,GO:0061053~somite development,GO:0071679~commissural neuron axon guidance,GO:0072175~epithelial tube formation,	GO:0005886~plasma membrane,GO:0005929~cilium,GO:0016020~membrane,GO:0030425~dendrite,GO:0042995~cell projection,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005113~patched binding,GO:0008142~oxysterol binding,GO:0034236~protein kinase A catalytic subunit binding,	IPR000539:Frizzled/Smoothened_7TM,IPR015526:Frizzled/SFRP,IPR017981:GPCR_2-like_7TM,IPR020067:Frizzled_dom,IPR035683:SMO_7TM,IPR036790:Frizzled_dom_sf,IPR041771:SMO_CRD,	dre04340:Hedgehog signaling pathway,			SM00063:FRI,SM01330:Frizzled,		KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:FZ,MUTAGEN:C->Y: In s294; reduced activity. Absence of muscle pioneer cells and reduced population of superficial slow fibers. Impaired intestinal lumen fusion, absence of differentiated smooth muscle surrounding the intestine, mislocalization of rab11a and increased expression of rab11 effector proteins.,MUTAGEN:G->R: In b641; recessive lethal mutation which results in reduced expression of nkx2.2 and ptch1, bulky U-shaped somites, ventral body curvature, reduced ventral forebrain and interocular distance, reduced dorsoventral extent of posterior diencephalon and spinal cord, poorly differentiated floor plate, abnormal pituitary development, deformation of the exocrine pancreas, loss of ptch1 expression in the otic vesicle, otic vesicle anterioposterior patterning defects, and elevated olig2 expression in cerebellar neurons.,MUTAGEN:R->L: In b577; recessive lethal mutation which shows defective anterior craniofacial development and small dysmorphic improperly looped hearts with reduced numbers of cardiac cells.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q56A07	sodium channel, voltage-gated, type II, beta(Scn2b)	Mus musculus			GO:0006811~ion transport,GO:0006814~sodium ion transport,GO:0007399~nervous system development,GO:0009408~response to heat,GO:0010467~gene expression,GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0046684~response to pyrethroid,GO:0060048~cardiac muscle contraction,GO:0060371~regulation of atrial cardiac muscle cell membrane depolarization,GO:0061337~cardiac conduction,GO:0086002~cardiac muscle cell action potential involved in contraction,GO:0086012~membrane depolarization during cardiac muscle cell action potential,GO:0086091~regulation of heart rate by cardiac conduction,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030315~T-tubule,GO:0034702~ion channel complex,	GO:0005248~voltage-gated sodium channel activity,GO:0005272~sodium channel activity,GO:0017080~sodium channel regulator activity,GO:0086006~voltage-gated sodium channel activity involved in cardiac muscle cell action potential,GO:1902282~voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,	IPR000920:Myelin_P0-rel,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00409:IG,	KW-0406~Ion transport,KW-0739~Sodium transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0915~Sodium,	KW-0407~Ion channel,KW-0851~Voltage-gated channel,KW-0894~Sodium channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain; with alpha subunit,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,REGION:Disordered,SITE:Binds SCN2A,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9WTU3	sodium channel, voltage-gated, type VIII, alpha(Scn8a)	Mus musculus			GO:0006811~ion transport,GO:0006814~sodium ion transport,GO:0007422~peripheral nervous system development,GO:0007517~muscle organ development,GO:0007605~sensory perception of sound,GO:0007626~locomotory behavior,GO:0007628~adult walking behavior,GO:0009636~response to toxic substance,GO:0019228~neuronal action potential,GO:0021554~optic nerve development,GO:0021675~nerve development,GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042552~myelination,GO:0050877~neurological system process,GO:0055085~transmembrane transport,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030018~Z disc,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0033268~node of Ranvier,GO:0034702~ion channel complex,GO:0034706~sodium channel complex,GO:0042995~cell projection,GO:0043025~neuronal cell body,GO:0043194~axon initial segment,GO:0048787~presynaptic active zone membrane,GO:0098688~parallel fiber to Purkinje cell synapse,GO:0098839~postsynaptic density membrane,GO:0098978~glutamatergic synapse,	GO:0000166~nucleotide binding,GO:0005216~ion channel activity,GO:0005248~voltage-gated sodium channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031402~sodium ion binding,GO:0046872~metal ion binding,	IPR000048:IQ_motif_EF-hand-BS,IPR001696:Na_channel_asu,IPR005821:Ion_trans_dom,IPR008054:Na_channel_a8su,IPR010526:Na_trans_assoc_dom,IPR024583:Na_trans_cytopl,IPR027359:Volt_channel_dom_sf,IPR043203:VGCC_Ca_Na,IPR044564:Na_chnl_inactivation_gate,				SM00015:IQ,	KW-0406~Ion transport,KW-0739~Sodium transport,KW-0813~Transport,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0915~Sodium,	KW-0407~Ion channel,KW-0851~Voltage-gated channel,KW-0894~Sodium channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DISULFID:Interchain; with SCN2B or SCN4B,DISULFID:Interchain; with the conotoxin GVIIJ (when the channel is not linked to SCN2B or SCN4B; the bond to SCN2B or SCN4B protects the channel from the inhibition by toxin),DOMAIN:IQ,DOMAIN:Ion transport,DOMAIN:Sodium ion transport-associated,DOMAIN:Voltage-gated Na+ ion channel cytoplasmic,INTRAMEM:Pore-forming,MUTAGEN:D->E: Decrease in sensitivity to the scorpion toxin BMK M1.,MUTAGEN:Q->A: Decreases interaction with CALM1 in the absence of calcium.,MUTAGEN:R->A: Decreases interaction with CALM1 in the absence of calcium.,MUTAGEN:R->A: Decreases interaction with CALM1 in the presence and absence of calcium and reduces rate of channel inactivation.,MUTAGEN:Y->A: Decreases interaction with CALM1 in the presence and absence of calcium and reduces rate of channel inactivation.,REGION:Disordered,REPEAT:I,REPEAT:II,REPEAT:III,REPEAT:IV,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=S1 of repeat I,TRANSMEM:Helical; Name=S1 of repeat II,TRANSMEM:Helical; Name=S1 of repeat III,TRANSMEM:Helical; Name=S1 of repeat IV,TRANSMEM:Helical; Name=S2 of repeat I,TRANSMEM:Helical; Name=S2 of repeat II,TRANSMEM:Helical; Name=S2 of repeat III,TRANSMEM:Helical; Name=S2 of repeat IV,TRANSMEM:Helical; Name=S3 of repeat I,TRANSMEM:Helical; Name=S3 of repeat II,TRANSMEM:Helical; Name=S3 of repeat III,TRANSMEM:Helical; Name=S3 of repeat IV,TRANSMEM:Helical; Name=S4 of repeat I,TRANSMEM:Helical; Name=S4 of repeat II,TRANSMEM:Helical; Name=S4 of repeat III,TRANSMEM:Helical; Name=S4 of repeat IV,TRANSMEM:Helical; Name=S5 of repeat I,TRANSMEM:Helical; Name=S5 of repeat II,TRANSMEM:Helical; Name=S5 of repeat III,TRANSMEM:Helical; Name=S5 of repeat IV,TRANSMEM:Helical; Name=S6 of repeat I,TRANSMEM:Helical; Name=S6 of repeat II,TRANSMEM:Helical; Name=S6 of repeat III,TRANSMEM:Helical; Name=S6 of repeat IV,
P53788	sodium voltage-gated channel beta subunit 1(SCN1B)	Oryctolagus cuniculus			GO:0006814~sodium ion transport,GO:0010765~positive regulation of sodium ion transport,GO:0060371~regulation of atrial cardiac muscle cell membrane depolarization,GO:0086002~cardiac muscle cell action potential involved in contraction,GO:0086091~regulation of heart rate by cardiac conduction,GO:1905152~positive regulation of voltage-gated sodium channel activity,	GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0030424~axon,GO:0043204~perikaryon,	GO:0005272~sodium channel activity,GO:0017080~sodium channel regulator activity,GO:0086062~voltage-gated sodium channel activity involved in Purkinje myocyte action potential,	IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR027098:Na_channel_b1/b3,IPR036179:Ig-like_dom_sf,	ocu04261:Adrenergic signaling in cardiomyocytes,				KW-0406~Ion transport,KW-0739~Sodium transport,KW-0813~Transport,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0915~Sodium,	KW-0407~Ion channel,KW-0851~Voltage-gated channel,KW-0894~Sodium channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q91V14	solute carrier family 12, member 5(Slc12a5)	Mus musculus			GO:0006811~ion transport,GO:0006813~potassium ion transport,GO:0006821~chloride transport,GO:0006884~cell volume homeostasis,GO:0006971~hypotonic response,GO:0007268~chemical synaptic transmission,GO:0007612~learning,GO:0009410~response to xenobiotic stimulus,GO:0030644~cellular chloride ion homeostasis,GO:0035264~multicellular organism growth,GO:0040040~thermosensory behavior,GO:0051452~intracellular pH reduction,GO:0055064~chloride ion homeostasis,GO:0055075~potassium ion homeostasis,GO:0055085~transmembrane transport,GO:0060996~dendritic spine development,GO:0071805~potassium ion transmembrane transport,GO:0072488~ammonium transmembrane transport,GO:1902476~chloride transmembrane transport,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0032590~dendrite membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0045202~synapse,GO:0071944~cell periphery,	GO:0008519~ammonium transmembrane transporter activity,GO:0015108~chloride transmembrane transporter activity,GO:0015293~symporter activity,GO:0015377~cation:chloride symporter activity,GO:0015379~potassium:chloride symporter activity,GO:0019901~protein kinase binding,GO:0022857~transmembrane transporter activity,GO:0046872~metal ion binding,	IPR000076:KCL_cotranspt,IPR004841:AA-permease/SLC12A_dom,IPR004842:SLC12A_fam,IPR018491:SLC12_C,	mmu04727:GABAergic synapse,				KW-0406~Ion transport,KW-0633~Potassium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0630~Potassium,KW-0868~Chloride,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Amino acid permease/ SLC12A,DOMAIN:SLC12A transporter C-terminal,MUTAGEN:EE->AA: Decreases endocytosis.,MUTAGEN:LL->AA: Inhibits endocytosis. Abolishes interaction with AP2A1.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Discontinuously helical,TRANSMEM:Helical,
Q0VGW6	solute carrier family 12, member 9 L homeolog(slc12a9.L)	Xenopus laevis			GO:0006811~ion transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0015377~cation:chloride symporter activity,GO:0022857~transmembrane transporter activity,	IPR004841:AA-permease/SLC12A_dom,IPR004842:SLC12A_fam,IPR018491:SLC12_C,					KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Amino acid permease/ SLC12A,DOMAIN:SLC12A transporter C-terminal,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q86YT5	solute carrier family 13 member 5(SLC13A5)	Homo sapiens			GO:0015729~oxaloacetate transport,GO:0015741~fumarate transport,GO:0015742~alpha-ketoglutarate transport,GO:0015744~succinate transport,GO:0015746~citrate transport,GO:0035674~tricarboxylic acid transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0055085~transmembrane transport,GO:0071285~cellular response to lithium ion,GO:0071422~succinate transmembrane transport,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005343~organic acid:sodium symporter activity,GO:0005515~protein binding,GO:0015137~citrate transmembrane transporter activity,GO:0015141~succinate transmembrane transporter activity,GO:0015370~solute:sodium symporter activity,GO:0017153~sodium:dicarboxylate symporter activity,GO:0042802~identical protein binding,	IPR001898:SLC13A/DASS,IPR031312:Na/sul_symport_CS,		615905~Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta,			KW-0406~Ion transport,KW-0739~Sodium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0986~Amelogenesis imperfecta,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0915~Sodium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:G->Q: No effect on its function in citrate transport.,MUTAGEN:I->A,F: Significant loss of function in citrate transport.,MUTAGEN:I->V: No effect on its function in citrate transport.,TRANSMEM:Helical,
B0S6T2	solute carrier family 15 member 2(slc15a2)	Danio rerio			GO:0001878~response to yeast,GO:0002376~immune system process,GO:0006857~oligopeptide transport,GO:0015031~protein transport,GO:0015833~peptide transport,GO:0015835~peptidoglycan transport,GO:0045087~innate immune response,GO:0055085~transmembrane transport,GO:0070424~regulation of nucleotide-binding oligomerization domain containing signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0030670~phagocytic vesicle membrane,	GO:0015293~symporter activity,GO:0015333~peptide:proton symporter activity,GO:0022857~transmembrane transporter activity,GO:0042937~tripeptide transporter activity,GO:0071916~dipeptide transmembrane transporter activity,	IPR000109:POT_fam,IPR018456:PTR2_symporter_CS,IPR036259:MFS_trans_sf,					KW-0391~Immunity,KW-0399~Innate immunity,KW-0571~Peptide transport,KW-0653~Protein transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,REGION:Extracellular domain (ECD),TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
B1AT66	solute carrier family 16 (monocarboxylic acid transporters), member 6(Slc16a6)	Mus musculus			GO:0015718~monocarboxylic acid transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,	GO:0005368~taurine transmembrane transporter activity,GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR011701:MFS,IPR020846:MFS_dom,IPR030766:MCT7,IPR036259:MFS_trans_sf,					KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	DOMAIN:Major facilitator superfamily (MFS) profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q7RTY1	solute carrier family 16 member 9(SLC16A9)	Homo sapiens			GO:0015718~monocarboxylic acid transport,GO:0015881~creatine transport,GO:0046415~urate metabolic process,GO:1902603~carnitine transmembrane transport,	GO:0005886~plasma membrane,	GO:0005308~creatine transmembrane transporter activity,GO:0005515~protein binding,GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015226~carnitine transmembrane transporter activity,GO:0015293~symporter activity,	IPR011701:MFS,IPR020846:MFS_dom,IPR030767:MCT9,IPR036259:MFS_trans_sf,					KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
Q3T9X0	solute carrier family 2 (facilitated glucose transporter), member 9(Slc2a9)	Mus musculus			GO:0015747~urate transport,GO:0015749~monosaccharide transport,GO:0015755~fructose transport,GO:0046415~urate metabolic process,GO:0055085~transmembrane transport,GO:1904659~glucose transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,	GO:0005353~fructose transmembrane transporter activity,GO:0005355~glucose transmembrane transporter activity,GO:0015143~urate transmembrane transporter activity,GO:0015149~hexose transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR003663:Sugar/inositol_transpt,IPR005828:MFS_sugar_transport-like,IPR005829:Sugar_transporter_CS,IPR020846:MFS_dom,IPR036259:MFS_trans_sf,IPR045263:GLUT,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Major facilitator superfamily (MFS) profile,MUTAGEN:N->Q: Decreased N-glycosylation.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,
Q6NWF1	solute carrier family 2 member 12(slc2a12)	Danio rerio			GO:0003179~heart valve morphogenesis,GO:0007507~heart development,GO:0008643~carbohydrate transport,GO:0044381~glucose import in response to insulin stimulus,GO:0055085~transmembrane transport,GO:0060047~heart contraction,GO:0072359~circulatory system development,GO:1904659~glucose transmembrane transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005355~glucose transmembrane transporter activity,GO:0015293~symporter activity,GO:0022857~transmembrane transporter activity,	IPR003663:Sugar/inositol_transpt,IPR005828:MFS_sugar_transport-like,IPR005829:Sugar_transporter_CS,IPR020846:MFS_dom,IPR036259:MFS_trans_sf,					KW-0762~Sugar transport,KW-0813~Transport,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9Z0E8	solute carrier family 22 (organic cation transporter), member 5(Slc22a5)	Mus musculus			GO:0006811~ion transport,GO:0006814~sodium ion transport,GO:0007005~mitochondrion organization,GO:0007512~adult heart development,GO:0007626~locomotory behavior,GO:0009437~carnitine metabolic process,GO:0009609~response to symbiotic bacterium,GO:0015697~quaternary ammonium group transport,GO:0015879~carnitine transport,GO:0034341~response to interferon-gamma,GO:0034612~response to tumor necrosis factor,GO:0048608~reproductive structure development,GO:0051649~establishment of localization in cell,GO:0055085~transmembrane transport,GO:0060731~positive regulation of intestinal epithelial structure maintenance,GO:0070715~sodium-dependent organic cation transport,GO:1900749~(R)-carnitine transport,GO:1902270~(R)-carnitine transmembrane transport,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0015101~organic cation transmembrane transporter activity,GO:0015199~amino-acid betaine transmembrane transporter activity,GO:0015226~carnitine transmembrane transporter activity,GO:0015293~symporter activity,GO:0015651~quaternary ammonium group transmembrane transporter activity,GO:0022857~transmembrane transporter activity,GO:0030165~PDZ domain binding,GO:1901235~(R)-carnitine transmembrane transporter activity,	IPR004749:Orgcat_transp/SVOP,IPR005828:MFS_sugar_transport-like,IPR005829:Sugar_transporter_CS,IPR020846:MFS_dom,IPR036259:MFS_trans_sf,IPR045915:S22A4/5,	mmu05231:Choline metabolism in cancer,				KW-0406~Ion transport,KW-0739~Sodium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,KW-0915~Sodium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Major facilitator superfamily (MFS) profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q66KG0	solute carrier family 22 member 16 L homeolog(slc22a16.L)	Xenopus laevis			GO:0006811~ion transport,GO:0055085~transmembrane transport,	GO:0016020~membrane,	GO:0022857~transmembrane transporter activity,	IPR005828:MFS_sugar_transport-like,IPR020846:MFS_dom,IPR036259:MFS_trans_sf,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Major facilitator superfamily (MFS) profile,TRANSMEM:Helical,
Q6NYN7	solute carrier family 22 member 6, like(slc22a6l)	Danio rerio			GO:0015711~organic anion transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,	GO:0008514~organic anion transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR005828:MFS_sugar_transport-like,IPR020846:MFS_dom,IPR036259:MFS_trans_sf,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:Major facilitator superfamily (MFS) profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
B0JZG0	solute carrier family 23 (ascorbic acid transporter), member 2(slc23a2)	Xenopus tropicalis			GO:0006811~ion transport,GO:0006814~sodium ion transport,GO:0007165~signal transduction,GO:0019852~L-ascorbic acid metabolic process,GO:0055085~transmembrane transport,GO:0071702~organic substance transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0098590~plasma membrane region,	GO:0005215~transporter activity,GO:0015229~L-ascorbic acid transporter activity,GO:0015293~symporter activity,GO:0022857~transmembrane transporter activity,	IPR000159:RA_dom,IPR006042:Xan_ur_permease,IPR006043:NCS2,IPR011524:SARAH_dom,IPR029071:Ubiquitin-like_domsf,IPR033614:RASSF1-6,IPR033618:RASSF2_RA,				SM00314:RA,	KW-0406~Ion transport,KW-0739~Sodium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0915~Sodium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ras-associating,DOMAIN:SARAH,REGION:Disordered,TRANSMEM:Helical,
Q9HC58	solute carrier family 24 member 3(SLC24A3)	Homo sapiens			GO:0006811~ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030282~bone mineralization,GO:0035725~sodium ion transmembrane transport,GO:0070588~calcium ion transmembrane transport,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0071944~cell periphery,	GO:0005262~calcium channel activity,GO:0008273~calcium, potassium:sodium antiporter activity,GO:0015293~symporter activity,	IPR004481:K/Na/Ca-exchanger,IPR004837:NaCa_Exmemb,IPR044880:NCX_ion-bd_dom_sf,					KW-0050~Antiport,KW-0109~Calcium transport,KW-0406~Ion transport,KW-0633~Potassium transport,KW-0739~Sodium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0630~Potassium,KW-0915~Sodium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,REGION:Disordered,REPEAT:Alpha-1,REPEAT:Alpha-2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9QZD8	solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10(Slc25a10)	Mus musculus			GO:0006094~gluconeogenesis,GO:0006817~phosphate ion transport,GO:0006839~mitochondrial transport,GO:0006869~lipid transport,GO:0008272~sulfate transport,GO:0015709~thiosulfate transport,GO:0015729~oxaloacetate transport,GO:0015743~malate transport,GO:0015744~succinate transport,GO:0035435~phosphate ion transmembrane transport,GO:0046166~glyceraldehyde-3-phosphate biosynthetic process,GO:0071422~succinate transmembrane transport,GO:0071423~malate transmembrane transport,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0031966~mitochondrial membrane,	GO:0005310~dicarboxylic acid transmembrane transporter activity,GO:0015114~phosphate ion transmembrane transporter activity,GO:0015116~sulfate transmembrane transporter activity,GO:0015117~thiosulfate transmembrane transporter activity,GO:0015131~oxaloacetate transmembrane transporter activity,GO:0015140~malate transmembrane transporter activity,GO:0015141~succinate transmembrane transporter activity,GO:0015291~secondary active transmembrane transporter activity,GO:0015297~antiporter activity,	IPR002030:Mit_uncoupling_UCP-like,IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,	mmu04964:Proximal tubule bicarbonate reclamation,				KW-0050~Antiport,KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,	REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
O43772	solute carrier family 25 member 20(SLC25A20)	Homo sapiens		h_cptPathway:Mitochondrial Carnitine Palmitoyltransferase (CPT) System,	GO:0001701~in utero embryonic development,GO:0006839~mitochondrial transport,GO:0006853~carnitine shuttle,GO:1902603~carnitine transmembrane transport,GO:1902616~acyl carnitine transmembrane transport,	GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0015227~acyl carnitine transmembrane transporter activity,	IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,	hsa04714:Thermogenesis,	212138~Carnitine-acylcarnitine translocase deficiency,			KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,	REPEAT:Solcar,REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Mitochondrial matrix,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q9H936	solute carrier family 25 member 22(SLC25A22)	Homo sapiens		h_rhodopsinPathway:Visual Signal Transduction,	GO:0006811~ion transport,GO:0015810~aspartate transport,GO:0015813~L-glutamate transport,GO:0043490~malate-aspartate shuttle,GO:0050796~regulation of insulin secretion,GO:0055085~transmembrane transport,GO:0070778~L-aspartate transport,GO:1902600~hydrogen ion transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0005280~hydrogen:amino acid symporter activity,GO:0005313~L-glutamate transmembrane transporter activity,GO:0015183~L-aspartate transmembrane transporter activity,	IPR002067:Mit_carrier,IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,		609304~Developmental and epileptic encephalopathy 3,			KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,		KW-0225~Disease variant,KW-0887~Epilepsy,	KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,REPEAT:Solcar,REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q66L49	solute carrier family 25 member 24(slc25a24)	Danio rerio			GO:0015866~ADP transport,GO:0015867~ATP transport,GO:0051503~adenine nucleotide transport,GO:0055085~transmembrane transport,GO:0071277~cellular response to calcium ion,GO:1990544~mitochondrial ATP transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0000295~adenine nucleotide transmembrane transporter activity,GO:0005347~ATP transmembrane transporter activity,GO:0005509~calcium ion binding,GO:0015297~antiporter activity,GO:0046872~metal ion binding,	IPR002048:EF_hand_dom,IPR002067:Mit_carrier,IPR002167:GDC-like,IPR011992:EF-hand-dom_pair,IPR018108:Mitochondrial_sb/sol_carrier,IPR018247:EF_Hand_1_Ca_BS,IPR023395:Mt_carrier_dom_sf,				SM00054:EFh,	KW-0050~Antiport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,			DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,REGION:C-terminal transmembrane transporter domain,REGION:Linker region,REGION:Regulatory N-terminal domain,REPEAT:Solcar,REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q5XGI1	solute carrier family 25 member 30(slc25a30)	Xenopus tropicalis			GO:0006839~mitochondrial transport,GO:0015698~inorganic anion transport,GO:0055085~transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0005452~inorganic anion exchanger activity,GO:0022857~transmembrane transporter activity,	IPR002030:Mit_uncoupling_UCP-like,IPR002067:Mit_carrier,IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,					KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REPEAT:Solcar,REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q6DG32	solute carrier family 25 member 36a(slc25a36a)	Danio rerio			GO:0000002~mitochondrial genome maintenance,GO:0055085~transmembrane transport,GO:1990519~mitochondrial pyrimidine nucleotide import,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0015218~pyrimidine nucleotide transmembrane transporter activity,	IPR002067:Mit_carrier,IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,					KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REPEAT:Solcar,REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q5U3V7	solute carrier family 25 member 43(slc25a43)	Danio rerio			GO:0055085~transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,		IPR002067:Mit_carrier,IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,					KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q8BGF9	solute carrier family 25, member 44(Slc25a44)	Mus musculus			GO:0006865~amino acid transport,GO:0009083~branched-chain amino acid catabolic process,GO:0015803~branched-chain amino acid transport,GO:0055085~transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0015658~branched-chain amino acid transmembrane transporter activity,	IPR002067:Mit_carrier,IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,IPR042164:SLC25A44,					KW-0029~Amino-acid transport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,REPEAT:Solcar,REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q5EBI0	solute carrier family 26, member 10(Slc26a10)	Mus musculus			GO:0055085~transmembrane transport,GO:0098661~inorganic anion transmembrane transport,	GO:0016020~membrane,GO:0016323~basolateral plasma membrane,	GO:0008509~anion transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015108~chloride transmembrane transporter activity,GO:0015116~sulfate transmembrane transporter activity,GO:0015297~antiporter activity,GO:0019531~oxalate transmembrane transporter activity,	IPR001902:SLC26A/SulP_fam,IPR002645:STAS_dom,IPR011547:SLC26A/SulP_dom,IPR036513:STAS_dom_sf,					KW-0050~Antiport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,			DOMAIN:STAS,REGION:Disordered,TRANSMEM:Helical,
Q8CIW6	solute carrier family 26, member 6(Slc26a6)	Mus musculus			GO:0006811~ion transport,GO:0006821~chloride transport,GO:0008272~sulfate transport,GO:0015701~bicarbonate transport,GO:0015724~formate transport,GO:0015797~mannitol transport,GO:0019532~oxalate transport,GO:0030321~transepithelial chloride transport,GO:0034220~ion transmembrane transport,GO:0038166~angiotensin-activated signaling pathway,GO:0042045~epithelial fluid transport,GO:0044849~estrous cycle,GO:0046724~oxalic acid secretion,GO:0048240~sperm capacitation,GO:0050892~intestinal absorption,GO:0051453~regulation of intracellular pH,GO:0051454~intracellular pH elevation,GO:0051649~establishment of localization in cell,GO:0055085~transmembrane transport,GO:0070528~protein kinase C signaling,GO:0070633~transepithelial transport,GO:0071320~cellular response to cAMP,GO:0071332~cellular response to fructose stimulus,GO:0071346~cellular response to interferon-gamma,GO:2001150~positive regulation of dipeptide transmembrane transport,	GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012506~vesicle membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031526~brush border membrane,GO:0031982~vesicle,GO:0034707~chloride channel complex,GO:0043231~intracellular membrane-bounded organelle,GO:0097225~sperm midpiece,	GO:0005254~chloride channel activity,GO:0005452~inorganic anion exchanger activity,GO:0005515~protein binding,GO:0008271~secondary active sulfate transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015108~chloride transmembrane transporter activity,GO:0015116~sulfate transmembrane transporter activity,GO:0015297~antiporter activity,GO:0015383~sulfate:bicarbonate antiporter activity,GO:0015499~formate transmembrane transporter activity,GO:0015562~efflux transmembrane transporter activity,GO:0019531~oxalate transmembrane transporter activity,GO:0030165~PDZ domain binding,GO:0042802~identical protein binding,	IPR001902:SLC26A/SulP_fam,IPR002645:STAS_dom,IPR011547:SLC26A/SulP_dom,IPR018045:S04_transporter_CS,IPR036513:STAS_dom_sf,	mmu04978:Mineral absorption,mmu05208:Chemical carcinogenesis - reactive oxygen species,				KW-0039~Anion exchange,KW-0050~Antiport,KW-0406~Ion transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SLC26A/SulP transporter,DOMAIN:STAS,MUTAGEN:T->A: Does not inhibit formate transport in PMA-induced cells.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9Y2P4	solute carrier family 27 member 6(SLC27A6)	Homo sapiens			GO:0000038~very long-chain fatty acid metabolic process,GO:0001676~long-chain fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0015909~long-chain fatty acid transport,GO:0044539~long-chain fatty acid import,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0042383~sarcolemma,	GO:0000166~nucleotide binding,GO:0004467~long-chain fatty acid-CoA ligase activity,GO:0005324~long-chain fatty acid transporter activity,GO:0015245~fatty acid transporter activity,GO:0031957~very long-chain fatty acid-CoA ligase activity,GO:0047676~arachidonate-CoA ligase activity,GO:1901480~oleate transporter activity,	IPR000873:AMP-dep_Synth/Lig_com,IPR020845:AMP-binding_CS,IPR025110:AMP-bd_C,IPR042099:ANL_N_sf,IPR045851:AMP-bd_C_sf,	hsa03320:PPAR signaling pathway,hsa04931:Insulin resistance,				KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0547~Nucleotide-binding,	KW-0436~Ligase,		DOMAIN:AMP-binding enzyme C-terminal,DOMAIN:AMP-dependent synthetase/ligase,TRANSMEM:Helical,
Q14542	solute carrier family 29 member 2(SLC29A2)	Homo sapiens			GO:0001504~neurotransmitter uptake,GO:0006836~neurotransmitter transport,GO:0006855~drug transmembrane transport,GO:0015851~nucleobase transport,GO:0015853~adenine transport,GO:0015854~guanine transport,GO:0015858~nucleoside transport,GO:0015860~purine nucleoside transmembrane transport,GO:0015861~cytidine transport,GO:0015862~uridine transport,GO:0032238~adenosine transport,GO:0035340~inosine transport,GO:0035344~hypoxanthine transport,GO:0035364~thymine transport,GO:0072531~pyrimidine-containing compound transmembrane transport,GO:1901642~nucleoside transmembrane transport,GO:1903716~guanine transmembrane transport,GO:1903791~uracil transmembrane transport,GO:1904823~purine nucleobase transmembrane transport,	GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,	GO:0005326~neurotransmitter transporter activity,GO:0005337~nucleoside transmembrane transporter activity,GO:0015205~nucleobase transmembrane transporter activity,GO:0015207~adenine transmembrane transporter activity,GO:0015208~guanine transmembrane transporter activity,GO:0015210~uracil transmembrane transporter activity,GO:0015211~purine nucleoside transmembrane transporter activity,GO:0015212~cytidine transmembrane transporter activity,GO:0015213~uridine transmembrane transporter activity,	IPR002259:Eqnu_transpt,IPR034764:ENT1/ENT2,IPR036259:MFS_trans_sf,	hsa05034:Alcoholism,		PIRSF016379:ENT,		KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:L->R: Reduces drastically localization at the cell surface and induces an significant reduction of adenosine or thymidine uptake; when associated with R-455.,MUTAGEN:L->R: Reduces drastically localization at the cell surface. No effect on uptake of adenosine and thymidine. Reduces drastically localization at the cell surface and induces an significant reduction of adenosine or thymidine uptake; when associated with R-456.,MUTAGEN:N->D: No difference in uridine or cytidine uptake. No differences in Km values and lower Vmax values for either uridine or cytidine uptake; when associated with D-48.,MUTAGEN:N->D: No difference in uridine or cytidine uptake. No differences in Km values and lower Vmax values for either uridine or cytidine uptake; when associated with D-57.,TRANSMEM:Helical,
Q5XHB4	solute carrier family 30 (zinc transporter), member 8(slc30a8)	Xenopus tropicalis			GO:0006811~ion transport,GO:0006812~cation transport,GO:0006829~zinc II ion transport,GO:0009749~response to glucose,GO:0010043~response to zinc ion,GO:0030073~insulin secretion,GO:0055085~transmembrane transport,GO:0071577~zinc II ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030658~transport vesicle membrane,GO:0030667~secretory granule membrane,GO:0031410~cytoplasmic vesicle,	GO:0005385~zinc ion transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,GO:0015297~antiporter activity,GO:0046872~metal ion binding,	IPR002524:Cation_efflux,IPR027469:Cation_efflux_TMD_sf,IPR036837:Cation_efflux_CTD_sf,					KW-0050~Antiport,KW-0406~Ion transport,KW-0813~Transport,KW-0864~Zinc transport,	KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,			BINDING:in chain A,BINDING:in chain B,MOTIF:HCH Motif; seals regulatory zinc-binding pocket,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal, vesicle,TRANSMEM:Helical,
Q6P0D1	solute carrier family 30 member 6(slc30a6)	Danio rerio			GO:0006811~ion transport,GO:0006812~cation transport,GO:0006829~zinc II ion transport,GO:0055085~transmembrane transport,GO:0071577~zinc II ion transmembrane transport,GO:1904257~zinc II ion import across Golgi membrane,	GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0032588~trans-Golgi network membrane,	GO:0005385~zinc ion transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,	IPR002524:Cation_efflux,IPR027469:Cation_efflux_TMD_sf,					KW-0406~Ion transport,KW-0813~Transport,KW-0864~Zinc transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0862~Zinc,			REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q27960	solute carrier family 34 member 2(SLC34A2)	Bos taurus			GO:0001701~in utero embryonic development,GO:0006817~phosphate ion transport,GO:0030643~cellular phosphate ion homeostasis,GO:0043627~response to estrogen,GO:0044341~sodium-dependent phosphate transport,	GO:0005903~brush border,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0031982~vesicle,	GO:0005436~sodium:phosphate symporter activity,GO:0031402~sodium ion binding,GO:0042301~phosphate ion binding,	IPR003841:Na/Pi_transpt,	bta04928:Parathyroid hormone synthesis, secretion and action,bta04978:Mineral absorption,				KW-0406~Ion transport,KW-0739~Sodium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0915~Sodium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=M1,TRANSMEM:Helical; Name=M2,TRANSMEM:Helical; Name=M3,TRANSMEM:Helical; Name=M4,TRANSMEM:Helical; Name=M5,TRANSMEM:Helical; Name=M6,TRANSMEM:Helical; Name=M7,TRANSMEM:Helical; Name=M8,
Q90X48	solute carrier family 35 member A5(slc35a5)	Danio rerio			GO:0008643~carbohydrate transport,GO:0055085~transmembrane transport,GO:0090481~pyrimidine nucleotide-sugar transmembrane transport,	GO:0000139~Golgi membrane,GO:0016020~membrane,	GO:0015165~pyrimidine nucleotide-sugar transmembrane transporter activity,GO:0015297~antiporter activity,GO:0022857~transmembrane transporter activity,	IPR007271:Nuc_sug_transpt,			PIRSF005799:UDP-gal_transpt,		KW-0050~Antiport,KW-0762~Sugar transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q2M3R5	solute carrier family 35 member G1(SLC35G1)	Homo sapiens			GO:0051480~regulation of cytosolic calcium ion concentration,GO:1990034~calcium ion export from cell,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,	IPR000620:EamA_dom,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:EamA,DOMAIN:EamA 1,DOMAIN:EamA 2,REGION:Disordered,TRANSMEM:Helical,
Q8VCX2	solute carrier family 35, member C2(Slc35c2)	Mus musculus			GO:0010629~negative regulation of gene expression,GO:0015786~UDP-glucose transport,GO:0036065~fucosylation,GO:0036066~protein O-linked fucosylation,GO:0045747~positive regulation of Notch signaling pathway,	GO:0005654~nucleoplasm,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0016020~membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0015297~antiporter activity,	IPR004853:Sugar_P_trans_dom,					KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Sugar phosphate transporter,REGION:Disordered,TRANSMEM:Helical,
Q8BZK4	solute carrier family 35, member F4(Slc35f4)	Mus musculus			GO:0055085~transmembrane transport,	GO:0016020~membrane,	GO:0022857~transmembrane transporter activity,	IPR000620:EamA_dom,IPR026505:Solute_c_fam_35_mem_F3/F4,					KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:EamA,REGION:Disordered,TRANSMEM:Helical,
Q7Z2H8	solute carrier family 36 member 1(SLC36A1)	Homo sapiens			GO:0006811~ion transport,GO:0006865~amino acid transport,GO:0015734~taurine transport,GO:0015808~L-alanine transport,GO:0015816~glycine transport,GO:0015824~proline transport,GO:0032328~alanine transport,GO:0035524~proline transmembrane transport,GO:0089718~amino acid import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,	GO:0005765~lysosomal membrane,GO:0005774~vacuolar membrane,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,	GO:0005280~hydrogen:amino acid symporter activity,GO:0005297~hydrogen:proline symporter activity,GO:0005368~taurine transmembrane transporter activity,GO:0005515~protein binding,GO:0015171~amino acid transmembrane transporter activity,GO:0015180~L-alanine transmembrane transporter activity,GO:0015187~glycine transmembrane transporter activity,GO:0015193~L-proline transmembrane transporter activity,GO:0022858~alanine transmembrane transporter activity,	IPR013057:AA_transpt_TM,	hsa04974:Protein digestion and absorption,				KW-0029~Amino-acid transport,KW-0769~Symport,KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Amino acid transporter transmembrane,MUTAGEN:C->A,S: Loss amino acid:proton symporter activity. No effect on localization to the plasma membrane.,MUTAGEN:C->A,S: No effect on amino acid:proton symporter activity. No effect on localization to the plasma membrane.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
O43826	solute carrier family 37 member 4(SLC37A4)	Homo sapiens			GO:0001780~neutrophil homeostasis,GO:0002318~myeloid progenitor cell differentiation,GO:0005977~glycogen metabolic process,GO:0006006~glucose metabolic process,GO:0006089~lactate metabolic process,GO:0006094~gluconeogenesis,GO:0006641~triglyceride metabolic process,GO:0006874~cellular calcium ion homeostasis,GO:0007584~response to nutrient,GO:0008202~steroid metabolic process,GO:0008643~carbohydrate transport,GO:0009749~response to glucose,GO:0014070~response to organic cyclic compound,GO:0015760~glucose-6-phosphate transport,GO:0030593~neutrophil chemotaxis,GO:0032682~negative regulation of chemokine production,GO:0035166~post-embryonic hemopoiesis,GO:0035435~phosphate ion transmembrane transport,GO:0042593~glucose homeostasis,GO:0042632~cholesterol homeostasis,GO:0045730~respiratory burst,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0031090~organelle membrane,	GO:0005515~protein binding,GO:0015152~glucose-6-phosphate transmembrane transporter activity,GO:0022857~transmembrane transporter activity,GO:0061513~glucose 6-phosphate:inorganic phosphate antiporter activity,	IPR000849:Sugar_P_transporter,IPR011701:MFS,IPR020846:MFS_dom,IPR021159:Sugar-P_transporter_CS,IPR036259:MFS_trans_sf,	hsa04973:Carbohydrate digestion and absorption,	232220~Glycogen storage disease Ib,232240~Glycogen storage disease Ic,619525~Congenital disorder of glycosylation, type IIw,	PIRSF002808:Hexose_phosphate_transp,		KW-0050~Antiport,KW-0762~Sugar transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,KW-0322~Glycogen storage disease,KW-0900~Congenital disorder of glycosylation,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:Major facilitator superfamily (MFS) profile,TRANSMEM:Helical,
Q6PEH9	solute carrier family 39 member 10(slc39a10)	Danio rerio			GO:0001837~epithelial to mesenchymal transition,GO:0006811~ion transport,GO:0006829~zinc II ion transport,GO:0010043~response to zinc ion,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,GO:0055113~epiboly involved in gastrulation with mouth forming second,GO:0071577~zinc II ion transmembrane transport,GO:0071578~zinc II ion transmembrane import,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,	GO:0005385~zinc ion transmembrane transporter activity,GO:0046873~metal ion transmembrane transporter activity,	IPR003689:ZIP,					KW-0406~Ion transport,KW-0813~Transport,KW-0864~Zinc transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0862~Zinc,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,REGION:Disordered,TRANSMEM:Helical,
L5KLU7	solute carrier family 39 member 4(SLC39A4)	Pteropus alecto			GO:0006882~cellular zinc ion homeostasis,GO:0071577~zinc II ion transmembrane transport,GO:0071578~zinc II ion transmembrane import,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0055038~recycling endosome membrane,	GO:0005385~zinc ion transmembrane transporter activity,GO:0042802~identical protein binding,	IPR003689:ZIP,IPR041137:ZIP4_N,IPR049406:ZIP4_12_EF-hand,	pale04978:Mineral absorption,pale05010:Alzheimer disease,pale05012:Parkinson disease,				KW-0406~Ion transport,KW-0813~Transport,KW-0864~Zinc transport,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	BINDING:M1 metal binding site,BINDING:M2 metal binding site,COMPBIAS:Basic and acidic residues,MOTIF:Essential for SLC39A4 endocytosis,REGION:Disordered,SITE:Essential role in Zn(2+) sensing,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,
Q9NUM3	solute carrier family 39 member 9(SLC39A9)	Homo sapiens			GO:0006882~cellular zinc ion homeostasis,GO:0007186~G-protein coupled receptor signaling pathway,GO:0070830~bicellular tight junction assembly,GO:0071577~zinc II ion transmembrane transport,GO:1905562~regulation of vascular endothelial cell proliferation,GO:2000654~regulation of cellular response to testosterone stimulus,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0031966~mitochondrial membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004930~G-protein coupled receptor activity,GO:0005385~zinc ion transmembrane transporter activity,GO:0005497~androgen binding,GO:0005515~protein binding,GO:0022883~zinc efflux transmembrane transporter activity,	IPR003689:ZIP,IPR045891:ZIP9,	hsa05010:Alzheimer disease,hsa05012:Parkinson disease,				KW-0406~Ion transport,KW-0813~Transport,KW-0864~Zinc transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0862~Zinc,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TRANSMEM:Helical,
P04920	solute carrier family 4 member 2(SLC4A2)	Homo sapiens			GO:0006820~anion transport,GO:0007283~spermatogenesis,GO:0015701~bicarbonate transport,GO:0030316~osteoclast differentiation,GO:0032956~regulation of actin cytoskeleton organization,GO:0043377~negative regulation of CD8-positive, alpha-beta T cell differentiation,GO:0045124~regulation of bone resorption,GO:0048565~digestive tract development,GO:0051453~regulation of intracellular pH,GO:0055085~transmembrane transport,GO:0070175~positive regulation of enamel mineralization,GO:0097186~amelogenesis,GO:0098660~inorganic ion transmembrane transport,GO:1902476~chloride transmembrane transport,GO:2000565~negative regulation of CD8-positive, alpha-beta T cell proliferation,	GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,	GO:0005452~inorganic anion exchanger activity,GO:0008509~anion transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0019899~enzyme binding,GO:0022853~active ion transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR001717:Anion_exchange,IPR002978:Anion_exchange_2,IPR003020:HCO3_transpt_euk,IPR011531:HCO3_transpt-like_TM_dom,IPR013769:Band3_cytoplasmic_dom,IPR016152:PTrfase/Anion_transptr,IPR018241:Anion_exchange_CS,	hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,	620366~Osteopetrosis, autosomal recessive 9,			KW-0039~Anion exchange,KW-0050~Antiport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0987~Osteopetrosis,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0488~Methylation,KW-0564~Palmitate,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Band 3 cytoplasmic,DOMAIN:Bicarbonate transporter-like transmembrane,LIPID:S-palmitoyl cysteine,REGION:Disordered,REGION:Membrane (anion exchange),TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6IR74	solute carrier family 44 (choline transporter), member 1 L homeolog(slc44a1.L)	Xenopus laevis			GO:0015871~choline transport,GO:0034229~ethanolamine transport,GO:0055085~transmembrane transport,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0015220~choline transmembrane transporter activity,GO:0015297~antiporter activity,GO:0022857~transmembrane transporter activity,GO:0034228~ethanolamine transmembrane transporter activity,	IPR007603:Choline_transptr-like,					KW-0050~Antiport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0519~Myristate,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5F4B8	solute carrier family 46 member 3(SLC46A3)	Gallus gallus			GO:0034486~vacuolar transmembrane transport,GO:1904613~cellular response to 2,3,7,8-tetrachlorodibenzodioxine,	GO:0005765~lysosomal membrane,GO:0016020~membrane,	GO:0005375~copper ion transmembrane transporter activity,GO:0015293~symporter activity,GO:0022857~transmembrane transporter activity,	IPR011701:MFS,IPR036259:MFS_trans_sf,					KW-0769~Symport,KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A1L1P9	solute carrier family 47 member 1(slc47a1)	Danio rerio			GO:0015695~organic cation transport,GO:0055085~transmembrane transport,GO:1990961~drug transmembrane export,	GO:0016020~membrane,GO:0016324~apical plasma membrane,	GO:0015101~organic cation transmembrane transporter activity,GO:0015297~antiporter activity,GO:0022857~transmembrane transporter activity,GO:0042910~xenobiotic transporter activity,	IPR002528:MATE_fam,IPR045069:MATE_euk,					KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A1L1P9	solute carrier family 47 member 2, tandem duplicate 1(slc47a2.1)	Danio rerio			GO:0015695~organic cation transport,GO:0055085~transmembrane transport,GO:1990961~drug transmembrane export,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,	GO:0015101~organic cation transmembrane transporter activity,GO:0015297~antiporter activity,GO:0022857~transmembrane transporter activity,GO:0042910~xenobiotic transporter activity,	IPR002528:MATE_fam,IPR045069:MATE_euk,					KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A8WHP3	solute carrier family 5 member 9(slc5a9)	Danio rerio			GO:0006811~ion transport,GO:0006814~sodium ion transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005412~glucose:sodium symporter activity,GO:0022857~transmembrane transporter activity,	IPR001734:Na/solute_symporter,IPR018212:Na/solute_symporter_CS,IPR038377:Na/Glc_symporter_sf,					KW-0406~Ion transport,KW-0739~Sodium transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0915~Sodium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
B0S5Y3	solute carrier family 52 member 3(slc52a3)	Danio rerio			GO:0032218~riboflavin transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0032217~riboflavin transporter activity,	IPR009357:Riboflavin_transptr,					KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
O88576	solute carrier family 6 (neurotransmitter transporter), member 18(Slc6a18)	Mus musculus			GO:0003333~amino acid transmembrane transport,GO:0006810~transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015804~neutral amino acid transport,GO:0035725~sodium ion transmembrane transport,GO:1990297~renal amino acid absorption,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,	GO:0005515~protein binding,GO:0015175~neutral amino acid transmembrane transporter activity,GO:0015293~symporter activity,	IPR000175:Na/ntran_symport,IPR002438:Neutral_aa_SLC6,IPR037272:SNS_sf,IPR042701:B0AT3_SLC6sbd,					KW-0029~Amino-acid transport,KW-0532~Neurotransmitter transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:D->K: No effect on protein abundance. Strong decreases of cell surface localization. Decreases alanine uptake.,MUTAGEN:D->N: Decreases protein abundance. Strong decreases of cell surface localization. Strong decreases on alanine uptake activity.,MUTAGEN:D->N: No effect on protein abundance. Increases localization to the cell membrane. Increases alanine uptake activity.,MUTAGEN:D->N: No effect on protein abundance. Strong decreases of cell surface localization. Decreases alanine uptake activity.,MUTAGEN:G->N: No effect on protein abundance. No effect on cell surface localization. No effect on alanine uptake activity.,MUTAGEN:G->R: No effect on protein abundance. Strong decreases of cell surface localization. Decreases alanine uptake activity.,MUTAGEN:G->S: No effect on protein abundance. No effect on cell surface expression. Decreases alanine uptake activity.,MUTAGEN:H->Y: No effect on protein abundance. No effect on cell surface localization. Increases alanine uptake activity.,MUTAGEN:I->T: No effect on protein abundance. No effect on cell surface localization. No effect on alanine uptake activity.,MUTAGEN:K->T: No effect on protein abundance. No effect on cell surface localization. No effect on alanine uptake activity.,MUTAGEN:L->P: No effect on protein abundance. No effect on cell surface localization. No effect on alanine uptake activity.,MUTAGEN:L->W: No effect on protein abundance. No effect on cell surface localization. Decreases alanine uptake activity.,MUTAGEN:M->C: No effect on protein abundance. No effect on cell surface localization. No effect on alanine uptake activity.,MUTAGEN:M->S: No effect on protein abundance. No effect on cell surface localization. No effect on alanine uptake activity.,MUTAGEN:N->D: No effect on protein abundance. Strong decreases of cell surface localization. Decreases alanine uptake.,MUTAGEN:Q->D: No effect on protein abundance. Almost complete loss of cell surface localization. Decreases alanine uptake activity.,MUTAGEN:Q->R: No effect on protein abundance. No effect on cell surface localization. No effect on alanine uptake activity.,MUTAGEN:Q->V: No effect on protein abundance. Strong decrease of cell surface localization. Decreases alanine uptake.,MUTAGEN:R->T: No effect on protein abundance. Strong decreases of cell surface localization. Decreases alanine uptake.,MUTAGEN:S->D: No effect on protein abundance. No effect on cell surface localization. No effect on alanine uptake activity.,MUTAGEN:S->R: No effect on protein abundance. Strong decreases of cell surface localization. Decreases alanine uptake activity.,MUTAGEN:Y->H: No effect on protein abundance. No effect on cell surface localization. No effect on alanine uptake activity.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
P48065	solute carrier family 6 member 12(SLC6A12)	Homo sapiens			GO:0003333~amino acid transmembrane transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015718~monocarboxylic acid transport,GO:0015812~gamma-aminobutyric acid transport,GO:0031460~glycine betaine transport,GO:0035725~sodium ion transmembrane transport,GO:0051936~gamma-aminobutyric acid reuptake,GO:0071702~organic substance transport,GO:0071705~nitrogen compound transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0042995~cell projection,GO:0098793~presynapse,	GO:0005332~gamma-aminobutyric acid:sodium symporter activity,GO:0005515~protein binding,GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015293~symporter activity,	IPR000175:Na/ntran_symport,IPR002983:Na/ntran_symport_betaine,IPR037272:SNS_sf,	hsa04721:Synaptic vesicle cycle,hsa04727:GABAergic synapse,				KW-0532~Neurotransmitter transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
P31646	solute carrier family 6 member 13(Slc6a13)	Rattus norvegicus			GO:0003333~amino acid transmembrane transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015718~monocarboxylic acid transport,GO:0015734~taurine transport,GO:0015812~gamma-aminobutyric acid transport,GO:0015881~creatine transport,GO:0035725~sodium ion transmembrane transport,GO:0051939~gamma-aminobutyric acid import,GO:0071705~nitrogen compound transport,GO:0089718~amino acid import across plasma membrane,	GO:0005886~plasma membrane,GO:0016323~basolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0042995~cell projection,	GO:0005283~sodium:amino acid symporter activity,GO:0005308~creatine transmembrane transporter activity,GO:0005332~gamma-aminobutyric acid:sodium symporter activity,GO:0005368~taurine transmembrane transporter activity,GO:0005369~taurine:sodium symporter activity,GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015185~gamma-aminobutyric acid transmembrane transporter activity,GO:0016597~amino acid binding,	IPR000175:Na/ntran_symport,IPR002981:Na/ntran_symport_GABA_GAT2,IPR037272:SNS_sf,	rno04721:Synaptic vesicle cycle,rno04727:GABAergic synapse,				KW-0532~Neurotransmitter transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
P23975	solute carrier family 6 member 2(SLC6A2)	Homo sapiens			GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0007268~chemical synaptic transmission,GO:0009410~response to xenobiotic stimulus,GO:0015844~monoamine transport,GO:0015874~norepinephrine transport,GO:0035725~sodium ion transmembrane transport,GO:0048265~response to pain,GO:0051583~dopamine uptake involved in synaptic transmission,GO:0051620~norepinephrine uptake,GO:0070050~neuron cellular homeostasis,GO:0071702~organic substance transport,GO:0071705~nitrogen compound transport,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0030424~axon,GO:0032809~neuronal cell body membrane,GO:0042734~presynaptic membrane,GO:0043005~neuron projection,	GO:0003779~actin binding,GO:0005326~neurotransmitter transporter activity,GO:0005328~neurotransmitter:sodium symporter activity,GO:0005330~dopamine:sodium symporter activity,GO:0005334~norepinephrine:sodium symporter activity,GO:0005515~protein binding,GO:0008504~monoamine transmembrane transporter activity,GO:0015293~symporter activity,GO:0022857~transmembrane transporter activity,GO:0043014~alpha-tubulin binding,GO:0046872~metal ion binding,GO:0048487~beta-tubulin binding,	IPR000175:Na/ntran_symport,IPR002435:Na/ntran_symport_noradrenaline,IPR037272:SNS_sf,	hsa04721:Synaptic vesicle cycle,	604715~Orthostatic intolerance,			KW-0532~Neurotransmitter transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0915~Sodium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
P28570	solute carrier family 6 member 8(Slc6a8)	Rattus norvegicus			GO:0006811~ion transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015812~gamma-aminobutyric acid transport,GO:0015871~choline transport,GO:0015881~creatine transport,GO:0030163~protein catabolic process,GO:0035725~sodium ion transmembrane transport,GO:0071705~nitrogen compound transport,GO:1990403~embryonic brain development,	GO:0005886~plasma membrane,GO:0016324~apical plasma membrane,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0098978~glutamatergic synapse,	GO:0005308~creatine transmembrane transporter activity,GO:0005309~creatine:sodium symporter activity,GO:0005332~gamma-aminobutyric acid:sodium symporter activity,GO:0015220~choline transmembrane transporter activity,	IPR000175:Na/ntran_symport,IPR002984:Na/ntran_symport_creatine,IPR037272:SNS_sf,					KW-0406~Ion transport,KW-0739~Sodium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0915~Sodium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
B0BMY1	solute carrier family 66 member 1(Slc66a1)	Rattus norvegicus			GO:0006865~amino acid transport,GO:0015819~lysine transport,GO:0080144~amino acid homeostasis,GO:1903401~L-lysine transmembrane transport,GO:1903826~arginine transmembrane transport,	GO:0005765~lysosomal membrane,GO:0016020~membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0015174~basic amino acid transmembrane transporter activity,GO:0015189~L-lysine transmembrane transporter activity,GO:0061459~L-arginine transmembrane transporter activity,	IPR006603:PQ-loop_rpt,	rno04148:Efferocytosis,			SM00679:CTNS,	KW-0029~Amino-acid transport,KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:PQ-loop 1,DOMAIN:PQ-loop 2,MOTIF:Di-leucine motif,MUTAGEN:LL->AA: Abolishes lysosomal localization.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q09143	solute carrier family 7 (cationic amino acid transporter, y+ system), member 1(Slc7a1)	Mus musculus			GO:0006865~amino acid transport,GO:0015807~L-amino acid transport,GO:0015819~lysine transport,GO:0015822~ornithine transport,GO:0032006~regulation of TOR signaling,GO:0042102~positive regulation of T cell proliferation,GO:0055085~transmembrane transport,GO:0089718~amino acid import across plasma membrane,GO:0097638~L-arginine import across plasma membrane,GO:1903352~L-ornithine transmembrane transport,GO:1903810~L-histidine import into cell,GO:1903826~arginine transmembrane transport,	GO:0005886~plasma membrane,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0032991~macromolecular complex,	GO:0000064~L-ornithine transmembrane transporter activity,GO:0001618~virus receptor activity,GO:0005290~L-histidine transmembrane transporter activity,GO:0005515~protein binding,GO:0015171~amino acid transmembrane transporter activity,GO:0015174~basic amino acid transmembrane transporter activity,GO:0015189~L-lysine transmembrane transporter activity,GO:0022857~transmembrane transporter activity,GO:0061459~L-arginine transmembrane transporter activity,	IPR002293:AA/rel_permease1,IPR004755:Cat_AA_permease,IPR029485:CAT_C,	mmu05206:MicroRNAs in cancer,		PIRSF006060:AA_transporter,		KW-0029~Amino-acid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cationic amino acid transporter C-terminal,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8BLQ7	solute carrier family 7 (cationic amino acid transporter, y+ system), member 4(Slc7a4)	Mus musculus			GO:0006865~amino acid transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0015171~amino acid transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR002293:AA/rel_permease1,IPR029485:CAT_C,			PIRSF006060:AA_transporter,		KW-0029~Amino-acid transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cationic amino acid transporter C-terminal,REGION:Disordered,TRANSMEM:Helical,
Q7YQK4	solute carrier family 7 member 5(SLC7A5)	Oryctolagus cuniculus			GO:0003333~amino acid transmembrane transport,GO:0015804~neutral amino acid transport,GO:0015823~phenylalanine transport,GO:0015827~tryptophan transport,GO:1904556~L-tryptophan transmembrane transport,	GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:1990184~amino acid transport complex,	GO:0015171~amino acid transmembrane transporter activity,GO:0015175~neutral amino acid transmembrane transporter activity,GO:0015179~L-amino acid transmembrane transporter activity,GO:0015190~L-leucine transmembrane transporter activity,GO:0015196~L-tryptophan transmembrane transporter activity,GO:0015297~antiporter activity,GO:0022857~transmembrane transporter activity,GO:0042605~peptide antigen binding,	IPR002293:AA/rel_permease1,IPR004760:L_AA_transporter,	ocu04150:mTOR signaling pathway,ocu05230:Central carbon metabolism in cancer,		PIRSF006060:AA_transporter,		KW-0029~Amino-acid transport,KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-1015~Disulfide bond,	DISULFID:Interchain (with C-210 in SLC3A2),MUTAGEN:C->S: No change to KM or Vmax for Phe.,MUTAGEN:C->S: No significant effect on inhibition by HgCl(2).,MUTAGEN:C->S: No significant effect on inhibition by HgCl(2). Decreased KM and Vmax for Phe. Similar affect on KM and Vmax for Phe; when associated with S-183.,MUTAGEN:C->S: No significant effect on inhibition by HgCl(2). Increased KM and Vmax for Phe.,MUTAGEN:C->S: No significant effect on inhibition by HgCl(2). Slightly decreased KM and Vmax for Phe.,MUTAGEN:C->S: No significant effect on inhibition by HgCl(2). Slightly decreased KM and Vmax for Phe. Similar affect on KM and Vmax for Phe; when associated with S-88. Slightly less decreased KM and Vmax for Phe; when associated with S-98.,MUTAGEN:C->S: No significant effect on inhibition by HgCl(2). Slightly decreased KM and Vmax for Phe. Slightly less decreased KM and Vmax for Phe; when associated with S-183.,MUTAGEN:C->S: No significant effect on inhibition by HgCl(2). Slightly increased KM but slightly decreased Vmax for Phe.,MUTAGEN:C->S: Prevents insertion into the plasma membrane and possibly protein folding.,MUTAGEN:G->D: Decreased KM and Vmax for Trp. Increased KM and Vmax for Phe; when associated with L-234.,MUTAGEN:W->L: Decreased KM and Vmax for Trp. Increased KM but decreased Vmax for Phe. Increased KM and Vmax for Phe; when associated with D-219.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q59I64	solute carrier family 7 member 6(slc7a6)	Danio rerio			GO:0003333~amino acid transmembrane transport,GO:0006809~nitric oxide biosynthetic process,GO:0006865~amino acid transport,GO:0015804~neutral amino acid transport,GO:0031460~glycine betaine transport,GO:0055085~transmembrane transport,GO:1903826~arginine transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0015179~L-amino acid transmembrane transporter activity,GO:0022857~transmembrane transporter activity,GO:0034618~arginine binding,GO:0061459~L-arginine transmembrane transporter activity,	IPR002293:AA/rel_permease1,			PIRSF006060:AA_transporter,		KW-0029~Amino-acid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P82251	solute carrier family 7 member 9(SLC7A9)	Homo sapiens			GO:0003333~amino acid transmembrane transport,GO:0015804~neutral amino acid transport,GO:0015811~L-cystine transport,GO:0065003~macromolecular complex assembly,GO:1902475~L-alpha-amino acid transmembrane transport,GO:1990822~basic amino acid transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,	GO:0005515~protein binding,GO:0015175~neutral amino acid transmembrane transporter activity,GO:0015184~L-cystine transmembrane transporter activity,GO:0015297~antiporter activity,GO:0022857~transmembrane transporter activity,GO:0042605~peptide antigen binding,GO:0046982~protein heterodimerization activity,	IPR002293:AA/rel_permease1,	hsa04974:Protein digestion and absorption,	220100~Cystinuria,	PIRSF006060:AA_transporter,		KW-0029~Amino-acid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0199~Cystinuria,KW-0225~Disease variant,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,DISULFID:Interchain (with C-114 in SLC3A1),MUTAGEN:C->S: Does not affect amino acid transport activity.,MUTAGEN:D->A: Complete loss of amino acid transport activity.,MUTAGEN:P->A,G,S,V: No effect on amino acid transport activity.,MUTAGEN:P->F,I,M,W: Decreased amino acid transport activity.,MUTAGEN:Q->A: Reduces amino acid transport activity.,MUTAGEN:S->A: Markedly reduces amino acid transport activity.,MUTAGEN:W->A: Abolishes amino acid transport activity.,MUTAGEN:W->A: Complete loss of amino acid transport activity.,MUTAGEN:Y->A: Loss of amino acid transport activity.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q86UD5	solute carrier family 9 member B2(SLC9B2)	Homo sapiens			GO:0006814~sodium ion transport,GO:0010351~lithium ion transport,GO:0030317~flagellated sperm motility,GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0055078~sodium ion homeostasis,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0072583~clathrin-dependent endocytosis,GO:1902600~hydrogen ion transmembrane transport,GO:2001206~positive regulation of osteoclast development,	GO:0005743~mitochondrial inner membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030672~synaptic vesicle membrane,GO:0031966~mitochondrial membrane,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0097228~sperm principal piece,	GO:0005515~protein binding,GO:0010348~lithium:proton antiporter activity,GO:0015297~antiporter activity,GO:0015385~sodium:proton antiporter activity,GO:0016491~oxidoreductase activity,GO:0042802~identical protein binding,	IPR002347:SDR_fam,IPR006153:Cation/H_exchanger,IPR020904:Sc_DH/Rdtase_CS,IPR036291:NAD(P)-bd_dom_sf,IPR038770:Na+/solute_symporter_sf,					KW-0050~Antiport,KW-0375~Hydrogen ion transport,KW-0406~Ion transport,KW-0739~Sodium transport,KW-0813~Transport,	KW-0282~Flagellum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0770~Synapse,KW-0966~Cell projection,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-0969~Cilium,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0520~NAD,KW-0915~Sodium,	KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Cation/H+ exchanger,MUTAGEN:A->E: Does not affect plasma membrane localization. Decreases Na(+) Li(+)/H(+) antiporter activity.,MUTAGEN:D->G: Abolishes Na(+) Li(+)/H(+) antiporter activity. Does not affect plasma membrane localization.,MUTAGEN:DD->CC: Loss of ion transport activity; Does not rescue insulin secretion defect induced by knockdown of SLC9B2 in Min6 cells.,MUTAGEN:E->A,K: Decreases Na(+) Li(+)/H(+) antiporter activity.,MUTAGEN:E->R: Abolishes Na(+) Li(+)/H(+) antiporter activity. Shifts the specificity of the transporter from Na(+) to Li(+); when associated with E-432. Decreases plasma membrane localization. Partially retained in the ER; when associated with E-432.,MUTAGEN:G->R: Abolishes Na(+) Li(+)/H(+) antiporter activity. Changes subcellular localization. Retained in the ER.,MUTAGEN:K->A: Does not affect Na(+) Li(+)/H(+) antiporter activity; when associated with A-58.,MUTAGEN:K->A: Does not affect tNa(+) Li(+)/H(+) antiporter activity; when associated with A-57.,MUTAGEN:K->E: Decreases Na(+) Li(+)/H(+) antiporter activity; when associated with K-57.,MUTAGEN:K->E: Decreases Na(+) Li(+)/H(+) antiporter activity; when associated with K-58.,MUTAGEN:K->E: Does not affect plasma membrane localization. Decreases the substrate specificity for Li(+).,MUTAGEN:P->A: Does not affect plasma membrane localization. Less sensitive to phloretin inhibition.,MUTAGEN:P->G: Does not affect plasma membrane localization. Abolishes antiporter activity. Less sensitive to phloretin inhibition.,MUTAGEN:P->S: Does not affect plasma membrane localization. Less sensitive to phloretin inhibition.,MUTAGEN:P->T: Does not affect plasma membrane localization. Less sensitive to phloretin inhibition.,MUTAGEN:R->E: Abolishes Na(+) Li(+)/H(+) antiporter activity. Shifts the specificity from Na(+) to Li(+); when associated with R-215. Decreases plasma membrane localization; when associated with R-215. Partially retained in the ER; when associated with R-215.,MUTAGEN:R->K,H: Loss of ion transport activity.,MUTAGEN:R->Q: Does not affect plasma membrane localization. Decreases the substrate specificity for Li(+).,MUTAGEN:V->L: Does not affect plasma membrane localization. Change in the substrate specificity with a preference for Li(+) over Na(+).,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=13,TRANSMEM:Helical; Name=14,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q9ERB5	solute carrier organic anion transporter family, member 1c1(Slco1c1)	Mus musculus			GO:0006811~ion transport,GO:0006869~lipid transport,GO:0015721~bile acid and bile salt transport,GO:0043252~sodium-independent organic anion transport,GO:0055085~transmembrane transport,GO:0070327~thyroid hormone transport,GO:2000611~positive regulation of thyroid hormone generation,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,	GO:0008514~organic anion transmembrane transporter activity,GO:0015125~bile acid transmembrane transporter activity,GO:0015347~sodium-independent organic anion transmembrane transporter activity,GO:0015349~thyroid hormone transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR002350:Kazal_dom,IPR004156:OATP,IPR020846:MFS_dom,IPR036058:Kazal_dom_sf,IPR036259:MFS_trans_sf,	mmu04919:Thyroid hormone signaling pathway,				KW-0406~Ion transport,KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Kazal-like,DOMAIN:Major facilitator superfamily (MFS) profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q8K078	solute carrier organic anion transporter family, member 4a1(Slco4a1)	Mus musculus			GO:0006811~ion transport,GO:0042403~thyroid hormone metabolic process,GO:0043252~sodium-independent organic anion transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,	GO:0008514~organic anion transmembrane transporter activity,GO:0015132~prostaglandin transmembrane transporter activity,GO:0015347~sodium-independent organic anion transmembrane transporter activity,GO:0015349~thyroid hormone transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR002350:Kazal_dom,IPR004156:OATP,IPR020846:MFS_dom,IPR036058:Kazal_dom_sf,IPR036259:MFS_trans_sf,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Kazal-like,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q32L50	somatomedin B and thrombospondin type 1 domain containing(SBSPON)	Bos taurus				GO:0005576~extracellular region,		IPR000884:TSP1_rpt,IPR001212:Somatomedin_B_dom,IPR036024:Somatomedin_B-like_dom_sf,IPR036383:TSP1_rpt_sf,IPR039942:SBSPO,IPR044004:TSP1_spondin_dom,						KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Alternate,DOMAIN:SMB,DOMAIN:TSP type-1,
Q5R4U9	sorcin(SRI)	Pongo abelii			GO:0006816~calcium ion transport,GO:0010459~negative regulation of heart rate,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0055118~negative regulation of cardiac muscle contraction,GO:0086004~regulation of cardiac muscle cell contraction,GO:1901077~regulation of relaxation of muscle,GO:1901844~regulation of cell communication by electrical coupling involved in cardiac conduction,	GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030018~Z disc,GO:0033017~sarcoplasmic reticulum membrane,GO:0042584~chromaffin granule membrane,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0005509~calcium ion binding,GO:0046982~protein heterodimerization activity,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,				SM00054:EFh,		KW-0472~Membrane,KW-0703~Sarcoplasmic reticulum,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,			DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,
Q6PHU5	sortilin 1(Sort1)	Mus musculus			GO:0001503~ossification,GO:0006622~protein targeting to lysosome,GO:0006895~Golgi to endosome transport,GO:0006897~endocytosis,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007275~multicellular organism development,GO:0008333~endosome to lysosome transport,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0010468~regulation of gene expression,GO:0014902~myotube differentiation,GO:0016050~vesicle organization,GO:0030154~cell differentiation,GO:0032509~endosome transport via multivesicular body sorting pathway,GO:0032868~response to insulin,GO:0045599~negative regulation of fat cell differentiation,GO:0046323~glucose import,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048227~plasma membrane to endosome transport,GO:0051005~negative regulation of lipoprotein lipase activity,GO:0090160~Golgi to lysosome transport,GO:0099558~maintenance of synapse structure,GO:1904037~positive regulation of epithelial cell apoptotic process,	GO:0005634~nucleus,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0030136~clathrin-coated vesicle,GO:0030140~trans-Golgi network transport vesicle,GO:0030425~dendrite,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031965~nuclear membrane,GO:0032580~Golgi cisterna membrane,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0010465~nerve growth factor receptor activity,GO:0019899~enzyme binding,GO:0030379~neurotensin receptor activity, non-G-protein coupled,GO:0048406~nerve growth factor binding,GO:1905394~retromer complex binding,	IPR006581:VPS10,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR031777:Sortilin_C,IPR031778:Sortilin_N,	mmu04142:Lysosome,mmu04722:Neurotrophin signaling pathway,mmu04979:Cholesterol metabolism,			SM00602:VPS10,	KW-0221~Differentiation,KW-0254~Endocytosis,KW-0813~Transport,KW-0892~Osteogenesis,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0539~Nucleus,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,LIPID:S-palmitoyl cysteine,MOTIF:DXXLL motif involved in the interaction with GGA1,MOTIF:Endocytosis signal,PROPEP:Removed in mature form,REGION:Disordered,REGION:Golgi to endosome transport and interactions with GGA1 and GGA2,REGION:Interactions with LRPAP1 and NGFB,REGION:Intrachain binding of the propeptide and the extracellular domain,REPEAT:BNR 1,REPEAT:BNR 2,REPEAT:BNR 3,REPEAT:BNR 4,REPEAT:BNR 5,REPEAT:BNR 6,REPEAT:BNR 7,REPEAT:BNR 8,REPEAT:BNR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6NUT7	sortilin 1a(sort1a)	Danio rerio			GO:0006895~Golgi to endosome transport,GO:0006897~endocytosis,GO:0016050~vesicle organization,GO:0071466~cellular response to xenobiotic stimulus,	GO:0005634~nucleus,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0032580~Golgi cisterna membrane,		IPR006581:VPS10,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR031777:Sortilin_C,IPR031778:Sortilin_N,	dre04142:Lysosome,			SM00602:VPS10,	KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0539~Nucleus,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:VPS10,LIPID:S-palmitoyl cysteine,MOTIF:Endocytosis signal,REGION:Disordered,REPEAT:BNR 1,REPEAT:BNR 2,REPEAT:BNR 3,REPEAT:BNR 4,REPEAT:BNR 5,REPEAT:BNR 6,REPEAT:BNR 7,REPEAT:BNR 8,REPEAT:BNR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6NUT7	sortilin 1b(sort1b)	Danio rerio			GO:0006895~Golgi to endosome transport,GO:0006897~endocytosis,GO:0016050~vesicle organization,GO:0071466~cellular response to xenobiotic stimulus,	GO:0005765~lysosomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0032580~Golgi cisterna membrane,		IPR006581:VPS10,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR031777:Sortilin_C,IPR031778:Sortilin_N,	dre04142:Lysosome,			SM00602:VPS10,	KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0539~Nucleus,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:VPS10,LIPID:S-palmitoyl cysteine,MOTIF:Endocytosis signal,REGION:Disordered,REPEAT:BNR 1,REPEAT:BNR 2,REPEAT:BNR 3,REPEAT:BNR 4,REPEAT:BNR 5,REPEAT:BNR 6,REPEAT:BNR 7,REPEAT:BNR 8,REPEAT:BNR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q99N27	sorting nexin 1(Snx1)	Rattus norvegicus			GO:0006886~intracellular protein transport,GO:0016197~endosomal transport,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031175~neuron projection development,GO:0031623~receptor internalization,GO:0034498~early endosome to Golgi transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0045732~positive regulation of protein catabolic process,GO:0072673~lamellipodium morphogenesis,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0030904~retromer complex,GO:0030905~retromer, tubulation complex,GO:0031901~early endosome membrane,GO:0031982~vesicle,GO:0032991~macromolecular complex,GO:0043197~dendritic spine,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0098793~presynapse,GO:0098999~extrinsic component of postsynaptic endosome membrane,GO:0099092~postsynaptic density, intracellular component,	GO:0005154~epidermal growth factor receptor binding,GO:0005158~insulin receptor binding,GO:0005515~protein binding,GO:0035091~phosphatidylinositol binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:1990459~transferrin receptor binding,GO:1990460~leptin receptor binding,	IPR001683:PX_dom,IPR005329:Sorting_nexin_N,IPR015404:Vps5_C,IPR027267:AH/BAR_dom_sf,IPR028660:SNX1_BAR,IPR034901:PX_SNX1,IPR036871:PX_dom_sf,	rno04144:Endocytosis,			SM00312:PX,	KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0966~Cell projection,KW-0967~Endosome,				KW-0446~Lipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:BAR,DOMAIN:PX,REGION:Disordered,REGION:Membrane-binding amphipathic helix,
Q7Z614	sorting nexin 20(SNX20)	Homo sapiens			GO:0015031~protein transport,	GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0031901~early endosome membrane,	GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:1901981~phosphatidylinositol phosphate binding,	IPR001683:PX_dom,IPR036871:PX_dom_sf,IPR039937:SNX20/SNX21,				SM00312:PX,	KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0967~Endosome,KW-1003~Cell membrane,				KW-0446~Lipid-binding,		KW-0597~Phosphoprotein,	DOMAIN:PX,MUTAGEN:R->Q: Decreased binding activity to all phospholipids.,REGION:Disordered,
Q96L94	sorting nexin 22(SNX22)	Homo sapiens			GO:0015031~protein transport,	GO:0030659~cytoplasmic vesicle membrane,	GO:0005515~protein binding,GO:0035091~phosphatidylinositol binding,GO:1901981~phosphatidylinositol phosphate binding,	IPR001683:PX_dom,IPR036871:PX_dom_sf,				SM00312:PX,	KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,			KW-0732~Signal,	KW-0446~Lipid-binding,			DOMAIN:PX,REGION:Disordered,
Q8WV41	sorting nexin 33(SNX33)	Homo sapiens			GO:0000281~mitotic cytokinesis,GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0007032~endosome organization,GO:0015031~protein transport,GO:0016197~endosomal transport,GO:0017038~protein import,GO:0036089~cleavage furrow formation,GO:0044351~macropinocytosis,GO:0045806~negative regulation of endocytosis,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0097320~plasma membrane tubulation,GO:2000009~negative regulation of protein localization to cell surface,GO:2000010~positive regulation of protein localization to cell surface,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,GO:0035091~phosphatidylinositol binding,GO:0042802~identical protein binding,	IPR001452:SH3_domain,IPR001683:PX_dom,IPR014536:Snx9_fam,IPR019497:Sorting_nexin_WASP-bd-dom,IPR027267:AH/BAR_dom_sf,IPR036028:SH3-like_dom_sf,IPR036871:PX_dom_sf,IPR037427:SNX33_BAR,	hsa05132:Salmonella infection,		PIRSF027744:Snx9,	SM00312:PX,SM00326:SH3,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0254~Endocytosis,KW-0498~Mitosis,KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0728~SH3 domain,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:BAR,DOMAIN:PX,DOMAIN:SH3,REGION:Disordered,
Q9Y5X2	sorting nexin 8(SNX8)	Homo sapiens			GO:0006886~intracellular protein transport,GO:0015031~protein transport,GO:0034498~early endosome to Golgi transport,GO:0042147~retrograde transport, endosome to Golgi,	GO:0005829~cytosol,GO:0016020~membrane,GO:0030904~retromer complex,GO:0031410~cytoplasmic vesicle,GO:0031901~early endosome membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0035091~phosphatidylinositol binding,GO:0042802~identical protein binding,	IPR001683:PX_dom,IPR027267:AH/BAR_dom_sf,IPR028662:SNX8/Mvp1,IPR035704:SNX8/Mvp1_PX,IPR036871:PX_dom_sf,IPR045734:Snx8_BAR_dom,				SM00312:PX,	KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0967~Endosome,				KW-0446~Lipid-binding,		KW-0597~Phosphoprotein,	DOMAIN:PX,REGION:Disordered,
Q99N27	sorting nexin-1-like(LOC102549158)	Rattus norvegicus			GO:0006886~intracellular protein transport,GO:0016197~endosomal transport,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031175~neuron projection development,GO:0031623~receptor internalization,GO:0034498~early endosome to Golgi transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0045732~positive regulation of protein catabolic process,GO:0072673~lamellipodium morphogenesis,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0030904~retromer complex,GO:0030905~retromer, tubulation complex,GO:0031901~early endosome membrane,GO:0031982~vesicle,GO:0032991~macromolecular complex,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,GO:0098793~presynapse,GO:0098999~extrinsic component of postsynaptic endosome membrane,GO:0099092~postsynaptic density, intracellular component,	GO:0005154~epidermal growth factor receptor binding,GO:0005158~insulin receptor binding,GO:0035091~phosphatidylinositol binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:1990459~transferrin receptor binding,GO:1990460~leptin receptor binding,	IPR001683:PX_dom,IPR005329:Sorting_nexin_N,IPR015404:Vps5_C,IPR027267:AH/BAR_dom_sf,IPR028660:SNX1_BAR,IPR034901:PX_SNX1,IPR036871:PX_dom_sf,				SM00312:PX,	KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0966~Cell projection,KW-0967~Endosome,				KW-0446~Lipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:BAR,DOMAIN:PX,REGION:Disordered,REGION:Membrane-binding amphipathic helix,
A6NEL2	sosondowah ankyrin repeat domain family member B(SOWAHB)	Homo sapiens					GO:0005515~protein binding,	IPR002110:Ankyrin_rpt,IPR036770:Ankyrin_rpt-contain_sf,				SM00248:ANK,					KW-0040~ANK repeat,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:ANK 1,REPEAT:ANK 2,
Q9NSC2	spalt like transcription factor 1(SALL1)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0003281~ventricular septum development,GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0008406~gonad development,GO:0021553~olfactory nerve development,GO:0021889~olfactory bulb interneuron differentiation,GO:0021983~pituitary gland development,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030325~adrenal gland development,GO:0031129~inductive cell-cell signaling,GO:0042733~embryonic digit morphogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048566~embryonic digestive tract development,GO:0060173~limb development,GO:0061034~olfactory bulb mitral cell layer development,GO:0072073~kidney epithelium development,GO:0072092~ureteric bud invasion,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0010369~chromocenter,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,		107480~Townes-Brocks branchiootorenal-like syndrome,107480~Townes-Brocks syndrome 1,		SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0209~Deafness,	KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 1; atypical,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q6ZWQ0	spectrin repeat containing, nuclear envelope 2(Syne2)	Mus musculus			GO:0007097~nuclear migration,GO:0021817~nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,GO:0030335~positive regulation of cell migration,GO:0031022~nuclear migration along microfilament,GO:0051641~cellular localization,GO:0051642~centrosome localization,GO:1902017~regulation of cilium assembly,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005640~nuclear outer membrane,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016529~sarcoplasmic reticulum,GO:0030016~myofibril,GO:0030018~Z disc,GO:0031258~lamellipodium membrane,GO:0031527~filopodium membrane,GO:0031965~nuclear membrane,GO:0031981~nuclear lumen,GO:0033017~sarcoplasmic reticulum membrane,GO:0034993~LINC complex,GO:0045111~intermediate filament cytoskeleton,	GO:0003779~actin binding,GO:0005515~protein binding,	IPR001589:Actinin_actin-bd_CS,IPR001715:CH_dom,IPR002017:Spectrin_repeat,IPR012315:KASH,IPR018159:Spectrin/alpha-actinin,IPR036872:CH_dom_sf,IPR039906:Anc-1-like,				SM00033:CH,SM00150:SPEC,SM01249:KASH,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0703~Sarcoplasmic reticulum,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DISULFID:Interchain (with C-577 in SUN2); alternate,DISULFID:Interchain (with C-759 in SUN1); alternate,DOMAIN:Calponin-homology (CH),DOMAIN:Calponin-homology (CH) 1,DOMAIN:Calponin-homology (CH) 2,DOMAIN:KASH,MUTAGEN:I->A: Impairs interaction with F-actin; when assocoated with A-128.,MUTAGEN:I->A: Impairs interaction with F-actin; when assocoated with A-131.,REGION:Actin-binding,REGION:Disordered,REGION:Sufficient for interaction with SUN2,REPEAT:Spectrin 1,REPEAT:Spectrin 10,REPEAT:Spectrin 11,REPEAT:Spectrin 12,REPEAT:Spectrin 13,REPEAT:Spectrin 14,REPEAT:Spectrin 15,REPEAT:Spectrin 16,REPEAT:Spectrin 17,REPEAT:Spectrin 18,REPEAT:Spectrin 19,REPEAT:Spectrin 2,REPEAT:Spectrin 20,REPEAT:Spectrin 21,REPEAT:Spectrin 22,REPEAT:Spectrin 23,REPEAT:Spectrin 24,REPEAT:Spectrin 25,REPEAT:Spectrin 26,REPEAT:Spectrin 27,REPEAT:Spectrin 28,REPEAT:Spectrin 29,REPEAT:Spectrin 3,REPEAT:Spectrin 30,REPEAT:Spectrin 31,REPEAT:Spectrin 32,REPEAT:Spectrin 33,REPEAT:Spectrin 34,REPEAT:Spectrin 35,REPEAT:Spectrin 36,REPEAT:Spectrin 37,REPEAT:Spectrin 38,REPEAT:Spectrin 39,REPEAT:Spectrin 4,REPEAT:Spectrin 40,REPEAT:Spectrin 41,REPEAT:Spectrin 42,REPEAT:Spectrin 43,REPEAT:Spectrin 44,REPEAT:Spectrin 45,REPEAT:Spectrin 46,REPEAT:Spectrin 47,REPEAT:Spectrin 48,REPEAT:Spectrin 49,REPEAT:Spectrin 5,REPEAT:Spectrin 50,REPEAT:Spectrin 51,REPEAT:Spectrin 52,REPEAT:Spectrin 53,REPEAT:Spectrin 54,REPEAT:Spectrin 55,REPEAT:Spectrin 56,REPEAT:Spectrin 6,REPEAT:Spectrin 7,REPEAT:Spectrin 8,REPEAT:Spectrin 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Perinuclear space,TRANSMEM:Helical; Anchor for type IV membrane protein,
Q2KN97	sperm antigen with calponin homology and coiled-coil domains 1 like(SPECC1L)	Gallus gallus			GO:0007049~cell cycle,GO:0030036~actin cytoskeleton organization,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005921~gap junction,GO:0031941~filamentous actin,	GO:0005515~protein binding,	IPR001715:CH_dom,IPR036872:CH_dom_sf,				SM00033:CH,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0206~Cytoskeleton,KW-0303~Gap junction,KW-0963~Cytoplasm,KW-0965~Cell junction,			KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Calponin-homology (CH),REGION:Disordered,
Q07617	sperm associated antigen 1(SPAG1)	Homo sapiens			GO:0007338~single fertilization,GO:0050821~protein stabilization,GO:0070286~axonemal dynein complex assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0101031~chaperone complex,	GO:0005525~GTP binding,GO:0016787~hydrolase activity,	IPR001440:TPR_1,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR025986:RPAP3-like_C,		615505~Ciliary dyskinesia, primary, 28,		SM00028:TPR,	KW-0278~Fertilization,	KW-0963~Cytoplasm,		KW-0990~Primary ciliary dyskinesia,KW-1012~Kartagener syndrome,KW-1186~Ciliopathy,	KW-0677~Repeat,KW-0802~TPR repeat,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
Q8N0X2	sperm associated antigen 16(SPAG16)	Homo sapiens			GO:0007288~sperm axoneme assembly,GO:0035082~axoneme assembly,GO:0060271~cilium assembly,GO:0090660~cerebrospinal fluid circulation,	GO:0005576~extracellular region,GO:0005930~axoneme,GO:0036126~sperm flagellum,GO:1990716~axonemal central apparatus,		IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,				SM00320:WD40,	KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0282~Flagellum,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q96N96	spermatogenesis associated 13(SPATA13)	Homo sapiens			GO:0016477~cell migration,GO:0030032~lamellipodium assembly,GO:0030334~regulation of cell migration,GO:0046847~filopodium assembly,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0032587~ruffle membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000219:DH-domain,IPR001452:SH3_domain,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR036028:SH3-like_dom_sf,	hsa04810:Regulation of actin cytoskeleton,			SM00233:PH,SM00325:RhoGEF,SM00326:SH3,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0728~SH3 domain,		KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DH,DOMAIN:PH,DOMAIN:SH3,REGION:ABR (APC-binding region) domain,REGION:C-terminal tail,REGION:Disordered,
Q8AXL1	spermidine/spermine N1-acetyltransferase 1(SAT1)	Gallus gallus			GO:0001525~angiogenesis,GO:0006596~polyamine biosynthetic process,GO:0009447~putrescine catabolic process,GO:0032918~spermidine acetylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004145~diamine N-acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0019809~spermidine binding,GO:0042802~identical protein binding,	IPR000182:GNAT_dom,IPR016181:Acyl_CoA_acyltransferase,	gga00330:Arginine and proline metabolism,gga01100:Metabolic pathways,gga04216:Ferroptosis,					KW-0963~Cytoplasm,					KW-0012~Acyltransferase,KW-0808~Transferase,		ACT_SITE:Proton donor,DOMAIN:N-acetyltransferase,
Q9NWM0	spermine oxidase(SMOX)	Homo sapiens			GO:0006596~polyamine biosynthetic process,GO:0006598~polyamine catabolic process,GO:0006805~xenobiotic metabolic process,GO:0046208~spermine catabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0016491~oxidoreductase activity,GO:0046592~polyamine oxidase activity,GO:0052894~norspermine:oxygen oxidoreductase activity,GO:0052895~N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,GO:0052901~spermine:oxygen oxidoreductase (spermidine-forming) activity,	IPR002937:Amino_oxidase,IPR036188:FAD/NAD-bd_sf,	hsa00330:Arginine and proline metabolism,hsa00410:beta-Alanine metabolism,hsa01100:Metabolic pathways,					KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Amine oxidase,MUTAGEN:C->R: No change in enzymatic activity.,REGION:Disordered,
Q92484	sphingomyelin phosphodiesterase acid like 3A(SMPDL3A)	Homo sapiens			GO:0009143~nucleoside triphosphate catabolic process,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008081~phosphoric diester hydrolase activity,GO:0008270~zinc ion binding,	IPR004843:Calcineurin-like_PHP_ApaH,IPR017064:ASM-like_Pdiesterase_prd,IPR029052:Metallo-depent_PP-like,IPR041805:ASMase/PPN1_MPP,IPR045473:ASM_C,			PIRSF036767:ASM-like_PDE,			KW-0964~Secreted,			KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,
O95977	sphingosine-1-phosphate receptor 4(S1PR4)	Homo sapiens			GO:0003376~sphingosine-1-phosphate signaling pathway,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0019222~regulation of metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005886~plasma membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0038036~sphingosine-1-phosphate receptor activity,	IPR000276:GPCR_Rhodpsn,IPR004061:S1P_rcpt,IPR004064:EDG6_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,LIPID:S-palmitoyl cysteine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q6DHG8	spindle and kinetochore associated complex subunit 1(ska1)	Danio rerio			GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0072686~mitotic spindle,	GO:0008017~microtubule binding,	IPR009829:SKA1,IPR042031:SKA1-MBD,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0995~Kinetochore,			KW-0175~Coiled coil,				COMPBIAS:Polar residues,REGION:Disordered,REGION:Microtubule binding,
Q58EL7	spindle and kinetochore associated complex subunit 3(ska3)	Danio rerio			GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,	GO:0008017~microtubule binding,	IPR033341:SKA3,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0995~Kinetochore,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q90WG1	spindlin 1(SPIN1)	Gallus gallus			GO:0007049~cell cycle,GO:0007276~gamete generation,	GO:0005634~nucleus,		IPR003671:SPIN/Ssty,IPR042567:SPIN/Ssty_sf,					KW-0131~Cell cycle,	KW-0539~Nucleus,							REGION:Disordered,
Q8R5B6	splA/ryanodine receptor domain and SOCS box containing 4(Spsb4)	Mus musculus			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,GO:0042752~regulation of circadian rhythm,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048511~rhythmic process,GO:1902916~positive regulation of protein polyubiquitination,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,	GO:0005515~protein binding,GO:1990756~protein binding, bridging involved in substrate recognition for ubiquitination,	IPR001496:SOCS_box,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR013320:ConA-like_dom_sf,IPR036036:SOCS_box-like_dom_sf,IPR043136:B30.2/SPRY_sf,				SM00449:SPRY,SM00969:SOCS_box,	KW-0090~Biological rhythms,KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,							DOMAIN:B30.2/SPRY,DOMAIN:SOCS box,
P43405	spleen associated tyrosine kinase(SYK)	Homo sapiens	74.CD47-IAP_with_avB3,	h_bcrPathway:BCR Signaling Pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,	GO:0001525~angiogenesis,GO:0001775~cell activation,GO:0001945~lymph vessel development,GO:0002092~positive regulation of receptor internalization,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002250~adaptive immune response,GO:0002281~macrophage activation involved in immune response,GO:0002283~neutrophil activation involved in immune response,GO:0002366~leukocyte activation involved in immune response,GO:0002554~serotonin secretion by platelet,GO:0002696~positive regulation of leukocyte activation,GO:0002862~negative regulation of inflammatory response to antigenic stimulus,GO:0006468~protein phosphorylation,GO:0006606~protein import into nucleus,GO:0007159~leukocyte cell-cell adhesion,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0009887~animal organ morphogenesis,GO:0010543~regulation of platelet activation,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019370~leukotriene biosynthetic process,GO:0019722~calcium-mediated signaling,GO:0030154~cell differentiation,GO:0030168~platelet activation,GO:0030183~B cell differentiation,GO:0030593~neutrophil chemotaxis,GO:0031334~positive regulation of protein complex assembly,GO:0031623~receptor internalization,GO:0032481~positive regulation of type I interferon production,GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production,GO:0032733~positive regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0032752~positive regulation of interleukin-3 production,GO:0032753~positive regulation of interleukin-4 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032765~positive regulation of mast cell cytokine production,GO:0032928~regulation of superoxide anion generation,GO:0032930~positive regulation of superoxide anion generation,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0035556~intracellular signal transduction,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038156~interleukin-3-mediated signaling pathway,GO:0042492~gamma-delta T cell differentiation,GO:0042742~defense response to bacterium,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043303~mast cell degranulation,GO:0043306~positive regulation of mast cell degranulation,GO:0043313~regulation of neutrophil degranulation,GO:0043366~beta selection,GO:0043410~positive regulation of MAPK cascade,GO:0045087~innate immune response,GO:0045579~positive regulation of B cell differentiation,GO:0045588~positive regulation of gamma-delta T cell differentiation,GO:0045780~positive regulation of bone resorption,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0048514~blood vessel morphogenesis,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050764~regulation of phagocytosis,GO:0050778~positive regulation of immune response,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050853~B cell receptor signaling pathway,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051712~positive regulation of killing of cells of other organism,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0071226~cellular response to molecule of fungal origin,GO:0071396~cellular response to lipid,GO:0071404~cellular response to low-density lipoprotein particle stimulus,GO:0071639~positive regulation of monocyte chemotactic protein-1 production,GO:0090237~regulation of arachidonic acid secretion,GO:0090330~regulation of platelet aggregation,GO:1904263~positive regulation of TORC1 signaling,GO:1990858~cellular response to lectin,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0019815~B cell receptor complex,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0032009~early phagosome,GO:0032991~macromolecular complex,GO:0042101~T cell receptor complex,	GO:0001784~phosphotyrosine binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016170~interleukin-15 receptor binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,GO:0035325~Toll-like receptor binding,GO:0042169~SH2 domain binding,GO:0043274~phospholipase binding,GO:0097110~scaffold protein binding,	IPR000719:Prot_kinase_dom,IPR000980:SH2,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR012234:Tyr_kinase_non-rcpt_SYK/ZAP70,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR023420:Kinase_SYK/ZAP-70_inter-SH2_sf,IPR035838:SYK/ZAP-70_N_SH2,IPR036860:SH2_dom_sf,	hsa04064:NF-kappa B signaling pathway,hsa04072:Phospholipase D signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04380:Osteoclast differentiation,hsa04611:Platelet activation,hsa04613:Neutrophil extracellular trap formation,hsa04625:C-type lectin receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa05152:Tuberculosis,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05168:Herpes simplex virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05171:Coronavirus disease - COVID-19,hsa05203:Viral carcinogenesis,	619381~Immunodeficiency 82 with systemic inflammation,	PIRSF000604:TyrPK_SYK,	SM00219:TyrKc,SM00252:SH2,	KW-0037~Angiogenesis,KW-0391~Immunity,KW-0399~Innate immunity,KW-0945~Host-virus interaction,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0727~SH2 domain,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,DOMAIN:SH2,DOMAIN:SH2 1,DOMAIN:SH2 2,MUTAGEN:S->A: Abolishes YWHAG binding.,MUTAGEN:Y->F: Loss of interaction with BLNK.,REGION:Interdomain A,REGION:Interdomain B,
Q9BWJ5	splicing factor 3b subunit 5(SF3B5)	Homo sapiens			GO:0000398~mRNA splicing, via spliceosome,GO:0006282~regulation of DNA repair,GO:0043484~regulation of RNA splicing,GO:0045893~positive regulation of transcription, DNA-templated,GO:1903241~U2-type prespliceosome assembly,	GO:0000124~SAGA complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0071005~U2-type precatalytic spliceosome,GO:0071011~precatalytic spliceosome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:1990935~splicing factor binding,	IPR009846:SF3b5/RDS3-10,IPR017089:Splicing_factor_3B_subunit_5,	hsa03040:Spliceosome,		PIRSF037010:Splicing_factor_3B_subunit_5,		KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,					KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Interaction with SF3B1 and SF3B3,SITE:Interaction with RNA,
Q1LVE8	splicing factor 3b, subunit 3(sf3b3)	Danio rerio			GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,GO:0071005~U2-type precatalytic spliceosome,	GO:0003676~nucleic acid binding,GO:0030620~U2 snRNA binding,	IPR004871:Cleavage/polyA-sp_fac_asu_C,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR018846:Cleavage/polyA-sp_fac_asu_N,IPR036322:WD40_repeat_dom_sf,	dre03040:Spliceosome,				KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,
Q5RDN2	sprouty related EVH1 domain containing 2(SPRED2)	Pongo abelii			GO:0007275~multicellular organism development,GO:0009966~regulation of signal transduction,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0043409~negative regulation of MAPK cascade,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:1902747~negative regulation of lens fiber cell differentiation,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030658~transport vesicle membrane,	GO:0019901~protein kinase binding,	IPR000697:WH1/EVH1_dom,IPR007875:Sprouty,IPR011993:PH-like_dom_sf,IPR023337:KBD,IPR041937:SPRE_EVH1,				SM00461:WH1,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,						KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:KBD,DOMAIN:SPR,DOMAIN:WH1,REGION:Disordered,
O76061	stanniocalcin 2(STC2)	Homo sapiens			GO:0006874~cellular calcium ion homeostasis,GO:0006979~response to oxidative stress,GO:0007566~embryo implantation,GO:0010629~negative regulation of gene expression,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0033280~response to vitamin D,GO:0040015~negative regulation of multicellular organism growth,GO:0043434~response to peptide hormone,GO:0046697~decidualization,GO:0046885~regulation of hormone biosynthetic process,GO:0071456~cellular response to hypoxia,GO:2001256~regulation of store-operated calcium entry,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0048471~perinuclear region of cytoplasm,	GO:0005179~hormone activity,GO:0019899~enzyme binding,GO:0020037~heme binding,GO:0042803~protein homodimerization activity,	IPR004978:Stanniocalcin,						KW-0964~Secreted,			KW-0732~Signal,		KW-0372~Hormone,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q7ZT42	staphylococcal nuclease and tudor domain containing 1(snd1)	Danio rerio			GO:0006402~mRNA catabolic process,GO:0031047~gene silencing by RNA,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016442~RISC complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004521~endoribonuclease activity,GO:0016894~endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,	IPR002071:Thermonucl_AS,IPR002999:Tudor,IPR016071:Staphylococal_nuclease_OB-fold,IPR016685:Silence_cplx_Nase-comp_TudorSN,IPR035437:SNase_OB-fold_sf,IPR047386:Tudor_TDRD11,			PIRSF017179:RISC-Tudor-SN,	SM00318:SNc,SM00333:TUDOR,		KW-0963~Cytoplasm,			KW-0677~Repeat,				DOMAIN:TNase-like,DOMAIN:TNase-like 1,DOMAIN:TNase-like 2,DOMAIN:TNase-like 3,DOMAIN:TNase-like 4,DOMAIN:Tudor,
P63043	stathmin 4(Stmn4)	Rattus norvegicus			GO:0007019~microtubule depolymerization,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0031175~neuron projection development,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0030426~growth cone,GO:0043005~neuron projection,	GO:0015631~tubulin binding,	IPR000956:Stathmin_fam,IPR030514:Stathmin_CS,IPR036002:Stathmin_sf,			PIRSF002285:Stathmin,			KW-0333~Golgi apparatus,KW-0966~Cell projection,			KW-0175~Coiled coil,			KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:SLD,LIPID:S-palmitoyl cysteine,REGION:Disordered,
O95793	staufen double-stranded RNA binding protein 1(STAU1)	Homo sapiens			GO:0007281~germ cell development,GO:0008298~intracellular mRNA localization,GO:0034599~cellular response to oxidative stress,GO:0035418~protein localization to synapse,GO:0045070~positive regulation of viral genome replication,GO:0046726~positive regulation by virus of viral protein levels in host cell,GO:0098964~anterograde dendritic transport of messenger ribonucleoprotein complex,GO:0099010~modification of postsynaptic structure,GO:1900273~positive regulation of long-term synaptic potentiation,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005791~rough endoplasmic reticulum,GO:0005829~cytosol,GO:0005875~microtubule associated complex,GO:0005886~plasma membrane,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030425~dendrite,GO:0032839~dendrite cytoplasm,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0044297~cell body,GO:0070062~extracellular exosome,GO:0098978~glutamatergic synapse,GO:1990124~messenger ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008157~protein phosphatase 1 binding,	IPR014720:dsRBD_dom,IPR032478:Staufen_C,IPR044475:STAU1_DSRM_3,				SM00358:DSRM,	KW-0945~Host-virus interaction,	KW-0256~Endoplasmic reticulum,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0732~Signal,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:DRBM,DOMAIN:DRBM 1,DOMAIN:DRBM 2,DOMAIN:DRBM 3,REGION:Disordered,
Q96LT4	sterile alpha motif domain containing 8(SAMD8)	Homo sapiens			GO:0006665~sphingolipid metabolic process,GO:0006686~sphingomyelin biosynthetic process,GO:0030148~sphingolipid biosynthetic process,GO:0046513~ceramide biosynthetic process,GO:1905373~ceramide phosphoethanolamine biosynthetic process,GO:2000303~regulation of ceramide biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,	GO:0002950~ceramide phosphoethanolamine synthase activity,GO:0016780~phosphotransferase activity, for other substituted phosphate groups,GO:0033188~sphingomyelin synthase activity,GO:0047493~ceramide cholinephosphotransferase activity,	IPR001660:SAM,IPR013761:SAM/pointed_sf,IPR025749:Sphingomyelin_synth-like_dom,IPR045221:Sphingomyelin_synth-like,				SM00454:SAM,	KW-0443~Lipid metabolism,KW-0746~Sphingolipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,		DOMAIN:SAM,MUTAGEN:D->E: Abolishes CPE synthase activity.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
P08842	steroid sulfatase(STS)	Homo sapiens			GO:0006706~steroid catabolic process,GO:0007565~female pregnancy,GO:0008544~epidermis development,	GO:0005764~lysosome,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004065~arylsulfatase activity,GO:0004773~steryl-sulfatase activity,GO:0008484~sulfuric ester hydrolase activity,GO:0046872~metal ion binding,	IPR000917:Sulfatase_N,IPR017850:Alkaline_phosphatase_core_sf,IPR024607:Sulfatase_CS,IPR032506:SGSH_C,	hsa00140:Steroid hormone biosynthesis,hsa01100:Metabolic pathways,	308100~Ichthyosis, X-linked,			KW-0443~Lipid metabolism,KW-0635~Pregnancy,KW-0753~Steroid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,		KW-0225~Disease variant,KW-0977~Ichthyosis,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,BINDING:via 3-oxoalanine,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:N-sulphoglucosamine sulphohydrolase C-terminal,DOMAIN:Sulfatase N-terminal,SITE:Not glycosylated,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
P35610	sterol O-acyltransferase 1(SOAT1)	Homo sapiens			GO:0008203~cholesterol metabolic process,GO:0010742~macrophage derived foam cell differentiation,GO:0010878~cholesterol storage,GO:0033344~cholesterol efflux,GO:0034379~very-low-density lipoprotein particle assembly,GO:0034383~low-density lipoprotein particle clearance,GO:0042632~cholesterol homeostasis,GO:0042986~positive regulation of amyloid precursor protein biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0000062~fatty-acyl-CoA binding,GO:0004772~sterol O-acyltransferase activity,GO:0005515~protein binding,GO:0008374~O-acyltransferase activity,GO:0015485~cholesterol binding,GO:0034736~cholesterol O-acyltransferase activity,GO:0042802~identical protein binding,	IPR004299:MBOAT_fam,IPR014371:Oat_ACAT_DAG_ARE,IPR030687:Sterol_acyltranf_meta,	hsa00100:Steroid biosynthesis,hsa04979:Cholesterol metabolism,		PIRSF000439:Oat_ACAT_DAG_ARE,PIRSF500230:Sterol_acyltranf_ACAT,		KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0012~Acyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,MOTIF:FYXDWWN motif,MUTAGEN:D->N: Low expression, loss of enzymatic activity.,MUTAGEN:F->A: Abolished homodimerization; when associated with 504-A--A-508.,MUTAGEN:F->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:H->A,C,N: Abolished cholesterol O-acyltransferase activity.,MUTAGEN:H->A: Abolished cholesterol O-acyltransferase activity.,MUTAGEN:H->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:K->A: Reduced cholesterol O-acyltransferase activity.,MUTAGEN:L->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:L->N: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:L->Q: Almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:N->A: Almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:N->G: Reduced cholesterol O-acyltransferase activity.,MUTAGEN:R->A: Reduced cholesterol O-acyltransferase activity.,MUTAGEN:R->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:S->A,T: Nearly normal expression and enzyme activity.,MUTAGEN:S->A: Abolished cholesterol O-acyltransferase activity.,MUTAGEN:S->L: No expression nor activity.,MUTAGEN:VF->AA: Almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:VFAVS->QFAVQ: In QQ mutant; almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:W->A: Almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:WTSLF->ATSLA: Abolished homodimerization; when associated with A-367.,MUTAGEN:Y->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:Y->F: Loss of enzymatic activity.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
P36956	sterol regulatory element binding transcription factor 1(SREBF1)	Homo sapiens	98.Dietary_Fat_and_Gene_Transcription,	h_s1pPathway:SREBP control of lipid synthesis,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0003062~regulation of heart rate by chemical signal,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006629~lipid metabolic process,GO:0006695~cholesterol biosynthetic process,GO:0007584~response to nutrient,GO:0007623~circadian rhythm,GO:0008286~insulin receptor signaling pathway,GO:0008610~lipid biosynthetic process,GO:0009267~cellular response to starvation,GO:0009410~response to xenobiotic stimulus,GO:0009749~response to glucose,GO:0009750~response to fructose,GO:0010867~positive regulation of triglyceride biosynthetic process,GO:0010883~regulation of lipid storage,GO:0019217~regulation of fatty acid metabolic process,GO:0030073~insulin secretion,GO:0030324~lung development,GO:0030522~intracellular receptor signaling pathway,GO:0031647~regulation of protein stability,GO:0032094~response to food,GO:0032526~response to retinoic acid,GO:0032570~response to progesterone,GO:0032933~SREBP signaling pathway,GO:0033762~response to glucagon,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0045444~fat cell differentiation,GO:0045471~response to ethanol,GO:0045542~positive regulation of cholesterol biosynthetic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046676~negative regulation of insulin secretion,GO:0051591~response to cAMP,GO:0071398~cellular response to fatty acid,GO:0090209~negative regulation of triglyceride metabolic process,GO:1901524~regulation of macromitophagy,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1903146~regulation of mitophagy,GO:1903214~regulation of protein targeting to mitochondrion,	GO:0000139~Golgi membrane,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0012507~ER to Golgi transport vesicle membrane,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001221~transcription cofactor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0032810~sterol response element binding,GO:0046983~protein dimerization activity,GO:1990837~sequence-specific double-stranded DNA binding,	IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,	hsa04152:AMPK signaling pathway,hsa04910:Insulin signaling pathway,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04936:Alcoholic liver disease,	158310~Mucoepithelial dysplasia, hereditary,619016~Ichthyosis, follicular, with atrichia and photophobia syndrome 2,		SM00353:HLH,	KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-0804~Transcription,KW-0805~Transcription regulation,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0968~Cytoplasmic vesicle,		KW-0225~Disease variant,KW-0977~Ichthyosis,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:BHLH,DOMAIN:bHLH,MOTIF:9aaTAD,MUTAGEN:D->A: Loss of proteolytic processing in response to low sterol.,MUTAGEN:D->A: No effect on proteolytic processing.,MUTAGEN:DRSR->AS: Strong reduction of proteolytic processing in response to low sterol.,MUTAGEN:G->A: No effect on proteolytic processing.,MUTAGEN:L->A: No effect on proteolytic processing.,MUTAGEN:M->A: No effect on proteolytic processing.,MUTAGEN:R->A: Loss of proteolytic processing in response to low sterol. Transcriptionally inactive.,MUTAGEN:R->A: No effect on proteolytic processing.,MUTAGEN:S->A: No effect on proteolytic processing.,MUTAGEN:Y->R: Abolished transactivation activity.,REGION:Disordered,REGION:Interaction with LMNA,REGION:Leucine-zipper,REGION:Transcriptional activation (acidic),SITE:Cleavage; by MBTPS1,SITE:Cleavage; by MBTPS2,SITE:Cleavage; by caspase-3 and caspase-7,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
O88822	sterol-C5-desaturase(Sc5d)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006694~steroid biosynthetic process,GO:0008202~steroid metabolic process,GO:0008610~lipid biosynthetic process,GO:0016126~sterol biosynthetic process,GO:0033490~cholesterol biosynthetic process via lathosterol,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0000248~C-5 sterol desaturase activity,GO:0005506~iron ion binding,GO:0016491~oxidoreductase activity,GO:0050046~lathosterol oxidase activity,	IPR006694:Fatty_acid_hydroxylase,	mmu00100:Steroid biosynthesis,mmu01100:Metabolic pathways,				KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0408~Iron,	KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	DOMAIN:Fatty acid hydroxylase,MOTIF:Histidine box-1,MOTIF:Histidine box-2,MOTIF:Histidine box-3,REGION:Disordered,TRANSMEM:Helical,
F1QPC3	store-operated calcium entry-associated regulatory factor(saraf)	Danio rerio			GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:2001256~regulation of store-operated calcium entry,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR009567:SARAF,					KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,			COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q499E5	storkhead box 2(Stox2)	Mus musculus			GO:0001893~maternal placenta development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009617~response to bacterium,GO:0009792~embryo development ending in birth or egg hatching,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,	IPR019391:Storkhead-box_winged-helix,IPR040126:STOX1/2,													COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:Winged helix Storkhead-box1,REGION:Disordered,
Q6TAW2	stress-associated endoplasmic reticulum protein family member 2(Serp2)	Mus musculus			GO:0015031~protein transport,GO:0030968~endoplasmic reticulum unfolded protein response,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR010580:ER_stress-assoc,					KW-0811~Translocation,KW-0813~Transport,KW-0834~Unfolded protein response,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
Q696W0	striated muscle enriched protein kinase a(spega)	Danio rerio			GO:0007517~muscle organ development,GO:0016310~phosphorylation,	GO:0005634~nucleus,GO:0030018~Z disc,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR017441:Protein_kinase_ATP_BS,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,				SM00060:FN3,SM00220:S_TKc,SM00408:IGc2,SM00409:IG,		KW-0539~Nucleus,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Ig-like 1,DOMAIN:Ig-like 2,DOMAIN:Ig-like 3,DOMAIN:Ig-like 4,DOMAIN:Ig-like 5,DOMAIN:Ig-like 6,DOMAIN:Protein kinase 1,DOMAIN:Protein kinase 2,REGION:Disordered,
P70302	stromal interaction molecule 1(Stim1)	Mus musculus			GO:0002115~store-operated calcium entry,GO:0005513~detection of calcium ion,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007207~phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,GO:0014902~myotube differentiation,GO:0032024~positive regulation of insulin secretion,GO:0032237~activation of store-operated calcium channel activity,GO:0045762~positive regulation of adenylate cyclase activity,GO:0045766~positive regulation of angiogenesis,GO:0051050~positive regulation of transport,GO:0051649~establishment of localization in cell,GO:0051924~regulation of calcium ion transport,GO:0070166~enamel mineralization,GO:0099105~ion channel modulating, G-protein coupled receptor signaling pathway,GO:2001256~regulation of store-operated calcium entry,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016529~sarcoplasmic reticulum,GO:0030426~growth cone,GO:0032541~cortical endoplasmic reticulum,GO:0032991~macromolecular complex,GO:0033017~sarcoplasmic reticulum membrane,GO:0044853~plasma membrane raft,GO:0045202~synapse,	GO:0002020~protease binding,GO:0005246~calcium channel regulator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0015279~store-operated calcium channel activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0051010~microtubule plus-end binding,GO:0099103~channel activator activity,GO:0099107~ion channel regulator activity involved in G-protein coupled receptor signaling pathway,	IPR001660:SAM,IPR013761:SAM/pointed_sf,IPR032393:SOAR,IPR037608:STIM,IPR037609:STIM1_SAM,	mmu04020:Calcium signaling pathway,mmu04611:Platelet activation,			SM00454:SAM,	KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0493~Microtubule,KW-0703~Sarcoplasmic reticulum,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:EF-hand,DOMAIN:SAM,DOMAIN:Stromal interaction molecule Orai1-activating region,MOTIF:Microtubule tip localization signal,REGION:Disordered,REGION:SOAR/CAD,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P50533	structural maintenance of chromosomes 2 L homeolog(smc2.L)	Xenopus laevis			GO:0007049~cell cycle,GO:0030261~chromosome condensation,GO:0051276~chromosome organization,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003395:RecF/RecN/SMC_N,IPR010935:SMC_hinge,IPR024704:SMC,IPR027120:Smc2_ABC,IPR027417:P-loop_NTPase,IPR036277:SMC_hinge_sf,			PIRSF005719:SMC,	SM00968:SMC_hinge,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			COMPBIAS:Basic and acidic residues,DOMAIN:SMC hinge,REGION:Disordered,
Q802R8	structural maintenance of chromosomes 6(smc6)	Takifugu rubripes			GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0090398~cellular senescence,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0016605~PML body,GO:0030915~Smc5-Smc6 complex,GO:0035861~site of double-strand break,	GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003395:RecF/RecN/SMC_N,IPR027417:P-loop_NTPase,IPR038729:Rad50/SbcC_AAA,					KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0779~Telomere,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			COMPBIAS:Basic and acidic residues,DOMAIN:Rad50/SbcC-type AAA,REGION:Disordered,REGION:Flexible hinge,
Q8IWU5	sulfatase 2(SULF2)	Homo sapiens			GO:0001822~kidney development,GO:0002063~chondrocyte development,GO:0003094~glomerular filtration,GO:0009611~response to wounding,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0014846~esophagus smooth muscle contraction,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030201~heparan sulfate proteoglycan metabolic process,GO:0032836~glomerular basement membrane development,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway,GO:0048706~embryonic skeletal system development,GO:0051216~cartilage development,GO:0060348~bone development,GO:0060384~innervation,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0097421~liver regeneration,GO:2000345~regulation of hepatocyte proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005795~Golgi stack,GO:0005886~plasma membrane,GO:0009986~cell surface,	GO:0004065~arylsulfatase activity,GO:0005509~calcium ion binding,GO:0005539~glycosaminoglycan binding,GO:0008449~N-acetylglucosamine-6-sulfatase activity,GO:0008484~sulfuric ester hydrolase activity,	IPR000917:Sulfatase_N,IPR014615:Extracellular_sulfatase,IPR017850:Alkaline_phosphatase_core_sf,IPR024607:Sulfatase_CS,IPR024609:Extracellular_sulfatase_C,			PIRSF036665:Sulf1,			KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-0654~Proteoglycan,	ACT_SITE:Nucleophile,BINDING:via 3-oxoalanine,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine,COMPBIAS:Basic and acidic residues,DOMAIN:Extracellular sulfatase C-terminal,DOMAIN:Sulfatase N-terminal,MUTAGEN:CC->AA: Loss of arylsulfatase activity.,MUTAGEN:KEK->AEA: No effect on N-acetylglucosamine-6-sulfatase activity. Significant loss of N-acetylglucosamine-6-sulfatase activity; when associated with 402-A--A-404.,MUTAGEN:KKK->AAA: No effect on N-acetylglucosamine-6-sulfatase activity. Significant loss of N-acetylglucosamine-6-sulfatase activity; when associated with 180-A--A-182.,REGION:Catalytic domain; necessary for arylsulfatase activity,REGION:Disordered,REGION:Hydrophilic domain; necessary for endoglucosamine-6-sulfatase activity,SITE:Cleavage; by furin,
Q7ZUS4	sulfotransferase family 1, cytosolic sulfotransferase 2(sult1st2)	Danio rerio			GO:0006584~catecholamine metabolic process,GO:0006629~lipid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0008202~steroid metabolic process,GO:0008210~estrogen metabolic process,GO:0051923~sulfation,	GO:0005737~cytoplasm,	GO:0004062~aryl sulfotransferase activity,GO:0004304~estrone sulfotransferase activity,GO:0008146~sulfotransferase activity,GO:0016740~transferase activity,	IPR000863:Sulfotransferase_dom,IPR027417:P-loop_NTPase,					KW-0128~Catecholamine metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,	KW-0963~Cytoplasm,					KW-0808~Transferase,		ACT_SITE:Proton acceptor,
Q9D939	sulfotransferase family, cytosolic, 1C, member 2(Sult1c2)	Mus musculus			GO:0051923~sulfation,	GO:0005737~cytoplasm,GO:0005764~lysosome,	GO:0004062~aryl sulfotransferase activity,GO:0008146~sulfotransferase activity,GO:0016740~transferase activity,	IPR000863:Sulfotransferase_dom,IPR027417:P-loop_NTPase,						KW-0458~Lysosome,KW-0963~Cytoplasm,					KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,
O46385	supervillin(SVIL)	Bos taurus			GO:0007010~cytoskeleton organization,GO:0008154~actin polymerization or depolymerization,GO:0032467~positive regulation of cytokinesis,GO:0051014~actin filament severing,GO:0051016~barbed-end actin filament capping,	GO:0002102~podosome,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0030496~midbody,GO:0032154~cleavage furrow,GO:0036449~microtubule minus-end,GO:0042995~cell projection,GO:0070161~anchoring junction,	GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0051015~actin filament binding,GO:0060090~binding, bridging,	IPR003128:Villin_headpiece,IPR007122:Villin/Gelsolin,IPR007123:Gelsolin-like_dom,IPR029006:ADF-H/Gelsolin-like_dom_sf,IPR036886:Villin_headpiece_dom_sf,				SM00153:VHP,SM00262:GEL,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0106~Calcium,	KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:HP,MUTAGEN:RY->AA: Diminishes interaction with TRIP6 and DYNLT1.,REGION:Disordered,REGION:Interaction with MYLK,REGION:Interaction with NEB,REPEAT:Gelsolin-like 1,REPEAT:Gelsolin-like 2,REPEAT:Gelsolin-like 3,REPEAT:Gelsolin-like 4,REPEAT:Gelsolin-like 5,
Q8C8N2	suppressor of cancer cell invasion(Scai)	Mus musculus			GO:0006351~transcription, DNA-templated,GO:0009968~negative regulation of signal transduction,GO:0030336~negative regulation of cell migration,GO:0035024~negative regulation of Rho protein signal transduction,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,	IPR016607:SCAI_metazoan/Viridiplantae,IPR022709:SCAI,			PIRSF013022:UCP013022,		KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0678~Repressor,KW-0734~Signal transduction inhibitor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Necessary to inhibit MRTFA-induced SRF transcriptional activity,REGION:Required for interaction with MRTFA,TRANSMEM:Helical,
Q9DBX3	sushi domain containing 2(Susd2)	Mus musculus			GO:0051782~negative regulation of cell division,GO:1902807~negative regulation of cell cycle G1/S phase transition,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,		IPR000436:Sushi_SCR_CCP_dom,IPR001212:Somatomedin_B_dom,IPR001846:VWF_type-D,IPR005533:AMOP_dom,IPR035976:Sushi/SCR/CCP_sf,IPR036024:Somatomedin_B-like_dom_sf,				SM00032:CCP,SM00216:VWD,SM00723:AMOP,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0043~Tumor suppressor,	KW-0732~Signal,KW-0768~Sushi,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Alternate,DOMAIN:AMOP,DOMAIN:SMB,DOMAIN:Sushi,DOMAIN:VWFD,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8TER0	sushi, nidogen and EGF like domains 1(SNED1)	Homo sapiens			GO:0007160~cell-matrix adhesion,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0005112~Notch binding,GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000436:Sushi_SCR_CCP_dom,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR003886:NIDO_dom,IPR003961:FN3_dom,IPR013032:EGF-like_CS,IPR013783:Ig-like_fold,IPR018097:EGF_Ca-bd_CS,IPR035976:Sushi/SCR/CCP_sf,IPR036116:FN3_sf,				SM00032:CCP,SM00060:FN3,SM00179:EGF_CA,SM00181:EGF,SM00539:NIDO,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13,DOMAIN:EGF-like 14,DOMAIN:EGF-like 15,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,DOMAIN:EGF-like 9,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Follistatin-like 1,DOMAIN:Follistatin-like 2,DOMAIN:NIDO,DOMAIN:Sushi,REGION:Disordered,
Q4LDE5	sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1(SVEP1)	Homo sapiens			GO:0003017~lymph circulation,GO:0007160~cell-matrix adhesion,GO:0008544~epidermis development,GO:0010467~gene expression,GO:0010572~positive regulation of platelet activation,GO:0036303~lymph vessel morphogenesis,GO:0045906~negative regulation of vasoconstriction,GO:0045959~negative regulation of complement activation, classical pathway,GO:0048014~Tie signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003682~chromatin binding,GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0098640~integrin binding involved in cell-matrix adhesion,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000436:Sushi_SCR_CCP_dom,IPR000742:EGF-like_dom,IPR001759:Pentraxin-related,IPR001881:EGF-like_Ca-bd_dom,IPR002035:VWF_A,IPR003410:HYR_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR011641:Tyr-kin_ephrin_A/B_rcpt-like,IPR013032:EGF-like_CS,IPR013111:EGF_extracell,IPR013320:ConA-like_dom_sf,IPR018097:EGF_Ca-bd_CS,IPR035976:Sushi/SCR/CCP_sf,IPR036465:vWFA_dom_sf,				SM00032:CCP,SM00159:PTX,SM00179:EGF_CA,SM00181:EGF,SM00327:VWA,SM01411:Ephrin_rec_like,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,	KW-0106~Calcium,KW-0430~Lectin,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8,DOMAIN:EGF-like 9,DOMAIN:HYR,DOMAIN:HYR 1,DOMAIN:HYR 2,DOMAIN:Pentraxin (PTX),DOMAIN:Sushi,DOMAIN:Sushi 1,DOMAIN:Sushi 10,DOMAIN:Sushi 11,DOMAIN:Sushi 12,DOMAIN:Sushi 13,DOMAIN:Sushi 14,DOMAIN:Sushi 15,DOMAIN:Sushi 16,DOMAIN:Sushi 17,DOMAIN:Sushi 18,DOMAIN:Sushi 19,DOMAIN:Sushi 2,DOMAIN:Sushi 20,DOMAIN:Sushi 21,DOMAIN:Sushi 22,DOMAIN:Sushi 23,DOMAIN:Sushi 24,DOMAIN:Sushi 25,DOMAIN:Sushi 26,DOMAIN:Sushi 27,DOMAIN:Sushi 28,DOMAIN:Sushi 29,DOMAIN:Sushi 3,DOMAIN:Sushi 30,DOMAIN:Sushi 31,DOMAIN:Sushi 32,DOMAIN:Sushi 33,DOMAIN:Sushi 34,DOMAIN:Sushi 4,DOMAIN:Sushi 5,DOMAIN:Sushi 6,DOMAIN:Sushi 7,DOMAIN:Sushi 8,DOMAIN:Sushi 9,DOMAIN:VWFA,MOTIF:Cell attachment site,REGION:Disordered,REGION:Important for the interaction with integrin ITGA9:ITGB1,REGION:O-glycosylated at one site,SITE:Required for interaction with integrin ITGA9:ITGB1,
A2AVA0	sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1(Svep1)	Mus musculus			GO:0001945~lymph vessel development,GO:0003017~lymph circulation,GO:0007155~cell adhesion,GO:0008544~epidermis development,GO:0010467~gene expression,GO:0010572~positive regulation of platelet activation,GO:0016477~cell migration,GO:0036303~lymph vessel morphogenesis,GO:0045906~negative regulation of vasoconstriction,GO:0045959~negative regulation of complement activation, classical pathway,GO:0048014~Tie signaling pathway,GO:0090136~epithelial cell-cell adhesion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0003682~chromatin binding,GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0098640~integrin binding involved in cell-matrix adhesion,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000436:Sushi_SCR_CCP_dom,IPR000742:EGF-like_dom,IPR001759:Pentraxin-related,IPR001881:EGF-like_Ca-bd_dom,IPR002035:VWF_A,IPR003410:HYR_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR011641:Tyr-kin_ephrin_A/B_rcpt-like,IPR013032:EGF-like_CS,IPR013320:ConA-like_dom_sf,IPR013783:Ig-like_fold,IPR018097:EGF_Ca-bd_CS,IPR024731:EGF_dom,IPR035976:Sushi/SCR/CCP_sf,IPR036465:vWFA_dom_sf,				SM00032:CCP,SM00159:PTX,SM00179:EGF_CA,SM00181:EGF,SM00327:VWA,SM01411:Ephrin_rec_like,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8,DOMAIN:EGF-like 9,DOMAIN:HYR 1,DOMAIN:HYR 2,DOMAIN:Pentraxin (PTX),DOMAIN:Sushi 1,DOMAIN:Sushi 10,DOMAIN:Sushi 11,DOMAIN:Sushi 12,DOMAIN:Sushi 13,DOMAIN:Sushi 14,DOMAIN:Sushi 15,DOMAIN:Sushi 16,DOMAIN:Sushi 17,DOMAIN:Sushi 18,DOMAIN:Sushi 19,DOMAIN:Sushi 2,DOMAIN:Sushi 20,DOMAIN:Sushi 21,DOMAIN:Sushi 22,DOMAIN:Sushi 23,DOMAIN:Sushi 24,DOMAIN:Sushi 25,DOMAIN:Sushi 26,DOMAIN:Sushi 27,DOMAIN:Sushi 28,DOMAIN:Sushi 29,DOMAIN:Sushi 3,DOMAIN:Sushi 30,DOMAIN:Sushi 31,DOMAIN:Sushi 32,DOMAIN:Sushi 33,DOMAIN:Sushi 34,DOMAIN:Sushi 4,DOMAIN:Sushi 5,DOMAIN:Sushi 6,DOMAIN:Sushi 7,DOMAIN:Sushi 8,DOMAIN:Sushi 9,DOMAIN:VWFA,MUTAGEN:D->A: No effect on the interaction with integrin ITGA9:ITGB1.,MUTAGEN:D->A: Reduces interaction with integrin ITGA9:ITGB1.,MUTAGEN:E->A: Abolishes interaction with integrin ITGA9:ITGB1.,MUTAGEN:E->A: No effect on the interaction with integrin ITGA9:ITGB1.,MUTAGEN:L->A: No effect on the interaction with integrin ITGA9:ITGB1.,MUTAGEN:M->A: No effect on the interaction with integrin ITGA9:ITGB1.,MUTAGEN:M->A: Reduces interaction with integrin ITGA9:ITGB1.,MUTAGEN:P->A: No effect on the interaction with integrin ITGA9:ITGB1.,MUTAGEN:Q->A: No effect on the interaction with integrin ITGA9:ITGB1.,MUTAGEN:V->A: No effect on the interaction with integrin ITGA9:ITGB1.,MUTAGEN:Y->A: No effect on the interaction with integrin ITGA9:ITGB1.,REGION:Important for the interaction with integrin ITGA9:ITGB1,SITE:Required for interaction with integrin ITGA9:ITGB1,
Q8R054	sushi-repeat-containing protein, X-linked 2(Srpx2)	Mus musculus			GO:0001525~angiogenesis,GO:0007155~cell adhesion,GO:0042325~regulation of phosphorylation,GO:0048870~cell motility,GO:0051965~positive regulation of synapse assembly,GO:0071625~vocalization behavior,GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis,GO:0098609~cell-cell adhesion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0045202~synapse,GO:0060076~excitatory synapse,GO:0097060~synaptic membrane,	GO:0005102~receptor binding,GO:0005201~extracellular matrix structural constituent,GO:0036458~hepatocyte growth factor binding,GO:0042802~identical protein binding,	IPR000436:Sushi_SCR_CCP_dom,IPR003410:HYR_dom,IPR025232:DUF4174,IPR035976:Sushi/SCR/CCP_sf,IPR043555:SRPX-like,				SM00032:CCP,	KW-0037~Angiogenesis,KW-0130~Cell adhesion,	KW-0770~Synapse,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,			KW-0325~Glycoprotein,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	DOMAIN:HYR,DOMAIN:Sushi 1,DOMAIN:Sushi 2,DOMAIN:Sushi 3,
Q9Z2I6	synaptic vesicle glycoprotein 2c(Sv2c)	Rattus norvegicus			GO:0006836~neurotransmitter transport,GO:0007268~chemical synaptic transmission,GO:0055085~transmembrane transport,GO:2000300~regulation of synaptic vesicle exocytosis,	GO:0008021~synaptic vesicle,GO:0030672~synaptic vesicle membrane,	GO:0005515~protein binding,GO:0022857~transmembrane transporter activity,	IPR001646:5peptide_repeat,IPR005828:MFS_sugar_transport-like,IPR005829:Sugar_transporter_CS,IPR011701:MFS,IPR020846:MFS_dom,IPR022308:SV2,IPR036259:MFS_trans_sf,	rno04512:ECM-receptor interaction,				KW-0532~Neurotransmitter transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0968~Cytoplasmic vesicle,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DOMAIN:Major facilitator superfamily (MFS) profile,MUTAGEN:N->A: Loss of one glycosylation site. No effect on C.botulinum neurotoxin type A (BoNT/A, botA) binding, but reduces the uptake of BoNT/A.,REGION:(Microbial infection) C.botulinum neurotoxin type A-binding,REGION:Disordered,REGION:Interaction with SYT1,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9UMS6	synaptopodin 2(SYNPO2)	Homo sapiens			GO:0030335~positive regulation of cell migration,GO:0032233~positive regulation of actin filament bundle assembly,GO:2000298~regulation of Rho-dependent protein serine/threonine kinase activity,	GO:0001725~stress fiber,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0030018~Z disc,GO:0043231~intracellular membrane-bounded organelle,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0031005~filamin binding,GO:0051371~muscle alpha-actinin binding,GO:0051393~alpha-actinin binding,GO:0071889~14-3-3 protein binding,	IPR001478:PDZ,IPR036034:PDZ_sf,				SM00228:PDZ,		KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,		KW-0043~Tumor suppressor,			KW-0009~Actin-binding,KW-0514~Muscle protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:PDZ,MOTIF:Nuclear localization signal,MOTIF:PPPY motif,REGION:Actin binding,REGION:Disordered,REGION:F-actin binding,REGION:F-actin bundling activity,REGION:Interaction with ACTN2,REGION:Interaction with BAG3,REGION:Interaction with FLNC,REGION:Interaction with VPS18,REGION:Interaction with YWHAB,REGION:Interaction with ZYX,
O43581	synaptotagmin 7(SYT7)	Homo sapiens			GO:0001778~plasma membrane repair,GO:0006906~vesicle fusion,GO:0006909~phagocytosis,GO:0014059~regulation of dopamine secretion,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0036465~synaptic vesicle recycling,GO:0045956~positive regulation of calcium ion-dependent exocytosis,GO:0046850~regulation of bone remodeling,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0050764~regulation of phagocytosis,GO:0050796~regulation of insulin secretion,GO:0070092~regulation of glucagon secretion,GO:0071277~cellular response to calcium ion,GO:0090119~vesicle-mediated cholesterol transport,GO:0090385~phagosome-lysosome fusion,GO:1900242~regulation of synaptic vesicle endocytosis,GO:1990926~short-term synaptic potentiation,GO:1990927~calcium ion regulated lysosome exocytosis,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0030424~axon,GO:0030670~phagocytic vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0031045~dense core granule,GO:0032009~early phagosome,GO:0042734~presynaptic membrane,GO:0045202~synapse,GO:0070062~extracellular exosome,GO:0098686~hippocampal mossy fiber to CA3 synapse,	GO:0000149~SNARE binding,GO:0001786~phosphatidylserine binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,	IPR000008:C2_dom,IPR001565:Synaptotagmin,IPR035892:C2_domain_sf,IPR037732:C2A_Synaptotagmin-7,IPR037741:C2B_Synaptotagmin-7,				SM00239:C2,	KW-0268~Exocytosis,	KW-0458~Lysosome,KW-0472~Membrane,KW-0576~Peroxisome,KW-0770~Synapse,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0112~Calmodulin-binding,	KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:C2 1,DOMAIN:C2 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Vesicular,TRANSMEM:Helical,
Q99N48	synaptotagmin-like 3(Sytl3)	Mus musculus			GO:0006886~intracellular protein transport,GO:0006887~exocytosis,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070382~exocytic vesicle,	GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008270~zinc ion binding,GO:0031267~small GTPase binding,GO:0042043~neurexin family protein binding,	IPR000008:C2_dom,IPR010911:Rab_BD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR035892:C2_domain_sf,IPR041282:FYVE_2,IPR043567:SYTL1-5_C2B,				SM00239:C2,		KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0677~Repeat,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:RabBD,MUTAGEN:EE->QQ: Binds phospholipids only in the absence of divalent cations.,MUTAGEN:KRK->QQQ: Binds phospholipids only in the absence of divalent cations.,REGION:Disordered,
O15079	syntaphilin(SNPH)	Homo sapiens			GO:0007269~neurotransmitter secretion,GO:0016081~synaptic vesicle docking,GO:0030182~neuron differentiation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005881~cytoplasmic microtubule,GO:0016020~membrane,GO:0043005~neuron projection,GO:0098793~presynapse,	GO:0005515~protein binding,GO:0017075~syntaxin-1 binding,	IPR028197:Syntaphilin/Syntabulin,						KW-0472~Membrane,KW-0770~Synapse,KW-0771~Synaptosome,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,TRANSMEM:Helical,
Q6ZWJ1	syntaxin binding protein 4(STXBP4)	Homo sapiens			GO:0006605~protein targeting,GO:0006974~cellular response to DNA damage stimulus,GO:0008286~insulin receptor signaling pathway,GO:0010827~regulation of glucose transport,GO:0010838~positive regulation of keratinocyte proliferation,GO:0050821~protein stabilization,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0071346~cellular response to interferon-gamma,GO:0099072~regulation of postsynaptic specialization membrane neurotransmitter receptor levels,GO:1902808~positive regulation of cell cycle G1/S phase transition,	GO:0031410~cytoplasmic vesicle,GO:0045335~phagocytic vesicle,GO:0070062~extracellular exosome,GO:0098685~Schaffer collateral - CA1 synapse,	GO:0005515~protein binding,GO:0019905~syntaxin binding,	IPR001202:WW_dom,IPR001478:PDZ,IPR011992:EF-hand-dom_pair,IPR036020:WW_dom_sf,IPR036034:PDZ_sf,				SM00228:PDZ,SM00456:WW,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	DOMAIN:PDZ,DOMAIN:WW,
Q8R3T5	syntaxin binding protein 6 (amisyn)(Stxbp6)	Mus musculus			GO:0035493~SNARE complex assembly,GO:0035542~regulation of SNARE complex assembly,	GO:0005737~cytoplasm,GO:0016020~membrane,		IPR028258:Sec3-PIP2_bind,IPR037821:STXBP6_PH,IPR037822:STXBP6_SNARE,IPR042855:V_SNARE_CC,				SM01313:Sec3-PIP2_bind,		KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,	DOMAIN:Exocyst complex component Sec3 PIP2-binding N-terminal,DOMAIN:V-SNARE coiled-coil homology,DOMAIN:v-SNARE coiled-coil homology,
Q9NZ50	synuclein gamma(SNCG)	Bos taurus			GO:0007165~signal transduction,GO:0007268~chemical synaptic transmission,GO:0008344~adult locomotory behavior,GO:0009306~protein secretion,GO:0014059~regulation of dopamine secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0048488~synaptic vesicle endocytosis,GO:0050808~synapse organization,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0043025~neuronal cell body,GO:0043679~axon terminus,GO:0048471~perinuclear region of cytoplasm,	GO:1903136~cuprous ion binding,	IPR001058:Synuclein,IPR002462:Synuclein_gamma,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:4 X 11 AA tandem repeats of [EGSA]-K-T-K-[EQ]-[GQ]-V-X(4),REGION:Disordered,REPEAT:1,REPEAT:2,REPEAT:3; approximate,REPEAT:4,
Q2KI45	tRNA methyltransferase 10C, mitochondrial RNase P subunit(TRMT10C)	Bos taurus			GO:0000964~mitochondrial RNA 5'-end processing,GO:0030488~tRNA methylation,GO:0070131~positive regulation of mitochondrial translation,GO:0070901~mitochondrial tRNA methylation,GO:0080009~mRNA methylation,GO:0090646~mitochondrial tRNA processing,GO:0097745~mitochondrial tRNA 5'-end processing,GO:1990180~mitochondrial tRNA 3'-end processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0030678~mitochondrial ribonuclease P complex,GO:0042645~mitochondrial nucleoid,GO:0043527~tRNA methyltransferase complex,	GO:0000049~tRNA binding,GO:0016429~tRNA (adenine-N1-)-methyltransferase activity,GO:0042802~identical protein binding,GO:0052905~tRNA (guanine(9)-N(1))-methyltransferase activity,	IPR007356:tRNA_m1G_MeTrfase_euk,IPR016009:tRNA_MeTrfase_TRMD/TRM10,IPR025812:Trm10_C_MTase_dom,IPR028564:MT_TRM10-typ,IPR038459:MT_TRM10-typ_sf,					KW-0819~tRNA processing,	KW-0496~Mitochondrion,KW-1135~Mitochondrion nucleoid,			KW-0175~Coiled coil,KW-0809~Transit peptide,	KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	DOMAIN:SAM-dependent MTase TRM10-type,TRANSIT:Mitochondrion,
Q4KLT3	tRNA methyltransferase 44 homolog L homeolog(trmt44.L)	Xenopus laevis			GO:0008033~tRNA processing,GO:0030488~tRNA methylation,GO:0032259~methylation,	GO:0005737~cytoplasm,	GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016300~tRNA (uracil) methyltransferase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0052665~tRNA (uracil-2'-O-)-methyltransferase activity,	IPR000571:Znf_CCCH,IPR011671:tRNA_uracil_MeTrfase,IPR029063:SAM-dependent_MTases_sf,					KW-0819~tRNA processing,	KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:C3H1-type,REGION:Disordered,ZN_FING:C3H1-type,
Q80WQ4	tRNA methyltransferase 9B(Trmt9b)	Mus musculus			GO:0002098~tRNA wobble uridine modification,GO:0008033~tRNA processing,GO:0008152~metabolic process,GO:0030488~tRNA methylation,GO:0032259~methylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0008168~methyltransferase activity,GO:0008175~tRNA methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016740~transferase activity,	IPR013216:Methyltransf_11,IPR029063:SAM-dependent_MTases_sf,IPR041698:Methyltransf_25,					KW-0819~tRNA processing,					KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	DOMAIN:Methyltransferase,REGION:Disordered,
Q5EAR5	tRNA phosphotransferase 1(trpt1)	Danio rerio			GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0008033~tRNA processing,		GO:0000215~tRNA 2'-phosphotransferase activity,GO:0016740~transferase activity,	IPR002745:Ptrans_KptA/Tpt1,IPR042080:RNA_2'-PTrans_N,IPR042081:RNA_2'-PTrans_C,					KW-0819~tRNA processing,					KW-0520~NAD,	KW-0808~Transferase,		REGION:Disordered,
Q6ZSZ6	teashirt zinc finger homeobox 1(TSHZ1)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009952~anterior/posterior pattern specification,GO:0010468~regulation of gene expression,GO:0042474~middle ear morphogenesis,GO:0060023~soft palate development,	GO:0000785~chromatin,GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001356:Homeobox_dom,IPR013087:Znf_C2H2_type,IPR027008:Teashirt_fam,		607842~Aural atresia, congenital,		SM00355:ZnF_C2H2,SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0371~Homeobox,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0678~Repressor,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:Homeobox; atypical,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3; atypical,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,
B3DJM5	teashirt zinc finger homeobox 1(tshz1)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010468~regulation of gene expression,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001356:Homeobox_dom,IPR013087:Znf_C2H2_type,IPR027008:Teashirt_fam,				SM00355:ZnF_C2H2,SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0371~Homeobox,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0678~Repressor,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:Homeobox,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,
Q3B7D3	tectonic family member 2(Tctn2)	Rattus norvegicus			GO:0006879~cellular iron ion homeostasis,GO:0007224~smoothened signaling pathway,GO:0030030~cell projection organization,GO:0036295~cellular response to increased oxygen levels,GO:0060271~cilium assembly,GO:1902600~hydrogen ion transmembrane transport,GO:1904491~protein localization to ciliary transition zone,	GO:0001669~acrosomal vesicle,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0033176~proton-transporting V-type ATPase complex,GO:0033179~proton-transporting V-type ATPase, V0 domain,GO:0035869~ciliary transition zone,GO:0036038~MKS complex,GO:0043229~intracellular organelle,GO:0048471~perinuclear region of cytoplasm,GO:1902495~transmembrane transporter complex,	GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR002490:V-ATPase_116kDa_su,IPR011677:Tectonic_dom,IPR040354:Tectonic,					KW-0406~Ion transport,KW-0813~Transport,KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,DOMAIN:Tectonic,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q99973	telomerase associated protein 1(TEP1)	Homo sapiens		h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,	GO:0000722~telomere maintenance via recombination,GO:0006278~RNA-dependent DNA biosynthetic process,	GO:0000781~chromosome, telomeric region,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:1990904~ribonucleoprotein complex,	GO:0002039~p53 binding,GO:0003720~telomerase activity,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019899~enzyme binding,GO:0070034~telomerase RNA binding,	IPR001680:WD40_rpt,IPR007111:NACHT_NTPase,IPR008850:TEP1_N,IPR008858:TROVE_dom,IPR011047:Quinoprotein_ADH-like_supfam,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR025139:DUF4062,IPR027417:P-loop_NTPase,IPR036322:WD40_repeat_dom_sf,IPR037214:TROVE_dom_sf,IPR045804:DUF5920,				SM00320:WD40,		KW-0158~Chromosome,KW-0539~Nucleus,KW-0779~Telomere,			KW-0677~Repeat,KW-0853~WD repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,		COMPBIAS:Polar residues,DOMAIN:NACHT,DOMAIN:TROVE,REGION:Disordered,REPEAT:TEP1 N-terminal 1,REPEAT:TEP1 N-terminal 2,REPEAT:TEP1 N-terminal 3,REPEAT:TEP1 N-terminal 4,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 10,REPEAT:WD 11,REPEAT:WD 12,REPEAT:WD 13,REPEAT:WD 14,REPEAT:WD 15,REPEAT:WD 16,REPEAT:WD 17,REPEAT:WD 18,REPEAT:WD 19,REPEAT:WD 2,REPEAT:WD 20,REPEAT:WD 21,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,REPEAT:WD 8,REPEAT:WD 9,
Q9NT68	teneurin transmembrane protein 2(TENM2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007165~signal transduction,GO:0007411~axon guidance,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0048666~neuron development,GO:0051491~positive regulation of filopodium assembly,GO:0098609~cell-cell adhesion,GO:0098942~retrograde trans-synaptic signaling by trans-synaptic protein complex,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0016605~PML body,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030425~dendrite,GO:0030426~growth cone,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0045202~synapse,GO:0045211~postsynaptic membrane,	GO:0005102~receptor binding,GO:0005509~calcium ion binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR006530:YD,IPR008969:CarboxyPept-like_regulatory,IPR009471:Ten_N,IPR011042:6-blade_b-propeller_TolB-like,IPR011044:Quino_amine_DH_bsu,IPR013111:EGF_extracell,IPR022385:Rhs_assc_core,IPR028916:Tox-GHH_dom,				SM00179:EGF_CA,SM00181:EGF,	KW-0130~Cell adhesion,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0771~Synaptosome,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0678~Repressor,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,DOMAIN:Teneurin N-terminal,REGION:Disordered,REPEAT:NHL 1,REPEAT:NHL 2,REPEAT:NHL 3,REPEAT:NHL 4,REPEAT:NHL 5,REPEAT:YD 1,REPEAT:YD 10,REPEAT:YD 11,REPEAT:YD 12,REPEAT:YD 13,REPEAT:YD 14,REPEAT:YD 15,REPEAT:YD 16,REPEAT:YD 17,REPEAT:YD 18,REPEAT:YD 19,REPEAT:YD 2,REPEAT:YD 20,REPEAT:YD 21,REPEAT:YD 22,REPEAT:YD 23,REPEAT:YD 3,REPEAT:YD 4,REPEAT:YD 5,REPEAT:YD 6,REPEAT:YD 7,REPEAT:YD 8,REPEAT:YD 9,SITE:Cleavage,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9W7R4	teneurin transmembrane protein 3(tenm3)	Danio rerio			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007165~signal transduction,GO:0007601~visual perception,GO:0010976~positive regulation of neuron projection development,GO:0030154~cell differentiation,GO:0031290~retinal ganglion cell axon guidance,GO:0048666~neuron development,GO:0070983~dendrite guidance,GO:1903385~regulation of homophilic cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0042995~cell projection,GO:0043005~neuron projection,	GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR000742:EGF-like_dom,IPR006530:YD,IPR008969:CarboxyPept-like_regulatory,IPR009471:Ten_N,IPR011042:6-blade_b-propeller_TolB-like,IPR022385:Rhs_assc_core,IPR028916:Tox-GHH_dom,IPR031325:RHS_repeat,				SM00181:EGF,	KW-0130~Cell adhesion,KW-0221~Differentiation,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7,DOMAIN:EGF-like 8,DOMAIN:Teneurin N-terminal,REGION:Disordered,REPEAT:NHL 1,REPEAT:NHL 2,REPEAT:NHL 3,REPEAT:NHL 4,REPEAT:NHL 5,REPEAT:YD 1,REPEAT:YD 10,REPEAT:YD 11,REPEAT:YD 12,REPEAT:YD 13,REPEAT:YD 14,REPEAT:YD 15,REPEAT:YD 16,REPEAT:YD 17,REPEAT:YD 18,REPEAT:YD 19,REPEAT:YD 2,REPEAT:YD 20,REPEAT:YD 21,REPEAT:YD 22,REPEAT:YD 23,REPEAT:YD 3,REPEAT:YD 4,REPEAT:YD 5,REPEAT:YD 6,REPEAT:YD 7,REPEAT:YD 8,REPEAT:YD 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q92089	terminal deoxynucleotidyl transferase(tdt)	Oncorhynchus mykiss			GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006304~DNA modification,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003912~DNA nucleotidylexotransferase activity,GO:0046872~metal ion binding,	IPR001357:BRCT_dom,IPR001726:TdT/Mu,IPR002054:DNA-dir_DNA_pol_X,IPR010996:DNA_pol_b-like_N,IPR018944:DNA_pol_lambd_fingers_domain,IPR019843:DNA_pol-X_BS,IPR022312:DNA_pol_X,IPR027292:TdT,IPR027421:DNA_pol_lamdba_lyase_dom_sf,IPR028207:DNA_pol_B_palm_palm,IPR029398:PolB_thumb,IPR036420:BRCT_dom_sf,IPR037160:DNA_Pol_thumb_sf,IPR043519:NT_sf,	omy03450:Non-homologous end-joining,		PIRSF000817:DNA_NT,PIRSF501175:TDT,	SM00292:BRCT,SM00483:POLXc,	KW-0780~Terminal addition,	KW-0539~Nucleus,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		DOMAIN:BRCT,MOTIF:Nuclear localization signal,REGION:Involved in DNA binding,
D3Z5S8	terminal nucleotidyltransferase 5A(Tent5a)	Mus musculus			GO:0009617~response to bacterium,GO:0030278~regulation of ossification,GO:0030501~positive regulation of bone mineralization,GO:0045669~positive regulation of osteoblast differentiation,GO:0048255~mRNA stabilization,	GO:0005737~cytoplasm,	GO:0016740~transferase activity,GO:1990817~RNA adenylyltransferase activity,	IPR012937:TET5,				SM01153:DUF1693,		KW-0963~Cytoplasm,			KW-0732~Signal,		KW-0808~Transferase,		MUTAGEN:Missing: Homozygous mice show severe morphological and skeletal abnormalities including short stature along with limb, rib, pelvis, and skull deformities with minimal trabecular bone and reduced cortical bone thickness in long bones.,
Q7ZUP1	terminal nucleotidyltransferase 5C(tent5c)	Danio rerio			GO:0045596~negative regulation of cell differentiation,GO:0048255~mRNA stabilization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,	GO:0003723~RNA binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:1990817~RNA adenylyltransferase activity,	IPR012937:TET5,				SM01153:DUF1693,		KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0548~Nucleotidyltransferase,KW-0694~RNA-binding,KW-0808~Transferase,
B2RX14	terminal uridylyl transferase 4(Tut4)	Mus musculus			GO:0001556~oocyte maturation,GO:0001816~cytokine production,GO:0006402~mRNA catabolic process,GO:0010586~miRNA metabolic process,GO:0010587~miRNA catabolic process,GO:0019827~stem cell population maintenance,GO:0031047~gene silencing by RNA,GO:0031054~pre-miRNA processing,GO:0031123~RNA 3'-end processing,GO:0031664~regulation of lipopolysaccharide-mediated signaling pathway,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032755~positive regulation of interleukin-6 production,GO:0061157~mRNA destabilization,GO:0070102~interleukin-6-mediated signaling pathway,GO:0071076~RNA 3' uridylation,GO:1990074~polyuridylation-dependent mRNA catabolic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0036464~cytoplasmic ribonucleoprotein granule,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0035198~miRNA binding,GO:0046872~metal ion binding,GO:0050265~RNA uridylyltransferase activity,GO:0070569~uridylyltransferase activity,	IPR001878:Znf_CCHC,IPR002058:PAP_assoc,IPR002934:Polymerase_NTP_transf_dom,IPR036390:WH_DNA-bd_sf,IPR036875:Znf_CCHC_sf,IPR043519:NT_sf,IPR045100:TUTase_dom,				SM00343:ZnF_C2HC,	KW-0943~RNA-mediated gene silencing,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:CCHC-type,DOMAIN:PAP-associated 1,DOMAIN:PAP-associated 2,DOMAIN:TUTase nucleotidyltransferase,MUTAGEN:C->A: No effect on basal uridylation activity, but loss of LIN28A-enhanced uridylation; when associated with A-326.,MUTAGEN:C->A: No effect on basal uridylation activity, but loss of LIN28A-enhanced uridylation; when associated with A-329.,MUTAGEN:D->A: Loss of nucleotidyltransferase activity and oocytes are unable to support early embryonic development; when associated with A-1026.,MUTAGEN:D->A: Loss of nucleotidyltransferase activity and oocytes are unable to support early embryonic development; when associated with A-1028.,REGION:Disordered,REGION:Required for interaction with LIN28A and pre-let-7 RNA,REGION:Sufficient for monouridylation activity,ZN_FING:CCHC-type 1,ZN_FING:CCHC-type 2,ZN_FING:CCHC-type 3,ZN_FING:Matrin-type,
Q8IWB9	testis expressed 2(TEX2)	Homo sapiens			GO:0006665~sphingolipid metabolic process,GO:0006869~lipid transport,GO:0007165~signal transduction,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0008289~lipid binding,	IPR031468:SMP_LBD,					KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0446~Lipid-binding,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SMP-LTD,REGION:Disordered,TRANSMEM:Helical,
Q5JUR7	testis expressed 30(TEX30)	Homo sapiens						IPR026555:NSL3/Tex30,IPR029058:AB_hydrolase,IPR046879:KANL3/Tex30_Abhydrolase,													DOMAIN:KANL3/Tex30 alpha/beta hydrolase-like,
A0A1L8GSA2	tet methylcytosine dioxygenase 3 S homeolog(tet3.S)	Xenopus laevis			GO:0001654~eye development,GO:0006211~5-methylcytosine catabolic process,GO:0006325~chromatin organization,GO:0006807~nitrogen compound metabolic process,GO:0007399~nervous system development,GO:0010468~regulation of gene expression,GO:0043412~macromolecule modification,GO:0044029~hypomethylation of CpG island,GO:0044238~primary metabolic process,GO:0080111~DNA demethylation,	GO:0005634~nucleus,GO:0005694~chromosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0008327~methyl-CpG binding,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0070579~methylcytosine dioxygenase activity,	IPR002857:Znf_CXXC,IPR024779:2OGFeDO_JBP1/TET_oxygenase_dom,IPR040175:TET1/2/3,IPR046942:TET_oxygenase,				SM01333:Tet_JBP,		KW-0158~Chromosome,KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0408~Iron,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0156~Chromatin regulator,KW-0217~Developmental protein,KW-0223~Dioxygenase,KW-0238~DNA-binding,KW-0560~Oxidoreductase,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CXXC-type,DOMAIN:Methylcytosine dioxygenase TET1-3 oxygenase,REGION:Disordered,ZN_FING:CXXC-type,
Q5RE11	tetraspanin 3(TSPAN3)	Pongo abelii				GO:0005886~plasma membrane,GO:0016020~membrane,		IPR000301:Tetraspanin_animals,IPR008952:Tetraspanin_EC2_sf,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin_CS,			PIRSF002419:Tetraspanin,			KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q96AY4	tetratricopeptide repeat domain 28(TTC28)	Homo sapiens			GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030496~midbody,	GO:0019900~kinase binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR024983:CHAT_dom,				SM00028:TPR,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:CHAT,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 11,REPEAT:TPR 12,REPEAT:TPR 13,REPEAT:TPR 14,REPEAT:TPR 15,REPEAT:TPR 16,REPEAT:TPR 17,REPEAT:TPR 18,REPEAT:TPR 19,REPEAT:TPR 2,REPEAT:TPR 20,REPEAT:TPR 21,REPEAT:TPR 22,REPEAT:TPR 23,REPEAT:TPR 24,REPEAT:TPR 25,REPEAT:TPR 26,REPEAT:TPR 27,REPEAT:TPR 28,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
Q6DI40	tetratricopeptide repeat domain 33(ttc33)	Danio rerio						IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,				SM00028:TPR,					KW-0677~Repeat,KW-0802~TPR repeat,				COMPBIAS:Polar residues,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
Q5PPS5	tetratricopeptide repeat domain 34 S homeolog(ttc34.S)	Xenopus laevis						IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR042161:TTC34,				SM00028:TPR,					KW-0677~Repeat,KW-0802~TPR repeat,				COMPBIAS:Basic and acidic residues,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,
A3KPN8	tetratricopeptide repeat domain 38(ttc38)	Danio rerio						IPR011990:TPR-like_helical_dom_sf,IPR033891:TTC38,									KW-0677~Repeat,KW-0802~TPR repeat,				REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
Q8N0Z6	tetratricopeptide repeat domain 5(TTC5)	Homo sapiens			GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009267~cellular response to starvation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061014~positive regulation of mRNA catabolic process,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0031410~cytoplasmic vesicle,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0043022~ribosome binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR032076:TTC5_OB,IPR038645:TTC5_OB_sf,		619244~Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism,		SM00028:TPR,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,		KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0677~Repeat,KW-0802~TPR repeat,			KW-0597~Phosphoprotein,	DOMAIN:Tetratricopeptide repeat protein 5 OB fold,MOTIF:Nuclear export signal,MUTAGEN:D->A: No change in interaction with 28S rRNA of ribosome-coding tubulin.,MUTAGEN:D->A: No change in interaction with N-terminal MREI motif of beta-tubulin nascent chain.,MUTAGEN:D->A: Partial loss of interaction with N-terminal MREI motif of beta-tubulin nascent chain. Loss of interaction with N-terminal MREI motif of beta-tubulin nascent chain; when associated with A-259.,MUTAGEN:E->A: Partial loss of interaction with N-terminal MREI motif of beta-tubulin nascent chain. Loss of interaction with N-terminal MREI motif of beta-tubulin nascent chain; when associated with D-225.,MUTAGEN:K->E: Loss of interaction with 28S rRNA of ribosome-coding tubulin, when associated with E-285. No change in interaction with N-terminal MREI motif of beta-tubulin nascent chain, when associated with E-285. Loss of tubulin autoregulation and accurate mitosis, when associated with E-285.,MUTAGEN:K->E: Loss of interaction with 28S rRNA of ribosome-coding tubulin, when associated with E-287. No change in interaction with N-terminal MREI motif of beta-tubulin nascent chain, when associated with E-287. Loss of tubulin autoregulation and accurate mitosis, when associated with E-287.,MUTAGEN:R->A: Loss of interaction with N-terminal MREI motif of beta-tubulin nascent chain. Loss of interaction with 28S rRNA of ribosome-coding tubulin. Loss of tubulin autoregulation and accurate mitosis.,REGION:Mediates interaction with 28S rRNA of ribosome-coding tubulin,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,SITE:Mediates interaction with N-terminal MREI motif of beta-tubulin nascent chain,
Q8VD72	tetratricopeptide repeat domain 8(Ttc8)	Mus musculus			GO:0001736~establishment of planar polarity,GO:0007411~axon guidance,GO:0007608~sensory perception of smell,GO:0015031~protein transport,GO:0021772~olfactory bulb development,GO:0030030~cell projection organization,GO:0032880~regulation of protein localization,GO:0034260~negative regulation of GTPase activity,GO:0035264~multicellular organism growth,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0045444~fat cell differentiation,GO:0048560~establishment of anatomical structure orientation,GO:0051492~regulation of stress fiber assembly,GO:0060122~inner ear receptor stereocilium organization,GO:0060219~camera-type eye photoreceptor cell differentiation,GO:0060271~cilium assembly,GO:0061326~renal tubule development,GO:0072659~protein localization to plasma membrane,GO:1903251~multi-ciliated epithelial cell differentiation,GO:1905515~non-motile cilium assembly,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0016020~membrane,GO:0032391~photoreceptor connecting cilium,GO:0034451~centriolar satellite,GO:0034464~BBSome,GO:0036064~ciliary basal body,GO:0042995~cell projection,GO:0060170~ciliary membrane,GO:0097730~non-motile cilium,	GO:0005515~protein binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR028796:BBS8,				SM00028:TPR,	KW-0653~Protein transport,KW-0813~Transport,KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0802~TPR repeat,				COMPBIAS:Polar residues,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,
Q9BGT1	tetratricopeptide repeat domain 9C(TTC9C)	Macaca fascicularis					GO:0005515~protein binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR039663:AIP/AIPL1/TTC9,				SM00028:TPR,					KW-0677~Repeat,KW-0802~TPR repeat,				REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
Q9H8H3	thiol methyltransferase 1A(TMT1A)	Homo sapiens			GO:0001649~osteoblast differentiation,GO:0006306~DNA methylation,GO:0042476~odontogenesis,GO:0080009~mRNA methylation,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0016020~membrane,GO:1904724~tertiary granule lumen,	GO:0001734~mRNA (N6-adenosine)-methyltransferase activity,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0018708~thiol S-methyltransferase activity,	IPR013216:Methyltransf_11,IPR029063:SAM-dependent_MTases_sf,					KW-0945~Host-virus interaction,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0551~Lipid droplet,KW-0963~Cytoplasm,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0488~Methylation,	DOMAIN:Methyltransferase type 11,REGION:Targeting to lipid droplets,TRANSMEM:Helical,
Q91W90	thioredoxin domain containing 5(Txndc5)	Mus musculus			GO:0006457~protein folding,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0003756~protein disulfide isomerase activity,GO:0015035~protein disulfide oxidoreductase activity,GO:0016491~oxidoreductase activity,GO:0016853~isomerase activity,	IPR005788:PDI_thioredoxin-like_dom,IPR013766:Thioredoxin_domain,IPR017937:Thioredoxin_CS,IPR036249:Thioredoxin-like_sf,	mmu04141:Protein processing in endoplasmic reticulum,					KW-0256~Endoplasmic reticulum,			KW-0676~Redox-active center,KW-0677~Repeat,KW-0732~Signal,		KW-0413~Isomerase,KW-0560~Oxidoreductase,	KW-1015~Disulfide bond,	DISULFID:Redox-active,DOMAIN:Thioredoxin,DOMAIN:Thioredoxin 1,DOMAIN:Thioredoxin 2,DOMAIN:Thioredoxin 3,MOTIF:Prevents secretion from ER,REGION:Disordered,
O14530	thioredoxin domain containing 9(TXNDC9)	Homo sapiens			GO:0000226~microtubule cytoskeleton organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0030496~midbody,	GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR013766:Thioredoxin_domain,IPR036249:Thioredoxin-like_sf,						KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,	DOMAIN:Thioredoxin,
Q9H3M7	thioredoxin interacting protein(TXNIP)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0006954~inflammatory response,GO:0007049~cell cycle,GO:0009410~response to xenobiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009749~response to glucose,GO:0015031~protein transport,GO:0030216~keratinocyte differentiation,GO:0032355~response to estradiol,GO:0032570~response to progesterone,GO:0042127~regulation of cell proliferation,GO:0042542~response to hydrogen peroxide,GO:0043065~positive regulation of apoptotic process,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0051592~response to calcium ion,GO:0051782~negative regulation of cell division,GO:0071228~cellular response to tumor cell,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR011021:Arrestin-like_N,IPR011022:Arrestin_C-like,IPR014752:Arrestin-like_C,IPR014756:Ig_E-set,	hsa04621:NOD-like receptor signaling pathway,			SM01017:Arrestin_C,	KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,				KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DISULFID:Interchain,DOMAIN:Arrestin C-terminal-like,
Q5M7W1	thioredoxin interacting protein(Txnip)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0006979~response to oxidative stress,GO:0007049~cell cycle,GO:0009410~response to xenobiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009749~response to glucose,GO:0015031~protein transport,GO:0030216~keratinocyte differentiation,GO:0032355~response to estradiol,GO:0032570~response to progesterone,GO:0042127~regulation of cell proliferation,GO:0042542~response to hydrogen peroxide,GO:0043065~positive regulation of apoptotic process,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0051592~response to calcium ion,GO:0051782~negative regulation of cell division,GO:0071228~cellular response to tumor cell,	GO:0005737~cytoplasm,	GO:0004857~enzyme inhibitor activity,GO:0031625~ubiquitin protein ligase binding,	IPR011021:Arrestin-like_N,IPR011022:Arrestin_C-like,IPR014752:Arrestin-like_C,IPR014756:Ig_E-set,	rno04621:NOD-like receptor signaling pathway,			SM01017:Arrestin_C,	KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,				KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DISULFID:Interchain,DOMAIN:Arrestin C-terminal-like,
Q9JLT4	thioredoxin reductase 2(Txnrd2)	Mus musculus			GO:0000305~response to oxygen radical,GO:0006979~response to oxidative stress,GO:0007507~heart development,GO:0009410~response to xenobiotic stimulus,GO:0010035~response to inorganic substance,GO:0010269~response to selenium ion,GO:0030097~hemopoiesis,GO:0045454~cell redox homeostasis,GO:0055093~response to hyperoxia,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0004791~thioredoxin-disulfide reductase activity,GO:0016491~oxidoreductase activity,GO:0016668~oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,GO:0042803~protein homodimerization activity,GO:0044877~macromolecular complex binding,GO:0050660~flavin adenine dinucleotide binding,	IPR001100:Pyr_nuc-diS_OxRdtase,IPR004099:Pyr_nucl-diS_OxRdtase_dimer,IPR006338:Thioredoxin/glutathione_Rdtase,IPR012999:Pyr_OxRdtase_I_AS,IPR016156:FAD/NAD-linked_Rdtase_dimer_sf,IPR023753:FAD/NAD-binding_dom,IPR036188:FAD/NAD-bd_sf,IPR046952:GSHR/TRXR-like,	mmu00450:Selenocompound metabolism,mmu05200:Pathways in cancer,mmu05225:Hepatocellular carcinoma,		PIRSF000350:Mercury_reductase_MerA,			KW-0496~Mitochondrion,			KW-0676~Redox-active center,KW-0809~Transit peptide,	KW-0274~FAD,KW-0285~Flavoprotein,KW-0520~NAD,KW-0521~NADP,KW-0547~Nucleotide-binding,	KW-0560~Oxidoreductase,	KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CROSSLNK:Cysteinyl-selenocysteine (Cys-Sec),DISULFID:Redox-active,DOMAIN:FAD/NAD(P)-binding,DOMAIN:Pyridine nucleotide-disulphide oxidoreductase dimerisation,NON_STD:Selenocysteine,TRANSIT:Mitochondrion,
Q8CDN6	thioredoxin-like 1(Txnl1)	Mus musculus				GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0015035~protein disulfide oxidoreductase activity,GO:0015036~disulfide oxidoreductase activity,	IPR000095:CRIB_dom,IPR008979:Galactose-bd-like_sf,IPR010400:PITH_dom,IPR013766:Thioredoxin_domain,IPR017937:Thioredoxin_CS,IPR036249:Thioredoxin-like_sf,IPR037047:PITH_dom_sf,					KW-0249~Electron transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0647~Proteasome,KW-0963~Cytoplasm,			KW-0676~Redox-active center,			KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DISULFID:Redox-active,DOMAIN:CRIB,DOMAIN:PITH,DOMAIN:Thioredoxin,
Q3U269	thiosulfate sulfurtransferase (rhodanese)-like domain containing 2(Tstd2)	Mus musculus						IPR001763:Rhodanese-like_dom,IPR020936:TrhO,IPR022111:Rhodanese_C,IPR036873:Rhodanese-like_dom_sf,IPR040503:TRHO_N,				SM00450:RHOD,								KW-0597~Phosphoprotein,	ACT_SITE:Cysteine persulfide intermediate,DOMAIN:Rhodanese,
Q8NFU3	thiosulfate sulfurtransferase like domain containing 1(TSTD1)	Homo sapiens			GO:0006006~glucose metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070221~sulfide oxidation, using sulfide:quinone oxidoreductase,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0048471~perinuclear region of cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0044877~macromolecular complex binding,GO:0050337~thiosulfate-thiol sulfurtransferase activity,	IPR001763:Rhodanese-like_dom,IPR036873:Rhodanese-like_dom_sf,IPR042457:TSTD1_mammal,				SM00450:RHOD,		KW-0963~Cytoplasm,					KW-0808~Transferase,		ACT_SITE:Cysteine persulfide intermediate,DOMAIN:Rhodanese,MUTAGEN:C->A,S: Leads to the loss of catalytic activity.,
P35440	thrombospondin 2(THBS2)	Gallus gallus			GO:0007155~cell adhesion,GO:0016525~negative regulation of angiogenesis,	GO:0005576~extracellular region,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008201~heparin binding,	IPR000742:EGF-like_dom,IPR000884:TSP1_rpt,IPR001007:VWF_dom,IPR001881:EGF-like_Ca-bd_dom,IPR003367:Thrombospondin_3-like_rpt,IPR008859:Thrombospondin_C,IPR013320:ConA-like_dom_sf,IPR017897:Thrombospondin_3_rpt,IPR024731:EGF_dom,IPR028974:TSP_type-3_rpt,IPR036383:TSP1_rpt_sf,IPR048287:TSPN-like_N,	gga04145:Phagosome,gga04510:Focal adhesion,gga04512:ECM-receptor interaction,			SM00179:EGF_CA,SM00181:EGF,SM00209:TSP1,SM00210:TSPN,SM00214:VWC,	KW-0130~Cell adhesion,				KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DISULFID:Interchain,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:Laminin G-like,DOMAIN:TSP C-terminal,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:VWFC,MOTIF:Cell attachment site,REGION:Disordered,REPEAT:TSP type-3,REPEAT:TSP type-3 1,REPEAT:TSP type-3 2,REPEAT:TSP type-3 3,REPEAT:TSP type-3 4,REPEAT:TSP type-3 5,REPEAT:TSP type-3 6,REPEAT:TSP type-3 7,REPEAT:TSP type-3 8,
P04183	thymidine kinase 1(TK1)	Homo sapiens	1.RBphosphoE2F,		GO:0006139~nucleobase-containing compound metabolic process,GO:0009157~deoxyribonucleoside monophosphate biosynthetic process,GO:0016310~phosphorylation,GO:0043097~pyrimidine nucleoside salvage,GO:0046092~deoxycytidine metabolic process,GO:0046104~thymidine metabolic process,GO:0046105~thymidine biosynthetic process,GO:0051289~protein homotetramerization,GO:0071897~DNA biosynthetic process,GO:1901135~carbohydrate derivative metabolic process,GO:1904860~DNA biosynthetic process involved in mitotic DNA replication,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0004137~deoxycytidine kinase activity,GO:0004797~thymidine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0019136~deoxynucleoside kinase activity,GO:0019206~nucleoside kinase activity,GO:0042802~identical protein binding,	IPR001267:Thymidine_kinase,IPR002624:DCK/DGK,IPR020633:Thymidine_kinase_CS,IPR027417:P-loop_NTPase,IPR031314:DNK_dom,	hsa00240:Pyrimidine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,		PIRSF000705:DNK,PIRSF035805:TK_cell,		KW-0237~DNA synthesis,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0935~Progressive external ophthalmoplegia,KW-1274~Primary mitochondrial disease,	KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Deoxynucleoside kinase,MOTIF:KEN box,MUTAGEN:K->A: Resistant to degradation in the mitotic exit phase.,MUTAGEN:KE->AA: Resistant to degradation in the mitotic exit phase.,MUTAGEN:KEN->AAA: Resistant to degradation in the mitotic exit phase.,MUTAGEN:L->A: 30-fold higher KM for thymidine.,MUTAGEN:M->I,A: 300-fold higher KM for thymidine.,MUTAGEN:S->A: Loss of phosphorylation. Constant expression during cell cycle. No effect on ATP-induced tetramerization.,MUTAGEN:S->D: Perturbes ATP-induced tetramerization. Retaines the enzymatic function with decreased thymidine affinity and catalytic efficiency.,MUTAGEN:S->P: No effect on phosphorylation.,MUTAGEN:T->S: 50-fold higher KM for thymidine.,REGION:Disordered,TRANSIT:Mitochondrion,
P04818	thymidylate synthetase(TYMS)	Homo sapiens	1.RBphosphoE2F,		GO:0006231~dTMP biosynthetic process,GO:0006235~dTTP biosynthetic process,GO:0006417~regulation of translation,GO:0007623~circadian rhythm,GO:0009410~response to xenobiotic stimulus,GO:0009636~response to toxic substance,GO:0017148~negative regulation of translation,GO:0019860~uracil metabolic process,GO:0032259~methylation,GO:0032570~response to progesterone,GO:0033189~response to vitamin A,GO:0034097~response to cytokine,GO:0035999~tetrahydrofolate interconversion,GO:0045471~response to ethanol,GO:0046683~response to organophosphorus,GO:0048589~developmental growth,GO:0051216~cartilage development,GO:0051384~response to glucocorticoid,GO:0051593~response to folic acid,GO:0060574~intestinal epithelial cell maturation,GO:0071897~DNA biosynthetic process,GO:0097421~liver regeneration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003729~mRNA binding,GO:0004799~thymidylate synthase activity,GO:0005542~folic acid binding,GO:0042803~protein homodimerization activity,GO:1990825~sequence-specific mRNA binding,	IPR000398:Thymidylate_synthase,IPR020940:Thymidylate_synthase_AS,IPR023451:Thymidate_synth/dCMP_Mease_dom,IPR036926:Thymidate_synth/dCMP_Mease_sf,IPR045097:Thymidate_synth/dCMP_Mease,	hsa00240:Pyrimidine metabolism,hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,hsa01523:Antifolate resistance,	620040~Dyskeratosis congenita, digenic,			KW-0545~Nucleotide biosynthesis,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0999~Mitochondrion inner membrane,		KW-0225~Disease variant,KW-1011~Dyskeratosis congenita,			KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Nucleophile,BINDING:in other chain,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Thymidylate synthase/dCMP hydroxymethylase,REGION:Disordered,
Q9W6I9	thyroid hormone receptor alpha(LOC110537966)	Oncorhynchus mykiss			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002154~thyroid hormone mediated signaling pathway,GO:0030154~cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048384~retinoic acid receptor signaling pathway,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0070324~thyroid hormone binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR001728:ThyrH_rcpt,IPR013088:Znf_NHR/GATA,IPR035500:NHR-like_dom_sf,	omy04080:Neuroactive ligand-receptor interaction,			SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0675~Receptor,		COMPBIAS:Basic and acidic residues,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,REGION:Disordered,
Q9PVE4	thyroid hormone receptor beta(thrb)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002154~thyroid hormone mediated signaling pathway,GO:0006355~regulation of transcription, DNA-templated,GO:0030154~cell differentiation,GO:0042670~retinal cone cell differentiation,GO:0042671~retinal cone cell fate determination,GO:0043010~camera-type eye development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046549~retinal cone cell development,GO:0048384~retinoic acid receptor signaling pathway,GO:0048839~inner ear development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0070324~thyroid hormone binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR001728:ThyrH_rcpt,IPR013088:Znf_NHR/GATA,IPR035500:NHR-like_dom_sf,	dre04080:Neuroactive ligand-receptor interaction,			SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0675~Receptor,		DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,REGION:Modulating,ZN_FING:NR C4-type,
Q6PH52	thyroid hormone receptor interactor 13(trip13)	Danio rerio			GO:0006302~double-strand break repair,GO:0007130~synaptonemal complex assembly,GO:0007131~reciprocal meiotic recombination,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0048477~oogenesis,GO:0051321~meiotic cell cycle,GO:0051598~meiotic recombination checkpoint,	GO:0005634~nucleus,GO:0005694~chromosome,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR003960:ATPase_AAA_CS,IPR027417:P-loop_NTPase,IPR044539:Pch2-like,	dre04110:Cell cycle,			SM00382:AAA,	KW-0221~Differentiation,KW-0469~Meiosis,KW-0744~Spermatogenesis,KW-0896~Oogenesis,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			DOMAIN:AAA+ ATPase,
O95049	tight junction protein 3(TJP3)	Homo sapiens			GO:0035633~maintenance of permeability of blood-brain barrier,GO:0045216~cell-cell junction organization,GO:0090557~establishment of endothelial intestinal barrier,GO:0098609~cell-cell adhesion,GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0030054~cell junction,	GO:0005515~protein binding,GO:0050839~cell adhesion molecule binding,	IPR001452:SH3_domain,IPR001478:PDZ,IPR005417:ZO,IPR005420:ZO-3,IPR008144:Guanylate_kin-like_dom,IPR008145:GK/Ca_channel_bsu,IPR027417:P-loop_NTPase,IPR036028:SH3-like_dom_sf,IPR036034:PDZ_sf,	hsa04530:Tight junction,			SM00072:GuKc,SM00228:PDZ,SM00326:SH3,		KW-0472~Membrane,KW-0539~Nucleus,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0728~SH3 domain,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Guanylate kinase-like,DOMAIN:PDZ,DOMAIN:PDZ 1,DOMAIN:PDZ 2,DOMAIN:PDZ 3,DOMAIN:SH3,REGION:Disordered,
Q6DBR4	timeless interacting protein(tipin)	Danio rerio			GO:0000076~DNA replication checkpoint,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0031297~replication fork processing,GO:0031573~intra-S DNA damage checkpoint,GO:0043111~replication fork arrest,GO:0044770~cell cycle phase transition,GO:0051301~cell division,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031298~replication fork protection complex,	GO:0003677~DNA binding,	IPR012923:Csm3,IPR040038:TIPIN/Csm3/Swi3,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0227~DNA damage,KW-0498~Mitosis,	KW-0539~Nucleus,KW-0963~Cytoplasm,							COMPBIAS:Polar residues,DOMAIN:Chromosome segregation in meiosis protein 3,REGION:Disordered,REGION:Interaction with TIMELESS,
Q7YRQ8	tissue factor pathway inhibitor 2(TFPI2)	Bos taurus			GO:0007596~blood coagulation,GO:0010466~negative regulation of peptidase activity,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR002223:Kunitz_BPTI,IPR008296:TFPI-like,IPR020901:Prtase_inh_Kunz-CS,IPR036880:Kunitz_BPTI_sf,			PIRSF001620:TFPI,	SM00131:KU,	KW-0094~Blood coagulation,KW-0356~Hemostasis,	KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,		KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:BPTI/Kunitz inhibitor 1,DOMAIN:BPTI/Kunitz inhibitor 2,DOMAIN:BPTI/Kunitz inhibitor 3,SITE:Reactive bond,
Q15399	toll like receptor 1(TLR1)	Homo sapiens			GO:0002224~toll-like receptor signaling pathway,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034137~positive regulation of toll-like receptor 2 signaling pathway,GO:0042116~macrophage activation,GO:0042495~detection of triacyl bacterial lipopeptide,GO:0045087~innate immune response,GO:0071727~cellular response to triacyl bacterial lipopeptide,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030670~phagocytic vesicle membrane,GO:0035354~Toll-like receptor 1-Toll-like receptor 2 protein complex,GO:0043235~receptor complex,GO:0045121~membrane raft,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0035663~Toll-like receptor 2 binding,GO:0038023~signaling receptor activity,GO:0042802~identical protein binding,GO:0050135~NAD(P)+ nucleosidase activity,GO:0061809~NAD+ nucleotidase, cyclic ADP-ribose generating,GO:0071723~lipopeptide binding,	IPR000157:TIR_dom,IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR017241:Toll-like_receptor,IPR032675:LRR_dom_sf,IPR035897:Toll_tir_struct_dom_sf,	hsa04620:Toll-like receptor signaling pathway,hsa05152:Tuberculosis,	613223~Leprosy, protection against,613223~Leprosy, susceptibility to, 5,	PIRSF037595:Toll-like_receptor,	SM00082:LRRCT,SM00255:TIR,SM00364:LRR_BAC,SM00369:LRR_TYP,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0520~NAD,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:LRRCT,DOMAIN:TIR,REGION:Interaction with bacterial lipopeptide,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 18,REPEAT:LRR 19,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6R5N8	toll-like receptor 13(Tlr13)	Mus musculus			GO:0002224~toll-like receptor signaling pathway,GO:0002376~immune system process,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0009615~response to virus,GO:0034178~toll-like receptor 13 signaling pathway,GO:0043408~regulation of MAPK cascade,GO:0045087~innate immune response,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0010008~endosome membrane,GO:0016020~membrane,	GO:0003723~RNA binding,GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0038023~signaling receptor activity,GO:0042802~identical protein binding,GO:0050135~NAD(P)+ nucleosidase activity,GO:0061809~NAD+ nucleotidase, cyclic ADP-ribose generating,	IPR000157:TIR_dom,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR017241:Toll-like_receptor,IPR025875:Leu-rich_rpt_4,IPR032675:LRR_dom_sf,IPR035897:Toll_tir_struct_dom_sf,				SM00255:TIR,SM00364:LRR_BAC,SM00365:LRR_SD22,SM00369:LRR_TYP,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,	KW-0472~Membrane,KW-0967~Endosome,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0520~NAD,	KW-0675~Receptor,KW-0694~RNA-binding,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:LRRCT,DOMAIN:TIR,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 18,REPEAT:LRR 19,REPEAT:LRR 2,REPEAT:LRR 20,REPEAT:LRR 21,REPEAT:LRR 22,REPEAT:LRR 23,REPEAT:LRR 24,REPEAT:LRR 25,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O42131	topoisomerase (DNA) II beta(TOP2B)	Gallus gallus			GO:0000712~resolution of meiotic recombination intermediates,GO:0000819~sister chromatid segregation,GO:0006265~DNA topological change,GO:0030183~B cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:1990904~ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003916~DNA topoisomerase activity,GO:0003918~DNA topoisomerase type II (ATP-hydrolyzing) activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR001154:TopoII_euk,IPR001241:Topo_IIA,IPR002205:Topo_IIA_dom_A,IPR003594:HATPase_C,IPR006171:TOPRIM_domain,IPR012542:DTHCT,IPR013506:Topo_IIA_bsu_dom2,IPR013757:Topo_IIA_A_a_sf,IPR013758:Topo_IIA_A/C_ab,IPR013759:Topo_IIA_B_C,IPR013760:Topo_IIA-like_dom_sf,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR018522:TopoIIA_CS,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR031660:TOPRIM_C,IPR034157:TOPRIM_TopoII,IPR036890:HATPase_C_sf,				SM00433:TOP2c,SM00434:TOP4c,		KW-0539~Nucleus,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0413~Isomerase,KW-0799~Topoisomerase,		ACT_SITE:O-(5'-phospho-DNA)-tyrosine intermediate,COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Histidine kinase/HSP90-like ATPase,DOMAIN:Topo IIA-type catalytic,DOMAIN:Toprim,REGION:Disordered,REGION:Interaction with DNA,SITE:Important for DNA bending; intercalates between base pairs of target DNA,SITE:Interaction with DNA,SITE:Transition state stabilizer,
Q9H497	torsin family 3 member A(TOR3A)	Homo sapiens				GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR010448:Torsin,IPR027417:P-loop_NTPase,IPR049337:TOR1A_C,						KW-0256~Endoplasmic reticulum,KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Torsin-1A C-terminal,MUTAGEN:E->Q: No effect on subcellular location.,
Q9UPV9	trafficking kinesin protein 1(TRAK1)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006493~protein O-linked glycosylation,GO:0006605~protein targeting,GO:0008333~endosome to lysosome transport,GO:0022008~neurogenesis,GO:0047496~vesicle transport along microtubule,GO:0048311~mitochondrion distribution,GO:0048813~dendrite morphogenesis,GO:0050772~positive regulation of axonogenesis,GO:0098957~anterograde axonal transport of mitochondrion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005938~cell cortex,GO:0030425~dendrite,GO:0031410~cytoplasmic vesicle,GO:0031966~mitochondrial membrane,GO:0044295~axonal growth cone,GO:0048471~perinuclear region of cytoplasm,GO:1904115~axon cytoplasm,	GO:0005515~protein binding,GO:0016740~transferase activity,GO:0017022~myosin binding,GO:0030911~TPR domain binding,GO:0050811~GABA receptor binding,	IPR006933:HAP1_N,IPR022154:TRAK1/2_C,		618201~Developmental and epileptic encephalopathy 68,		SM01423:Milton,SM01424:HAP1_N,		KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0967~Endosome,		KW-0225~Disease variant,KW-0887~Epilepsy,	KW-0175~Coiled coil,		KW-0808~Transferase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:O-linked (GlcNAc) serine,CARBOHYD:O-linked (GlcNAc) threonine,COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DOMAIN:HAP1 N-terminal,DOMAIN:Trafficking kinesin-binding protein C-terminal,MUTAGEN:Missing: Loss of interaction with OGT, but interacts with KIF5B and RHOT1/2 and is able to localize to mitochondria. Increased O-glycosylation of this protein by OGT.,MUTAGEN:S->A: Reduced O-glycosylation of this protein.,MUTAGEN:S->A: Reduced O-glycosylation of this protein; when associated with A-829.,MUTAGEN:S->A: Reduced O-glycosylation of this protein; when associated with A-830.,REGION:Disordered,REGION:Interaction with HGS,REGION:Interaction with OGT,
Q9NZ01	trans-2,3-enoyl-CoA reductase(TECR)	Homo sapiens			GO:0006629~lipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0030497~fatty acid elongation,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0017099~very-long-chain-acyl-CoA dehydrogenase activity,	IPR001104:3-oxo-5_a-steroid_4-DH_C,IPR029071:Ubiquitin-like_domsf,IPR039357:SRD5A/TECR,IPR049127:TECR-like_N,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,	614020~Intellectual developmental disorder, autosomal recessive 14,			KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0746~Sphingolipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Steroid 5-alpha reductase C-terminal,DOMAIN:TECR-like N-terminal,REGION:Disordered,TRANSMEM:Helical,
B5XGH3	transcription and mRNA export factor ENY2-2-like(LOC106605055)	Salmo salar			GO:0006325~chromatin organization,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006406~mRNA export from nucleus,GO:0015031~protein transport,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0000124~SAGA complex,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0070390~transcription export complex 2,GO:0071819~DUBm complex,	GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,	IPR018783:TF_ENY2,IPR038212:TF_EnY2_sf,					KW-0509~mRNA transport,KW-0653~Protein transport,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0811~Translocation,KW-0813~Transport,	KW-0539~Nucleus,					KW-0010~Activator,KW-0156~Chromatin regulator,
A0A0R4IBL7	transcription factor 12(tcf12)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0030154~cell differentiation,GO:0031175~neuron projection development,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046983~protein dimerization activity,	IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,				SM00353:HLH,	KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,	KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BHLH,DOMAIN:bHLH,REGION:Class A specific domain,REGION:Disordered,
P15881	transcription factor 4(TCF4)	Canis lupus dingo			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045666~positive regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0070369~beta-catenin-TCF7L2 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008013~beta-catenin binding,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,	IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,				SM00353:HLH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BHLH,DOMAIN:bHLH,REGION:Class A specific domain,REGION:Disordered,REGION:Essential for MYOD1 inhibition,REGION:Leucine-zipper,
P15881	transcription factor 4(TCF4)	Canis lupus familiaris			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045666~positive regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0016020~membrane,GO:0070369~beta-catenin-TCF7L2 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008013~beta-catenin binding,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,	IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,				SM00353:HLH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BHLH,DOMAIN:bHLH,REGION:Class A specific domain,REGION:Disordered,REGION:Essential for MYOD1 inhibition,REGION:Leucine-zipper,TRANSMEM:Helical,
Q9UL49	transcription factor like 5(TCFL5)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0042127~regulation of cell proliferation,GO:0045595~regulation of cell differentiation,	GO:0000785~chromatin,GO:0001673~male germ cell nucleus,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046983~protein dimerization activity,GO:1990837~sequence-specific double-stranded DNA binding,	IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,IPR039583:TCFL5/SOLH1/2,				SM00353:HLH,	KW-0221~Differentiation,KW-0744~Spermatogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:BHLH,DOMAIN:bHLH,REGION:Disordered,REGION:R1 epitope (recognized by Chagas's antibodies),REGION:R3 epitope (recognized by Chagas's antibodies),
Q90YG6	transcription initiation factor IIA subunit 2(gtf2a2)	Oncorhynchus mykiss			GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0051123~RNA polymerase II transcriptional preinitiation complex assembly,	GO:0005672~transcription factor TFIIA complex,GO:0016020~membrane,	GO:0003743~translation initiation factor activity,GO:0017025~TBP-class protein binding,	IPR003194:TFIIA_gsu,IPR009083:TFIIA_a-hlx,IPR009088:TFIIA_b-brl,IPR015871:TFIIA_gsu_C,IPR015872:TFIIA_gsu_N,	omy03022:Basal transcription factors,		PIRSF009415:Hum_TFIIA_gamma,		KW-0648~Protein biosynthesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0396~Initiation factor,		DOMAIN:Transcription initiation factor IIA gamma subunit C-terminal,DOMAIN:Transcription initiation factor IIA gamma subunit N-terminal,TRANSMEM:Helical,
Q503N9	transcriptional adaptor 2B(tada2b)	Danio rerio			GO:0006338~chromatin remodeling,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0035065~regulation of histone acetylation,GO:0048856~anatomical structure development,	GO:0005634~nucleus,GO:0070461~SAGA-type complex,	GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000433:Znf_ZZ,IPR001005:SANT/Myb,IPR009057:Homeobox-like_sf,IPR016827:Ada2/TADA2,IPR017884:SANT_dom,IPR036388:WH-like_DNA-bd_sf,IPR041983:ADA2-like_ZZ,IPR043145:Znf_ZZ_sf,			PIRSF025024:Transcriptional_adaptor_2,	SM00291:ZnF_ZZ,SM00717:SANT,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Basic and acidic residues,DOMAIN:SANT,REGION:Disordered,ZN_FING:ZZ-type,
P50616	transducer of ERBB2, 1(TOB1)	Homo sapiens		h_tob1Pathway:Role of Tob in T-cell activation,	GO:0008285~negative regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0017148~negative regulation of translation,GO:0030514~negative regulation of BMP signaling pathway,GO:0045668~negative regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0060212~negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0060390~regulation of SMAD protein import into nucleus,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030014~CCR4-NOT complex,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,GO:0046332~SMAD binding,	IPR002087:Anti_prolifrtn,IPR015676:Tob1/2,IPR036054:BTG-like_sf,	hsa03018:RNA degradation,			SM00099:btg1,		KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,DOMAIN:Anti-proliferative protein,MOTIF:Bipartite nuclear localization signal,MOTIF:Nuclear export signal,MUTAGEN:D->A: Impairs interaction with CNOT7 and CNOT8.,MUTAGEN:F->A: Impairs interaction with CNOT7 and CNOT8.,MUTAGEN:W->A: Impairs interaction with CNOT7 and CNOT8.,MUTAGEN:Y->A: Impairs interaction with CNOT7 and CNOT8.,REGION:Disordered,REGION:Important for nuclear localization,REGION:Required for interaction with CPEB3,
O75410	transforming acidic coiled-coil containing protein 1(TACC1)	Homo sapiens			GO:0000226~microtubule cytoskeleton organization,GO:0007052~mitotic spindle organization,GO:0008283~cell proliferation,GO:0021987~cerebral cortex development,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0030496~midbody,	GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0030331~estrogen receptor binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0035259~glucocorticoid receptor binding,GO:0042974~retinoic acid receptor binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0046965~retinoid X receptor binding,GO:0046966~thyroid hormone receptor binding,	IPR007707:TACC_C,IPR039915:TACC,					KW-0131~Cell cycle,KW-0132~Cell division,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0010~Activator,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0519~Myristate,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SPAZ 1,DOMAIN:SPAZ 2,DOMAIN:Transforming acidic coiled-coil-containing protein C-terminal,LIPID:N-myristoyl glycine,MOTIF:Bipartite nuclear localization signal 1,MOTIF:Bipartite nuclear localization signal 2,MUTAGEN:LI->AA: Decreases interaction with THRA.,MUTAGEN:S->A: Impairs phosphorylation by AURKC.,REGION:Disordered,REGION:Interaction with CH-TOG,REGION:Interaction with LSM7 and SNRPG,REGION:Interaction with TDRD7,REGION:Interaction with YEATS4,
Q9PTG8	transforming acidic coiled-coil containing protein 3 S homeolog(tacc3.S)	Xenopus laevis			GO:0006417~regulation of translation,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0017148~negative regulation of translation,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0032991~macromolecular complex,	GO:0005515~protein binding,GO:0031369~translation initiation factor binding,	IPR007707:TACC_C,IPR039915:TACC,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0810~Translation regulation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0652~Protein synthesis inhibitor,KW-0678~Repressor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Transforming acidic coiled-coil-containing protein C-terminal,MUTAGEN:D->K: Disrupts interactions with ckap5-a.,MUTAGEN:DD->AA: Disrupts interactions with ckap5-a.,MUTAGEN:FLL->AAA: Fails to bind eif4e; when associated with A-577.,MUTAGEN:T->A: Fails to bind eif4e; when associated with 581-AAA-583.,REGION:Disordered,
P10600	transforming growth factor beta 3(TGFB3)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_erythPathway:Erythrocyte Differentiation Pathway,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_il1rPathway:Signal transduction through IL1R,h_inflamPathway:Cytokines and Inflammatory Response,h_mapkPathway:MAPKinase Signaling Pathway,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_slrp2Pathway:Function of SLRP in Bone: An Integrated View,h_tgfbPathway:TGF beta signaling pathway,h_tob1Pathway:Role of Tob in T-cell activation,	GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007435~salivary gland morphogenesis,GO:0007565~female pregnancy,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010936~negative regulation of macrophage cytokine production,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030879~mammary gland development,GO:0032570~response to progesterone,GO:0032967~positive regulation of collagen biosynthetic process,GO:0034616~response to laminar fluid shear stress,GO:0042127~regulation of cell proliferation,GO:0042476~odontogenesis,GO:0042704~uterine wall breakdown,GO:0043065~positive regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0043627~response to estrogen,GO:0045216~cell-cell junction organization,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048286~lung alveolus development,GO:0048565~digestive tract development,GO:0048702~embryonic neurocranium morphogenesis,GO:0048839~inner ear development,GO:0050714~positive regulation of protein secretion,GO:0051491~positive regulation of filopodium assembly,GO:0051496~positive regulation of stress fiber assembly,GO:0051781~positive regulation of cell division,GO:0060325~face morphogenesis,GO:0060364~frontal suture morphogenesis,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0070483~detection of hypoxia,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1905075~positive regulation of occluding junction disassembly,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0030141~secretory granule,GO:0030315~T-tubule,GO:0031093~platelet alpha granule lumen,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,	GO:0005114~type II transforming growth factor beta receptor binding,GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0034713~type I transforming growth factor beta receptor binding,GO:0034714~type III transforming growth factor beta receptor binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:0050431~transforming growth factor beta binding,	IPR001111:TGF-b_propeptide,IPR001839:TGF-b_C,IPR015615:TGF-beta-rel,IPR015618:TGFB3,IPR016319:TGF-beta,IPR017948:TGFb_CS,IPR029034:Cystine-knot_cytokine,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04218:Cellular senescence,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa05140:Leishmaniasis,hsa05142:Chagas disease,hsa05144:Malaria,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05166:Human T-cell leukemia virus 1 infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,hsa05225:Hepatocellular carcinoma,hsa05226:Gastric cancer,hsa05321:Inflammatory bowel disease,hsa05323:Rheumatoid arthritis,hsa05410:Hypertrophic cardiomyopathy,hsa05414:Dilated cardiomyopathy,hsa05415:Diabetic cardiomyopathy,	107970~Arrhythmogenic right ventricular dysplasia 1,615582~Loeys-Dietz syndrome 5,	PIRSF001787:TGF-beta,	SM00204:TGFB,		KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,	KW-0732~Signal,		KW-0339~Growth factor,KW-0497~Mitogen,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0488~Methylation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DISULFID:Interchain,DOMAIN:TGF-beta family profile,DOMAIN:TGF-beta propeptide,MOTIF:Cell attachment site,MUTAGEN:Q->R: Abolishes methylation by N6AMT1.,REGION:Disordered,
Q3YBR2	transforming growth factor beta regulator 1(TBRG1)	Homo sapiens			GO:0006260~DNA replication,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0050821~protein stabilization,GO:0051726~regulation of cell cycle,GO:1990173~protein localization to nucleoplasm,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0005515~protein binding,	IPR003888:FYrich_N,IPR003889:FYrich_C,IPR040092:TBRG1,				SM00541:FYRN,SM00542:FYRC,	KW-0131~Cell cycle,	KW-0539~Nucleus,		KW-0043~Tumor suppressor,	KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,DOMAIN:FYR C-terminal,DOMAIN:FYR N-terminal,REGION:Disordered,
O93449	transforming growth factor beta-1 proprotein-like(LOC100136774)	Oncorhynchus mykiss			GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0030509~BMP signaling pathway,GO:0042127~regulation of cell proliferation,GO:0051781~positive regulation of cell division,GO:0060395~SMAD protein signal transduction,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005114~type II transforming growth factor beta receptor binding,GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0008083~growth factor activity,GO:0034714~type III transforming growth factor beta receptor binding,	IPR001111:TGF-b_propeptide,IPR001839:TGF-b_C,IPR003939:TGFb1,IPR015615:TGF-beta-rel,IPR016319:TGF-beta,IPR017948:TGFb_CS,IPR029034:Cystine-knot_cytokine,	omy04010:MAPK signaling pathway,omy04060:Cytokine-cytokine receptor interaction,omy04068:FoxO signaling pathway,omy04110:Cell cycle,omy04148:Efferocytosis,omy04218:Cellular senescence,omy04350:TGF-beta signaling pathway,omy04672:Intestinal immune network for IgA production,		PIRSF001787:TGF-beta,	SM00204:TGFB,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0732~Signal,		KW-0339~Growth factor,KW-0497~Mitogen,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,DISULFID:Interchain (with C-215),DISULFID:Interchain (with C-217),DISULFID:Interchain (with C-? in LTBP1 TB3 domain); in inactive form,DOMAIN:TGF-beta family profile,MOTIF:Cell attachment site,REGION:Arm domain,REGION:Bowtie tail,REGION:Straightjacket domain,
Q9R1Q8	transgelin 3(Tagln3)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0007015~actin filament organization,	GO:0005634~nucleus,GO:0015629~actin cytoskeleton,GO:0043209~myelin sheath,	GO:0051015~actin filament binding,	IPR000557:Calponin_repeat,IPR001715:CH_dom,IPR003096:SM22_calponin,IPR036872:CH_dom_sf,				SM00033:CH,								KW-0597~Phosphoprotein,	DOMAIN:Calponin-homology (CH),REGION:Disordered,REPEAT:Calponin-like,
P19966	transgelin(TAGLN)	Gallus gallus				GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR000557:Calponin_repeat,IPR001715:CH_dom,IPR003096:SM22_calponin,IPR036872:CH_dom_sf,				SM00033:CH,		KW-0963~Cytoplasm,					KW-0514~Muscle protein,	KW-0007~Acetylation,	DOMAIN:Calponin-homology (CH),REPEAT:Calponin-like,
P51176	transglutaminase 2(TGM2)	Bos taurus			GO:0006508~proteolysis,GO:0006590~thyroid hormone generation,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0010467~gene expression,GO:0014046~dopamine secretion,GO:0015705~iodide transport,GO:0018149~peptide cross-linking,GO:0018277~protein deamination,GO:0030878~thyroid gland development,GO:0031641~regulation of myelination,GO:0032471~negative regulation of endoplasmic reticulum calcium ion concentration,GO:0042446~hormone biosynthetic process,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043277~apoptotic cell clearance,GO:0043547~positive regulation of GTPase activity,GO:0045785~positive regulation of cell adhesion,GO:0050769~positive regulation of neurogenesis,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051260~protein homooligomerization,GO:0051561~positive regulation of mitochondrial calcium ion concentration,GO:0060348~bone development,GO:0060445~branching involved in salivary gland morphogenesis,GO:0060662~salivary gland cavitation,GO:0071314~cellular response to cocaine,GO:1903351~cellular response to dopamine,GO:1904015~cellular response to serotonin,GO:2000425~regulation of apoptotic cell clearance,	GO:0000785~chromatin,GO:0000786~nucleosome,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,	GO:0003810~protein-glutamine gamma-glutamyltransferase activity,GO:0005179~hormone activity,GO:0005509~calcium ion binding,GO:0005525~GTP binding,GO:0008233~peptidase activity,GO:0042393~histone binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0050568~protein-glutamine glutaminase activity,	IPR000716:Thyroglobulin_1,IPR001102:Transglutaminase_N,IPR002018:CarbesteraseB,IPR002931:Transglutaminase-like,IPR008958:Transglutaminase_C,IPR009030:Growth_fac_rcpt_cys_sf,IPR011641:Tyr-kin_ephrin_A/B_rcpt-like,IPR013783:Ig-like_fold,IPR013808:Transglutaminase_AS,IPR014756:Ig_E-set,IPR016324:Thyroglobulin,IPR019819:Carboxylesterase_B_CS,IPR023608:Transglutaminase_animal,IPR029058:AB_hydrolase,IPR036238:Transglutaminase_C_sf,IPR036857:Thyroglobulin_1_sf,IPR036985:Transglutaminase-like_sf,IPR038765:Papain-like_cys_pep_sf,	bta05016:Huntington disease,		PIRSF000459:TGM_EBP42,PIRSF001831:Thyroglobulin,	SM00211:TY,SM00460:TGc,SM01411:Ephrin_rec_like,	KW-0893~Thyroid hormones biosynthesis,	KW-0158~Chromosome,KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0342~GTP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0012~Acyltransferase,KW-0372~Hormone,KW-0378~Hydrolase,KW-0645~Protease,KW-0795~Thyroid hormone,KW-0808~Transferase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0405~Iodination,KW-0702~S-nitrosylation,KW-0765~Sulfation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CARBOHYD:N-linked (GlcNAc...) (complex) asparagine; alternate,CARBOHYD:N-linked (GlcNAc...) (high mannose) asparagine,CARBOHYD:N-linked (GlcNAc...) (hybrid) asparagine; alternate,COMPBIAS:Basic and acidic residues,CROSSLNK:Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?),DISULFID:Alternate,DOMAIN:Thyroglobulin type-1,DOMAIN:Thyroglobulin type-1 1,DOMAIN:Thyroglobulin type-1 10,DOMAIN:Thyroglobulin type-1 11,DOMAIN:Thyroglobulin type-1 2,DOMAIN:Thyroglobulin type-1 3,DOMAIN:Thyroglobulin type-1 4,DOMAIN:Thyroglobulin type-1 5,DOMAIN:Thyroglobulin type-1 6,DOMAIN:Thyroglobulin type-1 7,DOMAIN:Thyroglobulin type-1 8,DOMAIN:Thyroglobulin type-1 9,DOMAIN:Transglutaminase-like,REGION:Cholinesterase-like (ChEL),REGION:Disordered,REPEAT:Type II,REPEAT:Type IIIA,REPEAT:Type IIIB,SITE:Important for catalytic activity,SITE:Not glycosylated,
Q2TAA8	translin associated factor X interacting protein 1(TSNAXIP1)	Homo sapiens			GO:0007283~spermatogenesis,GO:0030154~cell differentiation,	GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR032755:TSNAXIP1_N,					KW-0221~Differentiation,KW-0744~Spermatogenesis,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:Translin-associated factor X-interacting protein 1 N-terminal,REGION:Disordered,
Q6DED0	translocation associated membrane protein 1 L homeolog(tram1.L)	Xenopus laevis			GO:0006616~SRP-dependent cotranslational protein targeting to membrane, translocation,GO:0015031~protein transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR006634:TLC-dom,IPR016447:Translocation_assoc_membrane,	xla04141:Protein processing in endoplasmic reticulum,		PIRSF005449:Translocation_assoc_membrane,	SM00724:TLC,	KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:TLC,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
P30408	transmembrane 4 L six family member 1(TM4SF1)	Homo sapiens			GO:0001825~blastocyst formation,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,	IPR008661:L6_membrane,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:C->G: Abolishes interaction with SDCBP2. Loss of colocalization with SDCBP2 at the apical region of the cell.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5RE43	transmembrane 4 L six family member 1(TM4SF1)	Pongo abelii				GO:0005886~plasma membrane,GO:0016020~membrane,		IPR008661:L6_membrane,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O76062	transmembrane 7 superfamily member 2(TM7SF2)	Homo sapiens			GO:0006695~cholesterol biosynthetic process,GO:0016126~sterol biosynthetic process,	GO:0005637~nuclear inner membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0043235~receptor complex,	GO:0005515~protein binding,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0050613~delta14-sterol reductase activity,GO:0050661~NADP binding,	IPR001171:ERG24_DHCR-like,IPR018083:Sterol_reductase_CS,	hsa00100:Steroid biosynthesis,hsa01100:Metabolic pathways,				KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0521~NADP,	KW-0560~Oxidoreductase,		REGION:Disordered,TRANSMEM:Helical,
Q969X1	transmembrane BAX inhibitor motif containing 1(TMBIM1)	Homo sapiens			GO:0043086~negative regulation of catalytic activity,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902045~negative regulation of Fas signaling pathway,GO:1903077~negative regulation of protein localization to plasma membrane,GO:2000504~positive regulation of blood vessel remodeling,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005765~lysosomal membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0035579~specific granule membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005123~death receptor binding,GO:0005515~protein binding,	IPR006214:Bax_inhibitor_1-related,						KW-0458~Lysosome,KW-0472~Membrane,KW-0967~Endosome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,REGION:Disordered,TRANSMEM:Helical,
Q6UXY8	transmembrane channel like 5(TMC5)	Homo sapiens			GO:0034220~ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0008381~mechanically-gated ion channel activity,	IPR012496:TMC_dom,IPR038900:TMC,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0407~Ion channel,		COMPBIAS:Polar residues,DOMAIN:TMC,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q28BQ6	transmembrane p24 trafficking protein 1(tmed1)	Xenopus tropicalis			GO:0006094~gluconeogenesis,GO:0006096~glycolytic process,GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0015031~protein transport,GO:1901135~carbohydrate derivative metabolic process,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030134~ER to Golgi transport vesicle,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004347~glucose-6-phosphate isomerase activity,GO:0005125~cytokine activity,GO:0038024~cargo receptor activity,GO:0097367~carbohydrate derivative binding,	IPR001672:G6P_Isomerase,IPR009038:GOLD_dom,IPR015720:Emp24-like,IPR018189:Phosphoglucose_isomerase_CS,IPR035476:SIS_PGI_1,IPR035482:SIS_PGI_2,IPR036598:GOLD_dom_sf,IPR046348:SIS_dom_sf,				SM01190:EMP24_GP25L,	KW-0324~Glycolysis,KW-0653~Protein transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0202~Cytokine,KW-0413~Isomerase,		DOMAIN:GOLD,MOTIF:COPI vesicle coat-binding,MOTIF:COPII vesicle coat-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q90515	transmembrane p24 trafficking protein 10(tmed10)	Takifugu rubripes			GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0030134~ER to Golgi transport vesicle,GO:0030658~transport vesicle membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,		IPR009038:GOLD_dom,IPR015720:Emp24-like,				SM01190:EMP24_GP25L,	KW-0653~Protein transport,KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:GOLD,MOTIF:COPI vesicle coat-binding,MOTIF:COPII vesicle coat-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q2KJ84	transmembrane p24 trafficking protein 5(TMED5)	Bos taurus			GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0015031~protein transport,GO:0090161~Golgi ribbon formation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0030134~ER to Golgi transport vesicle,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0070971~endoplasmic reticulum exit site,		IPR009038:GOLD_dom,IPR015720:Emp24-like,IPR036598:GOLD_dom_sf,				SM01190:EMP24_GP25L,	KW-0653~Protein transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:GOLD,MOTIF:Mediates export from ER,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
D3ZTX0	transmembrane p24 trafficking protein 7(Tmed7)	Rattus norvegicus			GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0015031~protein transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0012507~ER to Golgi transport vesicle membrane,GO:0030134~ER to Golgi transport vesicle,GO:0030663~COPI-coated vesicle membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0038024~cargo receptor activity,	IPR009038:GOLD_dom,IPR015720:Emp24-like,IPR036598:GOLD_dom_sf,				SM01190:EMP24_GP25L,	KW-0653~Protein transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:GOLD,MOTIF:COPI vesicle coat-binding,MOTIF:COPII vesicle coat-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q5I0E7	transmembrane p24 trafficking protein 9(Tmed9)	Rattus norvegicus			GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0010638~positive regulation of organelle organization,GO:0048205~COPI coating of Golgi vesicle,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0008021~synaptic vesicle,GO:0030134~ER to Golgi transport vesicle,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0005515~protein binding,GO:0019905~syntaxin binding,GO:0038024~cargo receptor activity,	IPR009038:GOLD_dom,IPR015720:Emp24-like,				SM01190:EMP24_GP25L,	KW-0653~Protein transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0175~Coiled coil,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:GOLD,MOTIF:COPI vesicle coat-binding,MOTIF:COPII vesicle coat-binding,REGION:Required for interaction with STX17,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q6XPS3	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2(TPTE2)	Homo sapiens			GO:0006661~phosphatidylinositol biosynthetic process,GO:0016311~dephosphorylation,GO:0034220~ion transmembrane transport,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004725~protein tyrosine phosphatase activity,GO:0005216~ion channel activity,GO:0016314~phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,GO:0016791~phosphatase activity,GO:0030171~voltage-gated proton channel activity,GO:0051800~phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,	IPR000242:PTP_cat,IPR000387:Tyr_Pase_dom,IPR005821:Ion_trans_dom,IPR014020:Tensin_C2-dom,IPR016130:Tyr_Pase_AS,IPR027359:Volt_channel_dom_sf,IPR029021:Prot-tyrosine_phosphatase-like,IPR029023:Tensin_phosphatase,IPR031846:Hvcn1,IPR035892:C2_domain_sf,IPR045102:PTP_VSP_TPTE,				SM01326:PTEN_C2,	KW-0406~Ion transport,KW-0443~Lipid metabolism,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,		ACT_SITE:Phosphocysteine intermediate,DOMAIN:C2 tensin-type,DOMAIN:Ion transport,DOMAIN:Phosphatase tensin-type,DOMAIN:Tyrosine specific protein phosphatases,MUTAGEN:C->S: Loss of activity.,REGION:Disordered,TRANSMEM:Helical,
Q91041	transmembrane protease serine 9-like(LOC115553834)	Gadus morhua			GO:0006508~proteolysis,GO:0007586~digestion,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR043504:Peptidase_S1_PA_chymotrypsin,				SM00020:Tryp_SPc,	KW-0222~Digestion,	KW-0964~Secreted,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,DOMAIN:Peptidase S1,PROPEP:Activation peptide,SITE:Required for specificity,
Q8K1T0	transmembrane protease, serine 3(Tmprss3)	Mus musculus			GO:0006508~proteolysis,GO:0006883~cellular sodium ion homeostasis,GO:0007605~sensory perception of sound,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043025~neuronal cell body,	GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0016787~hydrolase activity,GO:0017080~sodium channel regulator activity,	IPR001190:SRCR,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR002172:LDrepeatLR_classA_rpt,IPR009003:Peptidase_S1_PA,IPR017448:SRCR-like_dom,IPR018114:TRYPSIN_HIS,IPR023415:LDLR_class-A_CS,IPR033116:TRYPSIN_SER,IPR036055:LDL_receptor-like_sf,IPR036772:SRCR-like_dom_sf,IPR043504:Peptidase_S1_PA_chymotrypsin,				SM00020:Tryp_SPc,SM00192:LDLa,SM00202:SR,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:LDL-receptor class A,DOMAIN:Peptidase S1,DOMAIN:SRCR,SITE:Cleavage,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q5F3I6	transmembrane protein 104(TMEM104)	Gallus gallus				GO:0016020~membrane,		IPR013057:AA_transpt_TM,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Amino acid transporter transmembrane,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q3T0S0	transmembrane protein 128(TMEM128)	Bos taurus				GO:0016020~membrane,		IPR033579:TMEM128,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
Q5U239	transmembrane protein 145 L homeolog(tmem145.L)	Xenopus laevis			GO:0007186~G-protein coupled receptor signaling pathway,GO:0019236~response to pheromone,	GO:0016020~membrane,		IPR019336:GPR180/TMEM145_TM,IPR047831:GPR180/TMEM145,						KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:GPR180/TMEM145 transmembrane,TRANSMEM:Helical,
A5D7C9	transmembrane protein 150C(TMEM150C)	Bos taurus			GO:0019230~proprioception,GO:0071260~cellular response to mechanical stimulus,	GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,	GO:0008381~mechanically-gated ion channel activity,	IPR019402:Frag1/DRAM/Sfk1,						KW-0458~Lysosome,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5ZII6	transmembrane protein 167A(TMEM167A)	Gallus gallus			GO:0009306~protein secretion,GO:0046907~intracellular transport,	GO:0000139~Golgi membrane,		IPR009653:Ksh1,						KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A0JNG0	transmembrane protein 168(TMEM168)	Bos taurus			GO:2000058~regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0030133~transport vesicle,GO:0031965~nuclear membrane,	GO:0017080~sodium channel regulator activity,	IPR029713:TMEM168,						KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
Q96HH4	transmembrane protein 169(TMEM169)	Homo sapiens				GO:0016020~membrane,		IPR029386:TMEM169,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5T4T1	transmembrane protein 170B(TMEM170B)	Homo sapiens			GO:0016055~Wnt signaling pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR019334:Transmembrane_pr_170,					KW-0879~Wnt signaling pathway,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q498W5	transmembrane protein 198b(tmem198b)	Danio rerio			GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,		IPR025256:DUF4203,IPR040236:TMEM198,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:DUF4203,REGION:Disordered,TRANSMEM:Helical,
Q28GF8	transmembrane protein 205(tmem205)	Xenopus tropicalis				GO:0016020~membrane,		IPR025423:DUF4149,IPR042623:TMEM205,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
Q6NYP0	transmembrane protein 208(tmem208)	Danio rerio			GO:0006624~vacuolar protein processing,GO:0006914~autophagy,	GO:0005773~vacuole,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR008506:SND2/TMEM208,	dre03060:Protein export,				KW-0072~Autophagy,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,TRANSMEM:Helical,
Q7SZ56	transmembrane protein 218(tmem218)	Danio rerio			GO:0039021~pronephric glomerulus development,GO:0090660~cerebrospinal fluid circulation,GO:1901207~regulation of heart looping,	GO:0005576~extracellular region,GO:0005929~cilium,GO:0016020~membrane,GO:0042995~cell projection,		IPR026771:Tmem218,						KW-0472~Membrane,KW-0966~Cell projection,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
Q66IE4	transmembrane protein 237b(tmem237b)	Danio rerio			GO:0030030~cell projection organization,GO:0030111~regulation of Wnt signaling pathway,GO:0060027~convergent extension involved in gastrulation,GO:0060271~cilium assembly,	GO:0005929~cilium,GO:0016020~membrane,GO:0035869~ciliary transition zone,GO:0042995~cell projection,		IPR029409:TMEM237,					KW-0970~Cilium biogenesis/degradation,	KW-0472~Membrane,KW-0966~Cell projection,KW-0969~Cilium,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,REGION:Disordered,TRANSMEM:Helical,
A9JSM3	transmembrane protein 238(Tmem238)	Mus musculus				GO:0016020~membrane,		IPR029365:TMEM238,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8CIV2	transmembrane protein 259(Tmem259)	Mus musculus			GO:0034976~response to endoplasmic reticulum stress,GO:1904294~positive regulation of ERAD pathway,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0005515~protein binding,	IPR019144:Membralin,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TRANSMEM:Helical,
Q5F362	transmembrane protein 30A(TMEM30A)	Gallus gallus			GO:0006855~drug transmembrane transport,GO:0010976~positive regulation of neuron projection development,GO:0036010~protein localization to endosome,GO:0045332~phospholipid translocation,GO:0061092~positive regulation of phospholipid translocation,GO:0070863~positive regulation of protein exit from endoplasmic reticulum,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016324~apical plasma membrane,GO:0030658~transport vesicle membrane,GO:0031901~early endosome membrane,GO:0031902~late endosome membrane,GO:1990531~Lem3p-Dnf1p complex,	GO:0005198~structural molecule activity,GO:0015247~aminophospholipid transporter activity,	IPR005045:CDC50/LEM3_fam,	gga04148:Efferocytosis,		PIRSF015840:DUF284_TM_euk,		KW-0445~Lipid transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Exoplasmic loop,TRANSMEM:Helical,
Q8VEK0	transmembrane protein 30A(Tmem30a)	Mus musculus			GO:0006855~drug transmembrane transport,GO:0006869~lipid transport,GO:0010976~positive regulation of neuron projection development,GO:0015917~aminophospholipid transport,GO:0031175~neuron projection development,GO:0033036~macromolecule localization,GO:0036010~protein localization to endosome,GO:0045332~phospholipid translocation,GO:0061092~positive regulation of phospholipid translocation,GO:0070863~positive regulation of protein exit from endoplasmic reticulum,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0030658~transport vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031901~early endosome membrane,GO:0031902~late endosome membrane,GO:1990531~Lem3p-Dnf1p complex,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0015247~aminophospholipid transporter activity,	IPR005045:CDC50/LEM3_fam,	mmu04148:Efferocytosis,		PIRSF015840:DUF284_TM_euk,		KW-0445~Lipid transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Exoplasmic loop,TRANSMEM:Helical,
Q58EL2	transmembrane protein 35(tmem35)	Danio rerio			GO:0051131~chaperone-mediated protein complex assembly,GO:2000010~positive regulation of protein localization to cell surface,	GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,	GO:0030548~acetylcholine receptor regulator activity,	IPR040399:TMEM35A/B,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0576~Peroxisome,KW-0968~Cytoplasmic vesicle,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0143~Chaperone,		REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,
Q6P2T0	transmembrane protein 38A(tmem38a)	Danio rerio			GO:0006811~ion transport,GO:0006813~potassium ion transport,GO:0071805~potassium ion transmembrane transport,	GO:0005634~nucleus,GO:0016020~membrane,GO:0016529~sarcoplasmic reticulum,GO:0031965~nuclear membrane,GO:0033017~sarcoplasmic reticulum membrane,	GO:0005267~potassium channel activity,GO:0042802~identical protein binding,	IPR007866:TRIC_channel,					KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,KW-0539~Nucleus,KW-0703~Sarcoplasmic reticulum,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,		COMPBIAS:Basic and acidic residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical;Name=1,TRANSMEM:Helical;Name=2,TRANSMEM:Helical;Name=3,TRANSMEM:Helical;Name=4,TRANSMEM:Helical;Name=5,TRANSMEM:Helical;Name=6,TRANSMEM:Helical;Name=7,
Q5T3F8	transmembrane protein 63B(TMEM63B)	Homo sapiens			GO:0007605~sensory perception of sound,GO:0098655~cation transmembrane transport,	GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,	GO:0005227~calcium activated cation channel activity,GO:0008381~mechanically-gated ion channel activity,GO:1990760~osmolarity-sensing cation channel activity,	IPR003864:CSC1/OSCA1-like_7TM,IPR027815:CSC1/OSCA1-like_cyt,IPR032880:Csc1/OSCA1-like_N,IPR045122:Csc1-like,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0407~Ion channel,	KW-0597~Phosphoprotein,	DOMAIN:CSC1/OSCA1-like 7TM region,DOMAIN:CSC1/OSCA1-like N-terminal transmembrane,DOMAIN:CSC1/OSCA1-like cytosolic,REGION:Disordered,TRANSMEM:Helical,
Q5HYA8	transmembrane protein 67(TMEM67)	Homo sapiens			GO:0010826~negative regulation of centrosome duplication,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0035567~non-canonical Wnt signaling pathway,GO:0036503~ERAD pathway,GO:0060271~cilium assembly,	GO:0005789~endoplasmic reticulum membrane,GO:0005813~centrosome,GO:0016020~membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0035869~ciliary transition zone,GO:0036038~MKS complex,GO:0060170~ciliary membrane,	GO:0005515~protein binding,GO:0031005~filamin binding,GO:0051082~unfolded protein binding,	IPR009030:Growth_fac_rcpt_cys_sf,IPR019170:Meckelin,		216360~COACH syndrome 1,602152~RHYNS syndrome,607361~Meckel syndrome 3,610688~Joubert syndrome 6,613550~Nephronophthisis 11,615991~Bardet-Biedl syndrome 14, modifier of,			KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,KW-1003~Cell membrane,		KW-0083~Bardet-Biedl syndrome,KW-0209~Deafness,KW-0225~Disease variant,KW-0550~Obesity,KW-0682~Retinitis pigmentosa,KW-0979~Joubert syndrome,KW-0981~Meckel syndrome,KW-0983~Nephronophthisis,KW-0991~Intellectual disability,KW-1186~Ciliopathy,	KW-0175~Coiled coil,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,INTRAMEM:Helical; Name=4A,INTRAMEM:Helical; Name=4B,INTRAMEM:Helical; Name=5A,INTRAMEM:Helical; Name=5B,INTRAMEM:Helical; Name=6A,INTRAMEM:Helical; Name=6B,MUTAGEN:C->Y: Decreased function in non-canonical Wnt signaling activation. When expressed in TMEM67-null cells does not induce ROR2 phosphorylation upon stimulation by WNT5A.,MUTAGEN:G->R: Does not affect function in non-canonical Wnt signaling activation. When expressed in TMEM67-null cells it induces ROR2 phosphorylation upon stimulation by WNT5A.,MUTAGEN:H->R: Decreased function in non-canonical Wnt signaling activation. When expressed in TMEM67-null cells does not induce ROR2 phosphorylation upon stimulation by WNT5A.,MUTAGEN:T->I: Does not affect function in non-canonical Wnt signaling activation. When expressed in TMEM67-null cells it induces ROR2 phosphorylation upon stimulation by WNT5A.,REGION:Cysteine-rich,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Discontinuously helical; Name=4,TRANSMEM:Discontinuously helical; Name=5,TRANSMEM:Discontinuously helical; Name=6,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=7,
O15393	transmembrane serine protease 2(TMPRSS2)	Homo sapiens			GO:0006508~proteolysis,GO:0016540~protein autoprocessing,GO:0019081~viral translation,GO:0046598~positive regulation of viral entry into host cell,	GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001190:SRCR,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR002172:LDrepeatLR_classA_rpt,IPR009003:Peptidase_S1_PA,IPR017448:SRCR-like_dom,IPR018114:TRYPSIN_HIS,IPR023415:LDLR_class-A_CS,IPR033116:TRYPSIN_SER,IPR036055:LDL_receptor-like_sf,IPR036772:SRCR-like_dom_sf,IPR043504:Peptidase_S1_PA_chymotrypsin,	hsa05164:Influenza A,hsa05171:Coronavirus disease - COVID-19,hsa05202:Transcriptional misregulation in cancer,hsa05215:Prostate cancer,			SM00020:Tryp_SPc,SM00192:LDLa,SM00202:SR,	KW-0945~Host-virus interaction,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0068~Autocatalytic cleavage,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between non-catalytic and catalytic chains),DOMAIN:LDL-receptor class A,DOMAIN:Peptidase S1,DOMAIN:SRCR,MUTAGEN:R->Q: Loss of cleavage.,MUTAGEN:S->A: Loss of activity.,REGION:Disordered,SITE:Cleavage,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q8K4K3	tribbles pseudokinase 2(Trib2)	Mus musculus			GO:0006468~protein phosphorylation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032693~negative regulation of interleukin-10 production,GO:0043405~regulation of MAP kinase activity,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045599~negative regulation of fat cell differentiation,GO:0051443~positive regulation of ubiquitin-protein transferase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0004672~protein kinase activity,GO:0004860~protein kinase inhibitor activity,GO:0005524~ATP binding,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0055106~ubiquitin-protein transferase regulator activity,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,	IPR000719:Prot_kinase_dom,IPR011009:Kinase-like_dom_sf,IPR024104:Tribbles/Ser_Thr_kinase_40,				SM00220:S_TKc,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,					KW-0649~Protein kinase inhibitor,		COMPBIAS:Polar residues,DOMAIN:Protein kinase,REGION:Disordered,
O15417	trinucleotide repeat containing 18(TNRC18)	Homo sapiens				GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0003682~chromatin binding,	IPR001025:BAH_dom,IPR043151:BAH_sf,IPR048924:BAHCC1-like_Tudor,				SM00439:BAH,					KW-0175~Coiled coil,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BAH,DOMAIN:BAHCC1-like Tudor,REGION:Disordered,
Q80WC3	trinucleotide repeat containing 18(Tnrc18)	Mus musculus				GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0003682~chromatin binding,	IPR001025:BAH_dom,IPR043151:BAH_sf,IPR048924:BAHCC1-like_Tudor,				SM00439:BAH,					KW-0175~Coiled coil,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BAH,REGION:Disordered,
Q8NDV7	trinucleotide repeat containing adaptor 6A(TNRC6A)	Homo sapiens			GO:0007492~endoderm development,GO:0009267~cellular response to starvation,GO:0035195~gene silencing by miRNA,GO:0035278~miRNA mediated inhibition of translation,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,	GO:0000932~P-body,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016442~RISC complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR012677:Nucleotide-bd_a/b_plait_sf,IPR019486:Argonaute_hook_dom,IPR032226:TNRC6_PABC-bd,IPR034924:TNRC6A_RRM,IPR035979:RBD_domain_sf,		618074~Epilepsy, familial adult myoclonic, 6,			KW-0810~Translation regulation,KW-0943~RNA-mediated gene silencing,	KW-0963~Cytoplasm,		KW-0887~Epilepsy,	KW-0175~Coiled coil,		KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:RRM,DOMAIN:TNRC6 PABC binding,MUTAGEN:W->A: Does not impair interaction with AGO2; when associated with A-313; A-345; A-370 and A-420.,MUTAGEN:W->A: Does not impair interaction with AGO2; when associated with A-313; A-345; A-370 and A-483.,MUTAGEN:W->A: Does not impair interaction with AGO2; when associated with A-313; A-345; A-420 and A-483.,MUTAGEN:W->A: Does not impair interaction with AGO2; when associated with A-313; A-370; A-420 and A-483.,MUTAGEN:W->A: Does not impair interaction with AGO2; when associated with A-345; A-370; A-420 and A-483.,REGION:Disordered,REGION:Interaction with argonaute family proteins,REGION:PABPC1-interacting motif-2 (PAM2),REGION:Sufficient for interaction with AGO1 and AGO4,REGION:Sufficient for interaction with AGO1, AGO3 and AGO4,REGION:Sufficient for interaction with AGO2,
Q90XG0	triosephosphate isomerase 1b(tpi1b)	Danio rerio			GO:0006094~gluconeogenesis,GO:0006096~glycolytic process,GO:0019242~methylglyoxal biosynthetic process,GO:0019563~glycerol catabolic process,GO:0046166~glyceraldehyde-3-phosphate biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004807~triose-phosphate isomerase activity,GO:0008929~methylglyoxal synthase activity,GO:0016829~lyase activity,GO:0016853~isomerase activity,GO:0042803~protein homodimerization activity,	IPR000652:Triosephosphate_isomerase,IPR013785:Aldolase_TIM,IPR020861:Triosephosphate_isomerase_AS,IPR022896:TrioseP_Isoase_bac/euk,IPR035990:TIM_sf,	dre00010:Glycolysis / Gluconeogenesis,dre00051:Fructose and mannose metabolism,dre00562:Inositol phosphate metabolism,dre01100:Metabolic pathways,dre01200:Carbon metabolism,dre01230:Biosynthesis of amino acids,				KW-0312~Gluconeogenesis,KW-0324~Glycolysis,	KW-0963~Cytoplasm,					KW-0413~Isomerase,KW-0456~Lyase,		ACT_SITE:Electrophile,ACT_SITE:Proton acceptor,
Q14258	tripartite motif containing 25(TRIM25)	Homo sapiens		h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,	GO:0002753~cytoplasmic pattern recognition receptor signaling pathway,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0006979~response to oxidative stress,GO:0019076~viral release from host cell,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0032880~regulation of protein localization,GO:0033280~response to vitamin D,GO:0036503~ERAD pathway,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043627~response to estrogen,GO:0044790~negative regulation by host of viral release from host cell,GO:0045087~innate immune response,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046596~regulation of viral entry into host cell,GO:0046597~negative regulation of viral entry into host cell,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070936~protein K48-linked ubiquitination,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016604~nuclear body,	GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0039552~RIG-I binding,GO:0045296~cadherin binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR027370:Znf-RING_euk,IPR042753:TRIM25_SPRY_PRY,IPR043136:B30.2/SPRY_sf,	hsa04064:NF-kappa B signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa05164:Influenza A,			SM00184:RING,SM00449:SPRY,SM00589:PRY,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0833~Ubl conjugation pathway,KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0436~Ligase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15),DOMAIN:B30.2/SPRY,DOMAIN:RING-type,MUTAGEN:C->S: Almost complete loss of ZAP/ZC3HAV1 ubiquitination; when associated with S-50.,MUTAGEN:C->S: Almost complete loss of ZAP/ZC3HAV1 ubiquitination; when associated with S-53.,MUTAGEN:K->A: Almost complete loss of ubiquitination activity.,MUTAGEN:K->R: No ISGylation.,MUTAGEN:K->R: No effect on ISGylation.,MUTAGEN:N->D: Almost complete loss of ubiquitination activity.,MUTAGEN:R->P: Complete loss of viral inhibition independently of the host interferon response.,REGION:Disordered,REGION:Interaction with influenza A virus NS1,ZN_FING:RING-type,
P14373	tripartite motif containing 27(TRIM27)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002820~negative regulation of adaptive immune response,GO:0006469~negative regulation of protein kinase activity,GO:0007283~spermatogenesis,GO:0010507~negative regulation of autophagy,GO:0016925~protein sumoylation,GO:0032480~negative regulation of type I interferon production,GO:0032703~negative regulation of interleukin-2 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032729~positive regulation of interferon-gamma production,GO:0032897~negative regulation of viral transcription,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0042147~retrograde transport, endosome to Golgi,GO:0044790~negative regulation by host of viral release from host cell,GO:0045087~innate immune response,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051127~positive regulation of actin nucleation,GO:0070534~protein K63-linked ubiquitination,GO:0090281~negative regulation of calcium ion import,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0016605~PML body,GO:0030904~retromer complex,GO:0031965~nuclear membrane,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019789~SUMO transferase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR020457:Znf_B-box_chordata,IPR035791:SPRY/PRY_TRIM27,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0967~Endosome,		KW-0656~Proto-oncogene,	KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,KW-0808~Transferase,		DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,DOMAIN:SPRY-associated,MUTAGEN:C->A: Abolished E3 ubiquitin-protein ligase activity; when associated with A-16.,MUTAGEN:C->A: Abolished E3 ubiquitin-protein ligase activity; when associated with A-31.,SITE:Breakpoint for translocation to form the TRIM27/RET oncogene,ZN_FING:B box-type,ZN_FING:RING-type,
Q6E2N3	tripartite motif containing 33(trim33)	Danio rerio			GO:0016567~protein ubiquitination,GO:0030218~erythrocyte differentiation,GO:0030593~neutrophil chemotaxis,GO:0033333~fin development,GO:0034243~regulation of transcription elongation from RNA polymerase II promoter,GO:0035162~embryonic hemopoiesis,GO:0035166~post-embryonic hemopoiesis,GO:0048066~developmental pigmentation,GO:0048246~macrophage chemotaxis,GO:0060215~primitive hemopoiesis,GO:1905517~macrophage migration,GO:1990266~neutrophil migration,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,	IPR000315:Znf_B-box,IPR001487:Bromodomain,IPR001841:Znf_RING,IPR001965:Znf_PHD,IPR003649:Bbox_C,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR019786:Zinc_finger_PHD-type_CS,IPR019787:Znf_PHD-finger,IPR036427:Bromodomain-like_sf,				SM00184:RING,SM00249:PHD,SM00297:BROMO,SM00336:BBOX,SM00502:BBC,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,			KW-0103~Bromodomain,KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:B box-type,DOMAIN:Bromo,DOMAIN:PHD-type,DOMAIN:RING-type,REGION:Disordered,ZN_FING:B box-type 1; atypical,ZN_FING:B box-type 2,ZN_FING:PHD-type,ZN_FING:RING-type,
Q1XHU0	tripartite motif containing 39(TRIM39)	Pan troglodytes			GO:0006915~apoptotic process,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0016567~protein ubiquitination,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034470~ncRNA processing,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050821~protein stabilization,GO:1902806~regulation of cell cycle G1/S phase transition,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:1902555~endoribonuclease complex,GO:1990904~ribonucleoprotein complex,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR007175:Rpr2/Snm1/Rpp21,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR035033:PRY/SPRY_TRIM39,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0053~Apoptosis,KW-0819~tRNA processing,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,REGION:Disordered,REGION:Interaction with CDKN1A,ZN_FING:B box-type,ZN_FING:RING-type,
Q9HCM9	tripartite motif containing 39(TRIM39)	Homo sapiens			GO:0006915~apoptotic process,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0016567~protein ubiquitination,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050821~protein stabilization,GO:1902806~regulation of cell cycle G1/S phase transition,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR035033:PRY/SPRY_TRIM39,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0832~Ubl conjugation,	DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,REGION:Interaction with CDKN1A,ZN_FING:B box-type,ZN_FING:RING-type,
E7FAM5	tripartite motif containing 71, E3 ubiquitin protein ligase(trim71)	Danio rerio			GO:0000082~G1/S transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010172~embryonic body morphogenesis,GO:0021915~neural tube development,GO:0035278~miRNA mediated inhibition of translation,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051865~protein autoubiquitination,GO:0072089~stem cell proliferation,GO:2000177~regulation of neural precursor cell proliferation,	GO:0000932~P-body,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0035198~miRNA binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001258:NHL_repeat,IPR001298:Filamin/ABP280_rpt,IPR001841:Znf_RING,IPR011042:6-blade_b-propeller_TolB-like,IPR013083:Znf_RING/FYVE/PHD,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR017868:Filamin/ABP280_repeat-like,IPR017907:Znf_RING_CS,				SM00184:RING,SM00336:BBOX,SM00557:IG_FLMN,	KW-0833~Ubl conjugation pathway,KW-0943~RNA-mediated gene silencing,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0694~RNA-binding,KW-0808~Transferase,KW-9996~Developmental protein,		DOMAIN:B box-type,DOMAIN:RING-type,REGION:Disordered,REPEAT:Filamin,REPEAT:NHL,REPEAT:NHL 1,REPEAT:NHL 2,REPEAT:NHL 3,REPEAT:NHL 4,REPEAT:NHL 5,REPEAT:NHL 6,ZN_FING:B box-type 1; atypical,ZN_FING:B box-type 2,ZN_FING:RING-type,
Q8BGX0	tripartite motif-containing 23(Trim23)	Mus musculus			GO:0006886~intracellular protein transport,GO:0010508~positive regulation of autophagy,GO:0016192~vesicle-mediated transport,GO:0016567~protein ubiquitination,GO:0031401~positive regulation of protein modification process,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005525~GTP binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0019003~GDP binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR003649:Bbox_C,IPR005225:Small_GTP-bd_dom,IPR006689:Small_GTPase_ARF/SAR,IPR013083:Znf_RING/FYVE/PHD,IPR013087:Znf_C2H2_type,IPR017907:Znf_RING_CS,IPR024156:Small_GTPase_ARF,IPR027370:Znf-RING_euk,IPR027417:P-loop_NTPase,				SM00175:RAB,SM00177:ARF,SM00178:SAR,SM00184:RING,SM00336:BBOX,SM00502:BBC,	KW-0833~Ubl conjugation pathway,	KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0342~GTP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0808~Transferase,		REGION:ARF-like,ZN_FING:B box-type; degenerate,ZN_FING:RING-type; degenerate,
Q62158	tripartite motif-containing 27(Trim27)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002820~negative regulation of adaptive immune response,GO:0006469~negative regulation of protein kinase activity,GO:0010507~negative regulation of autophagy,GO:0032480~negative regulation of type I interferon production,GO:0032703~negative regulation of interleukin-2 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032729~positive regulation of interferon-gamma production,GO:0032897~negative regulation of viral transcription,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0042147~retrograde transport, endosome to Golgi,GO:0044790~negative regulation by host of viral release from host cell,GO:0045087~innate immune response,GO:0045814~negative regulation of gene expression, epigenetic,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051127~positive regulation of actin nucleation,GO:0070534~protein K63-linked ubiquitination,GO:0090281~negative regulation of calcium ion import,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0016605~PML body,GO:0030904~retromer complex,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0019789~SUMO transferase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR020457:Znf_B-box_chordata,IPR035791:SPRY/PRY_TRIM27,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,KW-0808~Transferase,		DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,REGION:Disordered,ZN_FING:B box-type,ZN_FING:RING-type,
Q8C006	tripartite motif-containing 35(Trim35)	Mus musculus			GO:0006915~apoptotic process,GO:0008285~negative regulation of cell proliferation,GO:0016567~protein ubiquitination,GO:0033028~myeloid cell apoptotic process,GO:0033034~positive regulation of myeloid cell apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0044790~negative regulation by host of viral release from host cell,GO:0045087~innate immune response,GO:0045930~negative regulation of mitotic cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR027370:Znf-RING_euk,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0053~Apoptosis,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,REGION:Disordered,ZN_FING:B box-type,ZN_FING:RING-type,
A5WVU9	triple QxxK/R motif containing(triqk)	Danio rerio				GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR024842:TRIQK,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
Q9JLH8	tropomodulin 4(Tmod4)	Mus musculus			GO:0006936~muscle contraction,GO:0007015~actin filament organization,GO:0030239~myofibril assembly,GO:0051694~pointed-end actin filament capping,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005865~striated muscle thin filament,GO:0030016~myofibril,	GO:0003779~actin binding,GO:0005523~tropomyosin binding,	IPR004934:TMOD,IPR032675:LRR_dom_sf,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,					KW-0009~Actin-binding,		COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q8AYG3	ttk protein kinase(ttk)	Danio rerio			GO:0001100~negative regulation of exit from mitosis,GO:0006996~organelle organization,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007060~male meiosis chromosome segregation,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0016310~phosphorylation,GO:0016321~female meiosis chromosome segregation,GO:0018105~peptidyl-serine phosphorylation,GO:0031101~fin regeneration,GO:0033316~meiotic spindle assembly checkpoint,GO:0034501~protein localization to kinetochore,GO:0042246~tissue regeneration,GO:0051301~cell division,GO:0060249~anatomical structure homeostasis,	GO:0000776~kinetochore,GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011990:TPR-like_helical_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR027084:Mps1_cat,	dre04110:Cell cycle,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,					KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,		ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Protein kinase,MUTAGEN:I->K: In zp1; temperature-sensitive mutation that blocks fin regeneration at the restrictive temperature.,REGION:Disordered,
P30883	tubulin beta 4B class IVb L homeolog(tubb4b.L)	Xenopus laevis			GO:0007017~microtubule-based process,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002453:Beta_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR013838:Beta-tubulin_BS,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	xla04145:Phagosome,xla04540:Gap junction,xla04814:Motor proteins,xla05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREI motif,REGION:Disordered,
P09244	tubulin beta class I(TUBB)	Gallus gallus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,	GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002453:Beta_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR013838:Beta-tubulin_BS,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	gga04145:Phagosome,gga04540:Gap junction,gga04814:Motor proteins,gga05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,MOTIF:MREI motif,REGION:Disordered,
Q6DIM3	tubulin delta 1(tubd1)	Xenopus tropicalis			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0007017~microtubule-based process,GO:0030030~cell projection organization,GO:0045880~positive regulation of smoothened signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,	IPR000217:Tubulin,IPR002967:Delta_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR017975:Tubulin_CS,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,	xtr04814:Motor proteins,			SM00864:Tubulin,	KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			DOMAIN:Tubulin/FtsZ GTPase,
Q5R5J7	tubulin folding cofactor C(TBCC)	Pongo abelii			GO:0007021~tubulin complex assembly,GO:0007023~post-chaperonin tubulin folding pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032391~photoreceptor connecting cilium,	GO:0003924~GTPase activity,GO:0015631~tubulin binding,	IPR006599:CARP_motif,IPR012945:Tubulin-bd_cofactor_C_dom,IPR016098:CAP/MinC_C,IPR017901:C-CAP_CF_C-like,IPR027684:TBCC,IPR031925:TBCC_N,IPR038397:TBCC_N_sf,				SM00673:CARP,		KW-0963~Cytoplasm,					KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:C-CAP/cofactor C-like,REGION:Disordered,
Q5PQJ7	tubulin folding cofactor E-like(Tbcel)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0006457~protein folding,GO:0007021~tubulin complex assembly,GO:0007023~post-chaperonin tubulin folding pathway,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0043014~alpha-tubulin binding,	IPR000626:Ubiquitin-like_dom,IPR029071:Ubiquitin-like_domsf,IPR032675:LRR_dom_sf,IPR044994:TBCE,IPR047991:TBCEL_Ubl,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0433~Leucine-rich repeat,KW-0677~Repeat,			KW-0597~Phosphoprotein,	DOMAIN:LRRCT,DOMAIN:Ubiquitin-like,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,
O94811	tubulin polymerization promoting protein(TPPP)	Homo sapiens			GO:0001578~microtubule bundle formation,GO:0014003~oligodendrocyte development,GO:0030953~astral microtubule organization,GO:0031334~positive regulation of protein complex assembly,GO:0031643~positive regulation of myelination,GO:0032273~positive regulation of protein polymerization,GO:0032288~myelin assembly,GO:0046785~microtubule polymerization,GO:0048709~oligodendrocyte differentiation,GO:0051301~cell division,GO:0051418~microtubule nucleation by microtubule organizing center,GO:0070507~regulation of microtubule cytoskeleton organization,GO:1904428~negative regulation of tubulin deacetylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005874~microtubule,GO:0048471~perinuclear region of cytoplasm,GO:0072686~mitotic spindle,GO:0097427~microtubule bundle,	GO:0000287~magnesium ion binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0015631~tubulin binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,	IPR008907:TPP/p25,IPR011992:EF-hand-dom_pair,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:O-linked (GlcNAc) serine,COMPBIAS:Basic and acidic residues,MUTAGEN:S->A: In 3Ala; abolished phosphorylation by ROCK1, leading to delayed entry into S-phase; when associated with A-107 and A-159.,MUTAGEN:S->A: In 3Ala; abolished phosphorylation by ROCK1, leading to delayed entry into S-phase; when associated with A-32 and A-107.,MUTAGEN:S->A: In 3Ala; abolished phosphorylation by ROCK1, leading to delayed entry into S-phase; when associated with A-32 and A-159.,MUTAGEN:S->A: In 4Ala; abolished phosphorylation by CDK1 without affecting G1/S-phase transition; when associated with A-14, A-18 and A-160.,MUTAGEN:S->A: In 4Ala; abolished phosphorylation by CDK1 without affecting G1/S-phase transition; when associated with A-14, A-18 and A-45.,MUTAGEN:S->A: In 4Ala; abolished phosphorylation by CDK1 without affecting G1/S-phase transition; when associated with A-14, A-45 and A-160.,MUTAGEN:S->E: In 3Glu; phosphomimetic mutant, leading to decreased transition of the G1/S-phase; when associated with E-07 and E-159.,MUTAGEN:S->E: In 3Glu; phosphomimetic mutant, leading to decreased transition of the G1/S-phase; when associated with E-32 and E-107.,MUTAGEN:S->E: In 3Glu; phosphomimetic mutant, leading to decreased transition of the G1/S-phase; when associated with E-32 and E-159.,MUTAGEN:S->E: In 4Glu; phosphomimetic mutant, does not affect G1/S-phase transition; when associated with E-14, E-18 and E-160.,MUTAGEN:S->E: In 4Glu; phosphomimetic mutant, does not affect G1/S-phase transition; when associated with E-14, E-18 and E-45.,MUTAGEN:S->E: In 4Glu; phosphomimetic mutant, does not affect G1/S-phase transition; when associated with E-14, E-45 and E-160.,MUTAGEN:T->A: In 4Ala; abolished phosphorylation by CDK1 without affecting G1/S-phase transition; when associated with A-18, A-45 and A-160.,MUTAGEN:T->E: In 4Glu; phosphomimetic mutant, does not affect G1/S-phase transition; when associated with E-18, E-45 and E-160.,REGION:Disordered,REGION:Mediates interaction with LIMK1,
A8CVX7	tubulin tyrosine ligase-like family, member 6(ttll6)	Danio rerio			GO:0000226~microtubule cytoskeleton organization,GO:0003341~cilium movement,GO:0018095~protein polyglutamylation,GO:0030030~cell projection organization,GO:0035082~axoneme assembly,GO:0036211~protein modification process,GO:0060296~regulation of cilium beat frequency involved in ciliary motility,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0036064~ciliary basal body,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0015631~tubulin binding,GO:0016874~ligase activity,GO:0016881~acid-amino acid ligase activity,GO:0046872~metal ion binding,GO:0070739~protein-glutamic acid ligase activity,GO:0070740~tubulin-glutamic acid ligase activity,	IPR004344:TTL/TTLL_fam,					KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,		COMPBIAS:Basic and acidic residues,DOMAIN:TTL,REGION:Disordered,REGION:c-MTBD region,SITE:Essential for specifying alpha-elongation versus initiation step of the polyglutamylase activity,SITE:Important for specifying alpha-elongation versus initiation step of the polyglutamylase activity,
Q6P9V9	tubulin, alpha 1A(Tuba1a)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0001764~neuron migration,GO:0001964~startle response,GO:0006886~intracellular protein transport,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007098~centrosome cycle,GO:0007224~smoothened signaling pathway,GO:0007613~memory,GO:0007626~locomotory behavior,GO:0008344~adult locomotory behavior,GO:0008542~visual learning,GO:0009612~response to mechanical stimulus,GO:0010001~glial cell differentiation,GO:0010467~gene expression,GO:0021542~dentate gyrus development,GO:0021696~cerebellar cortex morphogenesis,GO:0021766~hippocampus development,GO:0021859~pyramidal neuron differentiation,GO:0021987~cerebral cortex development,GO:0022008~neurogenesis,GO:0030182~neuron differentiation,GO:0030534~adult behavior,GO:0034612~response to tumor necrosis factor,GO:0035641~locomotory exploration behavior,GO:0046785~microtubule polymerization,GO:0048853~forebrain morphogenesis,GO:0048873~homeostasis of number of cells within a tissue,GO:0050807~regulation of synapse organization,GO:0050808~synapse organization,GO:0051402~neuron apoptotic process,GO:0061744~motor behavior,GO:0071277~cellular response to calcium ion,GO:0071353~cellular response to interleukin-4,GO:0072384~organelle transport along microtubule,GO:1902065~response to L-glutamate,	GO:0000793~condensed chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005879~axonemal microtubule,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,GO:0031594~neuromuscular junction,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0043209~myelin sheath,GO:0045121~membrane raft,GO:0045202~synapse,GO:0055037~recycling endosome,	GO:0003725~double-stranded RNA binding,GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0019904~protein domain specific binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000217:Tubulin,IPR002452:Alpha_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04210:Apoptosis,rno04530:Tight junction,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0944~Nitration,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREC motif,REGION:Disordered,SITE:Involved in polymerization,
Q6P9V9	tubulin, alpha 1B(Tuba1b)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0071353~cellular response to interleukin-4,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0015630~microtubule cytoskeleton,GO:0045121~membrane raft,	GO:0003725~double-stranded RNA binding,GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002452:Alpha_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04210:Apoptosis,rno04530:Tight junction,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0944~Nitration,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREC motif,REGION:Disordered,SITE:Involved in polymerization,
Q6P9V9	tubulin, alpha 1C(Tuba1c)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0071353~cellular response to interleukin-4,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0015630~microtubule cytoskeleton,GO:0045121~membrane raft,	GO:0003725~double-stranded RNA binding,GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002452:Alpha_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04210:Apoptosis,rno04530:Tight junction,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0944~Nitration,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREC motif,REGION:Disordered,SITE:Involved in polymerization,
P68373	tubulin, alpha 1C(Tuba1c)	Mus musculus		m_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors,	GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0007017~microtubule-based process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0015630~microtubule cytoskeleton,GO:0045121~membrane raft,	GO:0000166~nucleotide binding,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002452:Alpha_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	mmu04145:Phagosome,mmu04210:Apoptosis,mmu04530:Tight junction,mmu04540:Gap junction,mmu04814:Motor proteins,mmu05010:Alzheimer disease,mmu05012:Parkinson disease,mmu05014:Amyotrophic lateral sclerosis,mmu05016:Huntington disease,mmu05020:Prion disease,mmu05022:Pathways of neurodegeneration - multiple diseases,mmu05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0944~Nitration,	DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREC motif,SITE:Involved in polymerization,
Q6P9V9	tubulin, alpha 3A(Tuba3a)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0036098~male germ-line stem cell population maintenance,GO:0071353~cellular response to interleukin-4,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0015630~microtubule cytoskeleton,GO:0045121~membrane raft,	GO:0003725~double-stranded RNA binding,GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002452:Alpha_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04210:Apoptosis,rno04530:Tight junction,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0944~Nitration,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREC motif,REGION:Disordered,SITE:Involved in polymerization,
Q6P9V9	tubulin, alpha 3B(Tuba3b)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0036098~male germ-line stem cell population maintenance,GO:0071353~cellular response to interleukin-4,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0015630~microtubule cytoskeleton,GO:0045121~membrane raft,	GO:0003725~double-stranded RNA binding,GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002452:Alpha_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04210:Apoptosis,rno04530:Tight junction,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0944~Nitration,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREC motif,REGION:Disordered,SITE:Involved in polymerization,
Q6P9V9	tubulin, alpha 4A(Tuba4a)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0071353~cellular response to interleukin-4,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0015630~microtubule cytoskeleton,GO:0045121~membrane raft,	GO:0003725~double-stranded RNA binding,GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002452:Alpha_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04210:Apoptosis,rno04530:Tight junction,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0944~Nitration,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREC motif,REGION:Disordered,SITE:Involved in polymerization,
P85108	tubulin, beta 2A class IIa(Tubb2a)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0001764~neuron migration,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0021987~cerebral cortex development,GO:0050804~modulation of synaptic transmission,GO:1902669~positive regulation of axon guidance,GO:1990403~embryonic brain development,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0045171~intercellular bridge,GO:0072686~mitotic spindle,GO:0098685~Schaffer collateral - CA1 synapse,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000217:Tubulin,IPR002453:Beta_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR013838:Beta-tubulin_BS,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,	KW-0524~Neurogenesis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREI motif,REGION:Disordered,
P85108	tubulin, beta 2B class IIb(Tubb2b)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0001764~neuron migration,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0021987~cerebral cortex development,GO:0050804~modulation of synaptic transmission,GO:1902669~positive regulation of axon guidance,GO:1990403~embryonic brain development,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0045171~intercellular bridge,GO:0072686~mitotic spindle,GO:0098685~Schaffer collateral - CA1 synapse,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000217:Tubulin,IPR002453:Beta_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR013838:Beta-tubulin_BS,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,	KW-0524~Neurogenesis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREI motif,REGION:Disordered,
Q80WM9	tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)(Tnfrsf14)	Mus musculus			GO:0002250~adaptive immune response,GO:0002367~cytokine production involved in immune response,GO:0002376~immune system process,GO:0002720~positive regulation of cytokine production involved in immune response,GO:0031295~T cell costimulation,GO:0035739~CD4-positive, alpha-beta T cell proliferation,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0046642~negative regulation of alpha-beta T cell proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0072678~T cell migration,GO:1905675~negative regulation of adaptive immune memory response,GO:2000406~positive regulation of T cell migration,GO:2000562~negative regulation of CD4-positive, alpha-beta T cell proliferation,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,	GO:0001618~virus receptor activity,GO:0005515~protein binding,GO:0019955~cytokine binding,GO:0031625~ubiquitin protein ligase binding,	IPR001368:TNFR/NGFR_Cys_rich_reg,IPR022332:TNFR_14,IPR034031:TNFRSF14/UL144_N,	mmu03266:Virion - Herpesvirus,mmu04060:Cytokine-cytokine receptor interaction,mmu04061:Viral protein interaction with cytokine and cytokine receptor,mmu05168:Herpes simplex virus 1 infection,			SM00208:TNFR,	KW-0391~Immunity,KW-0399~Innate immunity,KW-0945~Host-virus interaction,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,KW-1183~Host cell receptor for virus entry,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:TNFR-Cys,REPEAT:TNFR-Cys,REPEAT:TNFR-Cys 1,REPEAT:TNFR-Cys 2,REPEAT:TNFR-Cys 3,TRANSMEM:Helical,
Q92143	tumor protein p53(tp53)	Xiphophorus maculatus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051262~protein tetramerization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:1990841~promoter-specific chromatin binding,	IPR002117:p53_tumour_suppressor,IPR008967:p53-like_TF_DNA-bd_sf,IPR010991:p53_tetrameristn,IPR011615:p53_DNA-bd,IPR012346:p53/RUNT-type_TF_DNA-bd_sf,IPR013872:p53_transactivation_domain,IPR036674:p53_tetramer_sf,	xma04010:MAPK signaling pathway,xma04110:Cell cycle,xma04115:p53 signaling pathway,xma04137:Mitophagy - animal,xma04210:Apoptosis,xma04216:Ferroptosis,xma04218:Cellular senescence,xma04310:Wnt signaling pathway,xma05168:Herpes simplex virus 1 infection,				KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,		KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:p53 DNA-binding,DOMAIN:p53 tetramerisation,DOMAIN:p53 transactivation,MOTIF:Bipartite nuclear localization signal,MOTIF:Nuclear export signal,REGION:Basic (repression of DNA-binding),REGION:Disordered,REGION:Interaction with DNA,REGION:Oligomerization,REGION:Transcription activation (acidic),SITE:Interaction with DNA,
Q8BTV1	tumor suppressor candidate 3(Tusc3)	Mus musculus			GO:0006486~protein glycosylation,GO:0015693~magnesium ion transport,GO:0018279~protein N-linked glycosylation via asparagine,GO:0050890~cognition,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0008250~oligosaccharyltransferase complex,GO:0016020~membrane,	GO:0015095~magnesium ion transmembrane transporter activity,	IPR021149:OligosaccharylTrfase_OST3/OST6,IPR036249:Thioredoxin-like_sf,	mmu00510:N-Glycan biosynthesis,mmu00513:Various types of N-glycan biosynthesis,mmu04141:Protein processing in endoplasmic reticulum,				KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0460~Magnesium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Redox-active,DOMAIN:Thioredoxin,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q0V9V9	tweety family member 1(ttyh1)	Xenopus tropicalis			GO:0006811~ion transport,GO:0006821~chloride transport,GO:0034220~ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030868~smooth endoplasmic reticulum membrane,GO:0034707~chloride channel complex,	GO:0005229~intracellular calcium activated chloride channel activity,GO:0005254~chloride channel activity,GO:0072320~volume-sensitive chloride channel activity,	IPR006990:Tweety,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,
Q6UFZ9	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide a(ywhaba)	Oncorhynchus mykiss			GO:0007165~signal transduction,	GO:0005737~cytoplasm,		IPR000308:14-3-3,IPR023409:14-3-3_CS,IPR023410:14-3-3_domain,IPR036815:14-3-3_dom_sf,	omy04110:Cell cycle,omy04114:Oocyte meiosis,		PIRSF000868:14-3-3,	SM00101:14_3_3,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,	DOMAIN:14-3-3,SITE:Interaction with phosphoserine on interacting protein,
Q8BYL4	tyrosyl-tRNA synthetase 2 (mitochondrial)(Yars2)	Mus musculus			GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006437~tyrosyl-tRNA aminoacylation,GO:0043039~tRNA aminoacylation,GO:0070184~mitochondrial tyrosyl-tRNA aminoacylation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016604~nuclear body,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004831~tyrosine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0042803~protein homodimerization activity,GO:0072545~tyrosine binding,	IPR001412:aa-tRNA-synth_I_CS,IPR002305:aa-tRNA-synth_Ic,IPR002307:Tyr-tRNA-ligase,IPR014729:Rossmann-like_a/b/a_fold,IPR024088:Tyr-tRNA-ligase_bac-type,IPR036986:S4_RNA-bd_sf,	mmu00970:Aminoacyl-tRNA biosynthesis,				KW-0648~Protein biosynthesis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,	KW-0007~Acetylation,	MOTIF:'HIGH' region,MOTIF:'KMSKS' region,TRANSIT:Mitochondrion,
Q9Y2X8	ubiquitin conjugating enzyme E2 D4 (putative)(UBE2D4)	Homo sapiens			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,GO:0032446~protein modification by small protein conjugation,GO:0035519~protein K29-linked ubiquitination,GO:0044314~protein K27-linked ubiquitination,GO:0070534~protein K63-linked ubiquitination,GO:0070936~protein K48-linked ubiquitination,GO:0070979~protein K11-linked ubiquitination,GO:0085020~protein K6-linked ubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019787~ubiquitin-like protein transferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:UBQ-conjugat_E2,IPR016135:UBQ-conjugating_enzyme/RWD,IPR023313:UBQ-conjugating_AS,	hsa03083:Polycomb repressive complex,hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,hsa05131:Shigellosis,			SM00212:UBCc,	KW-0833~Ubl conjugation pathway,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0808~Transferase,		ACT_SITE:Glycyl thioester intermediate,DOMAIN:UBC core,REGION:Disordered,
Q29503	ubiquitin conjugating enzyme E2 R2(UBE2R2)	Oryctolagus cuniculus			GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0070936~protein K48-linked ubiquitination,		GO:0004842~ubiquitin-protein transferase activity,GO:0005524~ATP binding,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:UBQ-conjugat_E2,IPR016135:UBQ-conjugating_enzyme/RWD,IPR023313:UBQ-conjugating_AS,	ocu04120:Ubiquitin mediated proteolysis,			SM00212:UBCc,	KW-0833~Ubl conjugation pathway,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Glycyl thioester intermediate,COMPBIAS:Acidic residues,DOMAIN:UBC core,REGION:Disordered,
Q9UTT1	ubiquitin hydrolase Ubp15(ubp15)	Schizosaccharomyces pombe			GO:0006508~proteolysis,GO:0031647~regulation of protein stability,GO:1904332~negative regulation of error-prone translesion synthesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004175~endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0101005~ubiquitinyl hydrolase activity,	IPR001394:Peptidase_C19_UCH,IPR002083:MATH/TRAF_dom,IPR008974:TRAF-like,IPR018200:USP_CS,IPR024729:USP7_ICP0-binding_dom,IPR028889:USP_dom,IPR029346:USP_C,IPR038765:Papain-like_cys_pep_sf,	spo03083:Polycomb repressive complex,			SM00061:MATH,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,					KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,		ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,DOMAIN:MATH,DOMAIN:USP,MUTAGEN:C->S: Decreases cleavage of the sde2 propeptide.,REGION:Disordered,
A2AN08	ubiquitin protein ligase E3 component n-recognin 4(Ubr4)	Mus musculus			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,GO:0045717~negative regulation of fatty acid biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR003126:Znf_UBR,IPR016024:ARM-type_fold,IPR025704:E3_Ub_ligase_UBR4_C,IPR036322:WD40_repeat_dom_sf,IPR045189:UBR4-like,IPR045841:E3_UBR4_N,IPR047509:UBR4-like_UBR-box,	mmu05165:Human papillomavirus infection,mmu05203:Viral carcinogenesis,			SM00396:ZnF_UBR1,	KW-0833~Ubl conjugation pathway,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0112~Calmodulin-binding,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:E3 ubiquitin ligase UBR4 C-terminal,DOMAIN:UBR-type,REGION:Disordered,TRANSMEM:Helical,ZN_FING:UBR-type,
Q08CZ0	ubiquitin protein ligase E3B(ube3b)	Xenopus tropicalis			GO:0000209~protein polyubiquitination,GO:0006486~protein glycosylation,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,	GO:0000139~Golgi membrane,	GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0004842~ubiquitin-protein transferase activity,GO:0016740~transferase activity,GO:0016874~ligase activity,GO:0030246~carbohydrate binding,GO:0061630~ubiquitin protein ligase activity,	IPR000048:IQ_motif_EF-hand-BS,IPR000569:HECT_dom,IPR000772:Ricin_B_lectin,IPR001173:Glyco_trans_2-like,IPR029044:Nucleotide-diphossugar_trans,IPR035983:Hect_E3_ubiquitin_ligase,IPR035992:Ricin_B-like_lectins,IPR044611:E3A/B/C-like,IPR045885:GalNAc-T,	xtr04120:Ubiquitin mediated proteolysis,			SM00015:IQ,SM00119:HECTc,SM00458:RICIN,	KW-0833~Ubl conjugation pathway,	KW-0472~Membrane,			KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0430~Lectin,KW-0464~Manganese,	KW-0808~Transferase,		ACT_SITE:Glycyl thioester intermediate,COMPBIAS:Basic and acidic residues,DOMAIN:HECT,DOMAIN:IQ,DOMAIN:Ricin B lectin,REGION:Disordered,
Q8BX13	ubiquitin protein ligase E3D(Ube3d)	Mus musculus			GO:0000209~protein polyubiquitination,GO:0006513~protein monoubiquitination,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051865~protein autoubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0016740~transferase activity,GO:0030332~cyclin binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0044390~ubiquitin-like protein conjugating enzyme binding,GO:0061630~ubiquitin protein ligase activity,	IPR019193:UBQ-conj_enz_E2-bd_prot,					KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,					KW-0808~Transferase,	KW-0007~Acetylation,KW-0832~Ubl conjugation,	REGION:HECT-like,REGION:Interaction with UBE2C,
A8HAL1	ubiquitin specific peptidase 16(usp16)	Danio rerio			GO:0006325~chromatin organization,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0010468~regulation of gene expression,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045901~positive regulation of translational elongation,GO:0051289~protein homotetramerization,GO:0051301~cell division,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,	GO:0003713~transcription coactivator activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0042393~histone binding,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,	IPR001394:Peptidase_C19_UCH,IPR001607:Znf_UBP,IPR013083:Znf_RING/FYVE/PHD,IPR018200:USP_CS,IPR028889:USP_dom,IPR030849:UBP16,IPR038765:Papain-like_cys_pep_sf,	dre03083:Polycomb repressive complex,			SM00290:ZnF_UBP,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0156~Chromatin regulator,KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,		ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:UBP-type,DOMAIN:USP,REGION:Disordered,ZN_FING:UBP-type,
O57429	ubiquitin specific peptidase 2(USP2)	Gallus gallus			GO:0006508~proteolysis,GO:0016579~protein deubiquitination,GO:0048511~rhythmic process,	GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0046872~metal ion binding,	IPR001394:Peptidase_C19_UCH,IPR018200:USP_CS,IPR028889:USP_dom,IPR038765:Papain-like_cys_pep_sf,					KW-0090~Biological rhythms,KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,		ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:USP,REGION:Disordered,
B1AQJ2	ubiquitin specific peptidase 36(Usp36)	Mus musculus			GO:0006325~chromatin organization,GO:0006508~proteolysis,GO:0007000~nucleolus organization,GO:0016242~negative regulation of macroautophagy,GO:0016579~protein deubiquitination,GO:0031647~regulation of protein stability,GO:0042981~regulation of apoptotic process,GO:0050821~protein stabilization,GO:2000232~regulation of rRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,GO:1990380~Lys48-specific deubiquitinase activity,	IPR001394:Peptidase_C19_UCH,IPR018200:USP_CS,IPR028889:USP_dom,IPR038765:Papain-like_cys_pep_sf,					KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,KW-0694~RNA-binding,KW-0788~Thiol protease,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:USP,REGION:Disordered,
Q70EL4	ubiquitin specific peptidase 43(USP43)	Homo sapiens			GO:0006508~proteolysis,GO:0019985~translesion synthesis,	GO:0005654~nucleoplasm,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0019785~ISG15-specific protease activity,	IPR001394:Peptidase_C19_UCH,IPR018200:USP_CS,IPR028889:USP_dom,IPR038765:Papain-like_cys_pep_sf,					KW-0833~Ubl conjugation pathway,						KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0488~Methylation,KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:USP,REGION:Disordered,
Q4V908	ubiquitin-conjugating enzyme E2S(ube2s)	Danio rerio			GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0010458~exit from mitosis,GO:0010994~free ubiquitin chain polymerization,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0051301~cell division,GO:0070979~protein K11-linked ubiquitination,GO:1904668~positive regulation of ubiquitin protein ligase activity,	GO:0005634~nucleus,GO:0005680~anaphase-promoting complex,	GO:0000166~nucleotide binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:UBQ-conjugat_E2,IPR016135:UBQ-conjugating_enzyme/RWD,IPR023313:UBQ-conjugating_AS,	dre04120:Ubiquitin mediated proteolysis,			SM00212:UBCc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0833~Ubl conjugation pathway,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0808~Transferase,		ACT_SITE:Glycyl thioester intermediate,COMPBIAS:Polar residues,DOMAIN:UBC core,REGION:Disordered,
Q08BH7	ubiquitin-conjugating enzyme E2T (putative)(ube2t)	Danio rerio			GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0051865~protein autoubiquitination,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003682~chromatin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:UBQ-conjugat_E2,IPR016135:UBQ-conjugating_enzyme/RWD,IPR023313:UBQ-conjugating_AS,	dre03460:Fanconi anemia pathway,			SM00212:UBCc,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0808~Transferase,		ACT_SITE:Glycyl thioester intermediate,DOMAIN:UBC core,REGION:Disordered,
Q9Z1N9	unc-13 homolog B(Unc13b)	Mus musculus			GO:0006887~exocytosis,GO:0007268~chemical synaptic transmission,GO:0007528~neuromuscular junction development,GO:0010808~positive regulation of synaptic vesicle priming,GO:0016079~synaptic vesicle exocytosis,GO:0016081~synaptic vesicle docking,GO:0016082~synaptic vesicle priming,GO:0016188~synaptic vesicle maturation,GO:0031914~negative regulation of synaptic plasticity,GO:0035249~synaptic transmission, glutamatergic,GO:0043065~positive regulation of apoptotic process,GO:0045921~positive regulation of exocytosis,GO:0048172~regulation of short-term neuronal synaptic plasticity,GO:0050714~positive regulation of protein secretion,GO:0050804~modulation of synaptic transmission,GO:0060384~innervation,GO:0060478~acrosomal vesicle exocytosis,GO:0061669~spontaneous neurotransmitter secretion,GO:0061789~dense core granule priming,GO:0071333~cellular response to glucose stimulus,GO:0090382~phagosome maturation,GO:0097151~positive regulation of inhibitory postsynaptic potential,GO:0099011~neuronal dense core vesicle exocytosis,GO:0099525~presynaptic dense core vesicle exocytosis,GO:1900426~positive regulation of defense response to bacterium,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030672~synaptic vesicle membrane,GO:0031594~neuromuscular junction,GO:0032009~early phagosome,GO:0042734~presynaptic membrane,GO:0043195~terminal bouton,GO:0044305~calyx of Held,GO:0045202~synapse,GO:0048786~presynaptic active zone,GO:0097060~synaptic membrane,GO:0097470~ribbon synapse,GO:0098686~hippocampal mossy fiber to CA3 synapse,GO:0098793~presynapse,GO:0098831~presynaptic active zone cytoplasmic component,GO:0098978~glutamatergic synapse,	GO:0001566~non-kinase phorbol ester receptor activity,GO:0005509~calcium ion binding,GO:0005516~calmodulin binding,GO:0005543~phospholipid binding,GO:0017075~syntaxin-1 binding,GO:0019905~syntaxin binding,GO:0019992~diacylglycerol binding,GO:0030742~GTP-dependent protein binding,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR002219:PE/DAG-bd,IPR010439:MUN_dom,IPR014770:Munc13_1,IPR014772:Munc13_dom-2,IPR020454:DAG/PE-bd,IPR027080:Unc-13,IPR035892:C2_domain_sf,IPR037302:Unc-13_C2B,IPR046349:C1-like_sf,	mmu04721:Synaptic vesicle cycle,			SM00109:C1,SM00239:C2,SM01145:DUF1041,	KW-0268~Exocytosis,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0770~Synapse,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:C2 3,DOMAIN:MHD1,DOMAIN:MHD2,DOMAIN:Phorbol-ester/DAG-type,REGION:Disordered,ZN_FING:Phorbol-ester/DAG-type,
C5IAW9	unc-5 netrin receptor B S homeolog(unc5b.S)	Xenopus laevis			GO:0007165~signal transduction,GO:0038007~netrin-activated signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005042~netrin receptor activity,	IPR000488:Death_domain,IPR000884:TSP1_rpt,IPR000906:ZU5_dom,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR011029:DEATH-like_dom_sf,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR033772:UPA,IPR036179:Ig-like_dom_sf,IPR036383:TSP1_rpt_sf,IPR037936:UNC5,IPR042156:Death_UNC5B,				SM00005:DEATH,SM00209:TSP1,SM00218:ZU5,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Death,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:ZU5,REGION:UPA domain,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O70405	unc-51 like kinase 1(Ulk1)	Mus musculus			GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0000423~macromitophagy,GO:0001764~neuron migration,GO:0006468~protein phosphorylation,GO:0006914~autophagy,GO:0007165~signal transduction,GO:0007265~Ras protein signal transduction,GO:0007409~axonogenesis,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0010508~positive regulation of autophagy,GO:0016236~macroautophagy,GO:0016241~regulation of macroautophagy,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0021707~cerebellar granule cell differentiation,GO:0021933~radial glia guided migration of cerebellar granule cell,GO:0031102~neuron projection regeneration,GO:0031175~neuron projection development,GO:0031333~negative regulation of protein complex assembly,GO:0031623~receptor internalization,GO:0031669~cellular response to nutrient levels,GO:0034198~cellular response to amino acid starvation,GO:0034727~piecemeal microautophagy of nucleus,GO:0042594~response to starvation,GO:0044805~late nucleophagy,GO:0046777~protein autophosphorylation,GO:0048668~collateral sprouting,GO:0048671~negative regulation of collateral sprouting,GO:0048675~axon extension,GO:0051386~regulation of neurotrophin TRK receptor signaling pathway,GO:0051649~establishment of localization in cell,GO:0061709~reticulophagy,GO:0098780~response to mitochondrial depolarisation,GO:1903059~regulation of protein lipidation,GO:2000786~positive regulation of autophagosome assembly,	GO:0000407~pre-autophagosomal structure,GO:0000421~autophagosome membrane,GO:0005737~cytoplasm,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0030424~axon,GO:0030659~cytoplasmic vesicle membrane,GO:0034045~pre-autophagosomal structure membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:1903349~omegasome membrane,GO:1990316~ATG1/ULK1 kinase complex,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019901~protein kinase binding,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:0051020~GTPase binding,GO:0051879~Hsp90 protein binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR016237:Ser/Thr_kin_STPK_Ulk-1/2,IPR017441:Protein_kinase_ATP_BS,IPR022708:Atg1-like_tMIT,IPR045269:Atg1-like,IPR048941:ATG1-like_MIT2,	mmu04137:Mitophagy - animal,mmu04140:Autophagy - animal,mmu04150:mTOR signaling pathway,mmu04152:AMPK signaling pathway,mmu04211:Longevity regulating pathway,mmu05010:Alzheimer disease,mmu05014:Amyotrophic lateral sclerosis,mmu05016:Huntington disease,mmu05017:Spinocerebellar ataxia,mmu05022:Pathways of neurodegeneration - multiple diseases,		PIRSF000580:Ser/Thr_PK_STPK_ULK-1/2,	SM00220:S_TKc,	KW-0072~Autophagy,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:ATG1-like MIT,DOMAIN:Protein kinase,DOMAIN:Serine/threonine-protein kinase Atg1-like tMIT,MUTAGEN:K->R: In K2R; abolished acetylation by KAT5/TIP60 and decreased kinase activity; when associated with R-162.,MUTAGEN:K->R: In K2R; abolished acetylation by KAT5/TIP60 and decreased kinase activity; when associated with R-606.,MUTAGEN:K->R: Loss of kinase activity and autophosphorylation.,MUTAGEN:S->A,D: Impairs interaction with AMPK and subsequent phosphorylation by AMPK.,MUTAGEN:S->A: Does not affect phosphorylation by AMPK in vitro.,MUTAGEN:S->A: Impairs phosphorylation by AMPK and ability to promote autophagy; when associated with A-317.,MUTAGEN:S->A: Impairs phosphorylation by AMPK and ability to promote autophagy; when associated with A-777.,MUTAGEN:T->A: Does not affect phosphorylation by AMPK in vitro.,REGION:C-terminal domain; mediates interaction with SESN2,REGION:Disordered,REGION:Interaction with GABARAP and GABARAPL2,
Q5VU43	uncharacterized LOC124904395(LOC124904395)	Homo sapiens			GO:0007098~centrosome cycle,GO:0030953~astral microtubule organization,GO:0065003~macromolecular complex assembly,GO:0090063~positive regulation of microtubule nucleation,GO:1903358~regulation of Golgi organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0030016~myofibril,	GO:0019899~enzyme binding,GO:0060090~binding, bridging,	IPR010630:Olduvai_dom,IPR012943:Cnn_1N,IPR040947:SMYLE_N,				SM01148:DUF1220,		KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Centrosomin N-terminal motif 1,DOMAIN:Olduvai,REGION:Disordered,SITE:Breakpoint for insertion to form PDE4DIP-PDGFRB fusion protein,
Q9W720	uncoupling protein 2(ucp2)	Danio rerio			GO:0006839~mitochondrial transport,GO:0009409~response to cold,GO:1990542~mitochondrial transmembrane transport,GO:1990845~adaptive thermogenesis,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0031966~mitochondrial membrane,	GO:0017077~oxidative phosphorylation uncoupler activity,	IPR002030:Mit_uncoupling_UCP-like,IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,					KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Purine nucleotide binding,REPEAT:Solcar,REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
A1L259	ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase(urad)	Danio rerio			GO:0000255~allantoin metabolic process,GO:0006144~purine nucleobase metabolic process,GO:0019628~urate catabolic process,	GO:0005777~peroxisome,	GO:0016829~lyase activity,GO:0016831~carboxy-lyase activity,GO:0051997~2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity,	IPR017580:OHCU_decarboxylase-1,IPR018020:OHCU_decarboxylase,IPR036778:OHCU_decarboxylase_sf,	dre00230:Purine metabolism,dre01100:Metabolic pathways,				KW-0659~Purine metabolism,	KW-0576~Peroxisome,					KW-0210~Decarboxylase,KW-0456~Lyase,		ACT_SITE:Proton donor,MOTIF:Microbody targeting signal,MUTAGEN:E->Q: Loss of activity.,MUTAGEN:H->N: Loss of activity.,MUTAGEN:R->Q: Loss of activity.,
O95045	uridine phosphorylase 2(UPP2)	Homo sapiens			GO:0006218~uridine catabolic process,GO:0006249~dCMP catabolic process,GO:0009116~nucleoside metabolic process,GO:0009164~nucleoside catabolic process,GO:0009166~nucleotide catabolic process,GO:0044206~UMP salvage,GO:0046108~uridine metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0045098~type III intermediate filament,	GO:0003824~catalytic activity,GO:0004850~uridine phosphorylase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0047847~deoxyuridine phosphorylase activity,	IPR000845:Nucleoside_phosphorylase_d,IPR010059:Uridine_phosphorylase_euk,IPR018016:Nucleoside_phosphorylase_CS,IPR035994:Nucleoside_phosphorylase_sf,	hsa00240:Pyrimidine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,								KW-0676~Redox-active center,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-1015~Disulfide bond,	DISULFID:Redox-active,DOMAIN:Nucleoside phosphorylase,
Q9NWZ5	uridine-cytidine kinase 1 like 1(UCKL1)	Homo sapiens			GO:0009224~CMP biosynthetic process,GO:0016310~phosphorylation,GO:0043097~pyrimidine nucleoside salvage,GO:0044206~UMP salvage,GO:0044211~CTP salvage,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004849~uridine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0043771~cytidine kinase activity,	IPR000764:Uridine_kinase-like,IPR000836:PRibTrfase_dom,IPR006083:PRK/URK,IPR027417:P-loop_NTPase,IPR029057:PRTase-like,	hsa00240:Pyrimidine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,				KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Phosphoribulokinase/uridine kinase,REGION:Disordered,
P15062	v-ets avian erythroblastosis virus E26 oncogene homolog 1(ETS1)	Gallus gallus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010595~positive regulation of endothelial cell migration,GO:0030154~cell differentiation,GO:0045765~regulation of angiogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets_dom,IPR003118:Pointed_dom,IPR013761:SAM/pointed_sf,IPR016311:Transform_prot_C-ets,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR041886:SAM_PNT-ETS-1,IPR045688:Ets1_N_flank,IPR046328:ETS_fam,	gga04218:Cellular senescence,		PIRSF001698:Transforming_factor_C-ets,	SM00251:SAM_PNT,SM00413:ETS,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0656~Proto-oncogene,			KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	DNA_BIND:ETS,DOMAIN:ETS,DOMAIN:PNT,REGION:Activation domain; required for transcription activation,REGION:Helix H4,REGION:Helix H5,REGION:Helix HI-1,REGION:Helix HI-2,
Q5THJ4	vacuolar protein sorting 13 homolog D(VPS13D)	Homo sapiens			GO:0006623~protein targeting to vacuole,GO:0006869~lipid transport,GO:0007005~mitochondrion organization,GO:0045053~protein retention in Golgi apparatus,GO:1901526~positive regulation of macromitophagy,	GO:0019898~extrinsic component of membrane,GO:0070062~extracellular exosome,		IPR009060:UBA-like_sf,IPR009543:VPS13_VAB,IPR015940:UBA,IPR026847:VPS13,IPR026854:VPS13-like_N,IPR031642:VPS13_mid_RBG,IPR031645:VPS13_DH-like,IPR031646:VPS13_extend_chorein,IPR041969:VP13D_UBA,IPR049424:VPS13_C,		607317~Spinocerebellar ataxia, autosomal recessive 4,		SM00165:UBA,	KW-0445~Lipid transport,KW-0813~Transport,			KW-0225~Disease variant,KW-0523~Neurodegeneration,				KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Chorein N-terminal,DOMAIN:SHR-BD,DOMAIN:UBA,DOMAIN:Vacuolar protein sorting-associated protein 13 DH-like,REGION:Disordered,
Q6NYY9	vacuole membrane protein 1(vmp1)	Danio rerio			GO:0006869~lipid transport,GO:0006914~autophagy,GO:0007030~Golgi organization,GO:0042953~lipoprotein transport,	GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0017128~phospholipid scramblase activity,		dre04140:Autophagy - animal,				KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0926~Vacuole,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,REGION:VTT domain,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P49696	valyl-tRNA synthetase 1(vars1)	Takifugu rubripes			GO:0006438~valyl-tRNA aminoacylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0002161~aminoacyl-tRNA editing activity,GO:0004832~valine-tRNA ligase activity,GO:0005524~ATP binding,	IPR001412:aa-tRNA-synth_I_CS,IPR002300:aa-tRNA-synth_Ia,IPR002303:Valyl-tRNA_ligase,IPR004046:GST_C,IPR009008:Val/Leu/Ile-tRNA-synth_edit,IPR009080:tRNAsynth_Ia_anticodon-bd,IPR010978:tRNA-bd_arm,IPR010987:Glutathione-S-Trfase_C-like,IPR013155:M/V/L/I-tRNA-synth_anticd-bd,IPR014729:Rossmann-like_a/b/a_fold,IPR019499:Val-tRNA_synth_tRNA-bd,IPR033705:Anticodon_Ia_Val,IPR036282:Glutathione-S-Trfase_C_sf,IPR037118:Val-tRNA_synth_C_sf,	tru00970:Aminoacyl-tRNA biosynthesis,				KW-0648~Protein biosynthesis,				KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,		DOMAIN:Aminoacyl-tRNA synthetase class Ia,DOMAIN:GST C-terminal,DOMAIN:Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase anticodon-binding,MOTIF:'HIGH' region,MOTIF:'KMSKS' region,REGION:Disordered,
Q28260	vascular cell adhesion molecule 1(VCAM1)	Canis lupus familiaris			GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007160~cell-matrix adhesion,GO:0009308~amine metabolic process,GO:0022614~membrane to membrane docking,GO:0034113~heterotypic cell-cell adhesion,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0042102~positive regulation of T cell proliferation,GO:0050901~leukocyte tethering or rolling,GO:0098609~cell-cell adhesion,GO:1904646~cellular response to beta-amyloid,	GO:0002102~podosome,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0030175~filopodium,GO:0045177~apical part of cell,GO:0071065~alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,	GO:0005178~integrin binding,GO:0008131~primary amine oxidase activity,GO:0098631~protein binding involved in cell adhesion,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003987:ICAM_VCAM_N,IPR003989:VCAM-1,IPR007110:Ig-like_dom,IPR008424:Ig_C2-set,IPR013098:Ig_I-set,IPR013151:Immunoglobulin,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR047012:ICAM_VCAM,	cfa04064:NF-kappa B signaling pathway,cfa04514:Cell adhesion molecules,cfa04668:TNF signaling pathway,cfa04670:Leukocyte transendothelial migration,cfa04933:AGE-RAGE signaling pathway in diabetic complications,cfa05143:African trypanosomiasis,cfa05144:Malaria,cfa05417:Lipid and atherosclerosis,cfa05418:Fluid shear stress and atherosclerosis,			SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,DOMAIN:Ig-like C2-type 7,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q28260	vascular cell adhesion molecule 1(VCAM1)	Canis lupus dingo			GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007160~cell-matrix adhesion,GO:0009308~amine metabolic process,GO:0022614~membrane to membrane docking,GO:0034113~heterotypic cell-cell adhesion,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0042102~positive regulation of T cell proliferation,GO:0050901~leukocyte tethering or rolling,GO:0098609~cell-cell adhesion,GO:1904646~cellular response to beta-amyloid,	GO:0002102~podosome,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0030175~filopodium,GO:0045177~apical part of cell,GO:0071065~alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,	GO:0005178~integrin binding,GO:0008131~primary amine oxidase activity,GO:0098631~protein binding involved in cell adhesion,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003987:ICAM_VCAM_N,IPR003989:VCAM-1,IPR007110:Ig-like_dom,IPR008424:Ig_C2-set,IPR013098:Ig_I-set,IPR013151:Immunoglobulin,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR047012:ICAM_VCAM,	clud04064:NF-kappa B signaling pathway,clud04514:Cell adhesion molecules,clud04668:TNF signaling pathway,clud04670:Leukocyte transendothelial migration,clud04933:AGE-RAGE signaling pathway in diabetic complications,clud05143:African trypanosomiasis,clud05144:Malaria,clud05417:Lipid and atherosclerosis,clud05418:Fluid shear stress and atherosclerosis,			SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,DOMAIN:Ig-like C2-type 7,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q14119	vascular endothelial zinc finger 1(VEZF1)	Homo sapiens			GO:0001525~angiogenesis,GO:0001885~endothelial cell development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006968~cellular defense response,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,		620247~Cardiomyopathy, dilated, 1OO,		SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,	KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,	KW-0007~Acetylation,	COMPBIAS:Polar residues,DOMAIN:C2H2-type,REGION:4 X 7 AA repeats of P-[LV]-T-[IL]-T-[ST]-P,REGION:Disordered,REPEAT:1,REPEAT:2,REPEAT:3,REPEAT:4,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,
P41588	vasoactive intestinal peptide receptor 2(Vipr2)	Mus musculus		m_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,	GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0048662~negative regulation of smooth muscle cell proliferation,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004999~vasoactive intestinal polypeptide receptor activity,GO:0008528~G-protein coupled peptide receptor activity,GO:0017046~peptide hormone binding,	IPR000832:GPCR_2_secretin-like,IPR001571:GPCR_2_VIP_rcpt,IPR001879:GPCR_2_extracellular_dom,IPR002284:GPCR_2_VIP_rcpt_2,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR036445:GPCR_2_extracell_dom_sf,IPR047035:VIP-R2_7TM,	mmu04024:cAMP signaling pathway,mmu04080:Neuroactive ligand-receptor interaction,			SM00008:HormR,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 2 profile 1,DOMAIN:G-protein coupled receptors family 2 profile 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P63025	vesicle-associated membrane protein 3(Vamp3)	Rattus norvegicus			GO:0001921~positive regulation of receptor recycling,GO:0006906~vesicle fusion,GO:0016192~vesicle-mediated transport,GO:0017156~calcium ion regulated exocytosis,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035493~SNARE complex assembly,GO:0042147~retrograde transport, endosome to Golgi,GO:0043001~Golgi to plasma membrane protein transport,GO:0051649~establishment of localization in cell,GO:0065003~macromolecular complex assembly,GO:0071346~cellular response to interferon-gamma,GO:1903531~negative regulation of secretion by cell,	GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0030136~clathrin-coated vesicle,GO:0030141~secretory granule,GO:0030665~clathrin-coated vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0031201~SNARE complex,GO:0031410~cytoplasmic vesicle,GO:0031901~early endosome membrane,GO:0043005~neuron projection,GO:0043231~intracellular membrane-bounded organelle,GO:0045202~synapse,GO:0045335~phagocytic vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0097708~intracellular vesicle,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0005515~protein binding,GO:0017075~syntaxin-1 binding,	IPR001388:Synaptobrevin-like,IPR016444:Synaptobrevin/VAMP,IPR042855:V_SNARE_CC,	rno04130:SNARE interactions in vesicular transport,rno04145:Phagosome,		PIRSF005409:Synaptobrevin_euk,		KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0771~Synaptosome,KW-0967~Endosome,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:V-SNARE coiled-coil homology,DOMAIN:v-SNARE coiled-coil homology,REGION:Disordered,SITE:(Microbial infection) Cleavage; by C.botulinum neurotoxin type D (BoNT/D, botD),SITE:(Microbial infection) Cleavage; by C.botulinum neurotoxin type F (BoNT/F, botF),SITE:(Microbial infection) Cleavage; by C.tetani toxin (tetX),TOPO_DOM:Cytoplasmic,TOPO_DOM:Vesicular,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
Q5XI52	vezatin, adherens junctions transmembrane protein(Vezt)	Rattus norvegicus			GO:0043009~chordate embryonic development,GO:0098609~cell-cell adhesion,	GO:0001669~acrosomal vesicle,GO:0002142~stereocilia ankle link complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0060171~stereocilium membrane,	GO:0017022~myosin binding,	IPR026858:Vezatin,IPR026859:Myosin-bd,						KW-0472~Membrane,KW-0539~Nucleus,KW-0965~Cell junction,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Myosin-binding,REGION:Disordered,TRANSMEM:Helical,
Q92155	vimentin(vim)	Cyprinus carpio			GO:0045109~intermediate filament organization,	GO:0005737~cytoplasm,GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0016363~nuclear matrix,GO:0030424~axon,	GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,	IPR002957:Keratin_I,IPR006821:Intermed_filament_DNA-bd,IPR018039:IF_conserved,IPR039008:IF_rod_dom,				SM01391:Filament,		KW-0206~Cytoskeleton,KW-0403~Intermediate filament,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,				DOMAIN:IF rod,REGION:Coil 1A,REGION:Coil 1B,REGION:Coil 2,REGION:Disordered,REGION:Head,REGION:Linker 1,REGION:Linker 12,REGION:Tail,SITE:Stutter,
P48674	vimentin(vim)	Oncorhynchus mykiss			GO:0045109~intermediate filament organization,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0016363~nuclear matrix,GO:0030424~axon,	GO:0005200~structural constituent of cytoskeleton,	IPR006821:Intermed_filament_DNA-bd,IPR018039:IF_conserved,IPR039008:IF_rod_dom,				SM01391:Filament,		KW-0206~Cytoskeleton,KW-0403~Intermediate filament,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,				COMPBIAS:Polar residues,DOMAIN:IF rod,REGION:Coil 1A,REGION:Coil 1B,REGION:Coil 2,REGION:Disordered,REGION:Head,REGION:Linker 1,REGION:Linker 12,REGION:Tail,SITE:Stutter,
Q7Z5L0	vitelline membrane outer layer 1 homolog(VMO1)	Homo sapiens				GO:0005615~extracellular space,GO:0070062~extracellular exosome,		IPR005515:VOMI,IPR036706:VOMI_sf,						KW-0964~Secreted,			KW-0732~Signal,			KW-1015~Disulfide bond,
E7FF10	von Willebrand factor A domain containing 1(vwa1)	Danio rerio			GO:0007409~axonogenesis,GO:0014032~neural crest cell development,GO:0051124~synaptic growth at neuromuscular junction,GO:0061035~regulation of cartilage development,	GO:0005576~extracellular region,GO:0005604~basement membrane,		IPR002035:VWF_A,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036465:vWFA_dom_sf,				SM00060:FN3,SM00327:VWA,		KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,			KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:VWFA,
Q9Y334	von Willebrand factor A domain containing 7(VWA7)	Homo sapiens				GO:0005576~extracellular region,		IPR036465:vWFA_dom_sf,						KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:VWFA,REGION:Disordered,
A8DZH4	xenotropic and polytropic retrovirus receptor 1b(xpr1b)	Danio rerio			GO:0001501~skeletal system development,GO:0006817~phosphate ion transport,GO:0014004~microglia differentiation,GO:0016036~cellular response to phosphate starvation,GO:0030225~macrophage differentiation,GO:0030643~cellular phosphate ion homeostasis,GO:0035435~phosphate ion transmembrane transport,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,	GO:0000822~inositol hexakisphosphate binding,GO:0015114~phosphate ion transmembrane transporter activity,GO:0015562~efflux transmembrane transporter activity,	IPR004331:SPX_dom,IPR004342:EXS_C,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:EXS,DOMAIN:SPX,REGION:Disordered,REGION:Important for inositol polyphosphate binding,SITE:Important for inositol polyphosphate binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5PZ43	xin actin binding repeat containing 1(xirp1)	Danio rerio			GO:0007015~actin filament organization,GO:0021782~glial cell development,GO:0030036~actin cytoskeleton organization,GO:0060041~retina development in camera-type eye,	GO:0001725~stress fiber,GO:0005925~focal adhesion,GO:0030054~cell junction,GO:0070161~anchoring junction,	GO:0003779~actin binding,GO:0051015~actin filament binding,	IPR012510:Actin-binding_Xin_repeat,IPR030072:XIRP1/XIRP2,						KW-0965~Cell junction,			KW-0677~Repeat,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:Xin,REPEAT:Xin 1,REPEAT:Xin 10,REPEAT:Xin 11,REPEAT:Xin 12,REPEAT:Xin 13,REPEAT:Xin 14,REPEAT:Xin 15,REPEAT:Xin 16,REPEAT:Xin 17,REPEAT:Xin 18,REPEAT:Xin 19,REPEAT:Xin 2,REPEAT:Xin 20,REPEAT:Xin 21,REPEAT:Xin 22,REPEAT:Xin 23,REPEAT:Xin 24,REPEAT:Xin 25,REPEAT:Xin 26,REPEAT:Xin 3,REPEAT:Xin 4,REPEAT:Xin 5,REPEAT:Xin 6,REPEAT:Xin 7,REPEAT:Xin 8,REPEAT:Xin 9,
Q5RDU7	yippee like 5(YPEL5)	Pongo abelii			GO:0008283~cell proliferation,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030496~midbody,GO:0097431~mitotic spindle pole,	GO:0046872~metal ion binding,	IPR004910:Yippee/Mis18/Cereblon,IPR034751:Yippee,IPR039058:Yippee_fam,						KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	DOMAIN:Yippee,
Q1L990	zgc:112052(zgc:112052)	Danio rerio			GO:0048666~neuron development,GO:0048741~skeletal muscle fiber development,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0031966~mitochondrial membrane,		IPR033369:C19orf12,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
A4QNZ7	zgc:123105(zgc:123105)	Danio rerio				GO:0005737~cytoplasm,	GO:0016491~oxidoreductase activity,	IPR026759:P33MONOX,						KW-0963~Cytoplasm,				KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,
Q7SZP2	zgc:65873(zgc:65873)	Danio rerio						IPR029089:DUF4660,												KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q3SZY7	zinc finger AN1-type containing 6(ZFAND6)	Bos taurus			GO:0006625~protein targeting to peroxisome,GO:0043066~negative regulation of apoptotic process,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0071356~cellular response to tumor necrosis factor,		GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0031593~polyubiquitin binding,	IPR000058:Znf_AN1,IPR002653:Znf_A20,IPR035896:AN1-like_Znf,				SM00154:ZnF_AN1,SM00259:ZnF_A20,					KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Disordered,ZN_FING:A20-type,ZN_FING:AN1-type,
Q8CHP0	zinc finger CCCH type containing 3(Zc3h3)	Mus musculus			GO:0031124~mRNA 3'-end processing,GO:0032927~positive regulation of activin receptor signaling pathway,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,	GO:0003677~DNA binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0070412~R-SMAD binding,	IPR000571:Znf_CCCH,IPR036855:Znf_CCCH_sf,				SM00356:ZnF_C3H1,	KW-0509~mRNA transport,KW-0813~Transport,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:C3H1-type,REGION:Disordered,ZN_FING:C3H1-type,ZN_FING:C3H1-type 1,ZN_FING:C3H1-type 2,ZN_FING:C3H1-type 3,ZN_FING:C3H1-type 4,ZN_FING:C3H1-type 5,
O75152	zinc finger CCCH-type containing 11A(ZC3H11A)	Homo sapiens			GO:0016973~poly(A)+ mRNA export from nucleus,	GO:0000346~transcription export complex,GO:0005654~nucleoplasm,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000571:Znf_CCCH,IPR036855:Znf_CCCH_sf,IPR041686:Znf-CCCH_3,				SM00356:ZnF_C3H1,	KW-0509~mRNA transport,KW-0813~Transport,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:C3H1-type,DOMAIN:Zinc-finger CCCH,REGION:Disordered,ZN_FING:C3H1-type,ZN_FING:C3H1-type 1,ZN_FING:C3H1-type 2,ZN_FING:C3H1-type 3,
Q9UGR2	zinc finger CCCH-type containing 7B(ZC3H7B)	Homo sapiens			GO:0010608~posttranscriptional regulation of gene expression,GO:0035196~production of miRNAs involved in gene silencing by miRNA,	GO:0005634~nucleus,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0035198~miRNA binding,GO:0046872~metal ion binding,	IPR000571:Znf_CCCH,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR036236:Znf_C2H2_sf,IPR036855:Znf_CCCH_sf,IPR039691:ZC3H7A/B,				SM00028:TPR,SM00356:ZnF_C3H1,	KW-0945~Host-virus interaction,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0802~TPR repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,MOTIF:LD motif; interaction with NSP3,MUTAGEN:DSS->AAA: Almost no effect on NSP3 binding.,MUTAGEN:LDD->AAA: Complete loss of NSP3 binding.,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,ZN_FING:C2H2-type,ZN_FING:C3H1-type 1,ZN_FING:C3H1-type 2,ZN_FING:C3H1-type 3,ZN_FING:C3H1-type 4,
B8A4F0	zinc finger DHHC-type palmitoyltransferase 16a(zdhhc16a)	Danio rerio			GO:0001654~eye development,GO:0006974~cellular response to DNA damage stimulus,GO:0007507~heart development,GO:0018345~protein palmitoylation,GO:0021537~telencephalon development,GO:0021898~commitment of multipotent stem cells to neuronal lineage in forebrain,GO:0021899~fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0016409~palmitoyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0019706~protein-cysteine S-palmitoyltransferase activity,	IPR001594:Palmitoyltrfase_DHHC,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0012~Acyltransferase,KW-0808~Transferase,		ACT_SITE:S-palmitoyl cysteine intermediate,DOMAIN:DHHC,DOMAIN:Palmitoyltransferase DHHC,TRANSMEM:Helical,
B1H1H3	zinc finger DHHC-type palmitoyltransferase 21(zdhhc21)	Danio rerio			GO:0006612~protein targeting to membrane,GO:0018230~peptidyl-L-cysteine S-palmitoylation,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0016409~palmitoyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0019706~protein-cysteine S-palmitoyltransferase activity,	IPR001594:Palmitoyltrfase_DHHC,						KW-0333~Golgi apparatus,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0012~Acyltransferase,KW-0808~Transferase,	KW-0449~Lipoprotein,KW-0564~Palmitate,	ACT_SITE:S-palmitoyl cysteine intermediate,DOMAIN:DHHC,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
F1QX91	zinc finger DHHC-type palmitoyltransferase 23b(zdhhc23b)	Danio rerio			GO:0006612~protein targeting to membrane,GO:0018230~peptidyl-L-cysteine S-palmitoylation,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0016409~palmitoyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0019706~protein-cysteine S-palmitoyltransferase activity,	IPR001594:Palmitoyltrfase_DHHC,						KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0012~Acyltransferase,KW-0808~Transferase,	KW-0449~Lipoprotein,KW-0564~Palmitate,	ACT_SITE:S-palmitoyl cysteine intermediate,DOMAIN:DHHC,DOMAIN:Palmitoyltransferase DHHC,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
O60315	zinc finger E-box binding homeobox 2(ZEB2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001935~endothelial cell proliferation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0010764~negative regulation of fibroblast migration,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0036446~myofibroblast differentiation,GO:0043149~stress fiber assembly,GO:0043542~endothelial cell migration,GO:0045636~positive regulation of melanocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048023~positive regulation of melanin biosynthetic process,GO:0048066~developmental pigmentation,GO:0048143~astrocyte activation,GO:0048856~anatomical structure development,GO:0070269~pyroptosis,GO:0072537~fibroblast activation,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0090649~response to oxygen-glucose deprivation,GO:0097324~melanocyte migration,GO:1903056~regulation of melanosome organization,GO:1904330~positive regulation of myofibroblast contraction,GO:1904520~regulation of myofibroblast cell apoptotic process,GO:1905603~regulation of maintenance of permeability of blood-brain barrier,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0019208~phosphatase regulator activity,GO:0046872~metal ion binding,	IPR001356:Homeobox_dom,IPR008598:Di19_Zn-bd,IPR009057:Homeobox-like_sf,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,	hsa05206:MicroRNAs in cancer,	235730~Mowat-Wilson syndrome,		SM00355:ZnF_C2H2,SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,		KW-0225~Disease variant,KW-0367~Hirschsprung disease,KW-0887~Epilepsy,KW-0991~Intellectual disability,	KW-0371~Homeobox,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DNA_BIND:Homeobox; atypical,DOMAIN:C2H2-type,REGION:Disordered,REGION:SMAD-MH2 binding domain,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4; atypical,ZN_FING:C2H2-type 5; atypical,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8; atypical,
Q5SVZ6	zinc finger MYM-type containing 1(ZMYM1)	Homo sapiens				GO:0005634~nucleus,	GO:0008270~zinc ion binding,GO:0046983~protein dimerization activity,	IPR008906:HATC_C_dom,IPR010507:Znf_MYM,IPR011017:TRASH_dom,IPR012337:RNaseH-like_sf,IPR025398:DUF4371,				SM00746:TRASH,		KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:HAT C-terminal dimerisation,DOMAIN:TRASH,REGION:Disordered,ZN_FING:MYM-type 1,ZN_FING:MYM-type 2,ZN_FING:MYM-type 3,ZN_FING:MYM-type 4,ZN_FING:TTF-type,
Q9P243	zinc finger and AT-hook domain containing(ZFAT)	Homo sapiens			GO:0002244~hematopoietic progenitor cell differentiation,GO:0006355~regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060712~spongiotrophoblast layer development,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,		608175~Autoimmune thyroid disease, susceptibility to, 3,		SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 17,ZN_FING:C2H2-type 18,ZN_FING:C2H2-type 19,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q802Y8	zinc finger and BTB domain containing 16a(zbtb16a)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001817~regulation of cytokine production,GO:0002682~regulation of immune system process,GO:0016567~protein ubiquitination,GO:0032481~positive regulation of type I interferon production,GO:0050767~regulation of neurogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ_dom,IPR011333:SKP1/BTB/POZ_sf,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00225:BTB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,DOMAIN:BTB,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q9ULJ3	zinc finger and BTB domain containing 21(ZBTB21)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0008327~methyl-CpG binding,GO:0031208~POZ domain binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ_dom,IPR011333:SKP1/BTB/POZ_sf,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,IPR041011:Znf_C2H2_6,				SM00225:BTB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:BTB,DOMAIN:C2H2-type,REGION:Disordered,REGION:Mediates homodimerization,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4; atypical,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6; atypical,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,
Q6P882	zinc finger and BTB domain containing 8A, gene 2(zbtb8a.2)	Xenopus tropicalis			GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ_dom,IPR011333:SKP1/BTB/POZ_sf,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00225:BTB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	DOMAIN:BTB,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,
Q8CE64	zinc finger protein (C2H2 type) 276(Zfp276)	Mus musculus			GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043035~chromatin insulator sequence binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR012934:Znf_AD,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,DOMAIN:ZAD,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,
P52739	zinc finger protein 131(ZNF131)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001817~regulation of cytokine production,GO:0002682~regulation of immune system process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005654~nucleoplasm,GO:0045111~intermediate filament cytoskeleton,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ_dom,IPR011333:SKP1/BTB/POZ_sf,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00225:BTB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BTB,DOMAIN:C2H2-type,MOTIF:Nuclear localization signal 1,MOTIF:Nuclear localization signal 2,MUTAGEN:K->R: No effect on sumoylation. Complete loss of CBX4 sumoylation; when associated with R-477 and R-601.,MUTAGEN:K->R: No effect on sumoylation; when associated with R-242 and R-281.,MUTAGEN:K->R: No effect on sumoylation; when associated with R-281 and R-289.,MUTAGEN:K->R: Significant loss of sumoylation. Complete loss of CBX4 sumoylation; when associated with R-477 and R-610.,MUTAGEN:K->R: Small loss of sumoylation. Complete loss of CBX4 sumoylation; when associated with R-601 and R-610.,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4; degenerate,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,
Q9UJW8	zinc finger protein 180(ZNF180)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,	hsa05168:Herpes simplex virus 1 infection,			SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:C2H2-type,DOMAIN:KRAB,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
F1QQA8	zinc finger protein 219(znf219)	Danio rerio			GO:0006355~regulation of transcription, DNA-templated,GO:0030903~notochord development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,		COMPBIAS:Acidic residues,COMPBIAS:Polar residues,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q5R5U3	zinc finger protein 271(ZNF271)	Pongo abelii			GO:0002437~inflammatory response to antigenic stimulus,GO:0045629~negative regulation of T-helper 2 cell differentiation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 17,ZN_FING:C2H2-type 18,ZN_FING:C2H2-type 19,ZN_FING:C2H2-type 1; degenerate,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 20,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q5VUA4	zinc finger protein 318(ZNF318)	Homo sapiens			GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051321~meiotic cell cycle,	GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0042803~protein homodimerization activity,	IPR003604:Matrin/U1-like-C_Znf_C2H2,				SM00451:ZnF_U1,	KW-0469~Meiosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,REGION:Interaction with AR,ZN_FING:Matrin-type 1,ZN_FING:Matrin-type 2,
Q567C6	zinc finger protein 367(znf367)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0033120~positive regulation of RNA splicing,GO:0045948~positive regulation of translational initiation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0015030~Cajal body,GO:0016607~nuclear speck,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0043022~ribosome binding,GO:0046872~metal ion binding,GO:0061770~translation elongation factor binding,	IPR006861:HABP4_PAIRBP1-bd,IPR013087:Znf_C2H2_type,IPR032381:IHABP4_N,IPR036236:Znf_C2H2_sf,IPR039764:HABP4/SERBP1-like,				SM00355:ZnF_C2H2,SM01233:HABP4_PAI-RBP1,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0810~Translation regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,
A1L1R6	zinc finger protein 423(znf423)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0043035~chromatin insulator sequence binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0678~Repressor,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13; atypical,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 17,ZN_FING:C2H2-type 18,ZN_FING:C2H2-type 19,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 20,ZN_FING:C2H2-type 21; degenerate,ZN_FING:C2H2-type 22,ZN_FING:C2H2-type 23,ZN_FING:C2H2-type 24,ZN_FING:C2H2-type 25,ZN_FING:C2H2-type 26,ZN_FING:C2H2-type 27,ZN_FING:C2H2-type 28,ZN_FING:C2H2-type 29,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9; degenerate,
Q8C0P7	zinc finger protein 451(Zfp451)	Mus musculus			GO:0016925~protein sumoylation,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0060633~negative regulation of transcription initiation from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0016605~PML body,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0016740~transferase activity,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0061665~SUMO ligase activity,	IPR013087:Znf_C2H2_type,IPR021623:LAP2alpha_C,IPR041192:PIN_11,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0808~Transferase,	KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:C2H2-type,DOMAIN:Lamina-associated polypeptide 2 alpha C-terminal,MOTIF:PLRP,REGION:Disordered,REGION:Important for interaction with SMAD4,REGION:Important for interaction with SUMO1 and SUMO2,REGION:Important for ubiquitin binding,REGION:Interaction with SUMO2 1,REGION:Interaction with SUMO2 2,REGION:Sufficient for E3 SUMO-protein ligase activity,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4; atypical,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8; atypical,ZN_FING:C2H2-type 9,
Q5JVG2	zinc finger protein 484(ZNF484)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0046872~metal ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,	hsa05168:Herpes simplex virus 1 infection,			SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:KRAB,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 17,ZN_FING:C2H2-type 18,ZN_FING:C2H2-type 19,ZN_FING:C2H2-type 1; degenerate,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3; degenerate,ZN_FING:C2H2-type 4; degenerate,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q6UFS5	zinc finger protein 503(znf503)	Danio rerio			GO:0030902~hindbrain development,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048596~embryonic camera-type eye morphogenesis,	GO:0005634~nucleus,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR022129:Tscrpt_rep_NocA-like,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0678~Repressor,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type,
Q499R0	zinc finger protein 518A(Zfp518a)	Rattus norvegicus			GO:0006325~chromatin organization,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0156~Chromatin regulator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,
B0BLT0	zinc finger protein 593(znf593)	Xenopus tropicalis			GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,GO:1990275~preribosome binding,	IPR001440:TPR_1,IPR001623:DnaJ_domain,IPR003604:Matrin/U1-like-C_Znf_C2H2,IPR011990:TPR-like_helical_dom_sf,IPR013087:Znf_C2H2_type,IPR019734:TPR_repeat,IPR022755:Znf_C2H2_jaz,IPR036236:Znf_C2H2_sf,IPR036869:J_dom_sf,				SM00028:TPR,SM00271:DnaJ,SM00451:ZnF_U1,	KW-0690~Ribosome biogenesis,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0732~Signal,KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Basic and acidic residues,DOMAIN:J,REGION:Disordered,REPEAT:TPR,TRANSMEM:Helical,ZN_FING:C2H2-type,
Q5R8X1	zinc finger protein 665(ZNF665)	Pongo abelii			GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,	pon05168:Herpes simplex virus 1 infection,			SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		DOMAIN:C2H2-type,DOMAIN:KRAB,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 17,ZN_FING:C2H2-type 18,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
A0A0R4IYX6	zinc finger protein 687a(znf687a)	Danio rerio				GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,IPR041697:Znf-C2H2_11,IPR045914:Zn532-like,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8; degenerate,ZN_FING:C2H2-type 9,
F6NSX9	zinc finger protein 687b(znf687b)	Danio rerio				GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,IPR041697:Znf-C2H2_11,IPR045914:Zn532-like,				SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 1; degenerate,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8; degenerate,ZN_FING:C2H2-type 9,
Q90ZE2	zinc finger protein 703(znf703)	Danio rerio			GO:0007368~determination of left/right symmetry,GO:0007420~brain development,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0030335~positive regulation of cell migration,GO:0030902~hindbrain development,GO:0034111~negative regulation of homotypic cell-cell adhesion,GO:0034333~adherens junction assembly,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048596~embryonic camera-type eye morphogenesis,GO:0060271~cilium assembly,GO:0060828~regulation of canonical Wnt signaling pathway,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR022129:Tscrpt_rep_NocA-like,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0678~Repressor,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2H2-type,MUTAGEN:M->G: Abrogates initiation of translation of isoform 2.,REGION:Disordered,REGION:Required for interaction with Groucho and hdac2 plays an important role in repression of transcription,REGION:Required for self-association and nuclear localization,ZN_FING:C2H2-type,
Q5ZMM5	zinc finger protein 706(ZNF706)	Gallus gallus			GO:0006417~regulation of translation,GO:0045892~negative regulation of transcription, DNA-templated,GO:1902455~negative regulation of stem cell population maintenance,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0046872~metal ion binding,	IPR007513:SERF-like_N,IPR013087:Znf_C2H2_type,IPR026939:ZNF706/At2g23090_sf,IPR045230:MBS1/2-like,					KW-0810~Translation regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,ZN_FING:C2H2-type,
Q7Z570	zinc finger protein 804A(ZNF804A)	Homo sapiens			GO:0010628~positive regulation of gene expression,GO:0010975~regulation of neuron projection development,GO:0010976~positive regulation of neuron projection development,GO:1902952~positive regulation of dendritic spine maintenance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030426~growth cone,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,GO:0098793~presynapse,GO:0098794~postsynapse,GO:1901588~dendritic microtubule,	GO:0046872~metal ion binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Basic and acidic residues,DOMAIN:C2H2-type,REGION:Disordered,TRANSMEM:Helical,ZN_FING:C2H2-type,
Q96IR2	zinc finger protein 845(ZNF845)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0046872~metal ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,	hsa05168:Herpes simplex virus 1 infection,			SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:KRAB,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 17,ZN_FING:C2H2-type 18,ZN_FING:C2H2-type 19,ZN_FING:C2H2-type 1; degenerate,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 20,ZN_FING:C2H2-type 21,ZN_FING:C2H2-type 22,ZN_FING:C2H2-type 23,ZN_FING:C2H2-type 24,ZN_FING:C2H2-type 25,ZN_FING:C2H2-type 26,ZN_FING:C2H2-type 27,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q05481	zinc finger protein 91(ZNF91)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010526~negative regulation of transposition, RNA-mediated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,	hsa05168:Herpes simplex virus 1 infection,			SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,		DOMAIN:C2H2-type,DOMAIN:KRAB,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14; degenerate,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 17,ZN_FING:C2H2-type 18,ZN_FING:C2H2-type 19,ZN_FING:C2H2-type 1; degenerate,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 20,ZN_FING:C2H2-type 21,ZN_FING:C2H2-type 22,ZN_FING:C2H2-type 23,ZN_FING:C2H2-type 24,ZN_FING:C2H2-type 25,ZN_FING:C2H2-type 26,ZN_FING:C2H2-type 27; degenerate,ZN_FING:C2H2-type 28,ZN_FING:C2H2-type 29,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 30,ZN_FING:C2H2-type 31,ZN_FING:C2H2-type 32,ZN_FING:C2H2-type 33,ZN_FING:C2H2-type 34,ZN_FING:C2H2-type 35,ZN_FING:C2H2-type 36,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
E9QAG8	zinc finger protein 932(Zfp932)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045668~negative regulation of osteoblast differentiation,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,				SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,		DOMAIN:C2H2-type,DOMAIN:KRAB,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q497H0	zinc finger, AN1-type domain 3(Zfand3)	Mus musculus					GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000058:Znf_AN1,IPR002653:Znf_A20,IPR035896:AN1-like_Znf,				SM00154:ZnF_AN1,SM00259:ZnF_A20,					KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:A20-type,REGION:Disordered,ZN_FING:A20-type,ZN_FING:AN1-type,
Q6P1E1	zinc finger, MIZ-type containing 1(Zmiz1)	Mus musculus			GO:0001570~vasculogenesis,GO:0001701~in utero embryonic development,GO:0003007~heart morphogenesis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007296~vitellogenesis,GO:0016925~protein sumoylation,GO:0021852~pyramidal neuron migration,GO:0030521~androgen receptor signaling pathway,GO:0045582~positive regulation of T cell differentiation,GO:0045747~positive regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,GO:0048589~developmental growth,GO:0048844~artery morphogenesis,GO:0060395~SMAD protein signal transduction,GO:0090398~cellular senescence,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0061665~SUMO ligase activity,	IPR004181:Znf_MIZ,IPR013083:Znf_RING/FYVE/PHD,IPR040797:Zmiz1_N,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,REGION:Sufficient for transactivation activity; sufficient for interaction with NOTCH1,REGION:Transactivation domain,ZN_FING:SP-RING-type,
A2T771	zinc fingers and homeoboxes 1(ZHX1)	Pan troglodytes			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR001356:Homeobox_dom,IPR009057:Homeobox-like_sf,IPR013087:Znf_C2H2_type,IPR024578:Homez_homeobox_dom,IPR036236:Znf_C2H2_sf,IPR041057:ZHX_Znf_C2H2,				SM00355:ZnF_C2H2,SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0371~Homeobox,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:Homeobox,DNA_BIND:Homeobox 1,DNA_BIND:Homeobox 2,DNA_BIND:Homeobox 3,DNA_BIND:Homeobox 4,DNA_BIND:Homeobox 5,DOMAIN:C2H2-type,DOMAIN:Homeobox,REGION:Disordered,REGION:Required for dimerization,REGION:Required for interaction with NFYA,REGION:Required for nuclear localization,REGION:Required for repressor activity,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,
I6M4H4	zona pellucida glycoprotein 1(ZP1)	Oryctolagus cuniculus			GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,GO:0060468~prevention of polyspermy,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0035805~egg coat,	GO:0032190~acrosin binding,GO:0035804~structural constituent of egg coat,	IPR000519:P_trefoil_dom,IPR001507:ZP_dom,IPR017957:P_trefoil_CS,IPR042235:ZP-C,IPR044913:P_trefoil_dom_sf,IPR048290:ZP_chr,				SM00018:PD,SM00241:ZP,	KW-0278~Fertilization,	KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	DOMAIN:P-type,DOMAIN:ZP,PROPEP:Removed in mature form,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P79762	zona pellucida sperm-binding protein 3(ZP3)	Gallus gallus			GO:0007339~binding of sperm to zona pellucida,GO:0032570~response to progesterone,GO:0033574~response to testosterone,GO:0035803~egg coat formation,GO:2000344~positive regulation of acrosome reaction,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0035805~egg coat,GO:0045177~apical part of cell,	GO:0032190~acrosin binding,GO:0035804~structural constituent of egg coat,GO:0042802~identical protein binding,	IPR001507:ZP_dom,IPR017977:ZP_dom_CS,IPR042235:ZP-C,IPR048290:ZP_chr,				SM00241:ZP,	KW-0278~Fertilization,	KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) threonine,COMPBIAS:Polar residues,DOMAIN:ZP,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-111.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-152.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-251.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-313.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-332.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-334.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-335.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-340.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-58.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-90.,MUTAGEN:C->A: Impaired secretion of processed zona pellucida sperm-binding protein 3; when associated with A-229.,MUTAGEN:C->A: Impaired secretion of processed zona pellucida sperm-binding protein 3; when associated with A-295.,MUTAGEN:E->A: No effect on secretion.,MUTAGEN:N->Q: Loss of N-glycosylation.,MUTAGEN:P->A: No effect on dimerization or secretion.,MUTAGEN:P->D: Abolishes secretion of processed zona pellucida sperm-binding protein 3.,MUTAGEN:R->A: Impaired homodimerization and abolished secretion of processed zona pellucida sperm-binding protein 3.,MUTAGEN:RFRR->AFAA: Abolishes cleavage of C-terminal propeptide.,MUTAGEN:T->A: Loss of O-glycosylation. No effect on secretion. Reduces binding to the sperm head by about 80%.,MUTAGEN:Y->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3.,PROPEP:Removed in mature form,REGION:Disordered,REGION:Extracellular hydrophobic patch,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
C0H9B6	zona pellucida-like domain containing 1a(zpld1a)	Salmo salar				GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009986~cell surface,GO:0016020~membrane,GO:0030659~cytoplasmic vesicle membrane,		IPR001507:ZP_dom,IPR042235:ZP-C,				SM00241:ZP,		KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:ZP,SITE:Cleavage,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
